Citrus Sinensis ID: 001908
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 997 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.945 | 0.933 | 0.446 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.941 | 0.916 | 0.456 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.932 | 0.902 | 0.440 | 0.0 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.863 | 0.878 | 0.344 | 1e-134 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.877 | 0.745 | 0.329 | 1e-124 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.938 | 0.850 | 0.307 | 1e-116 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.836 | 0.699 | 0.331 | 1e-116 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.872 | 0.789 | 0.328 | 1e-114 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.858 | 0.683 | 0.323 | 1e-113 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.907 | 0.902 | 0.314 | 1e-113 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/1016 (44%), Positives = 636/1016 (62%), Gaps = 73/1016 (7%)
Query: 19 LLLHSQSFSAHTNETDRLALLAIKSQL-HDPLGVTNSWNNSINLCQWAGVTCGHRHQRVT 77
+LL + F T+ETDR ALL KSQ+ D V +SWN+S LC W GVTCG +++RVT
Sbjct: 13 MLLETHGF---TDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVT 69
Query: 78 ELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLE------------ 125
L+L +GG +SP +GNLSFL ++L N F G IP+E+G L RLE
Sbjct: 70 HLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGP 129
Query: 126 ------------TLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKL 173
L L +N G +P+ L S +NL+ Y NN+ G++P +G L L
Sbjct: 130 IPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTL-L 188
Query: 174 EHISLARNHLTGMLPASIGNLSIIY-LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG 232
E ++L+ N+L G +P+ + L+ I+ L + N FSG PP+LYN+SSL+ + + N F+G
Sbjct: 189 EQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSG 248
Query: 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKN 292
L D+G+ LPNL F +G NYF+GSIP + SN S +E + + N TG + FG + N
Sbjct: 249 RLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPN 307
Query: 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIY 352
L L L N+LGS + DL+F+T LTNC++L+ L NRLGG LP SIANLS + +
Sbjct: 308 LKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLD 367
Query: 353 MGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPS 412
+G ISG+IP IGNL+NL L ++ N L+G +P +G+L NL+ + L SN L G IP+
Sbjct: 368 LGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPA 427
Query: 413 SLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFL 472
+GN+T++ L LS+N +G +P SLGNC +L+ L + DNKL G +P +I+ I L R L
Sbjct: 428 FIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLR-L 486
Query: 473 DLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP 532
D+ N L GSLP ++G L+NL L + N+ SG++P TL C +E ++GN F G IP
Sbjct: 487 DMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP 546
Query: 533 LSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQ 592
L+ L +KE+DLS N+LSG IPE+ + S LEYLNLS+N+ +G+VP KG+F N T V
Sbjct: 547 -DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVS 605
Query: 593 LTGNGKLCGGSNELHLPSC----PSKRSRKSTVLRLGKVGIPMIVSCLIL--STCFIIVY 646
+ GN LCGG L C PS + S+ L+ +G+ + ++ L+L +++
Sbjct: 606 IVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIW 665
Query: 647 ARRRRSKQESSISVP--MEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENG 704
R+R+ +E++ P +E +SY +L ATN FSSSNM+G GSFG+VYK +L
Sbjct: 666 LRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEK 725
Query: 705 TFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQ 764
VAVK+LN+ ++GA+KSF+AECE L++ RHRNL+K++T CSSIDF+G +F+AL+YE+M
Sbjct: 726 KVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMP 785
Query: 765 NGSLEEWLHQSNGQPEVCD--------LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816
NGSL+ WLH PE + L+L++RLNIAID+AS ++YLH HC PI H DL
Sbjct: 786 NGSLDMWLH-----PEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDL 840
Query: 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFD-TSMETQSSSIGIKGTVGYVPPGNIAKMLN 875
KPSNVLLD D+ AHVSDFGLAR L FD S Q SS G++GT+GY P
Sbjct: 841 KPSNVLLDDDLTAHVSDFGLARLLLK--FDEESFFNQLSSAGVRGTIGYAAP-------- 890
Query: 876 LPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMET 935
EYG+G + S+ GDVYS G++LLEMFT +RPTN +F G TL+ + K ALPE++++
Sbjct: 891 ----EYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDI 946
Query: 936 VDPSLLLAWSDGRRRA-KVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990
VD S+L G R V ECL V +G+ C ESP+ R+ V+ +L + R+
Sbjct: 947 VDESIL---HIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRE 999
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 768 bits (1982), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/1008 (45%), Positives = 639/1008 (63%), Gaps = 69/1008 (6%)
Query: 30 TNETDRLALLAIKSQLHDPLGVT-NSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGG 88
T ETD+ ALL KSQ+ + V SWN+S+ LC W GV CG +H+RVT +DL + G
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95
Query: 89 SLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNL 148
+SP+VGNLSFLR +NLA N FHG IP E+G LFRL+ L ++NN F G IP LS+CS+L
Sbjct: 96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155
Query: 149 LSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS------------- 195
+ N+L +P + G KL +SL RN+LTG PAS+GNL+
Sbjct: 156 STLDLSSNHLEQGVPLEFGSL-SKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIE 214
Query: 196 ------------IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLP 243
+I+ + N+F+G PP +YN+SSL + + N F+G L D G LP
Sbjct: 215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274
Query: 244 NLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNL 303
NLQ+ +G N F+G+IPE+ SN S++ +D+P N+ TGK+ + FGRL+NL L L N+L
Sbjct: 275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL 334
Query: 304 GSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIP 363
G+ + DLDF+ LTNCS+L+ L N+LGG LP IANLST +T++ +G N ISG+IP
Sbjct: 335 GNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIP 394
Query: 364 SGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDL 423
GIGNLV+L L + N LTG +P +G+L L+ + L SN L G IPSSLGN++ +T L
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454
Query: 424 FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
+L +N +G+IP SLG+C L+ LNL NKL G++P +++ + +L L++ N L G L
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPL 513
Query: 484 PLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKE 543
++G LK L+AL +S N+ SG+IP TL C LE +QGNSF G IP +R L ++
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRF 572
Query: 544 LDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGS 603
LDLS NNLSG IPE++ N S L+ LNLS N+FDG VPT+GVF N + + + GN LCGG
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGI 632
Query: 604 NELHLPSCPSKRSRKSTVLRLGKVGIPMIVSCLILSTCFI-------------IVYARRR 650
L L C + R+ + +R K+ I + VS ++ + + + R
Sbjct: 633 PSLQLQPCSVELPRRHSSVR--KI-ITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689
Query: 651 RSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK 710
++ + S S P++ ++ +SY EL + T FSSSN+IG G+FG+V+KG LG VA+K
Sbjct: 690 NNENDRSFS-PVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIK 748
Query: 711 ILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEE 770
+LNL ++GA KSF+AECE L RHRNL+K++T+CSS DF+G DF+ALVYE+M NG+L+
Sbjct: 749 VLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDM 808
Query: 771 WLH----QSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 826
WLH + G P L L RLNIAID+ASA+ YLH +C PI H D+KPSN+LLD D
Sbjct: 809 WLHPDEIEETGNPSRT-LGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKD 867
Query: 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE 886
+ AHVSDFGLA+ L DT Q SS G++GT+GY P EYGMG
Sbjct: 868 LTAHVSDFGLAQLLLKFDRDT-FHIQFSSAGVRGTIGYAAP------------EYGMGGH 914
Query: 887 ASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEK-VMETVDPSLLL-AW 944
S+ GDVYS G++LLE+FT +RPTN +F GLTLH F K AL ++ ++ D ++L A+
Sbjct: 915 PSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAY 974
Query: 945 SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992
+ + + ECL V R+GV+CS ESP+ R+ M + ++KL + R++
Sbjct: 975 A---QHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/1001 (44%), Positives = 617/1001 (61%), Gaps = 71/1001 (7%)
Query: 30 TNETDRLALLAIKSQL--HDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIG 87
+NETD ALL KSQ+ ++ V SWN+S C W GVTCG R +RV L+L +
Sbjct: 27 SNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLT 86
Query: 88 GSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSN 147
G +SP +GNLSFLR +NLA N+F IP+++G LFRL+ L ++ N G+IP++LS+CS
Sbjct: 87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146
Query: 148 LLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS------------ 195
L + N+L +P ++G S KL + L++N+LTG PAS+GNL+
Sbjct: 147 LSTVDLSSNHLGHGVPSELG-SLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQM 205
Query: 196 -------------IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTL 242
+++ + N FSG PP+LYN+SSLE++ L N F+GNL D G L
Sbjct: 206 RGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLL 265
Query: 243 PNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINN 302
PNL+ +G N F+G+IP++ +N S++E D+ NY +G + + FG+L+NLW L + N+
Sbjct: 266 PNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNS 325
Query: 303 LGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTI 362
LG+ ++ L+F+ + NC++L+ L NRLGG LP SIANLSTT+T +++G N ISGTI
Sbjct: 326 LGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTI 385
Query: 363 PSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTD 422
P IGNLV+L L +E N L+G +P G+L NLQ + L SN + G IPS GN+T +
Sbjct: 386 PHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQK 445
Query: 423 LFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGS 482
L L+SN G IP SLG C+ L+ L + N+L G +PQ+IL I +L+ ++DL NN L G
Sbjct: 446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGH 504
Query: 483 LPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIK 542
P EVG L+ LV L S N+ SG++P + GC +E MQGNSF G+IP + L S+K
Sbjct: 505 FPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLK 563
Query: 543 ELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602
+D S NNLSG+IP +L +L L LNLS N F+G VPT GVF N T V + GN +CGG
Sbjct: 564 NVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGG 623
Query: 603 SNELHLPSC---PSKRSRKSTVLRLGKV-GIPM-IVSCLILSTCFIIVYARRRRSKQESS 657
E+ L C S R RK +R V GI + I S L++ + + +R+ K +S
Sbjct: 624 VREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNAS 683
Query: 658 ISVPMEQ-----YFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL 712
P + + VSY EL AT+ FSS+N+IG G+FG+V+KG+LG VAVK+L
Sbjct: 684 DGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVL 743
Query: 713 NLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL 772
NL++ GA KSF+AECE + RHRNL+K+ITVCSS+D +G DF+ALVYE+M GSL+ WL
Sbjct: 744 NLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803
Query: 773 HQSNGQPEVCD----LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828
Q V D L+ ++LNIAID+ASA+EYLH HC P+ H D+KPSN+LLD D+
Sbjct: 804 -QLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLT 862
Query: 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888
AHVSDFGLA+ L+ + S Q SS G++GT+GY P EYGMG + S
Sbjct: 863 AHVSDFGLAQLLYKYDRE-SFLNQFSSAGVRGTIGYAAP------------EYGMGGQPS 909
Query: 889 VTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGR 948
+ GDVYS G++LLEMF+ ++PT+ F G LH + K S+L +
Sbjct: 910 IQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK-------------SILSGCTSSG 956
Query: 949 RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989
++E L V+++G+ CS E P +RM + + +L + R
Sbjct: 957 GSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 481 bits (1238), Expect = e-134, Method: Compositional matrix adjust.
Identities = 339/983 (34%), Positives = 500/983 (50%), Gaps = 122/983 (12%)
Query: 59 INLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEI 118
+++C W+GV C +V ELD+ +++GG +SP + NL+ L ++L+ N F G+IP EI
Sbjct: 51 VDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEI 110
Query: 119 GFLFR-LETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDI--GYSWLKLEH 175
G L L+ L L+ N G IP L + L+ N L G IP + S L++
Sbjct: 111 GSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQY 170
Query: 176 ISLARNHLTGMLPASIGN--LSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGN 233
I L+ N LTG +P + + +L + N+ +GTVP SL N ++L+ + L+ N +G
Sbjct: 171 IDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGE 230
Query: 234 LPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNL 293
LP + +P LQ + N+F S +N +N+E
Sbjct: 231 LPSQVISKMPQLQFLYLSYNHFV-----SHNNNTNLE----------------------- 262
Query: 294 WSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYM 353
F L N S L+ L N LGG + S+ +LS + I++
Sbjct: 263 ------------------PFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHL 304
Query: 354 GVNQISGTIPSGIG------------------------NLVNLNLLGIEFNQLTGNIPRE 389
N+I G+IP I L L + + N LTG IP E
Sbjct: 305 DQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPME 364
Query: 390 IGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449
+G + L + +S N L G+IP S GNL+ + L L NHL G +P SLG C NL L+L
Sbjct: 365 LGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDL 424
Query: 450 SDNKLIGAVPQQILT-ITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP 508
S N L G +P ++++ + L +L+L +NHL+G +PLE+ + ++++ +S N+ SG+IP
Sbjct: 425 SHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIP 484
Query: 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568
L C LE ++ N F ++P SL L +KELD+S N L+G IP + S L++L
Sbjct: 485 PQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHL 544
Query: 569 NLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRLGKVG 628
N S+N G V KG FS T G+ LCG + +C K S +L +
Sbjct: 545 NFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSL 602
Query: 629 IPMIVSC-----LILSTCF---IIVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNE 680
I V C L+ + F + VYA+ +E + +P +SY +L AT
Sbjct: 603 IATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQ--NDPKYPRISYQQLIAATGG 660
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALK---SFVAECEVLRNTRHRN 737
F++S++IG G FG VYKG+L N T VAVK+L+ K AL+ SF EC++L+ TRHRN
Sbjct: 661 FNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLD--PKTALEFSGSFKRECQILKRTRHRN 717
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
LI+IIT CS F ALV M NGSLE L+ G+ +L LIQ +NI D+A
Sbjct: 718 LIRIITTCSK-----PGFNALVLPLMPNGSLERHLYP--GEYSSKNLDLIQLVNICSDVA 770
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP----FDTSMETQS 853
I YLHH+ +VH DLKPSN+LLD +M A V+DFG++R + D S+ S
Sbjct: 771 EGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGS 830
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913
+ + G+VGY+ P EYGMG AS GDVYS GV+LLE+ + RRPT+ +
Sbjct: 831 TDGLLCGSVGYIAP------------EYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVL 878
Query: 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVE----ECLVTVIRIGVACSM 969
G +LHEF K P+ +E + L W + K E E ++ +I +G+ C+
Sbjct: 879 VNEGSSLHEFMKSHYPDS-LEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQ 937
Query: 970 ESPIERMEMRDVLAKLCAARQTL 992
+P R +M DV ++ ++ L
Sbjct: 938 YNPSTRPDMLDVAHEMGRLKEYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 323/979 (32%), Positives = 499/979 (50%), Gaps = 104/979 (10%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+T+LDL + G + GNL L+ + L N G+IP EIG L L L +N +
Sbjct: 218 LTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLT 277
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIG--- 192
GKIP L + L + Y+N L IP + + +L H+ L+ NHL G + IG
Sbjct: 278 GKIPAELGNLVQLQALRIYKNKLTSSIPSSL-FRLTQLTHLGLSENHLVGPISEEIGFLE 336
Query: 193 NLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGD 252
+L ++ LH N F+G P S+ N+ +L + + N +G LP D+G+ L NL+ + D
Sbjct: 337 SLEVLTLH--SNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL-LTNLRNLSAHD 393
Query: 253 NYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD 312
N +G IP S SN + ++++DL N TG++ FGR+ NL + +G N+ +D+
Sbjct: 394 NLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEIPDDI- 451
Query: 313 FVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNL 372
NCS L+ L+ +N L G L I L + + + N ++G IP IGNL +L
Sbjct: 452 -----FNCSNLETLSVADNNLTGTLKPLIGKLQK-LRILQVSYNSLTGPIPREIGNLKDL 505
Query: 373 NLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNH--- 429
N+L + N TG IPRE+ L LQ + + SN L+G IP + ++ L++ L LS+N
Sbjct: 506 NILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSG 565
Query: 430 ----------------LQGN-----IPPSLGNCKNLVSLNLSDNKLIGAVPQQIL-TITT 467
LQGN IP SL + L + ++SDN L G +P ++L ++
Sbjct: 566 QIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKN 625
Query: 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGL---------- 517
+ +L+ NN L G++P E+G L+ + + +S N FSG IP +L C +
Sbjct: 626 MQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNL 685
Query: 518 ------EIFH---------MQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
E+F + NSF G IP S ++ + LDLS NNL+G+IPE L NL
Sbjct: 686 SGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANL 745
Query: 563 SFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNEL------HLPSCPSKRS 616
S L++L L+ N+ G VP GVF N L GN LCG L S SKR+
Sbjct: 746 STLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRT 805
Query: 617 RKSTVLRLGKVGIPMIVSCLILSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSELSE 676
R ++ + +++ +++ TC + S + S + EL +
Sbjct: 806 RVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQ 865
Query: 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTR 734
AT+ F+S+N+IG S +VYKG L E+GT +AVK+LNL + A K F E + L +
Sbjct: 866 ATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLK 924
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
HRNL+KI+ ++ KALV +M+NG+LE+ +H S SL++++++ +
Sbjct: 925 HRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIG----SLLEKIDLCV 976
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+AS I+YLH PIVH DLKP+N+LLD D VAHVSDFG AR L F T +S
Sbjct: 977 HIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL---GFREDGSTTAS 1033
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT--NC 912
+ +GT+GY+ P E+ + + DV+S G++++E+ T++RPT N
Sbjct: 1034 TSAFEGTIGYLAP------------EFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLND 1081
Query: 913 MFQGGLTLHEFCKMAL--PEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970
+TL + + ++ K M V L + D K EE + +++ + C+
Sbjct: 1082 EDSQDMTLRQLVEKSIGNGRKGMVRV---LDMELGDSIVSLKQEEAIEDFLKLCLFCTSS 1138
Query: 971 SPIERMEMRDVLAKLCAAR 989
P +R +M ++L L R
Sbjct: 1139 RPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-116, Method: Compositional matrix adjust.
Identities = 344/1118 (30%), Positives = 510/1118 (45%), Gaps = 182/1118 (16%)
Query: 4 SISITCLATFIFSFSLLLHSQSFSAHTNETDRLALLAIKSQLHDPLGVTNSWNN-SINLC 62
+I I C +FI SL NE R+ LL K+ L+D G SWN N C
Sbjct: 9 AIVILCSFSFILVRSL-----------NEEGRV-LLEFKAFLNDSNGYLASWNQLDSNPC 56
Query: 63 QWAGVTCGHRHQRVTELDLRHQNIGGSLS---------------------PYVGNLSFLR 101
W G+ C H + VT +DL N+ G+LS P +LS R
Sbjct: 57 NWTGIACTHL-RTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCR 115
Query: 102 ---YINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNL 158
++L TN FHG IP ++ + L+ L L N G IP + + S+L V Y NNL
Sbjct: 116 SLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNL 175
Query: 159 VGEIPEDI--------------GYSWL---------KLEHISLARNHLTGMLPASIGNL- 194
G IP + G+S + L+ + LA N L G LP + L
Sbjct: 176 TGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQ 235
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
++ L + +N+ SG +PPS+ N+S LE + L N FTG++P +IG L ++ + N
Sbjct: 236 NLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIG-KLTKMKRLYLYTNQ 294
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLW-------------------- 294
+G IP N + ID N TG + FG + NL
Sbjct: 295 LTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGEL 354
Query: 295 ----SLDLGINNLGSGGANDLDFVTILTNC------------------SKLKVLAFEENR 332
LDL IN L +L F+ L + S VL N
Sbjct: 355 TLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANS 414
Query: 333 LGGVLPHSIANLST-----------------------TMTDIYMGVNQISGTIPSGIGNL 369
L G +P T ++T + +G NQ++G++P + NL
Sbjct: 415 LSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNL 474
Query: 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNH 429
NL L + N L+GNI ++G+L+NL+ + L++N G IP +GNLT + +SSN
Sbjct: 475 QNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQ 534
Query: 430 LQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGN 489
L G+IP LG+C + L+LS NK G + Q++ + L L L +N L G +P G+
Sbjct: 535 LTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYL-EILRLSDNRLTGEIPHSFGD 593
Query: 490 LKNLVALYISGNQFSGEIPVTLTGCTGLEI-FHMQGNSFRGSIPLSLRSLKSIKELDLSC 548
L L+ L + GN S IPV L T L+I ++ N+ G+IP SL +L+ ++ L L+
Sbjct: 594 LTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLND 653
Query: 549 NNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHL 608
N LSG+IP + NL L N+S N+ G VP VF GN LC
Sbjct: 654 NKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQ 713
Query: 609 PSCPSKRSRKSTVLRLGKVGIPMIVSCLILSTCFIIVY------ARRRRS-----KQESS 657
P P S+ + ++ + + ++C+++ + F+I + +RR + ++
Sbjct: 714 PLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTK 773
Query: 658 ISVPMEQYFPM--VSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM 715
V YFP +Y L +AT FS ++G+G+ G+VYK + G +AVK LN
Sbjct: 774 PDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEM-SGGEVIAVKKLNSR 832
Query: 716 QKGALK--SFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH 773
+GA SF AE L RHRN++K+ C + L+YEYM GSL E L
Sbjct: 833 GEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYH-----QNSNLLLYEYMSKGSLGEQLQ 887
Query: 774 QSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833
+ C L R IA+ A + YLHH C+P IVH D+K +N+LLD AHV D
Sbjct: 888 RGEKN---CLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGD 944
Query: 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDV 893
FGLA+ + D S S++ G+ GY+ P EY + + D+
Sbjct: 945 FGLAKLI-----DLSYSKSMSAVA--GSYGYIAP------------EYAYTMKVTEKCDI 985
Query: 894 YSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKV--METVDPSLLLAWSDGRRRA 951
YS GV+LLE+ T + P + QGG L + + ++ + +E D L D +
Sbjct: 986 YSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMIPTIEMFDARL-----DTNDKR 1039
Query: 952 KVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989
V E + V++I + C+ SP R MR+V+A + AR
Sbjct: 1040 TVHE-MSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1078), Expect = e-116, Method: Compositional matrix adjust.
Identities = 314/946 (33%), Positives = 475/946 (50%), Gaps = 112/946 (11%)
Query: 82 RHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTN 141
R+Q + GSL ++G L + LA N F GEIP EI L+ L LA+N SG IP
Sbjct: 314 RNQ-LSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRE 372
Query: 142 LSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHV 201
L +L + N L G I E++ L + L N + G +P + L ++ L +
Sbjct: 373 LCGSGSLEAIDLSGNLLSGTI-EEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALDL 431
Query: 202 GENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE 261
N F+G +P SL+ ++L N G LP +IG +L+ + DN +G IP
Sbjct: 432 DSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIG-NAASLKRLVLSDNQLTGEIPR 490
Query: 262 SFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCS 321
+++ +++L N F GK+ + G +L +LDLG NNL G D +T +
Sbjct: 491 EIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNL-QGQIPD-----KITALA 544
Query: 322 KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQ 381
+L+ L N L G +P + S I M + L + + + +N+
Sbjct: 545 QLQCLVLSYNNLSGSIP---SKPSAYFHQIEM----------PDLSFLQHHGIFDLSYNR 591
Query: 382 LTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNC 441
L+G IP E+G+ L I LS+N L G IP+SL LT +T L LS N L G+IP +GN
Sbjct: 592 LSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNS 651
Query: 442 KNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGN 501
L LNL++N+L G +P+ + +L + L+L N L+G +P +GNLK L + +S N
Sbjct: 652 LKLQGLNLANNQLNGHIPESFGLLGSLVK-LNLTKNKLDGPVPASLGNLKELTHMDLSFN 710
Query: 502 QFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLEN 561
SGE+ L+ L +++ N F G IP L +L ++ LD+S N LSG+IP +
Sbjct: 711 NLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICG 770
Query: 562 LSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCG---GSNELHLPSCPSKRSRK 618
L LE+LNL+ N+ GEVP+ GV + ++ L+GN +LCG GS+ C + ++
Sbjct: 771 LPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSD------CKIEGTKL 824
Query: 619 STVLRLGKVGIPMIVSCLILSTCFIIVYARRR---------------------------- 650
+ G G+ + + ++ F+ V++ RR
Sbjct: 825 RSA--WGIAGLMLGFTIIV----FVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQN 878
Query: 651 -------RSKQESSISVPM-EQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGE 702
RS++ SI++ M EQ V ++ EAT+ FS N+IG G FG+VYK L
Sbjct: 879 LYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPG 938
Query: 703 NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEY 762
T VAVK L+ + + F+AE E L +H NL+ ++ CS ++ K LVYEY
Sbjct: 939 EKT-VAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSF-----SEEKLLVYEY 992
Query: 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822
M NGSL+ WL G EV D S +RL IA+ A + +LHH P I+H D+K SN+L
Sbjct: 993 MVNGSLDHWLRNQTGMLEVLDWS--KRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNIL 1050
Query: 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYG 882
LD D V+DFGLAR + ++ E+ S++ I GT GY+PP EYG
Sbjct: 1051 LDGDFEPKVADFGLARLI------SACESHVSTV-IAGTFGYIPP------------EYG 1091
Query: 883 MGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF---QGGLTLHEFCKMALPEKVMETVDPS 939
+ A+ GDVYS GV+LLE+ T + PT F +GG + + K ++ +DP
Sbjct: 1092 QSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPL 1151
Query: 940 LLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
L+ ++ + +++I + C E+P +R M DVL L
Sbjct: 1152 LV--------SVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKAL 1189
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1060), Expect = e-114, Method: Compositional matrix adjust.
Identities = 309/940 (32%), Positives = 469/940 (49%), Gaps = 70/940 (7%)
Query: 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNS 133
+R+T I GSL +G L + LA N GE+PKEIG L +L ++L N
Sbjct: 193 KRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENE 252
Query: 134 FSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGN 193
FSG IP +S+C++L + Y+N LVG IP+++G LE + L RN L G +P IGN
Sbjct: 253 FSGFIPREISNCTSLETLALYKNQLVGPIPKELG-DLQSLEFLYLYRNGLNGTIPREIGN 311
Query: 194 LSI-IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGD 252
LS I + EN +G +P L N+ LE + L N TG +P+++ TL NL +
Sbjct: 312 LSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELS-TLKNLSKLDLSI 370
Query: 253 NYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD 312
N +G IP F + ++ L N +G + G +LW LD+ N+L
Sbjct: 371 NALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSG------R 424
Query: 313 FVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNL 372
+ L S + +L N L G +P I T+ + + N + G PS + VN+
Sbjct: 425 IPSYLCLHSNMIILNLGTNNLSGNIPTGITT-CKTLVQLRLARNNLVGRFPSNLCKQVNV 483
Query: 373 NLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG 432
+ + N+ G+IPRE+G LQ + L+ N G +P +G L+ + L +SSN L G
Sbjct: 484 TAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTG 543
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKN 492
+P + NCK L L++ N G +P ++ ++ L L L NN+L+G++P+ +GNL
Sbjct: 544 EVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQL-ELLKLSNNNLSGTIPVALGNLSR 602
Query: 493 LVALYISGNQFSGEIPVTLTGCTGLEI-FHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551
L L + GN F+G IP L TGL+I ++ N G IP L +L ++ L L+ NNL
Sbjct: 603 LTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNL 662
Query: 552 SGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHL--- 608
SG+IP NLS L N SYN G +P + N + GN LCG +
Sbjct: 663 SGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQ 719
Query: 609 PSCPSKRSRKSTVLRLGKVG--IPMIVSCLILSTCFIIVYARRR------RSKQESSIS- 659
P PS+ + K +R K+ ++ + L +IVY RR S Q+ S
Sbjct: 720 PFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSE 779
Query: 660 VPMEQYFPM---VSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ 716
+ ++ YFP ++ +L AT+ F S ++G+G+ G+VYK +L G +AVK L
Sbjct: 780 MSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVL-PAGYTLAVKKLASNH 838
Query: 717 KGA-----LKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEW 771
+G SF AE L N RHRN++K+ C + +G++ L+YEYM GSL E
Sbjct: 839 EGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC---NHQGSNL--LLYEYMPKGSLGEI 893
Query: 772 LHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831
LH + C+L +R IA+ A + YLHH C+P I H D+K +N+LLD AHV
Sbjct: 894 LHDPS-----CNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 948
Query: 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891
DFGLA+ + P SM I G+ GY+ P EY + +
Sbjct: 949 GDFGLAKVI-DMPHSKSMS------AIAGSYGYIAP------------EYAYTMKVTEKS 989
Query: 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRA 951
D+YS GV+LLE+ T + P + QGG ++ + + + + + L D R
Sbjct: 990 DIYSYGVVLLELLTGKAPVQPIDQGGDVVN-WVRSYIRRDALSSGVLDARLTLEDER--- 1045
Query: 952 KVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991
+ ++TV++I + C+ SP+ R MR V+ L + ++
Sbjct: 1046 -IVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERS 1084
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 304/940 (32%), Positives = 462/940 (49%), Gaps = 84/940 (8%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+ +L L + G + + N L+ ++L+ N G+IP + L L L L NNS
Sbjct: 339 LKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLE 398
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS 195
G + +++S+ +NL F Y NNL G++P++IG+ KLE + L N +G +P IGN +
Sbjct: 399 GTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLG-KLEIMYLYENRFSGEMPVEIGNCT 457
Query: 196 IIY-LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
+ + N+ SG +P S+ + L + L N GN+P +G + V + DN
Sbjct: 458 RLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLG-NCHQMTVIDLADNQ 516
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314
SGSIP SF + +E+ + N G + LKNL ++ N
Sbjct: 517 LSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNG--------- 567
Query: 315 TILTNCSKLKVLAFE--ENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNL 372
+I C L+F+ EN G +P + ST + + +G NQ +G IP G + L
Sbjct: 568 SISPLCGSSSYLSFDVTENGFEGDIPLELGK-STNLDRLRLGKNQFTGRIPRTFGKISEL 626
Query: 373 NLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG 432
+LL I N L+G IP E+G + L I L++N+L G IP+ LG L L+ +L LSSN G
Sbjct: 627 SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVG 686
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKN 492
++P + + N+++L L N L G++PQ+I + L+ L+L N L+G LP +G L
Sbjct: 687 SLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNA-LNLEENQLSGPLPSTIGKLSK 745
Query: 493 LVALYISGNQFSGEIPVTLTGCTGLE-IFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551
L L +S N +GEIPV + L+ + N+F G IP ++ +L ++ LDLS N L
Sbjct: 746 LFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQL 805
Query: 552 SGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSC 611
G++P + ++ L YLNLSYN+ +G++ K FS GN LCG L C
Sbjct: 806 VGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCGSP----LSHC 859
Query: 612 PSKRSRKSTVLRLGKVGIPMIVSCLILSTCFIIVYA----------RRRRSKQESSISVP 661
S+ L V I +S L ++V ++ R + S
Sbjct: 860 NRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNS 919
Query: 662 MEQYFPMVS---------YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL 712
P+ S + ++ EAT+ + MIG G G VYK L +NG +AVK
Sbjct: 920 SSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAEL-KNGETIAVK-- 976
Query: 713 NLMQKGAL---KSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLE 769
++ K L KSF E + L RHR+L+K++ CSS K L+YEYM NGS+
Sbjct: 977 KILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVW 1033
Query: 770 EWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829
+WLH + + L RL IA+ +A +EYLH+ C PPIVH D+K SNVLLD ++ A
Sbjct: 1034 DWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEA 1093
Query: 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASV 889
H+ DFGLA+ L +DT+ E S+ G+ GY+ P EY +A+
Sbjct: 1094 HLGDFGLAKILTGN-YDTNTE---SNTMFAGSYGYIAP------------EYAYSLKATE 1137
Query: 890 TGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALP--------EKVMETVDPSLL 941
DVYS+G++L+E+ T + PT MF + + + L EK++++ SLL
Sbjct: 1138 KSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLL 1197
Query: 942 LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981
EE V+ I + C+ P ER R
Sbjct: 1198 PC---------EEEAAYQVLEIALQCTKSYPQERPSSRQA 1228
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1053), Expect = e-113, Method: Compositional matrix adjust.
Identities = 318/1010 (31%), Positives = 475/1010 (47%), Gaps = 105/1010 (10%)
Query: 23 SQSFSAHTNETDRLALLAIKSQL----HDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTE 78
S +F+A ++ ALL++K+ L D +SW S + C W GVTC + VT
Sbjct: 14 SHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTS 73
Query: 79 LDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKI 138
LDL N+ G+LSP V +L L+ ++LA N G IP EI L L L L+NN F+G
Sbjct: 74 LDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSF 133
Query: 139 PTNLSS-CSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSII 197
P +SS NL Y NNL G++P + + +L H+ L N+ G +P S G+ +I
Sbjct: 134 PDEISSGLVNLRVLDVYNNNLTGDLPVSV-TNLTQLRHLHLGGNYFAGKIPPSYGSWPVI 192
Query: 198 -YLHVGENQFSGTVPPSLYNMSSLENILLDV-NGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
YL V N+ G +PP + N+++L + + N F LP +IG L L F +
Sbjct: 193 EYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIG-NLSELVRFDGANCGL 251
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVT 315
+G IP ++ + L +N F+G ++ G L +L S+DL NN+ +G +
Sbjct: 252 TGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLS-NNMFTG-----EIPA 305
Query: 316 ILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375
L +L N+L G +P I +L + + + N +G+IP +G LNL+
Sbjct: 306 SFAELKNLTLLNLFRNKLHGEIPEFIGDL-PELEVLQLWENNFTGSIPQKLGENGKLNLV 364
Query: 376 GIEFNQLTG------------------------NIPREIGQLRNLQAIGLSSNFLQGNIP 411
+ N+LTG +IP +G+ +L I + NFL G+IP
Sbjct: 365 DLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIP 424
Query: 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF 471
L L +T + L N+L G +P + G NL ++LS+N+L G +P I T + +
Sbjct: 425 KGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKL 484
Query: 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531
L L N G +P EVG L+ L + S N FSG I ++ C L + N G I
Sbjct: 485 L-LDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEI 543
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRV 591
P + ++K + L+LS N+L G IP + ++ L L+ SYN+ G VP G FS
Sbjct: 544 PNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYT 603
Query: 592 QLTGNGKLCGGSNELHLPSCPS--------KRSRKSTVLRLGKVGIPMIVSCLILSTCFI 643
GN LCG +L C S+ + + + ++ C I
Sbjct: 604 SFLGNPDLCGP----YLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVA 659
Query: 644 IVYARRRRSKQESSISVPMEQYFPMVSYSEL----SEATNEFSSSNMIGQGSFGSVYKGI 699
I+ AR + ES + + + ++ L + + N+IG+G G VYKG+
Sbjct: 660 IIKARSLKKASES-------RAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGV 712
Query: 700 LGENGTFVAVKILNLMQKGALKS--FVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757
+ NG VAVK L M +G+ F AE + L RHR++++++ CS+ +
Sbjct: 713 M-PNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-----HETNL 766
Query: 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817
LVYEYM NGSL E LH G L R IA++ A + YLHH C P IVH D+K
Sbjct: 767 LVYEYMPNGSLGEVLHGKKGG----HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVK 822
Query: 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP 877
+N+LLD + AHV+DFGLA+FL T I G+ GY+ P
Sbjct: 823 SNNILLDSNFEAHVADFGLAKFL------QDSGTSECMSAIAGSYGYIAP---------- 866
Query: 878 CLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEK--VMET 935
EY + DVYS GV+LLE+ T R+P G + KM K V++
Sbjct: 867 --EYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDSVLKV 924
Query: 936 VDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
+DP L + E + V + + C E +ER MR+V+ L
Sbjct: 925 LDPRL--------SSIPIHE-VTHVFYVAMLCVEEQAVERPTMREVVQIL 965
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 997 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.960 | 0.921 | 0.511 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.976 | 0.511 | 0.506 | 0.0 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.947 | 0.921 | 0.495 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.974 | 0.961 | 0.487 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.950 | 0.924 | 0.491 | 0.0 | |
| 224090977 | 1034 | predicted protein [Populus trichocarpa] | 0.962 | 0.928 | 0.477 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.960 | 0.937 | 0.479 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.974 | 0.945 | 0.475 | 0.0 | |
| 224116466 | 1008 | predicted protein [Populus trichocarpa] | 0.963 | 0.953 | 0.482 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.968 | 0.946 | 0.471 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2477), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/1018 (51%), Positives = 668/1018 (65%), Gaps = 60/1018 (5%)
Query: 22 HSQSFSAHTNETDRLALLAIKSQL-HDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELD 80
H +H NETDRLALLAIK+Q+ DPLG+T SWN+S++ C W GVTCGHRHQRV L+
Sbjct: 28 HPVVLPSHRNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLN 87
Query: 81 LRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPT 140
L ++ GSLSP +GNL+FL +NL NNFHG+IP+E+G L RL L L NNSFSG+IP
Sbjct: 88 LNSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPA 147
Query: 141 NLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSII--- 197
NLS CSNL+ F NNL+G IP +G S+ K+ + L N+LTG +P S+GNL+ I
Sbjct: 148 NLSRCSNLVYFRLGFNNLIGRIPSWLG-SYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSL 206
Query: 198 ----------------------YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLP 235
++ +G N FSG +P S+YNMSSLE L N G+LP
Sbjct: 207 SFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLP 266
Query: 236 LDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWS 295
D+ TLPNLQV IG+N F+GS+P S SNASN+ D+ ++ FTGKVSI FG + NLW
Sbjct: 267 WDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWG 326
Query: 296 LDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGV 355
L L N LG G A+DL F+ L C LKVL ++ GGVLP+SIANLST + + +
Sbjct: 327 LFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDN 386
Query: 356 NQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLG 415
NQ+SGTIP GIGNLVNL L + N TG+IP IG L+ L I LS N L G+IPSSLG
Sbjct: 387 NQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLG 446
Query: 416 NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLG 475
N+T + L L +NHL G IP S GN L L+LS N L G +P++++ + +L+ L+L
Sbjct: 447 NITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLA 506
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535
N L G LP EV LKNL L +S N+ SGEIP L C LE HM+GN F+GSIP S
Sbjct: 507 RNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSF 566
Query: 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTG 595
SL+ + +LDLS NNLSGQIPEFL+ LS L LNLS+N+F+G++PTKGVF+N T + G
Sbjct: 567 ISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAG 625
Query: 596 NGKLCGGSNELHLPSCPSKRSRKSTVLRLGKVGIPMIVSC--LILSTCFIIVYARRRRSK 653
N KLCGG ELHLP+CP + + R K+ I ++ L+L +++ RR +
Sbjct: 626 NNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKR 685
Query: 654 QESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN 713
+ S S + VSY L +AT FSS+N+IG G FGSVYKGILG++ T VAVK++
Sbjct: 686 EPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQ 745
Query: 714 LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH 773
L Q+GA+KSF AECE LRN RHRNL+K++T CSS+D++G DFKALVYE+M NGSLE WLH
Sbjct: 746 LHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLH 805
Query: 774 QSNGQPEVCD----LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829
E+ D LSL QRLNIAID+ASA++YLHHHC PIVH DLKPSN+LLD+DM A
Sbjct: 806 PVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTA 865
Query: 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASV 889
HV DFGLARF+ S +QSSSIG+KGT+GY P EYGMG++ S
Sbjct: 866 HVGDFGLARFI-PEAAGRSHPSQSSSIGLKGTIGYAAP------------EYGMGTKVSA 912
Query: 890 TGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGR- 948
GD YS G++LLEMFT +RPT MF L LH F KMALPE++ + +DP L + +
Sbjct: 913 LGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEE 972
Query: 949 ------------RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLVG 994
+R K+ ECL++++RIGV+CS+ESP ERM + + + +L R+ L+G
Sbjct: 973 TTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 950 bits (2456), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/1034 (50%), Positives = 672/1034 (64%), Gaps = 60/1034 (5%)
Query: 6 SITCLATFIFSFSLLLHSQSFSAHTNETDRLALLAIKSQL-HDPLGVTNSWNNSINLCQW 64
SI T IF S + S + NETDRLALLAIK+Q+ DPLG+T SWN+S++ C W
Sbjct: 43 SILVPYTIIFLHSPSPTTSSTILYGNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNW 102
Query: 65 AGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRL 124
GVTCGHRHQRV L+L ++ GSLSP +GNL+FL +NL NNFHG+IP+E+G L RL
Sbjct: 103 TGVTCGHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRL 162
Query: 125 ETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLT 184
L L NNSFSG+IP NLS CSNL+ F NNL+G IP +G S+ K+ + L N+LT
Sbjct: 163 RALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLG-SYPKVVRMQLHYNNLT 221
Query: 185 GMLPASIGNLSII-------------------------YLHVGENQFSGTVPPSLYNMSS 219
G +P S+GNL+ I ++ +G N FSG +P S+YNMSS
Sbjct: 222 GPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSS 281
Query: 220 LENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYF 279
LE L N G+LP D+ TLPNLQV IG+N F+G +P S SNASN+ D+ ++ F
Sbjct: 282 LEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNF 341
Query: 280 TGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPH 339
TGKVSI FG + NLW L L N LG G A+DL F+ L C LKVL ++ GGVLP+
Sbjct: 342 TGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPN 401
Query: 340 SIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAI 399
SIANLST + + + NQ+SGTIP GIGNLVNL L + N TG+IP IG L+ L I
Sbjct: 402 SIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRI 461
Query: 400 GLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVP 459
LS N L G+IPSSLGN+T + L L +NHL G IP S GN L L+LS N L G +P
Sbjct: 462 DLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIP 521
Query: 460 QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEI 519
++++ + +L+ L+L N L G LP EV LKNL L +S N+ SGEIP L C LE
Sbjct: 522 EKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEH 581
Query: 520 FHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEV 579
HM+GN F+GSIP S SL+ + +LDLS NNLSGQIPEFL+ LS L LNLS+N+F+G++
Sbjct: 582 LHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQL 640
Query: 580 PTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRLGKVGIPMIVSC--LI 637
PTKGVF+N T + GN KLCGG ELHLP+CP + + R K+ I ++ L+
Sbjct: 641 PTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLV 700
Query: 638 LSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYK 697
L +++ RR ++ S S + VSY L +AT FSS+N+IG G FGSVYK
Sbjct: 701 LIMSLLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYK 760
Query: 698 GILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757
G LG++ T VAVK++ L Q+GA+KSF AECE LRN RHRNL+K++T CSS+D++G DFKA
Sbjct: 761 GXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKA 820
Query: 758 LVYEYMQNGSLEEWLHQSNGQPEVCD----LSLIQRLNIAIDMASAIEYLHHHCQPPIVH 813
LVYE+M NGSLE WLH E+ D LSL QRLNIAID+ASA++YLHHHC PIVH
Sbjct: 821 LVYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVH 880
Query: 814 GDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKM 873
DLKPSN+LLD+DM AHV DFGLARF+ S +QSSSIG+KGT+GY P
Sbjct: 881 CDLKPSNILLDNDMTAHVGDFGLARFI-PEAAGRSHPSQSSSIGLKGTIGYAAP------ 933
Query: 874 LNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVM 933
EYGMG++ S GD YS G++LLEMFT +RPT MF L LH F KMALPE++
Sbjct: 934 ------EYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIA 987
Query: 934 ETVDPSLLLAWSDGR-------------RRAKVEECLVTVIRIGVACSMESPIERMEMRD 980
+ +DP L + + +R K+ ECL++++RIGV+CS+ESP ERM + +
Sbjct: 988 DIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITE 1047
Query: 981 VLAKLCAARQTLVG 994
+ +L R+ L+G
Sbjct: 1048 AIKELQLIRKILLG 1061
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2330), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/998 (49%), Positives = 652/998 (65%), Gaps = 53/998 (5%)
Query: 31 NETDRLALLAIKSQLHDPLGVT-NSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGS 89
NETD ALLA K+++ DP T +SWN+S++ C W G+TCG RH RV ++L Q + G+
Sbjct: 30 NETDYEALLAFKAKIQDPHSNTLSSWNDSLDFCNWPGITCGRRHGRVRIINLVDQKLAGT 89
Query: 90 LSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLL 149
LSPYVGN+SFLR I LA N HGEIP E+G L RL LML NNS GKIP NLS CS+L
Sbjct: 90 LSPYVGNISFLREIRLANNTIHGEIPPEVGRLLRLRVLMLTNNSIEGKIPANLSGCSSLA 149
Query: 150 SFVAYRNNLVGEIPEDIGY-----------------------SWLKLEHISLARNHLTGM 186
RN L GEIP ++G+ + LE +SL RN L G
Sbjct: 150 ELYIDRNKLGGEIPTELGFLSKLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRNVLEGT 209
Query: 187 LPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNL 245
+P S+G L + L +GEN+ SG +PPSLYN+S + L NGF G+LP ++G++ P+L
Sbjct: 210 IPDSLGRLKRLTSLLLGENKLSGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGLSFPHL 269
Query: 246 QVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGS 305
Q A+ N FSG IP S +NAS ++I+ N TGK+ IFG+L +L L G NNLG+
Sbjct: 270 QWLALWQNQFSGPIPGSLTNASELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGSNNLGT 329
Query: 306 GGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSG 365
GG +++ F+ LTNCS LKV++ NRL G LP ++ NLST M + N I G IPSG
Sbjct: 330 GGDDEMAFLASLTNCSMLKVVSINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVGRIPSG 389
Query: 366 IGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFL 425
IGNLVNL L ++ N TG IP G LR L+ L SN L G IPSSLGNL+L++ L+L
Sbjct: 390 IGNLVNLTFLYMDRNHFTGEIPTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLLSVLYL 449
Query: 426 SSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPL 485
N L+ IP SLG CKNLVSL LS L G++P+Q+ +++ L+L +N GSLP
Sbjct: 450 DDNKLKDTIPASLGGCKNLVSLGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLPS 509
Query: 486 EVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELD 545
+G+LK L L +S N SGEIP + GCT LE+ HM+ N F+GSIP S SL+ I+ LD
Sbjct: 510 TIGSLKGLSELDVSWNMLSGEIPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFLD 569
Query: 546 LSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNE 605
LSCNNLSGQ+P FL + F+ LNLSYN+F+GEVP KGVF+N++ V + GN KLCGG E
Sbjct: 570 LSCNNLSGQLPNFLVTIPFIS-LNLSYNNFEGEVPRKGVFTNESAVSVVGNDKLCGGILE 628
Query: 606 LHLPSCPSKRSRKSTVLRLG---KVGIPMIVSCLILSTCFIIVYARRRRSKQESSISVPM 662
LHLP CP+K +K+ + L + IP + I + F+ + +++R +E S +
Sbjct: 629 LHLPECPNKEPKKTKMSHLQYLLAITIPCALVGAITVSSFLFCWFKKKR--KEHSSDTLL 686
Query: 663 EQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS 722
++ FP +SY L +AT+ FS++N+IG GSF SVYKG + E+GT VA+K+LNL ++GA KS
Sbjct: 687 KESFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRRGASKS 746
Query: 723 FVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP--- 779
F ECE LRN RHRNL+KIIT CSSIDF+G +FKALVYEYM GSLE+WLH +
Sbjct: 747 FKDECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQETHDDQ 806
Query: 780 ---EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
+V +L++R+NIAID+A+A++YLHHHC PI+H D+KPSN+LLD DM+ H+ DFGL
Sbjct: 807 QINQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHLGDFGL 866
Query: 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896
AR +F + S+E SSS GIKGT GY P EYG G E S+ GDVYS
Sbjct: 867 AR-IFQEFSEPSLE--SSSAGIKGTTGYAAP------------EYGQGREVSIDGDVYSY 911
Query: 897 GVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEEC 956
G++LLEM T +RP + F+ GL LH F KMALP+ V+E DP +LL+ A +EEC
Sbjct: 912 GILLLEMMTGKRPIDDTFEKGLNLHMFAKMALPDHVIEITDP-VLLSERHLENAASMEEC 970
Query: 957 LVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLVG 994
L ++++IGVACSM+SP +RM+M V+ +L R T G
Sbjct: 971 LTSLVKIGVACSMDSPRDRMDMSRVVRELLMVRDTFQG 1008
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 901 bits (2329), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/1028 (48%), Positives = 669/1028 (65%), Gaps = 56/1028 (5%)
Query: 5 ISITCLATFIFSFSLLLHSQ---SFSAHT-NETDRLALLAIKSQLHDPLGVTNSWNNSIN 60
+ ++ +++ IF LLL Q SFS H NETDRL+LLA K+Q+ DPL +SWN S +
Sbjct: 1 MELSGMSSCIFCPLLLLIIQLSFSFSLHEGNETDRLSLLAFKAQITDPLDALSSWNASTH 60
Query: 61 LCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGF 120
C+W+GV CGHRHQR+ EL+L+ + G+LSP++GNLSFLR +NL N F +IP+E+G
Sbjct: 61 FCKWSGVICGHRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELGR 120
Query: 121 LFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLAR 180
LFRL+ L+L NN+FSG+IP N+SSCSNLL NNL G+IP +G S KL L
Sbjct: 121 LFRLQRLVLGNNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLG-SLSKLGAFVLQG 179
Query: 181 NHLTGMLPASIGNLSII-------------------------YLHVGENQFSGTVPPSLY 215
N+L G +P+S GNLS + Y V EN SGT+P S+
Sbjct: 180 NNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSIC 239
Query: 216 NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLP 275
N+SSL + L N G+LP D+G+ LPNL I N+ +G IP + SNAS I ++DL
Sbjct: 240 NISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLS 299
Query: 276 INYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGG 335
N TGK+ + L +L L + N+LG+G +DL F+ L N + L+ L +N GG
Sbjct: 300 YNNLTGKIPDL-ASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGG 358
Query: 336 VLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRN 395
VLP ++N ST + I G NQI G+IP+ IGNL++L+ L +E NQL G IP IG+L+N
Sbjct: 359 VLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQN 418
Query: 396 LQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLI 455
L A+ L+ N + G+IPSSLGN+T + ++ + N+LQG IP SLGN L+ L+LS N L
Sbjct: 419 LAALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLS 478
Query: 456 GAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCT 515
G +P+++L I++LS L L +N L GSLP EVG L NL L +S N+ SGEIP +L C
Sbjct: 479 GPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCK 538
Query: 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
LE + GN F G +P L SL++++ L LS NNLSGQIP+FL++ LE L+LSYN F
Sbjct: 539 SLEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDF 597
Query: 576 DGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPS---KRSRKSTVLRLGKVGIPMI 632
+GEVP +GVF N +R+ + GN KLCGG +L LP C S R + T L L + IP
Sbjct: 598 EGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLIL-IIAIPCG 656
Query: 633 VSCLILSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSF 692
++L T F++ Y+ R++K E + E F ++Y +L +AT+ FSSSN++G G+F
Sbjct: 657 FLGIVLMTSFLLFYS--RKTKDEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAF 714
Query: 693 GSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752
GSVY+G L +G VAVK+LNL++KGA KSF+AEC L N RHRNL+K+IT CSS DF+G
Sbjct: 715 GSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQG 774
Query: 753 ADFKALVYEYMQNGSLEEWLHQ---SNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQP 809
DFKALVYE+M NGSLEEWLH S+ PE +L L+QRLNIAID+ASA++YLH+HCQ
Sbjct: 775 NDFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQV 834
Query: 810 PIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGN 869
P+VH DLKPSNVLL DM A V DFGLARFL + +SSS+G+KGT+GY P
Sbjct: 835 PVVHCDLKPSNVLLGDDMTACVGDFGLARFL-PEASNQLPADESSSVGLKGTIGYAAP-- 891
Query: 870 IAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALP 929
EYGMGSE S GDVYS G++LLEMFT RRPT+ MF+ G LH + KM LP
Sbjct: 892 ----------EYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLP 941
Query: 930 EKVMETVDPSLL--LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987
+ V+E VDP+L + KV EC+V++I++G+ACS E P ERM + +V+ +L
Sbjct: 942 DNVLEFVDPTLREHEEMNHNDDSHKVMECMVSIIKVGLACSAELPGERMGIANVVVELHR 1001
Query: 988 ARQTLVGR 995
R+ L GR
Sbjct: 1002 IREMLDGR 1009
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/1003 (49%), Positives = 656/1003 (65%), Gaps = 55/1003 (5%)
Query: 31 NETDRLALLAIKSQL-HDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGS 89
NETDRL+LLA+KSQ+ +DP G+ +SWN S++ C W+GV CG RH+RV E+DL + GS
Sbjct: 32 NETDRLSLLALKSQITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLHSAQLVGS 91
Query: 90 LSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLL 149
LSP++GNLSFLR + L N F IP+E+G LFRL L L NN+F GKIP N+S CSNLL
Sbjct: 92 LSPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCSNLL 151
Query: 150 SFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSII--------YLH- 200
NNL G++P ++G S KL+ N+L G +P+S GNLS I YL
Sbjct: 152 ILSLSGNNLTGKLPIELG-SLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNYLQG 210
Query: 201 ----------------VGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPN 244
G N +G +PPS+YN+SSL + VN GNLP D+G+TLPN
Sbjct: 211 GIPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLTLPN 270
Query: 245 LQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLG 304
L++ + N FSGSIP +FSNAS I +I+L N TG+V + K W L + +N LG
Sbjct: 271 LEILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVPDLSSLSKLRW-LIVDVNYLG 329
Query: 305 SGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPS 364
+G +DL F+ L N + L+ L+ +N GG+LP I+N S + + G NQI G+IPS
Sbjct: 330 NGNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSIPS 389
Query: 365 GIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLF 424
GIGNL+ L+ LG+E NQLTG IP IG+L+NL + L N + GNIPSS+GN+T + +++
Sbjct: 390 GIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLEVY 449
Query: 425 LSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLP 484
LS+N+LQG IP SLGNC+NL+ L+L N L G++P+++++I + SR L L N L GSLP
Sbjct: 450 LSANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGSLP 509
Query: 485 LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKEL 544
LEVG L NL +S N+ SGEIP TL C LE +M+GN F+G IP SL SL++++ L
Sbjct: 510 LEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQIL 569
Query: 545 DLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSN 604
+LS NNLSG+IP+FL L L L+LS+N+ +GEVP +G+F+ + + GN KLCGG
Sbjct: 570 NLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGGMP 629
Query: 605 ELHLPSCPSKRSRKSTVLRLGK--VGIPMIVSCLILSTCFIIVYARRRRSKQESSISVPM 662
+L+L C SK+SRK K + IP +IL +++ + + + + +S S P
Sbjct: 630 QLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRPASGS-PW 688
Query: 663 EQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS 722
E F V+Y +L +ATN FS +N+IG GSFGSVYKGIL +G VAVK+ NL+++GA KS
Sbjct: 689 ESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 748
Query: 723 FVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC 782
F+AEC L N RHRNL+K++T CS IDF+G DFKALVYE+M NGSLEEWLH + E
Sbjct: 749 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAH 808
Query: 783 ---DLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
DLSL+QRLNIAID+ASA++YLH+HCQ IVH DLKPSNVLLD D+ AHV DFGLAR
Sbjct: 809 RRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARL 868
Query: 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM 899
L ++ Q+SSIG+KGT+GY P EYG+GSE S GDVYS G++
Sbjct: 869 LPQASHQLCLD-QTSSIGLKGTIGYAAP------------EYGLGSEVSPYGDVYSYGIL 915
Query: 900 LLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSD-----GRRRAKV- 953
LLE+FT RRPT+ +F+ GL LH F K ALP V E +DP L+ + RR + +
Sbjct: 916 LLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETSGDASRRMSHIG 975
Query: 954 --EECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLVG 994
ECL ++++GVACS E P ERME+ V +L R L+G
Sbjct: 976 NHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLG 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2308), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/1029 (47%), Positives = 662/1029 (64%), Gaps = 69/1029 (6%)
Query: 19 LLLHSQSFSAHT-----NETDRLALLAIKSQLH-DPLGVTNSWNNSINLCQWAGVTCGHR 72
+ LH+ SF+ NETD LALLAIK+Q+ DPLG+ +SWN+S++ C W G+ CG+
Sbjct: 18 IFLHAPSFTQAATTLSGNETDHLALLAIKAQIKLDPLGLMSSWNDSLHFCNWGGIICGNL 77
Query: 73 HQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANN 132
HQRV L+L H + GSLSP +GN+SFLR I+L N FHGEIP+EIG L RL+ + +NN
Sbjct: 78 HQRVITLNLSHYGLVGSLSPQIGNMSFLRGISLEQNYFHGEIPQEIGRLDRLKYINFSNN 137
Query: 133 SFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIG 192
SFSG+IP NLS CS+LL N L G+IP +G S KLE + L N+L G +P S+G
Sbjct: 138 SFSGEIPANLSGCSSLLMLRLGFNKLTGQIPYQLG-SLQKLERVQLHYNNLNGSVPDSLG 196
Query: 193 NL-------------------------SIIYLHVGENQFSGTVPPSLYNMSSLENILLDV 227
N+ ++ +L +G N SG +PP+++N+SSL L
Sbjct: 197 NISSVRSLSLSVNNFEGSIPDALGRLKTLNFLGLGLNNLSGMIPPTIFNLSSLIVFTLPY 256
Query: 228 NGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIF 287
N G LP D+G+TLPNLQV IG N+FSG +P S SNASN+ +D+ + FT KV+I F
Sbjct: 257 NQLHGTLPSDLGLTLPNLQVLNIGHNFFSGPLPVSISNASNLLELDIDTSNFT-KVTIDF 315
Query: 288 GRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTT 347
G L NLWSL L N LG G A+DL F+ LT C L++L + GGV+P SI NLST
Sbjct: 316 GGLPNLWSLALSSNPLGKGEADDLSFIDSLTKCRNLRLLDLSNSHFGGVIPDSIGNLSTQ 375
Query: 348 MTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQ 407
+ + + NQ+SG+IP+ I NL+NL L +E N L+G+IP +G L+ LQ + LS N L
Sbjct: 376 LFLLKLRGNQLSGSIPTVIENLLNLAELTVEKNYLSGSIPSVLGNLKMLQRLDLSENKLS 435
Query: 408 GNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITT 467
G IPSSLGN+T + + L N + G+IP S GN K L +L+LS N L G +P++++ +++
Sbjct: 436 GLIPSSLGNITQLFEFHLQKNQIMGSIPSSFGNLKYLQNLDLSQNLLSGTIPKEVMGLSS 495
Query: 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSF 527
L+ L+L N L G LP E NL NL L +S N+ G+IP +L C LE HMQGN F
Sbjct: 496 LTISLNLAQNQLTGPLPPEAQNLMNLGYLDVSENKLYGQIPSSLGSCVTLEKLHMQGNFF 555
Query: 528 RGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSN 587
G+IP S SL+ ++++DLS NNLSGQIP+FL+ L+ + LNLS+NHF+GEVP +G F N
Sbjct: 556 EGAIPPSFSSLRGLRDMDLSRNNLSGQIPQFLKRLALIS-LNLSFNHFEGEVPREGAFLN 614
Query: 588 KTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRLGKVGI----PMIVSCLILSTCFI 643
T + L+GN +LCGG +L LP C RS+ R K+ I P++V ++S I
Sbjct: 615 ATAISLSGNKRLCGGIPQLKLPRCVVNRSKNGKTSRRVKLMIAILTPLLVLVFVMSILVI 674
Query: 644 IVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGEN 703
++ R +S ++ VSY L +AT FSS+N+IG GSFGSVY+GIL N
Sbjct: 675 NRLRKKNRQSSLASSLSSKQELLLKVSYRNLHKATAGFSSANLIGAGSFGSVYRGILDPN 734
Query: 704 GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763
T VAVK+L + Q+ LKSF+AECE+L+N RHRNL+KI+T CSS+DF+G DFKALVYE+M
Sbjct: 735 ETVVAVKVLFMRQRKTLKSFMAECEILKNIRHRNLVKILTACSSVDFQGNDFKALVYEFM 794
Query: 764 QNGSLEEWLH---QSNG-QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPS 819
NG+LE WLH ++NG ++ LS QRLNIAID+A+A+ YLH+ C P+VH DLKPS
Sbjct: 795 PNGTLESWLHSFPRTNGINEDLKILSFHQRLNIAIDVAAALNYLHYQCHKPVVHCDLKPS 854
Query: 820 NVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCL 879
NVLLD+DM AHV DFGLARF+ + S +SSS+G+KGTVGY P
Sbjct: 855 NVLLDNDMTAHVGDFGLARFI-EEAINPSHRNESSSVGLKGTVGYAAP------------ 901
Query: 880 EYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPS 939
EYGMGS+ S+ GDVYS G++LLEMFT +RPT+ MF GL LH F K ALP+++ E VDP
Sbjct: 902 EYGMGSKPSMNGDVYSYGILLLEMFTGKRPTDDMFHDGLDLHNFVKTALPDQISEVVDPL 961
Query: 940 LLLAWS---------DGRRRAKV-----EECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
+ + R R ++ +E L+ ++RIG+ACS+ES ER ++DVL +L
Sbjct: 962 FVTGGEGDEEETGHLENRTRGQIKKDQMQESLIAILRIGIACSVESINERKNVKDVLTEL 1021
Query: 986 CAARQTLVG 994
R+ +G
Sbjct: 1022 QNVRRFFLG 1030
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/1027 (47%), Positives = 667/1027 (64%), Gaps = 69/1027 (6%)
Query: 14 IFSFSLLLHSQSFSAHT-NETDRLALLAIKSQLH-DPLGVTNSWNNSINLCQWAGVTCGH 71
IF LL S SFS + NETD+L+LL K+Q+ DPLG +SWN S CQW+GVTCG
Sbjct: 14 IFLQIYLLVSFSFSIYGGNETDKLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGVTCGR 73
Query: 72 RHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLAN 131
RHQRV ELDL + GSLSP++GNLSFLR +NLA N+ IP+E+G LFRLE L+L N
Sbjct: 74 RHQRVVELDLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLRN 133
Query: 132 NSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI 191
N+F G IP N+S C+NL R NL G++P ++G KL+ +++ N+ G +P S
Sbjct: 134 NTFDGGIPANISRCANLRILDFSRGNLTGKLPAELGL-LSKLQVLTIELNNFVGEIPYSF 192
Query: 192 GNLSII-------------------------YLHVGENQFSGTVPPSLYNMSSLENILLD 226
GNLS I L +G N SG +PPS++N+SSL +
Sbjct: 193 GNLSAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFP 252
Query: 227 VNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSII 286
VN G+LP +G+TLPNLQVF I N F G IP +FSNASN+ + N F GKV +
Sbjct: 253 VNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVPPL 312
Query: 287 FGRLKNLWSLDLGINNLGSGGANDLDFVTILTN-CSKLKVLAFEENRLGGVLPHSIANLS 345
+L L +G NNLG G NDL+FV L N + L+ L +N GGVLP ++N S
Sbjct: 313 SSS-HDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFS 371
Query: 346 TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF 405
T + + NQI G+IP+ IGNL+NL LG+E NQLTG IP +G+L+ L + L+ N
Sbjct: 372 TKLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNK 431
Query: 406 LQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTI 465
+ G IPSS+GN+T + + + N+L+G+IPPSLGN + L+SL LS N L G +P+++++I
Sbjct: 432 ISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSI 491
Query: 466 TTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGN 525
+LS +L L N L GSLP+E+ L NL L +S N+FSGEIP +L C LE H++ N
Sbjct: 492 PSLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEEN 551
Query: 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVF 585
+G IP++L SL++I+EL+LS NNL+GQIPEFLE+ LE LNLS+N F+GEVP +G F
Sbjct: 552 FLQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAF 611
Query: 586 SNKTRVQLTGNGKLCGGSNELHLPSCPSKR--SRKSTVLRLGKVGIPMIVSCLILSTCFI 643
N + + + GN KLCGG +L+L CPS + KS + +G +IL F+
Sbjct: 612 QNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFL 671
Query: 644 IVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGEN 703
+ Y R++ + ++ +E FP V+Y +L AT+ FSS+N+IG+GSFGSV+KGILG +
Sbjct: 672 LFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPD 731
Query: 704 GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763
VAVK+LNL++KGA KSF+AECE L++ RHRNL+K++T CSSIDF+G DFKALVYE+M
Sbjct: 732 KIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFM 791
Query: 764 QNGSLEEWLH------QSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817
NG+LEEWLH ++NG P+ D L+ RLNIAI MASA+ YLHH CQ PI+H DLK
Sbjct: 792 VNGNLEEWLHPVQTSDEANG-PKALD--LMHRLNIAIHMASALNYLHHDCQMPIIHCDLK 848
Query: 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP 877
PSN+LLD +M AHV DFGLAR F + Q+SS+G+KGT+GY P
Sbjct: 849 PSNILLDTNMTAHVGDFGLAR------FHSEASNQTSSVGLKGTIGYAAP---------- 892
Query: 878 CLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVD 937
EYG+G + S GDVYS G++LLEMFT +RP + MF+ GL LH + KMALP++++E VD
Sbjct: 893 --EYGIGGKVSTYGDVYSYGILLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVD 950
Query: 938 PSLL-----LAWSDGRRRA-----KVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987
P L+ + SD ++ CL+T+I++GVACS+E P ERM++ DV+ +L
Sbjct: 951 PLLVREIRSVNSSDEMGMYHIGPHEISACLMTIIKMGVACSVELPRERMDIGDVVTELNR 1010
Query: 988 ARQTLVG 994
+ TL+G
Sbjct: 1011 IKDTLLG 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/1040 (47%), Positives = 672/1040 (64%), Gaps = 68/1040 (6%)
Query: 2 LNSISITCLATFIFSFSLLLHSQSFSAHTNETDRLALLAIKSQL-HDPLGVTNSWNNSIN 60
L+ ISI L +F + L S S NETDRL+LLA K+ + DPL + +SWN S++
Sbjct: 3 LSGISIFILLWVLFLKMIQLSCSSLSGRGNETDRLSLLAFKAHITDDPLHILSSWNESLH 62
Query: 61 LCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGF 120
C+W+G+TCG RHQRV E+DL + GSL+ ++GNLSFLR +NL N+ IP+EIG
Sbjct: 63 FCKWSGITCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEIGR 122
Query: 121 LFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLAR 180
LFRL TL+L NSFSG+IP N+S CSNLL+ RNNL G++P ++ S KL+
Sbjct: 123 LFRLRTLILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAEL-KSLSKLQMFEFEI 181
Query: 181 NHLTGMLPASIGNLS---IIY----------------------LHVGENQFSGTVPPSLY 215
N+LTG + S NLS IIY +G + FSG +PPS++
Sbjct: 182 NYLTGEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSIF 241
Query: 216 NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLP 275
N+SSL + + +N GNLP D+G +LP L+V + N FSGSIP + SNASN+ +D+
Sbjct: 242 NLSSLTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDVS 301
Query: 276 INYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGG 335
N FTGKV + RL NL + + NNLG+G +DL F+ L N + L++LA EN LGG
Sbjct: 302 QNNFTGKVPSL-ARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLGG 360
Query: 336 VLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRN 395
VLP ++N ST + + G N+I G IPS I NL+ L LG E N+LTG+IP +G+L+N
Sbjct: 361 VLPEMLSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLKN 420
Query: 396 LQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLI 455
L + L+ N + G+IPSSLGN+T ++ + L N+L+G+IP SLGNC+ ++ ++LS N L
Sbjct: 421 LIKLYLNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNLS 480
Query: 456 GAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCT 515
G +P+++++I +LS LDL N GSLP+EVG L NL L +S N+ SGEIP +L CT
Sbjct: 481 GTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSCT 540
Query: 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
LE ++QGN+F+G+IP+SL SL+ I +L+LS NNL+GQIP F LE L+LSYN F
Sbjct: 541 RLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYNDF 600
Query: 576 DGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRK---STVLRL-GKVGIPM 631
+GEVP +GVF N + ++GN LCGG E++LP C +S K S LRL V
Sbjct: 601 EGEVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACCG 660
Query: 632 IVSCLILSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGS 691
+V L+L++ + + R++K+ S S ++ +F VSY L +AT+ FSS+N+IG GS
Sbjct: 661 VVGVLLLTSALLFCCLKMRKNKEASGSS--LDIFFQKVSYQNLLKATDGFSSANLIGAGS 718
Query: 692 FGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751
FGSVYKGIL + T +AVK+LNL KGA +SF+ EC+ L N RHRNL+K++T CSS DF+
Sbjct: 719 FGSVYKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDFE 778
Query: 752 GADFKALVYEYMQNGSLEEWLHQSNG----QPEVCDLSLIQRLNIAIDMASAIEYLHHHC 807
DFKALVYEYM NGSLEEWLH + QP LSLI+RL+I+ID+ASA++YLH+ C
Sbjct: 779 ENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPPRI-LSLIERLSISIDVASALDYLHNQC 837
Query: 808 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPP 867
Q P+VH DLKPSN+LLD DM AHV DFGLARFL A + SSSIGI+GTVGY P
Sbjct: 838 QVPVVHCDLKPSNILLDSDMTAHVGDFGLARFLIAA---PHHSSPSSSIGIRGTVGYAAP 894
Query: 868 GNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMA 927
EYGMGS+ S GDVY+ G++LLE+FT ++PT+ MF+ GL LH KMA
Sbjct: 895 ------------EYGMGSDVSTYGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAKMA 942
Query: 928 LPEKVMETVDPSLLLAWSDGRR--------------RAKVEECLVTVIRIGVACSMESPI 973
+P+++ DP LL+ +G R KV CL ++++IGV CS ESP
Sbjct: 943 MPDRLALAADPFLLITEDEGTSASATSASHRITCIARDKVLGCLNSILKIGVDCSAESPR 1002
Query: 974 ERMEMRDVLAKLCAARQTLV 993
+RM++ DV +L R L+
Sbjct: 1003 DRMDISDVANELVRIRNILL 1022
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116466|ref|XP_002331904.1| predicted protein [Populus trichocarpa] gi|222874576|gb|EEF11707.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/1019 (48%), Positives = 661/1019 (64%), Gaps = 58/1019 (5%)
Query: 13 FIFSFSLLLHSQSFS-AHTNETDRLALLAIKSQLHDPLGVTNSWNNSINLCQWAGVTCGH 71
+ SF ++ HS SFS A +E D+L+LLA K+Q+ DP +SWN S++ CQW+GV CG
Sbjct: 7 WFLSFQIIQHSFSFSLARGSEIDKLSLLAFKAQISDPTTKLSSWNESLHFCQWSGVKCGR 66
Query: 72 RHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLAN 131
+HQRV ELDL + GSLSP +GNLSFLR ++L N+F IP+EIG L RL+TL+L N
Sbjct: 67 QHQRVIELDLHSSQLVGSLSPSIGNLSFLRLLSLENNSFTNAIPQEIGRLVRLQTLILGN 126
Query: 132 NSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI 191
NSFSG+IP+N+S CSNLL NNL G +P +G S KL+ S +N+L G +P S
Sbjct: 127 NSFSGEIPSNISHCSNLLKLNLEGNNLTGNLPAGLG-SLSKLQVFSFRKNNLDGKIPLSF 185
Query: 192 GNLSII-------------------------YLHVGENQFSGTVPPSLYNMSSLENILLD 226
NLS I + +G N SGT+P SLYN+SSL + L
Sbjct: 186 ENLSSIIEIDGTLNNIQGGIPSSIGKLKTLNFFSLGSNNLSGTIPASLYNISSLIHFSLP 245
Query: 227 VNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSII 286
N F G LP +IG+TLPNLQ I DN SG +P + NA+ I L N FTGKV +
Sbjct: 246 YNQFHGTLPPNIGLTLPNLQYLGIHDNRLSGQLPATLINATKFTEIYLSYNKFTGKVPTL 305
Query: 287 FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLST 346
+ NL L + N LG G +DL F+ L+N SKL+ L + N GGVLP I+N ST
Sbjct: 306 -AIMPNLRILSMEENGLGKGEDDDLSFLYTLSNSSKLEDLYIDNNNFGGVLPDIISNFST 364
Query: 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFL 406
+ + G NQI GTIP GIGNLV+L+ LG+E N LTG+IP IG+L+NL L+ N L
Sbjct: 365 KLKQMAFGSNQIRGTIPDGIGNLVSLDTLGLEANHLTGSIPSSIGKLQNLADFFLNENKL 424
Query: 407 QGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTIT 466
G+IPSSLGN+T + + N+LQG+IPPSLGNC+NL+ L LS N L G +P+++L+I+
Sbjct: 425 SGSIPSSLGNITSLMQINFDQNNLQGSIPPSLGNCQNLLVLALSQNNLSGPIPKEVLSIS 484
Query: 467 TLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNS 526
+LS +L L N L GSLP EVG L L + IS N+ SGEIP +L C LE ++ GN
Sbjct: 485 SLSMYLVLSENQLTGSLPFEVGKLVTLGYMDISKNRLSGEIPASLGSCESLEHLYLDGNF 544
Query: 527 FRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFS 586
+G I SLRSL+++++L+LS NNLSGQIP+FL +L L+ L+LS+N +GEVP GVF
Sbjct: 545 LQGPISESLRSLRALQDLNLSHNNLSGQIPKFLGDLK-LQSLDLSFNDLEGEVPMHGVFE 603
Query: 587 NKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRLG-KVGIPMIVSCLILSTCFIIV 645
N + V + GN LCGG +L+LP+C SK ++ + +L V IP LI F+ +
Sbjct: 604 NTSAVSIAGNKNLCGGILQLNLPTCRSKSTKPKSSTKLTLTVAIPCGFIGLIFIASFLFL 663
Query: 646 YARR---RRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGE 702
+ R++K E S +P F V+Y +L +ATN FSS N++G GSFGSVYKG+L
Sbjct: 664 CCLKKSLRKTKNELSCEMP----FRTVAYKDLLQATNGFSSGNLVGAGSFGSVYKGVLAF 719
Query: 703 NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEY 762
+G VAVK+ NL+++GA KSF+ EC L N RHRNL+K++ C+ +D +G DFKALVYE+
Sbjct: 720 DGVTVAVKVFNLLREGASKSFMRECAALLNIRHRNLVKVLFACAGVDVQGNDFKALVYEF 779
Query: 763 MQNGSLEEWLHQSNG------QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816
M NGSLEEWLH + QP+ +L+LIQRLNIAID+A+A++YLH+ C+ PIVH DL
Sbjct: 780 MINGSLEEWLHPIHTLDLEVHQPK--NLNLIQRLNIAIDVANALDYLHNQCKMPIVHCDL 837
Query: 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNL 876
KPSNVLLD DM AHV DFGL +FL S +Q+SS+G+KGTVGY P
Sbjct: 838 KPSNVLLDGDMTAHVGDFGLLKFLSEA-SCQSSSSQTSSVGLKGTVGYAAP--------- 887
Query: 877 PCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETV 936
EYG+GSE S GDV+S G++LLEM T +RPT+ MF+ GL LH + K+ALP++V++
Sbjct: 888 ---EYGIGSEVSTFGDVHSYGILLLEMITGKRPTDSMFKDGLELHSYVKIALPDRVVDIA 944
Query: 937 DPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLVGR 995
DP LL G+ ++ ECL+++ +IGV CS + P ERM++ +V+A+L + +GR
Sbjct: 945 DPKLLTEVDQGKGTDQIVECLISISKIGVFCSEKFPKERMDISNVVAELNRTKANFLGR 1003
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2293), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/1025 (47%), Positives = 672/1025 (65%), Gaps = 59/1025 (5%)
Query: 6 SITCLATFIFSFSLLLHSQSFSAHTNETDRLALLAIKSQL-HDPLGVTNSWNNSINLCQW 64
S C +F+F SL+ S + S +TNETD LAL+ K+++ DPLG+ +SWN++I+ CQW
Sbjct: 4 SAFCFRSFVFLLSLI--SVTCSDYTNETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQW 61
Query: 65 AGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRL 124
GV+CG RHQRV L L+ + G++SP++GNLSFLR ++L N+F EIP ++G L L
Sbjct: 62 HGVSCGRRHQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSL 121
Query: 125 ETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLT 184
+ L NNS SG+IP ++S CSNL+S NNL GEIP ++G S LKL++++L N LT
Sbjct: 122 QIFSLHNNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELG-SLLKLKNLTLEVNGLT 180
Query: 185 GMLPASIGNLS-----------IIY---------------LHVGENQFSGTVPPSLYNMS 218
G +P S+GNLS I++ L++ +N+ SG +PPS++N+S
Sbjct: 181 GTIPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLS 240
Query: 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY 278
SL + + N F GNLP DIG++LPNL+ F+I N F+GSIP S SNASNIE++ + +N
Sbjct: 241 SLTALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNN 300
Query: 279 FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLP 338
TG+V + +L L L N+LGSG ANDL F++ LTN + L+ L+ + N GG LP
Sbjct: 301 LTGEVPTL-EKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELP 359
Query: 339 HSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQA 398
I+NLST + I + N I G+IP+GI LVNL + + N+++G IP IG+L+NL+
Sbjct: 360 KQISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEG 419
Query: 399 IGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAV 458
+ L N L G IPSS+GNLT + L+L N L+G+IP SLGNCK L+ L L N L G +
Sbjct: 420 LVLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDI 479
Query: 459 PQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLE 518
P + I +L ++ NH +GSLP+E+G L NL L +SGN SGEIP +L GC LE
Sbjct: 480 PPGLFGIFSL-LYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLE 538
Query: 519 IFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578
+M N F GSIP +L SL+ + + + S NNLSG+IPEF + + LE L+LSYN+F+G
Sbjct: 539 DLYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGM 598
Query: 579 VPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTV-LRLGKVGIPMIVSCLI 637
+P +G+F N T V + GN +LCGG+ EL LP C + ++ + L++ I ++++ +
Sbjct: 599 IPDEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLKLKIAIFAITVLLALAL 658
Query: 638 LSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYK 697
+ TC + +RR+R + + S M VSY L +ATN FSSSN++G GSFGSVYK
Sbjct: 659 VVTCLFLCSSRRKRREIKLS---SMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYK 715
Query: 698 GILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757
G+L +NG +AVK+LNLM++GA +SF+AECE LRN RHRNL+K++T CSSID+ G DFKA
Sbjct: 716 GMLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKA 775
Query: 758 LVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816
+VYE+M NGSLE+WLH G L+L+QRLNIAID+A A+EYLHHHC+ PI H DL
Sbjct: 776 IVYEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHCDL 835
Query: 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNL 876
KPSNVLLD ++ HV DFGLA+FL D +S+SIG++GT+GY PP
Sbjct: 836 KPSNVLLDDELTGHVGDFGLAKFLSGASLDYPT-NESTSIGVRGTIGYAPP--------- 885
Query: 877 PCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETV 936
EYG+G E S GD YS G++LLEMFT +RPT+ MF+ G LH F K A+PE+V +
Sbjct: 886 ---EYGVGGEVSAYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQIT 942
Query: 937 DPSLLLAWSDGR---------RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987
DP+LL G R ++ ECL +++RIG++CS+E P ERM++ D +A+L +
Sbjct: 943 DPTLLQEEPTGDDDKHEISSMRNSRPLECLNSILRIGISCSVEFPRERMKISDAVAQLHS 1002
Query: 988 ARQTL 992
R L
Sbjct: 1003 VRNEL 1007
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 997 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.895 | 0.884 | 0.438 | 1.8e-197 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.893 | 0.869 | 0.436 | 1.5e-195 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.894 | 0.884 | 0.430 | 2.8e-192 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.891 | 0.879 | 0.426 | 7.7e-190 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.882 | 0.853 | 0.426 | 1.4e-188 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.782 | 0.760 | 0.433 | 5.5e-164 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.757 | 0.928 | 0.426 | 2.4e-154 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.899 | 0.915 | 0.339 | 3.2e-129 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.537 | 0.449 | 0.334 | 2.3e-117 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.766 | 0.693 | 0.341 | 1.6e-115 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1912 (678.1 bits), Expect = 1.8e-197, P = 1.8e-197
Identities = 408/930 (43%), Positives = 579/930 (62%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+ LDL GG++ VG LS L Y+++ N G IP + RL L L +N
Sbjct: 92 LVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLG 151
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS 195
G +P+ L S +NL+ Y NN+ G++P +G L LE ++L+ N+L G +P+ + L+
Sbjct: 152 GSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTL-LEQLALSHNNLEGEIPSDVAQLT 210
Query: 196 IIY-LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
I+ L + N FSG PP+LYN+SSL+ + + N F+G L D+G+ LPNL F +G NY
Sbjct: 211 QIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNY 270
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314
F+GSIP + SN S +E + + N TG + FG + NL L L N+LGS + DL+F+
Sbjct: 271 FTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFL 329
Query: 315 TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXX 374
T LTNC++L+ L NRLGG LP SIANLS + + +G ISG+IP
Sbjct: 330 TSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQK 389
Query: 375 XXXEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434
+ N L+G +P +G+L NL+ + L SN L G IP+ +GN+T++ L LS+N +G +
Sbjct: 390 LILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIV 449
Query: 435 PPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLV 494
P SLGNC +L+ L + DNKL G +P +I+ I L R LD+ N L GSLP ++G L+NL
Sbjct: 450 PTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQDIGALQNLG 508
Query: 495 ALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554
L + N+ SG++P TL C +E ++GN F G IP L+ L +KE+DLS N+LSG
Sbjct: 509 TLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGS 567
Query: 555 IPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSC--- 611
IPE+ + S LEYLNLS+N+ +G+VP KG+F N T V + GN LCGG L C
Sbjct: 568 IPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQ 627
Query: 612 -PSKRSRKSTVLRLGKVGIPMIVSCLIL--STCFIIVYARRRRSKQESSISVP--MEQYF 666
PS + S+ L+ +G+ + ++ L+L +++ R+R+ +E++ P +E
Sbjct: 628 APSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLH 687
Query: 667 PMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAE 726
+SY +L ATN FSSSNM+G GSFG+VYK +L VAVK+LN+ ++GA+KSF+AE
Sbjct: 688 EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAE 747
Query: 727 CEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC---- 782
CE L++ RHRNL+K++T CSSIDF+G +F+AL+YE+M NGSL+ WLH + E+
Sbjct: 748 CESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE-EIHRPSR 806
Query: 783 DLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
L+L++RLNIAID+AS ++YLH HC PI H DLKPSNVLLD D+ AHVSDFGLAR L
Sbjct: 807 TLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLK 866
Query: 843 RPFDT-SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901
FD S Q SS G++GT+GY P EYG+G + S+ GDVYS G++LL
Sbjct: 867 --FDEESFFNQLSSAGVRGTIGYAAP------------EYGVGGQPSINGDVYSFGILLL 912
Query: 902 EMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRA-KVEECLVTV 960
EMFT +RPTN +F G TL+ + K ALPE++++ VD S+L G R V ECL V
Sbjct: 913 EMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHI---GLRVGFPVVECLTMV 969
Query: 961 IRIGVACSMESPIERMEMRDVLAKLCAARQ 990
+G+ C ESP+ R+ V+ +L + R+
Sbjct: 970 FEVGLRCCEESPMNRLATSIVVKELISIRE 999
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1894 (671.8 bits), Expect = 1.5e-195, P = 1.5e-195
Identities = 406/931 (43%), Positives = 577/931 (61%)
Query: 79 LDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKI 138
L+L G++ VGNL L+Y+N++ N F G IP + L TL L++N +
Sbjct: 110 LNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGV 169
Query: 139 PTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-II 197
P S S L+ RNNL G+ P +G + L+ + N + G +P I L +I
Sbjct: 170 PLEFGSLSKLVLLSLGRNNLTGKFPASLG-NLTSLQMLDFIYNQIEGEIPGDIARLKQMI 228
Query: 198 YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG 257
+ + N+F+G PP +YN+SSL + + N F+G L D G LPNLQ+ +G N F+G
Sbjct: 229 FFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTG 288
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+IPE+ SN S++ +D+P N+ TGK+ + FGRL+NL L L N+LG+ + DLDF+ L
Sbjct: 289 TIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGAL 348
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXXXXX 377
TNCS+L+ L N+LGG LP IANLST +T++ +G N ISG+IP
Sbjct: 349 TNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDL 408
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437
N LTG +P +G+L L+ + L SN L G IPSSLGN++ +T L+L +N +G+IP S
Sbjct: 409 GENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSS 468
Query: 438 LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALY 497
LG+C L+ LNL NKL G++P +++ + +L L++ N L G L ++G LK L+AL
Sbjct: 469 LGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGKLKFLLALD 527
Query: 498 ISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE 557
+S N+ SG+IP TL C LE +QGNSF G IP +R L ++ LDLS NNLSG IPE
Sbjct: 528 VSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPE 586
Query: 558 FLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSR 617
++ N S L+ LNLS N+FDG VPT+GVF N + + + GN LCGG L L C + R
Sbjct: 587 YMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPR 646
Query: 618 K-STVLRLGKVGIPMIVSCLILSTCFIIVY----------ARRRRSKQESSISVPMEQYF 666
+ S+V ++ + + +++ L+L C +VY R ++ + S S P++ ++
Sbjct: 647 RHSSVRKIITICVSAVMAALLL-LCLCVVYLCWYKLRVKSVRANNNENDRSFS-PVKSFY 704
Query: 667 PMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAE 726
+SY EL + T FSSSN+IG G+FG+V+KG LG VA+K+LNL ++GA KSF+AE
Sbjct: 705 EKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAE 764
Query: 727 CEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH----QSNGQPEVC 782
CE L RHRNL+K++T+CSS DF+G DF+ALVYE+M NG+L+ WLH + G P
Sbjct: 765 CEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRT 824
Query: 783 DLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
L L RLNIAID+ASA+ YLH +C PI H D+KPSN+LLD D+ AHVSDFGLA+ L
Sbjct: 825 -LGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLK 883
Query: 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
DT Q SS G++GT+GY P EYGMG S+ GDVYS G++LLE
Sbjct: 884 FDRDT-FHIQFSSAGVRGTIGYAAP------------EYGMGGHPSIMGDVYSFGIVLLE 930
Query: 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEK-VMETVDPSLLL-AWSDGRRRAKVEECLVTV 960
+FT +RPTN +F GLTLH F K AL ++ ++ D ++L A++ + + ECL V
Sbjct: 931 IFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYA---QHFNMVECLTLV 987
Query: 961 IRIGVACSMESPIERMEMRDVLAKLCAARQT 991
R+GV+CS ESP+ R+ M + ++KL + R++
Sbjct: 988 FRVGVSCSEESPVNRISMAEAISKLVSIRES 1018
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1863 (660.9 bits), Expect = 2.8e-192, P = 2.8e-192
Identities = 398/924 (43%), Positives = 571/924 (61%)
Query: 79 LDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKI 138
LDL + + GG++ +GNL L+Y+ + N GEIP + RL L L +N+ +
Sbjct: 95 LDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGV 154
Query: 139 PTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-II 197
P+ L S LL N+L G+ P I + L ++L NHL G +P I LS ++
Sbjct: 155 PSELGSLRKLLYLYLGLNDLKGKFPVFIR-NLTSLIVLNLGYNHLEGEIPDDIAMLSQMV 213
Query: 198 YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG 257
L + N FSG PP+ YN+SSLEN+ L NGF+GNL D G LPN+ ++ N+ +G
Sbjct: 214 SLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTG 273
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+IP + +N S +E+ + N TG +S FG+L+NL L+L N+LGS DL F+ L
Sbjct: 274 AIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDAL 333
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXXXXX 377
TNCS L L+ NRLGG LP SI N+ST +T + + N I G+IP
Sbjct: 334 TNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLL 393
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437
N LTG +P +G L L + L SN G IPS +GNLT + L+LS+N +G +PPS
Sbjct: 394 ADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPS 453
Query: 438 LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALY 497
LG+C +++ L + NKL G +P++I+ I TL L++ +N L+GSLP ++G L+NLV L
Sbjct: 454 LGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVH-LNMESNSLSGSLPNDIGRLQNLVELL 512
Query: 498 ISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE 557
+ N SG +P TL C +E+ ++Q N F G+IP ++ L +K +DLS NNLSG I E
Sbjct: 513 LGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIP-DIKGLMGVKNVDLSNNNLSGSISE 571
Query: 558 FLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSC----PS 613
+ EN S LEYLNLS N+F+G VPT+G+F N T V + GN LCG EL L C P
Sbjct: 572 YFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPP 631
Query: 614 KRSRKSTVLRLGKVGIPMIVSCLILSTCFIIVYARRRRSKQESSISVP--MEQYFPMVSY 671
+R ++L+ +G+ + ++ L+L + + ++R++ Q+ + S P +E + +SY
Sbjct: 632 VETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSY 691
Query: 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLR 731
+L AT+ FSSSN++G GSFG+V+K +L VAVK+LN+ ++GA+KSF+AECE L+
Sbjct: 692 GDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLK 751
Query: 732 NTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC----DLSLI 787
+ RHRNL+K++T C+SIDF+G +F+AL+YE+M NGSL++WLH + E+ L+L+
Sbjct: 752 DIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVE-EIHRPSRTLTLL 810
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
+RLNIAID+AS ++YLH HC PI H DLKPSN+LLD D+ AHVSDFGLAR L FD
Sbjct: 811 ERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLK--FDQ 868
Query: 848 -SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
S Q SS G++GT+GY P EYGMG + S+ GDVYS GV++LEMFT
Sbjct: 869 ESFFNQLSSAGVRGTIGYAAP------------EYGMGGQPSIHGDVYSFGVLVLEMFTG 916
Query: 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVA 966
+RPTN +F G TL+ + K ALPE+V++ D S+L S R V ECL ++ +G+
Sbjct: 917 KRPTNELFGGNFTLNSYTKAALPERVLDIADKSIL--HSGLRVGFPVLECLKGILDVGLR 974
Query: 967 CSMESPIERMEMRDVLAKLCAARQ 990
C ESP+ R+ + +L + R+
Sbjct: 975 CCEESPLNRLATSEAAKELISIRE 998
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1840 (652.8 bits), Expect = 7.7e-190, P = 7.7e-190
Identities = 396/929 (42%), Positives = 572/929 (61%)
Query: 79 LDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKI 138
LDL GG + VGNL L ++ +A N+ G IP + RL L L +N +
Sbjct: 95 LDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGV 154
Query: 139 PTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-II 197
P+ L S + L+ RNNL G++P +G + L+ + N++ G +P + LS ++
Sbjct: 155 PSELGSLTKLVILDLGRNNLKGKLPRSLG-NLTSLKSLGFTDNNIEGEVPDELARLSQMV 213
Query: 198 YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG 257
L + N+F G PP++YN+S+LE++ L +GF+G+L D G LPN++ +G+N G
Sbjct: 214 GLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVG 273
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+IP + SN S ++ + N TG + FG++ +L LDL N LGS DL+F+ L
Sbjct: 274 AIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSL 333
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXXXXX 377
TNC+ L++L+ RLGG LP SIAN+ST + + + N G+IP
Sbjct: 334 TNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQL 393
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437
N LTG +P +G+L L + L SN + G IPS +GNLT + L+LS+N +G +PPS
Sbjct: 394 GKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPS 453
Query: 438 LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALY 497
LG C +++ L + NKL G +P++I+ I TL L + N L+GSLP ++G+L+NLV L
Sbjct: 454 LGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVN-LSMEGNSLSGSLPNDIGSLQNLVKLS 512
Query: 498 ISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE 557
+ N+FSG +P TL C +E +QGNSF G+IP ++R L ++ +DLS N+LSG IPE
Sbjct: 513 LENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPE 571
Query: 558 FLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSC----PS 613
+ N S LEYLNLS N+F G+VP+KG F N T V + GN LCGG +L L C P
Sbjct: 572 YFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPP 631
Query: 614 KRSRKSTVLR----LGKVGIPMIVSCLILSTCFIIVYARRRRSKQESSISVP--MEQYFP 667
++ S+ L+ L +GI +++ +I S ++ + R+RR Q+++ VP +E +
Sbjct: 632 VETKHSSHLKKVAILVSIGIALLLLLVIAS--MVLCWFRKRRKNQQTNNLVPSKLEIFHE 689
Query: 668 MVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAEC 727
+SY +L ATN FSSSNM+G GSFG+V+K +L VAVK+LN+ ++GA+KSF+AEC
Sbjct: 690 KISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAEC 749
Query: 728 EVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC----D 783
E L++TRHRNL+K++T C+S DF+G +F+AL+YEY+ NGS++ WLH + E+
Sbjct: 750 ESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVE-EIRRPPRT 808
Query: 784 LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
L+L++RLNI ID+AS ++YLH HC PI H DLKPSNVLL+ D+ AHVSDFGLAR L
Sbjct: 809 LTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLK- 867
Query: 844 PFDT-SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
FD S Q SS G++GT+GY P EYGMG + S+ GDVYS GV+LLE
Sbjct: 868 -FDKESFLNQLSSAGVRGTIGYAAP------------EYGMGGQPSIHGDVYSFGVLLLE 914
Query: 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLL-LAWSDGRRRAKVEECLVTVI 961
MFT +RPT+ +F G LTLH + K+ALPEKV E D ++L + G R A ECL V+
Sbjct: 915 MFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTA---ECLTLVL 971
Query: 962 RIGVACSMESPIERMEMRDVLAKLCAARQ 990
+G+ C E P R+ +V +L + R+
Sbjct: 972 EVGLRCCEEYPTNRLATSEVAKELISIRE 1000
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1828 (648.5 bits), Expect = 1.4e-188, P = 1.4e-188
Identities = 395/927 (42%), Positives = 557/927 (60%)
Query: 79 LDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKI 138
L+L + G ++ VG L L+Y+N++ N G IP + RL T+ L++N +
Sbjct: 102 LNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGV 161
Query: 139 PTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-II 197
P+ L S S L +NNL G P +G + L+ + A N + G +P + L+ ++
Sbjct: 162 PSELGSLSKLAILDLSKNNLTGNFPASLG-NLTSLQKLDFAYNQMRGEIPDEVARLTQMV 220
Query: 198 YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG 257
+ + N FSG PP+LYN+SSLE++ L N F+GNL D G LPNL+ +G N F+G
Sbjct: 221 FFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTG 280
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+IP++ +N S++E D+ NY +G + + FG+L+NLW L + N+LG+ ++ L+F+ +
Sbjct: 281 AIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAV 340
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXXXXX 377
NC++L+ L NRLGG LP SIANLSTT+T +++G N ISGTIP
Sbjct: 341 ANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSL 400
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437
E N L+G +P G+L NLQ + L SN + G IPS GN+T + L L+SN G IP S
Sbjct: 401 ETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQS 460
Query: 438 LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALY 497
LG C+ L+ L + N+L G +PQ+IL I +L+ ++DL NN L G P EVG L+ LV L
Sbjct: 461 LGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLG 519
Query: 498 ISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE 557
S N+ SG++P + GC +E MQGNSF G+IP + L S+K +D S NNLSG+IP
Sbjct: 520 ASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPR 578
Query: 558 FLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSC---PSK 614
+L +L L LNLS N F+G VPT GVF N T V + GN +CGG E+ L C S
Sbjct: 579 YLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASP 638
Query: 615 RSRKSTVLRLGKV-GIPM-IVSCLILSTCFIIVYARRRRSKQESSISVPMEQ-----YFP 667
R RK +R V GI + I S L++ + + +R+ K +S P + +
Sbjct: 639 RKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHE 698
Query: 668 MVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAEC 727
VSY EL AT+ FSS+N+IG G+FG+V+KG+LG VAVK+LNL++ GA KSF+AEC
Sbjct: 699 KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAEC 758
Query: 728 EVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD---- 783
E + RHRNL+K+ITVCSS+D +G DF+ALVYE+M GSL+ WL Q V D
Sbjct: 759 ETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL-QLEDLERVNDHSRS 817
Query: 784 LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
L+ ++LNIAID+ASA+EYLH HC P+ H D+KPSN+LLD D+ AHVSDFGLA+ L+
Sbjct: 818 LTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYK- 876
Query: 844 PFDT-SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
+D S Q SS G++GT+GY P EYGMG + S+ GDVYS G++LLE
Sbjct: 877 -YDRESFLNQFSSAGVRGTIGYAAP------------EYGMGGQPSIQGDVYSFGILLLE 923
Query: 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIR 962
MF+ ++PT+ F G LH + K L S G A ++E L V++
Sbjct: 924 MFSGKKPTDESFAGDYNLHSYTKSILSG------------CTSSGGSNA-IDEGLRLVLQ 970
Query: 963 IGVACSMESPIERMEMRDVLAKLCAAR 989
+G+ CS E P +RM + + +L + R
Sbjct: 971 VGIKCSEEYPRDRMRTDEAVRELISIR 997
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 5.5e-164, P = 5.5e-164
Identities = 345/796 (43%), Positives = 498/796 (62%)
Query: 78 ELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGK 137
ELDL + G + P + LS L+ + L+ N+ G IP IG +L +L L++N G
Sbjct: 107 ELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGM 166
Query: 138 IPTNL-SSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS- 195
IP + +S +L + Y+N L GEIP +G + L+ L+ N L+G +P+S+G LS
Sbjct: 167 IPREIGASLKHLSNLYLYKNGLSGEIPSALG-NLTSLQEFDLSFNRLSGAIPSSLGQLSS 225
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
++ +++G+N SG +P S++N+SSL + N G +P + TL L+V +G N F
Sbjct: 226 LLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRF 285
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVT 315
G IP S +NAS++ +I + N F+G ++ FGRL+NL L L N + +D F++
Sbjct: 286 HGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFIS 345
Query: 316 ILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXXX 375
LTNCSKL+ L EN LGGVLP+S +NLST+++ + + +N+I+G+IP
Sbjct: 346 DLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHL 405
Query: 376 XXEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435
N G++P +G+L+NL + N L G+IP ++GNLT + L L +N G IP
Sbjct: 406 YLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIP 465
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495
+L N NL+SL LS N L G +P ++ I TLS +++ N+L GS+P E+G+LKNLV
Sbjct: 466 YTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVE 525
Query: 496 LYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555
+ N+ SG+IP TL C L ++Q N GSIP +L LK ++ LDLS NNLSGQI
Sbjct: 526 FHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQI 585
Query: 556 PEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSC-PSK 614
P L +++ L LNLS+N F GEVPT G F+ + + + GN KLCGG +LHLP C P
Sbjct: 586 PTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLL 645
Query: 615 RSRKS-TVLRLGKVGIPMIVSCLILSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSE 673
+RK VL + + + + ILS+ ++++ +R+K+ + M+ + P+VSYS+
Sbjct: 646 ENRKHFPVL---PISVSLAAALAILSSLYLLI-TWHKRTKKGAPSRTSMKGH-PLVSYSQ 700
Query: 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT 733
L +AT+ F+ +N++G GSFGSVYKG L VAVK+L L ALKSF AECE LRN
Sbjct: 701 LVKATDGFAPTNLLGSGSFGSVYKGKLNIQD-HVAVKVLKLENPKALKSFTAECEALRNM 759
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLNI 792
RHRNL+KI+T+CSSID +G DFKA+VY++M NGSLE+W+H ++N Q + L+L +R+ I
Sbjct: 760 RHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTI 819
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
+D+A A++YLH H P+VH D+K SNVLLD DMVAHV DFGLAR L TS+ Q
Sbjct: 820 LLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVD---GTSLIQQ 876
Query: 853 S-SSIGIKGTVGYVPP 867
S SS+G GT+GY P
Sbjct: 877 STSSMGFIGTIGYAAP 892
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1505 (534.8 bits), Expect = 2.4e-154, P = 2.4e-154
Identities = 328/769 (42%), Positives = 469/769 (60%)
Query: 34 DRLALLAIKSQLHDPLGVT-NSWNNSIN--LCQWAGVTCGHRH-QRVTELDLRHQNIGGS 89
D LALL+ KS L G + SWN S + C W GV CG RH RV +L LR N+ G
Sbjct: 34 DELALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRHPHRVVKLRLRSSNLAGI 93
Query: 90 LSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLL 149
+SP +GNLSFLR + L+ N+ G+IP+E+ L RL+ L+L NS SG+IP L + ++L
Sbjct: 94 ISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALGNLTSLS 153
Query: 150 SFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSG 208
N L G IP +G L ++LA N L+G +P+S G L + +L + N SG
Sbjct: 154 VLELTNNTLSGAIPSSLG-KLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAFNNLSG 212
Query: 209 TVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASN 268
+P ++N+SSL + N +G LP + LP+LQ + N F G IP S NASN
Sbjct: 213 AIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPASIGNASN 272
Query: 269 IEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAF 328
I I + +N F+G V GR++NL L+L + ND F+T LTNCS L+ +
Sbjct: 273 ISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCSNLQEVEL 332
Query: 329 EENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXXXXXEFNQLTGNIPR 388
+ GGVLP S++NLS+++ + + N+ISG++P N LTG++P
Sbjct: 333 GGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLANNSLTGSLPS 392
Query: 389 EIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLN 448
+L+NL+ + + +N L G++P ++GNLT +T++ + N G IP +LGN L +N
Sbjct: 393 SFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQIN 452
Query: 449 LSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP 508
L N IG +P +I +I LS LD+ +N+L GS+P E+G LKN+V + N+ SGE P
Sbjct: 453 LGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENP 512
Query: 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568
T+ C L+ +Q N GSIP++L LK + LDLS NNLSGQIP L ++ L L
Sbjct: 513 STIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSL 572
Query: 569 NLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSK-RSRKSTVLRLGKV 627
NLS+N F GEVPT GVF+N + + + GN +CGG ELHLP+C K R +K + L V
Sbjct: 573 NLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQILLLVV 632
Query: 628 GIPMIVSCLILSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMI 687
I ++ + + S ++++ +RR K+E + M+ + PM++Y +L +AT+ FSSS+++
Sbjct: 633 VICLVSTLAVFSLLYMLLTCHKRR-KKEVPATTSMQGH-PMITYKQLVKATDGFSSSHLL 690
Query: 688 GQGSFGSVYKGIL----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
G GSFGSVYKG GE + VAV++L L ALKSF AECE LRNTRHRNL+KI+T
Sbjct: 691 GSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVT 750
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLN 791
+CSSID +G DFKA+VY++M NGSLE+WLH ++N Q E L+L QR++
Sbjct: 751 ICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1268 (451.4 bits), Expect = 3.2e-129, P = 3.2e-129
Identities = 341/1005 (33%), Positives = 519/1005 (51%)
Query: 36 LALLAIKSQLHD----PLGVTNSWNNS--------INLCQWAGVTCGHRHQRVTELDLRH 83
+ +LA K H+ P +SW +S +++C W+GV C +V ELD+
Sbjct: 16 MTVLASKENDHELIKNPQNSLSSWISSSSSSSSMLVDVCNWSGVKCNKESTQVIELDISG 75
Query: 84 QNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLS 143
+++GG +SP + NL+ L ++L+ N F G+IP EIG L ETL LS
Sbjct: 76 RDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLH--ETLK------------QLS 121
Query: 144 SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI----GNLSIIYL 199
NLL G IP+++G +L ++ L N L G +P + + S+ Y+
Sbjct: 122 LSENLLH---------GNIPQELGLL-NRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYI 171
Query: 200 HVGENQFSGTVPPSLY-NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGS 258
+ N +G +P + + ++ L +LL N TG +P + + NL+ + N SG
Sbjct: 172 DLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNST-NLKWMDLESNMLSGE 230
Query: 259 IPES-FSNASNIEIIDLPINYFTG-----KVSIIFGRLKN---LWSLDLGINNLGSGGAN 309
+P S ++ + L N+F + F L N L L+L N+LG +
Sbjct: 231 LPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITS 290
Query: 310 DLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXX 369
+ +++ L + ++NR+ G +P I+NL +T + + N +SG IP
Sbjct: 291 SVRHLSV-----NLVQIHLDQNRIHGSIPPEISNL-LNLTLLNLSSNLLSGPIPRELCKL 344
Query: 370 XXXXXXXXEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNH 429
N LTG IP E+G + L + +S N L G+IP S GNL+ + L L NH
Sbjct: 345 SKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNH 404
Query: 430 LQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILT-ITTLSRFLDLGNNHLNGSLPLEVG 488
L G +P SLG C NL L+LS N L G +P ++++ + L +L+L +NHL+G +PLE+
Sbjct: 405 LSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELS 464
Query: 489 NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSC 548
+ ++++ +S N+ SG+IP L C LE ++ N F ++P SL L +KELD+S
Sbjct: 465 KMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSF 524
Query: 549 NNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHL 608
N L+G IP + S L++LN S+N G V KG FS T G+ LCG +
Sbjct: 525 NRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ- 583
Query: 609 PSCPSKRSRKSTVLR--LGKVGIPMIVSC---LILSTCF---IIVYARRRRSKQESSISV 660
+C K S +L L + P++ L+ + F + VYA+ +E
Sbjct: 584 -ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQ- 641
Query: 661 PMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL 720
+ +P +SY +L AT F++S++IG G FG VYKG+L N T VAVK+L+ K AL
Sbjct: 642 -NDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLD--PKTAL 697
Query: 721 K---SFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNG 777
+ SF EC++L+ TRHRNLI+IIT CS F ALV M NGSLE L+ G
Sbjct: 698 EFSGSFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYP--G 750
Query: 778 QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
+ +L LIQ +NI D+A I YLHH+ +VH DLKPSN+LLD +M A V+DFG++
Sbjct: 751 EYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGIS 810
Query: 838 RFLFARPFDTSMETQSS-SIG-----IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891
R + + + ++ T S S G + G+VGY+ P EYGMG AS G
Sbjct: 811 RLV--QGVEETVSTDDSVSFGSTDGLLCGSVGYIAP------------EYGMGKRASTHG 856
Query: 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRA 951
DVYS GV+LLE+ + RRPT+ + G +LHEF K P+ +E + L W +
Sbjct: 857 DVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDS-LEGIIEQALSRWKPQGKPE 915
Query: 952 KVE----ECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992
K E E ++ +I +G+ C+ +P R +M DV ++ ++ L
Sbjct: 916 KCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 2.3e-117, Sum P(3) = 2.3e-117
Identities = 185/553 (33%), Positives = 276/553 (49%)
Query: 33 TDRLALLAIKSQLHDPLGVTNSWN--NSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSL 90
++ +L++ K L +P + +SWN +S + C W GVTC RV L L ++ G +
Sbjct: 25 SETTSLISFKRSLENP-SLLSSWNVSSSASHCDWVGVTC--LLGRVNSLSLPSLSLRGQI 81
Query: 91 SPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLS 150
+ +L LR + LA N F G+IP EI L L+TL L+ NS +G +P LS LL
Sbjct: 82 PKEISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQLLY 141
Query: 151 FVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGT 209
N+ G +P S L + ++ N L+G +P IG LS + L++G N FSG
Sbjct: 142 LDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQ 201
Query: 210 VPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNI 269
+P + N+S L+N F G LP +I L +L + N SIP+SF N+
Sbjct: 202 IPSEIGNISLLKNFAAPSCFFNGPLPKEIS-KLKHLAKLDLSYNPLKCSIPKSFGELHNL 260
Query: 270 EIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFE 329
I++L G + G K+L SL L N+L +L + +LT + E
Sbjct: 261 SILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLT-------FSAE 313
Query: 330 ENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXXXXXXXEFNQLTGNIPRE 389
N+L G LP + + + + N+ SG IP N L+G+IPRE
Sbjct: 314 RNQLSGSLPSWMGKWKV-LDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRE 372
Query: 390 IGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449
+ +L+AI LS N L G I + + +L L++N + G+IP L L++L+L
Sbjct: 373 LCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDL 431
Query: 450 SDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV 509
N G +P+ + T L F N L G LP E+GN +L L +S NQ +GEIP
Sbjct: 432 DSNNFTGEIPKSLWKSTNLMEFT-ASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPR 490
Query: 510 TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLN 569
+ T L + ++ N F+G IP+ L S+ LDL NNL GQIP+ + L+ L+ L
Sbjct: 491 EIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLV 550
Query: 570 LSYNHFDGEVPTK 582
LSYN+ G +P+K
Sbjct: 551 LSYNNLSGSIPSK 563
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 1.6e-115, Sum P(2) = 1.6e-115
Identities = 278/815 (34%), Positives = 412/815 (50%)
Query: 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNS 133
+R+T I GSL +G L + LA N GE+PKEIG L +L ++L N
Sbjct: 193 KRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENE 252
Query: 134 FSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGN 193
FSG IP +S+C++L + Y+N LVG IP+++G LE + L RN L G +P IGN
Sbjct: 253 FSGFIPREISNCTSLETLALYKNQLVGPIPKELG-DLQSLEFLYLYRNGLNGTIPREIGN 311
Query: 194 LSI-IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGD 252
LS I + EN +G +P L N+ LE + L N TG +P+++ TL NL +
Sbjct: 312 LSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELS-TLKNLSKLDLSI 370
Query: 253 NYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD 312
N +G IP F + ++ L N +G + G +LW LD+ N+L SG
Sbjct: 371 NALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHL-SGRIPS-- 427
Query: 313 FVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSXXXXXXXX 372
++ + +N + +L N L G +P I T + + + N + G PS
Sbjct: 428 YLCLHSN---MIILNLGTNNLSGNIPTGITTCKT-LVQLRLARNNLVGRFPSNLCKQVNV 483
Query: 373 XXXXXEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG 432
N+ G+IPRE+G LQ + L+ N G +P +G L+ + L +SSN L G
Sbjct: 484 TAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTG 543
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKN 492
+P + NCK L L++ N G +P ++ ++ L L L NN+L+G++P+ +GNL
Sbjct: 544 EVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLE-LLKLSNNNLSGTIPVALGNLSR 602
Query: 493 LVALYISGNQFSGEIPVTLTGCTGLEI-FHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551
L L + GN F+G IP L TGL+I ++ N G IP L +L ++ L L+ NNL
Sbjct: 603 LTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNL 662
Query: 552 SGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGS-NEL--HL 608
SG+IP NLS L N SYN G +P + N + GN LCG N+
Sbjct: 663 SGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQ 719
Query: 609 PSCPSKRSRKSTVLRLGKV-GIPM-IVSCLILSTCFIIVYARRR------RSKQESSIS- 659
P PS+ + K +R K+ I ++ + L +IVY RR S Q+ S
Sbjct: 720 PFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSE 779
Query: 660 VPMEQYFPM---VSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ 716
+ ++ YFP ++ +L AT+ F S ++G+G+ G+VYK +L T K+ + +
Sbjct: 780 MSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHE 839
Query: 717 KG----ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL 772
G SF AE L N RHRN++K+ C+ +G++ L+YEYM GSL E L
Sbjct: 840 GGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNH---QGSNL--LLYEYMPKGSLGEIL 894
Query: 773 HQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832
H + C+L +R IA+ A + YLHH C+P I H D+K +N+LLD AHV
Sbjct: 895 HDPS-----CNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 949
Query: 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPP 867
DFGLA+ + P SM I G+ GY+ P
Sbjct: 950 DFGLAKVI-DMPHSKSMSA------IAGSYGYIAP 977
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4468 | 0.9458 | 0.9336 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00050192 | hypothetical protein (1011 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 997 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-108 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 9e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-04 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 357 bits (918), Expect = e-108
Identities = 301/1036 (29%), Positives = 473/1036 (45%), Gaps = 150/1036 (14%)
Query: 13 FIFSFSLLLHSQSFSAHTNETDRLALLAIKSQLHDPLGVTNSWNNSINLCQWAGVTCGHR 72
IF L + S H E + LL+ KS ++DPL ++WN+S ++C W G+TC +
Sbjct: 12 LIFMLFFLFLNFSML-HAEELE--LLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN- 67
Query: 73 HQRVTELDLRHQNIGGSLS------PYV-------GNLSF------------LRYINLAT 107
RV +DL +NI G +S PY+ LS LRY+NL+
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 108 NNF----------------------HGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSC 145
NNF GEIP +IG L+ L L N GKIP +L++
Sbjct: 128 NNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 146 SNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGEN 204
++L N LVG+IP ++G L+ I L N+L+G +P IG L S+ +L + N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 205 QFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFS 264
+G +P SL N+ +L+ + L N +G +P I +L L + DN SG IPE
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIPELVI 305
Query: 265 NASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLK 324
N+EI+ L N FTGK+ + LT+ +L+
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVA------------------------------LTSLPRLQ 335
Query: 325 VLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTG 384
VL N+ G +P ++ +T + + N ++G IP G+ + NL L + N L G
Sbjct: 336 VLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394
Query: 385 NIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444
IP+ +G R+L+ + L N G +PS L L+ L +S+N+LQG I + +L
Sbjct: 395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454
Query: 445 VSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFS 504
L+L+ NK G +P + LDL N +G++P ++G+L L+ L +S N+ S
Sbjct: 455 QMLSLARNKFFGGLPD--SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 505 GEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSF 564
GEIP L+ C L + N G IP S + + +LDLS N LSG+IP+ L N+
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572
Query: 565 LEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRL 624
L +N+S+NH G +P+ G F + GN LCGG LP C KR RK+
Sbjct: 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC--KRVRKTPSWWF 630
Query: 625 GKVGIPMIVSCLILSTCFIIVYARRRRS----KQESSISVPMEQYFPMVSYSELSEATNE 680
+ + ++ F V+ R R + + E+ Q+F S S N+
Sbjct: 631 -YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD--SKVSKSITIND 687
Query: 681 FSSS----NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHR 736
SS N+I +G G+ YKG +NG VK +N + S +A+ + +H
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-SEIAD---MGKLQHP 743
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N++K+I +C S KGA L++EY++ +L E L +LS +R IAI +
Sbjct: 744 NIVKLIGLCRS--EKGA---YLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGI 789
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A A+ +LH C P +V G+L P +++D H+ R T + SS
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS- 842
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
YV P E + + D+Y G++L+E+ T + P + F
Sbjct: 843 ------AYVAP------------ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 917 GLTLHEFCKMALPEKVMET-VDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
++ E+ + + ++ +DPS+ S + +V V+ + + C+ P R
Sbjct: 885 HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE------IVEVMNLALHCTATDPTAR 938
Query: 976 MEMRDVLAKLCAARQT 991
DVL L +A ++
Sbjct: 939 PCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 4e-41
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 36/220 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALK-SFVAECEVLRNTRHRNLIKIITVC 745
+G+G FG+VY + G VA+KI+ +L + E E+L+ H N++K+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ LV EY + GSL++ L ++ G+ LS + L I + + +EYLH
Sbjct: 61 EDENHLY-----LVMEYCEGGSLKDLLKENEGK-----LSEDEILRILLQILEGLEYLHS 110
Query: 806 HCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+ I+H DLKP N+LLD D ++DFGL++ L +S I GT Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT--------SDKSLLKTIVGTPAY 159
Query: 865 VPPGNIAKMLNLPCLEYGMG-SEASVTGDVYSLGVMLLEM 903
+ P E +G S D++SLGV+L E+
Sbjct: 160 MAP------------EVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 2e-39
Identities = 84/283 (29%), Positives = 121/283 (42%), Gaps = 52/283 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
+G+GSFG VY + G VA+K++ K + + E ++L+ +H N++++ V
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
F+ D LV EY + G L + L + LS + + SA+EYLH
Sbjct: 66 ----FEDEDKLYLVMEYCEGGDLFDLLKKRGR------LSEDEARFYLRQILSALEYLHS 115
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
IVH DLKP N+LLD D ++DFGLAR L T+ GT Y+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF---------VGTPEYM 163
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCK 925
P ++L YG D++SLGV+L E+ T + P F G L E K
Sbjct: 164 AP----EVLL--GKGYGKAV------DIWSLGVILYELLTGKPP----FPGDDQLLELFK 207
Query: 926 MALPEKV-----METVDPSL------LLAWSDGRRRAKVEECL 957
K + P LL D +R EE L
Sbjct: 208 KIGKPKPPFPPPEWDISPEAKDLIRKLLVK-DPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 83/276 (30%), Positives = 127/276 (46%), Gaps = 46/276 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G GSFG+VYK G VAVKIL + ++ E +LR H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
F+ D LV EY + G L ++L + LS + IA+ + +EYLH
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRGGP------LSEDEAKKIALQILRGLEYLH 115
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+ I+H DLKP N+LLD + V ++DFGLA+ L +++ SS GT Y
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKL--------LKSSSSLTTFVGTPWY 164
Query: 865 VPPGNIAKMLNLPCLE-YGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923
+ P E G+ DV+SLGV+L E+ T + P F G +
Sbjct: 165 MAP------------EVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGE---NIL 205
Query: 924 CKMALPEKVMETVDPSLLLAWSDGRRRAK--VEECL 957
++ L +++ WS G AK +++CL
Sbjct: 206 DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCL 241
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 36/225 (16%)
Query: 687 IGQGSFGSVYKGIL----GENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G+FG VYKG L T VAVK L + + F+ E +++ H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+ VC+ +G +V EYM G L ++L + + L+L L +A+ +A +E
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQIAKGME 116
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YL VH DL N L+ ++V +SDFGL+R ++ + K
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR-----------KRG 162
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
G +P K + L+ G + S DV+S GV+L E+FT
Sbjct: 163 GGKLPI----KWMAPESLKDGKFTSKS---DVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 5e-37
Identities = 80/306 (26%), Positives = 132/306 (43%), Gaps = 59/306 (19%)
Query: 686 MIGQGSFGSVYKGIL----GENGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIK 740
+G+G+FG VYKG L VAVK L ++ F+ E ++R H N++K
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
++ VC+ + +V EYM G L ++L ++ + +LSL L+ A+ +A +
Sbjct: 66 LLGVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGM 116
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
EYL +H DL N L+ ++V +SDFGL+R L + G K
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL------YDDDYYKVKGG-KL 166
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLT 919
+ ++ P L+ G + S DV+S GV+L E+FT P G++
Sbjct: 167 PIRWMAP---------ESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEP-----YPGMS 209
Query: 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979
E V+E + G R K C + ++ + C E P +R
Sbjct: 210 NAE---------VLEYLK--------KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFS 252
Query: 980 DVLAKL 985
+++ L
Sbjct: 253 ELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 80/306 (26%), Positives = 136/306 (44%), Gaps = 60/306 (19%)
Query: 686 MIGQGSFGSVYKGIL----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIK 740
+G+G+FG VYKG L G+ VAVK L + ++ F+ E ++R H N++K
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
++ VC+ + +V EYM+ G L +L ++ + LSL L+ A+ +A +
Sbjct: 66 LLGVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGM 115
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
EYL +H DL N L+ ++V +SDFGL+R L + G K
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL------YDDDYYRKRGG-KL 165
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLT 919
+ ++ P L+ G + S DV+S GV+L E+FT +P G++
Sbjct: 166 PIRWMAP---------ESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQP-----YPGMS 208
Query: 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979
E+V+E + +G R + C + + + C E P +R
Sbjct: 209 ---------NEEVLEYLK--------NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 980 DVLAKL 985
+++ L
Sbjct: 252 ELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 87/309 (28%), Positives = 137/309 (44%), Gaps = 56/309 (18%)
Query: 685 NMIGQGSFGSVYKGIL---GENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIK 740
+G+G+FG VYKG L T VAVK L + K F+ E V++ H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD---LSLIQRLNIAIDMA 797
++ VC+ + + LV EYM+ G L ++L +S + LSL L+ AI +A
Sbjct: 61 LLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+EYL VH DL N L+ D+V +SDFGL+R ++
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY-----------DDDYY 161
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQG 916
K T G +P + + L+ G+ + S DV+S GV+L E+FT P
Sbjct: 162 RKKTGGKLP----IRWMAPESLKDGIFTSKS---DVWSFGVLLWEIFTLGATP-----YP 209
Query: 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976
GL+ E V+E + G R K E C + + ++C P +R
Sbjct: 210 GLSNEE---------VLEYL--------RKGYRLPKPEYCPDELYELMLSCWQLDPEDRP 252
Query: 977 EMRDVLAKL 985
+++ +L
Sbjct: 253 TFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRN 737
E++ ++G+GSFGSVY + + G +AVK + L + L++ E +L + +H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+++ + + + EY+ GSL L + PE +I++ +
Sbjct: 61 IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLKKFGKLPE----PVIRKY--TRQIL 111
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+ YLH + IVH D+K +N+L+D D V ++DFG A+ L +ET +
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRL------GDIETGEGTGS 162
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
++GT ++ P E G E D++SLG ++EM T + P
Sbjct: 163 VRGTPYWMAP------------EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 68/261 (26%), Positives = 116/261 (44%), Gaps = 53/261 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
+GQGS G VYK G A+K +++ + K + E + LR+ ++K
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63
Query: 746 SSIDFKGADFK----ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
GA +K ++V EYM GSL + L + PE L+ I A + ++
Sbjct: 64 ----CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV-LAYI-----ARQILKGLD 113
Query: 802 YLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
YLH H I+H D+KPSN+L++ ++DFG+++ L + +++ ++ +
Sbjct: 114 YLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVL-----ENTLDQCNTFV--- 161
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919
GTV Y+ P I Y + D++SLG+ LLE + P + G +
Sbjct: 162 GTVTYMSPERIQGE------SYSYAA------DIWSLGLTLLECALGKFP--FLPPGQPS 207
Query: 920 LHEFCKMALPEKVMETVDPSL 940
L + + + PSL
Sbjct: 208 F-----FELMQAICDGPPPSL 223
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 46/236 (19%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLI 739
F IG+G FG VYK G VA+K++ L K + + E ++L+ +H N++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN------IA 793
K S K D +V E+ GSL++ L S Q L +
Sbjct: 61 KYYG---SYLKK--DELWIVMEFCSGGSLKDLLK-----------STNQTLTESQIAYVC 104
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
++ +EYLH + I+H D+K +N+LL D + DFGL+ L +M
Sbjct: 105 KELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---- 157
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT ++ P I Y + D++SLG+ +E+ + P
Sbjct: 158 -----VGTPYWMAPEVINGK------PYDYKA------DIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 69/245 (28%), Positives = 119/245 (48%), Gaps = 44/245 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVK--ILNLMQKGALKSFVAECEVLRNTRHRN 737
+ ++IG+G+FG VYKG+ E G FVA+K L +++ ALKS + E ++L+N +H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE-VCDLSLIQRLNIAIDM 796
++K I + +D ++ EY +NGSL + + + PE + + + Q L
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ----- 110
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ YLH + ++H D+K +N+L D V ++DFG+A L + +S
Sbjct: 111 --GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL------NDVSKDDAS- 158
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR------RRPT 910
+ GT ++ P I S AS D++SLG ++E+ T P
Sbjct: 159 -VVGTPYWMAPEVIE------------MSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
Query: 911 NCMFQ 915
+F+
Sbjct: 206 AALFR 210
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 684 SNMIGQGSFGSVYKG---ILGEN-GTFVAVKILNLMQKGALKS-FVAECEVLRNTRHRNL 738
+G+G FG V LG+N G VAVK LN + +S F E E+LR H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+K VC G L+ EY+ +GSL ++L + Q ++L + L + +
Sbjct: 69 VKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHRDQ-----INLKRLLLFSSQICK 120
Query: 799 AIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL-FARPFDTSMETQSSSI 856
++YL +H DL N+L++ + + +SDFGLA+ L + + E S I
Sbjct: 121 GMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910
Y P CL S+ S DV+S GV L E+FT P+
Sbjct: 177 -----FWYAP----------ECL---RTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 72/227 (31%), Positives = 109/227 (48%), Gaps = 38/227 (16%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
E IG+G FG V G G VAVK L A ++F+AE V+ RH NL
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNL 62
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
++++ V +G +V EYM GSL ++L +S G+ ++L Q+L A+D+
Sbjct: 63 VQLLGVV----LQGNPL-YIVTEYMAKGSLVDYL-RSRGRAV---ITLAQQLGFALDVCE 113
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+EYL + VH DL NVL+ D+VA VSDFGLA+ + S S + +
Sbjct: 114 GMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPV 163
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
K T P + + + S DV+S G++L E+++
Sbjct: 164 KWTA----PEALRE------------KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/227 (30%), Positives = 102/227 (44%), Gaps = 33/227 (14%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLI 739
EF+ +G G FG V++G L +N VA+KIL + F E + L+ RH++LI
Sbjct: 7 EFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+ VCS + ++ E M+ GSL +L GQ L + +++A +A
Sbjct: 66 SLFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEG 116
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+ YL +H DL N+L+ D+V V+DFGLAR L + I K
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYL---SSDKKIPYK 169
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
T P +G S S DV+S G++L EMFT
Sbjct: 170 WT---APEA----------ASHGTFSTKS---DVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 72/232 (31%), Positives = 107/232 (46%), Gaps = 37/232 (15%)
Query: 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKI 741
N IG G+FG VY + + G +AVK + + +K E +VL +H NL+K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63
Query: 742 ITVCSSIDFKGADF---KALVY-EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+ G + K ++ EY G+LEE L +G+ D +I+ + +
Sbjct: 64 --------YYGVEVHREKVYIFMEYCSGGTLEELLE--HGRIL--DEHVIRVY--TLQLL 109
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+ YLH H IVH D+KP+N+ LDH+ V + DFG A L T E S
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQS--- 162
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ GT Y+ P I G G + D++SLG ++LEM T +RP
Sbjct: 163 LAGTPAYMAPEVITG-------GKGKGHGRAA--DIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 46/263 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVL-RNTR 734
++F +IG+GSF +V E A+KIL+ L+++ +K E EVL R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H +IK+ F+ + V EY NG L +++ + L A
Sbjct: 61 HPGIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRK------YGSLDEKCTRFYAA 109
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL-------FARPFDT 847
++ A+EYLH I+H DLKP N+LLD DM ++DFG A+ L + T
Sbjct: 110 EILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 848 SMETQSSSIGIK-----GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
++++Q + GT YV P ++LN A + D+++LG ++ +
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSP----ELLN--------EKPAGKSSDLWALGCIIYQ 214
Query: 903 MFTRRRPTNCMFQGGLTLHEFCK 925
M T + P F+G F K
Sbjct: 215 MLTGKPP----FRGSNEYLTFQK 233
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-23
Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 30/228 (13%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRH-RNLIKII 742
+G+GSFG VY L + VA+K+L + ++ F+ E ++L + H N++K+
Sbjct: 8 LGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
F+ LV EY+ GSLE+ L + LS + L I + SA+EY
Sbjct: 65 DF-----FQDEGSLYLVMEYVDGGSLEDLLKKI---GRKGPLSESEALFILAQILSALEY 116
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
LH I+H D+KP N+LLD D V + DFGLA+ L ++ + GT
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLL--PDPGSTSSIPALPSTSVGT 171
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GY+ P + + + AS + D++SLG+ L E+ T P
Sbjct: 172 PGYMAPEVLLGLSL---------AYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 7e-23
Identities = 86/321 (26%), Positives = 142/321 (44%), Gaps = 77/321 (23%)
Query: 687 IGQGSFGSVYKG-----ILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIK 740
+G+G+FG V+ G + VAVK L A K F E E+L N +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNG---------QPEVCDLSLIQRLN 791
VC+ D +V+EYM++G L ++L +S+G + +L+L Q L
Sbjct: 73 FYGVCTE-----GDPPIMVFEYMEHGDLNKFL-RSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 792 IAIDMASAIEYL--HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
IA+ +AS + YL H VH DL N L+ +D+V + DFG++R ++ +
Sbjct: 127 IAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY---- 177
Query: 850 ETQSSSIGIKGT----VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ G + ++PP +I Y + S DV+S GV+L E+FT
Sbjct: 178 ------YRVGGHTMLPIRWMPPESIM---------YRKFTTES---DVWSFGVVLWEIFT 219
Query: 906 R-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIG 964
++P + L+ E V+E + GR + C V I
Sbjct: 220 YGKQP---WYG--LSNEE---------VIECIT--------QGRLLQRPRTCPSEVYDIM 257
Query: 965 VACSMESPIERMEMRDVLAKL 985
+ C P +R+ ++D+ +L
Sbjct: 258 LGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 7e-23
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 42/237 (17%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKII 742
IG+GSFG VY +G +K ++L M + + + E ++L+ H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN--GQPEVCDLSLIQRLNIAIDMASAI 800
F+ +V EY G L + + + G+P Q L+ + + A+
Sbjct: 66 E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP----FPEEQILDWFVQLCLAL 116
Query: 801 EYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+YLH I+H D+KP N+ L + + + DFG+++ L ++++ + +
Sbjct: 117 KYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKTVV--- 164
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GT Y+ P N P Y + S D++SLG +L E+ T + P F+G
Sbjct: 165 GTPYYLSPELCQ---NKP---Y---NYKS---DIWSLGCVLYELCTLKHP----FEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+GSFG V + G A+K+L ++++ ++ + E +L H ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ F+ + LV EY G L L + E + A ++ A+EYL
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGELFSHLSKEGRFSE----ERARF--YAAEIVLALEYL 109
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H I++ DLKP N+LLD D ++DFGLA+ L + T+ GT
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN--------TFCGTPE 158
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P E +G D +SLGV+L EM T + P
Sbjct: 159 YLAP------------EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 35/225 (15%)
Query: 685 NMIGQGSFGSVYKGILGENG---TFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIK 740
+IG G FG V +G L G VA+K L F+ E ++ H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ V + K ++ EYM+NGSL+++L +++G+ ++ Q + + +AS +
Sbjct: 70 LEGVVT----KSRPV-MIITEYMENGSLDKFLRENDGK-----FTVGQLVGMLRGIASGM 119
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
+YL VH DL N+L++ ++V VSDFGL+R L + + T+ I I+
Sbjct: 120 KYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW 174
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
T P IA Y + AS DV+S G+++ E+ +
Sbjct: 175 TA----PEAIA---------YRKFTSAS---DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALK--SFVAECEVLRNTRHRNLIKIITV 744
+G G FG V+ G T VAVK L + G + +F+ E ++++ RH L+++ V
Sbjct: 14 LGAGQFGEVWMG-TWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
CS + +V EYM GSL ++L G+ L L Q +++A +A + YL
Sbjct: 70 CS-----EEEPIYIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYLE 120
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+H DL N+L+ ++V ++DFGLAR + + + + IK T
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR---EGAKFPIKWTA-- 172
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
E ++ DV+S G++L E+ T R
Sbjct: 173 --------------PEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 84/292 (28%), Positives = 129/292 (44%), Gaps = 60/292 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V++G L N T VAVK L + G + K F+AE ++++ RH LI++ V
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
C+ + +V E M+ GSL E+L G+ L L Q +++A +AS + YL
Sbjct: 70 CTL-----EEPIYIVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAYLE 120
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ-SSSIGIKGTVG 863
+H DL NVL+ + + V+DFGLAR + E + G K +
Sbjct: 121 AQ---NYIHRDLAARNVLVGENNICKVADFGLARVI--------KEDIYEAREGAKFPIK 169
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923
+ P E + + S+ DV+S G++L E+ T R M G+T E
Sbjct: 170 WTAP------------EAALYNRFSIKSDVWSFGILLTEIVTYGR----MPYPGMTNAE- 212
Query: 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
V++ VD G R C + I + C E P +R
Sbjct: 213 --------VLQQVD--------QGYRMPCPPGCPKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 65/235 (27%), Positives = 114/235 (48%), Gaps = 42/235 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G++G VYK + G VA+K + + ++G + + E ++L+ RH N++++ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+S KG+ + +V+EYM + L L + + Q + ++YLH
Sbjct: 67 VTS-KGKGSIY--MVFEYMDH-DLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQYLH 117
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS---IGIKGT 861
+ I+H D+K SN+L+++D V ++DFGLAR T + + I T
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPY------TKRNSADYTNRVI----T 164
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
+ Y PP L L YG D++S+G +L E+F +P +FQG
Sbjct: 165 LWYRPP-----ELLLGATRYGPEV------DMWSVGCILAELFL-GKP---IFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 58/226 (25%), Positives = 115/226 (50%), Gaps = 32/226 (14%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLI 739
+ + + +G G +G VY+G+ + VAVK L ++ F+ E V++ +H NL+
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+++ VC+ + F ++ E+M G+L ++L + N Q +++ + L +A ++SA
Sbjct: 66 QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVLLYMATQISSA 116
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+EYL +H DL N L+ + + V+DFGL+R + + +T ++ G K
Sbjct: 117 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TGDTYTAHAGAK 166
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ + P ++A ++ S+ DV++ GV+L E+ T
Sbjct: 167 FPIKWTAPESLAY------------NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTRHRN 737
E + +G G FG V+ G VA+K ++++GA+ F+ E +V+ H N
Sbjct: 5 ELTFLKELGSGQFGVVHLGKW-RGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPN 60
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
L+++ VC+ + F +V EYM NG L +L + + + L++ D+
Sbjct: 61 LVQLYGVCTK---QRPIF--IVTEYMANGCLLNYLRE---RKGKLGTEWL--LDMCSDVC 110
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
A+EYL + +H DL N L+ D V VSDFGLAR++ + +SS G
Sbjct: 111 EAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-------TSSQG 160
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
K V + PP E S S DV+S GV++ E+F+
Sbjct: 161 TKFPVKWAPP------------EVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 91/300 (30%), Positives = 135/300 (45%), Gaps = 63/300 (21%)
Query: 687 IGQGSFGSVYKG-ILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
IG+G FG+V +G G+ VAVK N+ ++F+ E V+ H+NL++++ V
Sbjct: 14 IGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV- 67
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
I G +V E M G+L +L ++ G+ V S+IQ L ++D+A +EYL
Sbjct: 68 --ILHNGL---YIVMELMSKGNLVNFL-RTRGRALV---SVIQLLQFSLDVAEGMEYLE- 117
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
+VH DL N+L+ D VA VSDFGLAR SM +S + +K T
Sbjct: 118 --SKKLVHRDLAARNILVSEDGVAKVSDFGLARV-------GSMGVDNSKLPVKWT---A 165
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCK 925
P L++ S S DV+S GV+L E+F+ R + K
Sbjct: 166 PEA----------LKHKKFSSKS---DVWSYGVLLWEVFSYGR------------APYPK 200
Query: 926 MALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
M+L E V E V+ G R E C V + +C P +R + KL
Sbjct: 201 MSLKE-VKECVE--------KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 72/238 (30%), Positives = 113/238 (47%), Gaps = 34/238 (14%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA-ECEVLRNTRHRNL 738
E N IG G+ G+VYK I G A+K++ + ++ + E E+LR+ H N+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+K C + + + L+ E+M GSLE + + D+ A + S
Sbjct: 135 VK----CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADEQFLADV--------ARQILS 179
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
I YLH IVH D+KPSN+L++ ++DFG++R L +M+ +SS+
Sbjct: 180 GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSV-- 229
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GT+ Y+ P I LN G+ GD++SLGV +LE + R P QG
Sbjct: 230 -GTIAYMSPERINTDLN-------HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279
|
Length = 353 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 8e-20
Identities = 72/232 (31%), Positives = 119/232 (51%), Gaps = 39/232 (16%)
Query: 686 MIGQGSFGSVYKGIL---GENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIK- 740
+IG G FG V +G L G+ FVA+K L + + F++E ++ H N+I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 741 --IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
++T + ++ E+M+NG+L+ +L Q++GQ ++IQ + + +A+
Sbjct: 71 EGVVTKSRPV--------MIITEFMENGALDSFLRQNDGQ-----FTVIQLVGMLRGIAA 117
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
++YL + VH DL N+L++ ++V VSDFGL+RFL DTS T +SS+G
Sbjct: 118 GMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGG 171
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE-MFTRRRP 909
K + + P IA Y + AS DV+S G+++ E M RP
Sbjct: 172 KIPIRWTAPEAIA---------YRKFTSAS---DVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALK-SFVAECEVLRNTRHRNLIKIITVC 745
IG+G+FG VYKG+L N VAVK LK F+ E E+L+ H N++K+I VC
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+V E + GSL +L + + L++ + L +++D A+ +EYL
Sbjct: 62 VQ-----KQPIYIVMELVPGGSLLTFLRKKKNR-----LTVKKLLQMSLDAAAGMEYLES 111
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS---SIGIKGTV 862
+H DL N L+ + V +SDFG+ +R + + T S I IK T
Sbjct: 112 KN---CIHRDLAARNCLVGENNVLKISDFGM-----SREEEGGIYTVSDGLKQIPIKWT- 162
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
P L YG + S DV+S G++L E F+
Sbjct: 163 --APEA----------LNYGRYTSES---DVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 84/320 (26%), Positives = 140/320 (43%), Gaps = 70/320 (21%)
Query: 687 IGQGSFGSVYKGILGE--------NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
+G+G+FG V+ L E + VAVK L A K F E E+L N +H ++
Sbjct: 13 LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQS--------NGQPEVC--DLSLIQ 788
+K VC D +V+EYM++G L ++L +GQP +L L Q
Sbjct: 70 VKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
L+IA +AS + YL VH DL N L+ +++ + DFG++R +++ D
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST--DYY 179
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-R 907
+ + I+ ++PP +I M + + DV+S GV+L E+FT +
Sbjct: 180 RVGGHTMLPIR----WMPPESI------------MYRKFTTESDVWSFGVILWEIFTYGK 223
Query: 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVAC 967
+P FQ +V+E + + GR + C V I + C
Sbjct: 224 QP---WFQLS-----------NTEVIECI--------TQGRVLERPRVCPKEVYDIMLGC 261
Query: 968 SMESPIERMEMRDVLAKLCA 987
P +R+ ++++ L A
Sbjct: 262 WQREPQQRLNIKEIYKILHA 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 34/231 (14%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL---GENGTFVAVKILNL-MQKGALKSFVAECEVLRNTR 734
+ + +IG G FG V++GIL G VA+K L + + F++E ++
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H N+I++ V + FK A ++ EYM+NG+L+++L +G + S Q + +
Sbjct: 65 HHNIIRLEGVVTK--FKPA---MIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLR 114
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+A+ ++YL VH DL N+L++ ++ VSDFGL+R L P E +
Sbjct: 115 GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP-----EGTYT 166
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ G K + + P IA Y + AS DV+S G+++ E+ +
Sbjct: 167 TSGGKIPIRWTAPEAIA---------YRKFTSAS---DVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 77/319 (24%), Positives = 135/319 (42%), Gaps = 69/319 (21%)
Query: 687 IGQGSFGSVY----KGILGE-NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G+FG V+ +L E + VAVK L + A + F E E+L +H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLH----------QSNGQPEVCDLSLIQRLN 791
VC+ +V+EYM++G L +L L+L Q L
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA-PGQLTLGQMLA 126
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
IA +AS + YL VH DL N L+ +V + DFG++R +++ T
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--------T 175
Query: 852 QSSSIGIKGT--VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RR 908
+G + + ++PP +I + + + D++S GV+L E+FT ++
Sbjct: 176 DYYRVGGRTMLPIRWMPPESI------------LYRKFTTESDIWSFGVVLWEIFTYGKQ 223
Query: 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACS 968
P +Q T E ++ + GR + C V I C
Sbjct: 224 P---WYQLSNT--------------EAIE-----CITQGRELERPRTCPPEVYAIMQGCW 261
Query: 969 MESPIERMEMRDVLAKLCA 987
P +RM ++D+ ++L A
Sbjct: 262 QREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 40/223 (17%)
Query: 687 IGQGSFGSVYKGILGE-NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
IG+G FG V +LG+ G VAVK + ++F+AE V+ RH NL++++ V
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
++ KG + +V EYM GSL ++L +S G+ + L L ++D+ A+EYL
Sbjct: 69 --VEEKGGLY--IVTEYMAKGSLVDYL-RSRGRSVLGGDCL---LKFSLDVCEAMEYLEA 120
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
+ VH DL NVL+ D VA VSDFGL + E S+ K V +
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 166
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
P + + S DV+S G++L E+++ R
Sbjct: 167 APEALREKK------------FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTRHR 736
+E + IG G FG V+ G VA+K + ++GA+ + F+ E +V+ H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYW-LEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHP 59
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
L+++ VC + + LV+E+M++G L ++L G+ S L + +D+
Sbjct: 60 KLVQLYGVC----TERSPI-CLVFEFMEHGCLSDYLRAQRGK-----FSQETLLGMCLDV 109
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ YL ++H DL N L+ + V VSDFG+ RF+ + +SS
Sbjct: 110 CEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-------TSST 159
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
G K V + P + S S DV+S GV++ E+F+ +
Sbjct: 160 GTKFPVKWSSP---------EVFSFSKYSSKS---DVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 6e-18
Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITV 744
+G+G++G VYK + G VA+K + L + G + + E +L+ +H N++K++ V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 745 CSSIDFKGADFK-ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ K LV+EY L+++L + G LS +I + + Y
Sbjct: 67 IHTER------KLYLVFEYCDM-DLKKYLDKRPG-----PLSPNLIKSIMYQLLRGLAYC 114
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
H H I+H DLKP N+L++ D V ++DFGLAR
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 7e-18
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 64/241 (26%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVK-ILNLMQ-----KGALKSFVAECEVLRNTRHRNLIK 740
IG G++G V + G VA+K I N+ K L+ E ++LR+ RH N+I
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENIIG 63
Query: 741 IITVCSSIDFKGADFKAL--VYEYMQNGSLEEWLHQ--SNGQPEVCDLSL--IQRLNIAI 794
++ + DF + V E M+ LH+ + QP L+ IQ
Sbjct: 64 LLDI--LRPPSPEDFNDVYIVTELMETD-----LHKVIKSPQP----LTDDHIQY--FLY 110
Query: 795 DMASAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
+ ++YLH + ++H DLKPSN+L++ + + DFGLAR + + T+
Sbjct: 111 QILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 853 SSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
YV P + +L+ Y ++ D++S+G + E+ TR
Sbjct: 166 -----------YVVTRWYRAP-EL--LLS--SSRYT----KAI--DIWSVGCIFAELLTR 203
Query: 907 R 907
+
Sbjct: 204 K 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 40/225 (17%)
Query: 687 IGQGSFGSVYKGILGENGTF-VAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKIIT 743
+GQG FG V+ G NGT VA+K L + G + ++F+ E +V++ RH L+++
Sbjct: 14 LGQGCFGEVWMGTW--NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
V S + +V EYM GSL ++L G+ L L Q +++A +AS + Y+
Sbjct: 69 VVSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYV 118
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
+ VH DL+ +N+L+ ++V V+DFGLAR + + ++ G K +
Sbjct: 119 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIK 168
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
+ P E + ++ DV+S G++L E+ T+ R
Sbjct: 169 WTAP------------EAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 45/229 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL-KSFVAECEVLRNTRHRNLIKIITVC 745
+G G+ G V K + G +AVK + L A+ K + E ++L ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV------ 62
Query: 746 SSIDFKGADFK----ALVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAIDMASAI 800
F GA + ++ EYM GSL++ L + G+ PE ++ + IA+ + +
Sbjct: 63 ---GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE----RILGK--IAVAVLKGL 113
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH + I+H D+KPSN+L++ + DFG++ L T + G
Sbjct: 114 TYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----------G 161
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T Y+ P I G++ SV D++SLG+ L+E+ T R P
Sbjct: 162 TSSYMAPERIQ------------GNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 81/330 (24%), Positives = 141/330 (42%), Gaps = 67/330 (20%)
Query: 673 ELSEATNEFSSSNMIGQGSFGSVYKG-ILGENG----TFVAVKILNLMQKGALKS-FVAE 726
E+ + F +G+G+FG VYKG + G N T VA+K L + ++ F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 727 CEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCD- 783
E++ + +H N++ ++ VC+ +++EY+ +G L E+L + +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 784 -------LSLIQRLNIAIDMASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835
L L+IAI +A+ +EYL HH VH DL N L+ + +SDFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYS 895
L+R +++ + QS S+ V ++PP I + + + D++S
Sbjct: 170 LSRDIYSADY---YRVQSKSL---LPVRWMPPEAI------------LYGKFTTESDIWS 211
Query: 896 LGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEE 955
GV+L E+F+ F ++V+E + LL E+
Sbjct: 212 FGVVLWEIFSYGLQPYYGFSN-------------QEVIEMIRSRQLLPCP--------ED 250
Query: 956 CLVTVIRIGVACSMESPIERMEMRDVLAKL 985
C V + + C E P R +D+ +L
Sbjct: 251 CPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 68/238 (28%), Positives = 109/238 (45%), Gaps = 39/238 (16%)
Query: 681 FSSSNMIGQGSFGSVYKGILG-ENGTF--VAVKILNL--MQKGALKSFVAECEVLRNTRH 735
++G+G FGSV +G L ++G+ VAVK + L ++ F++E +++ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 736 RNLIKIITVCSSIDFKGADFKALV-YEYMQNGSLEEWLHQSN--GQPEVCDLSLIQRLNI 792
N++K+I VC K +V +M++G L +L S G PE L L L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE--KLPLQTLLKF 118
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
+D+A +EYL + +H DL N +L DM V+DFGL++ +++
Sbjct: 119 MVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--------- 166
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA----SVTGDVYSLGVMLLEMFTR 906
Y G IAKM P + S A + DV++ GV + E+ TR
Sbjct: 167 ----------DYYRQGRIAKM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 66/245 (26%), Positives = 110/245 (44%), Gaps = 56/245 (22%)
Query: 687 IGQGSFGSVYK----GIL-GENGTFVAVKILN-----LMQKGALKSFVAECEVLRNTRHR 736
IGQG+FG V++ G+L E T VAVK+L MQ F E ++ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAEFDHP 68
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEE--------WLHQSNGQ--------PE 780
N++K++ VC+ L++EYM G L E +
Sbjct: 69 NIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 781 VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
LS ++L IA +A+ + YL + VH DL N L+ +MV ++DFGL+R +
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
++ D +++ +I I+ ++PP +I + + DV++ GV+L
Sbjct: 181 YSA--DYYKASENDAIPIR----WMPPESI------------FYNRYTTESDVWAYGVVL 222
Query: 901 LEMFT 905
E+F+
Sbjct: 223 WEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQ-----KGALKSFVAECEVLRNTRHRNLIK 740
++G GSFGSVY+G+ ++G F AVK ++L + A+K E +L +H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 741 IITVCSSIDFKGADFKALVY-EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+ D ++ E + GSL + L + PE +I+ +
Sbjct: 67 YLGTEREED------NLYIFLELVPGGSLAKLLKKYGSFPE----PVIR--LYTRQILLG 114
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+EYLH VH D+K +N+L+D + V ++DFG+A+ + F S K
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---------K 162
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G+ ++ P IA YG + D++SLG +LEM T + P
Sbjct: 163 GSPYWMAPEVIA-----QQGGYG------LAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 38/236 (16%)
Query: 680 EFSSSNMIGQGSFGSVYKGI---LGENGTF-VAVKIL-NLMQKGALKSFVAECEVLRNTR 734
E ++G G+FG+VYKG+ GE VA+K+L A K + E V+ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H ++++++ +C S L+ + M G L +++ + LN +
Sbjct: 68 HPHVVRLLGICLSSQV------QLITQLMPLGCLLDYVRNHKDN-----IGSQYLLNWCV 116
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+A + YL +VH DL NVL+ ++DFGLA+ L +
Sbjct: 117 QIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---------DVDEK 164
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRP 909
+G G VP K + L + + + + S DV+S GV + E+ T +P
Sbjct: 165 EYHAEG--GKVP----IKWMALESILHRIYTHKS---DVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 60/244 (24%), Positives = 95/244 (38%), Gaps = 63/244 (25%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+GSFG+V K +G + K ++ M + + V+E +LR +H N I+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN---IVRY 64
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC---DLS-LIQR----------- 789
I + +Y M E C DL+ LIQ+
Sbjct: 65 YDRIIDRS---NQTLYIVM----------------EYCEGGDLAQLIQKCKKERKYIEEE 105
Query: 790 --LNIAIDMASAIEYLHH--HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF 845
I + A+ H+ ++H DLKP+N+ LD + + DFGLA+ L
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL----G 161
Query: 846 DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
S ++ GT Y+ P + M Y E S D++SLG ++ E+
Sbjct: 162 HDSSFAKT----YVGTPYYMSPEQLNHM------SY---DEKS---DIWSLGCLIYELCA 205
Query: 906 RRRP 909
P
Sbjct: 206 LSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
I +G++G V+ G A+K++ +++K + + E ++L + ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
S F+G LV EY+ G L L E + R+ IA ++ A+EYL
Sbjct: 59 YYS---FQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYL 109
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H + I+H DLKP N+L+D + ++DFGL++ R + + I GT
Sbjct: 110 HSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
Y+ P E +G S T D +SLG +L E
Sbjct: 167 YIAP------------EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 40/227 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALK---SFVA--ECEVLRNTRHRNLIKI 741
+G+G++ VYK E G VA+K + L ++ K +F A E ++L+ +H N+I +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+ V F LV+E+M+ LE+ + + L+ + + +E
Sbjct: 68 LDV-----FGHKSNINLVFEFME-TDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLE 116
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YLH + I+H DLKP+N+L+ D V ++DFGLAR F P + M Q T
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS-FGSP-NRKMTHQVV------T 165
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRR 907
Y P E G+ V D++S+G + E+ R
Sbjct: 166 RWYRAP------------ELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 40/222 (18%)
Query: 687 IGQGSFGSVYKGILGENGTF-VAVKILNLMQKGALKS--FVAECEVLRNTRHRNLIKIIT 743
+G G FG V G G + VA+K ++++G++ F+ E +V+ H L+++
Sbjct: 12 LGTGQFGVVKYGKW--RGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
VC+ + + +V EYM NG L +L + + + L L + D+ + YL
Sbjct: 67 VCTK---QRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYL 116
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
+H DL N L+D VSDFGL+R++ + +SS+G K V
Sbjct: 117 ESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-------TSSVGSKFPVR 166
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ PP E + S+ S DV++ GV++ E+++
Sbjct: 167 WSPP------------EVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 43/269 (15%)
Query: 685 NMIGQGSFGSVYKGILGENG---TFVAVKILN-LMQKGALKSFVAECEVLRNTRHRNLIK 740
+IG+G FG VY G L ++ AVK LN + ++ F+ E ++++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
++ +C + +G+ +V YM++G L ++ P V DL + + +A +
Sbjct: 61 LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
EYL VH DL N +LD V+DFGLAR ++ + + + + + +K
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP----------T 910
LE + + DV+S GV+L E+ TR P T
Sbjct: 169 MA----------------LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212
Query: 911 NCMFQGGLTLH-EFCKMALPEKVMETVDP 938
+ QG L E+C L E ++ P
Sbjct: 213 VYLLQGRRLLQPEYCPDPLYEVMLSCWHP 241
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-17
Identities = 42/85 (49%), Positives = 56/85 (65%)
Query: 375 LGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434
LG++ L G IP +I +LR+LQ+I LS N ++GNIP SLG++T + L LS N G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 435 PPSLGNCKNLVSLNLSDNKLIGAVP 459
P SLG +L LNL+ N L G VP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 38/232 (16%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRN 737
F +IG+G+FG V + A+K +N ++KG++++ + E +L+ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
L+ + S F+ + LV + + G L L Q E + I ++
Sbjct: 62 LVN---LWYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-----QVKFWIC-EIV 110
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
A+EYLH I+H D+KP N+LLD H++DF +A + + +
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---------TPDTLTTS 158
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT GY+ P E SV D +SLGV E +RP
Sbjct: 159 TSGTPGYMAP------------EVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/241 (25%), Positives = 112/241 (46%), Gaps = 55/241 (22%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G+GS+GSVYK I E G VA+K++ + + L+ + E +L+ ++K
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK------ 62
Query: 747 SIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA--- 799
+ G+ FK +V EY GS+ + + ++ + +L + IA +
Sbjct: 63 ---YYGSYFKNTDLWIVMEYCGAGSVSDIM-------KITNKTLTEEE-IAAILYQTLKG 111
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+EYLH + +H D+K N+LL+ + A ++DFG++ L +M +++ I
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT-----DTMAKRNTVI--- 160
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR------RPTNCM 913
GT ++ P I E G ++A D++SLG+ +EM + P +
Sbjct: 161 GTPFWMAPEVI--------QEIGYNNKA----DIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 914 F 914
F
Sbjct: 209 F 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 37/233 (15%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA---------LKSFVAECEVLRNTRHR 736
+IG GSFGSVY G+ +G +AVK + L A L + E +L+ +H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N+++ + SS+D AD + EY+ GS+ L+ E +L++ N +
Sbjct: 67 NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ YLH+ I+H D+K +N+L+D+ +SDFG+++ L A T S
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
++G+V ++ P + + D++SLG +++EM T + P
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTR------------KADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 26/166 (15%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL------NLMQKGALKSFVAECEVLRNTRHRNLI 739
++G+G++G V K G VA+K ++K AL+ E +VLR RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNG-QPEVCDLSLIQRLNIAIDMAS 798
+ KG + LV+EY++ LE G P+ + Q L
Sbjct: 64 NLKEAFRR---KGRLY--LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ------- 111
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP 844
AI Y H H I+H D+KP N+L+ V + DFG AR L ARP
Sbjct: 112 AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 76/284 (26%), Positives = 130/284 (45%), Gaps = 62/284 (21%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHR 736
++F IG+G++G VYK + G VA+K + L ++G + + E ++LR HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 737 NLIKIITVCS----SIDF---KGADFKALVYEYMQN---GSLEEWLHQSNGQPEVCDLSL 786
N++ + + + ++DF KGA + LV+EYM + G LE L +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGLVHFSED-------- 116
Query: 787 IQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA---R 843
+I M +E L++ + +H D+K SN+LL++ ++DFGLAR + R
Sbjct: 117 ----HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLE 902
P+ + T+ Y PP E +G E DV+S G +L E
Sbjct: 173 PYTNKVI----------TLWYRPP------------ELLLGEERYGPAIDVWSCGCILGE 210
Query: 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSD 946
+FT ++P +FQ E ++ L ++ + P+ W D
Sbjct: 211 LFT-KKP---IFQANQ---ELAQLELISRLCGSPCPA---VWPD 244
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 38/224 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V+ G N T VAVK L + G + +SF+ E ++++ RH L+++ V
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
S +V EYM GSL ++L G+ L L +++A +A+ + Y+
Sbjct: 70 VSEEPI------YIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE 119
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+ +H DL+ +N+L+ +V ++DFGLAR + + ++ G K + +
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-------TARQGAKFPIKW 169
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
P E + ++ DV+S G++L E+ T+ R
Sbjct: 170 TAP------------EAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 61/224 (27%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 687 IGQGSFGSVYKGI-LGENGTF--VAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKII 742
+G GSFG V +G G VAVK L + + F+ E ++ + H NLI++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRL-NIAIDMASAIE 801
V + +V E GSL + L + + LI L + A+ +A+ +
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLRK-DALGHF----LISTLCDYAVQIANGMR 111
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YL +H DL N+LL D + DFGL R L + + +K
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL-----PQNEDHYVMEEHLKVP 163
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ P L S AS DV+ GV L EMFT
Sbjct: 164 FAWCAP---------ESLRTRTFSHAS---DVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G+ G V+K E G VA+K + L + G + E + L+ +H ++K++ V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
G+ F LV EYM L E L +P L Q + + + Y+H
Sbjct: 68 FP----HGSGF-VLVMEYMP-SDLSEVLRDEE-RP----LPEAQVKSYMRMLLKGVAYMH 116
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP 844
I+H DLKP+N+L+ D V ++DFGLAR
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 42/228 (18%)
Query: 686 MIGQGSFGSVYKGIL---GENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIK 740
+IG G FG V G L G+ VA+K L +K + F++E ++ H N+I
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIH 69
Query: 741 ---IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
++T + +V EYM+NGSL+ +L + +GQ ++IQ + + +A
Sbjct: 70 LEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIA 116
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
S ++YL VH DL N+L++ ++V VSDFGL+R L P + + T+ I
Sbjct: 117 SGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTRGGKIP 172
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
I+ T P IA Y + AS DV+S G+++ E+ +
Sbjct: 173 IRWTA----PEAIA---------YRKFTSAS---DVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 40/225 (17%)
Query: 687 IGQGSFGSVYKGILGENGTF-VAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKIIT 743
+GQG FG V+ G NGT VA+K L + G + ++F+ E ++++ RH L+ +
Sbjct: 14 LGQGCFGEVWMGTW--NGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
V S + +V E+M GSL ++L + +G+ L L Q +++A +A + Y+
Sbjct: 69 VVSE------EPIYIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYI 118
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
+ +H DL+ +N+L+ ++V ++DFGLAR + + ++ G K +
Sbjct: 119 E---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-------TARQGAKFPIK 168
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
+ P E + ++ DV+S G++L E+ T+ R
Sbjct: 169 WTAP------------EAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 40/232 (17%)
Query: 687 IGQGSFGSV-----YKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G+FG V Y ++ VAVK L A K F E E+L N +H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLH--------QSNGQPEVCDLSLIQRLNIA 793
VC D +V+EYM++G L ++L + G +L+ Q L+IA
Sbjct: 73 YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPA-ELTQSQMLHIA 126
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+A+ + YL VH DL N L+ +++ + DFG++R +++ D
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST--DYYRVGGH 181
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ + I+ ++PP +I M + + DV+SLGV+L E+FT
Sbjct: 182 TMLPIR----WMPPESI------------MYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 25/165 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAEC----EV---LRNTRHRNLI 739
+G G+FGSVY E G VA+K K S+ EC EV + H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
K+ V F+ D V+EYM G+L + + G+P S +I +
Sbjct: 62 KLKEV-----FRENDELYFVFEYM-EGNLYQLMKDRKGKP----FSESVIRSIIYQILQG 111
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP 844
+ ++H H H DLKP N+L+ V ++DFGLAR + +RP
Sbjct: 112 LAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTF--VAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
+ + IG+G+ G VYK + T VA+K + L ++ + + E ++++ +H N+
Sbjct: 21 YKNLEKIGEGASGEVYKAT--DRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNI 77
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLI--QRLNIAIDM 796
+ S + +V EYM GSL + + Q + + Q + ++
Sbjct: 78 VDYY---DSYLVGDELW--VVMEYMDGGSLTDIITQ-------NFVRMNEPQIAYVCREV 125
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+EYLH ++H D+K N+LL D ++DFG A L +S
Sbjct: 126 LQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--------KSKRN 174
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+ GT ++ P I + +YG V D++SLG+M +EM
Sbjct: 175 SVVGTPYWMAPEVIKR------KDYGP----KV--DIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 46/234 (19%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNL 738
+GQGSFG VY+G+ GE T VA+K +N M++ F+ E V++ ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE--RIEFLNEASVMKEFNCHHV 71
Query: 739 IKIITVCSSIDFKGADFKALV-YEYMQNGSLEEWLHQSNGQPEVCDL----SLIQRLNIA 793
++++ V S G LV E M G L+ +L + E +L + + +A
Sbjct: 72 VRLLGVVS----TGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
++A + YL VH DL N ++ D+ + DFG+ R ++ ET
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--------ETDY 174
Query: 854 SSIGIKGT--VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
G KG V ++ P + L+ G+ + S DV+S GV+L EM T
Sbjct: 175 YRKGGKGLLPVRWMAPES---------LKDGVFTTKS---DVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 46/237 (19%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNL----------MQKGALKSFVAECEVLRNTRH 735
+IG+G++G VY + G +AVK + L QK +K+ +E E L++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
N+++ + ++ ++ EY+ GS+ L + L++ +
Sbjct: 68 LNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQV- 117
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF---LFARPFDTSMETQ 852
+ YLH I+H DLK N+L+D D + +SDFG+++ ++ + SM
Sbjct: 118 -LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM--- 170
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+G+V ++ P I Y G A V D++SLG ++LEMF RRP
Sbjct: 171 ------QGSVFWMAPEVIHS--------YSQGYSAKV--DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 70/224 (31%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 687 IGQGSFGSVYKGILGENGTF---VAVKILNLMQKGALKS-FVAECEVLRNTRHRNLIKII 742
+G G+FGSV KG+ VAVK L A K F+ E V+ H ++++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
VC KG LV E G L ++L + + V DL +A +A + Y
Sbjct: 63 GVC-----KGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDL-----KELAHQVAMGMAY 110
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
L VH DL NVLL + A +SDFG++R L A S ++++ G
Sbjct: 111 LE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA----GSDYYRATTAGRWPLK 163
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
Y P C+ YG S S DV+S GV L E F+
Sbjct: 164 WYAP----------ECINYGKFSSKS---DVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 71/301 (23%), Positives = 133/301 (44%), Gaps = 62/301 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V+ G T VA+K L ++G++ ++F+AE +++ +H L+++ V
Sbjct: 14 LGAGQFGEVWMGYY-NGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ ++ EYM+NGSL ++L G L++ + +++A +A + ++
Sbjct: 70 VTQEPI------YIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIE 119
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+ +H DL+ +N+L+ + ++DFGLAR + + T+ E G K + +
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TARE------GAKFPIKW 169
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFC 924
P I YG ++ DV+S G++L E+ T R
Sbjct: 170 TAPEAI---------NYGT---FTIKSDVWSFGILLTEIVTYGR---------------- 201
Query: 925 KMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME---MRDV 981
+P M +P ++ G R + + C + + C E P ER +R V
Sbjct: 202 ---IPYPGM--TNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSV 256
Query: 982 L 982
L
Sbjct: 257 L 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 42/240 (17%)
Query: 684 SNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLR---NTRHRNL 738
IG+G++G+VYK G FVA+K + L ++G S + E +L+ + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQ--SNGQPEVCDLSLIQRLNIAIDM 796
++++ VC LV+E++ ++ L S I+ ++ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIK--DLMRQL 116
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+++LH H IVH DLKP N+L+ D ++DFGLAR + +
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---------SFEMALT 164
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
+ T+ Y P E + S + D++S+G + E+F RRRP +F+G
Sbjct: 165 SVVVTLWYRAP------------EVLLQSSYATPVDMWSVGCIFAELF-RRRP---LFRG 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 27/232 (11%)
Query: 681 FSSSNMIGQGSFGSVYKGILG-ENGTF--VAVKIL--NLMQKGALKSFVAECEVLRNTRH 735
F+ M+G+G FGSV + L E+G+F VAVK+L ++ ++ F+ E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 736 RNLIKIITVCSSIDFKGA-DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
N+IK+I V KG ++ +M++G L +L S E L L + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
D+AS +EYL +H DL N +L+ +M V+DFGL++ ++ S
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIY-----------SG 166
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
+G +P +A LE + + DV++ GV + E+ TR
Sbjct: 167 DYYRQGCASKLPVKWLA-------LESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 43/227 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL------MQKGALKSFVAECEVLRNTRHRNLIK 740
IG+G++G VYK G VA+K + L + K AL+ E ++L+ H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
++ V F+ LV+E+M + + G PE SLI+ + + +
Sbjct: 63 LLDV-----FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPE----SLIK--SYLYQLLQGL 111
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
+ H H I+H DLKP N+L++ + V ++DFGLAR F P
Sbjct: 112 AFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVV------- 160
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
T Y P L L Y D++S+G + E+ +RR
Sbjct: 161 TRWYRAP-----ELLLGDKGYSTPV------DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 61/266 (22%)
Query: 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLR 731
L + T F +IG+G++G VYK + G VA+KI++++ ++ +K E +LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILR 57
Query: 732 N-TRHRNLIKIITVCSSIDFKGADFKA----------LVYEYMQNGS---LEEWLHQSNG 777
+ H N+ F GA K LV E GS L + L +
Sbjct: 58 KYSNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK 108
Query: 778 QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFG 835
+ + ++ I R + + YLH + ++H D+K N+LL + A V DFG
Sbjct: 109 RLKEEWIAYILR-----ETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFG 158
Query: 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYS 895
++ L D+++ +++ I GT ++ P IA Y S DV+S
Sbjct: 159 VSAQL-----DSTLGRRNTFI---GTPYWMAPEVIACDEQPDA-SYDARS------DVWS 203
Query: 896 LGVMLLEM------FTRRRPTNCMFQ 915
LG+ +E+ P +F+
Sbjct: 204 LGITAIELADGKPPLCDMHPMRALFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 86/316 (27%), Positives = 126/316 (39%), Gaps = 54/316 (17%)
Query: 686 MIGQGSFGSVYK---GILGEN-GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G+FGSV L +N G VAVK L L+ F E E+L++ +H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
VC S G LV EY+ GSL ++L + E D + L A + +E
Sbjct: 71 KGVCYS---AGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKL--LLYASQICKGME 122
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFD----TSMETQSSSIG 857
YL VH DL N+L++ + + DFGL + L P D E S I
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL---PQDKEYYKVREPGESPI- 175
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT----RRRPTNCM 913
Y P E S+ SV DV+S GV+L E+FT P
Sbjct: 176 ----FWYAP-------------ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-- 216
Query: 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973
EF +M +K + + L+ + R C + I C P
Sbjct: 217 --------EFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPS 268
Query: 974 ERMEMRDVLAKLCAAR 989
+R ++ ++ A R
Sbjct: 269 QRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 24/170 (14%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL------NLMQKGALKSFVAECEVLRN 732
++ + ++G+GS+G V K E G VA+K +++K A++ E +L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQ 56
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
RH NL+ +I V F+ LV+E++ + L++ NG D S +++
Sbjct: 57 LRHENLVNLIEV-----FRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLF 107
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
I IE+ H H I+H D+KP N+L+ V + DFG AR L A
Sbjct: 108 QI--LRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 42/223 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLI---KII 742
+G+GS+ +VYKGI NG VA+K++++ ++G + + E +L+ +H N++ II
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
++ F V+EYM L +++ Q G ++ L + + Y
Sbjct: 73 HTKETLTF--------VFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-----FQLLRGLAY 118
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
+H I+H DLKP N+L+ + ++DFGLAR S+ +Q+ S + T+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR-------AKSIPSQTYSSEVV-TL 167
Query: 863 GYVPPGNIAKMLNLPCLEYGMGS-EASVTGDVYSLGVMLLEMF 904
Y PP + +G+ + S D++ G + +EM
Sbjct: 168 WYRPPDVL------------LGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 7e-15
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS---FVAECEVLRNTRHRNLIKIIT 743
+G GSFG V +G + A+KIL+ + LK + E +L++ RH L+ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
F+ LV EY+ G L L +S PE ++ + + A+EYL
Sbjct: 69 S-----FQDDSNLYLVMEYVPGGELFSHLRKSGRFPE--PVARFYAAQVVL----ALEYL 117
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H IV+ DLKP N+LLD D ++DFG A+ + T + GT
Sbjct: 118 HS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT--------LCGTPE 163
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
Y+ P +L+ YG +V D ++LG+++ EM
Sbjct: 164 YLAP---EIILSKG---YGK----AV--DWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS-FVAECEVLRNTRHRNLIKIITVC 745
IG+G+FG V+ G L + T VAVK LK+ F+ E +L+ H N++++I VC
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH- 804
+ K + +V E +Q G +L + E L + + + + + A+ +EYL
Sbjct: 63 TQ---KQPIY--IVMELVQGGDFLTFL-----RTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
HC +H DL N L+ V +SDFG++R E + G +
Sbjct: 113 KHC----IHRDLAARNCLVTEKNVLKISDFGMSR-----------EEEDGVYASTGGMKQ 157
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+P K L YG S S DV+S G++L E F+
Sbjct: 158 IP----VKWTAPEALNYGRYSSES---DVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 67/255 (26%), Positives = 105/255 (41%), Gaps = 44/255 (17%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVA---VKILNLMQKGALKSFVAECEVLRNTR 734
F IG+G F VYK I +G VA V+I +M A + + E ++L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ----PEVCDLSLIQRL 790
H N+IK + S I+ + +V E G L + Q PE
Sbjct: 61 HPNVIKYLA--SFIE---NNELNIVLELADAGDLSRMIKHFKKQKRLIPER------TIW 109
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
+ + SA+E++H I+H D+KP+NV + V + D GL RF ++ +
Sbjct: 110 KYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTA 162
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910
S + GT Y+ P I + Y S D++SLG +L EM + P
Sbjct: 163 AHS----LVGTPYYMSPERIHEN------GYNFKS------DIWSLGCLLYEMAALQSP- 205
Query: 911 NCMFQGGLTLHEFCK 925
+ + L+ CK
Sbjct: 206 --FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 46/225 (20%)
Query: 687 IGQGSFGSVYKGILGENGTF--VAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKII 742
+G G FG V+ LG+ VA+K +N +GA+ + F+ E +V+ H L+++
Sbjct: 12 LGSGQFGVVH---LGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 743 TVCSSIDFKGADFKAL--VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
VC+ K L V E+M+NG L +L Q G+ LS L++ D+ +
Sbjct: 66 GVCTQQ-------KPLYIVTEFMENGCLLNYLRQRQGK-----LSKDMLLSMCQDVCEGM 113
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
EYL + +H DL N L+ V VSDFG+ R++ + +SS G K
Sbjct: 114 EYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKF 163
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
V + PP E S+ S DV+S GV++ E+FT
Sbjct: 164 PVKWSPP------------EVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 62/227 (27%), Positives = 89/227 (39%), Gaps = 38/227 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+G FG V + G A K L+ L ++ + + E ++L R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN-GQPEVCDLSLIQRLNIAIDMASAIEY 802
V + F+ D LV M G L+ H N G+P + + A + +E+
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEP---GFPEARAIFYAAQIICGLEH 110
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH Q IV+ DLKP NVLLD +SD GLA ++ G GT
Sbjct: 111 LH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA---------VELKGGKKIKGRAGTP 158
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GY+ P E G + D ++LG L EM R P
Sbjct: 159 GYMAP------------EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 60/234 (25%), Positives = 113/234 (48%), Gaps = 31/234 (13%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGALK-SFVAECEVLRNTRHR 736
+++ IGQG+FG V+K + VA+K +L +K + + E ++L+ +H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 737 NLIKIITVCSSIDFKGADFKA---LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
N++ +I +C + +K LV+E+ ++ L L N + LS I++ +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK---FTLSEIKK--VM 125
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+ + + Y+H + I+H D+K +N+L+ D + ++DFGL AR F S ++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL-----ARAFSLSKNSKP 177
Query: 854 SSIGIK-GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
+ + T+ Y PP L L +YG D++ G ++ EM+TR
Sbjct: 178 NRYTNRVVTLWYRPP-----ELLLGERDYGPPI------DMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 83/321 (25%), Positives = 135/321 (42%), Gaps = 64/321 (19%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFV--AVKIL-NLMQKGALKSFVAECEVL-RNTR 734
N+ ++IG+G+FG V K + ++G + A+K + K + F E EVL +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN----------GQPEVCDL 784
H N+I ++ C + +G + L EY +G+L ++L +S L
Sbjct: 67 HPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 785 SLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP 844
S Q L+ A D+A ++YL Q +H DL N+L+ + VA ++DFGL+R
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------ 172
Query: 845 FDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
+ +K T+G +P + + + L Y S + DV+S GV+L E+
Sbjct: 173 --------GQEVYVKKTMGRLP----VRWMAIESLNY---SVYTTNSDVWSYGVLLWEIV 217
Query: 905 TRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIG 964
+ C G+T E + LP+ G R K C V +
Sbjct: 218 SLGGTPYC----GMTCAELYE-KLPQ----------------GYRLEKPLNCDDEVYDLM 256
Query: 965 VACSMESPIERMEMRDVLAKL 985
C E P ER +L L
Sbjct: 257 RQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 79/326 (24%), Positives = 142/326 (43%), Gaps = 67/326 (20%)
Query: 685 NMIGQGSFGSVYKGILGENGTFV--AVKILN-LMQKGALKSFVAECEVL-RNTRHRNLIK 740
++IG+G+FG V + ++ ++G + A+K+L + + F E EVL + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQS----------NGQPEVCDLSLIQRL 790
++ C + +G + A+ EY G+L ++L +S L+ Q L
Sbjct: 68 LLGACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
A D+A+ ++YL + +H DL NVL+ ++ + ++DFGL+R
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------------ 167
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910
+ +K T+G +P + + + L Y + + S DV+S GV+L E+ +
Sbjct: 168 --GEEVYVKKTMGRLP----VRWMAIESLNYSVYTTKS---DVWSFGVLLWEIVSLGGTP 218
Query: 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970
C G+T E + LP+ G R K C V + C +
Sbjct: 219 YC----GMTCAELYE-KLPQ----------------GYRMEKPRNCDDEVYELMRQCWRD 257
Query: 971 SPIERMEMRDV---LAKLCAARQTLV 993
P ER + L+++ AR+ V
Sbjct: 258 RPYERPPFAQISVQLSRMLEARKAYV 283
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 69/291 (23%), Positives = 126/291 (43%), Gaps = 58/291 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V+ G N T VAVK L + G + ++F+ E +++ +H L+++ V
Sbjct: 14 LGAGQFGEVWMGYY-NNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ + ++ EYM GSL ++L G + L + ++ + +A + Y+
Sbjct: 70 VTK-----EEPIYIITEYMAKGSLLDFLKSDEGG----KVLLPKLIDFSAQIAEGMAYIE 120
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+ +H DL+ +NVL+ ++ ++DFGLAR + + T+ E G K + +
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TARE------GAKFPIKW 170
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFC 924
P + +N ++ DV+S G++L E+ T +
Sbjct: 171 TAP----EAINFGSF--------TIKSDVWSFGILLYEIVT-----------------YG 201
Query: 925 KMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
K+ P M D ++ A G R ++E C + I C E ER
Sbjct: 202 KIPYPG--MSNSD--VMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/223 (24%), Positives = 109/223 (48%), Gaps = 34/223 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
+G+G++ +VYKG G VA+K ++L ++G + + E +++ +H N++++ V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ + LV+EYM L++++ ++G D + ++ + + I + H
Sbjct: 68 HT-----ENKLMLVFEYMDK-DLKKYM-DTHGVRGALDPNTVK--SFTYQLLKGIAFCHE 118
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
+ ++H DLKP N+L++ ++DFGL AR F + T S+ + T+ Y
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGL-----ARAFGIPVNTFSNEV---VTLWYR 167
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRR 907
P + +GS T D++S+G ++ EM T R
Sbjct: 168 APDVL------------LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 57/235 (24%), Positives = 106/235 (45%), Gaps = 38/235 (16%)
Query: 681 FSSSNMIGQGSFGSVYKGILGE----NGTFVAVKIL----NLMQKGALKSFVAECEVLRN 732
+ S+++ +G+FG ++ GIL + V VK + + +Q + + E +L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLYG 64
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD--LSLIQRL 790
H+N++ I+ VC + ++Y YM G+L+ +L Q LS Q +
Sbjct: 65 LSHQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
++AI +A + YLH ++H D+ N ++D ++ ++D L+R LF + +
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
++ + K + L L S AS DV+S GV+L E+ T
Sbjct: 178 NENRPV---------------KWMALESLVNKEYSSAS---DVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 69/276 (25%), Positives = 108/276 (39%), Gaps = 44/276 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL-KSFVAECEVLRNTRHRN 737
+ + +G+G+ GSV K L G A+K + L K + E E+ ++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 738 LIKIITVC-----SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
++K SSI + EY + GSL+ + + ++ + I
Sbjct: 61 IVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK--I 110
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
A + + YLH I+H D+KPSN+LL + DFG+ S E
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV-----------SGELV 156
Query: 853 SSSIG-IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911
+S G GT Y+ P I G S+T DV+SLG+ LLE+ R P
Sbjct: 157 NSLAGTFTGTSFYMAPERIQ------------GKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 912 CMFQGGLTLHEFCKMALPEKVMETVD-PSLLLAWSD 946
+ L E + E D P + WS+
Sbjct: 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 78/307 (25%), Positives = 130/307 (42%), Gaps = 50/307 (16%)
Query: 687 IGQGSFGSV----YKGILGENGTFVAVKILNLMQKGA-LKSFVAECEVLRNTRHRNLIKI 741
+G+G FG V Y G VAVK L G + E E+LRN H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+C+ G + L+ E++ +GSL+E+L ++ + ++L Q+L A+ + ++
Sbjct: 72 KGICTE---DGGNGIKLIMEFLPSGSLKEYLPRNKNK-----INLKQQLKYAVQICKGMD 123
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YL VH DL NVL++ + + DFGL + ++ET +K
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK---------AIETDKEYYTVKDD 171
Query: 862 VG-----YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
+ Y P CL + S+ + DV+S GV L E+ T C +
Sbjct: 172 LDSPVFWYAP----------ECL---IQSKFYIASDVWSFGVTLYELLTY-----CDSES 213
Query: 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976
+ F KM P TV L+ +G+R + C V ++ C P +R
Sbjct: 214 S-PMTLFLKMIGPTHGQMTV-TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT 271
Query: 977 EMRDVLA 983
++++
Sbjct: 272 TFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 32/193 (16%)
Query: 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531
L L N L G +P ++ L++L ++ +SGN G IP +L T LE+ + NSF GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRV 591
P SL L S++ L+L+ N+LSG++P L G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHR-----ASF 520
Query: 592 QLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRLGKVGIPMIVSCLILSTCFIIVYARR-- 649
T N LCG +P + S ++G + + V+ L L C + + RR
Sbjct: 521 NFTDNAGLCG------IPGLRACGPHLSVGAKIG-IAFGVSVAFLFLVICAMCWWKRRQN 573
Query: 650 -RRSKQESSISVP 661
R+++ ++ P
Sbjct: 574 ILRAQRIAAREAP 586
|
Length = 623 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 69/248 (27%), Positives = 104/248 (41%), Gaps = 44/248 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRN 737
+F N IG+GSFG V+K + + A+K ++L M + + + E VL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+I+ S +D KG +V EY +NG L + L G+P D + R I I +
Sbjct: 61 IIRYYE--SFLD-KGK--LNIVMEYAENGDLHKLLKMQRGRPLPED--QVWRFFIQILL- 112
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL-----FARPFDTSMETQ 852
+ +LH I+H D+K N+ LD + D G+A+ L FA
Sbjct: 113 -GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-------- 160
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912
I GT Y+ P E + DV++LGV+L E T + P +
Sbjct: 161 -----IVGTPYYLSP------------ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
Query: 913 MFQGGLTL 920
QG L L
Sbjct: 204 NNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 68/227 (29%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 687 IGQGSFGSV----YKGILGENGTFVAVKILNLMQKGALKS-FVAECEVLRNTRHRNLIKI 741
+G+G FG V Y G VAVK L S + E +L+ H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
CS +G L+ EY+ GSL ++L + L+L Q L A + +
Sbjct: 72 KGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMA 121
Query: 802 YLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
YLH H+ +H DL NVLLD+D + + DFGLA+ A P + + G
Sbjct: 122 YLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAK---AVP-EGHEYYRVREDGDS 172
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
Y CL+ S AS DV+S GV L E+ T
Sbjct: 173 PVFWYAV----------ECLKENKFSYAS---DVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 40/224 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
++G+G+FG V+KG L ++ T VAVK +L Q+ +K F++E +L+ H N++K+I
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
VC+ +V E + G +L + +L Q + A+D A+ + YL
Sbjct: 60 VCTQ-----RQPIYIVMELVPGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYL 109
Query: 804 H-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT- 861
+C +H DL N L+ + V +SDFG++R + SS G+K
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--------QEDDGIYSSSGLKQIP 157
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ + P L YG S S DV+S G++L E F+
Sbjct: 158 IKWTAP---------EALNYGRYSSES---DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 45/238 (18%)
Query: 686 MIGQGSFGSV----YKGILGENGTF-VAVKIL--NLMQKGALKSFVAECEVLRNT-RHRN 737
+G+G+FG V G+ N T VAVK+L + +K L V+E E+++ +H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKN 77
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC----DLSLIQRL--- 790
+I ++ VC+ +G + +V EY +G+L ++L E + L
Sbjct: 78 IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 791 ---NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
+ A +A +E+L +H DL NVL+ D V ++DFGLAR
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------- 180
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ K T G +P K + L + + S DV+S GV+L E+FT
Sbjct: 181 --DIHHIDYYRKTTNGRLP----VKWMAPEALFDRVYTHQS---DVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 36/230 (15%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKI--LNLMQKGALKSFVAECEVLRNTRHRNL 738
F IG+G++G VYK G VA+K L+ +G + + E +L+ H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 739 IKIITVCSSIDFKGADFKA-LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+K++ V + + K LV+E++ + L++++ S L LI+ + +
Sbjct: 62 VKLLDVIHT------ENKLYLVFEFL-HQDLKKFMDAS--PLSGIPLPLIK--SYLFQLL 110
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+ + H H ++H DLKP N+L++ + ++DFGL AR F + T + +
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL-----ARAFGVPVRTYTHEV- 161
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
T+ Y P ++L L C Y S D++SLG + EM TRR
Sbjct: 162 --VTLWYRAP----EIL-LGCKYY------STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 76/311 (24%), Positives = 131/311 (42%), Gaps = 50/311 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTR---HRNLIKI 741
IG G++G+VYK +G FVA+K + + + G S V E +L+ H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQ--SNGQPEVCDLSLIQRLNIAIDMASA 799
+ VC++ LV+E++ L +L + G P L+++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+++LH +C IVH DLKP N+L+ ++DFGLAR + M +
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI-----YSCQMALTPVVV--- 169
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919
T+ Y P E + S + D++S+G + EMF RR+P +F G
Sbjct: 170 -TLWYRAP------------EVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSE 212
Query: 920 LHEFCK----MALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME----S 971
+ K + LP + D +L R V+ + + G +E +
Sbjct: 213 ADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFN 272
Query: 972 PIERMEMRDVL 982
P +R+ L
Sbjct: 273 PHKRISAFRAL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 46/231 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHR-NLIKII 742
I +G+FGSVY G + A+K+L +++ K + + AE ++ + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE--VCDLSLIQRLNIAIDMASAI 800
F+ D+ LV EY+ G + G PE ++ +
Sbjct: 64 YS-----FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--------QYIAEVVLGV 110
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
E LH Q I+H D+KP N+L+D ++DFGL+R G
Sbjct: 111 EDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------------KFVG 155
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911
T Y+ P I +G D +SLG ++ E P +
Sbjct: 156 TPDYLAPETI------------LGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 37/231 (16%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFV----AVKILN-LMQKGALKSFVAECEVLRNTR 734
E ++G G+FG+VYKGI G V A+KILN A F+ E ++ +
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H +L++++ VC S + LV + M +G L +++H+ ++ LN +
Sbjct: 68 HPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCV 116
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+A + YL + +VH DL NVL+ ++DFGLAR L E + +
Sbjct: 117 QIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL------EGDEKEYN 167
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ G G +P K + L C+ Y + S DV+S GV + E+ T
Sbjct: 168 ADG-----GKMP----IKWMALECIHYRKFTHQS---DVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 44/250 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVK-ILNLMQK-GALKSFVAECEVLRNTRHRNLIKIITV 744
+G+G+FG VYK + G VA+K IL +K G + + E ++L+ +H N++ +I +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 745 CSSIDFKGADFKALVY---EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
K + VY YM + L L + + + + + I
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK-----CYMLQLLEGIN 129
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YLH + I+H D+K +N+L+D+ + ++DFGL ARP+D
Sbjct: 130 YLH---ENHILHRDIKAANILIDNQGILKIADFGL-----ARPYDGP----------PPN 171
Query: 862 VGYVPPGNIAKMLNL--------PCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNC 912
G K NL P E +G T D++ +G + EMFT RRP
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPP--ELLLGERRYTTAVDIWGIGCVFAEMFT-RRP--- 225
Query: 913 MFQGGLTLHE 922
+ QG + +
Sbjct: 226 ILQGKSDIDQ 235
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 66/222 (29%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVL-RNTRHRNLIKII 742
IG+GSFG V +G F AVK+L +++K K +AE VL +N +H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI-AIDMASAIE 801
F+ AD V +Y+ G L L + PE R A ++ASA+
Sbjct: 62 ----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-------RARFYAAEIASALG 110
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YLH I++ DLKP N+LLD ++DFGL + +E ++ GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGIEHSKTTSTFCGT 159
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
Y+ P + K T D + LG +L EM
Sbjct: 160 PEYLAPEVLRK------------QPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRN 737
EF N IG+G++G VY+ +G VA+K + + + G S + E +L N RH N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQN--GSLEEWLHQSNGQPEV-CDLSLIQRLNIAI 794
++++ V K D LV EY + SL + + + +V C + +
Sbjct: 68 IVELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC---------LML 115
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
+ ++YLH + I+H DLK SN+LL ++DFGLAR
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 36/248 (14%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVK---ILNLMQKGALKSFVAECEVLRNTRHRN 737
F IG+G F VY+ +G VA+K I +LM A + E ++L+ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+IK F + +V E G L + Q + + + + +
Sbjct: 64 VIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY--FVQLC 116
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
SA+E++H ++H D+KP+NV + V + D GL RF +S T + S
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHS-- 165
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917
+ GT Y+ P I E G ++ D++SLG +L EM + P +
Sbjct: 166 LVGTPYYMSPERIH--------ENGYNFKS----DIWSLGCLLYEMAALQSP---FYGDK 210
Query: 918 LTLHEFCK 925
+ L+ CK
Sbjct: 211 MNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 58/297 (19%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVA--VKILNLMQKGALKSFVAECE---VLRN 732
E ++G G FG+V+KGI G + V I + + ++F + + +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
H +++++ +C GA + LV + GSL + + Q L + LN
Sbjct: 66 LDHAYIVRLLGICP-----GASLQ-LVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNW 114
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
+ +A + YL H +VH +L N+LL D + ++DFG+A L+ P D
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY--PDDKKYFYS 169
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912
I K + L + +G + S DV+S GV + EM +
Sbjct: 170 EHKTPI-------------KWMALESILFGRYTHQS---DVWSYGVTVWEMMS------- 206
Query: 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSM 969
+ M E P LL G R A+ + C + V + V C M
Sbjct: 207 -----YGAEPYAGMRPHEV------PDLL---EKGERLAQPQICTIDVYMVMVKCWM 249
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 33/176 (18%)
Query: 685 NMIGQGSFGSVYKGIL------GENGTFVAVKILNLMQKGAL----KSFVAECEVLRNTR 734
N +G G+FG VY+G G VAVK L +KGA K F+ E ++ N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH----QSNGQPEVCDLSLIQRL 790
H N++K++ VC + + ++ E M+ G L +L + G P L+L + L
Sbjct: 58 HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPL---LTLKELL 109
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFLF 841
+I +D+A YL Q +H DL N L+ D D V + DFGLAR ++
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 26/161 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL------NLMQKGALKSFVAECEVLRNTRHRNLIK 740
IG+GS+G V+K E G VA+K +++K AL+ E +L+ +H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+I V F+ LV+EY + L E G PE I A+
Sbjct: 65 LIEV-----FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH------LIKKIIWQTLQAV 113
Query: 801 EYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
+ H H+C +H D+KP N+L+ + DFG AR L
Sbjct: 114 NFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 34/171 (19%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG------ALKSFVAECEVLRNT 733
E+ N I +G++G VY+ + G VA+K L + ++ +L+ E +L
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLKL 61
Query: 734 RHRNLIKI--ITVCSSID--FKGADFKALVYEYMQNG--SLEEWLHQSNGQPEVCDLSLI 787
+H N++ + + V S++D + +V EY+++ SL E + Q Q EV L ++
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIY-------MVMEYVEHDLKSLMETMKQPFLQSEVKCL-ML 113
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
Q L S + +LH + I+H DLK SN+LL++ + + DFGLAR
Sbjct: 114 QLL-------SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 43/254 (16%)
Query: 687 IGQGSFGSVYKGI-LGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTR---HRNLIK 740
IG+G++G V+K L G FVA+K + + ++G S + E VLR+ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ VC+ LV+E++ L +L + +P V ++ ++ + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP-EPGVPTETI---KDMMFQLLRGL 123
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
++LH H +VH DLKP N+L+ ++DFGLAR S + +S+ +
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALTSVVV-- 171
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
T+ Y P E + S + D++S+G + EMF RR+P +F+G +
Sbjct: 172 TLWYRAP------------EVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDV 215
Query: 921 HEFCKM----ALPE 930
+ K+ LP
Sbjct: 216 DQLGKILDVIGLPG 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 38/231 (16%)
Query: 687 IGQGSFGSVYKGILGENGTF--VAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKII 742
+G+G FGSV +G L ++ + VAVK + + + ++ F++E ++ H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 743 TVC-SSIDFKGADFKALVYEYMQNGSLEEWLHQS--NGQPEVCDLSLIQRLNIAIDMASA 799
VC +++ +G ++ +M++G L +L S P+ ++ + D+AS
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML--VKFMTDIASG 124
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+EYL +H DL N +L+ +M V+DFGL++ ++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY------------------ 163
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEA----SVTGDVYSLGVMLLEMFTR 906
Y G IAKM P + S A + DV+S GV + E+ TR
Sbjct: 164 -NGDYYRQGRIAKM---PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 40/228 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIIT 743
++G+G+FG V+ + V +K + + M K + EC+VL+ H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ--PEVCDLSLIQRLNIAIDMASAIE 801
+F +V EY G+L E++ + E L ++ +A
Sbjct: 67 -----NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA-------- 113
Query: 802 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
LHH I+H DLK N+LLD H MV + DFG+++ L ++S + + G
Sbjct: 114 -LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------SSKSKAYTVVG 163
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
T Y+ P E G + D+++LG +L E+ + +R
Sbjct: 164 TPCYISP------------ELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 50/227 (22%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG G++G VYK G VA+K++ L + E +L+ RH N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA------ 64
Query: 747 SIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQ-PE-----VCDLSLIQRLNIAIDM 796
+ G+ + +V EY GSL++ + G E VC +L
Sbjct: 65 ---YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---------- 111
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ YLH + +H D+K +N+LL D ++DFG++ L A ++ + S I
Sbjct: 112 -KGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFI 162
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
G T ++ P A Y D+++LG+ +E+
Sbjct: 163 G---TPYWMAPEVAAVERKGG---YDGKC------DIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 53/243 (21%)
Query: 687 IGQGSFGSVY----KGI---LGENGT-------FVAVKILNL-MQKGALKSFVAECEVLR 731
+G+G FG V+ +G+ LGE VAVK+L + K A F+ E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 732 NTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQ---------SNGQPEVC 782
++ N+I+++ VC S D ++ EYM+NG L ++L Q +N P V
Sbjct: 73 RLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV- 126
Query: 783 DLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
S+ L +A+ +AS ++YL VH DL N L+ + ++DFG++R L++
Sbjct: 127 --SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
+ Y G + E + + + DV++ GV L E
Sbjct: 182 GDY------------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 903 MFT 905
MFT
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 43/235 (18%)
Query: 685 NMIGQGSFGSVYKGILGENGTFV--AVKILN-LMQKGALKSFVAECEVL-RNTRHRNLIK 740
++IG+G+FG V K + ++G + A+K + K + F E EVL + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN----------GQPEVCDLSLIQRL 790
++ C +G + A+ EY +G+L ++L +S LS Q L
Sbjct: 61 LLGACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
+ A D+A ++YL Q +H DL N+L+ + VA ++DFGL+R
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 160
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ +K T+G +P + + + L Y + + S DV+S GV+L E+ +
Sbjct: 161 --GQEVYVKKTMGRLP----VRWMAIESLNYSVYTTNS---DVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 67/223 (30%), Positives = 101/223 (45%), Gaps = 38/223 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVL-RNTRHRNLIKI 741
+IG+GSFG V +G+F AVK+L +++K +AE VL +N +H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
F+ A+ V +Y+ G L + H Q E C L R A ++ASAI
Sbjct: 62 -----HYSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARF-YAAEVASAIG 110
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YLH I++ DLKP N+LLD ++DFGL + +E + ++ GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVEPEETTSTFCGT 159
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
Y+ P + K T D + LG +L EM
Sbjct: 160 PEYLAPEVLRK------------EPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 60/239 (25%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNL---------MQKGALKSFVAECEVLRNTRHR 736
+IG+G++G+VY+G G VA+KI+NL +Q+ VA LR ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE-----VALLSQLRQSQPP 62
Query: 737 NLIKIITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
N+ K + G+ K ++ EY + GS+ L ++ E +S+I R
Sbjct: 63 NITK---------YYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKY-ISVIIR--- 108
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
++ A++Y+H ++H D+K +N+L+ + + DFG+A L Q
Sbjct: 109 --EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL----------NQ 153
Query: 853 SSS--IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+SS GT ++ P I + G D++SLG+ + EM T P
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITE-----------GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 75/315 (23%), Positives = 131/315 (41%), Gaps = 63/315 (20%)
Query: 687 IGQGSFGSVYKGIL----GENGTFVAVKIL-NLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+ +FG +YKG L ++ VA+K L ++ F E ++ H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV-----------CDLSLIQRL 790
+ V + +++EY+ G L E+L + +V L L
Sbjct: 73 LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
+IAI +A+ +EYL H VH DL N+L+ + +SD GL+R +++ +
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY---YR 181
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910
Q S+ + ++PP I YG S S D++S GV+L E+F+
Sbjct: 182 VQPKSL---LPIRWMPPEAIM---------YGKFSSDS---DIWSFGVVLWEIFS----- 221
Query: 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970
L + + ++V+E V LL S E+C + + C E
Sbjct: 222 -------FGLQPYYGFS-NQEVIEMVRKRQLLPCS--------EDCPPRMYSLMTECWQE 265
Query: 971 SPIERMEMRDVLAKL 985
P R +D+ +L
Sbjct: 266 GPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-12
Identities = 35/91 (38%), Positives = 57/91 (62%), Gaps = 1/91 (1%)
Query: 398 AIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA 457
+GL + L+G IP+ + L + + LS N ++GNIPPSLG+ +L L+LS N G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 458 VPQQILTITTLSRFLDLGNNHLNGSLPLEVG 488
+P+ + +T+L R L+L N L+G +P +G
Sbjct: 482 IPESLGQLTSL-RILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-12
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 39/289 (13%)
Query: 289 RLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAF-EENRLGGVLPHSIANLSTT 347
NL S+ + L L + L+ L +L+ + L G
Sbjct: 38 PDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS---ENLLNLLP 94
Query: 348 MTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIG-QLRNLQAIGLSSNFL 406
+ + + +N++ I S + L NL L ++ N +T +IP IG NL+ + LS N +
Sbjct: 95 LPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI 152
Query: 407 QGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTIT 466
+ ++PS L NL + +L LS N L ++P L N NL +L+LS NK+ +P +I ++
Sbjct: 153 E-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLS 209
Query: 467 TLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNS 526
L LDL NN + L + NLKNL L +S N+
Sbjct: 210 ALEE-LDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE---------------------- 245
Query: 527 FRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
+P S+ +L +++ LDLS N +S L +L+ L L+LS N
Sbjct: 246 ---DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSL 289
|
Length = 394 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 63/229 (27%), Positives = 91/229 (39%), Gaps = 33/229 (14%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+G FG V + G A K LN L ++ + + E +L R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-- 58
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ F+ LV M G L H N E + + S +E+L
Sbjct: 59 ---AYAFQTKTDLCLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H I++ DLKP NVLLD+D +SD GLA L + QS + G GT G
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--------KDGQSKTKGYAGTPG 162
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912
++ P E G E + D ++LGV L EM R P
Sbjct: 163 FMAP------------ELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 39/230 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGA-LKSFVAECEVLRNTRHRNLIKIITVC 745
IG G+ VY I N VA+K ++L + + E + + H N++K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSN---GQPEVCDLSLIQRLNIAI---DMASA 799
S F D LV Y+ GSL + + S G E IA ++
Sbjct: 67 S---FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI---------IATVLKEVLKG 114
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+EYLH + Q +H D+K N+LL D ++DFG++ L D T+
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL----ADGGDRTRKVRKTFV 167
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT ++ P + + +G +A D++S G+ +E+ T P
Sbjct: 168 GTPCWMAPEVMEQ-------VHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS---FVAECEVLRNTRHR 736
+ +G G+FG V+ + + A+K++ + + LK E VL+ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
+I++ + D F ++ EY+ G L +L S S L A ++
Sbjct: 62 FIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEI 110
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A+EYLH IV+ DLKP N+LLD + ++DFG A+ L R +
Sbjct: 111 VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT---------- 157
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+ GT Y+ P I G +V D ++LG+++ EM
Sbjct: 158 -LCGTPEYLAPEVIQS----------KGHNKAV--DWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 2/106 (1%)
Query: 356 NQ-ISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSL 414
NQ + G IP+ I L +L + + N + GNIP +G + +L+ + LS N G+IP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 415 GNLTLMTDLFLSSNHLQGNIPPSLGNCK-NLVSLNLSDNKLIGAVP 459
G LT + L L+ N L G +P +LG + S N +DN + +P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 70/291 (24%), Positives = 128/291 (43%), Gaps = 59/291 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V+ ++ T VAVK M+ G++ ++F+AE V++ +H L+K+ V
Sbjct: 14 LGAGQFGEVWMATYNKH-TKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ + ++ E+M GSL ++L G + L + ++ + +A + ++
Sbjct: 70 VTK------EPIYIITEFMAKGSLLDFLKSDEGSKQ----PLPKLIDFSAQIAEGMAFIE 119
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
Q +H DL+ +N+L+ +V ++DFGLAR + + T+ E G K + +
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TARE------GAKFPIKW 169
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFC 924
P I +G ++ DV+S G++L+E+ T R
Sbjct: 170 TAPEAI---------NFG---SFTIKSDVWSFGILLMEIVTYGR---------------- 201
Query: 925 KMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
+P M P ++ A G R + E C + I + C P ER
Sbjct: 202 ---IPYPGMSN--PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 56/246 (22%)
Query: 687 IGQGSFGSVYKG----ILGENG-TFVAVKILNLMQKGA----LKSFVAECEVLRNTRHRN 737
+G+G FG V K + G G T VAVK+L ++ A L+ ++E +L+ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNG------------------QP 779
+IK+ CS G L+ EY + GSL +L +S P
Sbjct: 65 VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 780 EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
+ L++ ++ A ++ ++YL + +VH DL NVL+ +SDFGL+R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM 899
++ D+ ++ I +K ++ ++ + + DV+S GV+
Sbjct: 177 VYEE--DSYVKRSKGRIPVK----WMAIESLFDHI------------YTTQSDVWSFGVL 218
Query: 900 LLEMFT 905
L E+ T
Sbjct: 219 LWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 64/257 (24%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
++F +IG+G+FG V+ + G A+K+L ++++ + AE ++L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
++K+ S F+ + LV EYM G L L + + PE R IA +
Sbjct: 61 PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIA-E 109
Query: 796 MASAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLA-------------- 837
+ A++ +H +H D+KP N+L+D D H+ +DFGL
Sbjct: 110 LVLALDSVHKLGF-----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLN 162
Query: 838 ----------RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA 887
+ R +S++ GT Y+ P E G+
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTV---GTPDYIAP------------EVLRGTPY 207
Query: 888 SVTGDVYSLGVMLLEMF 904
+ D +SLGV+L EM
Sbjct: 208 GLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 56/241 (23%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSF---VAECEVLRNTRHRN 737
F+ IG GSFG+VY VA+K ++ K + + + + E L+ RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 738 LIKIITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
+I++KG + LV EY GS + L EV L Q + IA
Sbjct: 77 ---------TIEYKGCYLREHTAWLVMEYCL-GSASDIL-------EVHKKPL-QEVEIA 118
Query: 794 I---DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
+ YLH H + +H D+K N+LL ++DFG A S+
Sbjct: 119 AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA----------SLV 165
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG--DVYSLGVMLLEMFTRRR 908
+ ++S GT ++ P I M E G DV+SLG+ +E+ R+
Sbjct: 166 SPANS--FVGTPYWMAPEVILAM-----------DEGQYDGKVDVWSLGITCIELAERKP 212
Query: 909 P 909
P
Sbjct: 213 P 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 53/230 (23%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+G+FG VY+ + A+K+L + K VA+ EV RN I V +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILVRT 50
Query: 747 SID-----------FKGADFKALVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAI 794
+D F+ LV +YM G L W Q G+ E R I
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSE-------DRAKFYI 102
Query: 795 -DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
++ A+E+LH + IV+ DLKP N+LLD + DFGL++ ++
Sbjct: 103 AELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--------ANLTDNK 151
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
++ GT Y+ P + E G D +SLGV++ EM
Sbjct: 152 TTNTFCGTTEYLAPEVLLD-------EKGYTKHV----DFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 40/225 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVC 745
+G+GS+ +VYKG G VA+K + L +GA + + E +L++ +H N I+T+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVTLH 69
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNG--QPEVCDLSLIQRLNIAIDMASAIEYL 803
I K LV+EY+ L++++ G L L Q L + Y
Sbjct: 70 DIIHTKKT--LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYC 119
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H ++H DLKP N+L+ ++DFGLAR A+ + +T S+ + T+
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPS--KTYSNEV---VTLW 168
Query: 864 YVPPGNIAKMLNLPCLEYGMGS-EASVTGDVYSLGVMLLEMFTRR 907
Y PP + +GS E S + D++ +G + EM T R
Sbjct: 169 YRPPDVL------------LGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 22/157 (14%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G++G+V+K E VA+K + L +G S + E +L+ +H+N++++ V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 745 CSSIDFKGADFK-ALVYEYMQNGSLEEWLHQSNGQ--PEVCDLSLIQRLNIAIDMASAIE 801
S D K LV+EY L+++ NG PE+ + Q L +
Sbjct: 68 LHS------DKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLK-------GLA 113
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
+ H H ++H DLKP N+L++ + ++DFGLAR
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 55/266 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNTRHRNLIKIITV 744
IG G++G V I +G VA+K I + L K + E ++LR+ +H N+I I +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 745 CSSIDFKGADFKA--LVYEYMQNGSLEEWLHQ--SNGQP---EVCDLSLIQRLNIAIDMA 797
GADFK +V + M++ LH + QP E L Q L
Sbjct: 73 LRP---PGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLR------ 118
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM-ETQSSSI 856
++Y+H ++H DLKPSN+L++ D + DFG+AR L + P + T+ +
Sbjct: 119 -GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA- 173
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
T Y P +L+LP EY + A D++S+G + EM RR+ +F G
Sbjct: 174 ----TRWYRAP---ELLLSLP--EY---TTAI---DMWSVGCIFAEMLGRRQ----LFPG 214
Query: 917 GLTLHEFCKMAL------PEKVMETV 936
+H+ K+ L E+V+ +
Sbjct: 215 KNYVHQL-KLILSVLGSPSEEVLNRI 239
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 40/221 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVC 745
+G+GS+ +VYKG NG VA+K++ L ++G + + E +L+ +H N++ + +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNG--QPEVCDLSLIQRLNIAIDMASAIEYL 803
+ + LV+EY+ L +++ + G PE L L Q L + Y+
Sbjct: 73 HT-----KETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYI 119
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H Q I+H DLKP N+L+ ++DFGLAR S+ + + S + T+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLAR-------AKSVPSHTYSNEVV-TLW 168
Query: 864 YVPPGNIAKMLNLPCLEYGMGS-EASVTGDVYSLGVMLLEM 903
Y PP + +GS E S D++ +G + +EM
Sbjct: 169 YRPPDVL------------LGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-11
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 28/237 (11%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKS-FVAECEVLRNTRHRNLIKII 742
+IG+G G VY VA+K + +L + LK F+ E ++ + H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 743 TVCSSID--------FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
++CS D +G K+L+ Q SL + L + L+I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF--------LSIFH 120
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+ + IEY+H ++H DLKP N+LL + D+G A F D
Sbjct: 121 KICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL----DI 173
Query: 855 SIGIKGTV--GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ + PG I + E +G AS + D+Y+LGV+L +M T P
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 8e-11
Identities = 73/282 (25%), Positives = 112/282 (39%), Gaps = 95/282 (33%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA------------ECEVLRNTR 734
+G+G++G V+K I VA+K K F A E L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQELG 64
Query: 735 -HRNLIKIITVCSSIDFKGADFKA-------LVYEYMQNGSLEEWLHQSNGQPEVCDLSL 786
H N++K++ V KA LV+EYM+ DL
Sbjct: 65 DHPNIVKLLNV----------IKAENDKDIYLVFEYMET-----------------DLHA 97
Query: 787 IQRLNIAIDM---------ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
+ R NI D+ A++Y+H ++H DLKPSN+LL+ D ++DFGLA
Sbjct: 98 VIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA 154
Query: 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSL 896
R L + + + T Y P E +GS G D++S+
Sbjct: 155 RSLSELEENPENPVLTDYV---ATRWYRAP------------EILLGSTRYTKGVDMWSV 199
Query: 897 GVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDP 938
G +L EM +P +F G TL++ EK++E + P
Sbjct: 200 GCILGEML-LGKP---LFPGTSTLNQL------EKIIEVIGP 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 33/233 (14%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVK---ILNLMQKGALKSFVAECEVLRNTRHR 736
F IG+G F VY+ + VA+K I +M A + V E ++L+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N+IK + F + +V E G L + + Q + + + + +
Sbjct: 63 NVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY--FVQL 115
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
SA+E++H ++H D+KP+NV + V + D GL RF +S T + S
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHS- 165
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ GT Y+ P I E G ++ D++SLG +L EM + P
Sbjct: 166 -LVGTPYYMSPERIH--------ENGYNFKS----DIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+GS G V G VAVK ++L ++ + E ++R+ +H N I+ + S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN---IVEMYS 83
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
S + D +V E+++ G+L + + + E Q + + + A+ +LH
Sbjct: 84 S--YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLAVLKALSFLHAQ 134
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVP 866
++H D+K ++LL D +SDFG F + + S + GT ++
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG-----FCAQVSKEVPRRKSLV---GTPYWMA 183
Query: 867 PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
P I++ L Y G+E D++SLG+M++EM
Sbjct: 184 PEVISR------LPY--GTEV----DIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 42/232 (18%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQ-----KGALKSFVAECEVLRNTRHRNLIK 740
++GQG+FG VY + G +AVK + K + + E ++L+N +H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
C D + F EYM GS+++ L E ++ ++ I +
Sbjct: 69 YYG-CLRDDETLSIF----MEYMPGGSVKDQLKAYGALTE----TVTRKYTRQI--LEGV 117
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK- 859
EYLH + IVH D+K +N+L D + DFG ++ L SS G+K
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT--------ICSSGTGMKS 166
Query: 860 --GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT ++ P I G G +A DV+S+G ++EM T + P
Sbjct: 167 VTGTPYWMSPEVI--------SGEGYGRKA----DVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 61/241 (25%), Positives = 113/241 (46%), Gaps = 41/241 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRN 737
+++ IG+G++G VYKG + G VA+K + L ++G + + E +L+ +H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 738 LIKIITVCSSIDFKGADFKA-LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
++ + V + + L++E++ L+++L S + + D L++ I
Sbjct: 61 IVCLQDVLMQ------ESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQI-- 110
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
I + H ++H DLKP N+L+D+ V ++DFGLAR F + + +
Sbjct: 111 LQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEV 162
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCMFQ 915
T+ Y P E +GS T D++S+G + EM T ++P +F
Sbjct: 163 V---TLWYRAP------------EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFH 203
Query: 916 G 916
G
Sbjct: 204 G 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 9/138 (6%)
Query: 37 ALLAIKSQLHDPLGVTNSWNNSINLCQ---WAGVTCG----HRHQRVTELDLRHQNIGGS 89
AL +KS L PL WN + Q W+G C + L L +Q + G
Sbjct: 376 ALQTLKSSLGLPLRF--GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGF 433
Query: 90 LSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLL 149
+ + L L+ INL+ N+ G IP +G + LE L L+ NSF+G IP +L ++L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 150 SFVAYRNNLVGEIPEDIG 167
N+L G +P +G
Sbjct: 494 ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 35/228 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
+G+G++GSVYK + G +A+K + L + + + E ++L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 746 SSIDFKGADF-KALVY---EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+DF GA F + VY EYM GSL++ L+ E +++R+ A+ ++
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKG--LK 116
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+L I+H D+KP+NVL++ + + DFG++ L A T++ QS
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS-------- 166
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P I Y +V DV+SLG+ +LEM R P
Sbjct: 167 --YMAPERIKSGGPNQNPTY------TVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+F +GQG +G V+ + G VA+K + L + ++ + E ++L T+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
L+K++ F+ ++ L EY+ G L+ LS +
Sbjct: 61 EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNNLGV------LSEDHARFYMAE 109
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
M A++ LH + +H DLKP N L+D ++DFGL++ + +
Sbjct: 110 MFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----------GIVTYA 155
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ G+ Y+ P ++L G T D +SLG ML E
Sbjct: 156 NSVVGSPDYMAP----EVLR--------GKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 30/177 (16%)
Query: 687 IGQGSFGSVY----KGIL------------GENGTFVAVKILNL-MQKGALKSFVAECEV 729
+G+G FG V+ +G+ G VAVK+L K A F+ E ++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 730 LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCDLSLI 787
+ + N+I+++ VC + +D ++ EYM+NG L ++L H+ E D+ I
Sbjct: 73 MSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 788 QR---LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841
+ +A +AS ++YL VH DL N L+ + ++DFG++R L+
Sbjct: 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 46/229 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G++G VYK G VA+K + L +G + + E +L+ H N+++++ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 745 CSSIDFKGADFKA-LVYEYMQNGSLEEWL----HQSNGQPEVCDLSLIQRLNIAIDMASA 799
S + K LV+E++ + L++++ P + L Q +
Sbjct: 67 VHS------ENKLYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQ-------LLQG 111
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
I Y H H ++H DLKP N+L+D + ++DFGLAR F + T + +
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVV-- 161
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRR 907
T+ Y P E +GS T D++S+G + EM RR
Sbjct: 162 -TLWYRAP------------EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 42/235 (17%)
Query: 687 IGQGSFGSVYKGILGENG-TFVAVKILNL----MQKGA------LKSFVAECEVLRNT-R 734
+G G+FG VYK NG +A+K +N+ K + V+E +++ R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H N+++ F D +V + ++ L E H ++ + + + + NI +
Sbjct: 68 HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFV 120
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
M A+ YLH + IVH DL P+N++L D ++DFGLA+ E++ +
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-------QKQPESKLT 171
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
S + GT+ Y P I K N P YG + DV++ G +L +M T + P
Sbjct: 172 S--VVGTILYSCP-EIVK--NEP---YGEKA------DVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 43/246 (17%)
Query: 669 VSYSELSEATNEFSSSNMIGQGSFGSVY----KGILGENG-TFVAVKILNLM-QKGALKS 722
S L E T +G+G FG V+ KGI E G T V VK L +
Sbjct: 2 FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54
Query: 723 FVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC 782
F E ++ R H+N+++++ +C + A+ ++ EY G L+++L + + E
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKL 109
Query: 783 D---LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
LS Q++ + +A +++L + VH DL N L+ VS L++
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166
Query: 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM 899
++ + + ++ P + + + S DV+S GV+
Sbjct: 167 VYNSEYYKLRNA-------LIPLRWLAPEAVQE------------DDFSTKSDVWSFGVL 207
Query: 900 LLEMFT 905
+ E+FT
Sbjct: 208 MWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 66/246 (26%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+FG VYK E G F A KI+ + + L+ F+ E ++L +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 747 S-------IDF-KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
I+F G +++ E LE L + + + M
Sbjct: 73 YENKLWILIEFCDGGALDSIMLE------LERGLTEPQIRY------------VCRQMLE 114
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
A+ +LH H ++H DLK N+LL D ++DFG++ A+ T ++ + + IG
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS----AKNKST-LQKRDTFIG- 165
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVT-----------GDVYSLGVMLLEMFTRR 907
P Y M E D++SLG+ L+E+
Sbjct: 166 ------TP--------------YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
Query: 908 RPTNCM 913
P + +
Sbjct: 206 PPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVL-RNTRHRNLIKI 741
+IG+GSFG V F AVK+L +++K K ++E VL +N +H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
F+ AD V +Y+ G L L Q E C L R A ++ASA+
Sbjct: 62 -----HFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARF-YAAEIASALG 110
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YLH IV+ DLKP N+LLD ++DFGL + ++E ++ GT
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNGTTSTFCGT 159
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
Y+ P + K T D + LG +L EM
Sbjct: 160 PEYLAPEVLHK------------QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 43/221 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IGQG+ G+VY I G VA+K +NL Q+ + + E V+R +H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD--- 83
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQS---NGQ-PEVCDLSLIQRLNIAIDMASAIEY 802
+ D +V EY+ GSL + + ++ GQ VC L A+E+
Sbjct: 84 --SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----------QALEF 130
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH + ++H D+K N+LL D ++DFG + QS + GT
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--------TPEQSKRSTMVGTP 179
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
++ P + + YG D++SLG+M +EM
Sbjct: 180 YWMAPEVVTRK------AYGPKV------DIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+GS+GSVYK + F A+K ++L M + + V E +L + H N+I
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII----- 62
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
F + +V EY G L + + + + ++ I R I I + ++ LH
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQALH 120
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
I+H DLK +N+LL + + + D G+++ L T + GT Y
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----------GTPHY 167
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911
+ P E G S D++SLG +L EM T P
Sbjct: 168 MAP------------EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 35/240 (14%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV 729
S + + +++ IGQG+ G+VY + G VA++ +NL Q+ + + E V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 730 LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQR 789
+R ++ N++ + + D +V EY+ GSL + + E C + Q
Sbjct: 71 MRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQI 118
Query: 790 LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
+ + A+E+LH + ++H D+K N+LL D ++DFG +
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--------T 167
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
QS + GT ++ P + + P + D++SLG+M +EM P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV------------DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G G FG V + A+K + +++ G + +E E+L H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ FK + ++ EY G L L E R IA + A EYL
Sbjct: 59 YRT---FKDKKYIYMLMEYCLGGELWTILRDRGLFDE-----YTARFYIAC-VVLAFEYL 109
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H+ I++ DLKP N+LLD + + DFG A+ L + +T + GT
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWT----FCGTPE 157
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
YV P I G + SV D +SLG++L E+ T R P
Sbjct: 158 YVAPEIIL----------NKGYDFSV--DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 65/261 (24%), Positives = 116/261 (44%), Gaps = 40/261 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+FG VYK E G A K++ + L+ ++ E E+L H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---G 76
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
+ + G + ++ E+ G+++ + + + + +I R M A++YLH
Sbjct: 77 AFYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQYLH-- 127
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVP 866
I+H DLK NVLL D ++DFG++ A+ T ++ + S IG T ++
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKT-LQRRDSFIG---TPYWMA 178
Query: 867 PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKM 926
P + C E + D++SLG+ L+EM P HE M
Sbjct: 179 PEVVM------C-ETMKDTPYDYKADIWSLGITLIEMAQIEPPH----------HELNPM 221
Query: 927 ALPEKVMETVDPSLLL--AWS 945
+ K+ ++ P+L WS
Sbjct: 222 RVLLKIAKSEPPTLSQPSKWS 242
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 69/245 (28%), Positives = 107/245 (43%), Gaps = 49/245 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVK-ILNLM--QKGALKSFVAECEVLRNTRHRNLIKIIT 743
IG+G++G V E VA+K I N + A ++ + E ++LR+ H N+I I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQ---SNGQP---EVCDLSLIQRLNIAIDMA 797
+ + + +VYE M LHQ S+ Q + C L Q L
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSS-QTLSDDHCQYFLYQLLR------ 119
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
++Y+H ++H DLKPSN+LL+ + + DFGLAR T+ E
Sbjct: 120 -GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTE 167
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917
T Y P L L C EY ++ DV+S+G + E+ R+P +F G
Sbjct: 168 YVVTRWYRAP-----ELLLNCSEYT----TAI--DVWSVGCIFAELLG-RKP---LFPGK 212
Query: 918 LTLHE 922
+H+
Sbjct: 213 DYVHQ 217
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 43/232 (18%)
Query: 686 MIGQGSFGSVYKGIL---GENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIK- 740
++G G FG + +G L + VA+ L + F+AE L H N+++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 741 --IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+IT +++ +V EYM NG+L+ +L + GQ L Q + + +AS
Sbjct: 72 EGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLPGLAS 118
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
++YL + VH L VL++ D+V +S F R + E +++
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTMSG 168
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE-MFTRRRP 909
K V + P I +Y S AS DV+S G+++ E M RP
Sbjct: 169 KSPVLWAAPEAI---------QYHHFSSAS---DVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 6e-10
Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 68/251 (27%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN------LMQKGALKSFVAECEV 729
E + + + + +G G++G V + G VA+K L+ + K + E +
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRL 67
Query: 730 LRNTRHRNLIKIITV----CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLS 785
L++ H N+I ++ V S DF+ D LV M DL+
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQ--DV-YLVTHLMG-----------------ADLN 107
Query: 786 LI---QRLN------IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
I Q+L+ + + ++Y+H I+H DLKPSN+ ++ D + DFGL
Sbjct: 108 NIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL 164
Query: 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896
AR D M G T Y P MLN + Y + T D++S+
Sbjct: 165 ARHT-----DDEM------TGYVATRWYRAP---EIMLNW--MHY------NQTVDIWSV 202
Query: 897 GVMLLEMFTRR 907
G ++ E+ T +
Sbjct: 203 GCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 46/242 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIK---II 742
+G+G++ +V+KG VA+K + L ++GA + + E +L+N +H N++ II
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
+ LV+EY+ + L+++L +L+ N+ I M +
Sbjct: 73 HTERCL--------TLVFEYLDS-DLKQYLDNCG--------NLMSMHNVKIFMFQLLRG 115
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
L + + I+H DLKP N+L++ ++DFGLAR S+ T++ S + T+
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR-------AKSVPTKTYSNEVV-TL 167
Query: 863 GYVPPGNIAKMLNLPCLEYGMGS-EASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921
Y PP + +GS E S D++ +G +L EM T R MF G
Sbjct: 168 WYRPPDVL------------LGSTEYSTPIDMWGVGCILYEMATGRP----MFPGSTVKE 211
Query: 922 EF 923
E
Sbjct: 212 EL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 82/329 (24%), Positives = 131/329 (39%), Gaps = 93/329 (28%)
Query: 685 NMIGQGSFGSVYKG-ILGENGTF----VAVKILNLMQKGALKS-FVAECEVLRNTRHRNL 738
+G G+FG VY+G G +G VAVK L +S F+ E ++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 739 IKIITVCSSIDFKGADFKALVY----EYMQNGSLEEWLHQSNGQPE-VCDLSLIQRLNIA 793
+++I V F+ L E M G L+ +L ++ +PE L++ L A
Sbjct: 72 VRLIGVS---------FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLARFLFA----RPFD 846
D+A +YL + +H D+ N LL VA ++DFG+AR ++ R
Sbjct: 123 RDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG------DVYSLGVML 900
+M + IK ++PP EA + G DV+S GV+L
Sbjct: 180 RAM------LPIK----WMPP------------------EAFLDGIFTSKTDVWSFGVLL 211
Query: 901 LEMFTRRRPTNCMFQGGLTLHEFCKMALP----EKVMETVDPSLLLAWSDGRRRAKVEEC 956
E+F+ M P ++VME V + G R + C
Sbjct: 212 WEIFS-----------------LGYMPYPGRTNQEVMEFV--------TGGGRLDPPKGC 246
Query: 957 LVTVIRIGVACSMESPIERMEMRDVLAKL 985
V RI C +P +R +L ++
Sbjct: 247 PGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 7e-10
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 46/175 (26%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
F+ IG+GSFG VYK I VA+K+++L + AE E+ ++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--------AEDEI------EDI 46
Query: 739 IKIITVCSSID------FKGA---DFK-ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQ 788
+ I S + G+ K ++ EY GS DL
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS-------------CLDLLKPG 93
Query: 789 RLN---IAI---DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
+L+ IA ++ +EYL H + I H D+K +N+LL + ++DFG++
Sbjct: 94 KLDETYIAFILREVLLGLEYL--HEEGKI-HRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 35/240 (14%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV 729
S + + +++ IGQG+ G+VY I G VA+K +NL Q+ + + E V
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 730 LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQR 789
+R ++ N++ + + D +V EY+ GSL + + E C + Q
Sbjct: 70 MRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV------TETC-MDEGQI 117
Query: 790 LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
+ + A+++LH + ++H D+K N+LL D ++DFG +
Sbjct: 118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--------T 166
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
QS + GT ++ P + + P + D++SLG+M +EM P
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV------------DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 60/312 (19%)
Query: 680 EFSSSNMIGQGSFGSVYKGIL---GENGTF-VAVKIL--NLMQKGALKSFVAECEVLRNT 733
E ++G G+FG+VYKGI GEN VA+K+L N K A K + E V+
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGV 66
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
+ +++ +C + + LV + M G L +++ ++ + DL LN
Sbjct: 67 GSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWC 115
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+ +A + YL + +VH DL NVL+ ++DFGLAR L D ET+
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----DID-ETEY 166
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913
+ G G VP +A LE + + DV+S GV + E+ T
Sbjct: 167 HADG-----GKVPIKWMA-------LESILHRRFTHQSDVWSYGVTVWELMTF------- 207
Query: 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973
G ++ +P + + P LL G R + C + V I V C M
Sbjct: 208 ---GAKPYD----GIPAREI----PDLLEK---GERLPQPPICTIDVYMIMVKCWMIDSE 253
Query: 974 ERMEMRDVLAKL 985
R R+++ +
Sbjct: 254 CRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+G+FG V +G + A+KIL ++ K + + E VL+NTRH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
F+ D V EY+ G L + H S + D + ++ SA++Y
Sbjct: 61 ----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRF----YGAEIVSALDY 110
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH IV+ DLK N++LD D ++DFGL + + ++ GT
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--------EGITDAATMKTFCGTP 159
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P + +YG D + LGV++ EM R P
Sbjct: 160 EYLAPEVLEDN------DYGRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 40/231 (17%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKILNLMQKGALKS---FVAECEVLRNTRHRNL 738
+GQGSFG VY+G GE T VAVK +N + +L+ F+ E V++ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH----QSNGQPEVCDLSLIQRLNIAI 794
++++ V S KG +V E M +G L+ +L ++ P +L + + +A
Sbjct: 72 VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
++A + YL+ VH DL N ++ HD + DFG+ R ++ ET
Sbjct: 127 EIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--------ETDYY 175
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
KG G +P + + L+ G+ + +S D++S GV+L E+ +
Sbjct: 176 R---KGGKGLLP----VRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 18/159 (11%)
Query: 686 MIGQGSFGSVYKGI---LGENGTFVAVKILNLMQKGALKS-FVAECEVLRNTRHRNLIKI 741
IG+G FG VY+G+ VAVK +++ F+ E ++R H +++K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
I V + + +V E G L +L + ++ L L + +++A+
Sbjct: 73 IGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALA 121
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
YL VH D+ NVL+ + DFGL+R+L
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 48/220 (21%)
Query: 705 TFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763
VAVK+L A + F+ E ++L N+ +++ VC+ ++ EYM
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYM 101
Query: 764 QNGSLEEWL--HQSNGQPEVCDLSLIQR---LNIAIDMASAIEYLHHHCQPPIVHGDLKP 818
+NG L ++L H + C+ + L +A +AS + YL VH DL
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158
Query: 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP- 877
N L+ + ++DFG++R L++ + + G P LP
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDY--------YRVQ-----GRAP---------LPI 196
Query: 878 ------CLEYGMGSEASVTGDVYSLGVMLLEMFT--RRRP 909
+ G + S DV++ GV L E+ T R +P
Sbjct: 197 RWMAWESVLLGKFTTKS---DVWAFGVTLWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 60/312 (19%)
Query: 680 EFSSSNMIGQGSFGSVYKGIL---GENGTF-VAVKIL-NLMQKGALKSFVAECEVLRNTR 734
EF ++G G+FG+VYKG+ GE VA+K L A K + E V+ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
+ ++ +++ +C + + L+ + M G L +++ + + + L LN +
Sbjct: 68 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREH--KDNIGSQYL---LNWCV 116
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+A + YL +VH DL NVL+ ++DFGLA+ L + E +
Sbjct: 117 QIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GADEKEYH 167
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913
+ G G VP K + L + + + + S DV+S GV + E+ T +P +
Sbjct: 168 AEG-----GKVP----IKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYD-- 213
Query: 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973
+P + ++ G R + C + V I V C M
Sbjct: 214 -------------GIPASEISSI-------LEKGERLPQPPICTIDVYMIMVKCWMIDAD 253
Query: 974 ERMEMRDVLAKL 985
R + R+++ +
Sbjct: 254 SRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 40/241 (16%)
Query: 677 ATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLMQKGALK---SFVAECE 728
A + + S +GQGSFG VY+GI E T VA+K +N + +++ F+ E
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 61
Query: 729 VLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH----QSNGQPEVCDL 784
V++ ++++++ V S ++ E M G L+ +L + P
Sbjct: 62 VMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 785 SLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP 844
SL + + +A ++A + YL+ + VH DL N ++ D + DFG+ R ++
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--- 170
Query: 845 FDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
ET KG G +P + ++ L+ G+ + S DV+S GV+L E+
Sbjct: 171 -----ETDYYR---KGGKGLLP----VRWMSPESLKDGVFTTYS---DVWSFGVVLWEIA 215
Query: 905 T 905
T
Sbjct: 216 T 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+G+FG V G + A+KIL ++ K + V E VL+NTRH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
F+ D V EY G L + H S + + + ++ SA+EY
Sbjct: 61 ----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----YGAEIVSALEY 110
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH +V+ D+K N++LD D ++DFGL + + ++ GT
Sbjct: 111 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTFCGTP 159
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P + +YG D + LGV++ EM R P
Sbjct: 160 EYLAPEVLEDN------DYGRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 76/329 (23%), Positives = 137/329 (41%), Gaps = 65/329 (19%)
Query: 673 ELSEATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLMQKGALKS-FVAE 726
E++ +T F +G+ FG VYKG L GE VA+K L +G L+ F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 727 CEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV----- 781
+ +H N++ ++ V + ++++ Y + L E+L + +V
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 782 -----CDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
L ++I +A+ +E+L H +VH DL NVL+ + +SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896
R ++A + M +S + I+ ++ P I M + S+ D++S
Sbjct: 171 FREVYAADYYKLM--GNSLLPIR----WMSPEAI------------MYGKFSIDSDIWSY 212
Query: 897 GVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEEC 956
GV+L E+F+ L +C + + V+E + +L D +C
Sbjct: 213 GVVLWEVFS------------YGLQPYCGYS-NQDVIEMIRNRQVLPCPD--------DC 251
Query: 957 LVTVIRIGVACSMESPIERMEMRDVLAKL 985
V + + C E P R +D+ ++L
Sbjct: 252 PAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+GS G V + +G VAVK ++L ++ + E ++R+ +H N++++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
+ D +V E+++ G+L + + + E Q + + + A+ LH
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVP 866
++H D+K ++LL HD +SDFG F + + S + GT ++
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVPRRKSLV---GTPYWMA 184
Query: 867 PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
P I++ LP G E D++SLG+M++EM P
Sbjct: 185 PELISR---LP-----YGPEV----DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 38/231 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVL-RNTRHRNLIKI 741
+IG+GSFG V +G AVK+L ++ + K +AE VL +N +H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
F+ + V +++ G L L + PE R A ++ASA+
Sbjct: 62 -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAA-EIASALG 110
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YLH IV+ DLKP N+LLD ++DFGL + + ++ GT
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--------EGIAQSDTTTTFCGT 159
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912
Y+ P I K T D + LG +L EM P C
Sbjct: 160 PEYLAPEVIRK------------QPYDNTVDWWCLGAVLYEMLYGLPPFYC 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 54/233 (23%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
F+ IG+GSFG VYKGI VA+KI++L + AE E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDEI------EDIQQ 51
Query: 741 IITVCSSID------FKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRL 790
ITV S D + G+ K ++ EY+ GS + L G E ++ I R
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILR- 108
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
++ ++YLH + +H D+K +NVLL ++DFG+A L +
Sbjct: 109 ----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--------TD 153
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
TQ GT ++ P I + S D++SLG+ +E+
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQ------------SAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI---- 741
+IG+G FG VY + G A+K L+ K +K E L +L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
VC + F D + + M G L L Q +G ++ A ++ +E
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFY-----ATEIILGLE 111
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
++H+ +V+ DLKP+N+LLD +SD GLA D S + +S+ GT
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV---GT 158
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GY+ P + K G+ + D +SLG ML ++ P
Sbjct: 159 HGYMAPEVLQK-----------GTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 59/238 (24%), Positives = 114/238 (47%), Gaps = 48/238 (20%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
++F + +G G+ G V+K +G +A K+++L K A+++ +++R
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN-----QIIRE------ 53
Query: 739 IKIITVCSS---IDFKGADFK----ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN 791
++++ C+S + F GA + ++ E+M GSL++ L ++ PE ++ +++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 109
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
IA+ + YL + I+H D+KPSN+L++ + DFG++ L
Sbjct: 110 IAV--IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---------- 155
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
S + GT Y+ P E G+ SV D++S+G+ L+EM R P
Sbjct: 156 DSMANSFVGTRSYMSP------------ERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 687 IGQGSFGSVYKGILGE-----NGTFVAVKILNLMQKGALKS--FVAECEVLRNTRHRNLI 739
IG G FG V ILGE V VK L + + F+ E + R+ +H NL+
Sbjct: 3 IGNGWFGKV---ILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 740 KIITVCSS-IDFKGADFKALVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLNIAIDMA 797
+ + C+ + LV E+ G L+ +L + D + +QR+ A ++A
Sbjct: 59 QCLGQCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIA 110
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+ +LH + +H DL N LL D+ + D+GL+ + + + +
Sbjct: 111 LGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL----- 162
Query: 858 IKGTVGYVPPGNIAKML------NLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
+VP IA L NL + + + +V+SLGV + E+F
Sbjct: 163 ------WVPLRWIAPELVDEVHGNL------LVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 77/298 (25%), Positives = 122/298 (40%), Gaps = 50/298 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI---- 741
+IG+G FG VY + G A+K L+ K +K E L +L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
VC S F D + + + M G L L Q +G ++ A ++ +E
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFY-----AAEIILGLE 111
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
++H+ +V+ DLKP+N+LLD +SD GLA D S + +S+ GT
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV---GT 158
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL- 920
GY+ P + K G+ ++S D +SLG ML ++ P F+ T
Sbjct: 159 HGYMAPEVLQK---------GVAYDSS--ADWFSLGCMLFKLLRGHSP----FRQHKTKD 203
Query: 921 -HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977
HE +M L T+ L ++S R+ +E L + + C E E
Sbjct: 204 KHEIDRMTL------TMAVELPDSFSP-ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVK--ILNLMQKGALKSFVAECEVLRNTRHRNLI-KIIT 743
IG+G++G VYK G VA+K L + ++G + + E +L+ I +++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWL---HQSNGQPEVCDLSLIQRLNIAIDMASAI 800
V + G LV+EY+ + L++++ + G+P I+ + +
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRP--LPAKTIKSF--MYQLLKGV 123
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAR 838
+ H H ++H DLKP N+L+D + ++D GL R
Sbjct: 124 AHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 40/225 (17%)
Query: 687 IGQGSFGSVYKGILGENGT--FVAVKIL-NLMQKGALK-SFVAECEVLRNTRHRNLIKII 742
+G G+FG+V KG+ + VAVKIL N ALK + E V++ + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
+C A+ LV E + G L ++L ++ E L+ ++++ + +Y
Sbjct: 63 GICE------AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGM------KY 110
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET--QSSSIGIKG 860
L VH DL NVLL A +SDFGL++ L + E ++ + G
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL------GADENYYKAKTHGKWP 161
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
Y P C+ Y S S DV+S GV++ E F+
Sbjct: 162 VKWYAP----------ECMNYYKFSSKS---DVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 64/260 (24%), Positives = 114/260 (43%), Gaps = 50/260 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+FG VYK E G A K+++ + L+ ++ E ++L + H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 747 SIDFKGADFKALVYEYMQNGSLEEW---LHQSNGQPE---VCDLSLIQRLNIAIDMASAI 800
F + ++ E+ G+++ L + +P+ VC +L A+
Sbjct: 71 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----------EAL 116
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH + I+H DLK N+L D ++DFG++ A+ T ++ + S IG
Sbjct: 117 NYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRT-IQRRDSFIG--- 165
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
T ++ P + C E DV+SLG+ L+EM P
Sbjct: 166 TPYWMAPEVVM------C-ETSKDRPYDYKADVWSLGITLIEMAQIEPPH---------- 208
Query: 921 HEFCKMALPEKVMETVDPSL 940
HE M + K+ ++ P+L
Sbjct: 209 HELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+GSFG V L E+G AVK+L ++Q ++ + E +L R+ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN--GQPEVCDLSLIQRLNIAIDMASAI 800
C F+ D V E++ G L + +S + A ++ SA+
Sbjct: 62 YCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR--------FYAAEITSAL 109
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
+LH I++ DLK NVLLDH+ ++DFG+ + TS G
Sbjct: 110 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--------FCG 158
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T Y+ P + +ML YG + D +++GV+L EM P
Sbjct: 159 TPDYIAPEILQEML------YG------PSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 58/235 (24%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL-KSFVAECEVLRNTRHRNLIKIITVC 745
+G G+ GSV K GT +A K++++ K ++ K + E +++ C
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE------------C 60
Query: 746 SS---IDFKGADFKA-----LVYEYMQNGSLEEWLHQSNG-QPEVCDLSLIQRLNIAIDM 796
S + F GA F + E+M GSL+ + E+ IA+ +
Sbjct: 61 RSPYIVSFYGA-FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-------KIAVAV 112
Query: 797 ASAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+ YL+ H I+H D+KPSN+L++ + DFG++ L DT +
Sbjct: 113 VEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV----- 163
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P I G + +V DV+SLG+ ++E+ + P
Sbjct: 164 -----GTSTYMSPERI------------QGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 58/240 (24%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL------KSFVAECEVLRNT 733
E++ ++G+G++G+VY G L G +AVK + L L + E ++L++
Sbjct: 1 EWTKGEVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
+H N+++ + C + ++ E++ GS+ L++ PE +++
Sbjct: 60 KHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--- 111
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+ YLH++C +VH D+K +NV+L + + + DFG AR L +
Sbjct: 112 ---LDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913
S + GT ++ P I E G G ++ D++S+G + EM T + P M
Sbjct: 166 KS--MHGTPYWMAPEVIN--------ESGYGRKS----DIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 45/229 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G++G VYK +A+K + L Q+ G + + E +L+ +H N++++ V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 745 CSSIDFKGADFKA-LVYEYMQNGSLEEWLHQS---NGQPEVCDLSLIQRLNIAIDMASAI 800
S + + LV+EY+ + L++ + S P + L Q + I
Sbjct: 70 VHS------EKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQ-------ILRGI 115
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLARFLFARPFDTSMETQSSSIGIK 859
Y H H ++H DLKP N+L+D A ++DFGL AR F + T + +
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGL-----ARAFGIPVRTFTHEV--- 164
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRR 907
T+ Y P E +GS S D++S+G + EM ++
Sbjct: 165 VTLWYRAP------------EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 65/248 (26%)
Query: 687 IGQGSFGSVYK----GILGEN---GTFVAVKIL--NLMQKGALKSFVAECEVLRNT-RHR 736
+G+G FG V + GI VAVK+L N K L ++E E+++ +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-LADLISEMELMKLIGKHK 78
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD------------L 784
N+I ++ VC+ +G + ++ EY G+L E+L +P D L
Sbjct: 79 NIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRAR--RPPGPDYTFDITKVPEEQL 131
Query: 785 SLIQRLNIAIDMASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
S ++ A +A +EYL C +H DL NVL+ D V ++DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGV--H 185
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA------SVTGDVYSLG 897
D +T + + +K M EA + DV+S G
Sbjct: 186 DIDYYKKTSNGRLPVK----------------------WMAPEALFDRVYTHQSDVWSFG 223
Query: 898 VMLLEMFT 905
+++ E+FT
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 45/281 (16%)
Query: 687 IGQGSFGSVYKGI--LGENGTFVAVKIL-NLMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G G+FG V KG+ + + VA+K+L N +K + E E++ + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
VC A+ LV E G L ++L +G+ + +S + L + M ++YL
Sbjct: 63 VCE------AEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMG--MKYL 111
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
VH DL NVLL + A +SDFGL++ L A D S S K +
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARS--AGKWPLK 163
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCM--------F 914
+ P C+ + S S DV+S G+ + E F+ ++P M
Sbjct: 164 WYAP---------ECINFRKFSSRS---DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211
Query: 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEE 955
+ G L C P ++ + + W D AKVEE
Sbjct: 212 EQGKRLD--CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-09
Identities = 22/41 (53%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 31 NETDRLALLAIKSQL-HDPLGVTNSWN-NSINLCQWAGVTC 69
DR ALLA KS L DP G +SWN +S + C W GVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 73/284 (25%), Positives = 112/284 (39%), Gaps = 68/284 (23%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGA---LKSFVAECEVLRNTRHRNLIKIIT 743
IG GSFG+VY VAVK ++ K + + E + L+ +H N
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82
Query: 744 VCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+I++KG K LV EY GS + L + + +P +Q + IA A
Sbjct: 83 ---TIEYKGCYLKEHTAWLVMEYCL-GSASDLL-EVHKKP-------LQEVEIAAITHGA 130
Query: 800 IE---YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
++ YLH H ++H D+K N+LL ++DFG S S +
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG------------SASKSSPAN 175
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG--DVYSLGVMLLEMFTRRRPTNCMF 914
GT ++ P I M E G DV+SLG+ +E+ R+ P
Sbjct: 176 SFVGTPYWMAPEVILAM-----------DEGQYDGKVDVWSLGITCIELAERKPP----- 219
Query: 915 QGGLTLHEFCKMALPEKVMETVDPSLLL-AWSDGRRRAKVEECL 957
L M+ + + P+L W+D R V+ CL
Sbjct: 220 -----LFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF-VDYCL 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 22/151 (14%)
Query: 706 FVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQ 764
VAVKIL K A F+ E ++L + N+I+++ VC D ++ EYM+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYME 102
Query: 765 NGSLEEWL--HQ-----SNGQPEVCD------LSLIQRLNIAIDMASAIEYLHHHCQPPI 811
NG L ++L H NG V +S L++A+ +AS ++YL
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159
Query: 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
VH DL N L+ ++ ++DFG++R L+A
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 48/230 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL------NLMQKGALKSFVAECEVLRNTRHRNLIK 740
+G G++G+V + G VA+K L L K A + E +L++ +H N+I
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78
Query: 741 IITVCS---SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
++ V + S+D + DF LV +M + H+ + IQ L M
Sbjct: 79 LLDVFTPDLSLD-RFHDF-YLVMPFMGTDLGKLMKHEKLSEDR------IQFL--VYQML 128
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
++Y+H I+H DLKP N+ ++ D + DFGLAR +T S G
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QTDSEMTG 174
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
T Y P I L + Y + T D++S+G ++ EM T +
Sbjct: 175 YVVTRWYRAPEVI-----LNWMHY------TQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 33/234 (14%)
Query: 680 EFSSSN---MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHR 736
E+ + ++G+G++G VY +A+K + ++ E + +HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N+++ + S F FK + E + GSL L G P + I I
Sbjct: 66 NIVQYLGSDSENGF----FK-IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQI-- 117
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
++YLH + IVH D+K NVL++ + V +SDFG ++ L + ET
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTET---- 168
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT+ Y+ P I K G G+ A D++SLG ++EM T + P
Sbjct: 169 --FTGTLQYMAPEVIDKGPR------GYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 59/238 (24%), Positives = 113/238 (47%), Gaps = 48/238 (20%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
++F + +G G+ G V K +G +A K+++L K A+++ +++R
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN-----QIIRE------ 53
Query: 739 IKIITVCSS---IDFKGADFK----ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN 791
++++ C+S + F GA + ++ E+M GSL++ L ++ PE ++ +++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVS 109
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
IA+ + YL Q I+H D+KPSN+L++ + DFG++ L
Sbjct: 110 IAV--LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---------- 155
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
S + GT Y+ P E G+ SV D++S+G+ L+E+ R P
Sbjct: 156 DSMANSFVGTRSYMSP------------ERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+GS G V G VAVK ++L ++ + E ++R+ H N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--- 86
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
+ D +V E+++ G+L + + + E Q + + + A+ YLH+
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVP 866
++H D+K ++LL D +SDFG F + + S + GT ++
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFG-----FCAQVSKEVPKRKSLV---GTPYWMA 186
Query: 867 PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
P I++ LP G+E D++SLG+M++EM P
Sbjct: 187 PEVISR---LP-----YGTEV----DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 70/237 (29%), Positives = 105/237 (44%), Gaps = 36/237 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
++F +IG+G+FG V + G A+KILN ++++ F E +VL N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAI 794
R + + F+ + LV +Y G L L + + PE D++ R +A
Sbjct: 61 RWITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE--DMA---RFYLA- 109
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQ 852
+M AI+ +H Q VH D+KP NVLL D H+ +DFG L A T
Sbjct: 110 EMVLAIDSVH---QLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLAD------GTV 158
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
S++ + GT Y+ P + M E G G D +SLGV + EM P
Sbjct: 159 QSNVAV-GTPDYISPEILQAM------EDGKGRYGPEC-DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 54/233 (23%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
F+ IG+GSFG V+KGI VA+KI++L + AE E+ ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDEI------EDIQQ 51
Query: 741 IITVCSSID------FKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRL 790
ITV S D + G+ K ++ EY+ GS + L E L Q
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIA 104
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
I ++ ++YLH + +H D+K +NVLL ++DFG+A L +
Sbjct: 105 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--------TD 153
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
TQ GT ++ P I + S D++SLG+ +E+
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQ------------SAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 687 IGQGSFGSVYKGIL---GENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKI 741
IG+GSFG K IL E+G +K +N+ M + E VL N +H N I
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN---I 61
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+ S + G + +V +Y + G L + ++ G Q L+ + + A++
Sbjct: 62 VQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVL----FPEDQILDWFVQICLALK 115
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
++H I+H D+K N+ L D + DFG+AR L ++++E + I GT
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCI---GT 164
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
Y+ P I + N P Y S D+++LG +L EM T
Sbjct: 165 PYYLSP-EICE--NRP---YNNKS------DIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG--ALKSFVAECEVLRNTRHR 736
N+F ++G+G++G V K E VA+K ++ ++ + E ++LR +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N++++ F+ LV+EY++ LE NG P S I +L
Sbjct: 61 NIVELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------ 109
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
AI + H + IVH D+KP N+L+ H+ V + DFG AR L
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 43/227 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+GS G V +G VAVK+++L ++ + E ++R+ +H+N++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE----VCDLSLIQRLNIAIDMASAIEY 802
G + L+ E++Q G+L + + Q+ E VC+ S++Q A+ Y
Sbjct: 88 ---LVGEELWVLM-EFLQGGALTDIVSQTRLNEEQIATVCE-SVLQ----------ALCY 132
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH ++H D+K ++LL D +SDFG F + + S + GT
Sbjct: 133 LHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG-----FCAQISKDVPKRKSLV---GTP 181
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
++ P I++ G+E D++SLG+M++EM P
Sbjct: 182 YWMAPEVISRTP--------YGTEV----DIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 27/167 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G GS G V+ + + VAVK + L ++K + E +++R H N++K+ V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 747 SIDFKGADFKA------------LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
G+D +V EYM+ L L Q E L + Q L
Sbjct: 73 P---SGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR--- 125
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFL 840
++Y+H ++H DLKP+NV ++ D+V + DFGLAR +
Sbjct: 126 ----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 60/248 (24%), Positives = 109/248 (43%), Gaps = 38/248 (15%)
Query: 662 MEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALK 721
ME+ +VS + + +++ IGQG+ G+V+ I G VA+K +NL ++ +
Sbjct: 5 MEKLRTIVS---IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE 61
Query: 722 SFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV 781
+ E V++ ++ N++ + F D +V EY+ GSL + + E
Sbjct: 62 LIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEYLAGGSLTDVV------TET 110
Query: 782 CDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841
C + Q + + A+E+LH + ++H D+K NVLL D ++DFG +
Sbjct: 111 C-MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI- 165
Query: 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901
QS + GT ++ P + + P + D++SLG+M +
Sbjct: 166 -------TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV------------DIWSLGIMAI 206
Query: 902 EMFTRRRP 909
EM P
Sbjct: 207 EMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHR 736
EF I +G+FG VY G N AVK++ +++ K + AE + L ++
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
++ + S A+ LV EY+ G ++ LH E + I ++
Sbjct: 65 FIVHLYYSLQS-----ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS------EV 113
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
A A++YLH H I+H DLKP N+L+ ++ ++DFGL++ R
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 58/226 (25%), Positives = 109/226 (48%), Gaps = 42/226 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIK---II 742
+G+G++ +VYKG VA+K + L ++GA + + E +L++ +H N++ II
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
S+ LV+EY+ + L+++L + I N+ + + +
Sbjct: 74 HTEKSL--------TLVFEYL-DKDLKQYLDDCG--------NSINMHNVKLFLFQLLRG 116
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
L++ + ++H DLKP N+L++ ++DFGLAR A+ T +T S+ + T+
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPT--KTYSNEV---VTL 168
Query: 863 GYVPPGNIAKMLNLPCLEYGMGS-EASVTGDVYSLGVMLLEMFTRR 907
Y PP + +GS + S D++ +G + EM T R
Sbjct: 169 WYRPPDIL------------LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 54/243 (22%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
F+ IG+GSFG V+KGI VA+KI++L + AE E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDEI------EDIQQ 51
Query: 741 IITVCSSID------FKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRL 790
ITV S D + G+ K ++ EY+ GS + L Q
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-------PFDEFQIA 104
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
+ ++ ++YLH + +H D+K +NVLL ++DFG+A L +
Sbjct: 105 TMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--------TD 153
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910
TQ GT ++ P I + S D++SLG+ +E+ P
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQ------------SAYDSKADIWSLGITAIELAKGEPPN 201
Query: 911 NCM 913
+ M
Sbjct: 202 SDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 687 IGQGSFGSVYKGILGE--NGTFVAVKILNLMQKGA----LKSFVAECEVLRNTRHRNLIK 740
IG G FG V +L E T VA ++ ++ A F+ + + R +H N+++
Sbjct: 3 IGNGWFGKV---LLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 741 IITVC-SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+ C +I + LV+EY + G L+ +L Q L L+QR+ A ++A+
Sbjct: 60 CLGQCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAG 111
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+ ++H H +H DL N L D+ V D+G+ + + + + +
Sbjct: 112 VTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK------- 161
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
VP +A L + +E + +V++LGV L E+F
Sbjct: 162 ----CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 52/251 (20%)
Query: 680 EFSSSNM-----IGQGSFGSVYK----GILGE---NGTFVAVKIL-NLMQKGALKSFVAE 726
E S + + +G+G FG V GI + VAVK+L + L V+E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 727 CEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP------ 779
E+++ +H+N+I ++ C+ + LV EY G+L E+L ++ P
Sbjct: 68 MEMMKMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYL-RARRPPGMDYSF 121
Query: 780 EVC-----DLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834
+ C L+ ++ A +A +EYL +H DL NVL+ D V ++DF
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894
GLAR + D +T + + +K ++ P E + DV+
Sbjct: 179 GLARDV--HNIDYYKKTTNGRLPVK----WMAP------------EALFDRVYTHQSDVW 220
Query: 895 SLGVMLLEMFT 905
S GV+L E+FT
Sbjct: 221 SFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 55/233 (23%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL-KSFVAECEVLRNTRHRNLIKIIT 743
++G G+ G+VYK +AVK++ L L K ++E E+L
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK----------- 55
Query: 744 VCSS---IDFKGADFK----ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
C S I F GA F ++ E+M GSL+ + PE ++ R IA+ +
Sbjct: 56 -CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPE----HVLGR--IAVAV 104
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ YL I+H D+KPSN+L++ + DFG++ L S +
Sbjct: 105 VKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----------VNSIAK 151
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P I+ G + + DV+SLG+ +E+ R P
Sbjct: 152 TYVGTNAYMAPERIS------------GEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 53/242 (21%)
Query: 687 IGQGSFGSVYKGILGE----------NGTFVAVKILNL-MQKGALKSFVAECEVLRNT-R 734
+G+G FG V ++ E T VAVK+L + L ++E E+++ +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP--EVC---------D 783
H+N+I ++ C+ G + ++ EY G+L E+L ++ P E C
Sbjct: 83 HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQ 136
Query: 784 LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
LS ++ A +A +EYL +H DL NVL+ D V ++DFGLAR +
Sbjct: 137 LSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--H 191
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
D +T + + +K ++ P + + Y S DV+S GV+L E+
Sbjct: 192 HIDYYKKTTNGRLPVK----WMAPEALFDRI------YTHQS------DVWSFGVLLWEI 235
Query: 904 FT 905
FT
Sbjct: 236 FT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+G+FG V G + A+KIL ++ K + + E VL+NTRH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
F+ D V EY G L + H S + D + R A ++ SA+ Y
Sbjct: 61 ----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRA---RFYGA-EIVSALGY 110
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
LH +V+ DLK N++LD D ++DFGL +
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 40/227 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHR 736
+F +G GSFG V G + A+K L +++ ++ E +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
++ ++ CS F+ + + E++ G L L ++ P D++ + +
Sbjct: 79 FIVNMM--CS---FQDENRVYFLLEFVVGGELFTHLRKAGRFPN--DVAKFYHAELVL-- 129
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A EYLH I++ DLKP N+LLD+ V+DFG A+ + R F
Sbjct: 130 --AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---------- 174
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+ GT Y+ P I G +V D +++GV+L E
Sbjct: 175 -LCGTPEYLAPEVIQS----------KGHGKAV--DWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 36/227 (15%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+G+FG V G + A+KIL ++ K + + E VL+N+RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
F+ D V EY G L + H S + S + ++ SA++Y
Sbjct: 61 ----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSALDY 110
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH + +V+ DLK N++LD D ++DFGL + ++ ++ GT
Sbjct: 111 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKTFCGTP 160
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P + +YG D + LGV++ EM R P
Sbjct: 161 EYLAPEVLEDN------DYGRAV------DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 32/235 (13%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
++F +IG+G+FG V + A+KILN ++++ F E VL N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAI 794
+ + + F+ ++ LV +Y G L L + + PE D++ R IA
Sbjct: 61 QWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE--DMA---RFYIA- 109
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+M AI +H Q VH D+KP NVLLD + ++DFG + T S
Sbjct: 110 EMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM------NQDGTVQS 160
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
S+ + GT Y+ P + M E GMG D +SLGV + EM P
Sbjct: 161 SVAV-GTPDYISPEILQAM------EDGMGKYGPEC-DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 36/227 (15%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+GSFG V L AVK+L ++Q ++ + E VL + +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
C F+ D V EY+ G L + +S E + A ++ +++
Sbjct: 62 HSC----FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP------RARFYAAEIVLGLQF 111
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH I++ DLK NVLLD + ++DFG+ + + ++ GT
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--------EGILGGVTTSTFCGTP 160
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P ++ YG +V D ++LGV+L EM + P
Sbjct: 161 DYIAPEILSYQ------PYG----PAV--DWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 20/144 (13%)
Query: 687 IGQGSFGSVYKGILGENG-------TFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLI 739
+GQG+F ++KGI E G T V +K+L+ + +SF ++ H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
VC D +V EY++ GSL+ +L ++ +++ +L +A +A A
Sbjct: 63 LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKNL-----INISWKLEVAKQLAWA 112
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLL 823
+ +L + HG++ NVLL
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 27/238 (11%)
Query: 669 VSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECE 728
+ S L + F ++G G++G VYKG + G A+K++++ + + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEIN 64
Query: 729 VLRN-TRHRNLIKIITVCSSIDFKGADFKA-LVYEYMQNGSLEEWLHQSNGQPEVCD-LS 785
+L+ + HRN+ G D + LV E+ GS+ + + + G D ++
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 786 LIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF 845
I R ++ + +LH H ++H D+K NVLL + + DFG++ L
Sbjct: 125 YICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----- 171
Query: 846 DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
D ++ +++ I GT ++ P IA N P Y S D++SLG+ +EM
Sbjct: 172 DRTVGRRNTFI---GTPYWMAPEVIACDEN-PDATYDYRS------DIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 45/237 (18%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN------LMQKGALKSFVAECEV 729
E ++S +G G++GSV I G VA+K L+ + K A + E +
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTL 67
Query: 730 LRNTRHRNLIKIITV-CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQ 788
L++ +H N+I ++ V S++ LV YMQ L + G P D +Q
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDK--VQ 120
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
L M ++Y+H I+H DLKP N+ ++ D + DFGLAR D
Sbjct: 121 YL--VYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAE 170
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
M G T Y P I L + Y T D++S+G ++ EM T
Sbjct: 171 M------TGYVVTRWYRAPEVI-----LNWMHYNQ------TVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 49/239 (20%)
Query: 686 MIGQGSFGSVY--KGILGEN-GTFVAVKILNLMQKGALK-----SFVAECEVLRNTRHRN 737
++GQGSFG V+ + I G + G A+K+L +K LK E ++L H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
++K+ F+ L+ ++++ G L L + EV + +A ++A
Sbjct: 60 IVKL-----HYAFQTEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLA-ELA 108
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
A+++LH I++ DLKP N+LLD + ++DFGL++ S++ + +
Sbjct: 109 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKKAYS 157
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GTV Y+ P + + + + + D +S GV++ EM T P FQG
Sbjct: 158 FCGTVEYMAPEVVNRRGH------------TQSADWWSFGVLMFEMLTGSLP----FQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 53/229 (23%), Positives = 81/229 (35%), Gaps = 49/229 (21%)
Query: 688 GQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
+ K T VAVK +NL K LK E R +H N++ +T
Sbjct: 11 EDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS- 67
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
F +V M GS E+ L H G PE+ I I D+ +A++Y+
Sbjct: 68 ----FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL----AIA--FILKDVLNALDYI 117
Query: 804 HH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
H +H +K S++LL D +S + + G + V
Sbjct: 118 HSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKH-------------GKRQRV 160
Query: 863 GYVPPGNIAKMLNLPCLE--------YGMGSEASVTGDVYSLGVMLLEM 903
+ P + K L E Y S D+YS+G+ E+
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS------DIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 8e-08
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 68/236 (28%)
Query: 687 IGQGSFGSV---YKGILGENGTFVAVKIL-----NLMQ-KGALKSFVAECEVLRNTRHRN 737
IG G+ G V Y + G+N VA+K L N+ K A + V +++ H+N
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKN 76
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID-- 795
+I ++ V + +F+ VY M E+ D +L Q + + +D
Sbjct: 77 IIGLLNVFTP-QKSLEEFQD-VYLVM----------------ELMDANLCQVIQMDLDHE 118
Query: 796 --------MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
M I++LH I+H DLKPSN+++ D + DFGLAR
Sbjct: 119 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------- 166
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
GT + P + + P + GMG + +V D++S+G ++ EM
Sbjct: 167 ----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 68/290 (23%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSF---VAECEVLRNTRHRN 737
F+ IG GSFG+VY VA+K ++ K + + + + E + L+ +H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 738 LIKIITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
SI++KG + LV EY GS + L + + +P +Q + IA
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYCL-GSASDLL-EVHKKP-------LQEVEIA 128
Query: 794 IDMASAIE---YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
A++ YLH H ++H D+K N+LL ++DFG A S+
Sbjct: 129 AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA----------SIA 175
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG--DVYSLGVMLLEMFTRRR 908
+ ++S GT ++ P I M E G DV+SLG+ +E+ R+
Sbjct: 176 SPANS--FVGTPYWMAPEVILAM-----------DEGQYDGKVDVWSLGITCIELAERKP 222
Query: 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLL-LAWSDGRRRAKVEECL 957
P L M+ + + P+L WSD R V+ CL
Sbjct: 223 P----------LFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF-VDSCL 261
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV--LRNTRHRNLIKIITV 744
IG+GSFG +Y + +K ++L + + ++ EV L +H N I+T
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN---IVTF 64
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+S G F +V EY G L + +++ G S Q L+ + ++ ++++H
Sbjct: 65 FASFQENGRLF--IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIH 118
Query: 805 HHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
I+H D+K N+ L + MVA + DFG+AR L + SME + + GT
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-----NDSMELAYTCV---GTPY 167
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P E + D++SLG +L E+ T + P
Sbjct: 168 YLSP------------EICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS---FVAECEV--LRNTRHRNLIK 740
++GQG+FG VY + G +A K + + S ECE+ L+N +H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---R 65
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
I+ + + + EYM GS+++ L E S+ ++ I +
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE----SVTRKYTRQI--LEGM 119
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH + IVH D+K +N+L D + DFG ++ L T + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICMSGTGIRSVTG 171
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T ++ P I+ G G +A DV+SLG ++EM T + P
Sbjct: 172 TPYWMSPEVISGE--------GYGRKA----DVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 43/227 (18%)
Query: 694 SVYKGILGENGTFVAVKILNLMQKGA---LKSFVAECEVLRNTRHRNLIKI----ITVCS 746
S+YKGI N V ++ KG + E + LR N++KI I +
Sbjct: 35 SIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
+ +L+ EY G L E L + DLS +L++AID + L+ +
Sbjct: 93 DLPRL-----SLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKY 141
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVP 866
P + +L + L+ + + GL + L + PF + Y
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV-----------NFMVYFS 188
Query: 867 PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913
KMLN + SE ++ D+YSLGV+L E+FT + P +
Sbjct: 189 Y----KMLN------DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 56/247 (22%)
Query: 681 FSSSNM-----IGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGALKSFVAECEVLRNTR 734
F++ ++ IG+G+FG+V K + +GT +AVK I + + + K + + +V+ R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--R 58
Query: 735 HRNLIKIITVCSSIDFKGADFKA----LVYEYMQNGSLEE-----WLHQSNGQPEVCDLS 785
+ I+ F GA F+ + E M + SL++ + + PE
Sbjct: 59 SSDCPYIVK------FYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE----E 107
Query: 786 LIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL---FA 842
++ + IA+ A+ YL + I+H D+KPSN+LLD + + DFG++ L A
Sbjct: 108 ILGK--IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163
Query: 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
+ D G Y+ P I P G V DV+SLG+ L E
Sbjct: 164 KTRDA------------GCRPYMAPERID-----PSARDGY----DVRSDVWSLGITLYE 202
Query: 903 MFTRRRP 909
+ T + P
Sbjct: 203 VATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 2/97 (2%)
Query: 158 LVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYN 216
L G IP DI L+ I+L+ N + G +P S+G++ S+ L + N F+G++P SL
Sbjct: 430 LRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 217 MSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDN 253
++SL + L+ N +G +P +G L + F DN
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 56/241 (23%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA---LKSFVAECEVLRNTRHRN 737
FS IG GSFG+VY N VA+K ++ K + + + E L+ RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 738 LIKIITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
+I ++G + LV EY GS + L + + +P +Q + IA
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLL-EVHKKP-------LQEVEIA 118
Query: 794 IDMASAIE---YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
A++ YLH H ++H D+K N+LL + + DFG A +
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------- 165
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG--DVYSLGVMLLEMFTRRR 908
+ + GT ++ P I M E G DV+SLG+ +E+ R+
Sbjct: 166 --APANXFVGTPYWMAPEVILAM-----------DEGQYDGKVDVWSLGITCIELAERKP 212
Query: 909 P 909
P
Sbjct: 213 P 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 36/236 (15%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHR 736
+F +IG+G+FG V L A+KILN ++++ F E +VL N ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAID 795
+ + F+ + LV +Y G L L + + PE + + IAID
Sbjct: 62 WITTL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME--TQS 853
++ LH+ VH D+KP N+L+D + ++DFG L ME T
Sbjct: 117 ---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKL--------MEDGTVQ 159
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
SS+ + GT Y+ P + M E G G D +SLGV + EM P
Sbjct: 160 SSVAV-GTPDYISPEILQAM------EDGKGKYGPEC-DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 50/240 (20%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG--ALKSFVAECEVLRNTRHRN 737
+ + + IG+G++G V G VA+K ++ + ++ + E ++LR +H N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64
Query: 738 LIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
+I I+ + F F +V E M E L++ LI+ +++ D
Sbjct: 65 IIGILDIIRPPSF--ESFNDVYIVQELM-----ETDLYK-----------LIKTQHLSND 106
Query: 796 --------MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
+ ++Y+H ++H DLKPSN+LL+ + + DFGLAR T
Sbjct: 107 HIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
T+ + T Y P I MLN + D++S+G +L EM + R
Sbjct: 164 GFLTEYVA-----TRWYRAP-EI--MLN--------SKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 19/118 (16%)
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
IA+ + A+EYLH + ++H D+KPSNVL++ + + DFG++ +L D+ +T
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKT 161
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ G Y+ P I LN V DV+SLG+ ++E+ T R P
Sbjct: 162 IDA-----GCKPYMAPERINPELNQ--------KGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 29/234 (12%)
Query: 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLR 731
L + F ++G G++G VYKG + G A+K++++ ++ +K E +L+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLK 57
Query: 732 N-TRHRNLIKIITVCSSIDFKGADFKA-LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQR 789
+ HRN+ + G D + LV E+ GS+ + + + G L
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWI 113
Query: 790 LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
I ++ + +LH H ++H D+K NVLL + + DFG++ L D ++
Sbjct: 114 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTV 165
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+++ I GT ++ P IA N P Y S D++SLG+ +EM
Sbjct: 166 GRRNTFI---GTPYWMAPEVIACDEN-PDATYDFKS------DLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA--ECEVLRNTRHRNLIKIITV 744
+G+G+FG E+ + V K +NL + + A E +L +H N II
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---IIAY 64
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ---PEVCDLSLIQRLNIAIDMASAIE 801
+ + EY G+L + + + GQ E+ L Q + SA+
Sbjct: 65 YNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-------IVSAVS 115
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM-ETQSSSIGIKG 860
Y+H + I+H D+K N+ L + + DFG+++ L + + SM ET + G
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS---EYSMAET------VVG 163
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
T Y+ P E G + + D+++LG +L E+ T +R
Sbjct: 164 TPYYMSP------------ELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 68/249 (27%), Positives = 104/249 (41%), Gaps = 52/249 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+G G V+ L G A+K+L+ ++++ +K + E E+L H + T
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ +S F+ + LV +Y G L L QP C + R A ++ A+EYL
Sbjct: 66 LYAS--FQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAA-EVLLALEYL 119
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGL--------------ARFLFARPFDT 847
H IV+ DLKP N+LL H+ SDF L R R
Sbjct: 120 H--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 848 SM--ETQSSSIGIK-----GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
S+ ET S + GT Y+ P I+ G G ++V D ++LG++L
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVIS----------GDGHGSAV--DWWTLGILL 222
Query: 901 LEMFTRRRP 909
EM P
Sbjct: 223 YEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRH 735
++F S +IG+G+FG V + G A+K L +++K + AE ++L +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
++K+ S F+ ++ L+ EY+ G + L + + E + + R IA +
Sbjct: 61 PWVVKL--YYS---FQDENYLYLIMEYLPGGDMMTLLMKKDTFTE--EET---RFYIA-E 109
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
AI+ +H +H D+KP N+LLD +SDFGL
Sbjct: 110 TILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 63/230 (27%), Positives = 108/230 (46%), Gaps = 48/230 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+ G V K + +G +A K+++L K A+ RN R L K++ C+
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAI----------RNQIIREL-KVLHECN 57
Query: 747 S---IDFKGADFK----ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
S + F GA + ++ E+M GSL++ L ++ PE +++ +++IA+
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----NILGKISIAV--LRG 111
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+ YL + I+H D+KPSN+L++ + DFG++ L SM
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANS-----FV 159
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P E G+ +V D++SLG+ L+EM R P
Sbjct: 160 GTRSYMSP------------ERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 51/222 (22%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
+G+G++ +V+KG VA+K + L ++GA + + E +L++ +H N++ + +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ LV+EY+ + L++++ +++ N+ I + + L +
Sbjct: 74 HT-----DKSLTLVFEYL-DKDLKQYMDDCG--------NIMSMHNVKIFLYQILRGLAY 119
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
+ ++H DLKP N+L++ ++DFGLAR S+ T++ S + T+ Y
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR-------AKSVPTKTYSNEVV-TLWYR 171
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
PP + SE S D++ +G + EM + R
Sbjct: 172 PPDVLLG-----------SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 68/269 (25%), Positives = 106/269 (39%), Gaps = 50/269 (18%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNT 733
E TN + +G G+FG V G VA+K I+ L K E ++L++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
RH N+I + S I + V E + L L + + L Q L
Sbjct: 67 RHENIISL----SDIFISPLEDIYFVTE-LLGTDLHRLLTSRPLEKQFIQYFLYQILR-- 119
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
++Y+H +VH DLKPSN+L++ + + DFGL AR D M
Sbjct: 120 -----GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGL-----ARIQDPQM---- 162
Query: 854 SSIGIKGTVGYVPPGNI-AKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912
GYV A + L +Y V D++S G + EM +P
Sbjct: 163 --------TGYVSTRYYRAPEIMLTWQKYD------VEVDIWSAGCIFAEML-EGKP--- 204
Query: 913 MFQGGLTLHEFCKMA-----LPEKVMETV 936
+F G +++F + P+ V+ T+
Sbjct: 205 LFPGKDHVNQFSIITDLLGTPPDDVINTI 233
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKS----------FVA--ECEVL 730
+G+G++G V K G VA+K + +++ K F E +++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 731 RNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRL 790
+H N++ ++ V + DF LV + M L++ + + L+ Q
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIMA-SDLKKVVDRK------IRLTESQVK 122
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
I + + + + LH +H DL P+N+ ++ + ++DFGLAR
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 34/175 (19%)
Query: 687 IGQGSFGSVYKGILGEN--GTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHRNLIKI 741
IG+G++G VYK G A+K G +S E +LR +H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 742 ITVCSSIDFKGADFKA-LVYEYMQNGSLEEWLHQSNGQPEVCDL------SLI-QRLNIA 793
+ V + AD L+++Y ++ + Q + + SL+ Q LN
Sbjct: 68 VEVF----LEHADKSVYLLFDYAEHDLWQIIKFHR--QAKRVSIPPSMVKSLLWQILN-- 119
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARP 844
+ YLH + ++H DLKP+N+L+ V + D GLAR LF P
Sbjct: 120 -----GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 67/232 (28%), Positives = 100/232 (43%), Gaps = 43/232 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECE--VLRNTRHRNLIKIITV 744
+G+GS+G V +G +K LNL + AE E +L +H N I+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64
Query: 745 CSSIDFKGADFKALVYEYM---QNGSLEEWLHQSNGQ--PEVCDLSLIQRLNIAIDMASA 799
S ++G D L+Y M + G L L + G+ PE Q + + +A A
Sbjct: 65 RES--WEGED--GLLYIVMGFCEGGDLYHKLKEQKGKLLPEN------QVVEWFVQIAMA 114
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
++YLH + I+H DLK NV L + V D G+AR L + + S+ I
Sbjct: 115 LQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-----ENQCDMASTLI--- 163
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911
GT Y+ P + N P Y S DV++LG + EM T + N
Sbjct: 164 GTPYYMSPELFS---NKP---YNYKS------DVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRN 737
F ++G+G FG V + G A K L + ++ + E ++L R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQ--SNGQPEVCDLSLIQRLNIAID 795
++ + + ++ D LV M G L+ ++ G E + + A +
Sbjct: 62 VVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG------RAVFYAAE 110
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+ +E LH Q IV+ DLKP N+LLD +SD GLA + P +++
Sbjct: 111 ICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIK----- 159
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G GTVGY+ P E + + D ++LG +L EM + P
Sbjct: 160 -GRVGTVGYMAP------------EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNT-RHRNLIKI 741
M+G+GSFG V+ L F A+K L ++ ++ + E VL H L +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
C+ F+ + V EY+ G L + + L + A ++ ++
Sbjct: 62 Y--CT---FQTKENLFFVMEYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQ 110
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+LH IV+ DLK N+LLD D ++DFG+ + +M + + GT
Sbjct: 111 FLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--------ENMLGDAKTCTFCGT 159
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P E +G + + + D +S GV+L EM + P
Sbjct: 160 PDYIAP------------EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 65/252 (25%), Positives = 109/252 (43%), Gaps = 54/252 (21%)
Query: 680 EFSSSNM-----IGQGSFGSVYKG-ILG------ENGTFVAVKIL--NLMQKGALKSFVA 725
EFS + +G+G FG V LG + VAVK+L + +K L V+
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVS 69
Query: 726 ECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQ--------SN 776
E E+++ +H+N+I ++ C+ + +V EY G+L E+L S
Sbjct: 70 EMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSY 124
Query: 777 GQPEVCD--LSLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833
V D ++ ++ +A +EYL C +H DL NVL+ + V ++D
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 180
Query: 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDV 893
FGLAR + D +T + + +K ++ P E + DV
Sbjct: 181 FGLARDV--NNIDYYKKTTNGRLPVK----WMAP------------EALFDRVYTHQSDV 222
Query: 894 YSLGVMLLEMFT 905
+S GV++ E+FT
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 60/232 (25%)
Query: 687 IGQGSFGSV---YKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKI 741
IG G+ G V Y +L N VA+K L+ + K E +++ H+N+I +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID------ 795
+ V + SLEE+ E+ D +L Q + + +D
Sbjct: 82 LNV-----------------FTPQKSLEEF-QDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 796 ----MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
M I++LH I+H DLKPSN+++ D + DFGLAR
Sbjct: 124 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------- 167
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
GT + P + + P + GMG + +V D++S+G ++ EM
Sbjct: 168 ------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 29/245 (11%)
Query: 664 QYFP-MVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS 722
Y M+ L + T+ + IG+G++G VYK ++G+ AVKIL+ + +
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEE 64
Query: 723 FVAECEVLRN-TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV 781
AE +L++ H N++K + D LV E GS+ E +
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL------ 118
Query: 782 CDLSLIQRLN---IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
L QRL+ I+ + A+ L H I+H D+K +N+LL + + DFG++
Sbjct: 119 --LICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS- 175
Query: 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898
A+ T + +S GT ++ P IA C E DV+SLG+
Sbjct: 176 ---AQLTSTRLRRNTSV----GTPFWMAPEVIA------C-EQQYDYSYDARCDVWSLGI 221
Query: 899 MLLEM 903
+E+
Sbjct: 222 TAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 60/232 (25%)
Query: 687 IGQGSFGSV---YKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKI 741
IG G+ G V Y IL N VA+K L+ + K E +++ H+N+I +
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID------ 795
+ V + SLEE+ E+ D +L Q + + +D
Sbjct: 89 LNV-----------------FTPQKSLEEF-QDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 796 ----MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
M I++LH I+H DLKPSN+++ D + DFGLAR
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------- 174
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
GT + P + + P + GMG + +V D++S+G ++ EM
Sbjct: 175 ------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 28/167 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGA-LKSFVAECEVLRNTRHRNLIKIIT 743
+IG+GS+G V I G VA+K I ++ + + + E ++LR RH ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 744 VC---SSIDFKGADFKALVYEYMQNGSLEEWLHQ---SNGQ--PEVCDLSLIQRLNIAID 795
+ S +FK +V+E M E LHQ +N PE L Q L
Sbjct: 67 IMLPPSRREFKDI---YVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR---- 114
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
A++Y+H + H DLKP N+L + D + DFGLAR F
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 62/248 (25%)
Query: 680 EFSSSNM-----IGQGSFGSVYKGI---LGENGTF--VAVKIL----NLMQKGALKSFVA 725
EF +N+ +G G+FG V + L ++ VAVK+L + ++ AL S
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87
Query: 726 ECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDL 784
E +++ + H N++ ++ C+ G ++ EY G L +L + L
Sbjct: 88 ELKIMSHLGNHENIVNLLGACT----IGGPI-LVITEYCCYGDLLNFLRRKRESF----L 138
Query: 785 SLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
+L L+ + +A + +L +C +H DL NVLL H + + DFGLAR
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR----- 189
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA------SVTGDVYSLG 897
I YV GN LP +++ M E+ + DV+S G
Sbjct: 190 -------------DIMNDSNYVVKGNA----RLP-VKW-MAPESIFNCVYTFESDVWSYG 230
Query: 898 VMLLEMFT 905
++L E+F+
Sbjct: 231 ILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 687 IGQGSFGSVYKGILGE--NGTFVAVKILNLMQKGALK----SFVAECEVLRNTRHRNLIK 740
IG G FG V +LGE G A ++ ++ A F+ E + R H N+++
Sbjct: 3 IGNGWFGKV---LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 741 IITVC-SSIDFKGADFKALVYEYMQNGSLEEWLHQSNG-QPEVCDLSLIQRLNIAIDMAS 798
+ C SI + LV E+ G L+ +L + G ++ ++QR+ A ++AS
Sbjct: 60 CLGQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVAS 111
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+ +LH Q +H DL N L D+ + D+GLA + + T+
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHA-- 163
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
VP +A L + + + + +++SLGV + E+FT
Sbjct: 164 ------VPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 47/238 (19%)
Query: 686 MIGQGSFGSVYKGIL----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
++G+GSFG + +L + + +I A++ E +L +H N I
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN---I 60
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ--PEVCDLSLIQRLNIAIDMASA 799
+ S F+ +V EY G L + + G+ PE I L + M
Sbjct: 61 VAFKES--FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE----DTI--LQWFVQMCLG 112
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
++++H + ++H D+K N+ L + + DFG AR L P + +
Sbjct: 113 VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-TSPG-------AYACTYV 161
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917
GT YVPP I + N+P Y S D++SLG +L E+ T + P FQ
Sbjct: 162 GTPYYVPP-EIWE--NMP---YNNKS------DIWSLGCILYELCTLKHP----FQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN-TRHRNLIKIITVC 745
IG+G++G V+K + +NG+ AVKIL+ + + AE +L+ + H N++K +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
D K D LV E GS+ + + + E ++ IA + A+ L H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-----RMEEPIIAYILHEALMGLQH 139
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
+H D+K +N+LL + + DFG++ A+ T + +S GT ++
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS----AQLTSTRLRRNTSV----GTPFWM 191
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
P IA C E + S DV+SLG+ +E+
Sbjct: 192 APEVIA------C-EQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEV--LRNTRHRNLIK 740
++G+G+FG VY + G +AVK + Q+ + + ECE+ L+N RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ K ++ EYM GS+++ L E ++ +R I +
Sbjct: 69 YYGCLRDPEEKKL---SIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQI--LQGV 119
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH + IVH D+K +N+L D + DFG ++ R M S GIK
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK----RIQTICM----SGTGIKS 168
Query: 861 TVG---YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G ++ P I+ G G +A DV+S+ ++EM T + P
Sbjct: 169 VTGTPYWMSPEVISGE--------GYGRKA----DVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 27/82 (32%), Positives = 48/82 (58%), Gaps = 2/82 (2%)
Query: 203 ENQ-FSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE 261
+NQ G +P + + L++I L N GN+P +G ++ +L+V + N F+GSIPE
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGSIPE 484
Query: 262 SFSNASNIEIIDLPINYFTGKV 283
S +++ I++L N +G+V
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 29/234 (12%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+F +++G+G FG V G A+K++ L+ + + F E ++L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
+ ++ F+ D LV EY G L L++ Q D + Q
Sbjct: 61 PWIPQLQYA-----FQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQ-----FY 107
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+A + +H Q VH D+KP NVL+D ++DFG A L T+ + +S
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL------TANKMVNSK 161
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ + GT Y+ P + M YG V D +SLGV+ EM R P
Sbjct: 162 LPV-GTPDYIAPEVLTTMNGDGKGTYG------VECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 54/244 (22%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL--KSFVAECEVLRNT 733
E + + + +G G++GSV + G VAVK L+ + + K E +L++
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 734 RHRNLIKIITVCS-SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLI---QR 789
+H N+I ++ V + + + + LV M DL+ I Q+
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----------------ADLNNIVKCQK 116
Query: 790 LN------IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
L + + ++Y+H I+H DLKPSN+ ++ D + DFGLAR
Sbjct: 117 LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----- 168
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
T G T Y P MLN + Y + T D++S+G ++ E+
Sbjct: 169 ------HTDDEMTGYVATRWYRAP---EIMLNW--MHY------NQTVDIWSVGCIMAEL 211
Query: 904 FTRR 907
T R
Sbjct: 212 LTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS---FVAECEV--LRNTRHRNLIK 740
++GQG+FG VY + G +AVK + + S ECE+ L+N H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ ++ E+M GS+++ L E ++ ++ I +
Sbjct: 69 YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTE----NVTRKYTRQI--LEGV 119
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH + IVH D+K +N+L D + DFG ++ L T + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL-----QTICLSGTGMKSVTG 171
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T ++ P I+ G G +A D++S+G ++EM T + P
Sbjct: 172 TPYWMSPEVISGE--------GYGRKA----DIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 38/233 (16%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRN 737
F ++G+G FG V + G A K L + ++ + E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN-GQPEVCDLSLIQRLNIAIDM 796
++ + + ++ D LV M G L+ H N G P + L A ++
Sbjct: 62 VVNL-----AYAYETKDALCLVLTIMNGGDLK--FHIYNMGNP---GFEEERALFYAAEI 111
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+E LH + V+ DLKP N+LLD +SD GLA + S
Sbjct: 112 LCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA---------VKIPEGESIR 159
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G GTVGY+ P + Y + + D + LG ++ EM + P
Sbjct: 160 GRVGTVGYMAPEVLNNQ------RYTL------SPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 55/241 (22%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA------LKSFVAECEVLRNT 733
E+ +G G+F S Y+ + GT +AVK + ++ + +++ E ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
H ++I+ + + F V E+M GS+ L + E ++ ++L
Sbjct: 61 NHPHIIR----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQL--- 112
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLFARPFDTSME 850
+ YLH + I+H D+K +N+L+D + ++DFG A L A+ E
Sbjct: 113 ---LRGLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAG-E 163
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910
Q +G T+ ++ P E G + + DV+S+G +++EM T + P
Sbjct: 164 FQGQLLG---TIAFMAP------------EVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
Query: 911 N 911
N
Sbjct: 209 N 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 44/231 (19%)
Query: 686 MIGQGSFGSVYKGILGE-NGT--FVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLI 739
++G+GSFG V +L E GT A+K+L ++Q + + E +L +
Sbjct: 2 VLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI-AIDMAS 798
+ C F+ D V EY+ G L + +S E R A ++
Sbjct: 59 TALHCC----FQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE-------PRSRFYAAEVTL 107
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
A+ +LH H +++ DLK N+LLD + ++DFG+ + + ++
Sbjct: 108 ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--------EGILNGVTTTTF 156
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + + LEYG SV D ++LGV++ EM + P
Sbjct: 157 CGTPDYIAPEILQE------LEYG----PSV--DWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 62/261 (23%), Positives = 102/261 (39%), Gaps = 56/261 (21%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRH 735
++F S +IG+G+FG V + G A+KIL ++++K + AE ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
++K+ F+ L+ E++ G + L + + E I +AID
Sbjct: 61 AWVVKMF-----YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-------RFLFAR----- 843
+ ++H D+KP N+LLD +SDFGL R F R
Sbjct: 116 AIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 844 -PFDTSMETQSS--------------SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888
P D S + +S + GT Y+ P E M + +
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP------------EVFMQTGYN 214
Query: 889 VTGDVYSLGVMLLEMFTRRRP 909
D +SLGV++ EM P
Sbjct: 215 KLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 58/242 (23%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG G+ G V G VAVK L+ + K E +L+ H+N+I ++ V
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID--------- 795
+ SLEE+ E+ D +L Q +++ +D
Sbjct: 89 -----------------FTPQKSLEEF-QDVYLVMELMDANLCQVIHMELDHERMSYLLY 130
Query: 796 -MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
M I++LH I+H DLKPSN+++ D + DFGLAR T +
Sbjct: 131 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TACT 175
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914
+ + P + + P + GMG + +V D++S+G ++ E+ + +F
Sbjct: 176 NF-------MMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGELVK----GSVIF 222
Query: 915 QG 916
QG
Sbjct: 223 QG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 34/192 (17%)
Query: 714 LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH 773
+++ G E +LR H ++I++ F F L+ + L +L
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGT-----FTYNKFTCLILPRYKT-DLYCYLA 174
Query: 774 QSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833
+CD+ I+R + AI+YLH + I+H D+K N+ ++H + D
Sbjct: 175 AKRNIA-ICDILAIER-----SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD 225
Query: 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDV 893
FG A F P D + G GT+ P +A+ P + D+
Sbjct: 226 FGAACF----PVDI---NANKYYGWAGTIATNAPELLARDPYGPAV------------DI 266
Query: 894 YSLGVMLLEMFT 905
+S G++L EM T
Sbjct: 267 WSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 36/233 (15%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHR 736
+F+ ++G+GSFG V A+KIL ++Q ++ + E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
+ + C F+ D V EY+ G L + Q E Q + A ++
Sbjct: 61 PFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP------QAVFYAAEI 110
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ + +LH + I++ DLK NV+LD + ++DFG+ + M ++
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------EHMVDGVTTR 159
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P IA YG SV D ++ GV+L EM + P
Sbjct: 160 TFCGTPDYIAPEIIAYQ------PYGK----SV--DWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 176 ISLARNHLTGMLPASIGNLSIIY-LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNL 234
+ L L G +P I L + +++ N G +PPSL +++SLE + L N F G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 235 PLDIGVTLPNLQVFAIGDNYFSGSIPES 262
P +G L +L++ + N SG +P +
Sbjct: 483 PESLG-QLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 49/245 (20%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
N+ + IG G+ G VYK + G +AVK + ++ E R L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR-------RTGNKE------ENKRIL 61
Query: 739 IKIITVCSSIDFK------GA---DFKALVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQ 788
+ + V S D G D + + + L++ L + G PE ++
Sbjct: 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPE----DILG 117
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
++ +AI A+ YL ++H D+KPSN+LLD + DFG++ L D+
Sbjct: 118 KMTVAI--VKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL----VDSK 169
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
+T+S G Y+ P I P +Y + DV+SLG+ L+E+ T +
Sbjct: 170 AKTRS-----AGCAAYMAPERIDP--PDPNPKY------DIRADVWSLGISLVELATGQF 216
Query: 909 P-TNC 912
P NC
Sbjct: 217 PYKNC 221
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 33/131 (25%), Positives = 57/131 (43%), Gaps = 16/131 (12%)
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
NI DM + +EY+H H I HGD+KP N+++D + ++ D+G+A
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910
+ + +GT+ Y L+ G+ + GD+ SLG +L+ + P
Sbjct: 187 KEQKDLH-RGTLYYAG------------LDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233
Query: 911 NCMFQGGLTLH 921
G +H
Sbjct: 234 KGFGHNGNLIH 244
|
Length = 294 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLR-NTRHRNLIKI 741
++G+GSFG V L F A+K L +++ ++ + E VL H L +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLNIAIDMASAI 800
C+ F+ + V EY+ G L H QS+G+ + A ++ +
Sbjct: 62 F--CT---FQTKEHLFFVMEYLNGGDL--MFHIQSSGR-----FDEARARFYAAEIICGL 109
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
++LH I++ DLK NVLLD D ++DFG+ + +M + + G
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK--------ENMNGEGKASTFCG 158
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T Y+ P I K G SV D +S GV+L EM + P
Sbjct: 159 TPDYIAP-EILK---------GQKYNESV--DWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 36/226 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+G FG V + G A K L+ L +K K + E E+L N I+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ + + K LV M G L+ H N ++ + ++ + + I +L
Sbjct: 58 LAYAFESK--THLCLVMSLMNGGDLK--YHIYNVGERGLEMERV--IHYSAQITCGILHL 111
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H IV+ D+KP NVLLD +SD GLA ++ + GT G
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---------VELKDGKTITQRAGTNG 159
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P E S D +++G + EM R P
Sbjct: 160 YMAP------------EILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 225 LDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVS 284
LD G G +P DI L +LQ + N G+IP S + +++E++DL N F G +
Sbjct: 425 LDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 285 IIFGRLKNLWSLDLGINNL 303
G+L +L L+L N+L
Sbjct: 484 ESLGQLTSLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 36/158 (22%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLI 739
+F IG G++G VYK G A+K++ L E ++++ +H N++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+ D + E+ GSL++ H + LS Q ++ +
Sbjct: 70 AYFG-----SYLRRDKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQG 118
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
+ YLH + +H D+K +N+LL + ++DFG++
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 23/164 (14%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN-----LMQKGALKSFVAECEVLRN-TRHRNLIK 740
IG+G+F V K + G + A+K + L Q L E + LR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSPHPNILR 62
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+I V D K ALV+E M + +L E L + +P L + + + ++
Sbjct: 63 LIEVL--FDRKTGRL-ALVFELM-DMNLYE-LIKGRKRP----LPEKRVKSYMYQLLKSL 113
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP 844
+++H + I H D+KP N+L+ D++ ++DFG R ++++P
Sbjct: 114 DHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKP 153
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 14/151 (9%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G++G VYK G AVKI+ L E +++ +H N++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG--- 73
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
+ + + EY GSL++ H + E ++ + R + + YLH
Sbjct: 74 --SYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-LQIAYVCR-----ETLQGLAYLHSK 125
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
+ +H D+K +N+LL + ++DFG+A
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 59/216 (27%)
Query: 702 ENGTFVAVK-------ILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA- 753
E FVA K +L + QKG + E +L+N H ++I++ GA
Sbjct: 79 EGRVFVATKPGQPDPVVLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTL----VSGAI 131
Query: 754 ------DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC 807
+ + +Y Y+ +P L + Q L I + + YLH
Sbjct: 132 TCMVLPHYSSDLYTYLTK----------RSRP----LPIDQALIIEKQILEGLRYLHAQ- 176
Query: 808 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPP 867
I+H D+K N+ ++ + D G A+F P +G+ GTV P
Sbjct: 177 --RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF---------LGLAGTVETNAP 225
Query: 868 GNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+A+ + + D++S G++L EM
Sbjct: 226 EVLAR------------DKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 57/237 (24%)
Query: 680 EFSSSNMIGQGSFGSVYKGILG--ENGTFVAVKILNLMQKGALKSFVAECEVLRNTR--- 734
+F+ +G GSFG V IL +N F V A+K F + ++++ +
Sbjct: 31 DFNFIRTLGTGSFGRV---ILATYKNEDFPPV---------AIKRF-EKSKIIKQKQVDH 77
Query: 735 ---HRNLIKIIT--VCSSI--DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLI 787
R ++ I C ++ FK + LV E++ G +L ++ P D+
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN--DVGCF 135
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
I + EYL IV+ DLKP N+LLD D ++DFG A+ + R +
Sbjct: 136 YAAQIVL----IFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT- 187
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
+ GT Y+ P +LN+ G G A D ++LG+ + E+
Sbjct: 188 ----------LCGTPEYIAP---EILLNV-----GHGKAA----DWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 27/148 (18%)
Query: 687 IGQGSFGSVYKGILGENGTF----------VAVKILNLMQKGALKSFVAECEVLRNTRHR 736
+GQG+F ++YKG+L V +K+L + +L +F ++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLNIAID 795
+L+K+ VC D +V EY++ G L+ +LH + N L + ++L
Sbjct: 62 HLVKLYGVCV------RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL----- 110
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLL 823
ASA+ YL +VHG++ N+L+
Sbjct: 111 -ASALHYLEDK---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 61/260 (23%), Positives = 101/260 (38%), Gaps = 56/260 (21%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHR 736
+F S +IG+G+FG V + G A+KIL ++++K + AE ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
++K+ F+ L+ E++ G + L + + E I +AID
Sbjct: 62 WVVKMF-----YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-------RFLFAR------ 843
+ ++H D+KP N+LLD +SDFGL R F R
Sbjct: 117 IHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 844 PFDTSMETQSS--------------SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASV 889
P D + + +S + GT Y+ P E M + +
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP------------EVFMQTGYNK 215
Query: 890 TGDVYSLGVMLLEMFTRRRP 909
D +SLGV++ EM P
Sbjct: 216 LCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 42/152 (27%), Positives = 64/152 (42%), Gaps = 29/152 (19%)
Query: 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817
LV EY+ G L + + PE A ++ A+ +LH + I++ DLK
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEE------HARFYAAEICIALNFLH---ERGIIYRDLK 123
Query: 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP 877
NVLLD D ++D+G+ + P DT+ GT Y+ P
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGL-GPGDTTST-------FCGTPNYIAP---------- 165
Query: 878 CLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
E G E + D ++LGV++ EM R P
Sbjct: 166 --EILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 56/236 (23%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL-----NLMQKGALKSFVAECEVLRNTRHRNLIKI 741
IG G+FG V+ +G VA+K + NL+ + K E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV---SCKRVFRELKMLCFFKHDNVLSA 64
Query: 742 ITVCSSIDFKGADFKALVY---EYMQNGSLEEWLHQ---SNGQPEVCD---LSLIQRLNI 792
+ + D +Y E MQ+ LH+ S QP D + L Q L
Sbjct: 65 LDILQPPHI---DPFEEIYVVTELMQSD-----LHKIIVSP-QPLSSDHVKVFLYQILR- 114
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
++YLH I+H D+KP N+L++ + V + DFGLAR D S
Sbjct: 115 ------GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR---VEEPDESKHMT 162
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRR 907
+ T Y P E MGS + D++S+G + E+ RR
Sbjct: 163 QEVV----TQYYRAP------------EILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 30/112 (26%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 283 VSIIFGRLKNLWSLD-LGINNLGSGG--ANDLDFVTILTNCSKLKVLAFEENRLGGVLPH 339
F K W +D LG++N G G ND+ + L+ + N + G +P
Sbjct: 407 ADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDI------SKLRHLQSINLSGNSIRGNIPP 460
Query: 340 SIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIG 391
S+ ++ T++ + + N +G+IP +G L +L +L + N L+G +P +G
Sbjct: 461 SLGSI-TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 36/232 (15%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
F ++G+G FG V + G A K L +K +K E L R +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVN 58
Query: 741 IITVCS-SIDFKGADFKALVYEYMQNGSLEEWLHQSN-GQPEVCDLSLIQR-LNIAIDMA 797
V S + ++ D LV M G L+ H N G P + QR + A ++
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDE----QRAIFYAAELC 112
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+E L + IV+ DLKP N+LLD +SD GLA + + G
Sbjct: 113 CGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA---------VQIPEGETVRG 160
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GTVGY+ P E + + + D + LG ++ EM + P
Sbjct: 161 RVGTVGYMAP------------EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 36/234 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+F + +I G++G+VY E A+K +N L+ + ++ E ++L T
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDIL--TFA 58
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
N + CS F+ +V EY++ G L N D++ R+ A +
Sbjct: 59 ENPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMA---RMYFA-E 109
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF----LFARPFDTSMET 851
A+EYLH++ IVH DLKP N+L+ ++DFGL++ L ++ +E
Sbjct: 110 TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 852 QSSSIGIK---GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
+ K GT Y+ P I L G G D +++G++L E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVI--------LRQGYGKPV----DWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 37/230 (16%)
Query: 687 IGQGSFGSVY--KGILGEN-GTFVAVKILN---LMQKG-ALKSFVAECEVLRNTRHRNLI 739
+G G++G V+ + + G + G A+K+L ++QK + E +VL R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
V F+ L+ +Y+ G L L+Q E S + R+ IA ++ A
Sbjct: 68 ----VTLHYAFQTDTKLHLILDYVNGGELFTHLYQR----EHFTESEV-RVYIA-EIVLA 117
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+++LH Q I++ D+K N+LLD + ++DFGL++ A E + +
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA-------EEEERAYSFC 167
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT+ Y+ P I G G D +SLGV+ E+ T P
Sbjct: 168 GTIEYMAPEVIRG---------GSGGHDKAV-DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+GSFG V L G + AVK L ++ ++ + E VL + +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLNIAIDMASAIE 801
C+ F+ + V E++ G L H Q G+ L + A ++ ++
Sbjct: 62 -YCT---FQTKEHLFFVMEFLNGGDL--MFHIQDKGR-----FDLYRATFYAAEIVCGLQ 110
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+LH I++ DLK NV+LD D ++DFG+ + ++ + + GT
Sbjct: 111 FLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK--------ENVFGDNRASTFCGT 159
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P E G + + + D +S GV+L EM + P
Sbjct: 160 PDYIAP------------EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 67/277 (24%), Positives = 108/277 (38%), Gaps = 82/277 (29%)
Query: 687 IGQGSFGSVY-----KGILGENGTFVAVKILNLMQKGALK-----SFVAECEVLRNTRHR 736
+G+GSFG+VY K + E +K+L + G L E ++L H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 737 NLIK------------IIT-VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD 783
++K IIT C D D K + E G ++ + +VC+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDL---DCK--LEELKHTG-------KTLSENQVCE 110
Query: 784 LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
IQ L + Y+H Q I+H DLK N+ L ++++ + DFG++R L
Sbjct: 111 W-FIQLL-------LGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL--- 155
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
M + + GT Y+ P + G S++ D++SLG +L EM
Sbjct: 156 -----MGSCDLATTFTGTPYYMSPEALKHQ--------GYDSKS----DIWSLGCILYEM 198
Query: 904 FTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSL 940
C F + L +++E PSL
Sbjct: 199 --------CCLAHAFEGQNFLSVVL--RIVEGPTPSL 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 672 SELSEATNE-FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVL 730
++++ + N+ + N+IG GSFG VY+ I + VA+K ++Q K+ E ++
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIM 113
Query: 731 RNTRHRNLIKIITVCSSIDFKGAD---FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLI 787
+N H N+I + + FK + F +V E++ ++ +++ L L+
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLV 172
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFA 842
+ + + A+ Y+H I H DLKP N+L+D + + DFG A+ L A
Sbjct: 173 KLY--SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223
|
Length = 440 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 681 FSSSNMIGQGSFGSVY--KGILG-ENGTFVAVKIL---NLMQKGALKSFV-AECEVLRNT 733
F ++G G++G V+ + + G ++G A+K+L ++QK E +VL +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
R + + D K L+ +Y+ G L L Q E Q + I
Sbjct: 62 RQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQIY 110
Query: 794 I-DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
++ A+E+LH + I++ D+K N+LLD + ++DFGL++ +
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-------DEV 160
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ GT+ Y+ P + G D +S+GV++ E+ T P
Sbjct: 161 ERAYSFCGTIEYMAPDIVR----------GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 767 SLEEW-LHQSNGQPEVCDLS-LIQRLNIAIDMASAIEYLHHH---CQPPIVHGDLKPSNV 821
EW + + + + R + + + L H I+HGDL P NV
Sbjct: 150 RRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNV 209
Query: 822 LLDHD-MVAHVSDFGLARF 839
L D D V+ DF A +
Sbjct: 210 LFDDDTDVSGFIDFDDAGY 228
|
Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRH 735
+F + +IG+G+FG V + G A+K L + +K L AE +VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
++ + F+ A + L+ E++ G L L + + E D + R +A +
Sbjct: 61 PWVVSLYY-----SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE--D---VTRFYMA-E 109
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
AIE +H + +H D+KP N+L+D +SDFGL+
Sbjct: 110 CVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 38/233 (16%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
F ++G+G FG V + G A K L +K +K E L + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQILEKVN 58
Query: 741 IITVCS-SIDFKGADFKALVYEYMQNGSLEEWLHQ--SNGQPEVCDLSLIQR-LNIAIDM 796
V S + ++ D LV M G L+ ++ + G E +R + A ++
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-------ERAVFYAAEI 111
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+E LH IV+ DLKP N+LLD +SD GLA + +
Sbjct: 112 TCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA---------VEIPEGETIR 159
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G GTVGY+ P E + + D + LG ++ EM + P
Sbjct: 160 GRVGTVGYMAP------------EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 687 IGQGSFGSV--YKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNTR-HRNLIKI 741
+GQG++G V + VA+K I N+ K L K + E ++LR+ R H+N+ +
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+ I F G + +YE + L + + +GQP L+ + + ++
Sbjct: 68 YDM--DIVFPGNFNELYLYEELMEADLHQIIR--SGQP----LTDAHFQSFIYQILCGLK 119
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
Y+H ++H DLKP N+L++ D + DFGLAR
Sbjct: 120 YIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 43/162 (26%)
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG--IKG 860
+HH ++H D+K +N+LL + + + DFG ++ A T S +G G
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA--------TVSDDVGRTFCG 207
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
T YV P E S D++SLGV+L E+ T +RP + G +
Sbjct: 208 TPYYVAP------------EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GENM 250
Query: 921 HEFCKMAL------------PEKVMETVDPSLLLAWSDGRRR 950
E L PE M+ + +LL SD +RR
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPE--MQEIVTALLS--SDPKRR 288
|
Length = 496 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 19/60 (31%), Positives = 28/60 (46%)
Query: 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
L+ + N + + L ++K LDLS NNL+ PE L L L+LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 42/236 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGE-NGT--FVAVKILN---LMQKGALKSFVAECEVLRNT 733
+F+ ++G+GSFG V +L E GT A+KIL ++Q ++ + E VL
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
+ + C F+ D V EY+ G L + Q E + A
Sbjct: 58 GKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP------HAVFYA 107
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
++A + +LH I++ DLK NV+LD + ++DFG+ + ++
Sbjct: 108 AEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--------ENIFGGK 156
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
++ GT Y+ P IA P YG SV D ++ GV+L EM + P
Sbjct: 157 TTRTFCGTPDYIAPEIIA---YQP---YG----KSV--DWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHRN 737
F +G G+FG V + A+K L +++ + + AE ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
++K+ F+ D V +Y+ G + L + PEV + R IA ++
Sbjct: 63 VVKLY-----YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV-----LARFYIA-ELT 111
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
AIE +H + +H D+KP N+L+D D ++DFGL
Sbjct: 112 LAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 29/152 (19%)
Query: 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817
V EY+ G L + + PE + +++ A+ YLH + I++ DLK
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLH---ERGIIYRDLK 123
Query: 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP 877
NVLLD + ++D+G+ + RP DT+ GT Y+ P
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTS-------TFCGTPNYIAP---------- 165
Query: 878 CLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
E G + + D ++LGV++ EM R P
Sbjct: 166 --EILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/143 (22%), Positives = 61/143 (42%), Gaps = 22/143 (15%)
Query: 699 ILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLI--KIITVCSSIDFKGADFK 756
+LG +KI +KGA E +L+ + L K++ + G +
Sbjct: 16 LLGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLASG---ESDGWSY- 69
Query: 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816
L+ E+++ +L+E +S ++ +IA +A + LH + HGDL
Sbjct: 70 -LLMEWIEGETLDE-------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115
Query: 817 KPSNVLLDHDMVAHVSDFGLARF 839
P N+L+D + + D+ A +
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 48/242 (19%)
Query: 680 EFSSSNMIGQGSFGSVY--KGILG-ENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-H 735
F ++G G++G V+ + + G + G A+K+L QK AL V + + + +TR
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVL---QKAAL---VQKAKTVEHTRTE 54
Query: 736 RNLIKIIT-----VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN--GQPEVCDLSLIQ 788
RN+++ + V F+ L+ +Y+ G + L+Q + + EV
Sbjct: 55 RNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV------- 107
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR-FLFARPFDT 847
R ++ A+E+LH + IV+ D+K N+LLD + ++DFGL++ FL
Sbjct: 108 RFYSG-EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL------- 156
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
E + + GT+ Y+ P I G G D +SLG+++ E+ T
Sbjct: 157 -SEEKERTYSFCGTIEYMAPEIIR----------GKGGHGKAV-DWWSLGILIFELLTGA 204
Query: 908 RP 909
P
Sbjct: 205 SP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 42/236 (17%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGE-NGT--FVAVKILN---LMQKGALKSFVAECEVLRNT 733
+F+ ++G+GSFG V +L E GT A+KIL ++Q ++ + E VL +
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
+ + C F+ D V EY+ G L + Q V + A
Sbjct: 58 GKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYQIQQ------VGRFKEPHAVFYA 107
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
++A + +LH I++ DLK NV+LD + ++DFG+ + +M
Sbjct: 108 AEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------ENMWDGV 156
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
++ GT Y+ P IA YG SV D ++ GV+L EM + P
Sbjct: 157 TTKTFCGTPDYIAPEIIAYQ------PYG----KSV--DWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 23/111 (20%)
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
A+ +LH + I++ DLK NVLLD + ++D+G+ + RP DT+
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTST-------F 156
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P E G + + D ++LGV++ EM R P
Sbjct: 157 CGTPNYIAP------------EILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 44/242 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIIT--- 743
IG+GSFG V + + A+K ++K + V+ EV R ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKT---IRKAHI---VSRSEVTHTLAERTVLAQVNCPF 54
Query: 744 -VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
V F+ + LV ++ G L L Q E R A ++ A+E
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTA-ELLCALEN 108
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH + +++ DLKP N+LLD+ + DFGL + +M+ + GT
Sbjct: 109 LH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL--------NMKDDDKTNTFCGTP 157
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP-----TNCMFQGG 917
Y+ P L G G +V D ++LGV+L EM T P N M++
Sbjct: 158 EYLAPE----------LLLGHGYTKAV--DWWTLGVLLYEMLTGLPPFYDENVNEMYRKI 205
Query: 918 LT 919
L
Sbjct: 206 LQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 50/233 (21%)
Query: 695 VYKGILGENGT---FVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSI--- 748
V ++G N T FVA + + +K K FV + + R+ + + C
Sbjct: 70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAK-FVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 749 ----DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN--------IAIDM 796
DFK D L+ EY G L + + Q L + L + +
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR----------LKEHLPFQEYEVGLLFYQI 178
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A++ +H ++H DLK +N+ L + + DFG F++ + S+ +S
Sbjct: 179 VLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFG-----FSKQYSDSVSLDVAS- 229
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P E S D++SLGV+L E+ T RP
Sbjct: 230 SFCGTPYYLAP------------ELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 32/131 (24%)
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
A+E+LH I++ DLKP N+LLD ++DFGL + S+ + +
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--------ESIHEGTVTHTF 160
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT---------RRRP 909
GT+ Y+ P E M S D +SLG ++ +M T R++
Sbjct: 161 CGTIEYMAP------------EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT 208
Query: 910 TNCMFQGGLTL 920
+ + +G L L
Sbjct: 209 IDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 6e-04
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 395 NLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL 454
NL+++ LS+N L + L + L LS N+L P + +L SL+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 17/153 (11%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
IG G+FG V + A+K L +++ + AE ++L + ++K+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
F+ D V +Y+ G + L + E DL+ R IA ++ AIE +
Sbjct: 68 ----YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE--DLA---RFYIA-ELTCAIESV 117
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
H + +H D+KP N+L+D D ++DFGL
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 39/186 (20%)
Query: 726 ECEVLRNTRHRNLIKIITVCSSIDF-----KGADFKALVYEYMQNGSLEEWLHQSNGQPE 780
E L H N++KI + S + DF +Y +M + + + W +P
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-W----KDRP- 264
Query: 781 VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
L Q I + A+EY+H ++H D+K N+ L+ D + DFG
Sbjct: 265 ----LLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGT---- 313
Query: 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
A PF+ E ++ G GTV P +A +T D++S G++L
Sbjct: 314 -AMPFEK--EREAFDYGWVGTVATNSPEILAG-----------DGYCEIT-DIWSCGLIL 358
Query: 901 LEMFTR 906
L+M +
Sbjct: 359 LDMLSH 364
|
Length = 501 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 8e-04
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 57/228 (25%)
Query: 690 GSFGSVYKGILGENGT---FVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
G FG V +L T FV KI+ A++ V + ++++ + N IK+ +
Sbjct: 27 GKFGKVS--VLKHKPTQKLFV-QKIIKAKNFNAIEPMVHQ--LMKD--NPNFIKLYYSVT 79
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
++ L+ +Y+++G L + L + LS + I + A+ LH H
Sbjct: 80 TLKGH-----VLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH 128
Query: 807 CQPPIVHGDLKPSNVLLDHDMV-AHVSDFGLARFLFARPFDTSMETQSSSIGIK----GT 861
I+H D+K NVL D ++ D+GL + IG GT
Sbjct: 129 ---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK----------------IIGTPSCYDGT 169
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ Y P I V+ D +++GV+ E+ T + P
Sbjct: 170 LDYFSPEKIKGHNY------------DVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHRN 737
F +G G+FG V + A+K L +++ + + AE ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
++++ F+ D V +Y+ G + L + PE DL+ R IA ++
Sbjct: 63 VVRLY-----YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE--DLA---RFYIA-ELT 111
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
A+E +H + +H D+KP N+L+D D ++DFGL
Sbjct: 112 CAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G+G++G VYK + + + G S E +LR +H N+I + V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 747 SIDFKGADFKA-LVYEYMQNGSLEEW----LH---QSNGQPEVCDLSLIQRLNIAIDMAS 798
S +D K L+++Y ++ + W H ++N +P S+++ L I
Sbjct: 69 S----HSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI--LD 119
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARPF 845
I YLH + ++H DLKP+N+L+ ++D G AR LF P
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPL 166
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 62/234 (26%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS--FVAECEVLRNTRHRNLIKIITV 744
+G G++GSV VAVK L+ + + + E +L++ +H N+I ++ V
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 745 ---CSSID----------FKGADFKALV-YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRL 790
+SI+ GAD +V + + + ++ ++Q
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ---------------- 126
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
+ ++Y+H I+H DLKPSNV ++ D + DFGLAR +
Sbjct: 127 -----LLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------Q 167
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
G T Y P MLN + Y T D++S+G ++ E+
Sbjct: 168 ADDEMTGYVATRWYRAP---EIMLNW--MHYNQ------TVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 29/173 (16%)
Query: 687 IGQGSFGSVYKGIL--GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+G++G VYK G++ A+K + G S E +LR +H N+I + V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 745 CSSIDFKGADFKA-LVYEYMQNGSLEEW----LH---QSNGQPEVCDLSLIQRLNIAIDM 796
S AD K L+++Y ++ + W H ++N +P +++ L I
Sbjct: 67 FLS----HADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI-- 117
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARPF 845
I YLH + ++H DLKP+N+L+ ++D G AR LF P
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPL 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 36/147 (24%), Positives = 62/147 (42%), Gaps = 25/147 (17%)
Query: 762 YMQNGSLEEWLHQSNGQPEVCD--LSLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKP 818
+++ SL + + Q ++ L+L + + +A +E+L C +H DL
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAA 207
Query: 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPC 878
N+LL + V + DFGLAR ++ P YV G+ L
Sbjct: 208 RNILLSENNVVKICDFGLARDIYKDP------------------DYVRKGDARLPLKWMA 249
Query: 879 LEYGMGSEASVTGDVYSLGVMLLEMFT 905
E ++ DV+S GV+L E+F+
Sbjct: 250 PETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 26/98 (26%)
Query: 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT----VGYVPP 867
+H D+ NVLL VA + DFGLAR + S+ + +KG V ++ P
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR---------DIMNDSNYV-VKGNARLPVKWMAP 283
Query: 868 GNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+I C+ +V DV+S G++L E+F+
Sbjct: 284 ESI-----FDCV-------YTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.003
Identities = 74/325 (22%), Positives = 124/325 (38%), Gaps = 16/325 (4%)
Query: 85 NIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSS 144
N L + L L ++ + + + + + L L +L L N N+S
Sbjct: 57 NTLLLLPSSLSRLLSLDLLSPSGISSL-DGSENLLNLLPLPSLDLNLNRLRS----NISE 111
Query: 145 CSNL--LSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHV 201
L L+ + NN + +IP IG L+ + L+ N + LP+ + NL ++ L +
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170
Query: 202 GENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE 261
N S +P L N+S+L N+ L N + +LP +I L L+ + +N +
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE-LLSALEELDLSNN-SIIELLS 226
Query: 262 SFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSG-GANDLDFVTILTNC 320
S SN N+ ++L N I G L NL +LDL N + S L + L
Sbjct: 227 SLSNLKNLSGLELSNNKLEDLPESI-GNLSNLETLDLSNNQISSISSLGSLTNLRELDLS 285
Query: 321 SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQI-SGTIPSGIGNLVNLNLLGIEF 379
A L +L + NL T+ + + +N I G + L I
Sbjct: 286 GNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILE 345
Query: 380 NQLTGNIPREIGQLRNLQAIGLSSN 404
+ NL + +
Sbjct: 346 SLNNLWTLDNALDESNLNRYIVKNP 370
|
Length = 394 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 42/164 (25%), Positives = 58/164 (35%), Gaps = 38/164 (23%)
Query: 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIA 871
+H DL N+LL + V + DFGLAR ++ P YV G+
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDP------------------DYVRKGSAR 237
Query: 872 KMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEK 931
L E + DV+S GV+L E+F+ + G EFC+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP---YPGVQINEEFCQR----- 289
Query: 932 VMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
DG R E + RI +AC P ER
Sbjct: 290 ------------LKDGTRMRAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAE---CEVLRNTRHRNLIK 740
+G+G FG V + G A+K L +++ + ++S + E E + RH L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ C F+ D V EY G L +H +V S + + A + +
Sbjct: 67 LFA-C----FQTEDHVCFVMEYAAGGDLMMHIHT-----DV--FSEPRAVFYAACVVLGL 114
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
+YLH + IV+ DLK N+LLD + ++DFGL
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 997 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.02 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.27 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-116 Score=1122.16 Aligned_cols=900 Identities=31% Similarity=0.510 Sum_probs=663.6
Q ss_pred CHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCeeeeeeecCCCCcEEEEeccCCCCCCcccccccCcccccccccccccc
Q 001908 31 NETDRLALLAIKSQLHDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNF 110 (997)
Q Consensus 31 ~~~~~~aLl~~k~~~~~~~~~~~sW~~~~~~c~w~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l 110 (997)
.++|+.||++||+++.||.+.+.+|+.+.+||.|.||+|++ .++|+.|||++|++.|.+++.+..+++|++|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 46899999999999988988899998888999999999985 56999999999999999999999999999999999999
Q ss_pred CCCCCccCC-CCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccccccCcCcC
Q 001908 111 HGEIPKEIG-FLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPA 189 (997)
Q Consensus 111 ~g~~p~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~ 189 (997)
+|.+|..+. .+++|++|+|++|.++|.+|. +.+.+|++|++++|.+.+.+|..++ .+++|++|+|++|.+.+.+|.
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHh-cCCCCCEEECccCcccccCCh
Confidence 999998765 788888888888888877775 4566777777777777777776664 466777777777777777777
Q ss_pred ccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCC
Q 001908 190 SIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASN 268 (997)
Q Consensus 190 ~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 268 (997)
.+++++ +.+|++++|++++.+|..++++++|++|+|++|++++.+|..++ ++++|++|++++|++++.+|.+|+++++
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 261 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKN 261 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHh-cCCCCCEEECcCceeccccChhHhCCCC
Confidence 777663 55677777777777777777777777777777777766766654 5667777777777777667767777777
Q ss_pred CcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCc------------------chhhhhccCCCCcEEEeec
Q 001908 269 IEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDL------------------DFVTILTNCSKLKVLAFEE 330 (997)
Q Consensus 269 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~------------------~~~~~l~~l~~L~~L~L~~ 330 (997)
|++|+|++|++++..|..+..+++|++|+|++|++....+..+ ..+..+..+++|+.|++++
T Consensus 262 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~ 341 (968)
T PLN00113 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341 (968)
T ss_pred CCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcC
Confidence 7777777777666666666666666666666666653211000 1123344445555555555
Q ss_pred CccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccc
Q 001908 331 NRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNI 410 (997)
Q Consensus 331 N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 410 (997)
|.+.+.+|..+..+ .+|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+
T Consensus 342 n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~ 420 (968)
T PLN00113 342 NKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420 (968)
T ss_pred CCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeEC
Confidence 55555555544444 44555555555555555555555555555555555555566666666666777777777776666
Q ss_pred hhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccc
Q 001908 411 PSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNL 490 (997)
Q Consensus 411 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l 490 (997)
|..|.++++|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ...++ +.|++++|++++.+|..|.++
T Consensus 421 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~~~~~~~~l 498 (968)
T PLN00113 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGAVPRKLGSL 498 (968)
T ss_pred ChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccc-eEEECcCCccCCccChhhhhh
Confidence 7777777777777777777777777767777777777777777777766654 34566 889999999999999999999
Q ss_pred cccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeC
Q 001908 491 KNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNL 570 (997)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 570 (997)
++|+.|+|++|++++.+|..+.++++|++|+|++|.++|.+|..|..+++|+.|||++|+++|.+|..+..+++|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCcccCCCCCcCCCCcceeecCCCCcCCCCCCCCCCCCCCcCCCCcccccccccccceeeehhhhhheeeeeeeeec
Q 001908 571 SYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRLGKVGIPMIVSCLILSTCFIIVYARRR 650 (997)
Q Consensus 571 s~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~r~ 650 (997)
++|+++|.+|..+++.++....+.|||.+||..+....++|..... ...+...+++.++++++++++++++++.++|
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---TPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---cceeeeehhHHHHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999999766555677753221 1111111111112112222222222222222
Q ss_pred ccccccCCCCccc---c-cCCc--cChHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHH
Q 001908 651 RSKQESSISVPME---Q-YFPM--VSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFV 724 (997)
Q Consensus 651 ~~~~~~~~~~~~~---~-~~~~--~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~ 724 (997)
+..+.++...... . .+.. ............|+..+.||+|+||.||+|+...++..||||+++..... ..
T Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~ 731 (968)
T PLN00113 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PS 731 (968)
T ss_pred hcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cH
Confidence 2111111111000 0 0000 01112233345678889999999999999999889999999998643321 23
Q ss_pred HHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh
Q 001908 725 AECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804 (997)
Q Consensus 725 ~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH 804 (997)
+|++.+++++|||||+++++|.. .+..++||||+++|+|.++++. ++|.++.+++.||++|++|||
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH 797 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLH 797 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhc
Confidence 46889999999999999999754 3468999999999999999963 688999999999999999999
Q ss_pred hCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCC
Q 001908 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMG 884 (997)
Q Consensus 805 ~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~ 884 (997)
..+.++|+||||||+||+++.++.+++. ||.+.... ......||+.|+|||.+ .+
T Consensus 798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------------~~~~~~~t~~y~aPE~~------------~~ 852 (968)
T PLN00113 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------------TDTKCFISSAYVAPETR------------ET 852 (968)
T ss_pred cCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------------cCCCccccccccCcccc------------cC
Confidence 7666699999999999999999988876 66543321 11123678999999544 45
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcch-hhhhhcCcccccccccchhhhhHHHHHHHHHHH
Q 001908 885 SEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPE-KVMETVDPSLLLAWSDGRRRAKVEECLVTVIRI 963 (997)
Q Consensus 885 ~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~l 963 (997)
..++.++|||||||++|||+||+.||+........+.+|.+..... .....+|+.+.... ....++..++.++
T Consensus 853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l 926 (968)
T PLN00113 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV------SVNQNEIVEVMNL 926 (968)
T ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC------CccHHHHHHHHHH
Confidence 7789999999999999999999999976555555666666544322 23344555443221 1223456678899
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 964 GVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 964 i~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
+.+||+.||++||||+|++++|+++.+
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999998865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-60 Score=611.40 Aligned_cols=491 Identities=34% Similarity=0.534 Sum_probs=412.8
Q ss_pred cccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCcccc-CCCcccchhccccccccccccccccccccccee
Q 001908 98 SFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLS-SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHI 176 (997)
Q Consensus 98 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~-~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L 176 (997)
.+++.|||++|.++|.+|..+..+++|++|+|++|.++|.+|..+. ++++|++|++++|++.|.+|.. .+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~---~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc---ccCCCCEE
Confidence 4689999999999999999999999999999999999999999877 8999999999999999999974 36899999
Q ss_pred ecccccccCcCcCccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcC
Q 001908 177 SLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255 (997)
Q Consensus 177 ~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l 255 (997)
+|++|.+++.+|..+++++ +++|++++|.+.+.+|..++++++|++|+|++|++++.+|..++ ++++|++|+|++|++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l 224 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNL 224 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHc-CcCCccEEECcCCcc
Confidence 9999999999999999984 67899999999999999999999999999999999999998876 799999999999999
Q ss_pred cCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCC
Q 001908 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGG 335 (997)
Q Consensus 256 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 335 (997)
++.+|..++++++|++|+|++|++++.+|..|+++++|++|+|++|++... .+..+.++++|++|++++|++.+
T Consensus 225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~------~p~~l~~l~~L~~L~Ls~n~l~~ 298 (968)
T PLN00113 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGP------IPPSIFSLQKLISLDLSDNSLSG 298 (968)
T ss_pred CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeecc------CchhHhhccCcCEEECcCCeecc
Confidence 999999999999999999999999999999999999999999999999753 34566778888888888888888
Q ss_pred CCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhc
Q 001908 336 VLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLG 415 (997)
Q Consensus 336 ~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 415 (997)
.+|..+.++ ++|+.|++++|.+++.+|..++++++|+.|++++|++++.+|..++.+++|+.|+|++|++++.+|.++.
T Consensus 299 ~~p~~~~~l-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~ 377 (968)
T PLN00113 299 EIPELVIQL-QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377 (968)
T ss_pred CCChhHcCC-CCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh
Confidence 888877776 6788888888888877777777788888888888888777777777777777777777777766666666
Q ss_pred CCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccc------------------------ccccccc
Q 001908 416 NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILT------------------------ITTLSRF 471 (997)
Q Consensus 416 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------------------------l~~ll~~ 471 (997)
.+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+.. ++++ +.
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~ 456 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL-QM 456 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC-cE
Confidence 5555555555555555555555555555555555555555555544444 4444 45
Q ss_pred cccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccc
Q 001908 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551 (997)
Q Consensus 472 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 551 (997)
|+|++|++.+.+|..+ ..++|+.|++++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|+.|+|++|++
T Consensus 457 L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 457 LSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred EECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence 5555555555555443 246677888888888888888999999999999999999999999999999999999999999
Q ss_pred cccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCcCC
Q 001908 552 SGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKLCG 601 (997)
Q Consensus 552 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~C~ 601 (997)
+|.+|..+..+++|+.|||++|+++|.+|.. ..+..+..+++.+|+..+.
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 9999999999999999999999999999875 5577899999999998763
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=415.11 Aligned_cols=289 Identities=42% Similarity=0.680 Sum_probs=241.6
Q ss_pred cCCccChHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEee
Q 001908 665 YFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744 (997)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 744 (997)
....+++.++..||++|...+.||+|+||.||+|... +++.||||++........++|..|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4566899999999999999999999999999999997 558999998875443314569999999999999999999999
Q ss_pred eeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
|.+.+ ++.++|||||++|+|.++++..... +++|.+|++||.++|+||+|||+.+.|+|+||||||+|||+|
T Consensus 140 C~e~~----~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 140 CLEGG----EHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred EecCC----ceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 97532 2699999999999999999986532 589999999999999999999999988999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccc-cccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI-KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+++++||+|||+|+..+.. ....... .||.+|+|| ||...+..+.|+|||||||++.|+
T Consensus 212 ~~~~aKlsDFGLa~~~~~~--------~~~~~~~~~gt~gY~~P------------Ey~~~g~lt~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG--------DTSVSTTVMGTFGYLAP------------EYASTGKLTEKSDVYSFGVVLLEL 271 (361)
T ss_pred CCCCEEccCccCcccCCcc--------ccceeeecCCCCccCCh------------hhhccCCcCcccccccchHHHHHH
Confidence 9999999999999654210 0111111 799999999 677778999999999999999999
Q ss_pred HhCCCCCCcCc-CCCccHHHHHHhhcch-hhhhhcCccccc-ccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 904 FTRRRPTNCMF-QGGLTLHEFCKMALPE-KVMETVDPSLLL-AWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 904 ltg~~P~~~~~-~~~~~~~~~~~~~~~~-~~~~~~d~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
+||+.|.+... .+...+.+|++....+ +..+++||.+.. .+.+ .++...+.+++..|++.+|++||+|.|
T Consensus 272 itgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~-------~~~~~~~~~~a~~C~~~~~~~RP~m~~ 344 (361)
T KOG1187|consen 272 ITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD-------EKEVKKLAELALRCLRPDPKERPTMSQ 344 (361)
T ss_pred HhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCCh-------HHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence 99999887544 3445578887665544 788999999863 2211 145667999999999999999999999
Q ss_pred HHHHHHHHH
Q 001908 981 VLAKLCAAR 989 (997)
Q Consensus 981 vl~~L~~~~ 989 (997)
|+++|+.+.
T Consensus 345 Vv~~L~~~~ 353 (361)
T KOG1187|consen 345 VVKELEGIL 353 (361)
T ss_pred HHHHHHhhc
Confidence 999996554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=373.18 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=207.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc-eE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD-FK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~-~~ 756 (997)
.+.+..+.||+|..|+|||++++.+++.+|+|++.. .++...+++.+|+++++..+||+||.+||.|. .+. ..
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~-----~~~~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY-----SNGEEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE-----eCCceE
Confidence 355667899999999999999999999999999963 34455688999999999999999999999953 344 69
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
+++||||++|+|++++...+ .+++...-+|+.+|++||.|||+.. +|+||||||+|||++..|+|||||||.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccc
Confidence 99999999999999998764 4788899999999999999999742 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
++.+.. .....++||..|||||.+. +..|+.++||||||+.++|+++|+.||......
T Consensus 226 S~~lvn----------S~a~tfvGT~~YMsPERi~------------g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~ 283 (364)
T KOG0581|consen 226 SGILVN----------SIANTFVGTSAYMSPERIS------------GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP 283 (364)
T ss_pred cHHhhh----------hhcccccccccccChhhhc------------CCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence 988732 2345678999999996654 678999999999999999999999998754222
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHH-HHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVE-ECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+.+.......+. .|.+ +. .+.+++.+++..|+++||.+||+++|+++
T Consensus 284 ~~~~~~Ll~~Iv~~p-----pP~l------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEP-----PPRL------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCHHHHHHHHhcCC-----CCCC------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 233333322221111 1111 11 35678899999999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=393.06 Aligned_cols=262 Identities=32% Similarity=0.489 Sum_probs=209.5
Q ss_pred cCccCCcccccCcceEEEEEECCCCcE-EEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTF-VAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~-vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+....+.+|+|+||+||+|.++ |+. ||||++.... ....+.|.+|+.+|.+++|||||+++|+|.... ...
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cce
Confidence 3344566999999999999995 555 9999997433 222679999999999999999999999986532 268
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-cEecCCCCCCeeeCCCC-cEEEccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP-IVHGDLKPSNVLLDHDM-VAHVSDF 834 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~-ivHrDlk~~NIll~~~~-~~kl~DF 834 (997)
++||||+++|+|.++++... ...+++..+++||.|||+||+|||++ + ||||||||+|||++.++ ++||+||
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCC
Confidence 99999999999999998841 12599999999999999999999999 7 99999999999999998 9999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++...... .......||+.|||||++.. | ...|+.|+|||||||++|||+||+.||....
T Consensus 189 Glsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~-------~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 189 GLSREKVISK--------TSMTSVAGTYRWMAPEVLRG-------E---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred ccceeecccc--------ccccCCCCCccccChhhhcC-------C---CCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 9998652211 22233689999999988863 1 5679999999999999999999999998553
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
. .......+. . +.+...+.+|+..+..+|..||..||+.||++.+++..|+.+.....
T Consensus 251 ~-~~~~~~v~~--------~------------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 251 P-VQVASAVVV--------G------------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred H-HHHHHHHHh--------c------------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 2 111111100 1 11112233478889999999999999999999999999999877554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=375.15 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=202.4
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch-------hhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-------GALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||+++...- .......+|+++|++++|||||++.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~----- 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF----- 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence 44678889999999999999999999999999999963211 112345799999999999999999999
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC---
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--- 826 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~--- 826 (997)
|+.++..||||||++||+|.+++-..+ .+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 555668899999999999999998876 355556688999999999999999 99999999999999866
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCC-ccchhHHHHHHHHHHHh
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS-VTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~-~~~DvwSlGvvl~ellt 905 (997)
..+||+|||+|+... ........|||+.|.|||++... +..++ .++|+||+|||+|.+++
T Consensus 316 ~llKItDFGlAK~~g---------~~sfm~TlCGTpsYvAPEVl~~k----------g~~~~~~kVDiWSlGcvLfvcLs 376 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSG---------EGSFMKTLCGTPSYVAPEVLASK----------GVEYYPSKVDIWSLGCVLFVCLS 376 (475)
T ss_pred eEEEecccchhhccc---------cceehhhhcCCccccChhheecC----------CeecccchheeeeccceEEEEec
Confidence 789999999999762 33455668999999999988742 22233 48999999999999999
Q ss_pred CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 906 RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 906 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
|.+||.+..++.....+... .+.. ...+...+..++..++|.+|+..||++|||+.|+++
T Consensus 377 G~pPFS~~~~~~sl~eQI~~----G~y~--------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 377 GYPPFSEEYTDPSLKEQILK----GRYA--------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCCCcccccCCccHHHHHhc----Cccc--------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 99999865443322222211 1100 001122334556779999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=391.88 Aligned_cols=260 Identities=31% Similarity=0.477 Sum_probs=215.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.+.++..+.||+|-||+||.|.++ ...+||+|.++... ...+.|.+|+++|++++|++||+++++|.. ++..|
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piy 277 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIY 277 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceE
Confidence 345567889999999999999996 45589999997542 234788899999999999999999999864 23799
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
||||||+.|+|.++++...+ ..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+|
T Consensus 278 IVtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred EEEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999999998332 2488899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+......+ .......-+..|.|||++. .+.++.|+|||||||+||||+| |+.||..+.
T Consensus 351 r~~~d~~Y-------~~~~~~kfPIkWtAPEa~~------------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-- 409 (468)
T KOG0197|consen 351 RLIGDDEY-------TASEGGKFPIKWTAPEALN------------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-- 409 (468)
T ss_pred cccCCCce-------eecCCCCCCceecCHHHHh------------hCCcccccceeehhhhHHHHhccCCCCCCCCC--
Confidence 94422221 1222233467899996665 5889999999999999999999 888877432
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
..+. ....+.+++++.|..||+.++++|..||+.+|++|||++.+...++++...-
T Consensus 410 ---n~ev-----------------~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 410 ---NEEV-----------------LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ---HHHH-----------------HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 2221 2223567788889999999999999999999999999999999998887543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=393.95 Aligned_cols=474 Identities=27% Similarity=0.385 Sum_probs=306.9
Q ss_pred cEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcc
Q 001908 75 RVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAY 154 (997)
Q Consensus 75 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~ 154 (997)
.++.|++++|.+. .+.+.+.+|..|.+|++++|+++ +.|+++|.+..++.|+.|+|+++ ++|++++++.+|+.++.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 4667777777764 45566777777777777777777 77777777777777777777777 777777777777777777
Q ss_pred cccccccccccccccccccceeecccccccCcCcCccCcc-hhhhhhccCccccccCCCcccCCCccceeeccCCCCCCC
Q 001908 155 RNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGN 233 (997)
Q Consensus 155 ~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ 233 (997)
+|.+. ++|++++ .+..|+.|+..+|+++ ++|+.++++ ++..+++.+|++.. +|+..-+++.|++||...|-++ .
T Consensus 123 ~n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 123 SNELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-c
Confidence 77776 6666665 3566677777777776 455555555 34456667776663 4444444666777776666665 6
Q ss_pred CCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcch
Q 001908 234 LPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313 (997)
Q Consensus 234 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 313 (997)
+|+.++ .+.+|..|+|.+|+|. .+| +|..++.|+.|+++.|+|.-.+.+..+.+.+|.+|||..|+++. .
T Consensus 198 lP~~lg-~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke-------~ 267 (565)
T KOG0472|consen 198 LPPELG-GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE-------V 267 (565)
T ss_pred CChhhc-chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccccc-------C
Confidence 666665 5666666666666666 445 56666666666666666664444444566666666666666654 3
Q ss_pred hhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCC---CCCCEEe-------ccCCC--
Q 001908 314 VTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNL---VNLNLLG-------IEFNQ-- 381 (997)
Q Consensus 314 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~-------L~~N~-- 381 (997)
|+.++-+++|++||+|+|.|+ .+|.+++++ .|+.|-+.+|-+.. +-..+-+. .-|++|. ++.-+
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl--hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~ 343 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL--HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGG 343 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc--eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCccc
Confidence 444555666666666666665 345555554 45555555555441 11111000 0011111 01000
Q ss_pred -C-CCC----CCCCcccccccceeccccccccccchhhhcCCCC---CCeEEeecCcCCCCCCCCCCCCCCCcEEecCCC
Q 001908 382 -L-TGN----IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTL---MTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDN 452 (997)
Q Consensus 382 -l-~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 452 (997)
- .+. .......+.+.+.|+++.-+++ .+|.....-.. .+..+++.|++. ++|..+..++.+++.-+..|
T Consensus 344 ~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsn 421 (565)
T KOG0472|consen 344 TETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSN 421 (565)
T ss_pred ccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhc
Confidence 0 000 1112234566778888888887 56655444333 677888888887 67777777666555433333
Q ss_pred cccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCC
Q 001908 453 KLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP 532 (997)
Q Consensus 453 ~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 532 (997)
+..+.+|..++.++++ .+|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++....|
T Consensus 422 n~isfv~~~l~~l~kL-t~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~ 498 (565)
T KOG0472|consen 422 NKISFVPLELSQLQKL-TFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDP 498 (565)
T ss_pred CccccchHHHHhhhcc-eeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccCh
Confidence 3344778788888887 78888888877 77888888888888888888887 778777777777777777788876666
Q ss_pred hhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCc
Q 001908 533 LSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 533 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 576 (997)
..+.+|.+|.+|||.+|.|. .+|+.++++++|++|++++|+|.
T Consensus 499 ~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 499 SGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 66888888888888888887 77888888888888888888887
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=379.89 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=209.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
..|...+.||+|||+++|.+++.++|+.||+|++.. ......+...+||++.++++|||||+++++ |++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 579999999999999999999988999999999974 345667889999999999999999999999 778889
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
+|+|.|+|+.++|.++++++. ++++.+++.+.+||+.|+.|||+. +|+|||||-.|+|++++.+|||+|||
T Consensus 93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 999999999999999999654 589999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|..+.. ..+.....||||.|.|||++. ....+..+||||+|||||-|++|++||+..
T Consensus 164 LAt~le~--------~~Erk~TlCGTPNYIAPEVl~------------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-- 221 (592)
T KOG0575|consen 164 LATQLEY--------DGERKKTLCGTPNYIAPEVLN------------KSGHSFEVDIWSLGCVMYTLLVGRPPFETK-- 221 (592)
T ss_pred eeeeecC--------cccccceecCCCcccChhHhc------------cCCCCCchhhhhhhhHHHhhhhCCCCcccc--
Confidence 9998732 234566789999999997765 577899999999999999999999999843
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+.+..... +..+..-|. ....+-.+||.++++.||.+|||+.+|+.
T Consensus 222 ---~vkety~~I---k~~~Y~~P~---------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 ---TVKETYNKI---KLNEYSMPS---------------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---hHHHHHHHH---HhcCccccc---------------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 222221111 111222222 12334568999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=359.03 Aligned_cols=200 Identities=31% Similarity=0.562 Sum_probs=178.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
..+|...++||+|+||+||+|+++.++.+||||.+... .....+.+..|+.+|+.++|||||.+++++. .+++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCCe
Confidence 35788889999999999999999999999999999755 5566778899999999999999999999954 4569
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC------CcE
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------MVA 829 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~------~~~ 829 (997)
.|+|||||.||||.+|++.++ .+++...+.++.|+|.|+++||++ +||||||||+|||++.. -.+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 999999999999999999986 488899999999999999999999 99999999999999865 468
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+|+.+. ........+|++.|||||++. .++|+.|+|+||.|+|+|+|++|+.|
T Consensus 155 KIADFGfAR~L~---------~~~~a~tlcGSplYMAPEV~~------------~~~YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 155 KIADFGFARFLQ---------PGSMAETLCGSPLYMAPEVIM------------SQQYDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred EecccchhhhCC---------chhHHHHhhCCccccCHHHHH------------hccccchhhHHHHHHHHHHHHhCCCC
Confidence 999999999873 233445679999999997664 57899999999999999999999999
Q ss_pred CCc
Q 001908 910 TNC 912 (997)
Q Consensus 910 ~~~ 912 (997)
|+.
T Consensus 214 f~a 216 (429)
T KOG0595|consen 214 FDA 216 (429)
T ss_pred ccc
Confidence 984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=348.92 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=209.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEec--ccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce-
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF- 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~- 755 (997)
.+|++.++||.|.||+||+++...+|..||.|.++ ..+....+....|+.+|++++|||||+++++. +..+..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----f~~~~ev 94 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----FIEDNEV 94 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh----hhccchh
Confidence 46889999999999999999999999999999987 34556678899999999999999999998853 333444
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCeeeCCCCcEEEcc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+++|||||+.|+|.+.++....+ ...+++..+|+++.|++.||..+|++ .+. |.||||||.||+++.+|.||++|
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence 89999999999999999865532 23588999999999999999999994 235 99999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++.+.. ........+|||.||+||++. +.+|+.++||||+||++|||+.-++||...
T Consensus 172 fGL~r~l~s--------~~tfA~S~VGTPyYMSPE~i~------------~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 172 FGLGRFLSS--------KTTFAHSLVGTPYYMSPERIH------------ESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred chhHhHhcc--------hhHHHHhhcCCCcccCHHHHh------------cCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 999998732 223445578999999996654 688999999999999999999999999843
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhH-HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKV-EECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.+.+......... ..+.+ +.+..++..||..|+..||+.||+...+++.+..
T Consensus 232 -----n~~~L~~KI~qgd-----------------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 232 -----NLLSLCKKIEQGD-----------------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----cHHHHHHHHHcCC-----------------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3444332221111 11112 3456678899999999999999986555555544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=399.32 Aligned_cols=267 Identities=29% Similarity=0.492 Sum_probs=221.4
Q ss_pred hhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
..+....+.||+|+||+||+|+.. .....||||.++...+. ...+|++|+++++.++|||||+++|+|.+.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--- 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG--- 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC---
Confidence 345667899999999999999874 34457999999866555 789999999999999999999999999764
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCC--------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPE--------VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
+..|||+|||..|||.+||........ ..+++..+.+.||.|||.||+||-++ .+|||||.++|+||
T Consensus 562 --~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 562 --DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV 636 (774)
T ss_pred --CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence 489999999999999999997653221 22488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 824 DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 824 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+++..|||+|||+++.++..++..... ...-+..|||| |.+..+++++++|||||||||||+
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~------~t~lPIRWMpp------------EsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRG------NTLLPIRWMPP------------ESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccC------CceeeeecCCH------------HHhhcCcccchhhhhhhhhhhhhh
Confidence 999999999999999987776654321 22346799999 555579999999999999999999
Q ss_pred Hh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 904 FT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 904 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
++ |+.||+....+ ++.+.+. ++...+.++.||.+++.||..||+..|++||+++||-
T Consensus 699 FsyG~QPy~glSn~--------------EVIe~i~--------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 699 FSYGKQPYYGLSNQ--------------EVIECIR--------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hccccCcccccchH--------------HHHHHHH--------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99 99998854322 1111111 2223456788999999999999999999999999999
Q ss_pred HHHHHHHHHh
Q 001908 983 AKLCAARQTL 992 (997)
Q Consensus 983 ~~L~~~~~~~ 992 (997)
..|++..++-
T Consensus 757 ~~L~~~~~~s 766 (774)
T KOG1026|consen 757 SRLQAWAQAS 766 (774)
T ss_pred HHHHHHHhcC
Confidence 9999987754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=344.84 Aligned_cols=268 Identities=21% Similarity=0.321 Sum_probs=204.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+.|+...++|+|+||+||+|+.+++|+.||||++... ++...+-.++|+++|++++|+|+|.++.+ |......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 3577889999999999999999999999999999633 23445667999999999999999999999 6677899
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++|+|||+- ++.+-++.... .++...+.++.+|++.|+.|+|++ +|+||||||+||||+.+|.+|+||||+
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 999999955 66666766542 377889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.+.. ....-+.++.|.+|+|||.+-+ +.+|+..+||||.||++.||++|.+-|.+.
T Consensus 148 AR~L~~--------pgd~YTDYVATRWYRaPELLvG-----------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--- 205 (396)
T KOG0593|consen 148 ARTLSA--------PGDNYTDYVATRWYRAPELLVG-----------DTQYGKPVDIWAIGCVFAELLTGEPLWPGR--- 205 (396)
T ss_pred hHhhcC--------CcchhhhhhhhhhccChhhhcc-----------cCcCCCcccchhhhHHHHHHhcCCcCCCCc---
Confidence 998732 2233455789999999987753 478999999999999999999999987643
Q ss_pred CccHHHHHHh------hcchhh-hhhcCcccccccccchhhh-----hHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKM------ALPEKV-METVDPSLLLAWSDGRRRA-----KVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~------~~~~~~-~~~~d~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.++++.... ..|... .....+.+.+..-+..+.+ .......-+.++++.|++.||++|++.+|++.
T Consensus 206 -SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 206 -SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred -chHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 334333221 122111 0111222221111111101 11122336789999999999999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=379.33 Aligned_cols=477 Identities=26% Similarity=0.360 Sum_probs=407.8
Q ss_pred ccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhccccccccccccccccccccccee
Q 001908 97 LSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHI 176 (997)
Q Consensus 97 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L 176 (997)
-..|+.|++++|.+. .+-+.+.+|..|.+|++++|.++ ++|+.+|.+..++.++.++|++. .+|+.++ ++.+|..|
T Consensus 44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~-s~~~l~~l 119 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIG-SLISLVKL 119 (565)
T ss_pred hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHh-hhhhhhhh
Confidence 356889999999999 66667899999999999999999 99999999999999999999998 8999987 57899999
Q ss_pred ecccccccCcCcCccCcc-hhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcC
Q 001908 177 SLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255 (997)
Q Consensus 177 ~L~~N~l~g~~p~~~~~l-~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l 255 (997)
+.++|.+. .+|++++.+ .+..++..+|+++ ++|..++++.+|..|++.+|++. .+|+..- +++.|++||.-+|-+
T Consensus 120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~L 195 (565)
T KOG0472|consen 120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLDCNSNLL 195 (565)
T ss_pred hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHH-HHHHHHhcccchhhh
Confidence 99999999 677788876 5678999999999 78999999999999999999999 6777665 489999999999998
Q ss_pred cCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCC
Q 001908 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGG 335 (997)
Q Consensus 256 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 335 (997)
+ .+|+.++.+.+|+.|||.+|+|...+ .|.++..|+.|.++.|.|+.+++. ...++++|.+|||.+|+++
T Consensus 196 ~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae------~~~~L~~l~vLDLRdNklk- 265 (565)
T KOG0472|consen 196 E-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAE------HLKHLNSLLVLDLRDNKLK- 265 (565)
T ss_pred h-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHH------Hhcccccceeeeccccccc-
Confidence 8 89999999999999999999998655 899999999999999999876553 4568999999999999999
Q ss_pred CCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCccccc--ccceecc-------ccccc
Q 001908 336 VLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLR--NLQAIGL-------SSNFL 406 (997)
Q Consensus 336 ~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L-------s~N~l 406 (997)
..|+.+.-+ ++|.+||+++|.|+ .+|.+++++ .|+.|-+.+|-+..+..+-+.+=+ -|++|.= +.-.=
T Consensus 266 e~Pde~clL-rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~ 342 (565)
T KOG0472|consen 266 EVPDEICLL-RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEG 342 (565)
T ss_pred cCchHHHHh-hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcc
Confidence 678888776 78999999999998 678889999 899999999988743222222111 1333321 11100
Q ss_pred ----ccc-ch---hhhcCCCCCCeEEeecCcCCCCCCCCCCCCCC---CcEEecCCCcccCCcccccccccccccccccC
Q 001908 407 ----QGN-IP---SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKN---LVSLNLSDNKLIGAVPQQILTITTLSRFLDLG 475 (997)
Q Consensus 407 ----~~~-~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls 475 (997)
.+. .+ .....+.+.+.|+++.=+++ .+|+....-.. .+..+++.|++. ++|..+..+..+.+.++++
T Consensus 343 ~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ls 420 (565)
T KOG0472|consen 343 GTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLS 420 (565)
T ss_pred cccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhh
Confidence 001 11 12334667899999999999 57765444333 789999999998 9999999999987889999
Q ss_pred CCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccC
Q 001908 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555 (997)
Q Consensus 476 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 555 (997)
+|.++ .+|..++.+++|..|+|++|.+. .+|..++.+..|+.|++|+|+|. .+|..+..+..|+.+-.++|++....
T Consensus 421 nn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd 497 (565)
T KOG0472|consen 421 NNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVD 497 (565)
T ss_pred cCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccC
Confidence 99988 88999999999999999999998 89999999999999999999999 89999999999999999999999777
Q ss_pred chhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCc
Q 001908 556 PEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKL 599 (997)
Q Consensus 556 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~ 599 (997)
|+.+.++.+|..|||.+|.+...+|..+.+.+++.+.+.|||..
T Consensus 498 ~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 498 PSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 77799999999999999999999998899999999999999885
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=362.32 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=211.4
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
.....+|.+++.||+|+|++|++|+.+++++.||||++.+ ..+..++...+|-++|.++ +||.|++++.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 3455789999999999999999999999999999999963 2344557778899999999 89999999987 7
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
++...+|+|+||+++|+|.++|++.+ .+++.-.+.+|.+|+.|++|||+. |||||||||+|||+|.||++|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 78889999999999999999999987 588889999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCc---cccccc--cccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh
Q 001908 831 VSDFGLARFLFARPFDTS---METQSS--SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~---~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt 905 (997)
|+|||.|+.+.+...... ...... ...++||..|++||++. ++..++.+|+|+|||++|.|+.
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~------------~~~~~~~sDiWAlGCilyQmla 282 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN------------DSPAGPSSDLWALGCILYQMLA 282 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc------------CCCCCcccchHHHHHHHHHHhc
Confidence 999999999865433311 111111 25589999999997665 5788999999999999999999
Q ss_pred CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 906 RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 906 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
|.+||.+.. .+..+ ++++..--+ .++..++.+.+|+.+.+..||.+|+|.+||.+
T Consensus 283 G~PPFra~N----eyliF------qkI~~l~y~-------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 283 GQPPFRAAN----EYLIF------QKIQALDYE-------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCCcccc----HHHHH------HHHHHhccc-------------CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 999998431 11111 111111111 11222456779999999999999999988865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=370.18 Aligned_cols=270 Identities=27% Similarity=0.406 Sum_probs=214.8
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
.++++..+++.+...||+|.||+||+|+|. | .||||+++.. .++..+.|+.|+..+++-+|.||+-+.|||..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p- 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP- 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence 556666677888999999999999999995 3 3999999743 345778999999999999999999999998653
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
..+||+.+|+|-+|+.+++... ..+++.+.+.||+||++||.|||++ +|+|||+|+.|||+.++++|
T Consensus 461 -----~~AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 461 -----PLAIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred -----ceeeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence 3499999999999999999865 3589999999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+|..-. .-..........|...|||||++.... ..+|++++||||||||+|||+||..|
T Consensus 528 kIgDFGLatvk~------~w~g~~q~~qp~gsilwmAPEvIRmqd---------~nPfS~qSDVYaFGiV~YELltg~lP 592 (678)
T KOG0193|consen 528 KIGDFGLATVKT------RWSGEQQLEQPHGSLLWMAPEVIRMQD---------DNPFSFQSDVYAFGIVWYELLTGELP 592 (678)
T ss_pred EEecccceeeee------eeccccccCCCccchhhhcHHHHhhcc---------cCCCCcccchhhhhHHHHHHHhCcCC
Confidence 999999986421 111122233456888999999997321 57899999999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
|.... -++.+.+.-+. ...|... ..-..|+.+|.+|+..||.+++++||.+.+++..|+++.
T Consensus 593 ysi~~-----~dqIifmVGrG----~l~pd~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 593 YSIQN-----RDQIIFMVGRG----YLMPDLS---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cCCCC-----hhheEEEeccc----ccCccch---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 87221 11111111111 0111111 112367889999999999999999999999999998876
Q ss_pred HH
Q 001908 990 QT 991 (997)
Q Consensus 990 ~~ 991 (997)
..
T Consensus 655 ~~ 656 (678)
T KOG0193|consen 655 PS 656 (678)
T ss_pred hc
Confidence 63
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=349.26 Aligned_cols=245 Identities=26% Similarity=0.387 Sum_probs=201.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
..++|++.++||+|+||+||.++.+++++.||+|++++. ...+.+...+|..+|.+++||.||+++.. |++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 356899999999999999999999999999999999743 34456788999999999999999999866 8889
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+.+|+|+||+.||.|..+|++.+ .+++..+.-++.+|+.||.|||++ +|||||+||+|||+|++|+++|+|
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEec
Confidence 99999999999999999999876 478888899999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++.... .......++||+.|||||++. +.+|+.++|+||+||++|||++|.+||...
T Consensus 169 FgL~k~~~~--------~~~~t~tfcGT~eYmAPEil~------------~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 169 FGLCKEDLK--------DGDATRTFCGTPEYMAPEILL------------GKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred cccchhccc--------CCCccccccCCccccChHHHh------------cCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 999986422 223334589999999996654 678999999999999999999999999842
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
+..++.+.....+... -|. ....+..+++.+.+..||++|..
T Consensus 229 -----~~~~~~~~I~~~k~~~--~p~---------------~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 229 -----DVKKMYDKILKGKLPL--PPG---------------YLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -----cHHHHHHHHhcCcCCC--CCc---------------cCCHHHHHHHHHHhccCHHHhcC
Confidence 3333333332222000 000 01234568899999999999963
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=346.29 Aligned_cols=279 Identities=25% Similarity=0.397 Sum_probs=223.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc--CCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT--RHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++.+..+.||+|.||+||+|.| .|+.||||+|...+ ++.+.+|.++.+.. +|+||+.+++.-.. +-..-.++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEEE
Confidence 6778889999999999999999 58999999997544 37889999999874 99999999986221 11223568
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-----HCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-----~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
++|++|.+.|||+||+.... ++....++++..+|.||++||. +.+|.|+|||||+.||||..++++.|
T Consensus 285 wLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 99999999999999999865 8889999999999999999994 45789999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC-----
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR----- 906 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg----- 906 (997)
+|+|+|....... ..........+||..|||||+++...+..+||. -..+||||||.|+||++.+
T Consensus 358 ADLGLAv~h~~~t----~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes------yk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 358 ADLGLAVRHDSDT----DTIDIPPNPRVGTKRYMAPEVLDETINMKHFES------YKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred eeceeeEEecccC----CcccCCCCCccceeeccChHHhhhhcChhhhhh------hhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999998764322 234455667899999999999997777666663 2468999999999998764
Q ss_pred -----CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 907 -----RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 907 -----~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
+.||++....+..++++.+...-++. +|.+... ....++...+.++|+.||..+|..|.|+-.+
T Consensus 428 i~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~----RP~ipnr-------W~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFEEMRKVVCVQKL----RPNIPNR-------WKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred EehhhcCCcccCCCCCCCHHHHhcceeeccc----CCCCCcc-------cccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 46777666666666665443333332 2222222 2345678899999999999999999999999
Q ss_pred HHHHHHHHHH
Q 001908 982 LAKLCAARQT 991 (997)
Q Consensus 982 l~~L~~~~~~ 991 (997)
.+.|.++-+.
T Consensus 497 KKtl~~l~~~ 506 (513)
T KOG2052|consen 497 KKTLAKLSNS 506 (513)
T ss_pred HHHHHHHhcC
Confidence 9999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=354.53 Aligned_cols=271 Identities=21% Similarity=0.298 Sum_probs=206.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 754 (997)
.-++|...++||.|+||.||+|+..+++..||||+++..- ..+...-.||++.|++++ ||||+++..++.+ ...
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCc
Confidence 3468999999999999999999999999999999987432 222334478999999998 9999999999543 223
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
.+++||||| ..+|++.++.++. .+++..++.|+.||++||+|+|.+ |+.|||+||+||||.....+||+||
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence 899999999 4599999998742 599999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.+... ..-+.++-|.+|+|||++-. .+-|+.+.||||+|||++|+.+-++-|.+..
T Consensus 155 GLARev~Sk---------pPYTeYVSTRWYRAPEvLLr-----------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 155 GLAREVRSK---------PPYTEYVSTRWYRAPEVLLR-----------SGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccccccccC---------CCcchhhhcccccchHHhhh-----------ccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 999987433 23345788999999988753 5779999999999999999999998876432
Q ss_pred CCCccHHHHHHhh--cchhhhhhcCc------cccccccc--ch-hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA--LPEKVMETVDP------SLLLAWSD--GR-RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~--~~~~~~~~~d~------~~~~~~~~--~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+++..+.. +.....+.... .+...+.. +. .......+..+..+++..|+++||++||||+|+++
T Consensus 215 ----E~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 215 ----EIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred ----HHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 233322221 11000000000 00000000 00 01111236677889999999999999999999986
Q ss_pred H
Q 001908 984 K 984 (997)
Q Consensus 984 ~ 984 (997)
.
T Consensus 291 ~ 291 (538)
T KOG0661|consen 291 H 291 (538)
T ss_pred C
Confidence 4
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.83 Aligned_cols=372 Identities=21% Similarity=0.233 Sum_probs=278.5
Q ss_pred hhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCc
Q 001908 198 YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPIN 277 (997)
Q Consensus 198 ~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 277 (997)
.|++++|+++..-+..|.++.+|++++|..|.++ .||.... ...+|+.|+|.+|.|+..-.++++.+..|+.||||.|
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 4888888888777777888888888888888887 7776554 4566888888888888777777888888888888888
Q ss_pred cCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcc
Q 001908 278 YFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQ 357 (997)
Q Consensus 278 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~ 357 (997)
.|+.+....|..-.++++|+|++|+|+.+..+.| .++.+|..|.|+.|+++...+..|.++ +.|+.|+|..|+
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F------~~lnsL~tlkLsrNrittLp~r~Fk~L-~~L~~LdLnrN~ 232 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHF------DSLNSLLTLKLSRNRITTLPQRSFKRL-PKLESLDLNRNR 232 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccc------cccchheeeecccCcccccCHHHhhhc-chhhhhhccccc
Confidence 8888777788877888888888888887776543 466677888888888886666666666 667778888887
Q ss_pred cccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCC
Q 001908 358 ISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437 (997)
Q Consensus 358 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 437 (997)
|.-.--..|.+|++|+.|.|..|.|+..-...|..+.++++|+|+.|+++..-..|+.+|+.|+.|+||+|.|..+-++.
T Consensus 233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence 77444566777777888888888777777777777777888888888777666677777777888888888777777777
Q ss_pred CCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccc---cccCC
Q 001908 438 LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV---TLTGC 514 (997)
Q Consensus 438 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l 514 (997)
....++|++|+|++|+++..-+..|..+..| +.|+|++|+++..-...|..+++|++|||++|.|++.|.+ .|.++
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L-e~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl 391 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQL-EELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGL 391 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHh-hhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccc
Confidence 7777777888888887775555666666666 7777777777766666777777777777777777766653 46677
Q ss_pred cCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCC
Q 001908 515 TGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 515 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
++|+.|+|.+|+|..+.-.+|.+++.|+.|||.+|.|..+-|.+|..+ .|++|-+..-.+-+.+.
T Consensus 392 ~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 392 PSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred hhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEecc
Confidence 777777777777775445677777777777777777777777777777 77777666555544443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.58 Aligned_cols=263 Identities=20% Similarity=0.298 Sum_probs=209.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|....+||.|..++||+|+...++..||||++.... ....+.+++|++.|+.++||||++++.. |..+...
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence 468999999999999999999999999999999997432 3346899999999999999999999887 5556799
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+||.||.+|++.+.++..-.. .+++..+..|.+++++||.|||.+ |.+|||||+.||||+.+|.|||+|||.
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999999999986522 388999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+..+.... .+.........||++|||||++.. ....|+.|+|||||||...|+.+|..||.....-
T Consensus 173 sa~l~~~G----~R~~~rf~tfvgtp~wmAPEvl~q----------~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 173 SASLFDSG----DRQVTRFNTFVGTPCWMAPEVLMQ----------QLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred eeeecccC----ceeeEeeccccCcccccChHHhhh----------cccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 88775432 111111166789999999999653 1357999999999999999999999999854221
Q ss_pred CccHHHHHHhhcchhh----hhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKV----METVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~----~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+..-+.+.... ....|. .+.......+.+++..|+..||++|||++++++
T Consensus 239 -----kvLl~tLqn~pp~~~t~~~~~------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 239 -----KVLLLTLQNDPPTLLTSGLDK------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -----HHHHHHhcCCCCCcccccCCh------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111111 111111 111223347889999999999999999999975
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=377.32 Aligned_cols=271 Identities=28% Similarity=0.470 Sum_probs=223.6
Q ss_pred CccChHHHHHHhhcC---------ccCCcccccCcceEEEEEECCCCc---EEEEEEeccc-chhhHHHHHHHHHHHhhc
Q 001908 667 PMVSYSELSEATNEF---------SSSNMIGQGSFGSVYKGILGENGT---FVAVKILNLM-QKGALKSFVAECEVLRNT 733 (997)
Q Consensus 667 ~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~V~~~~~~~~~~---~vAvK~~~~~-~~~~~~~~~~E~~~l~~l 733 (997)
...+++|.-++..+| .+.++||.|.||+||+|+.+..|+ .||||.++.. .+.+..+|..|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 345666666655544 467899999999999999986664 6999999854 456778999999999999
Q ss_pred CCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEe
Q 001908 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVH 813 (997)
Q Consensus 734 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivH 813 (997)
+||||+++.|+. .....++||+|||++|+|+.||++.+++ +.+.+...+.++|+.||+||-+. ++||
T Consensus 688 dHPNIIrLEGVV-----Tks~PvMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLsdm---~YVH 754 (996)
T KOG0196|consen 688 DHPNIIRLEGVV-----TKSKPVMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLSDM---NYVH 754 (996)
T ss_pred CCCcEEEEEEEE-----ecCceeEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHhhc---Cchh
Confidence 999999999994 4456899999999999999999998754 88889999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchh
Q 001908 814 GDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDV 893 (997)
Q Consensus 814 rDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dv 893 (997)
|||.++||||+.+-.+|++|||+++.+.+++. .......-.-+..|.|||.+. ..+++.++||
T Consensus 755 RDLAARNILVNsnLvCKVsDFGLSRvledd~~-----~~ytt~GGKIPiRWTAPEAIa------------~RKFTsASDV 817 (996)
T KOG0196|consen 755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTLGGKIPIRWTAPEAIA------------YRKFTSASDV 817 (996)
T ss_pred hhhhhhheeeccceEEEeccccceeecccCCC-----ccccccCCccceeecChhHhh------------hcccCchhhc
Confidence 99999999999999999999999997643321 111111122356899996554 6889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCC
Q 001908 894 YSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972 (997)
Q Consensus 894 wSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 972 (997)
|||||||||.++ |.+||-++... ......+++++.+-+.+||..+.+||..||++|-
T Consensus 818 WSyGIVmWEVmSyGERPYWdmSNQ----------------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 818 WSYGIVMWEVMSYGERPYWDMSNQ----------------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred cccceEEEEecccCCCcccccchH----------------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHh
Confidence 999999999887 99998755322 1222335667778888999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHH
Q 001908 973 IERMEMRDVLAKLCAAR 989 (997)
Q Consensus 973 ~~Rps~~evl~~L~~~~ 989 (997)
.+||.+.||+..|.++.
T Consensus 876 ~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 876 NRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hcCCCHHHHHHHHHHHh
Confidence 99999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=322.29 Aligned_cols=269 Identities=24% Similarity=0.355 Sum_probs=206.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.+|...+++|+|.||.||+|++..+|+.||||+++.. .++......+||+.|+.++|+||+.++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 4678889999999999999999999999999999743 33345678999999999999999999999 5667789
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
.+|+|||+. +|+..++... ..+...++..++.++++|++|+|++ .|.||||||.|+|++++|.+||+|||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEEeccc-cHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 999999965 9999998765 3588999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+...++. ......+-|.+|+|||.+-+ ...|+..+||||.|||+.||+-|.+-|. +
T Consensus 148 Ar~f~~p~--------~~~~~~V~TRWYRAPELLfG-----------sr~Yg~~VDmWavGCI~AELllr~P~fp----G 204 (318)
T KOG0659|consen 148 ARFFGSPN--------RIQTHQVVTRWYRAPELLFG-----------SRQYGTGVDMWAVGCIFAELLLRVPFFP----G 204 (318)
T ss_pred hhccCCCC--------cccccceeeeeccChHHhcc-----------chhcCCcchhhhHHHHHHHHHccCCCCC----C
Confidence 99874432 22233378999999976643 3568999999999999999998766543 3
Q ss_pred CccHHHHHHhh--c----chhhhhhc---CcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 917 GLTLHEFCKMA--L----PEKVMETV---DPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 917 ~~~~~~~~~~~--~----~~~~~~~~---d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..++++..... + ++.+.+.. |-.....+...........+..+..+++..|+..||.+|++++|+++.
T Consensus 205 ~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 205 DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 44555443321 1 11222111 111011111111111112234556899999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=349.90 Aligned_cols=275 Identities=24% Similarity=0.354 Sum_probs=207.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+.|+..++||+|+||.||+|++..+|+.||+|+++.. .++......+||.+|++++||||+++.+...+. ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 34677889999999999999999999999999999744 355667889999999999999999999987643 2468
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
+|+|+|||+. ||.-++.... ..++..++..++.|++.||+|+|++ +|.|||||.+|||||.+|.+||+|||
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EEEEEecccc-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence 9999999955 9999887643 3589999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+++.... ....+..+-|.+|+|||.+-. ...|+.++|+||.|||+.||++|++.|....+
T Consensus 264 LAr~y~~~~-------~~~~T~rVvTLWYRpPELLLG-----------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 264 LARFYTPSG-------SAPYTSRVVTLWYRPPELLLG-----------ATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred ceeeccCCC-------CcccccceEEeeccChHHhcC-----------CcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 999763321 122445678999999987764 35699999999999999999999999874321
Q ss_pred CCccHHHHHHhh-cc-hhhhhhcCcccccccc--cchh---hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMA-LP-EKVMETVDPSLLLAWS--DGRR---RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~-~~-~~~~~~~d~~~~~~~~--~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
- ..++...+.. .| +..+...+--....+. ..+. .......+....+|+..++..||.+|.|+.++++
T Consensus 326 v-eQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 326 V-EQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred H-HHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 1111111111 11 1111111111101111 0111 1112334567789999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=386.26 Aligned_cols=270 Identities=27% Similarity=0.466 Sum_probs=221.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc-----EEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT-----FVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
...+..+.||+|+||.||.|...+... .||||.++. .+.+...+|.+|..+|+.++|||||+++|+|..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----- 766 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----- 766 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----
Confidence 455677899999999999999864333 389999874 456677899999999999999999999999854
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCC-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPE-VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
....++++|||++|+|..||++.+.... ...+.....+.++.|||+|+.||+++ ++|||||.++|+|++...+|||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 4578999999999999999998743221 23588999999999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPT 910 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 910 (997)
+|||+|+.+....+..... ...-+..|||||.+. ++.++.|+|||||||++||++| |..||
T Consensus 844 aDFGlArDiy~~~yyr~~~------~a~lPvkWm~PEsl~------------d~iFtskSDvWsFGVllWEifslG~~PY 905 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHG------EAMLPVKWMPPESLK------------DGIFTSKSDVWSFGVLLWEIFSLGATPY 905 (1025)
T ss_pred cccchhHhhhhchheeccC------ccccceecCCHHHHh------------hcccccccchhhhHHHHHHHHhCCCCCC
Confidence 9999999776554433211 123456899996654 5889999999999999999999 89998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
......+ +...+..+++.+.+..|+..++++|..||+.+|++||++..+++++.++.+
T Consensus 906 ~~~~n~~----------------------v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 906 PSRSNFE----------------------VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCcchHH----------------------HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 7432110 111122344667788999999999999999999999999999999999988
Q ss_pred HhhccC
Q 001908 991 TLVGRL 996 (997)
Q Consensus 991 ~~~~~~ 996 (997)
+..+.+
T Consensus 964 ~~~~~~ 969 (1025)
T KOG1095|consen 964 AALGTI 969 (1025)
T ss_pred hhccCc
Confidence 776543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=360.67 Aligned_cols=382 Identities=21% Similarity=0.231 Sum_probs=343.3
Q ss_pred cccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCccc
Q 001908 205 QFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVS 284 (997)
Q Consensus 205 ~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 284 (997)
++.|.+|. .-+.||+++|+++ .+....|.++++||++++.+|.++ .||.......+|+.|+|.+|.|+.+-.
T Consensus 71 ~l~g~lp~------~t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~s 142 (873)
T KOG4194|consen 71 RLKGFLPS------QTQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTS 142 (873)
T ss_pred ccCCcCcc------ceeeeeccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccH
Confidence 45566664 3457999999999 788888889999999999999999 889877777889999999999999999
Q ss_pred ccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCC
Q 001908 285 IIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPS 364 (997)
Q Consensus 285 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~ 364 (997)
+.++.++.|++||||.|.|+.++.. .+..-.++++|+|++|+|+...-..|..+. +|.+|.|+.|+|+...+.
T Consensus 143 e~L~~l~alrslDLSrN~is~i~~~------sfp~~~ni~~L~La~N~It~l~~~~F~~ln-sL~tlkLsrNrittLp~r 215 (873)
T KOG4194|consen 143 EELSALPALRSLDLSRNLISEIPKP------SFPAKVNIKKLNLASNRITTLETGHFDSLN-SLLTLKLSRNRITTLPQR 215 (873)
T ss_pred HHHHhHhhhhhhhhhhchhhcccCC------CCCCCCCceEEeeccccccccccccccccc-hheeeecccCcccccCHH
Confidence 9999999999999999999998765 344667899999999999998889999985 899999999999988888
Q ss_pred CCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCC
Q 001908 365 GIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444 (997)
Q Consensus 365 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 444 (997)
.|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|..|.+...-...|..+.++++|+|+.|+++..-..++.+++.|
T Consensus 216 ~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L 295 (873)
T KOG4194|consen 216 SFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSL 295 (873)
T ss_pred HhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchh
Confidence 99999999999999999985446789999999999999999998888899999999999999999998888999999999
Q ss_pred cEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccC
Q 001908 445 VSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQG 524 (997)
Q Consensus 445 ~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 524 (997)
+.|+||+|.|...-++.+.-.++| ++|+|++|+|+...+..|..|..|++|+|++|.++..-...|.++++|+.|||++
T Consensus 296 ~~L~lS~NaI~rih~d~WsftqkL-~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~ 374 (873)
T KOG4194|consen 296 EQLDLSYNAIQRIHIDSWSFTQKL-KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRS 374 (873)
T ss_pred hhhccchhhhheeecchhhhcccc-eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcC
Confidence 999999999998888888888888 9999999999988889999999999999999999977778999999999999999
Q ss_pred ccccccCCh---hccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCcC
Q 001908 525 NSFRGSIPL---SLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKLC 600 (997)
Q Consensus 525 N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~C 600 (997)
|.|++.|.. .|..|++|+.|+|.+|+|..+.-.+|.+++.|++|||.+|.+...-|.. .++ .++.+.+..-..+|
T Consensus 375 N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 375 NELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLC 453 (873)
T ss_pred CeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEE
Confidence 999987754 5888999999999999999666689999999999999999999877765 333 77888888888999
Q ss_pred CCC
Q 001908 601 GGS 603 (997)
Q Consensus 601 ~~~ 603 (997)
+|.
T Consensus 454 DCq 456 (873)
T KOG4194|consen 454 DCQ 456 (873)
T ss_pred ecc
Confidence 874
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=367.30 Aligned_cols=274 Identities=21% Similarity=0.269 Sum_probs=218.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEee-eeccCcCC-Cce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITV-CSSIDFKG-ADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~-~~~ 755 (997)
.++++.+.|.+|||+.||.|+....|..||+|++-..++...+...+||++|+.|. |+|||.+++. .....-.+ ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 45678899999999999999998777999999998778888899999999999996 9999999993 32221122 356
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
++++||||+||.|-+++.++.. ..+++.++++|+.|+++|+++||.. +|+|+|||||.+||||+.+|..||||||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 8899999999999999997652 2489999999999999999999997 6789999999999999999999999999
Q ss_pred cchhcccCCC-CCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPF-DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
.|......+. .......+.......|+.|+|||.++ ...+.+.++|+||||+||+||.|+....||+...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID---------lysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID---------LYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh---------hhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 9987644331 11111222334455899999999985 4556778999999999999999999999998431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.- .+++ ..+..+-...+...+.+||..||..||.+||++-||+..+.++...
T Consensus 263 ~l-----------------aIln--------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 KL-----------------AILN--------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ce-----------------eEEe--------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 10 0000 1111122234567889999999999999999999999999988753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.84 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=202.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|...+.||+|+||+||++....+|...|||..........+.+.+|+.+|++++|||||+++|...... ....++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---CeeeEe
Confidence 46778899999999999999999889999999987554334677899999999999999999999632211 136899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCcEEEcccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLA 837 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFg~a 837 (997)
+|||+++|+|.+++...++ .+++..++++++||++|++|||++ +|+||||||+|||++. ++.+||+|||.|
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccc
Confidence 9999999999999998763 388999999999999999999999 9999999999999999 799999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... ...........||+.|||||++.. +.....++||||+||++.||+||.+||.....
T Consensus 166 ~~~~~~-----~~~~~~~~~~~Gtp~~maPEvi~~-----------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-- 227 (313)
T KOG0198|consen 166 KKLESK-----GTKSDSELSVQGTPNYMAPEVIRN-----------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-- 227 (313)
T ss_pred cccccc-----cccccccccccCCccccCchhhcC-----------CCcCCccchhhhcCCEEEeccCCCCcchhhcc--
Confidence 876320 111223345789999999977642 22334699999999999999999999874200
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
............ .-| ..+.....+..+++.+|+..||++||||.+++..-..
T Consensus 228 -~~~~~~~ig~~~-----~~P------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 228 -EAEALLLIGRED-----SLP------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -hHHHHHHHhccC-----CCC------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 011111111111 011 1122234566789999999999999999999876543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.16 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=208.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
..|+...+||+|+.|.||.|....+++.||||++........+-+..|+.+|+..+|+|||.++..|. -.+..++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeEE
Confidence 46778899999999999999999999999999998777777788899999999999999999998754 3468999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|||||++|+|.+.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++.
T Consensus 348 VMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 999999999999998764 88999999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.+.. ........+||+.|||||+.. ...|++|+||||||++++||+-|.+||-- +.
T Consensus 418 qi~~--------~~~KR~TmVGTPYWMAPEVvt------------rk~YG~KVDIWSLGIMaIEMveGEPPYln----E~ 473 (550)
T KOG0578|consen 418 QISE--------EQSKRSTMVGTPYWMAPEVVT------------RKPYGPKVDIWSLGIMAIEMVEGEPPYLN----EN 473 (550)
T ss_pred cccc--------ccCccccccCCCCccchhhhh------------hcccCccccchhhhhHHHHHhcCCCCccC----CC
Confidence 7633 223556689999999996654 57899999999999999999999999862 11
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+....... .-..|.+ ..++.....+.+++.+|+..||++|++++|+++
T Consensus 474 PlrAlyLIa------~ng~P~l----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 474 PLRALYLIA------TNGTPKL----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred hHHHHHHHh------hcCCCCc----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 222221111 1111111 122334567889999999999999999999975
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=312.76 Aligned_cols=281 Identities=19% Similarity=0.223 Sum_probs=220.0
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.+|+|||+-||.++.-.+++.||+|++.-...+..+..++|++..++++|||++++++++....-......
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999999988999999999976666777889999999999999999999999766544456779
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+++.|+..|+|.+.++..... +..+++.++++|+.+|++||++||+.. |+++||||||.||++.+.+.+++.|||.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 9999999999999999976532 335899999999999999999999983 3699999999999999999999999999
Q ss_pred chhcccCCCCCccc-cccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 837 ARFLFARPFDTSME-TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
++...-........ .........-|..|+|||.+. +-.+...+.++|||||||++|+|+.|..||+...+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~---------vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN---------VKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchhee---------cccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 98753211111100 111122344688999999885 34567789999999999999999999999985544
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.+..+.-. +..+.+ ..+........+.+++++|++.||.+||++.+++..+.++
T Consensus 247 ~GgSlaLA-----------v~n~q~--------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 QGGSLALA-----------VQNAQI--------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cCCeEEEe-----------eecccc--------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 33222110 000010 0111111456788999999999999999999999988765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.46 Aligned_cols=199 Identities=29% Similarity=0.424 Sum_probs=178.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|+..+.||.|+||+|.+++.+.+|..+|+|+++.. ...+.++...|..+|+.+.||.++++++. +.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence 35788999999999999999999999999999999743 34556788899999999999999999988 55677
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
+.||||||++||.|..++++.+ .++...++.+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 9999999999999999999876 488889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
|+|+.+.. .....||||.|+|||++. ..+|..++|.|||||++|||+.|.+||.+.
T Consensus 189 GFAK~v~~-----------rT~TlCGTPeYLAPEii~------------sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 189 GFAKRVSG-----------RTWTLCGTPEYLAPEIIQ------------SKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred cceEEecC-----------cEEEecCCccccChHHhh------------cCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 99997632 245679999999996654 678999999999999999999999999843
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=355.14 Aligned_cols=269 Identities=23% Similarity=0.380 Sum_probs=204.0
Q ss_pred HhhcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSID 749 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 749 (997)
..++|++.++||+|+||.||+|.+ +.+++.||||+++.. .....+.+.+|+++++++ +||||++++++|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 456899999999999999999975 234568999998743 233456789999999999 89999999998743
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCC--------------------------------------------------
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQP-------------------------------------------------- 779 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 779 (997)
.....++||||+++|+|.+++.......
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 2346899999999999999998643110
Q ss_pred ------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCcccccc
Q 001908 780 ------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853 (997)
Q Consensus 780 ------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~ 853 (997)
....+++..+.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+....... ..
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------~~ 231 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------YV 231 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc------hh
Confidence 012477888999999999999999999 999999999999999999999999999986532111 11
Q ss_pred ccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhh
Q 001908 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKV 932 (997)
Q Consensus 854 ~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 932 (997)
......++..|+|||++. +..++.++|||||||++|||++ |..||...... ..+.....
T Consensus 232 ~~~~~~~~~~y~aPE~~~------------~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~~---- 291 (338)
T cd05102 232 RKGSARLPLKWMAPESIF------------DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEFCQRLK---- 291 (338)
T ss_pred cccCCCCCccccCcHHhh------------cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHh----
Confidence 112234678899996553 5678999999999999999997 99998743211 11111000
Q ss_pred hhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 933 METVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 933 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
....+ ..+..+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 292 -~~~~~------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 292 -DGTRM------------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred -cCCCC------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 01123355788999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.15 Aligned_cols=247 Identities=30% Similarity=0.483 Sum_probs=206.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|.+.+.||+|.||+||||+.+.+.+.||+|.+.+. .+.+.+.+.+|+++++.++||||+.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 4788899999999999999999999999999999744 34457789999999999999999999998 7778899
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++|+||+.| +|..++.... .+++..++.++.+++.|+.|||+. +|.|||+||+||+++.+|++|++|||+
T Consensus 77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 999999966 9999999876 478889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.+.. .........|||.|||||+. .+++|+..+|+||+|||+||+.+|++||...
T Consensus 147 Ar~m~~--------~t~vltsikGtPlYmAPElv------------~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--- 203 (808)
T KOG0597|consen 147 ARAMST--------NTSVLTSIKGTPLYMAPELV------------EEQPYDHTSDLWSLGCILYELYVGQPPFYAR--- 203 (808)
T ss_pred hhhccc--------CceeeeeccCcccccCHHHH------------cCCCccchhhHHHHHHHHHHHhcCCCCchHH---
Confidence 987622 23345567899999999655 4689999999999999999999999999732
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+.+.++....+. +.+ +......+..++...+..||..|.+..+++.
T Consensus 204 --si~~Lv~~I~~d~----v~~--------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 --SITQLVKSILKDP----VKP--------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --HHHHHHHHHhcCC----CCC--------------cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2333333332211 111 1123445678888999999999999998864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.07 Aligned_cols=265 Identities=25% Similarity=0.450 Sum_probs=221.4
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
++++-...+..+.++||-|.||.||.|.|+...-.||||.++.. ....++|.+|+.+|+.++|||+|+++|+|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~---- 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH---- 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc----
Confidence 44555566788899999999999999999988889999999743 4567899999999999999999999999864
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
+...|||+|||..|+|.+|+++.... .++....+.+|.||+.||+||..+ .+||||+.++|+|+.++..|||
T Consensus 335 -EpPFYIiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 335 -EPPFYIITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred -CCCeEEEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence 34789999999999999999987633 366778899999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPT 910 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 910 (997)
+|||+++.+..+.+ .......-+..|.|||.+. ...++.|+|||+|||+|||+.| |..||
T Consensus 407 ADFGLsRlMtgDTY-------TAHAGAKFPIKWTAPEsLA------------yNtFSiKSDVWAFGVLLWEIATYGMsPY 467 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTY-------TAHAGAKFPIKWTAPESLA------------YNTFSIKSDVWAFGVLLWEIATYGMSPY 467 (1157)
T ss_pred eccchhhhhcCCce-------ecccCccCcccccCccccc------------ccccccchhhHHHHHHHHHHHhcCCCCC
Confidence 99999998854332 2222233467899997665 4678999999999999999999 88887
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
... ++.+. ++..+.++++..++.|++.+++||.+||++.|.+||++.|+.+.++.+.+
T Consensus 468 PGi-----dlSqV-----------------Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 468 PGI-----DLSQV-----------------YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCc-----cHHHH-----------------HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 632 22222 12234566777889999999999999999999999999999999987543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=338.32 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=200.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
..++|+..++||+|+||.||.|+-+.+|..+|+|++++. ..++++..+.|-.+|...++|.||+++.. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 447899999999999999999999999999999999743 35567888999999999999999999976 7888
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+++|+||||.+|||+..+|...+ .++...+..++.+++.|++.+|.. ||+||||||+|+|||..|++||+|
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 99999999999999999999877 478888889999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCC-----------------CCcccc----------------------ccccccccccccccCCcchhccc
Q 001908 834 FGLARFLFARPF-----------------DTSMET----------------------QSSSIGIKGTVGYVPPGNIAKML 874 (997)
Q Consensus 834 Fg~a~~~~~~~~-----------------~~~~~~----------------------~~~~~~~~gt~~y~aPE~l~~~~ 874 (997)
||++.-+..... ...... .......+|||.|||||++
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl---- 360 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL---- 360 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH----
Confidence 999864421000 000000 0111235699999999655
Q ss_pred ccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHH
Q 001908 875 NLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVE 954 (997)
Q Consensus 875 ~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 954 (997)
.+..|+..+|+||+|||+|||+.|.+||...... ......+... ..+.... ..
T Consensus 361 --------l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr--~~l~fP~----------------~~ 413 (550)
T KOG0605|consen 361 --------LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWR--ETLKFPE----------------EV 413 (550)
T ss_pred --------hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh--hhccCCC----------------cC
Confidence 4678999999999999999999999999843211 1111111111 0010111 11
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCC---HHHHH
Q 001908 955 ECLVTVIRIGVACSMESPIERME---MRDVL 982 (997)
Q Consensus 955 ~~~~~l~~li~~cl~~dP~~Rps---~~evl 982 (997)
.+..+-.++|.+|+. ||+.|.. ++||.
T Consensus 414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred cccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 122455689999998 9999985 45543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.07 Aligned_cols=266 Identities=24% Similarity=0.287 Sum_probs=199.0
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------------hhhHHHHHHHHHHHhhcCCCCcceE
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------------KGALKSFVAECEVLRNTRHRNLIKI 741 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l 741 (997)
...++|++.+.||+|.||.|-+|+...+++.||||++.+.. -...+..++||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999999999999999996321 1123578999999999999999999
Q ss_pred EeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCe
Q 001908 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNV 821 (997)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NI 821 (997)
+.+..+ ...+.+|||+|||..|.+...-. ....++..++++++++++.||+|||.+ +|+||||||+|+
T Consensus 174 iEvLDD---P~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL 241 (576)
T KOG0585|consen 174 IEVLDD---PESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL 241 (576)
T ss_pred EEeecC---cccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence 998654 34678999999998877643211 112388999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHH
Q 001908 822 LLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901 (997)
Q Consensus 822 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ 901 (997)
|++++|+|||+|||.+......... ..........|||.|+|||....-. .....+.+.||||+||+||
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~---~~d~~L~~tvGTPAF~APE~c~~~~--------~~~~~g~a~DiWalGVTLY 310 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDE---GSDDQLSRTVGTPAFFAPELCSGGN--------SFSYSGFALDIWALGVTLY 310 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCcc---ccHHHHhhcCCCccccchHhhcCCC--------CccccchhhhhhhhhhhHH
Confidence 9999999999999999765322111 1122233378999999998765311 0122467889999999999
Q ss_pred HHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 902 EMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 902 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
.|+.|+.||.+.+ .-+..... +...+. .+...+.-..+.+||.+++.+||+.|.+..+|
T Consensus 311 CllfG~~PF~~~~-----~~~l~~KI--------vn~pL~--------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 311 CLLFGQLPFFDDF-----ELELFDKI--------VNDPLE--------FPENPEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred HhhhccCCcccch-----HHHHHHHH--------hcCccc--------CCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence 9999999997431 11111111 111110 01111234567799999999999999999998
Q ss_pred HHHH
Q 001908 982 LAKL 985 (997)
Q Consensus 982 l~~L 985 (997)
....
T Consensus 370 k~Hp 373 (576)
T KOG0585|consen 370 KLHP 373 (576)
T ss_pred eecc
Confidence 6543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.56 Aligned_cols=279 Identities=27% Similarity=0.382 Sum_probs=207.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhh--cCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN--TRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
....+..+.||+|+||.||||+. .++.||||++... ..+.|..|-++.+. ++|+||++++++-...+ ...-.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccc
Confidence 34556678999999999999999 5799999998643 44778888888776 58999999998733221 11346
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCcEecCCCCCCeeeCCCCcE
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC------QPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~------~~~ivHrDlk~~NIll~~~~~~ 829 (997)
.++|+||.+.|+|.+|++... .+|....+|+..+++||+|||+.. +|+|+|||||++||||.+|+++
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 899999999999999999876 899999999999999999999754 6799999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
.|+|||+|..+.+... . ......+||..|||||++.+..++.. ...=.+.||||+|.|+|||+++..-
T Consensus 356 cIaDFGLAl~~~p~~~-----~-~d~~~qVGT~RYMAPEvLEgainl~d------~~Afkr~DvYamgLVLWEi~SRC~~ 423 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKP-----Q-GDTHGQVGTRRYMAPEVLEGAINLQD------RDAFKRIDVYAMGLVLWEIASRCTD 423 (534)
T ss_pred EeeccceeEEecCCCC-----C-cchhhhhhhhhhcCHHHHhhhccccc------HHHHHHHHHHHHHHHHHHHHhhccc
Confidence 9999999998853221 1 12233789999999999987554321 2233468999999999999986432
Q ss_pred CC--------cCcC----CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 910 TN--------CMFQ----GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 910 ~~--------~~~~----~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++ ..++ ....++++-.... .+..+|.+...|.. ...+..+.+.+..||.+||+.|.|
T Consensus 424 ~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV----~kK~RP~~p~~W~~-------h~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 424 ADPGPVPEYQLPFEAEVGNHPTLEEMQELVV----RKKQRPKIPDAWRK-------HAGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred ccCCCCCcccCchhHHhcCCCCHHHHHHHHH----hhccCCCChhhhhc-------CccHHHHHHHHHHHcCCchhhhhh
Confidence 21 1111 1122232222111 12223333333322 134567889999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 001908 978 MRDVLAKLCAARQTL 992 (997)
Q Consensus 978 ~~evl~~L~~~~~~~ 992 (997)
+.=|.+++.++....
T Consensus 493 A~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 493 AGCVEERMAELMMLW 507 (534)
T ss_pred hHHHHHHHHHHhccC
Confidence 999999998876543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.04 Aligned_cols=278 Identities=23% Similarity=0.297 Sum_probs=210.8
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEec--ccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.+....|...+.||+|+||.|++|.++.+|+.||+|++. .......++..+|+++++.++|+||+.+.++........
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344556777899999999999999999999999999986 445556678899999999999999999999977644445
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
-..+|+|+|+| +.+|.+.++.+. .++..++..+.+|+++|++|+|+. +|+|||+||+|++++.+...||+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEec
Confidence 56799999999 669999999875 478889999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+..... ......+.++.|.+|+|||++.. ...|+.+.||||.|||+.||++|++-|.+
T Consensus 168 DFGLAR~~~~~------~~~~~mTeYVaTRWYRAPElll~-----------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 168 DFGLARYLDKF------FEDGFMTEYVATRWYRAPELLLN-----------SSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred cccceeecccc------CcccchhcceeeeeecCHHHHhc-----------cccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 99999976332 22334466789999999998754 46799999999999999999999998874
Q ss_pred CcCCCccHHHHHH--hhcc---hhhhhhcCcc-c---ccccccchhhh---hHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 913 MFQGGLTLHEFCK--MALP---EKVMETVDPS-L---LLAWSDGRRRA---KVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 913 ~~~~~~~~~~~~~--~~~~---~~~~~~~d~~-~---~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
.. .+++... ..++ +.....+... . ........+.+ ......+.-.+++.+|+..||.+|+|+.|
T Consensus 231 ~d----~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 231 KD----YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred Cc----hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 32 1222111 1111 1111111100 0 00000000011 11123345679999999999999999999
Q ss_pred HHH
Q 001908 981 VLA 983 (997)
Q Consensus 981 vl~ 983 (997)
+++
T Consensus 307 AL~ 309 (359)
T KOG0660|consen 307 ALA 309 (359)
T ss_pred Hhc
Confidence 975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=344.48 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=205.9
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
-|+.++.||.|+.|.|..|++..+|+.+|||++... .+.....+.+||.+|+-+.||||+++|++ |++..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCceE
Confidence 478889999999999999999999999999999754 22334567889999999999999999999 6778899
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+|.||+++|.|.+++..++ ++.+.+..++++||+.|+.|+|+. +|+|||+||+|+|+|..+.+||+|||+
T Consensus 88 ylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred EEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccce
Confidence 99999999999999999887 477889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
|..-. .+......||+++|.|||++ .|.+| +.++||||.|||+|.|+||+.||++
T Consensus 159 AsLe~---------~gklLeTSCGSPHYA~PEIV------------~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--- 214 (786)
T KOG0588|consen 159 ASLEV---------PGKLLETSCGSPHYAAPEIV------------SGRPYDGRPSDVWSCGVILFALLTGKLPFDD--- 214 (786)
T ss_pred eeccc---------CCccccccCCCcccCCchhh------------cCCCCCCCccccchhHHHHHHHHhCCCCCCC---
Confidence 97542 23344567999999999655 45666 5689999999999999999999983
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.++........... ..++.+.+.+..+|+.+|+..||++|.|++||.+.
T Consensus 215 --dNir~LLlKV~~G~------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 215 --DNIRVLLLKVQRGV------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --ccHHHHHHHHHcCc------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 23444332221111 11223445677799999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.99 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=202.0
Q ss_pred ccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 682 SSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
...+-||.|+.|.||+|+. .++.||||+++.-. ..+|+-|++++|+||+.|.|+|.... ..|||||
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiME 192 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIME 192 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc-----eeEEeee
Confidence 3457899999999999999 57889999875332 23678899999999999999997543 7899999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
||+.|-|++.++... ++.......|..+||.||.|||.+ .|||||+|+-||||+.+..|||+|||-++...
T Consensus 193 fCa~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred ccccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999876 477778889999999999999999 99999999999999999999999999998762
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 921 (997)
.......++||..|||||++. ..+++.|+||||||||||||+||..||.+....
T Consensus 264 ---------~~STkMSFaGTVaWMAPEvIr------------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----- 317 (904)
T KOG4721|consen 264 ---------DKSTKMSFAGTVAWMAPEVIR------------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----- 317 (904)
T ss_pred ---------hhhhhhhhhhhHhhhCHHHhh------------cCCcccccceehhHHHHHHHHhcCCCccccchh-----
Confidence 223456689999999997665 478899999999999999999999998732110
Q ss_pred HHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 922 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
. -++.+ -...-..+.+..|+.-+.-|+++||+-.|..||++++++..|.-..+++
T Consensus 318 A--------IIwGV--------GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 318 A--------IIWGV--------GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred e--------eEEec--------cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 0 00011 1111234567788999999999999999999999999999887554443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=337.35 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=202.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
..|+..+.||+|.||.||+|.+..+++.||+|++... .+.+.+++++|+.++.+++++||.++|+.+. ....++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----ecccHH
Confidence 4577779999999999999999999999999999843 4556788999999999999999999999854 345899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++||||.||++.+.++... .+++..+.-+.+++..|+.|||++ +.+|||||+.||++..+|.||++|||.|
T Consensus 88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 9999999999999998765 236667777899999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
..+.. .......++||+.|||||++. +..|+.|+||||||++.+||++|.+|+.....
T Consensus 159 ~ql~~--------~~~rr~tfvGTPfwMAPEVI~------------~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-- 216 (467)
T KOG0201|consen 159 GQLTN--------TVKRRKTFVGTPFWMAPEVIK------------QSGYDTKADIWSLGITAIELAKGEPPHSKLHP-- 216 (467)
T ss_pred eeeec--------hhhccccccccccccchhhhc------------cccccchhhhhhhhHHHHHHhcCCCCCcccCc--
Confidence 87632 222336689999999996664 57899999999999999999999999863311
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
-++...+.+. ........+.+.+.+++..|+..||+.||+|.++++
T Consensus 217 ------------mrvlflIpk~--------~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 217 ------------MRVLFLIPKS--------APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ------------ceEEEeccCC--------CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1111111111 011111245667899999999999999999999976
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.52 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=220.9
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCC----CcEEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGEN----GTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
+...+..+..+.||+|-||.||+|.+... .-.||||.-+. ......+.|..|+.+|++++||||++++|+|.+
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-- 462 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-- 462 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--
Confidence 33445566778999999999999998532 23588898875 445567899999999999999999999999875
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
...++|||.++-|.|..|++.+.. .++......++.||+.||+|||+. .+|||||.++|||+.+...|
T Consensus 463 ----~P~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 463 ----QPMWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred ----cceeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCccee
Confidence 358999999999999999998763 478888999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRR 908 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~ 908 (997)
|++|||+++.+....+..+ ....-+..|||||.+. -.+++.++|||-|||++||++. |..
T Consensus 531 KLaDFGLSR~~ed~~yYka-------S~~kLPIKWmaPESIN------------fRrFTtASDVWMFgVCmWEIl~lGvk 591 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKA-------SRGKLPIKWMAPESIN------------FRRFTTASDVWMFGVCMWEILSLGVK 591 (974)
T ss_pred eecccchhhhccccchhhc-------cccccceeecCccccc------------hhcccchhhHHHHHHHHHHHHHhcCC
Confidence 9999999998755444332 1233467899996554 5789999999999999999998 999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
||.+.. ........+.+.+.+.+..||+.++.++.+||.+||.+||++.|+...|.++
T Consensus 592 Pfqgvk----------------------NsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 592 PFQGVK----------------------NSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred cccccc----------------------ccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 987432 2334455677888899999999999999999999999999999999999999
Q ss_pred HHH
Q 001908 989 RQT 991 (997)
Q Consensus 989 ~~~ 991 (997)
.++
T Consensus 650 ~qe 652 (974)
T KOG4257|consen 650 LQE 652 (974)
T ss_pred HHH
Confidence 873
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.66 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=201.2
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc----ch-hhHHHHHHHHHHHhhcC-CCCcceEEeeeeccC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM----QK-GALKSFVAECEVLRNTR-HRNLIKIITVCSSID 749 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 749 (997)
.....|.+.+.||+|+||.|+.|....+++.||+|+++.. .. ...+.+.+|+.++++++ ||||++++.++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~---- 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF---- 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence 3456899999999999999999999999999999987643 11 23456678999999998 99999999994
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-Cc
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV 828 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~ 828 (997)
......++||||+.+|+|.+++...+ .+.+....++++|++.|++|+|++ +|+||||||+||+++.+ ++
T Consensus 90 -~t~~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 90 -ATPTKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred -ecCCeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 45567999999999999999999844 377789999999999999999999 99999999999999999 99
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-C-CccchhHHHHHHHHHHHhC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-A-SVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~-~~~~DvwSlGvvl~elltg 906 (997)
+||+|||++.... .........+||+.|+|||++.. .. | +.++||||+||++|.|++|
T Consensus 160 ~Kl~DFG~s~~~~--------~~~~~l~t~cGsp~Y~aPEvl~~------------~~~Y~g~~aDvWS~GViLy~ml~G 219 (370)
T KOG0583|consen 160 LKLSDFGLSAISP--------GEDGLLKTFCGSPAYAAPEVLSG------------KGTYSGKAADVWSLGVILYVLLCG 219 (370)
T ss_pred EEEeccccccccC--------CCCCcccCCCCCcccCCHHHhCC------------CCCcCCchhhhhhhHHHHHHHHhC
Confidence 9999999998652 12334556799999999977763 33 5 4789999999999999999
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHH-HHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEEC-LVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
+.||++. ............. . ..+... .++...++.+|+..||.+|+++.+++
T Consensus 220 ~~PF~d~-----~~~~l~~ki~~~~---~---------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 220 RLPFDDS-----NVPNLYRKIRKGE---F---------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCCCc-----cHHHHHHHHhcCC---c---------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9999852 2222211110000 0 001111 34567899999999999999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=348.41 Aligned_cols=269 Identities=26% Similarity=0.400 Sum_probs=212.4
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCc---E-EEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEe
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGT---F-VAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIIT 743 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~-vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 743 (997)
...++...++....++||+|+||+||+|+.+..+. . ||||..+. .......++.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34455555667777999999999999999974422 3 89999874 34667889999999999999999999999
Q ss_pred eeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
++.. ....|+|||+|+||+|.+++++..+ .++..++.+++.+.|+||+|||++ +++||||.++|+|+
T Consensus 229 Va~~-----~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~ 295 (474)
T KOG0194|consen 229 VAVL-----EEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLY 295 (474)
T ss_pred EEcC-----CCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHhee
Confidence 9654 4589999999999999999998763 388999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 824 DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 824 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+.++.+||+|||+++.-.. + ........-+..|+|||.+. .+.|+.++|||||||++||+
T Consensus 296 ~~~~~vKISDFGLs~~~~~--~------~~~~~~~klPirWLAPEtl~------------~~~~s~kTDV~sfGV~~~Ei 355 (474)
T KOG0194|consen 296 SKKGVVKISDFGLSRAGSQ--Y------VMKKFLKKLPIRWLAPETLN------------TGIFSFKTDVWSFGVLLWEI 355 (474)
T ss_pred cCCCeEEeCccccccCCcc--e------eeccccccCcceecChhhhc------------cCccccccchhheeeeEEee
Confidence 9999999999999875310 0 01111113467899997665 46899999999999999999
Q ss_pred Hh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 904 FT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 904 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
++ |..||...... .+...+ . ..+++.+.+...+..+..++.+||..+|++||+|.++.
T Consensus 356 f~~g~~Py~g~~~~--~v~~kI---~----------------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 356 FENGAEPYPGMKNY--EVKAKI---V----------------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred eccCCCCCCCCCHH--HHHHHH---H----------------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 99 88898744211 111111 0 11122222334577888999999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001908 983 AKLCAARQTLV 993 (997)
Q Consensus 983 ~~L~~~~~~~~ 993 (997)
+.++.+.+...
T Consensus 415 ~~l~~~~~~~~ 425 (474)
T KOG0194|consen 415 KKLEALEKKKE 425 (474)
T ss_pred HHHHHHHhccc
Confidence 99999877543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=307.90 Aligned_cols=262 Identities=27% Similarity=0.379 Sum_probs=211.1
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhc-CCCCcceEEee
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNT-RHRNLIKIITV 744 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 744 (997)
-....+.|...+.+|.|..++|.++..+.+|+.+|+|++.... ....+.-.+|+++|+++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3445567888999999999999999999999999999996321 11234558899999998 79999999999
Q ss_pred eeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
++.+.+.++|+|.|+.|.|.+++.+.. .+++...++|++|+.+|++|||.+ .|||||+||+|||++
T Consensus 92 -----yes~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILld 157 (411)
T KOG0599|consen 92 -----YESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLD 157 (411)
T ss_pred -----ccCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeec
Confidence 566778999999999999999998764 588999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
++.++||+|||+|+.+ ..+......||||+|.|||.+....+ -....|+..+|+||+|||||.++
T Consensus 158 dn~~i~isDFGFa~~l---------~~GekLrelCGTPgYLAPEtikC~m~------e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQL---------EPGEKLRELCGTPGYLAPETIKCSMY------ENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred cccceEEeccceeecc---------CCchhHHHhcCCCcccChhheeeecc------cCCCCccchhhHHHHHHHHHHHH
Confidence 9999999999999987 34456677899999999999986543 23567899999999999999999
Q ss_pred hCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 TRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.|.+||.... .--+.++ +++- .++ ...++-.+....+.++|.+|+..||.+|.|++|+++
T Consensus 223 aGcpPFwHRk-----QmlMLR~-----ImeG-------kyq--F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 223 AGCPPFWHRK-----QMLMLRM-----IMEG-------KYQ--FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cCCCchhHHH-----HHHHHHH-----HHhc-------ccc--cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 9999987320 0000011 1110 000 011223344567889999999999999999999976
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=372.66 Aligned_cols=473 Identities=26% Similarity=0.337 Sum_probs=320.7
Q ss_pred ccccccCccccccccccccccCCCCCc-cCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccc
Q 001908 90 LSPYVGNLSFLRYINLATNNFHGEIPK-EIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGY 168 (997)
Q Consensus 90 ~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~ 168 (997)
||..+..-..|+.|+++.|.+- ..|- .+...-+|+.||||+|.++ ..|..|..+..|+.|.+++|.+. .+|.+..
T Consensus 13 ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~- 88 (1081)
T KOG0618|consen 13 IPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCS- 88 (1081)
T ss_pred cchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhh-
Confidence 4444444444555555555444 2221 1222333555555555554 55555555555555555555443 4443333
Q ss_pred cccccceeecccccccCcCcCccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccE
Q 001908 169 SWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQV 247 (997)
Q Consensus 169 ~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~ 247 (997)
.+.+|++|.|.+|.+. .+|.++..+. +.+|+++.|+|. .+|..+..++.++.+..++|.-...++. ..++.
T Consensus 89 ~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~------~~ik~ 160 (1081)
T KOG0618|consen 89 NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ------TSIKK 160 (1081)
T ss_pred hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc------ccchh
Confidence 3445556666666655 5566666663 445666666665 6777777777777777777722212221 12677
Q ss_pred EEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEE
Q 001908 248 FAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLA 327 (997)
Q Consensus 248 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 327 (997)
+++..|.+.+.++..+.+++. .|||++|.+. ......+.+|+.|....|+++.+.. ..++|+.|+
T Consensus 161 ~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~----------~g~~l~~L~ 225 (1081)
T KOG0618|consen 161 LDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI----------SGPSLTALY 225 (1081)
T ss_pred hhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe----------cCcchheee
Confidence 778888888888877777776 7888888876 2345677788888888888876432 356788888
Q ss_pred eecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccccccc
Q 001908 328 FEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQ 407 (997)
Q Consensus 328 L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 407 (997)
.++|.++...+... +.+|+++++++|+++ .+|++++.+.+|+.++..+|+|+ .+|..+..+++|+.|....|.++
T Consensus 226 a~~n~l~~~~~~p~---p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~ 300 (1081)
T KOG0618|consen 226 ADHNPLTTLDVHPV---PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE 300 (1081)
T ss_pred eccCcceeeccccc---cccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh
Confidence 88888884433322 256888888888888 45688888889999999999886 77888888888889999999888
Q ss_pred ccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCC-CcEEecCCCcccCCcccccccccccccccccCCCcccCCCccc
Q 001908 408 GNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKN-LVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLE 486 (997)
Q Consensus 408 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~ 486 (997)
.+|.....++.|++|+|..|+|....+..|.-+.. |..|+.+.|++. ..|..-......++.|++.+|.++...-..
T Consensus 301 -yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 301 -YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred -hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhh
Confidence 67777888888899999999888433333333333 677777888776 455333333333377888888888777667
Q ss_pred cccccccceeccccccccccccc-cccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCC
Q 001908 487 VGNLKNLVALYISGNQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFL 565 (997)
Q Consensus 487 ~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 565 (997)
+.+.++|+.|+|++|+|. .+|. .+.++..|++|+||+|+++ .+|.++.+++.|++|...+|+|. ..| .+..++.|
T Consensus 379 l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL 454 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQL 454 (1081)
T ss_pred hccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcc
Confidence 778888888888888887 5554 5677888888888888888 77888888888888888888887 566 77788888
Q ss_pred CEEeCCCCcCcc-cCCCCCcCCCCcceeecCCCCcC
Q 001908 566 EYLNLSYNHFDG-EVPTKGVFSNKTRVQLTGNGKLC 600 (997)
Q Consensus 566 ~~L~ls~N~l~~-~~p~~~~~~~~~~~~~~~N~~~C 600 (997)
+.+|||.|+|+- .+|.....++++.++++||+|+=
T Consensus 455 ~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 455 KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred eEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 888888888874 33443333678888888888743
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.76 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=207.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
-+|++.+.||+|.||.|-+|.....|+.||||.++. .+++..-.+++||++|..++||||+.++.+ |++.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence 468888999999999999999988999999999864 344556678999999999999999999999 788889
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
..+||||..+|.|++|+.+.+ .+++.+.+++++||+.|+.|+|.+ +++|||+|.+|||+|.++++||+|||
T Consensus 128 IvivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence 999999999999999999877 588899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
++..+ ........+||++-|.+||++. |.+| ++.+|-||+||++|.++.|..||+..
T Consensus 199 LSNly---------~~~kfLqTFCGSPLYASPEIvN------------G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~- 256 (668)
T KOG0611|consen 199 LSNLY---------ADKKFLQTFCGSPLYASPEIVN------------GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR- 256 (668)
T ss_pred hhhhh---------ccccHHHHhcCCcccCCccccC------------CCCCCCCccchhhHHHHHHHHhhcccccCCc-
Confidence 99765 2334566789999999997665 4455 57899999999999999999999843
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
+...++++.......+...|. .-.-+|.+|+..+|++|.|+.||...
T Consensus 257 ----Dhk~lvrQIs~GaYrEP~~PS-------------------dA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 257 ----DHKRLVRQISRGAYREPETPS-------------------DASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ----hHHHHHHHhhcccccCCCCCc-------------------hHHHHHHHHHhcCcccchhHHHHhhh
Confidence 334444444333333333222 23468999999999999999998653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=329.42 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=199.0
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchh---hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG---ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
...||+|+++.||+|.+ +|+.||||+++..... ..+.+.+|++++++++||||+++++++... .......++||
T Consensus 25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~ 101 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL 101 (283)
T ss_pred CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence 36799999999999999 7899999999744322 256788999999999999999999987541 12345789999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.+.. .+++....+++.|++.|+.|||+.. +++||||||+||++++++++||+|||+++..
T Consensus 102 Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 102 EYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred EeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 9999999999998754 4788899999999999999999742 7889999999999999999999999999865
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
... .....|+..|+|||.+... ...++.++|||||||++|||++|+.||.... .
T Consensus 174 ~~~-----------~~~~~~~~~y~aPE~~~~~----------~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~ 227 (283)
T PHA02988 174 SSP-----------PFKNVNFMVYFSYKMLNDI----------FSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----T 227 (283)
T ss_pred ccc-----------cccccCcccccCHHHhhhc----------cccccchhhhhHHHHHHHHHHHCCCCCCCCC-----H
Confidence 221 1124578999999876521 2568899999999999999999999997431 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
.+......... ..+ ..+..++..+.+++.+||+.||++|||++|+++.|+...+
T Consensus 228 ~~~~~~i~~~~----~~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 228 KEIYDLIINKN----NSL------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHHhcC----CCC------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 12111110000 000 1112346678899999999999999999999999987653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=324.60 Aligned_cols=270 Identities=24% Similarity=0.329 Sum_probs=200.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.|...+.+|.|+||.||+|+..++++.||||+.-.... .--+|+++|+.++|||||++..++....-.++-...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 56678999999999999999999999999998754332 22469999999999999999988765432223456799
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-CcEEEcccccch
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAR 838 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFg~a~ 838 (997)
||||+. +|.++++..... ...++...++-++.|+.+|++|||+. +|+||||||+|+|+|.+ |.+||||||.|+
T Consensus 101 leymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 999977 999999964211 11366778888999999999999998 99999999999999976 899999999999
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.+. .......+.-|..|+|||.+-+ ...|+.+.||||.|||+.||+-|++-|.+... ..
T Consensus 175 ~L~---------~~epniSYicSRyYRaPELifg-----------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~d 233 (364)
T KOG0658|consen 175 VLV---------KGEPNISYICSRYYRAPELIFG-----------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VD 233 (364)
T ss_pred eec---------cCCCceeEEEeccccCHHHHcC-----------ccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HH
Confidence 872 2333455678999999987754 34689999999999999999999998875321 12
Q ss_pred cHHHHHHhh-cc-hhhhhhcC--------cccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMA-LP-EKVMETVD--------PSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~-~~-~~~~~~~d--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+++.++.. .| ++...... |.+....- ..-.....+++..+++.+++.++|.+|.++.|+++
T Consensus 234 QL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~---~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 234 QLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPW---HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHHHHhCCCCHHHHhhcCcccccccCcccccccc---eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 233333332 11 11111111 22211100 00122344567889999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.50 Aligned_cols=273 Identities=22% Similarity=0.299 Sum_probs=202.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|+..++|++|+||.||+|+++.+++.||+|+++... .+-.-...+||.+|.+++|||||.+-.+.... .-+..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---cccee
Confidence 57888999999999999999999999999999997433 23334568999999999999999999887643 34569
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+|||||+- ||...+.... .++...++.-++.|+++|++|||.. .|+|||+||+|+|+++.|.+||+|||+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred eeeHHHHHh-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccch
Confidence 999999955 9999998875 2588899999999999999999999 899999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.+..+. ...+..+-|.+|+|||.+-. ...|+++.||||+|||+.||+++++-|....+-
T Consensus 224 AR~ygsp~--------k~~T~lVVTLWYRaPELLLG-----------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 224 AREYGSPL--------KPYTPLVVTLWYRAPELLLG-----------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred hhhhcCCc--------ccCcceEEEeeecCHHHhcC-----------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 99874431 22344678999999987754 356899999999999999999999987644321
Q ss_pred CccHHHHHHh-hcc-hhhhh-hcCcccc--cccccch----hhhhHHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKM-ALP-EKVME-TVDPSLL--LAWSDGR----RRAKVEE-CLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~-~~~-~~~~~-~~d~~~~--~~~~~~~----~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
++ +...... ..| +..+. ....... ..+.... +..+... ....=++++..++.+||++|.|+.|.++
T Consensus 285 dQ-l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 285 DQ-LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HH-HHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11 1111111 111 11111 1111100 0000000 0000000 2245578999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.21 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=200.3
Q ss_pred hhcCccCCcccccCcceEEEEEEC---CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||.||+|.++ ..+..||+|+++.. .....+.+.+|++++++++||||+++++++. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 357889999999999999999874 34678999998754 2344567899999999999999999999854 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++..... .+++.+++.++.|++.|++|||++ +++||||||+||+++.++++|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 689999999999999999986431 478999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||.+....... ........++..|+|||.+. +..++.++|||||||++||+++ |..||..
T Consensus 151 fg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 151 FRRLQEDKSEA-------IYTTMSGKSPVLWAAPEAIQ------------YHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred Ccccccccccc-------hhcccCCCCceeecCHHHHh------------hCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 99876431110 01111234567899996553 5678899999999999999775 9999874
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
... .+...... + +...+.+..++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 212 ~~~-----~~~~~~~~-----~------------~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 212 MSG-----QDVIKAVE-----D------------GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCH-----HHHHHHHH-----C------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 321 11111110 0 000111234567788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=341.96 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=200.1
Q ss_pred hhcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
.++|++.++||+|+||+||+|++ ..++..||||+++.. .....+.+.+|+++++.+ +||||++++++|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 45789999999999999999975 345678999999743 233456788999999999 8999999999964
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCC----------------------------------------------------
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQ---------------------------------------------------- 778 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 778 (997)
..+..++||||+++|+|.++++.....
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 455789999999999999999764310
Q ss_pred -----------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 779 -----------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 779 -----------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
.+...+++..+++++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0112478889999999999999999999 99999999999999999999999999997652
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTL 920 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 920 (997)
.... ........++..|+|||.+ .+..++.++|||||||++|||++ |..||....... ..
T Consensus 266 ~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~ 326 (375)
T cd05104 266 NDSN------YVVKGNARLPVKWMAPESI------------FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF 326 (375)
T ss_pred Cccc------ccccCCCCCCcceeChhHh------------cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH
Confidence 2110 0111223456789999655 35678999999999999999998 888886432211 11
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.+..... ..+ ..+...+.++.+++.+||..||++||++.|+++.|++.
T Consensus 327 ~~~~~~~--------~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 327 YKMIKEG--------YRM------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHhC--------ccC------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111100 000 00112245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=332.08 Aligned_cols=268 Identities=24% Similarity=0.363 Sum_probs=198.1
Q ss_pred hhcCccCCcccccCcceEEEEEECC----------------CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGE----------------NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIK 740 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 740 (997)
.++|++.++||+|+||.||+|.++. ++..||+|++... .......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999998642 3447999998753 2334567899999999999999999
Q ss_pred EEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCC-------------CcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 001908 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP-------------EVCDLSLIQRLNIAIDMASAIEYLHHHC 807 (997)
Q Consensus 741 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~~~~~i~~~i~~~L~yLH~~~ 807 (997)
+++++.. .+..++||||+++|+|.+++....... ....+++..+++++.||+.|++|||+.
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 9999643 457899999999999999997643111 112467888999999999999999999
Q ss_pred CCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC
Q 001908 808 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA 887 (997)
Q Consensus 808 ~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~ 887 (997)
+|+||||||+||+++.++.+||+|||+++....... ........++..|+|||.+. ++.+
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~ 217 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY------YRIQGRAVLPIRWMAWECIL------------MGKF 217 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCce------eEecCcCCCCccccCHHHHh------------cCCC
Confidence 999999999999999999999999999976522111 11122334578899996553 4678
Q ss_pred CccchhHHHHHHHHHHHh--CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHh
Q 001908 888 SVTGDVYSLGVMLLEMFT--RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGV 965 (997)
Q Consensus 888 ~~~~DvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~ 965 (997)
+.++|||||||++|||++ +..||..... ....+............. . ...+..++..+.+++.
T Consensus 218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~~~li~ 282 (304)
T cd05096 218 TTASDVWAFGVTLWEILMLCKEQPYGELTD--EQVIENAGEFFRDQGRQV-Y------------LFRPPPCPQGLYELML 282 (304)
T ss_pred CchhhhHHHHHHHHHHHHccCCCCCCcCCH--HHHHHHHHHHhhhccccc-c------------ccCCCCCCHHHHHHHH
Confidence 999999999999999987 5567653321 111111111100000000 0 0011234567899999
Q ss_pred hcCCCCCCCCCCHHHHHHHHH
Q 001908 966 ACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 966 ~cl~~dP~~Rps~~evl~~L~ 986 (997)
+||..||++|||+.||.+.|+
T Consensus 283 ~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 283 QCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHccCCchhCcCHHHHHHHHh
Confidence 999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=327.57 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=195.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.|+..+.||+|+||+||+|....+++.||+|++.... ......+.+|++++++++|++|+++++++ ...+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3677899999999999999999899999999986332 22334678899999999999999999884 445689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999988865432 1478899999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+..... ........||..|+|||.+ .+..++.++||||+||++|||++|+.||......
T Consensus 149 ~~~~~~---------~~~~~~~~g~~~y~aPE~~------------~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 149 AVQIPE---------GETVRGRVGTVGYMAPEVI------------NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred cEEcCC---------CCeecCCCCCCCccCHhhh------------cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 976421 1112234689999999655 4567899999999999999999999999753221
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
. ....... .... .. ...+......+.+++.+||+.||++||+ ++++++
T Consensus 208 ~-~~~~~~~-~~~~-------~~----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 208 V-KREEVDR-RVKE-------DQ----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred h-hHHHHHH-Hhhc-------cc----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1 1111110 0000 00 0001122456789999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=338.34 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=193.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.+|+..++||+|+||+||+|++..+++.||||++... .....+.+.+|+++++.++|+||+++++++ ...+..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 4567788999999999999999989999999998643 233456789999999999999999999984 4456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+.. ..+...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999986532 245667889999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... ........||..|+|||.+.. +...+...+.++|||||||++|||++|+.||.....
T Consensus 216 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-- 278 (353)
T PLN00034 216 RILAQT--------MDPCNSSVGTIAYMSPERINT-------DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-- 278 (353)
T ss_pred eecccc--------cccccccccCccccCcccccc-------ccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 765211 111223568999999997753 111233456789999999999999999999973211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
............. ..+. .+..+..++.+++.+||+.||++||++.|+++.
T Consensus 279 ~~~~~~~~~~~~~-----~~~~------------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 279 GDWASLMCAICMS-----QPPE------------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccHHHHHHHHhcc-----CCCC------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111110000 0000 011234568899999999999999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=331.53 Aligned_cols=273 Identities=22% Similarity=0.338 Sum_probs=196.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.++||+|+||+||+|+.+.+++.||+|+++... ......+.+|++++++++||||+++++++ ...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 367999999999999999999999899999999987432 22334678899999999999999999984 445689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++ ++|.+++....+ .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999995 688888876432 377888999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
++..... ........||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 150 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 150 ARAKSVP--------SHTYSNEVVTLWYRPPDVLLG-----------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred ceeccCC--------CccCCCCcccCCCCChHHHcC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 8753111 111223468999999976642 245788999999999999999999999753221
Q ss_pred CccHHHHHHhh-cchh--hhh-----hcCcccccccccchh--hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMA-LPEK--VME-----TVDPSLLLAWSDGRR--RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~-~~~~--~~~-----~~d~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+....... .+.. +.. ..++........... ..........+.+++.+|++.||++|||+.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 211 QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 11111111100 0000 000 000100000000000 0000012345779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=329.17 Aligned_cols=271 Identities=21% Similarity=0.312 Sum_probs=196.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.++||+|+||+||+|+.+.+++.||+|+++... ......+.+|++++++++||||+++++++ ...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 46899999999999999999999899999999987432 22345678999999999999999999984 4456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||++ |+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence 9999996 599999876531 367889999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... ........+++.|+|||.+.. ...++.++||||+||++|||+||++||......
T Consensus 151 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~- 210 (288)
T cd07871 151 RAKSVP--------TKTYSNEVVTLWYRPPDVLLG-----------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVK- 210 (288)
T ss_pred eeccCC--------CccccCceecccccChHHhcC-----------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 754211 111223467899999976532 245788999999999999999999998643211
Q ss_pred ccHHHHHHhh---cchhhhhhcCcc-ccc----ccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA---LPEKVMETVDPS-LLL----AWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~---~~~~~~~~~d~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+....... ....+....+.. ... .+..............+..+++.+|+..||++|||++|+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111110 011111111100 000 00000000000112345679999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.08 Aligned_cols=361 Identities=25% Similarity=0.387 Sum_probs=211.5
Q ss_pred cEEEEeccCCCCC-CcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhc
Q 001908 75 RVTELDLRHQNIG-GSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVA 153 (997)
Q Consensus 75 ~v~~L~L~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l 153 (997)
-|...|+++|.++ +.+|..+..++.+++|-|..-++. .+|++++.|.+|++|.+++|++. ++-..++.|+.|+++++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 4778899999998 468999999999999999999988 89999999999999999999998 77888888888888888
Q ss_pred cccccc-ccccccccccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCC
Q 001908 154 YRNNLV-GEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG 232 (997)
Q Consensus 154 ~~n~~~-g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g 232 (997)
.+|++. ..||.++| .+..|+.||||+|++. ..|..+.+-+++-.|+||+|+|.
T Consensus 86 R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~------------------------EvP~~LE~AKn~iVLNLS~N~Ie- 139 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR------------------------EVPTNLEYAKNSIVLNLSYNNIE- 139 (1255)
T ss_pred hccccccCCCCchhc-ccccceeeecchhhhh------------------------hcchhhhhhcCcEEEEcccCccc-
Confidence 877774 34666665 3556666666666665 45666666666666666666665
Q ss_pred CCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcc
Q 001908 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD 312 (997)
Q Consensus 233 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 312 (997)
.||..+|.+|+.|-+||||+|++. .+|.....+..|++|+|++|. +...
T Consensus 140 tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP------------------------L~hf------ 188 (1255)
T KOG0444|consen 140 TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP------------------------LNHF------ 188 (1255)
T ss_pred cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh------------------------hhHH------
Confidence 666666666666666666666665 444444445555555555444 4321
Q ss_pred hhhhhccCCCCcEEEeecCccC-CCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcc
Q 001908 313 FVTILTNCSKLKVLAFEENRLG-GVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIG 391 (997)
Q Consensus 313 ~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 391 (997)
-...+..+++|++|.+++.+-+ ..+|.++..+ .+|.+++++.|.+. ..|+.+.++++|+.|+||+|+|+ .+.-..+
T Consensus 189 QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l-~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 189 QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDL-HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred HHhcCccchhhhhhhcccccchhhcCCCchhhh-hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 1223445566666766665443 2234443333 33444444444444 44444444455555555555544 2222333
Q ss_pred cccccceeccccccccccchhhhcCCCCCCeEEeecCcCCC-CCCCCCCCCCCCcEEecCCCcccCCccccccccccccc
Q 001908 392 QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG-NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSR 470 (997)
Q Consensus 392 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~ 470 (997)
...+|++|+||.|+++ .+|.+++.|++|+.|++.+|+++- -+|..++.+.+|+++..++|++. .+|..++.+..| +
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL-~ 342 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKL-Q 342 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHH-H
Confidence 3344445555555554 444455555555555555554431 14444444444444444444443 444444444444 4
Q ss_pred ccccCCCcccCCCccccccccccceeccccc
Q 001908 471 FLDLGNNHLNGSLPLEVGNLKNLVALYISGN 501 (997)
Q Consensus 471 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 501 (997)
.|.|+.|++- .+|+.+.-|+.|+.||+..|
T Consensus 343 kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 343 KLKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred Hhccccccee-echhhhhhcCCcceeeccCC
Confidence 4444444443 34444444444444444444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.53 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=192.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.||+|+||.||+|+.+.+++.||+|+++.. .......+.+|++++++++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 4689999999999999999999999999743 233446778899999999999999999884 44668999999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999998654 478889999999999999999999 99999999999999999999999999987531
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 921 (997)
. .........||+.|+|||++. +..++.++||||+||++|||++|+.||.... ..
T Consensus 147 ~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~ 201 (323)
T cd05571 147 S--------DGATMKTFCGTPEYLAPEVLE------------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HE 201 (323)
T ss_pred c--------CCCcccceecCccccChhhhc------------CCCCCccccCcccchhhhhhhcCCCCCCCCC-----HH
Confidence 1 111223457999999996653 5678899999999999999999999986321 11
Q ss_pred HHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 922 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
......... +... +.....++.+++.+||+.||++|| ++.++++
T Consensus 202 ~~~~~~~~~------~~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 202 KLFELILME------EIRF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHcC------CCCC------------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111111100 0000 112245677999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.47 Aligned_cols=200 Identities=25% Similarity=0.397 Sum_probs=172.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||.||++++..++..||+|++... .....+.+.+|++++++++||||+++++++. ..+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 36899999999999999999999999999999998754 3334567899999999999999999999854 35589
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++.... .+++..+..++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 99999999999999998654 3788899999999999999999863 699999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
+..... .......||+.|+|||.+. +..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~----------~~~~~~~g~~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 151 SGQLID----------SMANSFVGTRSYMSPERLQ------------GTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccccc----------cccccCCCCcCcCCHhHhc------------CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 875421 1122346899999996553 56788999999999999999999999963
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=312.26 Aligned_cols=278 Identities=23% Similarity=0.360 Sum_probs=205.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCC-cceEEeeeeccC-cCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRN-LIKIITVCSSID-FKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~~~ 753 (997)
...|...++||+|+||+||+|+.+.+|+.||+|+++... ++......+|+.+++.++|+| |+++++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777788999999999999999999999999997543 345567899999999999999 999999975432 2233
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||++. +|.+++....... ...+...++.+++|+++|++|||++ +|+||||||+||+|+++|.+||+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 478999999955 9999998865221 2356678999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+....+ ........+|..|+|||++-. ...|+...||||+|||++||+++++-|.+.
T Consensus 164 FGlAra~~ip--------~~~yt~evvTlWYRaPEvLlG-----------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~ 224 (323)
T KOG0594|consen 164 FGLARAFSIP--------MRTYTPEVVTLWYRAPEVLLG-----------STSYSTSVDIWSLGCIFAEMFTRRPLFPGD 224 (323)
T ss_pred cchHHHhcCC--------cccccccEEEeeccCHHHhcC-----------CCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence 9999865211 122345678999999977653 235899999999999999999999888755
Q ss_pred cCCCccHHHHHHh----hcc--hhhhhhc-Ccccccccccch-hhhhHHHHH---HHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 914 FQGGLTLHEFCKM----ALP--EKVMETV-DPSLLLAWSDGR-RRAKVEECL---VTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 914 ~~~~~~~~~~~~~----~~~--~~~~~~~-d~~~~~~~~~~~-~~~~~~~~~---~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
.+ +.+.... ..| +.+.... -+..+..+.... ........+ ....+++.+|+..+|++|.|++.++
T Consensus 225 se----~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 225 SE----IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred cH----HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 43 2222111 111 1121111 111111111111 111111111 3678999999999999999999998
Q ss_pred HH
Q 001908 983 AK 984 (997)
Q Consensus 983 ~~ 984 (997)
..
T Consensus 301 ~h 302 (323)
T KOG0594|consen 301 TH 302 (323)
T ss_pred cC
Confidence 75
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.70 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=195.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|..+.+++.||+|++.... ....+.+.+|++++++++||||++++++ +.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence 36889999999999999999999899999999986422 2344678899999999999999999987 445678
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 999999999999999998754 478888999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 147 ~~~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~- 202 (291)
T cd05612 147 FAKKLRD-----------RTWTLCGTPEYLAPEVIQ------------SKGHNKAVDWWALGILIYEMLVGYPPFFDDN- 202 (291)
T ss_pred cchhccC-----------CcccccCChhhcCHHHHc------------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 9976521 112346899999997654 4567899999999999999999999987421
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 984 (997)
..+......... .. .+......+.+++.+||+.||++||+ ++|+++.
T Consensus 203 ----~~~~~~~i~~~~------~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 203 ----PFGIYEKILAGK------LE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----HHHHHHHHHhCC------cC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111111000 00 01112345779999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=341.64 Aligned_cols=266 Identities=22% Similarity=0.358 Sum_probs=200.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECC-----CCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSID 749 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 749 (997)
..++|++.+.||+|+||.||+|++.. ++..||+|+++.. .......+.+|+++++.+ +|+||++++++|.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--- 112 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--- 112 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence 34589999999999999999998643 3357999999743 333456788999999999 8999999999854
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCC---------------------------------------------------
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQ--------------------------------------------------- 778 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 778 (997)
..+..++||||+++|+|.++++.....
T Consensus 113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 345899999999999999998653210
Q ss_pred -------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCC
Q 001908 779 -------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF 845 (997)
Q Consensus 779 -------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~ 845 (997)
.....+++.++++++.||+.|++|||++ +|+||||||+||++++++++||+|||+++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~- 266 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS- 266 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc-
Confidence 0112478888999999999999999999 99999999999999999999999999997652211
Q ss_pred CCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHH
Q 001908 846 DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFC 924 (997)
Q Consensus 846 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 924 (997)
.........++..|+|||++ .+..++.++|||||||++|||++ |+.||....... ......
T Consensus 267 -----~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~ 328 (374)
T cd05106 267 -----NYVVKGNARLPVKWMAPESI------------FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMV 328 (374)
T ss_pred -----ceeeccCCCCccceeCHHHh------------cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHH
Confidence 00111223356789999655 35678999999999999999997 999987432211 111110
Q ss_pred HhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 925 KMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 925 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
.. ...+.. +...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 329 ~~--------~~~~~~------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 329 KR--------GYQMSR------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred Hc--------ccCccC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00 000000 0112457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=343.05 Aligned_cols=367 Identities=27% Similarity=0.433 Sum_probs=272.1
Q ss_pred cCccccccccccccccC-CCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhccccccccccccccccccccc
Q 001908 95 GNLSFLRYINLATNNFH-GEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKL 173 (997)
Q Consensus 95 ~~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L 173 (997)
+-|+..+-.|+|+|.|+ +..|.....+++++.|.|....+. .+|+.++.|.+|.
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLE------------------------ 58 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLE------------------------ 58 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhh------------------------
Confidence 45677788999999999 568999999999999999999997 8888888877665
Q ss_pred ceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCC-CCCCccccccCCCccEEEecC
Q 001908 174 EHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFT-GNLPLDIGVTLPNLQVFAIGD 252 (997)
Q Consensus 174 ~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~-g~lp~~~~~~l~~L~~L~L~~ 252 (997)
+|.+++|++. .+-. .+..++.|+.+++..|++. ..||.++| ++..|++||||+
T Consensus 59 -HLs~~HN~L~-~vhG-----------------------ELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLSh 112 (1255)
T KOG0444|consen 59 -HLSMAHNQLI-SVHG-----------------------ELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSH 112 (1255)
T ss_pred -hhhhhhhhhH-hhhh-----------------------hhccchhhHHHhhhccccccCCCCchhc-ccccceeeecch
Confidence 5555555554 1111 2223334444444444443 24666666 566666777777
Q ss_pred CcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCc
Q 001908 253 NYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENR 332 (997)
Q Consensus 253 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 332 (997)
|++. ..|..+.+.+++-+|+||+|+|..++...|-+|+.|-+||||+|++..+ |+.+..+..|+.|+|++|.
T Consensus 113 NqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-------PPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 113 NQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-------PPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred hhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc-------CHHHHHHhhhhhhhcCCCh
Confidence 7776 6788888888888888888888888888888899999999999998864 4567788888888888887
Q ss_pred cCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCC-CCCCCCcccccccceeccccccccccch
Q 001908 333 LGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLT-GNIPREIGQLRNLQAIGLSSNFLQGNIP 411 (997)
Q Consensus 333 l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 411 (997)
+... . | ..+..+++|++|.+++.+=+ ..+|.++..|.+|..+|||.|.+. .+|
T Consensus 185 L~hf------Q----L---------------rQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 185 LNHF------Q----L---------------RQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hhHH------H----H---------------hcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 6521 0 1 12234667777777776554 457888888888888888888888 788
Q ss_pred hhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccC-CCccccccc
Q 001908 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG-SLPLEVGNL 490 (997)
Q Consensus 412 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~-~~p~~~~~l 490 (997)
+++.++++|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|+.++.++.| +.|.+.+|+++- -+|..++.|
T Consensus 239 ecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL-~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL-TKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred HHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHH-HHHHhccCcccccCCccchhhh
Confidence 88888888888888888888 56666666778888888888887 777777777777 677777777652 367777777
Q ss_pred cccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccc
Q 001908 491 KNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551 (997)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 551 (997)
.+|+.+..++|++. .+|+.++.|.+|+.|.|++|++. ++|.++.-|+.|+.|||..|.=
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 77777777777776 77777777777777777777776 6777777777777777777743
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=328.14 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=208.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce-
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF- 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~- 755 (997)
++|...+++|+|+||.++.++++..++.||+|.+.. ..+..++....|+.++++++|||||.+.+. |..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCce
Confidence 468889999999999999999999999999999973 334455688999999999999999999998 444555
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+|||+||+||++.+.+.++.+ ..+++.++.+|+.|++.|+.|||++ +|+|||||+.|||++.++.|||+|||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence 9999999999999999998773 3588999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+...+.. .......||+.||.||.++ +.+|..|+||||+||++|||++-+++|...
T Consensus 152 laK~l~~~~--------~~a~tvvGTp~YmcPEil~------------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-- 209 (426)
T KOG0589|consen 152 LAKILNPED--------SLASTVVGTPYYMCPEILS------------DIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-- 209 (426)
T ss_pred hhhhcCCch--------hhhheecCCCcccCHHHhC------------CCCCCccCcchhhcchHHHHHhcccccCcc--
Confidence 999873321 2344578999999996654 678999999999999999999999998743
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
++...+....+.. .. +.+..+..++..++..|+..+|..||++.+++.+
T Consensus 210 ---~m~~Li~ki~~~~----~~-------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 210 ---NMSELILKINRGL----YS-------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---chHHHHHHHhhcc----CC-------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2333222221111 11 1223345678899999999999999999999987
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=333.05 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=200.0
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (997)
.-++|...++||+|.||.|++|..+.+++.||||++++. ...+++..+.|..++... +||.++.++.. |+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 446899999999999999999999999999999999853 345667788899988877 59999999987 888
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
++++|+||||+.||++..+.+... +++..+.-+|..|+.||.|||++ +|||||||-+|||+|.+|.+||+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~-------F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDV-------FSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEeccc-------ccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 999999999999999655555443 89999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+++.. +..+.....++||+.|||||++. +..|+.++|+|||||+||||+.|..||..
T Consensus 511 DFGlcKe~--------m~~g~~TsTfCGTpey~aPEil~------------e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 511 DFGLCKEG--------MGQGDRTSTFCGTPEFLAPEVLT------------EQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred cccccccc--------CCCCCccccccCChhhcChhhhc------------cCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999864 22334556789999999996665 68899999999999999999999999984
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
.. -++.-.....+ ++. .|..+..+...|+.+++..+|++|..+
T Consensus 571 dd-----Eee~FdsI~~d---~~~---------------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 571 DD-----EEEVFDSIVND---EVR---------------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC-----HHHHHHHHhcC---CCC---------------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 32 22221111100 111 122334566789999999999999976
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.08 Aligned_cols=261 Identities=28% Similarity=0.495 Sum_probs=202.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCC-----cEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENG-----TFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
++|++.+.||+|+||.||+|.....+ ..||+|+++... ......+.+|++.+++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 47889999999999999999886444 679999986433 334567899999999999999999999854 3
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCC----------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPE----------VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
.+..+++|||+++|+|.+++.......+ ...+++..++.++.|++.|++|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 4578999999999999999987532111 13478889999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
+++++.+||+|||+++....... ........+++.|+|||.+ .+..++.++|||||||++||
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADY------YRVQSKSLLPVRWMPPEAI------------LYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred EcCCCcEEECCCcceeecccccc------ccccCCCcccccccCHHHh------------ccCcCchhhhHHHHHHHHHH
Confidence 99999999999999976522111 1112233567889999654 35678899999999999999
Q ss_pred HHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 903 MFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 903 llt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
|++ |..||..... .+.... +.... ....+..++.++.+++.+||+.||++||+++|+
T Consensus 219 l~~~g~~p~~~~~~-----~~~~~~---------i~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 219 IFSYGLQPYYGFSN-----QEVIEM---------IRSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred HHcCCCCCCCCCCH-----HHHHHH---------HHcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 998 9999874321 111111 10000 011123457789999999999999999999999
Q ss_pred HHHHHH
Q 001908 982 LAKLCA 987 (997)
Q Consensus 982 l~~L~~ 987 (997)
++.|++
T Consensus 277 ~~~l~~ 282 (283)
T cd05048 277 HTRLRS 282 (283)
T ss_pred HHHHhc
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.67 Aligned_cols=271 Identities=22% Similarity=0.308 Sum_probs=197.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+.+|++++++++|+||+++++++ ...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 4688999999999999999999989999999998743 233456778999999999999999999884 445689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++++.+..+..... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 99999998877765543322 378889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+....... ........||+.|+|||++. +..++.++||||+||++|||++|++||......
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~ 207 (287)
T cd07848 147 ARNLSEGS-------NANYTEYVATRWYRSPELLL------------GAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207 (287)
T ss_pred cccccccc-------cccccccccccccCCcHHHc------------CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 98652211 11122356899999996553 566889999999999999999999999753211
Q ss_pred CccHHHHHHh--hcchhhhhh--cCccccc-ccc-----cchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKM--ALPEKVMET--VDPSLLL-AWS-----DGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~--~~~~~~~~~--~d~~~~~-~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ........ ..+...... .++.... .+. .............++.+++.+|++.||++|||++|+++
T Consensus 208 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 208 D-QLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred H-HHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 11111110 001100000 0111000 000 00001111224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=301.18 Aligned_cols=253 Identities=22% Similarity=0.336 Sum_probs=201.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++.|++.+.||+|.|+.||++..+.+|+.+|+|++.. ......+++.+|+.+.+.++||||+++... +....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence 45678888999999999999999999999999999862 334456788999999999999999999987 56678
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHV 831 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl 831 (997)
..|+|+|+|.|++|..-|-++. .+++..+-++.+||++|++|+|.+ +|||||+||+|+++.+ .--+|+
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred eeEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence 9999999999999987776652 367888899999999999999999 9999999999999953 346899
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|..+. .+....++.|||+|||||++. ..+|+..+|||+.|||+|-++.|++||.
T Consensus 155 ~~FGvAi~l~---------~g~~~~G~~GtP~fmaPEvvr------------kdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 155 ADFGLAIEVN---------DGEAWHGFAGTPGYLSPEVLK------------KDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred cccceEEEeC---------CccccccccCCCcccCHHHhh------------cCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 9999998762 344556789999999997776 4689999999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+. +.+...+...... .+...|. .....++-.+++.+|+..||++|+|+.|+++
T Consensus 214 ~~-----~~~rlye~I~~g~-yd~~~~~-------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 214 DE-----DQHRLYEQIKAGA-YDYPSPE-------------WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred Cc-----cHHHHHHHHhccc-cCCCCcc-------------cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 42 2222222211110 0000011 1112334568999999999999999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=363.26 Aligned_cols=462 Identities=27% Similarity=0.336 Sum_probs=287.4
Q ss_pred cEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcc
Q 001908 75 RVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAY 154 (997)
Q Consensus 75 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~ 154 (997)
++..|||++|.+ +.+|..+..+.+|+.|+++.|.+. ..|.+++++.+|++|+|.+|.+. .+|.++..+.+|++|+++
T Consensus 46 ~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeecccccc-ccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 367777777666 467777777777777777777776 66777777777777777777776 777777777777777777
Q ss_pred cccccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCC
Q 001908 155 RNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNL 234 (997)
Q Consensus 155 ~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~l 234 (997)
.|++. .+|..+. .++.++.++.++|... ..+|......+++..|.+.+.++..+.+++. .|+|.+|++. .+
T Consensus 123 ~N~f~-~~Pl~i~-~lt~~~~~~~s~N~~~----~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~ 193 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIE-VLTAEEELAASNNEKI----QRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VL 193 (1081)
T ss_pred hhccC-CCchhHH-hhhHHHHHhhhcchhh----hhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hh
Confidence 77765 6666664 3566677777777322 2233344556777777777777777777766 6777777765 22
Q ss_pred CccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchh
Q 001908 235 PLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314 (997)
Q Consensus 235 p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 314 (997)
. ...+.+|+.+....|+++... -...+|+.|+.++|.++...+. ..-.+|+++++++|+++. .|
T Consensus 194 d---ls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~-------lp 257 (1081)
T KOG0618|consen 194 D---LSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSN-------LP 257 (1081)
T ss_pred h---hhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--cccccceeeecchhhhhc-------ch
Confidence 2 124566777777777765322 1234677777777777633221 223567777777777765 34
Q ss_pred hhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCccccc
Q 001908 315 TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLR 394 (997)
Q Consensus 315 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 394 (997)
+++..+.+|+.++..+|++. .+|..+... ++|+.|.+.+|.++ -+|.....++.|++|+|..|+|....+..|.-+.
T Consensus 258 ~wi~~~~nle~l~~n~N~l~-~lp~ri~~~-~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~ 334 (1081)
T KOG0618|consen 258 EWIGACANLEALNANHNRLV-ALPLRISRI-TSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLN 334 (1081)
T ss_pred HHHHhcccceEecccchhHH-hhHHHHhhh-hhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhh
Confidence 56677777777777777774 556655555 56677777777776 5566666677777777777777643333333333
Q ss_pred c-cceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccc-ccccccccccc
Q 001908 395 N-LQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQ-ILTITTLSRFL 472 (997)
Q Consensus 395 ~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~ll~~L 472 (997)
. |..|+.+.|++....-..=..+..|+.|++.+|+++...-..+.+.+.|+.|+|++|++. .+|+. +.++..+ +.|
T Consensus 335 ~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~L-eeL 412 (1081)
T KOG0618|consen 335 ASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEEL-EEL 412 (1081)
T ss_pred HHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHh-HHH
Confidence 2 566666666666322111223455666777777776665566666666777777777665 45543 3344444 666
Q ss_pred ccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccC-ChhccccCcCCeeeCccccc
Q 001908 473 DLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI-PLSLRSLKSIKELDLSCNNL 551 (997)
Q Consensus 473 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l 551 (997)
+||+|+++ .+|..+.++..|++|...+|++. ..| .+..++.|+.+|+|.|+|+... |..... ++|++|||++|.=
T Consensus 413 ~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 413 NLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR 488 (1081)
T ss_pred hcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence 66666666 56666666666666666666665 555 6666666666666666665332 322222 5666666666652
Q ss_pred cccCchhccCCCCCCEEeCCCC
Q 001908 552 SGQIPEFLENLSFLEYLNLSYN 573 (997)
Q Consensus 552 ~~~~p~~~~~l~~L~~L~ls~N 573 (997)
.-..-+.|..++++...+++-|
T Consensus 489 l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 489 LVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cccchhhhHHhhhhhheecccC
Confidence 2233445555555555555555
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.95 Aligned_cols=278 Identities=22% Similarity=0.293 Sum_probs=199.8
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.++||+|+||.||+|+...+++.||||+++.. .......+.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999999989999999998632 223345688999999999999999999987654433445689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+ +++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecC-CCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 999999 569999987654 478899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+....... .........||+.|+|||++... ...++.++|||||||++|||+||++||......
T Consensus 151 ~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~- 214 (338)
T cd07859 151 RVAFNDTP-----TAIFWTDYVATRWYRAPELCGSF----------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV- 214 (338)
T ss_pred cccccccC-----ccccccCCCCCCCcCCHHHHhcc----------ccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-
Confidence 76422111 11112345789999999876421 246788999999999999999999998643210
Q ss_pred ccHHHHHHhhc----chhhhhhcCcc---cccccccchhhh---hHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMAL----PEKVMETVDPS---LLLAWSDGRRRA---KVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~----~~~~~~~~d~~---~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.......... +.......... ...........+ ........+.+++.+||..||++|||+.|+++.
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 215 -HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred -HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 00000000000 000000000000 001234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.03 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=203.9
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeecc
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQ 764 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~ 764 (997)
-+||+|.||+||.|++..+...+|||.+........+-+..||...++++|+|||+++|.| ..+++.-|.||.++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence 4799999999999999999999999999877777778899999999999999999999985 34568899999999
Q ss_pred CCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC-CCCcEEEcccccchhcccC
Q 001908 765 NGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 765 ~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFg~a~~~~~~ 843 (997)
||+|.+.++..-+. ..-++.++-.+.+||++||.|||++ .|||||||-.||||+ -.|.+||+|||-++.+..
T Consensus 656 GGSLSsLLrskWGP---lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg- 728 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG- 728 (1226)
T ss_pred CCcHHHHHHhccCC---CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-
Confidence 99999999976532 1226778888999999999999999 999999999999997 568999999999988732
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
.......+.||..|||||+++.- ...|+.++|||||||.+.||.||++||.........+.+.
T Consensus 729 -------inP~TETFTGTLQYMAPEvIDqG----------~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV 791 (1226)
T KOG4279|consen 729 -------INPCTETFTGTLQYMAPEVIDQG----------PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV 791 (1226)
T ss_pred -------CCccccccccchhhhChHhhccC----------CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh
Confidence 22334457899999999998742 3568999999999999999999999998542221111110
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+.++ ...+.+++...+-..+|.+|+.+||.+||++++++.
T Consensus 792 ------------------GmyK--vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 ------------------GMYK--VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ------------------ccee--cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 0011 112345566677788999999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.57 Aligned_cols=276 Identities=27% Similarity=0.381 Sum_probs=202.3
Q ss_pred hcCccCCcccccCcceEEEEEE----CCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGIL----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||.||+|.. ..+++.||+|++........+.+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4788899999999999999984 34688999999986666666788999999999999999999998643 2345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++..... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence 68999999999999999976431 378899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++....... .........++..|+|||.+. +..++.++|||||||++|||++|..|+....
T Consensus 153 g~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 215 (284)
T cd05081 153 GLTKVLPQDKE-----YYKVREPGESPIFWYAPESLT------------ESKFSVASDVWSFGVVLYELFTYSDKSCSPP 215 (284)
T ss_pred cccccccCCCc-----ceeecCCCCCceEeeCHHHhc------------cCCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence 99986532111 000111123445699996553 4668899999999999999999877754221
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
. .+................+..........+....++.++.+++.+||..+|++|||++|+++.|+++
T Consensus 216 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 216 A------EFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred h------hhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1 1110000000000000000000000111111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=337.27 Aligned_cols=245 Identities=21% Similarity=0.294 Sum_probs=195.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|++++++++||||+++++++ ...+.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence 5788999999999999999999999999999998643 223456788999999999999999999985 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999998754 367788889999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~elltg~~pf~~~~- 219 (329)
T PTZ00263 164 FAKKVPD-----------RTFTLCGTPEYLAPEVIQ------------SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT- 219 (329)
T ss_pred CceEcCC-----------CcceecCChhhcCHHHHc------------CCCCCCcceeechHHHHHHHHcCCCCCCCCC-
Confidence 9976421 112357899999997654 4667899999999999999999999986321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
..+......... ... +......+.+++.+||..||++||+ ++|+++
T Consensus 220 ----~~~~~~~i~~~~------~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 220 ----PFRIYEKILAGR------LKF------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----HHHHHHHHhcCC------cCC------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111111111100 000 0012345679999999999999997 577653
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=332.09 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=201.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|+..+.||+|+||.||+|++..+++ .||+|+++.. .....+.+.+|+.+++.++||||++++++|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 579999999999999999999865555 4899998643 33445778899999999999999999999753
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++|+||+++|+|.+++.+... .+++..+++++.||+.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 246799999999999999987542 377889999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+++....... ........++..|+|||.+ .+..++.++|||||||++|||++ |+.||..
T Consensus 153 fG~a~~~~~~~~------~~~~~~~~~~~~y~apE~~------------~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 153 FGLAKLLGADEK------EYHAEGGKVPIKWMALESI------------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred ccccccccCCCc------ceeccCCccceeecChHHh------------ccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999986532111 0111122346789999654 35678899999999999999998 9999863
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.. ..+...... .. ...+.+..+..++.+++.+||..+|++||++.+++..+.++..+.
T Consensus 215 ~~-----~~~~~~~~~-~~----------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 215 IP-----ASEISSILE-KG----------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CC-----HHHHHHHHh-CC----------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 21 111111100 00 000011123456789999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.39 Aligned_cols=275 Identities=23% Similarity=0.332 Sum_probs=196.4
Q ss_pred hcCccCCcccccCcceEEEEEEC-CCCcEEEEEEecccc--hhhHHHHHHHHHHHhhc---CCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG-ENGTFVAVKILNLMQ--KGALKSFVAECEVLRNT---RHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~ 752 (997)
++|++.+.||+|+||+||+|++. .+++.||+|+++... ......+.+|+++++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999985 356889999986332 22334566788777765 6999999999986543445
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
....++||||++ ++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 567999999995 699999976542 2378899999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.++..... .......||+.|+|||.+. +..++.++|||||||++|||++|++||..
T Consensus 153 Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 153 DFGLARIYSFQ---------MALTSVVVTLWYRAPEVLL------------QSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred cccceEeccCC---------cccccccccccccChHHHh------------CCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 99999754211 1223456899999997653 45688899999999999999999999974
Q ss_pred CcCCCccHHHHHHhh---cchhhhhhc--CcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKMA---LPEKVMETV--DPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~---~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ..+....... .+..+.... .......................+.+++.+|++.||++|||+.|+++
T Consensus 212 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 212 SSDV-DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCHH-HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 3211 1111111110 001110000 00000000000000011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=292.61 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=205.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
+.++|.+++.||+|.||.||.|+.+.++-.||+|++.+. ..+....+.+|+++-+.++||||+++|+| |.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 346899999999999999999999999999999999633 23345688999999999999999999999 5567
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...|+++||.++|+++..++.+... .++......+..|+|.|+.|+|.+ .|+||||||+|+|++..+..|++|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence 7999999999999999999965532 477778889999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||-+... ........+||..|.||| ...+..++..+|+|++|++.||++.|.+||+..
T Consensus 168 fGwsV~~----------p~~kR~tlcgt~dyl~pE------------mv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 168 FGWSVHA----------PSNKRKTLCGTLDYLPPE------------MVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred CCceeec----------CCCCceeeecccccCCHh------------hcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 9988542 234456689999999995 445788999999999999999999999999865
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
. .+..+.+. ...+..+|.. ......++|..|+.++|.+|.+..|+++.
T Consensus 226 ~-~~etYkrI-------~k~~~~~p~~---------------is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 226 S-HSETYKRI-------RKVDLKFPST---------------ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred h-hHHHHHHH-------HHccccCCcc---------------cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 3 22122221 1112222221 23356789999999999999999998763
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=334.13 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=199.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++ ...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 36889999999999999999999899999999997432 23456788999999999999999999985 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 999999999999999997654 478889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||....
T Consensus 147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~------------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~- 202 (333)
T cd05600 147 LSKGIVT-----------YANSVVGSPDYMAPEVL------------RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST- 202 (333)
T ss_pred CCccccc-----------ccCCcccCccccChhHh------------cCCCCCCccceecchHHHhhhhhCCCCCCCCC-
Confidence 9975421 22345789999999655 35678899999999999999999999987431
Q ss_pred CCccHHHHHHhhcchhhhhhc-CcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETV-DPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..+....... ..... .+... + .......++.+++.+|+..+|++||+++|+++.
T Consensus 203 ----~~~~~~~i~~--~~~~~~~~~~~----~-----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 203 ----PNETWENLKY--WKETLQRPVYD----D-----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----HHHHHHHHHh--ccccccCCCCC----c-----cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1111111000 00000 00000 0 001234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.10 Aligned_cols=262 Identities=22% Similarity=0.369 Sum_probs=201.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|++.+.||+|+||+||+|++..+++ +||+|++.... .....++..|+..+++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 578889999999999999999976666 47778775332 2334677888889999999999999998632
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++++||+++|+|.+++..... .+++..+..++.||+.|++|||++ +++||||||+||+++.++.+|++|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 347899999999999999986542 378999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||.++...... .........++..|+|||.+ .++.++.++|||||||++||+++ |+.||..
T Consensus 153 fg~~~~~~~~~------~~~~~~~~~~~~~y~~pE~~------------~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 153 FGVADLLYPDD------KKYFYSEHKTPIKWMALESI------------LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred CccceeccCCC------cccccCCCCCcccccCHHHh------------ccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99997653211 11112234577789999654 35678999999999999999998 9999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
... ....+..... . ... .+..++..+.+++.+||..+|++|||+.|+++.|.++..+.
T Consensus 215 ~~~--~~~~~~~~~~---~--~~~---------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 215 MRP--HEVPDLLEKG---E--RLA---------------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCH--HHHHHHHHCC---C--cCC---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 311 1111111100 0 000 01123456788999999999999999999999999987765
Q ss_pred hc
Q 001908 993 VG 994 (997)
Q Consensus 993 ~~ 994 (997)
.+
T Consensus 273 ~~ 274 (279)
T cd05111 273 PR 274 (279)
T ss_pred cc
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.61 Aligned_cols=261 Identities=25% Similarity=0.310 Sum_probs=205.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.+.|+..+.||+|.-|+||+++.+.++..+|+|++.+.. .....++..|.+||+.++||.++.+|+. |+.+.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence 356778899999999999999999899999999997432 3345677889999999999999999998 77788
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
+.|+|||||+||+|....+++.+. .++...++.+|.+|+.||+|||-. |||+||+||+||||.++|++-++||
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence 999999999999999999988743 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCC-C------------------------------C-----------------ccccccccccccccccccC
Q 001908 835 GLARFLFARPF-D------------------------------T-----------------SMETQSSSIGIKGTVGYVP 866 (997)
Q Consensus 835 g~a~~~~~~~~-~------------------------------~-----------------~~~~~~~~~~~~gt~~y~a 866 (997)
.++......+. . . +.........++||-.|.|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 99876522100 0 0 0112233455779999999
Q ss_pred CcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCccccccccc
Q 001908 867 PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSD 946 (997)
Q Consensus 867 PE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 946 (997)
||++ .|...+.++|+|+|||++|||+.|..||..... ..++...+.+. ..-.-.
T Consensus 304 PEvI------------~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~NIv~~~----l~Fp~~--------- 357 (459)
T KOG0610|consen 304 PEVI------------RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-KETLRNIVGQP----LKFPEE--------- 357 (459)
T ss_pred ceee------------ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHHHHhcCC----CcCCCC---------
Confidence 9555 577889999999999999999999999985422 22333322211 000001
Q ss_pred chhhhhHHHHHHHHHHHHhhcCCCCCCCCCC----HHHHHH
Q 001908 947 GRRRAKVEECLVTVIRIGVACSMESPIERME----MRDVLA 983 (997)
Q Consensus 947 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~ 983 (997)
.+...+..+||.+.+.+||++|.. +.||.+
T Consensus 358 -------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 358 -------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -------CcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 122346679999999999999998 666643
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.39 Aligned_cols=239 Identities=23% Similarity=0.327 Sum_probs=189.2
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
||+|+||.||+|+...+++.||+|+++.. .......+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 69999999999999989999999998632 234456788999999999999999999885 4456899999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999998654 478889999999999999999999 9999999999999999999999999998753211
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
........||+.|+|||++. +..++.++||||+||++|||++|+.||... ...+.
T Consensus 147 --------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~ 201 (312)
T cd05585 147 --------DDKTNTFCGTPEYLAPELLL------------GHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEM 201 (312)
T ss_pred --------CCccccccCCcccCCHHHHc------------CCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHH
Confidence 11223457999999996553 567889999999999999999999998732 12222
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC---HHHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME---MRDVL 982 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl 982 (997)
........ .. .+.....++.+++.+||..||++||+ +.|++
T Consensus 202 ~~~~~~~~------~~------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 202 YRKILQEP------LR------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHcCC------CC------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 22111100 00 01123456779999999999999985 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.14 Aligned_cols=256 Identities=25% Similarity=0.463 Sum_probs=201.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|++.++||+|+||.||+|.++.+++.||+|++... ....+.+.+|++++++++|+||+++++++. ..+..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEE
Confidence 4688899999999999999999988999999998743 333567899999999999999999999854 3457899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
+|||+++++|.+++..... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.
T Consensus 80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 9999999999999976432 2478899999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
....... .......++..|+|||.+ .+..++.++|||||||++|||++ |..||...
T Consensus 153 ~~~~~~~-------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~---- 209 (263)
T cd05052 153 LMTGDTY-------TAHAGAKFPIKWTAPESL------------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---- 209 (263)
T ss_pred cccccee-------eccCCCCCccccCCHHHh------------ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----
Confidence 6522111 111122346689999654 35678889999999999999998 89998632
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
...+...... ....+ ..+..++.++.+++.+||..+|++||++.|+.+.|+.+
T Consensus 210 -~~~~~~~~~~-----~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 210 -DLSQVYELLE-----KGYRM------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CHHHHHHHHH-----CCCCC------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1222111110 00000 01122356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.85 Aligned_cols=242 Identities=25% Similarity=0.350 Sum_probs=191.4
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.||+|+||.||+++.+.+++.||+|+++.. .......+.+|++++++++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 4689999999999999989999999999743 233456778899999999999999999884 44568999999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999987654 478899999999999999999999 99999999999999999999999999987532
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 921 (997)
.. ........||+.|+|||.+ .+..++.++|||||||++|||++|+.||.... ..
T Consensus 147 ~~--------~~~~~~~~gt~~y~aPE~~------------~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~ 201 (323)
T cd05595 147 SD--------GATMKTFCGTPEYLAPEVL------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HE 201 (323)
T ss_pred CC--------CCccccccCCcCcCCcccc------------cCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HH
Confidence 11 1112235689999999654 45678899999999999999999999986331 11
Q ss_pred HHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 922 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
+......... ... +.....++.+++.+||+.||++|| ++.++++
T Consensus 202 ~~~~~~~~~~------~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 202 RLFELILMEE------IRF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHhcCC------CCC------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1111111000 000 112345677999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.06 Aligned_cols=265 Identities=23% Similarity=0.394 Sum_probs=198.8
Q ss_pred CccCCcccccCcceEEEEEECCCCc--EEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CCCce
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGT--FVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KGADF 755 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~--~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~ 755 (997)
|.+.++||+|+||.||+|++..++. .||+|.++.. .....+.+.+|+++++.++|+||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999976665 6899988643 34456788999999999999999999998754321 12335
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+++|||+++|+|.+++...........+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999986433222223478999999999999999999998 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 914 (997)
+++....... ........+++.|+|||.. .+..++.++|||||||++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~------------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 158 LSKKIYNGDY------YRQGRIAKMPVKWIAIESL------------ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred cccccCcccc------eecCCcccCCcccCCHHHc------------cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9986532111 0111223456789999544 45678899999999999999999 788886421
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
. .+.......... . ..+..++..+.+++.+||..+|++|||+.++++.|+++
T Consensus 220 ~-----~~~~~~~~~~~~-----~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 220 N-----SEIYDYLRQGNR-----L------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred H-----HHHHHHHHcCCC-----C------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 111111100000 0 00112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=328.35 Aligned_cols=200 Identities=26% Similarity=0.416 Sum_probs=171.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.++||+|+||.||+|++..++..+|+|++... .......+.+|++++++++|+||+++++++.. .+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 46899999999999999999999989999999998743 33445678999999999999999999999643 5589
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++.... .+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999999998654 3678889999999999999999752 799999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
+..... .......|+..|+|||.+. +..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~----------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 151 SGQLID----------SMANSFVGTRSYMSPERLQ------------GTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred chhhhh----------hccccCCCCccccCHHHhc------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 875421 1112346899999996553 56688899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.46 Aligned_cols=265 Identities=24% Similarity=0.398 Sum_probs=201.2
Q ss_pred CccCCcccccCcceEEEEEECCC---CcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CCCc
Q 001908 681 FSSSNMIGQGSFGSVYKGILGEN---GTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KGAD 754 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 754 (997)
|++.+.||+|+||.||+|+...+ +..||+|+++.. .......+.+|++.++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999998643 378999998743 23345688999999999999999999998754332 2334
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++++||+++|+|.+++...........+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 5899999999999999987654322233588999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|.++........ .......++..|+|||.+ .+..++.++|||||||++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~------------~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYY------RQGRIAKMPVKWIAIESL------------ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccc------cccccccCCccccCHhhc------------ccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 999866332111 111122346789999654 35668889999999999999999 88888642
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.. .+...... ....+ ..+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus 220 ~~-----~~~~~~~~-----~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 220 EN-----HEIYDYLR-----HGNRL------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CH-----HHHHHHHH-----cCCCC------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 11111100 00000 11123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.08 Aligned_cols=251 Identities=29% Similarity=0.444 Sum_probs=195.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||.||+|+++ .+..+|+|.+.... ...+.+.+|++++++++||||+++++++. ..+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence 56888999999999999999986 56689999886332 23467889999999999999999999854 3457899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.++++.... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999986432 378899999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
....... .......++..|+|||.+ .+..++.++||||||+++|||++ |+.||....
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--- 206 (256)
T cd05114 149 YVLDDEY-------TSSSGAKFPVKWSPPEVF------------NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--- 206 (256)
T ss_pred ccCCCce-------eccCCCCCchhhCChhhc------------ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---
Confidence 6522111 111223456689999654 35668889999999999999999 899986331
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
..+......... ....+ ...+.++.+++.+||..+|++||++.++++.|
T Consensus 207 --~~~~~~~i~~~~--~~~~~---------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 207 --NYEVVEMISRGF--RLYRP---------------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --HHHHHHHHHCCC--CCCCC---------------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111111111000 00011 11235688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.89 Aligned_cols=251 Identities=32% Similarity=0.523 Sum_probs=189.8
Q ss_pred cCCcccccCcceEEEEEEC----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 683 SSNMIGQGSFGSVYKGILG----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
..+.||.|.||.||+|.+. ..+..||||+++.. .....+.+.+|++.+++++||||++++|+|.. .+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence 4578999999999999997 44678999999643 33447899999999999999999999999863 33589
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++.... ...+++.+++.|+.||++||.|||++ +++|+||+++||++++++.+||+|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp EEEE--TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred ccccccccccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 9999999999999999872 12489999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
....... .............|+|||.+.. ..++.++||||||+++||+++ |+.||...
T Consensus 151 ~~~~~~~------~~~~~~~~~~~~~~~aPE~~~~------------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--- 209 (259)
T PF07714_consen 151 RPISEKS------KYKNDSSQQLPLRYLAPEVLKD------------GEYTKKSDVYSFGMLLYEILTLGKFPFSDY--- 209 (259)
T ss_dssp EETTTSS------SEEESTTSESGGGGS-HHHHHH------------SEESHHHHHHHHHHHHHHHHTTSSGTTTTS---
T ss_pred ccccccc------cccccccccccccccccccccc------------cccccccccccccccccccccccccccccc---
Confidence 7652111 1122233456778999977653 458999999999999999999 77887643
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
...+........ .+.+.+..++..+.+++..||+.+|++||++++++++|
T Consensus 210 --~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 --DNEEIIEKLKQG-----------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --CHHHHHHHHHTT-----------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --cccccccccccc-----------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112211111000 00111223456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.84 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=204.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
...+|++.++||+|+||.||+|.+.. +..+|+|++..........+.+|+++++.++|+||+++++++. ..+..
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 45679999999999999999999985 8899999998665555678899999999999999999999854 45578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++....+ ..+++.++++++.|++.|+.|||+. +|+||||||+||++++++.+||+|||.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999987542 2478999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
+........ ......++..|+|||.+ .+..++.++||||||+++|+|++ |+.||....
T Consensus 151 ~~~~~~~~~--------~~~~~~~~~~~~~PE~~------------~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~- 209 (261)
T cd05148 151 ARLIKEDVY--------LSSDKKIPYKWTAPEAA------------SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN- 209 (261)
T ss_pred hhhcCCccc--------cccCCCCceEecCHHHH------------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-
Confidence 976522111 11133457789999654 35678889999999999999998 899986432
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+...... .... .+.+..++..+.+++.+||..||++|||++++.+.|++
T Consensus 210 ----~~~~~~~~~-----~~~~------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 210 ----NHEVYDQIT-----AGYR------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----HHHHHHHHH-----hCCc------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111111100 0000 01112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=331.17 Aligned_cols=268 Identities=22% Similarity=0.344 Sum_probs=203.2
Q ss_pred hhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
.++|++.+.||+|+||.||+|... .+++.||+|+++.. .....+.+.+|+++++++ +|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 457999999999999999999753 34578999998743 233456788899999999 89999999998743
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCC---------------------------------------------------
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQP--------------------------------------------------- 779 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 779 (997)
.....+++|||+++++|.+++.......
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 3457899999999999999987532100
Q ss_pred ----CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCcccccccc
Q 001908 780 ----EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855 (997)
Q Consensus 780 ----~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~ 855 (997)
....+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+++.+...... ...
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------~~~ 232 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VRK 232 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch------hhc
Confidence 012578999999999999999999999 9999999999999999999999999999876321110 111
Q ss_pred ccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhh
Q 001908 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVME 934 (997)
Q Consensus 856 ~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (997)
....++..|+|||.+ .+..++.++|||||||++|||++ |..||....... .+... . ..
T Consensus 233 ~~~~~~~~y~aPE~~------------~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~---~-----~~ 291 (337)
T cd05054 233 GDARLPLKWMAPESI------------FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRR---L-----KE 291 (337)
T ss_pred cCCCCCccccCcHHh------------cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHH---H-----hc
Confidence 223456789999654 45778999999999999999998 999986432111 11110 0 00
Q ss_pred hcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 935 TVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 935 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
...+ ..+..+..++.+++.+||+.+|++||++.|+++.|+++.++
T Consensus 292 ~~~~------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 292 GTRM------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred cCCC------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000 01112345788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=323.44 Aligned_cols=264 Identities=23% Similarity=0.368 Sum_probs=209.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+...+.++||+|-||+|..+... .+.+||||+++... .....+|.+|+++|.+++||||++++|+|.. ++..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchH
Confidence 45567899999999999999995 57999999998554 4456899999999999999999999999965 34799
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+|||++|+|.+|+.+.... ........+|+.||+.||+||.+. .+||||+.++|+|++.++++||+|||++
T Consensus 612 mI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 999999999999999987421 134556678999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh--CCCCCCcCcC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT--RRRPTNCMFQ 915 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt--g~~P~~~~~~ 915 (997)
+.+...++.. .....+-+..|||||.+ .-++++.++|||+||+++||+++ ...||....+
T Consensus 685 R~lysg~yy~------vqgr~vlpiRwmawEsi------------llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 685 RNLYSGDYYR------VQGRAVLPIRWMAWESI------------LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred cccccCCcee------eecceeeeeeehhHHHH------------HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 9876544433 23334567899999655 45889999999999999999876 7788875432
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
+ .+++-....++.. ... .-...+.-|+..++++|..||+.|-++||+++++...|.+.
T Consensus 747 e--~vven~~~~~~~~-------~~~------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 747 E--QVVENAGEFFRDQ-------GRQ------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred H--HHHHhhhhhcCCC-------Ccc------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2 1111111111111 100 01234556888999999999999999999999999988764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=322.43 Aligned_cols=267 Identities=26% Similarity=0.459 Sum_probs=206.1
Q ss_pred hhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
..+|.+.+.||+|+||.||++... .++..+|+|.+........+.+.+|++++++++|+||+++++++. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 357889999999999999999852 345679999987666666678999999999999999999999864 3
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCC-------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQ-------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~ 825 (997)
.+..++||||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +++||||||+||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 45789999999999999999754310 1122489999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh
Q 001908 826 DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 826 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt 905 (997)
++.+|++|||.++....... ........++..|+|||.+ .+..++.++|||||||++|||++
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESI------------MYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred CCcEEeccCCccccccCCce------eecCCCCCccccccCHHHh------------ccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999986532111 1111223457789999654 35678899999999999999999
Q ss_pred -CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 906 -RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 906 -g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
|..||..... .+.......... +. .+..++.++.+++.+||+.+|.+|||+.|+.+.
T Consensus 218 ~g~~p~~~~~~-----~~~~~~i~~~~~-----~~------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~ 275 (288)
T cd05093 218 YGKQPWYQLSN-----NEVIECITQGRV-----LQ------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275 (288)
T ss_pred CCCCCCCCCCH-----HHHHHHHHcCCc-----CC------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 8999864321 111111100000 00 011234568899999999999999999999999
Q ss_pred HHHHHHHh
Q 001908 985 LCAARQTL 992 (997)
Q Consensus 985 L~~~~~~~ 992 (997)
|+++.++.
T Consensus 276 l~~~~~~~ 283 (288)
T cd05093 276 LQNLAKAS 283 (288)
T ss_pred HHHHHHhc
Confidence 99988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=335.29 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=198.3
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
..++|++.+.||+|+||+||+|+...+++.||+|++... .....+.+.+|+++++.++||||+++++++ ...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 456899999999999999999999999999999999632 223345678899999999999999999884 456
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++|+|.+++.... ++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNYD-------IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 68999999999999999997643 67778888999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+....... ........||+.|+|||++... .....++.++|||||||++|||++|+.||...
T Consensus 186 fG~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 186 FGTCMKMDANG-------MVRCDTAVGTPDYISPEVLKSQ--------GGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred ccceeeccCCC-------cccCCCCCCCcCeECHHHhccC--------CCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 99997642211 1112345799999999887531 11345789999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE--RMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~ 983 (997)
. ............. ....+. ......++.+++.+|+..+|++ |+++.|+++
T Consensus 251 ~-----~~~~~~~i~~~~~-~~~~~~-------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 251 S-----LVGTYSKIMDHKN-SLTFPD-------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred C-----HHHHHHHHHcCCC-cCCCCC-------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1 1111111110000 000000 0012346678999999999988 999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.83 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=192.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.||+|+||.||+|+.+.+++.||+|++... .......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 4689999999999999999999999999643 233456788999999999999999999884 45668999999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999987654 478899999999999999999999 99999999999999999999999999987531
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 921 (997)
.. ........||+.|+|||.+. +..++.++||||+||++|||++|+.||... ...
T Consensus 147 ~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~ 201 (328)
T cd05593 147 TD--------AATMKTFCGTPEYLAPEVLE------------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHE 201 (328)
T ss_pred Cc--------ccccccccCCcCccChhhhc------------CCCCCccCCccccchHHHHHhhCCCCCCCC-----CHH
Confidence 11 11123357999999996553 567889999999999999999999998632 112
Q ss_pred HHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001908 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLAK 984 (997)
Q Consensus 922 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 984 (997)
+........ +..+ +.....++.+++.+|+..||++|| ++.|+++.
T Consensus 202 ~~~~~~~~~------~~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 202 KLFELILME------DIKF------------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHhccC------CccC------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 211111100 0000 112234677899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=333.84 Aligned_cols=265 Identities=19% Similarity=0.227 Sum_probs=195.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|++.+.||+|+||.||+|.+..+++.||+|+.. ...+.+|++++++++||||+++++++. .....++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEE
Confidence 57999999999999999999999999999999753 235678999999999999999999853 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|+|++ .++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 161 v~e~~-~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred EEecC-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 99999 579999887654 378889999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC--
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG-- 916 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~-- 916 (997)
..... .........||+.|+|||++. +..++.++||||+||++|||+||+.||......
T Consensus 231 ~~~~~-------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 231 FPVDI-------NANKYYGWAGTIATNAPELLA------------RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred ccccc-------cccccccccCccCCCChhhhc------------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 53111 111223457999999996553 567899999999999999999999886533211
Q ss_pred Ccc----HHHHHHhhc--chhhh----hhcCccc-------ccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 917 GLT----LHEFCKMAL--PEKVM----ETVDPSL-------LLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 917 ~~~----~~~~~~~~~--~~~~~----~~~d~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
... +........ +.... ...+... ................+.++.+++.+|++.||++|||++
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~ 371 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAE 371 (391)
T ss_pred cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHH
Confidence 101 111111100 00000 0000000 000000001112224466788999999999999999999
Q ss_pred HHHH
Q 001908 980 DVLA 983 (997)
Q Consensus 980 evl~ 983 (997)
|+++
T Consensus 372 elL~ 375 (391)
T PHA03212 372 ALLD 375 (391)
T ss_pred HHhc
Confidence 9985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=341.30 Aligned_cols=275 Identities=22% Similarity=0.303 Sum_probs=194.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc---CCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF---KGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~ 754 (997)
.++|++.++||+|+||.||+|+...+++.||||++.... ....+|+.+++.++|+||+++++++....+ ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999999899999999885332 233579999999999999999987643222 1223
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEcc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSD 833 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~D 833 (997)
..++||||++ +++.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 5779999996 478877764321 112478899999999999999999999 999999999999999665 799999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+..... .......||+.|+|||++.. ...++.++||||+||++|||++|.+||...
T Consensus 215 FGla~~~~~~---------~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 215 FGSAKNLLAG---------QRSVSYICSRFYRAPELMLG-----------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cccchhccCC---------CCcccCCCCcCccCHHHhcC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999865221 11223568999999976532 245889999999999999999999999743
Q ss_pred cCCCccHHHHHHhh-cc-hhhhhhcCccccc-ccc----cchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMA-LP-EKVMETVDPSLLL-AWS----DGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~-~~-~~~~~~~d~~~~~-~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
... ..+....... .+ ........+.... .+. .......+...+.++.+++.+||..||++|||+.|+++
T Consensus 275 ~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 275 SSV-DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred ChH-HHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 211 1111111110 00 0111111111100 000 00001112234567889999999999999999999974
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=317.75 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=200.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCC---CcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGEN---GTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||.||+|+++.+ ...||+|+++.. .......+.+|+.++++++|+||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence 35789999999999999999998643 457999998743 3344567899999999999999999999853 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++++|.+++....+ .+++..+++++.|++.|++|||+. +|+||||||+||++++++.+|++|
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence 578999999999999999987542 478999999999999999999998 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+++...... .........++..|+|||.+ .+..++.++||||||+++|||++ |..||..
T Consensus 150 fg~~~~~~~~~------~~~~~~~~~~~~~y~~Pe~~------------~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 150 FGLSRRLEDSE------ATYTTKGGKIPIRWTAPEAI------------AYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cchhhcccccc------cceeccCCCCCccccChhhh------------ccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 99998763111 01111123456789999644 45678899999999999999998 9999863
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.. ..+..... .... ..+.+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 212 ~~-----~~~~~~~~-----~~~~------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 212 MS-----NQDVIKAV-----EDGY------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-----HHHHHHHH-----HcCC------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 31 11111110 0000 0001123356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.82 Aligned_cols=268 Identities=23% Similarity=0.351 Sum_probs=203.3
Q ss_pred HHhhcCccCCcccccCcceEEEEEECC-----CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcC-CCCcceEEeeeecc
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLM-QKGALKSFVAECEVLRNTR-HRNLIKIITVCSSI 748 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 748 (997)
...++|++.+.||+|+||.||+|++.. .+..||||+++.. .....+.+.+|+++++++. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~-- 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT-- 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--
Confidence 335688999999999999999998742 2347999999743 3344568899999999996 999999999964
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCC--------------------------------------------------
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQ-------------------------------------------------- 778 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------- 778 (997)
..+..++||||+++|+|.+++++....
T Consensus 112 ---~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 112 ---KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 345799999999999999998764210
Q ss_pred ----------------------------------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 779 ----------------------------------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 779 ----------------------------------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
.....+++..+.+++.|+++|++|||+. +|+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence 0012377888899999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+||+++.++.+||+|||+++....... ........++..|+|||.+ .+..++.++|||||||
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DiwSlGv 327 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSN------YVSKGSTFLPVKWMAPESI------------FDNLYTTLSDVWSYGI 327 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceecccccc------ccccCCcCCCcceEChhhh------------cCCCCCchhhHHHHHH
Confidence 999999999999999999976522111 1112223467889999655 3567889999999999
Q ss_pred HHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 899 MLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 899 vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++|||++ |..||........ +... ..... ....+..++..+.+++.+||..+|++||+
T Consensus 328 il~ellt~g~~P~~~~~~~~~-~~~~--------~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 328 LLWEIFSLGGTPYPGMIVDST-FYNK--------IKSGY------------RMAKPDHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred HHHHHHHCCCCCCcccchhHH-HHHH--------HhcCC------------CCCCCccCCHHHHHHHHHHCccCHhHCcC
Confidence 9999997 9999874321110 0000 00000 01112234667889999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 001908 978 MRDVLAKLCAARQ 990 (997)
Q Consensus 978 ~~evl~~L~~~~~ 990 (997)
+.++.+.|+++.+
T Consensus 387 ~~~l~~~l~~l~~ 399 (400)
T cd05105 387 FLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHHHcC
Confidence 9999999988653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.11 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=212.8
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.|.+...||.|+||.||+|+.++++-..|.|++.....+..+++.-||+||..++||+||++++.| ..++.++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceEEE
Confidence 466778899999999999999988888899999988888899999999999999999999999884 445689999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
.|||.||-.+..+-.-+. .+...++..+++|++.||.|||++ .|+|||+|+.|||++-+|.++++|||.+..
T Consensus 108 iEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred EeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999988876542 488999999999999999999999 999999999999999999999999998865
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
. ..+......+.|||+|||||+... |.+.+.+|+.++||||||+.+.||..+.+|-... ..
T Consensus 180 n--------~~t~qkRDsFIGTPYWMAPEVvmC-------ET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel----np 240 (1187)
T KOG0579|consen 180 N--------KSTRQKRDSFIGTPYWMAPEVVMC-------ETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL----NP 240 (1187)
T ss_pred c--------hhHHhhhccccCCcccccchheee-------ccccCCCchhhhhHHhhhhHHHHHhccCCCcccc----ch
Confidence 3 223445566899999999999876 8889999999999999999999999999995421 01
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+.-..... ..-.|. ..++..+...+.+++..|+..||..||++.++++
T Consensus 241 MRVllKia------KSePPT----------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 241 MRVLLKIA------KSEPPT----------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHh------hcCCCc----------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11111111 111111 2234556678889999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.62 Aligned_cols=246 Identities=20% Similarity=0.277 Sum_probs=194.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCC-cEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENG-TFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||.||+|+++.++ ..||+|++... .....+.+.+|+++++.++||||+++++++ ...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence 357999999999999999999876554 68999998632 233456788999999999999999999995 445
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence 68999999999999999998754 478889999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++.... ......||+.|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 175 FG~a~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 175 FGFAKVVDT-----------RTYTLCGTPEYIAPEILL------------NVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCCCeecCC-----------CcceecCChhhcCHHHHh------------CCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 999975411 112357899999997664 456788999999999999999999999742
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
. ............. .. +......+.+++.+|++.||++|+ +++++++
T Consensus 232 ~-----~~~~~~~i~~~~~------~~------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 232 E-----PLLIYQKILEGII------YF------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred C-----HHHHHHHHhcCCC------CC------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1 1111111100000 00 011233567899999999999995 7888765
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=321.46 Aligned_cols=268 Identities=25% Similarity=0.356 Sum_probs=201.1
Q ss_pred CccCCcccccCcceEEEEEE----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 681 FSSSNMIGQGSFGSVYKGIL----GENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
|++.+.||+|+||+||++.. ..+++.||+|+++... ......+.+|++++++++||||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 48889999999999988654 3467889999987443 3345678899999999999999999998753 23456
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.+++.... +++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+|++|||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~-------l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence 899999999999999997643 88999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++....... .........++..|+|||.+. +..++.++|||||||++|||+||..||.....
T Consensus 153 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~PE~~~------------~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 215 (283)
T cd05080 153 LAKAVPEGHE-----YYRVREDGDSPVFWYAVECLK------------ENKFSYASDVWSFGVTLYELLTHCDSKQSPPK 215 (283)
T ss_pred cccccCCcch-----hhccCCCCCCCceeeCHhHhc------------ccCCCcccccHHHHHHHHHHHhCCCCCCCCcc
Confidence 9976532110 001112234566799996553 45678899999999999999999999864321
Q ss_pred CCccHHHHHHhhcc----hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALP----EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 916 ~~~~~~~~~~~~~~----~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
. +.+....... ....+..+... ..+.+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 216 ~---~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 216 K---FEEMIGPKQGQMTVVRLIELLERGM--------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred h---hhhhhcccccccchhhhhhhhhcCC--------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1 1111111100 01111111111 01112345678899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.54 Aligned_cols=261 Identities=29% Similarity=0.509 Sum_probs=201.8
Q ss_pred hhcCccCCcccccCcceEEEEEECC-----CCcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++|.+.+.||+|+||.||+|+... +++.||+|+++..... ..+.+.+|++++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 3568889999999999999998753 3578999999754433 4578999999999999999999999954
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCC--------CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNG--------QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
.....++||||+++++|.+++..... ......+++.++..++.|++.|+.|||++ +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 34689999999999999999987542 11223478889999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 824 DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 824 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+.++.+|++|||.++....... ........+++.|+|||.+ .+..++.++|||||||++|||
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDY------YRVGGHTMLPIRWMPPESI------------MYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred cCCCeEEECCcccceecccCcc------eecCCCCcccceecChhhh------------ccCCcchhhhHHHHHHHHHHH
Confidence 9999999999999976522111 0111223457889999654 457789999999999999999
Q ss_pred Hh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 904 FT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 904 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
++ |..||.... ..+.......... ...+..++..+.+++.+||..||++||++.|++
T Consensus 218 ~~~g~~p~~~~~-----~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 218 FTYGKQPWYGLS-----NEEVIECITQGRL-----------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred HhcCCCCCCCCC-----HHHHHHHHHcCCc-----------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 99 999986331 1111111110000 000112356788999999999999999999999
Q ss_pred HHHH
Q 001908 983 AKLC 986 (997)
Q Consensus 983 ~~L~ 986 (997)
+.|+
T Consensus 276 ~~l~ 279 (280)
T cd05049 276 ERLQ 279 (280)
T ss_pred HHhh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=319.45 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=202.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCc----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.++|+..++||+|+||+||+|++..+++ +||+|+++.. .......+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4678899999999999999999876666 4899998643 33445678899999999999999999998743
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
...++++||+++|+|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||++++++.+||+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence 247899999999999999986532 378899999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTN 911 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 911 (997)
|||+++....... ........+++.|+|||.. .+..++.++|||||||++|||++ |..||.
T Consensus 152 dfG~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 152 DFGLARLLDIDET------EYHADGGKVPIKWMALESI------------LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred CCCceeecccccc------eeecCCCccchhhCCHHHh------------ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999986522110 0011122356789999654 35678899999999999999998 899986
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.... ..+....... . ..+.+..++.++.+++.+||..||++||++.++++.+..+..+
T Consensus 214 ~~~~--~~~~~~~~~~--------~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 214 GIPA--REIPDLLEKG--------E------------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCH--HHHHHHHHCC--------C------------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 4311 1111111100 0 0001112355788999999999999999999999999988765
Q ss_pred h
Q 001908 992 L 992 (997)
Q Consensus 992 ~ 992 (997)
.
T Consensus 272 ~ 272 (279)
T cd05109 272 P 272 (279)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=320.81 Aligned_cols=265 Identities=28% Similarity=0.477 Sum_probs=205.3
Q ss_pred hcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|.+.+.||+|+||.||+|++. .++..+|+|.+........+.+.+|++++++++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 56888899999999999999864 245579999987666556678899999999999999999999864 34
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
+..++||||+++++|.+++...... .....+++..++.++.|++.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 5789999999999999999764310 0112478999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 824 DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 824 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+.++.+||+|||+++....... ........++..|+|||.+ .+..++.++|||||||++|||
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~il~el 218 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESI------------MYRKFTTESDVWSFGVILWEI 218 (291)
T ss_pred ccCCcEEECCCCcccccCCCce------eecCCCCCcceeecChHHh------------ccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999976532211 1112234567889999654 456788999999999999999
Q ss_pred Hh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 904 FT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 904 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
+| |+.||..... .+........... ..+..++..+.+++.+||..+|++||++++++
T Consensus 219 ~t~g~~p~~~~~~-----~~~~~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 219 FTYGKQPWFQLSN-----TEVIECITQGRVL-----------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred HhCCCCCCCCCCH-----HHHHHHHhCCCCC-----------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 99 9999864321 1111110000000 00112356788999999999999999999999
Q ss_pred HHHHHHHHH
Q 001908 983 AKLCAARQT 991 (997)
Q Consensus 983 ~~L~~~~~~ 991 (997)
+.|.++...
T Consensus 277 ~~l~~~~~~ 285 (291)
T cd05094 277 KILHALGKA 285 (291)
T ss_pred HHHHHHHhh
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.66 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=203.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|+...+++.||||+++. ........+.+|++++++++||||+++++++. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 478899999999999999999998999999998753 23344567889999999999999999999854 3458
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++|+||+++|+|.+++...... ...++...++.++.|++.|++|||++ +++|+||||+||+++.++.++++|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 89999999999999988653311 12478889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+....... .......|+..|+|||.+. +..++.++||||+|+++|||++|+.||.....
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~------------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 211 (267)
T cd08228 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIH------------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred cceeccchh--------HHHhcCCCCccccChhhhc------------cCCCCchhhHHHHHHHHHHHhcCCCCCccccc
Confidence 987652211 1112346888999996553 45678899999999999999999999863211
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
...++.... .....+.. .....+..+.+++.+||..+|++||++.++++.++.++
T Consensus 212 ---~~~~~~~~~-----~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 212 ---NLFSLCQKI-----EQCDYPPL-----------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---cHHHHHHHH-----hcCCCCCC-----------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112221111 00001110 01234567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=321.20 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=199.8
Q ss_pred HHhhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
.++++|++.+.||+|+||.||+|.++ ..+..||+|++... .......+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--- 79 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 35678999999999999999999864 23567999998633 2234567889999999999999999999853
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCC----CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQP----EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~ 825 (997)
.....++||||+++|+|.+++.+..... ....+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 80 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 80 --QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 154 (277)
T ss_pred --CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcC
Confidence 4557899999999999999997643211 123467889999999999999999998 9999999999999999
Q ss_pred CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh
Q 001908 826 DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 826 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt 905 (997)
++.+|++|||+++........ .......+++.|+|||.+ .++.++.++|||||||++|||++
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~~l~el~~ 216 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESL------------KDGVFTTYSDVWSFGVVLWEIAT 216 (277)
T ss_pred CCCEEECCCCCccccCCccee------ecCCCCccCHhhcChhHh------------hcCCcCchhHHHHHHHHHHHHHc
Confidence 999999999998765322110 111123457789999654 35678999999999999999999
Q ss_pred -CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 906 -RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 906 -g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
|..||.... ..+.......... + ..+..++..+.+++.+||+.+|++|||+.|+++.
T Consensus 217 ~~~~p~~~~~-----~~~~~~~~~~~~~-----~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 217 LAEQPYQGMS-----NEQVLRFVMEGGL-----L------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCCC-----HHHHHHHHHcCCc-----C------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788876321 1121111100000 0 0011235578899999999999999999999998
Q ss_pred HH
Q 001908 985 LC 986 (997)
Q Consensus 985 L~ 986 (997)
|+
T Consensus 275 l~ 276 (277)
T cd05062 275 IK 276 (277)
T ss_pred hh
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=317.35 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=199.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++||||+++++++. ..+..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence 57999999999999999999998899999999997554445567889999999999999999999854 3458899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.++++... .+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999997653 478889999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......|+..|+|||.+... ....++.++||||+||++|||++|+.||......
T Consensus 155 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~---------~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-- 215 (267)
T cd06646 155 KITATI--------AKRKSFIGTPYWMAPEVAAVE---------KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-- 215 (267)
T ss_pred eecccc--------cccCccccCccccCHhHcccc---------cCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--
Confidence 652111 112234688899999866321 2345778999999999999999999998633111
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
...... ... ....+... .....+..+.+++.+||..+|++||+++++++.
T Consensus 216 --~~~~~~--~~~--~~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 216 --RALFLM--SKS--NFQPPKLK----------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --hhheee--ecC--CCCCCCCc----------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 000000 000 00000000 011234577899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=332.36 Aligned_cols=262 Identities=19% Similarity=0.256 Sum_probs=197.4
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
+....++|++.+.||+|+||.||+|+.+.+++.||+|++... .....+.+.+|+++++.++||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~----- 112 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF----- 112 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 334457899999999999999999999999999999998632 223345678899999999999999999984
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.+++..++||||+++|+|.+++.... ++...+..++.||+.||+|||++ +|+||||||+||++++++.+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~~-------~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSNYD-------VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence 45678999999999999999997543 67788999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+...... ........||+.|+|||++.... ..+.++.++||||+||++|||++|+.||
T Consensus 183 L~DFG~a~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~~~--------~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 183 LADFGTCMKMDETG-------MVRCDTAVGTPDYISPEVLKSQG--------GDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred EEecccceecccCC-------ceecccCCCCcccCCHHHHhccC--------CCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 99999997652111 11123457999999998875311 1234788999999999999999999999
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE--RMEMRDVLAK 984 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 984 (997)
.... ........ .+......+ +........+.+++..|+..+|.+ |+++.|+++.
T Consensus 248 ~~~~-----~~~~~~~i--------~~~~~~~~~------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 248 YADS-----LVGTYSKI--------MDHKNSLNF------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCC-----HHHHHHHH--------HhCCcccCC------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 7431 11111111 000000000 001112345668888898755543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=345.06 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=199.3
Q ss_pred cCccCCcccccCcceEEEEEECCC-CcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGEN-GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.|.+.+.||+|++|.||+|....+ ++.||+|.+..........+.+|+++++.++||||+++++++. ..+..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 488899999999999999998766 7889999876555555667888999999999999999999954 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.++++.... ...++++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 143 v~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 9999999999998875321 122478889999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... ........+||+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 218 ~~~~~~------~~~~~~~~~gt~~y~aPE~~------------~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~----- 274 (478)
T PTZ00267 218 QYSDSV------SLDVASSFCGTPYYLAPELW------------ERKRYSKKADMWSLGVILYELLTLHRPFKGP----- 274 (478)
T ss_pred ecCCcc------ccccccccCCCccccCHhHh------------CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----
Confidence 652211 11123345799999999655 3567899999999999999999999998632
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+........ ..++ .+..+...+.+++..||..||++||++.+++.
T Consensus 275 ~~~~~~~~~~~~----~~~~-------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 275 SQREIMQQVLYG----KYDP-------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CHHHHHHHHHhC----CCCC-------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112211111100 0000 01123456789999999999999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=317.14 Aligned_cols=255 Identities=24% Similarity=0.425 Sum_probs=198.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence 467899999999999999999976 66789999886433 2356889999999999999999999884 3456789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++|||+++|+|.++++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+
T Consensus 78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999999976432 2478889999999999999999998 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
....... ........++..|+|||.+ .+..++.++|||||||++|||+| |+.||......
T Consensus 151 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 151 RVIEDNE-------YTAREGAKFPIKWTAPEAI------------NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred eecCCCc-------eeccCCCccceecCCHHHh------------ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 7652211 0111223456789999654 35668889999999999999998 99998642111
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
....... ..... +....++.++.+++.+||+.+|++||+++++.+.|++
T Consensus 212 --~~~~~~~--------~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 212 --DVMSALQ--------RGYRM------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --HHHHHHH--------cCCCC------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111100 00000 0011234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=332.52 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=196.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+...+++.||||++... .......+.+|+++++.++|+||+++++++ ...+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 4789999999999999999999999999999999643 233446678899999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 999999999999999998754 478889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccc------------------------------cccccccccccccccCCcchhcccccCccccCCCC
Q 001908 836 LARFLFARPFDTSME------------------------------TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS 885 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~ 885 (997)
+++............ ........+||+.|+|||++. +.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~ 214 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL------------QT 214 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc------------CC
Confidence 987652211000000 000112346999999996653 56
Q ss_pred CCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHh
Q 001908 886 EASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGV 965 (997)
Q Consensus 886 ~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~ 965 (997)
.++.++|||||||++|||++|..||.... ..+......... .... . +......+.+.+++.
T Consensus 215 ~~~~~~DiwSlG~il~el~~G~~Pf~~~~-----~~~~~~~i~~~~------~~~~--~------~~~~~~s~~~~~li~ 275 (364)
T cd05599 215 GYNKECDWWSLGVIMYEMLVGYPPFCSDN-----PQETYRKIINWK------ETLQ--F------PDEVPLSPEAKDLIK 275 (364)
T ss_pred CCCCeeeeecchhHHHHhhcCCCCCCCCC-----HHHHHHHHHcCC------CccC--C------CCCCCCCHHHHHHHH
Confidence 78899999999999999999999997432 111111110000 0000 0 000012345678888
Q ss_pred hcCCCCCCCCCC---HHHHHH
Q 001908 966 ACSMESPIERME---MRDVLA 983 (997)
Q Consensus 966 ~cl~~dP~~Rps---~~evl~ 983 (997)
+|+. +|.+|++ +.|+++
T Consensus 276 ~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 276 RLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHcc-CHhhcCCCCCHHHHhc
Confidence 9996 9999998 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=322.48 Aligned_cols=264 Identities=27% Similarity=0.401 Sum_probs=200.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcE--EEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTF--VAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||.||+|.++.++.. +|+|.++.. .......+.+|++++.++ +|+||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 35788999999999999999998767654 577776532 334456788999999999 8999999999853 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQP----------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
+..++||||+++|+|.++++...... ....+++.+++.++.|++.|++|||+. +|+||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 57999999999999999998654211 112478999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 824 DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 824 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+.++.+||+|||++..... ........++..|+|||.+. +..++.++|||||||++|||
T Consensus 158 ~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~el 216 (303)
T cd05088 158 GENYVAKIADFGLSRGQEV---------YVKKTMGRLPVRWMAIESLN------------YSVYTTNSDVWSYGVLLWEI 216 (303)
T ss_pred cCCCcEEeCccccCcccch---------hhhcccCCCcccccCHHHHh------------ccCCcccccchhhhhHHHHH
Confidence 9999999999999863210 01111123466799996553 45678899999999999999
Q ss_pred Hh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 904 FT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 904 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
+| |..||.... ..+..... + ..... ..+..++.++.+++.+||+.+|++||++.+++
T Consensus 217 lt~g~~p~~~~~-----~~~~~~~~-~----~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 274 (303)
T cd05088 217 VSLGGTPYCGMT-----CAELYEKL-P----QGYRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274 (303)
T ss_pred HhcCCCCcccCC-----hHHHHHHH-h----cCCcC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 98 999986331 11111111 0 00000 00112345678999999999999999999999
Q ss_pred HHHHHHHHHh
Q 001908 983 AKLCAARQTL 992 (997)
Q Consensus 983 ~~L~~~~~~~ 992 (997)
+.++++.+..
T Consensus 275 ~~l~~~~~~~ 284 (303)
T cd05088 275 VSLNRMLEER 284 (303)
T ss_pred HHHHHHHHhh
Confidence 9999876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=328.25 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=189.4
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHH---hhcCCCCcceEEeeeeccCcCCCc
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVL---RNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
|++.+.||+|+||.||+|.++.+++.||||+++.. .....+.+.+|++++ +.++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 66788999999999999999989999999999743 223345666776655 556899999999984 4456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+++|+|..+++.. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 899999999999999988653 388999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++.... .........|++.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 146 g~~~~~~~--------~~~~~~~~~g~~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 146 GLCKEGMG--------FGDRTSTFCGTPEFLAPEVLT------------ETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred cCCccCCC--------CCCcccccccCccccCHhHhc------------CCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 99864311 111223457999999996553 5678899999999999999999999987431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
..+........ .+. .+...+..+.+++.+||..||++|| ++.++++
T Consensus 206 -----~~~~~~~i~~~------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 206 -----EEEVFDSIVND------EVR------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----HHHHHHHHHhC------CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111111000 000 0112345677999999999999999 4555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.46 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=192.4
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
+.||+|+||.||+|+++.+++.||+|.+... .......+.+|++++++++||||++++++|. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 4699999999999999889999999987633 3344567899999999999999999999864 345789999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++.... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+......
T Consensus 76 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 76 QGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999999997543 1378899999999999999999999 9999999999999999999999999998754211
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHE 922 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 922 (997)
.. ........++..|+|||.+ .++.++.++|||||||++|||++ |..||...... ....
T Consensus 148 ~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~ 207 (252)
T cd05084 148 VY------ASTGGMKQIPVKWTAPEAL------------NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTRE 207 (252)
T ss_pred cc------cccCCCCCCceeecCchhh------------cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHH
Confidence 10 0001112235679999654 35668889999999999999998 88888632110 0000
Q ss_pred HHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 923 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
. ...... ...+..++..+.+++.+|+..+|++|||+.++.+.|+
T Consensus 208 ~------------~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 208 A------------IEQGVR--------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred H------------HHcCCC--------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0 000000 0111233567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=340.62 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=204.6
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC-
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK- 751 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 751 (997)
....++|++.+.||+|+||+||+|+...+++.||||++... .......+.+|+..+..++|+|++++...+...+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999999989999999998643 344556788999999999999999988765432211
Q ss_pred --CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 752 --GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 752 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
.....++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 112478999999999999999764321 23578899999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+++....... ........||+.|+|||.+. +..++.++|||||||++|||++|+.|
T Consensus 183 kL~DFGls~~~~~~~~------~~~~~~~~Gt~~Y~aPE~~~------------~~~~s~k~DVwSlGvilyeLltG~~P 244 (496)
T PTZ00283 183 KLGDFGFSKMYAATVS------DDVGRTFCGTPYYVAPEIWR------------RKPYSKKADMFSLGVLLYELLTLKRP 244 (496)
T ss_pred EEEecccCeecccccc------ccccccccCCcceeCHHHhC------------CCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999976532111 11223457999999996553 56789999999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
|... ...+......... .+ +.+..+++++.+++.+||+.||++||++.++++.
T Consensus 245 f~~~-----~~~~~~~~~~~~~----~~-------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 245 FDGE-----NMEEVMHKTLAGR----YD-------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC-----CHHHHHHHHhcCC----CC-------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 8632 2222222211110 00 0112235678899999999999999999999763
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.19 Aligned_cols=273 Identities=24% Similarity=0.344 Sum_probs=196.2
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhc---CCCCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNT---RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~ 754 (997)
+|++.+.||+|+||+||+|+.+.+++.||+|+++... ......+.+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999999999999999986432 22234556777777665 799999999987654444456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||++ ++|.+++..... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 7899999996 599999876542 2378899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++..... .......||..|+|||++. +..++.++||||+||++|||++|++||....
T Consensus 153 g~~~~~~~~---------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 153 GLARIYSCQ---------MALTPVVVTLWYRAPEVLL------------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred CccccccCc---------ccCCCccccccccCchHhh------------CCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 999765211 1122346789999996553 4668899999999999999999999986432
Q ss_pred CCCccHHHHHHhh-cch--hhhhhcCcccccccccch---hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA-LPE--KVMETVDPSLLLAWSDGR---RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~-~~~--~~~~~~d~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+.+..... .+. .+....... ...+.... ......+....+.+++.+|+..||++|||+.|++.
T Consensus 212 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 212 EA-DQLGKIFDLIGLPPEDDWPRDVTLP-RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HH-HHHHHHHHHhCCCChhhCccccccc-ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 1111111110 000 000000000 00000000 00111234456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.04 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=197.5
Q ss_pred ccCCcccccCcceEEEEEECCCCcEEE---EEEec-ccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 682 SSSNMIGQGSFGSVYKGILGENGTFVA---VKILN-LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vA---vK~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+...+||+|+|-+||+|.+..+|..|| ||.-+ ...+...+.|..|+++|+.++|+||+++|.++.+.. .....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence 456789999999999999999999887 33322 234555689999999999999999999999976532 35688
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-CcEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFg~ 836 (997)
+|+|.|..|+|..|.++.+ ..+...++.|++||++||.|||++ .|+|+|||||=+||||+.+ |.|||+|.|+
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred eeeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 9999999999999999877 478889999999999999999997 6899999999999999854 8999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+... ........|||.|||||... ..|...+||||||++++||+|+.+||..
T Consensus 193 Atl~r----------~s~aksvIGTPEFMAPEmYE-------------E~YnE~VDVYaFGMCmLEMvT~eYPYsE---- 245 (632)
T KOG0584|consen 193 ATLLR----------KSHAKSVIGTPEFMAPEMYE-------------ENYNELVDVYAFGMCMLEMVTSEYPYSE---- 245 (632)
T ss_pred HHHhh----------ccccceeccCccccChHHHh-------------hhcchhhhhhhhhHHHHHHHhccCChhh----
Confidence 98751 12223378999999998764 5689999999999999999999999862
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.....+.++ ++..-+.|.-....+ .+++.++|.+|+.. .++|||+.|+++
T Consensus 246 C~n~AQIYK-----KV~SGiKP~sl~kV~-----------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 246 CTNPAQIYK-----KVTSGIKPAALSKVK-----------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hCCHHHHHH-----HHHcCCCHHHhhccC-----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 122223222 222223332221111 24567899999999 999999999975
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=330.72 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=192.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.|+..+.||+|+||+||+|+...+++.||+|++... .......+.+|++++++++|+||+++++++ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 578899999999999999999999999999999643 234456789999999999999999999985 445689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999999999998754 377888899999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCc---------------------------------------cccccccccccccccccCCcchhcccccC
Q 001908 837 ARFLFARPFDTS---------------------------------------METQSSSIGIKGTVGYVPPGNIAKMLNLP 877 (997)
Q Consensus 837 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 877 (997)
++.......... ...........||+.|+|||++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------ 221 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL------ 221 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc------
Confidence 864311000000 00000112357999999996653
Q ss_pred ccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHH
Q 001908 878 CLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECL 957 (997)
Q Consensus 878 ~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 957 (997)
+..++.++|||||||++|||+||+.||...... ........... .... +......
T Consensus 222 ------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~-----~~~~----------~~~~~~s 276 (381)
T cd05626 222 ------RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT----ETQLKVINWEN-----TLHI----------PPQVKLS 276 (381)
T ss_pred ------CCCCCCccceeehhhHHHHHHhCCCCCcCCCHH----HHHHHHHcccc-----ccCC----------CCCCCCC
Confidence 466889999999999999999999999743211 11100000000 0000 0000123
Q ss_pred HHHHHHHhh--cCCCCCCCCCCHHHHHH
Q 001908 958 VTVIRIGVA--CSMESPIERMEMRDVLA 983 (997)
Q Consensus 958 ~~l~~li~~--cl~~dP~~Rps~~evl~ 983 (997)
++..+++.+ |+..+|..||++.|+++
T Consensus 277 ~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 277 PEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 455677776 55667777999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.98 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=200.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCc---EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGT---FVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|+..+.||+|+||.||+|+...+++ .+|+|+++.. .....+.+..|++++++++|+|++++.+++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 4578889999999999999999875554 7999998744 3444577899999999999999999999854 44
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 578999999999999999976432 378889999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||++........ ..........+..|+|||.+ .+..++.++|||||||++|||++ |+.||..
T Consensus 151 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 151 FGLSRVLEDDPE-----GTYTTSGGKIPIRWTAPEAI------------AYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred Cccceecccccc-----cceeccCCCcCceecCHHHh------------hcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 999876522111 01111112235679999654 35678899999999999999998 9999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.. ..+....... .. ..+....++.++.+++.+||..+|++||++.++++.|.++
T Consensus 214 ~~-----~~~~~~~i~~---------~~--------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 214 MS-----NHEVMKAIND---------GF--------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-----HHHHHHHHhc---------CC--------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 31 1111111100 00 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.63 Aligned_cols=263 Identities=24% Similarity=0.389 Sum_probs=200.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc--EEEEEEecc-cchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT--FVAVKILNL-MQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vAvK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||.||+|..+.++. .+|+|.++. ......+.+.+|+++++++ +||||+++++++. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 478899999999999999999876664 468888874 2334456789999999999 7999999999854 345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQP----------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
..++|+||+++|+|.+++.+..... ....+++..++.++.|++.|++|||+. +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 7899999999999999997643211 112478899999999999999999998 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.++.+||+|||++..... .........+..|+|||.+ .+..++.++|||||||++|||+
T Consensus 154 ~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 154 ENLASKIADFGLSRGEEV---------YVKKTMGRLPVRWMAIESL------------NYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred CCCeEEECCcCCCccccc---------eeccCCCCcCccccCchhh------------ccCCCCchhhHHHHHHHHHHHH
Confidence 999999999999863210 0011112235579999654 3567889999999999999999
Q ss_pred h-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 T-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+ |..||.... ..+....... ...+ ..+..++..+.+++.+||..+|.+||++.++++
T Consensus 213 t~g~~pf~~~~-----~~~~~~~~~~-----~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 213 SLGGTPYCGMT-----CAELYEKLPQ-----GYRM------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred cCCCCCCCCCC-----HHHHHHHHhc-----CCCC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8 999986431 1111111100 0000 011123457889999999999999999999999
Q ss_pred HHHHHHHHh
Q 001908 984 KLCAARQTL 992 (997)
Q Consensus 984 ~L~~~~~~~ 992 (997)
.|+++.+..
T Consensus 271 ~l~~~~~~~ 279 (297)
T cd05089 271 QLSRMLEAR 279 (297)
T ss_pred HHHHHHHhh
Confidence 999888754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.93 Aligned_cols=247 Identities=21% Similarity=0.317 Sum_probs=190.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|+.+++++ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 4689999999999999999999999999743 233456678899999988 799999999984 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999987654 488999999999999999999999 9999999999999999999999999998743
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC---C
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG---G 917 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~---~ 917 (997)
.. .........||+.|+|||++. +..++.++|||||||++|||++|+.||+..... .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05588 147 IR--------PGDTTSTFCGTPNYIAPEILR------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206 (329)
T ss_pred cc--------CCCccccccCCccccCHHHHc------------CCCCCCccceechHHHHHHHHHCCCCccccccccccc
Confidence 11 111223457899999996653 567889999999999999999999999742211 1
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC------HHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME------MRDVL 982 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl 982 (997)
....++......... .. .+......+.+++.+|++.||++||+ +.|++
T Consensus 207 ~~~~~~~~~~~~~~~-----~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 207 QNTEDYLFQVILEKQ-----IR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred ccchHHHHHHHHcCC-----CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 111111111110000 00 01112346789999999999999997 55664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=318.80 Aligned_cols=261 Identities=25% Similarity=0.445 Sum_probs=198.4
Q ss_pred hcCccCCcccccCcceEEEEEEC----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.+|++.++||+|+||.||+|... ..+..||+|.+... .......+.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 46788899999999999999853 45678999998743 3334467889999999999999999999853 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCC-----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQ-----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
+..++||||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +|+||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 5789999999999999999643210 0112478889999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
+++++.+|++|||+++....... ........++..|+|||.+ .+..++.++|||||||++||
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~il~e 218 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADY------YRVQPKSLLPIRWMPPEAI------------MYGKFSSDSDIWSFGVVLWE 218 (283)
T ss_pred EcCCCcEEeccccccccccCCcc------eecccCCCccceecChHHh------------ccCCCCchhhhHHHHHHHHH
Confidence 99999999999999986532211 1112223456789999654 35678899999999999999
Q ss_pred HHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 903 MFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 903 llt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
|++ |..||.... ..+.......... .+.+..++.++.+++.+||+.||++||++.++
T Consensus 219 l~~~g~~p~~~~~-----~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 276 (283)
T cd05090 219 IFSFGLQPYYGFS-----NQEVIEMVRKRQL-----------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276 (283)
T ss_pred HHcCCCCCCCCCC-----HHHHHHHHHcCCc-----------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 999 888986321 1111111110000 00112235678899999999999999999999
Q ss_pred HHHHHH
Q 001908 982 LAKLCA 987 (997)
Q Consensus 982 l~~L~~ 987 (997)
.+.|.+
T Consensus 277 ~~~l~~ 282 (283)
T cd05090 277 HTRLRS 282 (283)
T ss_pred HHHhhc
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.45 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=198.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|++++++++|+||+++++++. ..+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence 3467899999999999999999986 56789999987433 23467889999999999999999999853 45578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred eeeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcce
Confidence 99999999999999997654 12478999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
++....... ........+..|+|||.+ .+..++.++||||||+++|||+| |+.||....
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~- 209 (261)
T cd05068 150 ARVIKEDIY-------EAREGAKFPIKWTAPEAA------------LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT- 209 (261)
T ss_pred EEEccCCcc-------cccCCCcCceeccCcccc------------ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-
Confidence 987632111 111112234689999544 45678899999999999999999 999986321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+..... . ..... +.+..++.++.+++.+|++.+|++||++.++.+.|++
T Consensus 210 ----~~~~~~~~-~----~~~~~------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 210 ----NAEVLQQV-D----QGYRM------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----HHHHHHHH-H----cCCCC------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11111100 0 00000 0111234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.62 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=206.3
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
-|.+..+||+|+||.||+|.++++|+.+|+|.+.... ..+++.+|+.+|++++.+++|++||.|.. ...+++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceEee
Confidence 3678899999999999999999999999999986543 45788999999999999999999998533 3469999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
||||..|+..+.++.++. ++.+.++..+.+.-++||+|||.. .-+|||||+.|||++.+|.+|++|||.|-.
T Consensus 107 MEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred hhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence 999999999999998763 588899999999999999999998 889999999999999999999999999976
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
+. .+-.......||+.|||||++.. -.|..++||||+|+...||..|++||.+...
T Consensus 179 LT--------DTMAKRNTVIGTPFWMAPEVI~E------------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---- 234 (502)
T KOG0574|consen 179 LT--------DTMAKRNTVIGTPFWMAPEVIEE------------IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---- 234 (502)
T ss_pred hh--------hhHHhhCccccCcccccHHHHHH------------hccchhhhHhhhcchhhhhhcCCCCcccccc----
Confidence 52 23345566889999999988863 4688999999999999999999999874311
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+ +....+ .-++......+++...++-+++++|+...|++|-|+-++++
T Consensus 235 ---M-------RAIFMI------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 235 ---M-------RAIFMI------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ---c-------ceeEec------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 0 000000 00112223457788889999999999999999999998865
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.16 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=187.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|+.+.+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 4699999999999999999999999999743 233456678899988877 899999999984 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999887654 478889999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC---
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG--- 917 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~--- 917 (997)
... ........||+.|+|||++. +..++.++|||||||++|||++|+.||.......
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05618 147 LRP--------GDTTSTFCGTPNYIAPEILR------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206 (329)
T ss_pred cCC--------CCccccccCCccccCHHHHc------------CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc
Confidence 111 11223457899999996553 5678899999999999999999999996322111
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
.....+........ +.. .+......+.+++.+||+.||++||++
T Consensus 207 ~~~~~~~~~~i~~~-----~~~------------~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 207 QNTEDYLFQVILEK-----QIR------------IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cccHHHHHHHHhcC-----CCC------------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11111111110000 000 011223457799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=329.21 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=190.4
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.||+|+||.||+|+.+.+++.||+|+++.. .......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 4689999999999999989999999999743 233446678899999999999999999884 44568999999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999987654 47889999999999999999997 6 8999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
... ........||+.|+|||++. +..++.++|||||||++|||+||+.||.... .
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~ 201 (325)
T cd05594 147 IKD--------GATMKTFCGTPEYLAPEVLE------------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----H 201 (325)
T ss_pred CCC--------CcccccccCCcccCCHHHHc------------cCCCCCccccccccceeeeeccCCCCCCCCC-----H
Confidence 211 11122356999999996653 5678899999999999999999999986321 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
.+........ .... +.....++.+++.+|++.||++|+ +++++++
T Consensus 202 ~~~~~~i~~~------~~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 202 EKLFELILME------EIRF------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHhcC------CCCC------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1111111000 0000 111244677899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=327.26 Aligned_cols=208 Identities=25% Similarity=0.346 Sum_probs=172.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+...+++.||+|+++... ......+.+|++++++++|+||+++++++ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47889999999999999999999899999999996432 23446778899999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 999999999999999998754 478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCc---------------------------cccccccccccccccccCCcchhcccccCccccCCCCCCC
Q 001908 836 LARFLFARPFDTS---------------------------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888 (997)
Q Consensus 836 ~a~~~~~~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~ 888 (997)
+|+.......... ..........+||+.|+|||++. +..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------------~~~~~ 214 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM------------QTGYN 214 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc------------CCCCC
Confidence 9976522110000 00001112457999999996653 56788
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCc
Q 001908 889 VTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 889 ~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
.++|||||||++|||++|+.||..
T Consensus 215 ~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 215 KLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred CchhhhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.88 Aligned_cols=273 Identities=23% Similarity=0.312 Sum_probs=206.7
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccC
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSID 749 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 749 (997)
++.+..+.++|++.+.||+|+||.||+|....+++.+|+|+++... .....+.+|+.+++++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567789999999999999999999999899999999986432 2235678899999999 6999999999876544
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
....+..++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 45567899999999999999988643211 12478888999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
|++|||.++...... .......|++.|+|||.+.. +...+..++.++||||+||++|||++|+.|
T Consensus 164 kl~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~~~~Dv~slGvi~~el~~g~~p 228 (286)
T cd06638 164 KLVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIAC-------EQQLDSTYDARCDVWSLGITAIELGDGDPP 228 (286)
T ss_pred EEccCCceeecccCC--------CccccccCCCcccChhhhch-------hhhccccccchhhhhhHHHHHHHHhcCCCC
Confidence 999999987652211 11223468999999987753 112245678899999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
|..... ....... ... ..+.. ..+..+..++.+++.+||..||++|||+.|+++.
T Consensus 229 ~~~~~~----~~~~~~~--~~~----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 229 LADLHP----MRALFKI--PRN----PPPTL----------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCch----hHHHhhc--ccc----CCCcc----------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 874311 1111000 000 00000 0011123467899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.66 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=191.1
Q ss_pred cccccCcceEEEEEEC--CCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEee
Q 001908 686 MIGQGSFGSVYKGILG--ENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
.||+|+||.||+|.++ ..+..||+|++.... ....+.+.+|++++++++|+||++++++|. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 4899999999999875 445679999987543 333467899999999999999999999863 2367999999
Q ss_pred ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhccc
Q 001908 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842 (997)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~ 842 (997)
+++|+|.+++..... .+++..+++++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+.....
T Consensus 76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 999999999975431 478899999999999999999999 999999999999999999999999999975422
Q ss_pred CCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHH
Q 001908 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLH 921 (997)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 921 (997)
... .........++..|+|||.+. +..++.++|||||||++||+++ |..||...... .+.
T Consensus 148 ~~~-----~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~ 208 (257)
T cd05115 148 DDS-----YYKARSAGKWPLKWYAPECIN------------FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVM 208 (257)
T ss_pred Ccc-----ceeccCCCCCCcccCCHHHHc------------cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHH
Confidence 110 001111223457899996543 4568889999999999999996 99998743211 111
Q ss_pred HHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 922 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
..+... .....+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 209 ~~~~~~--------------------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 209 SFIEQG--------------------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHCC--------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111000 00011123456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.48 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=202.0
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcC-CC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFK-GA 753 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~-~~ 753 (997)
.++..|++.+.||+|+||.||+|....+++.||+|++.... .....+..|+++++++ +|+|++++++++...... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677889999999999999999999899999999986443 3346788999999998 799999999997653322 13
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 568999999999999999986432 2478889999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||++..... .........|+..|+|||.+... ...+..++.++||||+||++|||++|+.||...
T Consensus 155 fg~~~~~~~--------~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 155 FGVSAQLDR--------TVGRRNTFIGTPYWMAPEVIACD-------ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred CCCceeccc--------ccccCCcccccccccCHhHhccc-------cCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999875411 11122345689999999877531 112456888999999999999999999998643
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ...... . .....+.. ....++.++.+++.+||..+|.+|||+.|+++
T Consensus 220 ~~----~~~~~~-~-----~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 220 HP----MRALFL-I-----PRNPAPRL-----------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CH----HHHHHH-H-----hcCCCCCC-----------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 21 111100 0 00000000 00123456789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=330.25 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=200.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+...+++.||+|+++.. .......+.+|+++++.++|+||+++++++ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 4688999999999999999999989999999999743 224456788999999999999999999884 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 999999999999999998763 478889999999999999999998 99999999999999999999999999
Q ss_pred cchhcccCCCCC---------------------ccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhH
Q 001908 836 LARFLFARPFDT---------------------SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894 (997)
Q Consensus 836 ~a~~~~~~~~~~---------------------~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dvw 894 (997)
+++......... ............||+.|+|||++. +..++.++|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Diw 214 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR------------GTPYGLECDWW 214 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc------------CCCCCCceeeE
Confidence 998653321000 000011223456999999996654 45789999999
Q ss_pred HHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 895 SLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 895 SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
||||++|||++|+.||.... ..+....... .. .... .+.....++++.+++..|+. ||++
T Consensus 215 SlG~il~ell~g~~Pf~~~~-----~~~~~~~i~~-----~~-~~~~--------~p~~~~~~~~~~~li~~ll~-dp~~ 274 (350)
T cd05573 215 SLGVILYEMLYGFPPFYSDT-----LQETYNKIIN-----WK-ESLR--------FPPDPPVSPEAIDLICRLLC-DPED 274 (350)
T ss_pred ecchhhhhhccCCCCCCCCC-----HHHHHHHHhc-----cC-Cccc--------CCCCCCCCHHHHHHHHHHcc-Chhh
Confidence 99999999999999987432 1111111100 00 0000 00000134567899999997 9999
Q ss_pred CCC-HHHHHHH
Q 001908 975 RME-MRDVLAK 984 (997)
Q Consensus 975 Rps-~~evl~~ 984 (997)
||+ +.|+++.
T Consensus 275 R~~s~~~ll~h 285 (350)
T cd05573 275 RLGSFEEIKSH 285 (350)
T ss_pred cCCCHHHHhcC
Confidence 999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=330.28 Aligned_cols=276 Identities=21% Similarity=0.253 Sum_probs=196.7
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.++||+|+||.||+|....+++.||+|++... .....+.+.+|+++++.++|+||+++++++...+.......|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998632 233456788999999999999999999986543322223789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999995 68888886543 478899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+...... ........+|+.|+|||.+.. ...++.++||||+||++|||++|+.||......
T Consensus 151 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 211 (372)
T cd07853 151 RVEEPDE-------SKHMTQEVVTQYYRAPEILMG-----------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI- 211 (372)
T ss_pred eecccCc-------cccCCCCCcCCCcCCHHHHcC-----------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-
Confidence 7542111 111223467899999976542 234788999999999999999999999743211
Q ss_pred ccHHHHHHhhc-c--hhhhhhc---Ccccccc-cccch---hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMAL-P--EKVMETV---DPSLLLA-WSDGR---RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~-~--~~~~~~~---d~~~~~~-~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..+........ + ....... ...+... ..... ......+...++.+++.+|++.||++|||+.|+++.
T Consensus 212 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 01111110000 0 0000000 0000000 00000 000011224567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=333.80 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=209.7
Q ss_pred CccCCcccccCcceEEEEEECCCCc----EEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
....++||+|+||+||+|.|-..|+ +||+|++.. ...+..+++..|+-+|.+++|||+++++|+|... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence 4557899999999999999965554 689999863 3445568899999999999999999999998653 3
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
..+|++|++.|+|.+|++..++ .+-....+.|..|||+||.|||++ +.|||||.++||||.+-..+||.|||
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 8899999999999999998663 366788899999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 914 (997)
+|+...+.... .......-.+.|||= |.+....|+.++|||||||.+||++| |..||+...
T Consensus 844 la~ll~~d~~e------y~~~~gK~pikwmal------------e~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 844 LAKLLAPDEKE------YSAPGGKVPIKWMAL------------ESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred hhhccCccccc------ccccccccCcHHHHH------------HHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 99987432211 111112234567776 45556889999999999999999999 999987542
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.. + +...++.+.+.+++.-|..+++.++.+||..|+..||+++++..++.+...+.
T Consensus 906 ~~-----e-----------------I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 906 AE-----E-----------------IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred HH-----H-----------------hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 21 1 11112344456778889999999999999999999999999999999876554
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=326.23 Aligned_cols=242 Identities=23% Similarity=0.299 Sum_probs=188.9
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCC-CcceEEeeeeccCcCCCce
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHR-NLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~ 755 (997)
+|++.+.||+|+||.||+|+.+.+++.||||+++.. .....+.+..|+++++.++|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 578899999999999999999989999999999743 234456778899999999765 577787774 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 999999999999999997654 377889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++.... .........||+.|+|||++ .+..++.++||||+||++|||+||+.||....
T Consensus 147 ~~~~~~~--------~~~~~~~~~gt~~y~aPE~~------------~~~~~~~~~DiwslGvil~elltG~~pf~~~~- 205 (324)
T cd05587 147 MCKENIF--------GGKTTRTFCGTPDYIAPEII------------AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED- 205 (324)
T ss_pred cceecCC--------CCCceeeecCCccccChhhh------------cCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-
Confidence 9864311 11122345789999999655 35678899999999999999999999997431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
..+........ .... +.....++.+++.+|+..||++|++.
T Consensus 206 ----~~~~~~~i~~~------~~~~------------~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 206 ----EDELFQSIMEH------NVSY------------PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----HHHHHHHHHcC------CCCC------------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11111111000 0000 01123456789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.01 Aligned_cols=264 Identities=17% Similarity=0.242 Sum_probs=199.3
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeec
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSS 747 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 747 (997)
..++....++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+.+|+++++.++||||+++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 344555668999999999999999999999999999999998632 223345678899999999999999999884
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
......++||||+++|+|.+++.... ++...+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 113 ---QDDRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence 44568999999999999999997643 67788889999999999999999 999999999999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||+|+...... ........||+.|+|||++.... ....++.++||||+||++|||++|+
T Consensus 180 ~ikL~DfG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~--------~~~~~~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 180 HLKLADFGTCMKMNKEG-------MVRCDTAVGTPDYISPEVLKSQG--------GDGYYGRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred CEEEEeCCceeEcCcCC-------cccccCcccCccccCHHHHhccC--------CCccCCCccceeehhHHHHHHHhCC
Confidence 99999999997652211 11123457999999998875311 1234788999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcch-hhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPE-KVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE--RMEMRDVLAK 984 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 984 (997)
.||.... ........... ...... ........+.+++..|+..++.+ |+++.|+++.
T Consensus 245 ~Pf~~~~-----~~~~~~~i~~~~~~~~~~---------------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 245 TPFYADS-----LVGTYSKIMNHKNSLTFP---------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCCCC-----HHHHHHHHHcCCCcccCC---------------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 9997431 11111111000 000000 01122345678999999844433 7788888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=323.83 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=185.4
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|+...+++.||+|+++.. .....+.+..|.+++... +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 4699999999999999989999999999743 223345556677777654 899999999884 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999997654 478889999999999999999999 9999999999999999999999999999754
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||.... .
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~ 201 (316)
T cd05592 147 MNG--------EGKASTFCGTPDYIAPEILK------------GQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----E 201 (316)
T ss_pred CCC--------CCccccccCCccccCHHHHc------------CCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----H
Confidence 211 11223457899999996553 5678899999999999999999999997431 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
.+....... ..+.. +..+..++.+++.+||..||++||++.+
T Consensus 202 ~~~~~~i~~------~~~~~------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 202 DELFDSILN------DRPHF------------PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred HHHHHHHHc------CCCCC------------CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 121111100 00100 1112345678999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.50 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=199.7
Q ss_pred cCccCCcccccCcceEEEEEECC-----CCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
+|++.+.||+|+||.||+|+... ....+|+|++.... ......+.+|+++++.++||||+++++.|. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47788999999999999998742 23578999886433 334567889999999999999999999854 34
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCC------------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQ------------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 815 (997)
+..++++||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 5789999999999999998764211 1123478999999999999999999998 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHH
Q 001908 816 LKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYS 895 (997)
Q Consensus 816 lk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwS 895 (997)
|||+||++++++.+||+|||+++....... ........++..|+|||.+ .+..++.++||||
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~apE~~------------~~~~~~~~~Di~s 214 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDS------YVKRSKGRIPVKWMAIESL------------FDHIYTTQSDVWS 214 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccc------hhcccCCCCCccccCHHHH------------ccCCcchHhHHHH
Confidence 999999999999999999999976522111 0111223456789999654 3566889999999
Q ss_pred HHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 896 LGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 896 lGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
|||++|||+| |..||.... ..+... ..+.... ...+..++.++.+++.+||+.+|++
T Consensus 215 lG~~l~el~t~g~~p~~~~~-----~~~~~~---------~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~ 272 (290)
T cd05045 215 FGVLLWEIVTLGGNPYPGIA-----PERLFN---------LLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDK 272 (290)
T ss_pred HHHHHHHHHhcCCCCCCCCC-----HHHHHH---------HHhCCCC--------CCCCCCCCHHHHHHHHHHccCCccc
Confidence 9999999999 999986321 111111 1110000 0011223457889999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 001908 975 RMEMRDVLAKLCAARQ 990 (997)
Q Consensus 975 Rps~~evl~~L~~~~~ 990 (997)
||+++|+++.|+++..
T Consensus 273 Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 273 RPTFADISKELEKMMV 288 (290)
T ss_pred CCCHHHHHHHHHHHHh
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.23 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=189.5
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
||+|+||+||+++++.+++.||+|++.... ....+.+..|+++++.++|+||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999899999999986322 22335678899999999999999999874 4456899999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++|+|.+++..... ....+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 99999988865321 122478999999999999999999999 9999999999999999999999999998754221
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
. .......||+.|+|||.+. +..++.++|||||||++|||++|+.||....... ...+.
T Consensus 151 ~--------~~~~~~~g~~~y~aPE~~~------------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~ 209 (280)
T cd05608 151 Q--------SKTKGYAGTPGFMAPELLQ------------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKEL 209 (280)
T ss_pred C--------ccccccCCCcCccCHHHhc------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHH
Confidence 1 1122356899999996553 5678899999999999999999999997432111 11111
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
..... .... ..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 210 ~~~~~--------~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 210 KQRIL--------NDSV----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHhhc--------ccCC----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11100 0000 01122355678999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.30 Aligned_cols=268 Identities=22% Similarity=0.375 Sum_probs=201.0
Q ss_pred hhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQ-KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
.++|++.+.||+|+||+||+|.+. .+++.||||+++... ....+.+.+|++++.++ +|+||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 457999999999999999999852 467889999997432 33456788999999999 68999999998743
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCC---------------------------------------------------
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQP--------------------------------------------------- 779 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 779 (997)
.....++||||+++|+|.+++.......
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 2346899999999999999997642100
Q ss_pred ----------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCcc
Q 001908 780 ----------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849 (997)
Q Consensus 780 ----------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~ 849 (997)
....+++..+.+++.|+++|++|||++ +|+||||||+||+++.++++|++|||+++.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc----
Confidence 001367888899999999999999999 999999999999999999999999999976522111
Q ss_pred ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhc
Q 001908 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMAL 928 (997)
Q Consensus 850 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 928 (997)
........++..|+|||.+ .+..++.++|||||||++|||++ |..||...... .......
T Consensus 235 --~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~- 295 (343)
T cd05103 235 --YVRKGDARLPLKWMAPETI------------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRL- 295 (343)
T ss_pred --hhhcCCCCCCcceECcHHh------------cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHHH-
Confidence 0111123456789999654 35678899999999999999997 89998643211 1111100
Q ss_pred chhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 929 PEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 929 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
....... .+....+++.+++..||+.+|++||++.|+++.|+.+.++
T Consensus 296 ----~~~~~~~------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 296 ----KEGTRMR------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ----hccCCCC------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000 0011234678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.68 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=194.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.... .....+.+|++++++++|+||+++++++. ..+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEE
Confidence 46888999999999999999986 56789999986332 23356888999999999999999999853 4457899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999986542 478999999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
...... ........++..|+|||.+ .+..++.++|||||||++|||++ |+.||.....
T Consensus 149 ~~~~~~-------~~~~~~~~~~~~y~~Pe~~------------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-- 207 (256)
T cd05059 149 YVLDDQ-------YTSSQGTKFPVKWAPPEVF------------DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-- 207 (256)
T ss_pred eccccc-------ccccCCCCCCccccCHHHh------------ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--
Confidence 652211 1111122345679999654 35678889999999999999999 8999864311
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
.+..... ...... ..+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus 208 ---~~~~~~~-----~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 208 ---SEVVESV-----SAGYRL------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---HHHHHHH-----HcCCcC------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111110 000000 01112456788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.40 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=200.3
Q ss_pred hcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|+..++||+|+||.||+|... .++..+|+|.+..........+.+|++++++++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence 57888999999999999999752 346689999987666666778999999999999999999999854 34
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCC---------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQ---------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
+..+++|||+++++|.+++...... .....+++..++.++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 5789999999999999999865311 1112478899999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
+++.+||+|||+++...... .........+++.|+|||.+ .+..++.++|||||||++|||+
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~il~el~ 218 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTD------YYRVGGRTMLPIRWMPPESI------------LYRKFTTESDIWSFGVVLWEIF 218 (280)
T ss_pred CCCCEEECCCCceeEcCCCc------eeecCCCccccccccCHHHh------------ccCCcCchhhHHHHHHHHHHHH
Confidence 99999999999997552211 01111223456789999644 4567899999999999999999
Q ss_pred h-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 T-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+ |.+||..... .+....... ... ...+..++..+.+++.+||..||++||+++|+.+
T Consensus 219 ~~g~~p~~~~~~-----~~~~~~~~~-----~~~------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 219 TYGKQPWYQLSN-----TEAIECITQ-----GRE------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCCCCCccCCH-----HHHHHHHHc-----Ccc------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8 8999863211 111100000 000 0011133566889999999999999999999999
Q ss_pred HHHH
Q 001908 984 KLCA 987 (997)
Q Consensus 984 ~L~~ 987 (997)
.|++
T Consensus 277 ~l~~ 280 (280)
T cd05092 277 RLQA 280 (280)
T ss_pred HHhC
Confidence 8863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.24 Aligned_cols=237 Identities=26% Similarity=0.363 Sum_probs=186.8
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|+.+.+++.||+|+++.. .....+.+..|.++++.. +||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4689999999999999989999999998642 233456677888888876 699999999984 4566899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999999999998754 478889999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||.+. +..++.++||||+||++|||++|+.||.... .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~ 201 (320)
T cd05590 147 IF--------NGKTTSTFCGTPDYIAPEILQ------------EMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----E 201 (320)
T ss_pred Cc--------CCCcccccccCccccCHHHHc------------CCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----H
Confidence 11 111223457899999997654 4668889999999999999999999997431 2
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
.+.......... ..+ .....++.+++.+|++.||++||++
T Consensus 202 ~~~~~~i~~~~~---~~~---------------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 202 DDLFEAILNDEV---VYP---------------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHhcCCC---CCC---------------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 222111111000 000 1123467799999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=309.22 Aligned_cols=262 Identities=25% Similarity=0.383 Sum_probs=204.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|....+++.||+|.++. ......+.+.+|++++++++|+|++++++++. ..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 578999999999999999999998999999998863 22334578899999999999999999999854 3568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++..... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++++|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 8999999999999999875321 122478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+....... .......++..|+|||.+ .+..++.++|||||||++|+|++|+.||....
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~y~apE~~------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~- 210 (267)
T cd08224 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERI------------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK- 210 (267)
T ss_pred eeeeccCCC--------cccceecCCccccCHHHh------------ccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-
Confidence 987542211 111234578899999654 35678889999999999999999999986321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
....+...... ....+.. .....+..+.+++.+||..+|++||++.++++.++.++
T Consensus 211 --~~~~~~~~~~~-----~~~~~~~-----------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 211 --MNLYSLCKKIE-----KCDYPPL-----------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --ccHHHHHhhhh-----cCCCCCC-----------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111111100 0000000 01134557889999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.15 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=194.8
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.|+..+.||+|+||+||++....+++.||+|++.... ......+.+|++++++++|+||+++++++ ...+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 3778899999999999999998899999999986422 22235567899999999999999999884 445689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999998875431 2478899999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+..... ........|+..|+|||.+. +..++.++||||+||++|||++|+.||......
T Consensus 149 ~~~~~~---------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 149 AVEIPE---------GETIRGRVGTVGYMAPEVVK------------NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred ceecCC---------CCccccccCCCCccCcHHhc------------CCCCCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence 875421 11112346899999996553 567888999999999999999999999743211
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
....+.... +.... ...+...+..+.+++.+||..||++|| ++.++++
T Consensus 208 -~~~~~~~~~---------~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 208 -VKREEVERR---------VKEDQ---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -hHHHHHHHH---------hhhcc---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 011111000 00000 001112345678999999999999999 7888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.35 Aligned_cols=271 Identities=20% Similarity=0.310 Sum_probs=196.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|...++||+|+||.||+|+.+.+++.||+|+++... ......+.+|++++++++||||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 46889999999999999999999899999999987432 223356788999999999999999999854 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 99999964 89888876532 367888999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+...... .......+|+.|+|||.+.. ...++.++||||+||++|||+||+.||......
T Consensus 152 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~- 211 (309)
T cd07872 152 RAKSVPT--------KTYSNEVVTLWYRPPDVLLG-----------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE- 211 (309)
T ss_pred eecCCCc--------cccccccccccccCCHHHhC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 7542111 11123457899999976542 245788999999999999999999999743211
Q ss_pred ccHHHHHHhh--cchhhhhhcCcc-cc-----cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA--LPEKVMETVDPS-LL-----LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~--~~~~~~~~~d~~-~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.......... .....+..+... .. ..+..............+..+++.+|++.||++|||+.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 212 DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 1111111110 000111001000 00 000000000111123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.57 Aligned_cols=267 Identities=25% Similarity=0.412 Sum_probs=203.0
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCC-----CcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeec
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGEN-----GTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSS 747 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 747 (997)
....++|+..+.||+|+||.||+|..... ...+|+|++... .......+.+|+++++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT- 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-
Confidence 34456789999999999999999988633 368999998743 334456788999999999 7999999999854
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 817 (997)
..+..+++|||+++|+|.++++..... .....+++..+++++.|++.|++|||+. +|+|||||
T Consensus 87 ----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlk 159 (293)
T cd05053 87 ----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA 159 (293)
T ss_pred ----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccc
Confidence 345789999999999999999764310 1123588999999999999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHH
Q 001908 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897 (997)
Q Consensus 818 ~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlG 897 (997)
|+||+++.++.+|++|||.++....... ........++..|+|||.+ .+..++.++||||||
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG 221 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDY------YRKTTNGRLPVKWMAPEAL------------FDRVYTHQSDVWSFG 221 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccc------eeccCCCCCCccccCHHHh------------ccCCcCcccceeehh
Confidence 9999999999999999999986532211 0111122356789999654 356788999999999
Q ss_pred HHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 898 VMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 898 vvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
|++||+++ |..||.... ..+...... ....+ ..+..++..+.+++.+||..+|++||
T Consensus 222 ~il~el~~~g~~p~~~~~-----~~~~~~~~~-----~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp 279 (293)
T cd05053 222 VLLWEIFTLGGSPYPGIP-----VEELFKLLK-----EGYRM------------EKPQNCTQELYHLMRDCWHEVPSQRP 279 (293)
T ss_pred hHHHHHhcCCCCCCCCCC-----HHHHHHHHH-----cCCcC------------CCCCCCCHHHHHHHHHHcccCcccCc
Confidence 99999998 889876321 111111110 00000 01112355788999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 001908 977 EMRDVLAKLCAAR 989 (997)
Q Consensus 977 s~~evl~~L~~~~ 989 (997)
|+.|+++.|+++.
T Consensus 280 s~~eil~~l~~~~ 292 (293)
T cd05053 280 TFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHHHhh
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.21 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=194.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||+||+|++. ++..||+|.++... ...+.+.+|++++++++||||+++++++.. .+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence 57888999999999999999886 45569999887432 234678999999999999999999998643 446899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.+++..... .+++..++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 9999999999999976432 478999999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
....... .......++..|+|||.+ .+..++.++|||||||++|||++ |..||.....
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~pe~~------------~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-- 207 (256)
T cd05113 149 YVLDDEY-------TSSVGSKFPVRWSPPEVL------------LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-- 207 (256)
T ss_pred ecCCCce-------eecCCCccChhhCCHHHH------------hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--
Confidence 6532111 111223456789999655 34668889999999999999999 9999863211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
.+........ ..+.. +......+.+++.+||+.+|++||++.++++.+
T Consensus 208 ---~~~~~~~~~~-----~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 208 ---SETVEKVSQG-----LRLYR------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ---HHHHHHHhcC-----CCCCC------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 1111111000 00000 011245778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.14 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=189.5
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
||+|+||.||+++.+.+|+.||+|++.... ....+.+..|++++++++||||+++.+++ ....+.++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999899999999986321 22334566799999999999999999884 4566899999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99999999876442 2378889999999999999999999 9999999999999999999999999998765211
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
.......|+..|+|||.+. +..++.++||||+||++|||++|+.||....... ...+.
T Consensus 149 ---------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~ 206 (277)
T cd05607 149 ---------KTITQRAGTNGYMAPEILK------------EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEEL 206 (277)
T ss_pred ---------ceeeccCCCCCccCHHHHc------------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHH
Confidence 1122346899999996553 4668899999999999999999999987432111 11111
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
..... ...... .......++.+++.+||+.||++||+++|+++.+
T Consensus 207 ~~~~~--------~~~~~~---------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 207 KRRTL--------EDEVKF---------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHhh--------cccccc---------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 11111 000000 0012245678999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=343.58 Aligned_cols=272 Identities=24% Similarity=0.313 Sum_probs=203.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.++||+|+||.||+|++..+++.||+|+++.. .+...+.+.+|++++++++||||+++++++. ..+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 4789999999999999999999989999999998642 2234567899999999999999999999864 3558
Q ss_pred EEEEEeeccCCCHHHHhhcCCCC-----CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQ-----PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.++||||+++|+|.+++...... ......++..+++++.||++||+|||++ +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 99999999999999998753211 0112356778899999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCc----------cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHH
Q 001908 831 VSDFGLARFLFARPFDTS----------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl 900 (997)
|+|||+|+.......... ...........||+.|+|||.+ .+..++.++|||||||++
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l------------~g~~~S~kSDIWSLGVIL 221 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL------------LGVPASESTDIYALGVIL 221 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh------------cCCCCCcHhHHHHHHHHH
Confidence 999999986521110000 0001112235699999999654 456789999999999999
Q ss_pred HHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-CHH
Q 001908 901 LEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-EMR 979 (997)
Q Consensus 901 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ 979 (997)
|||+||+.||....... ... . . ...++.-. ....+.++.+.+++.+|++.||++|| +++
T Consensus 222 yELLTG~~PF~~~~~~k--i~~---~---~---~i~~P~~~---------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 222 YQMLTLSFPYRRKKGRK--ISY---R---D---VILSPIEV---------APYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred HHHHHCCCCCCCcchhh--hhh---h---h---hccChhhc---------cccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999997421110 000 0 0 00011000 00113456678999999999999996 677
Q ss_pred HHHHHHHHHHH
Q 001908 980 DVLAKLCAARQ 990 (997)
Q Consensus 980 evl~~L~~~~~ 990 (997)
++.+.|+...+
T Consensus 282 eLl~~Le~~lq 292 (932)
T PRK13184 282 ELKQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHHHh
Confidence 77777877654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.41 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=204.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|.+..++..||+|++........+.+.+|++++++++|+||+++++++. .....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 356889999999999999999998889999999998666666678999999999999999999999853 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++.+... .+++..+..++.|++.|+.|||++ +|+|+||||+||+++.++.+||+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 99999999999999976431 478899999999999999999999 9999999999999999999999999988
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ........+++.|+|||.+.. +...+..++.++|||||||++|||++|+.||.....
T Consensus 151 ~~~~~~--------~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-- 213 (280)
T cd06611 151 AKNKST--------LQKRDTFIGTPYWMAPEVVAC-------ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-- 213 (280)
T ss_pred hhhccc--------ccccceeecchhhcCHHHHhh-------cccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--
Confidence 754211 111223568899999987753 223345678899999999999999999999874311
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
........ ....+.. ..+..+...+.+++..||..+|++||++.++++.
T Consensus 214 --~~~~~~~~------~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 214 --MRVLLKIL------KSEPPTL----------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --HHHHHHHh------cCCCCCc----------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11110000 0000110 0111234567899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.07 Aligned_cols=268 Identities=22% Similarity=0.331 Sum_probs=201.8
Q ss_pred HHHhhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcC-CCCcceEEeeeec
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTR-HRNLIKIITVCSS 747 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 747 (997)
....++|.+.++||+|+||.||+|+++ ..++.||+|+++.. .....+.+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344567888999999999999999964 34568999999743 2333457889999999997 9999999999643
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCC-------------------------------------------------
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQ------------------------------------------------- 778 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------- 778 (997)
....++||||+++|+|.+++++....
T Consensus 113 -----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 113 -----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred -----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 45799999999999999999864310
Q ss_pred -------------------------------------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 001908 779 -------------------------------------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815 (997)
Q Consensus 779 -------------------------------------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 815 (997)
.....+++..++.++.|++.|++|||+. +|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCccc
Confidence 0112467788899999999999999998 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHH
Q 001908 816 LKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYS 895 (997)
Q Consensus 816 lk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwS 895 (997)
|||+||++++++.+|++|||+++....... ........++..|+|||.+. +..++.++||||
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dvws 326 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSN------YISKGSTFLPLKWMAPESIF------------NNLYTTLSDVWS 326 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceecccccc------cccCCCcCCCCceeChHHhc------------CCCCCcHhHHHH
Confidence 999999999999999999999976422110 01112235678899996553 466889999999
Q ss_pred HHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 896 LGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 896 lGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
|||++|||++ |+.||....... ......... ..+ ..+..+..++.+++.+||..+|.+
T Consensus 327 lGvil~e~l~~g~~P~~~~~~~~----~~~~~~~~~-----~~~------------~~p~~~~~~l~~li~~cl~~~P~~ 385 (401)
T cd05107 327 FGILLWEIFTLGGTPYPELPMNE----QFYNAIKRG-----YRM------------AKPAHASDEIYEIMQKCWEEKFEI 385 (401)
T ss_pred HHHHHHHHHHcCCCCCCCCCchH----HHHHHHHcC-----CCC------------CCCCCCCHHHHHHHHHHcCCChhH
Confidence 9999999998 888986432111 110000000 000 001123457889999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 001908 975 RMEMRDVLAKLCAAR 989 (997)
Q Consensus 975 Rps~~evl~~L~~~~ 989 (997)
||+++|+++.|+++.
T Consensus 386 RPs~~ell~~L~~~~ 400 (401)
T cd05107 386 RPDFSQLVHLVGDLL 400 (401)
T ss_pred CcCHHHHHHHHHHHh
Confidence 999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.71 Aligned_cols=268 Identities=23% Similarity=0.388 Sum_probs=206.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECC----CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGE----NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
..++|++.+.||+|+||.||+|.+.. ++..||+|++... .......+.+|++++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---- 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE---- 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 35688999999999999999999874 2678999988643 34456778999999999999999999998743
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCC--CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQ--PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
.....++++||+++|+|.+++...... .....+++..++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence 345789999999999999999765321 1123588999999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRR 908 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~ 908 (997)
|++|||+++.+...... .......++..|+|||.+. +..++.++|||||||++||+++ |+.
T Consensus 157 kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~------------~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 157 KITDNALSRDLFPMDYH------CLGDNENRPVKWMALESLV------------NKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred EECCCCCcccccCCceE------EeCCCCCcchhccCHHHHh------------cCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 99999999865332211 0111234567899996553 4668899999999999999999 999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
||.... ...+..+.. ..... .....++.++.+++.+||..||++|||+.|+++.|+++
T Consensus 219 p~~~~~--~~~~~~~~~--------~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 219 PYVEID--PFEMAAYLK--------DGYRL------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CcCcCC--HHHHHHHHH--------cCCCC------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 986421 111111100 00000 01112456788999999999999999999999999998
Q ss_pred HHH
Q 001908 989 RQT 991 (997)
Q Consensus 989 ~~~ 991 (997)
..+
T Consensus 277 ~~~ 279 (280)
T cd05043 277 HAQ 279 (280)
T ss_pred Hhc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.57 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=198.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCC---cEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENG---TFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.+|++.+.||+|+||.||+|++..++ ..+|+|.++.. .....+.+.+|++++++++||||+++++++. ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 57888999999999999999886443 37999998643 2334568899999999999999999999853 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++++|++||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence 78999999999999999986542 378899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|.+........ .........++..|+|||.+ .+..++.++|||||||++||+++ |..||...
T Consensus 151 g~~~~~~~~~~-----~~~~~~~~~~~~~y~~pe~~------------~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 151 GLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAI------------AYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred Ccccccccccc-----eeeecCCCccceeecCHhHh------------ccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 99986532111 00111112335689999554 45678899999999999999887 99998643
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.. .+...... +... .+.+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 214 ~~-----~~~~~~~~-----~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 214 SN-----QDVIKAIE-----EGYR------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CH-----HHHHHHHh-----CCCc------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 21 11111110 0000 011112356778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.15 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=198.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||.||+|+...+++.||+|+++.........+.+|+.+++.++||||+++++++. ..+..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 57888899999999999999998899999999997655555567889999999999999999999853 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++.... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 999999999999997654 478899999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... ........|+..|+|||.+.. .....++.++||||+||++|||++|..||.......
T Consensus 155 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~- 216 (267)
T cd06645 155 QITAT--------IAKRKSFIGTPYWMAPEVAAV---------ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR- 216 (267)
T ss_pred EccCc--------ccccccccCcccccChhhhcc---------ccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-
Confidence 54211 111233568999999987632 113457889999999999999999999986332110
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... .. .. ...+.... ...++..+.+++.+|+..+|++||+++++++
T Consensus 217 ~~~~~---~~-~~---~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 217 ALFLM---TK-SN---FQPPKLKD----------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hHHhh---hc-cC---CCCCcccc----------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 00 00 00000000 0012345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.10 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=189.4
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|+...+++.||+|+++.. .....+.+..|.++++.+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 4699999999999999989999999998743 233445677899998876 799999999984 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999997654 478889999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
... ........||+.|+|||++. +..++.++||||+||++|||++|+.||.... .
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~ 201 (321)
T cd05591 147 ILN--------GVTTTTFCGTPDYIAPEILQ------------ELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----E 201 (321)
T ss_pred ccC--------CccccccccCccccCHHHHc------------CCCCCCccceechhHHHHHHhcCCCCCCCCC-----H
Confidence 211 11223456899999997654 4678899999999999999999999997432 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-------CHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-------EMRDVLA 983 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~ 983 (997)
.+......... ...| .....++.+++.+|+..||++|| +++++++
T Consensus 202 ~~~~~~i~~~~---~~~p---------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 202 DDLFESILHDD---VLYP---------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHcCC---CCCC---------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11111111100 0000 11234677899999999999999 7777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=312.05 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=199.7
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.|++.+.||+|+||.||+|....++..+|+|.+........+.+.+|+++++.++|+|++++++++.. .+..++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence 36788999999999999999998899999999976655666788999999999999999999998643 4589999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 81 IEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999887533 1478899999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
.... ........++..|+|||.+.. ....+..++.++|||||||++|||++|++||.....
T Consensus 153 ~~~~--------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---- 213 (282)
T cd06643 153 NTRT--------IQRRDSFIGTPYWMAPEVVMC-------ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---- 213 (282)
T ss_pred cccc--------ccccccccccccccCHhhccc-------cCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----
Confidence 4211 111223468899999987753 112245678899999999999999999999874311
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........ .. ..+.. ..+..++.++.+++.+||+.+|.+||++.++++
T Consensus 214 ~~~~~~~~-~~-----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 214 MRVLLKIA-KS-----EPPTL----------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHHh-hc-----CCCCC----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111100 00 00000 011123456789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.98 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=199.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|++|.||+|+.+.+++.||+|.+... .....+.+.+|++++++++|||++++++++. ..+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 477889999999999999999989999999998632 3445678899999999999999999999854 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... ..+++..++.++.|++.|+.|||+. +|+|+||||+||+++.++.+|++|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999999999987532 2478899999999999999999998 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... ........|++.|+|||.. .+..++.++|||||||++|||++|+.||....
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--- 205 (256)
T cd08529 149 KLLSDN--------TNFANTIVGTPYYLSPELC------------EDKPYNEKSDVWALGVVLYECCTGKHPFDANN--- 205 (256)
T ss_pred eeccCc--------cchhhccccCccccCHHHh------------cCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---
Confidence 765221 1112234678899999654 45668889999999999999999999987432
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..+........ ..+ ..+...+.++.+++.+||+.+|++||++.++++.
T Consensus 206 --~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 206 --QGALILKIIRG-----VFP------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HHHHHHHHHcC-----CCC------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111111000 000 0111345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.67 Aligned_cols=268 Identities=22% Similarity=0.369 Sum_probs=201.8
Q ss_pred HHhhcCccCCcccccCcceEEEEEECC-----CCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
...++|++.++||+|+||.||+|..++ .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--- 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 346789999999999999999997642 34589999886432 233456788999999999999999999854
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCC----CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQP----EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~ 825 (997)
..+..++||||+++|+|.+++....... .....++..+..++.|++.|++|||++ +|+||||||+||++++
T Consensus 80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~ 154 (288)
T cd05061 80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAH 154 (288)
T ss_pred --CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcC
Confidence 3457899999999999999998643211 123456778899999999999999999 9999999999999999
Q ss_pred CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh
Q 001908 826 DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 826 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt 905 (997)
++.+|++|||+++........ .......++..|+|||.+ .++.++.++|||||||++|||++
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~------------~~~~~~~~~DvwslG~~l~el~~ 216 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESL------------KDGVFTTSSDMWSFGVVLWEITS 216 (288)
T ss_pred CCcEEECcCCccccccccccc------cccCCCcccccccCHHHh------------ccCCCChHhHHHHHHHHHHHHHh
Confidence 999999999999865322211 111123456789999654 45678899999999999999999
Q ss_pred -CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 906 -RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 906 -g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
|..||.... ..+...... +.... ..+..++..+.+++.+|++.+|++|||+.|+++.
T Consensus 217 ~~~~p~~~~~-----~~~~~~~~~--------~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 274 (288)
T cd05061 217 LAEQPYQGLS-----NEQVLKFVM--------DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 274 (288)
T ss_pred CCCCCCCCCC-----HHHHHHHHH--------cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 788886321 122211110 00000 0112235678999999999999999999999999
Q ss_pred HHHHHHH
Q 001908 985 LCAARQT 991 (997)
Q Consensus 985 L~~~~~~ 991 (997)
+++....
T Consensus 275 l~~~~~~ 281 (288)
T cd05061 275 LKDDLHP 281 (288)
T ss_pred HHhhcCC
Confidence 9876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.39 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=187.2
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|++..+++.||||+++... ......+..|..++... +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999999899999999997431 23345667788888764 899999999985 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999998653 478889999999999999999999 9999999999999999999999999998743
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||++. +..++.++||||+||++|||++|+.||.... .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~ 201 (316)
T cd05619 147 ML--------GDAKTCTFCGTPDYIAPEILL------------GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----E 201 (316)
T ss_pred CC--------CCCceeeecCCccccCHHHHc------------CCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----H
Confidence 11 111223456899999996653 5678899999999999999999999997431 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR-DVL 982 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 982 (997)
.+..... ....+.. +.....++.+++.+||..||++||++. ++.
T Consensus 202 ~~~~~~i------~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 202 EELFQSI------RMDNPCY------------PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHH------HhCCCCC------------CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1111111 0001110 011234567899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=309.90 Aligned_cols=262 Identities=23% Similarity=0.366 Sum_probs=203.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+|++.+.||+|+||.||+|+...+++.||||.+... .......+.+|+++++.++|+||+++++++. ..+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 4688899999999999999999889999999987632 2334567889999999999999999999854 3558
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+++|||+++++|.+++..... ....+++..++.++.|++.|++|||++ +++|+||||+||+++.++.++++|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 9999999999999999875331 122478999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+....... .......|+..|+|||.+. +..++.++||||||+++|||++|..||.....
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~~~ape~~~------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIH------------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred hhhccccCC--------cccccccCCcCccCHHHhc------------CCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 987652211 1112346888999996553 45678899999999999999999999863211
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
+ ..+... .......+.. ........+.+++.+||..+|++|||+.+|++.++++.
T Consensus 212 ~---~~~~~~-----~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 212 N---LYSLCK-----KIEQCDYPPL-----------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred h---HHHHhh-----hhhcCCCCCC-----------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 111111 1111111110 01124567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=318.31 Aligned_cols=205 Identities=21% Similarity=0.319 Sum_probs=161.2
Q ss_pred CCcccccCcceEEEEEEC--CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 684 SNMIGQGSFGSVYKGILG--ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
.++||+|+||+||+|+.+ .+++.||+|+++... ....+.+|++++++++||||+++++++.. ......++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999975 366889999986432 23457789999999999999999998643 23457899999
Q ss_pred eccCCCHHHHhhcCCCC---CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee----CCCCcEEEccc
Q 001908 762 YMQNGSLEEWLHQSNGQ---PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF 834 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DF 834 (997)
|++ ++|.+++...... .....++...++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 994 5898887643211 1122478889999999999999999999 99999999999999 46689999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
|+|+...... ..........||+.|+|||++.. ...++.++||||+||++|||++|++||...
T Consensus 157 G~a~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPL-----KPLADLDPVVVTFWYRAPELLLG-----------ARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCC-----ccccccCCccccccccCCHHHcC-----------CCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9997652211 11112234578999999976542 245788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.00 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=190.6
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|+++.+++.||+|+++.. .......+.+|+++++.+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 4699999999999999989999999999743 233456678899999887 799999999984 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999998754 478999999999999999999999 9999999999999999999999999998643
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||.+ .+..++.++|||||||++|||++|+.||.... .
T Consensus 147 ~~--------~~~~~~~~~g~~~y~aPE~~------------~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~ 201 (318)
T cd05570 147 IL--------GGVTTSTFCGTPDYIAPEIL------------SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----E 201 (318)
T ss_pred Cc--------CCCcccceecCccccCHHHh------------cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----H
Confidence 11 11112335689999999655 35678899999999999999999999997331 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM-----RDVLA 983 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~ 983 (997)
.+........ ... .+...+..+.+++.+||..||++||++ .++++
T Consensus 202 ~~~~~~i~~~------~~~------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 202 DELFQSILED------EVR------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHcC------CCC------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1111111100 000 011224567899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=319.83 Aligned_cols=242 Identities=22% Similarity=0.303 Sum_probs=187.8
Q ss_pred CcccccCcceEEEEEEC---CCCcEEEEEEeccc----chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 685 NMIGQGSFGSVYKGILG---ENGTFVAVKILNLM----QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+.||+|+||.||+++.. .+++.||+|+++.. .......+.+|++++++++||||+++++++ ..++..|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 67999999999999863 46889999998642 123345678899999999999999999884 4456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++.... .+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 77 LILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999997654 367778888999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 148 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~G~~pf~~~~--- 204 (323)
T cd05584 148 KESIHE--------GTVTHTFCGTIEYMAPEILM------------RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--- 204 (323)
T ss_pred eecccC--------CCcccccCCCccccChhhcc------------CCCCCCcceecccHHHHHHHhcCCCCCCCCC---
Confidence 753211 11123356899999996553 4567889999999999999999999997421
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
..+......... .. .+.....++.+++.+||+.||++|| ++.++++
T Consensus 205 --~~~~~~~~~~~~------~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 205 --RKKTIDKILKGK------LN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --HHHHHHHHHcCC------CC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111111100 00 0111234677999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=309.68 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=193.6
Q ss_pred CcccccCcceEEEEEECCCC---cEEEEEEecccch-hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENG---TFVAVKILNLMQK-GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
++||+|+||.||+|++...+ ..||+|.+..... ...+.+.+|++++++++|+|++++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999876444 7899999874432 34567899999999999999999999853 23579999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++..
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999998654 478899999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCcc
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLT 919 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 919 (997)
..... .........++..|+|||.+ .+..++.++|||||||++|||++ |..||.... ...
T Consensus 146 ~~~~~-----~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~ 206 (257)
T cd05060 146 GAGSD-----YYRATTAGRWPLKWYAPECI------------NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAE 206 (257)
T ss_pred ecCCc-----ccccccCccccccccCHHHh------------cCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHH
Confidence 22110 11111122345689999644 45678899999999999999998 999986431 111
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
+....... .. .+.+..++..+.+++.+||..+|++||++.++.+.|+++
T Consensus 207 ~~~~~~~~---~~-----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 207 VIAMLESG---ER-----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHcC---Cc-----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11111110 00 011122356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=329.13 Aligned_cols=260 Identities=21% Similarity=0.269 Sum_probs=193.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.++||+|+||+||+|+...+++.||||++... .....+.+.+|++++++++||||+++++++ .+..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 4788999999999999999999999999999998632 233456788999999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999998654 477888899999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCC--------cccc-------------------------------ccccccccccccccCCcchhccccc
Q 001908 836 LARFLFARPFDT--------SMET-------------------------------QSSSIGIKGTVGYVPPGNIAKMLNL 876 (997)
Q Consensus 836 ~a~~~~~~~~~~--------~~~~-------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~ 876 (997)
+|+......... .... ........||+.|+|||++.
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----- 221 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL----- 221 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-----
Confidence 996432110000 0000 00001246999999996653
Q ss_pred CccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHH
Q 001908 877 PCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEEC 956 (997)
Q Consensus 877 ~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 956 (997)
+..++.++|||||||++|||++|+.||..... .+........ ...+ .+. .....
T Consensus 222 -------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~------~~~~--~~p------~~~~~ 275 (377)
T cd05629 222 -------QQGYGQECDWWSLGAIMFECLIGWPPFCSENS-----HETYRKIINW------RETL--YFP------DDIHL 275 (377)
T ss_pred -------cCCCCCceeeEecchhhhhhhcCCCCCCCCCH-----HHHHHHHHcc------CCcc--CCC------CCCCC
Confidence 56788999999999999999999999964311 1111111000 0000 000 00012
Q ss_pred HHHHHHHHhhcCCCCCCCC---CCHHHHHHH
Q 001908 957 LVTVIRIGVACSMESPIER---MEMRDVLAK 984 (997)
Q Consensus 957 ~~~l~~li~~cl~~dP~~R---ps~~evl~~ 984 (997)
..++.+++.+|+. +|.+| +++.|+++.
T Consensus 276 s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 276 SVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 3456789999997 66665 599988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.30 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=199.9
Q ss_pred HhhcCccCCcccccCcceEEEEEECC-----CCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+.... ......+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF---- 79 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc----
Confidence 45789999999999999999999976 67889999886433 334567899999999999999999999854
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCC-CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC--
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-- 827 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-- 827 (997)
..+..++||||+++++|.+++...... .....+++..+++++.||+.|++|||++ +++||||||+||+++.++
T Consensus 80 -~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 80 -ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred -cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence 345679999999999999999875421 1223588999999999999999999999 999999999999998765
Q ss_pred -cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-
Q 001908 828 -VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT- 905 (997)
Q Consensus 828 -~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt- 905 (997)
.+|++|||+++....... .........+..|+|||.+. +..++.++|||||||++|||++
T Consensus 156 ~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~~ 217 (277)
T cd05036 156 RVAKIADFGMARDIYRASY------YRKGGRAMLPIKWMPPEAFL------------DGIFTSKTDVWSFGVLLWEIFSL 217 (277)
T ss_pred cceEeccCccccccCCccc------eecCCCCCccHhhCCHHHHh------------cCCcCchhHHHHHHHHHHHHHcC
Confidence 699999999986522111 00111223356899996553 5678999999999999999997
Q ss_pred CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 906 RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 906 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
|..||..... .+......... .+ ..+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 218 g~~pf~~~~~-----~~~~~~~~~~~-----~~------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 218 GYMPYPGRTN-----QEVMEFVTGGG-----RL------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred CCCCCCCCCH-----HHHHHHHHcCC-----cC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 9999874321 11111110000 00 00122356788999999999999999999999987
Q ss_pred H
Q 001908 986 C 986 (997)
Q Consensus 986 ~ 986 (997)
.
T Consensus 276 ~ 276 (277)
T cd05036 276 Q 276 (277)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=325.32 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=198.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+.+.+++.||+|+++... ....+.+.+|+++++.++|+||+++++++ ...+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 46889999999999999999999999999999997432 23456788999999999999999999884 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.+... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 9999999999999999987531 478889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|....... ........||+.|+|||.+..... .....++.++|||||||++|||++|+.||....
T Consensus 148 ~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~- 213 (330)
T cd05601 148 SAARLTANK-------MVNSKLPVGTPDYIAPEVLTTMNG------DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT- 213 (330)
T ss_pred CCeECCCCC-------ceeeecccCCccccCHHHhccccc------cccCCCCCcceeecccceeeeeccCCCCCCCCC-
Confidence 997652211 112233468999999988753211 114567889999999999999999999987431
Q ss_pred CCccHHHHHHhhcch-hhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPE-KVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+........ .... + +.......++.+++..|+. +|++||++.++++
T Consensus 214 ----~~~~~~~i~~~~~~~~---------~------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 214 ----SAKTYNNIMNFQRFLK---------F------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----HHHHHHHHHcCCCccC---------C------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11111111000 0000 0 0001123457789999997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.44 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=191.1
Q ss_pred cccccCcceEEEEEE--CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 686 MIGQGSFGSVYKGIL--GENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~--~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+||+|+||.||+|.+ ..+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999975 3567899999986432 334578899999999999999999999853 235789999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
|+++|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999997643 478889999999999999999999 99999999999999999999999999997652
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTL 920 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 920 (997)
.... .........++..|+|||.+. ...++.++|||||||++|||++ |..||..... ...
T Consensus 147 ~~~~-----~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~ 207 (257)
T cd05116 147 ADEN-----YYKAKTHGKWPVKWYAPECMN------------YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEV 207 (257)
T ss_pred CCCC-----eeeecCCCCCCccccCHhHhc------------cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 2111 001112223467899996553 4568889999999999999998 9999874311 111
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.+.... .. .+ +.+..++.++.+++.+||+.||++||++++|.+.|++
T Consensus 208 ~~~i~~---~~-----~~------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 208 TQMIES---GE-----RM------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHC---CC-----CC------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111110 00 00 0111235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.78 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=197.7
Q ss_pred hcCccCCcccccCcceEEEEEECC-----CCcEEEEEEecccch-hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLMQK-GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.+|.+.++||+|+||.||+|.... .++.||+|+++.... ...+.+.+|+++++.++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 357788999999999999998753 357899999974433 33467889999999999999999999854 3
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
.+..++++||+++++|.+++...... .....+++..+++++.|++.|++|+|+. +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 45789999999999999998643210 1122478888999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
+++++.+||+|||+++....... ........+++.|+|||.+ .++.++.++|||||||++||
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADY------YKLMGNSLLPIRWMSPEAI------------MYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred ecCCCceEecccccccccccchh------eeeccCccCCccccCHHHH------------hcCCCCcchhHHHHHHHHHH
Confidence 99999999999999876522111 1111223457889999655 34668889999999999999
Q ss_pred HHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 903 MFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 903 llt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
|++ |..||.... ..+.......... .+.+..++..+.+++..||+.+|++||+++++
T Consensus 219 l~~~g~~p~~~~~-----~~~~~~~i~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 219 VFSYGLQPYCGYS-----NQDVIEMIRNRQV-----------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HHcCCCCCCCCCC-----HHHHHHHHHcCCc-----------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 998 888876321 1122111111000 01122356678899999999999999999999
Q ss_pred HHHHH
Q 001908 982 LAKLC 986 (997)
Q Consensus 982 l~~L~ 986 (997)
++.|+
T Consensus 277 ~~~l~ 281 (283)
T cd05091 277 HSRLR 281 (283)
T ss_pred HHHhh
Confidence 99886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.69 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=200.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCC-----CcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGEN-----GTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++|++.+.||+|+||.||+|..+.. +..||+|.+.... ......+.+|+++++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 46788999999999999999988643 3789999986432 334567889999999999999999999854
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCC----CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQP----EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
.....++||||+++|+|.+++....... ....+++..++.++.|++.|+.|||+. +|+||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 4468999999999999999997654211 122468889999999999999999999 999999999999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-C
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-R 906 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g 906 (997)
.+||+|||.++....... ........++..|+|||.+. ++.++.++|||||||++||++| |
T Consensus 157 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~t~g 218 (277)
T cd05032 157 TVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMAPESLK------------DGVFTTKSDVWSFGVVLWEMATLA 218 (277)
T ss_pred CEEECCcccchhhccCcc------cccCCCCCccccccCHHHHh------------cCCCCcccchHHHHHHHHHhhccC
Confidence 999999999986532211 11122334678899996553 4668889999999999999998 8
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
..||.... ..+...... +.. ....+..++.++.+++.+||..+|++|||+.++++.|+
T Consensus 219 ~~p~~~~~-----~~~~~~~~~--------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 219 EQPYQGLS-----NEEVLKFVI--------DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCccCC-----HHHHHHHHh--------cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 99986321 111111110 000 00111223567889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.38 Aligned_cols=271 Identities=24% Similarity=0.398 Sum_probs=200.7
Q ss_pred hcCccCCcccccCcceEEEEEE----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGIL----GENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
+.|++.+.||+|+||.||.|+. ..++..||+|.++... ......+.+|++++++++|+|++++.+++... +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 4578899999999999999985 3467899999987443 33456789999999999999999999987532 24
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++++|.+++.+... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence 568999999999999999976431 378899999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.++....... .........++..|+|||.+ .+..++.++|||||||++|||+|++.|+...
T Consensus 153 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~apE~~------------~~~~~~~~~Di~slG~il~ellt~~~~~~~~ 215 (284)
T cd05079 153 FGLTKAIETDKE-----YYTVKDDLDSPVFWYAPECL------------IQSKFYIASDVWSFGVTLYELLTYCDSESSP 215 (284)
T ss_pred CccccccccCcc-----ceeecCCCCCCccccCHHHh------------ccCCCCccccchhhhhhhhhhhcCCCCCccc
Confidence 999986532111 01111234567789999654 3567888999999999999999988775422
Q ss_pred cCCCccHHHHHHh----hcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKM----ALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 914 ~~~~~~~~~~~~~----~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
... ..+.... ........... .+...+.+..++.++.+++.+||+.+|++||+++|+++.++++
T Consensus 216 ~~~---~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 216 MTL---FLKMIGPTHGQMTVTRLVRVLE--------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cch---hhhhcccccccccHHHHHHHHH--------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 110 0000000 00000000000 0000111123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.19 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=197.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|++..+ ..||+|+++.... ..+.+.+|++++++++|+||+++++++. .+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 35689999999999999999998744 5699999874332 2357889999999999999999998742 24579
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++.+... ..+++..+..++.|+++||+|+|+. +++||||||+||++++++.+||+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence 99999999999999986431 2478899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+...... ........++..|+|||.. .+..++.++|||||||++|||+| |..||.....
T Consensus 150 ~~~~~~~-------~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~- 209 (262)
T cd05071 150 RLIEDNE-------YTARQGAKFPIKWTAPEAA------------LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN- 209 (262)
T ss_pred eeccccc-------cccccCCcccceecCHhHh------------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-
Confidence 7652211 1111223467789999644 35678999999999999999999 8888864321
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.+...... ... ..+...+++..+.+++.+|++.+|++||++.++++.|++.
T Consensus 210 ----~~~~~~~~-----~~~------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 210 ----REVLDQVE-----RGY------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----HHHHHHHh-----cCC------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11111000 000 0011223466788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.26 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=198.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|+..+.||+|+||.||+|+...+++.||+|.+........+.+.+|+++++.++|+|++++++++. .....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 47888999999999999999998899999999997655555577889999999999999999999854 3458999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++.... +++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 95 v~e~~~~~~L~~~~~~~~-------~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 95 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred eecccCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999999997542 67889999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......|++.|+|||.+. +..++.++|||||||++|+|++|+.||.....
T Consensus 165 ~~~~~~--------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--- 221 (296)
T cd06654 165 QITPEQ--------SKRSTMVGTPYWMAPEVVT------------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--- 221 (296)
T ss_pred hccccc--------cccCcccCCccccCHHHHc------------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 642211 1122346889999996553 46678899999999999999999999964321
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
........ ... .+.. ..+......+.+++.+||..+|++||++.|+++.
T Consensus 222 -~~~~~~~~-~~~-----~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 222 -LRALYLIA-TNG-----TPEL----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -HHhHHHHh-cCC-----CCCC----------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11111000 000 0000 0112234567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.29 Aligned_cols=241 Identities=22% Similarity=0.319 Sum_probs=187.0
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|+++.+++.||+|+++... ......+..|..++... +||||+++++++ ...++.++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999997432 23345667788888764 899999999984 4566899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999997654 378889999999999999999999 9999999999999999999999999998643
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||++. +..++.++||||+||++|||++|+.||.... .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~ 201 (316)
T cd05620 147 VF--------GDNRASTFCGTPDYIAPEILQ------------GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----E 201 (316)
T ss_pred cc--------CCCceeccCCCcCccCHHHHc------------CCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----H
Confidence 11 111223457899999996653 5678899999999999999999999997321 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR-DVL 982 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 982 (997)
.+...... ...+... .....++.+++.+||+.||++||++. ++.
T Consensus 202 ~~~~~~~~------~~~~~~~------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 202 DELFESIR------VDTPHYP------------RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHH------hCCCCCC------------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11111110 0011110 01234567899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.04 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=199.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc---EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT---FVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.+|++.+.||+|+||.||+|+.+.+++ .||+|+++.. .......+..|++++++++||||+++.+++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 457889999999999999999876554 6999998743 344567899999999999999999999984 4456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++....+ .+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 78999999999999999986542 378899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|.+........... .........+..|+|||.+ .+..++.++|||||||++||+++ |..||...
T Consensus 151 g~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 151 GLSRFLEDDTSDPT---YTSSLGGKIPIRWTAPEAI------------AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred ccccccccCccccc---cccccCCCcceeecCHhHh------------ccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 99876532211110 0001111124579999654 45678899999999999999887 99998643
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
. ..+...... ... ..+.+.+++..+.+++.+||..+|++||++.++++.|+++
T Consensus 216 ~-----~~~~~~~i~-----~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 216 S-----NQDVINAIE-----QDY------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-----HHHHHHHHH-----cCC------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 111111110 000 0111223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=323.52 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=193.3
Q ss_pred cCccCCcccccCcceEEEEEEC---CCCcEEEEEEeccc----chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLM----QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 751 (997)
+|++.+.||+|+||+||+++.. .+++.||+|++... .....+.+.+|+++++++ +|++|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 4788999999999999998863 47889999998632 223345678899999999 59999999988 44
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
..+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 5668999999999999999997654 478889999999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+++...... ........||+.|+|||++.. ...++.++|||||||++|||+||+.||.
T Consensus 147 ~DfG~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 147 TDFGLSKEFLSEE-------KERTYSFCGTIEYMAPEIIRG-----------KGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred eeCcCCccccccC-------CCccccccCCccccCHHHhcC-----------CCCCCCccccccchhhhhhhhcCCCCCC
Confidence 9999997642211 112234579999999977642 1346789999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
..... ........... ..++.. +......+.+++.+||+.||++|| +++|+++
T Consensus 209 ~~~~~-~~~~~~~~~~~------~~~~~~------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 209 LEGER-NTQSEVSRRIL------KCDPPF------------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCC-CCHHHHHHHHh------cCCCCC------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 43221 11112111110 011111 111244677899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=314.80 Aligned_cols=269 Identities=21% Similarity=0.295 Sum_probs=199.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.++||+|+||.||++++..++..+|+|.++.. .......+.+|++++++++||||+++++++. .++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 3688999999999999999999989999999998743 3334567889999999999999999999854 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++++.. .+++..+..++.|+++||+|||+++ +++||||||+||+++.++.+||+|||.+
T Consensus 76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999998754 4788889999999999999999742 8999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ......|+..|+|||.+ .+..++.++|||||||++|||++|+.||.....
T Consensus 148 ~~~~~~----------~~~~~~~~~~~~aPE~~------------~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-- 203 (308)
T cd06615 148 GQLIDS----------MANSFVGTRSYMSPERL------------QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-- 203 (308)
T ss_pred cccccc----------ccccCCCCcCccChhHh------------cCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--
Confidence 654211 11235688999999654 355678899999999999999999999863321
Q ss_pred ccHHHHHHhhcchhhhhhcC--cccccccc---------------cchhhhh-HHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 918 LTLHEFCKMALPEKVMETVD--PSLLLAWS---------------DGRRRAK-VEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d--~~~~~~~~---------------~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
........... ........ ........ ....... ......++.+++.+||..+|++||++.
T Consensus 204 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 282 (308)
T cd06615 204 KELEAMFGRPV-SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK 282 (308)
T ss_pred hhHHHhhcCcc-ccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 11111111000 00000000 00000000 0000000 011345688999999999999999999
Q ss_pred HHHHHH
Q 001908 980 DVLAKL 985 (997)
Q Consensus 980 evl~~L 985 (997)
|+++.-
T Consensus 283 ~ll~~~ 288 (308)
T cd06615 283 ELTKHP 288 (308)
T ss_pred HHhcCh
Confidence 998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=319.57 Aligned_cols=207 Identities=29% Similarity=0.367 Sum_probs=171.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+++...+++.||+|++... .....+.+.+|+.+++.++|+||+++++++ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4789999999999999999999989999999998632 223446688899999999999999999984 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.+... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999976431 378889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
++....... ........||+.|+|||++..... ....++.++||||+||++|||++|+.||..
T Consensus 148 ~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 148 SCLRLLADG-------TVQSNVAVGTPDYISPEILQAMED-------GKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeecCCCC-------CccccceeccccccCHHHHhhccc-------cccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 987542211 111223468999999988763210 124578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.65 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=198.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-----KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
+.|+..+.||+|++|.||+|....++++||+|++.... ....+.+.+|++++++++||||+++++++ ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 46889999999999999999998899999999986322 22346788999999999999999999995 445
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++|+||+++++|.+++.... .++...+.+++.|++.|+.|||+. +|+||||||+||++++++.+||+|
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 68999999999999999998654 367888899999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.++...... ..........|+..|+|||.+. +..++.++||||+||++|||++|+.||...
T Consensus 148 fg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 148 FGASKRLQTIC-----SSGTGMKSVTGTPYWMSPEVIS------------GEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccceeccccc-----cccccccCCCcCccccCcceec------------cCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 99987652211 0111112345788999996654 456889999999999999999999998642
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
. ........... ...+ ..+..+...+.+++..||..+|++|||+.|+++.
T Consensus 211 ~----~~~~~~~~~~~-----~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 211 E----AMAAIFKIATQ-----PTNP------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred c----hHHHHHHHhcc-----CCCC------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 11111110000 0000 1112335567899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=328.47 Aligned_cols=207 Identities=21% Similarity=0.326 Sum_probs=170.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.|+..++||+|+||+||+|+...+++.||+|++.... ......+.+|++++++++|+||+++++++ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5888999999999999999999999999999986432 33456788999999999999999999985 445689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++.+.. .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999999999997654 367788899999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCC----Cc-----------------------------------cccccccccccccccccCCcchhcccccC
Q 001908 837 ARFLFARPFD----TS-----------------------------------METQSSSIGIKGTVGYVPPGNIAKMLNLP 877 (997)
Q Consensus 837 a~~~~~~~~~----~~-----------------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 877 (997)
|+........ .. ...........||+.|+|||++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------ 221 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL------ 221 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc------
Confidence 8543110000 00 00000112356999999996653
Q ss_pred ccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 878 CLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 878 ~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
+..++.++||||+||++|||++|+.||..
T Consensus 222 ------~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 222 ------RTGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred ------CCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 56788999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.02 Aligned_cols=242 Identities=22% Similarity=0.290 Sum_probs=188.8
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCce
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+|++.+.||+|+||+||+|+.+.+++.||+|+++... ....+.+..|..++... +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 5788999999999999999999899999999987432 23345567788888777 588899998884 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 999999999999999997654 378889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++..... ........||+.|+|||++. +..++.++|||||||++|||+||+.||....
T Consensus 147 ~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlGvil~elltg~~Pf~~~~- 205 (323)
T cd05616 147 MCKENMWD--------GVTTKTFCGTPDYIAPEIIA------------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED- 205 (323)
T ss_pred CceecCCC--------CCccccCCCChhhcCHHHhc------------CCCCCCccchhchhHHHHHHHhCCCCCCCCC-
Confidence 98753111 11223457899999996553 5678999999999999999999999997431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
..+......... ... +.....++.+++.+|++.||++|++.
T Consensus 206 ----~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 206 ----EDELFQSIMEHN------VAY------------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----HHHHHHHHHhCC------CCC------------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111111111000 000 11123456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=308.95 Aligned_cols=256 Identities=24% Similarity=0.450 Sum_probs=191.6
Q ss_pred CcccccCcceEEEEEECC---CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGE---NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~---~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|.+.. .+..||+|++... .....+.+.+|+.+++.++||||++++++|.. .++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998743 3457999998533 33456788899999999999999999998643 334678999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999986532 256778889999999999999999 9999999999999999999999999999765
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC-CCCCCcCcCCCcc
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLT 919 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~~~~~~ 919 (997)
...... .........++..|+|||.+ .+..++.++|||||||++|||++| .+||... .
T Consensus 149 ~~~~~~----~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~ 207 (262)
T cd05058 149 YDKEYY----SVHNHTGAKLPVKWMALESL------------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----D 207 (262)
T ss_pred cCCcce----eecccccCcCCccccChhHh------------ccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----C
Confidence 321110 01111223457789999654 346688999999999999999995 5555422 1
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
..+........ .. ...+..++..+.+++.+||..+|++||++.|+++.|+++..
T Consensus 208 ~~~~~~~~~~~-----~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 208 SFDITVYLLQG-----RR------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHHhcC-----CC------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11111111000 00 00111234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.10 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=200.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+.|++.++||+|+||.||+|+...+++.||+|++........+.+.+|+++++.++|+||+++++++. .+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 56889999999999999999999899999999998766666788899999999999999999999854 3458999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|..++.+... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999988865431 378899999999999999999999 99999999999999999999999999886
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... ........++..|+|||.+.. +......++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---- 219 (292)
T cd06644 159 KNVKT--------LQRRDSFIGTPYWMAPEVVMC-------ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---- 219 (292)
T ss_pred ecccc--------ccccceecCCccccCceeecc-------ccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc----
Confidence 53211 111223467889999987642 11123557889999999999999999999986421
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+...... ....+.. ..+..+..++.+++.+||..+|++||++.|+++
T Consensus 220 -~~~~~~~~~-----~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 220 -PMRVLLKIA-----KSEPPTL----------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -HHHHHHHHh-----cCCCccC----------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111100 0001110 011123456789999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=316.40 Aligned_cols=267 Identities=22% Similarity=0.378 Sum_probs=203.6
Q ss_pred HHhhcCccCCcccccCcceEEEEEEC-------CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeee
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILG-------ENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCS 746 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 746 (997)
....+|++.+.||+|+||.||+|+.. ..+..||+|+++.. .....+.+.+|+++++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34568899999999999999999752 23457999998643 234457789999999999 8999999999854
Q ss_pred ccCcCCCceEEEEEeeccCCCHHHHhhcCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 001908 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP----------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816 (997)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 816 (997)
.....++||||+++|+|.+++....... ....+++.++++++.||++|+.|||++ +|+||||
T Consensus 92 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dl 163 (304)
T cd05101 92 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL 163 (304)
T ss_pred -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence 3457899999999999999998753211 123478889999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHH
Q 001908 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896 (997)
Q Consensus 817 k~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSl 896 (997)
||+||+++.++.+||+|||.++....... ........+++.|+|||++ .+..++.++|||||
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~sl 225 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDY------YKKTTNGRLPVKWMAPEAL------------FDRVYTHQSDVWSF 225 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccc------cccccCCCCCceeeCchhh------------ccCCCCchhhHHHH
Confidence 99999999999999999999986532111 1111223456789999654 35678899999999
Q ss_pred HHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCC
Q 001908 897 GVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975 (997)
Q Consensus 897 Gvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 975 (997)
||++|||++ |..||... ...+......... . ...+..++..+.+++.+||+.+|++|
T Consensus 226 G~~l~el~~~g~~p~~~~-----~~~~~~~~~~~~~-----~------------~~~~~~~~~~~~~li~~cl~~~p~~R 283 (304)
T cd05101 226 GVLMWEIFTLGGSPYPGI-----PVEELFKLLKEGH-----R------------MDKPANCTNELYMMMRDCWHAIPSHR 283 (304)
T ss_pred HHHHHHHHcCCCCCcccC-----CHHHHHHHHHcCC-----c------------CCCCCCCCHHHHHHHHHHcccChhhC
Confidence 999999998 78887532 2222221110000 0 00112345678899999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 001908 976 MEMRDVLAKLCAARQ 990 (997)
Q Consensus 976 ps~~evl~~L~~~~~ 990 (997)
|++.|+++.|.++..
T Consensus 284 ps~~e~l~~l~~~~~ 298 (304)
T cd05101 284 PTFKQLVEDLDRILT 298 (304)
T ss_pred CCHHHHHHHHHHHHH
Confidence 999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=323.52 Aligned_cols=274 Identities=22% Similarity=0.245 Sum_probs=196.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 753 (997)
..++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999989999999998632 3334567889999999999999999999865322 1223
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...|+||||+++ ++.+.+.. .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 458999999965 67776643 267788899999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++.... ........||+.|+|||++ .+..++.++||||+||++|||++|+.||...
T Consensus 167 fg~a~~~~~---------~~~~~~~~~t~~y~aPE~~------------~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 167 FGLARTACT---------NFMMTPYVVTRYYRAPEVI------------LGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCCcccccc---------CccCCCCcccCCCCCchhc------------cCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999975421 1112335689999999655 3567889999999999999999999999743
Q ss_pred cCCCccHHHHHHhhc-c-hhhh--------hhc--Cccccc--------ccccchhhhhHHHHHHHHHHHHhhcCCCCCC
Q 001908 914 FQGGLTLHEFCKMAL-P-EKVM--------ETV--DPSLLL--------AWSDGRRRAKVEECLVTVIRIGVACSMESPI 973 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~-~-~~~~--------~~~--d~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 973 (997)
... ........... + .... ... .+.... .+..............++.+++.+|+..||+
T Consensus 226 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 304 (359)
T cd07876 226 DHI-DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304 (359)
T ss_pred CHH-HHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence 211 01111111000 0 0000 000 000000 0000000000111235678999999999999
Q ss_pred CCCCHHHHHHH
Q 001908 974 ERMEMRDVLAK 984 (997)
Q Consensus 974 ~Rps~~evl~~ 984 (997)
+|||+.|+++.
T Consensus 305 ~R~t~~e~l~h 315 (359)
T cd07876 305 KRISVDEALRH 315 (359)
T ss_pred cCCCHHHHhcC
Confidence 99999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=320.28 Aligned_cols=238 Identities=27% Similarity=0.355 Sum_probs=184.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECE-VLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|+++.+++.||+|++.... ......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46899999999999999999999999986432 223344555555 46778999999999884 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999997654 478888999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||.+. +..++.++|||||||++|||++|+.||... ..
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~ 201 (323)
T cd05575 147 IE--------HSKTTSTFCGTPEYLAPEVLR------------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DT 201 (323)
T ss_pred cc--------CCCccccccCChhhcChhhhc------------CCCCCccccccccchhhhhhhcCCCCCCCC-----CH
Confidence 11 111223457899999996553 567889999999999999999999999743 12
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
.+......... ... ....+..+.+++.+|++.||++||+++
T Consensus 202 ~~~~~~i~~~~------~~~------------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 202 AEMYDNILNKP------LRL------------KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHcCC------CCC------------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22211111100 000 001244677899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.98 Aligned_cols=195 Identities=29% Similarity=0.406 Sum_probs=168.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-C-----CCcceEEeeeeccCcCCC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-H-----RNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~~ 753 (997)
+|.+.+.||+|+||.|-+|.+..+++.||||+++... .-..+...|+.+|..++ | -|+|++++| |.-.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 7899999999999999999999999999999997543 33456678999999986 4 489999999 5667
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC--cEEE
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHV 831 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~--~~kl 831 (997)
++.|||+|.+ .-+|+++++..... .++...++.++.||+.||.+||+. +|||+||||+|||+.+.+ .+||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 7999999999 55999999987643 489999999999999999999999 999999999999997654 7999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+... .....+..+..|+|| |++.|.+|+.+.||||||||++||++|.+-|.
T Consensus 333 IDFGSSc~~~-----------q~vytYiQSRfYRAP------------EVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 333 IDFGSSCFES-----------QRVYTYIQSRFYRAP------------EVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred EecccccccC-----------Ccceeeeeccccccc------------hhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 9999998652 122356788999999 55668999999999999999999999977765
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=329.09 Aligned_cols=260 Identities=20% Similarity=0.246 Sum_probs=192.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+|++.+.||+|+||+||+|+...+++.||||++.... ......+.+|++++++++|+||+++++++ ...+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36889999999999999999999899999999986322 23346788999999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.+.. .++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999998754 367788889999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCC---------------c--------------------cccccccccccccccccCCcchhcccccCccc
Q 001908 836 LARFLFARPFDT---------------S--------------------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLE 880 (997)
Q Consensus 836 ~a~~~~~~~~~~---------------~--------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e 880 (997)
+|.......... . ...........||+.|+|||++.
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------- 217 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL--------- 217 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc---------
Confidence 985331000000 0 00000112357999999996654
Q ss_pred cCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHH
Q 001908 881 YGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTV 960 (997)
Q Consensus 881 ~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l 960 (997)
+..++.++|||||||++|||++|+.||..... .+......... .....+. ......++
T Consensus 218 ---~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~-~~~~~~~-------------~~~~s~~~ 275 (376)
T cd05598 218 ---RTGYTQLCDWWSVGVILYEMLVGQPPFLADTP-----AETQLKVINWE-TTLHIPS-------------QAKLSREA 275 (376)
T ss_pred ---CCCCCcceeeeeccceeeehhhCCCCCCCCCH-----HHHHHHHhccC-ccccCCC-------------CCCCCHHH
Confidence 56788999999999999999999999974321 11111100000 0000000 01123345
Q ss_pred HHHHhhcCCCCCCCCC---CHHHHHHH
Q 001908 961 IRIGVACSMESPIERM---EMRDVLAK 984 (997)
Q Consensus 961 ~~li~~cl~~dP~~Rp---s~~evl~~ 984 (997)
.+++.+|+ .+|++|+ ++.|+++.
T Consensus 276 ~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 276 SDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 67777766 4999999 88888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.48 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=202.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEec--ccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 753 (997)
....|++.++||+||.+.||++... +.+.||+|++. ..+......|..|+..|.++ .|.+|+++++|- -.+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d 432 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTD 432 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccC
Confidence 4467999999999999999999886 55667777654 44566778999999999999 599999999983 346
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
++.||||||- ..+|..+++++... ..+| .++.+-.|++.|+.++|.. ||||.|+||.|+++ -.|.+||+|
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~----~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLID 502 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSI----DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLID 502 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCC----CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeee
Confidence 7999999987 66999999988743 2334 7788899999999999999 99999999999999 558999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.|..+.++. +.......+||+.||+||.+..+......+ -..-..++++||||+|||+|+|+.|+.||...
T Consensus 503 FGIA~aI~~DT------TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~-~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 503 FGIANAIQPDT------TSIVKDSQVGTVNYMSPEALTDMSSSRENG-KSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred echhcccCccc------cceeeccccCcccccCHHHHhhccccccCC-CcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 99998874432 233445578999999999998764321100 00123678999999999999999999998732
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. -.| .++..+.||...-.|.+... ..++.++|+.|+..||++||+..++++
T Consensus 576 ~------n~~------aKl~aI~~P~~~Iefp~~~~-------~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 576 I------NQI------AKLHAITDPNHEIEFPDIPE-------NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred H------HHH------HHHHhhcCCCccccccCCCC-------chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1 111 23444555543222222111 123789999999999999999999975
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=312.63 Aligned_cols=271 Identities=23% Similarity=0.271 Sum_probs=204.9
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
.++..++++|++.+.||+|+||.||+|....+++.+|+|++..... ....+.+|+.+++++ +|||++++++++...+.
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 4445567889999999999999999999998999999999864322 235677899999998 89999999999865443
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
...+..++||||+++++|.++++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 344678999999999999999875321 112478899999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||.+....... .......|+..|+|||.+... ...+..++.++|||||||++|||++|+.||
T Consensus 169 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 169 LVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACE-------QQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred Eeecccchhccccc--------ccccCccCCccccChhhhcCC-------CCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 99999987652211 111234688899999877531 112334688999999999999999999998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... ...... . .....+.. ..++.....+.+++.+||..+|++||++.|+++
T Consensus 234 ~~~~~----~~~~~~-~-----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 234 FDMHP----VKTLFK-I-----PRNPPPTL----------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCcH----HHHHHH-H-----hcCCCCCC----------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 74321 111100 0 00000010 011123446889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=321.31 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=204.2
Q ss_pred cCccCCcccccCcceEEEEEECCCC-c--EEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENG-T--FVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~-~--~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+....+.||+|.||.|++|.|...+ + .||||.++..... ...+|.+|+.+|-+++|+|++++||+..+ ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------ch
Confidence 3455688999999999999996433 2 5899999866554 67899999999999999999999998543 46
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+||||.++.|+|.+.+++.. ...+-....-.++.|||+||.||.++ +.||||+.++|+++-..-.|||+|||
T Consensus 185 ~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence 899999999999999999832 12477788889999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 914 (997)
+.+.+....... .......-.+.|+|||.+. ...++.++|||+|||++|||+| |..||-...
T Consensus 258 LmRaLg~ned~Y-----vm~p~rkvPfAWCaPEsLr------------h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 258 LMRALGENEDMY-----VMAPQRKVPFAWCAPESLR------------HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred ceeccCCCCcce-----EecCCCcCcccccCHhHhc------------cccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 999874433221 1122233467899996654 6789999999999999999999 788876321
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
...+.+.+| ++.+.+.++.|+++++++++.||.++|++|||+.++.+.+
T Consensus 321 --------------g~qIL~~iD--------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 321 --------------GIQILKNID--------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --------------HHHHHHhcc--------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 011222223 3445566788999999999999999999999999997443
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=317.03 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=203.0
Q ss_pred hhcCccCCcccccCcceEEEEEECC-------CCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGE-------NGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
.++|.+.+.||+|+||.||+|++.. +...+|+|+++.. .......+.+|+++++.+ +|+||++++++|..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 3679999999999999999998642 2357999999743 234456788899999999 79999999999643
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQP----------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
.+..++||||+++|+|.+++....... ....+++.++++++.|++.|++|||+. +++||||||
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 457899999999999999998753210 122478999999999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+||+++.++++||+|||.++....... ........++..|+|||.+ .+..++.++|||||||
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DvwslG~ 230 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEAL------------FDRIYTHQSDVWSFGV 230 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccch------hhccccCCCccceeChHHh------------ccCCCCcHHHHHHHHH
Confidence 999999999999999999876522110 0011112345689999654 3566889999999999
Q ss_pred HHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 899 MLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 899 vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++|||++ |..||... ...+......... ....+..++.++.+++.+||..+|++||+
T Consensus 231 ~l~el~~~g~~p~~~~-----~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 288 (307)
T cd05098 231 LLWEIFTLGGSPYPGV-----PVEELFKLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPT 288 (307)
T ss_pred HHHHHHcCCCCCCCcC-----CHHHHHHHHHcCC-----------------CCCCCCcCCHHHHHHHHHHcccChhhCcC
Confidence 9999998 88887532 2222211110000 00111234567889999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 001908 978 MRDVLAKLCAARQTL 992 (997)
Q Consensus 978 ~~evl~~L~~~~~~~ 992 (997)
+.++++.|.++.+..
T Consensus 289 ~~evl~~l~~~~~~~ 303 (307)
T cd05098 289 FKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=308.68 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=196.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|... .+..||+|.+..... ..+.+.+|++++++++|+|++++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcE
Confidence 357889999999999999999886 667799999875333 2367899999999999999999998752 23578
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++|||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+|++|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence 99999999999999986431 2478999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
....... ........++..|+|||.+ .+..++.++||||||+++|||++ |..||....
T Consensus 150 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-- 208 (260)
T cd05070 150 RLIEDNE-------YTARQGAKFPIKWTAPEAA------------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-- 208 (260)
T ss_pred eeccCcc-------cccccCCCCCccccChHHH------------hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence 7642211 0111123356789999654 35668899999999999999999 888986421
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+........ .. .+.+...+.++.+++.+|+..+|++|||+.++.+.|++
T Consensus 209 ---~~~~~~~~~~~-----~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 209 ---NREVLEQVERG-----YR------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---HHHHHHHHHcC-----CC------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111111000 00 01112335578899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=309.69 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=193.0
Q ss_pred CcccccCcceEEEEEECCCCc--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGT--FVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|+...++. .+|+|.++.. .....+.+.+|+++++++ +||||+++++++.. .+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 368999999999999987765 4688888643 334456788999999999 79999999998643 45789999
Q ss_pred eeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 761 EYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999865421 1122478899999999999999999998 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRP 909 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P 909 (997)
++|||++..... .........+..|+|||.+ .+..++.++|||||||++|||++ |..|
T Consensus 153 l~dfgl~~~~~~---------~~~~~~~~~~~~y~apE~~------------~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 153 IADFGLSRGQEV---------YVKKTMGRLPVRWMAIESL------------NYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred ECCCCCccccch---------hhhccCCCCccccCChHHH------------ccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999853210 0111112345679999654 35668899999999999999997 9999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
|.... ..+........ ... ..+..++.++.+++.+||+.+|.+|||+.|+++.|.++.
T Consensus 212 f~~~~-----~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 212 YCGMT-----CAELYEKLPQG-----YRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ccccC-----HHHHHHHHhCC-----CCC------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 86421 11111111000 000 011123456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.62 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=198.2
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+|++.++||+|+||.||++++..+++.||+|.++. ......+.+.+|+++++.++|+||+++.+++ ...+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 47888999999999999999999999999999863 2344557788999999999999999999984 44568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.+++...... .++...++.++.|++.|+.|||++ +|+|+||||+||++++++.++++|||.+.
T Consensus 76 v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGK----LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEeeCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999998764322 367888999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... ........|++.|+|||++. +..++.++||||||+++|+|++|..||...
T Consensus 149 ~~~~~--------~~~~~~~~~~~~~~aPE~~~------------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~----- 203 (255)
T cd08219 149 LLTSP--------GAYACTYVGTPYYVPPEIWE------------NMPYNNKSDIWSLGCILYELCTLKHPFQAN----- 203 (255)
T ss_pred eeccc--------ccccccccCCccccCHHHHc------------cCCcCchhhhhhhchhheehhhccCCCCCC-----
Confidence 54211 11122356888999997654 456888999999999999999999998732
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
............. .. +.+..+...+.+++.+||+.||++||++.+++.+
T Consensus 204 ~~~~~~~~~~~~~----~~-------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 204 SWKNLILKVCQGS----YK-------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHhcCC----CC-------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111111110000 00 0011234467799999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=324.31 Aligned_cols=275 Identities=20% Similarity=0.214 Sum_probs=198.0
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKG 752 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 752 (997)
...++|+..+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4557899999999999999999999889999999998642 3334567789999999999999999999865322 123
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
....++||||+++ ++.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 3468999999954 77777753 267888999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+++.... ........||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 162 Dfg~~~~~~~---------~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 162 DFGLARTAGT---------SFMMTPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred eCcccccCCC---------ccccCCccccCCccCHHHHc------------CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999975421 11123356899999996553 56788999999999999999999999974
Q ss_pred CcCCCccHHHHHHhhc--chhhhhhcCccccc---------------ccccch---hhhhHHHHHHHHHHHHhhcCCCCC
Q 001908 913 MFQGGLTLHEFCKMAL--PEKVMETVDPSLLL---------------AWSDGR---RRAKVEECLVTVIRIGVACSMESP 972 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~---------------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP 972 (997)
.... ..+........ .........+.... .+.+.. ..........++.+++.+|+..||
T Consensus 221 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 299 (355)
T cd07874 221 RDYI-DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_pred CCHH-HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCc
Confidence 3211 01111111000 00000000000000 000000 000011123467899999999999
Q ss_pred CCCCCHHHHHHH
Q 001908 973 IERMEMRDVLAK 984 (997)
Q Consensus 973 ~~Rps~~evl~~ 984 (997)
++|||+.|+++.
T Consensus 300 ~~Rps~~ell~h 311 (355)
T cd07874 300 AKRISVDEALQH 311 (355)
T ss_pred hhcCCHHHHhcC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=308.11 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=195.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|.+.++||+|+||.||+|.+.. +..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 568889999999999999999864 4569999886433 23467889999999999999999998752 235789
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence 9999999999999986432 2478899999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
...... ........++..|+|||.. .+..++.++|||||||++|||+| |+.||.....
T Consensus 151 ~~~~~~-------~~~~~~~~~~~~y~~Pe~~------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 209 (260)
T cd05069 151 LIEDNE-------YTARQGAKFPIKWTAPEAA------------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-- 209 (260)
T ss_pred EccCCc-------ccccCCCccchhhCCHHHh------------ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 652111 1111223456789999644 45678899999999999999999 8999864311
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.+..... .....+ +.+...+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 210 ---~~~~~~~-----~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 210 ---REVLEQV-----ERGYRM------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---HHHHHHH-----HcCCCC------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111110 000000 0112235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.43 Aligned_cols=268 Identities=23% Similarity=0.387 Sum_probs=197.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCC--------------CcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGEN--------------GTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKII 742 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~--------------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 742 (997)
.++|++.++||+|+||.||+|+.... ...||+|+++.. .......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35799999999999999999987532 235899998743 334456789999999999999999999
Q ss_pred eeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCC------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 001908 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816 (997)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 816 (997)
+++. .....++||||+++++|.+++...... .....+++..+++++.|++.|++|||+. +++||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9954 455789999999999999999754311 1112468889999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHH
Q 001908 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896 (997)
Q Consensus 817 k~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSl 896 (997)
||+||++++++.+|++|||++....... .........++..|+|||.+ .++.++.++|||||
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DvwSl 217 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGD------YYRIQGRAVLPIRWMAWESI------------LLGKFTTASDVWAF 217 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCc------ceeccCcCcCceeecChhhh------------ccCCcCchhhHHHH
Confidence 9999999999999999999997652211 11111223457789999654 35678999999999
Q ss_pred HHHHHHHHh--CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 897 GVMLLEMFT--RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 897 Gvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
||++|||++ +..||...... ..+... ...... ....... .....++..+.+++.+||..+|++
T Consensus 218 G~~l~el~~~~~~~p~~~~~~~-~~~~~~-~~~~~~-----~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~ 282 (295)
T cd05097 218 GVTLWEMFTLCKEQPYSLLSDE-QVIENT-GEFFRN-----QGRQIYL--------SQTPLCPSPVFKLMMRCWSRDIKD 282 (295)
T ss_pred HHHHHHHHHcCCCCCCcccChH-HHHHHH-HHhhhh-----ccccccC--------CCCCCCCHHHHHHHHHHcCCCchh
Confidence 999999998 56676632111 111110 000000 0000000 001123467899999999999999
Q ss_pred CCCHHHHHHHHH
Q 001908 975 RMEMRDVLAKLC 986 (997)
Q Consensus 975 Rps~~evl~~L~ 986 (997)
||++.+|++.|+
T Consensus 283 RPs~~~i~~~l~ 294 (295)
T cd05097 283 RPTFNKIHHFLR 294 (295)
T ss_pred CcCHHHHHHHHh
Confidence 999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.33 Aligned_cols=249 Identities=29% Similarity=0.400 Sum_probs=196.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||.||+|.. .+..||+|.++... ..+.+.+|++++++++|+|++++++++. ...+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence 4788899999999999999987 57889999986432 3467889999999999999999998753 33457899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++.+... ..+++..++.++.|++.|++|||++ +|+||||||+||++++++.+|++|||+++
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred EEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence 9999999999999987542 2378889999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
..... .....++..|+|||.+. +..++.++|||||||++|||++ |+.||...
T Consensus 151 ~~~~~-----------~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---- 203 (256)
T cd05082 151 EASST-----------QDTGKLPVKWTAPEALR------------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---- 203 (256)
T ss_pred ecccc-----------CCCCccceeecCHHHHc------------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----
Confidence 54211 11223456899996553 4668889999999999999998 99998632
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
...+........ ..+ ..+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 204 -~~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 204 -PLKDVVPRVEKG-----YKM------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CHHHHHHHHhcC-----CCC------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 122221111000 000 0112345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=314.81 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=200.1
Q ss_pred HHhhcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLMQ-KGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
...++|.+.+.||+|+||.||+|.+ ...+..||+|+++... ....+.+.+|+++++++ +|+||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT-- 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--
Confidence 3446799999999999999999975 2345689999987432 33456789999999999 7999999999864
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
..+..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||++ +|+|+||||+||+++.++.
T Consensus 110 ---~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~ 179 (302)
T cd05055 110 ---IGGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKI 179 (302)
T ss_pred ---cCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCe
Confidence 34578999999999999999986432 1378999999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RR 907 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~ 907 (997)
+|++|||.++....... ........++..|+|||.+ .+..++.++||||+||++|||++ |.
T Consensus 180 ~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 180 VKICDFGLARDIMNDSN------YVVKGNARLPVKWMAPESI------------FNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred EEECCCcccccccCCCc------eeecCCCCcccccCCHhhh------------ccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 99999999976522110 0111223457789999654 35668899999999999999998 99
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.||....... ...+... ....+. .+...+.++.+++.+||..+|++||++.|+++.|++
T Consensus 242 ~p~~~~~~~~-~~~~~~~--------~~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 242 NPYPGMPVDS-KFYKLIK--------EGYRMA------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCcCCCCchH-HHHHHHH--------cCCcCC------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 9986432111 0111100 000000 001123567899999999999999999999999987
Q ss_pred H
Q 001908 988 A 988 (997)
Q Consensus 988 ~ 988 (997)
+
T Consensus 301 ~ 301 (302)
T cd05055 301 Q 301 (302)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=318.72 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=188.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|+...+++.||+|+++.. .....+.+.+|+.++.++ +|++|+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 4699999999999999999999999999743 233456788999999888 699999999984 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999987654 488999999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC-cc
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG-LT 919 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-~~ 919 (997)
.. .........||+.|+|||.+ .+..++.++|||||||++|||++|+.||....... ..
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~------------~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~ 206 (327)
T cd05617 147 LG--------PGDTTSTFCGTPNYIAPEIL------------RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206 (327)
T ss_pred cC--------CCCceecccCCcccCCHHHH------------CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc
Confidence 11 11122345799999999655 35678899999999999999999999996432211 11
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
..+.......... .. .+......+.+++.+|++.||++|++++
T Consensus 207 ~~~~~~~~~~~~~-----~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 207 TEDYLFQVILEKP-----IR------------IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred cHHHHHHHHHhCC-----CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1111111110000 00 0111234567899999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=316.30 Aligned_cols=267 Identities=24% Similarity=0.394 Sum_probs=202.2
Q ss_pred hhcCccCCcccccCcceEEEEEEC-------CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-------ENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
.++|.+.++||+|+||.||+|+.. .....||+|+++.. .......+.+|+++++++ +||||++++++|.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 467889999999999999999763 23457999998743 234456788999999999 6999999999864
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
..+..++||||+++|+|.+++...... .....+++.++.+++.|++.|++|||++ +|+||||||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 345789999999999999999875321 1123488999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+||+++.++.+|++|||.++........ .......++..|+|||.+ .+..++.++|||||||
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DiwslG~ 224 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYY------KKTSNGRLPVKWMAPEAL------------FDRVYTHQSDVWSFGI 224 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccc------cccccCCCCccccCHHHH------------ccCCcCccchhhHHHH
Confidence 9999999999999999999765221110 011112345679999654 3567889999999999
Q ss_pred HHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 899 MLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 899 vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++|||++ |..||.... ..+.......... . ..+..++.++.+++.+||+.+|++||+
T Consensus 225 ~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~-----~------------~~~~~~~~~l~~li~~cl~~~p~~Rps 282 (314)
T cd05099 225 LMWEIFTLGGSPYPGIP-----VEELFKLLREGHR-----M------------DKPSNCTHELYMLMRECWHAVPTQRPT 282 (314)
T ss_pred HHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCC-----C------------CCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 9999999 888886321 1111111100000 0 011233557789999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 001908 978 MRDVLAKLCAARQTL 992 (997)
Q Consensus 978 ~~evl~~L~~~~~~~ 992 (997)
+.|+++.|.++....
T Consensus 283 ~~~ll~~l~~~~~~~ 297 (314)
T cd05099 283 FKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=314.11 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=199.7
Q ss_pred hhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++|++.+.||+|+||.||+|... .++..||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 467999999999999999999874 257789999987432 334567889999999999999999999854
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCC----------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQ----------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 815 (997)
..+..++||||+++|+|.+++...... .....+++..++.++.|++.|++|||+. +++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 345789999999999999999854311 1123478889999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHH
Q 001908 816 LKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYS 895 (997)
Q Consensus 816 lk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwS 895 (997)
|||+||+++.++.+|++|||.+..+..... .........+..|+|||.+ .+..++.++||||
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~s 217 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADY------YKASENDAIPIRWMPPESI------------FYNRYTTESDVWA 217 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCcc------ccccCCCccChhhcCHHHH------------hcCCCCchhHHHH
Confidence 999999999999999999999876532211 0111122345679999654 3567899999999
Q ss_pred HHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 896 LGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 896 lGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
|||++|||++ |..||.... ..+.......... .+.+..++.++.+++.+||..+|++
T Consensus 218 lG~il~el~~~~~~p~~~~~-----~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~ 275 (288)
T cd05050 218 YGVVLWEIFSYGMQPYYGMA-----HEEVIYYVRDGNV-----------------LSCPDNCPLELYNLMRLCWSKLPSD 275 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCCC-----------------CCCCCCCCHHHHHHHHHHcccCccc
Confidence 9999999998 888876321 1222111111000 0011123567889999999999999
Q ss_pred CCCHHHHHHHHHH
Q 001908 975 RMEMRDVLAKLCA 987 (997)
Q Consensus 975 Rps~~evl~~L~~ 987 (997)
|||+.|+++.|++
T Consensus 276 Rpt~~el~~~l~~ 288 (288)
T cd05050 276 RPSFASINRILQR 288 (288)
T ss_pred CCCHHHHHHHhhC
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=306.74 Aligned_cols=250 Identities=31% Similarity=0.462 Sum_probs=198.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||.||+|.. .++.||+|+++.... ..+.+.+|+.++++++|+||+++++++. ..+..+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence 45788999999999999999998 588999999975543 5678899999999999999999999854 356799
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999986542 1478999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+..... .....++..|+|||.+ .++.++.++||||||+++||+++ |+.||....
T Consensus 150 ~~~~~~-----------~~~~~~~~~~~ape~~------------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-- 204 (256)
T cd05039 150 KEASQG-----------QDSGKLPVKWTAPEAL------------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-- 204 (256)
T ss_pred cccccc-----------cccCCCcccccCchhh------------cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--
Confidence 765111 0112345679999644 35678889999999999999997 999986331
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+........ ..+ ..+..++..+.+++.+||..+|++||++.|++++|.+
T Consensus 205 ---~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 205 ---LKDVVPHVEKG-----YRM------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---HHHHHHHHhcC-----CCC------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11111110000 000 0011235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.43 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=189.8
Q ss_pred CcccccCcceEEEEEEC--CCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILG--ENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.||+|+||.||+|.+. .++..+|+|.++... ......+.+|+.++++++||||+++++++. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 46899999999999874 245679999886433 233457889999999999999999999854 3457899999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
|+++|+|.+++...... .....++..+.+++.|++.|++|||+. +++||||||+||+++.++++|++|||.++...
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999864321 122356778889999999999999999 99999999999999999999999999987542
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTL 920 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 920 (997)
.... ........++..|+|||++..... ......++.++|||||||++|||++ |+.||....... .
T Consensus 152 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~ 218 (269)
T cd05087 152 KEDY------YVTPDQLWVPLRWIAPELVDEVHG-----NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--V 218 (269)
T ss_pred Ccce------eecCCCcCCcccccCHhHhccccc-----cccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--H
Confidence 2111 111223457888999988753210 0112346889999999999999996 999986432111 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
... ..........++.... .....+.+++..|| .+|++|||++||++.|.
T Consensus 219 ~~~---~~~~~~~~~~~~~~~~------------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 LTY---TVREQQLKLPKPRLKL------------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHH---HhhcccCCCCCCccCC------------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 0001111111111110 12345678999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.07 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=197.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|..+ +++.||+|++..... ....+.+|++++++++|+|++++++++. .+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence 467899999999999999999976 678899999874332 3467889999999999999999998742 34689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++|||+++++|.+++....+ ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence 99999999999999876442 2478899999999999999999998 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
........ .......++..|+|||.+ .+..++.++|||||||++||+++ |+.||....
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~~pe~~------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-- 208 (260)
T cd05067 150 RLIEDNEY-------TAREGAKFPIKWTAPEAI------------NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-- 208 (260)
T ss_pred eecCCCCc-------ccccCCcccccccCHHHh------------ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--
Confidence 76521111 111223456789999654 35668889999999999999999 999987432
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+...... ..... +.+...+.++.+++.+||+.+|++||+++++...|+.
T Consensus 209 ---~~~~~~~~~-----~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 209 ---NPEVIQNLE-----RGYRM------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---hHHHHHHHH-----cCCCC------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111110 00000 0011234578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=349.42 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=203.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
-+|+...+||.|.||.||-|...++|...|+|.++.. .....+.+.+|..++..++|||+|+++|+ -...+..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHREKV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHHHH
Confidence 4677889999999999999999999999999988743 23445678899999999999999999998 3445689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
+|.||||++|+|.+.+...+ -.++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccc
Confidence 99999999999999998765 256667778899999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|..+.+... ..........||+.|||||++.+.. +.+...++||||+|||+.||+||+.||.....+
T Consensus 1381 a~ki~~~~~----~~~~el~~~~GT~~YMAPEvit~t~---------~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1381 AVKIKNNAQ----TMPGELQSMMGTPMYMAPEVITGTK---------GKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred eeEecCchh----cCCHHHHhhcCCchhcCchhhcccc---------cCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 998855421 1123345678999999998886532 244566899999999999999999998754322
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
-..+..... +...+.|+....+=.+++..|+..||++|.++.|+++
T Consensus 1448 ~aIMy~V~~---------------------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1448 WAIMYHVAA---------------------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hHHHhHHhc---------------------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 222221111 1111222333445568899999999999999987765
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.31 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=198.7
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
-|...+.||.|+||.||-|++..+.+.||||++.... .+.-.++.+|+..|++++|||++.+-|+|. .+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchH
Confidence 4666788999999999999999999999999997443 333467899999999999999999999853 34568
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+||||| -|+-.|.+.-.. .++....+..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.
T Consensus 102 WLVMEYC-lGSAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred HHHHHHH-hccHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 9999999 568888776543 2477889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|.... ....++|||.|||||++-.+. .+.|+-++||||+||+..|+.-.++|+-.+
T Consensus 173 Asi~~------------PAnsFvGTPywMAPEVILAMD---------EGqYdgkvDvWSLGITCIELAERkPPlFnM--- 228 (948)
T KOG0577|consen 173 ASIMA------------PANSFVGTPYWMAPEVILAMD---------EGQYDGKVDVWSLGITCIELAERKPPLFNM--- 228 (948)
T ss_pred hhhcC------------chhcccCCccccchhHheecc---------ccccCCccceeeccchhhhhhhcCCCccCc---
Confidence 97652 234578999999999997654 488999999999999999999999996422
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+...+... .--.|.+ ...++...+..++..|+..-|.+|||..++++
T Consensus 229 -NAMSALYHIA------QNesPtL-----------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 229 -NAMSALYHIA------QNESPTL-----------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -hHHHHHHHHH------hcCCCCC-----------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1122211111 1111111 12345667888999999999999999998865
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=310.83 Aligned_cols=274 Identities=25% Similarity=0.378 Sum_probs=203.9
Q ss_pred hcCccCCcccccCcceEEEEEECC----CCcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGE----NGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|+..+.||+|+||.||+|++.. ++..||||+++..... ..+.+.+|+++++.++|+||+++++++.. .+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 467888999999999999999753 4789999999755443 56789999999999999999999998643 235
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 678999999999999999986542 378899999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+........ .........++..|+|||.+ .+..++.++||||||+++|||+||+.|+...
T Consensus 153 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~~Pe~~------------~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 153 FGLAKVLPEDKD-----YYYVKEPGESPIFWYAPECL------------RTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccccccCCc-----ceeccCCCCCcccccCcHHH------------ccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 999987632111 01111123455679999654 3457888999999999999999999997643
Q ss_pred cCCCccHHHHHHh-hcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKM-ALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 914 ~~~~~~~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
......+...... .......+..... ...+.+..++.++.+++.+||+.+|++|||+.|++++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLKEG--------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cchhccccccccccccHHHHHHHHHcC--------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2211100000000 0000001111100 01111234557889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.80 Aligned_cols=272 Identities=22% Similarity=0.335 Sum_probs=205.1
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEEEEEee
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
.+.||+|+|+.|.-++...+|.+||||++.+.....+....+|++++.+.+ |+||++++.+ |+++...|+|||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEec
Confidence 367999999999999998899999999998877777889999999999985 9999999999 7788899999999
Q ss_pred ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC---cEEEcccccchh
Q 001908 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLARF 839 (997)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFg~a~~ 839 (997)
|.||.|..+|+++. .+++.++.++..+|+.||+|||.+ ||.|||+||+|||..+.. -|||+||.++.-
T Consensus 158 m~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccc
Confidence 99999999999876 588889999999999999999999 999999999999998765 479999998765
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC--CC
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ--GG 917 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~--~~ 917 (997)
+.... +.+..........+|+..|||||+..-..+ ....|+.++|.||+|||+|-|++|.+||...=. -+
T Consensus 229 ~k~~~-~~spastP~L~tPvGSAEfMAPEVVd~fv~-------qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 229 IKLNN-DCSPASTPELLTPVGSAEFMAPEVVDVFVD-------QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred cccCC-CCCCCCCccccCcccchhhcchhHHhhhcc-------ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 42211 111233344556789999999999864322 234588899999999999999999999974322 11
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+-.+.++. ..+...+.+......+. + ..-.....+-.+++...+..|+..|.++.+++.
T Consensus 301 WdrGe~Cr~-CQ~~LFesIQEGkYeFP-d----kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRV-CQNKLFESIQEGKYEFP-D----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHH-HHHHHHHHHhccCCcCC-h----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111 11222233322221110 0 001112234567888888899999999988865
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=312.12 Aligned_cols=272 Identities=22% Similarity=0.338 Sum_probs=195.7
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|++|.||+|+.+.+++.||+|+++.. .......+.+|++++++++|||++++++++. .++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 478889999999999999999989999999998643 2233467789999999999999999999954 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||++ ++|.+++..... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999996 689998876432 12478999999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ........+++.|+|||.+.. ...++.++|||||||++|||+||++||.......
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~ 209 (285)
T cd07861 149 RAFGIP--------VRVYTHEVVTLWYRAPEVLLG-----------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID 209 (285)
T ss_pred eecCCC--------cccccCCcccccccChHHhcC-----------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 754211 111122356889999976542 2346889999999999999999999987432111
Q ss_pred ccHHHHHHhh--cchhhhhh-cC-ccccc---ccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA--LPEKVMET-VD-PSLLL---AWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~--~~~~~~~~-~d-~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ........ .....+.. .+ +.... .+.............+++.+++.+||..||++|||+.+++.
T Consensus 210 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 210 Q-LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred H-HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000000 00000000 00 00000 00000000111123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.55 Aligned_cols=267 Identities=23% Similarity=0.389 Sum_probs=198.0
Q ss_pred hcCccCCcccccCcceEEEEEECC----------------CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGE----------------NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKI 741 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 741 (997)
++|++.++||+|+||.||++.+.. ++..||+|++... .......+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999986532 3446899999743 33445788999999999999999999
Q ss_pred EeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCC-----CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 001908 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP-----EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816 (997)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 816 (997)
++++. ..+..++||||+++|+|.+++....... ....+++.++..++.|++.|++|||+. +|+||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 99854 3457899999999999999998754221 123477889999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHH
Q 001908 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896 (997)
Q Consensus 817 k~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSl 896 (997)
||+||+++.++.+|++|||+++.+..... ........++..|+|||.. .++.++.++|||||
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~------------~~~~~~~~~DiwSl 218 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDY------YRIQGRAVLPIRWMSWESI------------LLGKFTTASDVWAF 218 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcc------eeccCcCcCccccCCHHHH------------hcCCccchhhhhHH
Confidence 99999999999999999999976522111 0111223346789999643 35678999999999
Q ss_pred HHHHHHHHh--CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 897 GVMLLEMFT--RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 897 Gvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
||++|||++ |..||..... .+..... .+..+...... ..+.+..++..+.+++.+||+.||++
T Consensus 219 G~~l~el~~~~~~~p~~~~~~-----~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~ 283 (296)
T cd05095 219 GVTLWEILTLCKEQPYSQLSD-----EQVIENT-----GEFFRDQGRQV-----YLPKPALCPDSLYKLMLSCWRRNAKE 283 (296)
T ss_pred HHHHHHHHHhCCCCCccccCh-----HHHHHHH-----HHHHhhccccc-----cCCCCCCCCHHHHHHHHHHcCCCccc
Confidence 999999998 6778763211 1111100 00000000000 00111234567889999999999999
Q ss_pred CCCHHHHHHHHH
Q 001908 975 RMEMRDVLAKLC 986 (997)
Q Consensus 975 Rps~~evl~~L~ 986 (997)
||++.|+++.|+
T Consensus 284 Rp~~~~i~~~l~ 295 (296)
T cd05095 284 RPSFQEIHATLL 295 (296)
T ss_pred CCCHHHHHHHHh
Confidence 999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=308.90 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=200.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCC---CcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGEN---GTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||.||+|.+... ...||+|+..... ....+.+.+|++++++++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 35688899999999999999987543 3468999887544 4456788999999999999999999998642
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++|+|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEcc
Confidence 357899999999999999976431 378999999999999999999998 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+++....... .......++..|+|||.+ ....++.++|||||||++||+++ |..||..
T Consensus 151 ~g~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 151 FGLSRYLEDESY-------YKASKGKLPIKWMAPESI------------NFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred Cceeeecccccc-------eecCCCCccccccChhhh------------ccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999976532211 111122345689999654 34668899999999999999996 9999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.... +...... .... ...+..++.++.+++.+|+..+|++|||+.++++.|.++..+
T Consensus 212 ~~~~-----~~~~~~~-----~~~~------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 212 VKNN-----DVIGRIE-----NGER------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCHH-----HHHHHHH-----cCCc------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3211 1111000 0000 011123456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=319.03 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=185.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECE-VLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++|+||+++++++ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46999999999999999899999999986422 222334444444 56788999999999884 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+....+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999998654 366778888999999999999999 9999999999999999999999999999753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||++. +..++.++||||+||++|||++|+.||.... .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~ 201 (325)
T cd05602 147 IE--------HNGTTSTFCGTPEYLAPEVLH------------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----T 201 (325)
T ss_pred cc--------CCCCcccccCCccccCHHHHc------------CCCCCCccccccccHHHHHHhcCCCCCCCCC-----H
Confidence 21 111223457999999996654 5678899999999999999999999997421 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.+.......... ... ......+.+++.+|++.||++||++.+.+..
T Consensus 202 ~~~~~~i~~~~~--~~~----------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 202 AEMYDNILNKPL--QLK----------------PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHhCCc--CCC----------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 121111110000 000 1123456789999999999999998755443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=315.86 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=204.0
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch---hhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK---GALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 752 (997)
....|++.+.||+|.||.||+++.+.+|+.+|+|++..... .......+|+++|+++. |||||.+.++ |++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence 34578889999999999999999999999999999974432 24468899999999998 9999999999 556
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC----Cc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MV 828 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~ 828 (997)
....++|||++.||.|.+.+.+. .+++..+..++.||+.|+.|||+. ||+|||+||+|+|+... +.
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence 67999999999999999999886 178889999999999999999998 99999999999999644 47
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+|++|||+|..... .......+||+.|+|||++. +..|+..+||||+||++|.|++|.+
T Consensus 178 ik~~DFGla~~~~~---------~~~~~~~~Gtp~y~APEvl~------------~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKP---------GERLHTIVGTPEYVAPEVLG------------GRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred EEEeeCCCceEccC---------CceEeeecCCccccCchhhc------------CCCCCcccchhHHHHHHHHHhhCCC
Confidence 99999999987622 34456689999999996664 4789999999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
||........ .... ...+. +..++. | ........+++..|+..||.+|+|+.++++.
T Consensus 237 PF~~~~~~~~-~~~i----~~~~~-~f~~~~----w---------~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 237 PFWGETEFEI-FLAI----LRGDF-DFTSEP----W---------DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCcCCChhHH-HHHH----HcCCC-CCCCCC----c---------cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 9985432211 1111 11111 111111 1 1223456789999999999999999999873
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.70 Aligned_cols=268 Identities=22% Similarity=0.371 Sum_probs=199.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCC----------------cEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENG----------------TFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIK 740 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----------------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 740 (997)
.++|++.++||+|+||.||+|+....+ ..||+|++.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357899999999999999999876433 568999987432 345678899999999999999999
Q ss_pred EEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCC-----CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 001908 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP-----EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815 (997)
Q Consensus 741 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 815 (997)
+++++. ..+..+++|||+++++|.+++....... ....+++..++.++.|++.|++|||+. +|+|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999864 3468999999999999999998754211 112478999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHH
Q 001908 816 LKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYS 895 (997)
Q Consensus 816 lk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwS 895 (997)
|||+||+++.++.+|++|||.++....... ........++..|+|||.+ .+..++.++||||
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~s 217 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDY------YRVQGRAPLPIRWMAWESV------------LLGKFTTKSDVWA 217 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcc------eeecCcCCCCceecCHHHh------------hcCCCCccchhhh
Confidence 999999999999999999999876532211 1112234567889999654 3467889999999
Q ss_pred HHHHHHHHHh--CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCC
Q 001908 896 LGVMLLEMFT--RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973 (997)
Q Consensus 896 lGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 973 (997)
|||++|||++ +..||...... ............ .+.... ...+..++.++.+++.+||..||+
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~ 282 (296)
T cd05051 218 FGVTLWEILTLCREQPYEHLTDQ--QVIENAGHFFRD-----DGRQIY--------LPRPPNCPKDIYELMLECWRRDEE 282 (296)
T ss_pred hHHHHHHHHhcCCCCCCCCcChH--HHHHHHHhcccc-----cccccc--------CCCccCCCHHHHHHHHHHhccChh
Confidence 9999999998 67777633211 111110000000 000000 001122346789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 001908 974 ERMEMRDVLAKLC 986 (997)
Q Consensus 974 ~Rps~~evl~~L~ 986 (997)
+|||+.|+++.|+
T Consensus 283 ~Rpt~~el~~~L~ 295 (296)
T cd05051 283 DRPTFREIHLFLQ 295 (296)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.14 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=194.2
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ....+.+.+|+.++++++|++++++++++. ..+..+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence 677889999999999999999999999999986322 222355678999999999999999998853 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 99999999999999865432 2478889999999999999999998 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... .......|+..|+|||.+. +..++.++||||+||++|||++|+.||.......
T Consensus 150 ~~~~~~---------~~~~~~~g~~~y~aPE~~~------------~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~ 208 (285)
T cd05630 150 VHVPEG---------QTIKGRVGTVGYMAPEVVK------------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208 (285)
T ss_pred eecCCC---------ccccCCCCCccccChHHHc------------CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence 654211 1112346899999996553 5678899999999999999999999997432111
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
..... .... .. .... .+..+..++.+++.+||+.||++||| +.|+++
T Consensus 209 -~~~~~-~~~~-~~----~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 209 -KREEV-ERLV-KE----VQEE------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hHHHH-Hhhh-hh----hhhh------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01111 0000 00 0000 01123456789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=319.71 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=188.5
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCce
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 755 (997)
+|+..+.||+|+||+||+|+.+.+++.||+|++... .....+.+..|+++++.+. |++|+++.++ +...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence 477889999999999999999999999999998743 2334466788999988885 5677788877 344568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.... .+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 999999999999999997654 478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++..... ........||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 147 ~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslGvil~elltG~~pf~~~~- 205 (323)
T cd05615 147 MCKEHMVD--------GVTTRTFCGTPDYIAPEIIA------------YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED- 205 (323)
T ss_pred cccccCCC--------CccccCccCCccccCHHHHc------------CCCCCCccchhhhHHHHHHHHhCCCCCCCCC-
Confidence 98753211 11123356899999996553 5668899999999999999999999997432
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
............ ... +.....++.+++.+|+..+|++|++.
T Consensus 206 ----~~~~~~~i~~~~------~~~------------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 206 ----EDELFQSIMEHN------VSY------------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----HHHHHHHHHhCC------CCC------------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111111000 000 11123456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.68 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=188.8
Q ss_pred CcccccCcceEEEEEECC--CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGE--NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~--~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.||+|+||.||+|+... ....+|+|.+... .......+.+|++.++.++|+||+++++++. ..+..++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 368999999999997642 3457888887633 2334567889999999999999999999864 3457899999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
|+++|+|.+++....... ....++...+.++.||+.|++|||++ +|+||||||+||++++++++||+|||++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999998764321 11246778889999999999999999 99999999999999999999999999986542
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTL 920 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 920 (997)
.... ........++..|+|||++..... ......++.++|||||||++|||++ |..||...... ..+
T Consensus 152 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~ 219 (269)
T cd05042 152 PEDY------YITKDCHAVPLRWLAPELVEIRGQ-----DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVL 219 (269)
T ss_pred cchh------eeccCCCCCcccccCHHHHhhccc-----cccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHH
Confidence 2111 011122345678999998753211 1123567889999999999999999 77887633111 011
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
.. ..........++.. ...++..+.+++..|| .||++|||++||++.|.
T Consensus 220 ~~----~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 220 KQ----VVREQDIKLPKPQL------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HH----HhhccCccCCCCcc------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 11111111111111 1123456678888999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=319.30 Aligned_cols=243 Identities=27% Similarity=0.359 Sum_probs=186.1
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHH-HHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECE-VLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||+||+|+.+.+|+.||+|++... .......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 4689999999999999999999999998643 2223345555655 46778999999999884 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999987654 478889999999999999999999 9999999999999999999999999998743
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||++. +..++.++|||||||++|||++|+.||.... .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~ 201 (325)
T cd05604 147 IA--------QSDTTTTFCGTPEYLAPEVIR------------KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----V 201 (325)
T ss_pred CC--------CCCCcccccCChhhCCHHHHc------------CCCCCCcCccccccceehhhhcCCCCCCCCC-----H
Confidence 11 111223457999999996653 5678889999999999999999999997431 2
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.+.......... ...+ .....+.+++.+|++.+|++||++++.++.
T Consensus 202 ~~~~~~~~~~~~--~~~~----------------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 202 AEMYDNILHKPL--VLRP----------------GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HHHHHHHHcCCc--cCCC----------------CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 222111111000 0000 123456789999999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.89 Aligned_cols=271 Identities=19% Similarity=0.299 Sum_probs=197.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.++||+|+||.||+|+.+.+++.||+|.++... ......+.+|++++++++|+||+++++++ ..++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence 57899999999999999999999899999999986432 23345678899999999999999999995 3456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 81 lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred EEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 9999996 599999876532 377889999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ........+++.|+|||.+.. ...++.++|||||||++|||+||++||......
T Consensus 152 ~~~~~~--------~~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~- 211 (301)
T cd07873 152 RAKSIP--------TKTYSNEVVTLWYRPPDILLG-----------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE- 211 (301)
T ss_pred hccCCC--------CCcccccceeecccCcHHHhC-----------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 754211 111123356889999986542 234778999999999999999999999743211
Q ss_pred ccHHHHHHhh---cchhhhhhcCcccccc-----cccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA---LPEKVMETVDPSLLLA-----WSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~---~~~~~~~~~d~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+....... ....+....+...... +...............+.+++.+|++.||.+|||++|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 212 EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111111100 0001111111000000 0000000111223456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=312.44 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=198.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++. ..+..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence 67999999999999999999998899999999997555555577889999999999999999999854 4558999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++.+.. +++.++..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 94 v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 94 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred eecccCCCCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999997643 67889999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......+++.|+|||.+. +..++.++|||||||++|++++|..||.......
T Consensus 164 ~~~~~~--------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~- 222 (297)
T cd06656 164 QITPEQ--------SKRSTMVGTPYWMAPEVVT------------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR- 222 (297)
T ss_pred EccCCc--------cCcCcccCCccccCHHHHc------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-
Confidence 542211 1122346888999996553 5667889999999999999999999996422110
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ... ...+. ...+...+..+.+++.+||..+|++||++.++++
T Consensus 223 ---~~~~-~~~-----~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 223 ---ALYL-IAT-----NGTPE----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---heee-ecc-----CCCCC----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000 00000 0011223456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.79 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=201.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.+|++.+.||+|+||+||+|.++.++. .||+|+..... ......+.+|++++++++|+||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 578899999999999999999875554 58999886443 3345678899999999999999999998753
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 478999999999999999987542 378999999999999999999998 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||.++....... ........++..|+|||.+ ....++.++|||||||++||+++ |+.||..
T Consensus 153 fg~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 153 FGLAKLLDVDEK------EYHAEGGKVPIKWMALESI------------LHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred CcccccccCccc------ceecCCCcccccccCHHHh------------hcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999986532111 0011122345689999654 34678899999999999999999 9999874
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.. ..++........ ..+.+..+...+.+++.+||..+|++||++.++++.|.++..+.
T Consensus 215 ~~-----~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 215 IP-----AVEIPDLLEKGE-----------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred CC-----HHHHHHHHhCCC-----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 31 111111110000 00011113346789999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.70 Aligned_cols=205 Identities=21% Similarity=0.317 Sum_probs=161.0
Q ss_pred CCcccccCcceEEEEEECC--CCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 684 SNMIGQGSFGSVYKGILGE--NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
..+||+|+||+||+|+.+. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ......++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 3689999999999999753 55789999986432 23467889999999999999999998753 23567899999
Q ss_pred eccCCCHHHHhhcCCC---CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee----CCCCcEEEccc
Q 001908 762 YMQNGSLEEWLHQSNG---QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF 834 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DF 834 (997)
|++ ++|.+++..... ......+++..++.++.|++.||+|||+. +|+||||||+||++ +.++++||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 985 588888764321 11123478889999999999999999999 99999999999999 56789999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
|+|+....... .........||+.|+|||.+.. ...++.++||||+||++|||+||++||...
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLG-----------ARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCcc-----cccccCcceecccccCcHHhcC-----------CCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99986522111 1112234568999999976542 245788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.79 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=198.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|++.+.||.|+||.||+|....+++.||+|.+........+.+.+|+++++.++|+|++++++++. ..+..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 46889999999999999999998899999999997655555677889999999999999999999854 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|+||+++++|.+++.... +++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 94 v~e~~~~~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 94 VMEYLAGGSLTDVVTETC-------MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEecCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 999999999999987543 78899999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......++..|+|||.+ .+..++.++|||||||++|+|++|+.||.....
T Consensus 164 ~~~~~~--------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--- 220 (296)
T cd06655 164 QITPEQ--------SKRSTMVGTPYWMAPEVV------------TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--- 220 (296)
T ss_pred hccccc--------ccCCCcCCCccccCcchh------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 642211 112234688899999654 356678899999999999999999999864321
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........ ... .+.. ..+...+..+.+++.+||..||++||++.++++
T Consensus 221 -~~~~~~~~-~~~-----~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 221 -LRALYLIA-TNG-----TPEL----------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -HHHHHHHH-hcC-----Cccc----------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11110000 000 0000 011223456788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.76 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=193.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++.. .+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 3678889999999999999999889999999998643 33345678899999999999999999998643 45789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999997652 256778889999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
..... .......||..|+|||.+ .+..++.++|||||||++|+|++|+.||.......
T Consensus 143 ~~~~~----------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~ 200 (279)
T cd06619 143 TQLVN----------SIAKTYVGTNAYMAPERI------------SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200 (279)
T ss_pred eeccc----------ccccCCCCChhhcCceee------------cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccc
Confidence 75421 112235689999999654 35678899999999999999999999997533221
Q ss_pred ccH--HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTL--HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
... .+... .......+... ......++.+++.+||+.+|++||+++|+++.
T Consensus 201 ~~~~~~~~~~-----~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 201 GSLMPLQLLQ-----CIVDEDPPVLP-----------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cccchHHHHH-----HHhccCCCCCC-----------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111 01000 00000011110 01123467899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=332.42 Aligned_cols=272 Identities=19% Similarity=0.278 Sum_probs=192.7
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCC------CCcceEEeee
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH------RNLIKIITVC 745 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 745 (997)
.++....++|++.++||+|+||+||+|.+..+++.||||+++... ...+.+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455688999999999999999999998899999999996432 223455667777777654 4588888875
Q ss_pred eccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC
Q 001908 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825 (997)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~ 825 (997)
.. ...+.++|||++ +++|.+++.+.. .+++..+..++.||+.||+|||++. +|+||||||+|||++.
T Consensus 201 ~~----~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 201 QN----ETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMET 267 (467)
T ss_pred Ec----CCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEec
Confidence 32 345789999998 779999987654 4788999999999999999999732 8999999999999987
Q ss_pred CC----------------cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCc
Q 001908 826 DM----------------VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASV 889 (997)
Q Consensus 826 ~~----------------~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~ 889 (997)
++ .+||+|||.+... ........||+.|+|||++ .+..++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----------~~~~~~~~gt~~Y~APE~~------------~~~~~~~ 324 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----------RHSRTAIVSTRHYRSPEVV------------LGLGWMY 324 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccC-----------ccccccccCCccccCcHHh------------hcCCCCc
Confidence 66 4999999987532 1122346799999999655 3567899
Q ss_pred cchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhh---cchhhhh---------hcC----------cccccccccc
Q 001908 890 TGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMA---LPEKVME---------TVD----------PSLLLAWSDG 947 (997)
Q Consensus 890 ~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~---~~~~~~~---------~~d----------~~~~~~~~~~ 947 (997)
++|||||||++|||++|+.||...... .....+... .+..+.. ..+ +.....+...
T Consensus 325 ~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (467)
T PTZ00284 325 STDMWSMGCIIYELYTGKLLYDTHDNL--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA 402 (467)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcc
Confidence 999999999999999999999743211 111111110 1111110 000 0000000000
Q ss_pred hhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 948 RRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 948 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. .........+.+++..||..||++|||+.|+++
T Consensus 403 ~~-~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 403 RP-VREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred cc-hhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00 000011345789999999999999999999986
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.91 Aligned_cols=270 Identities=23% Similarity=0.345 Sum_probs=205.7
Q ss_pred ChHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
+..++......|++.+.||+|+||.||+|+...+++.||+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555566789999999999999999999999899999999986543 2345678899999998 799999999987532
Q ss_pred Cc-CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 749 DF-KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 749 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
.. ...+..+++|||+++|+|.+++...... .+++..+..++.|+++|++|||+. +|+||||||+||++++++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 21 2346789999999999999999865422 367888899999999999999999 999999999999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||.+...... ........|+..|+|||.+.. +...+..++.++|||||||++|||++|+
T Consensus 159 ~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~l~~-------~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 159 EVKLVDFGVSAQLDRT--------VGRRNTFIGTPYWMAPEVIAC-------DENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred CEEEeeCcchhhhhcc--------ccCCCcccccccccCHhhcCc-------ccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 9999999998754211 111223568899999987642 1122456788999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.||..... ...... ......+.. ....++.++.+++.+||..||.+||++.|+++
T Consensus 224 ~p~~~~~~----~~~~~~------~~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 224 PPLCDMHP----MRALFL------IPRNPPPKL-----------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCccccCH----Hhhhhh------HhhCCCCCC-----------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 99864321 111100 000011111 01134567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.33 Aligned_cols=267 Identities=23% Similarity=0.329 Sum_probs=205.3
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc-CCC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF-KGA 753 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~~ 753 (997)
..+++|++.+.||+|++|.||+|..+.+++.||+|++..... ..+.+.+|+++++++ +|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356789999999999999999999988899999999875443 346789999999999 79999999999765432 335
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+|++|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 6789999999999999998753311 12478899999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+...... ........|+..|+|||.+.. +......++.++|||||||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 157 FGVSAQLDST--------LGRRNTFIGTPYWMAPEVIAC-------DEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred Cccceecccc--------hhhhcCccccccccCHhHhcc-------cccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9998754211 112233568899999998753 1122456788999999999999999999998632
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ...... . .....+.. ..+..+...+.+++.+||..||++|||+.|+++
T Consensus 222 ~~----~~~~~~-~-----~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 222 HP----MRALFK-I-----PRNPPPTL----------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ch----HHHHHH-h-----hccCCCCC----------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 111100 0 00001111 112234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=313.81 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=200.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCc----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.++|+..+.||+|+||.||+|++..++. .||+|++.... ......+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 4578888999999999999999876665 57888886432 3334578899999999999999999998743
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
...++++||+++|+|.+++..... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence 236799999999999999986531 378889999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTN 911 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 911 (997)
|||+++...... .........++..|+|||.+ .+..++.++|||||||++|||++ |+.||.
T Consensus 152 Dfg~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 152 DFGLARLLEGDE------KEYNADGGKMPIKWMALECI------------HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred cccccccccCcc------cccccCCCccccccCCHHHh------------ccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999998652211 00111223456789999654 35678899999999999999998 889986
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.... ....++.... .. .+.+..++..+.+++..||..+|++||++.++++.+.++..+
T Consensus 214 ~~~~--~~~~~~~~~~----------~~----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 214 GIPT--REIPDLLEKG----------ER----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCH--HHHHHHHHCC----------CC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3211 1111111100 00 000112345678999999999999999999999999998765
Q ss_pred hh
Q 001908 992 LV 993 (997)
Q Consensus 992 ~~ 993 (997)
..
T Consensus 272 ~~ 273 (303)
T cd05110 272 PQ 273 (303)
T ss_pred hh
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=316.49 Aligned_cols=261 Identities=24% Similarity=0.273 Sum_probs=194.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.++||+|+||+||+++.+.+++.||+|++... .......+.+|+.++..++|++|+++++++ .+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 4788999999999999999999989999999998632 223345678899999999999999999884 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.+... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999986431 378888999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
++....... ........||+.|+|||++.... .....++.++|||||||++|||++|+.||...
T Consensus 148 ~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-- 211 (332)
T cd05623 148 SCLKLMEDG-------TVQSSVAVGTPDYISPEILQAME-------DGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-- 211 (332)
T ss_pred hheecccCC-------cceecccccCccccCHHHHhccc-------cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--
Confidence 987542211 11122357999999998875321 11345788999999999999999999999732
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCC--CCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI--ERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~Rps~~evl~~ 984 (997)
...+.............. + .....+..++.+++.+|+..+++ .|+++.|+++.
T Consensus 212 ---~~~~~~~~i~~~~~~~~~-p------------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 212 ---SLVETYGKIMNHKERFQF-P------------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---CHHHHHHHHhCCCccccC-C------------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 121211111100000000 0 00112345667888888765444 37889888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.82 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=196.4
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccchhh--HHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA--LKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.+.||+|+||+||+++...+++.||+|++....... .....+|+.++++++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 567899999999999999999999999999997554332 2234569999999999999999999543 568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999999998433 478999999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
... ..........++..|+|||.+. .+..++.++||||+|+++|+|++|..||.... ..
T Consensus 147 ~~~--------~~~~~~~~~~~~~~y~aPE~~~-----------~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~ 205 (260)
T PF00069_consen 147 KLS--------ENNENFNPFVGTPEYMAPEVLQ-----------QGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SD 205 (260)
T ss_dssp EST--------STTSEBSSSSSSGGGSCHHHHT-----------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HH
T ss_pred ccc--------cccccccccccccccccccccc-----------cccccccccccccccccccccccccccccccc--ch
Confidence 530 1122333457899999997654 15678999999999999999999999988441 00
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
................... ........+.+++..||+.||++||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 206 DQLEIIEKILKRPLPSSSQ--------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHHTHHHHHTT--------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhhhhhhhccccccccccc--------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111001100000 00011267889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.19 Aligned_cols=239 Identities=23% Similarity=0.315 Sum_probs=186.6
Q ss_pred CcccccCcceEEEEEE---CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 685 NMIGQGSFGSVYKGIL---GENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~---~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
+.||+|+||.||+++. +.+++.||+|+++... ......+.+|++++++++||||+++++++ ...+..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 5799999999999876 3578999999997432 22335667899999999999999999984 445689999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999997653 478899999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
.... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 148 ~~~~--------~~~~~~~~g~~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~tg~~p~~~~~----- 202 (318)
T cd05582 148 SIDH--------EKKAYSFCGTVEYMAPEVVN------------RRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----- 202 (318)
T ss_pred cCCC--------CCceecccCChhhcCHHHHc------------CCCCCCccceeccceEeeeeccCCCCCCCCC-----
Confidence 4211 11223457899999997654 4567889999999999999999999987321
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
..+.......... . .+......+.+++.+||+.||++||++.+
T Consensus 203 ~~~~~~~i~~~~~------~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 203 RKETMTMILKAKL------G------------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHcCCC------C------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111111110000 0 01122456779999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.09 Aligned_cols=241 Identities=24% Similarity=0.403 Sum_probs=185.1
Q ss_pred CcccccCcceEEEEEECCCCc-------EEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 685 NMIGQGSFGSVYKGILGENGT-------FVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~-------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+.||+|+||.||+|..+..+. +||+|++........+.+.+|+.+++.++||||+++++++.. ++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 469999999999999865443 488888865555556788899999999999999999999643 45789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc--------E
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--------A 829 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~ 829 (997)
+||||+++|+|.++++.... .+++..++.++.||+.|++|||++ +|+||||||+||+++.++. +
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 99999999999999987542 478889999999999999999999 9999999999999987765 6
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC-C
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR-R 908 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~-~ 908 (997)
|++|||.+..... .....++..|+|||++.. ...++.++|||||||++|||++|. .
T Consensus 148 ~l~d~g~~~~~~~------------~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~~l~~l~~g~~~ 204 (258)
T cd05078 148 KLSDPGISITVLP------------KEILLERIPWVPPECIEN-----------PQNLSLAADKWSFGTTLWEIFSGGDK 204 (258)
T ss_pred EecccccccccCC------------chhccccCCccCchhccC-----------CCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999998865421 122457889999976542 234788999999999999999985 5
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
||.... ...... .... .... +.....++.+++.+||+.+|++|||++++++.|
T Consensus 205 ~~~~~~-----~~~~~~-~~~~------~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 205 PLSALD-----SQKKLQ-FYED------RHQL------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred Chhhcc-----HHHHHH-HHHc------cccC------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 544211 000000 0000 0000 001134678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.32 Aligned_cols=238 Identities=26% Similarity=0.340 Sum_probs=183.1
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECE-VLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|+...+++.||+|++.... ......+.+|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999899999999986322 223344555554 57889999999999884 4456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .++...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999999887643 367788899999999999999999 9999999999999999999999999998743
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||... +.
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~ 201 (321)
T cd05603 147 VEP--------EETTSTFCGTPEYLAPEVLR------------KEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DV 201 (321)
T ss_pred CCC--------CCccccccCCcccCCHHHhc------------CCCCCCcCcccccchhhhhhhcCCCCCCCC-----CH
Confidence 111 11223457899999996653 466888999999999999999999999742 12
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
.+.......... . .+.....++.+++.+|++.||++||++.
T Consensus 202 ~~~~~~i~~~~~------~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 202 SQMYDNILHKPL------Q------------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHhcCCC------C------------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 222111111000 0 0011234677999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.57 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=199.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|++++++++|+||+++++++ ...+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence 3688899999999999999999989999999988643 334456788999999999999999999984 3456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... ...+++..+..++.|++.|+.|||+++ +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999876421 124789999999999999999999743 8999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ......+++.|+|||.+.... ......++.++|||||||++|||++|+.||......
T Consensus 151 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~------~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~- 213 (286)
T cd06622 151 GNLVAS----------LAKTNIGCQSYMAPERIKSGG------PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA- 213 (286)
T ss_pred ccccCC----------ccccCCCccCccCcchhcCCC------CCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-
Confidence 754211 112245788999998775321 112345688999999999999999999998643111
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.......... ....+. .+..+..++.+++.+||..+|++||++.+++..
T Consensus 214 -~~~~~~~~~~-----~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 214 -NIFAQLSAIV-----DGDPPT------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -hHHHHHHHHh-----hcCCCC------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111100000 000011 112245667899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.61 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=190.5
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||++++++|.. .+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 46899999999999976 68899999987443 3334578899999999999999999998643 45789999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++..... .+++..++.++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++......
T Consensus 75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999999876432 378899999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHE 922 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 922 (997)
. ........++..|+|||.+ .+..++.++|||||||++||+++ |..||..... ..
T Consensus 147 ~-------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~ 202 (250)
T cd05085 147 I-------YSSSGLKQIPIKWTAPEAL------------NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQ 202 (250)
T ss_pred c-------cccCCCCCCcccccCHHHh------------ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HH
Confidence 1 0111122346679999654 35668889999999999999998 9999864311 11
Q ss_pred HHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 923 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
...... ...... .+..++.++.+++.+||..+|++||++.|+++.|.
T Consensus 203 ~~~~~~-----~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 203 AREQVE-----KGYRMS------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHH-----cCCCCC------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111000 000000 01123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.57 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=183.0
Q ss_pred cccccCcceEEEEEECCC------------------------CcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceE
Q 001908 686 MIGQGSFGSVYKGILGEN------------------------GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI 741 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~------------------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 741 (997)
.||+|+||.||+|....+ ...||+|++..........+.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999985321 23589999875555555678899999999999999999
Q ss_pred EeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCe
Q 001908 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNV 821 (997)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NI 821 (997)
+++|.. ....++||||+++|+|..++..... .+++..+.+++.||++||+|||++ +|+||||||+||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 999754 4478999999999999999976432 377888999999999999999999 999999999999
Q ss_pred eeCCCC-------cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhH
Q 001908 822 LLDHDM-------VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894 (997)
Q Consensus 822 ll~~~~-------~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dvw 894 (997)
+++..+ .+|++|||.+..... .....++..|+|||.+.. ...++.++|||
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~------------~~~~~~~~~~~aPe~~~~-----------~~~~~~~~Dv~ 205 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALS------------REERVERIPWIAPECVPG-----------GNSLSTAADKW 205 (274)
T ss_pred EEeccCcccCccceeeecCCcccccccc------------ccccccCCcccCchhhcC-----------CCCCCcHHHHH
Confidence 998654 489999998864311 112346788999976532 24578999999
Q ss_pred HHHHHHHHHH-hCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCC
Q 001908 895 SLGVMLLEMF-TRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973 (997)
Q Consensus 895 SlGvvl~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 973 (997)
||||++||++ +|+.||....... ...+... ..... ......+.+++.+||+.+|+
T Consensus 206 slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~----------~~~~~------------~~~~~~~~~li~~cl~~~p~ 261 (274)
T cd05076 206 SFGTTLLEICFDGEVPLKERTPSE--KERFYEK----------KHRLP------------EPSCKELATLISQCLTYEPT 261 (274)
T ss_pred HHHHHHHHHHhCCCCCccccChHH--HHHHHHh----------ccCCC------------CCCChHHHHHHHHHcccChh
Confidence 9999999985 6899986432111 1111000 00000 01123578999999999999
Q ss_pred CCCCHHHHHHHH
Q 001908 974 ERMEMRDVLAKL 985 (997)
Q Consensus 974 ~Rps~~evl~~L 985 (997)
+|||+.++++.|
T Consensus 262 ~Rps~~~il~~L 273 (274)
T cd05076 262 QRPSFRTILRDL 273 (274)
T ss_pred hCcCHHHHHHhh
Confidence 999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=341.57 Aligned_cols=263 Identities=20% Similarity=0.297 Sum_probs=200.5
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
+...++|.+.+.||+|+||+||+|++..++..||+|++... .......+..|+.++++++||||+++++++.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence 34557899999999999999999999999999999998642 33445778999999999999999999998643 23
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCcEecCCCCCCeeeCC---
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQ----PPIVHGDLKPSNVLLDH--- 825 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~----~~ivHrDlk~~NIll~~--- 825 (997)
....|+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+... .+|+||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 45789999999999999999864211 1248899999999999999999998521 25999999999999964
Q ss_pred --------------CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 826 --------------DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 826 --------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
.+.+||+|||++...... .......||+.|+|||++.. ....++.++
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---------s~~~s~vGTp~YmAPEvL~g----------e~~~~s~KS 224 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---------SMAHSCVGTPYYWSPELLLH----------ETKSYDDKS 224 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccc---------ccccccCCCccccCHHHHhc----------cCCCCCchh
Confidence 345999999999764211 11223568999999987642 124578899
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
|||||||++|||+||..||.... ........... . +... ....+.++.++|..||..+
T Consensus 225 DVWSLG~ILYELLTGk~PF~~~~----~~~qli~~lk~-----~--p~lp-----------i~~~S~eL~dLI~~~L~~d 282 (1021)
T PTZ00266 225 DMWALGCIIYELCSGKTPFHKAN----NFSQLISELKR-----G--PDLP-----------IKGKSKELNILIKNLLNLS 282 (1021)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCC----cHHHHHHHHhc-----C--CCCC-----------cCCCCHHHHHHHHHHhcCC
Confidence 99999999999999999996321 22222111100 0 0000 0012456789999999999
Q ss_pred CCCCCCHHHHHH
Q 001908 972 PIERMEMRDVLA 983 (997)
Q Consensus 972 P~~Rps~~evl~ 983 (997)
|.+||++.|+++
T Consensus 283 PeeRPSa~QlL~ 294 (1021)
T PTZ00266 283 AKERPSALQCLG 294 (1021)
T ss_pred hhHCcCHHHHhc
Confidence 999999999984
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=335.91 Aligned_cols=268 Identities=22% Similarity=0.341 Sum_probs=193.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-------
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID------- 749 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 749 (997)
..+|+..+.||+||||.||+++.+-+|+.||||++... +......+.+|+..+++++|||||+++..+.+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35677889999999999999999999999999999743 4445678899999999999999999984432211
Q ss_pred ------------------------------------------------------c------------------------C
Q 001908 750 ------------------------------------------------------F------------------------K 751 (997)
Q Consensus 750 ------------------------------------------------------~------------------------~ 751 (997)
+ +
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred ---------------------CC--------ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHH
Q 001908 752 ---------------------GA--------DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802 (997)
Q Consensus 752 ---------------------~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~y 802 (997)
.+ ...||-||||+..++++++.++... -.....++++++|++|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHHHH
Confidence 00 2468899999998888888776411 1356789999999999999
Q ss_pred HhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhccc---------C-CCCCccccccccccccccccccCCcchhc
Q 001908 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA---------R-PFDTSMETQSSSIGIKGTVGYVPPGNIAK 872 (997)
Q Consensus 803 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~---------~-~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 872 (997)
+|++ |||||||||.|||+++++.|||+|||+|+.... . ............+..+||.-|+|||++..
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 999999999999999999999999999998421 0 00111122234566789999999999875
Q ss_pred ccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhh
Q 001908 873 MLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAK 952 (997)
Q Consensus 873 ~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 952 (997)
.. ...|+.|+||||+|||+|||+. ||...++.-..+.......+|.. ....++.
T Consensus 790 ~~---------~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~------------- 843 (1351)
T KOG1035|consen 790 TS---------SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE------------- 843 (1351)
T ss_pred cc---------cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc-------------
Confidence 32 2579999999999999999985 56532211111111100001111 0111111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 953 VEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 953 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+.=.++|.+++++||++||||.|++.
T Consensus 844 ----~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 844 ----HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 112247999999999999999999975
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=313.21 Aligned_cols=266 Identities=25% Similarity=0.398 Sum_probs=201.9
Q ss_pred HhhcCccCCcccccCcceEEEEEECC-------CCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeec
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGE-------NGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSS 747 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 747 (997)
...+|++.+.||+|+||.||+|++.. .+..||+|+++.. .....+.+.+|+++++++ +|+||++++++|.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc-
Confidence 34578999999999999999998642 2236899988743 234457889999999999 7999999999864
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 817 (997)
..+..++++||+++|+|.+++.+.... .....+++.++++++.|++.|++|||++ +|+|||||
T Consensus 89 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlk 161 (334)
T cd05100 89 ----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLA 161 (334)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccc
Confidence 345789999999999999999865321 1123478899999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHH
Q 001908 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897 (997)
Q Consensus 818 ~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlG 897 (997)
|+||+++.++.+||+|||.++....... ........++..|+|||++ .+..++.++||||||
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG 223 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDY------YKKTTNGRLPVKWMAPEAL------------FDRVYTHQSDVWSFG 223 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccc------cccccCCCcCceEcCHHHh------------ccCCcCchhhhHHHH
Confidence 9999999999999999999976522110 0111223345679999654 356788899999999
Q ss_pred HHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 898 VMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 898 vvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
|++|||++ |..||... ...+........... ..+..++.++.+++.+||+.+|++||
T Consensus 224 ~il~el~~~g~~p~~~~-----~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 224 VLLWEIFTLGGSPYPGI-----PVEELFKLLKEGHRM-----------------DKPANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred HHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCC-----------------CCCCCCCHHHHHHHHHHcccChhhCc
Confidence 99999999 88887632 222222211110000 01112345788999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q 001908 977 EMRDVLAKLCAARQ 990 (997)
Q Consensus 977 s~~evl~~L~~~~~ 990 (997)
++.|+++.|.++..
T Consensus 282 s~~ell~~l~~~~~ 295 (334)
T cd05100 282 TFKQLVEDLDRVLT 295 (334)
T ss_pred CHHHHHHHHHHHhh
Confidence 99999999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.88 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=199.0
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++.+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|++++++++|+||+++++++. ..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----EN 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cC
Confidence 3455667777789999999999999998889999999987665556678899999999999999999999854 35
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCcEEEc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVS 832 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~ 832 (997)
+..++|+||+++++|.+++...... ...+...+..++.|++.|++|||++ +|+||||||+||+++. ++.+||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence 6899999999999999999864311 1126778889999999999999999 9999999999999986 6799999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.+...... ........|++.|+|||.+... ...++.++|||||||++|+|++|+.||..
T Consensus 152 dfg~~~~~~~~--------~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 152 DFGTSKRLAGI--------NPCTETFTGTLQYMAPEVIDKG----------PRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred cchhheecccC--------CCccccCCCCccccChhhhccc----------cccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 99998754211 1112224578999999766421 12367899999999999999999999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... ...+ ... . ....+. .+..+.+++.+++.+||..+|++|||+.|++.
T Consensus 214 ~~~~~--~~~~-~~~----~-~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 214 LGEPQ--AAMF-KVG----M-FKIHPE------------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccChh--hhHh-hhh----h-hccCCC------------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 31111 0000 000 0 000000 11233456789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=301.21 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=188.3
Q ss_pred CcccccCcceEEEEEECCCC--cEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGENG--TFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.||+|+||.||+|.....+ ..+++|.+.... ....+.+.+|++.++.++||||++++++|. .....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 36999999999999764222 346677765432 344578899999999999999999999864 3457899999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
|+++|+|.+++++.... ....+...++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999875321 12356777889999999999999999 99999999999999999999999999986431
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTL 920 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 920 (997)
... .........++..|+|||++..... ......++.++|||||||++|||++ |..||.... .
T Consensus 151 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~ 214 (268)
T cd05086 151 KED------YIETEDDKCVPLRWLAPELVGEFHG-----GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-----D 214 (268)
T ss_pred cch------hhhcccCCcCcccccCchhcccccC-----ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-----H
Confidence 111 0111223467889999987753110 1123456789999999999999997 566775321 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
.+..............++..... ....+.+++..|| .+|++||+++|+++.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 215 REVLNHVIKDQQVKLFKPQLELP------------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHhhcccccCCCccCCC------------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11211111122222233332211 2345678889999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.08 Aligned_cols=274 Identities=20% Similarity=0.195 Sum_probs=197.5
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 753 (997)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.... +...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999989999999998642 2334567889999999999999999999864322 2233
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...|+||||++ +++.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 46899999995 478887753 267888999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.... ........||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 170 fG~a~~~~~---------~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 170 FGLARTAGT---------SFMMTPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCCccccCC---------CCcccCCcccCCcCCHHHHh------------CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 999975421 11123356899999996653 567889999999999999999999999743
Q ss_pred cCCCccHHHHHHhhc--chhhhhhcCccc----------ccc-----cccch---hhhhHHHHHHHHHHHHhhcCCCCCC
Q 001908 914 FQGGLTLHEFCKMAL--PEKVMETVDPSL----------LLA-----WSDGR---RRAKVEECLVTVIRIGVACSMESPI 973 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~--~~~~~~~~d~~~----------~~~-----~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~ 973 (997)
... ..+........ .........+.. ... +.+.. ..........++.+++.+|+..||+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 307 (364)
T cd07875 229 DHI-DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307 (364)
T ss_pred CHH-HHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence 211 11111111000 000101110000 000 00000 0000011234678999999999999
Q ss_pred CCCCHHHHHHH
Q 001908 974 ERMEMRDVLAK 984 (997)
Q Consensus 974 ~Rps~~evl~~ 984 (997)
+|||+.|+++.
T Consensus 308 ~R~t~~e~L~h 318 (364)
T cd07875 308 KRISVDEALQH 318 (364)
T ss_pred cCCCHHHHhcC
Confidence 99999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.11 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=198.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
..|+..+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|++++++++|+||+++++++. +....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 4577889999999999999999888999999998743 2445678899999999999999999999854 355899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++.... +++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+
T Consensus 79 lv~e~~~~~~L~~~i~~~~-------l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 79 IIMEYLGGGSALDLLRAGP-------FDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEecCCCCcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 9999999999999987532 67888999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
....... .......++..|+|||.+ .+..++.++|||||||++|||+||..||......
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~apE~~------------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~- 207 (277)
T cd06640 149 GQLTDTQ--------IKRNTFVGTPFWMAPEVI------------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM- 207 (277)
T ss_pred eeccCCc--------cccccccCcccccCHhHh------------ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-
Confidence 7652211 112234578899999654 3566889999999999999999999998743211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.... ..... ........++..+.+++.+||+.+|++||++.|+++.
T Consensus 208 ----~~~~---------~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 208 ----RVLF---------LIPKN--------NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----hHhh---------hhhcC--------CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0000 00000 0011223456778899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=313.53 Aligned_cols=277 Identities=17% Similarity=0.184 Sum_probs=195.3
Q ss_pred cCCccccc--CcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 683 SSNMIGQG--SFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 683 ~~~~lg~G--~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+.++||+| +|++||+++.+.+|+.||+|+++.. .....+.+.+|+++++.++||||+++++++. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45789999 6789999999999999999999743 2334567788999999999999999999964 3558999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99999999999999764311 378899999999999999999999 99999999999999999999999998765
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.......... ..........++..|+|||++... ...++.++|||||||++|||++|+.||........
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 150 SMINHGQRLR-VVHDFPKYSVKVLPWLSPEVLQQN----------LQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cccccccccc-ccccccccccceecccChHHhhcc----------cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 4422111000 001111223567889999776421 13578999999999999999999999975432211
Q ss_pred cHHHHHHhhcchhh------hh---------hcCcccccc---------cccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 919 TLHEFCKMALPEKV------ME---------TVDPSLLLA---------WSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 919 ~~~~~~~~~~~~~~------~~---------~~d~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
.... .....+... .+ ..+...... .......+......+++.+++.+||+.||++
T Consensus 219 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 219 LLEK-LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred HHHH-hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 1111 000000000 00 000000000 0000001112234567889999999999999
Q ss_pred CCCHHHHHH
Q 001908 975 RMEMRDVLA 983 (997)
Q Consensus 975 Rps~~evl~ 983 (997)
|||++|+++
T Consensus 298 Rpt~~ell~ 306 (327)
T cd08227 298 RPSASTLLN 306 (327)
T ss_pred cCCHHHHhc
Confidence 999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=318.73 Aligned_cols=242 Identities=23% Similarity=0.275 Sum_probs=183.0
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhc---CCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNT---RHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
||+|+||+||+|+.+.+++.||||++.... ......+..|..++... +||||+++++++ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 699999999999999899999999986321 22334556677777665 699999999884 4556899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..+..++.||++|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999987654 478889999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .........||+.|+|||++.. ...++.++||||+||++|||++|+.||... ..
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~ 202 (330)
T cd05586 147 LT--------DNKTTNTFCGTTEYLAPEVLLD-----------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DT 202 (330)
T ss_pred CC--------CCCCccCccCCccccCHHHHcC-----------CCCCCCccceeccccEEEEeccCCCCCCCC-----CH
Confidence 21 1112234579999999976642 234788999999999999999999998642 12
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC----HHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME----MRDVLA 983 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~ 983 (997)
.+......... ..... .....++.+++.+||+.||++||+ +.|+++
T Consensus 203 ~~~~~~i~~~~------~~~~~-----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 203 QQMYRNIAFGK------VRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHcCC------CCCCC-----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 22111111000 00000 012345678999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.33 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=198.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|+..+.||+|+||.||+|..+.+++.||+|.+..... .+.+.+|++++++++|+||+++++++. .....++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEE
Confidence 578999999999999999999998899999999875433 578999999999999999999999854 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
++||+++++|.+++.... ..+++..++.++.|+++|+.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 76 ~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 999999999999997643 2478999999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......++..|+|||.+. +..++.++|||||||++|+|++|+.||.......
T Consensus 148 ~~~~~~--------~~~~~~~~~~~y~~PE~~~------------~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~- 206 (256)
T cd06612 148 QLTDTM--------AKRNTVIGTPFWMAPEVIQ------------EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR- 206 (256)
T ss_pred hcccCc--------cccccccCCccccCHHHHh------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-
Confidence 652211 1122345788999997654 4568889999999999999999999987432110
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ... .. ...+. ...+......+.+++.+||..+|++|||+.|+++
T Consensus 207 ---~~-~~~-~~----~~~~~----------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 207 ---AI-FMI-PN----KPPPT----------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---hh-hhh-cc----CCCCC----------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 000 00 00000 0112233456789999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=300.09 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=195.0
Q ss_pred CcccccCcceEEEEEECC-CCc--EEEEEEecccch-hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGE-NGT--FVAVKILNLMQK-GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~-~~~--~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|++|.||+|.+.. +++ .||+|++..... ...+.+.+|++.+++++|+||+++++++. . ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999864 333 699999975544 56678999999999999999999999853 2 5789999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++..
T Consensus 75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999987542 2478999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCcc
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLT 919 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 919 (997)
..... .........++..|+|||.+ .+..++.++|||||||++|||++ |+.||....
T Consensus 148 ~~~~~-----~~~~~~~~~~~~~y~~pE~~------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----- 205 (257)
T cd05040 148 PQNED-----HYVMEEHLKVPFAWCAPESL------------RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS----- 205 (257)
T ss_pred ccccc-----ceecccCCCCCceecCHHHh------------cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 32111 11111234567889999654 35678899999999999999999 999986321
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
..+...... .. ... ...+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 206 ~~~~~~~~~-----~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 206 GSQILKKID-----KE-GER----------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHH-----hc-CCc----------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111111100 00 000 0111233567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=316.35 Aligned_cols=277 Identities=20% Similarity=0.232 Sum_probs=198.2
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-c
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSID-F 750 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 750 (997)
..+..++|++.+.||+|+||+||+|....+++.||||++.... ....+.+.+|++++++++|+||+++++++.... .
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3345678999999999999999999998899999999986432 223456788999999999999999998864321 1
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
......++++|++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEE
Confidence 2234578999988 78999888653 378899999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+++.... ......||+.|+|||++.. ...++.++||||+||++|||++|+.||
T Consensus 159 l~Dfg~~~~~~~-----------~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 159 ILDFGLARQADD-----------EMTGYVATRWYRAPEIMLN-----------WMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred EcCCccceecCC-----------CcCCccccccccCchHhcC-----------CccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 999999975421 1123468999999976642 245788999999999999999999998
Q ss_pred CcCcCCCccHHHHHHhh--cchhhhhhcCcccc----ccc---ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 911 NCMFQGGLTLHEFCKMA--LPEKVMETVDPSLL----LAW---SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~----~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
...... ..+..+.... ........+..... ... .............+.+.+++.+|+..||++|||+.|+
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el 295 (343)
T cd07878 217 PGNDYI-DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295 (343)
T ss_pred CCCCHH-HHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 642110 0111111100 00000000000000 000 0000000001123457799999999999999999999
Q ss_pred HHH
Q 001908 982 LAK 984 (997)
Q Consensus 982 l~~ 984 (997)
++.
T Consensus 296 l~h 298 (343)
T cd07878 296 LAH 298 (343)
T ss_pred hcC
Confidence 853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.73 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=196.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccch---------hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK---------GALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
+|.+...||+|+||.||+|....+++.||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 47788999999999999999988899999998863221 12357889999999999999999999854
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
..+..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 4568899999999999999997654 477888999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||.++.......... .........|+..|+|||.+ .+..++.++||||+||++|+|++|+.||
T Consensus 147 l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~y~~pe~~------------~~~~~~~~~Dv~slG~il~~l~~g~~p~ 212 (267)
T cd06628 147 ISDFGISKKLEANSLSTK--TNGARPSLQGSVFWMAPEVV------------KQTSYTRKADIWSLGCLVVEMLTGKHPF 212 (267)
T ss_pred ecccCCCcccccccccCC--ccccccccCCCcCccChhHh------------ccCCCCchhhhHHHHHHHHHHhhCCCCC
Confidence 999999987632211111 11112234588899999654 3566788999999999999999999998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... ..... .......+.. +...+..+.+++.+||+.||++||++.|+++
T Consensus 213 ~~~~~----~~~~~------~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 213 PDCTQ----LQAIF------KIGENASPEI------------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCccH----HHHHH------HHhccCCCcC------------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 74211 11110 0001111111 1123456789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.43 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=201.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||+++++++ ......++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 5788999999999999999999888999999999866555678899999999999999999999984 34568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
+|||+++++|.+++..... .++...+..++.|++.|++|||+. +|+|+||||+||++++++.+||+|||.+.
T Consensus 78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 9999999999999987521 478889999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... ........++..|+|||.+... ....++.++|||||||++|||+||+.||......
T Consensus 150 ~~~~~--------~~~~~~~~~~~~y~~Pe~~~~~---------~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-- 210 (262)
T cd06613 150 QLTAT--------IAKRKSFIGTPYWMAPEVAAVE---------RKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-- 210 (262)
T ss_pred hhhhh--------hhccccccCCccccCchhhccc---------ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 65221 1112235678899999765421 0136788999999999999999999998643211
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
....... . ....+.. .......+.++.+++.+||..+|.+|||+.|++.
T Consensus 211 --~~~~~~~--~---~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 211 --RALFLIS--K---SNFPPPK---------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --HHHHHHH--h---ccCCCcc---------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1100000 0 0000000 0112233556889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.22 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=193.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-----QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.+|+..+.||+|+||.||+|....+++.||+|++... .......+.+|++++++++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 4688999999999999999999889999999988632 12344678899999999999999999998643 224
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 57899999999999999997654 367888999999999999999998 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++....... .........++..|+|||.+ .+..++.++||||+||++|||++|+.||...
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 150 FGASKRLQTICM-----SGTGIRSVTGTPYWMSPEVI------------SGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred CCCccccccccc-----cCCccccCCccccccCHHHh------------CCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 999876522110 11111234588899999654 3566889999999999999999999998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ...... . ......+.+ +......+.+++ .||..+|++||+++|+++
T Consensus 213 ~~----~~~~~~-~----~~~~~~~~~------------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 213 EA----MAAIFK-I----ATQPTNPQL------------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ch----HHHHHH-H----hcCCCCCCC------------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11 111100 0 000011111 112234556666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=287.92 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=202.1
Q ss_pred HhhcCccC-CcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSS-NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
.+++|++. ++||-|-.|.|-.+..+.+++++|+|++... ...++|++..-.. .|||||.++++|... +.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 34566654 5789999999999999999999999998643 4567788876544 699999999998664 66777
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHV 831 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl 831 (997)
.+.+|||.|+||.|...+++++.. .+++.++-.|++||..|+.|||+. .|.||||||+|+|... |-.+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 899999999999999999998743 489999999999999999999999 9999999999999975 458999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+... ........+-|+.|+|||++. ..+|+..+|+||+||++|-|++|.+||+
T Consensus 206 tDfGFAK~t~---------~~~~L~TPc~TPyYvaPevlg------------~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 206 TDFGFAKETQ---------EPGDLMTPCFTPYYVAPEVLG------------PEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred cccccccccC---------CCccccCCcccccccCHHHhC------------chhcCCCCCccchhHHHHHhhcCCCccc
Confidence 9999998642 123345567899999997765 4679999999999999999999999999
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ..+..-.+..+...-.+..+ ++-.+...+..++|..+++.+|++|.|+.|++.
T Consensus 265 S~hg--~aispgMk~rI~~gqy~FP~-------------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 265 SNHG--LAISPGMKRRIRTGQYEFPE-------------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCC--ccCChhHHhHhhccCccCCC-------------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 6532 11211111111111111111 122344556789999999999999999999864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.09 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=196.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+.|+..+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++||||+++++++ ......+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence 3466778899999999999999888999999998743 244556889999999999999999999985 4456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++... .+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.+|++|||++
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 79 IIMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence 999999999999998653 378889999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ........|+..|+|||.+ .+..++.++|||||||++|||++|+.||......
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~- 207 (277)
T cd06642 149 GQLTDT--------QIKRNTFVGTPFWMAPEVI------------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM- 207 (277)
T ss_pred ccccCc--------chhhhcccCcccccCHHHh------------CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-
Confidence 765221 1112234578899999654 3566888999999999999999999998633211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..... . .....+.. ...++.++.+++.+||..+|++||++.|+++.
T Consensus 208 ----~~~~~-~----~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 208 ----RVLFL-I----PKNSPPTL------------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----hHHhh-h----hcCCCCCC------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00000 0 00001111 11235567899999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.31 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=192.8
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
|+..+.||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++|++++++.+++ ...+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 667789999999999999999899999999986432 22335578899999999999999998874 4456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 99999999999999875431 2488999999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... .......|+..|+|||.+ .+..++.++||||+||++|||++|..||.......
T Consensus 150 ~~~~~~---------~~~~~~~g~~~~~aPE~~------------~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 150 VKIPEG---------ESIRGRVGTVGYMAPEVL------------NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred eecCCC---------CcccCCCCCcCccChHHh------------cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 654211 111234689999999654 35678899999999999999999999997432110
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
..... ... .... .... ......++.+++..||..||++||+ +.++++
T Consensus 209 -~~~~~-~~~----~~~~-~~~~------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 209 -KREEV-DRR----VLET-EEVY------------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -HHHHH-HHh----hhcc-cccc------------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 01111 000 0000 0000 1122445678999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.95 Aligned_cols=254 Identities=31% Similarity=0.510 Sum_probs=198.4
Q ss_pred CcccccCcceEEEEEECCC---CcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGEN---GTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|..... +..||+|+++..... ..+.+.+|++.++.++|+|++++++++. .....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4699999999999999755 889999999754333 3678899999999999999999999854 356899999
Q ss_pred eeccCCCHHHHhhcCCCC---CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 761 EYMQNGSLEEWLHQSNGQ---PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
||+++++|.+++...... .....+++..+++++.|++.|++|||++ +|+||||||+||+++.++.+|++|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999875211 0012589999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
........ ........++..|+|||.+. ...++.++||||+||++|||++ |..||....
T Consensus 153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-- 212 (262)
T cd00192 153 RDVYDDDY------YRKKTGGKLPIRWMAPESLK------------DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-- 212 (262)
T ss_pred cccccccc------cccccCCCcCccccCHHHhc------------cCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--
Confidence 87632211 11223455788999997554 4578899999999999999999 699987541
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
..+....... . .....+..++.++.+++.+||..+|++||++.|+++.|+
T Consensus 213 ---~~~~~~~~~~-----~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 213 ---NEEVLEYLRK-----G------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---HHHHHHHHHc-----C------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111111100 0 001112233567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.19 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=172.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|+..+.||+|+||+||+|+.+.+++.||+|+++.. .......+.+|++++.+++|++|+++++++ .+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 3688899999999999999999989999999999642 233456788899999999999999999884 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999998654 478889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCc---------------------------cccccccccccccccccCCcchhcccccCccccCCCCCCC
Q 001908 836 LARFLFARPFDTS---------------------------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888 (997)
Q Consensus 836 ~a~~~~~~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~ 888 (997)
+++.......... ..........+||+.|+|||++. +..++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~------------~~~~~ 214 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM------------QTGYN 214 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc------------CCCCC
Confidence 9875422100000 00001112357999999996653 56788
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCc
Q 001908 889 VTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 889 ~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
.++|||||||++|||++|+.||..
T Consensus 215 ~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 215 KLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred CcceeccccceeeecccCCCCCCC
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.69 Aligned_cols=271 Identities=23% Similarity=0.343 Sum_probs=194.5
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|+..+.||+|+||.||+|++..+|+.||+|+++.. .......+.+|++++++++|+||++++++ +.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence 477889999999999999999999999999998643 22234567889999999999999999998 45566899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+||++ ++|.+++..... .+++..++.++.||++|+.|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 9999996 588888875431 378999999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+...... .......++..|+|||.+.. ...++.++|||||||++|||+||+.|+.......
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 147 RAFGIPV--------RCYSAEVVTLWYRPPDVLFG-----------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred hccCCCC--------CCcCCCccccCCcChHHHhC-----------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 7542110 11123457889999976642 2346889999999999999999999865332211
Q ss_pred ccHHHHHHhhc-c-hh----hhhhcCcccccccccchh-hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMAL-P-EK----VMETVDPSLLLAWSDGRR-RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~-~-~~----~~~~~d~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+........ + .. .....+......+..... .........++.+++.+||..||++|||+.|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 11111100000 0 00 000001000000000000 0111123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.61 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=197.2
Q ss_pred CccCCcccccCcceEEEEEEC---CCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC-Cc
Q 001908 681 FSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG-AD 754 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-~~ 754 (997)
|.+.+.||+|+||.||+|.++ .+++.||||++... .....+.+.+|++++++++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999874 35789999998643 3345667889999999999999999999875432111 12
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++++||+++|+|.+++...........+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3578999999999999886443222223478889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|.++....... ........+++.|++||.+. ...++.++|||||||++|||++ |++||...
T Consensus 158 g~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~------------~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDY------YRQGCASKLPVKWLALESLA------------DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcc------eecCCCccCchhhcCHhHHh------------cCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 99986522111 11112234567899996553 4567889999999999999999 88887633
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.. ........ .. .... .+..++..+.+++.+||..+|++||+++++++.|+++
T Consensus 220 ~~--~~~~~~~~--~~------~~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 220 EN--SEIYNYLI--KG------NRLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CH--HHHHHHHH--cC------CcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 11111100 00 0000 0112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.91 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=200.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++. .....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEE
Confidence 357888999999999999999999899999999886432 334578899999999999999999999964 34689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++.+.. .+++..+..++.+++.|+.|||+.. +++||||||+||+++.++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence 99999999999999987653 4788999999999999999999742 899999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+..... .......|+..|+|||.+ .+..++.++|||||||++|++++|+.||......
T Consensus 151 ~~~~~~----------~~~~~~~~~~~~~aPE~~------------~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 151 SGELIN----------SIADTFVGTSTYMSPERI------------QGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred ccchhh----------hccCccccCcccCCHHHH------------ccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 865411 111234689999999654 3467888999999999999999999999854321
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
...... ................ ......+++..+.+++.+||..||++|||+.|+++..
T Consensus 209 ~~~~~~--~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 209 DDGQDD--PMGILDLLQQIVQEPP--------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhhhh--hhHHHHHHHHHhhccC--------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 100000 0000000000000000 0000112456788999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.52 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=198.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.++||+|+||.||+|... +++.||||.+..... ..+.+.+|++++++++|+|++++++++ ......
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCce
Confidence 3468999999999999999999986 567899999874332 346789999999999999999999984 344578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++.+... ..+++.++..++.|++.|++|||++ +++|+||||+||++++++.+|++|||.
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred EEEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence 999999999999999987542 2478999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
++...... ........++..|+|||.+ .+..++.++||||+||++||+++ |+.||....
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~- 209 (261)
T cd05034 150 ARLIEDDE-------YTAREGAKFPIKWTAPEAA------------NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT- 209 (261)
T ss_pred ceeccchh-------hhhhhccCCCccccCHHHh------------ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 87652211 1111122345689999654 35678889999999999999999 999986331
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
......... .... .+.+..++.++.+++.+|+..+|++||+++++.+.|+.
T Consensus 210 ----~~~~~~~~~-----~~~~------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 210 ----NREVLEQVE-----RGYR------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----HHHHHHHHH-----cCCC------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111111110 0000 00111224578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=298.62 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=197.0
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|++|.||+++.+.+++.||+|++... .....+.+.+|++++++++|+|++++.+.+. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 478899999999999999999988999999998633 2344567889999999999999999988742 1234689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++|||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 99999999999999986432 2478999999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
....... .......+++.|+|||.+ .+..++.++||||+||+++||++|+.||....
T Consensus 150 ~~~~~~~--------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--- 206 (257)
T cd08223 150 RVLENQC--------DMASTLIGTPYYMSPELF------------SNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--- 206 (257)
T ss_pred EEecccC--------CccccccCCcCccChhHh------------cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---
Confidence 7652211 112234688999999654 35678889999999999999999999986321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
............. +. .+.....++.+++.+||..+|++||++.++++
T Consensus 207 --~~~~~~~~~~~~~-----~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 207 --MNSLVYRIIEGKL-----PP------------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --HHHHHHHHHhcCC-----CC------------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1221111110000 00 01123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=303.88 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=198.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||.|+||.||+|+...+++.||+|++.... ......+.+|+++++.++|+|++++.+++. +....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 36888999999999999999999899999999987432 444567889999999999999999999854 346899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+||+++++|.+++... .+++..+..++.|++.|+.|||++ +++||||+|+||++++++.++++|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999999864 378899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+...... .......++..|+|||.+. +..++.++|||||||++|||+||+.||.....
T Consensus 146 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~------------~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-- 203 (274)
T cd06609 146 GQLTSTM--------SKRNTFVGTPFWMAPEVIK------------QSGYDEKADIWSLGITAIELAKGEPPLSDLHP-- 203 (274)
T ss_pred eeecccc--------cccccccCCccccChhhhc------------cCCCCchhhHHHHHHHHHHHHhCCCCcccCch--
Confidence 8763211 1223356788999996553 45689999999999999999999999874321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+..... . ....+.... ..++.++.+++.+||..+|++|||++++++
T Consensus 204 ---~~~~~~~-~----~~~~~~~~~-----------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 204 ---MRVLFLI-P----KNNPPSLEG-----------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---HHHHHHh-h----hcCCCCCcc-----------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1110000 0 001111100 003456788999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.71 Aligned_cols=279 Identities=20% Similarity=0.242 Sum_probs=202.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+++|++.++||+|+||.||+|++..+++.||+|++... .......+.+|++++++++|+||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999999989999999998643 23344667889999999999999999998766555555678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++|+||++ +++.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 99999995 5888888654 388899999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+........ .........||..|+|||.+.. ...++.++||||+||++|+|++|+.||......
T Consensus 153 ~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 153 ARIADPEHD-----HTGFLTEYVATRWYRAPEIMLN-----------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred eeecccccc-----ccCCcCCcCcCCCccChHHhhC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 976522111 1112233568999999976431 345788999999999999999999999643110
Q ss_pred CccHHHHHHhh---cchhhhhhcCcccccc---cccchhhh---hHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 917 GLTLHEFCKMA---LPEKVMETVDPSLLLA---WSDGRRRA---KVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 917 ~~~~~~~~~~~---~~~~~~~~~d~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.....+.... .++......+...... .......+ .......++.+++.+||+.+|++|||+.|+++.
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 217 -HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred -HHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011110000 0111111111110000 00000000 011234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.05 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=192.9
Q ss_pred CcccccCcceEEEEEECCCC------cEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 685 NMIGQGSFGSVYKGILGENG------TFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+.||+|+||.||+|+..... +.||+|.+.... ......+.+|+++++.++||||+++++++. ..+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 46899999999999986433 689999886432 344567889999999999999999999854 345789
Q ss_pred EEEeeccCCCHHHHhhcCCCCC-CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-----cEEE
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQP-EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHV 831 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-----~~kl 831 (997)
+||||+++++|.+++....... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .+|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999998643221 223478899999999999999999998 999999999999999888 8999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPT 910 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 910 (997)
+|||+++....... ........++..|+|||.+ .++.++.++|||||||++|||+| |+.||
T Consensus 153 ~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slG~il~ellt~g~~p~ 214 (269)
T cd05044 153 GDFGLARDIYKSDY------YRKEGEGLLPVRWMAPESL------------LDGKFTTQSDVWSFGVLMWEILTLGQQPY 214 (269)
T ss_pred CCcccccccccccc------cccCcccCCCccccCHHHH------------ccCCcccchhHHHHHHHHHHHHHcCCCCC
Confidence 99999976532211 1111223456789999655 35678899999999999999998 99998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
..... .+..... +.. .....+...+..+.+++.+||..+|++||+++++++.|.
T Consensus 215 ~~~~~-----~~~~~~~---------~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 215 PALNN-----QEVLQHV---------TAG--------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccCH-----HHHHHHH---------hcC--------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 63211 1111100 000 000111234567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=301.00 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=199.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|+..+.||+|+||.||.++...+++.+|+|++... .....+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 478899999999999999999989999999998643 3445677899999999999999999999953 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++|||+++++|.+++.+... ..+++.++..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 99999999999999987531 2478899999999999999999998 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
....... .......|++.|+|||.+. +..++.++||||||+++|||++|+.||...
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~ape~~~------------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---- 204 (256)
T cd08221 149 KILGSEY--------SMAETVVGTPYYMSPELCQ------------GVKYNFKSDIWALGCVLYELLTLKRTFDAT---- 204 (256)
T ss_pred EEccccc--------ccccccCCCccccCHhhcC------------CCCCCCcchhHHHHHHHHHHHHCCCCCCCC----
Confidence 7652211 1123356889999996543 456788999999999999999999998632
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
...+.......... . .....++..+.+++.+||..+|++||++.|+++.
T Consensus 205 -~~~~~~~~~~~~~~----~-------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 205 -NPLNLVVKIVQGNY----T-------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CHHHHHHHHHcCCC----C-------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11121111111000 0 0012234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=315.83 Aligned_cols=194 Identities=22% Similarity=0.350 Sum_probs=161.9
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
....+|++.+.||+|+||.||+|+...+++.||+|+.... ....|+.++++++|+||+++++++. ....
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE-----eCCe
Confidence 3446799999999999999999999988999999985422 2356899999999999999999854 3457
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++|+||+ .++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence 89999999 569999887643 2478999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
.++.... ........||+.|+|||++ .+..++.++|||||||++|||+++..|+
T Consensus 203 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~------------~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 203 AAQFPVV---------APAFLGLAGTVETNAPEVL------------ARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccc---------CcccccccccccccCCeec------------CCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9974311 1112335689999999654 4567899999999999999999965544
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=299.60 Aligned_cols=241 Identities=22% Similarity=0.395 Sum_probs=184.4
Q ss_pred CcccccCcceEEEEEECCC------------CcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 685 NMIGQGSFGSVYKGILGEN------------GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
+.||+|+||.||+|+.... ..+||+|++..........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 4689999999999986422 23689999876555555688899999999999999999999643
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc----
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---- 828 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---- 828 (997)
....++||||+++|+|..++..... .+++..+++++.||++|++|||++ +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 4467999999999999999876431 378889999999999999999999 9999999999999987664
Q ss_pred ---EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH-
Q 001908 829 ---AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF- 904 (997)
Q Consensus 829 ---~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell- 904 (997)
+|++|||.+..... .....++..|+|||.+.. +..++.++|||||||++|||+
T Consensus 148 ~~~~~l~d~g~~~~~~~------------~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~~l~el~~ 204 (262)
T cd05077 148 GPFIKLSDPGIPITVLS------------RQECVERIPWIAPECVED-----------SKNLSIAADKWSFGTTLWEICY 204 (262)
T ss_pred CceeEeCCCCCCccccC------------cccccccccccChhhhcC-----------CCCCCchhHHHHHHHHHHHHHh
Confidence 89999999865411 122457889999976531 356788999999999999998
Q ss_pred hCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 905 TRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 905 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
+|..||.... ..+.... .. ..... ......++.+++.+||+.||.+||++.++++.
T Consensus 205 ~~~~p~~~~~-----~~~~~~~------~~---~~~~~----------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 205 NGEIPLKDKT-----LAEKERF------YE---GQCML----------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCCCCCCcc-----hhHHHHH------Hh---cCccC----------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 5888875321 1111000 00 00000 00113467899999999999999999999987
Q ss_pred H
Q 001908 985 L 985 (997)
Q Consensus 985 L 985 (997)
+
T Consensus 261 ~ 261 (262)
T cd05077 261 I 261 (262)
T ss_pred c
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.92 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=194.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|++.+.||+|+||.||+|.+. .++.+|+|++.... .....+.+|++++++++|||++++++++ ......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEE
Confidence 47888999999999999999986 57789999886432 2235788999999999999999999985 34457899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence 9999999999999976532 367889999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
....... .......++..|+|||.+ .++.++.++|||||||++|||++ |+.||....
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~~~aPe~~------------~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--- 206 (256)
T cd05112 149 FVLDDQY-------TSSTGTKFPVKWSSPEVF------------SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--- 206 (256)
T ss_pred ecccCcc-------cccCCCccchhhcCHhHh------------ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 6532111 111223356789999654 35678889999999999999998 999986321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
..+........ ....++. ..+.++.+++.+||+.+|++||++.|+++.|+
T Consensus 207 --~~~~~~~~~~~--~~~~~~~---------------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 207 --NSEVVETINAG--FRLYKPR---------------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --HHHHHHHHhCC--CCCCCCC---------------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11111111000 0000111 12456889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.36 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=196.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|... .+..+|+|++... ....+.+.+|++++++++|+||+++.+++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 357889999999999999999876 5667999988643 2345678899999999999999999988532 4689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++|||+++++|.+++.+... ...++.+++.++.|++.|+.|||+. +++||||||+||+++.++.+|++|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence 99999999999999987532 2478889999999999999999998 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
....... ........++..|+|||.+ .+..++.++|||||||++|+++| |+.||....
T Consensus 150 ~~~~~~~-------~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-- 208 (260)
T cd05073 150 RVIEDNE-------YTAREGAKFPIKWTAPEAI------------NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-- 208 (260)
T ss_pred eeccCCC-------cccccCCcccccccCHhHh------------ccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--
Confidence 7542211 1111223456789999654 35668889999999999999999 899986431
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+........ ... +.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 209 ---~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 209 ---NPEVIRALERG-----YRM------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---HHHHHHHHhCC-----CCC------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111110000 000 0011234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=298.34 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=198.3
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|+..+.||+|+||.||+++...+++.||+|++... .....+.+.+|++++++++|+||+++++++ ...++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 478899999999999999999989999999998632 334456889999999999999999999984 4566899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... ..+++.++++++.|++.|++|||++ +++|+||+|+||+++.++.++++|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 99999999999999986442 1368889999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ........|++.|+|||.+ .+..++.++|||||||++++|++|+.||...
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~~~~pe~~------------~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---- 204 (256)
T cd08218 149 RVLNST--------VELARTCIGTPYYLSPEIC------------ENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---- 204 (256)
T ss_pred eecCcc--------hhhhhhccCCccccCHHHh------------CCCCCCCccchhHHHHHHHHHHcCCCCccCC----
Confidence 754221 1111234578899999654 3566788999999999999999999998632
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+.......... + ..+.....++.+++.+||+.+|++||++.|+++
T Consensus 205 -~~~~~~~~~~~~~~-----~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 205 -NMKNLVLKIIRGSY-----P------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CHHHHHHHHhcCCC-----C------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 12222111111100 0 011233557889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=304.96 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=192.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHH-HhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEV-LRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||.||+|+++.+|+.||+|+++... ......+..|+.. ++..+||||+++++++. .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 46889999999999999999999899999999987432 2223455566665 56678999999999864 34579
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
+++|||++ |+|.+++...... ...+++..++.++.||+.|++|||+++ +++||||||+||+++.++.+||+|||.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999995 6898888764321 235899999999999999999999853 799999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+...... .......|+..|+|||.+.... ....++.++|||||||++|||++|+.||.....
T Consensus 151 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~- 212 (283)
T cd06617 151 SGYLVDS---------VAKTIDAGCKPYMAPERINPEL--------NQKGYDVKSDVWSLGITMIELATGRFPYDSWKT- 212 (283)
T ss_pred ccccccc---------cccccccCCccccChhhcCCcc--------cccccCccccchhhHHHHHHHHhCCCCCCcccc-
Confidence 8764211 1112245788999998765311 124578899999999999999999999863221
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........ .....+... ...++.++.+++.+||..+|++||++.|+++
T Consensus 213 --~~~~~~~~------~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 213 --PFQQLKQV------VEEPSPQLP-----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CHHHHHHH------HhcCCCCCC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111100 000111110 0113456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=308.02 Aligned_cols=268 Identities=23% Similarity=0.334 Sum_probs=197.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.++||+|+||.||+|.++.+++.||+|++.... ....+.+.+|+++++.++|+||+++++++ ...+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 46888999999999999999998889999999886322 22346788999999999999999999984 456689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++++++.++..... .+++..++.++.||+.|++|||+. +++|+|++|+||++++++.+|++|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999999988776543 378999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+....... .......++..|+|||.+.. ...++.++|||||||++|||++|++||....
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~-- 205 (286)
T cd07846 147 ARTLAAPG--------EVYTDYVATRWYRAPELLVG-----------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS-- 205 (286)
T ss_pred eeeccCCc--------cccCcccceeeccCcHHhcc-----------ccccCchHhHHHHHHHHHHHHcCCCCCCCCc--
Confidence 87652211 11223457889999976532 2446789999999999999999999986321
Q ss_pred CccHHHHHHh-----hcchhhhhhcCccc------cccc-ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKM-----ALPEKVMETVDPSL------LLAW-SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~-----~~~~~~~~~~d~~~------~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
....+... ..........+... .... ............+..+.+++.+||..+|++||+++++++
T Consensus 206 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 206 --DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred --hHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 11111110 00111111111000 0000 000001111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.26 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=199.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|+..+.||+|+||.||+|..+.+++.||+|++.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 36788899999999999999999899999999987543 345577899999999999999999999854 346899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
+++||+++++|.+++.... ..++...+.+++.|++.|++|||+ . +++|+||||+||++++++.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999998753 247888999999999999999999 7 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+...... ......++..|+|||.+. +..++.++|||||||++|+|++|+.||......
T Consensus 148 ~~~~~~~----------~~~~~~~~~~y~~PE~~~------------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 205 (265)
T cd06605 148 SGQLVNS----------LAKTFVGTSSYMAPERIQ------------GNDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205 (265)
T ss_pred chhhHHH----------HhhcccCChhccCHHHHc------------CCCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Confidence 8765211 111156888999996553 567889999999999999999999998754322
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.....+...... ....+... ......++.+++.+||..+|++|||+.|+++
T Consensus 206 ~~~~~~~~~~~~-----~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 206 PDGIFELLQYIV-----NEPPPRLP-----------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cccHHHHHHHHh-----cCCCCCCC-----------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 222222211111 00001110 0114556889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=299.25 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=191.8
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccch-hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
++||+|+||.||+|.... ++.||+|++..... .....+.+|++++++++|+||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 479999999999999976 99999999875433 34578899999999999999999999854 445789999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++..... .+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||.++.....
T Consensus 75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999976431 367889999999999999999999 9999999999999999999999999999754211
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHE 922 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 922 (997)
.. ........++..|+|||.+ .++.++.++|||||||++|||+| |..||..... ..
T Consensus 147 ~~------~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~ 203 (251)
T cd05041 147 IY------TVSDGLKQIPIKWTAPEAL------------NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQ 203 (251)
T ss_pred cc------eeccccCcceeccCChHhh------------ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HH
Confidence 10 0111112345679999654 35678899999999999999999 8888764321 11
Q ss_pred HHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 923 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
..... .... ....+..++.++.+++.+||..+|++|||+.|+++.|.
T Consensus 204 ~~~~~---------~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 204 TRERI---------ESGY--------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHH---------hcCC--------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 10000 0000 00011233567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=299.83 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=193.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-----QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|++.+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++++++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 4788999999999999999999989999999988532 123456788999999999999999999975431 23
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++++|.+++.... .+++..+.+++.|++.||+|||++ +|+|+||||+||+++.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 46889999999999999997654 367788899999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.++....... .........|+..|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 150 FGASKRLQTICL-----SGTGMKSVTGTPYWMSPEVIS------------GEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred Cccccccccccc-----cccccccCCCCccccChhhhc------------CCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 999876522111 111122345889999996553 456788999999999999999999998632
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ......... .....+. .+......+.+++.+|+. +|++||++.|+++
T Consensus 213 ~----~~~~~~~~~-----~~~~~~~------------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 213 E----AMAAIFKIA-----TQPTNPV------------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred c----hHHHHHHHh-----cCCCCCC------------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 111111000 0000110 112234456788889985 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=320.00 Aligned_cols=269 Identities=21% Similarity=0.248 Sum_probs=193.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
...|.+.+.||+|+||.||+|++..+++.||||.... ..+.+|++++++++|+||+++++++.. .+..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence 4479999999999999999999998999999996432 345689999999999999999998543 45789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|||++ .++|.+++..... .+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 237 lv~e~~-~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EEEEcc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 999999 5799999876431 489999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC-
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG- 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~- 916 (997)
+...... .........||..|+|||++ .+..++.++|||||||++|||++|..|+......
T Consensus 308 ~~~~~~~------~~~~~~~~~GT~~Y~APE~~------------~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 308 CFARGSW------STPFHYGIAGTVDTNAPEVL------------AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred eeccccc------ccccccccCCCcCCcCHHHH------------cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 7652211 11112345799999999655 3567899999999999999999988765432211
Q ss_pred --Ccc---HHHHHHhh-cc-hhhhhhcCccccccc--------ccchh---hhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 917 --GLT---LHEFCKMA-LP-EKVMETVDPSLLLAW--------SDGRR---RAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 917 --~~~---~~~~~~~~-~~-~~~~~~~d~~~~~~~--------~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
... +...+... .. ..+.......+...+ ..... ..........+.+++.+||..||++|||+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa 449 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA 449 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH
Confidence 111 11111110 00 000000000000000 00000 00001122367889999999999999999
Q ss_pred HHHHHH
Q 001908 979 RDVLAK 984 (997)
Q Consensus 979 ~evl~~ 984 (997)
.|+++.
T Consensus 450 ~elL~h 455 (461)
T PHA03211 450 AELLRL 455 (461)
T ss_pred HHHhhC
Confidence 999863
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=306.22 Aligned_cols=271 Identities=23% Similarity=0.296 Sum_probs=196.2
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccch-----hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-----GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
+|+..+.||+|+||.||+|....+++.||+|+++.... .....+..|++++++++|+||+++++++. +.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 47788999999999999999988899999999974332 23456778999999999999999999854 356
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+ +|+|.+++.... ..+++..++.++.||++||+|||++ +|+|+||||+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 899999999 899999997643 1488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++...... .......+++.|+|||.+.. ...++.++|||||||++|||++|.+||....
T Consensus 147 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 147 GLARSFGSPN--------RKMTHQVVTRWYRAPELLFG-----------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred eeeeeccCCC--------ccccccccceeeeCHHHHhC-----------CCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 9997652211 11122346788999976532 2456889999999999999999987776322
Q ss_pred CCCccHHHHHHhhc-c--hhhhhh--c-CcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMAL-P--EKVMET--V-DPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~-~--~~~~~~--~-d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
. ...+........ + ...... . +......................+.+++.+||+.+|++|||+.|+++.
T Consensus 208 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 208 D-IDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred c-HHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1 111111111000 0 000000 0 000000000000001112335678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=312.29 Aligned_cols=207 Identities=27% Similarity=0.334 Sum_probs=171.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+++.+.+++.||+|++... .......+.+|+.+++.++|++|+++++++ ...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 4789999999999999999999989999999998642 223345678899999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++.+... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 9999999999999999986431 377888999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
+++...... ........||+.|+|||++.... ...+.++.++|||||||++|||++|+.||..
T Consensus 148 ~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 148 SCLKMNQDG-------TVQSSVAVGTPDYISPEILQAME-------DGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeeccCCC-------ceeeccccCCcccCCHHHHhccc-------cCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 997652211 11112356999999998775321 0114578899999999999999999999973
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=300.79 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=199.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|+||.||+|....+++.||+|++... .....+.+..|++++++++|+||+++++++.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 478889999999999999999989999999998632 34445678899999999999999999987643 2345689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH-----~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
++|||+++++|.+++..... ....+++..++.++.|++.|++||| +. +++|+||||+||+++.++.+|++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence 99999999999999976431 1235889999999999999999999 66 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.+....... .......++..|+|||.+. +..++.++||||||+++|+|++|+.||..
T Consensus 153 d~g~~~~~~~~~--------~~~~~~~~~~~~~~pE~~~------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 153 DFGLAKILGHDS--------SFAKTYVGTPYYMSPEQLN------------HMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred cccccccccCCc--------ccccccccCCCccChhhhc------------CCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 999998652211 1122346889999996654 45678899999999999999999999874
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+...... ....+ ..+...+.++.+++.+|+..+|++||++.+|++
T Consensus 213 ~~-----~~~~~~~~~-----~~~~~------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 213 RN-----QLQLASKIK-----EGKFR------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cC-----HHHHHHHHh-----cCCCC------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 32 112111110 00000 111233567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.77 Aligned_cols=264 Identities=24% Similarity=0.298 Sum_probs=198.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|...++||.|++|.||+|....+++.||+|++.... ......+.+|++++++++||||++++++|.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 36788899999999999999998899999999987432 2345778999999999999999999998753 2345789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... ....++...+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 99999999999998765321 112478888999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ......++..|+|||.+. +..++.++||||+||++|+|++|..||.......
T Consensus 153 ~~~~~~----------~~~~~~~~~~y~~pE~~~------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 210 (287)
T cd06621 153 GELVNS----------LAGTFTGTSFYMAPERIQ------------GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210 (287)
T ss_pred cccccc----------ccccccCCccccCHHHhc------------CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC
Confidence 654211 111345788999996543 5668889999999999999999999997542211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
....+......... .+.+.... .........+.+++.+||..+|++|||+.|+++
T Consensus 211 ~~~~~~~~~~~~~~-----~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 211 LGPIELLSYIVNMP-----NPELKDEP------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CChHHHHHHHhcCC-----chhhccCC------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111111111000 00000000 000113456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.27 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=195.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ------KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
+|+..+.||+|+||+||+|... +++.+|+|.++... ......+.+|++++++++|+||+++.+++. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 4788999999999999999875 78899999886321 223456889999999999999999999964 34
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++|+||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +|+|+||||+||++++++.+||+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 68999999999999999997653 367888999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+.......... ..........|+..|+|||.+ .+..++.++||||+||++|+|++|+.||...
T Consensus 146 fg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~------------~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 146 FGCARRLAWVGLHG--THSNMLKSMHGTPYWMAPEVI------------NESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred chhhHhhhhccccc--cccccccccCCCccccChhhh------------cCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 99998653211111 011112234689999999654 4566789999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ......... .....+.. +..+..++.+++.+||..+|++||++.|+++
T Consensus 212 ~~----~~~~~~~~~----~~~~~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 212 DR----LAAMFYIGA----HRGLMPRL------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred Ch----HHHHHHhhh----ccCCCCCC------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 21 111100000 00000111 1123456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=305.77 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=195.4
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.|.....||+|+||.||++....++..||||++........+.+.+|+.+++.++|+|++++++.+. ..+..++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence 3444577999999999999998889999999987655555677899999999999999999999854 45689999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
|||+++++|.+++... .+++.++..++.||+.|++|||++ +|+||||||+||+++.++++||+|||++..
T Consensus 98 ~e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 98 MEFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred EeCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999999998653 277889999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
.... ........|+..|+|||.+ .+..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~--------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---- 223 (292)
T cd06658 168 VSKE--------VPKRKSLVGTPYWMAPEVI------------SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---- 223 (292)
T ss_pred cccc--------cccCceeecCccccCHHHH------------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 4221 1112234688999999655 345678899999999999999999999863211
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.... .. ......+.... .......+.+++..||..||++|||+.|+++.
T Consensus 224 ~~~~-~~-----~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 224 LQAM-RR-----IRDNLPPRVKD----------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHH-HH-----HHhcCCCcccc----------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 00 00111111110 01123457789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.66 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=196.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|+..+.||+|+||.||+|....+++.+|+|++... .......+.+|++++++++|+|++++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 478889999999999999999989999999998643 334467889999999999999999999874 4456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-CcEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFg~ 836 (997)
+||||+++++|.+++.+... ..+++..+..++.|++.|++|||++ +|+|+||||+||+++.+ +.+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 99999999999999987542 2378889999999999999999999 99999999999999855 4689999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+...... .......|+..|+|||.+. +..++.++||||||+++|+|++|+.||....
T Consensus 149 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-- 205 (256)
T cd08220 149 SKILSSK---------SKAYTVVGTPCYISPELCE------------GKPYNQKSDIWALGCVLYELASLKRAFEAAN-- 205 (256)
T ss_pred ceecCCC---------ccccccccCCcccCchhcc------------CCCCCcccchHHHHHHHHHHHhCCCCcccCc--
Confidence 9765221 1122346788999996553 4567889999999999999999999986431
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
............ .. +.+..+...+.+++..||..+|++|||+.|+++
T Consensus 206 ---~~~~~~~~~~~~-----~~------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 206 ---LPALVLKIMSGT-----FA------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---hHHHHHHHHhcC-----CC------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111110000 00 001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=299.24 Aligned_cols=252 Identities=29% Similarity=0.530 Sum_probs=196.7
Q ss_pred CccCCcccccCcceEEEEEECCCC----cEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENG----TFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+++.+.||+|+||.||+|++...+ ..||+|+++..... ..+.+..|+++++.++|+||+++++++. ..+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence 456789999999999999998665 88999999754433 5678899999999999999999999854 3468
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+++|||+++++|.+++...... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 99999999999999999875421 178999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 914 (997)
.++......... .....+++.|+|||.+ .+..++.++||||+||++|||++ |+.||...
T Consensus 149 ~~~~~~~~~~~~-------~~~~~~~~~y~~Pe~~------------~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~- 208 (258)
T smart00219 149 LSRDLYDDDYYK-------KKGGKLPIRWMAPESL------------KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM- 208 (258)
T ss_pred Cceecccccccc-------cccCCCcccccChHHh------------ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 998763321110 1122367899999654 34668899999999999999999 78887642
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
...+.......... ...+..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus 209 ----~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 ----SNEEVLEYLKKGYR-----------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CHHHHHHHHhcCCC-----------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111111100000 001112456788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=317.30 Aligned_cols=269 Identities=22% Similarity=0.228 Sum_probs=193.4
Q ss_pred hhcCccCCcccccCcceEEEEEEC--CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG--ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
..+|.+.+.||+|+||.||+|... ..+.+||+|.+... ....+|++++++++||||+++++++ .....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 357999999999999999999764 34578999987532 2346799999999999999999884 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++|||++. ++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 999999994 68999985433 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+...... .........||+.|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 231 ~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 231 AACKLDAHP------DTPQCYGWSGTLETNSPELLA------------LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccCccc------ccccccccccccCccCHhHhc------------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 997653211 111223457999999996553 56788999999999999999999999875432
Q ss_pred CC--ccHHHHHHhhc--chhhhhhcC----ccccc---ccccchhhh---hHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 916 GG--LTLHEFCKMAL--PEKVMETVD----PSLLL---AWSDGRRRA---KVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 916 ~~--~~~~~~~~~~~--~~~~~~~~d----~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
.. ..+....+... +........ +.+.. ........+ .......++.+++.+|+..||++|||+.|+
T Consensus 293 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~ 372 (392)
T PHA03207 293 KSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372 (392)
T ss_pred CCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence 21 11111111100 000000000 00000 000000000 001124567789999999999999999999
Q ss_pred HHH
Q 001908 982 LAK 984 (997)
Q Consensus 982 l~~ 984 (997)
+..
T Consensus 373 l~~ 375 (392)
T PHA03207 373 LSL 375 (392)
T ss_pred hhC
Confidence 864
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.45 Aligned_cols=260 Identities=22% Similarity=0.379 Sum_probs=198.7
Q ss_pred hcCccCCcccccCcceEEEEEECC-----CCcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
++|+..+.||+|+||.||+|+.+. ..+.||+|.+...... ..+.+.+|++++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 578889999999999999999753 3467999988654433 4578899999999999999999999853 3
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCC---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPE---VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
.+..++||||+++|+|.+++........ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 4578999999999999999986552211 12478999999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRR 908 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~ 908 (997)
|++|||++........ .......++..|+|||.+ .+..++.++|||||||++|+|++ |..
T Consensus 157 ~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 157 KVSLLSLSKDVYNSEY-------YKLRNALIPLRWLAPEAV------------QEDDFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred EEcccccccccCcccc-------cccCCceeEEeecChhhh------------ccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999875422111 112223467789999654 34567889999999999999999 788
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
||..... .............. ..+..++..+.+++.+||..+|++||++.|+++.|.
T Consensus 218 p~~~~~~-----~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 218 PFYGLSD-----EEVLNRLQAGKLEL----------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cccccch-----HHHHHHHHcCCcCC----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 8863321 11111110000000 001123557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.96 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=195.9
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcC---CCCcceEEeeeeccCcCCCce
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTR---HRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~ 755 (997)
.|+..+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|++++++++ |||++++++++. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 477889999999999999999889999999998643 3344567889999999986 999999999854 3558
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.++++.. .+++..++.++.|++.|++|||+. +|+|+||+|+||+++.++.++++|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 89999999999999998754 378899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+....... .......|+..|+|||.+.. +..++.++|||||||++|+|++|..||.....
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 147 VAALLNQNS--------SKRSTFVGTPYWMAPEVITE-----------GKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred ceeecCCCc--------cccccccCCcceeCHHHhcc-----------CCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 997653211 11223468889999976531 34568899999999999999999999864311
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
......... ...+.+.. ...+.++.+++.+||+.||++||++.|+++.
T Consensus 208 -----~~~~~~~~~-----~~~~~~~~-----------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 208 -----FRAMMLIPK-----SKPPRLED-----------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -----hhhhhcccc-----CCCCCCCc-----------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111100000 00011100 0134578899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=328.53 Aligned_cols=214 Identities=26% Similarity=0.341 Sum_probs=183.9
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeec
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSS 747 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 747 (997)
..++.-..++|.+.+.||+|+||.|..++.+.+++.||+|++.+. ......-|..|-++|..-+.+.|+.+.-.
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 345555668999999999999999999999999999999999753 23345678899999999999999988655
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
|+++.++|+|||||+||+|-..+.+.. .++..-++.++..|+-||+-+|+. |+|||||||+|||+|..|
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 888999999999999999999999876 367777888999999999999999 999999999999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
++|++|||.+..+..+ ....+...+|||.|++||++....+ ..+.|++.+|+||+||++|||+.|.
T Consensus 213 HikLADFGsClkm~~d-------G~V~s~~aVGTPDYISPEvLqs~~~-------~~g~yG~ecDwWSlGV~~YEMlyG~ 278 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDAD-------GTVRSSVAVGTPDYISPEVLQSQGD-------GKGEYGRECDWWSLGVFMYEMLYGE 278 (1317)
T ss_pred cEeeccchhHHhcCCC-------CcEEeccccCCCCccCHHHHHhhcC-------CccccCCccchhhhHHHHHHHHcCC
Confidence 9999999999876321 2223445689999999999986432 1378999999999999999999999
Q ss_pred CCCCc
Q 001908 908 RPTNC 912 (997)
Q Consensus 908 ~P~~~ 912 (997)
.||+.
T Consensus 279 TPFYa 283 (1317)
T KOG0612|consen 279 TPFYA 283 (1317)
T ss_pred CcchH
Confidence 99984
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=299.06 Aligned_cols=247 Identities=31% Similarity=0.448 Sum_probs=193.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||.||++.. +++.||+|+++... ....+.+|++++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 5789999999999999999976 68889999986432 33678899999999999999999998532 24699
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++++|.+++..... ..+++..++.++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 9999999999999986542 2478889999999999999999998 99999999999999999999999999986
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
..... ......+..|+|||.+ .++.++.++|||||||++|||++ |+.||....
T Consensus 149 ~~~~~-----------~~~~~~~~~y~~pe~~------------~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--- 202 (254)
T cd05083 149 VGSMG-----------VDNSKLPVKWTAPEAL------------KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--- 202 (254)
T ss_pred ecccc-----------CCCCCCCceecCHHHh------------ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC---
Confidence 53110 1112345679999644 45678899999999999999998 999986431
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+........ ..+ ..+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus 203 --~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 203 --LKEVKECVEKG-----YRM------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --HHHHHHHHhCC-----CCC------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11211111000 000 0011235677899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=299.87 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=198.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
..+.|+..++||+|+||+||.++.+.+|+.||.|.+.+. ......-...|-+++.+++.+.||.+--. |+.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTk 257 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETK 257 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCC
Confidence 346788999999999999999999999999999988532 23334567889999999999988876543 7788
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+.+|+|+..|.||+|.-+|...++ ..+++..++.+|.+|+.||++||.. +||+||+||+|||+|++|+++|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeec
Confidence 899999999999999999987763 3589999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
.|+|..+.. .......+||.+|||||++++ +.|+...|+||+||++|||+.|+.||...
T Consensus 331 LGLAvei~~---------g~~~~~rvGT~GYMAPEvl~n------------e~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 331 LGLAVEIPE---------GKPIRGRVGTVGYMAPEVLQN------------EVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred cceEEecCC---------CCccccccCcccccCHHHHcC------------CcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 999987632 223344589999999987764 56999999999999999999999998732
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
-+ +...+.+|......- ...++...++..++....+..||++|...+
T Consensus 390 Ke--------------Kvk~eEvdrr~~~~~-----~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 390 KE--------------KVKREEVDRRTLEDP-----EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hh--------------hhhHHHHHHHHhcch-----hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11 111112222222110 011223345567788899999999997543
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.12 Aligned_cols=277 Identities=20% Similarity=0.292 Sum_probs=197.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|+..+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+++++++ +|+||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999999899999999986432 22345778899999999 4699999999876543333445
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCcEEEccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDF 834 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DF 834 (997)
.++||||+++ +|.+++...... ....+++..++.++.||+.||.|||++ +|+||||||+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999975 899988765422 123578999999999999999999999 9999999999999998 899999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++...... .......+++.|+|||.+.. ...++.++|||||||++|||++|..||....
T Consensus 156 g~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 156 GLGRAFSIPV--------KSYTHEIVTLWYRAPEVLLG-----------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred ccceecCCCc--------cccCCcccccCCCChHHhhC-----------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9987542211 11122346788999976532 2457889999999999999999999987432
Q ss_pred CCCccHHHHHHhh----cch-hhh-hhcCccc---ccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA----LPE-KVM-ETVDPSL---LLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~----~~~-~~~-~~~d~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+..... .+. ... ....... ...+..............++.+++.+||..||++||++.|++.
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 217 ----ELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ----HHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 122211110 000 000 0000000 0000000000111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.19 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=194.4
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
|....+||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++|||++++++++. ..+..++|+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 444568999999999999998889999999987544445567889999999999999999999854 456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++++|.+++... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999988653 378899999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.... .......|+..|+|||.+. +..++.++|||||||++|||++|+.||..... .
T Consensus 168 ~~~~--------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~ 223 (297)
T cd06659 168 SKDV--------PKRKSLVGTPYWMAPEVIS------------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----V 223 (297)
T ss_pred cccc--------ccccceecCccccCHHHHc------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 2211 1122356889999996553 45678899999999999999999999863211 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
... ..... ...+... ........+.+++.+||..+|++||++.++++.
T Consensus 224 ~~~-~~~~~-----~~~~~~~----------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 224 QAM-KRLRD-----SPPPKLK----------NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHH-HHHhc-----cCCCCcc----------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111 11000 0000000 001123457789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=297.22 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=197.7
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ------KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
+|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++|+||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 4788899999999999999998899999999986432 22356889999999999999999999985 445
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVS 832 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~ 832 (997)
+..++|+||+++++|.+++.+.. .+++..+..++.|++.|++|||++ +++|+||||+||+++.++ .+||+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 68999999999999999997654 478889999999999999999999 999999999999998776 69999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.+........ ..........++..|+|||.+. +..++.++||||+||++|+|++|..||..
T Consensus 147 dfg~~~~~~~~~~----~~~~~~~~~~~~~~~~~PE~~~------------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 147 DFGAAARLAAKGT----GAGEFQGQLLGTIAFMAPEVLR------------GEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred ccccccccccccc----cCCccccccccccceeCHhHhc------------cCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 9999977633211 1111223346889999996553 45678899999999999999999999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... .......... .... ...+.....++.+++.+|+..+|++||++.|+++
T Consensus 211 ~~~~~--~~~~~~~~~~----~~~~------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 211 EKHSN--HLALIFKIAS----ATTA------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCcc--hHHHHHHHhc----cCCC------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 32111 1111000000 0000 0112234567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.89 Aligned_cols=270 Identities=21% Similarity=0.300 Sum_probs=196.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|+..+.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|++++++++|+|++++++++. .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 46888999999999999999999889999999986332 223456789999999999999999999854 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++++++..++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++++||+|||.
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999988888776543 378999999999999999999998 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+....... .......++..|+|||.+.. ...++.++|||||||++|||++|+.||......
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 147 ARILTGPG--------DDYTDYVATRWYRAPELLVG-----------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred ceecCCCc--------ccccCcccccccCCHHHHhC-----------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 97652211 01123457889999976532 245788999999999999999999999743221
Q ss_pred CccHHHHHHhhcc---hhhhhhcCccc--ccc-cccch----hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALP---EKVMETVDPSL--LLA-WSDGR----RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~---~~~~~~~d~~~--~~~-~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..... ..... ....+..+... ... ..... ...........+.+++.+||..+|++||++.|++.
T Consensus 208 ~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 208 D-QLYLI-RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred H-HHHHH-HHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 1 01110 00000 00001110000 000 00000 00011123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.09 Aligned_cols=271 Identities=21% Similarity=0.268 Sum_probs=198.3
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++|+|++++++++ ......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4788899999999999999998899999999987433 33456789999999999999999999985 3456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+ +++|.+++.... ..+++.+++.++.||++|++|||+. +++|+||||+||+++.++.++++|||.+
T Consensus 76 ~v~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEeccc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999 999999987644 2488999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
....... ........|+..|+|||.+.. ...++.++||||+||++|||++|.+||..... .
T Consensus 147 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~ 207 (286)
T cd07832 147 RLFSEEE-------PRLYSHQVATRWYRAPELLYG-----------ARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-I 207 (286)
T ss_pred ccccCCC-------CCccccccCcccccCceeeec-----------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-H
Confidence 7652211 011223468899999976531 23468899999999999999999887753221 1
Q ss_pred ccHHHHHHhh---cchhhhhhcCcccc--cccccchh---hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA---LPEKVMETVDPSLL--LAWSDGRR---RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~---~~~~~~~~~d~~~~--~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+....... .+..+.+..+.... ..+..... .....+....+.+++.+|+..+|++||+++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111100 00011110000000 00000000 0011133467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.19 Aligned_cols=289 Identities=24% Similarity=0.282 Sum_probs=212.2
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l 758 (997)
|...+.||+|+||.||+++.+.+|+.||||.++.. ....++.+.+|+++|++++|+|||+++++=.... .-..+...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45668899999999999999999999999999753 3445678899999999999999999998722111 011345789
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC--CCC--cEEEccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDM--VAHVSDF 834 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~--~~kl~DF 834 (997)
|||||.+|||+..+.+..+ ...++..+.+.+..+++.||.|||++ +|+||||||.||++. .+| ..||+||
T Consensus 95 vmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 9999999999999987653 24589999999999999999999999 999999999999995 333 5799999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.|+.+. .........||..|.+||.... .+.|+..+|.|||||++||++||..||....
T Consensus 169 G~Arel~---------d~s~~~S~vGT~~YLhPel~E~-----------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 169 GAARELD---------DNSLFTSLVGTEEYLHPELYER-----------QKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccccCC---------CCCeeeeecCchhhcChHHHhh-----------ccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9999762 2335566889999999977642 4678889999999999999999999998654
Q ss_pred CCCccHHHHHHh--hcchhhhhhcCcccccccccchhhhhH----HHHHHHHHHHHhhcCCCCCCCCC--CHHHHHHHHH
Q 001908 915 QGGLTLHEFCKM--ALPEKVMETVDPSLLLAWSDGRRRAKV----EECLVTVIRIGVACSMESPIERM--EMRDVLAKLC 986 (997)
Q Consensus 915 ~~~~~~~~~~~~--~~~~~~~~~~d~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rp--s~~evl~~L~ 986 (997)
......+-.... ..+..+....++...+...-....+.+ ......+-+++..++..+|.+|. .+.+..+.+.
T Consensus 229 ~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 229 GPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred CccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 332222211111 111112112222221111111112221 22334566778888999999999 8888888888
Q ss_pred HHHHHhhcc
Q 001908 987 AARQTLVGR 995 (997)
Q Consensus 987 ~~~~~~~~~ 995 (997)
+|....+.+
T Consensus 309 dIL~~~vvh 317 (732)
T KOG4250|consen 309 DILNLKVVH 317 (732)
T ss_pred HHHhhheeE
Confidence 887655443
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=296.16 Aligned_cols=248 Identities=20% Similarity=0.290 Sum_probs=199.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.-|...+.||+|.|++|-+|++--+|.+||||++.+.. .-....+++|+..|+-++|||||++|.+ .......
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceE
Confidence 45788899999999999999998899999999997543 3344678999999999999999999998 5566789
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC-CCCcEEEcccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFG 835 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFg 835 (997)
|+|.|.-++|+|.+||-+... .+.+....+++.||+.|+.|+|.. .+||||+||+||.+- .-|-||+.|||
T Consensus 93 yLiLELGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEEEEecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 999999999999999987652 377888999999999999999999 899999999998764 56899999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCC-ccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS-VTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
++-.+ ..+......||+..|-|||++- |..|+ +++||||+|||+|.+++|++||+...
T Consensus 165 FSNkf---------~PG~kL~TsCGSLAYSAPEILL------------GDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 165 FSNKF---------QPGKKLTTSCGSLAYSAPEILL------------GDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred ccccC---------CCcchhhcccchhhccCchhhh------------cCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 98765 3345566789999999996654 55564 57899999999999999999998542
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+.+. +-- -+...+-+ +.....+..++|..|+..||++|.+..+|..
T Consensus 224 DSET-LTm--ImDCKYtv--------------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 224 DSET-LTM--IMDCKYTV--------------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred chhh-hhh--hhcccccC--------------------chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2211 000 00011111 1122345568999999999999999999864
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.33 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=198.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|.+.+.||+|+||.||+|....+++.||+|++........+.+.+|+.++++++|||++++++++. ..+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 67889999999999999999998889999999987555555677899999999999999999999854 3457999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|+||+++++|.+++.+.. +++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||.+.
T Consensus 94 v~e~~~~~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 94 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEecCCCCcHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 999999999999997643 67889999999999999999999 99999999999999999999999999887
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......|++.|+|||.+. +..++.++|||||||++|++++|+.||.......
T Consensus 164 ~~~~~~--------~~~~~~~~~~~y~~PE~~~------------~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~- 222 (293)
T cd06647 164 QITPEQ--------SKRSTMVGTPYWMAPEVVT------------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR- 222 (293)
T ss_pred cccccc--------cccccccCChhhcCchhhc------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-
Confidence 542211 1122346888999996543 4567889999999999999999999997432110
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
......... .+. .......+..+.+++.+||..+|++||++.+++..
T Consensus 223 ---~~~~~~~~~------~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 223 ---ALYLIATNG------TPE----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---heeehhcCC------CCC----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 000 00111234567899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.90 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=195.0
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|+..+.||+|++|.||+|+...+++.||||+++... ......+.+|++++++++||||+++++++ .+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4788899999999999999999899999999986432 22345788999999999999999999984 4556899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+. ++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.+
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999995 689999876432 2478999999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+...... .......++..|+|||.+.. ...++.++|||||||++|||+||+.||......
T Consensus 148 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~- 207 (284)
T cd07860 148 RAFGVPV--------RTYTHEVVTLWYRAPEILLG-----------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI- 207 (284)
T ss_pred hhcccCc--------cccccccccccccCCeEEec-----------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-
Confidence 7552211 11122346789999976532 233578899999999999999999998643211
Q ss_pred ccHHHHHHhh-cch-hhhhhcC--cccccc---cccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA-LPE-KVMETVD--PSLLLA---WSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~-~~~-~~~~~~d--~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
....+..... .+. ..+.... +..... +...............+.+++.+||+.||++|||++|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 208 DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 1111111110 000 0000000 000000 0000000001123356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=302.83 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=197.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||++..+.+++.||+|.+.... ....+.+.+|+++++.++||||+++++++ ...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 36888999999999999999999999999999986432 23446778999999999999999999884 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 999999999999999997654 478888999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCc-------cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 836 LARFLFARPFDTS-------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 836 ~a~~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
.++.......... ...........++..|+|||.+ .+..++.++|||||||++|||++|..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI------------LRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhc------------cCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9874211100000 0000111224578899999544 45678899999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
||... ...+........ ....+.. ...++..+.+++.+||+.+|++||++.++.+.++.
T Consensus 215 pf~~~-----~~~~~~~~~~~~---~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 215 PFFGD-----TPEELFGQVISD---DIEWPEG------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCC-----CHHHHHHHHHhc---ccCCCCc------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 98632 112211111000 0001110 01235567899999999999999997666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.58 Aligned_cols=274 Identities=23% Similarity=0.357 Sum_probs=194.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++++|.+.+.||+|+||.||+|..+.+++.||+|++.... ......+.+|+++++.++|+||+++.+++ ..++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 3578999999999999999999998899999999986432 22334677899999999999999999985 34568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||++ +++.+++..... .+.+..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 999999995 688887765431 367778889999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++..... ........++..|+|||.+.. ...++.++|||||||++|||++|+.||.....
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 149 LARAKSIP--------SQTYSSEVVTLWYRPPDVLLG-----------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred cccccCCC--------CCCCCCccccccccCCceeec-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 98754211 111123356889999976531 23467889999999999999999999974432
Q ss_pred CCccHHHHHHh-hcchh-hhhhc--Cccccccccc---chhhhh---HHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKM-ALPEK-VMETV--DPSLLLAWSD---GRRRAK---VEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~-~~~~~-~~~~~--d~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
....+.+.... ..+.. ..... -+.....+.. ...... .......+.+++.+|+..||++|||++|++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 210 VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 11111111100 00100 00000 0000000000 000000 0011356779999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.09 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=197.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch---hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK---GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|+..+.||+|+||+||+|....+++.||+|.+..... ...+.+.+|+++++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 368889999999999999999998899999999974322 2456788999999999999999999984 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.+++....+ ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 9999999999999999986432 2478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCcc---------------------ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhH
Q 001908 836 LARFLFARPFDTSM---------------------ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894 (997)
Q Consensus 836 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dvw 894 (997)
++............ ..........||..|+|||.+. +..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------------~~~~~~~~Di~ 216 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS------------GDGHGSAVDWW 216 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc------------CCCCCchHHHH
Confidence 98765321110000 0011122346889999996654 45678899999
Q ss_pred HHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 895 SLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 895 SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
||||++|+|++|+.||...... ..+. ...+.... + +.....+..+.+++.+||..+|++
T Consensus 217 slG~ll~~l~~g~~pf~~~~~~----~~~~---------~~~~~~~~--~------~~~~~~~~~~~~li~~~l~~~p~~ 275 (316)
T cd05574 217 TLGILLYEMLYGTTPFKGSNRD----ETFS---------NILKKEVT--F------PGSPPVSSSARDLIRKLLVKDPSK 275 (316)
T ss_pred HHHHHHHHHhhCCCCCCCCchH----HHHH---------HHhcCCcc--C------CCccccCHHHHHHHHHHccCCHhH
Confidence 9999999999999998743211 1110 00110000 0 001113567889999999999999
Q ss_pred CCC----HHHHHH
Q 001908 975 RME----MRDVLA 983 (997)
Q Consensus 975 Rps----~~evl~ 983 (997)
||+ +.|+++
T Consensus 276 R~s~~~~~~~ll~ 288 (316)
T cd05574 276 RLGSKRGAAEIKQ 288 (316)
T ss_pred CCCchhhHHHHHc
Confidence 999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.17 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=192.3
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+.+....||.|+.|.||+++.+.+|...|||.+... ..++.+++...++++..- ++|.||+.+||+. .+..+.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHH
Confidence 445567899999999999999999999999999744 455567778888877665 4999999999954 344678
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+.||.| ...++..++.-.. ++++.-.=++...+++||.||-+++ +|+|||+||+|||+|+.|++|++|||.+
T Consensus 168 IcMelM-s~C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 889988 3355555554331 3667677788899999999999997 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
-++... .......|-+.|||||.+.... ...|+.++|||||||.++|+.||+.||..-..+.
T Consensus 240 GrlvdS---------kAhtrsAGC~~YMaPERidp~~---------~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF 301 (391)
T KOG0983|consen 240 GRLVDS---------KAHTRSAGCAAYMAPERIDPPD---------KPKYDIRADVWSLGITLVELATGQYPYKGCKTDF 301 (391)
T ss_pred ceeecc---------cccccccCCccccCccccCCCC---------CCccchhhhhhhhccchhhhhcccCCCCCCCccH
Confidence 876332 2233457889999999997532 4679999999999999999999999997432221
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+... .....|.+.. .....+.+.+++..|+..|+.+||...++++
T Consensus 302 e~ltkv---------ln~ePP~L~~----------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 302 EVLTKV---------LNEEPPLLPG----------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHH---------HhcCCCCCCc----------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111111 1111122211 1113567789999999999999999998865
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.58 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=194.8
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-----KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
+|+..+.||+|+||.||+|....+++.||+|++.... +...+.+.+|+++++.++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4777899999999999999998889999999986432 234578899999999999999999999853 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++++||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 8999999999999999997653 478889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-CCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
|.+....... ......|+..|+|||.+. ... ++.++|||||||++|+|++|+.||...
T Consensus 147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~------------~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIA------------QQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred ccceeccccc---------cccccCCCcceeCHHHhc------------CCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 9987642211 122356888999997553 233 788999999999999999999998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ............ .+. .+......+.+++.+||..+|++||++.++++
T Consensus 206 ~~----~~~~~~~~~~~~-----~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 206 EG----VAAVFKIGRSKE-----LPP------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cH----HHHHHHHHhccc-----CCC------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 21 111100000000 000 01122456778999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.54 Aligned_cols=240 Identities=25% Similarity=0.443 Sum_probs=186.0
Q ss_pred CcccccCcceEEEEEECCCC----------cEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 685 NMIGQGSFGSVYKGILGENG----------TFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
+.||+|+||.||+|.+..++ ..||+|++...... ...+.+|++++++++|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46899999999999997666 35888887644333 5788999999999999999999998643 3
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-------
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM------- 827 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~------- 827 (997)
..++||||+++|+|.+++..... .+++..+..++.||+.|++|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 57999999999999999987542 378889999999999999999999 999999999999999888
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-C
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-R 906 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g 906 (997)
.+|++|||++..... .....++..|+|||.+... ...++.++|||||||++|||++ |
T Consensus 146 ~~kl~Dfg~a~~~~~------------~~~~~~~~~y~aPE~~~~~----------~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 146 FIKLSDPGIPITVLS------------REERVERIPWIAPECIRNG----------QASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred eEEeCCCCccccccc------------ccccccCCCccChhhhcCC----------CCCcchhhHHHHHHHHHHHHHhCC
Confidence 899999999976421 1123466789999765421 1367889999999999999999 5
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
..||...... ....... +..... .+ ...++.+++.+||..+|++|||+.|+++.|
T Consensus 204 ~~p~~~~~~~--~~~~~~~-----------~~~~~~---------~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 204 EEPLSTLSSS--EKERFYQ-----------DQHRLP---------MP--DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCcccCCch--hHHHHHh-----------cCCCCC---------CC--CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 7777643211 0111100 000000 00 015678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.59 Aligned_cols=272 Identities=21% Similarity=0.344 Sum_probs=193.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|++|.||+|+.+.+++.||+|.+.... ......+.+|++++++++|+||+++++++ ...+..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 57889999999999999999998889999999986432 22234567899999999999999999985 3456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||++ ++|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 80 lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred EEEecCC-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence 9999997 599999876542 378889999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+...... .......++..|+|||.+.. ...++.++||||+||++|||++|+.||.......
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 211 (291)
T cd07844 151 RAKSVPS--------KTYSNEVVTLWYRPPDVLLG-----------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211 (291)
T ss_pred cccCCCC--------ccccccccccccCCcHHhhc-----------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 6531110 11112346788999976531 2447889999999999999999999996432111
Q ss_pred ccHHHHHHhh-c--chhhhhhcCc-ccc---c-ccccchhhhhH--HHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA-L--PEKVMETVDP-SLL---L-AWSDGRRRAKV--EECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~-~--~~~~~~~~d~-~~~---~-~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+....+.. . +.......+. ... . ........... ........+++.+|++.+|++|||+.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1111111100 0 0000000000 000 0 00000000000 001146679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=298.21 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=196.2
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.|...+.||+|++|.||+|....+++.||+|+++.......+.+.+|+.+++.++|+||+++++++. ..+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 4556689999999999999998889999999987555555677889999999999999999999854 45688999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
+||+++++|.+++... .+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.+..
T Consensus 95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999999873 278889999999999999999999 999999999999999999999999998875
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
.... ........|++.|+|||.+ .+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~--------~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----- 219 (285)
T cd06648 165 VSKE--------VPRRKSLVGTPYWMAPEVI------------SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----- 219 (285)
T ss_pred hccC--------CcccccccCCccccCHHHh------------cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----
Confidence 4221 1112234588999999654 35668889999999999999999999986321
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+..... .....+... .....+..+.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~-----~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 220 PLQAMKRI-----RDNLPPKLK----------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHH-----HhcCCCCCc----------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11111111 000011110 01113457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=295.93 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=194.8
Q ss_pred cCccCCcccccCcceEEEEEECC-CCcEEEEEEeccc----------chhhHHHHHHHHHHHhh-cCCCCcceEEeeeec
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGE-NGTFVAVKILNLM----------QKGALKSFVAECEVLRN-TRHRNLIKIITVCSS 747 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 747 (997)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+... ......++..|++++.+ ++|+||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999986 6789999988522 22334567788888865 79999999999853
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
..+..++||||+++++|.+++...... ...+++..+++++.|++.|+.|||+.. +++|+||||+||+++.++
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCC
Confidence 456899999999999999988653211 124788899999999999999999631 899999999999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+|++|||.+....... ......|+..|+|||.+ .+..++.++||||||+++|||++|+
T Consensus 152 ~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~------------~~~~~~~~~Dv~slG~ll~~l~~g~ 210 (269)
T cd08528 152 KVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIV------------KNEPYGEKADVWAFGCILYQMCTLQ 210 (269)
T ss_pred cEEEecccceeeccccc---------ccccccCcccCcChhhh------------cCCCCchHHHHHHHHHHHHHHHhCC
Confidence 99999999997642211 22345688899999654 3566889999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
.||... .............. .+.. .......+.+++.+||..||++||++.|+.++++
T Consensus 211 ~p~~~~-----~~~~~~~~~~~~~~----~~~~------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 211 PPFYST-----NMLSLATKIVEAVY----EPLP------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred Cccccc-----CHHHHHHHHhhccC----CcCC------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 998632 11111111100000 0000 0112456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.87 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=196.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+-|+..+.||+|+||.||+|....++..||+|++... .....+.+.+|++++++++|+||+++++++. ..+..+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEE
Confidence 3477889999999999999999888999999998643 2344567889999999999999999999854 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++
T Consensus 79 lv~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 79 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccc
Confidence 999999999999998753 378899999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ........++..|+|||.+. +..++.++|||||||++|+|++|..||.....
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~y~~PE~~~------------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-- 206 (277)
T cd06641 149 GQLTDT--------QIKRNTFVGTPFWMAPEVIK------------QSAYDSKADIWSLGITAIELAKGEPPHSELHP-- 206 (277)
T ss_pred eecccc--------hhhhccccCCccccChhhhc------------cCCCCchhhHHHHHHHHHHHHcCCCCCCccch--
Confidence 755221 11122346788999996543 45678899999999999999999999864211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
....... .. ...+. ....++.++.+++.+||..+|.+||++.++++.
T Consensus 207 ---~~~~~~~-~~----~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 207 ---MKVLFLI-PK----NNPPT------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---HHHHHHH-hc----CCCCC------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111100 00 00000 011234567899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=305.26 Aligned_cols=280 Identities=18% Similarity=0.238 Sum_probs=197.9
Q ss_pred cCccCCcccccCcceEEEEEECC--CCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGE--NGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.|++.++||+|+||.||+|+... +++.||+|++.... ......+.+|++++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47788999999999999999987 78999999997532 34456778899999999999999999997532 236
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC----CCcEE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH----DMVAH 830 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~----~~~~k 830 (997)
..++||||+++ ++.+++....... ...++...++.++.|++.|++|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence 89999999964 7877776443211 12578889999999999999999999 9999999999999999 99999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
++|||+++....... .........++..|+|||.+.. ...++.++|||||||++|||++|++||
T Consensus 153 l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 153 IGDLGLARLFNAPLK-----PLADLDPVVVTIWYRAPELLLG-----------ARHYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred ECCCccccccCCCcc-----cccccCCccccccccCHHHHhC-----------CCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 999999986532111 1112233567889999976532 245788999999999999999999999
Q ss_pred CcCcCCCc--------cHHHHHHhhc-c--hhhh------hhcC---cccccccc-cchhhhhHH--HHHHHHHHHHhhc
Q 001908 911 NCMFQGGL--------TLHEFCKMAL-P--EKVM------ETVD---PSLLLAWS-DGRRRAKVE--ECLVTVIRIGVAC 967 (997)
Q Consensus 911 ~~~~~~~~--------~~~~~~~~~~-~--~~~~------~~~d---~~~~~~~~-~~~~~~~~~--~~~~~l~~li~~c 967 (997)
........ .+.+...... + .... +..+ ......+. ......... ....++.+++.+|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 296 (316)
T cd07842 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296 (316)
T ss_pred cCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHH
Confidence 75433220 0111111000 0 0000 0000 00000000 000000011 2345688999999
Q ss_pred CCCCCCCCCCHHHHHH
Q 001908 968 SMESPIERMEMRDVLA 983 (997)
Q Consensus 968 l~~dP~~Rps~~evl~ 983 (997)
+..||++|||+.|+++
T Consensus 297 l~~~P~~Rps~~eil~ 312 (316)
T cd07842 297 LEYDPTKRITAEEALE 312 (316)
T ss_pred hcCCcccCcCHHHHhc
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=300.99 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=194.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+.|+..+.||+|+||+||+|+...+++.||+|++... .....+.+.+|+++++.++||||+++.++|.. .+.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence 4588889999999999999999889999999998632 23344678899999999999999999999653 457
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||++ |++.+++..... .+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.+||+|||
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 899999996 688777764331 378899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
++..... .....+++.|+|||++... ....++.++||||||+++|||+||+.||.....
T Consensus 161 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~---------~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 161 SASLVSP------------ANSFVGTPYWMAPEVILAM---------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred cceecCC------------CCCccCCccccCceeeecc---------CCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 9865411 1124578899999876321 135578899999999999999999999863211
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.... .... ....+.. ....+...+.+++.+||..+|++||++.+++..
T Consensus 220 ----~~~~-~~~~-----~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 220 ----MSAL-YHIA-----QNDSPTL-----------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----HHHH-HHHh-----cCCCCCC-----------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1110 0000 0000000 012345678899999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=293.24 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=201.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch-hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|++|.||+|+...+++.||+|++..... ...+.+.+|++++++++|+|++++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 368889999999999999999998899999999875443 45678899999999999999999999854 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
+||||+++++|.+++.... .++...++.++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999998653 47889999999999999999999 8 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+....... .......++..|+|||.+. +..++.++||||||+++|+|+||+.||.....
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~~y~~pE~~~------------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~- 205 (264)
T cd06623 147 SKVLENTL--------DQCNTFVGTVTYMSPERIQ------------GESYSYAADIWSLGLTLLECALGKFPFLPPGQ- 205 (264)
T ss_pred ceecccCC--------CcccceeecccccCHhhhC------------CCCCCchhhHHHHHHHHHHHHhCCCCCccccc-
Confidence 87652211 1112346788999996543 45788899999999999999999999875432
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEE-CLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
....+..... .....+.. ... ++..+.+++.+||+.+|++||++.|+++.
T Consensus 206 -~~~~~~~~~~-----~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 206 -PSFFELMQAI-----CDGPPPSL------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCHHHHHHHH-----hcCCCCCC------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111111 11111111 111 35678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=295.38 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=195.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc----------hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ----------KGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
+|...+.||+|+||.||+|....+++.||+|+++... ....+.+.+|++++++++|+|++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 4778899999999999999998889999999885311 112346788999999999999999999854
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
..+..++||||+++++|.+++.... .+++..+..++.|++.|+.|||++ +++||||+|+||+++.++.+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 4568999999999999999998753 478889999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
|++|||.++...... .........|+..|+|||.+... ...++.++||||||+++||+++|..|
T Consensus 148 ~l~d~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~----------~~~~~~~~Dv~slG~~l~~l~~g~~p 211 (272)
T cd06629 148 KISDFGISKKSDDIY------DNDQNMSMQGSVFWMAPEVIHSY----------SQGYSAKVDIWSLGCVVLEMFAGRRP 211 (272)
T ss_pred EEeeccccccccccc------cccccccccCCccccCHHHhccc----------cCCCCccchhHHHHHHHHHHHhCCCC
Confidence 999999987542110 11112334688899999766421 12478899999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
|.... ......... .......+++.. ..+++..+.+++.+||..+|++||++.|+++
T Consensus 212 ~~~~~----~~~~~~~~~-~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 212 WSDEE----AIAAMFKLG-NKRSAPPIPPDV------------SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCcc----hHHHHHHhh-ccccCCcCCccc------------cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 86321 111111100 000000011110 1123567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=295.87 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=201.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|+||+||+|....++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+. ..+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 47889999999999999999998889999999986432 335678899999999999999999998853 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||.+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 99999999999999986432 12478899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
......... .........|+..|+|||.+.. ...++.++|||||||++|||++|+.||.......
T Consensus 150 ~~~~~~~~~----~~~~~~~~~~~~~y~~Pe~~~~-----------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 150 ASLADGGDR----TRKVRKTFVGTPCWMAPEVMEQ-----------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred HHhccCccc----cccccccccCChhhcChHHHcc-----------ccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 876432211 0012234568899999976642 1257889999999999999999999987432211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+.+... . ..+..... ......+.++.+++.+||..||++||++.|+++
T Consensus 215 -~~~~~~~----~-----~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 215 -VLMLTLQ----N-----DPPSLETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -hHHHHhc----C-----CCCCcCCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111100 0 00010000 001233567789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=299.78 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=186.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCC---CcEEEEEEecccchhhH-----------HHHHHHHHHHhhcCCCCcceEEe
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGEN---GTFVAVKILNLMQKGAL-----------KSFVAECEVLRNTRHRNLIKIIT 743 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 743 (997)
.++|.+.+.||+|+||+||+|++..+ +..+|+|+......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999766 66778886543221110 11122333455678999999998
Q ss_pred eeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
++.... ......++++|++ ..++.+.+.... ..++..+..++.|++.|++|||+. +|+||||||+||++
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKL-VENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred eeeEec-CCceEEEEEEehh-ccCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 754321 1223567888887 347777665432 245677889999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 824 DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 824 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+.++.+||+|||+|+.......... ..........||+.|+|||+ +.+..++.++|||||||++|||
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~------------~~~~~~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDA------------HNGACVTRRGDLESLGYCMLKW 226 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHH------------hCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999987632211110 01112233469999999954 4467789999999999999999
Q ss_pred HhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 904 FTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 904 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
++|+.||.........+... .... ......+.. ....++..+.+++..||..+|++||++.++.+
T Consensus 227 ~~g~~P~~~~~~~~~~~~~~-~~~~---~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 227 AGIKLPWKGFGHNGNLIHAA-KCDF---IKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhCCCCCCccccchHHHHHh-HHHH---HHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999997543222111111 0000 000000000 11234567889999999999999999999998
Q ss_pred HH
Q 001908 984 KL 985 (997)
Q Consensus 984 ~L 985 (997)
.+
T Consensus 292 ~~ 293 (294)
T PHA02882 292 IF 293 (294)
T ss_pred hh
Confidence 76
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.07 Aligned_cols=244 Identities=25% Similarity=0.318 Sum_probs=194.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++ .....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 4688999999999999999999989999999998642 233456788999999999999999999984 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.+++.... .++...+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999998764 478889999999999999999998 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
++...... .....|++.|+|||.+. +..++.++||||||+++|+|++|+.||....
T Consensus 147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~- 202 (290)
T cd05580 147 FAKRVKGR-----------TYTLCGTPEYLAPEIIL------------SKGYGKAVDWWALGILIYEMLAGYPPFFDDN- 202 (290)
T ss_pred CccccCCC-----------CCCCCCCccccChhhhc------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCC-
Confidence 98765221 22346889999996543 4567889999999999999999999986332
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVL 982 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl 982 (997)
..+........ +..+ +......+.+++.+||..+|++|+ +++|++
T Consensus 203 ----~~~~~~~~~~~------~~~~------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 203 ----PIQIYEKILEG------KVRF------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ----HHHHHHHHhcC------CccC------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11111111000 0000 111245677899999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=301.27 Aligned_cols=273 Identities=21% Similarity=0.264 Sum_probs=196.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||.||+|+++.+++.+|+|.++... ......+.+|++++++++||||+++++++... .....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 57889999999999999999999889999999997432 22234567899999999999999999986532 23689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++ ++|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 99999996 599999876542 478999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
++...... .......+++.|+|||.+.. ...++.++||||+||++|||++|+.||......
T Consensus 153 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 153 AREYGSPL--------KPYTQLVVTLWYRAPELLLG-----------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred eeeccCCc--------cccccccccccccCchhhcC-----------CccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 87653211 11123457889999976542 233678999999999999999999998743211
Q ss_pred CccHHHHHHhh---cchhhhhhcC--cccccccccch----hhhhHHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMA---LPEKVMETVD--PSLLLAWSDGR----RRAKVEE-CLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~---~~~~~~~~~d--~~~~~~~~~~~----~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.......... ....+....+ ......+.... ....+.. ....+.+++.+||+.+|++|||+.|++.
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 214 -DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred -HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0111110000 0000000000 00000000000 0000001 2456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=294.42 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=198.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccch--hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|+..+.||+|+||.||+|....+++.||+|+++.... ...+.+..|++++++++|+||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 47888999999999999999988899999999875433 3668899999999999999999999984 3456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+||+++++|.+++.... .+++..++.++.|++.|+.|||+. +|+|+||+|+||++++++.+||+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999998653 367788999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
.......... ........++..|+|||.+... ....++.++||||||+++||+++|+.||......
T Consensus 147 ~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~- 212 (264)
T cd06626 147 VKLKNNTTTM----GEEVQSLAGTPAYMAPEVITGG---------KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE- 212 (264)
T ss_pred cccCCCCCcc----cccccCCcCCcCccChhhccCC---------CCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-
Confidence 8763322111 1102235678899999776421 0133788999999999999999999999743211
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ...... .....+.. +........+.+++.+||+.+|++||++.|++.
T Consensus 213 --~-~~~~~~-----~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 213 --F-QIMFHV-----GAGHKPPI----------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --H-HHHHHH-----hcCCCCCC----------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 110000 00001111 001112456678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=292.50 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=195.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|+||.||+|..+.++..||+|.+... .....+.+.+|++++++++|+||+++++++ ...+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 477889999999999999999989999999998643 223446778999999999999999999985 3456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFg~ 836 (997)
+|+||+++++|.+++..... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999976542 2478999999999999999999999 999999999999999886 569999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+...... ........|++.|+|||.+ .+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~~~~ape~~------------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--- 205 (257)
T cd08225 149 ARQLNDS--------MELAYTCVGTPYYLSPEIC------------QNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--- 205 (257)
T ss_pred chhccCC--------cccccccCCCccccCHHHH------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCc---
Confidence 8765221 1112234588899999654 3466888999999999999999999998632
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+......... ..+. ......++.+++.+||..+|++|||+.|+++
T Consensus 206 --~~~~~~~~~~~~~----~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 206 --NLHQLVLKICQGY----FAPI-------------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --cHHHHHHHHhccc----CCCC-------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1222222111111 0000 0112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=294.41 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=197.5
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 4788899999999999999998899999999996432 2456788999999999999999999987 4556789
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++|+||+++++|.+++.... .++...+..++.|+++|++|||+. +++|+||||+||++++++.++++|||.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999998752 478889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+....... ......|+..|+|||.+. +..++.++||||+|+++|+|++|..||......
T Consensus 147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~------------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 205 (258)
T cd05578 147 ATKVTPDT---------LTTSTSGTPGYMAPEVLC------------RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205 (258)
T ss_pred ccccCCCc---------cccccCCChhhcCHHHHc------------ccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence 87652211 123356788999996654 455788999999999999999999998754321
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH--HHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM--RDVL 982 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl 982 (997)
....+...... .. ...+...+..+.+++.+||..||.+||++ +|++
T Consensus 206 --~~~~~~~~~~~------~~------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 206 --IRDQIRAKQET------AD------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --HHHHHHHHhcc------cc------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11121111100 00 01112234678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=305.58 Aligned_cols=279 Identities=22% Similarity=0.286 Sum_probs=201.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++.+++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 368999999999999999999999999999999986432 234567788999999999999999998765432 33457
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+. ++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 899999995 69999987644 378899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.++....... ..........|+..|+|||.+.. ...++.++|||||||++|||++|+.||.....
T Consensus 153 ~~~~~~~~~~----~~~~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 153 MARGLSSSPT----EHKYFMTEYVATRWYRAPELLLS-----------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred cceeecccCc----CCCcccccccccccccChHHhcC-----------CcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 9976532211 11111233468899999976542 24578899999999999999999999974321
Q ss_pred CCccHHHHHHh--hcchhhhhhc-Cccccc---ccccchh---hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKM--ALPEKVMETV-DPSLLL---AWSDGRR---RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~--~~~~~~~~~~-d~~~~~---~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. .+...... ..+....+.. +..... .+..... .......+.++.+++.+||+.+|++||++.+++.
T Consensus 218 ~~-~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 218 VH-QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HH-HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 10 01110000 0000111000 000000 0000000 0011234567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=279.36 Aligned_cols=213 Identities=23% Similarity=0.322 Sum_probs=173.0
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCc----EEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
-...|+..++||+|+||.||+|..+.+.. .+|+|.++.. ..+.....-+|+..++.++|||++.+..++..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~--- 98 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS--- 98 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc---
Confidence 34578999999999999999996653433 6899999744 23445677899999999999999999998643
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC----
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---- 826 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~---- 826 (997)
.+..+++++||.+- +|.+.|+-...... ..++...+..|..||+.|+.|||++ =|.|||+||.||++..+
T Consensus 99 -~d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 99 -HDKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER 172 (438)
T ss_pred -cCceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence 25689999999965 99999986553222 3588899999999999999999999 79999999999999887
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
|.|||+|||+|+.+..+- ..-......+-|..|+|||.+-. ...|+.+.||||.|||+.||+|-
T Consensus 173 G~VKIaDlGlaR~~~~pl-----kpl~s~d~VVVTiWYRAPELLLG-----------a~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPL-----KPLASLDPVVVTIWYRAPELLLG-----------ARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred CeeEeecccHHHHhhccc-----cccccCCceEEEEEecChHHhcc-----------cccccchhhhHHHHHHHHHHHcc
Confidence 899999999999873321 11223345678999999987754 34589999999999999999999
Q ss_pred CCCCCcCc
Q 001908 907 RRPTNCMF 914 (997)
Q Consensus 907 ~~P~~~~~ 914 (997)
.+-|.+..
T Consensus 237 ~PlF~g~E 244 (438)
T KOG0666|consen 237 EPLFKGRE 244 (438)
T ss_pred Cccccchh
Confidence 98887653
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=299.68 Aligned_cols=279 Identities=20% Similarity=0.309 Sum_probs=195.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc---CCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF---KGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~ 753 (997)
++|++.++||+|+||.||+|+.+.+++.||||++.... ......+.+|++++++++||||++++++|..... ...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47899999999999999999999899999999886332 2223456789999999999999999999765431 123
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||++ +++.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 46799999995 58988887643 1378999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+.......... ........++..|+|||.+.. ...++.++||||||+++|||++|+.||...
T Consensus 163 fg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 163 FGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLG-----------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CCCcccccCCcccC----CCCccCcccCccccCcHHhcC-----------CcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99998653221110 111223457889999976542 233678999999999999999999998643
Q ss_pred cCCCccHHHHHHhh---cchhhh-hhcCccccc--ccccchhhhhH-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 914 FQGGLTLHEFCKMA---LPEKVM-ETVDPSLLL--AWSDGRRRAKV-----EECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 914 ~~~~~~~~~~~~~~---~~~~~~-~~~d~~~~~--~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
... ......... .+.... ...+..... ........... ......+.+++.+||..||++|||+.|++
T Consensus 228 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 228 TEQ--HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CHH--HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 211 111111111 011000 000000000 00000000000 01124567899999999999999999987
Q ss_pred H
Q 001908 983 A 983 (997)
Q Consensus 983 ~ 983 (997)
+
T Consensus 306 ~ 306 (310)
T cd07865 306 N 306 (310)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=306.53 Aligned_cols=280 Identities=21% Similarity=0.237 Sum_probs=202.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|.+.+.||+|+||+||+|+...+++.||||+++.. .......+.+|+++++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999999989999999998632 2333456788999999999999999999875433233346
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++|+||+. ++|.+++.... .+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 899999995 79999987654 478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++...... .......++..|+|||.+.. ...++.++|||||||++|+|++|+.||.....
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLN-----------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred cccccCCCc--------ccccccccccCccChHHHhc-----------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 997652211 11223457889999976542 23478899999999999999999999864311
Q ss_pred CCccHHHHHHhh----cchhhhhhcCcccccc------cccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH-
Q 001908 916 GGLTLHEFCKMA----LPEKVMETVDPSLLLA------WSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK- 984 (997)
Q Consensus 916 ~~~~~~~~~~~~----~~~~~~~~~d~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~- 984 (997)
.......... .++......++..... ............+..++.+++.+||+.+|++|||++|+++.
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 215 --VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred --HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 0001111000 0001100011100000 00000011112345678899999999999999999999876
Q ss_pred -HHHH
Q 001908 985 -LCAA 988 (997)
Q Consensus 985 -L~~~ 988 (997)
++.+
T Consensus 293 ~~~~~ 297 (337)
T cd07858 293 YLASL 297 (337)
T ss_pred chhhh
Confidence 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=306.74 Aligned_cols=275 Identities=21% Similarity=0.227 Sum_probs=198.4
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKG 752 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 752 (997)
...++|+..+.||+|+||.||+|+...+++.||+|++.. ........+.+|++++++++|+||+++++++.... +.+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 345789999999999999999999998999999999863 23334467788999999999999999999865321 223
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
....++||||++ ++|.+.+... ++...+..++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 346899999995 5888887642 67788899999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.++..... .......++..|+|||.+ .+..++.++||||+||++|+|++|+.||..
T Consensus 161 Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 161 DFGLARTAGTS---------FMMTPYVVTRYYRAPEVI------------LGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred cCccceeCCCC---------CCCCCCcccccccCHHHH------------hCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 99999764211 112234578899999655 356788999999999999999999999874
Q ss_pred CcCCCccHHHHHHhh--cchhhhhhcCccccccc---------------cc----chhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 913 MFQGGLTLHEFCKMA--LPEKVMETVDPSLLLAW---------------SD----GRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~~~---------------~~----~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
.... ..+....... .+..+.+..++...... .+ ..........+..+.+++.+|++.|
T Consensus 220 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 298 (353)
T cd07850 220 TDHI-DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298 (353)
T ss_pred CCHH-HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCC
Confidence 3210 0011111000 00111111111000000 00 0000001123556789999999999
Q ss_pred CCCCCCHHHHHHH
Q 001908 972 PIERMEMRDVLAK 984 (997)
Q Consensus 972 P~~Rps~~evl~~ 984 (997)
|++|||+.|+++.
T Consensus 299 P~~R~t~~eiL~~ 311 (353)
T cd07850 299 PEKRISVDDALQH 311 (353)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=299.28 Aligned_cols=271 Identities=26% Similarity=0.360 Sum_probs=197.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||.||+|.++.+++.||+|+++.. .....+.+.+|++++++++|+||+++++++. ..+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 3688899999999999999999989999999998643 2334577899999999999999999999864 35589
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++++.+..+..... .+++..+..++.||+.|++|||+. +++|||++|+||++++++.+||+|||.
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99999998877766655432 378889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCC-CCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS-EASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+........ .......++..|+|||.+. +. .++.++||||||+++|+|++|+.||.....
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~------------~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 147 ARALRARPA-------SPLTDYVATRWYRAPELLV------------GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred ccccCCCcc-------ccccCcccccCCcCCchhc------------CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 976532111 1222356788999997654 34 678899999999999999999999874321
Q ss_pred CCccHHHHHHh--hcchhhhhhc--Cccccc-ccccch-----hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKM--ALPEKVMETV--DPSLLL-AWSDGR-----RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~--~~~~~~~~~~--d~~~~~-~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. .+...... ..+....... ++.... .+.+.. ....+..++.++.+++.+||..+|++||+++++++
T Consensus 208 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 208 ID-QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HH-HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 10 00000000 0000000000 111000 000000 00111223677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.82 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=200.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
...|.+.+.||+|.|++|.+|++..++..||+|++++.. ....+.+.+|+++|..++|||||+++.+ ...+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecce
Confidence 356888999999999999999999999999999997543 3334568999999999999999999999 445668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
+|+||||+.+|.+.+++.+.+. ........++.|+++|++|+|++ .|||||||++||+++.+.++||+|||
T Consensus 130 lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence 9999999999999999998873 33478888999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-CCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
++..+ .........+|++.|.|||++. +.. .++++|+||+|+++|-|+.|..||+..
T Consensus 201 fS~~~---------~~~~~lqt~cgsppyAaPEl~~------------g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~- 258 (596)
T KOG0586|consen 201 FSTFF---------DYGLMLQTFCGSPPYAAPELFN------------GKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ- 258 (596)
T ss_pred cceee---------cccccccccCCCCCccChHhhc------------CcccCCcceehhhhhhhheeeeecccccCCc-
Confidence 99876 2344556689999999997665 333 367899999999999999999999843
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.+.+.-...+..++ +.+. ....+..+++++++..+|.+|++++++.+.
T Consensus 259 ----~lk~Lr~rvl~gk~----------------rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 259 ----NLKELRPRVLRGKY----------------RIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----ccccccchheeeee----------------cccc--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 22221111111110 0010 111234589999999999999999999764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.49 Aligned_cols=241 Identities=27% Similarity=0.345 Sum_probs=194.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|...+.||+|.||.|..++.+.+++.||+|++++. ...++.+-..|-.+|+..+||.+..+--. |+..+.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCce
Confidence 6788999999999999999999999999999999743 45556777889999999999998876533 788899
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||..||.|.-++...+ .+++...+.+..+|+.||.|||++ +||+||+|.+|.++|.+|++||+|||
T Consensus 243 lCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence 999999999999999988765 467778888899999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++.- ...+.....+||||.|.|||++. +..|+.++|+|.+|||+|||.+|+.||.....
T Consensus 314 LCKE~--------I~~g~t~kTFCGTPEYLAPEVle------------DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 314 LCKEE--------IKYGDTTKTFCGTPEYLAPEVLE------------DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred cchhc--------ccccceeccccCChhhcCchhhc------------cccccceeehhhhhHHHHHHHhccCcccccch
Confidence 99753 22334556689999999997775 56799999999999999999999999984321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
..+.+.+-+ +.+ .++....++-..++...+..||++|.
T Consensus 374 --~kLFeLIl~-------ed~--------------kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 374 --EKLFELILM-------EDL--------------KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --hHHHHHHHh-------hhc--------------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 112221111 000 01112223445788889999999997
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=297.49 Aligned_cols=270 Identities=23% Similarity=0.331 Sum_probs=194.7
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.+.||+|++|.||+|.++.+|+.||+|++.... ......+.+|++++++++|+|++++++++. ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 567889999999999999998899999999986432 233457888999999999999999999854 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
+|||+ +++|.+++..... ..+++..++.++.|+++||+|||++ +++||||+|+||+++.++.+|++|||.+.
T Consensus 76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 76 VFEFL-DLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEecc-CcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 99999 4699999876542 2478999999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... ........++..|+|||.+.. ...++.++|||||||++|||++|+.||...... .
T Consensus 148 ~~~~~--------~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~ 207 (283)
T cd07835 148 AFGVP--------VRTYTHEVVTLWYRAPEILLG-----------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-D 207 (283)
T ss_pred ccCCC--------ccccCccccccCCCCCceeec-----------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 54211 111122346889999975531 234688999999999999999999998643211 0
Q ss_pred cHHHHHHhh-cch-hhhhh--cCcccccccc---cchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMA-LPE-KVMET--VDPSLLLAWS---DGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~-~~~-~~~~~--~d~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
......... .+. ..+.. ..+....... .............++.+++.+|++.+|++|||++|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 208 QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111111110 000 00000 0000000000 00001111123357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=295.78 Aligned_cols=272 Identities=22% Similarity=0.326 Sum_probs=197.7
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+|++.++||+|++|.||+|+...+++.||+|+++... ......+.+|++++++++|+||+++++++. ..+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 4788999999999999999999899999999987443 233466788999999999999999999854 4558899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||++ ++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||.+.
T Consensus 76 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEecCC-ccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 999997 489998876542 12478999999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......++..|+|||.+.. ...++.++|||||||++|+|++|+.||.......
T Consensus 149 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~- 208 (284)
T cd07836 149 AFGIPV--------NTFSNEVVTLWYRAPDVLLG-----------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED- 208 (284)
T ss_pred hhcCCc--------cccccccccccccChHHhcC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 542110 11122356889999976532 2346789999999999999999999987542211
Q ss_pred cHHHHHHhh-cc-hhhhh-hcC-cccccccc---cchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMA-LP-EKVME-TVD-PSLLLAWS---DGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~-~~-~~~~~-~~d-~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
......... .+ ...++ ..+ +....... +..........+..+.+++.+|++.||.+||++.|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111110 00 00000 000 00000000 00001111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=325.31 Aligned_cols=270 Identities=26% Similarity=0.417 Sum_probs=212.0
Q ss_pred HHHhhcCccCCcccccCcceEEEEEEC----C---CCcEEEEEEecc-cchhhHHHHHHHHHHHhhc-CCCCcceEEeee
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILG----E---NGTFVAVKILNL-MQKGALKSFVAECEVLRNT-RHRNLIKIITVC 745 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~---~~~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 745 (997)
+...++..+.+.+|+|+||.|++|... . ....||||.++. ....+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333444566679999999999999753 1 145799999973 3345678999999999998 599999999998
Q ss_pred eccCcCCCceEEEEEeeccCCCHHHHhhcCC---------CCCCc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 001908 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSN---------GQPEV-CDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815 (997)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~-~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 815 (997)
.. .+..++|+||++.|+|.++++..+ ..... ..+.....+.++.|||.||+||++. +++|||
T Consensus 372 t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRD 443 (609)
T KOG0200|consen 372 TQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRD 443 (609)
T ss_pred cc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchh
Confidence 65 568999999999999999999877 11111 2388899999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHH
Q 001908 816 LKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYS 895 (997)
Q Consensus 816 lk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwS 895 (997)
+.++|||++++..+||+|||+|+......+... ......-+..|||||.+. +..|+.++||||
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-----~~~~~~LP~kWmApEsl~------------~~~ft~kSDVWS 506 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRT-----KSSAGTLPVKWMAPESLF------------DRVFTSKSDVWS 506 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEe-----cCCCCccceeecCHHHhc------------cCcccccchhhH
Confidence 999999999999999999999997644332211 001101244699996664 477999999999
Q ss_pred HHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 896 LGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 896 lGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
|||++||++| |..||..... .. .+.....++.+..+|..|..+++++|..||+.+|++
T Consensus 507 fGI~L~EifsLG~~PYp~~~~----~~-----------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~ 565 (609)
T KOG0200|consen 507 FGILLWEIFTLGGTPYPGIPP----TE-----------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPED 565 (609)
T ss_pred HHHHHHHHhhCCCCCCCCCCc----HH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCccc
Confidence 9999999999 8888864210 01 111122455666778889999999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 001908 975 RMEMRDVLAKLCAARQ 990 (997)
Q Consensus 975 Rps~~evl~~L~~~~~ 990 (997)
||++.|+.+.++...+
T Consensus 566 RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 566 RPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCHHHHHHHHHHHHH
Confidence 9999999999999654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=289.12 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=195.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-----QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.+|++.+.||+|+||.||+|+...+++.||+|++... .......+.+|++++++++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 4788999999999999999999989999999987522 233456888999999999999999999986432 23
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++++||+++++|.+++.... .+++..+++++.|++.|+.|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 56889999999999999997653 367888999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.++....... .........++..|+|||.+ .+..++.++|||||||++||+++|+.||...
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 150 FGASKRIQTICM-----SGTGIKSVTGTPYWMSPEVI------------SGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccccccc-----cCccccccCCcccccCHhhh------------cCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 999986522110 11111234688999999654 3566788999999999999999999998632
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ......... ....++.. +....+.+.+++.+||. +|..||++.+++.
T Consensus 213 ~----~~~~~~~~~-----~~~~~~~~------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 213 E----AMAAIFKIA-----TQPTKPML------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred C----HHHHHHHHH-----cCCCCCCC------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 111111100 00011111 11234567899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=299.54 Aligned_cols=274 Identities=24% Similarity=0.299 Sum_probs=195.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||.||+|.++.+++.||+|+++... ......+.+|++++++++|+|++++++++... ..+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 357999999999999999999999899999999986432 22234567899999999999999999986432 2356
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||++ ++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 899999995 58998887643 2478999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+....... .......++..|+|||.+.. ...++.++||||+||++|||++|++||.....
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 154 LARTYGLPA--------KPMTPKVVTLWYRAPELLLG-----------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred eeeecCCcc--------CCCCcccccccccChhhhcC-----------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 997653211 11122345788999976542 24478899999999999999999999874321
Q ss_pred CCccHHHHHHhh-cc-hhhhhhcC-ccccccc--ccc---hhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMA-LP-EKVMETVD-PSLLLAW--SDG---RRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~-~~-~~~~~~~d-~~~~~~~--~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..+....... .+ ...+...+ ......+ ... ..........+.+.+++.+|+..||++|||+.|+++
T Consensus 215 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 215 I-EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred H-HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1 1111111100 00 01100000 0000000 000 000011123456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=293.97 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=183.5
Q ss_pred cccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhh---cCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRN---TRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.||+|+||.||++....+++.||+|++.... ......+.+|..+++. .+|++|+.+++++. ..+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999998899999999886322 1222334445444443 47999999988843 45589999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999997654 488999999999999999999999 999999999999999999999999999865
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
... .......|+..|+|||.+.. +..++.++||||+||++|||++|..||.......
T Consensus 147 ~~~----------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-- 203 (279)
T cd05633 147 FSK----------KKPHASVGTHGYMAPEVLQK-----------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-- 203 (279)
T ss_pred ccc----------cCccCcCCCcCccCHHHhcC-----------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--
Confidence 411 01123468999999975531 3457889999999999999999999997442211
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLAK 984 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 984 (997)
......... ..+.. .+...+.++.+++.+|++.||++|| +++|+++.
T Consensus 204 ~~~~~~~~~------~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 204 KHEIDRMTL------TVNVE------------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHhh------cCCcC------------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111111100 00111 1122355778999999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=303.32 Aligned_cols=279 Identities=21% Similarity=0.294 Sum_probs=199.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 753 (997)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+++++++ +|+||+++++++.. ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 45689999999999999999999988899999998853 2233345678899999999 99999999998643 224
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||++ ++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 46899999996 5999998764 277888999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+.......... .........|+..|+|||.+.. ...++.++|||||||++|||++|+.||...
T Consensus 151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLG-----------STRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccchhccccccccc---cCcchhcccccccccCceeeec-----------cccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99998763322110 1112233568999999976532 245778999999999999999999998643
Q ss_pred cCCCccHHHHHHhh--cchhhhhhc----Ccccccccccch---hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 914 FQGGLTLHEFCKMA--LPEKVMETV----DPSLLLAWSDGR---RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 914 ~~~~~~~~~~~~~~--~~~~~~~~~----d~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.... ......... ......... ...+........ .......++.++.+++.+||+.+|++|||+.++++.
T Consensus 217 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 217 STLN-QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred ChHH-HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 2111 011111100 000000000 000000000000 001111245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=294.38 Aligned_cols=268 Identities=19% Similarity=0.268 Sum_probs=193.2
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.++||+|+||.||+|+...+++.||+|+++.. .........+|+.+++++. |+|++++++++... ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 56788999999999999999989999999998743 2222334567899999885 99999999996532 2257899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||++ |++.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||.++
T Consensus 78 v~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 78 VFELMD-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEecCC-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 999996 588888876431 478999999999999999999999 9999999999999999 999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... ......++..|+|||.+. .+..++.++||||+||++|||++|..||......
T Consensus 148 ~~~~~~---------~~~~~~~~~~y~aPE~~~-----------~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-- 205 (282)
T cd07831 148 GIYSKP---------PYTEYISTRWYRAPECLL-----------TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-- 205 (282)
T ss_pred ccccCC---------CcCCCCCCcccCChhHhh-----------cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--
Confidence 652211 112245788999997543 2345688999999999999999999999643211
Q ss_pred cHHHHHHhhc---chhhhhhcCcccccc--ccc---chhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMAL---PEKVMETVDPSLLLA--WSD---GRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~---~~~~~~~~d~~~~~~--~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.......... +..+.....+..... +.. ..........+..+.+++.+||..+|++||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 206 DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111111110 111111111100000 000 0001112244678899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=283.85 Aligned_cols=275 Identities=24% Similarity=0.384 Sum_probs=225.4
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCC-----cEEEEEEec-ccchhhHHHHHHHHHHHhhcCCCCcceEEee
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENG-----TFVAVKILN-LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vAvK~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 744 (997)
.+++.....+++....+-+|.||+||.|.|++.. +.|-+|.++ ..++.+...+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4455666677888889999999999999887443 345667665 3455667888999999999999999999999
Q ss_pred eeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCC--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE--VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
+.+ +.+..++++.++..|+|..|+...++... ...++..+...+|.|++.|++|||+. +|+|.||.++|++
T Consensus 356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV 428 (563)
T ss_pred Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence 864 45678899999999999999995443221 22467778899999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
||+.-.+|++|=.+++.+++.+++.-.... ..+..||+||.+.+ ..|+.++|||||||++||
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnE------nRPvkWMslEal~n------------~~yssasDvWsfGVllWE 490 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNE------NRPVKWMSLEALQN------------SHYSSASDVWSFGVLLWE 490 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCC------CCcccccCHHHHhh------------hhhcchhhhHHHHHHHHH
Confidence 999999999999999999888776543222 35678999987764 678999999999999999
Q ss_pred HHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccc-cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 903 MFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLL-LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 903 llt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
|+| |+.||.+ +||.-. .-.+++++..++.+||++++.+|.-||+.+|++||+++|
T Consensus 491 Lmtlg~~Pyae-----------------------IDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 491 LMTLGKLPYAE-----------------------IDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred HHhcCCCCccc-----------------------cCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 999 8999762 233322 234778888999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q 001908 981 VLAKLCAARQTLV 993 (997)
Q Consensus 981 vl~~L~~~~~~~~ 993 (997)
+...|.+..-.+.
T Consensus 548 lv~cLseF~~qlt 560 (563)
T KOG1024|consen 548 LVICLSEFHTQLT 560 (563)
T ss_pred HHHHHHHHHHHHh
Confidence 9999999876653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=290.00 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=190.5
Q ss_pred hHHHHHHhhcCccCCcc--cccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeec
Q 001908 671 YSELSEATNEFSSSNMI--GQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSS 747 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 747 (997)
..+.....++|++.+.+ |+|+||.||+++.+.++..+|+|++....... .|+.....+ +|+|++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~- 79 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT- 79 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe-
Confidence 34555566788887777 99999999999999999999999986432111 122222222 7999999999854
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
..+..++||||+++++|.+++.... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++
T Consensus 80 ----~~~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 80 ----TLKGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK 146 (267)
T ss_pred ----cCCeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence 3458999999999999999998754 488999999999999999999999 999999999999999998
Q ss_pred -cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 828 -VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 828 -~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
.++|+|||.++.... .....++..|+|||++. +..++.++||||+||++|||++|
T Consensus 147 ~~~~l~dfg~~~~~~~------------~~~~~~~~~y~aPE~~~------------~~~~~~~~DvwslG~il~~l~~g 202 (267)
T PHA03390 147 DRIYLCDYGLCKIIGT------------PSCYDGTLDYFSPEKIK------------GHNYDVSFDWWAVGVLTYELLTG 202 (267)
T ss_pred CeEEEecCccceecCC------------CccCCCCCcccChhhhc------------CCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999875421 11235789999996553 56678899999999999999999
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-MRDVLA 983 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~ 983 (997)
+.||............+.... ... ..........+.+++.+||+.+|.+||+ ++|+++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~---------~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 203 KHPFKEDEDEELDLESLLKRQ---------QKK----------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCCCCCCCcchhhHHHHHHhh---------ccc----------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 999974432221222221111 000 0011133556789999999999999996 588874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=293.33 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=199.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..+.|+..+.||+|+||.||+|.+..+++.||+|+++.... ..+.+.+|++++++++|+|++++++++.. .+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEE
Confidence 45678888999999999999999988899999999975544 45678899999999999999999998643 4689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++|+||+++++|.+++.... ..+++..+..++.|++.|++|||.. +|+|+|++|+||+++.++.+||+|||.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence 99999999999999998754 2488999999999999999999998 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+...... ........++..|+|||.+ .+..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~~~~~~~--------~~~~~~~~~~~~y~~PE~~------------~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~- 221 (286)
T cd06614 163 AAQLTKE--------KSKRNSVVGTPYWMAPEVI------------KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP- 221 (286)
T ss_pred hhhhccc--------hhhhccccCCcccCCHhHh------------cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-
Confidence 8754211 1112234578899999654 356678999999999999999999999863211
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ....... . +. ......++..+.+++.+||+.+|.+||++.+++.
T Consensus 222 ---~~~~-~~~~~~~----~-~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 222 ---LRAL-FLITTKG----I-PP----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---HHHH-HHHHhcC----C-CC----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111 0000000 0 00 0111224567889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=295.30 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=190.9
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|...+.||+|+||+||++.+..+++.||+|++... .......+.+|+.++.++. |+||+++++++. .+...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence 566678999999999999999999999999998643 2344567889999999996 999999999853 355789
Q ss_pred EEEeeccCCCHHHHhh---cCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 758 LVYEYMQNGSLEEWLH---QSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
++|||++ +++.++.. ... ...+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVL----KSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeec
Confidence 9999985 46555432 221 124788999999999999999999743 8999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++..... .......|+..|+|||.+.... +..++.++||||+||++|||++|+.||....
T Consensus 153 g~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~---------~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 153 GISGQLVDS---------IAKTRDAGCRPYMAPERIDPSA---------RDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred chhHHhccC---------CccccccCccCccCHHHhcccc---------ccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 999765221 1112335788999998765310 1368889999999999999999999986321
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
...+........ ..+.... .....++.++.+++.+||..+|++|||+.|+++.
T Consensus 215 ----~~~~~~~~~~~~-----~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 215 ----SVFDQLTQVVKG-----DPPILSN--------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----hHHHHHhhhcCC-----CCCcCCC--------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111000 0111100 0011245678899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=297.09 Aligned_cols=269 Identities=19% Similarity=0.183 Sum_probs=188.7
Q ss_pred CcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCH
Q 001908 691 SFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSL 768 (997)
Q Consensus 691 ~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL 768 (997)
++|.||.++...+++.||||++... .....+.+.+|++++++++|+||+++++++ ...+..+++|||+++|+|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCH
Confidence 4455666666668999999998743 345567899999999999999999999984 445689999999999999
Q ss_pred HHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCc
Q 001908 769 EEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848 (997)
Q Consensus 769 ~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~ 848 (997)
.+++...... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+...........
T Consensus 87 ~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 87 EDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999865321 377888999999999999999999 999999999999999999999999999876643221110
Q ss_pred cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhc
Q 001908 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMAL 928 (997)
Q Consensus 849 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 928 (997)
..........++..|+|||.+... ...++.++|||||||++|||++|+.||.......... +......
T Consensus 160 -~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~ 227 (314)
T cd08216 160 -VVHDFPKSSVKNLPWLSPEVLQQN----------LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTV 227 (314)
T ss_pred -ccccccccccccccccCHHHhcCC----------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccC
Confidence 111122334578899999876521 1347889999999999999999999997542211111 1110000
Q ss_pred chhhh----hhcCcccc--------cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 929 PEKVM----ETVDPSLL--------LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 929 ~~~~~----~~~d~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+.... ........ .................++.+++.+||..||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 00000000 000000111112233457889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=295.88 Aligned_cols=280 Identities=23% Similarity=0.316 Sum_probs=198.7
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC----
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSID---- 749 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 749 (997)
...++|++.+.||+|+||.||+|..+.+++.||+|+++... ......+.+|++++++++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999999889999999997432 233456778999999999999999999875432
Q ss_pred -cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 750 -FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 750 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
..+....++|+||+++ ++.+.+.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1123478999999965 7877776542 2488999999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||.+........ .......++..|+|||.+.. ...++.++||||+||++|||++|++
T Consensus 155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLG-----------EERYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred EEeCcccccccccCCcc-------cccccceeccCccChHHhcC-----------CCCCCchhHHHHHHHHHHHHHhCCC
Confidence 99999999976522110 11122345778999976532 2346789999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhh---cchhhhhhcCccccccc--ccc---hhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMA---LPEKVMETVDPSLLLAW--SDG---RRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~~~~~~--~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
||..... ...+....... .+............... ... .........+..+.+++..||..+|++||++.+
T Consensus 217 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 217 IFQANQE-LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred CCCCCCh-HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9874311 11111111110 00000000000000000 000 000111123567899999999999999999999
Q ss_pred HHH
Q 001908 981 VLA 983 (997)
Q Consensus 981 vl~ 983 (997)
++.
T Consensus 296 il~ 298 (302)
T cd07864 296 ALN 298 (302)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=293.84 Aligned_cols=272 Identities=23% Similarity=0.323 Sum_probs=196.6
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.+.||+|+||.||+|+...+++.||+|++... .......+.+|++++++++|+|++++++++... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 56788999999999999999988999999999754 233456788999999999999999999996532 1368999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|+||++ ++|.+++.... ..+++..++.++.||++|++|||+. +++|+||||+||++++++.+|++|||.+.
T Consensus 78 v~e~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred Eecccc-ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 999996 49999887653 2478999999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
....... .......++..|+|||.+.. ...++.++||||||+++|||+||+.||...... .
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~ 209 (287)
T cd07840 149 PYTKRNS-------ADYTNRVITLWYRPPELLLG-----------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-E 209 (287)
T ss_pred eccCCCc-------ccccccccccccCCceeeEc-----------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-H
Confidence 6532210 11223356788999975532 234688999999999999999999998743211 1
Q ss_pred cHHHHHHhhc---chhhhhhcCc----cccccc-ccchhhhhHHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMAL---PEKVMETVDP----SLLLAW-SDGRRRAKVEE-CLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~---~~~~~~~~d~----~~~~~~-~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+........ ...+....+. ...... ........... ++.++.+++.+||..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 210 QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111000 0000000000 000000 00000011111 2667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=294.12 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=192.8
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEee
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
...+||+|+||.||++..+.+++.||+|++..........+.+|+.+++.++|+|++++++++. ..+..++||||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 98 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEF 98 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEec
Confidence 3467999999999999999899999999987555555677899999999999999999999854 45689999999
Q ss_pred ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhccc
Q 001908 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842 (997)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~ 842 (997)
+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 99 ~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 99 LEGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred CCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9999999988643 268889999999999999999999 999999999999999999999999998875422
Q ss_pred CCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHH
Q 001908 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHE 922 (997)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 922 (997)
. ........|++.|+|||.+ .+..++.++||||+||++|||++|..||.... ..+
T Consensus 169 ~--------~~~~~~~~~~~~y~~pE~~------------~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-----~~~ 223 (292)
T cd06657 169 E--------VPRRKSLVGTPYWMAPELI------------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLK 223 (292)
T ss_pred c--------cccccccccCccccCHHHh------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHH
Confidence 1 1112234688999999654 34567889999999999999999999986321 111
Q ss_pred HHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 923 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... .....+... .....+..+.+++.+||..+|.+||++.|+++
T Consensus 224 ~~~~~-----~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 224 AMKMI-----RDNLPPKLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHH-----HhhCCcccC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11110 000111100 01122446778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=291.05 Aligned_cols=273 Identities=24% Similarity=0.348 Sum_probs=195.2
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhc---CCCCcceEEeeeeccCcCCCce
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNT---RHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~ 755 (997)
|++.+.||+|+||.||+|+++.+++.||+|+++.. .......+.+|+++++++ +|+|++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 56788999999999999999888999999999732 222335566788877666 5999999999976654333345
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+++|||++ ++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 899999996 589998876432 1478999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+...... .......++..|+|||.+ .+..++.++|||||||++|||++|++||.....
T Consensus 153 ~~~~~~~~---------~~~~~~~~~~~~~~PE~~------------~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 153 LARIYSFE---------MALTSVVVTLWYRAPEVL------------LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred cceeccCC---------cccccccccccccChHHh------------ccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 98765211 111223578899999655 356688899999999999999999999874321
Q ss_pred CCccHHHHHHhh-cchhhhhhcCcc-cccccccch---hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMA-LPEKVMETVDPS-LLLAWSDGR---RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~-~~~~~~~~~d~~-~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+..+.... .+.......... ....+.... ......+....+.+++.+||..||++||++.|+++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 212 -ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred -HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 11122221111 000000000000 000000000 01111233467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=295.05 Aligned_cols=272 Identities=22% Similarity=0.315 Sum_probs=193.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|++|+||+|+++.+++.||+|++.... ....+.+.+|++++++++|+||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 46889999999999999999998899999999986432 233467889999999999999999999953 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCcEEEcccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFG 835 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFg 835 (997)
++||||++ +++.+++..... ...++..+..++.||+.||+|||++ +++||||||+||+++. ++.+||+|||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99999995 588888865432 1357788889999999999999999 9999999999999985 5679999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
++....... .......+++.|+|||.+.. ...++.++||||+||++|+|+||++||.....
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~ 209 (294)
T PLN00009 149 LARAFGIPV--------RTFTHEVVTLWYRAPEILLG-----------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209 (294)
T ss_pred cccccCCCc--------cccccCceeecccCHHHHhC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 997542210 11122356889999976532 24578899999999999999999999874321
Q ss_pred CCccHHHHHHh-hc-chhhhhh-cC-ccc---ccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKM-AL-PEKVMET-VD-PSL---LLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~-~~-~~~~~~~-~d-~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..+.+.... .. ....+.. .+ +.. ...+..............++.+++.+|++.+|++||++.++++
T Consensus 210 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 210 I-DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred H-HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111111100 00 0000000 00 000 0000000000011123456789999999999999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-33 Score=275.18 Aligned_cols=281 Identities=22% Similarity=0.333 Sum_probs=201.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEec--ccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc---CCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF---KGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~ 753 (997)
..|....+||+|.||+||+|+.+.+|++||+|++- ...++-.....+|+++++.+.|+|++.++.+|....- ...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35666789999999999999999999999998663 2333444677899999999999999999999866431 123
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...|+||++|+- +|.-.+.... ..++..++.+++.++..||.|+|.. .|+|||+||+|+||+.+|.+||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 458999999955 8988887653 2588999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+....+... ........+-|.+|++||.+-. ...|+++.|||..|||+.||+|+.+-+...
T Consensus 168 FGlar~fs~~~n~----~kprytnrvvTLwYrppEllLG-----------~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 168 FGLARAFSTSKNV----VKPRYTNRVVTLWYRPPELLLG-----------DREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred cccccceeccccc----CCCCcccceeeeecCCHHHhhc-----------ccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 9999765332211 1112334567999999987654 467899999999999999999998877643
Q ss_pred cCCCc--cHHHHHHhhcchhhhhhcCcccccccc----cchhhhhHHHHH------HHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 914 FQGGL--TLHEFCKMALPEKVMETVDPSLLLAWS----DGRRRAKVEECL------VTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 914 ~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~----~~~~~~~~~~~~------~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
..... .+...+...-++.+.++..-.+....+ ..+.....++.. ++-++++..++..||.+|++++++
T Consensus 233 teqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~a 312 (376)
T KOG0669|consen 233 TEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQA 312 (376)
T ss_pred hHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhh
Confidence 22110 111222222222222222212211110 001111112222 256789999999999999999998
Q ss_pred HH
Q 001908 982 LA 983 (997)
Q Consensus 982 l~ 983 (997)
+.
T Consensus 313 ln 314 (376)
T KOG0669|consen 313 LN 314 (376)
T ss_pred hc
Confidence 64
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=296.09 Aligned_cols=284 Identities=20% Similarity=0.256 Sum_probs=195.9
Q ss_pred Cccccc--CcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQG--SFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G--~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
..||+| +||+||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++++. ..+..++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 456666 8899999999989999999998643 3344578899999999999999999999954 456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||++++++.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+...
T Consensus 79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 79 PFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred ecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 999999999999875421 378889999999999999999998 9999999999999999999999999876543
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
........ ..........++..|+|||.+... ...++.++||||+||++|||++|+.||..........
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 152 VRNGQKAK-VVYDFPQFSTSVLPWLSPELLRQD----------LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred hccCcccc-ccccccccccCccCccChhhhcCC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 22111000 000111122356679999766421 1347889999999999999999999997542211100
Q ss_pred HHHHHhh--------cchhhhhh----------cCccc-c----ccc-ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 921 HEFCKMA--------LPEKVMET----------VDPSL-L----LAW-SDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 921 ~~~~~~~--------~~~~~~~~----------~d~~~-~----~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
....... .+...... +.... . ... ......+....+...+.+++.+||..||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 300 (328)
T cd08226 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300 (328)
T ss_pred HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence 0000000 00000000 00000 0 000 00011122345667899999999999999999
Q ss_pred CHHHHHH--HHHHHHHH
Q 001908 977 EMRDVLA--KLCAARQT 991 (997)
Q Consensus 977 s~~evl~--~L~~~~~~ 991 (997)
|+.|+++ .+..+.+.
T Consensus 301 ta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 301 SASSLLSHAFFKQVKEQ 317 (328)
T ss_pred CHHHHhhCHHHHHHHHh
Confidence 9999964 34444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=284.65 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=198.4
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
+|+..+.||+|++|.||++....+++.+|+|++........+.+.+|++++++++|++++++++++. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4778899999999999999998889999999997655556678899999999999999999999854 34689999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
+||+++++|.+++.... ..+++..+..++.|++.|++|||.. +++|+||+|+||+++.++.+||+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999999999998753 2478999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
..... ......++..|+|||.+. +..++.++||||||+++|+|++|+.||.....
T Consensus 148 ~~~~~---------~~~~~~~~~~~~~PE~~~------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---- 202 (253)
T cd05122 148 LSDTK---------ARNTMVGTPYWMAPEVIN------------GKPYDYKADIWSLGITAIELAEGKPPYSELPP---- 202 (253)
T ss_pred ccccc---------cccceecCCcccCHHHHc------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCch----
Confidence 52211 023456888999996554 45578899999999999999999999863311
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+......... .+.. .....++..+.+++.+||..||++|||+.|+++
T Consensus 203 -~~~~~~~~~~~-----~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 203 -MKALFKIATNG-----PPGL----------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -HHHHHHHHhcC-----CCCc----------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11100000000 0000 001112456889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=303.59 Aligned_cols=276 Identities=20% Similarity=0.282 Sum_probs=195.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC---------
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID--------- 749 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 749 (997)
.+|++.+.||+|+||.||+|....+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57899999999999999999999999999999997655556678889999999999999999998754321
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC-CCCc
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMV 828 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~ 828 (997)
+......++||||++ ++|.+++... .+++..++.++.||+.|++|||+. +|+||||||+||+++ +++.
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 111246799999996 5999888653 278889999999999999999999 999999999999997 4568
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+|++|||.++...... ..........++..|+|||.+.. +..++.++|||||||++|||++|+.
T Consensus 154 ~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwSlGvil~el~~g~~ 217 (342)
T cd07854 154 LKIGDFGLARIVDPHY-----SHKGYLSEGLVTKWYRSPRLLLS-----------PNNYTKAIDMWAAGCIFAEMLTGKP 217 (342)
T ss_pred EEECCcccceecCCcc-----ccccccccccccccccCHHHHhC-----------ccccCchhhHHHHHHHHHHHHhCCC
Confidence 8999999987542111 01111122357889999976532 3457889999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcch-------hhhhhcCcccc-cccc-cchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPE-------KVMETVDPSLL-LAWS-DGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~-------~~~~~~d~~~~-~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
||....... ........ .+. ........... .... .............++.+++.+|+..||++|||+.
T Consensus 218 pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 295 (342)
T cd07854 218 LFAGAHELE-QMQLILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295 (342)
T ss_pred CCCCCCHHH-HHHHHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence 997432110 01111000 000 00000000000 0000 0000001112345678999999999999999999
Q ss_pred HHHH
Q 001908 980 DVLA 983 (997)
Q Consensus 980 evl~ 983 (997)
|+++
T Consensus 296 ell~ 299 (342)
T cd07854 296 EALM 299 (342)
T ss_pred HHhC
Confidence 9974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=297.31 Aligned_cols=284 Identities=22% Similarity=0.308 Sum_probs=198.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc---CC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF---KG 752 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 752 (997)
.++|++.++||+|+||.||+|+++.+++.||+|++.... ......+.+|++++++++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999899999999986332 2223466789999999999999999987644321 22
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
....++|+||++ +++.+.+.... ..+++..+..++.|+++||+|||++ +|+||||||+||++++++.+|++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 346899999995 47887776533 2488999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccc---cccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 833 DFGLARFLFARPFDTSME---TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
|||++............. .........+++.|+|||.+.. ...++.++|||||||++|||++|++|
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-----------ERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-----------CCccCchhHhHHHHHHHHHHHhCCCC
Confidence 999998653322111100 1112233467889999976542 24578899999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhh--cchhhh-------hhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 910 TNCMFQGGLTLHEFCKMA--LPEKVM-------ETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
|...... .......... .....+ ...+......... ..........+.+.+++.+|+..||++|||+.|
T Consensus 227 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 227 LQGKSDI-DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred CCCCCHH-HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCc-cHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 8643211 1111111100 000000 0000000000000 000111122356889999999999999999999
Q ss_pred HHH
Q 001908 981 VLA 983 (997)
Q Consensus 981 vl~ 983 (997)
++.
T Consensus 305 ll~ 307 (311)
T cd07866 305 ALE 307 (311)
T ss_pred Hhc
Confidence 874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=289.42 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=191.4
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccch---hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQK---GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++|+||+++++.+ ......++++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999998899999999864332 4556789999999999999999998874 4566899999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999998754 478899999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
................++..|+|||... +..++.++||||||+++||+++|..||.... ..+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~------------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~ 209 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVIL------------GQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEI 209 (265)
T ss_pred cccccccccccccCcccCccccCHHHhc------------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHH
Confidence 1110000111223356788999996553 4557889999999999999999999987432 1111
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
........ . . + +.....+..+.+++.+||+.+|++|||++.+.+.+
T Consensus 210 ~~~~~~~~----~--~----~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 210 FQNILNGK----I--E----W------PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHhcCC----c--C----C------CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11110000 0 0 0 00001256778999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=289.92 Aligned_cols=243 Identities=24% Similarity=0.315 Sum_probs=182.3
Q ss_pred cccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHH---HHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECE---VLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.||+|+||.||+|....+++.||+|++.... ......+..|.. .++..+||+|+++.+++ ...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999999998889999999886421 111122333433 34445799999999884 455689999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
|||+++|+|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999987543 488999999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
.... ......|+..|+|||.+.. +..++.++||||+||++|||++|+.||...... .
T Consensus 147 ~~~~----------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~--~ 203 (278)
T cd05606 147 FSKK----------KPHASVGTHGYMAPEVLQK-----------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--D 203 (278)
T ss_pred cCcc----------CCcCcCCCcCCcCcHHhcC-----------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc--c
Confidence 4211 1123468999999976531 235788999999999999999999999743211 1
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
..+..... ...++.+ +.....++.+++.+|+..+|++|| ++.++++
T Consensus 204 ~~~~~~~~------~~~~~~~------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 204 KHEIDRMT------LTMAVEL------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hHHHHHHh------hccCCCC------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11110000 0011111 111245678999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=289.12 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=198.3
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.++||+|+||.||+++...+++.+|+|++... .......+.+|++++++++|+||+++.+++ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 478889999999999999999989999999998643 334456778999999999999999999884 4457899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++...... ...+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 999999999999999774311 12478899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ......+++.|+|||.+ .+..++.++|+||+|+++|||++|+.||....
T Consensus 151 ~~~~~~----------~~~~~~~~~~~~~Pe~~------------~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--- 205 (256)
T cd08530 151 KVLKKN----------MAKTQIGTPHYMAPEVW------------KGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--- 205 (256)
T ss_pred hhhccC----------CcccccCCccccCHHHH------------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 876322 11224578899999654 35667889999999999999999999987431
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+......... ....+.....++.+++.+|+..+|++||++.|+++
T Consensus 206 --~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 206 --MQDLRYKVQRGK-----------------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --HHHHHHHHhcCC-----------------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111110000 00111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=291.87 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=187.6
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
||+|+||+||+|..+.+++.||+|++.... ......+.+|++++++++||||+++++++ ...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 699999999999999899999999986322 22345667899999999999999999884 4456899999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++..... ..+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+.....
T Consensus 76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~- 147 (277)
T cd05577 76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG- 147 (277)
T ss_pred CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-
Confidence 99999999986542 2478899999999999999999999 999999999999999999999999999876421
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
........++..|+|||.+. +..++.++||||+||++|+|++|+.||...... ....+.
T Consensus 148 --------~~~~~~~~~~~~y~~PE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~ 206 (277)
T cd05577 148 --------GKKIKGRAGTPGYMAPEVLQ------------GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEEL 206 (277)
T ss_pred --------CCccccccCCCCcCCHHHhc------------CCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHH
Confidence 11112345788999996543 456888999999999999999999998743221 111111
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
...... . .. ..+....+.+.+++.+||..+|++|| ++.+++.
T Consensus 207 ~~~~~~-~-----~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 207 KRRTLE-M-----AV------------EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred Hhcccc-c-----cc------------cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 110000 0 00 01112245678999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=283.85 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=200.3
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|+..+.||+|++|.||+|....+++.|++|++.... ....+.+.+|++++++++|+||+++++++... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 4778899999999999999999899999999987543 24567889999999999999999999986432 126899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+||+++++|.+++.... .+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999999998754 488999999999999999999998 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
......... .......++..|+|||.+. +..++.++||||||+++|+|++|..||....
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--- 207 (260)
T cd06606 149 KRLGDIETG------EGTGSVRGTPYWMAPEVIR------------GEEYGRAADIWSLGCTVIEMATGKPPWSELG--- 207 (260)
T ss_pred Eeccccccc------ccccCCCCCccccCHhhhc------------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 866322110 1123456888999996554 4558889999999999999999999987543
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
......... ..... ....+...+..+.+++.+|+..+|++||++.|+++
T Consensus 208 -~~~~~~~~~--------~~~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 208 -NPMAALYKI--------GSSGE--------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -chHHHHHhc--------cccCC--------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111111110 00000 00111223567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=286.16 Aligned_cols=243 Identities=24% Similarity=0.300 Sum_probs=190.0
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
||+|+||.||+|+...+++.||+|++.... ....+.+.+|++++++++|+||+++++++ .++...++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 699999999999998889999999986322 23457789999999999999999999985 3456899999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++.+.. .++...+..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.++.....
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999999998754 377889999999999999999998 9999999999999999999999999999765221
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
. ......++..|+|||.+. +..++.++||||+|+++|+|++|..||.....+ ..+.
T Consensus 147 ~---------~~~~~~~~~~~~~PE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~ 202 (262)
T cd05572 147 Q---------KTWTFCGTPEYVAPEIIL------------NKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEI 202 (262)
T ss_pred c---------ccccccCCcCccChhHhc------------CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHH
Confidence 1 122346788999996543 456788999999999999999999998744221 1111
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
.... .+... ....+...+..+.+++.+||..+|++||+ ++|+++
T Consensus 203 ~~~~--------~~~~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 203 YNDI--------LKGNG--------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHH--------hccCC--------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1110 00000 00111122567889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=293.26 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=193.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+.|+..+.||+|+||.||+|+...+++.||+|.+.. ......+.+.+|+++++.++|+|++++.+++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 447778899999999999999998999999998863 223344678899999999999999999998643 457
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+. |++.+++..... .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 899999996 688887764431 378889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
++..... .....+++.|+|||.+... ....++.++|||||||++|||++|+.||.....
T Consensus 161 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~---------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 161 SASIMAP------------ANXFVGTPYWMAPEVILAM---------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred cceeecC------------cccccCCccccCHHHHhhc---------ccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 9875421 1224578899999876421 134578899999999999999999999863211
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
.+...... ....+.. ....+...+.+++.+||..+|++||++.++++.-.
T Consensus 220 -----~~~~~~~~-----~~~~~~~-----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 220 -----MSALYHIA-----QNESPAL-----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----HHHHHHHh-----hcCCCCc-----------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01000000 0000000 01123456789999999999999999999876533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=250.30 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=193.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|...++||+|.||+||+|+.+++++.||+|+++. .+++......+|+-+++.++|+|||+++++ ...+....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 46677899999999999999999999999999873 344556788999999999999999999998 55677899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+|||. .+|..+...-.+ .++...++.++.|+++|+.|+|+. .+.|||+||.|.+|+.+|+.|++|||+|
T Consensus 78 lvfe~cd-qdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred EeHHHhh-HHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 9999994 489998887653 378889999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+....+ .......+-|..|++|.++-. ..-|+++.|+||.||++.|+.. |++-|...
T Consensus 149 rafgip--------vrcysaevvtlwyrppdvlfg-----------akly~tsidmwsagcifaelanagrplfpg~--- 206 (292)
T KOG0662|consen 149 RAFGIP--------VRCYSAEVVTLWYRPPDVLFG-----------AKLYSTSIDMWSAGCIFAELANAGRPLFPGN--- 206 (292)
T ss_pred hhcCCc--------eEeeeceeeeeeccCcceeee-----------eehhccchHhhhcchHHHHHhhcCCCCCCCC---
Confidence 865221 112234567899999954421 2447889999999999999998 55545422
Q ss_pred CccHHHHHHhh-------cchhhhhhc---Ccccccccccchhhhh-HHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMA-------LPEKVMETV---DPSLLLAWSDGRRRAK-VEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~-------~~~~~~~~~---d~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
++.+..... ..+.+..+. |-.....+.......+ ....-..=.+++++.+.-+|..|+++.++++
T Consensus 207 --dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 207 --DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred --cHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222221111 111222211 1111111111000000 0111112346777888889999999998875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=287.69 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=199.4
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|++++++++|+|++++.+.+. ..+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 4788899999999999999998889999999997443 345677899999999999999999999843 346899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|+||+++++|.+++..... ....+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 99999999999999987531 113588999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
....... .......|++.|+|||... +..++.++||||+|+++++|++|+.||....
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~------------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--- 207 (258)
T cd08215 151 KVLSSTV--------DLAKTVVGTPYYLSPELCQ------------NKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--- 207 (258)
T ss_pred eecccCc--------ceecceeeeecccChhHhc------------cCCCCccccHHHHHHHHHHHHcCCCCCCCCc---
Confidence 7652211 1222346888999996543 4567889999999999999999999986431
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+......... .+. .+..++.++.+++.+||..+|++|||+.|+++
T Consensus 208 --~~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 --LLELALKILKGQ-----YPP------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --HHHHHHHHhcCC-----CCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222211111100 000 01123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=291.51 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=190.7
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
|...++||+|+||+||+|+...+++.||+|++... .....+.+.+|+++++.++|+|++++++++.. .+..+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 56667899999999999999889999999998632 22344678889999999999999999999643 45789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+. |++.+++..... .+++.+++.++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999995 688888765431 378899999999999999999999 9999999999999999999999999988
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
.... ......|+..|+|||.+... ..+.++.++|||||||++|||++|..||.....
T Consensus 169 ~~~~------------~~~~~~~~~~y~aPE~~~~~---------~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-- 225 (313)
T cd06633 169 SKSS------------PANSFVGTPYWMAPEVILAM---------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-- 225 (313)
T ss_pred cccC------------CCCCccccccccChhhcccc---------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--
Confidence 6421 11234688899999876321 235578899999999999999999999864311
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
........ ... .+... .......+.+++.+||+.+|++||++.++++.
T Consensus 226 --~~~~~~~~-~~~-----~~~~~-----------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 226 --MSALYHIA-QND-----SPTLQ-----------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --HHHHHHHH-hcC-----CCCCC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110000 000 00000 01123457889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=291.94 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=193.4
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.|+..+.||+|+||.||+|++..++..||+|++... .......+.+|++++++++|+|++++++++.. .+..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence 367788999999999999999889999999998632 23344678899999999999999999998643 4578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++ |++.+.+.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||+
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 99999996 58888776533 1478999999999999999999999 999999999999999999999999998
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+..... .....|++.|+|||.+... ..+.++.++|||||||++|||++|+.||....
T Consensus 172 ~~~~~~------------~~~~~~~~~y~aPE~~~~~---------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-- 228 (317)
T cd06635 172 ASIASP------------ANSFVGTPYWMAPEVILAM---------DEGQYDGKVDVWSLGITCIELAERKPPLFNMN-- 228 (317)
T ss_pred ccccCC------------cccccCCccccChhhhhcC---------CCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--
Confidence 864311 1224578899999876321 23567889999999999999999999986421
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
.......... . ..+. .....+...+.+++.+||+.+|.+||++.++++...
T Consensus 229 --~~~~~~~~~~-~-----~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 229 --AMSALYHIAQ-N-----ESPT-----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred --HHHHHHHHHh-c-----cCCC-----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1111100000 0 0000 001123456789999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=290.56 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=193.4
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccch-hhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-GALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.+.||+|++|+||+|+...+++.||+|++..... .......+|++.+++++ |+|++++++++ ...+..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 6678899999999999999988899999999864322 22334567899999998 99999999985 34668999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+ +|+|.+++..... ..+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||.+.
T Consensus 76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99999 8899999887541 2478999999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... .......++..|+|||.+.. ...++.++||||||++++||++|++||.......
T Consensus 148 ~~~~~---------~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~- 206 (283)
T cd07830 148 EIRSR---------PPYTDYVSTRWYRAPEILLR-----------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEID- 206 (283)
T ss_pred eccCC---------CCcCCCCCcccccCceeeec-----------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-
Confidence 65221 11123457889999976532 3457889999999999999999999986432111
Q ss_pred cHHHHHHhh---cchhhh------hhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMA---LPEKVM------ETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~---~~~~~~------~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+....... ....+. ...+...... ...............+.+++.+||..+|++|||++|++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF-APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HHHHHHHhcCCCChhhhhhHhhhhcccccccccc-ccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 011100000 000000 0000000000 000000001112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=312.85 Aligned_cols=278 Identities=19% Similarity=0.173 Sum_probs=184.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCc-EEEEEE--------------ec---ccchhhHHHHHHHHHHHhhcCCCCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGT-FVAVKI--------------LN---LMQKGALKSFVAECEVLRNTRHRNL 738 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~vAvK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni 738 (997)
..++|++.++||+|+||+||+|..+.... .++.|. +. .........+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987653222 122221 10 1112234567899999999999999
Q ss_pred ceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 739 v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
+++++++. ..+..|+|+|++ .+++.+++........ .......+..++.|++.||+|||++ +|+||||||
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKY-DFDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEecc-ccCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 99999954 455789999999 5688888765432111 1233566788999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+|||++.++.+||+|||+|+..... .........||..|+|||++ .+..++.++|||||||
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~-------~~~~~~~~~gt~~y~aPE~~------------~~~~~~~~~DiwSlGv 356 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKE-------REAFDYGWVGTVATNSPEIL------------AGDGYCEITDIWSCGL 356 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcc-------cccccccccCCcCCCCchhh------------cCCCCCcHHHHHHHHH
Confidence 9999999999999999999765221 11122335799999999655 3567899999999999
Q ss_pred HHHHHHhCCCC-CCcCcCC-CccHHHHHHhh------cch---hhhhhcCcccccc-cccchhhhhHHHHHHHHHHHHhh
Q 001908 899 MLLEMFTRRRP-TNCMFQG-GLTLHEFCKMA------LPE---KVMETVDPSLLLA-WSDGRRRAKVEECLVTVIRIGVA 966 (997)
Q Consensus 899 vl~elltg~~P-~~~~~~~-~~~~~~~~~~~------~~~---~~~~~~d~~~~~~-~~~~~~~~~~~~~~~~l~~li~~ 966 (997)
++|||++|..| +...... ...+.+..... .++ +..+.++...... ...-.........+.++.+++.+
T Consensus 357 il~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~k 436 (501)
T PHA03210 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVK 436 (501)
T ss_pred HHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHH
Confidence 99999998754 4322111 01111111110 000 1111111100000 00000000011123457788999
Q ss_pred cCCCCCCCCCCHHHHHH
Q 001908 967 CSMESPIERMEMRDVLA 983 (997)
Q Consensus 967 cl~~dP~~Rps~~evl~ 983 (997)
|+..||++|||+.|+++
T Consensus 437 mL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 437 MLTFDWHLRPGAAELLA 453 (501)
T ss_pred HhccCcccCcCHHHHhh
Confidence 99999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=286.05 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=197.2
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccch--hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|++|.||+|+...+++.||+|.+..... ...+.+.+|++++++++|+|++++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 47788999999999999999988899999999975443 45678899999999999999999999854 346899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
++|||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 9999999999999998653 478999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
....... .......++..|+|||... +..++.++||||+|+++|+|++|+.||....
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~------------~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--- 203 (254)
T cd06627 147 TKLNDVS--------KDDASVVGTPYWMAPEVIE------------MSGASTASDIWSLGCTVIELLTGNPPYYDLN--- 203 (254)
T ss_pred eecCCCc--------ccccccccchhhcCHhhhc------------CCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---
Confidence 8653211 1123346788999997553 3447889999999999999999999986321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
......... . . ..+. .+...+..+.+++.+||..+|++||++.|++.
T Consensus 204 -~~~~~~~~~-~-~----~~~~------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 204 -PMAALFRIV-Q-D----DHPP------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -HHHHHHHHh-c-c----CCCC------------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111111110 0 0 0000 01122456779999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=282.78 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=199.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CC-----CcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HR-----NLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~ 751 (997)
+++|.+...+|+|+||.|-++.+++++..||||+++..... .+..+-|+++++++. +. -+|++.+| |+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 78899999999999999999999999999999999865443 356678999999993 32 25566555 66
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC------
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH------ 825 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~------ 825 (997)
..++.|+|+|.+ |-|+.+++..+. ..+++..+++.|+.|++++++|||+. +++|-|+||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 678999999999 779999999865 34689999999999999999999999 9999999999999942
Q ss_pred --------------CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 826 --------------DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 826 --------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+..+|++|||.|+.. .+.....+.|..|+|| |++.+-+++..+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-----------~e~hs~iVsTRHYRAP------------EViLgLGwS~pC 290 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFD-----------HEHHSTIVSTRHYRAP------------EVILGLGWSQPC 290 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCccee-----------ccCcceeeeccccCCc------------hheeccCcCCcc
Confidence 346999999999753 1222556789999999 556678999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHH--h---hcchhhhhhcCccc-----cccccc-------------ch
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCK--M---ALPEKVMETVDPSL-----LLAWSD-------------GR 948 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~--~---~~~~~~~~~~d~~~-----~~~~~~-------------~~ 948 (997)
||||+||||+|+.||..-|..-. +.+..+. . ..|..+..-.+... ...|.+ ..
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHe----n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ck 366 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHE----NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCK 366 (415)
T ss_pred CceeeeeEEEEeeccceecccCC----cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCc
Confidence 99999999999999999887332 2222211 1 22322222220000 001100 00
Q ss_pred h----hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 949 R----RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 949 ~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. +........++++|+..|+.+||++|+|+.|++.
T Consensus 367 pl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 367 PLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 0 1112244567999999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-33 Score=275.30 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=190.6
Q ss_pred ccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhh-cCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 682 SSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRN-TRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
+....||.|+||+|+|..++..|+..|||+++... ..+.+++..|.+...+ =+.||||++||.+. .++..++.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWiC 141 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWIC 141 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceeee
Confidence 33567999999999999999999999999998443 3556788888886544 47999999999863 34468999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
||.| ..+++.+.+.--. .....+++.-.-+|+...+.||+||-+.. .|+|||+||+|||++..|.+|++|||.+-.
T Consensus 142 MELM-d~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 142 MELM-DISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred HHHH-hhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999 4476655432110 00123666677788888999999999876 899999999999999999999999999876
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
+.. ........|-..|||||.+.+. +..|+.++||||+|++++|+.||..||... ...
T Consensus 218 Lv~---------SiAkT~daGCrpYmAPERi~p~----------~~gyDiRSDvWSLGITL~EvAtG~fPyr~w---~sv 275 (361)
T KOG1006|consen 218 LVD---------SIAKTVDAGCRPYMAPERIDPS----------DKGYDIRSDVWSLGITLYEVATGNFPYRKW---DSV 275 (361)
T ss_pred HHH---------HHHhhhccCCccccChhccCCc----------cCCcchhhhhhhhcceEeeeecCCCCcchH---HHH
Confidence 622 2233445788999999998753 346999999999999999999999998732 111
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
+++. .+. ..-||....... ...+....+.+++..|+.+|-..||...++++.
T Consensus 276 feql-~~V------v~gdpp~l~~~~------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 276 FEQL-CQV------VIGDPPILLFDK------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHH-HHH------HcCCCCeecCcc------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1221 111 111222221111 011234578899999999999999999998653
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=284.30 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=184.1
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHH-hhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVL-RNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.||+|+||.||+|....+++.||+|+++... ......+..|..++ ...+|+|++++++++. ..+..++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 56899999999999998899999999986432 22223445555544 4458999999999853 456899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++++|.+++.... .+++..+.+++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++..
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999997654 377888999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
.. .....++..|+|||.+. +..++.++||||+|+++|||++|..||.... .
T Consensus 148 ~~------------~~~~~~~~~y~~pe~~~------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~ 198 (260)
T cd05611 148 LE------------NKKFVGTPDYLAPETIL------------GVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----P 198 (260)
T ss_pred cc------------cccCCCCcCccChhhhc------------CCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----H
Confidence 11 12345788999996543 4557899999999999999999999986321 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
.+........ ..+ +. ......++..+.+++.+||..+|++||++.++.+.+
T Consensus 199 ~~~~~~~~~~----~~~------~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 199 DAVFDNILSR----RIN------WP----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHHhc----ccC------CC----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1111110000 000 00 001113456788999999999999999876554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=296.50 Aligned_cols=278 Identities=19% Similarity=0.315 Sum_probs=193.8
Q ss_pred hcCc-cCCcccccCcceEEEEEECCCCcEEEEEEecccchhh--------------HHHHHHHHHHHhhcCCCCcceEEe
Q 001908 679 NEFS-SSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA--------------LKSFVAECEVLRNTRHRNLIKIIT 743 (997)
Q Consensus 679 ~~~~-~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 743 (997)
++|. +.+.||+|+||+||+|.+..+++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4577999999999999998899999999986332111 124678999999999999999999
Q ss_pred eeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
++. ..+..++||||++ |+|.+++.... .++......++.|++.|++|||+. +|+||||||+||++
T Consensus 88 ~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 88 VYV-----EGDFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred EEe-----cCCcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 854 4568999999996 69999987643 478889999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccchhcccCCCCCcc------ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHH
Q 001908 824 DHDMVAHVSDFGLARFLFARPFDTSM------ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897 (997)
Q Consensus 824 ~~~~~~kl~DFg~a~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlG 897 (997)
+.++.+|++|||.+.....+...... ..........++..|+|||.+.. ...++.++||||+|
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG 221 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-----------AEKYHFAVDMWSVG 221 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc-----------CCCCCcHHHHHHHH
Confidence 99999999999999766422111100 01111122346888999976531 23468899999999
Q ss_pred HHHHHHHhCCCCCCcCcCCCccHHHHHHhhc-c--hhhhhhcC-cccc--cccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 898 VMLLEMFTRRRPTNCMFQGGLTLHEFCKMAL-P--EKVMETVD-PSLL--LAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 898 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~--~~~~~~~d-~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
|++|||++|++||......+ .+........ + ..+....+ +... ..............+..++.+++.+|+..+
T Consensus 222 ~~l~el~tg~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 222 CIFAELLTGKPLFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred HHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC
Confidence 99999999999987432111 1111111000 0 00000000 0000 000000001111223567889999999999
Q ss_pred CCCCCCHHHHHH
Q 001908 972 PIERMEMRDVLA 983 (997)
Q Consensus 972 P~~Rps~~evl~ 983 (997)
|++||++.|++.
T Consensus 301 P~~R~s~~~~l~ 312 (335)
T PTZ00024 301 PLERISAKEALK 312 (335)
T ss_pred chhccCHHHHhc
Confidence 999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=297.82 Aligned_cols=283 Identities=20% Similarity=0.258 Sum_probs=203.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+|++.+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|++++++++|+||+++.+++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788999999999999999998889999999987433 34457889999999999999999999986543222334789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+
T Consensus 81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 9999996 58999987653 488999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCC-CCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS-EASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
......... ........++..|+|||.+. +. .++.++||||+|+++|+|++|+.||......
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLL------------SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred Eeecccccc-----cccccccccccCcCCceeee------------cccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 875332110 01123346788999997654 33 6888999999999999999999999744211
Q ss_pred CccHHHHHHhh-c-chhhhhhcCccccccc----ccchh---hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--H
Q 001908 917 GLTLHEFCKMA-L-PEKVMETVDPSLLLAW----SDGRR---RAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK--L 985 (997)
Q Consensus 917 ~~~~~~~~~~~-~-~~~~~~~~d~~~~~~~----~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L 985 (997)
. .+....... . +.......+......+ ..... .......+..+.+++..||+.+|++||++.++++. +
T Consensus 214 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 214 D-QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred H-HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 0 011110000 0 0000000000000000 00000 00111245678899999999999999999999874 5
Q ss_pred HHHHH
Q 001908 986 CAARQ 990 (997)
Q Consensus 986 ~~~~~ 990 (997)
++..+
T Consensus 293 ~~~~~ 297 (330)
T cd07834 293 AQLHD 297 (330)
T ss_pred Hhhcc
Confidence 55443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=301.59 Aligned_cols=266 Identities=21% Similarity=0.305 Sum_probs=216.2
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCC
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 753 (997)
..-+..|.+.+.||.|.||.||+++.+.+++.+|+|+.....+.+ +++..|+++++.. +|||++.+++++.-.+...+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 334567889999999999999999999999999999997554433 5567788899887 79999999999987777788
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+.+++|||||.+||..|.++.-.+. .+.|..+..|.+.++.|+.+||.. .++|||||-.|||++.++.||+.|
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~----rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGN----RLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhccc----chhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 9999999999999999999876532 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+..+. .+........||+.|||||+++.. --....|+..+|+||+|++..||.-|.+|+.++
T Consensus 167 FGvSaQld--------sT~grRnT~iGtP~WMAPEViac~-------e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 167 FGVSAQLD--------STVGRRNTFIGTPYWMAPEVIACD-------ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeeeeeee--------cccccccCcCCCcccccceeeecc-------cCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 99998762 233445667899999999999874 334567888999999999999999999998754
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..- +..-.+. ..+......++....++-++|..|+..|-+.||++.++++
T Consensus 232 HPm--------------raLF~Ip------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 232 HPM--------------RALFLIP------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chh--------------hhhccCC------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 211 0000000 0111112235566788999999999999999999988864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=294.39 Aligned_cols=274 Identities=22% Similarity=0.272 Sum_probs=198.6
Q ss_pred HHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 673 ELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
++...+++|++.+.||+|+||.||+|....+++.||+|++.. ......+.+.+|++++++++||||+++.+++..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 80 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS--- 80 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec---
Confidence 345577899999999999999999999998999999998853 223345678899999999999999999998642
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.....++|+||+ +++|.++++... ++...+..++.|+++|++|||+. +|+||||||+||++++++.+|
T Consensus 81 -~~~~~~lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~ 148 (328)
T cd07856 81 -PLEDIYFVTELL-GTDLHRLLTSRP-------LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK 148 (328)
T ss_pred -CCCcEEEEeehh-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence 234689999998 669998887543 67778889999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
++|||.+..... ......++..|+|||.+.. +..++.++|||||||++|||++|+.||
T Consensus 149 l~dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slG~il~el~tg~~~f 206 (328)
T cd07856 149 ICDFGLARIQDP-----------QMTGYVSTRYYRAPEIMLT-----------WQKYDVEVDIWSAGCIFAEMLEGKPLF 206 (328)
T ss_pred eCccccccccCC-----------CcCCCcccccccCceeeec-----------cCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999874311 1122456888999975431 246788999999999999999999998
Q ss_pred CcCcCCCccHHHHHHh--hcchhhhhh-cCcc---cccccccchhhhh---HHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 911 NCMFQGGLTLHEFCKM--ALPEKVMET-VDPS---LLLAWSDGRRRAK---VEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~--~~~~~~~~~-~d~~---~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
...... ......... ..++++.+. .+.. ...........+. ...+...+.+++.+|+..+|++||++.++
T Consensus 207 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el 285 (328)
T cd07856 207 PGKDHV-NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285 (328)
T ss_pred CCCCHH-HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 643210 000000000 001111110 0000 0000000000010 11234678899999999999999999998
Q ss_pred HHH
Q 001908 982 LAK 984 (997)
Q Consensus 982 l~~ 984 (997)
+..
T Consensus 286 l~~ 288 (328)
T cd07856 286 LAH 288 (328)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=289.87 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=191.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ......+.+|++++.+. .|+||+++++++. ....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence 357888999999999999999998889999999997432 23445667788777666 4999999999964 3457
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+++|||+ ++++.+++..... .+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||+|||
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence 99999998 4578777765331 4788899999999999999999732 89999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+...... .......++..|+|||.+.... ..+.++.++||||||+++|||++|+.||.....
T Consensus 161 ~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~--------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 223 (296)
T cd06618 161 ISGRLVDS---------KAKTRSAGCAAYMAPERIDPPD--------PNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223 (296)
T ss_pred cchhccCC---------CcccCCCCCccccCHhhcCCCC--------CccccccchhHHHHHHHHHHHHhCCCCCCcchh
Confidence 98765221 1112235788999998765311 024578899999999999999999999864211
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
. .+......... .+.. . ....+..++.+++.+||+.||++||++.++++.
T Consensus 224 ~----~~~~~~~~~~~-----~~~~----~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 224 E----FEVLTKILQEE-----PPSL----P------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred H----HHHHHHHhcCC-----CCCC----C------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 11111111000 0000 0 000234567899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=294.32 Aligned_cols=277 Identities=19% Similarity=0.240 Sum_probs=194.4
Q ss_pred cCccCCcccccCcceEEEEEECCC--CcEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGEN--GTFVAVKILNLM--QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
+|++.+.||+|+||.||+|+...+ +..||+|++... .....+.+.+|+++++++ +|+||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 477889999999999999999877 889999998632 222346778899999999 599999999875432 12335
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++++||++ ++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 6788999985 69999987543 478899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++........ .........||..|+|||.+.. ...++.++||||+||++|+|++|++||....
T Consensus 150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLS-----------FQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred CCceeccccccc----ccccccCcccCccccCcHHHhC-----------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 999865322111 1111233568999999976531 2457889999999999999999999987432
Q ss_pred CCCccHHHHHHhh--cc-hhhhhhcCcccc---cccccchhh---hhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA--LP-EKVMETVDPSLL---LAWSDGRRR---AKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~--~~-~~~~~~~d~~~~---~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. .......... .+ +......++... ......... .........+.+++.+|++.||++|||+.|+++
T Consensus 215 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 215 YV-DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HH-HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 0011100000 00 000000000000 000000000 000112456889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=287.45 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=199.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 754 (997)
++|.+.+.||+|+||.||+|+.+.+++.||+|++... .....+.+.+|++++++++ |+||++++++ +.+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence 4688999999999999999999989999999998642 2334567889999999998 9999999988 45566
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++.+.. .+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 8999999999999999998764 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCc------------cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 835 GLARFLFARPFDTS------------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 835 g~a~~~~~~~~~~~------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
|.+........... ...........++..|+|||... +..++.++||||+|+++++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~------------~~~~~~~~Di~slG~~l~~ 214 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN------------EKPAGKSSDLWALGCIIYQ 214 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhC------------CCCCChhhhHHHHHHHHHH
Confidence 99987643221100 00112233456788999996543 4557889999999999999
Q ss_pred HHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH----
Q 001908 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM---- 978 (997)
Q Consensus 903 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---- 978 (997)
+++|+.||..... .... .. ... .+.. .+...+..+.+++.+||..+|++||++
T Consensus 215 l~~g~~p~~~~~~----~~~~-~~-----~~~-~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 271 (280)
T cd05581 215 MLTGKPPFRGSNE----YLTF-QK-----ILK-LEYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGY 271 (280)
T ss_pred HHhCCCCCCCccH----HHHH-HH-----HHh-cCCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCH
Confidence 9999999874321 1100 00 000 0000 011224567899999999999999999
Q ss_pred HHHHH
Q 001908 979 RDVLA 983 (997)
Q Consensus 979 ~evl~ 983 (997)
.|+++
T Consensus 272 ~~ll~ 276 (280)
T cd05581 272 DELKA 276 (280)
T ss_pred HHHhc
Confidence 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=295.50 Aligned_cols=280 Identities=20% Similarity=0.239 Sum_probs=201.5
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeecc
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSI 748 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 748 (997)
..++....++|+..+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456667789999999999999999999999889999999998642 222346678899999999999999999986532
Q ss_pred C-cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 749 D-FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 749 ~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
. +......+++++++ +++|.+++.... +++..++.++.|+++|++|||+. +|+||||||+||++++++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 2 12234578888887 789998886543 78899999999999999999999 999999999999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||+++.... ......++..|+|||.+.. ...++.++|||||||++|||++|+
T Consensus 158 ~~kl~dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 158 ELKILDFGLARHTDD-----------EMTGYVATRWYRAPEIMLN-----------WMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred CEEEecccccccccc-----------cccccccCCCccCHHHHhC-----------ccCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999875311 1223467889999976542 245788999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhh--cchhhhhhcCccccccc-------ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 908 RPTNCMFQGGLTLHEFCKMA--LPEKVMETVDPSLLLAW-------SDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
.||..... ...+....... .+......+.......+ ..............++.+++..|++.||++||++
T Consensus 216 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 294 (345)
T cd07877 216 TLFPGTDH-IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 294 (345)
T ss_pred CCCCCCCH-HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence 99864321 11111111111 01111111110000000 0000000000124567899999999999999999
Q ss_pred HHHHHH
Q 001908 979 RDVLAK 984 (997)
Q Consensus 979 ~evl~~ 984 (997)
.+++..
T Consensus 295 ~e~l~h 300 (345)
T cd07877 295 AQALAH 300 (345)
T ss_pred HHHhcC
Confidence 998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.65 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=196.9
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccch--hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.+.||+|++|.||+|....+++.+|+|+++.... .....+.+|++++++++|+||+++++++ ...+..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 5677899999999999999988999999999864322 3456788899999999999999999984 34568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|+||+++ ++.+++.... ..+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEeccCC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 9999965 9998887753 1478899999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......++..|+|||.+.. ...++.++||||+|+++|+|+||+.||......+
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~-----------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~- 206 (283)
T cd05118 147 SFGSPV--------RPYTHYVVTRWYRAPELLLG-----------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID- 206 (283)
T ss_pred ecCCCc--------ccccCccCcccccCcHHHhc-----------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 653211 11122457889999976542 2367889999999999999999999986432110
Q ss_pred cHHHHHHhh---cchhhhhhcC--ccccccc---ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMA---LPEKVMETVD--PSLLLAW---SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~---~~~~~~~~~d--~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+....... .+.......+ ......+ ..........+...++.+++.+||+.||.+||++.+++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 207 QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011110000 0000000000 0000000 000001122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=297.03 Aligned_cols=274 Identities=21% Similarity=0.271 Sum_probs=197.2
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KG 752 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~ 752 (997)
+..++|++.+.||+|+||.||+|+...+++.||+|++... .....+.+.+|++++++++|+|++++.+++...+. ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4567899999999999999999999989999999998632 23344667889999999999999999887533221 12
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
....++|+||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence 23489999999 67999998763 388999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.+..... ......++..|+|||.+.. ...++.++||||+||++||+++|+.||..
T Consensus 161 dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 161 DFGLARHTDD-----------EMTGYVATRWYRAPEIMLN-----------WMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cccccccccc-----------cccCCcccccccCHHHHhC-----------CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999975421 1223457889999987642 23578899999999999999999999864
Q ss_pred CcCCCccHHHHHHh--hcchhhhhhcC-cccc---cccccchhh---hhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKM--ALPEKVMETVD-PSLL---LAWSDGRRR---AKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~--~~~~~~~~~~d-~~~~---~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ..+...... ..+......+. .... .......+. ........++.+++.+|+..+|++|||+.|+++
T Consensus 219 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 219 SDHI-DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CChH-HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 3211 011111000 00111111000 0000 000000000 001123567889999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=293.10 Aligned_cols=276 Identities=21% Similarity=0.266 Sum_probs=198.0
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-c
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-F 750 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 750 (997)
+....++|++.+.||+|+||.||+|....+++.||||++... .......+.+|++++++++|+||+++++++.... .
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344567899999999999999999999989999999998532 2223456789999999999999999999864321 1
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
......++||||+ +++|.+++... .+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence 1123568999999 77999888653 378899999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
++|||.+..... ......+++.|+|||.+.. ...++.++||||+||++|++++|+.||
T Consensus 159 l~dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~ll~~l~~g~~pf 216 (343)
T cd07880 159 ILDFGLARQTDS-----------EMTGYVVTRWYRAPEVILN-----------WMHYTQTVDIWSVGCIMAEMLTGKPLF 216 (343)
T ss_pred Eeeccccccccc-----------CccccccCCcccCHHHHhC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999875411 1123457889999976642 134788999999999999999999998
Q ss_pred CcCcCCCccHHHHHHhh--cchhhhhhcCcccc----cc---cccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 911 NCMFQGGLTLHEFCKMA--LPEKVMETVDPSLL----LA---WSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~----~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
...... ....+..... .+..+...+..... .. ............+..++.+++.+|++.||++|||+.++
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 217 KGHDHL-DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred CCCCHH-HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 743211 0111111100 01111111110000 00 00000001112334568899999999999999999998
Q ss_pred HH
Q 001908 982 LA 983 (997)
Q Consensus 982 l~ 983 (997)
++
T Consensus 296 l~ 297 (343)
T cd07880 296 LA 297 (343)
T ss_pred hc
Confidence 83
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=283.73 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=191.4
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-----QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
+|.+.++||+|+||.||++++...+..+++|+.+.. .......+.+|++++++++||||+++++++ ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 478889999999999999999877777777776532 222344677899999999999999999884 3455
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++...... ...+++..++.++.|++.|++|||+. +++|+||||+||++++ +.+|++||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 789999999999999998753211 12588999999999999999999999 9999999999999975 67999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++...... .......|++.|+|||.+ .+..++.++||||||+++|+|++|..||...
T Consensus 150 g~~~~~~~~~--------~~~~~~~~~~~~~~pe~~------------~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~- 208 (260)
T cd08222 150 GVSRLLMGSC--------DLATTFTGTPYYMSPEAL------------KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ- 208 (260)
T ss_pred CceeecCCCc--------ccccCCCCCcCccCHHHH------------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-
Confidence 9987653211 112234578899999654 3456788999999999999999999998632
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+..... .....+. .+..++.++.+++.+||..+|++||++.|+++
T Consensus 209 ----~~~~~~~~~-----~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 209 ----NFLSVVLRI-----VEGPTPS------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----cHHHHHHHH-----HcCCCCC------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111111111 0011111 11234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=286.49 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=193.9
Q ss_pred cCccCCcccccCcceEEEEEEC---CCCcEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLMQ----KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 751 (997)
+|++.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +|+||+++.++ +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 4778899999999999999864 467889999986322 22345678899999999 69999999987 44
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
.....++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 5668999999999999999987643 378889999999999999999998 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+++...... ........|+..|+|||.+... ....+.++||||||+++|||++|..||.
T Consensus 147 ~dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 147 TDFGLSKEFLAEE-------EERAYSFCGTIEYMAPEVIRGG----------SGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred EECcccccccccc-------ccccccccCCccccCHHHhcCC----------CCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 9999987653211 1111234588899999765421 1236789999999999999999999986
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.... .....+....... .++. .+......+.+++.+||..+|++|||++++.+.|..
T Consensus 210 ~~~~-~~~~~~~~~~~~~------~~~~------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 210 VDGE-QNSQSEISRRILK------SKPP------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCcc-cchHHHHHHHHHc------cCCC------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 3211 1111111111100 0000 111234567899999999999999999888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=284.79 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=191.1
Q ss_pred cCccCCcccccCcceEEEEEEC---CCCcEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLMQ----KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 751 (997)
+|++.+.||+|+||.||+|+.. .+|+.||+|+++... ....+.+.+|+++++++ +|++|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999874 478899999986422 22346678899999999 599999998874 4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
.....++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++++||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 4568899999999999999998654 367888999999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||++....... ........|+..|+|||.+... ...++.++||||||+++|+|++|+.||.
T Consensus 147 ~dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 147 TDFGLSKEFHEDE-------VERAYSFCGTIEYMAPDIVRGG----------DGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred eeCccceeccccc-------ccccccccCCcccCChhhccCC----------CCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 9999987542111 1112235688999999765421 1346788999999999999999999986
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
.... .....+........ .+. .+..+...+.+++.+||..+|++|| ++.+++.
T Consensus 210 ~~~~-~~~~~~~~~~~~~~------~~~------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 210 VDGE-KNSQAEISRRILKS------EPP------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCc-cccHHHHHHHhhcc------CCC------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 3211 11122221111000 000 0112345678999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=292.10 Aligned_cols=277 Identities=23% Similarity=0.277 Sum_probs=195.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 754 (997)
.++|...+.||+|+||.||+|++..+++.||+|++... .......+.+|++++++++|+||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999999888999999998632 2223456789999999999999999999875432 11234
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++|+||+. .++.++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEecccc-cCHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 5799999995 477776531 377889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++.... ......++..|+|||.+.. +..++.++|||||||++|||++|+.||....
T Consensus 162 g~~~~~~~-----------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 162 GLARHADA-----------EMTGYVVTRWYRAPEVILN-----------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCCcCCCC-----------CCCCceeeecccChhhhcC-----------ccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99875311 1123467889999976532 2457889999999999999999999997431
Q ss_pred CCCccHHHHHHhh-cc-hhhhhhcCccccccc-------ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH-
Q 001908 915 QGGLTLHEFCKMA-LP-EKVMETVDPSLLLAW-------SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK- 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~-~~-~~~~~~~d~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~- 984 (997)
.. ..+....... .+ .......+......+ ...............+.+++.+||+.||++||++.|++..
T Consensus 220 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~ 298 (342)
T cd07879 220 YL-DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298 (342)
T ss_pred HH-HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 10 0111111100 00 011111110000000 0000000001234567899999999999999999999843
Q ss_pred -HHHHH
Q 001908 985 -LCAAR 989 (997)
Q Consensus 985 -L~~~~ 989 (997)
+++.+
T Consensus 299 ~f~~~~ 304 (342)
T cd07879 299 YFDSFR 304 (342)
T ss_pred chhhcc
Confidence 55544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=279.14 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=201.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---c----hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---Q----KGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
..++|-..+.||+|||++||+|.+-...+.||||+-... . +.-.+...+|.++.+.++||.||++|+|+..
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-- 538 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-- 538 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee--
Confidence 346777889999999999999999888899999986421 1 1224577899999999999999999999742
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---C
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---D 826 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~ 826 (997)
+.+.+|-|.|||+|-+|+-|++... ..++.+++.|+.||+.||.||.+. .|+|+|=|+||.|||+.+ .
T Consensus 539 --DtdsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 539 --DTDSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred --ccccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence 3567899999999999999999876 478889999999999999999987 679999999999999954 4
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
|.+||.|||+++.+....++.. ..........||++|.+||.+.-.. .....+.|+||||.|||+|.++.|
T Consensus 610 GeIKITDFGLSKIMdddSy~~v-dGmeLTSQgAGTYWYLPPEcFvVgk--------ePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSV-DGMELTSQGAGTYWYLPPECFVVGK--------EPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred ceeEeeecchhhhccCCccCcc-cceeeecccCceeeecCcceeecCC--------CCCccccceeeEeeehhhhhhhcc
Confidence 7899999999999866554332 2223344568999999998765211 134578899999999999999999
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
+.||....... ++-+.........+.....|.+ ..+-..+|.+|+.+.-++|....++.
T Consensus 681 rKPFGhnqsQQ-dILqeNTIlkAtEVqFP~KPvV----------------sseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 681 RKPFGHNQSQQ-DILQENTILKATEVQFPPKPVV----------------SSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCCCCCchhHH-HHHhhhchhcceeccCCCCCcc----------------CHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 99997542221 2222111111112222222222 12345678888888888887776664
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=251.70 Aligned_cols=213 Identities=23% Similarity=0.342 Sum_probs=169.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhh-cCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRN-TRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++......||+|+||.|-+-++..+|+..|+|.+... ..+..++..+|+.+..+ ..+|.+|+++|. +..+..
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~regd 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFREGD 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhcccc
Confidence 34455567899999999999999999999999999743 34445677888887654 579999999997 455678
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++.||.| .-||..+.++.-... ...++..+=+||..|.+||.|||++. .++|||+||+|||++.+|+||+||||
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g--~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKG--GTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcC--CcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 99999999 448887766533221 24677788899999999999999986 89999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.+-.+.+ ........|-..|||||.+.. |.- ...|+.++||||+|+.+.||.+++.||+....
T Consensus 195 IsG~L~d---------SiAkt~daGCkpYmaPEri~~-------e~n-~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 195 ISGYLVD---------SIAKTMDAGCKPYMAPERINP-------ELN-QKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred cceeehh---------hhHHHHhcCCCccCChhhcCc-------ccC-cccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 9876522 112222467889999999975 332 34899999999999999999999999986544
Q ss_pred CC
Q 001908 916 GG 917 (997)
Q Consensus 916 ~~ 917 (997)
..
T Consensus 258 pF 259 (282)
T KOG0984|consen 258 PF 259 (282)
T ss_pred HH
Confidence 43
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=281.30 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=195.1
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|+..+.||+|+||.||+|+...+++.||+|++.... ....+.+..|++++++++|+|++++++++. +.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 566789999999999999999889999999997542 333467788999999999999999999853 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||++ ++|.+++.+.. ..+++..+++++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+.
T Consensus 76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 999997 59999998753 1488999999999999999999999 99999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
...... .......++..|+|||.+.. ...++.++|||||||++||+++|++||...... .
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~ 206 (282)
T cd07829 147 AFGIPL--------RTYTHEVVTLWYRAPEILLG-----------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-D 206 (282)
T ss_pred ccCCCc--------cccCccccCcCcCChHHhcC-----------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-H
Confidence 652211 11122345778999976542 236788999999999999999999998643211 0
Q ss_pred cHHHHHHhh---cchhhhhhcCcc-ccccc---ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMA---LPEKVMETVDPS-LLLAW---SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~---~~~~~~~~~d~~-~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+....... ....+....+-. ....+ ...............+.+++.+||..+|++||++.|++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 011111100 000110110000 00000 000000111122457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=290.18 Aligned_cols=241 Identities=25% Similarity=0.252 Sum_probs=191.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCce
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+++|.+...+|.|+|+.|..+....+++..|||++.... .+-.+|+.++... +||||+++.++ +.+..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCCce
Confidence 3567888888999999999999999999999999997542 2334577666555 79999999999 456779
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee-CCCCcEEEccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHVSDF 834 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DF 834 (997)
.|+|||.+.++-+.+.+.... .....+..|+.+|+.|++|||++ ||||||+||+|||+ ++.++++|+||
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred eeeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence 999999999999888888765 22367788999999999999999 99999999999999 69999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++..... ....+-|..|+|||++. ..+|++++||||||++||+|++|+.||....
T Consensus 461 G~a~~~~~~-----------~~tp~~t~~y~APEvl~------------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 461 GFWSELERS-----------CDTPALTLQYVAPEVLA------------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred chhhhCchh-----------hcccchhhcccChhhhc------------cCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 999876221 33346688999997765 5789999999999999999999999998654
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+ .+...+....+.. +...+.-.+|+.+|++.||.+||+|.++.+
T Consensus 518 ~~----~ei~~~i~~~~~s--------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 518 AG----IEIHTRIQMPKFS--------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ch----HHHHHhhcCCccc--------------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 43 1111111111111 122345578999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=309.51 Aligned_cols=147 Identities=29% Similarity=0.483 Sum_probs=130.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|.+.++||+|+||+||+|.+..+++.||||+++.. .......+.+|+++++.++|+||+++++++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 5789999999999999999999989999999998642 233446788999999999999999999884 34568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++++|.+++.... .+++..++.++.||+.||+|||.. +|+||||||+|||++.++.+||+|||
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 999999999999999997654 367888999999999999999999 99999999999999999999999999
Q ss_pred cchh
Q 001908 836 LARF 839 (997)
Q Consensus 836 ~a~~ 839 (997)
+++.
T Consensus 150 ls~~ 153 (669)
T cd05610 150 LSKV 153 (669)
T ss_pred CCcc
Confidence 9863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=282.03 Aligned_cols=243 Identities=21% Similarity=0.328 Sum_probs=194.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEec---ccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++.....||-|+||+|=++..+.....+|+|+++ ..+..+.++...|-.+|...+.|.||++|.. |.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 34556678999999999999986554458888886 3456667889999999999999999999987 677889
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
+|++||-|-||.+...+++++ .++..+.+.++..+++|++|||++ +||+||+||+|.+++.+|-+|+.|||
T Consensus 495 vYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 999999999999999999887 477788889999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.+ ........++||+.|+|||++ .....+.++|.||+|+++||+++|.+||....
T Consensus 566 FAKki---------~~g~KTwTFcGTpEYVAPEII------------LnKGHD~avDyWaLGIli~ELL~G~pPFs~~d- 623 (732)
T KOG0614|consen 566 FAKKI---------GSGRKTWTFCGTPEYVAPEII------------LNKGHDRAVDYWALGILIYELLTGSPPFSGVD- 623 (732)
T ss_pred hHHHh---------ccCCceeeecCCcccccchhh------------hccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-
Confidence 99987 344556678999999999555 45778899999999999999999999997431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
.+..+......-..++. |......-.++|++.++.+|.+|..
T Consensus 624 ---pmktYn~ILkGid~i~~-----------------Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 624 ---PMKTYNLILKGIDKIEF-----------------PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hHHHHHHHHhhhhhhhc-----------------ccccchhHHHHHHHHHhcCcHhhhc
Confidence 12222111100011111 1112233457888999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=271.15 Aligned_cols=237 Identities=28% Similarity=0.358 Sum_probs=187.7
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
||+|+||.||++....+++.||+|+++... ....+.+..|++++++++|+|+++++++ +......++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence 699999999999998889999999986432 2245678999999999999999999987 44567899999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccC
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~ 843 (997)
++++|.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999998764 478899999999999999999998 9999999999999999999999999998765221
Q ss_pred CCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHH
Q 001908 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923 (997)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 923 (997)
. .......++..|+|||... +...+.++|+||||+++||+++|..||..... .+.
T Consensus 147 ~--------~~~~~~~~~~~~~~Pe~~~------------~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~ 201 (250)
T cd05123 147 G--------SRTNTFCGTPEYLAPEVLL------------GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEI 201 (250)
T ss_pred C--------CcccCCcCCccccChHHhC------------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence 1 1223456788999996543 45578899999999999999999999864321 111
Q ss_pred HHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 924 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
...... .... .+...+..+.+++.+||..||++||++.+
T Consensus 202 ~~~~~~------~~~~------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 202 YEKILK------DPLR------------FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHhc------CCCC------------CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111110 0000 11112456789999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=280.87 Aligned_cols=195 Identities=28% Similarity=0.441 Sum_probs=165.8
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEe
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
.++||+|.||+||-|+++.+|+.||||++.+ ........++.|+.+|++++||.||.+... ++.++..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 5799999999999999999999999999973 334455788999999999999999999887 566779999999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC---cEEEcccccch
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLAR 838 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFg~a~ 838 (997)
-+ .|+..+.|-.... ..++......+..||+.||.|||.+ +|+|+|+||+|||+.+.. .+||+|||+|+
T Consensus 644 Kl-~GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEK----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hh-cchHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 99 4566666554321 1377778888999999999999999 999999999999997543 89999999999
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
.+.. .......+||+.|.|||++. ...|...-||||.|||+|.-++|..||..
T Consensus 716 iIgE---------ksFRrsVVGTPAYLaPEVLr------------nkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 716 IIGE---------KSFRRSVVGTPAYLAPEVLR------------NKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ecch---------hhhhhhhcCCccccCHHHHh------------hccccccccceeeeEEEEEEecccccCCC
Confidence 8743 33445678999999997776 47788999999999999999999999984
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.60 Aligned_cols=221 Identities=20% Similarity=0.153 Sum_probs=171.7
Q ss_pred cCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHH
Q 001908 690 GSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLE 769 (997)
Q Consensus 690 G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 769 (997)
|.+|.||+++++.+++.||+|++.... .+.+|...+....||||+++++++ ...+..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999986542 223455555556799999999984 4456899999999999999
Q ss_pred HHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCcc
Q 001908 770 EWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849 (997)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~ 849 (997)
+++.+.. .+++..+..++.|+++|++|||++ +|+||||||+||+++.++.++++|||.+.....
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------- 137 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------- 137 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc-------
Confidence 9997654 378899999999999999999999 999999999999999999999999998765421
Q ss_pred ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcc
Q 001908 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALP 929 (997)
Q Consensus 850 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 929 (997)
......++..|+|||.. .+..++.++||||+||++|||++|+.|+......
T Consensus 138 ----~~~~~~~~~~y~aPE~~------------~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------- 188 (237)
T cd05576 138 ----SCDGEAVENMYCAPEVG------------GISEETEACDWWSLGAILFELLTGKTLVECHPSG------------- 188 (237)
T ss_pred ----ccccCCcCccccCCccc------------CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------
Confidence 11223456789999644 3566788999999999999999999886522110
Q ss_pred hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 930 EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 930 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
....... ..+......+.+++.+|++.||++||++.
T Consensus 189 --~~~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 189 --INTHTTL------------NIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred --ccccccc------------CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 0000000 00112245678899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=250.13 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=199.4
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCce
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 755 (997)
..++|++.+++|+|.|++||.|..-.+.++++||++++... +.+.+|+.+|+.+. ||||++++++..++. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccC
Confidence 34689999999999999999999888999999999986544 67889999999996 999999999866432 455
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-CcEEEccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDF 834 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DF 834 (997)
..+|+||+.+.+....... ++...++.+..++++||+|+|++ ||.|||+||.|++||.. -..+++|+
T Consensus 110 paLiFE~v~n~Dfk~ly~t---------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT---------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred chhHhhhhccccHHHHhhh---------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 7899999999888776643 66678899999999999999999 99999999999999965 47999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|.+.-+ . ..-...+.+..|--||.+... ..|+.+-|+|||||++..|+..+.||-...
T Consensus 178 GLAEFYHp-----~----~eYnVRVASRyfKGPELLVdy-----------~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 178 GLAEFYHP-----G----KEYNVRVASRYFKGPELLVDY-----------QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred chHhhcCC-----C----ceeeeeeehhhcCCchheeec-----------hhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 99988622 1 122234567788899888643 457888999999999999999999987554
Q ss_pred CCCccHHHHHHhhcchhh-------hhhcCcccccccccchhhh--------hHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 915 QGGLTLHEFCKMALPEKV-------METVDPSLLLAWSDGRRRA--------KVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~-------~~~~d~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
+....++..+...-.+.. .-..||....-.....+.+ ...-..++..+++.+.++.|..+|+|++
T Consensus 238 dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 238 DNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred CCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence 443333333222111111 1112333222111111100 0001125667999999999999999999
Q ss_pred HHHH
Q 001908 980 DVLA 983 (997)
Q Consensus 980 evl~ 983 (997)
|+++
T Consensus 318 Eam~ 321 (338)
T KOG0668|consen 318 EAMA 321 (338)
T ss_pred HHhc
Confidence 9875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=267.09 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=168.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 752 (997)
...+|.+..+||+|+||.|-+|..+.+.+.||||+++.. ....++--+.|-++|+--. -|.++++..+ |+.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQT 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQT 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhh
Confidence 345799999999999999999999999999999999743 2222333355666776554 5566666655 666
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
-+.+|+||||+.||+|--++++.+ .+.+..+..+|.+||-||-|||++ ||++||+|..||+++.+|++||+
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence 779999999999999999999877 356677888999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+++.- .........++||+.|+|||++ ..++|+.++|+|||||++|||+.|++||+.
T Consensus 493 DFGmcKEn--------i~~~~TTkTFCGTPdYiAPEIi------------~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 493 DFGMCKEN--------IFDGVTTKTFCGTPDYIAPEII------------AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred eccccccc--------ccCCcceeeecCCCcccccceE------------EecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 99999753 2233445568999999999555 468999999999999999999999999984
Q ss_pred C
Q 001908 913 M 913 (997)
Q Consensus 913 ~ 913 (997)
.
T Consensus 553 e 553 (683)
T KOG0696|consen 553 E 553 (683)
T ss_pred C
Confidence 3
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=295.87 Aligned_cols=285 Identities=18% Similarity=0.169 Sum_probs=174.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCC----CcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeec-cCcC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGEN----GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSS-IDFK 751 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 751 (997)
..++|...++||+|+||.||+|++..+ +..||+|++...... +.+..| .++...+.+++.++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 899999987643221 111111 1222222223222211111 0013
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCC--------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQ--------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 817 (997)
.....++|+||+++++|.+++...... ..........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 456799999999999999999764310 0001112334668999999999999999 99999999
Q ss_pred CCCeeeCC-CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCcc----------ccCCCCC
Q 001908 818 PSNVLLDH-DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCL----------EYGMGSE 886 (997)
Q Consensus 818 ~~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~----------e~~~~~~ 886 (997)
|+|||++. ++.+||+|||+|+..... .........+|+.|+|||.+......+.. .......
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999986 689999999999765211 11122345789999999976432211000 0011223
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhc----c-hhhhhhcCcccccccccchhhhhHHHHHHHHH
Q 001908 887 ASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMAL----P-EKVMETVDPSLLLAWSDGRRRAKVEECLVTVI 961 (997)
Q Consensus 887 ~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~----~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~ 961 (997)
+..++||||+||++|||+++..|++. ....+..... . ..+.....+......... ............
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~d~~~~~~~ 427 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRG--FEVLDLDGGAGW 427 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhh--hhhccccchHHH
Confidence 55678999999999999997766432 1111111110 0 011111111100000000 000001122345
Q ss_pred HHHhhcCCCCCCCCCCHHHHHH
Q 001908 962 RIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 962 ~li~~cl~~dP~~Rps~~evl~ 983 (997)
+++.+|+..||++|||++|+++
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhC
Confidence 8999999999999999999976
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=264.40 Aligned_cols=137 Identities=25% Similarity=0.448 Sum_probs=117.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC--------CCCcceEEeeeeccC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR--------HRNLIKIITVCSSID 749 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~ 749 (997)
..+|.+.++||.|.|++||+|.+..+.+.||+|+.+..... .+....||++|++++ ..+||++++.+....
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36899999999999999999999999999999999744322 356688999999873 347999999876543
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
.+..++|||+|+. |.+|..+|....-+ .++...+++|++||+.||+|||++| +|+|-||||+|||+
T Consensus 156 -pNG~HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 -PNGQHVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred -CCCcEEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4567899999999 77999999986532 4888999999999999999999999 99999999999999
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=270.95 Aligned_cols=212 Identities=23% Similarity=0.342 Sum_probs=174.0
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
-|...+.||-|+||+|.++...++...||+|.+++.+ ..++.....|-+||...+.+.||++|-. |++++.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCce
Confidence 4667789999999999999998899999999987443 4456778899999999999999999865 7888999
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+||||++||++-.+|.+.+ .+.+..++.++.++.+|+++.|.. |+|||||||+|||||.+|++|+.|||+
T Consensus 705 YFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccc
Confidence 99999999999999998876 467777788888999999999999 999999999999999999999999999
Q ss_pred chhcc---cCCCCCcc-------------------------------ccccccccccccccccCCcchhcccccCccccC
Q 001908 837 ARFLF---ARPFDTSM-------------------------------ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYG 882 (997)
Q Consensus 837 a~~~~---~~~~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~ 882 (997)
+.-.. +..+.... .........+||+.|+|||++.
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~----------- 844 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA----------- 844 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-----------
Confidence 76431 00000000 0001112346999999997765
Q ss_pred CCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 883 MGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 883 ~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...|+..+|+||.|||||||+.|++||......+
T Consensus 845 -r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 845 -RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred -ccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 4678999999999999999999999998665443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=251.29 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=195.3
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (997)
..++|+..++||+|+|+.|..++.+.+.+.||+|++++. .++..+-.+.|-.+..+. +||.+|-+..+ |+.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence 347899999999999999999999999999999999742 334445556777777766 79999888776 777
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
+...++|.||++||+|--++++++ .+++.+++.+..+|.-|+.|||++ ||++||+|..|+++|..|++|+.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeec
Confidence 889999999999999999888876 477888999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+++.-. ........++|||.|.|||++. +..|+.++|+|++||+++||..|+.||+.
T Consensus 394 dygmcke~l--------~~gd~tstfcgtpnyiapeilr------------geeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 394 DYGMCKEGL--------GPGDTTSTFCGTPNYIAPEILR------------GEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ccchhhcCC--------CCCcccccccCCCcccchhhhc------------ccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 999997542 2334455689999999996654 67899999999999999999999999984
Q ss_pred Cc--CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 913 MF--QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 913 ~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
.. ..+.+.+.+.-+.+-++-..+.+ .....-..+++.-++.||++|.
T Consensus 454 vgm~n~d~ntedylfqvilekqiripr-----------------slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 454 VGMDNPDMNTEDYLFQVILEKQIRIPR-----------------SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ecCCCcccchhHHHHHHHhhhcccccc-----------------eeehhhHHHHHHhhcCCcHHhc
Confidence 32 22333444433322221111111 1112233577788899999886
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=253.61 Aligned_cols=206 Identities=22% Similarity=0.324 Sum_probs=165.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.+.+..+.||-|+||.||.+++..+|+.||+|++...- -...+.+.+|++++..++|.|++..+++.......--...
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 35667899999999999999999999999999886432 2345788999999999999999998887433221122357
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+++|.|. .+|...+-... .++...+.-+.+||++|++|||+. +|.||||||.|.+++++...||+|||+
T Consensus 133 YV~TELmQ-SDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGL 202 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGL 202 (449)
T ss_pred HHHHHHHH-hhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccc
Confidence 88999884 48888776644 467778888999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|+....+ ........+-|..|+|||++.+ ...|+.+.||||.|||+.|++..+.-|..
T Consensus 203 ARvee~d-------~~~hMTqEVVTQYYRAPEiLMG-----------aRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 203 ARTWDQR-------DRLNMTHEVVTQYYRAPELLMG-----------ARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ccccchh-------hhhhhHHHHHHHHhccHHHhhc-----------chhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 9865221 1222233456889999987764 35689999999999999999998888763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=256.94 Aligned_cols=239 Identities=30% Similarity=0.379 Sum_probs=187.6
Q ss_pred CcceEEEEEECCCCcEEEEEEecccchhh-HHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHH
Q 001908 691 SFGSVYKGILGENGTFVAVKILNLMQKGA-LKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLE 769 (997)
Q Consensus 691 ~~g~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 769 (997)
+||.||+|+...+++.+|+|++....... .+.+.+|++.+++++|+|++++++++.. ....++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999998889999999997554433 6789999999999999999999998643 45899999999999999
Q ss_pred HHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCcc
Q 001908 770 EWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849 (997)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~ 849 (997)
+++.... .+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 9998654 278889999999999999999999 99999999999999999999999999998653211
Q ss_pred ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcc
Q 001908 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALP 929 (997)
Q Consensus 850 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 929 (997)
......++..|+|||... +..++.++||||+|++++++++|..||..... ..........
T Consensus 142 ----~~~~~~~~~~~~~pE~~~------------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~~~~~ 201 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLL------------GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFKKIGK 201 (244)
T ss_pred ----ccccccCCcCCCCHHHHc------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhc
Confidence 223456788999996553 46678899999999999999999999874311 1111111000
Q ss_pred hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 930 EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 930 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...... .....++.++.+++.+|+..+|++||++.++++
T Consensus 202 -~~~~~~--------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 202 -PKPPFP--------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -cCCCCc--------------cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000000 000003457889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=276.40 Aligned_cols=287 Identities=16% Similarity=0.200 Sum_probs=182.7
Q ss_pred HhhcCccCCcccccCcceEEEEEEC----------------CCCcEEEEEEecccchhhHHH--------------HHHH
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILG----------------ENGTFVAVKILNLMQKGALKS--------------FVAE 726 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vAvK~~~~~~~~~~~~--------------~~~E 726 (997)
..++|++.++||+|+||+||+|... ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 345689999987543332233 3346
Q ss_pred HHHHhhcCCCCc-----ceEEeeeeccCc---CCCceEEEEEeeccCCCHHHHhhcCCCC------------------CC
Q 001908 727 CEVLRNTRHRNL-----IKIITVCSSIDF---KGADFKALVYEYMQNGSLEEWLHQSNGQ------------------PE 780 (997)
Q Consensus 727 ~~~l~~l~h~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~ 780 (997)
+.++.+++|.++ +++++||..... ...+..++||||+++++|.++++...+. ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777654211 1235689999999999999999753210 01
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccc
Q 001908 781 VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860 (997)
Q Consensus 781 ~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~g 860 (997)
....++..++.++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||+++...... ........+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-------~~~~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-------NFNPLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-------ccCccccCC
Confidence 12356788899999999999999999 99999999999999999999999999997542111 111112235
Q ss_pred cccccCCcchhcccccCccc----------cCCCCCCCccchhHHHHHHHHHHHhCCC-CCCcCcCCCccHHHHHHhhcc
Q 001908 861 TVGYVPPGNIAKMLNLPCLE----------YGMGSEASVTGDVYSLGVMLLEMFTRRR-PTNCMFQGGLTLHEFCKMALP 929 (997)
Q Consensus 861 t~~y~aPE~l~~~~~~~~~e----------~~~~~~~~~~~DvwSlGvvl~elltg~~-P~~~~~~~~~~~~~~~~~~~~ 929 (997)
|+.|+|||.+......+... .........+.||||+||++++|+++.. ||.....-.....++...
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~--- 449 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND--- 449 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch---
Confidence 78999999876321100000 0000112235799999999999999875 654221100000000000
Q ss_pred hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCC---CCCCCHHHHHH
Q 001908 930 EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP---IERMEMRDVLA 983 (997)
Q Consensus 930 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~ 983 (997)
...+...... ...+ ...........+++.+|+..+| .+|+|++|+++
T Consensus 450 ~~~~r~~~~~-~~~~------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 450 LNRWRMYKGQ-KYDF------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHHHhhccc-CCCc------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000000000 0000 0111223456789999999766 68999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=278.96 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=181.5
Q ss_pred CccCCcccccCcc-eEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFG-SVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|...+.+|.|+.| .||+|.. .|+.||||++-. +..+.+.+|++.++.- +|||||++++. -.+..+.|+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence 3445678999987 4899999 688999998753 2335678999999988 59999999876 456789999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---C--CcEEEcc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---D--MVAHVSD 833 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~--~~~kl~D 833 (997)
..|.| ..+|.++++.... +.........+.+..|+++|+++||+. +|||||+||.||||+. + .+++|+|
T Consensus 581 alELC-~~sL~dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 581 ALELC-ACSLQDLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EehHh-hhhHHHHHhcccc--chhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence 99999 5599999998411 110111134567789999999999998 9999999999999976 3 4789999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC-CCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~ 912 (997)
||+++.+.....+ -.......||-+|+|||.+.. ..-+.++||||+|||+|+.++| ..||.+
T Consensus 655 fglsKkl~~~~sS-----~~r~s~~sGt~GW~APE~L~~------------~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 655 FGLSKKLAGGKSS-----FSRLSGGSGTSGWQAPEQLRE------------DRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred cccccccCCCcch-----hhcccCCCCcccccCHHHHhc------------cccCcccchhhcCceEEEEecCCccCCCc
Confidence 9999998543321 122455679999999988763 3445689999999999999995 899985
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
....+.++..- . ..+.. .. + ..+| +-.+||.+|++++|..||++.+|+
T Consensus 718 ~~~R~~NIl~~------~-------~~L~~-L~-----~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 718 SLERQANILTG------N-------YTLVH-LE-----P-LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hHHhhhhhhcC------c-------cceee-ec-----c-CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 43322221110 0 00000 00 0 0111 446899999999999999999994
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=236.26 Aligned_cols=263 Identities=17% Similarity=0.215 Sum_probs=193.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.+.|.+.+.+|+|.||.+-+++++.+.+.+|+|.+.... ...++|.+|..---.+ .|.||+.-|++. |+..+..
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 457999999999999999999999999999999886432 2347888888765555 599999988775 6777889
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC--CCCcEEEccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDF 834 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DF 834 (997)
.+++||++.|+|.+-+...+ +-+....+++.|+++|++|+|++ .+||||||.+||||- +..++|++||
T Consensus 98 vF~qE~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence 99999999999999887754 66677889999999999999999 999999999999994 3358999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++.... ......-+..|.|||+.....+ ..-.+.+.+|||.||+++|.++||..||....
T Consensus 168 G~t~k~g~-----------tV~~~~~~~~y~~pe~~~~~~n-------e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 168 GLTRKVGT-----------TVKYLEYVNNYHAPELCDTVVN-------EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred ccccccCc-----------eehhhhhhcccCCcHHHhhccc-------cceEecccccchheeeeeeeeecCCCcchhhh
Confidence 99875411 1112234567999998764322 12345778999999999999999999998544
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
..+..+.+|.....+.. +...+... + ..+...++.++-+.++|++|-...++.++-...
T Consensus 230 ~~d~~Y~~~~~w~~rk~-~~~P~~F~----------~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 230 IMDKPYWEWEQWLKRKN-PALPKKFN----------P----FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ccCchHHHHHHHhcccC-ccCchhhc----------c----cCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 44444555533332211 11111111 0 122344566688889999996666666655443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=269.07 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=203.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|....++|.|+||.||||+++.+++..|+|+++..........+.|+-+++..+|+||+.+++-| -..+..++
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklwi 89 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLWI 89 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcEE
Confidence 5788899999999999999999999999999999977777777888999999999999999999874 44668999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
.||||.+|+|.+..+-.. ++++.++..+.+..++|++|||++ +=+|||||-.||++++.|.+|++|||.+.
T Consensus 90 cMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred EEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchh
Confidence 999999999999887655 588889999999999999999999 88999999999999999999999999987
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.+. .+..+...+.||+.|||||+..- ...+.|...+|||+.|+...|+---++|..+...
T Consensus 161 qit--------ati~KrksfiGtpywmapEvaav---------erkggynqlcdiwa~gitAiel~eLqpplfdlhp--- 220 (829)
T KOG0576|consen 161 QIT--------ATIAKRKSFIGTPYWMAPEVAAV---------ERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--- 220 (829)
T ss_pred hhh--------hhhhhhhcccCCccccchhHHHH---------HhcccccccccccccccchhhhhhcCCcccccch---
Confidence 652 23345566889999999998753 3457899999999999999999887777432110
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+....-+ ..+..+|-.. .......+.+-++++.|+..+|++||++.-+++
T Consensus 221 -mr~l~Lm-----TkS~~qpp~l---------kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 221 -MRALFLM-----TKSGFQPPTL---------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -HHHHHHh-----hccCCCCCcc---------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0000000 0011111110 011123445778999999999999999877653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=257.64 Aligned_cols=199 Identities=24% Similarity=0.397 Sum_probs=168.3
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhcC---CCCcceEEeee
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNTR---HRNLIKIITVC 745 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 745 (997)
...+|+..+.+|+|+||.|+.|.++++...|+||.+.+.. +...-..-.||++|..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf- 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF- 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe-
Confidence 3457899999999999999999999999999999885321 111123456999999997 9999999999
Q ss_pred eccCcCCCceEEEEEeec-cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 746 SSIDFKGADFKALVYEYM-QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
|++.++.|++||-. ++.+|.++|.... .+++.....|++||+.|+++||++ +|||||||-+|+.++
T Consensus 638 ----FEddd~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd 704 (772)
T KOG1152|consen 638 ----FEDDDYYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD 704 (772)
T ss_pred ----eecCCeeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence 77888999999986 4569999999876 478889999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEM 903 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~el 903 (997)
.+|.+|++|||.|......+ ...++||..|.|||++.+ ..| +..-|||++|+++|.+
T Consensus 705 ~~g~~klidfgsaa~~ksgp----------fd~f~gtv~~aapevl~g------------~~y~gk~qdiwalgillyti 762 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSGP----------FDVFVGTVDYAAPEVLGG------------EKYLGKPQDIWALGILLYTI 762 (772)
T ss_pred cCCeEEEeeccchhhhcCCC----------cceeeeeccccchhhhCC------------CccCCCcchhhhhhheeeEE
Confidence 99999999999997663333 234689999999977763 344 4567999999999999
Q ss_pred HhCCCCCC
Q 001908 904 FTRRRPTN 911 (997)
Q Consensus 904 ltg~~P~~ 911 (997)
+...-||+
T Consensus 763 vykenpyy 770 (772)
T KOG1152|consen 763 VYKENPYY 770 (772)
T ss_pred EeccCCCc
Confidence 99999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=241.66 Aligned_cols=267 Identities=22% Similarity=0.254 Sum_probs=194.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~ 755 (997)
.+|.-.+.+|.|.- .|..|.+.-.+++||+|+... ......+...+|...+..++|+||++++.++.-... ..-..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999998 888898888999999998742 223344678899999999999999999998643211 11245
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+|||+| .++|.+.+.. .++-.++..+..|+++|+.|||+. +|+|||+||+||++..++.+||.|||
T Consensus 96 ~y~v~e~m-~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 89999999 6699999883 367788999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... ......+..|..|+|||++. +..+.+.+||||.||++.||++|+.-|.
T Consensus 164 ~ar~e~~---------~~~mtpyVvtRyyrapevil------------~~~~ke~vdiwSvGci~gEli~~~Vlf~---- 218 (369)
T KOG0665|consen 164 LARTEDT---------DFMMTPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGELILGTVLFP---- 218 (369)
T ss_pred hhcccCc---------ccccCchhheeeccCchhee------------ccCCcccchhhhhhhHHHHHhhceEEec----
Confidence 9986421 12445578899999996654 4558999999999999999999999876
Q ss_pred CCccHHHHHHhh--c---chhhhhhcCcccccc---------------cccchhhh---hHHHHHHHHHHHHhhcCCCCC
Q 001908 916 GGLTLHEFCKMA--L---PEKVMETVDPSLLLA---------------WSDGRRRA---KVEECLVTVIRIGVACSMESP 972 (997)
Q Consensus 916 ~~~~~~~~~~~~--~---~~~~~~~~d~~~~~~---------------~~~~~~~~---~~~~~~~~l~~li~~cl~~dP 972 (997)
+...+.+|.... + ...+++...+..... +.+.-... ...-......+++.+|+..+|
T Consensus 219 g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~p 298 (369)
T KOG0665|consen 219 GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDP 298 (369)
T ss_pred CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccCh
Confidence 233444443321 0 011111111110000 00000000 000112245688999999999
Q ss_pred CCCCCHHHHHH
Q 001908 973 IERMEMRDVLA 983 (997)
Q Consensus 973 ~~Rps~~evl~ 983 (997)
++|.+++++++
T Consensus 299 e~Risv~daL~ 309 (369)
T KOG0665|consen 299 EKRISVDDALR 309 (369)
T ss_pred hhcccHHHHhc
Confidence 99999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=246.38 Aligned_cols=282 Identities=26% Similarity=0.368 Sum_probs=205.5
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECC---CCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeec
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGE---NGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSS 747 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 747 (997)
++.+...+.|..+++||+|.|++||+|.... ..+.||+|.+..... ...+..|+++|..+ .+.||+++.++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~--- 103 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC--- 103 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh---
Confidence 3455666889999999999999999999876 778999999875433 35578999999998 59999999988
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD- 826 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~- 826 (997)
+...+.+++|+||++-.+..++... ++...+..+.+.+..||.++|.+ |||||||||+|++.+..
T Consensus 104 --~rnnd~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t 169 (418)
T KOG1167|consen 104 --FRNNDQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRT 169 (418)
T ss_pred --hccCCeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccccc
Confidence 7778899999999999899888875 66788999999999999999999 99999999999999854
Q ss_pred CcEEEcccccchhcccCC----------------------------------CCC--ccccccccccccccccccCCcch
Q 001908 827 MVAHVSDFGLARFLFARP----------------------------------FDT--SMETQSSSIGIKGTVGYVPPGNI 870 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~----------------------------------~~~--~~~~~~~~~~~~gt~~y~aPE~l 870 (997)
+.-.|.|||+|....... +.. ............||++|+|||++
T Consensus 170 ~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL 249 (418)
T KOG1167|consen 170 QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL 249 (418)
T ss_pred CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH
Confidence 688999999998321100 000 01112233446699999999988
Q ss_pred hcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhh----------cchh--hhhh---
Q 001908 871 AKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMA----------LPEK--VMET--- 935 (997)
Q Consensus 871 ~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~----------~~~~--~~~~--- 935 (997)
-+. +..+++.||||.|||+.-+++++.||-...++-..+.+.+-.. .+++ .++.
T Consensus 250 ~k~-----------~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~ 318 (418)
T KOG1167|consen 250 FRC-----------PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNI 318 (418)
T ss_pred hhc-----------cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccc
Confidence 753 4568899999999999999999999875444433333322111 1112 1110
Q ss_pred -cCcccccccccc-----h-------hh-hhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 936 -VDPSLLLAWSDG-----R-------RR-AKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 936 -~d~~~~~~~~~~-----~-------~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.....+... + .. ...+..+...++++.+|+..||.+|.|++|+++
T Consensus 319 ~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 319 PTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011111111111 0 01 111223347889999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-25 Score=228.46 Aligned_cols=212 Identities=31% Similarity=0.508 Sum_probs=177.9
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccC
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQN 765 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 765 (997)
||+|++|.||+++...+++.+++|++...... ..+.+.+|++.++.++|++++++++++. .....++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 68999999999999877999999999755432 3567899999999999999999999854 34689999999998
Q ss_pred CCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCcEEEcccccchhcccCC
Q 001908 766 GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLFARP 844 (997)
Q Consensus 766 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFg~a~~~~~~~ 844 (997)
++|.+++.... ..+++..++.++.+++++++|||+. +++|+||+|.||+++. ++.++++|||.+.......
T Consensus 76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99999998752 1378899999999999999999999 9999999999999999 8999999999997652211
Q ss_pred CCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHH
Q 001908 845 FDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFC 924 (997)
Q Consensus 845 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 924 (997)
. ......+...|++||.... ...++.++|+|++|++++++
T Consensus 148 ~--------~~~~~~~~~~~~~pe~~~~-----------~~~~~~~~D~~~lg~~~~~l--------------------- 187 (215)
T cd00180 148 S--------LLKTIVGTPAYMAPEVLLG-----------KGYYSEKSDIWSLGVILYEL--------------------- 187 (215)
T ss_pred c--------hhhcccCCCCccChhHhcc-----------cCCCCchhhhHHHHHHHHHH---------------------
Confidence 0 1223457788999976642 12678899999999999999
Q ss_pred HhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 925 KMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 925 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.++.+++..|+..+|++||++.++++.
T Consensus 188 ---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 245689999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=242.64 Aligned_cols=207 Identities=22% Similarity=0.298 Sum_probs=170.0
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC------CCCcceEEeee
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR------HRNLIKIITVC 745 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~ 745 (997)
.--+.....|.+....|+|-|++|.+|.+...|+.||||++..... ..+.=.+|+++|++++ .-|+++++..
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~- 502 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH- 502 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-
Confidence 3345566789999999999999999999999999999999974322 2244478999999984 3477887766
Q ss_pred eccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC
Q 001908 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825 (997)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~ 825 (997)
|....++|+|||-. .-+|.+.+++.+.. ..+....+..++.|+.-||..|-.. +|+|.||||.||||++
T Consensus 503 ----F~hknHLClVFE~L-slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 503 ----FKHKNHLCLVFEPL-SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred ----hhhcceeEEEehhh-hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 56677999999988 44999999988743 3477889999999999999999998 9999999999999997
Q ss_pred CC-cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 826 DM-VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 826 ~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.- ..||||||.|...... ..+.+.-+..|.|| |.+.|-.|+...|+||.||+|||+.
T Consensus 572 ~k~iLKLCDfGSA~~~~en----------eitPYLVSRFYRaP------------EIiLG~~yd~~iD~WSvgctLYElY 629 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASEN----------EITPYLVSRFYRAP------------EIILGLPYDYPIDTWSVGCTLYELY 629 (752)
T ss_pred CcceeeeccCccccccccc----------cccHHHHHHhccCc------------ceeecCcccCCccceeeceeeEEee
Confidence 65 6799999999765221 22334567789999 5556888999999999999999999
Q ss_pred hCCCCCCcC
Q 001908 905 TRRRPTNCM 913 (997)
Q Consensus 905 tg~~P~~~~ 913 (997)
||+.-|.+.
T Consensus 630 tGkIlFpG~ 638 (752)
T KOG0670|consen 630 TGKILFPGR 638 (752)
T ss_pred ccceecCCC
Confidence 999988754
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-27 Score=247.48 Aligned_cols=411 Identities=19% Similarity=0.195 Sum_probs=239.9
Q ss_pred EccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCcccc
Q 001908 128 MLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFS 207 (997)
Q Consensus 128 ~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~ 207 (997)
|=++-.|+ +||.++..= -.++++..|+++ .||+..|..+.+|+.||||+|+|+-+-|..|
T Consensus 52 dCr~~GL~-eVP~~LP~~--tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF---------------- 111 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLPPE--TVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAF---------------- 111 (498)
T ss_pred EccCCCcc-cCcccCCCc--ceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhh----------------
Confidence 33444444 666655432 123344444444 5555555555555555555555554445444
Q ss_pred ccCCCcccCCCccceeeccC-CCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCccccc
Q 001908 208 GTVPPSLYNMSSLENILLDV-NGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSII 286 (997)
Q Consensus 208 g~ip~~l~~l~~L~~L~L~~-N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 286 (997)
..+.+|.+|-+-+ |+|+ .+|...|.+|..|+.|.+.-|++.-...+.|..+.+|..|.|.+|.+..+....
T Consensus 112 -------~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~t 183 (498)
T KOG4237|consen 112 -------KGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGT 183 (498)
T ss_pred -------hhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhcccc
Confidence 4444444333322 4444 445444444555555555555554444444555555555555555554444444
Q ss_pred ccccCccCeeEccCccCCCCCC------CCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCccccc
Q 001908 287 FGRLKNLWSLDLGINNLGSGGA------NDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISG 360 (997)
Q Consensus 287 ~~~l~~L~~L~Ls~N~l~~~~~------~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~ 360 (997)
|..+..++.+.+..|.+-.... ..-..+..++......-..+.++++..+-+..|......+..-..+....-+
T Consensus 184 f~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~ 263 (498)
T KOG4237|consen 184 FQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS 263 (498)
T ss_pred ccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC
Confidence 5555555555555444211000 0000011223333334444555555544444444332222222223333333
Q ss_pred ccC-CCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCC
Q 001908 361 TIP-SGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLG 439 (997)
Q Consensus 361 ~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 439 (997)
+-| ..|..|++|+.|+|++|+|+++-+.+|.++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|.
T Consensus 264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~ 343 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ 343 (498)
T ss_pred cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence 444 4689999999999999999999999999999999999999999977778899999999999999999999999999
Q ss_pred CCCCCcEEecCCCcccCC-----cccc----------cccccccccccccCCCcccC---CCcccccc---------ccc
Q 001908 440 NCKNLVSLNLSDNKLIGA-----VPQQ----------ILTITTLSRFLDLGNNHLNG---SLPLEVGN---------LKN 492 (997)
Q Consensus 440 ~l~~L~~L~L~~N~l~~~-----~p~~----------~~~l~~ll~~L~Ls~N~l~~---~~p~~~~~---------l~~ 492 (997)
.+..|.+|+|-.|.+.-. +-+| -+.-+..++.++++.+.+.. ..|++.+. .+-
T Consensus 344 ~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c 423 (498)
T KOG4237|consen 344 TLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTC 423 (498)
T ss_pred ccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcch
Confidence 999999999999876310 0000 01112222455555554431 12322221 112
Q ss_pred c-ceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCC
Q 001908 493 L-VALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571 (997)
Q Consensus 493 L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 571 (997)
+ ++..-|++.++ .+|..+. ..-.+|++.+|.++ .+|.+ .+.+| .+|||+|+++..-...|.++++|.+|-||
T Consensus 424 ~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlils 496 (498)
T KOG4237|consen 424 LDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILS 496 (498)
T ss_pred hhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEe
Confidence 2 23345555554 5554443 24467888899988 67776 66777 88999999887777788888999888888
Q ss_pred CC
Q 001908 572 YN 573 (997)
Q Consensus 572 ~N 573 (997)
+|
T Consensus 497 yn 498 (498)
T KOG4237|consen 497 YN 498 (498)
T ss_pred cC
Confidence 87
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=227.19 Aligned_cols=201 Identities=33% Similarity=0.517 Sum_probs=169.5
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
|+..+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56778999999999999999877899999999765444 5678899999999999999999999854 34578999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
+||+++++|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++++|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 999999999999987542 167889999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
..... ........++..|++||... ....++.++|||+||++++||++|+.||..
T Consensus 148 ~~~~~-------~~~~~~~~~~~~~~~pe~~~-----------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDL-------AALLKTVKGTPFYLAPEVLL-----------GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCcc-------cccccceeccCCcCCHhHhc-----------CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 63221 00223346778899997652 245677799999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=253.16 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=123.5
Q ss_pred cceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEcc
Q 001908 220 LENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLG 299 (997)
Q Consensus 220 L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 299 (997)
-..|+|+.|.|+ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+..+ .. .++|++|+|+
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsLP-~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSLP-VL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCccc-Cc---ccccceeecc
Confidence 456677777776 6776554 35666666666666 34432 345556666666555432 11 2344444444
Q ss_pred CccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccC
Q 001908 300 INNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEF 379 (997)
Q Consensus 300 ~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 379 (997)
+|.|+.+ |.. ...|+.|++++|+|+ .+|.. .++|+.|+|++
T Consensus 271 ~N~L~~L-------------------------------p~l----p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~ 311 (788)
T PRK15387 271 SNPLTHL-------------------------------PAL----PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSD 311 (788)
T ss_pred CCchhhh-------------------------------hhc----hhhcCEEECcCCccc-ccccc---ccccceeECCC
Confidence 4444332 111 122333333333333 12221 23455555555
Q ss_pred CCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcc
Q 001908 380 NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVP 459 (997)
Q Consensus 380 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 459 (997)
|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|... .+|+.|++++|+++ .+|
T Consensus 312 N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~-~LP 378 (788)
T PRK15387 312 NQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLP 378 (788)
T ss_pred Ccccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---cccceehhhccccc-cCc
Confidence 55553 23211 234455555555542 3321 1245555555555552 33221 23444444444444 233
Q ss_pred cccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccC
Q 001908 460 QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLK 539 (997)
Q Consensus 460 ~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 539 (997)
. . ..+|+.|++++|+|+ .+|... ++|+.|++++|+|+ .+|... .
T Consensus 379 ~-------------------------l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~ 422 (788)
T PRK15387 379 A-------------------------L---PSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---S 422 (788)
T ss_pred c-------------------------c---ccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---h
Confidence 2 1 123455555555554 233221 34555555555555 244322 2
Q ss_pred cCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCC
Q 001908 540 SIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 540 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 4455666666665 4555566666666666666666655443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=251.62 Aligned_cols=263 Identities=24% Similarity=0.353 Sum_probs=160.4
Q ss_pred hhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCcc
Q 001908 199 LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY 278 (997)
Q Consensus 199 L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 278 (997)
|++++|.|+ .+|+.+. ++|+.|++++|+++ .+|. ..++|++|+|++|+|+ .+|.. ..+|+.|+|++|.
T Consensus 206 LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 206 LNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence 555666665 5666665 36788888888887 5764 2577888888888888 45643 3578888888888
Q ss_pred CCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCccc
Q 001908 279 FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQI 358 (997)
Q Consensus 279 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l 358 (997)
|+..+. . .++|+.|+|++|+|+.++. ..++|++|+|++|++++ +|.. ...|+.|++++|+|
T Consensus 274 L~~Lp~-l---p~~L~~L~Ls~N~Lt~LP~----------~p~~L~~LdLS~N~L~~-Lp~l----p~~L~~L~Ls~N~L 334 (788)
T PRK15387 274 LTHLPA-L---PSGLCKLWIFGNQLTSLPV----------LPPGLQELSVSDNQLAS-LPAL----PSELCKLWAYNNQL 334 (788)
T ss_pred hhhhhh-c---hhhcCEEECcCCccccccc----------cccccceeECCCCcccc-CCCC----cccccccccccCcc
Confidence 875432 2 2567788888888876543 23568888888888774 3331 23455566666666
Q ss_pred ccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCC
Q 001908 359 SGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL 438 (997)
Q Consensus 359 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 438 (997)
++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+
T Consensus 335 ~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt------- 395 (788)
T PRK15387 335 TS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT------- 395 (788)
T ss_pred cc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-------
Confidence 53 3321 1345555666665553 3322 1344455555555552 3332 133444555555444
Q ss_pred CCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCcc
Q 001908 439 GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLE 518 (997)
Q Consensus 439 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 518 (997)
.+|... .++ +.|++++|+|+ .+|.. ..+|+.|++++|+|+ .+|..+.++++|+
T Consensus 396 ------------------~LP~l~---s~L-~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~ 448 (788)
T PRK15387 396 ------------------SLPVLP---SEL-KELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSET 448 (788)
T ss_pred ------------------CCCCcc---cCC-CEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCC
Confidence 233221 223 55566666655 34432 235677888888887 6788888888888
Q ss_pred EEEccCccccccCChhcccc
Q 001908 519 IFHMQGNSFRGSIPLSLRSL 538 (997)
Q Consensus 519 ~L~Ls~N~l~~~~p~~~~~l 538 (997)
.|+|++|+|++.+|..+..+
T Consensus 449 ~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 449 TVNLEGNPLSERTLQALREI 468 (788)
T ss_pred eEECCCCCCCchHHHHHHHH
Confidence 88888888887777766443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=265.05 Aligned_cols=335 Identities=19% Similarity=0.210 Sum_probs=172.0
Q ss_pred cccCCCccEEEecCCc------CcCCCCCCCCCCC-CCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCc
Q 001908 239 GVTLPNLQVFAIGDNY------FSGSIPESFSNAS-NIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDL 311 (997)
Q Consensus 239 ~~~l~~L~~L~L~~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 311 (997)
|.++++|+.|.+.++. +...+|+.|..++ +|+.|++.+|.++.. |..| ...+|+.|+|++|++..++.
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~l-P~~f-~~~~L~~L~L~~s~l~~L~~--- 628 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCM-PSNF-RPENLVKLQMQGSKLEKLWD--- 628 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCC-CCcC-CccCCcEEECcCcccccccc---
Confidence 3345555555554332 2233444444443 355555555555433 2233 34555555555555554322
Q ss_pred chhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcc
Q 001908 312 DFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIG 391 (997)
Q Consensus 312 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 391 (997)
.+..+++|++|+|++|...+.+|. +..+ ++|+.|++++|..-..+|..++++++|+.|++++|..-+.+|..+
T Consensus 629 ----~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l-~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i- 701 (1153)
T PLN03210 629 ----GVHSLTGLRNIDLRGSKNLKEIPD-LSMA-TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI- 701 (1153)
T ss_pred ----ccccCCCCCEEECCCCCCcCcCCc-cccC-CcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-
Confidence 234455555555555543334443 3333 455556665555444556666666666666666654333455444
Q ss_pred cccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCccc-------CCccccccc
Q 001908 392 QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLI-------GAVPQQILT 464 (997)
Q Consensus 392 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~p~~~~~ 464 (997)
++++|+.|+|++|...+.+|.. .++|+.|+|++|.+. .+|..+ .+++|+.|++.++... ...|.....
T Consensus 702 ~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~ 776 (1153)
T PLN03210 702 NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTML 776 (1153)
T ss_pred CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhc
Confidence 4566666666665444444432 345566666666665 345443 3555666655553211 011111111
Q ss_pred ccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCee
Q 001908 465 ITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKEL 544 (997)
Q Consensus 465 l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 544 (997)
.++| +.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|
T Consensus 777 ~~sL-~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L 851 (1153)
T PLN03210 777 SPSL-TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDL 851 (1153)
T ss_pred cccc-hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEe
Confidence 2333 566666665555666666666666666666654333555544 5666666666665443344432 2456666
Q ss_pred eCccccccccCchhccCCCCCCEEeCCC-CcCcccCCCCCcCCCCcceeecCC
Q 001908 545 DLSCNNLSGQIPEFLENLSFLEYLNLSY-NHFDGEVPTKGVFSNKTRVQLTGN 596 (997)
Q Consensus 545 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~~~~~~~~~~~N 596 (997)
+|++|.++ .+|..+..+++|+.|+|++ |+|.+..+....+..+..+.+.++
T Consensus 852 ~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 852 NLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence 66666665 4566666666666666665 445543333344555555555543
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=265.22 Aligned_cols=339 Identities=21% Similarity=0.260 Sum_probs=265.7
Q ss_pred CCcccCCCccceeeccCCC------CCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCccc
Q 001908 211 PPSLYNMSSLENILLDVNG------FTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVS 284 (997)
Q Consensus 211 p~~l~~l~~L~~L~L~~N~------l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 284 (997)
+..|.+|.+|+.|.+..+. +...+|..+..-.++|+.|++.+|.++ .+|..| ...+|+.|+|++|++.. ++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cc
Confidence 3457788899998886653 334567666533456999999998886 778777 57889999999999875 45
Q ss_pred ccccccCccCeeEccCcc-CCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccC
Q 001908 285 IIFGRLKNLWSLDLGINN-LGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIP 363 (997)
Q Consensus 285 ~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p 363 (997)
..+..+++|+.|+|++++ +..++ .+..+++|++|+|++|.....+|..+.++ ++|+.|++++|..-+.+|
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip--------~ls~l~~Le~L~L~~c~~L~~lp~si~~L-~~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP--------DLSMATNLETLKLSDCSSLVELPSSIQYL-NKLEDLDMSRCENLEILP 698 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC--------ccccCCcccEEEecCCCCccccchhhhcc-CCCCEEeCCCCCCcCccC
Confidence 567889999999998764 44332 36678899999999988777889888887 689999999876555777
Q ss_pred CCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcC-------CCCCCC
Q 001908 364 SGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHL-------QGNIPP 436 (997)
Q Consensus 364 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-------~~~~p~ 436 (997)
..+ ++++|+.|++++|...+.+|.. .++|++|+|++|.++ .+|..+ .+++|+.|++.++.. ....+.
T Consensus 699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~ 772 (1153)
T PLN03210 699 TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPL 772 (1153)
T ss_pred CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchh
Confidence 766 7899999999998776666653 467899999999987 677665 578888888887432 222222
Q ss_pred CCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcC
Q 001908 437 SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTG 516 (997)
Q Consensus 437 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 516 (997)
.+...++|+.|+|++|...+.+|..+.++++| +.|++++|..-+.+|..+ ++++|+.|++++|.....+|.. ..+
T Consensus 773 ~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L-~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~n 847 (1153)
T PLN03210 773 MTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL-EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STN 847 (1153)
T ss_pred hhhccccchheeCCCCCCccccChhhhCCCCC-CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccc
Confidence 33345789999999998888899999999998 899999986555788766 7899999999997655566653 367
Q ss_pred ccEEEccCccccccCChhccccCcCCeeeCcc-ccccccCchhccCCCCCCEEeCCCCc
Q 001908 517 LEIFHMQGNSFRGSIPLSLRSLKSIKELDLSC-NNLSGQIPEFLENLSFLEYLNLSYNH 574 (997)
Q Consensus 517 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ls~N~ 574 (997)
|+.|+|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.++++++.
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 899999999998 7899999999999999998 5665 578888899999999999884
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-25 Score=231.96 Aligned_cols=406 Identities=18% Similarity=0.215 Sum_probs=224.8
Q ss_pred ccccccCCCCCccCCCCCCCeEEEccCCCccccCCc-cccCCCcccchhcccccccccccccccccccccceeec-cccc
Q 001908 105 LATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPT-NLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISL-ARNH 182 (997)
Q Consensus 105 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L-~~N~ 182 (997)
=++-.++ ++|..+- ..-+.++|..|+++ .||+ .|+.+.+|+.||+++|++. .|-++.|..+.+|..|-+ ++|+
T Consensus 53 Cr~~GL~-eVP~~LP--~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 53 CRGKGLT-EVPANLP--PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred ccCCCcc-cCcccCC--CcceEEEeccCCcc-cCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCc
Confidence 3444444 6776654 35678999999999 6665 6888999999999999998 666666667777766544 4477
Q ss_pred ccCcCcCccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCC
Q 001908 183 LTGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE 261 (997)
Q Consensus 183 l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~ 261 (997)
|+..--..|+.|+ ++.|.+.-|++.-.....|..+.+|..|.|..|.+. .|+...+..+.+++.+.+..|.+-.
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic---- 202 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC---- 202 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc----
Confidence 7743334555553 334555666665444455555555555555555555 4555444455555555555554110
Q ss_pred CCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcc--------------------hhhhhccCC
Q 001908 262 SFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD--------------------FVTILTNCS 321 (997)
Q Consensus 262 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--------------------~~~~l~~l~ 321 (997)
..+++.+.. +....|..+++..-.....+.++++..+.+..+. ....|..++
T Consensus 203 -dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~ 274 (498)
T KOG4237|consen 203 -DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP 274 (498)
T ss_pred -ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence 000000000 1112233444444444444444444443332111 112355555
Q ss_pred CCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecc
Q 001908 322 KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401 (997)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 401 (997)
+|+.|+|++|+|+++-+.+|... ..+++|+|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|.|
T Consensus 275 ~L~~lnlsnN~i~~i~~~aFe~~-a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l 353 (498)
T KOG4237|consen 275 NLRKLNLSNNKITRIEDGAFEGA-AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNL 353 (498)
T ss_pred cceEeccCCCccchhhhhhhcch-hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeeh
Confidence 55555555555555555555554 34555555555555444455555555555555555555555555555555555555
Q ss_pred cccccccc-----chhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC---Ccccccc---------c
Q 001908 402 SSNFLQGN-----IPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG---AVPQQIL---------T 464 (997)
Q Consensus 402 s~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~---~~p~~~~---------~ 464 (997)
-.|.+.-. +-+|+. .+.-.|..| . ..-..++.+.++++.+.. ..|+..+ .
T Consensus 354 ~~Np~~CnC~l~wl~~Wlr-----------~~~~~~~~~-C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~ 420 (498)
T KOG4237|consen 354 LSNPFNCNCRLAWLGEWLR-----------KKSVVGNPR-C-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPP 420 (498)
T ss_pred ccCcccCccchHHHHHHHh-----------hCCCCCCCC-C-CCCchhccccchhccccccccCCccccCCCCCCCCCCC
Confidence 55544210 111111 111111111 0 111234455555554321 1111111 1
Q ss_pred ccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCee
Q 001908 465 ITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKEL 544 (997)
Q Consensus 465 l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 544 (997)
.+-+-+...-|++.++ .+|..+. ..-++|++.+|.++ .+|.. .+.+| .+++++|+++..-...|.++.+|.+|
T Consensus 421 c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tl 493 (498)
T KOG4237|consen 421 CTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTL 493 (498)
T ss_pred cchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhhee
Confidence 1222244556666665 5555432 35678999999998 78877 66778 89999999986667789999999999
Q ss_pred eCccc
Q 001908 545 DLSCN 549 (997)
Q Consensus 545 ~Ls~N 549 (997)
-||+|
T Consensus 494 ilsyn 498 (498)
T KOG4237|consen 494 ILSYN 498 (498)
T ss_pred EEecC
Confidence 99876
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=246.48 Aligned_cols=377 Identities=20% Similarity=0.274 Sum_probs=197.1
Q ss_pred CCCCCHHHHHHHHHHHHhcCCCCCCCCC----CCCCCCCCeeee----------------eeecCCCCcEEEEeccCCCC
Q 001908 27 SAHTNETDRLALLAIKSQLHDPLGVTNS----WNNSINLCQWAG----------------VTCGHRHQRVTELDLRHQNI 86 (997)
Q Consensus 27 ~~~~~~~~~~aLl~~k~~~~~~~~~~~s----W~~~~~~c~w~g----------------v~C~~~~~~v~~L~L~~~~l 86 (997)
++...++|.+.+++..+.+.-|. .+.+ |++.+++|-=.. |.|.. +.||.+..-+...
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~~~ 133 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPA-YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTESEQ 133 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCc-hhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--Ccccccccccccc
Confidence 44457899999999999987763 4555 999999995443 67753 4577766554221
Q ss_pred CCcccccccCccccccccc----cccccCCCCC---cc-----CCCCCCCeEEEccCCCccccCCccccCCCcccchhcc
Q 001908 87 GGSLSPYVGNLSFLRYINL----ATNNFHGEIP---KE-----IGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAY 154 (997)
Q Consensus 87 ~g~~~~~l~~l~~L~~L~L----s~N~l~g~~p---~~-----~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~ 154 (997)
.....+ .-..-.+... ..+.-.+.-+ .. -+-..+...|+|+++.++ .+|..+. .+|+.|+++
T Consensus 134 ~~~~~~---~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls 207 (754)
T PRK15370 134 ASSASG---SKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILD 207 (754)
T ss_pred cccCCC---CCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEec
Confidence 111100 0000000000 0000000000 00 011123444555555444 3444433 234444444
Q ss_pred cccccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCC
Q 001908 155 RNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNL 234 (997)
Q Consensus 155 ~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~l 234 (997)
+|++. .+|..++ .+|++|++++|+|+ .+|..+.. ++..|+|++|++. .+|..+. ++|+.|+|++|+++ .+
T Consensus 208 ~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~~-~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~L 277 (754)
T PRK15370 208 NNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLPD-TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CL 277 (754)
T ss_pred CCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhhc-cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cc
Confidence 44444 3444432 24555555555555 33443321 2344555555555 4555543 35666666666666 46
Q ss_pred CccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchh
Q 001908 235 PLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314 (997)
Q Consensus 235 p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 314 (997)
|..++ ++|+.|++++|+|++ +|..+. ++|+.|++++|+++..++.. .++|++|++++|.++.++.
T Consensus 278 P~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP~~l---~~sL~~L~Ls~N~Lt~LP~------ 342 (754)
T PRK15370 278 PENLP---EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTALPETL---PPGLKTLEAGENALTSLPA------ 342 (754)
T ss_pred ccccC---CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccCCccc---cccceeccccCCccccCCh------
Confidence 65543 356666666666663 444332 35666777777766543222 1466667777777665432
Q ss_pred hhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCc----
Q 001908 315 TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI---- 390 (997)
Q Consensus 315 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---- 390 (997)
.+ .++|+.|++++|+++ .+|..+. +.|+.|++++|+|+ .+|..+. .+|+.|++++|+|+ .+|..+
T Consensus 343 -~l--~~sL~~L~Ls~N~L~-~LP~~lp---~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~ 411 (754)
T PRK15370 343 -SL--PPELQVLDVSKNQIT-VLPETLP---PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFR 411 (754)
T ss_pred -hh--cCcccEEECCCCCCC-cCChhhc---CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHh
Confidence 11 246777777777776 3554432 45777777777776 3454443 35777778888777 444433
Q ss_pred ccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCC-CCCCCCCCCCCCcEEecCCCccc
Q 001908 391 GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG-NIPPSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~ 455 (997)
..++++..|+|.+|.++. ..+.+|+.| ++.+.+.| .++...+.+.+++....-.+.+.
T Consensus 412 ~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~ 470 (754)
T PRK15370 412 GEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ 470 (754)
T ss_pred hcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHh
Confidence 344677888888888872 233344444 34455443 33444444455554433334333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=224.21 Aligned_cols=175 Identities=20% Similarity=0.181 Sum_probs=132.5
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECC-CCcEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCCcceEEeeeecc
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGE-NGTFVAVKILNLM-----QKGALKSFVAECEVLRNTRHRNLIKIITVCSSI 748 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 748 (997)
.....+|+..+.||+|+||+||+|+++. +++.||||++... .....+.+.+|++++++++|+|+++.+..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 3455789999999999999999999875 6788899987532 22345678999999999999999853322
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC-CCCCeeeCCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL-KPSNVLLDHDM 827 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl-k~~NIll~~~~ 827 (997)
. +..++||||++|++|.. .... . ...++.|+++|++|||++ +|+|||| ||+||+++.++
T Consensus 90 -~---~~~~LVmE~~~G~~L~~-~~~~---------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 90 -T---GKDGLVRGWTEGVPLHL-ARPH---------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred -c---CCcEEEEEccCCCCHHH-hCcc---------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence 1 24799999999999963 2111 1 145788999999999999 9999999 99999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcc
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKM 873 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 873 (997)
.+||+|||+|+................-....+++.|+|||.+...
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999976432211111111122356788899999988753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=203.12 Aligned_cols=170 Identities=22% Similarity=0.226 Sum_probs=125.0
Q ss_pred CCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCC
Q 001908 766 GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF 845 (997)
Q Consensus 766 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~ 845 (997)
|+|.++++.... .+++.+++.++.||++||+|||++ + ||+||+++.++.+|+ ||.++....
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~--- 61 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP--- 61 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc---
Confidence 689999986431 489999999999999999999998 5 999999999999999 999876421
Q ss_pred CCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHH
Q 001908 846 DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCK 925 (997)
Q Consensus 846 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 925 (997)
....||+.|||||++. +..++.++|||||||++|||+||+.||.........+.....
T Consensus 62 ----------~~~~g~~~y~aPE~~~------------~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 119 (176)
T smart00750 62 ----------EQSRVDPYFMAPEVIQ------------GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119 (176)
T ss_pred ----------ccCCCcccccChHHhc------------CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence 1125889999996654 567889999999999999999999998643221111111111
Q ss_pred hhcchhhhhhcCcccccccccchhhhhHHHHH--HHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 926 MALPEKVMETVDPSLLLAWSDGRRRAKVEECL--VTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 926 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
... ..++.. ........ .++.+++..||..+|++||++.|+++.+..+..+
T Consensus 120 ~~~------~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 120 GMP------ADDPRD---------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred Hhc------cCCccc---------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 100 000000 01111222 2688999999999999999999999998877653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=258.22 Aligned_cols=207 Identities=16% Similarity=0.204 Sum_probs=135.6
Q ss_pred hcCC-CCcceEEeeeeccCc--CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 001908 732 NTRH-RNLIKIITVCSSIDF--KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQ 808 (997)
Q Consensus 732 ~l~h-~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~ 808 (997)
.++| +||+++++++..... ...+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 3445 577777776522211 1224577888988 669999997532 2488999999999999999999999
Q ss_pred CCcEecCCCCCCeeeCCC-------------------CcEEEcccccchhcccCCC---CC---c--ccccccccccccc
Q 001908 809 PPIVHGDLKPSNVLLDHD-------------------MVAHVSDFGLARFLFARPF---DT---S--METQSSSIGIKGT 861 (997)
Q Consensus 809 ~~ivHrDlk~~NIll~~~-------------------~~~kl~DFg~a~~~~~~~~---~~---~--~~~~~~~~~~~gt 861 (997)
+|+||||||+|||++.. +.+|++|||+++....... .. . ...........||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 99999999999999654 4455666666543211000 00 0 0000111224689
Q ss_pred ccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccc
Q 001908 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLL 941 (997)
Q Consensus 862 ~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 941 (997)
+.|||||++ .+..++.++|||||||++|||++|.+|+... ...+..... ....+..
T Consensus 179 ~~Y~APE~~------------~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~--------~~~~~~~- 234 (793)
T PLN00181 179 SWYTSPEED------------NGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRH--------RVLPPQI- 234 (793)
T ss_pred cceEChhhh------------ccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHH--------hhcChhh-
Confidence 999999654 4577899999999999999999998886421 001111100 0011110
Q ss_pred cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 942 LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........+++.+||+.+|.+||++.|+++
T Consensus 235 ------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 ------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ------------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 011233457888999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=205.49 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=186.0
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEec--ccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
...+|.+...|+.|+|+|. |..+++|++. .......++|..|.-.++.+.||||..+++.|.. +.+..++.
T Consensus 194 l~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~is 266 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVIIS 266 (448)
T ss_pred hhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEee
Confidence 4567899999999999995 5567778775 3344455789999999999999999999999865 45899999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc--ccccch
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLAR 838 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~--DFg~a~ 838 (997)
.||+.|+|+..+++..+. .++..+..++|.+|++|++|||+.. |-|.---+.++.++||++.+++|+ |--++-
T Consensus 267 q~mp~gslynvlhe~t~v----vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred eeccchHHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee
Confidence 999999999999987632 4788899999999999999999974 344455788999999999988874 433322
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.. .+..-.+.||+||.++.... ...-.++|+|||++++||+.|...||.+...-
T Consensus 342 qe---------------~gr~y~pawmspealqrkpe---------d~n~raadmwsfaillwel~trevpfadlspm-- 395 (448)
T KOG0195|consen 342 QE---------------VGRAYSPAWMSPEALQRKPE---------DLNIRAADMWSFAILLWELNTREVPFADLSPM-- 395 (448)
T ss_pred ec---------------cccccCcccCCHHHHhcCch---------hcchhhhhHHHHHHHHHHhhccccccccCCch--
Confidence 11 12233678999998875331 22345799999999999999999999754221
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
+- .+.+ ..+-.++. .+....+.+.++|.-|++.||.+||.++.|+-.|+++.
T Consensus 396 --ec--gmki---aleglrv~------------ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 396 --EC--GMKI---ALEGLRVH------------IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --hh--hhhh---hhcccccc------------CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 10 0100 00111111 12223457889999999999999999999998888753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-21 Score=212.83 Aligned_cols=271 Identities=21% Similarity=0.209 Sum_probs=195.9
Q ss_pred cCccCCcccccCcceEEEEEECCCC-cEEEEEEecccchhhHHHHHHHHHHHhhcCC----CCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENG-TFVAVKILNLMQKGALKSFVAECEVLRNTRH----RNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~ 754 (997)
.|.+.++||+|+||.||.|....++ ..+|+|+...........+..|+.++..+.. +++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987554 5789998765433322367789999988863 57888887621 3566
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-----CcE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-----MVA 829 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~ 829 (997)
+.++||+.+ |.+|.++..... ...++..+..+|+.|++.+|+++|+. |++||||||.|++++.. ..+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 889999998 889999886654 12488999999999999999999999 99999999999999865 369
Q ss_pred EEcccccchhcccCCCCCc-cccccc-cccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 830 HVSDFGLARFLFARPFDTS-METQSS-SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~-~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+.|||+|+.......... ...... .....||..|+++ ..+.+...+.+.|+||++.++.|+..|.
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~------------~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI------------NVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccH------------HHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 9999999994321111111 011111 3456799999999 6777889999999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.||........ ..+...... . ..... .....+.++.++...+-..+..++|....+...+.+
T Consensus 235 LPW~~~~~~~~-~~~~~~~~~-~---~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 235 LPWEALEMTDL-KSKFEKDPR-K---LLTDR-------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred CCCccccccch-HHHHHHHhh-h---hcccc-------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 99864322111 111110000 0 00000 001123455566666666899999999999999888
Q ss_pred HHHHh
Q 001908 988 ARQTL 992 (997)
Q Consensus 988 ~~~~~ 992 (997)
...+.
T Consensus 297 ~~~~~ 301 (322)
T KOG1164|consen 297 VFDSE 301 (322)
T ss_pred HHHhc
Confidence 76653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-22 Score=235.87 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=134.7
Q ss_pred ccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEc
Q 001908 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDL 298 (997)
Q Consensus 219 ~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 298 (997)
+...|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+.. |..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip---~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP---EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSI-PATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc---cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccC-Chhhh--ccccEEEC
Confidence 4567788888877 6776553 45677777777777 4555443 3666666666666643 22221 24555555
Q ss_pred cCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEecc
Q 001908 299 GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIE 378 (997)
Q Consensus 299 s~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 378 (997)
++|++..+ |..+. ..|+.|++++|+|+ .+|..+. ++|+.|+++
T Consensus 249 s~N~L~~L-------------------------------P~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 249 SINRITEL-------------------------------PERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred cCCccCcC-------------------------------ChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 55555433 33221 23444444444444 2344332 356677777
Q ss_pred CCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCc
Q 001908 379 FNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAV 458 (997)
Q Consensus 379 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 458 (997)
+|+|++ +|..+. ++|+.|+|++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+++ .+
T Consensus 292 ~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~L 361 (754)
T PRK15370 292 DNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VL 361 (754)
T ss_pred CCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cC
Confidence 776663 444332 356777777777763 454332 566777777777764 555443 56677777777665 45
Q ss_pred ccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccc----cCCcCccEEEccCcccc
Q 001908 459 PQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTL----TGCTGLEIFHMQGNSFR 528 (997)
Q Consensus 459 p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~ 528 (997)
|..+. +.+ +.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ ..++.+..|++.+|.++
T Consensus 362 P~~lp--~~L-~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 362 PETLP--PTI-TTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred Chhhc--CCc-CEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 54332 233 55666666666 3444332 24666666666665 444332 22344555555555554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-22 Score=230.66 Aligned_cols=265 Identities=21% Similarity=0.255 Sum_probs=188.7
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHH--HhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEV--LRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++...+.+|++.|=.|.+|+++ .|. |+||++-... .-..+.+.++++- ...++|||++++.-+ .......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence 6777899999999999999996 454 9999995443 3334444444443 444589999988765 3445677
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+|-+|. .-+|+|++..+. -+...+.+.||.|++.|+..+|+. +|+|+|||.+||||+.-.-+.|+||..
T Consensus 97 ylvRqyv-khnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHH-hhhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence 8888888 459999998765 467788899999999999999999 999999999999999999999999998
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-CCccchhHHHHHHHHHHHh-CCCCCCcCc
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFT-RRRPTNCMF 914 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 914 (997)
-+..+-+...++.......+. ..-.+|.|||.+....+.. ....... .+++.||||+|||++|+++ |++||+
T Consensus 167 FKPtYLPeDNPadf~fFFDTS-rRRtCYiAPERFv~~~~~~--~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~--- 240 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTS-RRRTCYIAPERFVSALGKT--SVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT--- 240 (1431)
T ss_pred cCCccCCCCCcccceEEEecC-CceeeecChHhhhcccccc--ccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---
Confidence 776654444443333222222 2334899999997633111 2222333 6789999999999999999 788887
Q ss_pred CCCccHHHHHHhhcchhhhhhcCccc-ccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSL-LLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
+.+ .+.++-.+..++.. ....++ ..+..++..|++.||++|.++.++++.-.+
T Consensus 241 -----LSQ----L~aYr~~~~~~~e~~Le~Ied-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 241 -----LSQ----LLAYRSGNADDPEQLLEKIED-----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred -----HHH----HHhHhccCccCHHHHHHhCcC-----------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 221 12222222222221 111111 246689999999999999999999987443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-20 Score=187.61 Aligned_cols=268 Identities=18% Similarity=0.208 Sum_probs=198.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.|.++++||+|.||+++.|+.--++++||||.-...++ ...+..|....+.+ ..++|..++-+ -...-+-.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~NiL 101 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNIL 101 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeee-----ccccchhhh
Confidence 68999999999999999999988999999998653322 24566778877777 57888887754 233456789
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-----cEEEcc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHVSD 833 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-----~~kl~D 833 (997)
|+|.. |.+|+|...-.+. .++..++..+|.|++.-++|+|++ ..|+|||||+|+||...+ .+.++|
T Consensus 102 VidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 99998 8899999887653 489999999999999999999999 999999999999998654 689999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+...++..+.- -.........||..||+- ..+.|.+.+.+.|+=|+|-++.+.+.|..||...
T Consensus 173 FGmAK~YrDp~TkqH-IPYrE~KSLsGTARYMSI------------NTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQH-IPYREHKSLSGTARYMSI------------NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccchhhhcCcccccc-CccccccccccceeeeEe------------eccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 999998855443221 222334456799999987 7788999999999999999999999999999854
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
-... .-..+.. +-+..-.. ......+..|.++.+-+.-.-+.+-.+-|..+-+-..+.++...
T Consensus 240 KA~t-nK~kYeK---------IGe~Kr~T-----~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 240 KADT-NKEKYEK---------IGETKRST-----PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cCcc-hHHHHHH---------hccccccC-----CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 3221 1111111 11100000 00112233455666666667777888888877777766666554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=183.78 Aligned_cols=208 Identities=26% Similarity=0.338 Sum_probs=165.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCC-CCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH-RNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~ 756 (997)
...|.+.++||.|+||.+|.|..-.+|.+||+|+-..... -..+..|..+.+.+++ ..|..+..| ..+..+-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccccccc
Confidence 4679999999999999999999999999999998753322 2456778888888864 456666655 4456688
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC---CcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~D 833 (997)
.+|||.. |.+|++...-... .++..+++-.|-|++.-++|+|.+ +++||||||+|.|+.-+ ..+.++|
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 9999999 8899999876542 388999999999999999999999 99999999999999754 4688999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+...+..... .-.........||..|.+- ..+.+.+.+...|+=|+|.|+.+.-.|..||...
T Consensus 158 FGLaKky~d~~t~~-HIpyre~r~ltGTaRYASi------------nAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQ-HIPYREDRNLTGTARYASI------------NAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccchhhhccccccc-cCccccCCccceeeeehhh------------hhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 99999875432211 1122233446789999876 4455667788999999999999999999999865
Q ss_pred c
Q 001908 914 F 914 (997)
Q Consensus 914 ~ 914 (997)
.
T Consensus 225 k 225 (341)
T KOG1163|consen 225 K 225 (341)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-20 Score=219.34 Aligned_cols=257 Identities=19% Similarity=0.219 Sum_probs=183.2
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEecc-----cchhh-HHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILNL-----MQKGA-LKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~-----~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..+.+|.|++|.|+.+......+.++.|.+.. ..... ...+..|..+-..+.|+|++..+..+.+. ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence 46789999999888888876666666665431 11111 11245566667778999998877764332 223
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
.-+||||++ +|..++.... .+....+-.++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence 333999999 9999998763 266677888999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCc-cchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASV-TGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~-~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+.....+.. .........+|+.+|+|||++. +..|.+ ..||||.|+++..|.+|+.||.....
T Consensus 467 ~~vf~~~~e----~~~~~~~g~~gS~pY~apE~~~------------~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 467 ASVFRYPWE----KNIHESSGIVGSDPYLAPEVLT------------GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred ceeeccCcc----hhhhhhcCcccCCcCcCccccc------------ccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 875422111 1124456688999999996554 566765 58999999999999999999874433
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
...... .....+ ......+........+.+...++..|+++||.+|.|+++|++.
T Consensus 531 ~~~~~~----------~~~~~~----~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 531 SDNSFK----------TNNYSD----QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccchh----------hhcccc----ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 222110 000000 0111122233345567778899999999999999999999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-18 Score=194.05 Aligned_cols=267 Identities=29% Similarity=0.393 Sum_probs=191.1
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccchh---hHHHHHHHHHHHhhcCCC-CcceEEeeeeccCcCCCceE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG---ALKSFVAECEVLRNTRHR-NLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~ 756 (997)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 667789999999999999996 78999998743322 467889999999999988 799999985 334458
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEcccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFG 835 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFg 835 (997)
++++|++.++++.+++...... ..+.......+..|++.+++|+|+. +++|||+||+||+++..+ .++++|||
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 9999999999999777765311 2477889999999999999999999 999999999999999998 79999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.++............ .......||..|+|||.+.... ...++...|+||+|++++++++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~---------~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLS---------LAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cceecCCCCcccccc--ccccccccccccCCHHHhcCCC---------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 998542221110000 1345578999999997654210 14678899999999999999999999664322
Q ss_pred C--CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 916 G--GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 916 ~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
. .....+...... .+........... ......+.+++..|+..+|..|.++.+....
T Consensus 217 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 217 SSATSQTLKIILELP--------TPSLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccHHHHHHHHHhcC--------CcccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 011111111110 0000000000000 1223456788889999999999998887664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-19 Score=184.78 Aligned_cols=176 Identities=16% Similarity=0.171 Sum_probs=131.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhh---HHH------HHHHHHHHhhcCCCCcceEEeeeec
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA---LKS------FVAECEVLRNTRHRNLIKIITVCSS 747 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~~~~~~ 747 (997)
..++|+..+.+|.|+||.||.+.. ++..+|+|+++...... ... +.+|++.+++++|++|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 457899999999999999999766 46689999997432222 122 5789999999999999999888543
Q ss_pred cCc---CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 748 IDF---KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 748 ~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
... ......++||||++|.+|.++.. .+. ....+++.++..+|.. |++|||+||+||+++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 211 12346899999999999988732 222 2356899999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.+| ++++|||.......+. |-+ .+.....+..++|+|+||+.+....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~---------------------a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRK---------------------AKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchh---------------------hHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 999 9999999876431100 000 1222344667899999999987654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-21 Score=176.92 Aligned_cols=166 Identities=30% Similarity=0.535 Sum_probs=115.4
Q ss_pred CCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCC
Q 001908 365 GIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444 (997)
Q Consensus 365 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 444 (997)
.+.++.+.+.|.|++|+++ .+|+.++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3445677788888888888 67778888889999999999998 78888888899999999988888 788888888888
Q ss_pred cEEecCCCcccC-CcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEcc
Q 001908 445 VSLNLSDNKLIG-AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQ 523 (997)
Q Consensus 445 ~~L~L~~N~l~~-~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 523 (997)
+.|||.+|++.. .+|..|+. ++.|+.|+|+.|.+. .+|..++++++|+.|.+.
T Consensus 105 evldltynnl~e~~lpgnff~-------------------------m~tlralyl~dndfe-~lp~dvg~lt~lqil~lr 158 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFY-------------------------MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLR 158 (264)
T ss_pred hhhhccccccccccCCcchhH-------------------------HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeec
Confidence 888888888752 34444444 444555555555554 455555555555555555
Q ss_pred CccccccCChhccccCcCCeeeCccccccccCchhccC
Q 001908 524 GNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLEN 561 (997)
Q Consensus 524 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 561 (997)
.|.+- ..|..++.+.+|+.|.+.+|+++ .+|..+++
T Consensus 159 dndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 159 DNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred cCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 55554 45555555555666666666655 45555544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=181.45 Aligned_cols=139 Identities=18% Similarity=0.150 Sum_probs=106.8
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchh--h------------------------HHHHHHHHHHHhhcCCCC
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG--A------------------------LKSFVAECEVLRNTRHRN 737 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~n 737 (997)
...||+|++|.||+|... +|+.||||+++..... . .....+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999743211 0 012245999999998877
Q ss_pred cceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCcEecCC
Q 001908 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDL 816 (997)
Q Consensus 738 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yL-H~~~~~~ivHrDl 816 (997)
+.....+. . ...++||||++++++........ .++.....+++.|++.++.|+ |+. +|+||||
T Consensus 81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCCcEEE----e---cCCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 64333221 1 12389999998877765433222 377888999999999999999 687 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccchhc
Q 001908 817 KPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 817 k~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+||+++ ++.++++|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 588999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=173.78 Aligned_cols=193 Identities=17% Similarity=0.058 Sum_probs=137.3
Q ss_pred ccCCcccccCcceEEEEEECCCCcEEEEEEecccchh----hHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceE
Q 001908 682 SSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG----ALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++++ |+++++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4568899999999997766 6788887777643221 1225789999999995 5889999886 146
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC-CCCCeeeCCCCcEEEcccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL-KPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DFg 835 (997)
+++|||++|.+|.+.... ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|+|||
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 999999999998754321 1124678999999999999 9999999 7999999999999999999
Q ss_pred cchhcccCCCC-----CccccccccccccccccccCCcchhcccccCccccCCCCCCC-ccchhHHHHHHHHHHHhCCCC
Q 001908 836 LARFLFARPFD-----TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS-VTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 836 ~a~~~~~~~~~-----~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~-~~~DvwSlGvvl~elltg~~P 909 (997)
+|......... ...-..........++.|++|+.-. .-...+ ...+.++.|+-+|.++|++.|
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~-----------~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERR-----------VLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHh-----------hhccchhHHHHHHHhcchHHHHHhccCC
Confidence 99854221100 0000000011123566777775321 122233 567999999999999999988
Q ss_pred CCc
Q 001908 910 TNC 912 (997)
Q Consensus 910 ~~~ 912 (997)
...
T Consensus 207 ~~~ 209 (218)
T PRK12274 207 HWE 209 (218)
T ss_pred ccc
Confidence 653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-21 Score=178.69 Aligned_cols=179 Identities=29% Similarity=0.436 Sum_probs=141.5
Q ss_pred CCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccce
Q 001908 416 NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495 (997)
Q Consensus 416 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~ 495 (997)
++.+++.|-||+|+++ .+|..+..+.+|+.|++++|++. .+|.++..++++ +.|+++-|++. ..|..|+.++.|+.
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~kl-r~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKL-RILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhh-hheecchhhhh-cCccccCCCchhhh
Confidence 4445555556666665 45555566666666666666655 566666666666 66666666666 78888999999999
Q ss_pred eccccccccc-cccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCc
Q 001908 496 LYISGNQFSG-EIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574 (997)
Q Consensus 496 L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 574 (997)
|||++|++.. .+|..|..++.|+-|+|+.|.|. .+|..++++++|+.|.+..|.+- ..|..++.++.|++|.+.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 9999998864 57999999999999999999998 89999999999999999999998 789999999999999999999
Q ss_pred CcccCCCCCcC---CCCcceeecCCCCcC
Q 001908 575 FDGEVPTKGVF---SNKTRVQLTGNGKLC 600 (997)
Q Consensus 575 l~~~~p~~~~~---~~~~~~~~~~N~~~C 600 (997)
++-.+|..+.+ .+.....++.|||.-
T Consensus 185 l~vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 185 LTVLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred eeecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 99888876544 445667788898854
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-20 Score=210.33 Aligned_cols=282 Identities=25% Similarity=0.316 Sum_probs=136.1
Q ss_pred EeccCccCC-CcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCccccccccccccc
Q 001908 272 IDLPINYFT-GKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTD 350 (997)
Q Consensus 272 L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~ 350 (997)
|+|+.+.++ ......|..+.+|+.|+++++.++..+. ..++..+...++|++|+++++.+.+ .+..+
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~--~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~--------- 70 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAA--KALASALRPQPSLKELCLSLNETGR-IPRGL--------- 70 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHH--HHHHHHHhhCCCceEEeccccccCC-cchHH---------
Confidence 444444444 2233344445555555555555432111 1233344555556666666655542 11111
Q ss_pred ccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccc---cceeccccccccc----cchhhhcCC-CCCCe
Q 001908 351 IYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRN---LQAIGLSSNFLQG----NIPSSLGNL-TLMTD 422 (997)
Q Consensus 351 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~ 422 (997)
..++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.
T Consensus 71 ---------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 71 ---------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141 (319)
T ss_pred ---------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceE
Confidence 122334444556666666666665544444444444 6666666666652 223344455 66666
Q ss_pred EEeecCcCCCC----CCCCCCCCCCCcEEecCCCcccCC----cccccccccccccccccCCCcccCC----Cccccccc
Q 001908 423 LFLSSNHLQGN----IPPSLGNCKNLVSLNLSDNKLIGA----VPQQILTITTLSRFLDLGNNHLNGS----LPLEVGNL 490 (997)
Q Consensus 423 L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~ll~~L~Ls~N~l~~~----~p~~~~~l 490 (997)
|+|++|.+++. ++..+..+++|++|++++|.+++. ++..+...+++ +.|++++|.+++. ++..+..+
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L-~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL-EVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCC-CEEeccCCccChHHHHHHHHHhccc
Confidence 66666666632 223344555666666666666532 11222222333 4455555544422 22233445
Q ss_pred cccceecccccccccccccccc-----CCcCccEEEccCcccc----ccCChhccccCcCCeeeCcccccccc----Cch
Q 001908 491 KNLVALYISGNQFSGEIPVTLT-----GCTGLEIFHMQGNSFR----GSIPLSLRSLKSIKELDLSCNNLSGQ----IPE 557 (997)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 557 (997)
++|++|++++|.+++.....+. ..+.|+.|++++|.++ ..+...+..+++|+.+|+++|.++.. ...
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 5666666666666542222222 1255666666666654 12233444455666666666666533 333
Q ss_pred hccCC-CCCCEEeCCCCcC
Q 001908 558 FLENL-SFLEYLNLSYNHF 575 (997)
Q Consensus 558 ~~~~l-~~L~~L~ls~N~l 575 (997)
.+... +.|++|++.+|++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 301 SLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhhcCCchhhcccCCCCC
Confidence 33333 4555555555543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=181.98 Aligned_cols=212 Identities=19% Similarity=0.215 Sum_probs=146.3
Q ss_pred CCCCcceEEeeeeccC----------------------cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHH
Q 001908 734 RHRNLIKIITVCSSID----------------------FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN 791 (997)
Q Consensus 734 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 791 (997)
.|||||++.+++.+.- ...+...|+||..+ ..+|.+++..+. .+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-------CchHHHHH
Confidence 5999999988753321 12245688999998 459999998875 56667778
Q ss_pred HHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC--CCC--cEEEcccccchhcccCCCCCccccccccccccccccccCC
Q 001908 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDM--VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPP 867 (997)
Q Consensus 792 i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~--~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 867 (997)
|..|+++|+.|||.+ ||.|||+|++|||+. +|+ ...|+|||.+--....... ...........|...-|||
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlq--lpy~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQ--LPYESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccc--cccccccccCCCcceecch
Confidence 899999999999999 999999999999994 444 5788999987532111100 1111122234567789999
Q ss_pred cchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccc
Q 001908 868 GNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDG 947 (997)
Q Consensus 868 E~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 947 (997)
|+...+.+... ..-..|+|.|+.|.+.||+++..-||+...+--.+...+ .+.
T Consensus 421 Ei~ta~PGp~a------vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y---------------------qe~ 473 (598)
T KOG4158|consen 421 EIATAVPGPNA------VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY---------------------QES 473 (598)
T ss_pred hhhhcCCCCce------eeccchhhhhhhhhhHHHHhccCCcccccchheechhhh---------------------hhh
Confidence 98865432110 112358999999999999999999998521111111111 111
Q ss_pred hhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 948 RRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 948 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
.....++.+++.+.+++...++.||++|++..-+...+
T Consensus 474 qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 474 QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 22234556777888999999999999999977665544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=174.68 Aligned_cols=138 Identities=21% Similarity=0.207 Sum_probs=108.7
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchh--------------------------hHHHHHHHHHHHhhcCCCC
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG--------------------------ALKSFVAECEVLRNTRHRN 737 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n 737 (997)
.+.||+|++|.||+|+.. +|+.||||+++..... ....+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999998743210 0122357899999999998
Q ss_pred cceEEeeeeccCcCCCceEEEEEeeccCCCHHHH-hhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecC
Q 001908 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEW-LHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGD 815 (997)
Q Consensus 738 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrD 815 (997)
+.....+.. ...++||||++++++... +... ..+.....+++.|++.++.|+|+ . ||+|||
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKDV-------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchhhhhhhc-------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 754443321 124899999988755443 3322 35677889999999999999999 8 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccchhc
Q 001908 816 LKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 816 lk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
|||+||+++ ++.++++|||+|+..
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceec
Confidence 999999998 899999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=193.17 Aligned_cols=225 Identities=26% Similarity=0.384 Sum_probs=165.0
Q ss_pred HhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 001908 730 LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQP 809 (997)
Q Consensus 730 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~ 809 (997)
|+.+.|.|+.+++|.+... ...+.|.+||..|+|.+.+.... ..+++.....+.++|++||.|+|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s--- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNS--- 67 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcC---
Confidence 4578999999999998653 58899999999999999998743 3589999999999999999999998
Q ss_pred Cc-EecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCC
Q 001908 810 PI-VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888 (997)
Q Consensus 810 ~i-vHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~ 888 (997)
+| .|+.++++|+++|....+|++|||+....... .............-|.|||.+..... .......+
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~------~~~~~~~~~~~~~lw~aPellr~~~~-----~~~~~~~~ 136 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEET------AEPEAHHPIRKALLWTAPELLRGALS-----QSLESALT 136 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhccccccc------ccccccchhHHHHhccCHHHhccccc-----cccccccc
Confidence 55 99999999999999999999999998765320 01111112224557999998875321 11113367
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcC
Q 001908 889 VTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACS 968 (997)
Q Consensus 889 ~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 968 (997)
.++||||||++++|+++...||+........ .+.+.... +.......|.+.. ..+.++++..++..||
T Consensus 137 ~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~-~~~~~~~rP~i~~----------~~e~~~~l~~l~~~cw 204 (484)
T KOG1023|consen 137 QKGDIYSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVK-KGGSNPFRPSIEL----------LNELPPELLLLVARCW 204 (484)
T ss_pred ccCCeehHHHHHHHHHhccCccccccccCCh-HHHHHHHH-hcCCCCcCcchhh----------hhhcchHHHHHHHHhc
Confidence 8899999999999999999999864333322 22222211 1112223333221 1144557889999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHH
Q 001908 969 MESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 969 ~~dP~~Rps~~evl~~L~~~~~ 990 (997)
..+|.+||+++++-..++.+..
T Consensus 205 ~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 205 EEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccChhhCccHHHHHhhhhhhcc
Confidence 9999999999999888887665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-18 Score=180.98 Aligned_cols=248 Identities=20% Similarity=0.250 Sum_probs=152.1
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcC----------CCCcceEEeeee
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTR----------HRNLIKIITVCS 746 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~ 746 (997)
.+...+.||.|+++.||.+++.++++++|||++... .....+.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 445678999999999999999999999999998632 2334566666665554432 212222222211
Q ss_pred ccC----cC-----CCc---eEEEEEeeccCCCHHHHhhc---CCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 001908 747 SID----FK-----GAD---FKALVYEYMQNGSLEEWLHQ---SNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPI 811 (997)
Q Consensus 747 ~~~----~~-----~~~---~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~i 811 (997)
-.. +. ... ..+++|+-+ .+||.+++.. .... ........++.+..|+++.+++||+. |+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 100 00 001 246677777 5588887653 2211 11244566778889999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 812 vHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+|+||||+|++++.+|.++++||+....... .......+..|.+||......... . ....++.+.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----------~~~~~~~~~~~~PPe~~~~~~~~~--~--~~~~~t~~~ 231 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----------RYRCSEFPVAFTPPELESCAGQFG--Q--NNAPYTFAT 231 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTE-----------EEEGGGS-TTTS-HHHHHHHTSCH--H--SEEEE-HHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCc-----------eeeccCCCcccCChhhhhhhcccC--c--ccceeeecc
Confidence 9999999999999999999999998765311 111123457789998765421100 0 224578899
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
|.|++|+++|.|++++.||+....... ++. .+..+. +.++.+.+||..+++++
T Consensus 232 DaW~LG~~ly~lWC~~lPf~~~~~~~~------------------~~~---~f~~C~------~~Pe~v~~LI~~lL~~~ 284 (288)
T PF14531_consen 232 DAWQLGITLYSLWCGRLPFGLSSPEAD------------------PEW---DFSRCR------DMPEPVQFLIRGLLQRN 284 (288)
T ss_dssp HHHHHHHHHHHHHHSS-STCCCGGGST------------------SGG---GGTTSS---------HHHHHHHHHHT-SS
T ss_pred CHHHHHHHHHHHHHccCCCCCCCcccc------------------ccc---cchhcC------CcCHHHHHHHHHHccCC
Confidence 999999999999999999984422110 000 111111 45678899999999999
Q ss_pred CCCC
Q 001908 972 PIER 975 (997)
Q Consensus 972 P~~R 975 (997)
|.+|
T Consensus 285 ~~~R 288 (288)
T PF14531_consen 285 PEDR 288 (288)
T ss_dssp GGGS
T ss_pred cccC
Confidence 9988
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.8e-20 Score=205.24 Aligned_cols=283 Identities=22% Similarity=0.280 Sum_probs=146.0
Q ss_pred eeeccCCCCCCCCCccccccCCCccEEEecCCcCcC----CCCCCCCCCCCCcEEeccCccCCC------cccccccccC
Q 001908 222 NILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG----SIPESFSNASNIEIIDLPINYFTG------KVSIIFGRLK 291 (997)
Q Consensus 222 ~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~ 291 (997)
.|+|+.+.+++.-=..++..+++|++|+++++.++. .++..+...++|++|+++++.+.+ .++..|..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 467777777632222334456667777777777643 244555566666666666666552 1123344444
Q ss_pred ccCeeEccCccCCCCCCCCcchhhhhccC---CCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCC
Q 001908 292 NLWSLDLGINNLGSGGANDLDFVTILTNC---SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGN 368 (997)
Q Consensus 292 ~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~ 368 (997)
+|+.|++++|.+.... +..+..+ ++|++|++++|++++... ..+...+..
T Consensus 82 ~L~~L~l~~~~~~~~~------~~~~~~l~~~~~L~~L~ls~~~~~~~~~---------------------~~l~~~l~~ 134 (319)
T cd00116 82 GLQELDLSDNALGPDG------CGVLESLLRSSSLQELKLNNNGLGDRGL---------------------RLLAKGLKD 134 (319)
T ss_pred ceeEEEccCCCCChhH------HHHHHHHhccCcccEEEeeCCccchHHH---------------------HHHHHHHHh
Confidence 5555555555443211 1111111 224444444444432100 011122333
Q ss_pred C-CCCCEEeccCCCCCCC----CCCCcccccccceecccccccccc----chhhhcCCCCCCeEEeecCcCCCC----CC
Q 001908 369 L-VNLNLLGIEFNQLTGN----IPREIGQLRNLQAIGLSSNFLQGN----IPSSLGNLTLMTDLFLSSNHLQGN----IP 435 (997)
Q Consensus 369 l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 435 (997)
+ ++|+.|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++
T Consensus 135 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 214 (319)
T cd00116 135 LPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA 214 (319)
T ss_pred CCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHH
Confidence 3 5666666666666632 222344445566666666666532 233344445666666666665432 22
Q ss_pred CCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccc----ccccccc
Q 001908 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFS----GEIPVTL 511 (997)
Q Consensus 436 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~ 511 (997)
..+..+++|++|++++|.+++.....+... . ....+.|+.|++++|.++ ..+...+
T Consensus 215 ~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~-----------------~---~~~~~~L~~L~l~~n~i~~~~~~~l~~~~ 274 (319)
T cd00116 215 ETLASLKSLEVLNLGDNNLTDAGAAALASA-----------------L---LSPNISLLTLSLSCNDITDDGAKDLAEVL 274 (319)
T ss_pred HHhcccCCCCEEecCCCcCchHHHHHHHHH-----------------H---hccCCCceEEEccCCCCCcHHHHHHHHHH
Confidence 334445556666666655543111111100 0 012357788888888776 2334455
Q ss_pred cCCcCccEEEccCcccccc----CChhcccc-CcCCeeeCccccc
Q 001908 512 TGCTGLEIFHMQGNSFRGS----IPLSLRSL-KSIKELDLSCNNL 551 (997)
Q Consensus 512 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l 551 (997)
..+++|+++++++|.++.. ....+... +.|+.||+.+|.+
T Consensus 275 ~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 275 AEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred hcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 6667888888888888744 34444444 6888888888754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-18 Score=204.49 Aligned_cols=153 Identities=30% Similarity=0.459 Sum_probs=127.8
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCC----eeeeeeecC--CC--CcEEEEeccCCCCCCcccccccCcccc
Q 001908 29 HTNETDRLALLAIKSQLHDPLGVTNSWNNSINLC----QWAGVTCGH--RH--QRVTELDLRHQNIGGSLSPYVGNLSFL 100 (997)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~~~sW~~~~~~c----~w~gv~C~~--~~--~~v~~L~L~~~~l~g~~~~~l~~l~~L 100 (997)
.+.+.|..||++||+++.+|.. .+|++ ..|| .|.||+|+. .. .+|+.|+|++|++.|.+|+.++.|++|
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 3567899999999999876643 48974 3443 799999953 22 369999999999999999999999999
Q ss_pred ccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeeccc
Q 001908 101 RYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLAR 180 (997)
Q Consensus 101 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~ 180 (997)
++|+|++|++.|.+|..++.+++|++|||++|+|+|.+|..++++++|+.|++++|++.|.+|..++....++..+++++
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 99999999999999999999999999999999999999999999999988888888888877777664444555666666
Q ss_pred cccc
Q 001908 181 NHLT 184 (997)
Q Consensus 181 N~l~ 184 (997)
|...
T Consensus 525 N~~l 528 (623)
T PLN03150 525 NAGL 528 (623)
T ss_pred Cccc
Confidence 6543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=168.07 Aligned_cols=139 Identities=18% Similarity=0.228 Sum_probs=106.5
Q ss_pred ccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-----CCCCcceEEeeeeccCcCCCce-
Q 001908 682 SSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-----RHRNLIKIITVCSSIDFKGADF- 755 (997)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~- 755 (997)
...+.||+|+||.||. +..++.+ +||++........+.+.+|+++++.+ .||||+++++++... .+.+.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence 4467899999999995 5556655 69998765444567889999999999 579999999996542 12234
Q ss_pred EEEEEee--ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCcEecCCCCCCeeeCCC----Cc
Q 001908 756 KALVYEY--MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI-EYLHHHCQPPIVHGDLKPSNVLLDHD----MV 828 (997)
Q Consensus 756 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L-~yLH~~~~~~ivHrDlk~~NIll~~~----~~ 828 (997)
..+|+|| +++|+|.+++.+.. ++.. ..++.|++.++ +|||++ +|+||||||+||+++.. +.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 3378999 55799999997632 3333 34577888777 999999 99999999999999743 48
Q ss_pred EEEcccccc
Q 001908 829 AHVSDFGLA 837 (997)
Q Consensus 829 ~kl~DFg~a 837 (997)
++|+||+-+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-18 Score=191.26 Aligned_cols=187 Identities=25% Similarity=0.302 Sum_probs=152.1
Q ss_pred cccccCcceEEEEE---ECCCCcEEEEEEecccch--hhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEEEE
Q 001908 686 MIGQGSFGSVYKGI---LGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 686 ~lg~G~~g~V~~~~---~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.+|+|.||.|+.+. ..+.++.+|+|+.+.... ........|..++...+ ||.++++... ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 37999999998643 345678899998864321 11224566888888886 9999988765 6677889999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
.+|..+|++...+.+.. .++......+...++-|++++|.. +|+|||+|++||+++.+|++|+.|||.++.
T Consensus 76 ld~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 99999999999988765 356667777888899999999999 999999999999999999999999999987
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
.... ...+||..|||||++. ....++|.||||+++|||+||..||..
T Consensus 147 ~v~~------------~~~cgt~eymApEI~~--------------gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKE------------KIACGTYEYRAPEIIN--------------GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhh------------hhcccchhhhhhHhhh--------------ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 5221 1118999999998764 356789999999999999999999873
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=167.35 Aligned_cols=143 Identities=20% Similarity=0.166 Sum_probs=111.6
Q ss_pred hcCccCCcccccCcceEEEEE-ECCCCcEEEEEEecccchh------------------------hHHHHHHHHHHHhhc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGI-LGENGTFVAVKILNLMQKG------------------------ALKSFVAECEVLRNT 733 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l 733 (997)
.-|++.+.||+|++|.||+|. ...+|+.||+|+++..... ....+.+|++.++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 5568999999998743210 112356899999999
Q ss_pred CCC--CcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-
Q 001908 734 RHR--NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP- 810 (997)
Q Consensus 734 ~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~- 810 (997)
.+. .+.+++++ ...++||||++++++........ .........++.|++.++.|||.. +
T Consensus 108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~ 169 (237)
T smart00090 108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GE 169 (237)
T ss_pred HhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence 753 34444442 13489999999988876543322 244556788999999999999999 8
Q ss_pred cEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 811 IVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 811 ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
|+||||||+||+++ ++.++++|||.|...
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.3e-16 Score=188.70 Aligned_cols=201 Identities=23% Similarity=0.286 Sum_probs=149.0
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC---CCCcceEEeeeecc
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR---HRNLIKIITVCSSI 748 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 748 (997)
.+.+...+.|.+.+.||+|+||.||+|.... |+.||+|+-+.....+ |.-=.+++.+++ -+-|..+...
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a---- 762 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSA---- 762 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHH----
Confidence 3445566789999999999999999999985 9999999986433221 111122333333 1222333222
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH--- 825 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~--- 825 (997)
+...+..++|+||.+.|+|.+++.... ..++.-++.++.|+++.++.||.. +|||+||||+|.++..
T Consensus 763 -~~~~~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~ 832 (974)
T KOG1166|consen 763 -HVFQNASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREIC 832 (974)
T ss_pred -HccCCcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccC
Confidence 222446789999999999999999443 478889999999999999999999 9999999999999953
Q ss_pred ----CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHH
Q 001908 826 ----DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901 (997)
Q Consensus 826 ----~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ 901 (997)
...++|+|||.|-.+.. ........+.++|-.+-.+ |...|..++.++|.|.++.+++
T Consensus 833 ~~~~~~~l~lIDfG~siDm~l------fp~~~~F~~~~~td~f~C~------------EM~~grpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 833 ADSDSKGLYLIDFGRSIDMKL------FPDGTKFKAVWHTDLFDCI------------EMREGRPWTYQIDYFGLAATVH 894 (974)
T ss_pred CCCcccceEEEecccceeeeE------cCCCcEEeeeeccccchhH------------HHhcCCCCchhhhhHHHHHHHH
Confidence 34789999999876522 1122344455666666656 5556899999999999999999
Q ss_pred HHHhCCC
Q 001908 902 EMFTRRR 908 (997)
Q Consensus 902 elltg~~ 908 (997)
.|+.|++
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-17 Score=178.67 Aligned_cols=202 Identities=26% Similarity=0.323 Sum_probs=134.6
Q ss_pred CccCCcccccCcceEEEEEECCC---CcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEe-------eeeccCc
Q 001908 681 FSSSNMIGQGSFGSVYKGILGEN---GTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIIT-------VCSSIDF 750 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-------~~~~~~~ 750 (997)
+.+.+..+..+++.++..+...+ ...++.|..+...........+++-.+....|-+..-+.. .......
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 34445566666666665544322 2334444433222122233344444444443333322222 0000001
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
....+.|+.|++|...+|.+|+..... ....++.....++.|++.|++| + +.+|||+||.||+...+..+|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhh
Confidence 112358899999999999999986542 2346788999999999999999 6 899999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt 905 (997)
|.|||+........ +............||..||+||.+ .+..|+.++||||+|++++|+++
T Consensus 397 IgDFgl~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi------------~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQI------------RGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhheeecccCC--cccchhhhhhhcccccccCCHHHH------------hhhhhhhhcchhhHHHHHHHHHH
Confidence 99999987763322 112223345567899999999554 47889999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-16 Score=183.09 Aligned_cols=216 Identities=24% Similarity=0.312 Sum_probs=145.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.+|..++.|..|+||.||.++++.+.+.+|+|+-+ .. .+++ ||..+.+ ....
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----------lilR-----nilt~a~-----------npfv 134 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----------LILR-----NILTFAG-----------NPFV 134 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----------hhhh-----ccccccC-----------Ccce
Confidence 57888999999999999999999999999995432 11 1111 1222221 1122
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
| ||-...++..+.. +. +.+.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+++
T Consensus 135 v------gDc~tllk~~g~l------Pv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 135 V------GDCATLLKNIGPL------PV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred e------chhhhhcccCCCC------cc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence 2 3444444443311 11 237899999999 99999999999999999999999999988
Q ss_pred hcccCCCC-------CccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 839 FLFARPFD-------TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 839 ~~~~~~~~-------~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
........ ............+||+.|+||| ++....|+..+|+|++|+|+||.+.|..||.
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe------------VilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE------------VILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChh------------hhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 75221000 0012223334568999999995 4556789999999999999999999999987
Q ss_pred cCcCCCccHHHHHHhhcchh--hhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 912 CMFQGGLTLHEFCKMALPEK--VMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
.. .-++.....+.+. +.+. |+ ..+.+..+++.+.++.+|.+|--..
T Consensus 260 Gd-----tpeelfg~visd~i~wpE~-de----------------a~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 260 GD-----TPEELFGQVISDDIEWPEE-DE----------------ALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred CC-----CHHHHHhhhhhhhcccccc-Cc----------------CCCHHHHHHHHHHHHhChHhhcccc
Confidence 43 2222222222111 1111 11 2245667889999999999998444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=157.42 Aligned_cols=134 Identities=22% Similarity=0.345 Sum_probs=110.5
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--------GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+.||+|++|.||+|.+ .+..|++|+...... .....+.+|++++..+.|+++.....++. .....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 5799999999999998 678899998653211 12246788999999999998876666543 23467
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++|++|.+++.... . .+..++.+++.++.++|.. +++|+|++|+||+++ ++.++++|||.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 89999999999999986532 1 7788999999999999999 999999999999999 88999999998
Q ss_pred chh
Q 001908 837 ARF 839 (997)
Q Consensus 837 a~~ 839 (997)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=154.54 Aligned_cols=141 Identities=23% Similarity=0.194 Sum_probs=109.7
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch----------------------hhHHHHHHHHHHHhh
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK----------------------GALKSFVAECEVLRN 732 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~ 732 (997)
......|.+.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.++..
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 333345888899999999999999886 799999998753210 011235778889999
Q ss_pred cCCCC--cceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 001908 733 TRHRN--LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP 810 (997)
Q Consensus 733 l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ 810 (997)
+.|++ +++.++. ...++||||+++++|.+.... .....++.+++.++.++|+. +
T Consensus 90 l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~---g 145 (198)
T cd05144 90 LYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH---G 145 (198)
T ss_pred HHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---C
Confidence 98774 4444432 245899999999998765431 13456889999999999998 9
Q ss_pred cEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 811 IVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 811 ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
|+||||||+||++++++.++|+|||.+...
T Consensus 146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 146 IIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.9e-15 Score=178.08 Aligned_cols=144 Identities=23% Similarity=0.322 Sum_probs=111.9
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEec--ccc------hhhHHHHHHHHHHHhhcCCCCcceEE
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQ------KGALKSFVAECEVLRNTRHRNLIKII 742 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~--~~~------~~~~~~~~~E~~~l~~l~h~niv~l~ 742 (997)
+.........|...+.||+|+||+||+|.+. +..+++|+.. ... ....+.+.+|+++++.++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3333334455677899999999999999985 3344444332 111 11235678999999999999998877
Q ss_pred eeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
.++.. ....++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||+
T Consensus 403 ~~~~~-----~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NIL 460 (535)
T PRK09605 403 IYDVD-----PEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFI 460 (535)
T ss_pred EEEEe-----CCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEE
Confidence 66432 345789999999999999885 2456899999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchh
Q 001908 823 LDHDMVAHVSDFGLARF 839 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~ 839 (997)
+ .++.++|+|||+|+.
T Consensus 461 l-~~~~~~liDFGla~~ 476 (535)
T PRK09605 461 V-RDDRLYLIDFGLGKY 476 (535)
T ss_pred E-ECCcEEEEeCccccc
Confidence 9 678999999999974
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.5e-15 Score=153.36 Aligned_cols=130 Identities=24% Similarity=0.365 Sum_probs=103.7
Q ss_pred cccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.||+|+||.||+|.+ ++..|++|+..... ......+.+|+++++.++|+++.....++. ..+..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 379999999999996 67889999864321 112356788999999998876554443322 233568
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||++|++|.+++.... . .++.+++.++.++|+. +++|+|++|+||+++ ++.++++|||.+
T Consensus 74 lv~e~~~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEECCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999999999999876532 0 6789999999999999 999999999999999 899999999988
Q ss_pred hh
Q 001908 838 RF 839 (997)
Q Consensus 838 ~~ 839 (997)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-14 Score=174.93 Aligned_cols=118 Identities=36% Similarity=0.588 Sum_probs=102.6
Q ss_pred ccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCC
Q 001908 492 NLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571 (997)
Q Consensus 492 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 571 (997)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCC--CcCCCCcceeecCCCCcCCCCCCCCCCCCC
Q 001908 572 YNHFDGEVPTK--GVFSNKTRVQLTGNGKLCGGSNELHLPSCP 612 (997)
Q Consensus 572 ~N~l~~~~p~~--~~~~~~~~~~~~~N~~~C~~~~~~~~~~c~ 612 (997)
+|+++|.+|.. ..+.....+.+.+|+.+|+.+. .+.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence 99999999965 2233456789999999998533 46675
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-15 Score=166.40 Aligned_cols=196 Identities=28% Similarity=0.440 Sum_probs=158.9
Q ss_pred CCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcE
Q 001908 367 GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVS 446 (997)
Q Consensus 367 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 446 (997)
..+..-...||+.|++. .+|..+..+..|+.+.|+.|.+. .+|..++++..|++|||+.|+++ ..|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34556667888999988 78888888889999999999998 78999999999999999999998 7888888877 899
Q ss_pred EecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcc
Q 001908 447 LNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNS 526 (997)
Q Consensus 447 L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (997)
|-+++|+++ .+|..++....+ ..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|.+++ .-.|..||+|+|+
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCc
Confidence 999999987 888888866666 77888888888 78888888888888888888887 7777777 4458888888888
Q ss_pred ccccCChhccccCcCCeeeCccccccccCchhccCC---CCCCEEeCCCC
Q 001908 527 FRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENL---SFLEYLNLSYN 573 (997)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~ls~N 573 (997)
++ .||..|.+|+.|++|-|.+|.|. ..|..++.. .-.++|+..-.
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 88 78888888888888888888887 566655432 22355665555
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.4e-14 Score=143.20 Aligned_cols=135 Identities=25% Similarity=0.277 Sum_probs=97.0
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchh--hHHH----------------------HHHHHHHHhhcCCCC--
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG--ALKS----------------------FVAECEVLRNTRHRN-- 737 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n-- 737 (997)
.+.||+|+||+||+|... +++.||||+++..... .... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999986 7999999998643211 1111 134566666664432
Q ss_pred cceEEeeeeccCcCCCceEEEEEeeccCCCHHHH-hhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecC
Q 001908 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEW-LHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGD 815 (997)
Q Consensus 738 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrD 815 (997)
+.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. . +|+|||
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 4444432 135899999998543211 11111 01 4567889999999999999 7 999999
Q ss_pred CCCCCeeeCCCCcEEEcccccchhc
Q 001908 816 LKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 816 lk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
|||+||+++ ++.++++|||.|...
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccc
Confidence 999999999 999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=135.04 Aligned_cols=135 Identities=22% Similarity=0.276 Sum_probs=110.8
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCC--CCcceEEeeeeccCcCCCceEEEEE
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH--RNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
+.+.||+|.++.||++... +..+++|+...... ...+.+|++.++.++| .++++++++. ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 3578999999999999984 47899999864433 4678899999999976 5888888873 3346789999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
||++++.+..+ +......++.+++++++++|....++++|+|++|+||+++.++.++++|||.++.
T Consensus 73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99988776543 3346677899999999999986444799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.8e-16 Score=167.81 Aligned_cols=177 Identities=29% Similarity=0.457 Sum_probs=164.1
Q ss_pred cccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccc
Q 001908 392 QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF 471 (997)
Q Consensus 392 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~ 471 (997)
.+.--...||+.|++. ++|..++.+..|+.+.|.+|.+. .+|..++++..|+.|||+.|+++ ..|..++.++- +.
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpL--kv 147 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPL--KV 147 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcc--ee
Confidence 4555678899999999 89999999999999999999999 79999999999999999999998 89998888763 78
Q ss_pred cccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccc
Q 001908 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551 (997)
Q Consensus 472 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 551 (997)
|-+++|+++ .+|..++.+..|..||.|.|.+. .+|..++++.+|+.|++..|++. .+|..+..| .|..||+|+|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 999999999 89999999999999999999998 89999999999999999999999 788888866 589999999999
Q ss_pred cccCchhccCCCCCCEEeCCCCcCccc
Q 001908 552 SGQIPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 552 ~~~~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
+ .+|-.|.+|+.|++|-|.+|+|+.+
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCCC
Confidence 8 8999999999999999999999954
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-13 Score=143.68 Aligned_cols=139 Identities=18% Similarity=0.144 Sum_probs=105.6
Q ss_pred CCccc-ccCcceEEEEEECCCCcEEEEEEeccc-------------chhhHHHHHHHHHHHhhcCCCCc--ceEEeeeec
Q 001908 684 SNMIG-QGSFGSVYKGILGENGTFVAVKILNLM-------------QKGALKSFVAECEVLRNTRHRNL--IKIITVCSS 747 (997)
Q Consensus 684 ~~~lg-~G~~g~V~~~~~~~~~~~vAvK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~ 747 (997)
...|| .|+.|+||.+.. .+..+|||.+... .......+.+|++++.+++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45687 899999999988 4778999988521 11233567889999999998875 666766432
Q ss_pred cCcCCCceEEEEEeeccC-CCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC
Q 001908 748 IDFKGADFKALVYEYMQN-GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 826 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~ 826 (997)
.. ......++|||++++ .+|.+++.... ++.. .+.+++.++.+||+. ||+||||||+|||++.+
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~~-------l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQEAP-------LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD 178 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhcCC-------CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence 11 112234699999997 69999886532 3332 356899999999999 99999999999999999
Q ss_pred CcEEEcccccchh
Q 001908 827 MVAHVSDFGLARF 839 (997)
Q Consensus 827 ~~~kl~DFg~a~~ 839 (997)
+.++++|||.++.
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-14 Score=172.07 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=183.6
Q ss_pred hcCccCCcccccCcceEEEEEEC-CCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG-ENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 754 (997)
..|.+.+.||+|+|+.|-.+... .....+|+|.+.... .........|..+-+.+. |+|++++++. ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCCc
Confidence 46777888999999999987763 344567777765332 333445566777777776 9999999998 55667
Q ss_pred eEEEEEeeccCCCHHHHhh-cCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCcEecCCCCCCeeeCCCC-cEEE
Q 001908 755 FKALVYEYMQNGSLEEWLH-QSNGQPEVCDLSLIQRLNIAIDMASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDM-VAHV 831 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH-~~~~~~ivHrDlk~~NIll~~~~-~~kl 831 (997)
..++++||.+++++.+-+. ... ...+......+..|+..++.|+| +. +++|||+||+|.+++..+ ..|+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred ccccccCcccccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence 8999999999999998883 322 12344456678899999999999 77 999999999999999999 9999
Q ss_pred cccccchhcccCCCCCccccccccccccc-cccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKG-TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
+|||+|...... ..........+| ++.|+|||..... .-..+..|+||.|+++.-+++|..|+
T Consensus 167 ~df~~At~~~~~-----~g~~~~~~~~~g~s~~y~a~E~~~~~-----------~~~~~~~d~~S~g~~l~~~~~g~~p~ 230 (601)
T KOG0590|consen 167 ADFGLATAYRNK-----NGAERSLKDRCGSSPPYGAPEHLSGK-----------AYRGPSVDVWSLGIVLSAMLTGELPW 230 (601)
T ss_pred CCchhhcccccc-----CCcceeeecccCCCCCCCCcccccch-----------hhcCCCcccccccccccccccCCCCc
Confidence 999999876331 123344555678 9999999765421 33467889999999999999999998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
............|.... +......|. .......++..+++..+|..|.+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~---------~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 231 DFPSRKDGRYSSWKSNK---------GRFTQLPWN---------SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccccceeecccc---------cccccCccc---------cCChhhhhcccccccCCchhccccccccc
Confidence 85544333222221111 000000011 11223457778888899999999887643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.2e-13 Score=156.71 Aligned_cols=181 Identities=33% Similarity=0.496 Sum_probs=100.3
Q ss_pred ccccceeccccccccccchhhhcCCC-CCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccc
Q 001908 393 LRNLQAIGLSSNFLQGNIPSSLGNLT-LMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF 471 (997)
Q Consensus 393 l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~ 471 (997)
++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++. .+|......+.+ +.
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L-~~ 190 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL-NN 190 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh-hh
Confidence 344455555555554 3444444442 5555555555554 34444455555555555555554 444433344444 45
Q ss_pred cccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccc
Q 001908 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551 (997)
Q Consensus 472 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 551 (997)
|++++|+++ .+|.....+..|++|++++|++. .++..+..+.++..+.+++|++. .++..++.++.++.|++++|++
T Consensus 191 L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred eeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccc
Confidence 555555555 44444444455666666666443 45556666666666666666665 3356666666677777777777
Q ss_pred cccCchhccCCCCCCEEeCCCCcCcccCCCC
Q 001908 552 SGQIPEFLENLSFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 552 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 582 (997)
+ .++. +..+.+++.|++++|.++..+|..
T Consensus 268 ~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 268 S-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred c-cccc-ccccCccCEEeccCccccccchhh
Confidence 6 3333 666777777777777776665543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-13 Score=155.86 Aligned_cols=186 Identities=38% Similarity=0.563 Sum_probs=147.4
Q ss_pred CCCCCCCCEEeccCCCCCCCCCCCccccc-ccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCC
Q 001908 366 IGNLVNLNLLGIEFNQLTGNIPREIGQLR-NLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444 (997)
Q Consensus 366 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 444 (997)
+..++.++.|++.+|+++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|
T Consensus 112 ~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L 188 (394)
T COG4886 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188 (394)
T ss_pred hhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence 344467888888888888 5666666664 8888888888888 67777888888888888888888 577666678888
Q ss_pred cEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccC
Q 001908 445 VSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQG 524 (997)
Q Consensus 445 ~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 524 (997)
+.|++++|++. .+|........+ +.|++++|++. ..+..+.++.++..|.+++|++. .++..++.++.++.|++++
T Consensus 189 ~~L~ls~N~i~-~l~~~~~~~~~L-~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~ 264 (394)
T COG4886 189 NNLDLSGNKIS-DLPPEIELLSAL-EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN 264 (394)
T ss_pred hheeccCCccc-cCchhhhhhhhh-hhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccc
Confidence 88888888887 777766555556 78888888654 56777888899999999999987 5578888889999999999
Q ss_pred ccccccCChhccccCcCCeeeCccccccccCchhcc
Q 001908 525 NSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLE 560 (997)
Q Consensus 525 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 560 (997)
|+++ .++. ++.+.+|+.||+++|.++...|....
T Consensus 265 n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 265 NQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred cccc-cccc-ccccCccCEEeccCccccccchhhhc
Confidence 9998 4544 88899999999999999876665544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.4e-12 Score=144.23 Aligned_cols=141 Identities=20% Similarity=0.235 Sum_probs=101.4
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchhh----------------------------------------HHHH
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA----------------------------------------LKSF 723 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~----------------------------------------~~~~ 723 (997)
.+.||+|++|.||+|+.+ +|+.||||+.+...... .-++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999997 78999999986431110 0134
Q ss_pred HHHHHHHhhc----CCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHH-
Q 001908 724 VAECEVLRNT----RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS- 798 (997)
Q Consensus 724 ~~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~- 798 (997)
.+|++.+.++ +|.+-+.+-.++.+ .....++||||++|++|.++...... .. .+.+++.+++.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARS 268 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHH
Confidence 5566666555 23333444444432 23357999999999999887654221 12 23456666666
Q ss_pred HHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 799 ~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
.+..+|.. |++|+|+||.||+++.+++++++|||++..+
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 46888988 9999999999999999999999999999765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=132.81 Aligned_cols=208 Identities=22% Similarity=0.325 Sum_probs=142.1
Q ss_pred HHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 001908 729 VLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQ 808 (997)
Q Consensus 729 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~ 808 (997)
-+-++.|.|+|++..|+.+..+.+.....+++|||..|++..++++... .+..+......+|+.||..||.|||+. .
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445679999999999877766677789999999999999999997652 233466777889999999999999995 7
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccc--cccccccccccccccCCcchhcccccCccccCCCCC
Q 001908 809 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME--TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE 886 (997)
Q Consensus 809 ~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~ 886 (997)
|+|+|+++.-+-|++..+|-+|+.--...... .... .........+-++|.|| |+.....
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h------~s~~~~~~~Ek~~~~~~~g~~a~------------~sg~~tn 258 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH------PSVNSTREAEKSVNTSLPGFSAP------------ESGTTTN 258 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccc------hhhhhhhHhhhhccccCCccccC------------CcCcccc
Confidence 89999999999999999999998632211111 1000 01111223467789999 4444455
Q ss_pred CCccchhHHHHHHHHHHHhCCCC-CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHh
Q 001908 887 ASVTGDVYSLGVMLLEMFTRRRP-TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGV 965 (997)
Q Consensus 887 ~~~~~DvwSlGvvl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~ 965 (997)
.+.++|||+||++..||..+..- .+.. .....+. .....+ . ..+++. =.+.+.
T Consensus 259 ~~~a~dIy~fgmcAlemailEiq~tnse---S~~~~ee-------~ia~~i----~-~len~l-----------qr~~i~ 312 (458)
T KOG1266|consen 259 TTGASDIYKFGMCALEMAILEIQSTNSE---SKVEVEE-------NIANVI----I-GLENGL-----------QRGSIT 312 (458)
T ss_pred cccchhhhhhhHHHHHHHHheeccCCCc---ceeehhh-------hhhhhe----e-eccCcc-----------ccCcCc
Confidence 66789999999999999987653 1110 0000110 000000 0 000000 025788
Q ss_pred hcCCCCCCCCCCHHHHHH
Q 001908 966 ACSMESPIERMEMRDVLA 983 (997)
Q Consensus 966 ~cl~~dP~~Rps~~evl~ 983 (997)
+|++..|..||+|++++.
T Consensus 313 kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 313 KCLEGEPNGRPDARLLLF 330 (458)
T ss_pred ccccCCCCCCcchhhhhc
Confidence 999999999999998854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.5e-12 Score=143.39 Aligned_cols=253 Identities=23% Similarity=0.261 Sum_probs=177.6
Q ss_pred hcCccCCcccc--cCcceEEEEEE--CCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcC
Q 001908 679 NEFSSSNMIGQ--GSFGSVYKGIL--GENGTFVAVKILNL--MQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFK 751 (997)
Q Consensus 679 ~~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 751 (997)
+.|.+.+.+|. |.+|.||.+.. +.++..+|+|.-+. ........=.+|......++ |++.++.... +.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WE 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cc
Confidence 35667788999 99999999998 88999999998542 22222233355666666664 9999986665 67
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCcEecCCCCCCeeeCCC-
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS----AIEYLHHHCQPPIVHGDLKPSNVLLDHD- 826 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~----~L~yLH~~~~~~ivHrDlk~~NIll~~~- 826 (997)
+.+..++-+|++ +.++.++.+..... ++....+.+..+... |+.++|.. .++|-|+||.||+...+
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~-----~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCNF-----LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhccccc-----CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence 778899999999 57888888875531 445566677777777 99999999 99999999999999999
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
..++++|||+...+....+... ........|...|++||.++ +-++.+.|+|++|.+..+..++
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~---~~~~~r~~~~~~Y~~ke~~~-------------~l~~~~~di~sl~ev~l~~~l~ 323 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSV---FKVSKRPEGDCIYAAKELLN-------------GLATFASDIFSLGEVILEAILG 323 (524)
T ss_pred ceeecCCcceeEEccCCccccc---eeeeecCCCCceEeChhhhc-------------cccchHhhhcchhhhhHhhHhh
Confidence 8999999999987754433222 12223336778899998875 5678899999999999999998
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+....... .| .+.+... +..++ .+.-..++...+..|+..+|..|++.+.+..
T Consensus 324 ~~~~~~g~~~-----~W--~~~r~~~---ip~e~------------~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 324 SHLPSVGKNS-----SW--SQLRQGY---IPLEF------------CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccCCCCC-----Cc--ccccccc---Cchhh------------hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 7654322100 00 0000000 00000 0011223445788999999999999776643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.1e-11 Score=139.80 Aligned_cols=145 Identities=17% Similarity=0.184 Sum_probs=96.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchh----------------------------------hH---
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG----------------------------------AL--- 720 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~----------------------------------~~--- 720 (997)
..+|+. +.||+|++|.||+|+.+++|+.||||+.++.... -.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 7999999999999999877999999999743110 01
Q ss_pred ---HHHHHHHHHHhhc----CCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHh--hcCCCCCCcCCCCHHHHHH
Q 001908 721 ---KSFVAECEVLRNT----RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCDLSLIQRLN 791 (997)
Q Consensus 721 ---~~~~~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~ 791 (997)
-++.+|+..+.++ .+...+.+-.++.+ -....++||||++|+.+.++- ...+ .+.. .
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g-------~d~~---~ 263 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAG-------TDMK---L 263 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcC-------CCHH---H
Confidence 1234455555444 24444444444422 234678999999999998752 2221 2211 1
Q ss_pred HHHHHHHH-HHHHhhCCCCCcEecCCCCCCeeeCCCC----cEEEcccccchhc
Q 001908 792 IAIDMASA-IEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHVSDFGLARFL 840 (997)
Q Consensus 792 i~~~i~~~-L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFg~a~~~ 840 (997)
++...+.. +..++.. |++|+|+||.||+++.++ ++++.|||++..+
T Consensus 264 la~~~v~~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 264 LAERGVEVFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 22222222 2334456 999999999999999988 9999999998776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.4e-12 Score=129.22 Aligned_cols=203 Identities=25% Similarity=0.252 Sum_probs=130.8
Q ss_pred CCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecC-cCCCCCCCCCCCCCCCcE
Q 001908 368 NLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN-HLQGNIPPSLGNCKNLVS 446 (997)
Q Consensus 368 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~ 446 (997)
-+.+|+.+.++.+.-..+ -+-...-+.|+++...+.-++ ..|. +-..+.+..+.-+.- -.+|..-..+.....|++
T Consensus 212 ~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~-~~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~Lte 288 (490)
T KOG1259|consen 212 AFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQ-DVPS-LLPETILADPSGSEPSTSNGSALVSADTWQELTE 288 (490)
T ss_pred Hhhhhheeeeeccchhhe-eceeecCchhheeeeeccccc-cccc-ccchhhhcCccCCCCCccCCceEEecchHhhhhh
Confidence 344555555554433211 111112355777777666555 2221 212222222221111 122333333444566888
Q ss_pred EecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcc
Q 001908 447 LNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNS 526 (997)
Q Consensus 447 L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (997)
+|||+|.++ .+..+..-++.+ +.|++|+|.+.. +. .+..|++|+.||||+|.++ .+..+=..+-+.+.|.|++|.
T Consensus 289 lDLS~N~I~-~iDESvKL~Pki-r~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~ 363 (490)
T KOG1259|consen 289 LDLSGNLIT-QIDESVKLAPKL-RRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNK 363 (490)
T ss_pred ccccccchh-hhhhhhhhccce-eEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhh
Confidence 888888876 666666666776 888888888873 32 3777889999999999998 677777778889999999998
Q ss_pred ccccCChhccccCcCCeeeCccccccccC-chhccCCCCCCEEeCCCCcCcccCC
Q 001908 527 FRGSIPLSLRSLKSIKELDLSCNNLSGQI-PEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
|.. -..++.+-+|..||+++|+|.... -..+++++.|+++.|.+|++.+.+.
T Consensus 364 iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 364 IET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred Hhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 862 235777888999999999997422 2568899999999999999987554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.2e-10 Score=126.25 Aligned_cols=170 Identities=17% Similarity=0.232 Sum_probs=126.5
Q ss_pred EEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCC
Q 001908 697 KGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN 776 (997)
Q Consensus 697 ~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 776 (997)
.|..+.++.+|.|.+.+...........+-++.++.++||+|++++.. ++.++..|+|+|.+. -|..++++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKELG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHHhH
Confidence 567777899999998875555445667788889999999999999987 566778999999873 5777777643
Q ss_pred CCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccc
Q 001908 777 GQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856 (997)
Q Consensus 777 ~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~ 856 (997)
...+-..++||+.||.|||..| +++|++|.-.-|+|++.|..||++|.++...... .....
T Consensus 103 ---------~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~--------~~~~~ 163 (690)
T KOG1243|consen 103 ---------KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF--------NAPAK 163 (690)
T ss_pred ---------HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC--------Ccccc
Confidence 2345567889999999999876 8999999999999999999999999988654110 00001
Q ss_pred cccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 857 ~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
...--..|..|+.... -....|.|-|||+++|++.|
T Consensus 164 ~~~~~~s~~~P~~~~~--------------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDP--------------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhcccChhhcCc--------------cccchhhhhHHHHHHHHhCc
Confidence 1111223555643221 11356999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-10 Score=116.93 Aligned_cols=130 Identities=19% Similarity=0.171 Sum_probs=95.3
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCc-ceEEeeeeccCcCCCceEEEEEee
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL-IKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
.+.++.|.++.||+++. .++.|++|+...... ....+.+|+++++.+.+.++ .+++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 45789999999999987 478899999764332 12346789999998865554 4454431 1235799999
Q ss_pred ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
++|.++.+. . . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.|.
T Consensus 73 i~G~~l~~~----~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE----D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc----c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999887643 0 0 11235678999999999982 11259999999999998 6789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.5e-10 Score=110.62 Aligned_cols=137 Identities=18% Similarity=0.175 Sum_probs=98.4
Q ss_pred CCcccccCcceEEEEEECC------CCcEEEEEEecccc------------h----------hhHHHH----HHHHHHHh
Q 001908 684 SNMIGQGSFGSVYKGILGE------NGTFVAVKILNLMQ------------K----------GALKSF----VAECEVLR 731 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~------~~~~vAvK~~~~~~------------~----------~~~~~~----~~E~~~l~ 731 (997)
...||.|.-+.||.|.... .+..+|||+.+... + ...+.+ .+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 35789999885210 0 112223 38999999
Q ss_pred hcCC--CCcceEEeeeeccCcCCCceEEEEEeeccCCCHH-HHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHH-hhCC
Q 001908 732 NTRH--RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLE-EWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL-HHHC 807 (997)
Q Consensus 732 ~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yL-H~~~ 807 (997)
++.. -++.+.+++ ...++||||+.+..+. ..++.. .++..+...+..+++.+|.++ |..
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 9853 466677654 2468999999664332 122221 134445667789999999999 777
Q ss_pred CCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 808 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 808 ~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
+++|+|+++.||+++ ++.+.++|||.|...
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999996 578999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-11 Score=140.49 Aligned_cols=199 Identities=27% Similarity=0.330 Sum_probs=91.4
Q ss_pred CCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCC-CCCCCCC
Q 001908 366 IGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS-LGNCKNL 444 (997)
Q Consensus 366 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L 444 (997)
+..+++|++|++++|+|+...+ +..++.|+.|++++|.|+. ...+..+++|+.+++++|++...-+ . ...+.++
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l 188 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIEN-DELSELISL 188 (414)
T ss_pred hhhhhcchheeccccccccccc--hhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhh-hhhhhccch
Confidence 3445555555555555553322 3344445566666666552 1334445556666666666553222 1 3455556
Q ss_pred cEEecCCCcccCCcccccccccccccccccCCCcccCCCcccccccc--ccceeccccccccccccccccCCcCccEEEc
Q 001908 445 VSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLK--NLVALYISGNQFSGEIPVTLTGCTGLEIFHM 522 (997)
Q Consensus 445 ~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 522 (997)
+.+++++|.+. ....+..+..+ ..+++..|.++..-+. ..+. .|+.+++++|++. .++..+..+..+..|++
T Consensus 189 ~~l~l~~n~i~--~i~~~~~~~~l-~~~~l~~n~i~~~~~l--~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~ 262 (414)
T KOG0531|consen 189 EELDLGGNSIR--EIEGLDLLKKL-VLLSLLDNKISKLEGL--NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDL 262 (414)
T ss_pred HHHhccCCchh--cccchHHHHHH-HHhhcccccceeccCc--ccchhHHHHHHhcccCccc-cccccccccccccccch
Confidence 66666666553 11122222222 3345555555422211 1111 2556666666655 33344445555555555
Q ss_pred cCccccccCChhccccCcCCeeeCccccccc---cCchh-ccCCCCCCEEeCCCCcCcc
Q 001908 523 QGNSFRGSIPLSLRSLKSIKELDLSCNNLSG---QIPEF-LENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 523 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~-~~~l~~L~~L~ls~N~l~~ 577 (997)
.+|++...- .+.....+..+.++.|.+.. ..... ....+.++.+.+.+|+...
T Consensus 263 ~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 263 SSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred hhccccccc--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccc
Confidence 555554221 12333444455555555431 11111 3334445555555555444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.3e-11 Score=138.82 Aligned_cols=215 Identities=30% Similarity=0.358 Sum_probs=153.1
Q ss_pred cccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 348 MTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 348 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
++.+.+..|.|. .+-..+..+++|..|++..|+|.. +...+..+++|++|+|++|+|+.. ..+..++.|+.|++++
T Consensus 74 l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhheecc
Confidence 444445555554 233456778899999999999984 333377889999999999999854 3467778899999999
Q ss_pred CcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccc
Q 001908 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 428 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
|.|+. ...+..+++|+.+++++|++...-+.....+..+ +.+++++|.+.. ...+..+..+..+++..|.++-.-
T Consensus 150 N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l-~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 150 NLISD--ISGLESLKSLKLLDLSYNRIVDIENDELSELISL-EELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLE 224 (414)
T ss_pred Ccchh--ccCCccchhhhcccCCcchhhhhhhhhhhhccch-HHHhccCCchhc--ccchHHHHHHHHhhcccccceecc
Confidence 99983 3445668899999999999874433103556666 778899998863 334455666777788888887322
Q ss_pred cccccCCc--CccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCc
Q 001908 508 PVTLTGCT--GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 508 p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 576 (997)
+ +..+. .|+.+++++|++. .++..+..++.+..||+++|++... ..+.....+..+.+..|.+.
T Consensus 225 ~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 225 G--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred C--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 2 22223 3888899999887 4556777888888899998888743 33555666777778888776
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.1e-11 Score=128.14 Aligned_cols=160 Identities=22% Similarity=0.180 Sum_probs=86.2
Q ss_pred CCCccEEEecCCcCcCCCC--CCCCCCCCCcEEeccCccCCCccc--ccccccCccCeeEccCccCCCCCCCCcchhhhh
Q 001908 242 LPNLQVFAIGDNYFSGSIP--ESFSNASNIEIIDLPINYFTGKVS--IIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317 (997)
Q Consensus 242 l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l 317 (997)
+.+|+...|.+..+. ..+ +....|++++.||||+|-|+...+ .....|++|+.|+|+.|++.....+...
T Consensus 120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~----- 193 (505)
T KOG3207|consen 120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT----- 193 (505)
T ss_pred HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch-----
Confidence 344444455444443 222 345667777888888887765432 3456788888888888888765443222
Q ss_pred ccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCC-CCccccccc
Q 001908 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIP-REIGQLRNL 396 (997)
Q Consensus 318 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L 396 (997)
..++.|+.|.|+.|.++-.--.++....++++.|+|..|..-+........+..|+.|||++|++-...- ...+.++.|
T Consensus 194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccch
Confidence 2567788888888887732222222223455555555554322333333344455555555555542110 223444555
Q ss_pred ceecccccccc
Q 001908 397 QAIGLSSNFLQ 407 (997)
Q Consensus 397 ~~L~Ls~N~l~ 407 (997)
..|+++.+.+.
T Consensus 274 ~~Lnls~tgi~ 284 (505)
T KOG3207|consen 274 NQLNLSSTGIA 284 (505)
T ss_pred hhhhccccCcc
Confidence 55555555444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.8e-12 Score=132.52 Aligned_cols=16 Identities=25% Similarity=0.480 Sum_probs=9.6
Q ss_pred CCCccceeeccCCCCC
Q 001908 216 NMSSLENILLDVNGFT 231 (997)
Q Consensus 216 ~l~~L~~L~L~~N~l~ 231 (997)
.+++|++|+|.+|.+.
T Consensus 118 s~~~L~eL~L~N~Glg 133 (382)
T KOG1909|consen 118 SCTDLEELYLNNCGLG 133 (382)
T ss_pred hccCHHHHhhhcCCCC
Confidence 3556666666666654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.2e-12 Score=129.72 Aligned_cols=198 Identities=25% Similarity=0.301 Sum_probs=118.6
Q ss_pred CcEEEEeccCCCCCC----cccccccCccccccccccccccCC----CCCcc-------CCCCCCCeEEEccCCCccccC
Q 001908 74 QRVTELDLRHQNIGG----SLSPYVGNLSFLRYINLATNNFHG----EIPKE-------IGFLFRLETLMLANNSFSGKI 138 (997)
Q Consensus 74 ~~v~~L~L~~~~l~g----~~~~~l~~l~~L~~L~Ls~N~l~g----~~p~~-------~~~l~~L~~L~Ls~N~l~g~i 138 (997)
..+++|+|++|.+.- .+.+.+.+.+.|+.-++|+- |+| .+|+. +-.+++|++||||+|.|.-.-
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 468999999999844 35677888899999999863 343 45643 445679999999999997544
Q ss_pred CccccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcch--hhhhhccCccccccCCCcccC
Q 001908 139 PTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS--IIYLHVGENQFSGTVPPSLYN 216 (997)
Q Consensus 139 P~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~--~~~L~l~~N~l~g~ip~~l~~ 216 (997)
+..++.+- .++..|++|.|.+|.+. |..=+.+. +..|. .|+.- +.
T Consensus 109 ~~~l~~ll---------------------~s~~~L~eL~L~N~Glg---~~ag~~l~~al~~l~--~~kk~-------~~ 155 (382)
T KOG1909|consen 109 IRGLEELL---------------------SSCTDLEELYLNNCGLG---PEAGGRLGRALFELA--VNKKA-------AS 155 (382)
T ss_pred hHHHHHHH---------------------HhccCHHHHhhhcCCCC---hhHHHHHHHHHHHHH--HHhcc-------CC
Confidence 44433221 12445667777777664 21111121 12222 33322 23
Q ss_pred CCccceeeccCCCCCCCCCc----cccccCCCccEEEecCCcCcC----CCCCCCCCCCCCcEEeccCccCCCccc----
Q 001908 217 MSSLENILLDVNGFTGNLPL----DIGVTLPNLQVFAIGDNYFSG----SIPESFSNASNIEIIDLPINYFTGKVS---- 284 (997)
Q Consensus 217 l~~L~~L~L~~N~l~g~lp~----~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~---- 284 (997)
-+.|+++..++|++. .-+. ..+...+.|+.+.++.|.|.. .+-..|..+++|++|||.+|-|+....
T Consensus 156 ~~~Lrv~i~~rNrle-n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLE-NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CcceEEEEeeccccc-cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 356788888888775 2222 223455777788888777642 123456777777777777777764432
Q ss_pred ccccccCccCeeEccCccCCCC
Q 001908 285 IIFGRLKNLWSLDLGINNLGSG 306 (997)
Q Consensus 285 ~~~~~l~~L~~L~Ls~N~l~~~ 306 (997)
..++.+++|+.|+++++.++.-
T Consensus 235 kaL~s~~~L~El~l~dcll~~~ 256 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENE 256 (382)
T ss_pred HHhcccchheeecccccccccc
Confidence 2334444555555555555443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-10 Score=85.19 Aligned_cols=39 Identities=56% Similarity=1.039 Sum_probs=31.2
Q ss_pred HHHHHHHHHHHHhcC-CCCCCCCCCCCC--CCCCeeeeeeec
Q 001908 32 ETDRLALLAIKSQLH-DPLGVTNSWNNS--INLCQWAGVTCG 70 (997)
Q Consensus 32 ~~~~~aLl~~k~~~~-~~~~~~~sW~~~--~~~c~w~gv~C~ 70 (997)
++|++||++||+++. ||.+.+.+|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 679999999999997 577899999876 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.1e-11 Score=127.44 Aligned_cols=212 Identities=22% Similarity=0.202 Sum_probs=131.8
Q ss_pred CCCCCCCcEEeccCccCCCccc-ccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccc
Q 001908 263 FSNASNIEIIDLPINYFTGKVS-IIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSI 341 (997)
Q Consensus 263 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 341 (997)
=.++.+|+.+.|.+........ .....+++++.||||.|-+.... ........+++|+.|+|+.|++.-......
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~----~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~ 192 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWF----PVLKIAEQLPSLENLNLSSNRLSNFISSNT 192 (505)
T ss_pred hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHH----HHHHHHHhcccchhcccccccccCCccccc
Confidence 4577889999998888764433 45678899999999999887532 234556788999999999998873322211
Q ss_pred cccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCC-CCCCcccccccceeccccccccccchhhhcCCCCC
Q 001908 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN-IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLM 420 (997)
Q Consensus 342 ~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 420 (997)
.. .+++|+.|.|+.|.|+.. +-.....+++|+.|+|..|...+.-......+..|
T Consensus 193 ~~------------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L 248 (505)
T KOG3207|consen 193 TL------------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTL 248 (505)
T ss_pred hh------------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHH
Confidence 11 345566666666666521 11223345666677776664333333444555666
Q ss_pred CeEEeecCcCCCCCC--CCCCCCCCCcEEecCCCcccCC-cccc-----cccccccccccccCCCcccCCCc--cccccc
Q 001908 421 TDLFLSSNHLQGNIP--PSLGNCKNLVSLNLSDNKLIGA-VPQQ-----ILTITTLSRFLDLGNNHLNGSLP--LEVGNL 490 (997)
Q Consensus 421 ~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~ll~~L~Ls~N~l~~~~p--~~~~~l 490 (997)
+.|||++|++.. .+ ...+.++.|..|+++.+.+... +|+. ...++++ ++|+++.|++. ..+ ..+..+
T Consensus 249 ~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL-~~L~i~~N~I~-~w~sl~~l~~l 325 (505)
T KOG3207|consen 249 QELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKL-EYLNISENNIR-DWRSLNHLRTL 325 (505)
T ss_pred hhccccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccc-eeeecccCccc-cccccchhhcc
Confidence 677777766652 33 3455666677777776666422 1221 1334555 77777777774 222 235567
Q ss_pred cccceeccccccccc
Q 001908 491 KNLVALYISGNQFSG 505 (997)
Q Consensus 491 ~~L~~L~Ls~N~l~~ 505 (997)
++|+.|....|.|+.
T Consensus 326 ~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 326 ENLKHLRITLNYLNK 340 (505)
T ss_pred chhhhhhcccccccc
Confidence 788888888998873
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.4e-10 Score=117.68 Aligned_cols=197 Identities=23% Similarity=0.221 Sum_probs=135.8
Q ss_pred cccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCC-CcccCCccccccccccccc
Q 001908 392 QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD-NKLIGAVPQQILTITTLSR 470 (997)
Q Consensus 392 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~ll~ 470 (997)
-+.+|+.+.+|...-. .+-.-...-+.|+++...+.-++. .|. +-..+.+.-..-+. ....|..-..+-..+.+ +
T Consensus 212 ~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~L-t 287 (490)
T KOG1259|consen 212 AFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQD-VPS-LLPETILADPSGSEPSTSNGSALVSADTWQEL-T 287 (490)
T ss_pred Hhhhhheeeeeccchh-heeceeecCchhheeeeecccccc-ccc-ccchhhhcCccCCCCCccCCceEEecchHhhh-h
Confidence 3455555555554332 121222233678888887776652 221 11112221111111 11233333344445556 8
Q ss_pred ccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcccc
Q 001908 471 FLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNN 550 (997)
Q Consensus 471 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 550 (997)
.+|||+|.|+ .+.+++.-++.++.|++|+|.+. .+- .+..+.+|+.||||+|.++ .+..+-..+-+.++|.|+.|.
T Consensus 288 elDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~ 363 (490)
T KOG1259|consen 288 ELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNK 363 (490)
T ss_pred hccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhh
Confidence 8999999999 77788888999999999999998 443 3889999999999999998 666677788899999999999
Q ss_pred ccccCchhccCCCCCCEEeCCCCcCccc--CCCCCcCCCCcceeecCCCC
Q 001908 551 LSGQIPEFLENLSFLEYLNLSYNHFDGE--VPTKGVFSNKTRVQLTGNGK 598 (997)
Q Consensus 551 l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p~~~~~~~~~~~~~~~N~~ 598 (997)
|... ..+.++-+|..||+++|++... +-..+.++-+..+.+.+||.
T Consensus 364 iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 364 IETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred Hhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 9743 5678889999999999999742 33346778888899999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.8e-10 Score=127.15 Aligned_cols=247 Identities=19% Similarity=0.127 Sum_probs=165.3
Q ss_pred hhcCccCCcccccCcceEEEEEEC-CCCcEEEEEEecccchh--hHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-ENGTFVAVKILNLMQKG--ALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 753 (997)
..+|..+..||.|.|+.|++...+ .++..|++|........ ....-..|+.+...+ .|.+++..+.. |...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cccc
Confidence 457888999999999999998876 67788999977532221 112235566666666 47777776554 4455
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-CcEEEc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVS 832 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~ 832 (997)
+..|+--|||++++....+.... .++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQ------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHH------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcc
Confidence 67789999999998877764322 256677889999999999999998 99999999999999886 788999
Q ss_pred ccccchhcccCCCCCcccccccccccccccccc-CCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYV-PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
|||.++.+.- ........-.++ .+|++. ....+..++|++|||.-+.|.+++.+--.
T Consensus 410 ~~~~~t~~~~-----------~~~~~~~~~r~~p~~~~~~-----------e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 410 DFGCWTRLAF-----------SSGVFHHIDRLYPIAEILL-----------EDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ccccccccce-----------ecccccccccccccchhhc-----------cccccccccccccccccccccccCcccCc
Confidence 9999864310 111112223333 244333 23556789999999999999999865322
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
.. .. ... +....-+.. .....++..+.+.+...++..||.+.+......
T Consensus 468 ~~-~~---~~~---------i~~~~~p~~-------------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 468 SG-VQ---SLT---------IRSGDTPNL-------------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cc-cc---cee---------eecccccCC-------------CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11 00 000 000000000 011134456777888899999998877655443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.1e-08 Score=107.15 Aligned_cols=282 Identities=16% Similarity=0.111 Sum_probs=167.6
Q ss_pred ccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeec--cCcCCCceEEE
Q 001908 682 SSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSS--IDFKGADFKAL 758 (997)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~~~~~~l 758 (997)
...+.||+|+.+.+|-.-. -+. .+.|+...-.... -.+.++.|... .||-+..-+.|=.. +..+......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~---~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAA---QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecch--hhc-hhheeecCCCchH---HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4578899999999996432 122 3457775332211 11233344433 56644331222000 00112223567
Q ss_pred EEeeccCC-CHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 759 VYEYMQNG-SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 759 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+|..+++. -...++...........++|...++.++.++.+.+-||+. |.+-+|+.++|+|+++++.|.+.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 77777553 2333333333223345689999999999999999999999 9999999999999999999999986654
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC-CCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~~~ 916 (997)
... ..+....-.+|...|.+||...- -.+.+...+...|-|.+||++|+++.| +.||......
T Consensus 165 qi~---------~ng~~~~cpVg~~eftPPElQ~~-------~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~ 228 (637)
T COG4248 165 QIN---------ANGTLHLCPVGVSEFTPPELQTL-------PSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI 228 (637)
T ss_pred eec---------cCCceEecccCccccCCHHHhcc-------ccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence 432 12223334578899999986541 123355567788999999999999986 9998754321
Q ss_pred C---ccHH-HHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCC--CCCCCCCHHHHHHHHHHHHH
Q 001908 917 G---LTLH-EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME--SPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 917 ~---~~~~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~Rps~~evl~~L~~~~~ 990 (997)
+ ...+ ......+.+ ..|... + +.......-..-.++++.-+..+|+.. .+.-|||++..+..|.++.+
T Consensus 229 ~~ap~p~E~~Ia~g~f~y----a~~~~~-g-~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 229 SDAPNPLETDIAHGRFAY----ASDQRR-G-LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred CCCCCcchhhhhcceeee----chhccC-C-CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1 1111 111100000 000000 0 000000000112244555666688765 35689999999999999988
Q ss_pred Hhhc
Q 001908 991 TLVG 994 (997)
Q Consensus 991 ~~~~ 994 (997)
++.+
T Consensus 303 ~L~~ 306 (637)
T COG4248 303 QLKK 306 (637)
T ss_pred hhhh
Confidence 7754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.3e-10 Score=110.79 Aligned_cols=78 Identities=24% Similarity=0.274 Sum_probs=25.2
Q ss_pred ccccceeccccccccccccccc-cCCcCccEEEccCccccccCC-hhccccCcCCeeeCccccccccCc----hhccCCC
Q 001908 490 LKNLVALYISGNQFSGEIPVTL-TGCTGLEIFHMQGNSFRGSIP-LSLRSLKSIKELDLSCNNLSGQIP----EFLENLS 563 (997)
Q Consensus 490 l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~ 563 (997)
+++|+.|++++|+|+ .++..+ ..+++|+.|+|++|+|...-- ..+..+++|+.|+|.+|.++.. + ..+..+|
T Consensus 63 L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP 140 (175)
T PF14580_consen 63 LPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLP 140 (175)
T ss_dssp -TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-T
T ss_pred hhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcC
Confidence 444555555555554 232222 234555555555555542211 2344555666666666665522 2 1345566
Q ss_pred CCCEEe
Q 001908 564 FLEYLN 569 (997)
Q Consensus 564 ~L~~L~ 569 (997)
+|+.||
T Consensus 141 ~Lk~LD 146 (175)
T PF14580_consen 141 SLKVLD 146 (175)
T ss_dssp T-SEET
T ss_pred hhheeC
Confidence 666665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.1e-10 Score=109.76 Aligned_cols=112 Identities=23% Similarity=0.327 Sum_probs=42.1
Q ss_pred ccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCcc
Q 001908 214 LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNL 293 (997)
Q Consensus 214 l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 293 (997)
+.+..++++|+|++|+|+ .|. .++..+.+|+.|+|++|.|+. ++ .+..+++|++|++++|+|+...+.....+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 344556777788888776 443 444457788888888888874 33 47788899999999999987644333568899
Q ss_pred CeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccC
Q 001908 294 WSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLG 334 (997)
Q Consensus 294 ~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 334 (997)
++|+|++|+|..... ...+..+++|++|+|.+|.+.
T Consensus 91 ~~L~L~~N~I~~l~~-----l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 91 QELYLSNNKISDLNE-----LEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -EEE-TTS---SCCC-----CGGGGG-TT--EEE-TT-GGG
T ss_pred CEEECcCCcCCChHH-----hHHHHcCCCcceeeccCCccc
Confidence 999999999987543 355778889999999998876
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-08 Score=97.21 Aligned_cols=129 Identities=26% Similarity=0.354 Sum_probs=94.6
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEeccc--------chhhHHHHHHHHHHHhhcCCCC--cceEEeeeeccCcCCCc
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLM--------QKGALKSFVAECEVLRNTRHRN--LIKIITVCSSIDFKGAD 754 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--------~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~ 754 (997)
..+++|+-+.+|.+.+ -|.++++|.-.+. ..-....-.+|+.+++++.--. +..++++ +++
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 4578999999999988 4555777754211 1112345678999998875433 3334433 355
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
...++|||++|..|.+.+.... ..++..|-.-+.-||.. +|+|+|+.++||++..+. +.++||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~~-------------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEAR-------------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhcc-------------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence 7789999999999998887641 23455666677789999 999999999999997665 999999
Q ss_pred ccchh
Q 001908 835 GLARF 839 (997)
Q Consensus 835 g~a~~ 839 (997)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99964
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-08 Score=106.62 Aligned_cols=145 Identities=23% Similarity=0.288 Sum_probs=106.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccch-hhHHHHHHHHHHHhhcCC--CCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-GALKSFVAECEVLRNTRH--RNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.++.|.++.||+++.. +|+.+++|+...... .....+.+|+++++.+.+ ..+.+++.++.... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 56899999999999885 467899999764322 134577899999999975 34577777643211 1135689999
Q ss_pred eccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 001908 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC---------------------------------- 807 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~---------------------------------- 807 (997)
|++|+++.+.+... .++..+...++.++++++.+||+..
T Consensus 81 ~i~G~~l~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 81 RVDGRVLRDRLLRP-------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EeCCEecCCCCCCC-------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99998887755321 2556667777888888888887421
Q ss_pred -------------------CCCcEecCCCCCCeeeCC--CCcEEEcccccchh
Q 001908 808 -------------------QPPIVHGDLKPSNVLLDH--DMVAHVSDFGLARF 839 (997)
Q Consensus 808 -------------------~~~ivHrDlk~~NIll~~--~~~~kl~DFg~a~~ 839 (997)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236899999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2e-08 Score=96.32 Aligned_cols=142 Identities=24% Similarity=0.292 Sum_probs=101.0
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEeccc--------chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--------QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
....+-||+-+.|+++.+ .|+.+.||.-... ..-......+|+..+.++.--.|..-.-+ +.+..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 467889999999999999 6888888754211 12234566889999988753332222212 22233
Q ss_pred eEEEEEeeccC-CCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC---cEE
Q 001908 755 FKALVYEYMQN-GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAH 830 (997)
Q Consensus 755 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~k 830 (997)
.-.++|||++| .++.+++....... .........+.+|-+.+.-||.. +|+|+|+.++||++..++ .+.
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~----~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDE----SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCc----ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 56799999976 48888888754221 22223367788888899999999 999999999999997666 468
Q ss_pred Ecccccch
Q 001908 831 VSDFGLAR 838 (997)
Q Consensus 831 l~DFg~a~ 838 (997)
++|||++.
T Consensus 157 lIdfgls~ 164 (229)
T KOG3087|consen 157 LIDFGLSS 164 (229)
T ss_pred EEeecchh
Confidence 99999985
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.1e-09 Score=127.84 Aligned_cols=277 Identities=22% Similarity=0.189 Sum_probs=143.5
Q ss_pred cccceeecccccccCcCcCccCcchhhhhhccCccc-cccCCC-cccCCCccceeeccCCCCCCCCCccccccCCCccEE
Q 001908 171 LKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQF-SGTVPP-SLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVF 248 (997)
Q Consensus 171 ~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l-~g~ip~-~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L 248 (997)
...+...+-+|.+. .++....+..+.+|.+..|.. ...++. .|..++.|..|||++|.=-+.+|..++ .|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~-~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG-ELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh-hhhhhhcc
Confidence 44555555566554 344444444455555566641 123333 355577777777777665567777776 67777777
Q ss_pred EecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEe
Q 001908 249 AIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAF 328 (997)
Q Consensus 249 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L 328 (997)
+|++..++ .+|..++++..|.+|++..+.-...++.....|.+|++|.+-.-... .+......+.++.+|+.+..
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~----~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALS----NDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccc----cchhhHHhhhcccchhhhee
Confidence 77777777 77777777777777777777665556666666777777777655421 11122334455555555555
Q ss_pred ecCccCC-CCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCccccc------ccceecc
Q 001908 329 EENRLGG-VLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLR------NLQAIGL 401 (997)
Q Consensus 329 ~~N~l~~-~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~------~L~~L~L 401 (997)
....... .-......+.+..+.+.+..+... ..+..+..+.+|+.|.+.++.++........... ++..+..
T Consensus 676 ~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~ 754 (889)
T KOG4658|consen 676 TISSVLLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSI 754 (889)
T ss_pred ecchhHhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHh
Confidence 3332200 000111111122223333222222 4455666677777777777766533222221111 1222211
Q ss_pred ccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC
Q 001908 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 402 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 456 (997)
.+...- ..+.+.--.++|+.|++........+.+....+..+..+.+..+.+.+
T Consensus 755 ~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 755 LNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred hccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 111111 123333344666666666666554444444445555555555555443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.7e-09 Score=85.02 Aligned_cols=61 Identities=41% Similarity=0.564 Sum_probs=41.3
Q ss_pred CCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccC
Q 001908 243 PNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNL 303 (997)
Q Consensus 243 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 303 (997)
|+|++|++++|+++...+.+|.++++|++|++++|+++...+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655556677777777777777777766666777777777777766654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.8e-09 Score=84.50 Aligned_cols=60 Identities=37% Similarity=0.538 Sum_probs=33.9
Q ss_pred CccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcC
Q 001908 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575 (997)
Q Consensus 516 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 575 (997)
+|++|++++|+|+...+..|..+++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544444555555555555555555555555555666666666665553
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4e-09 Score=124.63 Aligned_cols=211 Identities=23% Similarity=0.303 Sum_probs=141.4
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
..+.+.+.+-+-+|.++.++.+.-...|.-.+.|+..... ..+.+....+-.+.-..++|-++....- +...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence 3355666778888999999998887777666666543221 1111222222222222234444433322 3345
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...+++++|..+++|...++..... +..-.......+..+.+|||.. .+.|||++|.|.++..++..+++|
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~------saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCL------SAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCc------ccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence 6789999999999999999886632 2222233445678899999998 799999999999999999999999
Q ss_pred cccchhcccC----------------CCCCc-------cccccccccccccccccCCcchhcccccCccccCCCCCCCcc
Q 001908 834 FGLARFLFAR----------------PFDTS-------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVT 890 (997)
Q Consensus 834 Fg~a~~~~~~----------------~~~~~-------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~ 890 (997)
||........ ..... ...........||+.|.+||.. .+......
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~------------lg~~hgs~ 1015 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL------------LGRRHGSA 1015 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc------------ccccCCCc
Confidence 9854433211 00000 0011224456799999999554 46777889
Q ss_pred chhHHHHHHHHHHHhCCCCCCcC
Q 001908 891 GDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 891 ~DvwSlGvvl~elltg~~P~~~~ 913 (997)
+|+|+.|++++|.++|.+||...
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCCc
Confidence 99999999999999999999854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.5e-07 Score=100.86 Aligned_cols=178 Identities=19% Similarity=0.234 Sum_probs=133.0
Q ss_pred CcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEeeccC-CCHH
Q 001908 691 SFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQN-GSLE 769 (997)
Q Consensus 691 ~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 769 (997)
...+.|++....+|..|++|+++............-+++.+++.|.|+|++..++....| ++...++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 346889999999999999999953322222233456888999999999999998764433 34568999999987 5888
Q ss_pred HHhhcCCCCC---------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 770 EWLHQSNGQP---------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 770 ~~l~~~~~~~---------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
+.--...... .....++..+|.++.|+..||.++|+. |...+-+.+.+|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7655433211 223467788999999999999999999 9999999999999999999999888776544
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
..++ .+| + .--.+-|.=.||.+++-+.||..-
T Consensus 444 ~~d~--------------------~~~--l---------------e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDP--------------------TEP--L---------------ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCC--------------------Ccc--h---------------hHHhhhhHHHHHHHHHHHhhcccc
Confidence 2211 111 1 112356888999999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.5e-07 Score=98.72 Aligned_cols=146 Identities=14% Similarity=0.047 Sum_probs=100.3
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCC--cceEEeeeeccCcC
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG-----------ALKSFVAECEVLRNTRHRN--LIKIITVCSSIDFK 751 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~ 751 (997)
+.+-+.....|++... .|+.|.||........ ....+.+|...+.++...+ +++.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 3344444445777776 6788999977432211 1124788999888874333 33444443221111
Q ss_pred CCceEEEEEeeccCC-CHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-----
Q 001908 752 GADFKALVYEYMQNG-SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH----- 825 (997)
Q Consensus 752 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~----- 825 (997)
.....++|||++++. +|.+++..... .+.+...+..++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 134578999999875 89999864321 1244566778999999999999999 9999999999999975
Q ss_pred --CCcEEEcccccchh
Q 001908 826 --DMVAHVSDFGLARF 839 (997)
Q Consensus 826 --~~~~kl~DFg~a~~ 839 (997)
++.+.++||+.++.
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46899999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.2e-07 Score=95.29 Aligned_cols=125 Identities=27% Similarity=0.246 Sum_probs=81.3
Q ss_pred eEEEEEECCCCcEEEEEEecccc--------------------------hhhHHHHHHHHHHHhhcCCC--CcceEEeee
Q 001908 694 SVYKGILGENGTFVAVKILNLMQ--------------------------KGALKSFVAECEVLRNTRHR--NLIKIITVC 745 (997)
Q Consensus 694 ~V~~~~~~~~~~~vAvK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~ 745 (997)
.||.|... +|.++|||+.+... ........+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999885 78899999875210 00123568899999999755 567777651
Q ss_pred eccCcCCCceEEEEEeecc--CCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCcEecCCCCCCee
Q 001908 746 SSIDFKGADFKALVYEYMQ--NGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY-LHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~y-LH~~~~~~ivHrDlk~~NIl 822 (997)
..++||||++ |..+....... ++......++.+++..+.. +|.. ||+|+|+.+.||+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred ---------CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 3579999998 54444433221 1112345667788886666 4677 9999999999999
Q ss_pred eCCCCcEEEcccccchhc
Q 001908 823 LDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~ 840 (997)
++++ .+.++|||.|...
T Consensus 140 v~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EETT-CEEE--GTTEEET
T ss_pred eecc-eEEEEecCcceec
Confidence 9887 9999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.2e-09 Score=123.22 Aligned_cols=180 Identities=25% Similarity=0.238 Sum_probs=114.8
Q ss_pred hhhhcCCCCCCeEEeecCcCCCCCCCCCCCC-CCCcEEecCCCccc----------CCcccccccccccccccccCCCcc
Q 001908 411 PSSLGNLTLMTDLFLSSNHLQGNIPPSLGNC-KNLVSLNLSDNKLI----------GAVPQQILTITTLSRFLDLGNNHL 479 (997)
Q Consensus 411 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~~p~~~~~l~~ll~~L~Ls~N~l 479 (997)
|-.+....+|++|.|.+..|.. -..+..+ ..|+.|.- +|.+. |.+-..+- ...| ...+.+.|++
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~-Wn~L-~~a~fsyN~L 176 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPV-WNKL-ATASFSYNRL 176 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchh-hhhH-hhhhcchhhH
Confidence 5567778899999999998863 1111111 23444432 22221 11111111 1223 5567788888
Q ss_pred cCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhc
Q 001908 480 NGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFL 559 (997)
Q Consensus 480 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 559 (997)
. ....++.-++.|+.||||+|+++... .+..|+.|+.|||+.|.++-..--....++ |+.|.|++|.++.. ..+
T Consensus 177 ~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gi 250 (1096)
T KOG1859|consen 177 V-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGI 250 (1096)
T ss_pred H-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhH
Confidence 7 56667777788888888888887332 677788888888888888733323444444 88888888888743 456
Q ss_pred cCCCCCCEEeCCCCcCcccCC--CCCcCCCCcceeecCCCCcCC
Q 001908 560 ENLSFLEYLNLSYNHFDGEVP--TKGVFSNKTRVQLTGNGKLCG 601 (997)
Q Consensus 560 ~~l~~L~~L~ls~N~l~~~~p--~~~~~~~~~~~~~~~N~~~C~ 601 (997)
.+|++|+.|||++|-|++.-- ..+.+..+..++++|||.-|.
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 778888888888888875322 224566778888888887773
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.6e-08 Score=121.20 Aligned_cols=227 Identities=21% Similarity=0.216 Sum_probs=109.4
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEee
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS 426 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 426 (997)
.|..|||++|.=-+.+|..+++|.+|++|+|++..++ .+|..+++|..|.+|++..+.-...+|.....|++|++|.+.
T Consensus 572 ~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 572 LLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred ceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEee
Confidence 3333444433333355566666666666666666666 566666666666666666665544555555556666666665
Q ss_pred cCcCC--CCCCCCCCCCCCCcEEecCCCcccCCcc---cccccccccccccccCCCcccCCCccccccccccceeccccc
Q 001908 427 SNHLQ--GNIPPSLGNCKNLVSLNLSDNKLIGAVP---QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGN 501 (997)
Q Consensus 427 ~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 501 (997)
.-... ...-..+.++.+|+.+....... .+- .....+..+.+.+.+..+... ..+..+..+.+|+.|.+.+.
T Consensus 651 ~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~ 727 (889)
T KOG4658|consen 651 RSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDC 727 (889)
T ss_pred ccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcC
Confidence 54422 11222233444444444422221 011 111112222223333333322 34455666677777777776
Q ss_pred cccccccccccCCc------CccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcC
Q 001908 502 QFSGEIPVTLTGCT------GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575 (997)
Q Consensus 502 ~l~~~~p~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 575 (997)
.++........... ++..+...+...- ..+.+....++|+.|++.+......+.+....+..++.+-+..+.+
T Consensus 728 ~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~ 806 (889)
T KOG4658|consen 728 GISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKL 806 (889)
T ss_pred CCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccc
Confidence 66532222211111 1111111111111 1222333446777777776666555555556666666655666666
Q ss_pred ccc
Q 001908 576 DGE 578 (997)
Q Consensus 576 ~~~ 578 (997)
.+.
T Consensus 807 ~~l 809 (889)
T KOG4658|consen 807 EGL 809 (889)
T ss_pred ccc
Confidence 554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.6e-07 Score=94.79 Aligned_cols=134 Identities=26% Similarity=0.211 Sum_probs=97.8
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc--------------------c--hhhHHHHHHHHHHHhhcCCC--
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--------------------Q--KGALKSFVAECEVLRNTRHR-- 736 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~-- 736 (997)
..++.+||.|.-|.||.|... .|.++|||.=+.. + .-.+..+.+|.++|+++.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999997 7899999943210 0 11245678899999999755
Q ss_pred CcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 001908 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816 (997)
Q Consensus 737 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 816 (997)
.+.+.+++ +..++||||++|-.|...-- +......++..|++-+.-.-.. ||||+|+
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~-----------~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLRL-----------DVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecccC-----------cccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 67776665 36789999998865544221 1222334455555555555566 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccch
Q 001908 817 KPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 817 k~~NIll~~~~~~kl~DFg~a~ 838 (997)
.+-||+++++|.+.++||-.+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999997664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.5e-06 Score=87.67 Aligned_cols=144 Identities=19% Similarity=0.144 Sum_probs=106.2
Q ss_pred ccccCcceEEEEEECCCCcEEEEEEeccc-----c-hhhHHHHHHHHHHHhhcCC--CCcceEEeeeeccCcCCCceEEE
Q 001908 687 IGQGSFGSVYKGILGENGTFVAVKILNLM-----Q-KGALKSFVAECEVLRNTRH--RNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-----~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~l 758 (997)
-|+||.+-|++... .|+.+-+|.-... . +-....|.+|...++++.. -.+.+.+ ++............+
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36799999999887 4557889977511 1 3345789999999998853 2345544 332211223455789
Q ss_pred EEeeccC-CCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc--EEEcccc
Q 001908 759 VYEYMQN-GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--AHVSDFG 835 (997)
Q Consensus 759 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFg 835 (997)
|+|-+++ .+|.+++.+... .+.+...+..+..+|++.+.-||.. |+.|+|+.+.||+++.++. ++++||.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 9998854 599999876431 1356677789999999999999999 9999999999999986676 9999998
Q ss_pred cchhc
Q 001908 836 LARFL 840 (997)
Q Consensus 836 ~a~~~ 840 (997)
-++..
T Consensus 176 k~r~~ 180 (216)
T PRK09902 176 KSRRR 180 (216)
T ss_pred ccchh
Confidence 77643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-09 Score=122.28 Aligned_cols=129 Identities=28% Similarity=0.360 Sum_probs=93.9
Q ss_pred CCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccc-cccCCcCccEEE
Q 001908 443 NLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV-TLTGCTGLEIFH 521 (997)
Q Consensus 443 ~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 521 (997)
.|...+.+.|.+. .+...+.-++.+ ++|||++|+++..- .+..+++|+.|||++|.|. .+|. ...++. |+.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~al-e~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPAL-ESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHh-hhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 4666777777776 555555555666 78888888887432 6778888899999999988 5554 344555 89999
Q ss_pred ccCccccccCChhccccCcCCeeeCccccccccCc-hhccCCCCCCEEeCCCCcCcccC
Q 001908 522 MQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIP-EFLENLSFLEYLNLSYNHFDGEV 579 (997)
Q Consensus 522 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~ 579 (997)
+++|.++.. ..+.+|++|+.|||++|-|++.-- ..+..|..|+.|+|.||++.+..
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999988732 357788899999999998875322 33566778889999999987543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-08 Score=90.84 Aligned_cols=59 Identities=20% Similarity=0.330 Sum_probs=26.4
Q ss_pred ccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcccccc
Q 001908 492 NLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552 (997)
Q Consensus 492 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (997)
.++.|+|++|+|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.||..+|.+.
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 3444444444444 34444444444444444444444 34444444444444444444443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=3e-06 Score=87.63 Aligned_cols=110 Identities=27% Similarity=0.281 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhhcC--CCCcceEEeeeeccCcCCCceEEEEEeeccCC-CHHHHhhcCCCCCCcCCCCHHHHHHHHHHH
Q 001908 720 LKSFVAECEVLRNTR--HRNLIKIITVCSSIDFKGADFKALVYEYMQNG-SLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796 (997)
Q Consensus 720 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i 796 (997)
...+.+|...+..+. .=.+++.+++..... ......++|+|++++. +|.+++..... .+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l 127 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRAL 127 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHH
Confidence 346778888877774 333555666543321 1124568999999874 89999987431 3445677899999
Q ss_pred HHHHHHHhhCCCCCcEecCCCCCCeeeCCCC---cEEEcccccchh
Q 001908 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHVSDFGLARF 839 (997)
Q Consensus 797 ~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFg~a~~ 839 (997)
++.++-||.. ||+|+|+++.|||++.++ .+.++||+.++.
T Consensus 128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.1e-06 Score=96.88 Aligned_cols=138 Identities=19% Similarity=0.246 Sum_probs=94.5
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccchh------------------------------h----------HHHHH
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG------------------------------A----------LKSFV 724 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~------------------------------~----------~~~~~ 724 (997)
..|+.++-|.||+|+.+ +|+.||||+.++.-.. . +-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 78999999999999998 6999999988632100 0 11335
Q ss_pred HHHHHHhhc----CCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHh--hcCCCCCCcCCCCHHHHHHHHHHHHH
Q 001908 725 AECEVLRNT----RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCDLSLIQRLNIAIDMAS 798 (997)
Q Consensus 725 ~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~i~~~i~~ 798 (997)
+|+..+.++ +...-+++-.+| ++......++|||++|..+.+.. ++.+ .+. ..++..+++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-------~d~---k~ia~~~~~ 275 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWIDGIKISDIAALKSAG-------IDR---KELAELLVR 275 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEeeCCEecccHHHHHhcC-------CCH---HHHHHHHHH
Confidence 566656554 223333344444 33345679999999998888874 4432 442 334444444
Q ss_pred H-HHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 799 A-IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 799 ~-L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
+ +..+-.. |+.|.|..|.||+++.+|++.+.|||+...+
T Consensus 276 ~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 276 AFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 4 2333344 8999999999999999999999999998765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.8e-08 Score=87.63 Aligned_cols=41 Identities=17% Similarity=0.242 Sum_probs=15.7
Q ss_pred ccccccccceeccccccccccccccccCCcCccEEEccCccc
Q 001908 486 EVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSF 527 (997)
Q Consensus 486 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 527 (997)
++..++.|+.|+++.|.+. ..|..+..+.+|-.|+..+|.+
T Consensus 95 E~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 95 ELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred HHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 3333333333333333333 3333333333333333333333
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 997 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-40 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-40 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-15 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 6e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 7e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 8e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 8e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 9e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 470 bits (1211), Expect = e-152
Identities = 158/551 (28%), Positives = 258/551 (46%), Gaps = 26/551 (4%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
LD+ + G S + + L+ +N+++N F G IP L L+ L LA N F+G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTG 283
Query: 137 KIPTNLS-SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPA-SIGNL 194
+IP LS +C L N+ G +P G S LE ++L+ N+ +G LP ++ +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLKM 342
Query: 195 -SIIYLHVGENQFSGTVPPSLYNMS-SLENILLDVNGFTGNLPLDIG-VTLPNLQVFAIG 251
+ L + N+FSG +P SL N+S SL + L N F+G + ++ LQ +
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 252 DNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDL 311
+N F+G IP + SN S + + L NY +G + G L L L L +N L G
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML-EG----- 456
Query: 312 DFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVN 371
+ L L+ L + N L G +P ++N T + I + N+++G IP IG L N
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNC-TNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 372 LNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ 431
L +L + N +GNIP E+G R+L + L++N G IP+++ + +++N +
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIA 571
Query: 432 GNIPPSLGNCKNLVSLNLSDN--KLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGN 489
G + N + + N + G +Q+ ++T ++ + G N
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR-NPCNITSRVYGGHTSPTFDN 630
Query: 490 LKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549
+++ L +S N SG IP + L I ++ N GSIP + L+ + LDLS N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 550 NLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLP 609
L G+IP+ + L+ L ++LS N+ G +P G F + N LCG LP
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLP 746
Query: 610 SCPSKRSRKST 620
C +
Sbjct: 747 RCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 462 bits (1191), Expect = e-149
Identities = 163/573 (28%), Positives = 261/573 (45%), Gaps = 33/573 (5%)
Query: 25 SFSAHT---NETDRLALLAIKSQLHDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELDL 81
SF A + L++ K L D + W+++ N C + GVTC R +VT +DL
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNKNPCTFDGVTC--RDDKVTSIDL 57
Query: 82 RHQNI---GGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKI 138
+ + ++S + +L+ L + L+ ++ +G + L +L L+ NS SG +
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPV 116
Query: 139 PT--NLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI---GN 193
T +L SCS L N L G LE + L+ N ++G
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 194 L-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGD 252
+ +L + N+ SG V S +LE + + N F+ +P +G LQ I
Sbjct: 177 CGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP-FLG-DCSALQHLDISG 232
Query: 253 NYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD 312
N SG + S + ++++++ N F G I LK+L L L N +G D
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVG--PIPPLPLKSLQYLSLAENKF-TGEIPD-- 287
Query: 313 FVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIP-SGIGNLVN 371
+ C L L N G +P + S + + + N SG +P + +
Sbjct: 288 --FLSGACDTLTGLDLSGNHFYGAVPPFFGSCS-LLESLALSSNNFSGELPMDTLLKMRG 344
Query: 372 LNLLGIEFNQLTGNIPREIGQLR-NLQAIGLSSNFLQGNIPSSLGNLTL--MTDLFLSSN 428
L +L + FN+ +G +P + L +L + LSSN G I +L + +L+L +N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 429 HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVG 488
G IPP+L NC LVSL+LS N L G +P + +++ L L L N L G +P E+
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-DLKLWLNMLEGEIPQELM 463
Query: 489 NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSC 548
+K L L + N +GEIP L+ CT L + N G IP + L+++ L LS
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 549 NNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581
N+ SG IP L + L +L+L+ N F+G +P
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-20
Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 9/117 (7%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
++ + GG SP N + +++++ N G IPKEIG + L L L +N S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 136 GKIPTNLSSCSNL----LSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLP 188
G IP + L LS N L G IP+ + + L I L+ N+L+G +P
Sbjct: 670 GSIPDEVGDLRGLNILDLS----SNKLDGRIPQAMS-ALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-14
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 2/92 (2%)
Query: 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNS 133
+ LD+ + + G + +G++ +L +NL N+ G IP E+G L L L L++N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 134 FSGKIPTNLSSCSNLLSF-VAYRNNLVGEIPE 164
G+IP +S+ + L ++ NNL G IPE
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSN-NNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-06
Identities = 17/61 (27%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 540 SIKELDLSCNNLS---GQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGN 596
+ +DLS L+ + L +L+ LE L LS +H +G V ++ T + L+ N
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
Query: 597 G 597
Sbjct: 111 S 111
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-100
Identities = 104/597 (17%), Positives = 190/597 (31%), Gaps = 71/597 (11%)
Query: 34 DRLALLAIKSQLHDPLGVTN--------SWNNSINLCQWA---GVTCGHRHQRVTELDLR 82
D LAL I L+ +WN + L W GV+ + RVT L L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLE 89
Query: 83 HQNIGGSLSPYVGNLSFLRYINLATNNFHG----EIPKEIGFLFRLETLMLANNSFSGKI 138
G + +G L+ L + L ++ PK I E +
Sbjct: 90 GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149
Query: 139 PTNLS--SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-S 195
S+L+ + I + + LK I N++T + ++ L
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT-LKDTQIGQLSNNITF-VSKAVMRLTK 207
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
+ ++G + F + + E L L +L + +
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWD-NLKDLTDVEVYNCPN 261
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSII--------FGRLKNLWSLDLGINNLGSGG 307
+P +++I++ N + + + + +G NNL +
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321
Query: 308 ANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIG 367
T L KL +L N+L G LP + + + + + NQI+ + G
Sbjct: 322 VE-----TSLQKMKKLGMLECLYNQLEGKLP-AFGSE-IKLASLNLAYNQITEIPANFCG 374
Query: 368 NLVNLNLLGIEFNQLTGNIPR--EIGQLRNLQAIGLSSNFLQG-------NIPSSLGNLT 418
+ L N+L IP + + + AI S N + + +
Sbjct: 375 FTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 419 LMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL-------IGAVPQQILTITTLSRF 471
++ + LS+N + L S+NL N L + + L
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL-TS 492
Query: 472 LDLGNNHLNGSLP-LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQ------G 524
+DL N L L LV + +S N FS P + L+ F ++ G
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 525 NSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581
N P + S+ +L + N++ + N + L++ N +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-53
Identities = 59/402 (14%), Positives = 116/402 (28%), Gaps = 34/402 (8%)
Query: 79 LDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSF---- 134
+ + + NL L + + ++P + L ++ + +A N
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 135 ----SGKIPTNLSSCSNLLSFVAYRNNL-VGEIPEDIGYSWLKLEHISLARNHLTGMLPA 189
+ + + NNL + + KL + N L G
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEG-KLP 347
Query: 190 SIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGV-TLPNLQV 247
+ G+ + L++ NQ + +EN+ N +P ++ +
Sbjct: 348 AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSA 406
Query: 248 FAIGDNYFSG-------SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300
N + + N+ I+L N + +F L S++L
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466
Query: 301 NNLGSGGANDLDFVTI-LTNCSKLKVLAFEENRLGGVLPHSIANLS-TTMTDIYMGVNQI 358
N L N L N L + N+L L + + I + N
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF 525
Query: 359 SGTIPSGIGNLVNLNLLGIE------FNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPS 412
S P+ N L GI N+ P I +L + + SN ++ +
Sbjct: 526 SK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE 583
Query: 413 SLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL 454
+ ++ L + N + L +K
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-47
Identities = 72/405 (17%), Positives = 132/405 (32%), Gaps = 52/405 (12%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFH--------GEIPKEIGFLFRLETLM 128
T++++ + L ++ L ++ IN+A N + + +++ +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 129 LANNSF-SGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGML 187
+ N+ + + T+L L N L G++P G S +KL ++LA N +T +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FG-SEIKLASLNLAYNQITEIP 369
Query: 188 PASIGNL-SIIYLHVGENQFSGTVPPSL--YNMSSLENILLDVNGFTG-------NLPLD 237
G + L N+ +P ++S + I N L
Sbjct: 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 238 IGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTG-------KVSIIFGRL 290
N+ + +N S E FS S + I+L N T + F
Sbjct: 429 PF-KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 291 KNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLST---- 346
L S+DL N L + ++D T L + N P N ST
Sbjct: 488 YLLTSIDLRFNKL-TKLSDDFRA----TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541
Query: 347 -TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF 405
N+ P GI +L L I N + + +I N+ + + N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNP 598
Query: 406 LQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLS 450
S + L + Q + + +L++
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKTQ--------DIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-38
Identities = 36/227 (15%), Positives = 79/227 (34%), Gaps = 16/227 (7%)
Query: 367 GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGN----IPSSLGNLTLMTD 422
G + L+L E +G +P IGQL L+ + L S+ + N P +
Sbjct: 81 GRVTGLSL---EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 423 LFLSSNHLQGNIPPSLG--NCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLN 480
H Q + +L+ ++ + ++ + ++ + +N++
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ-IGQLSNNI- 195
Query: 481 GSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKS 540
+ V L L Y+ + F E E + L +LK
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKD 250
Query: 541 IKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSN 587
+ ++++ ++P FL+ L ++ +N++ N K +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 1e-97
Identities = 85/308 (27%), Positives = 130/308 (42%), Gaps = 14/308 (4%)
Query: 311 LDFVTILTNCSKL----KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT--IPS 364
L L N + L GVL + + + ++ + + IPS
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70
Query: 365 GIGNLVNLNLLGI-EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDL 423
+ NL LN L I N L G IP I +L L + ++ + G IP L + + L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 424 FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
S N L G +PPS+ + NLV + N++ GA+P + + L + + N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 484 PLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKE 543
P NL NL + +S N G+ V + H+ NS + + K++
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 544 LDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGS 603
LDL N + G +P+ L L FL LN+S+N+ GE+P G N LCG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307
Query: 604 NELHLPSC 611
LP+C
Sbjct: 308 ---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-70
Identities = 75/323 (23%), Positives = 125/323 (38%), Gaps = 43/323 (13%)
Query: 30 TNETDRLALLAIKSQLHDPLGVTNSWNNSINLCQ--WAGVTCGHRHQ--RVTELDLRHQN 85
N D+ ALL IK L +P +SW + + C W GV C Q RV LDL N
Sbjct: 3 CNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 86 IGGSLS---------------------------PYVGNLSFLRYINLATNNFHGEIPKEI 118
+ P + L+ L Y+ + N G IP +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 119 GFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISL 178
+ L TL + N+ SG +P ++SS NL+ N + G IP+ G +++
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 179 ARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDI 238
+RN LTG +P + NL++ ++ + N G + + + I L N +L +
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KV 240
Query: 239 GVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDL 298
G NL + +N G++P+ + + +++ N G++ G L+
Sbjct: 241 G-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAY 298
Query: 299 GINNLGSGGANDLDFVTILTNCS 321
N G L C+
Sbjct: 299 ANNKCLCGS--------PLPACT 313
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 3e-84
Identities = 97/536 (18%), Positives = 178/536 (33%), Gaps = 27/536 (5%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
LDL + S + L+ ++L+ L L TL+L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM-LPASIGNL 194
S S+L VA NL IG L+ +++A N + LP NL
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 195 -SIIYLHVGENQFSGTVPPSLYNMSSLENIL----LDVNGFTGNLPLDIGVTLPNLQVFA 249
++ +L + N+ L + + + L +N P L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK--EIRLHKLT 206
Query: 250 IGDNYFSGSIPE-SFSNASNIEIIDLPINYFTGKVSI---IFGRLKNLWSLDLGINNLGS 305
+ +N+ S ++ + + +E+ L + F + ++ L+ L +L + L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 306 GGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSG 365
D + + + + + + V S + + + +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFGQFPTLK 323
Query: 366 IGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQ--GNIPSSLGNLTLMTDL 423
+ +L L F G L +L+ + LS N L G S T + L
Sbjct: 324 LKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 424 FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
LS N + + + + L L+ + L + +LD+ + H +
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 484 PLEVGNLKNLVALYISGNQFSGEI-PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIK 542
L +L L ++GN F P T L + P + SL S++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 543 ELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT--KGVFSNKTRVQLTGN 596
L++S NN + L+ L+ L+ S NH + S+ + LT N
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 2e-78
Identities = 93/520 (17%), Positives = 175/520 (33%), Gaps = 36/520 (6%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
LDL I +LS L + L N L L+ L+ + +
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS- 195
+ L N + + + LEH+ L+ N + + + L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 196 ----IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIG 251
+ L + N + + P + L + L N + N+ L L+V +
Sbjct: 175 MPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 252 DNYFSGS------IPESFSNASNIEIIDLPINYFTGKVSII---FGRLKNLWSLDLGINN 302
F + N+ I + + Y + I F L N+ S L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 303 LGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTI 362
+ V + + L + G + +L + G
Sbjct: 294 IER--------VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK------RLTFTSNKGGN 339
Query: 363 PSGIGNLVNLNLLGIEFNQLT--GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLM 420
+L +L L + N L+ G + +L+ + LS N + + S+ L +
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398
Query: 421 TDLFLSSNHLQGNIPPS-LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHL 479
L ++L+ S + +NL+ L++S A +++L L + N
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSF 457
Query: 480 NGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSL 538
+ ++ L+NL L +S Q P + L++ +M N+F + L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 517
Query: 539 KSIKELDLSCNNLSGQIPEFLENL-SFLEYLNLSYNHFDG 577
S++ LD S N++ + L++ S L +LNL+ N F
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 3e-68
Identities = 100/528 (18%), Positives = 177/528 (33%), Gaps = 39/528 (7%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSF-S 135
+ L L I LS L+ + N IG L L+ L +A+N S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGY---SWLKLEHISLARNHLTGMLPASIG 192
K+P S+ +NL N + D+ L + L+ N + + P +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 193 NLSIIYLHVGENQFSGTVPP-SLYNMSSLENILLDVNGFTG--NLPLDIGVTLPNLQVFA 249
+ + L + N S V + ++ LE L + F NL L L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 250 IGDNYFS------GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNL 303
I + + I + F+ +N+ L + L+L
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKF 316
Query: 304 GSGGANDLDFVTILT-------------NCSKLKVLAFEENRLG--GVLPHSIANLSTTM 348
G L + LT + L+ L N L G S T++
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT-TSL 375
Query: 349 TDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQ 407
+ + N + T+ S L L L + + L + LRNL + +S +
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 408 GNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKLIGAVPQQILTIT 466
L+ + L ++ N Q N P +NL L+LS +L P +++
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 467 TLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGC-TGLEIFHMQGN 525
+L + L++ +N+ L +L L S N L + L ++ N
Sbjct: 495 SL-QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 526 SFRGSIPLS--LRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571
F + L+ +K ++L + + P + + L LN++
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-LNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-53
Identities = 70/425 (16%), Positives = 134/425 (31%), Gaps = 42/425 (9%)
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
S L + N S ++ L+ + L +L +L + N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ-SLSHLSTLILTGNP 87
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314
+FS S+++ + + G LK L L++ N + S +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY--- 144
Query: 315 TILTNCSKLKVLAFEENRLGGVLPHSIA---NLSTTMTDIYMGVNQISGTIPSGIGNLVN 371
+N + L+ L N++ + + + + + +N ++ I G +
Sbjct: 145 --FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIR 201
Query: 372 LNLLGIEFNQLTGNIPRE-IGQLRNLQAIGLSSNFLQGN------IPSSLGNLTLMTDLF 424
L+ L + N + N+ + I L L+ L + S+L L +T
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 425 LSSNHL---QGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILT----------------I 465
+L +I N+ S +L +
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 466 TTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQ--FSGEIPVTLTGCTGLEIFHMQ 523
L L G +L +L L +S N F G + G T L+ +
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 524 GNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIP-EFLENLSFLEYLNLSYNHFDGEVPTK 582
N + + L+ ++ LD +NL +L L YL++S+ H
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN-- 438
Query: 583 GVFSN 587
G+F+
Sbjct: 439 GIFNG 443
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-45
Identities = 66/368 (17%), Positives = 118/368 (32%), Gaps = 45/368 (12%)
Query: 243 PNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINN 302
+ + + N SF + ++++DL + L +L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 303 LGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQI-SGT 361
+ S S L+ L E L + I +L T+ ++ + N I S
Sbjct: 88 IQSLALGAFS------GLSSLQKLVAVETNLASLENFPIGHL-KTLKELNVAHNLIQSFK 140
Query: 362 IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIG----LSSNFLQGNIPSSLGNL 417
+P NL NL L + N++ ++ L + + LS N + P + +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 418 TLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS--RFLDL 474
L L L +N N+ + L L + + + L L +
Sbjct: 201 RL-HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 475 GNNHLN------GSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSF- 527
L + L N+ + + + G + + F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFG 317
Query: 528 ------------------RGSIPLSLRSLKSIKELDLSCNNLS--GQIPEFLENLSFLEY 567
+G S L S++ LDLS N LS G + + L+Y
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 568 LNLSYNHF 575
L+LS+N
Sbjct: 378 LDLSFNGV 385
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-37
Identities = 42/263 (15%), Positives = 82/263 (31%), Gaps = 34/263 (12%)
Query: 343 NLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLS 402
NL + ++ + N + + L +L + ++ L +L + L+
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 403 SNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQI 462
N +Q + L+ + L +L +G+ K L LN++ N +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS------ 138
Query: 463 LTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIF-- 520
LP NL NL L +S N+ L + +
Sbjct: 139 ------------------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 521 --HMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE-FLENLSFLEYLNLSYNHFDG 577
+ N P + + + + +L L N S + + ++ L+ LE L F
Sbjct: 181 SLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 578 ----EVPTKGVFSNKTRVQLTGN 596
E K + +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEF 262
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 25/142 (17%), Positives = 47/142 (33%), Gaps = 5/142 (3%)
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495
P + N+ + +P + T LDL N L + L
Sbjct: 2 PCVEVVPNIT-YQCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQV 56
Query: 496 LYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555
L +S + + L + GN + + L S+++L NL+
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 556 PEFLENLSFLEYLNLSYNHFDG 577
+ +L L+ LN+++N
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 23/129 (17%), Positives = 45/129 (34%), Gaps = 2/129 (1%)
Query: 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNS 133
+ +T LDL + +LS L+ +N++ NNF L L+ L + N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 134 FSGKIPTNLSSC-SNLLSFVAYRNNLVGEIPEDIGYSWLK-LEHISLARNHLTGMLPASI 191
L S+L +N+ W+K + + + P+
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 192 GNLSIIYLH 200
+ ++ L+
Sbjct: 590 QGMPVLSLN 598
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 6e-81
Identities = 105/321 (32%), Positives = 161/321 (50%), Gaps = 40/321 (12%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECE 728
S EL A++ FS+ N++G+G FG VYKG L +GT VAVK L +G F E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 729 VLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQ 788
++ HRNL+++ C + + LVY YM NGS+ L + L +
Sbjct: 80 MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPP--LDWPK 132
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
R IA+ A + YLH HC P I+H D+K +N+LLD + A V DFGLA+ + + DT
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DTH 190
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
+ T ++GT+G++ P EY ++S DV+ GVMLLE+ T +R
Sbjct: 191 VTTA-----VRGTIGHIAP------------EYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 909 PTNCMF---QGGLTLHEFCKMALPE-KVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIG 964
+ + L ++ K L E K+ VD L + +E + +I++
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--------QGNYKDEEVEQLIQVA 285
Query: 965 VACSMESPIERMEMRDVLAKL 985
+ C+ SP+ER +M +V+ L
Sbjct: 286 LLCTQSSPMERPKMSEVVRML 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 4e-80
Identities = 100/547 (18%), Positives = 185/547 (33%), Gaps = 30/547 (5%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
L+L+H + + L ++L +N+ L TL L++N S
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWL-KLEHISLARNHLTGMLPASIGNL- 194
NL + N + E++ L+ + L+ N + P +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 195 SIIYLHVGENQFSGTVPPSL---YNMSSLENILLDVNGFTGNLPLDI-GVTLPNLQVFAI 250
+ L + Q ++ L +S+ N+ L + + G+ NL + +
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 251 GDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGAND 310
N + +SF+ +E L N S L N+ L+L + +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK-RSFTKQSISL 314
Query: 311 LDFVTI----LTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI 366
I L+ L E+N + G+ + L + + + + S +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNE 373
Query: 367 --GNLVNLNL--LGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIP-SSLGNLTLMT 421
+L + L L + N+++ L +L+ + L N + + L +
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 422 DLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL--IGAVPQQILTITTLSRFLDLGNNHL 479
+++LS N S +L L L L + + P + L LDL NN++
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL-TILDLSNNNI 492
Query: 480 NGSLPLEVGNLKNLVALYISGNQFS--------GEIPVTLTGCTGLEIFHMQGNSFRGSI 531
+ L+ L L + N + G L G + L I +++ N F
Sbjct: 493 ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT--KGVFSNKT 589
+ L +K +DL NNL+ N L+ LNL N F N T
Sbjct: 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT 612
Query: 590 RVQLTGN 596
+ + N
Sbjct: 613 ELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 1e-78
Identities = 107/543 (19%), Positives = 189/543 (34%), Gaps = 41/543 (7%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
TEL L +I + L ++L+ N L L+ L+L+NN
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 137 KIPTNLS--SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIG-- 192
L + S+L N + P + +L + L L L +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFH-AIGRLFGLFLNNVQLGPSLTEKLCLE 218
Query: 193 --NLSIIYLHVGENQFSGTVPPSLYNM--SSLENILLDVNGFTGNLPLDIGVTLPNLQVF 248
N SI L + +Q S T + + ++L + L N LP L+ F
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA-WLPQLEYF 277
Query: 249 AIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSI---------IFGRLKNLWSLDLG 299
+ N S N+ ++L ++ +S+ F LK L L++
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 300 INNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTD---IYMGVN 356
N++ +N + T LK L+ + + +S + + + N
Sbjct: 338 DNDIPGIKSN------MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391
Query: 357 QISGTIPSGIGNLVNLNLLGIEFNQLTGNIP-REIGQLRNLQAIGLSSNFLQGNIPSSLG 415
+IS L +L +L + N++ + +E L N+ I LS N +S
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 416 NLTLMTDLFLSSNHLQG--NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLD 473
+ + L L L+ + P +NL L+LS+N + + + L LD
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILD 510
Query: 474 LGNNHLN--------GSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGN 525
L +N+L G + L +L L + N F L+I + N
Sbjct: 511 LQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE-FLENLSFLEYLNLSYNHFDGEVPTKGV 584
+ + S+K L+L N ++ + F L L++ +N FD +
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 585 FSN 587
F N
Sbjct: 631 FVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 2e-76
Identities = 95/521 (18%), Positives = 177/521 (33%), Gaps = 52/521 (9%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+T L+L H + + S L +++ N P+ L L+ L L +N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL- 194
+ C+N L + L N + +
Sbjct: 87 QLSDKTFAFCTN-------------------------LTELHLMSNSIQKIKNNPFVKQK 121
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGV-TLPNLQVFAIGDN 253
++I L + N S T + + +L+ +LL N ++ + +L+ + N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 254 YFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFG---RLKNLWSLDLGINNLGSGGAND 310
P F + + L ++ ++ +L L + L +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 311 LDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLV 370
+ L +L N L V S A L + ++ N I + L
Sbjct: 242 FLG----LKWTNLTMLDLSYNNLNVVGNDSFAWL-PQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 371 NLNLL---------GIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMT 421
N+ L I L L+ L+ + + N + G + L +
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356
Query: 422 DLFLSSNHLQGNIPPSLG----NCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNN 477
L LS++ + L LNL+ NK+ + L LDLG N
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL-EVLDLGLN 415
Query: 478 HLNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG--SIPLS 534
+ L + L+N+ +Y+S N++ + L+ ++ + + S P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 535 LRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
+ L+++ LDLS NN++ + LE L LE L+L +N+
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 1e-72
Identities = 87/507 (17%), Positives = 171/507 (33%), Gaps = 29/507 (5%)
Query: 100 LRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLV 159
+ + ++P ++ + L L +N N + S L S N +
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 160 GEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMS 218
PE L+ ++L N L+ + + ++ LH+ N
Sbjct: 63 KLEPELCQ-KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASN--IEIIDLPI 276
+L + L NG + L V L NLQ + +N E +N ++ ++L
Sbjct: 122 NLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 277 NYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGV 336
N F + L+ L L LG + + + + + ++ L+ ++L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGP---SLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 337 LPHSIANLS-TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRN 395
+ L T +T + + N ++ L L +E+N + + L N
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 396 LQAIGLSSNFLQGNI---------PSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVS 446
++ + L +F + +I S L + L + N + G NL
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 447 LNLSDNKL-IGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQF 503
L+LS++ + + + S L+L N ++ L +L L + N+
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 504 SGEIPV-TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSG--QIPEFLE 560
E+ G + ++ N + S + S++ L L L P +
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 561 NLSFLEYLNLSYNHFDGEVPTKGVFSN 587
L L L+LS N+ +
Sbjct: 478 PLRNLTILDLSNNNIANIND--DMLEG 502
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-55
Identities = 77/392 (19%), Positives = 141/392 (35%), Gaps = 28/392 (7%)
Query: 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY 278
S E T +P D+ N+ V + N +F+ S + +D+ N
Sbjct: 5 SHEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 279 FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLP 338
+ + +L L L+L N L C+ L L N + +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDK------TFAFCTNLTELHLMSNSIQKIKN 114
Query: 339 HSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIG--QLRNL 396
+ + + + N +S T L NL L + N++ E+ +L
Sbjct: 115 NPFVKQ-KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 397 QAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLG---NCKNLVSLNLSDNK 453
+ + LSSN ++ P + + LFL++ L ++ L ++ +L+LS+++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 454 LIGAVPQQI--LTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTL 511
L L T L LDL N+LN L L ++ N +L
Sbjct: 234 LSTTSNTTFLGLKWTNL-TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 512 TGCTGLEIFHMQGNSFRGSI---------PLSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
G + +++ + + SI S + LK ++ L++ N++ G L
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 563 SFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLT 594
L+YL+LS + T F + L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 8e-51
Identities = 73/446 (16%), Positives = 147/446 (32%), Gaps = 40/446 (8%)
Query: 56 NNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSF--LRYINLATNNFHGE 113
N + + + + L L + + + + L + L ++L+ NN +
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 114 IPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKL 173
+L +LE L N+ +L N+ R+
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS----------------F 307
Query: 174 EHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFT- 231
S++ L + S L + +L++ +N G + +L+ + L + +
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
Query: 232 GNLPLDI--GVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSI-IFG 288
L + + L + + N S ++FS ++E++DL +N +++ +
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 289 RLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGV--LPHSIANLST 346
L+N++ + L N L+ L L V P L
Sbjct: 428 GLENIFEIYLSYNKY------LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL-R 480
Query: 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLT--------GNIPREIGQLRNLQA 398
+T + + N I+ + L L +L ++ N L G + L +L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 399 IGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAV 458
+ L SN +L + + L N+L N +L SLNL N +
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 459 PQQILTITTLSRFLDLGNNHLNGSLP 484
+ LD+ N + +
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 269 bits (688), Expect = 1e-76
Identities = 105/651 (16%), Positives = 193/651 (29%), Gaps = 94/651 (14%)
Query: 31 NETDRLALLAIKSQLH-----------DPLGVTNSWNNSINLCQWA---GVTCGHRHQRV 76
D AL AI L + + +WN + L W GV + + RV
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRV 325
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
T L L G + +G L+ L+ ++ T++ + +
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYS-----WLKLEHISLARNHLTGMLPASI 191
L+ + + PE LK I N +T + +I
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAI 444
Query: 192 GNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAI 250
L + ++ + F+ ++ E+ D N L L +L +
Sbjct: 445 QRLTKLQIIYFANSPFTY-DNIAV----DWEDANSDYAKQYENEELSWS-NLKDLTDVEL 498
Query: 251 GDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSII---------FGRLKNLWSLDLGIN 301
+ +P+ + ++ +++ N + + +G N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT 361
NL L KL +L N++ + + +TD+ + NQI
Sbjct: 559 NLEE-----FPASASLQKMVKLGLLDCVHNKVRHL--EAFGTN-VKLTDLKLDYNQIE-E 609
Query: 362 IPSGIG-NLVNLNLLGIEFNQLTGNIPR--EIGQLRNLQAIGLSSNFLQG---NIPSSLG 415
IP + LG N+L IP + + ++ S N + NI S+
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 416 NLTL--MTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL-------IGAVPQQILTIT 466
+ + + LS N +Q + ++ LS+N + +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 467 TLSRFLDLGNNHLNGSLP--LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQG 524
L +DL N L SL L L + +S N FS P + L+ F ++
Sbjct: 729 LL-TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRH 785
Query: 525 NSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGV 584
D N + Q P + L L + N +V + +
Sbjct: 786 Q------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVD-EKL 825
Query: 585 FSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRLGKVGIPMIVSC 635
+ + N + + + S VL I C
Sbjct: 826 TPQLYILDIADNPNI-----SIDVTSVCPYIEAGMYVLLYD--KTQDIRGC 869
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-53
Identities = 73/530 (13%), Positives = 159/530 (30%), Gaps = 52/530 (9%)
Query: 3 NSISITCLATFIFSFSLLLHSQSFSAHTNETDRLALLAIKSQLHDPLGVTNSWNNSINLC 62
+S +++ + + + ++ L + L +++ ++IN
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR-----LNLSDLLQDAINRN 411
Query: 63 QWAGVTCGHRHQRVTELDL-RHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFL 121
+ + + N +S + L+ L+ I A + F +
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD--- 468
Query: 122 FRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARN 181
E + S+ +L Y + ++P+ + +L+ +++A N
Sbjct: 469 --WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL-PELQSLNIACN 525
Query: 182 HLTGM---------LPASIGNL-SIIYLHVGENQFSG-TVPPSLYNMSSLENILLDVNGF 230
L I ++G N SL M L + N
Sbjct: 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV 585
Query: 231 TGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSII-FGR 289
+L G T L + N + + +E + N +I
Sbjct: 586 R-HLE-AFG-TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKS 642
Query: 290 LKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMT 349
+ + S+D N +GS G N + + N + A + ++
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDY-KGINASTVTLSYNEIQKFPTELFATG-SPIS 700
Query: 350 DIYMGVNQIS-------GTIPSGIGNLVNLNLLGIEFNQLTGNIPREI--GQLRNLQAIG 400
I + N ++ N L + + FN+LT + + L L +
Sbjct: 701 TIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMD 759
Query: 401 LSSNFLQGNIPSSLGNLTLMTDL------FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL 454
+S N P+ N + + N + P + C +L+ L + N +
Sbjct: 760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818
Query: 455 IGAVPQQILTITTLSRFLDLGNNHL-NGSLPLEVGNLK-NLVALYISGNQ 502
V +++ L LD+ +N + + ++ + L Q
Sbjct: 819 RK-VDEKLT--PQL-YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 3e-72
Identities = 104/340 (30%), Positives = 149/340 (43%), Gaps = 41/340 (12%)
Query: 648 RRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFV 707
SS VP E Y V +L EATN F +IG G FG VYKG+L +G V
Sbjct: 10 NSINDALSSSYLVPFESYR--VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKV 66
Query: 708 AVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGS 767
A+K ++ F E E L RH +L+ +I C + L+Y+YM+NG+
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGN 121
Query: 768 LEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827
L+ L+ S+ +S QRL I I A + YLH I+H D+K N+LLD +
Sbjct: 122 LKRHLYGSDLPTMS--MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENF 176
Query: 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA 887
V ++DFG+++ T + T +KGT+GY+ P EY +
Sbjct: 177 VPKITDFGISK-KGTELDQTHLSTV-----VKGTLGYIDP------------EYFIKGRL 218
Query: 888 SVTGDVYSLGVMLLEMFTRRRPTNCMFQGG-LTLHEFCKMALPE-KVMETVDPSLLLAWS 945
+ DVYS GV+L E+ R + L E+ + ++ + VDP+L
Sbjct: 219 TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR 278
Query: 946 DGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
E L V C S +R M DVL KL
Sbjct: 279 --------PESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-67
Identities = 102/538 (18%), Positives = 180/538 (33%), Gaps = 47/538 (8%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
L+ + + L L +++L + RL+TL+L N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVG-----------------------EIPEDIGYSWLK 172
T LS L + + I G+ K
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 173 LEHISLARNHLTGMLPASIG---NLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNG 229
L+ + N + + + + + L++ N + + P ++ + +++
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQ 213
Query: 230 FTGNLPLDI-GVTLPNLQVFAIGDNYFSGSIPESFSN--ASNIEIIDLPINYFTGKVSII 286
+ + T+ +L + D P F ++E I+L +YF S
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 287 FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLST 346
F L LDL +L + L S LK L N+ + S +N
Sbjct: 274 FHCFSGLQELDLTATHLSE-------LPSGLVGLSTLKKLVLSANKFENLCQISASNF-P 325
Query: 347 TMTDIYMGVNQISGTIPSG-IGNLVNLNLLGIEFNQLT--GNIPREIGQLRNLQAIGLSS 403
++T + + N + +G + NL NL L + + + ++ L +LQ++ LS
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 404 NFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS-LGNCKNLVSLNLSDNKLIGAVPQQI 462
N + + L L+ L+ S N L LNLS + L + Q
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445
Query: 463 LTITTLSRFLDLGNNHLNGSLPLEVG---NLKNLVALYISGNQFSGEIPVTLTGCTGLEI 519
+ L + L+L NH + L L L +S S T +
Sbjct: 446 DGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 520 FHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG 577
+ N S +L LK I L+L+ N++S +P L LS +NL N D
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-64
Identities = 86/539 (15%), Positives = 179/539 (33%), Gaps = 30/539 (5%)
Query: 68 TCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETL 127
C + T + + + + + + + N L L L
Sbjct: 7 KCIEKEVNKT-YNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 128 MLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWL-KLEHISLARNHLTGM 186
L S L + V N L+ + S L+H+ + ++ +
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL--SGPKALKHLFFIQTGISSI 120
Query: 187 LPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNL 245
+ N ++ L++G N S P + L+ + N D+ L
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS-LQQA 179
Query: 246 QVFAIGDNY-FSGSIPESFSNASNIEIIDLPINYFTGKV--SIIFGRLKNLWSLDLGINN 302
++ N I +++ + ++ + + +++LW +
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 303 LGSGGANDLDFVTILTNC-SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT 361
D+ C ++ + +++ + ++ + + ++ + +S
Sbjct: 240 D-----EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF-SGLQELDLTATHLS-E 292
Query: 362 IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPS-SLGNLTLM 420
+PSG+ L L L + N+ +L + + N + + + L NL +
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 421 TDLFLSSNHLQ--GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNH 478
+L LS + ++ L N +L SLNLS N+ + + L LDL
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL-ELLDLAFTR 411
Query: 479 LNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPL---S 534
L NL L L +S + G L+ ++QGN F S
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 535 LRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQL 593
L++L ++ L LS +LS +L + +++LS+N S+ + L
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSHLKGIYL 528
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-50
Identities = 84/470 (17%), Positives = 149/470 (31%), Gaps = 25/470 (5%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
L I + N L + L +N+ + +L+ L NN+
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 137 KIPTNLSSCSNL-LSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS 195
++SS + N + I S + ++ ++ + N +
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 196 IIYLHVGE------NQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFA 249
I L +G S V L MS +E+I L + F + + LQ
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMS-VESINLQKHYFFN-ISSNTFHCFSGLQELD 284
Query: 250 IGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGAN 309
+ + S +P S ++ + L N F I +L L + N
Sbjct: 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 310 DLDFVTILTNCSKLKVLAFEENRLG--GVLPHSIANLSTTMTDIYMGVNQISGTIPSGIG 367
L N L+ L + + + NL + + + + N+
Sbjct: 344 G-----CLENLENLRELDLSHDDIETSDCCNLQLRNL-SHLQSLNLSYNEPLSLKTEAFK 397
Query: 368 NLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS 426
L LL + F +L + L L+ + LS + L + L + L L
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 427 SNHLQGNI---PPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
NH SL L L LS L + Q T + +DL +N L S
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 484 PLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPL 533
+ +LK + L ++ N S +P L + +++ N +
Sbjct: 517 IEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-65
Identities = 93/328 (28%), Positives = 140/328 (42%), Gaps = 54/328 (16%)
Query: 670 SYSELSEATNEFSS------SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA---- 719
S+ EL TN F N +G+G FG VYKG + N T VAVK L M
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73
Query: 720 LKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP 779
+ F E +V+ +H NL++++ S D LVY YM NGSL + L +G P
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 780 EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
LS R IA A+ I +LH + +H D+K +N+LLD A +SDFGLAR
Sbjct: 129 P---LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR- 181
Query: 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM 899
+ T M ++ I GT Y+ P E + E + D+YS GV+
Sbjct: 182 ASEKFAQTVMTSR-----IVGTTAYMAP------------EA-LRGEITPKSDIYSFGVV 223
Query: 900 LLEMFTRRRPTNCMFQGGLTLHEFCKMALPEK--VMETVDPSLLLAWSDGRRRAKVEECL 957
LLE+ T + + L + + E+ + + +D + +
Sbjct: 224 LLEIITGLPAVD-EHREPQLLLDIKEEIEDEEKTIEDYIDKKM---------NDADSTSV 273
Query: 958 VTVIRIGVACSMESPIERMEMRDVLAKL 985
+ + C E +R +++ V L
Sbjct: 274 EAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 8e-62
Identities = 94/542 (17%), Positives = 173/542 (31%), Gaps = 58/542 (10%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+DL + S N S L++++L+ K L L L+L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM-LPASIGNL 194
P + S ++L + VA L IG + L+ +++A N + LPA NL
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQL-ITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 195 -SIIYLHVGENQFSG---------------------------TVPPSLYNMSSLENILLD 226
+++++ + N + + L + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 227 VNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNAS--------NIEIIDLPINY 278
N + N+ L L V + F S I+ L
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 279 FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLP 338
+ F L N+ ++ L ++ + + K + L+ +L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--------LEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 339 HSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLT--GNIPREIGQLRNL 396
+ L + + + +N+ S I L +L+ L + N L+ G +L
Sbjct: 325 LDLPFLKS----LTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 397 QAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS-LGNCKNLVSLNLSDNKLI 455
+ + LS N + ++ L + L + L+ S + + L+ L++S
Sbjct: 379 RHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 456 GAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTGC 514
L +T+L L + N + V N NL L +S Q
Sbjct: 438 IDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 515 TGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574
L++ +M N+ L S+ LD S N + L + NL+ N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 575 FD 576
Sbjct: 557 VA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 6e-51
Identities = 86/508 (16%), Positives = 161/508 (31%), Gaps = 28/508 (5%)
Query: 98 SFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNN 157
S + I+L+ N L+ L L+ +L + + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 158 LVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSG-TVPPSLY 215
+ LE++ L + IG L ++ L+V N +P
Sbjct: 92 IQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 216 NMSSLENILLDVNGFTGNLPLDIGV---TLPNLQVFAIGDNYFSGSIPESFSNASNIEII 272
N+++L ++ L N D+ + N ++F + +
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHEL 209
Query: 273 DLPINYFTGKV-SIIFGRLKNLWSLDLGINNLGSG---GANDLDFVTILTNCSKLKVLAF 328
L N+ + + L L L + + + L + +
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID-EFRL 268
Query: 329 EENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPR 388
L+ ++ + + I + L I QL
Sbjct: 269 TYTNDFSDDIVKFHCLA-NVSAMSLAGVSIK-YLEDVP-KHFKWQSLSIIRCQLKQF--- 322
Query: 389 EIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ--GNIPPSLGNCKNLVS 446
L L+++ L+ N +G+I L ++ L LS N L G S +L
Sbjct: 323 PTLDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 447 LNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSG 505
L+LS N I + + + L + LD ++ L +L+ L+ L IS
Sbjct: 381 LDLSFNGAII-MSANFMGLEEL-QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 506 EIPVTLTGCTGLEIFHMQGNSFRGSIPLS-LRSLKSIKELDLSCNNLSGQIPEFLENLSF 564
+ G T L M GNSF+ + + + ++ LDLS L + L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 565 LEYLNLSYNHFDGEVPTKGVFSNKTRVQ 592
L+ LN+S+N+ ++ +
Sbjct: 499 LQLLNMSHNNLLFLDS--SHYNQLYSLS 524
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-35
Identities = 76/431 (17%), Positives = 137/431 (31%), Gaps = 38/431 (8%)
Query: 208 GTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNAS 267
G++ P + + ++ + +P DI + + + N SFSN S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 268 NIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLA 327
++ +DL + L +L +L L N + S + + L+ L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG------SFSGLTSLENLV 110
Query: 328 FEENRLGGVLPHSIANLSTTMTDIYMGVNQISG-TIPSGIGNLVNLNLLGIEFNQLTGNI 386
E +L + I L T+ + + N I +P+ NL NL + + +N +
Sbjct: 111 AVETKLASLESFPIGQL-ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169
Query: 387 PREIGQLRNLQA----IGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNC 441
++ LR + +S N + + + L +L L N NI L N
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKL-HELTLRGNFNSSNIMKTCLQNL 228
Query: 442 KNLVSLNLSDNKLIGAVPQQILTITTLSRF-------LDLGNNHLNGSLPLEVGNLKNLV 494
L L + +I + + L + ++ L N+
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288
Query: 495 ALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554
A+ ++G + + + + L L L K L L+ N S
Sbjct: 289 AMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL---KSLTLTMNKGS-- 341
Query: 555 IPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSK 614
I L L YL+LS N +S+ L L N + S
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGC--CSYSDLGTNSLR---HLDLSFNGAIIMSANFM 396
Query: 615 RSRKSTVLRLG 625
+ L
Sbjct: 397 GLEELQHLDFQ 407
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-23
Identities = 51/335 (15%), Positives = 109/335 (32%), Gaps = 46/335 (13%)
Query: 75 RVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSF 134
+ E L + N L+ + ++LA + + +++ F+ ++L +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 135 SGKIPTNLSSCSNL-LSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGN 193
+L +L L+ N + + L ++ L+RN L+ S +
Sbjct: 320 KQFPTLDLPFLKSLTLT-----MNKGSISFKKVALP--SLSYLDLSRNALSFSGCCSYSD 372
Query: 194 L---SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAI 250
L S+ +L + N + + + L+++ + ++L L I
Sbjct: 373 LGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
Query: 251 GDNYFSGSIPESFSNASNIEIIDLPINYFTGKV-SIIFGRLKNLWSLDLGINNLGSGGAN 309
F +++ + + N F S +F NL LDL L
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 310 DLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNL 369
+ +L++L N+S N + S L
Sbjct: 492 ------VFDTLHRLQLL----------------NMSH---------NNLLFLDSSHYNQL 520
Query: 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSN 404
+L+ L FN++ + ++L L++N
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-59
Identities = 74/337 (21%), Positives = 125/337 (37%), Gaps = 59/337 (17%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV 729
L + + +G FG V+K L +VAVKI +S+ E EV
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP---IQDKQSWQNEYEV 69
Query: 730 --LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLI 787
L +H N+++ I D L+ + + GSL ++L + +S
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANV-------VSWN 121
Query: 788 QRLNIAIDMASAIEYLHHH-------CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
+ +IA MA + YLH +P I H D+K NVLL +++ A ++DFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS-----EASVTGDVYS 895
+ ++ + G GT Y+ P E G+ +A + D+Y+
Sbjct: 182 ------EAGKSAGDTHGQVGTRRYMAP------------EVLEGAINFQRDAFLRIDMYA 223
Query: 896 LGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALP--EKVMETV-----DPSLLLAWSDGR 948
+G++L E+ +R + + E P E + E V P L W
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK-- 281
Query: 949 RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
+ + C R+ V ++
Sbjct: 282 -----HAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-58
Identities = 73/334 (21%), Positives = 131/334 (39%), Gaps = 42/334 (12%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV 729
+ SE S + +IG+G +G+VYKG L + VAVK+ + + ++F+ E +
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNI 58
Query: 730 --LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLI 787
+ H N+ + I + G LV EY NGSL ++L +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWV 111
Query: 788 QRLNIAIDMASAIEYLH------HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841
+A + + YLH H +P I H DL NVL+ +D +SDFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901
E +++I GT+ Y+ P + +NL E A D+Y+LG++
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE-----SALKQVDMYALGLIYW 226
Query: 902 EMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWS----DGRR------RA 951
E+F R T+ + + + + P+ + +R
Sbjct: 227 EIFMRC--TDLFPGESVP-----EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK 279
Query: 952 KVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
+ + ++ C + R+ + ++
Sbjct: 280 ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-51
Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 34/269 (12%)
Query: 644 IVYARRRRSKQESSI-SVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGE 702
+ + + I + + + ++ + + IG GSFG+V++
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-- 58
Query: 703 NGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760
+G+ VAVKIL + F+ E +++ RH N++ + + ++V
Sbjct: 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPNLSIVT 113
Query: 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSN 820
EY+ GSL LH+S + + L +RL++A D+A + YLH+ PPIVH +LK N
Sbjct: 114 EYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPN 169
Query: 821 VLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLE 880
+L+D V DFGL+R T SS GT ++ P E
Sbjct: 170 LLVDKKYTVKVCDFGLSRLK--------ASTFLSSKSAAGTPEWMAP------------E 209
Query: 881 YGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
++ DVYS GV+L E+ T ++P
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-51
Identities = 102/546 (18%), Positives = 187/546 (34%), Gaps = 29/546 (5%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
LDL + S + L+ ++L+ L L TL+L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM-LPASIGNL 194
S S+L VA NL IG+ L+ +++A N + LP NL
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHL-KTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 195 -SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGN----LPLDIGVTLPNLQVFA 249
++ +L + N+ L + + + L ++ + N + + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD-LSLNPMNFIQPGAFKEI-RLHKLT 206
Query: 250 IGDNYFSGSIPE-SFSNASNIEIIDLPINYFTGK---VSIIFGRLKNLWSLDLGINNLGS 305
+ +N+ S ++ + + +E+ L + F + L+ L +L + L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 306 GGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSG 365
D + + + + + + V S + + Q
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT----- 321
Query: 366 IGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQ--GNIPSSLGNLTLMTDL 423
L +L L N+ N E+ L +L+ + LS N L G S T + L
Sbjct: 322 -LKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 424 FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
LS N + + + + L L+ + L + +LD+ + H +
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 484 PLEVGNLKNLVALYISGNQFSGEI-PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIK 542
L +L L ++GN F P T L + P + SL S++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 543 ELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFS---NKTRVQLTGNGKL 599
L+++ N L + L+ L+ + L N +D P S NK + G+ K
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAK- 556
Query: 600 CGGSNE 605
C GS +
Sbjct: 557 CSGSGK 562
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-38
Identities = 85/497 (17%), Positives = 152/497 (30%), Gaps = 43/497 (8%)
Query: 71 HRHQRVTELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEIGFLFRLETLML 129
+ LDL I ++ +LS L + L N L L+ L+
Sbjct: 49 FSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 130 ANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPA 189
+ + + L N + + + LEH+ L+ N + +
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 190 SIGNLS-----IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPN 244
+ L + L + N + + P + L + L N + N+ L
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226
Query: 245 LQVFAIGDNYFSG-----SIPES-FSNASNIEIIDLPINY---FTGKVSIIFGRLKNLWS 295
L+V + F +S N+ I + + Y + + +F L N+ S
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 296 LDLGINNLGSGGANDLDFVTILT---------------NCSKLKVLAFEENRLGGVLPHS 340
L + D + LK L F N+ G S
Sbjct: 287 FSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA--FS 342
Query: 341 IANLSTTMTDIYMGVNQIS--GTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQA 398
+L ++ + + N +S G +L L + FN + + L L+
Sbjct: 343 EVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 400
Query: 399 IGLSSNFLQGNIPSS-LGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA 457
+ + L+ S +L + L +S H + +L L ++ N
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 458 VPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTGCTG 516
I T FLDL L L +L +L L ++ NQ T
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519
Query: 517 LEIFHMQGNSFRGSIPL 533
L+ + N + S P
Sbjct: 520 LQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-35
Identities = 73/422 (17%), Positives = 144/422 (34%), Gaps = 34/422 (8%)
Query: 181 NHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGV 240
+ +P ++ S L + N S ++ L+ + L +
Sbjct: 17 LNFYK-IPDNLPF-STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ 73
Query: 241 TLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300
+L +L + N +FS S+++ + + G LK L L++
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 301 NNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIA---NLSTTMTDIYMGVNQ 357
N + S +N + L+ L N++ + + + + + +N
Sbjct: 134 NLIQS-----FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 358 ISGTIPSGIGNLVNLNLLGIEFNQLTGNIPRE-IGQLRNLQAIGL------SSNFLQGNI 410
++ I G + L+ L + N + N+ + I L L+ L + L+
Sbjct: 189 MN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 411 PSSLGNLTLMTDLFLSSNHLQG---NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITT 467
S+L L +T +L +I N+ S +L + +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNF 304
Query: 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGN-- 525
+ L+L N LK+L L + N+ + LE + N
Sbjct: 305 GWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGL 359
Query: 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVF 585
SF+G S S+K LDLS N + + L LE+L+ +++ ++ VF
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 417
Query: 586 SN 587
+
Sbjct: 418 LS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-26
Identities = 68/368 (18%), Positives = 115/368 (31%), Gaps = 45/368 (12%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
IP++ + + +DL N S F L LDL + +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ----- 73
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377
+ S L L N + + + + L +++ + ++ IG+L L L +
Sbjct: 74 -SLSHLSTLILTGNPIQSLALGAFSGL-SSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 378 EFNQLT-GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLT----LMTDLFLSSNHLQG 432
N + +P L NL+ + LSSN +Q + L L L L LS N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGS---LPLEVGN 489
I P L L L +N V + + L +
Sbjct: 192 -IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 490 LKNLVALYISGNQ------FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLR------- 536
L+ L L I + + +I T + F + + S
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 537 ------------SLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGV 584
LKS+K L + N + +L LE+L+LS N +
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGN-AFSEV-DLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 585 FSNKTRVQ 592
T ++
Sbjct: 369 DFGTTSLK 376
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 42/264 (15%), Positives = 80/264 (30%), Gaps = 34/264 (12%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
NL + ++ + N + + L +L + ++ L +L + L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQ 461
+ N +Q + L+ + L +L +G+ K L LN++ N +
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI------- 136
Query: 462 ILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIF- 520
+ LP NL NL L +S N+ L + +
Sbjct: 137 -----------------QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 521 ---HMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE-FLENLSFLEYLNLSYNHFD 576
+ N I + +L L N S + + ++ L+ LE L F
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 577 G----EVPTKGVFSNKTRVQLTGN 596
E K + +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEF 262
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-15
Identities = 29/157 (18%), Positives = 54/157 (34%), Gaps = 6/157 (3%)
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495
P + N+ + + +P + T LDL N L + L
Sbjct: 2 PCVEVVPNI-TYQCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQV 56
Query: 496 LYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555
L +S + + L + GN + + L S+++L NL+
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 556 PEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQ 592
+ +L L+ LN+++N FSN T ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLE 152
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-51
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 42/234 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
E ++G+G+FG V K VA+K + + K+F+ E L H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNI 63
Query: 739 IKIITVCSSIDFKGADFKAL--VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
+K GA + V EY + GSL LH + P + ++ +
Sbjct: 64 VK---------LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSWCLQC 111
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+ + YLH ++H DLKP N+LL V + DFG A + Q+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----------QTHM 160
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
KG+ ++ P E GS S DV+S G++L E+ TRR+P
Sbjct: 161 TNNKGSAAWMAP------------EVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 34/233 (14%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA--LKSFVAECEVLRNTRHR 736
+ + + + G ++KG G + VK+L + + F EC LR H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N++ ++ C S A L+ +M GSL LH+ + Q + A+DM
Sbjct: 68 NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFALDM 120
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A + +LH +P I L +V++D DM A +S + S
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------------QSP 166
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G +V P + K ++ D++S V+L E+ TR P
Sbjct: 167 GRMYAPAWVAPEALQKK------PEDTNRRSA---DMWSFAVLLWELVTREVP 210
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 74/338 (21%), Positives = 127/338 (37%), Gaps = 71/338 (21%)
Query: 662 MEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL-------NL 714
FP L++ NE IG+G FG V+KG L ++ + VA+K L
Sbjct: 4 GGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 715 MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWL 772
+ F E ++ N H N++K G +V E++ G L L
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVK---------LYGLMHNPPRMVMEFVPCGDLYHRL 112
Query: 773 HQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-----HDM 827
+ +L + +D+A IEY+ + PPIVH DL+ N+ L +
Sbjct: 113 LDKAHP-----IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPV 166
Query: 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA 887
A V+DFGL++ ++ S G+ G ++ P + + Y +E
Sbjct: 167 CAKVADFGLSQ-----------QSVHSVSGLLGNFQWMAP----ETIGAEEESY---TEK 208
Query: 888 SVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDG 947
+ D YS ++L + T P F + + K+ + E +G
Sbjct: 209 A---DTYSFAMILYTILTGEGP----FDE----YSYGKIKFINMIRE-----------EG 246
Query: 948 RRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
R E+C + + C P +R ++ +L
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-48
Identities = 100/506 (19%), Positives = 178/506 (35%), Gaps = 71/506 (14%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+ L N+ + +L + + + + +L L + +NN +
Sbjct: 26 KMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 81
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL- 194
P L + + L+ + N + P + + L ++L N +T + P + NL
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LA-NLTNLTGLTLFNNQITDIDP--LKNLT 134
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
++ L + N S +L ++SL+ + N T PL L L+ I N
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKPLA---NLTTLERLDISSNK 188
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314
S + +N+E + N + G L NL L L N L +
Sbjct: 189 VSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--------I 236
Query: 315 TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNL 374
L + + L L N++ + P ++ L T +T++ +G NQIS P + L L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGL-TKLTELKLGANQISNISP--LAGLTALTN 291
Query: 375 LGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434
L + NQL P I L+NL + L N + P + +LT + LF +N +
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-- 345
Query: 435 PPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLV 494
SL N N+ L+ N+ I+ L+ + NL +
Sbjct: 346 VSSLANLTNINWLSAGHNQ-----------ISDLT----------------PLANLTRIT 378
Query: 495 ALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554
L ++ ++ + + P ++ S E D++ N S
Sbjct: 379 QLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-Y 435
Query: 555 IPEFLENLSFLEYLNLSYNHFDGEVP 580
E S + F G V
Sbjct: 436 TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-43
Identities = 99/480 (20%), Positives = 185/480 (38%), Gaps = 56/480 (11%)
Query: 123 RLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNH 182
L + + ++ +I ++ + + V + N+ + + ++ + R
Sbjct: 2 PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLG 57
Query: 183 LTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVT 241
+ + L ++ ++ NQ + L N++ L +IL++ N PL
Sbjct: 58 IKS--IDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLA---N 110
Query: 242 LPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGIN 301
L NL + +N + P N +N+ ++L N + ++ L +L L G
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL--SGLTSLQQLSFG-- 164
Query: 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT 361
N + + L N + L+ L N++ +A L T + + NQIS
Sbjct: 165 -------NQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKL-TNLESLIATNNQISDI 214
Query: 362 IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMT 421
P +G L NL+ L + NQL + L NL + L++N + P L LT +T
Sbjct: 215 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 268
Query: 422 DLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS--RFLDLGNNHL 479
+L L +N + L L +L L++N+L + I I+ L +L L N++
Sbjct: 269 ELKLGANQISN--ISPLAGLTALTNLELNENQL-----EDISPISNLKNLTYLTLYFNNI 321
Query: 480 NGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLK 539
+ P+ +L L L+ N+ S +L T + N PL+ +L
Sbjct: 322 SDISPV--SSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NLT 375
Query: 540 SIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQ---LTGN 596
I +L L+ + + N+S N N G + S+ +T N
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVS---IPNTVKNV-TGALIAPATISDGGSYTEPDITWN 431
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-30
Identities = 79/425 (18%), Positives = 157/425 (36%), Gaps = 70/425 (16%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
T+++ + + ++P + NL+ L I + N P + L L L L NN +
Sbjct: 71 TQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-S 195
L + +NL N + + L+ +S N +T + P + NL +
Sbjct: 127 --IDPLKNLTNLNRLELSSNTISD--ISALSGL-TSLQQLSF-GNQVTDLKP--LANLTT 178
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
+ L + N+ S L +++LE+++ N + PL L NL ++ N
Sbjct: 179 LERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQL 233
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGS---------- 305
+ ++ +N+ +DL N + L L L LG N + +
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTAL 289
Query: 306 ----GGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT 361
N L+ ++ ++N L L N + + P +++L T + ++ N++S
Sbjct: 290 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL-TKLQRLFFYNNKVSD- 345
Query: 362 IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMT 421
S + NL N+N L NQ++ P + L + +GL+ + N+++
Sbjct: 346 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSI-- 400
Query: 422 DLFLSSNHLQGNIPPS-LGNCKNLVSLNLSDNKLI-----------------------GA 457
N I P+ + + + +++ N G
Sbjct: 401 -PNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459
Query: 458 VPQQI 462
V Q +
Sbjct: 460 VTQPL 464
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-48
Identities = 75/317 (23%), Positives = 121/317 (38%), Gaps = 49/317 (15%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV--LRNTRHRNLIKII 742
IG+G +G V+ G G VAVK+ ++ S+ E E+ RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
L+ +Y +NGSL ++L + L L +A S + +
Sbjct: 98 AADIKGTGSWTQL-YLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCH 149
Query: 803 LH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
LH +P I H DLK N+L+ + ++D GLA + E
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF----ISDTNEVDIPPNT 205
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917
GT Y+PP + + LN + + D+YS G++L E+ R C+ G
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQS---YIMA---DMYSFGLILWEVARR-----CVSGGI 254
Query: 918 LTLHEFCKMALPEKVMETVDPSLLLAWS----DGRR-----RAKVEECLVTVIRIGVACS 968
+ ++ LP + DPS R R +ECL + ++ C
Sbjct: 255 VEEYQ-----LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309
Query: 969 MESPIERMEMRDVLAKL 985
+P R+ V L
Sbjct: 310 AHNPASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-48
Identities = 66/317 (20%), Positives = 121/317 (38%), Gaps = 49/317 (15%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV--LRNTRHRNLIKII 742
+G+G +G V++G G VAVKI + KS+ E E+ RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
+ L+ Y + GSL ++L + L + L I + +AS + +
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAH 120
Query: 803 LH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
LH +P I H DLK N+L+ + ++D GLA ++ + +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH----SQSTNQLDVGNNP 176
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917
GT Y+ P + + + + C + + D+++ G++L E+ R
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDS---YKRV---DIWAFGLVLWEVARRMVSNG------ 224
Query: 918 LTLHEFCKMALPEKVMETVDPSLLLAWS----DGRR-----RAKVEECLVTVIRIGVACS 968
P + DPS D +R R + L ++ ++ C
Sbjct: 225 ----IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW 280
Query: 969 MESPIERMEMRDVLAKL 985
++P R+ + L
Sbjct: 281 YQNPSARLTALRIKKTL 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 78/305 (25%), Positives = 127/305 (41%), Gaps = 59/305 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG GSFG+VYKG +G VAVK+LN+ L++F E VLR TRH N++ +
Sbjct: 32 IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
++ A+V ++ + SL LH S + + + ++IA A ++YLH
Sbjct: 89 STAPQL------AIVTQWCEGSSLYHHLHASETK-----FEMKKLIDIARQTARGMDYLH 137
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
I+H DLK +N+ L D + DFGLA E G++ +
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL------SGSILW 188
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFC 924
+ P I + P S S DVY+ G++L E+ T + P +
Sbjct: 189 MAPEVIRMQDSNPY------SFQS---DVYAFGIVLYELMTGQLP-------------YS 226
Query: 925 KMALPEKVMETVDPSLLLAWSDGRRRAKV----EECLVTVIRIGVACSMESPIERMEMRD 980
+ ++++E V G + C + R+ C + ER
Sbjct: 227 NINNRDQIIEMVG--------RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR 278
Query: 981 VLAKL 985
+LA++
Sbjct: 279 ILAEI 283
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-47
Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 30/236 (12%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV--LRNTRHRNLIKII 742
IG+G FG V++G G VAVKI + ++ +S+ E E+ RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
+ + LV +Y ++GSL ++L++ +++ + +A+ AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAH 154
Query: 803 LH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
LH +P I H DLK N+L+ + ++D GLA + +
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH----DSATDTIDIAPNH 210
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913
GT Y+ P + +N+ E + + D+Y++G++ E+ R
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFES---FKRA---DIYAMGLVFWEIARRCSIGGIH 260
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 60/263 (22%), Positives = 112/263 (42%), Gaps = 34/263 (12%)
Query: 649 RRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVA 708
R ++ S S+ ++++ + + +L +IG+G FG VY G +G VA
Sbjct: 12 RSFPRKASQTSIFLQEW--DIPFEQLEI-------GELIGKGRFGQVYHGRW--HGE-VA 59
Query: 709 VKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNG 766
++++++ + LK+F E R TRH N++ + C S A++ +
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PPHLAIITSLCKGR 114
Query: 767 SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 826
+L + + L + + IA ++ + YLH I+H DLK NV D+
Sbjct: 115 TLYSVVRDAKIV-----LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG 166
Query: 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE 886
V ++DFGL + E + G + ++ P I ++ + S+
Sbjct: 167 KV-VITDFGLFS-ISGVLQAGRREDKLR--IQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222
Query: 887 ASVTGDVYSLGVMLLEMFTRRRP 909
S DV++LG + E+ R P
Sbjct: 223 HS---DVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 68/305 (22%), Positives = 110/305 (36%), Gaps = 51/305 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G+G FG K E G + +K L + ++F+ E +V+R H N++K I V
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
K + EY++ G+L + + Q QR++ A D+AS + YLH
Sbjct: 78 ----KDKRL-NFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIASGMAYLHSM 127
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS------METQSSSIGIKG 860
I+H DL N L+ + V+DFGLAR + + + G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
++ P + E DV+S G++L E+ R
Sbjct: 185 NPYWMAP---------EMINGRSYDEKV---DVFSFGIVLCEIIGRVNAD---------- 222
Query: 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980
P+ + T+D L R C + I V C P +R
Sbjct: 223 --------PDYLPRTMD--FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK 272
Query: 981 VLAKL 985
+ L
Sbjct: 273 LEHWL 277
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 48/243 (19%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL----MQKGALKSFVAECEVLRNTR 734
E + +IG G FG VY+ G VAVK +++ E ++ +
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H N+I + VC K + LV E+ + G L L + +N A+
Sbjct: 65 HPNIIALRGVCL----KEPNL-CLVMEFARGGPLNRVLSGKR-------IPPDILVNWAV 112
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLD--------HDMVAHVSDFGLARFLFARPFD 846
+A + YLH PI+H DLK SN+L+ + + ++DFGLAR
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------- 165
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
+++ + G ++ P + M S+ S DV+S GV+L E+ T
Sbjct: 166 ---WHRTTKMSAAGAYAWMAP---------EVIRASMFSKGS---DVWSYGVLLWELLTG 210
Query: 907 RRP 909
P
Sbjct: 211 EVP 213
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-43
Identities = 99/535 (18%), Positives = 178/535 (33%), Gaps = 38/535 (7%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEI-GFLFRLETLMLANNSF 134
L L I + L L+ + L + I KE L L L L ++
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 135 SGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLK-LEHISLARNHLTGM-LPASIG 192
P +L Y L + +D + LK L + L++N + + L S G
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145
Query: 193 NL-SIIYLHVGENQFSGTVPPSLYN--MSSLENILLDVNGFTGNLPLDIGVTLPNLQVFA 249
L S+ + NQ L +L L N + +D G + +
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205
Query: 250 IGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGAN 309
+ SG N ++I N + + ++ G +N+
Sbjct: 206 LEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI-----K 253
Query: 310 DLDFVTILTNC-SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGN 368
D D T S ++ L + + L + + + N+I+
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYNKINKIADEAFYG 312
Query: 369 LVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN 428
L NL +L + +N L L + I L N + + L + L L N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 429 HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV- 487
L ++ ++ + LS NKL+ + I + + L N L L
Sbjct: 373 ALT-----TIHFIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDILYFL 422
Query: 488 GNLKNLVALYISGNQFSG-EIPVTLTGCTGLEIFHMQGNSFRGSIPLSL-----RSLKSI 541
+ +L L ++ N+FS T + LE + N + + L L +
Sbjct: 423 LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482
Query: 542 KELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGN 596
+ L L+ N L+ P +L+ L L+L+ N + + +N + ++ N
Sbjct: 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL-TVLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-37
Identities = 113/613 (18%), Positives = 202/613 (32%), Gaps = 69/613 (11%)
Query: 77 TELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEI-GFLFRLETLMLANNSF 134
L+L Q ++ NL LR ++L ++ + + + LF L L L
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGL 109
Query: 135 SGKI--PTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIG 192
S + + L +N + L+ I + N + + +
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169
Query: 193 NLSII---YLHVGENQFSGTVPPSLYN-MSSLENILLDVNGFTGN--------------- 233
L + + N V M+ N++L++ +GN
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229
Query: 234 -LPLDIGVTLPNLQVFAIGDNYFSGSIPESFSN--ASNIEIIDLPINYFTGKVSIIFGRL 290
+ ++ G + +F+ S++ +DL + S +F L
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289
Query: 291 KNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTD 350
K+L L+L N + N + L+VL N LG + + L +
Sbjct: 290 KDLKVLNLAYNKI-----NKIADEA-FYGLDNLQVLNLSYNLLGELYSSNFYGL-PKVAY 342
Query: 351 IYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNI 410
I + N I+ L L L + N LT I + ++ I LS N L
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL---- 393
Query: 411 PSSLGNLTL-MTDLFLSSNHLQG-NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTL 468
+L + L + LS N L+ +I L +L L L+ N+ Q +
Sbjct: 394 -VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 469 SRFLDLGNNHLNGSLPLEV-----GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQ 523
L LG N L + E+ L +L LY++ N + P + T L +
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512
Query: 524 GNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKG 583
N L +++ LD+S N L P+ +LS L++++N F E
Sbjct: 513 SNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICECELS- 566
Query: 584 VFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRK---------STVLRLGKVGIPMIVS 634
F N N + G +++ S L + + +
Sbjct: 567 TFINWLNHT---NVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIV 623
Query: 635 CLILSTCFIIVYA 647
C + T F++
Sbjct: 624 CTVTLTLFLMTIL 636
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-37
Identities = 92/508 (18%), Positives = 174/508 (34%), Gaps = 46/508 (9%)
Query: 95 GNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAY 154
G ++F R+ NL ++P+ L E L+L+ N ++ L
Sbjct: 6 GRIAFYRFCNLT------QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELG 56
Query: 155 RNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPS 213
I ++ + L + L + + + P + L + L + S V
Sbjct: 57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD 116
Query: 214 --LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSN--ASNI 269
N+ +L + L N L +L+ N +
Sbjct: 117 GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL 176
Query: 270 EIIDLPINYFTGKVSIIFGRLKN------LWSLDLGINNL----GSGGANDLDFVTI--L 317
L N +VS+ +G+ N L LD+ N +N + L
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANL-STTMTDIYMGVNQISGTIPSGI-GNLVNLNLL 375
+ F + + ++ A L +++ + + + ++ S + L +L +L
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVL 295
Query: 376 GIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435
+ +N++ L NLQ + LS N L S+ L + + L NH+
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495
+ + L +L+L DN L + + L N L +LP
Sbjct: 356 QTFKFLEKLQTLDLRDNAL------TTIHFIPSIPDIFLSGNKLV-TLPKINLTANL--- 405
Query: 496 LYISGNQFSG-EIPVTLTGCTGLEIFHMQGNSFRG-SIPLSLRSLKSIKELDLSCNNLSG 553
+++S N+ +I L L+I + N F S + S+++L L N L
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 554 QI-----PEFLENLSFLEYLNLSYNHFD 576
+ E LS L+ L L++N+ +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLN 493
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-35
Identities = 76/472 (16%), Positives = 160/472 (33%), Gaps = 50/472 (10%)
Query: 144 SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVG 202
SCS YR + ++P+ + E + L+ N++ + +S L + L +G
Sbjct: 1 SCSFDGRIAFYRFCNLTQVPQVLN----TTERLLLSFNYIRTVTASSFPFLEQLQLLELG 56
Query: 203 ENQFSGTVPP-SLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSI-- 259
T+ + N+ +L + L + L D L +L + S ++
Sbjct: 57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 260 PESFSNASNIEIIDLPINYFTG-KVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILT 318
F N + +DL N + FG+L +L S+D N + ++L+ + T
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 319 NCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIE 378
L + N L + ++ + + +SG N +++ G
Sbjct: 176 ----LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNF 224
Query: 379 FNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL 438
N ++ + + ++ G + ++ ++ L
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS------------------ 266
Query: 439 GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYI 498
++ L+LS + ++ ++ + L+L N +N L NL L +
Sbjct: 267 ----SVRHLDLSHGF-VFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 499 SGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEF 558
S N G + +Q N + + L+ ++ LDL N L+
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----T 376
Query: 559 LENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPS 610
+ + + + LS N +P + +N + L L +P
Sbjct: 377 IHFIPSIPDIFLSGNKL-VTLPKINLTANLIHLSENRLENLDILYFLLRVPH 427
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-43
Identities = 98/500 (19%), Positives = 173/500 (34%), Gaps = 88/500 (17%)
Query: 90 LSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLL 149
++P + +FL+ ++N E+P E + A + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGE----- 56
Query: 150 SFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGT 209
R V + + + + + L L+ LP +L L N +
Sbjct: 57 ----QREMAVSRLRDCLD---RQAHELELNNLGLS-SLPELPPHLE--SLVASCNSLT-E 105
Query: 210 VPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNI 269
+P ++ SL ++ + P L+ + +N +PE N+S +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP--------LLEYLGVSNNQLE-KLPE-LQNSSFL 155
Query: 270 EIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFE 329
+IID+ N + +L + G N L + L N L + +
Sbjct: 156 KIIDVDNNSLK----KLPDLPPSLEFIAAGNNQLEE--------LPELQNLPFLTAIYAD 203
Query: 330 ENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPRE 389
N L LP +L + I G N + + NL L + + N L +P
Sbjct: 204 NNSLK-KLPDLPLSLES----IVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDL 255
Query: 390 IGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL----------- 438
L L + N+L ++P +LT + + L +PP+L
Sbjct: 256 PPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSNEIR 310
Query: 439 ---GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495
+L LN+S+NKLI +P + L NHL +P NLK L
Sbjct: 311 SLCDLPPSLEELNVSNNKLI-ELPALPPRLERL----IASFNHLA-EVPELPQNLKQL-- 362
Query: 496 LYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555
++ N E P L + NS +P ++LK +L + N L +
Sbjct: 363 -HVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLK---QLHVETNPLR-EF 411
Query: 556 PEFLENLSFLEYLNLSYNHF 575
P+ E+ +E L ++
Sbjct: 412 PDIPES---VEDLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 85/449 (18%), Positives = 139/449 (30%), Gaps = 80/449 (17%)
Query: 72 RHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLAN 131
++ EL+L + + SL +L + + N+ E+P+ L L
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 132 NSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI 191
+ S +P L L NN + ++PE S L+ I + N L LP
Sbjct: 124 KALSD-LPPLLEY----LGV---SNNQLEKLPELQNSS--FLKIIDVDNNSLK-KLPDLP 172
Query: 192 GNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIG 251
+L ++ G NQ P L N+ L I D N LP +L+ G
Sbjct: 173 PSL--EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPL----SLESIVAG 223
Query: 252 DNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDL 311
+N N + I N + +L +L++ N L
Sbjct: 224 NNILE--ELPELQNLPFLTTIYADNNLLK----TLPDLPPSLEALNVRDNYL-------- 269
Query: 312 DFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVN 371
+ L L EN G L NL + N+I ++ +L
Sbjct: 270 --TDLPELPQSLTFLDVSENIFSG-LSELPPNLYY----LNASSNEIR-SLCDLPPSLEE 321
Query: 372 LNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ 431
LN+ N+L +P +L L S N L +P NL L + N L+
Sbjct: 322 LNV---SNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLK---QLHVEYNPLR 370
Query: 432 GNIPPSLGN----------------CKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLG 475
P + +NL L++ N L P ++ L +
Sbjct: 371 -EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL----RMN 424
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFS 504
+ + L +
Sbjct: 425 SERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 49/273 (17%), Positives = 97/273 (35%), Gaps = 40/273 (14%)
Query: 336 VLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRN 395
+ P +++N T + + + ++ +P N+ + +++ N P G+ R
Sbjct: 3 INPRNVSN--TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 396 LQAIGLSSNFLQG------------NIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKN 443
+ L + ++P +L L S N L +P + K+
Sbjct: 60 MAVSRLRDCLDRQAHELELNNLGLSSLPELPPHL---ESLVASCNSLT-ELPELPQSLKS 115
Query: 444 LVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQF 503
L+ N + L + L +L + NN L LP E+ N L + + N
Sbjct: 116 LLVDNNNLKALSD--------LPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL 165
Query: 504 SGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLS 563
++P LE N +P L++L + + N+L ++P+ +
Sbjct: 166 K-KLPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS-- 216
Query: 564 FLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGN 596
LE + N + E+P T + N
Sbjct: 217 -LESIVAGNNILE-ELPELQNLPFLTTIYADNN 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-43
Identities = 53/327 (16%), Positives = 116/327 (35%), Gaps = 27/327 (8%)
Query: 257 GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTI 316
GS ++S E + + + + + ++ D N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR----------NRWHSAWR 51
Query: 317 LTNCSKLKVLAFEENRLGGVLPHSIANL-STTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375
N + ++ L + + + + + P L +L +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 376 GIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435
I+ L +P + Q L+ + L+ N L+ +P+S+ +L + +L + + +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 436 PSLGNC---------KNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLE 486
L + NL SL L + ++P I + L + L + N+ L+ +L
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLS-ALGPA 224
Query: 487 VGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDL 546
+ +L L L + G P G L+ ++ S ++PL + L +++LDL
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 547 SCNNLSGQIPEFLENLSFLEYLNLSYN 573
++P + L + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-41
Identities = 51/299 (17%), Positives = 101/299 (33%), Gaps = 31/299 (10%)
Query: 288 GRLKNLWSLDL-GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLST 346
+L G L + +L+ + +S
Sbjct: 9 HHSSGRENLYFQGSTALRP-------YHDVLSQWQRHYNADRNRWHSAWRQANS------ 55
Query: 347 TMTDIYMGVNQISGTIPSGIGNLVNLNL--LGIEFNQLTGNIPREIGQLRNLQAIGLSSN 404
I + + + L + L P + +L +LQ + + +
Sbjct: 56 NNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 405 FLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILT 464
L +P ++ + L L+ N L+ +P S+ + L L++ + +P+ + +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 465 ITTLS--------RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTG 516
+ L L + SLP + NL+NL +L I + S + +
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230
Query: 517 LEIFHMQGNSFRGSIPLSLRSLKSIKELDLS-CNNLSGQIPEFLENLSFLEYLNLSYNH 574
LE ++G + + P +K L L C+NL +P + L+ LE L+L
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 50/328 (15%), Positives = 99/328 (30%), Gaps = 28/328 (8%)
Query: 242 LPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGIN 301
+ + + S D + + N
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIETRTGR 66
Query: 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT 361
L + D + T L L P L + + + + +
Sbjct: 67 ALKA----TADLLEDATQ-PGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM-E 118
Query: 362 IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLM- 420
+P + L L + N L +P I L L+ + + + +P L +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 421 --------TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFL 472
L L ++ ++P S+ N +NL SL + ++ L A+ I + L L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL-EEL 234
Query: 473 DLGNNHLNGSLPLEVGNLKNLVALYISG-NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531
DL + P G L L + + +P+ + T LE ++G +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFL 559
P + L + + + +L Q+ +
Sbjct: 294 PSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-36
Identities = 59/384 (15%), Positives = 112/384 (29%), Gaps = 86/384 (22%)
Query: 124 LETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHL 183
E L ++ LS + R + + + L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SNNPQIETRTGRAL 68
Query: 184 TGMLPASIGNLSI---IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGV 240
+ + + + L + P + +S L+++ +D G LP +
Sbjct: 69 K-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ- 124
Query: 241 TLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300
L+ + N ++P S L L L
Sbjct: 125 QFAGLETLTLARNPLR-ALPAS------------------------IASLNRLRELS--- 156
Query: 301 NNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISG 360
+ C +L LP +A+
Sbjct: 157 ----------------IRACPELT-----------ELPEPLASTD--------------- 174
Query: 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLM 420
LVNL L +E+ + ++P I L+NL+++ + ++ L + ++ +L +
Sbjct: 175 -ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLN 480
+L L N PP G L L L D + +P I +T L + LDL
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK-LDLRGCVNL 290
Query: 481 GSLPLEVGNLKNLVALYISGNQFS 504
LP + L + + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 51/363 (14%), Positives = 104/363 (28%), Gaps = 103/363 (28%)
Query: 78 ELDLRHQNIGGSLSPYVGNLSF--LRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+++ R + + + + + + L + + P + L L+ + +
Sbjct: 59 QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS 195
++P + + L + RN L +P I S +L +S+ LP + +
Sbjct: 118 -ELPDTMQQFAGLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEPLASTD 174
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
+ +L+++ L+ G +LP I L NL+ I ++
Sbjct: 175 A--------------SGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSLKIRNSPL 218
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVT 315
S ++ + L L LD
Sbjct: 219 S-ALGPA------------------------IHHLPKLEELD------------------ 235
Query: 316 ILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375
L C+ L+ P + L L L
Sbjct: 236 -LRGCTALR-----------NYPPIFGGRA----------------------PLKRLILK 261
Query: 376 GIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435
+ L +P +I +L L+ + L +PS + L + + HLQ +
Sbjct: 262 D--CSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLD 317
Query: 436 PSL 438
Sbjct: 318 QHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 34/202 (16%), Positives = 63/202 (31%), Gaps = 18/202 (8%)
Query: 384 GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKN 443
G+ + + + L + + H S N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----N 56
Query: 444 LVSLNLSDNKLIGAVPQQILTITTLS-RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQ 502
+ + + A + T L+L + L P + L +L + I
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 503 FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
E+P T+ GLE + N R ++P S+ SL ++EL + ++PE L +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 563 SF---------LEYLNLSYNHF 575
L+ L L +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGI 195
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 42/212 (19%), Positives = 74/212 (34%), Gaps = 18/212 (8%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
+ + + L + + L + LA N +P I L RL L +
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 137 KIPTNLSSCS---------NLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGML 187
++P L+S NL S + +P I + L+ + + + L+ L
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLSA-L 221
Query: 188 PASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLEN-ILLDVNGFTGNLPLDIGVTLPNL 245
+I +L + L + PP + L+ IL D + LPLDI L L
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH-RLTQL 279
Query: 246 QVFAIGDNYFSGSIPESFSNASNIEIIDLPIN 277
+ + +P + II +P +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 21/112 (18%), Positives = 39/112 (34%), Gaps = 3/112 (2%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
L +R+ + +L P + +L L ++L P G L+ L+L + S
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLP 188
+P ++ + L + +P I I + HL L
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA-QLPANCIILV-PPHLQAQLD 317
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 1/88 (1%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
ELDLR + P G + L+ + L + +P +I L +LE L L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPE 164
++P+ ++ + +L ++ +
Sbjct: 292 RLPSLIAQLPANCIILV-PPHLQAQLDQ 318
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 75/364 (20%), Positives = 145/364 (39%), Gaps = 38/364 (10%)
Query: 213 SLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEII 272
+++ +L T + + L ++ + + SI +N+E +
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 273 DLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENR 332
+L N T L L +L +G N + ++ L N + L+ L E+
Sbjct: 72 NLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--------ISALQNLTNLRELYLNEDN 121
Query: 333 LGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ 392
+ + P +ANL T M + +G N + S + N+ LN L + +++ P I
Sbjct: 122 ISDISP--LANL-TKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IAN 175
Query: 393 LRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDN 452
L +L ++ L+ N ++ P L +LT + N + P + N L SL + +N
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231
Query: 453 KLIGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVT 510
K+ + + LS +L++G N ++ + V +L L L + NQ S
Sbjct: 232 KITD-----LSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISDISV-- 282
Query: 511 LTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNL 570
L + L + N + L ++ L LS N+++ P L +LS ++ +
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 571 SYNH 574
+
Sbjct: 341 ANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 84/398 (21%), Positives = 156/398 (39%), Gaps = 61/398 (15%)
Query: 156 NNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSL 214
+ +I D + + L + +T ++ L SI L V + + +
Sbjct: 9 PAPINQIFPDADLA--EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGI 62
Query: 215 YNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDL 274
+++LE + L+ N T PL L L IG N + + N +N+ + L
Sbjct: 63 EYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKIT--DISALQNLTNLRELYL 117
Query: 275 PINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLG 334
+ + L ++SL+LG N+ S ++ L+N + L L E+++
Sbjct: 118 NEDNISD--ISPLANLTKMYSLNLGANHNLS-------DLSPLSNMTGLNYLTVTESKVK 168
Query: 335 GVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLR 394
V P IANL T + + + NQI P + +L +L+ NQ+T P + +
Sbjct: 169 DVTP--IANL-TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 395 NLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL 454
L ++ + +N + S L NL+ +T L + +N + ++ + L LN+ N+
Sbjct: 222 RLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQ- 276
Query: 455 IGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGC 514
I+ +S + NL L +L+++ NQ E + G
Sbjct: 277 ----------ISDIS----------------VLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 515 TGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552
T L + N PL+ SL + D + +
Sbjct: 311 TNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 77/385 (20%), Positives = 147/385 (38%), Gaps = 60/385 (15%)
Query: 121 LFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLAR 180
L +L S + + ++ V + + I Y LE+++L
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEY-LTNLEYLNLNG 75
Query: 181 NHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIG 239
N +T + P + NL + L++G N+ T +L N+++L + L+ + + PL
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLA-- 129
Query: 240 VTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLG 299
L + +G N+ S SN + + + + + L +L+SL L
Sbjct: 130 -NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLN 185
Query: 300 INNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQIS 359
N + ++ L + + L N++ + P +AN+ T + + +G N+I+
Sbjct: 186 YNQIED--------ISPLASLTSLHYFTAYVNQITDITP--VANM-TRLNSLKIGNNKIT 234
Query: 360 GTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTL 419
P + NL L L I NQ++ + L L+ + + SN + S L NL+
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQ 288
Query: 420 MTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHL 479
+ LFL++N L +G NL +L LS N IT +
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH-----------ITDIR---------- 327
Query: 480 NGSLPLEVGNLKNLVALYISGNQFS 504
+ +L + + +
Sbjct: 328 ------PLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 5e-09
Identities = 18/103 (17%), Positives = 35/103 (33%), Gaps = 8/103 (7%)
Query: 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531
L +N P +L + + + + + + G SI
Sbjct: 5 LATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SI 59
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574
+ L +++ L+L+ N ++ P L NL L L + N
Sbjct: 60 Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-42
Identities = 97/520 (18%), Positives = 192/520 (36%), Gaps = 50/520 (9%)
Query: 104 NLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIP 163
+ + +F IP + +++L L+ N + +L +C+NL + + + I
Sbjct: 11 DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIE 66
Query: 164 EDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSG-TVPPSLYNMSSLE 221
D YS LEH+ L+ NHL+ + + G L S+ YL++ N + V N+++L+
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 222 NILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTG 281
+ + + L +L I +S + +I + L ++
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 282 KVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSI 341
+ I L ++ L+L NL + + S +K LAF + L + +
Sbjct: 187 LLEIFADILSSVRYLELRDTNLAR---FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 342 ANLSTTMTDI---------YMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN-----IP 387
L + ++ G+ + + + L + + I + +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 388 REIGQLRNLQAIGLSSNFLQ---GNIPSSLGNLTLMTDLFLSSNHLQGNIPPS---LGNC 441
L ++ I + ++ + + L +L L LS N + + G
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEF---LDLSENLMVEEYLKNSACKGAW 360
Query: 442 KNLVSLNLSDNKLIGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEVGNLKNLVALYIS 499
+L +L LS N L ++ + + TL LD+ N + +P + + L +S
Sbjct: 361 PSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418
Query: 500 GNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFL 559
+ + LE+ + N+ S L L L +EL +S N L +P+
Sbjct: 419 STGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLK-TLPDAS 470
Query: 560 ENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQ---LTGN 596
L + +S N + G+F T +Q L N
Sbjct: 471 -LFPVLLVMKISRNQL--KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-20
Identities = 42/271 (15%), Positives = 100/271 (36%), Gaps = 19/271 (7%)
Query: 319 NCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIE 378
+C V + P + L+ M + + N+I+ + NL +L ++
Sbjct: 3 SCDASGVCDGRSRSFTSI-P---SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 379 FNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG-NIPP 436
+++ I + L +L+ + LS N L S G L+ + L L N Q +
Sbjct: 59 SSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 437 SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVAL 496
N NL +L + + + + + T L++ L + +++++ L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 497 YISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG-----------SIPLSLRSLKSIKELD 545
+ ++ + + + + + ++ + S P+ + + D
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 546 LSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
S N L ++ ++ LS +E+ + + N
Sbjct: 238 ESFNELL-KLLRYILELSEVEFDDCTLNGLG 267
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 32/124 (25%), Positives = 55/124 (44%), Gaps = 4/124 (3%)
Query: 469 SRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528
S D + S+P + + +L +S N+ + L C L++ ++ +
Sbjct: 7 SGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 529 GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNK 588
+ SL S++ LDLS N+LS + LS L+YLNL N + + +F N
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNL 122
Query: 589 TRVQ 592
T +Q
Sbjct: 123 TNLQ 126
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 70/407 (17%), Positives = 138/407 (33%), Gaps = 36/407 (8%)
Query: 209 TVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASN 268
+ +L ++ +D+ + +TL N ++ ++ +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFE-DITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 269 IEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAF 328
+E+++L + F + L +G N + + + N L VL
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH------VFQNVPLLTVLVL 124
Query: 329 EENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIP 387
E N L + N +T + M N + I +L L + N+LT ++
Sbjct: 125 ERNDLSSLPRGIFHNT-PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 181
Query: 388 REIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSL 447
+ + +L +S N L S+L + +L S N + + + L L
Sbjct: 182 --LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 231
Query: 448 NLSDNKLIGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFS 504
L N L + +DL N L + ++ L LYIS N+
Sbjct: 232 KLQHNNLT-----DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 285
Query: 505 GEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSF 564
+ + L++ + N + + ++ L L N++ + L
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHT 340
Query: 565 LEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSC 611
L+ L LS+N +D + +F N R + + C +L C
Sbjct: 341 LKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-30
Identities = 69/417 (16%), Positives = 140/417 (33%), Gaps = 62/417 (14%)
Query: 143 SSCSNLLSFVAYRNNLVGEIPEDIGYSWL-----KLEHISLARNHLTGMLPASIGNL-SI 196
SNL + + + +D+ + + + ++ + + + A + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 197 IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFS 256
L++ + Q + +++ + + N LP + +P L V + N S
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 257 GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTI 316
S+P IF L +L + NNL +
Sbjct: 131 -SLPRG-----------------------IFHNTPKLTTLSMSNNNLERIEDD------T 160
Query: 317 LTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLG 376
+ L+ L NRL V I +L + N +S + + + L
Sbjct: 161 FQATTSLQNLQLSSNRLTHVDLSLIPSL----FHANVSYNLLST-----LAIPIAVEELD 211
Query: 377 IEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP 436
N + + L + L N L + L N + ++ LS N L+ +
Sbjct: 212 ASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 266
Query: 437 SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVAL 496
+ L L +S+N+ + A+ I TL + LDL +NHL + L L
Sbjct: 267 PFVKMQRLERLYISNNR-LVALNLYGQPIPTL-KVLDLSHNHLL-HVERNQPQFDRLENL 323
Query: 497 YISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG----SIPLSLRSLKSIKELDLSCN 549
Y+ N + L+ L+ + N + ++ ++ ++ + D C
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARP-AVDDADQHCK 376
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 67/418 (16%), Positives = 145/418 (34%), Gaps = 57/418 (13%)
Query: 96 NLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYR 155
+++ E L + + N++ K+P L ++R
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL--------LDSFR 69
Query: 156 NNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSL 214
+E ++L + + + +I L++G N P
Sbjct: 70 Q----------------VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 113
Query: 215 YNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDL 274
N+ L ++L+ N + +LP I P L ++ +N ++F ++++ + L
Sbjct: 114 QNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 172
Query: 275 PINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLG 334
N T + + +L+ ++ N L + L ++ L N +
Sbjct: 173 SSNRLT---HVDLSLIPSLFHANVSYNLL-----------STLAIPIAVEELDASHNSIN 218
Query: 335 GVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQL 393
V L T + + N + T + + N L + + +N+L I ++
Sbjct: 219 VVRGPVNVEL----TILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKM 271
Query: 394 RNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNK 453
+ L+ + +S+N L + + + L LS NHL ++ + L +L L N
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 454 LIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTL 511
I + TL + L L +N + + + +N+ + +I L
Sbjct: 330 -IVTLKLSTH--HTL-KNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQL 381
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 34/250 (13%), Positives = 76/250 (30%), Gaps = 48/250 (19%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
L L + + + L + N++ N + +E L ++NS +
Sbjct: 168 QNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN- 218
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSI 196
+ ++ +L + L N+LT + +
Sbjct: 219 VVRGPVNV---------------------------ELTILKLQHNNLTD-TAWLLNYPGL 250
Query: 197 IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFS 256
+ + + N+ + M LE + + N L L +P L+V + N+
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ-PIPTLKVLDLSHNHLL 308
Query: 257 GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTI 316
+ + +E + L N ++ L +L L N+ + +
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW-----DCNSLRAL 359
Query: 317 LTNCSKLKVL 326
N ++ V
Sbjct: 360 FRNVARPAVD 369
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 71/298 (23%), Positives = 131/298 (43%), Gaps = 51/298 (17%)
Query: 685 NMIGQGSFGSVYKGIL---GENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLI 739
++G+G FGSV +G L VAVK + L + ++ F++E +++ H N+I
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+++ VC + +G ++ +M+ G L +L S + + L L +D+A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 800 IEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+EYL + + +H DL N +L DM V+DFGL++ ++ S
Sbjct: 160 MEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIY-----------SGDYYR 204
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGG 917
+G + +P K + + L + + S DV++ GV + E+ TR P + G
Sbjct: 205 QGRIAKMP----VKWIAIESLADRVYTSKS---DVWAFGVTMWEIATRGMTP----YP-G 252
Query: 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
+ HE + + + G R + E+CL + I +C P++R
Sbjct: 253 VQNHE---------MYDYLL--------HGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 78/383 (20%), Positives = 139/383 (36%), Gaps = 62/383 (16%)
Query: 614 KRSRKSTVLRLGKVGIPMIVSCLILSTCFIIVYARRRRSKQESSISVPMEQYFPMVSYSE 673
++ G G+ I S LST Q ++
Sbjct: 19 ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78
Query: 674 LSEATNEFSSSN-----MIGQGSFGSVYKGIL---GENGTFVAVKILN-LMQKGALKSFV 724
+ SS +IG+G FG VY G L AVK LN + G + F+
Sbjct: 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 138
Query: 725 AECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDL 784
E ++++ H N++ ++ +C +G+ +V YM++G L ++ P V DL
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL 194
Query: 785 SLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
+ + +A +++L VH DL N +LD V+DFGLAR ++ +
Sbjct: 195 -----IGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
FD+ + + +K L+ + S DV+S GV+L E+
Sbjct: 246 EFDSVHNKTGAKLPVKWM----AL---------ESLQTQKFTTKS---DVWSFGVLLWEL 289
Query: 904 FTR-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIR 962
TR P + + + + GRR + E C +
Sbjct: 290 MTRGAPP----YPD---------VN-TFDITVYLL--------QGRRLLQPEYCPDPLYE 327
Query: 963 IGVACSMESPIERMEMRDVLAKL 985
+ + C R ++++++
Sbjct: 328 VMLKCWHPKAEMRPSFSELVSRI 350
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 72/309 (23%), Positives = 126/309 (40%), Gaps = 52/309 (16%)
Query: 685 NMIGQGSFGSVYKGIL---GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLI 739
M+G+G FGSV + L + VAVK+L +++ ++ F+ E ++ H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 740 KIITVCSSIDFKGADFKAL-VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
K++ V KG + + +M++G L +L S +L L + +D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 799 AIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+EYL + +H DL N +L DM V+DFGL+R ++ S
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIY-----------SGDYY 193
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQG 916
+G +P K L L L + + S DV++ GV + E+ TR + P +
Sbjct: 194 RQGCASKLP----VKWLALESLADNLYTVHS---DVWAFGVTMWEIMTRGQTP----YA- 241
Query: 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976
G+ E + + G R + EC+ V + C P +R
Sbjct: 242 GIENAE---------IYNYLI--------GGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284
Query: 977 EMRDVLAKL 985
+ +L
Sbjct: 285 SFTCLRMEL 293
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-33
Identities = 68/396 (17%), Positives = 135/396 (34%), Gaps = 36/396 (9%)
Query: 209 TVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASN 268
+ +L ++ +D+ + +TL N ++ ++ +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFE-DITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 269 IEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAF 328
+E+++L + F + L +G N + + + N L VL
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH------VFQNVPLLTVLVL 130
Query: 329 EENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIP 387
E N L + N +T + M N + I +L L + N+LT ++
Sbjct: 131 ERNDLSSLPRGIFHNT-PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 187
Query: 388 REIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSL 447
+ + +L +S N L S+L + +L S N + + + L L
Sbjct: 188 --LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 237
Query: 448 NLSDNKLIGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFS 504
L N L + +DL N L + ++ L LYIS N+
Sbjct: 238 KLQHNNLT-----DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 291
Query: 505 GEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSF 564
+ + L++ + N + + ++ L L N++ + L
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHT 346
Query: 565 LEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLC 600
L+ L LS+N +D + +F N R + + C
Sbjct: 347 LKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 74/431 (17%), Positives = 142/431 (32%), Gaps = 47/431 (10%)
Query: 131 NNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPAS 190
+ + P SNL + + + +D+ + E I+L N+
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFG---FEDITL--NNQK------ 54
Query: 191 IGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAI 250
+ + L + +E + L+ + +Q +
Sbjct: 55 -------IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYM 106
Query: 251 GDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGAND 310
G N P F N + ++ L N + IF L +L + NNL +
Sbjct: 107 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD- 165
Query: 311 LDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLV 370
+ L+ L NRL V I +L + N +S + +
Sbjct: 166 -----TFQATTSLQNLQLSSNRLTHVDLSLIPSLFH----ANVSYNLLST-----LAIPI 211
Query: 371 NLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHL 430
+ L N + + + L + L N L + L N + ++ LS N L
Sbjct: 212 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266
Query: 431 QGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNL 490
+ + + L L +S+N+ + A+ I TL + LDL +NHL +
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTL-KVLDLSHNHLL-HVERNQPQF 323
Query: 491 KNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNN 550
L LY+ N + L+ L+ + N + + +L +++ + +
Sbjct: 324 DRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDAD 378
Query: 551 LSGQIPEFLEN 561
+I LE+
Sbjct: 379 QHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 70/325 (21%), Positives = 129/325 (39%), Gaps = 32/325 (9%)
Query: 258 SIPESFSNASNI----EIIDLPINYFTGKVSIIF--GRLKNLWSLDLGINNLGSGGANDL 311
PE SN+ D+ I+ T V F L N + + + A
Sbjct: 12 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA-- 69
Query: 312 DFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLV 370
+L + ++++L + ++ + ++ A T+ +YMG N I +P + N+
Sbjct: 70 ----LLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMGFNAIR-YLPPHVFQNVP 123
Query: 371 NLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNH 429
L +L +E N L+ ++PR I L + +S+N L+ + T + +L LSSN
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 430 LQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGN 489
L ++ +L N+S N L L I LD +N +N +
Sbjct: 183 LT-HVDL--SLIPSLFHANVSYNLL------STLAIPIAVEELDASHNSINV---VRGPV 230
Query: 490 LKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549
L L + N + + L GL + N + ++ ++ L +S N
Sbjct: 231 NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 288
Query: 550 NLSGQIPEFLENLSFLEYLNLSYNH 574
L + + + + L+ L+LS+NH
Sbjct: 289 RLV-ALNLYGQPIPTLKVLDLSHNH 312
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 74/469 (15%), Positives = 161/469 (34%), Gaps = 72/469 (15%)
Query: 121 LFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLAR 180
L + + N++ ++P + S+ ++E ++L
Sbjct: 50 LNNQKIVTFKNSTMR-------------------------KLPAALLDSFRQVELLNLND 84
Query: 181 NHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPS-LYNMSSLENILLDVNGFTGNLPLDI 238
+ + + +I L++G N +PP N+ L ++L+ N + +LP I
Sbjct: 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 142
Query: 239 GVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDL 298
P L ++ +N ++F ++++ + L N T + + +L+ ++
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSLFHANV 199
Query: 299 GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQI 358
N L + L ++ L N + V L T + + N +
Sbjct: 200 SYNLL-----------STLAIPIAVEELDASHNSINVVRGPVNVEL----TILKLQHNNL 244
Query: 359 SGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNL 417
T + + N L + + +N+L I +++ L+ + +S+N L + +
Sbjct: 245 --TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 418 TLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS--RFLDLG 475
+ L LS NHL ++ + L +L L N + L ++T + L L
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI------VTLKLSTHHTLKNLTLS 353
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535
+N + + + +N+ + +I L + + + P
Sbjct: 354 HNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH----GLCCKESDK-----PYLD 402
Query: 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGV 584
R L+ I + Q + Y G VP +G
Sbjct: 403 RLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 78/508 (15%), Positives = 166/508 (32%), Gaps = 63/508 (12%)
Query: 78 ELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEI-GFLFRLETLMLANNSFSG 136
++ + Q L+ + + + ++P + ++E L L +
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 88
Query: 137 KIPTN-LSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI--GN 193
+I T + + N + +P + + L + L RN L+ LP I
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 194 LSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDN 253
+ L + N + +SL+N+ L N T ++ L +P+L + N
Sbjct: 147 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYN 202
Query: 254 YFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313
S + + +E +D N + L L L NNL
Sbjct: 203 LLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTDTAW----- 249
Query: 314 VTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLN 373
L N L + N L ++ H + + +Y+ N++ + + L
Sbjct: 250 ---LLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLERLYISNNRLV-ALNLYGQPIPTLK 304
Query: 374 LLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGN 433
+L + N L ++ R Q L+ + L N + + L + +L LS N N
Sbjct: 305 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 360
Query: 434 IPPSLGNCKNLVSLNLSDNKLIGAVPQQ----ILTITTLSRFLDLGNNHLNGSLPLEVGN 489
+L +N+ + D + Q + + +LD ++ + +E
Sbjct: 361 SLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVE--- 415
Query: 490 LKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549
++ C+ + + + L+ ++L+ N
Sbjct: 416 ----------------KVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVN 459
Query: 550 NLSGQI----PEFLENLSFLEYLNLSYN 573
L ++ E ++ L+ L+ +
Sbjct: 460 ELRAEVQQLTNEQIQQEQLLQGLHAEID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 10/126 (7%), Positives = 29/126 (23%), Gaps = 25/126 (19%)
Query: 449 LSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP 508
+ + + + + E L N + + ++P
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYD-VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP 67
Query: 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568
L S + ++ L+L+ + ++ L
Sbjct: 68 -----------------------AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKL 104
Query: 569 NLSYNH 574
+ +N
Sbjct: 105 YMGFNA 110
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 16/112 (14%), Positives = 42/112 (37%), Gaps = 8/112 (7%)
Query: 74 QRVTELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANN 132
+ E+DL + + + + + L + ++ N + + L+ L L++N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
Query: 133 SFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLT 184
+ N L + N++V + + L++++L+ N
Sbjct: 312 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS---THHTLKNLTLSHNDWD 358
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 74/303 (24%), Positives = 116/303 (38%), Gaps = 59/303 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN-LMQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
IG+G+FG V+ G L + T VAVK + F+ E +L+ H N++++I VC
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ +V E +Q G +L ++ G L + L + D A+ +EYL
Sbjct: 182 T-----QKQPIYIVMELVQGGDFLTFL-RTEGAR----LRVKTLLQMVGDAAAGMEYLES 231
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS--IGIKGTVG 863
+H DL N L+ V +SDFG++R D + +K T
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWT-- 282
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLHE 922
P + YG S S DV+S G++L E F+ P + L+ +
Sbjct: 283 --APEALN---------YGRYSSES---DVWSFGILLWETFSLGASP----YP-NLSNQQ 323
Query: 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982
E V+ G R E C V R+ C P +R +
Sbjct: 324 ---------TREFVE--------KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366
Query: 983 AKL 985
+L
Sbjct: 367 QEL 369
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 56/357 (15%), Positives = 111/357 (31%), Gaps = 32/357 (8%)
Query: 237 DIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSL 296
+I ++ + D+ ++ +A N++ +DL N + + L L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 297 DLGINNLGSGGA--------------NDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIA 342
+L N L N + L ++ L N + V
Sbjct: 64 NLSSNVLYETLDLESLSTLRTLDLNNNYV---QELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 343 NLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTG-NIPREIGQLRNLQAIGL 401
+IY+ N+I+ G + L ++ N++ N L+ + L
Sbjct: 121 GK----KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQ 461
NF+ ++ + + L LSSN L + P + + ++L +NKL+ + +
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 462 ILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFH 521
+ L DL N + L KN ++ CT + H
Sbjct: 233 LRFSQNL-EHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 522 MQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSF----LEYLNLSYNH 574
L ++K + + + G E LE ++
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-33
Identities = 61/368 (16%), Positives = 124/368 (33%), Gaps = 26/368 (7%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+I E N + +I + + ++ + N+ LDL N L A D L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD------L 54
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377
+KL++L N L L + +L +T+ + + N + + ++ L
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESL-STLRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG-NIPP 436
N ++ + + + I L++N + G + + L L N + N
Sbjct: 107 ANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 437 SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVAL 496
+ L LNL N + V Q++ L + LDL +N L + E + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVV-FAKL-KTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 497 YISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIP 556
+ N+ I L LE F ++GN F K+ + ++ +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTG 277
Query: 557 EFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRS 616
+ E + + + ++ + L G +E C +
Sbjct: 278 QNEEECTVPTLGHYGAYCCE--DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 617 RKSTVLRL 624
+ +
Sbjct: 336 ARQREIDA 343
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 59/494 (11%), Positives = 135/494 (27%), Gaps = 80/494 (16%)
Query: 89 SLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNL 148
++ N + + + ++ + + ++ L L+ N S +L+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK- 59
Query: 149 LSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFS 207
LE ++L+ N L L + +L ++ L + N
Sbjct: 60 ------------------------LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93
Query: 208 GTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNAS 267
L S+E + N + + G N+ + +N + S
Sbjct: 94 -----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIY---LANNKITMLRDLDEGCRS 144
Query: 268 NIEIIDLPINYFTG-KVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVL 326
++ +DL +N + + L L+L N + V +KLK L
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD--------VKGQVVFAKLKTL 196
Query: 327 AFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNI 386
+LS+ N+++ + + + + + N+L I
Sbjct: 197 ----------------DLSS---------NKLA-FMGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 387 PREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVS 446
+ + +NL+ L N ++ ++ + C
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 447 LNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGS----LPLEVGNLKNLVALYISGNQ 502
+ +P + + GS L E N + Q
Sbjct: 289 GHYGAYC-CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 503 FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
+ I + + + R+ + ++ E
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQ 406
Query: 563 SFLEYLNLSYNHFD 576
S L+ L ++
Sbjct: 407 SPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 59/452 (13%), Positives = 126/452 (27%), Gaps = 41/452 (9%)
Query: 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNS 133
R + ++ +L+ + ++ ++L+ N ++ +LE L L++N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 134 FSGKIP-----------------TNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHI 176
+ L ++ + A NN+ + G ++I
Sbjct: 70 LYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-SRVSCSRGQG---KKNI 125
Query: 177 SLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLY-NMSSLENILLDVNGFTGNL 234
LA N +T + G + YL + N+ L + +LE++ L N
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-- 183
Query: 235 PLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLW 294
+ V L+ + N + + F +A+ + I L N + +NL
Sbjct: 184 -VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 295 SLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMG 354
DL N G D + +++ +A + + L T T + G
Sbjct: 241 HFDLRGNGFHCGTLRDF-----FSKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYG 292
Query: 355 VNQISGTIPSGIGNLVNLNLLGIEFNQLTGN----IPREIGQLRNLQAIGLSSNFLQGNI 410
L+ L G+ + E + I + I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 411 PSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSR 470
L L + L I + + L
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPLQL 411
Query: 471 FLDLGNNHLNGSLPLEVGNLKNLVALYISGNQ 502
+ + + + + + ++
Sbjct: 412 LRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 68/329 (20%), Positives = 129/329 (39%), Gaps = 57/329 (17%)
Query: 663 EQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGIL---GENGTFVAVKILN-LMQKG 718
+ V + + ++ + +IG+G FG VY G L AVK LN + G
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 719 ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ 778
+ F+ E ++++ H N++ ++ +C +G+ +V YM++G L ++
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHN 124
Query: 779 PEVCDLSLIQRLNIAIDMASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
P V DL + + +A ++YL VH DL N +LD V+DFGLA
Sbjct: 125 PTVKDL-----IGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897
R ++ + + + + + +K L+ + S DV+S G
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWM----AL---------ESLQTQKFTTKS---DVWSFG 219
Query: 898 VMLLEMFTR-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEEC 956
V+L E+ TR P + + + + GRR + E C
Sbjct: 220 VLLWELMTRGAPP----YPD---------VN-TFDITVYLL--------QGRRLLQPEYC 257
Query: 957 LVTVIRIGVACSMESPIERMEMRDVLAKL 985
+ + + C R ++++++
Sbjct: 258 PDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 50/238 (21%), Positives = 100/238 (42%), Gaps = 22/238 (9%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G+G F V +G F A+K + ++ + E ++ R H N+++++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94
Query: 747 SIDFKGADFKA-LVYEYMQNGSLEEWL--HQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ +GA +A L+ + + G+L + + G L+ Q L + + + +E +
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF----LTEDQILWLLLGICRGLEAI 150
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS-METQSSSIGIKGTV 862
H H DLKP+N+LL + + D G + T + T+
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
Y P ++ ++ + + E + DV+SLG +L M P + +FQ G ++
Sbjct: 208 SYRAP----ELFSVQ--SHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 71/319 (22%), Positives = 126/319 (39%), Gaps = 57/319 (17%)
Query: 663 EQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGIL---GENGTFVAVKILN-LMQKG 718
V + S +IG+G FG VY G +N A+K L+ + +
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 719 ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ 778
+++F+ E ++R H N++ +I + +G ++ YM +G L +++
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQRN 120
Query: 779 PEVCDLSLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
P V DL ++ + +A +EYL VH DL N +LD V+DFGLA
Sbjct: 121 PTVKDL-----ISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLA 171
Query: 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897
R + R + + + + + + +K T L+ + S DV+S G
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWT----AL---------ESLQTYRFTTKS---DVWSFG 215
Query: 898 VMLLEMFTR-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEEC 956
V+L E+ TR P ++ + P + + GRR + E C
Sbjct: 216 VLLWELLTRGAPP----YRH---------ID-PFDLTHFLA--------QGRRLPQPEYC 253
Query: 957 LVTVIRIGVACSMESPIER 975
++ ++ C P R
Sbjct: 254 PDSLYQVMQQCWEADPAVR 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 33/243 (13%)
Query: 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNT 733
S + + + S+++GQG+ +V++G + G A+K+ N + + + E EVL+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQ---SNGQPEVCDLSLIQRL 790
H+N++K+ + + K L+ E+ GSL L + + G PE L +++
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR-- 119
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARPFD 846
D+ + +L + IVH ++KP N++ D V ++DFG AR L D
Sbjct: 120 ----DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDD 169
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
+ + GT Y+ P M L + T D++S+GV T
Sbjct: 170 EQFVS------LYGTEEYLHP----DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 907 RRP 909
P
Sbjct: 220 SLP 222
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 62/316 (19%), Positives = 116/316 (36%), Gaps = 25/316 (7%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+I E N + +I + + ++ + N+ LDL N L A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377
+KL++L N L L + +L +T+ + + N + + ++ L
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESL-STLRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG-NIPP 436
N ++ + GQ + I L++N + G + + L L N + N
Sbjct: 107 ANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 437 SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVAL 496
+ L LNL N + V Q++ L + LDL +N L + E + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVV-FAKL-KTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 497 YISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR-GSIPLSLRSLKSIKELDLSCN-NLSGQ 554
+ N+ I L LE F ++GN F G++ + ++ + L+GQ
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 555 IPEFLENLSFLEYLNL 570
E + Y
Sbjct: 279 NEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 44/262 (16%), Positives = 98/262 (37%), Gaps = 17/262 (6%)
Query: 316 ILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375
I N ++ K+ ++ L L + + ++ + N +S + + L LL
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSA-WNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 376 GIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435
+ N L ++ L L+ + L++N++ L + L ++N++ +
Sbjct: 64 NLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG-SLPLEVGNLKNLV 494
S G + ++ L++NK+ + + ++LDL N ++ + + L
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 495 ALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554
L + N ++ L+ + N + +S + + L N L
Sbjct: 173 HLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 555 IPEFLENLSFLEYLNLSYNHFD 576
I + L LE+ +L N F
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 45/230 (19%), Positives = 84/230 (36%), Gaps = 21/230 (9%)
Query: 362 IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMT 421
I N + + + L + N++ + LS N L + L T +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 422 DLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL--IGAVPQ-QILT-----ITTLS---- 469
L LSSN L L + L +L+L++N + + P + L I+ +S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRG 119
Query: 470 ---RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG-EIPVTLTGCTGLEIFHMQGN 525
+ + L NN + L+ G + L + N+ LE ++Q N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
+ +K LDLS N L+ + ++ + + +++L N
Sbjct: 180 FIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 50/394 (12%), Positives = 116/394 (29%), Gaps = 82/394 (20%)
Query: 89 SLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNL 148
++ N + + + ++ + + ++ L L+ N S +L+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK- 59
Query: 149 LSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFS 207
LE ++L+ N L L + +L ++ L + N
Sbjct: 60 ------------------------LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93
Query: 208 GTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNAS 267
L S+E + N + + + + +N + S
Sbjct: 94 -----ELLVGPSIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRS 144
Query: 268 NIEIIDLPINYFTG-KVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVL 326
++ +DL +N + + L L+L N + V +KLK L
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD--------VKGQVVFAKLKTL 196
Query: 327 AFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNI 386
+LS+ N+++ + + + + + N+L I
Sbjct: 197 ----------------DLSS---------NKLA-FMGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 387 PREIGQLRNLQAIGLSSNFLQ-GNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLV 445
+ + +NL+ L N G + + + + + +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVP 286
Query: 446 SLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHL 479
+L +P R + LG++H
Sbjct: 287 TLGHYGAYCCEDLPA-----PFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 2/93 (2%)
Query: 482 SLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSI 541
++ N ++ + + ++ + GN L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 542 KELDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574
+ L+LS N L + + E+LS L L+L+ N+
Sbjct: 61 ELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNY 91
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 74/304 (24%), Positives = 110/304 (36%), Gaps = 59/304 (19%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL---GENGTFVAVKILN---LMQKGALKSFVAECEVLRN 732
+ +G GSFG V +G VAVK L L Q A+ F+ E + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
HRNLI++ V + K +V E GSL + L + G L
Sbjct: 78 LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 126
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
A+ +A + YL +H DL N+LL + + DFGL R L D + +
Sbjct: 127 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-DHYVMQE 182
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTN 911
+ P L+ S AS D + GV L EMFT + P
Sbjct: 183 HRKVPFAWC----AP---------ESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEP-- 224
Query: 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971
GL + ++ +D +G R + E+C + + V C
Sbjct: 225 ---WIGLNGSQ---------ILHKID-------KEGERLPRPEDCPQDIYNVMVQCWAHK 265
Query: 972 PIER 975
P +R
Sbjct: 266 PEDR 269
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 80/315 (25%), Positives = 136/315 (43%), Gaps = 62/315 (19%)
Query: 687 IGQGSFGSVYKGIL---GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKI 741
IG G G V G L G+ VA+K L ++ F++E ++ H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRL 115
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
V + +G +V EYM+NGSL+ +L +GQ +++Q + + + + +
Sbjct: 116 EGVVT----RGRLA-MIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAGMR 165
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
YL VH DL NVL+D ++V VSDFGL+R L P D + T I I+ T
Sbjct: 166 YLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-DAAYTTTGGKIPIRWT 221
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTL 920
P + + S AS DV+S GV++ E+ RP + +T
Sbjct: 222 ----AP---------EAIAFRTFSSAS---DVWSFGVVMWEVLAYGERP----YW-NMTN 260
Query: 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER---ME 977
+ V+ +V+ +G R C + ++ + C + +R +
Sbjct: 261 RD---------VISSVE--------EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 978 MRDVLAKLCAARQTL 992
+ VL L + ++L
Sbjct: 304 IVSVLDALIRSPESL 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 74/346 (21%), Positives = 125/346 (36%), Gaps = 53/346 (15%)
Query: 662 MEQYFPMVSYSELSEATNEFSSSNM-----IGQGSFGSVYKGIL----GENGTFVAVKIL 712
M + + + F ++ +G+G+FGSV G VAVK L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 713 NLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL 772
+ F E ++L+ ++K V G LV EY+ +G L ++L
Sbjct: 61 QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFL 117
Query: 773 HQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHV 831
+ + L + L + + +EYL C VH DL N+L++ + +
Sbjct: 118 QRHRAR-----LDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKI 168
Query: 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891
+DFGLA+ L D + + I P L + S S
Sbjct: 169 ADFGLAKLLPLDK-DYYVVREPGQSPIFWY----AP---------ESLSDNIFSRQS--- 211
Query: 892 DVYSLGVMLLEMFTR-RRP-TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRR 949
DV+S GV+L E+FT + + + E AL ++E ++ +G+R
Sbjct: 212 DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-LLELLE--------EGQR 262
Query: 950 RAKVEECLVTVIRIGVACSMESPIER---MEMRDVLAKLCAARQTL 992
C V + C SP +R + L L + +
Sbjct: 263 LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-32
Identities = 32/289 (11%), Positives = 64/289 (22%), Gaps = 51/289 (17%)
Query: 647 ARRRRSKQESSISVPMEQY-FPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGT 705
A + + +++ + S LS+ + + G V+ E
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 706 FVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLI---------------------KI 741
A+K+ + L+ +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV-CDLSLIQRLNIAIDMASAI 800
+ D L+ LE + D ++ + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
L +VHG P N+ + D + D T S
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA-----LWKVGTRGPASS------V 253
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
V Y P L + + LG+ + ++ P
Sbjct: 254 PVTYAPR------EFLNASTATFTHAL----NAWQLGLSIYRVWCLFLP 292
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-32
Identities = 68/397 (17%), Positives = 130/397 (32%), Gaps = 78/397 (19%)
Query: 172 KLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFT 231
+++ + LT LP + I L + +N + ++P
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA-HITTLVIPDNNLT-SLPALP----------------- 80
Query: 232 GNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLK 291
P L+ + N + S+P + I P+ +
Sbjct: 81 -----------PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPS 121
Query: 292 NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDI 351
L L + N L S + L+ L+ +N+L LP + L +
Sbjct: 122 GLCKLWIFGNQLTS----------LPVLPPGLQELSVSDNQLA-SLPALPSEL----CKL 166
Query: 352 YMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIP 411
+ NQ++ ++P L L++ NQL ++P +L L +N L ++P
Sbjct: 167 WAYNNQLT-SLPMLPSGLQELSVSD---NQLA-SLPTLPSELYKLW---AYNNRLT-SLP 217
Query: 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF 471
+ L +L +S N L ++P L L +S N+L ++P + L
Sbjct: 218 ALPSGLK---ELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPM---LPSGL-LS 265
Query: 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531
L + N L LP + +L + + + GN S L T + F +
Sbjct: 266 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568
+ R +++ + + L
Sbjct: 325 ASAPRETRAL--HLAAADWLVPAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 71/364 (19%), Positives = 131/364 (35%), Gaps = 77/364 (21%)
Query: 218 SSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPIN 277
+ + + +G T LP + ++ I DN + S+P + +++ N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 278 YFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVL 337
T + ++ L L + +L + + L L N+L L
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----------PALPSG---LCKLWIFGNQLT-SL 136
Query: 338 PHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQ 397
P L ++ + NQ++ ++P+ L L NQLT ++P L+ L
Sbjct: 137 PVLPPGL----QELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQELS 187
Query: 398 AIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA 457
+S N L ++P+ L L+ +N L ++P L L +S N+L +
Sbjct: 188 ---VSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLPALPSG---LKELIVSGNRL-TS 235
Query: 458 VPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGL 517
+P + L + L + N L SLP+ L +L + NQ +
Sbjct: 236 LPV---LPSEL-KELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT------------- 274
Query: 518 EIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG 577
+P SL L S ++L N LS + + L ++ + FD
Sbjct: 275 ------------RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDM 322
Query: 578 EVPT 581
+
Sbjct: 323 AGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-24
Identities = 71/421 (16%), Positives = 123/421 (29%), Gaps = 102/421 (24%)
Query: 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNS 133
+T L + N+ SL L R + ++ N +P L L
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 134 FSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGN 193
+P+ L L N + +P L+ +S++ N L LPA
Sbjct: 116 LP-ALPSGLCK----LWI---FGNQLTSLPVLPP----GLQELSVSDNQLA-SLPALPSE 162
Query: 194 LSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDN 253
L L NQ + +LP+ LQ ++ DN
Sbjct: 163 LC--KLWAYNNQLT-------------------------SLPMLPS----GLQELSVSDN 191
Query: 254 YFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313
+ S+P L LW+ + + +L +
Sbjct: 192 QLA-SLPTL------------------------PSELYKLWAYNNRLTSLPA-------- 218
Query: 314 VTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLN 373
S LK L NRL LP + L ++ + N+++ ++P L++L+
Sbjct: 219 -----LPSGLKELIVSGNRLTS-LPVLPSEL----KELMVSGNRLT-SLPMLPSGLLSLS 267
Query: 374 LLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGN 433
+ NQLT +P + L + + L N L +L +T
Sbjct: 268 V---YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMA 323
Query: 434 IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNL 493
+ + L VP + R+ G + L + L
Sbjct: 324 GASAPRETRALHLAA-----ADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
Query: 494 V 494
Sbjct: 379 E 379
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-15
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 20/135 (14%)
Query: 441 CKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISG 500
LN+ ++ L +P + T L + +N+L SLP L+ L +SG
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPAHIT---TLVIPDNNLT-SLPALPPELRT---LEVSG 90
Query: 501 NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLE 560
NQ + +PV G L IF + +L + N L+ +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPP 141
Query: 561 NLSFLEYLNLSYNHF 575
L+ L++S N
Sbjct: 142 G---LQELSVSDNQL 153
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+GSF +VYKG+ E VA L + K + F E E+L+ +H N+++
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
S KG LV E M +G+L+ +L + +++ + +++LH
Sbjct: 94 WESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKI----KVLRS--WCRQILKGLQFLH 146
Query: 805 HHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
PPI+H DLK N+ + + D GLA S + + GT
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----------RASFAKAVIGTPE 195
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
++ P + +Y DVY+ G+ +LEM T P
Sbjct: 196 FMAPEMYEE-------KYDESV------DVYAFGMCMLEMATSEYP 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 68/311 (21%), Positives = 116/311 (37%), Gaps = 49/311 (15%)
Query: 687 IGQGSFGSVYKGIL----GENGTFVAVKIL-NLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G FG V G VAVK L + E E+LRN H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+C+ G + L+ E++ +GSL+E+L ++ + ++L Q+L A+ + ++
Sbjct: 89 KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGMD 140
Query: 802 YLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YL VH DL NVL++ + + DFGL + + + +
Sbjct: 141 YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDRDSPVFW 195
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT--RRRPTNCMFQGGL 918
P CL AS DV+S GV L E+ T + +
Sbjct: 196 Y----AP---------ECLMQSKFYIAS---DVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER--- 975
+M + ++ T+ +G+R C V ++ C P R
Sbjct: 240 IGPTHGQMTVTR-LVNTLK--------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF 290
Query: 976 MEMRDVLAKLC 986
+ + L
Sbjct: 291 QNLIEGFEALL 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 57/229 (24%), Positives = 88/229 (38%), Gaps = 28/229 (12%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNL--IK 740
IG G V++ L E A+K +NL L S+ E L + + I+
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ + +V E N L WL + + +M A+
Sbjct: 93 LYDY-----EITDQYIYMVMECG-NIDLNSWLKKKKSIDP----WERKS--YWKNMLEAV 140
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
+H H IVH DLKP+N L+ M+ + DFG+A + ++Q G
Sbjct: 141 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ------VG 190
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
TV Y+PP K ++ S+ S DV+SLG +L M + P
Sbjct: 191 TVNYMPP-EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 66/321 (20%), Positives = 113/321 (35%), Gaps = 16/321 (4%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
++PE + ++DL N F +L L+L N + +
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AF 76
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLG 376
N L+ L NRL + LS +T + + N+I + + +L NL L
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGLSN-LTKLDISENKIV-ILLDYMFQDLYNLKSLE 134
Query: 377 IEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435
+ N L I L +L+ + L L +L +L + L L ++
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLV 494
S L L +S + + L L L + + +L ++P +L L
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL-TSLSITHCNLT-AVPYLAVRHLVYLR 251
Query: 495 ALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554
L +S N S L L+ + G P + R L ++ L++S N L+
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL 311
Query: 555 IPEFLENLSFLEYLNLSYNHF 575
++ LE L L N
Sbjct: 312 EESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 68/315 (21%), Positives = 125/315 (39%), Gaps = 18/315 (5%)
Query: 243 PNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINN 302
++ +G N + F++ ++E ++L N + F L NL +L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 303 LGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTI 362
L + T S L L EN++ +L + +L + + +G N + I
Sbjct: 92 LKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDL-YNLKSLEVGDNDLV-YI 143
Query: 363 PSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLM 420
L +L L +E LT +IP E L L + L + S L +
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202
Query: 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLN 480
L +S + P+ NL SL+++ + AVP + RFL+L N ++
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN-LTAVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 481 GSLPLEV-GNLKNLVALYISGNQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPLSL-RS 537
++ + L L + + G Q + + G L + ++ GN ++ S+ S
Sbjct: 262 -TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 538 LKSIKELDLSCNNLS 552
+ +++ L L N L+
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-20
Identities = 61/313 (19%), Positives = 120/313 (38%), Gaps = 14/313 (4%)
Query: 98 SFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNN 157
+ R ++L N E LE L L N S P ++ NL + N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 158 LVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYN 216
L IP + L + ++ N + +L +L ++ L VG+N +
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 217 MSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPI 276
++SLE + L+ T ++P + L L V + + SF ++++++
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 277 NYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGV 336
+ ++ NL SL + NL + + ++ + + L+ L N + +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTA-----VPYLA-VRHLVYLRFLNLSYNPISTI 263
Query: 337 LPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLR 394
+ L + +I + Q++ + L L +L + NQLT + + +
Sbjct: 264 EGSMLHEL-LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVG 320
Query: 395 NLQAIGLSSNFLQ 407
NL+ + L SN L
Sbjct: 321 NLETLILDSNPLA 333
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 52/240 (21%), Positives = 99/240 (41%), Gaps = 34/240 (14%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN 737
++F ++GQG+FG V K + + A+K + + L + ++E +L + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 738 LIKIITV-----CSSIDFKGADFKALVY---EYMQNGSLEEWLHQSNGQPEVCDLSLIQR 789
+++ K+ ++ EY +NG+L + +H N + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-----DEY 118
Query: 790 LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
+ + A+ Y+H I+H DLKP N+ +D + DFGLA+ + +
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 850 ETQSSSIGIK------GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
++Q+ GT YV + + Y E D+YSLG++ EM
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH-----YN---EKI---DMYSLGIIFFEM 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 65/317 (20%)
Query: 687 IGQGSFGSVYKGIL----GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIK 740
IG G FG VYKG+L G+ VA+K L +K + F+ E ++ H N+I+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIR 110
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ V S ++ EYM+NG+L+++L + +G+ S++Q + + +A+ +
Sbjct: 111 LEGVISK-----YKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGIAAGM 160
Query: 801 EYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+YL + + VH DL N+L++ ++V VSDFGL+R L P + + T I I+
Sbjct: 161 KYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EATYTTSGGKIPIR 215
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGL 918
T P + Y + AS DV+S G+++ E+ T RP + L
Sbjct: 216 WT----AP---------EAISYRKFTSAS---DVWSFGIVMWEVMTYGERP----YW-EL 254
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER--- 975
+ HE VM+ ++ DG R +C + ++ + C + R
Sbjct: 255 SNHE---------VMKAIN--------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF 297
Query: 976 MEMRDVLAKLCAARQTL 992
++ +L KL A +L
Sbjct: 298 ADIVSILDKLIRAPDSL 314
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-31
Identities = 62/234 (26%), Positives = 114/234 (48%), Gaps = 37/234 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHR 736
+ + + +G G +G VY+G+ + VAVK L + M+ + F+ E V++ +H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 276
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
NL++++ VC+ + F ++ E+M G+L ++L + N Q +S + L +A +
Sbjct: 277 NLVQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNRQE----VSAVVLLYMATQI 327
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+SA+EYL +H +L N L+ + + V+DFGL+R + + +T ++
Sbjct: 328 SSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM-------TGDTYTAHA 377
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
G K + + P L Y S S DV++ GV+L E+ T P
Sbjct: 378 GAKFPIKWTAP---------ESLAYNKFSIKS---DVWAFGVLLWEIATYGMSP 419
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 78/316 (24%), Positives = 136/316 (43%), Gaps = 64/316 (20%)
Query: 687 IGQGSFGSVYKGIL---GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G G FG V G L + VA+K L +K F+ E ++ H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
V + + +V EYM+NGSL+ +L + + Q ++IQ + + +AS ++
Sbjct: 112 EGVVTK-----SKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMK 161
Query: 802 YL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YL VH DL N+L++ ++V VSDFGL R L P + + T+ I I+
Sbjct: 162 YLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTRGGKIPIRW 216
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLT 919
T P + Y + AS DV+S G++L E+ + RP + ++
Sbjct: 217 T----SP---------EAIAYRKFTSAS---DVWSYGIVLWEVMSYGERP----YW-EMS 255
Query: 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER---M 976
+ V++ VD +G R +C + ++ + C + R
Sbjct: 256 NQD---------VIKAVD--------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 977 EMRDVLAKLCAARQTL 992
++ +L KL +L
Sbjct: 299 QIVSILDKLIRNPGSL 314
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 52/251 (20%), Positives = 96/251 (38%), Gaps = 43/251 (17%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV 729
+++ +F +IG G FG V+K +G +K + + A + E +
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKA 57
Query: 730 LRNTRHRNLIK--------IITVCSSIDFKGADFKALVY---EYMQNGSLEEWLHQSNGQ 778
L H N++ +S ++ E+ G+LE+W+ + G+
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 779 PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838
L + L + + ++Y+H +++ DLKPSN+ L + DFGL
Sbjct: 118 K----LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898
L + KGT+ Y+ P I+ +YG D+Y+LG+
Sbjct: 171 SL-----KNDGKRTR----SKGTLRYMSPEQISSQ------DYGKEV------DLYALGL 209
Query: 899 MLLEMFTRRRP 909
+L E+
Sbjct: 210 ILAELLHVCDT 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 67/318 (21%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENG----TFVAVKIL--NLMQKGALKSFVAECEVLRN 732
EF ++G G+FG+VYKG+ G VA+K L K A K + E V+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
+ ++ +++ +C + + L+ + M G L +++ + + LN
Sbjct: 74 VDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN-----IGSQYLLNW 122
Query: 793 AIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
+ +A + YL VH DL NVL+ ++DFGLA+ L +
Sbjct: 123 CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHA 176
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPT 910
+ + IK + + + + S DV+S GV + E+ T +P
Sbjct: 177 EGGKVPIKWM----AL---------ESILHRIYTHQS---DVWSYGVTVWELMTFGSKP- 219
Query: 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970
+ G+ E + ++ G R + C + V I C M
Sbjct: 220 ---YD-GIPASE---------ISSILE--------KGERLPQPPICTIDVYMIMRKCWMI 258
Query: 971 SPIER---MEMRDVLAKL 985
R E+ +K+
Sbjct: 259 DADSRPKFRELIIEFSKM 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 27/240 (11%)
Query: 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNT 733
S + + + S+++GQG+ +V++G + G A+K+ N + + + E EVL+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
H+N++K+ + + K L+ E+ GSL L + + L + L +
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVL 118
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARPFDTSM 849
D+ + +L + IVH ++KP N++ D V ++DFG AR L D
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQF 172
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ + GT Y+ P M L + T D++S+GV T P
Sbjct: 173 VS------LYGTEEYLHP----DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRN 737
+F +G+G FG V++ + A+K + L ++ A + + E + L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 738 LIK----IITVCSSIDFKGADFKALVY---EYMQNGSLEEWLHQSNGQPEVCDLSLIQRL 790
+++ + ++ + + K +Y + + +L++W++ E + S+ L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVC--L 121
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL----FARPFD 846
+I + +A A+E+LH ++H DLKPSN+ D V V DFGL + +
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
T M + G GT Y+ P I Y D++SLG++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGN------SYSHKV------DIFSLGLILFELLY 225
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 34/232 (14%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNL--IK 740
IG G V++ L E A+K +NL L S+ E L + + I+
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ + +V E N L WL + +R + +M A+
Sbjct: 74 LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW------ERKSYWKNMLEAV 121
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
+H H IVH DLKP+N L+ M+ + DFG+A + ++Q G
Sbjct: 122 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ------VG 171
Query: 861 TVGYVPP---GNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
TV Y+PP +++ + + ++ DV+SLG +L M + P
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKS----DVWSLGCILYYMTYGKTP 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 43/226 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGA-LKSFVAECEVLRNTRHRNLIKIITVC 745
IG+G FG V G G VAVK + A ++F+AE V+ RH NL++++ V
Sbjct: 29 IGKGEFGDVMLGDY--RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL-H 804
+ +V EYM GSL ++L L L ++D+ A+EYL
Sbjct: 84 V----EEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEG 135
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
++ VH DL NVL+ D VA VSDFGL + + S + + +K T
Sbjct: 136 NNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT--- 181
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
P L S S DV+S G++L E+++ R P
Sbjct: 182 -AP---------EALREKKFSTKS---DVWSFGILLWEIYSFGRVP 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 46/297 (15%)
Query: 687 IGQGSFGSVYKGIL----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKII 742
+G+G+FGSV G VAVK L + L+ F E E+L++ +H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
VC S + L+ EY+ GSL ++L + + + I+ L + +EY
Sbjct: 78 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEY 129
Query: 803 LH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
L +H DL N+L++++ + DFGL + L + + I
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWY 184
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT---RRRPTNCMFQGGL 918
P L S AS DV+S GV+L E+FT + + F +
Sbjct: 185 ----AP---------ESLTESKFSVAS---DVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
+ +M + ++E + + R + + C + I C + +R
Sbjct: 229 GNDKQGQMIVFH-LIELLK--------NNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 67/322 (20%), Positives = 114/322 (35%), Gaps = 73/322 (22%)
Query: 669 VSYSELSEATNEFSSSN------MIGQGSFGSVYKGILGENG--TFVAVKIL--NLMQKG 718
++ E+ +G G+FG+V KG VAVKIL
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 719 ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ 778
+AE V++ + ++++I +C + + LV E + G L ++L Q N
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKYL-QQNRH 113
Query: 779 PEVCDLSLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
+ + + ++ ++YL + VH DL NVLL A +SDFGL+
Sbjct: 114 -----VKDKNIIELVHQVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 838 RFLFARPFDTSMETQSSSIG---IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894
+ L ++ + G +K P C+ Y S S DV+
Sbjct: 165 KALR----ADENYYKAQTHGKWPVKWY----AP---------ECINYYKFSSKS---DVW 204
Query: 895 SLGVMLLEMFTR-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKV 953
S GV++ E F+ ++P G+ E V ++ G R
Sbjct: 205 SFGVLMWEAFSYGQKP-----YRGMKGSE---------VTAMLE--------KGERMGCP 242
Query: 954 EECLVTVIRIGVACSMESPIER 975
C + + C R
Sbjct: 243 AGCPREMYDLMNLCWTYDVENR 264
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 59/271 (21%), Positives = 98/271 (36%), Gaps = 38/271 (14%)
Query: 648 RRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFV 707
R+ + + + +S +S IG G V++ L E
Sbjct: 25 FERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIY 83
Query: 708 AVKILNL--MQKGALKSFVAECEVLRNTRHRNL--IKIITVCSSIDFKGADFKALVYEYM 763
A+K +NL L S+ E L + + I++ + +V E
Sbjct: 84 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMEC- 137
Query: 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823
N L WL + + +M A+ +H H IVH DLKP+N L+
Sbjct: 138 GNIDLNSWLKKKKSIDP----WERKS--YWKNMLEAVHTIHQHG---IVHSDLKPANFLI 188
Query: 824 DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPP-----GNIAKMLNLPC 878
M+ + DFG+A + DT+ + S + G V Y+PP + ++
Sbjct: 189 VDGML-KLIDFGIANQM---QPDTTSVVKDSQV---GAVNYMPPEAIKDMSSSRENGKSK 241
Query: 879 LEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ S DV+SLG +L M + P
Sbjct: 242 SKISPKS------DVWSLGCILYYMTYGKTP 266
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 78/306 (25%), Positives = 135/306 (44%), Gaps = 64/306 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G G +G VY+G+ + VAVK L + M+ + F+ E V++ +H NL++++ V
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL- 803
C+ + F ++ E+M G+L ++L + N Q +S + L +A ++SA+EYL
Sbjct: 78 CT----REPPF-YIITEFMTYGNLLDYLRECNRQE----VSAVVLLYMATQISSAMEYLE 128
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
+ +H DL N L+ + + V+DFGL+R + DT + IK T
Sbjct: 129 KKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWT-- 179
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLHE 922
P ++A Y S S DV++ GV+L E+ T P + G+ L +
Sbjct: 180 --APESLA---------YNKFSIKS---DVWAFGVLLWEIATYGMSP----YP-GIDLSQ 220
Query: 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER---MEMR 979
V E ++ R + E C V + AC +P +R E+
Sbjct: 221 ---------VYELLE--------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 263
Query: 980 DVLAKL 985
+
Sbjct: 264 QAFETM 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G FG V G G VAVK + + + +F+AE V+ RH NL++++ V
Sbjct: 201 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 254
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ +V EYM GSL ++L L L ++D+ A+EYL
Sbjct: 255 IV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLE 306
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+ VH DL NVL+ D VA VSDFGL + + S + + +K T
Sbjct: 307 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT--- 353
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
P L S S DV+S G++L E+++ R P
Sbjct: 354 -AP---------EALREKKFSTKS---DVWSFGILLWEIYSFGRVP 386
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 60/304 (19%)
Query: 687 IGQGSFGSVYKGIL----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKII 742
+G+G+FGSV G VAVK L + L+ F E E+L++ +H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
VC S + L+ EY+ GSL ++L + + + I+ L + +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEY 160
Query: 803 LH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
L +H DL N+L++++ + DFGL + L P D
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEY------------ 201
Query: 862 VGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSLGVMLLEMFT---RRRPTN 911
Y + P L S AS DV+S GV+L E+FT + +
Sbjct: 202 --YKVKEP-GE---SPIFWYAPESLTESKFSVAS---DVWSFGVVLYELFTYIEKSKSPP 252
Query: 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971
F + + +M + ++E + + R + + C + I C +
Sbjct: 253 AEFMRMIGNDKQGQMIVFH-LIELLK--------NNGRLPRPDGCPDEIYMIMTECWNNN 303
Query: 972 PIER 975
+R
Sbjct: 304 VNQR 307
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 53/242 (21%), Positives = 105/242 (43%), Gaps = 24/242 (9%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN-TRHRNLIKIITV 744
++ +G F VY+ +G A+K L ++ ++ + E ++ + H N+++ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 745 CSSI--DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
S + + L+ + G L E+L + + LS L I A+++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP---LSCDTVLKIFYQTCRAVQH 151
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS----IGI 858
+H +PPI+H DLK N+LL + + DFG A + P + + + I
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918
T Y P ++++L + +G + D+++LG +L + R+ P F+ G
Sbjct: 211 NTTPMYRTP----EIIDLY-SNFPIGEKQ----DIWALGCILYLLCFRQHP----FEDGA 257
Query: 919 TL 920
L
Sbjct: 258 KL 259
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 65/316 (20%), Positives = 113/316 (35%), Gaps = 75/316 (23%)
Query: 687 IGQGSFGSVYKGIL---GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKI 741
IG+G FG V++GI VA+K + F+ E +R H +++K+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 81
Query: 742 ITVCSS----IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
I V + I + E G L +L L L + A ++
Sbjct: 82 IGVITENPVWI----------IMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLS 126
Query: 798 SAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+A+ YL VH D+ NVL+ + + DFGL+R++ T + +
Sbjct: 127 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKL 179
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQ 915
IK P + + + AS DV+ GV + E+ +P FQ
Sbjct: 180 PIKWM----AP---------ESINFRRFTSAS---DVWMFGVCMWEILMHGVKP----FQ 219
Query: 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
G+ ++ V+ ++ +G R C T+ + C P R
Sbjct: 220 -GVKNND---------VIGRIE--------NGERLPMPPNCPPTLYSLMTKCWAYDPSRR 261
Query: 976 ---MEMRDVLAKLCAA 988
E++ L+ +
Sbjct: 262 PRFTELKAQLSTILEE 277
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 62/404 (15%), Positives = 129/404 (31%), Gaps = 51/404 (12%)
Query: 173 LEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFT 231
A + S L ++ L + + + ++ L ++ N T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 232 GNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLK 291
LD+ NL A N + ++ + + + ++ N T + +
Sbjct: 78 T---LDLS-QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNP 127
Query: 292 NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDI 351
L L+ N L ++D +++ ++L L N+ L + T +T +
Sbjct: 128 LLTYLNCARNTL-----TEID----VSHNTQLTELDCHLNKKITKLD--VTPQ-TQLTTL 175
Query: 352 YMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIP 411
N+I+ + + LN L + N +T + + Q L + SSN L I
Sbjct: 176 DCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID 228
Query: 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF 471
+ LT +T S N L + S L +L+ L + +T ++
Sbjct: 229 --VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL------LEIDLTHNTQL 277
Query: 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531
+ L+V + L L + E+ L+ L ++ +
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL 333
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
+S +K L ++ + + L +
Sbjct: 334 DVS--HNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 67/403 (16%), Positives = 127/403 (31%), Gaps = 53/403 (13%)
Query: 172 KLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFT 231
L + + +T + + L N + T+ S ++L + D N T
Sbjct: 43 TLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKLT 98
Query: 232 GNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLK 291
NL + L L N + + S + ++ N T I
Sbjct: 99 -NLDVT---PLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNT 148
Query: 292 NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDI 351
L LD +N + +T ++L L N++ + ++ + +
Sbjct: 149 QLTELDCHLNKKIT--------KLDVTPQTQLTTLDCSFNKITEL---DVSQN-KLLNRL 196
Query: 352 YMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIP 411
N I+ + + + L L N+LT I + L L S N L
Sbjct: 197 NCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDV 250
Query: 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS-- 469
S+L LT L L I L + L+ + I + L +T +
Sbjct: 251 STLSKLT---TLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI-----KELDVTHNTQL 299
Query: 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG 529
LD + L++ LV LY++ + + E+ ++ T L+ +
Sbjct: 300 YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ- 352
Query: 530 SIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSY 572
S+ + ++ + E L N S ++
Sbjct: 353 DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 63/439 (14%), Positives = 138/439 (31%), Gaps = 61/439 (13%)
Query: 78 ELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGK 137
+ + + L+ L ++ ++ ++ I L L L+ +N+ +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT- 78
Query: 138 IPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSII 197
+LS +NL N L + KL +++ N LT L S N +
Sbjct: 79 --LDLSQNTNLTYLACDSNKLT-NLD---VTPLTKLTYLNCDTNKLTK-LDVS-QNPLLT 130
Query: 198 YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG 257
YL+ N + + S + + L + +N L + L N +
Sbjct: 131 YLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKIT- 183
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+ S + ++ N T + + L LD N L ++D
Sbjct: 184 ELD--VSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKL-----TEIDV---- 229
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377
T ++L N L + +++ L T ++ + + L+ G
Sbjct: 230 TPLTQLTYFDCSVNPLTELDVSTLSKL----TTLHCIQTDLLEIDLTHNTQLIYFQAEGC 285
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437
++ ++ L + + + + L + L+L++ L +
Sbjct: 286 --RKIK---ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD-- 334
Query: 438 LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALY 497
+ + L SL+ + I +++ + L NN G +
Sbjct: 335 VSHNTKLKSLSCVNA--------HIQDFSSVGKIPALNNNFEAE------GQTITMPKET 380
Query: 498 ISGNQFSGEIPVTLTGCTG 516
++ N + + L G
Sbjct: 381 LTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 62/379 (16%), Positives = 125/379 (32%), Gaps = 51/379 (13%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
T+L NI + + + L Y+ +N + + L +L L N +
Sbjct: 67 TKLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT- 119
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWL-KLEHISLARNHLTGMLPASIGNLS 195
++S L RN L +I S +L + N L +
Sbjct: 120 --KLDVSQNPLLTYLNCARNTL-----TEIDVSHNTQLTELDCHLNKKITKLDVT-PQTQ 171
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
+ L N+ + + L + D N T L L+ L N
Sbjct: 172 LTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKL 224
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVT 315
+ I + + + D +N T + L L +L +L ++D
Sbjct: 225 T-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDL-----LEID--- 270
Query: 316 ILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375
LT+ ++L E R L + + T + + I+ + + L L
Sbjct: 271 -LTHNTQLIYFQAEGCRKIKELD--VTHN-TQLYLLDCQAAGIT-ELD--LSQNPKLVYL 323
Query: 376 GIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435
+ +LT + + L+++ + +Q + S +G + + + F +
Sbjct: 324 YLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPK 378
Query: 436 PSLGNCKNLVSLNLSDNKL 454
+L N N +++ +S + L
Sbjct: 379 ETLTN--NSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 58/374 (15%), Positives = 114/374 (30%), Gaps = 60/374 (16%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
T L + +L V L+ L Y+N TN ++ + L L A N+ +
Sbjct: 88 TYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT- 140
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-S 195
++S + L + N + ++ +L + + N +T + +
Sbjct: 141 --EIDVSHNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKITEL---DVSQNKL 192
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
+ L+ N + L L + N T + + L L F N
Sbjct: 193 LNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EIDVT---PLTQLTYFDCSVNPL 245
Query: 256 SGSIPESFSN-----ASNIEIIDLPINYFTGKV-----------SIIFGRLKNLWSLDLG 299
+ + S +++++ + + T + + L+ LD
Sbjct: 246 TELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQ 305
Query: 300 INNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQIS 359
+ +LD + KL L L + +++ T + + I
Sbjct: 306 AAGI-----TELDL----SQNPKLVYLYLNNTELTEL---DVSHN-TKLKSLSCVNAHIQ 352
Query: 360 GTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQ-AIGLSSNFLQGNI----PSSL 414
S +G + LN Q +P+E +L A+ GN P
Sbjct: 353 -DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDG 409
Query: 415 GNLTLMTDLFLSSN 428
G T+ N
Sbjct: 410 GVYDQATNTITWEN 423
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-30
Identities = 48/238 (20%), Positives = 82/238 (34%), Gaps = 43/238 (18%)
Query: 686 MIGQGSFGSVYKGI-LGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIIT 743
I G G +Y + NG V +K L A +AE + L H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
D G +V EY+ SL+ Q L + + + +++ A+ YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--------LPVAEAIAYLLEILPALSYL 198
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H +V+ DLKP N++L + + + D G + + GT G
Sbjct: 199 HSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----------NSFGYLY--GTPG 242
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921
+ P E +V D+Y++G L + G
Sbjct: 243 FQAP------------EIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNGRYVDG 283
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 5e-30
Identities = 45/293 (15%), Positives = 95/293 (32%), Gaps = 46/293 (15%)
Query: 645 VYARRRRSKQESSIS-VPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGEN 703
+ +S +S +S P SEL E ++GQ + + E
Sbjct: 38 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 97
Query: 704 GTFVAVKILNLMQKGA------LKSFVAECEVLRNTRH-------------RNLIKIITV 744
G V + ++ +K V +LR ++ +L+K
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 745 CSSIDFKGADFKA------LVYEYMQ--NGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
I + + +Y MQ + E L + + L RL + + +
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQV 215
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ LHH+ +VH L+P +++LD ++ F + +
Sbjct: 216 IRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE-----HLVRDGARVVSS---- 263
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ G+ PP + + + + D ++LG+++ ++ P
Sbjct: 264 ---VSRGFEPP-ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 76/323 (23%), Positives = 114/323 (35%), Gaps = 65/323 (20%)
Query: 687 IGQGSFGSVYKGIL----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G FG V G VAVK L + E ++LR H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
C GA LV EY+ GSL ++L + + + L Q L A + +
Sbjct: 99 KGCCED---AGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 148
Query: 802 YLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH H +H DL NVLLD+D + + DFGLA+ + G
Sbjct: 149 YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-----------------G 187
Query: 861 TVGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSLGVMLLEMFT--RRRPTN 911
Y + P CL+ AS DV+S GV L E+ T +
Sbjct: 188 HEYYRVRED-GD---SPVFWYAPECLKEYKFYYAS---DVWSFGVTLYELLTHCDSSQSP 240
Query: 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971
L +M + + E ++ G R + ++C V + C
Sbjct: 241 PTKFLELIGIAQGQMTVLR-LTELLE--------RGERLPRPDKCPAEVYHLMKNCWETE 291
Query: 972 PIER---MEMRDVLAKLCAARQT 991
R + +L + Q
Sbjct: 292 ASFRPTFENLIPILKTVHEKYQG 314
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-30
Identities = 44/292 (15%), Positives = 85/292 (29%), Gaps = 52/292 (17%)
Query: 648 RRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFV 707
+ + + P SEL E ++GQ + + E G
Sbjct: 47 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106
Query: 708 AVKILNLMQK---GALKSFVAECEVLRNTRH----------------RNLIKIITVCSSI 748
V + ++ A+K E LR R +L+K I
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 749 DFKGAD--------FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ + F + E L + + L RL + + + +
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQVIRLL 224
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
LHH+ +VH L+P +++LD ++ F S +
Sbjct: 225 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE-----HLVRDGASAVSP-------I 269
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTG---DVYSLGVMLLEMFTRRRP 909
G+ PP A + ++ D ++LG+ + ++ P
Sbjct: 270 GRGFAPPETTA-----ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 57/252 (22%), Positives = 98/252 (38%), Gaps = 46/252 (18%)
Query: 670 SYSELSEATNEFSSSNM--------IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGA 719
S + T +M IG+GSFG E+G +K +N+ M
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 720 LKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ- 778
+ E VL N +H N+++ F+ +V +Y + G L + ++ G
Sbjct: 67 REESRREVAVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 779 -PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
E I L+ + + A++++H I+H D+K N+ L D + DFG+A
Sbjct: 122 FQE----DQI--LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIA 172
Query: 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897
R L + T ++ GT Y+ P Y S D+++LG
Sbjct: 173 RVLNS----TVELARA----CIGTPYYLSPEICENK------PYNNKS------DIWALG 212
Query: 898 VMLLEMFTRRRP 909
+L E+ T +
Sbjct: 213 CVLYELCTLKHA 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 69/316 (21%), Positives = 121/316 (38%), Gaps = 63/316 (19%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENG----TFVAVKILN-LMQKGALKSFVAECEVLRNT 733
E ++G G FG+V+KG+ G V +K++ + + ++ + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
H ++++++ +C + LV +Y+ GSL + + Q G L LN
Sbjct: 73 DHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWG 121
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+ +A + YL H +VH +L NVLL V+DFG+A L D +
Sbjct: 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSE 176
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNC 912
+ IK + +G + S DV+S GV + E+ T P
Sbjct: 177 AKTPIKWM----AL---------ESIHFGKYTHQS---DVWSYGVTVWELMTFGAEP--- 217
Query: 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972
GL L E V + ++ G R A+ + C + V + V C M
Sbjct: 218 --YAGLRLAE---------VPDLLE--------KGERLAQPQICTIDVYMVMVKCWMIDE 258
Query: 973 IER---MEMRDVLAKL 985
R E+ + ++
Sbjct: 259 NIRPTFKELANEFTRM 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 70/293 (23%), Positives = 111/293 (37%), Gaps = 63/293 (21%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG G FG V+ G N VA+K + M + + F+ E EV+ H L+++ V
Sbjct: 16 IGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL- 803
C LV E+M++G L ++L G + L + +D+ + YL
Sbjct: 72 CLE-----QAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYLE 121
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
+H DL N L+ + V VSDFG+ RF+ D + + +K
Sbjct: 122 EACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWA-- 172
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLHE 922
P + S S DV+S GV++ E+F+ + P
Sbjct: 173 --SP---------EVFSFSRYSSKS---DVWSFGVLMWEVFSEGKIP------------- 205
Query: 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
+ + E V+E + G R K V +I C E P +R
Sbjct: 206 YENRSNSE-VVEDIS--------TGFRLYKPRLASTHVYQIMNHCWRERPEDR 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 67/325 (20%), Positives = 122/325 (37%), Gaps = 65/325 (20%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL----GENGTFVAVKIL--NLMQKGALKSFVAECEVLRN 732
EF ++G G+FG+VYKG+ + VA+K L K A K + E V+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
+ ++ +++ +C + + L+ + M G L +++ + + LN
Sbjct: 74 VDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN-----IGSQYLLNW 122
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
+ +A + YL +VH DL NVL+ ++DFGLA+ L + +
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAE 177
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTN 911
+ IK + + + + S DV+S GV + E+ T +P
Sbjct: 178 GGKVPIKWM----AL---------ESILHRIYTHQS---DVWSYGVTVWELMTFGSKP-- 219
Query: 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971
G+ E + ++ G R + C + V I V C M
Sbjct: 220 ---YDGIPASE---------ISSILE--------KGERLPQPPICTIDVYMIMVKCWMID 259
Query: 972 PIER---MEMRDVLAKLCAARQTLV 993
R E+ +K+ Q +
Sbjct: 260 ADSRPKFRELIIEFSKMARDPQRYL 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 59/237 (24%), Positives = 91/237 (38%), Gaps = 37/237 (15%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIIT 743
IG GS+G K +G + K L+ M + + V+E +LR +H N I+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
I + +V EY + G L + Q L L + + A++
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY----LDEEFVLRVMTQLTLALK 125
Query: 802 YLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
H ++H DLKP+NV LD + DFGLAR L + + +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFAKTFV--- 177
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GT Y+ P + +M Y S D++SLG +L E+ P F
Sbjct: 178 GTPYYMSPEQMNRM------SYNEKS------DIWSLGCLLYELCALMPP----FTA 218
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-29
Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+GQG FG V+ G VA+K L M ++F+ E +V++ RH L+++ V
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
S +V EYM GSL ++L G+ L L Q +++A +AS + Y+
Sbjct: 248 VSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 297
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
VH DL+ +N+L+ ++V V+DFGLAR + + Q + IK T
Sbjct: 298 RMN---YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWT--- 348
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
P YG + S DV+S G++L E+ T+ R P
Sbjct: 349 -AP---------EAALYGRFTIKS---DVWSFGILLTELTTKGRVP 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 71/300 (23%)
Query: 687 IGQGSFGSVYKGIL--GENGTFVAVKIL----NLMQKGALKSFVAECEVLRNTRHRNLIK 740
+G G+FGSV +G+ + VA+K+L + + E +++ + +++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 74
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+I VC + LV E G L ++L + + + + ++ +
Sbjct: 75 LIGVCQAEALM------LVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGM 123
Query: 801 EYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG-- 857
+YL + VH DL NVLL + A +SDFGL++ L + S G
Sbjct: 124 KYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKW 175
Query: 858 -IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQ 915
+K P C+ + S S DV+S GV + E + ++P
Sbjct: 176 PLKWY----AP---------ECINFRKFSSRS---DVWSYGVTMWEALSYGQKP-----Y 214
Query: 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
+ E VM ++ G+R EC + + C + +R
Sbjct: 215 KKMKGPE---------VMAFIE--------QGKRMECPPECPPELYALMSDCWIYKWEDR 257
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 43/228 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V+ G T VAVK L M +F+AE +++ +H+ L+++ V
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAV 76
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL- 803
+ + ++ EYM+NGSL ++L +G L++ + L++A +A + ++
Sbjct: 77 VTQ------EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIE 126
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS-IGIKGTV 862
+ +H DL+ +N+L+ + ++DFGLAR + D + + IK T
Sbjct: 127 ERNY----IHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWT- 177
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
P I YG + S DV+S G++L E+ T R P
Sbjct: 178 ---APEAIN---------YGTFTIKS---DVWSFGILLTEIVTHGRIP 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 63/293 (21%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V G VA+K++ M + F+ E +V+ N H L+++ V
Sbjct: 32 LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL- 803
C+ ++ EYM NG L +L + + Q L + D+ A+EYL
Sbjct: 88 CTK-----QRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEYLE 137
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
+H DL N L++ V VSDFGL+R++ D + S ++ +
Sbjct: 138 SKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWS-- 188
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLHE 922
PP + Y S S D+++ GV++ E+++ + P ++ T E
Sbjct: 189 --PPEVLM---------YSKFSSKS---DIWAFGVLMWEIYSLGKMP----YE-RFTNSE 229
Query: 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
E + G R + V I +C E ER
Sbjct: 230 ---------TAEHIA--------QGLRLYRPHLASEKVYTIMYSCWHEKADER 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 57/296 (19%), Positives = 113/296 (38%), Gaps = 64/296 (21%)
Query: 687 IGQGSFGSVYKGIL---GENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G FG VY+G+ VAVK + F++E +++N H +++K+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFMSEAVIMKNLDHPHIVKL 78
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
I + + ++ E G L +L ++ +V L + ++ + A+
Sbjct: 79 IGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMA 127
Query: 802 YL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YL +C VH D+ N+L+ + DFGL+R++ + + + + IK
Sbjct: 128 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED---EDYYKASVTRLPIKW 180
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLT 919
P + + + AS DV+ V + E+ + ++P F L
Sbjct: 181 M----SP---------ESINFRRFTTAS---DVWMFAVCMWEILSFGKQP----FF-WLE 219
Query: 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
+ V+ ++ G R K + C + + C P +R
Sbjct: 220 NKD---------VIGVLE--------KGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 82/515 (15%), Positives = 176/515 (34%), Gaps = 70/515 (13%)
Query: 76 VTELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSF 134
T L++ I L +LS LR + ++ N F LE L L++N
Sbjct: 23 TTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 135 SGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM-LPASIGN 193
+S + V L+H+ L+ N + + GN
Sbjct: 82 VK------------ISC----HPTV------------NLKHLDLSFNAFDALPICKEFGN 113
Query: 194 L-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDI--GVTLPNLQVFAI 250
+ + +L + + + +++ + +L+ + + +L +
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 251 GDNYFSGSIPESFSNASNIEIIDLPINYFTGK----VSIIFGRLKNLWSLDLGINNLGSG 306
+ F + S +N+E+ ++ K +SI+ N +L +NN+
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI-ET 232
Query: 307 GANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTT----MTDIYMGVNQISGTI 362
N + L + + + +L G L + S T ++ + +
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 363 PSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTD 422
N+N+ + ++ + S+N L + + G+LT +
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 423 LFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGS 482
L L N L+ + + SL + LD+ N ++
Sbjct: 353 LILQMNQLK-ELSKIAEMTTQMKSL----------------------QQLDISQNSVSYD 389
Query: 483 LPLEV-GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSI 541
K+L++L +S N + I L +++ + N + SIP + L+++
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEAL 446
Query: 542 KELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
+EL+++ N L + L+ L+ + L N +D
Sbjct: 447 QELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 5e-19
Identities = 64/411 (15%), Positives = 132/411 (32%), Gaps = 37/411 (9%)
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
L++ +N S + ++S L +++ N L + + L+ + N
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNK 80
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTG-KVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313
I N++ +DL N F + FG + L L L +L +
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 314 VTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLN 373
+ I +L E P + + +T I + I ++
Sbjct: 138 LNISKV-----LLVLGETYGEKEDPEGLQDFNTESLHI----VFPTNKEFHFILDVSVKT 188
Query: 374 LLGIEFNQLTGN-----------IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTL--- 419
+ +E + + I ++ L + L++ N + L
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 420 MTDLFLSSNHLQGNIPPSLGNC--KNLVSLNLSD--NKLIGAVPQQILTITTLSRFLDLG 475
+ +S+ LQG + + +L +L++ + + G I I + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLS- 534
+ L + + L S N + + T LE +Q N + +
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA 367
Query: 535 --LRSLKSIKELDLSCNNLSGQIP-EFLENLSFLEYLNLSYNHFDGEVPTK 582
+KS+++LD+S N++S L LN+S N +
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 60/370 (16%), Positives = 114/370 (30%), Gaps = 33/370 (8%)
Query: 243 PNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINN 302
+ I NY S + S + I+ + N +F + L LDL N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 303 LGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHS--IANLSTTMTDIYMGVNQISG 360
L + LK L N LP N+ + + + + +
Sbjct: 81 LVK-----ISC----HPTVNLKHLDLSFNAFD-ALPICKEFGNM-SQLKFLGLSTTHLEK 129
Query: 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLM 420
+ I +L +L + + L++ L F + ++++
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 421 TDLFLSSNHLQGN-----------IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS 469
T L ++++ I L L +L L++ + +IL + +
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 470 R--FLDLGNNHLNGSLPLEVG-----NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHM 522
+ + N L G L +LK L + + F + + I +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 523 QGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK 582
+ R L + LD S N L+ + E +L+ LE L L N
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367
Query: 583 GVFSNKTRVQ 592
+ + +Q
Sbjct: 368 EMTTQMKSLQ 377
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 73/303 (24%), Positives = 120/303 (39%), Gaps = 63/303 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V G VAVK++ M + F E + + H L+K V
Sbjct: 16 LGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL- 803
CS K +V EY+ NG L +L +S+G+ L Q L + D+ + +L
Sbjct: 72 CS----KEYPI-YIVTEYISNGCLLNYL-RSHGK----GLEPSQLLEMCYDVCEGMAFLE 121
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H +H DL N L+D D+ VSDFG+ R++ D + + + +K +
Sbjct: 122 SHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWS-- 172
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLHE 922
P Y S S DV++ G+++ E+F+ + P + T E
Sbjct: 173 --APEVFH---------YFKYSSKS---DVWAFGILMWEVFSLGKMP----YD-LYTNSE 213
Query: 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982
V+ V G R + T+ +I +C E P +R + +L
Sbjct: 214 ---------VVLKVS--------QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLL 256
Query: 983 AKL 985
+ +
Sbjct: 257 SSI 259
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 52/236 (22%), Positives = 94/236 (39%), Gaps = 38/236 (16%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN-TRHRNL 738
F +++G G+ G++ + + VAVK + E ++LR H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNV 80
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
I+ K F+ + E +L+E++ Q + ++ + + S
Sbjct: 81 IRYFCT-----EKDRQFQYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTS 129
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+ +LH IVH DLKP N+L+ + A +SDFGL + L + S
Sbjct: 130 GLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL-----AVGRHSFS 181
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G+ GT G++ P +ML+ C E D++S G + + +
Sbjct: 182 RRSGVPGTEGWIAP----EMLSEDCKE-NPTYTV----DIFSAGCVFYYVISEGSH 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+GQG FG V+ G VA+K L M ++F+ E +V++ RH L+++ V
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
S +V EYM GSL ++L G+ L L Q +++A +AS + Y+
Sbjct: 331 VSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE 380
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
VH DL+ +N+L+ ++V V+DFGLAR + + Q + IK T
Sbjct: 381 RMN---YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWT--- 431
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
P YG + S DV+S G++L E+ T+ R P
Sbjct: 432 -AP---------EAALYGRFTIKS---DVWSFGILLTELTTKGRVP 464
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 66/334 (19%), Positives = 116/334 (34%), Gaps = 44/334 (13%)
Query: 238 IGVTLPNLQVFAIGDNYFSGSIP----ESFSNASNIEIIDLPINYFTGKVSIIF-GRLKN 292
+ + LP F++ N F +I + FS E LP VS++ +
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 293 LWSLDLGINNLGSGGANDLDFVTIL--TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTD 350
L L NL + L ++ VL +N L LP A+L
Sbjct: 61 FSELQLNRLNL-----------SSLPDNLPPQITVLEITQNALI-SLPELPASL----EY 104
Query: 351 IYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNI 410
+ N++S T+P +L +L++ NQLT +P L + +N L +
Sbjct: 105 LDACDNRLS-TLPELPASLKHLDVDN---NQLT-MLPELPALLEYI---NADNNQLT-ML 155
Query: 411 PSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL--IGAVPQQILTITTL 468
P +L L + +N L +P + L +L++S N L + AVP +
Sbjct: 156 PELPTSLE---VLSVRNNQLTF-LPELPES---LEALDVSTNLLESLPAVPVRNHHSEET 208
Query: 469 SRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528
F N + +P + +L + + N S I +L+ T +H F
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
Query: 529 GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
S + + + + +
Sbjct: 268 MSDGQQNTLHRPLADAVT--AWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 61/296 (20%), Positives = 103/296 (34%), Gaps = 44/296 (14%)
Query: 295 SLDLGINNLGSGGANDL---------DFVTILTNCSKLKVLAFEENRLGGVLPHSI-ANL 344
S+ L INN S N D+ + K + N +L +
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61
Query: 345 STTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSN 404
+++ + +S ++P + + +L I N L ++P L L N
Sbjct: 62 ----SELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYLD---ACDN 110
Query: 405 FLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILT 464
L +P +L L + +N L +P L +N +N+L +P+
Sbjct: 111 RLS-TLPELPASLK---HLDVDNNQLT-MLPELPAL---LEYINADNNQL-TMLPELP-- 159
Query: 465 ITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLE----IF 520
T+L L + NN L LP +L+ L +S N +P E F
Sbjct: 160 -TSL-EVLSVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFF 212
Query: 521 HMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
+ N IP ++ SL + L N LS +I E L + + +F
Sbjct: 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-20
Identities = 55/322 (17%), Positives = 97/322 (30%), Gaps = 63/322 (19%)
Query: 114 IPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLK- 172
I I F L N + S + A E + +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISG--TYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 173 LEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG 232
+ L R +L+ LP ++ I L + +N ++P ++ L+ N +
Sbjct: 61 FSELQLNRLNLSS-LPDNLPP-QITVLEITQNALI-SLPELPASLEYLD---ACDNRLS- 113
Query: 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKN 292
LP +L+ + +N + +PE
Sbjct: 114 TLPELPA----SLKHLDVDNNQLT-MLPEL---------------------------PAL 141
Query: 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIY 352
L ++ N L + + L+VL+ N+L LP +L +
Sbjct: 142 LEYINADNNQLTM----------LPELPTSLEVLSVRNNQLT-FLPELPESL----EALD 186
Query: 353 MGVNQISGTIPSGIGNLVNLNLLGIEF----NQLTGNIPREIGQLRNLQAIGLSSNFLQG 408
+ N + ++P+ + I F N++T +IP I L I L N L
Sbjct: 187 VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244
Query: 409 NIPSSLGNLTLMTDLFLSSNHL 430
I SL T D +
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYF 266
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKILNLMQKGA----LKSFVAECEVLRNTRHRN 737
+GQGSFG VY+G+ E T VA+K +N + A F+ E V++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL----HQSNGQPEVCDLSLIQRLNIA 793
+++++ V S ++ E M G L+ +L P + SL + + +A
Sbjct: 90 VVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 794 IDMASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
++A + YL+ + VH DL N ++ D + DFG+ R +
Sbjct: 145 GEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR-----------DIY 189
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
+ KG G +P + ++ L+ G+ + S DV+S GV+L E+ T
Sbjct: 190 ETDYYRKGGKGLLP----VRWMSPESLKDGVFTTYS---DVWSFGVVLWEIATL 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-28
Identities = 66/345 (19%), Positives = 123/345 (35%), Gaps = 74/345 (21%)
Query: 648 RRRRSKQESSISVP-MEQYFPMVSYSELSEATN----EFSSSNM-----IGQGSFGSVYK 697
++ + ++SV + Y ++ + + E + IG+G FG V++
Sbjct: 349 NEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQ 408
Query: 698 GIL---GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752
GI VA+K + F+ E +R H +++K+I V +
Sbjct: 409 GIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKLIGVIT------ 461
Query: 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH-HHCQPPI 811
+ ++ E G L +L L L + A +++A+ YL
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLESKRF---- 512
Query: 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIA 871
VH D+ NVL+ + + DFGL+R++ T + + IK P
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWM----AP---- 561
Query: 872 KMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLHEFCKMALPE 930
+ + + AS DV+ GV + E+ +P FQ G+ ++
Sbjct: 562 -----ESINFRRFTSAS---DVWMFGVCMWEILMHGVKP----FQ-GVKNND-------- 600
Query: 931 KVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
V+ ++ +G R C T+ + C P R
Sbjct: 601 -VIGRIE--------NGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V+ ++ VAVK + M ++F+AE V++ +H L+K+ V
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLVKLHAV 251
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ + ++ E+M GSL ++L G L + ++ + +A + ++
Sbjct: 252 VTK------EPIYIITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIE 301
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+H DL+ +N+L+ +V ++DFGLAR + D + G K + +
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTARE---GAKFPIKW 351
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
P + +G + S DV+S G++L+E+ T R P
Sbjct: 352 TAP---------EAINFGSFTIKS---DVWSFGILLMEIVTYGRIP 385
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-28
Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G G FG V + I + G VA+K + + + E ++++ H N++ V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 745 C-SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
D L EY + G L ++L+Q C L + D++SA+ YL
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYL 137
Query: 804 HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
H + I+H DLKP N++L ++ + D G A+ L G
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTE------FVG 185
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915
T+ Y+ P ++L +Y VT D +S G + E T RP +Q
Sbjct: 186 TLQYLAP----ELLE--QKKYT------VTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 63/267 (23%), Positives = 95/267 (35%), Gaps = 44/267 (16%)
Query: 648 RRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFV 707
+R + E + V + + V Y E E + + +G+GSFG V++ + G
Sbjct: 28 QRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 708 AVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA----LVYEYM 763
AVK + L + E ++ GA + + E +
Sbjct: 87 AVKKVRL--EVFRVE---ELVACAGLSSPRIVP---------LYGAVREGPWVNIFMELL 132
Query: 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823
+ GSL + + Q PE +EYLH I+HGD+K NVLL
Sbjct: 133 EGGSLGQLIKQMGCLPE----DRAL--YYLGQALEGLEYLHTRR---ILHGDVKADNVLL 183
Query: 824 DHD-MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYG 882
D A + DFG A L S+ T I GT ++ P E
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAP------------EVV 228
Query: 883 MGSEASVTGDVYSLGVMLLEMFTRRRP 909
MG D++S M+L M P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 61/325 (18%), Positives = 119/325 (36%), Gaps = 71/325 (21%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKIL--NLMQKGALKSFVAECEVLRN-TRHRNL 738
+G+G+FG V + VAVK+L ++ ++E ++L + H N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 93
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL----------HQSNGQPEVCDLSLIQ 788
+ ++ C+ ++ E+ + G+L +L + L+L
Sbjct: 94 VNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 789 RLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
+ + +A +E+L C +H DL N+LL V + DFGLAR +
Sbjct: 150 LICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDI------- 198
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR- 906
++ +P K + + + + S DV+S GV+L E+F+
Sbjct: 199 ----YKDPDYVRKGDARLP----LKWMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLG 247
Query: 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVA 966
P + G + + E+ + +G R + + + +
Sbjct: 248 ASP----YPG---------VKIDEEFCRRLK--------EGTRMRAPDYTTPEMYQTMLD 286
Query: 967 CSMESPIER---MEMRDVLAKLCAA 988
C P +R E+ + L L A
Sbjct: 287 CWHGEPSQRPTFSELVEHLGNLLQA 311
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 65/242 (26%), Positives = 102/242 (42%), Gaps = 57/242 (23%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G+FG V+ ++ VAVK L A K F E E+L N +H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWL----------HQSNGQPEVCDLSLIQRLN 791
VC G +V+EYM++G L ++L + +L L Q L+
Sbjct: 83 YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 792 IAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
IA +AS + YL H VH DL N L+ +++ + DFG++R +++
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD------ 187
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSLGVMLLEM 903
Y G LP + Y + S DV+S GV+L E+
Sbjct: 188 -------------YYRVGGHTM---LPIRWMPPESIMYRKFTTES---DVWSFGVILWEI 228
Query: 904 FT 905
FT
Sbjct: 229 FT 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 59/294 (20%)
Query: 687 IGQGSFGSVYKGIL-GENGTF-VAVKIL-NLMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G G+FGSV +G+ VA+K+L +K + + E +++ + ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
VC + LV E G L ++L + + + + ++ ++YL
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKYL 452
Query: 804 -HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
+ VH +L NVLL + A +SDFGL++ L A + +K
Sbjct: 453 EEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWY- 506
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLH 921
P C+ + S S DV+S GV + E + ++P
Sbjct: 507 ---AP---------ECINFRKFSSRS---DVWSYGVTMWEALSYGQKP------------ 539
Query: 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
+ KM PE VM ++ G+R EC + + C + +R
Sbjct: 540 -YKKMKGPE-VMAFIE--------QGKRMECPPECPPELYALMSDCWIYKWEDR 583
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 49/241 (20%), Positives = 100/241 (41%), Gaps = 56/241 (23%)
Query: 687 IGQGSFGSVYKGIL-------GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLI 739
+GQG+F ++KG+ + T V +K+L+ + +SF ++ H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
VC D LV E+++ GSL+ +L ++ ++++ +L +A +A+A
Sbjct: 76 LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLAAA 125
Query: 800 IEYL-HHHCQPPIVHGDLKPSNVLLDHD--------MVAHVSDFGLARFLFARPFDTSME 850
+ +L + +HG++ N+LL + +SD G++ + +
Sbjct: 126 MHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--------LP 173
Query: 851 TQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMG-SEASVTGDVYSLGVMLLEMFTR-RR 908
I PP C+E + A+ D +S G L E+ + +
Sbjct: 174 KDILQERIPWV----PP---------ECIENPKNLNLAT---DKWSFGTTLWEICSGGDK 217
Query: 909 P 909
P
Sbjct: 218 P 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 42/234 (17%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G+FG V+ ++ VAVK L + A + F E E+L +H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWL---------HQSNGQPEVCDLSLIQRLNI 792
VC+ +G +V+EYM++G L +L L L Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 793 AIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
A +A+ + YL H VH DL N L+ +V + DFG++R +++ D
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST--DYYRVG 217
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ + I+ PP + Y + S DV+S GV+L E+FT
Sbjct: 218 GRTMLPIRWM----PP---------ESILYRKFTTES---DVWSFGVVLWEIFT 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 65/319 (20%), Positives = 122/319 (38%), Gaps = 77/319 (24%)
Query: 644 IVYARRRRSKQESSISVPMEQYFPMVSYSELSEATN----EFSSSN-----MIGQGSFGS 694
+ Y +++ K + + ++ + ++ EF +N +G G+FG
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGK 61
Query: 695 VYKGIL-----GENGTFVAVKILNLMQKGA----LKSFVAECEVLRN-TRHRNLIKIITV 744
V + + VAVK+L A ++ ++E +++ + +H N++ ++
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHENIVNLLGA 118
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWL--------HQSNGQPEVCDLSLIQRLNIAIDM 796
C+ G ++ EY G L +L S L+ + +
Sbjct: 119 CT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 797 ASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
A + +L +C +H D+ NVLL + VA + DFGLAR
Sbjct: 174 AQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARD---------------- 213
Query: 856 IGIKGTVGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSLGVMLLEMFTR-R 907
I Y+ GN A+ LP + + + S DV+S G++L E+F+
Sbjct: 214 --IMNDSNYIVKGN-AR---LPVKWMAPESIFDCVYTVQS---DVWSYGILLWEIFSLGL 264
Query: 908 RPTNCMFQGGLTLHEFCKM 926
P + G L +F K+
Sbjct: 265 NP----YPGILVNSKFYKL 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 61/268 (22%), Positives = 102/268 (38%), Gaps = 43/268 (16%)
Query: 645 VYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENG 704
+ Q P Y + ++ IG+G F VY+ +G
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIE----------KKIGRGQFSEVYRAACLLDG 57
Query: 705 TFVAVK---ILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYE 761
VA+K I +LM A + E ++L+ H N +I +S F + +V E
Sbjct: 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN---VIKYYAS--FIEDNELNIVLE 112
Query: 762 YMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNV 821
G L + Q + + + + SA+E++H ++H D+KP+NV
Sbjct: 113 LADAGDLSRMIKHFKKQKRLIPERTV--WKYFVQLCSALEHMHSRR---VMHRDIKPANV 167
Query: 822 LLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEY 881
+ V + D GL RF +S T + S + GT Y+ P E
Sbjct: 168 FITATGVVKLGDLGLGRFF------SSKTTAAHS--LVGTPYYMSP------------ER 207
Query: 882 GMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ + D++SLG +L EM + P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
++G+G++G VY G N +A+K + + E + ++ +H+N+++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83
Query: 746 SSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
+ G+ + + E + GSL L G + + I + ++
Sbjct: 84 ----YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLK 136
Query: 802 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH + IVH D+K NVL++ + V +SDFG ++ L + G
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL--------AGINPCTETFTG 185
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T+ Y+ P ++++ YG + D++SLG ++EM T + P
Sbjct: 186 TLQYMAP----EIIDKGPRGYGKAA------DIWSLGCTIIEMATGKPP 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 46/237 (19%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLI 739
+G+ FG VYKG L GE VA+K L + F E + +H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-LREEFRHEAMLRARLQHPNVV 75
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWL----------HQSNGQPEVCDLSLIQR 789
++ V + K ++++ Y +G L E+L + + L
Sbjct: 76 CLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 790 LNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
+++ +A+ +EYL HH VH DL NVL+ + +SD GL R ++A D
Sbjct: 131 VHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAA--DYY 184
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+S + I+ P + YG S S D++S GV+L E+F+
Sbjct: 185 KLLGNSLLPIRWM----AP---------EAIMYGKFSIDS---DIWSYGVVLWEVFS 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 77/329 (23%), Positives = 130/329 (39%), Gaps = 73/329 (22%)
Query: 685 NMIGQGSFGSVYKGILGENG--TFVAVKIL--NLMQKGALKSFVAECEVLRN-TRHRNLI 739
++IG+G+FG V K + ++G A+K + + + F E EVL H N+I
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNII 89
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQS----------NGQPEVCDLSLIQR 789
++ C +G + L EY +G+L ++L +S LS Q
Sbjct: 90 NLLGACEH---RGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 790 LNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
L+ A D+A ++YL +H DL N+L+ + VA ++DFGL+R +
Sbjct: 145 LHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQ-----EVY 195
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-R 907
++ + ++ L Y + + S DV+S GV+L E+ +
Sbjct: 196 VKKTMGRLPVRWM----AI---------ESLNYSVYTTNS---DVWSYGVLLWEIVSLGG 239
Query: 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVAC 967
P +C M E + E + G R K C V + C
Sbjct: 240 TP-------------YCGMTCAE-LYEKLP--------QGYRLEKPLNCDDEVYDLMRQC 277
Query: 968 SMESPIER---MEMRDVLAKLCAARQTLV 993
E P ER ++ L ++ R+T V
Sbjct: 278 WREKPYERPSFAQILVSLNRMLEERKTYV 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 72/316 (22%), Positives = 124/316 (39%), Gaps = 71/316 (22%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKILN-LMQKGALKSFVAECEVLRNTRHRNLIK 740
+G G+FG VY+G + + VAVK L + + F+ E ++ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV-CDLSLIQRLNIAIDMASA 799
I V + ++ E M G L+ +L ++ +P L+++ L++A D+A
Sbjct: 98 CIGVSL----QSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 800 IEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+YL +H +H D+ N LL VA + DFG+AR + +S
Sbjct: 153 CQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIYRAS 197
Query: 856 IGIKGTVGYVP-----PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRP 909
KG +P P G+ + + D +S GV+L E+F+ P
Sbjct: 198 YYRKGGCAMLPVKWMPP---------EAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMP 245
Query: 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSM 969
+ + E V+E V G R + C V RI C
Sbjct: 246 ----YP-SKSNQE---------VLEFVT--------SGGRMDPPKNCPGPVYRIMTQCWQ 283
Query: 970 ESPIERMEMRDVLAKL 985
P +R +L ++
Sbjct: 284 HQPEDRPNFAIILERI 299
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 50/238 (21%)
Query: 687 IGQGSFGSVYKG---ILGENGTFVAVKIL--NLMQ-KGALKSFVAECEVLRNTRHRNLIK 740
+G G +VY IL VA+K + + + LK F E H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNI---KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 741 IITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+I V + LV EY++ +L E++ +G LS+ +N +
Sbjct: 76 MIDV-------DEEDDCYYLVMEYIEGPTLSEYIES-HGP-----LSVDTAINFTNQILD 122
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
I++ H IVH D+KP N+L+D + + DFG+A+ L +TS+ TQ++ +
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSL-TQTNH--V 172
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GTV Y P E G D+YS+G++L EM P F G
Sbjct: 173 LGTVQYFSP------------EQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNG 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 53/244 (21%), Positives = 91/244 (37%), Gaps = 14/244 (5%)
Query: 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFL--QGNIPSSLGNLT 418
++P+GI + L +E N+L +L L + LSSN L +G S T
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 419 LMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNH 478
+ L LS N + + + + L L+ + L + +LD+ + H
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 479 LNGSLPLEV-GNLKNLVALYISGNQFSGEI-PVTLTGCTGLEIFHMQGNSFRGSIP-LSL 535
+ L +L L ++GN F P T L + + +
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT---KGVFSNKTRVQ 592
SL S++ L++S NN + L+ L+ L+ S NH + S+ +
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLN 254
Query: 593 LTGN 596
LT N
Sbjct: 255 LTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 49/243 (20%), Positives = 100/243 (41%), Gaps = 13/243 (5%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLT--GNIPREIGQLRNLQA 398
+ ++ T + + N++ ++P G+ L L L + N L+ G + +L+
Sbjct: 24 TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82
Query: 399 IGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL-GNCKNLVSLNLSDNKLIGA 457
+ LS N + + S+ L + L ++L+ S+ + +NL+ L++S
Sbjct: 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH-TRV 140
Query: 458 VPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPV-TLTGCT 515
I + L + N + ++ L+NL L +S Q ++ +
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 199
Query: 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE--FLENLSFLEYLNLSYN 573
L++ +M N+F + L S++ LD S N++ + S L +LNL+ N
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
Query: 574 HFD 576
F
Sbjct: 259 DFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 56/308 (18%), Positives = 103/308 (33%), Gaps = 39/308 (12%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
S+P S+ ++L N +F +L L L L N L G
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSD---- 74
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLG 376
+ LK L N + + + L + + + + + +L NL L
Sbjct: 75 FGTTSLKYLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 132
Query: 377 IEFNQLTGNIPREI-GQLRNLQAIGLSSN-FLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434
I I L +L+ + ++ N F + +P L +T L LS L+ +
Sbjct: 133 ISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL 190
Query: 435 PP-SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV--GNLK 491
P + + +L LN+S N ++ + LD NH+ + +
Sbjct: 191 SPTAFNSLSSLQVLNMSHNN-FFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPS 248
Query: 492 NLVALYISGNQFSGEIPVTLTGCT-GLEIFHMQGNSFRGSI----------PLSLRSLKS 540
+L L ++ N F+ CT + F R + P +
Sbjct: 249 SLAFLNLTQNDFA---------CTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG-MP 298
Query: 541 IKELDLSC 548
+ L+++C
Sbjct: 299 VLSLNITC 306
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 42/211 (19%), Positives = 84/211 (39%), Gaps = 8/211 (3%)
Query: 100 LRYINLATNNFHGEIPKEIGFLFRLETLMLANN--SFSGKIPTNLSSCSNLLSFVAYRNN 157
+ L +N L +L L L++N SF G + ++L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 158 LVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI--GNLSIIYLHVGENQFSGTVPPSLY 215
++ + + +LEH+ ++L M S+ ++IYL +
Sbjct: 90 VI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 216 NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE-SFSNASNIEIIDL 274
+SSLE + + N F N DI L NL + + +F++ S+++++++
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206
Query: 275 PINYFTGKVSIIFGRLKNLWSLDLGINNLGS 305
N F + + L +L LD +N++ +
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 60/271 (22%), Positives = 96/271 (35%), Gaps = 52/271 (19%)
Query: 647 ARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTF 706
RR + E+S ++ Y P S + F + +G GS+G V+K E+G
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQ---SFQRLSRLGHGSYGEVFKVRSKEDGRL 84
Query: 707 VAVKILNL--MQKGALKSFVAECEVLRN-TRHRNLIKIITVCSSIDFKGADFKA----LV 759
AVK +AE +H ++ + A + L
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR---------LEQAWEEGGILYLQ 135
Query: 760 YEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818
E SL++ PE Q D A+ +LH +VH D+KP
Sbjct: 136 TELCG-PSLQQHCEAWGASLPEA------QVWGYLRDTLLALAHLHSQ---GLVHLDVKP 185
Query: 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPC 878
+N+ L + DFGL L T+ + +G Y+ P ++L
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVEL-----GTAGAGEV----QEGDPRYMAP----ELLQGS- 231
Query: 879 LEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
YG + DV+SLG+ +LE+
Sbjct: 232 --YGTAA------DVFSLGLTILEVACNMEL 254
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 60/275 (21%), Positives = 98/275 (35%), Gaps = 21/275 (7%)
Query: 323 LKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQ 381
+L + N++ + NL + + + N+IS I G LV L L + NQ
Sbjct: 54 TALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111
Query: 382 LTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ-GNIPP-SLG 439
L +P + LQ + + N + S L M + L +N L+ I +
Sbjct: 112 LK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 440 NCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYI 498
K L + ++D I +PQ + +L L L N + + L NL L +
Sbjct: 169 GMKKLSYIRIADTN-ITTIPQGLPP--SL-TELHLDGNKIT-KVDAASLKGLNNLAKLGL 223
Query: 499 SGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSG----- 553
S N S +L L H+ N +P L K I+ + L NN+S
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 554 -QIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSN 587
P + + ++L N F
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 49/268 (18%), Positives = 103/268 (38%), Gaps = 25/268 (9%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
+L + + N+I+ NL NL+ L + N+++ P L L+ + L
Sbjct: 48 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107
Query: 402 SSNFLQ---GNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKL-IG 456
S N L+ +P +L +L + N + + ++ + L N L
Sbjct: 108 SKNQLKELPEKMPKTL------QELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 457 AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV-TLTGCT 515
+ ++ + + ++ ++P G +L L++ GN+ + ++ +L G
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIP--QGLPPSLTELHLDGNKIT-KVDAASLKGLN 216
Query: 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
L + NS SL + ++EL L+ N L ++P L + +++ + L N+
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 576 ----DGEVPTKGVFSNKTRVQ---LTGN 596
+ G + K L N
Sbjct: 276 SAIGSNDFCPPGYNTKKASYSGVSLFSN 303
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 52/294 (17%), Positives = 107/294 (36%), Gaps = 27/294 (9%)
Query: 291 KNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTD 350
+ LDL N + D N L L N++ + P + A L +
Sbjct: 52 PDTALLDLQNNKITEIKDGDF------KNLKNLHTLILINNKISKISPGAFAPL-VKLER 104
Query: 351 IYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQ-G 408
+Y+ NQ+ +P + L L + N++T + + + L + + L +N L+
Sbjct: 105 LYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 409 NIPS-SLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITT 467
I + + + ++ + ++ ++ IP L +L L+L NK I V L
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK-ITKVDAASLKGLN 216
Query: 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSF 527
L L N ++ + N +L L+++ N+ ++P L +++ ++ N+
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 528 RG------SIPLSLRSLKSIKELDLSCNNLS-GQIPEFL-ENLSFLEYLNLSYN 573
P S + L N + +I + + L
Sbjct: 276 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 63/326 (19%), Positives = 120/326 (36%), Gaps = 37/326 (11%)
Query: 143 SSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHV 201
C L V + + ++P+D+ + L N +T + NL + L +
Sbjct: 27 FRCQCHLRVVQCSDLGLEKVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLIL 83
Query: 202 GENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE 261
N+ S P + + LE + L N LP LQ + +N + + +
Sbjct: 84 INNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEK---MPKTLQELRVHENEIT-KVRK 138
Query: 262 -SFSNASNIEIIDLPINYFTGKV--SIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILT 318
F+ + + +++L N + F +K L + + N+ TI
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI----------TTIPQ 188
Query: 319 NC-SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLG 376
L L + N++ V S+ L + + + N IS + +G N +L L
Sbjct: 189 GLPPSLTELHLDGNKITKVDAASLKGL-NNLAKLGLSFNSIS-AVDNGSLANTPHLRELH 246
Query: 377 IEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSS-------LGNLTLMTDLFLSSNH 429
+ N+L +P + + +Q + L +N + I S+ + + L SN
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNP 304
Query: 430 LQ-GNIPPSLGNC-KNLVSLNLSDNK 453
+Q I PS C ++ L + K
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 66/341 (19%), Positives = 119/341 (34%), Gaps = 53/341 (15%)
Query: 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY 278
L + G +P D+ P+ + + +N + F N N+ + L N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 279 FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLP 338
+ F L L L L N L L+ L EN + V
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMP---------KTLQELRVHENEITKVRK 138
Query: 339 HSIANLSTTMTDIYMGVNQI-SGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNL 396
L M + +G N + S I +G + L+ + I +T IP+ G +L
Sbjct: 139 SVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSL 194
Query: 397 QAIGLSSNFLQGNIPS-SLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKL 454
+ L N + + + SL L + L LS N + + SL N +L L+L++NKL
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL 252
Query: 455 IGAVPQQILTITTLSRFLDLGNNHLNG------SLPLEVGNLKNLVALYISGNQFSGEIP 508
+ VP + + + + L NN+++ P + + + N
Sbjct: 253 V-KVPGGLADHKYI-QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP------ 304
Query: 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549
++ + +Q ++FR + + L
Sbjct: 305 --------VQYWEIQPSTFRC--------VYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 36/220 (16%)
Query: 380 NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SL 438
L +P+++ + + L +N + NL + L L +N + I P +
Sbjct: 41 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAF 96
Query: 439 GNCKNLVSLNLSDNKLIGAVPQQILT-----------ITTLS----------RFLDLGNN 477
L L LS N+L +P+++ IT + ++LG N
Sbjct: 97 APLVKLERLYLSKNQL-KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
Query: 478 HLNGSLPLEVG---NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP-L 533
L S +E G +K L + I+ + IP L L H+ GN +
Sbjct: 156 PLK-SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAA 210
Query: 534 SLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573
SL+ L ++ +L LS N++S L N L L+L+ N
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 30/167 (17%), Positives = 53/167 (31%), Gaps = 15/167 (8%)
Query: 96 NLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTN-LSSCSNLLSFVAY 154
+ L YI +A N IP+ G L L L N + K+ L +NL
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 155 RNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSG----- 208
N++ + + L + L N L +P + + I +++ N S
Sbjct: 225 FNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 209 -TVPPSLYNMSSLENILLDVNGFT-GNLPLDIGVTLPNLQVFAIGDN 253
P +S + L N + + +G+
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 74/362 (20%), Positives = 133/362 (36%), Gaps = 77/362 (21%)
Query: 651 RSKQESSISVPMEQYFPMVSYSELSEATNEFSSSN-----MIGQGSFGSVYKGIL----- 700
R S + + Y + EF +G+G FG V
Sbjct: 48 RITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK 107
Query: 701 --GENGTFVAVKIL--NLMQKGALKSFVAECEVLRN-TRHRNLIKIITVCSSIDFKGADF 755
+ VAVK+L + +K L V+E E+++ +H+N+I ++ C+ +
Sbjct: 108 DKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPL 162
Query: 756 KALVYEYMQNGSLEEWL----------HQSNGQPEVCDLSLIQRLNIAIDMASAIEYL-H 804
++ EY G+L E+L + ++ ++ +A +EYL
Sbjct: 163 -YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
C +H DL NVL+ + V ++DFGLAR + + K T G
Sbjct: 222 QKC----IHRDLAARNVLVTENNVMKIADFGLAR-----------DINNIDYYKKTTNGR 266
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLTLHEF 923
+P K + L + + S DV+S GV++ E+FT P + G+ + E
Sbjct: 267 LP----VKWMAPEALFDRVYTHQS---DVWSFGVLMWEIFTLGGSP----YP-GIPVEE- 313
Query: 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983
+ + + +G R K C + + C P +R + ++
Sbjct: 314 --------LFKLLK--------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357
Query: 984 KL 985
L
Sbjct: 358 DL 359
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 63/247 (25%)
Query: 687 IGQGSFGSVYKGIL-------GENGTFVAVKIL--NLMQKGALKSFVAECEVLRN-TRHR 736
+G+G+FG V + VAVK+L + +K L V+E E+++ +H+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHK 101
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL----------HQSNGQPEVCDLSL 786
N+I ++ C+ G + ++ EY G+L E+L + ++
Sbjct: 102 NIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 787 IQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF 845
++ +A +EYL C +H DL NVL+ + V ++DFGLAR
Sbjct: 157 KDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD------ 206
Query: 846 DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSLGV 898
I Y N + LP L + + S DV+S GV
Sbjct: 207 ------------INNIDYYKKTTN-GR---LPVKWMAPEALFDRVYTHQS---DVWSFGV 247
Query: 899 MLLEMFT 905
++ E+FT
Sbjct: 248 LMWEIFT 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 50/236 (21%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLI 739
+G G+FG VY+G + + VAVK L ++ F+ E ++ H+N++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISKFNHQNIV 137
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV-CDLSLIQRLNIAIDMAS 798
+ I V + ++ E M G L+ +L ++ +P L+++ L++A D+A
Sbjct: 138 RCIGVSL----QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 799 AIEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+YL +H +H D+ N LL VA + DFG+AR + +
Sbjct: 193 GCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIYRA 237
Query: 855 SIGIKGTVGYVP-----PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
KG +P P G+ + + D +S GV+L E+F+
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFM---------EGIFTSKT---DTWSFGVLLWEIFS 281
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 54/245 (22%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKIL--NLMQKGALKSFVAECEVLRNTRHRNLI 739
+G+G FG V K T VAVK+L N L+ ++E VL+ H ++I
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLSEFNVLKQVNHPHVI 89
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWL------------------HQSNGQPEV 781
K+ CS + L+ EY + GSL +L S P+
Sbjct: 90 KLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 782 CDLSLIQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
L++ ++ A ++ ++YL VH DL N+L+ +SDFGL+R +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
+ +K + G +P K + + L + + S DV+S GV+L
Sbjct: 201 Y-----------EEDSYVKRSQGRIP----VKWMAIESLFDHIYTTQS---DVWSFGVLL 242
Query: 901 LEMFT 905
E+ T
Sbjct: 243 WEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-26
Identities = 66/278 (23%), Positives = 104/278 (37%), Gaps = 69/278 (24%)
Query: 664 QYFPMVSYSELSEATNEFSSSN-----MIGQGSFGSVYKGIL-----GENGTFVAVKIL- 712
Y M + E+ +N IG+G+FG V++ E T VAVK+L
Sbjct: 27 MYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK 86
Query: 713 -NLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEW 771
F E ++ + N++K++ VC+ G L++EYM G L E+
Sbjct: 87 EEASAD-MQADFQREAALMAEFDNPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEF 140
Query: 772 LHQS------------------NGQPEVCDLSLIQRLNIAIDMASAIEYLH-HHCQPPIV 812
L P LS ++L IA +A+ + YL V
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----V 196
Query: 813 HGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVP-----P 867
H DL N L+ +MV ++DFGL+R S+ +P P
Sbjct: 197 HRDLATRNCLVGENMVVKIADFGLSR-----------NIYSADYYKADGNDAIPIRWMPP 245
Query: 868 GNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
+ Y + S DV++ GV+L E+F+
Sbjct: 246 ---------ESIFYNRYTTES---DVWAYGVVLWEIFS 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 43/230 (18%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
+G+G F ++ + A KI+ L++ + E + R+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ---PEVCDLSLIQRLNIAIDMASA 799
F+ DF +V E + SL E LH+ PE L Q +
Sbjct: 82 GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLG 127
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+YLH + ++H DLK N+ L+ D+ + DFGLA + + +
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------LC 176
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P ++K G E DV+S+G ++ + + P
Sbjct: 177 GTPNYIAPEVLSKK--------GHSFEV----DVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 43/230 (18%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKII 742
+G+G F ++ + A KI+ L++ + E + R+ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ---PEVCDLSLIQRLNIAIDMASA 799
F+ DF +V E + SL E LH+ PE L Q +
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLG 153
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+YLH + ++H DLK N+ L+ D+ + DFGLA + + +
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------LC 202
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P ++K G E DV+S+G ++ + + P
Sbjct: 203 GTPNYIAPEVLSKK--------GHSFEV----DVWSIGCIMYTLLVGKPP 240
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 40/237 (16%)
Query: 686 MIGQGSFGSVYKG---ILGENGTFVAVKIL--NLMQ-KGALKSFVAECEVLRNTRHRNLI 739
++G G V+ VAVK+L +L + F E + H ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHR---DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+ + + +V EY+ +L + +H G ++ + + + D A
Sbjct: 76 AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHT-EGP-----MTPKRAIEVIADACQA 128
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+ + H + I+H D+KP+N+++ V DFG+AR A + TQ+++ +
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR---AIADSGNSVTQTAA--VI 180
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GT Y+ P E G DVYSLG +L E+ T P F G
Sbjct: 181 GTAQYLSP------------EQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG 221
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 71/336 (21%), Positives = 123/336 (36%), Gaps = 92/336 (27%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKILNLMQKGA----LKSFVAECEVLRN-TRHR 736
+G G+FG V + + VAVK+L A ++ ++E +VL H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL------------HQSNGQPEVCDL 784
N++ ++ C+ G ++ EY G L +L + + + L
Sbjct: 88 NIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 785 SLIQRLNIAIDMASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
L L+ + +A + +L +C +H DL N+LL H + + DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR----- 193
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSL 896
IK YV GN A+ LP + + + S DV+S
Sbjct: 194 -------------DIKNDSNYVVKGN-AR---LPVKWMAPESIFNCVYTFES---DVWSY 233
Query: 897 GVMLLEMFTR-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEE 955
G+ L E+F+ P + G M + K + + +G R E
Sbjct: 234 GIFLWELFSLGSSP----YPG---------MPVDSKFYKMIK--------EGFRMLSPEH 272
Query: 956 CLVTVIRIGVACSMESPIER---MEMRDVLAKLCAA 988
+ I C P++R ++ ++ K +
Sbjct: 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKI 741
+G+G FG+VY ++ +A+K+L L + G E E+ + RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
F A L+ EY G++ L + + E + I L A+A+
Sbjct: 75 YGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALS 123
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
Y H ++H D+KP N+LL ++DFG + + GT
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----------GT 170
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+ Y+PP +M+ G + V D++SLGV+ E
Sbjct: 171 LDYLPP----EMIE------GRMHDEKV--DLWSLGVLCYEF 200
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 49/242 (20%), Positives = 93/242 (38%), Gaps = 48/242 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN-----------------LMQKGALKSFVAECEV 729
+ QG F + ++ F A+K + K F E ++
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 730 LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCDLSLI 787
+ + ++ + + D ++YEYM+N S+ ++ + C + +
Sbjct: 97 ITDIKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
I + ++ Y+H+ I H D+KPSN+L+D + +SDFG + ++ +
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
S GT ++PP + + G A V D++SLG+ L MF
Sbjct: 210 SR----------GTYEFMPP----EFFSNESSYNG----AKV--DIWSLGICLYVMFYNV 249
Query: 908 RP 909
P
Sbjct: 250 VP 251
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 39/247 (15%)
Query: 679 NEFSSSNMIGQGSFGSV-YKGILGENGTFVAVKILNLMQKGALKSFVAECEVLR-NTRHR 736
N S ++G GS G+V ++G G VAVK M + E ++L + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKR---MLIDFCDIALMEIKLLTESDDHP 69
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD-LSLIQRLNIAID 795
N+I+ F + E N +L++ + N E +++
Sbjct: 70 NVIRYYCS-----ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDH-------------DMVAHVSDFGLARFLFA 842
+AS + +LH I+H DLKP N+L+ ++ +SDFGL + L
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-- 178
Query: 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
+S T ++ GT G+ P + + NL + D++S+G +
Sbjct: 179 DSGQSSFRTNLNNPS--GTSGWRAPELLEESNNLQTKRR-LTRSI----DIFSMGCVFYY 231
Query: 903 MFTRRRP 909
+ ++ +
Sbjct: 232 ILSKGKH 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 79/393 (20%), Positives = 139/393 (35%), Gaps = 110/393 (27%)
Query: 646 YARRRRSKQESSISVPME------QYFPMVSYSELSEATN-EFSSSN-----MIGQGSFG 693
+ +++ + ES + + +YF V + E EF N ++G G+FG
Sbjct: 1 HKYKKQFRYESQLQMVQVTGSSDNEYFY-VDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59
Query: 694 SVYKGIL-----GENGTFVAVKILNLMQKGA----LKSFVAECEVLRN-TRHRNLIKIIT 743
V VAVK+L + A ++ ++E +++ H N++ ++
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWL-----------------HQSNGQPEVCDLSL 786
C+ G + L++EY G L +L + + ++ L+
Sbjct: 117 ACTL---SGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 787 IQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF 845
L A +A +E+L C VH DL NVL+ H V + DFGLAR
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR------- 220
Query: 846 DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSLGV 898
I YV GN A+ LP L G+ + S DV+S G+
Sbjct: 221 -----------DIMSDSNYVVRGN-AR---LPVKWMAPESLFEGIYTIKS---DVWSYGI 262
Query: 899 MLLEMFTR-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECL 957
+L E+F+ P + G + + + + +G + +
Sbjct: 263 LLWEIFSLGVNP----YPG---------IPVDANFYKLIQ--------NGFKMDQPFYAT 301
Query: 958 VTVIRIGVACSMESPIER---MEMRDVLAKLCA 987
+ I +C +R + L A
Sbjct: 302 EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 47/285 (16%), Positives = 89/285 (31%), Gaps = 53/285 (18%)
Query: 651 RSKQESSISVPMEQYFPMVSYS----------ELSEATNEFSSSNMIGQGSFGSVYKGIL 700
K S +S P+ Y + E + +++G+G+F VY+
Sbjct: 27 IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQ 86
Query: 701 G-----ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755
G +N +K+ E L+ + +K + +
Sbjct: 87 GDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNG 141
Query: 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815
LV E G+L ++ PE + ++ A+ M IE +H I+HGD
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEK-VMPQGLVISFAMRMLYMIEQVHDC---EIIHGD 197
Query: 816 LKPSNVLLDHDMVAH-----------VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+KP N +L + + + D G + + P T + T G+
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC------ETSGF 251
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ML+ + D + + + M
Sbjct: 252 QCV----EMLS------NKPWNYQI--DYFGVAATVYCMLFGTYM 284
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 67/411 (16%), Positives = 132/411 (32%), Gaps = 62/411 (15%)
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
+ Y+ + N + S + L+ + ++ + + L +L + + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314
F + F L NL L L NL +
Sbjct: 91 FL-QLETG-----------------------AFNGLANLEVLTLTQCNLDGAVLSG---- 122
Query: 315 TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-------- 366
+ L++L +N + + P S + + N++ +I
Sbjct: 123 NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKH 181
Query: 367 ---GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPS---SLGNLTLM 420
L ++ L + L + ++ + LS N + ++ T +
Sbjct: 182 FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI 241
Query: 421 TDLFLSSNH-----LQGNIPPSLGNC-------KNLVSLNLSDNKLIGAVPQQILTITTL 468
L LS+++ N + + +LS +K I A+ + + + T
Sbjct: 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK-IFALLKSVFSHFTD 300
Query: 469 SRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPV-TLTGCTGLEIFHMQGNS 526
L L N +N + L +L+ L +S N I LE+ + N
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNH 358
Query: 527 FRGSIPL-SLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
R ++ S L ++KEL L N L + L+ L+ + L N +D
Sbjct: 359 IR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 74/414 (17%), Positives = 135/414 (32%), Gaps = 52/414 (12%)
Query: 76 VTELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEI-GFLFRLETLMLANNS 133
V +DL +I L+ L L+++ + I L L L L N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 134 FSGKIPTN-LSSCSNLLSFVAYRNNL-VGEIPEDIGYSWLKLEHISLARNHLTGMLPASI 191
F ++ T + +NL + NL + + LE + L N++ + PAS
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 192 ----GNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQV 247
++ L N+ L N LL L ++ +
Sbjct: 150 FLNMRRFHVLDLT--FNKVKSICEEDLLNFQGKHFTLLR---------------LSSITL 192
Query: 248 FAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGG 307
+ + + + ++I +DL N F ++ F
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG-------------- 238
Query: 308 ANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTT-MTDIYMGVNQISGTIPSGI 366
+++ + S +F + L + + + ++I + +
Sbjct: 239 ---TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSV 294
Query: 367 -GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLF 424
+ +L L + N++ I L +L + LS NFL NL + L
Sbjct: 295 FSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353
Query: 425 LSSNHLQGNIPP-SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNN 477
LS NH++ + S NL L L N+L +VP I T + + L N
Sbjct: 354 LSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 71/389 (18%), Positives = 142/389 (36%), Gaps = 48/389 (12%)
Query: 243 PNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSI-IFGRLKNLWSLDLGIN 301
++ + N + SFS +++ + + + F L +L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRL-GGVLPHSIANLSTTMTDIYMGVNQISG 360
L+ + L+VL + L G VL + T++ + + N I
Sbjct: 90 QFLQ-----LE-TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK 143
Query: 361 TIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQ-----------LRNLQAIGLSSNFLQG 408
P+ N+ ++L + FN++ +I E L ++ ++ +L
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 409 NIPSSLGNLTLMTDLFLSSNHLQGNIPP---SLGNCKNLVSLNLSDNKLIGAVPQQI--- 462
+ T +T L LS N + ++ + SL LS++ +G+
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 463 ---------LTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPV-TL 511
L + + + DL + + +L V + +L L ++ N+ + +I
Sbjct: 263 DPDNFTFKGLEASGV-KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAF 319
Query: 512 TGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE-FLENLSFLEYLNL 570
G T L ++ N +L ++ LDLS N++ + + L L+ L L
Sbjct: 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELAL 378
Query: 571 SYNHFDGEVPTKGVF---SNKTRVQLTGN 596
N VP G+F ++ ++ L N
Sbjct: 379 DTNQLK-SVP-DGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 50/290 (17%), Positives = 93/290 (32%), Gaps = 35/290 (12%)
Query: 339 HSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQ 397
H + L + + + +N I+ + L +L L +E I L +L
Sbjct: 23 HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 398 AIGLSSNFLQGNIPSS-LGNLTLMTDLFLSSNHLQGNIPP--SLGNCKNLVSLNLSDNKL 454
+ L N + + L + L L+ +L G + +L L L DN +
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 455 IGAVPQQILTITTLSRFLDLGNNHLN----------GSLPLEVGNLKNLVALYISGNQFS 504
P LDL N + + L ++ ++
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201
Query: 505 GEIPVTLTGCTGLEIFHMQGNSFRGSIP---LSLRSLKSIKELDLSCNN-----LSGQIP 556
E T + + GN F+ S+ + I+ L LS +
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 557 EFLENLSF-------LEYLNLSYNHFDGEVPTKGVFSNKTRVQ---LTGN 596
+ +N +F ++ +LS + + K VFS+ T ++ L N
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKI-FALL-KSVFSHFTDLEQLTLAQN 309
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 63/247 (25%), Positives = 100/247 (40%), Gaps = 63/247 (25%)
Query: 687 IGQGSFGSVYKGIL-------GENGTFVAVKIL--NLMQKGALKSFVAECEVLRN-TRHR 736
+G+G+FG V T VAVK+L + +K L ++E E+++ +H+
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHK 135
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWL----------HQSNGQPEVCDLSL 786
N+I ++ C+ + ++ EY G+L E+L + LS
Sbjct: 136 NIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 787 IQRLNIAIDMASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF 845
++ A +A +EYL C +H DL NVL+ D V ++DFGLAR
Sbjct: 191 KDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR------- 239
Query: 846 DTSMETQSSSIGIKGTVGYVPPGNIAKMLNLP-------CLEYGMGSEASVTGDVYSLGV 898
I Y N + LP L + + S DV+S GV
Sbjct: 240 -----------DIHHIDYYKKTTN-GR---LPVKWMAPEALFDRIYTHQS---DVWSFGV 281
Query: 899 MLLEMFT 905
+L E+FT
Sbjct: 282 LLWEIFT 288
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 47/270 (17%), Positives = 99/270 (36%), Gaps = 43/270 (15%)
Query: 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRN 732
S T EF IG G FGSV+K + +G A+K ++ + E
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 733 -TRHRNLIKIITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLI 787
+H ++++ + A + + EY GSL + + ++ + +
Sbjct: 67 LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPF-- 845
+ ++ + + + Y+H +VH D+KPSN+ + + + + +A
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 846 ----DTSMETQSSSIGI-KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
D T+ SS + +G ++ + + Y +A D+++L + +
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQE-------NYTHLPKA----DIFALALTV 221
Query: 901 LEMFTRRRPTNCMFQGGLTLHEFCKMALPE 930
+ + G HE + LP
Sbjct: 222 VCAAGAEPL----PRNGDQWHEIRQGRLPR 247
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 54/236 (22%), Positives = 105/236 (44%), Gaps = 10/236 (4%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAI 399
+ + + + N I I + +L +L +L + N + I L +L +
Sbjct: 71 QGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTL 128
Query: 400 GLSSNFLQGNIPS-SLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKLIGA 457
L N+L IPS + L+ + +L+L +N ++ +IP + +L+ L+L + K +
Sbjct: 129 ELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEY 186
Query: 458 VPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGL 517
+ + ++L+LG ++ +P + L L L +SGN F P + G + L
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 518 EIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573
+ + + + L S+ EL+L+ NNLS + L +L L+L +N
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 45/223 (20%), Positives = 87/223 (39%), Gaps = 16/223 (7%)
Query: 380 NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SL 438
L+ +P+ I N + + L N +Q + +L + L L N ++ I +
Sbjct: 64 RGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAF 119
Query: 439 GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALY 497
+L +L L DN + +P + R L L NN + S+P + +L+ L
Sbjct: 120 NGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLD 177
Query: 498 ISGNQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIP 556
+ + I G L+ ++ + + +P +L L ++EL++S N+ P
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRP 235
Query: 557 EFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQ---LTGN 596
LS L+ L + + + + F + L N
Sbjct: 236 GSFHGLSSLKKLWVMNSQVS-LIE-RNAFDGLASLVELNLAHN 276
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 55/277 (19%), Positives = 101/277 (36%), Gaps = 47/277 (16%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGS--GGANDLDFVT 315
+P+ SN ++L N + F L +L L LG N++ GA
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA------- 118
Query: 316 ILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNL 374
+ L L +N L + + L + + ++++ N I +IPS + +L
Sbjct: 119 -FNGLASLNTLELFDNWLTVIPSGAFEYL-SKLRELWLRNNPIE-SIPSYAFNRVPSLMR 175
Query: 375 LGI-EFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG 432
L + E +L I L NL+ + L ++ ++P+ L L + +L +S NH
Sbjct: 176 LDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP- 231
Query: 433 NIPP-SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLK 491
I P S +L L + +++ + + + L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFD------------------------GLA 266
Query: 492 NLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528
+LV L ++ N S T L H+ N +
Sbjct: 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 52/285 (18%), Positives = 90/285 (31%), Gaps = 63/285 (22%)
Query: 123 RLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNH 182
L L N+ +L RN++ +I L + L N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNW 134
Query: 183 LTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVT 241
LT + + L + L + N ++P F
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA---------------FNR--------- 169
Query: 242 LPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGIN 301
+P+L +G+ I E F L NL L+LG+
Sbjct: 170 VPSLMRLDLGELKKLEYISEG-----------------------AFEGLFNLKYLNLGMC 206
Query: 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT 361
N+ + LT L+ L N + P S L +++ +++ +Q+S
Sbjct: 207 NIKD--------MPNLTPLVGLEELEMSGNHFPEIRPGSFHGL-SSLKKLWVMNSQVS-L 256
Query: 362 IPSG-IGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSN 404
I L +L L + N L+ ++P ++ LR L + L N
Sbjct: 257 IERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 32/156 (20%), Positives = 61/156 (39%), Gaps = 9/156 (5%)
Query: 77 TELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEI-GFLFRLETLMLANNSF 134
EL LR+ I S+ Y + L ++L I + LF L+ L L +
Sbjct: 150 RELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208
Query: 135 SGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL 194
+P L+ L N+ EI + L+ + + + ++ + + L
Sbjct: 209 K-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265
Query: 195 -SIIYLHVGENQFSGTVPPSLY-NMSSLENILLDVN 228
S++ L++ N S ++P L+ + L + L N
Sbjct: 266 ASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+GSF VY+ G VA+K+++ + + G ++ E ++ +H +++++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ---PEVCDLSLIQRLNIAIDMASAI 800
F+ +++ LV E NG + +L E + ++ + +
Sbjct: 79 Y-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQI------ITGM 125
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YLH H I+H DL SN+LL +M ++DFGLA L T + G
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYT------LCG 174
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
T Y+ P + G E+ DV+SLG M +
Sbjct: 175 TPNYISPEIATRS--------AHGLES----DVWSLGCMFYTL 205
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 54/240 (22%), Positives = 94/240 (39%), Gaps = 19/240 (7%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
+S T + + N IS L +L L + N+++ + LR LQ + +
Sbjct: 50 KEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109
Query: 402 SSNFL---QGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKL-IG 456
S N L N+PSSL +L + N ++ +P +N+ + + N L
Sbjct: 110 SKNHLVEIPPNLPSSL------VELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENS 162
Query: 457 AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV-TLTGCT 515
L +L + L +P + L L++ N+ I + L +
Sbjct: 163 GFEPGAFDGLKL-NYLRISEAKLT-GIP--KDLPETLNELHLDHNKIQ-AIELEDLLRYS 217
Query: 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
L + N R SL L +++EL L N LS ++P L +L L+ + L N+
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 54/275 (19%), Positives = 96/275 (34%), Gaps = 22/275 (8%)
Query: 323 LKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQ 381
+L + N + + L + + + N+IS I L L L I N
Sbjct: 56 TTLLDLQNNDISELRKDDFKGL-QHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113
Query: 382 LTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ-GNIPPSLGN 440
L IP +L + + N ++ L M + + N L+ P +
Sbjct: 114 LV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 441 CKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYIS 499
L L +S+ KL +P+ + TL L L +N + ++ LE L L +
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDLPE--TL-NELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 500 GNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE-- 557
NQ +L+ L H+ N +P L LK ++ + L NN++ ++
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVND 283
Query: 558 -----FLENLSFLEYLNLSYNHFDGEVPTKGVFSN 587
F ++ ++L N F
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 61/340 (17%), Positives = 107/340 (31%), Gaps = 53/340 (15%)
Query: 173 LEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG 232
L + + L +P I L + N S + L ++L N +
Sbjct: 35 LRVVQCSDLGLKA-VPKEISP-DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91
Query: 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKN 292
+ L LQ I N+ P S+ + + + N +F L+N
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRN 148
Query: 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIY 352
+ +++G N L + G F + KL L E +L G+ L+ ++
Sbjct: 149 MNCIEMGGNPLENSGFEPGAF-----DGLKLNYLRISEAKLTGIPKDLPETLNE----LH 199
Query: 353 MGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIP 411
+ N+I I L LG+ NQ+ I
Sbjct: 200 LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIE-----------------------N 234
Query: 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS-- 469
SL L + +L L +N L +P L + K L + L N I V
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN-ITKVGVNDFCPVGFGVK 292
Query: 470 ----RFLDLGNNHLNGSLPLEVG---NLKNLVALYISGNQ 502
+ L NN + ++ + + +A+ +
Sbjct: 293 RAYYNGISLFNNPVP-YWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 44/219 (20%), Positives = 73/219 (33%), Gaps = 35/219 (15%)
Query: 380 NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SL 438
L +P+EI + + L +N + L + L L +N + I +
Sbjct: 43 LGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAF 98
Query: 439 GNCKNLVSLNLSDNKLIGAVPQQILT-----------ITTLS----------RFLDLGNN 477
+ L L +S N L+ +P + + I + +++G N
Sbjct: 99 SPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157
Query: 478 HLNGSLPLEVGNLK--NLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP-LS 534
L + E G L L IS + + IP L L H+ N + +I
Sbjct: 158 PLE-NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQ-AIELED 212
Query: 535 LRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573
L + L L N + L L L L+L N
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN 251
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 62/286 (21%), Positives = 102/286 (35%), Gaps = 26/286 (9%)
Query: 62 CQWAGVTCGHRH---------QRVTELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFH 111
C V C T LDL++ +I L L L + L N
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS 91
Query: 112 GEIPKEIGFLFRLETLMLANNSFSGKIPTNL-SSCSNL-LSFVAYRNNLVGEIPEDIGYS 169
K L +L+ L ++ N +IP NL SS L + +N + ++P+ +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIH-----DNRIRKVPKGVFSG 145
Query: 170 WLKLEHISLARNHLT--GMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDV 227
+ I + N L G P + L + YL + E + + +P L +L + LD
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDH 202
Query: 228 NGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIF 287
N + L+ + L +G N S S + + L N + +V
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 288 GRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRL 333
LK L + L NN+ G ND V + ++ N +
Sbjct: 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/237 (20%), Positives = 89/237 (37%), Gaps = 46/237 (19%)
Query: 686 MIGQGSFGSVYKG---ILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLI 739
++G+G G VY+ + VA+K+++ E + +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERI---VALKLMSETLSSDPVFRTRMQREARTAGRLQEPH-- 95
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
++ + + G + + + L L + G L+ + + I + SA
Sbjct: 96 -VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRR-QGP-----LAPPRAVAIVRQIGSA 146
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
++ H H D+KP N+L+ D A++ DFG+A D + TQ +
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT----TDEKL-TQLGN--TV 196
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GT+ Y+ P E S A+ D+Y+L +L E T P +QG
Sbjct: 197 GTLYYMAP------------ERFSESHATYRADIYALTCVLYECLTGSPP----YQG 237
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 8/235 (3%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAI 399
+ST + + NQI I +L +L +L + N + I L NL +
Sbjct: 60 DGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTL 117
Query: 400 GLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL-GNCKNLVSLNLSDNKLIGAV 458
L N L + L+ + +L+L +N ++ +IP +L L+L + K + +
Sbjct: 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYI 176
Query: 459 PQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLE 518
+ + R+L+L +L +P + L L L +SGN S P + G L+
Sbjct: 177 SEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234
Query: 519 IFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573
M + + + +L+S+ E++L+ NNL+ + L LE ++L +N
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 18/224 (8%)
Query: 380 NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SL 438
L +P I N + + L N +Q +S +L + L LS NH++ I +
Sbjct: 53 KNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAF 108
Query: 439 GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALY 497
NL +L L DN+ + +P + + L L NN + S+P + +L L
Sbjct: 109 NGLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166
Query: 498 ISG-NQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555
+ + S I G + L ++ + R IP +L L + ELDLS N+LS
Sbjct: 167 LGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIR 223
Query: 556 PEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQ---LTGN 596
P + L L+ L + + + + F N + L N
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQ-VIE-RNAFDNLQSLVEINLAHN 265
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 58/275 (21%), Positives = 106/275 (38%), Gaps = 43/275 (15%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+P+ S +N +++L N F L++L L L N++ +
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG------AF 108
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLG 376
+ L L +NRL + + L + + ++++ N I +IPS + +L L
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYL-SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166
Query: 377 I-EFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434
+ E +L+ I L NL+ + L+ L+ IP+ L L + +L LS NHL I
Sbjct: 167 LGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AI 222
Query: 435 PP-SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNL 493
P S +L L + ++ I + + NL++L
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQ-IQVIERNAFD------------------------NLQSL 257
Query: 494 VALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528
V + ++ N + T LE H+ N +
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 64/266 (24%), Positives = 107/266 (40%), Gaps = 21/266 (7%)
Query: 144 SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVG 202
SCSN S V + E+P+ I + ++L N + + S +L + L +
Sbjct: 40 SCSNQFSKVICVRKNLREVPDGISTN---TRLLNLHENQIQIIKVNSFKHLRHLEILQLS 96
Query: 203 ENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE- 261
N + +++L + L N T +P V L L+ + +N SIP
Sbjct: 97 RNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154
Query: 262 SFSNASNIEIIDLP-INYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNC 320
+F+ ++ +DL + + F L NL L+L + NL + LT
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--------IPNLTPL 206
Query: 321 SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSG-IGNLVNLNLLGIEF 379
KL L N L + P S L + ++M +QI I NL +L + +
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGL-MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAH 264
Query: 380 NQLTGNIPREI-GQLRNLQAIGLSSN 404
N LT +P ++ L +L+ I L N
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 40/203 (19%), Positives = 73/203 (35%), Gaps = 12/203 (5%)
Query: 77 TELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEIGF--LFRLETLMLANNS 133
L L +I ++ L+ L + L N IP F L +L+ L L NN
Sbjct: 91 EILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGA-FVYLSKLKELWLRNNP 147
Query: 134 FSGKIPTNL-SSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIG 192
IP+ + +L + I E L +++LA +L +P
Sbjct: 148 IE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP 205
Query: 193 NLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGD 252
+ + L + N S P S + L+ + + + + + L +L +
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAH 264
Query: 253 NYFSGSIPES-FSNASNIEIIDL 274
N + +P F+ ++E I L
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHL 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 11/157 (7%)
Query: 77 TELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEIGF--LFRLETLMLANNS 133
EL LR+ I S+ Y + LR ++L I + F L L L LA +
Sbjct: 139 KELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA-FEGLSNLRYLNLAMCN 196
Query: 134 FSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGN 193
+IP L+ L N+L I + L+ + + ++ + + + N
Sbjct: 197 LR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253
Query: 194 L-SIIYLHVGENQFSGTVPPSLY-NMSSLENILLDVN 228
L S++ +++ N + +P L+ + LE I L N
Sbjct: 254 LQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 29/133 (21%), Positives = 44/133 (33%), Gaps = 28/133 (21%)
Query: 443 NLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQ 502
+ L VP I T T L L+L N + +L++L L +S N
Sbjct: 44 QFSKVICVRKNLR-EVPDGISTNTRL---LNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 503 FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
I ++ +F G L ++ L+L N L+ L
Sbjct: 100 ----------------IRTIEIGAFNG--------LANLNTLELFDNRLTTIPNGAFVYL 135
Query: 563 SFLEYLNLSYNHF 575
S L+ L L N
Sbjct: 136 SKLKELWLRNNPI 148
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 39/220 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+G FG+VY +N +A+K+L L ++G E E+ + RH N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
F L+ E+ G L + L + E + ++ L A A+ Y
Sbjct: 82 Y-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------ADALHYC 130
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H ++H D+KP N+L+ + ++DFG + + T GT+
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----------GTLD 177
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
Y+PP +M+ G + V D++ GV+ E
Sbjct: 178 YLPP----EMIE------GKTHDEKV--DLWCAGVLCYEF 205
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 73/488 (14%), Positives = 149/488 (30%), Gaps = 66/488 (13%)
Query: 124 LETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHL 183
+ L L+ NS S ++S S L N + + + LE++ ++ N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 184 TGMLPASIGNLSIIYLHVGENQFSGTVPPSLY--NMSSLENILLDVNGFTGNLPLDIGVT 241
+ + +L + L N F +P N++ L + L F L L
Sbjct: 113 QNISCCPMASLRHLDLS--FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAH 168
Query: 242 LPNLQVFA-IGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300
L + + + G ES N ++ L + + + + L L L
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227
Query: 301 NNLGSGGA--------------------------NDLDFVTILTN--CSKLKVLAFEENR 332
L V + ++ L
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287
Query: 333 LGGVLPHSIANLSTTMTDI----YMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPR 388
+ + S T ++ + + +N+ + +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 389 EIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLN 448
+ + + N ++ L + L L N L+ N KN+ SL
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLE 406
Query: 449 LSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP 508
D L N+ + + ++++ L +S N +G +
Sbjct: 407 TLDVSL---------------------NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445
Query: 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568
L +++ + N SIP + L++++EL+++ N L + L+ L+Y+
Sbjct: 446 RCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYI 502
Query: 569 NLSYNHFD 576
L N +D
Sbjct: 503 WLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 61/405 (15%), Positives = 125/405 (30%), Gaps = 32/405 (7%)
Query: 198 YLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG 257
L + +N S P + +S L + L N +L + + +L+ + N
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ- 113
Query: 258 SIPESFSNASNIEIIDLPINYFTG-KVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTI 316
+I +++ +DL N F V FG L L L L + + +
Sbjct: 114 NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171
Query: 317 LTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQ-ISGTIPSGIGNLVNLNLL 375
L + G S+ +TT+ + N S + + L +L L
Sbjct: 172 SCILLDL-----VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226
Query: 376 GIEFNQLTGNIPREI--GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGN 433
I+ N R + ++ ++ S+ + ++
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 434 IPPSLGNCKNLVSLNLSDNKL---------IGAVPQQILTITTLSRFLDLGNNHLNGSLP 484
+ + + L + + ++ L +
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 485 LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP---LSLRSLKSI 541
+ + + L + N F+ + + L+ +Q N + + L +++ S+
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL 405
Query: 542 KELDLSCNNL-SGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVF 585
+ LD+S N+L S + LNLS N T VF
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML-----TGSVF 445
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 43/242 (17%), Positives = 92/242 (38%), Gaps = 12/242 (4%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIG 400
+L + + N IS I L L +L + N++ ++ + ++L+ +
Sbjct: 48 KDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLD 106
Query: 401 LSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS--LGNCKNLVSLNLSDNKLIGAV 458
+S N LQ NI + + L LS N +P GN L L LS K
Sbjct: 107 VSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 459 PQQILTITTLSRFLDLGNNHLNGSLP--LEVGNLKNLVALYISGNQFSGEIPVTLTGCTG 516
+ + LDL + H+ G L++ N L ++ + FS ++ +++
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222
Query: 517 LEIFHMQGNSFRGSIPLSL--RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574
L++ +++ N ++ + L+++ ++ ++ F + Y +
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282
Query: 575 FD 576
Sbjct: 283 IY 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 55/267 (20%), Positives = 112/267 (41%), Gaps = 52/267 (19%)
Query: 648 RRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFV 707
++ K+ + ++ + ++F + +G G+ G V+K +G +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKD--------DDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 708 AVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA----LVYEY 762
A K+++L ++ + E +VL ++ F GA + + E+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---------FYGAFYSDGEISICMEH 112
Query: 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822
M GSL++ L ++ PE + + ++I + + YL + I+H D+KPSN+L
Sbjct: 113 MDGGSLDQVLKKAGRIPEQI----LGK--VSIAVIKGLTYLREKHK--IMHRDVKPSNIL 164
Query: 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYG 882
++ + DFG++ L ++ + GT Y+ P +
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSMANSFV----------GTRSYMSPERLQ----------- 203
Query: 883 MGSEASVTGDVYSLGVMLLEMFTRRRP 909
G+ SV D++S+G+ L+EM R P
Sbjct: 204 -GTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 55/255 (21%), Positives = 105/255 (41%), Gaps = 24/255 (9%)
Query: 317 LTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLG 376
+ +A ++ + + A+L +T + ++ TI G+ L NL L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADL-DGITTLSAFGTGVT-TI-EGVQYLNNLIGLE 69
Query: 377 IEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP 436
++ NQ+T ++ + L + + LS N L S++ L + L L+S + ++ P
Sbjct: 70 LKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT-DVTP 124
Query: 437 SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEVGNLKNLV 494
L NL L L N++ I + L+ ++L +GN ++ PL NL L
Sbjct: 125 -LAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLT 176
Query: 495 ALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554
L N+ S +I L L H++ N PL+ + ++ + L+ ++ Q
Sbjct: 177 TLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQ 232
Query: 555 IPEFLENLSFLEYLN 569
+ NL +
Sbjct: 233 PVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 54/300 (18%), Positives = 112/300 (37%), Gaps = 31/300 (10%)
Query: 214 LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIID 273
+++ I + T + L + + + +I E +N+ ++
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLE 69
Query: 274 LPINYFTGKVSII-FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENR 332
L N T + L + L+L N L + V+ + +K L +
Sbjct: 70 LKDNQIT---DLAPLKNLTKITELELSGNPLKN--------VSAIAGLQSIKTLDLTSTQ 118
Query: 333 LGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ 392
+ V P +A L + + +Y+ +NQI+ S + L NL L I Q++ ++ +
Sbjct: 119 ITDVTP--LAGL-SNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLT-PLAN 171
Query: 393 LRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDN 452
L L + N + +I S L +L + ++ L +N + ++ P L N NL + L++
Sbjct: 172 LSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQ 227
Query: 453 KLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLT 512
+ Q + L + P + + + ++ N S V+ T
Sbjct: 228 TITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYT 284
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 23/211 (10%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
L+L+ I L+P + NL+ + + L+ N + I L ++TL L + +
Sbjct: 66 IGLELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-S 195
T L+ SNL N + I G + L+++S+ ++ + P + NL
Sbjct: 122 --VTPLAGLSNLQVLYLDLNQIT-NISPLAGLT--NLQYLSIGNAQVSDLTP--LANLSK 174
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
+ L +N+ S L ++ +L + L N + PL NL + + +
Sbjct: 175 LTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLA---NTSNLFIVTLTNQTI 229
Query: 256 SGSIPESFSN------ASNIEIIDLPINYFT 280
+ +N + +
Sbjct: 230 TNQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 8/219 (3%)
Query: 361 TIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTL 419
+P GI + L N+++ RNL + L SN L ++ L L
Sbjct: 25 AVPVGIPAASQRIFL---HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 420 MTDLFLSSNHLQGNIPPS-LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNH 478
+ L LS N ++ P+ L +L+L + + + ++L L +N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG-LQELGPGLFRGLAALQYLYLQDNA 140
Query: 479 LNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRS 537
L +LP + +L NL L++ GN+ S G L+ + N P + R
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 538 LKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
L + L L NNLS E L L L+YL L+ N +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 45/266 (16%), Positives = 83/266 (31%), Gaps = 42/266 (15%)
Query: 144 SCSNLLSFVAY--RNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLH 200
C N + L +P I + + I L N ++ + AS + L
Sbjct: 7 VCYNEPKVTTSCPQQGLQ-AVPVGIPAA---SQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 201 VGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIP 260
+ N + + ++ LE + L N ++ L L + +
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG 121
Query: 261 ESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNC 320
+F L L L L N L + + +
Sbjct: 122 PG-----------------------LFRGLAALQYLYLQDNALQALPDD------TFRDL 152
Query: 321 SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEF 379
L L NR+ V + L ++ + + N+++ + +L L L +
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGL-HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
Query: 380 NQLTGNIPREI-GQLRNLQAIGLSSN 404
N L+ +P E LR LQ + L+ N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 36/207 (17%), Positives = 73/207 (35%), Gaps = 6/207 (2%)
Query: 100 LRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTN-LSSCSNLLSFVAYRNNL 158
+ I L N L L L +N + +I + + L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 159 VGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPP-SLYN 216
+ + + +L + L R L + P L ++ YL++ +N +P + +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 217 MSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPI 276
+ +L ++ L N + ++P L +L + N + P +F + + + L
Sbjct: 152 LGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 277 NYFTGKVSIIFGRLKNLWSLDLGINNL 303
N + + L+ L L L N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 53/246 (21%), Positives = 98/246 (39%), Gaps = 68/246 (27%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVA------------------ 725
IG+GS+G V + T+ A+K+L+ L+++
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 726 -----ECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE 780
E +L+ H N++K++ V +D D +V+E + G
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQG-------------P 124
Query: 781 VCDLSLIQRLNIAI------DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834
V ++ ++ L+ D+ IEYLH+ I+H D+KPSN+L+ D ++DF
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894
G++ + D + GT ++ P + L+ + G DV+
Sbjct: 182 GVSNEF--KGSDALLSNTV------GTPAFMAP----ESLSETRKIFS-GKAL----DVW 224
Query: 895 SLGVML 900
++GV L
Sbjct: 225 AMGVTL 230
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVA-ECEVLRNTRHRNLIKII 742
+G+GS+G V + + E AVKIL L + ++ V E ++LR RH+N+I+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
V + + +V EY G E + + Q + +EY
Sbjct: 73 DV---LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVCQAHGYFCQLIDGLEY 124
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
LH IVH D+KP N+LL +S G+A L D + T G+
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------GSP 175
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ PP ++ N + G + D++S GV L + T P
Sbjct: 176 AFQPP----EIANGLDT-FS-GFKV----DIWSAGVTLYNITTGLYP 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 39/224 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ---------KGALKSFVAECEVLRN-TRHR 736
+G+G V + I AVKI+++ + ++ + E ++LR + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N+I++ ++ F LV++ M+ G L ++L + E + I R +
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSE-KETRKIMR-----AL 133
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
I LH IVH DLKP N+LLD DM ++DFG + L P +
Sbjct: 134 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DP-GEKLRE----- 182
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
+ GT Y+ P I +N YG E D++S GV++
Sbjct: 183 -VCGTPSYLAPEIIECSMNDNHPGYGK--EV----DMWSTGVIM 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 55/284 (19%), Positives = 99/284 (34%), Gaps = 75/284 (26%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG-ALKSFVAECEVL------- 730
+F +G+G FG V++ + A+K + L + A + + E + L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 731 ---------------------------------------------RNTRHRNLIKIITVC 745
+ R TV
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ + + + +L++W+++ + + + L+I I +A A+E+LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVC--LHIFIQIAEAVEFLHS 182
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL----FARPFDTSMETQSSSIGIKGT 861
++H DLKPSN+ D V V DFGL + + T M ++ G GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
Y+ P E G+ S D++SLG++L E+
Sbjct: 240 KLYMSP------------EQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEV-LRNTRHRNLIKIITV 744
+G+G++G V K +G +AVK + + K + + ++ +R +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70
Query: 745 CSSIDFKGADFK----ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
F GA F+ + E M + SL+++ Q + + ++ + IA+ + A+
Sbjct: 71 -----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
E+LH ++H D+KPSNVL++ + DFG++ +L + + G
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL-----VDDV-AKDIDA---G 171
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
Y+ P I LN SV D++SLG+ ++E+
Sbjct: 172 CKPYMAPERINPELN--------QKGYSVKSDIWSLGITMIEL 206
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 35/169 (20%), Positives = 69/169 (40%), Gaps = 13/169 (7%)
Query: 340 SIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAI 399
+ A + ++T I + ++ +GI N+ L I T P I L NL+ +
Sbjct: 39 TEAQM-NSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERL 93
Query: 400 GLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVP 459
+ + + +L LT +T L +S + +I + + S++LS N I
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI---- 149
Query: 460 QQILTITTLS--RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE 506
I+ + TL + L++ + ++ +E + L LY G+
Sbjct: 150 TDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 26/189 (13%), Positives = 62/189 (32%), Gaps = 15/189 (7%)
Query: 392 QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD 451
+ L + + + +LT + L++ ++ ++ + N+ L +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 452 NKLIGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV 509
I+ LS L + + + L +L L IS + I
Sbjct: 76 IHA-----TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 510 TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLN 569
+ + + N I L++L +K L++ + + +E+ L L
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187
Query: 570 LSYNHFDGE 578
G+
Sbjct: 188 AFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 35/171 (20%), Positives = 64/171 (37%), Gaps = 21/171 (12%)
Query: 409 NIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTL 468
NIP S + L + + +L + L++ + +T +
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANI--------NVTDLTGI 62
Query: 469 S-----RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQ 523
+ L + N H P+ L NL L I G + + L+G T L + +
Sbjct: 63 EYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 524 GNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574
++ SI + +L + +DLS N I L+ L L+ LN+ ++
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 22/148 (14%), Positives = 52/148 (35%), Gaps = 7/148 (4%)
Query: 455 IGAVPQQILTITTLSRFLDLGNNHL--NGSLPLEVGNLKNLVALYISGNQFSGEIPVTLT 512
G Q S F N L + + + + +L + ++ + +
Sbjct: 6 TGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IE 63
Query: 513 GCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSY 572
++ + P+S L +++ L + +++ L L+ L L++S+
Sbjct: 64 YAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 573 NHFDGEVPTK-GVFSNKTRVQLTGNGKL 599
+ D + TK + L+ NG +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 21/147 (14%), Positives = 52/147 (35%), Gaps = 13/147 (8%)
Query: 214 LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIID 273
+ +++++ ++ T P+ L NL+ I + + S +++ ++D
Sbjct: 62 IEYAHNIKDLTINNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 274 LPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRL 333
+ + + L + S+DL N + + L +LK L + + +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGA-------ITDIMPLKTLPELKSLNIQFDGV 171
Query: 334 GGVLPHSIANLSTTMTDIYMGVNQISG 360
I + + +Y I G
Sbjct: 172 HDYRG--IEDF-PKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 18/134 (13%), Positives = 50/134 (37%), Gaps = 9/134 (6%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
+L + + + + +P + LS L + + + + + L L L +++++
Sbjct: 69 KDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 137 KIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLK-LEHISLARNHLTGMLPASIGNLS 195
I T +++ + S N + +I L L+ +++ + + I +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM---PLKTLPELKSLNIQFDGVHDYRG--IEDFP 181
Query: 196 -IIYLHVGENQFSG 208
+ L+ G
Sbjct: 182 KLNQLYAFSQTIGG 195
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 32/224 (14%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA-ECEVLRNTRHRNLIKIITVC 745
+G+G++G V + VAVKI+++ + + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ + L EY G L + + G PE +L + + YLH
Sbjct: 75 RE-----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
I H D+KP N+LLD +SDFGLA + + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYV 174
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
P + + E+ DV+S G++L M P
Sbjct: 175 APELLKR------REF-HAEPV----DVWSCGIVLTAMLAGELP 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 57/277 (20%), Positives = 105/277 (37%), Gaps = 52/277 (18%)
Query: 643 IIVYARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSS--------NMIGQGSFGS 694
++ +RR S I++ + + V + + + + + +G G+ G
Sbjct: 91 LVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150
Query: 695 VYKGILGENGTFVAVKILN--------LMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
V + VA++I++ + + E E+L+ H +IKI
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
+ D+ +V E M+ G L + + + E M A++YLH +
Sbjct: 211 AEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYLHEN 258
Query: 807 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
I+H DLKP NVLL + D + ++DFG ++ + S + GT
Sbjct: 259 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------LGETSLMRTLCGTPT 306
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y+ P + + Y D +SLGV+L
Sbjct: 307 YLAPEVLVSVGTAG---Y--NRAV----DCWSLGVIL 334
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 53/288 (18%), Positives = 103/288 (35%), Gaps = 29/288 (10%)
Query: 292 NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDI 351
+ SLDL N + +DL C L+ L N + + S ++L ++ +
Sbjct: 53 AVKSLDLSNNRITYISNSDLQ------RCVNLQALVLTSNGINTIEEDSFSSL-GSLEHL 105
Query: 352 YMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGN 409
+ N +S + S L +L L + N + L LQ + + +
Sbjct: 106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
Query: 410 IPS-SLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTL 468
I LT + +L + ++ LQ P SL + +N+ L L + + + + +T+
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ-HILLLEIFVDVTSS 223
Query: 469 SRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528
L+L + L+ ++ S +L + S
Sbjct: 224 VECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 529 GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
+ L + + EL+ S N L + L+ L+ + L N +D
Sbjct: 268 -QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 44/201 (21%), Positives = 77/201 (38%), Gaps = 8/201 (3%)
Query: 380 NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SL 438
L +IP + ++++ LS+N + S L + L L+SN + I S
Sbjct: 41 GSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSF 96
Query: 439 GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALY 497
+ +L L+LS N L + + FL+L N + +L L L
Sbjct: 97 SSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 498 ISGNQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIP 556
+ +I G T LE + + + P SL+S++++ L L +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 557 EFLENLSFLEYLNLSYNHFDG 577
F++ S +E L L D
Sbjct: 216 IFVDVTSSVECLELRDTDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 58/305 (19%), Positives = 115/305 (37%), Gaps = 39/305 (12%)
Query: 107 TNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDI 166
++ IP G +++L L+NN + ++L C NL + V N + I ED
Sbjct: 39 SSGSLNSIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95
Query: 167 GYSWLKLEHISLARNHLTGMLPASI----GNLSIIYLHVGENQFSGTVPPS--LYNMSSL 220
S LEH+ L+ N+L+ L +S +L+ + L N + T+ + +++ L
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLL--GNPYK-TLGETSLFSHLTKL 151
Query: 221 ENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFT 280
+ + + + L L+ I + P+S + N+ + L +
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 281 GKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHS 340
+ I ++ L+L +L + F + L +S
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDT----------------------FHFSELSTGETNS 249
Query: 341 IANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAI 399
+ T ++ + + + + + L L NQL ++P I +L +LQ I
Sbjct: 250 LIKK-FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKI 306
Query: 400 GLSSN 404
L +N
Sbjct: 307 WLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 41/246 (16%), Positives = 79/246 (32%), Gaps = 18/246 (7%)
Query: 71 HRHQRVTELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEIGF--LFRLETL 127
R + L L I ++ +L L +++L+ N + F L L L
Sbjct: 73 QRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW-FKPLSSLTFL 129
Query: 128 MLANNSFSGKIPTNL-SSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM 186
L N + T+L S + L + +I LE + + + L
Sbjct: 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189
Query: 187 LPASIGNL-SIIYLHVGENQFSGTVPPSLY-NMSSLENILLDVNGFTGN-------LPLD 237
P S+ ++ ++ +L + Q + SS+E + L +
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 238 IGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLD 297
+ + I D + + + S + ++ N IF RL +L +
Sbjct: 249 SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307
Query: 298 LGINNL 303
L N
Sbjct: 308 LHTNPW 313
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 52/255 (20%), Positives = 86/255 (33%), Gaps = 63/255 (24%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKI-----LNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
IGQGS+G V I + A+KI + + ++ E +++ H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRL----------- 790
V ++ + LV E G L + L+ + +
Sbjct: 94 YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 791 -----------------------NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827
NI + SA+ YLH+ I H D+KP N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 828 VAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS 885
+ DFGL++ + GT +V P ++LN YG
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMT----TKAGTPYFVAP----EVLNTTNESYGPKC 257
Query: 886 EASVTGDVYSLGVML 900
D +S GV+L
Sbjct: 258 ------DAWSAGVLL 266
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-21
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 41/237 (17%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRH 735
+ + +G G++G V A+KI+ + + + E VL+ H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
N++K+ F+ LV E + G L + + EV +I+
Sbjct: 96 PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------Q 144
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQ 852
+ S + YLH H IVH DLKP N+LL + D + + DFGL+ E Q
Sbjct: 145 VLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---------FENQ 192
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + K + C DV+S+GV+L + P
Sbjct: 193 KKMKERLGTAYYIAPEVLRKKYDEKC-------------DVWSIGVILFILLAGYPP 236
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 65/267 (24%), Positives = 107/267 (40%), Gaps = 42/267 (15%)
Query: 647 ARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSS----SNMIGQGSFGSVYKGILGE 702
A++ Q Q A EF ++IG+G V + +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 703 NGTFVAVKILNL--------MQKGALKSFVAECEVLRN-TRHRNLIKIITVCSSIDFKGA 753
G AVKI+ + + ++ E +LR H ++I +I S +
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-----S 172
Query: 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVH 813
F LV++ M+ G L ++L + E + I R + A+ +LH + IVH
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEK-ETRSIMR-----SLLEAVSFLHANN---IVH 223
Query: 814 GDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKM 873
DLKP N+LLD +M +SDFG + L P + + GT GY+ P +
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHL--EP-GEKLRE------LCGTPGYLAPEILKCS 274
Query: 874 LNLPCLEYGMGSEASVTGDVYSLGVML 900
++ YG E D+++ GV+L
Sbjct: 275 MDETHPGYGK--EV----DLWACGVIL 295
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 43/221 (19%), Positives = 69/221 (31%), Gaps = 18/221 (8%)
Query: 368 NLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLS-SNFLQGNIPSSLGNL-----TLMT 421
+ L L +E ++TG P + + L+ N + L L +
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 422 DLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVP---QQILTITTLSRFLDLGNNH 478
L ++ H + L +L+LSDN +G + L L N
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 479 LN---GSLPLEVGNLKNLVALYISGNQFSGEIPVTL-TGCTGLEIFHMQGNSFRGSIPLS 534
+ G L L +S N + L ++ + +P
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
Query: 535 LRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
L + LDLS N L P E L + L+L N F
Sbjct: 272 L--PAKLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 52/274 (18%), Positives = 84/274 (30%), Gaps = 19/274 (6%)
Query: 337 LPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNL 396
L +L + + + T +L L + + + L
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97
Query: 397 QAIGLSSNFLQGNIPSSLGNLTL--MTDLFLSSNHLQG--NIPPSLGNC--KNLVSLNLS 450
Q + L + + G P L T + L L + L L L+++
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 451 DNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLE----VGNLKNLVALYISGNQF--- 503
+ +Q+ L LDL +N G L L L +
Sbjct: 158 QAHSLNFSCEQVRVFPAL-STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 504 SGEIPVTLTGCTGLEIFHMQGNSFRGSIP-LSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
SG L+ + NS R + S + L+LS L Q+P+ L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--P 273
Query: 563 SFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGN 596
+ L L+LSYN D P+ + L GN
Sbjct: 274 AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGN 306
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 41/248 (16%), Positives = 75/248 (30%), Gaps = 28/248 (11%)
Query: 343 NLSTTMTDIYMGVNQISGTIPSGIGNLVNLN-LLGIEFNQLTGNIPREIGQLRNLQAIGL 401
N S D N + G +L LL + +I + +L+ + +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 402 SSNFLQGNIPSS---LGNLTLMTDLFLSSNHLQGNIPPSLGNC--KNLVSLNLSDNKLIG 456
+ + I + ++ + +L L + + G PP L +L LNL +
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 457 AVPQQILTITTLS----RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLT 512
+ + + L + H +V L L +S N GE +
Sbjct: 136 -RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 513 GCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSY 572
C PL +L+ + + SG L+ L+LS+
Sbjct: 195 LC-----------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237
Query: 573 NHFDGEVP 580
N
Sbjct: 238 NSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 50/310 (16%), Positives = 88/310 (28%), Gaps = 74/310 (23%)
Query: 161 EIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSL 220
+I + + L + + L G L +G + L + + +GT PP L +
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGAL-RVLGISGLQELTLENLEVTGTAPPPLLEATGP 121
Query: 221 ENILLDVN-----GFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLP 275
+ +L++ L P L+V +I + E + +DL
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 276 INYFTGKV----SIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN 331
N G+ ++ + L L L +
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGM---------------------------- 213
Query: 332 RLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIG 391
SG + V L L + N L
Sbjct: 214 ------------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 392 Q-LRNLQAIGLSSNFLQ---GNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSL 447
L ++ LS L+ +P+ L + L LS N L N PS + +L
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPAKL------SVLDLSYNRLDRN--PSPDELPQVGNL 301
Query: 448 NLSDNKLIGA 457
+L N + +
Sbjct: 302 SLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 36/211 (17%), Positives = 62/211 (29%), Gaps = 14/211 (6%)
Query: 31 NETDRLALLAIKSQLHDPLGVTNSWNNSIN-LCQWAGVTCGHRHQRVTELDLRHQNIGGS 89
E A + L + N N S W + L + +
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 90 LSPYVGNLSFLRYINLATNNFHGEIPKEI----GFLFRLETLMLANN---SFSGKIPTNL 142
V L ++L+ N GE L+ L L N + SG
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 143 SSCSNLLSFVAYRNNLVGEIPEDIGYSWL-KLEHISLARNHLTGMLPASIGNLSIIYLHV 201
++ L N+L + W +L ++L+ L +P + + L +
Sbjct: 225 AARVQLQGLDLSHNSL-RDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA-KLSVLDL 281
Query: 202 GENQFSGTVPPSLYNMSSLENILLDVNGFTG 232
N+ PS + + N+ L N F
Sbjct: 282 SYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-21
Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 42/229 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G+GSFG V G AVK+++ + QK +S + E ++L+ H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
F+ + LV E G L + + EV +I++ + S I Y+
Sbjct: 94 F-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYM 142
Query: 804 HHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
H + IVH DLKP N+LL D + DFGL+ E G
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---------FEASKKMKDKIG 190
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T Y+ P + + C DV+S GV+L + + P
Sbjct: 191 TAYYIAPEVLHGTYDEKC-------------DVWSTGVILYILLSGCPP 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 6e-21
Identities = 47/232 (20%), Positives = 84/232 (36%), Gaps = 49/232 (21%)
Query: 687 IGQG--SFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKII 742
IG+G +V G +V V+ +NL + E V + H N++
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWL--HQSNGQPEVCDLSLIQRLNIAI---DMA 797
F + +V +M GS ++ + H +G E+ IA +
Sbjct: 93 AT-----FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVL 138
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
A++Y+HH VH +K S++L+ D ++S S G
Sbjct: 139 KALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSN-------------LSMISHG 182
Query: 858 IKGTVGYVPPGNIAKMLN------LPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+ V + P K+L L G +++ D+YS+G+ E+
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACEL 230
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 32/224 (14%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA-ECEVLRNTRHRNLIKIITVC 745
+G+G++G V + VAVKI+++ + + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ + L EY G L + + G PE +L + + YLH
Sbjct: 75 RE-----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV 865
I H D+KP N+LLD +SDFGLA + + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYV 174
Query: 866 PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
P + + E+ DV+S G++L M P
Sbjct: 175 APELLKR------REF-HAEPV----DVWSCGIVLTAMLAGELP 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 44/225 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--------LMQKGALKSFVAECEVLRNTRHRNL 738
+G G+ G V + VA+KI++ + + E E+L+ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
IKI + D+ +V E M+ G L + + + E M
Sbjct: 78 IKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLL 125
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
A++YLH + I+H DLKP NVLL + D + ++DFG ++ L + M T
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT---- 175
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
+ GT Y+ P + + Y D +SLGV+L
Sbjct: 176 --LCGTPTYLAPEVLVSVGTAG---Y--NRAV----DCWSLGVIL 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-21
Identities = 62/265 (23%), Positives = 119/265 (44%), Gaps = 44/265 (16%)
Query: 662 MEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG--- 718
M + + V E +++ IGQG+FG V+K + G VA+K + + +
Sbjct: 1 MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59
Query: 719 ---ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA---LVYEYMQNGSLEEWL 772
AL+ E ++L+ +H N++ +I +C + K LV+++ ++ L L
Sbjct: 60 PITALR----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL 114
Query: 773 HQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832
+ +L + + + + + Y+H + I+H D+K +NVL+ D V ++
Sbjct: 115 SNVLVK-----FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA 166
Query: 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTG 891
DFGLAR F+ ++ ++ + + T+ Y PP E +G
Sbjct: 167 DFGLARA-FSLAKNSQPNRYTNRV-V--TLWYRPP------------ELLLGERDYGPPI 210
Query: 892 DVYSLGVMLLEMFTRRRPTNCMFQG 916
D++ G ++ EM+T R P + QG
Sbjct: 211 DLWGAGCIMAEMWT-RSP---IMQG 231
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+GSFG V K AVK++N + + + E E+L+ H N++K+ +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ + +V E G L + + + E D + I + + S I Y+H
Sbjct: 90 -----LEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIK-----QVFSGITYMH 138
Query: 805 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
H IVH DLKP N+LL + D + DFGL+ + +T M+ GT
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQ-NTKMKD------RIGT 186
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y+ P + + C DV+S GV+L
Sbjct: 187 AYYIAPEVLRGTYDEKC-------------DVWSAGVIL 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 48/237 (20%), Positives = 90/237 (37%), Gaps = 39/237 (16%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVL-RNTRHR 736
N+ + +G G+ G V+K + G +AVK + K K + + +V+ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 737 NLIKIITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
+++ G + E M + + PE + + +
Sbjct: 85 YIVQ---------CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI----LGK--M 129
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
+ + A+ YL ++H D+KPSN+LLD + DFG++ L +
Sbjct: 130 TVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD-----DK-AK 181
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
S G Y+ P I + + DV+SLG+ L+E+ T + P
Sbjct: 182 DRSA---GCAAYMAPERIDP-------PDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN-TRHRNLIKIITV 744
++G+G+ V I AVKI+ E E+L HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
F+ D LV+E M+ GS+ +H+ E + S++ + D+ASA+++LH
Sbjct: 80 -----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASVVVQ-----DVASALDFLH 128
Query: 805 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+ I H DLKP N+L + + DF L + + + T G+
Sbjct: 129 NKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GS 184
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y+ P + + + Y D++SLGV+L
Sbjct: 185 AEYMAP-EVVEAFSEEASIYD----KRC--DLWSLGVIL 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 49/255 (19%), Positives = 97/255 (38%), Gaps = 48/255 (18%)
Query: 662 MEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA-L 720
M + + +S + ++ +IG G+ V VA+K +NL + +
Sbjct: 1 MSEDSSALPWSINRD---DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57
Query: 721 KSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE 780
+ E + + H N++ S F D LV + + GS+ + + +
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYY--TS---FVVKDELWLVMKLLSGGSVLD-IIKHIVAKG 111
Query: 781 VCDLSLIQRLNIAI---DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
++ IA ++ +EYLH + Q +H D+K N+LL D ++DFG++
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168
Query: 838 RFLFARPFDTSMETQSSSIG---------IKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888
FL T + + + +G ++ GY +A
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-------------------DFKA- 208
Query: 889 VTGDVYSLGVMLLEM 903
D++S G+ +E+
Sbjct: 209 ---DIWSFGITAIEL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 2e-20
Identities = 56/321 (17%), Positives = 113/321 (35%), Gaps = 53/321 (16%)
Query: 282 KVSIIFG--RLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPH 339
+ IF +L ++ + + + + +
Sbjct: 10 PIKQIFPDDAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIANNSDI-----K 56
Query: 340 SIANLS--TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQ 397
S+ + +T +++ N+++ + NL NL L ++ N++ ++ + L+ L+
Sbjct: 57 SVQGIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLK 112
Query: 398 AIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA 457
++ L N + +I + L +L + L+L +N + +I L L +L+L DN
Sbjct: 113 SLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDN----- 163
Query: 458 VPQQILTITTLSRF-----LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLT 512
QI I L+ L L NH++ L LKNL L + + + +
Sbjct: 164 ---QISDIVPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQS 218
Query: 513 GCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSY 572
S +S + D N+ +PEF +SF+ Y ++
Sbjct: 219 NLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 271
Query: 573 NHFDGEVPTKGVFSNKTRVQL 593
K F + L
Sbjct: 272 G------KAKARFHGRVTQPL 286
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.6 bits (224), Expect = 7e-19
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 41/219 (18%)
Query: 356 NQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLG 415
I I ++ +T + +L ++ I +++ ++ ++ +
Sbjct: 9 TPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQ 62
Query: 416 NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLG 475
L +T LFL+ N L +I P L N KNL L L +N +I +++L
Sbjct: 63 YLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDEN--------KIKDLSSLK------ 106
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535
+LK L +L + N S +I L LE ++ N LS
Sbjct: 107 -------------DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS- 150
Query: 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574
L + L L N +S I L L+ L+ L LS NH
Sbjct: 151 -RLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNH 186
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.9 bits (217), Expect = 6e-18
Identities = 57/296 (19%), Positives = 105/296 (35%), Gaps = 40/296 (13%)
Query: 214 LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIID 273
+ L T + + L ++ ++ S+ + N+ +
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 71
Query: 274 LPINYFTGKVSII--FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN 331
L N K++ I LKNL L L N + DL L + KLK L+ E N
Sbjct: 72 LNGN----KLTDIKPLTNLKNLGWLFLDENKI-----KDLSS---LKDLKKLKSLSLEHN 119
Query: 332 RLGGVLPHSIANLS--TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPRE 389
+ I L + +Y+G N+I T + + L L+ L +E NQ++ +I
Sbjct: 120 GI-----SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-P 170
Query: 390 IGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449
+ L LQ + LS N + ++ +L L + L L S N ++
Sbjct: 171 LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228
Query: 450 SDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG 505
+D ++T +S D ++ LP + + ++ +
Sbjct: 229 TDG--------SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 2e-14
Identities = 38/154 (24%), Positives = 64/154 (41%), Gaps = 13/154 (8%)
Query: 420 MTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHL 479
M + S ++ I P + NL + AV Q L ++ + N+ +
Sbjct: 1 MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVTQNELN--SI-DQIIANNSDI 55
Query: 480 NGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLK 539
++ L N+ L+++GN+ + +I LT L + N + + SL+ LK
Sbjct: 56 KSVQGIQ--YLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLS-SLKDLK 109
Query: 540 SIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573
+K L L N +S I L +L LE L L N
Sbjct: 110 KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 43/323 (13%), Positives = 96/323 (29%), Gaps = 23/323 (7%)
Query: 96 NLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYR 155
+ NL + + L ++ ++ N+ + + N+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 156 NNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSL 214
N L +I L + L N + + + +L + L + N S + L
Sbjct: 75 NKLT-DIKPLTNLK--NLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-L 127
Query: 215 YNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDL 274
++ LE++ L N T L L L ++ DN S I + + ++ + L
Sbjct: 128 VHLPQLESLYLGNNKITDITVLS---RLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYL 182
Query: 275 PINYFTGKVSII--FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENR 332
N +S + LKNL L+L + N + +
Sbjct: 183 SKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
Query: 333 LGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ 392
+ + N+ + + V+ I + + + + + ++
Sbjct: 239 ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDG 298
Query: 393 LRNLQAIGLSSNFLQGNIPSSLG 415
+ + P+ G
Sbjct: 299 TVIKTKVEAGTRITAPKPPTKQG 321
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 36/218 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVC 745
+G G+FG V+ +G +K +N + + ++ AE EVL++ H N+IKI V
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
F+ +V E + G L E + + + + LS + M +A+ Y H
Sbjct: 89 ----FEDYHNMYIVMETCEGGELLERIVSAQARGKA--LSEGYVAELMKQMMNALAYFHS 142
Query: 806 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
+VH DLKP N+L + DFGLA + D GT
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KS-DEHSTN------AAGTA 190
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y+ P + + C D++S GV++
Sbjct: 191 LYMAPEVFKRDVTFKC-------------DIWSAGVVM 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
S IG+GS G V +G VAVK+++L ++ + E ++R+ +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 741 IITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
+ ++ E++Q G+L + + Q L+ Q + +
Sbjct: 107 ---------MYKSYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAV 150
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A+ YLH ++H D+K ++LL D +SDFG F + + S +
Sbjct: 151 LQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG-----FCAQISKDVPKRKSLV 202
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
GT ++ P I++ Y +E D++SLG+M++EM
Sbjct: 203 ---GTPYWMAPEVISRS------LY--ATEV----DIWSLGIMVIEM 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 68/218 (31%), Positives = 96/218 (44%), Gaps = 39/218 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G G+FG V G G VAVKILN + + E + L+ RH ++IK+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
V I F +V EY+ G L +++ + E+ L Q++ SA++Y
Sbjct: 79 V---ISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYC 127
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL-ARFLFARPFDTSMETQSSSIGIKGTV 862
H H +VH DLKP NVLLD M A ++DFGL TS G+
Sbjct: 128 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----------GSP 174
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y P I+ L Y G E D++S GV+L
Sbjct: 175 NYAAPEVISGRL------YA-GPEV----DIWSCGVIL 201
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 38/224 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGA-LKSFVAECEV-LRNTRHRNLIKIITV 744
IG+G++GSV K + +G +AVK + K + + +V +R++ +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85
Query: 745 CSSIDFKGADFKA----LVYEYMQNGSLEEWLHQS-NGQPEVCDLSLIQRLNIAIDMASA 799
F GA F+ + E M + S +++ + +V ++ + I + A
Sbjct: 86 -----FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKA 137
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+ +L + + I+H D+KPSN+LLD + DFG++ L S+ ++
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SI-AKTRDA--- 186
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
G Y+ P I + Y V DV+SLG+ L E+
Sbjct: 187 GCRPYMAPERIDP--SASRQGY------DVRSDVWSLGITLYEL 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 51/231 (22%), Positives = 96/231 (41%), Gaps = 44/231 (19%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
+ +G G+FG VYK E G A K++ + L+ ++ E E+L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 741 IITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQ-PEVCDLSLIQRLNIAI- 794
GA + ++ E+ G+++ + + + E I +
Sbjct: 81 ---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---------IQVV 122
Query: 795 --DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
M A+ +LH I+H DLK NVL+ + ++DFG++ +++ +
Sbjct: 123 CRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN-----LKTLQKR 174
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
S I GT ++ P + + +A D++SLG+ L+EM
Sbjct: 175 DSFI---GTPYWMAPEVVMCETM---KDTPYDYKA----DIWSLGITLIEM 215
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
++ IGQG+ G+VY + G VA++ +NL Q+ + + E V+R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 741 IITVCSSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI-- 794
+ + +V EY+ GSL + + + + + IA
Sbjct: 82 ---------YLDSYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDEGQIAAVC 122
Query: 795 -DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+ A+E+LH + ++H D+K N+LL D ++DFG F +S
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPEQSKRS 174
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
+ + GT ++ P + G + D++SLG+M +EM
Sbjct: 175 TMV---GTPYWMAPEVVT--------RKAYGPKV----DIWSLGIMAIEM 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 54/235 (22%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKII 742
IG+G++G+V+K E VA+K + L G S + E +L+ +H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
V S LV+E+ L+++ D +++ + + +
Sbjct: 68 DVLHS---DKKLT--LVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSF--LFQLLKGLGF 116
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
H ++H DLKP N+L++ + +++FGLAR F P + S+ + T+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA-FGIP----VRCYSAEVV---TL 165
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCMFQG 916
Y PP + G++ T D++S G + E+ RP +F G
Sbjct: 166 WYRPP------------DVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPG 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 39/217 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+F V+ G A+K + S E VL+ +H N++ + +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
++ LV + + G L + + + E D SL+ + + SA++YLH +
Sbjct: 75 ---YESTTHYYLVMQLVSGGELFDRILERGVYTEK-DASLVIQ-----QVLSAVKYLHEN 125
Query: 807 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
IVH DLKP N+L + + ++DFGL++ T GT G
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----------ACGTPG 172
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
YV P ++L + D +S+GV+
Sbjct: 173 YVAP----EVLA----QKPYSKAV----DCWSIGVIT 197
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 52/233 (22%), Positives = 85/233 (36%), Gaps = 63/233 (27%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--------LMQKGALKSFVAECEVLRNTRHRNL 738
+G G+FG V+ + E V VK + ++ L E +L H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 739 IKIITVCSSIDF---------KGADFKALVYEY-MQNGSLEEWLHQSNGQPEVCDLSLIQ 788
IK++ + + F G D ++ + ++ L+E P
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLD----LFAFIDRHPRLDE--------PLAS------ 133
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARP-FDT 847
I + SA+ YL I+H D+K N+++ D + DFG A +L F T
Sbjct: 134 --YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
GT+ Y P + Y G E +++SLGV L
Sbjct: 189 FC----------GTIEYCAPEVLMGNP------YR-GPEL----EMWSLGVTL 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 62/242 (25%), Positives = 111/242 (45%), Gaps = 35/242 (14%)
Query: 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-GALKSFVAECEVLRNTRH 735
++++F +G G++ +VYKG+ G +VA+K + L + G + + E +++ +H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
N++++ V + + LV+E+M N L++++ L L
Sbjct: 63 ENIVRLYDVIHT---ENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+ + + H + I+H DLKP N+L++ + DFGLAR F P + T SS
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIP----VNTFSSE 168
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCMF 914
+ T+ Y P + MGS T D++S G +L EM T +P +F
Sbjct: 169 V---VTLWYRAP------------DVLMGSRTYSTSIDIWSCGCILAEMIT-GKP---LF 209
Query: 915 QG 916
G
Sbjct: 210 PG 211
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 55/240 (22%), Positives = 102/240 (42%), Gaps = 49/240 (20%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHR 736
F ++G G++G VYKG + G A+K++++ + E +L+ HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 737 NLIKIITVCSSIDFKGADFKA----------LVYEYMQNGSLEEWLHQSNGQPEVCDLSL 786
N+ + GA K LV E+ GS+ + + + G
Sbjct: 82 NIAT---------YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------- 125
Query: 787 IQRLNIAI---DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFAR 843
++ IA ++ + +LH H ++H D+K NVLL + + DFG++ L
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--- 179
Query: 844 PFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
D ++ +++ I GT ++ P IA N + ++ D++SLG+ +EM
Sbjct: 180 --DRTVGRRNTFI---GTPYWMAPEVIACDEN---PDATYDFKS----DLWSLGITAIEM 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 56/217 (25%), Positives = 81/217 (37%), Gaps = 39/217 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+GS+G V + A K + + F E E++++ H N+I++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
F+ LV E G L E + E D + I + D+ SA+ Y H
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERVVHKRVFRE-SDAARIMK-----DVLSAVAYCHKL 125
Query: 807 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
+ H DLKP N L D + DFGLA +P M T GT
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KP-GKMMRT------KVGTPY 173
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
YV P + + C D +S GVM+
Sbjct: 174 YVSPQVLEGLYGPEC-------------DEWSAGVMM 197
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 41/230 (17%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKII 742
M+G+GSFG V K AVK++N + + + E E+L+ H N++K+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
+ + + +V E G L + + + E +I+ + S I Y
Sbjct: 88 EI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITY 136
Query: 803 LHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+H H IVH DLKP N+LL + D + DFGL+ + +
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---------FQQNTKMKDRI 184
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + + C DV+S GV+L + + P
Sbjct: 185 GTAYYIAPEVLRGTYDEKC-------------DVWSAGVILYILLSGTPP 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 63/250 (25%), Positives = 106/250 (42%), Gaps = 41/250 (16%)
Query: 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSF-------VAE 726
S AT+ + IG G++G+VYK +G FVA+K + + G VA
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 727 CEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSL 786
L H N+++++ VC++ LV+E++ L +L ++
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAET 121
Query: 787 IQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFD 846
I+ L +++LH +C IVH DLKP N+L+ ++DFGLAR ++
Sbjct: 122 IKDL--MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI-YSYQMA 175
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
+ T+ Y P E + S + D++S+G + EMF
Sbjct: 176 LTPVVV--------TLWYRAP------------EVLLQSTYATPVDMWSVGCIFAEMFR- 214
Query: 907 RRPTNCMFQG 916
R+P +F G
Sbjct: 215 RKP---LFCG 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G+F V G VA+KI++ + +L+ E +++ H N++K+ V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
I+ + + L+ EY G + ++L E + + + SA++Y H
Sbjct: 83 ---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEK------EARSKFRQIVSAVQYCH 131
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837
IVH DLK N+LLD DM ++DFG +
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 41/218 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN-TRHRNLIKIITVC 745
+G+GSF K + ++ AVKI++ K + E L+ H N++K+ V
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV- 74
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
F LV E + G L E + + E + S I R + SA+ ++H
Sbjct: 75 ----FHDQLHTFLVMELLNGGELFERIKKKKHFSE-TEASYIMR-----KLVSAVSHMHD 124
Query: 806 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
+VH DLKP N+L + ++ + DFG AR P + ++T T+
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK--PPDNQPLKT------PCFTL 173
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y P + + Y S D++SLGV+L
Sbjct: 174 HYAAPELLNQN------GYD----ESC--DLWSLGVIL 199
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 58/228 (25%), Positives = 81/228 (35%), Gaps = 43/228 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL-KSFVA-ECEVLRNTRHRNLIKIITV 744
IG G+FG VAVK + +GA V E R+ RH N+++ V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ A++ EY G L E + + E Q+L S + Y H
Sbjct: 85 ILT-----PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH 133
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGL-ARFLFARPFDTSMETQSSSIGIKGT 861
I H DLK N LLD + DFG + +++ GT
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----------GT 180
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y+ P + + EY G A DV+S GV L M P
Sbjct: 181 PAYIAPEVLLR------QEYD-GKIA----DVWSCGVTLYVMLVGAYP 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 56/278 (20%), Positives = 98/278 (35%), Gaps = 56/278 (20%)
Query: 652 SKQESSISVPMEQYFPMVSYSELSEATNEFSS----SNMIGQGSFGSVYKGILGENGTFV 707
S Q + + + + +G G++G V +
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 708 AVKILN-------------LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754
A+K++ + + E +L++ H N+IK+ V F+
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKK 119
Query: 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHG 814
+ LV E+ + G L E + + E +++++ + S I YLH H IVH
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------ILSGICYLHKHN---IVHR 170
Query: 815 DLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIA 871
D+KP N+LL + + + DFGL+ F GT Y+ P +
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSF---------FSKDYKLRDRLGTAYYIAPEVLK 221
Query: 872 KMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
K N C DV+S GV++ + P
Sbjct: 222 KKYNEKC-------------DVWSCGVIMYILLCGYPP 246
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 59/243 (24%), Positives = 107/243 (44%), Gaps = 46/243 (18%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-GALKSFVAECEVLRNTRHRN 737
+ + +G+G++ +VYKG VA+K + L + GA + + E +L++ +H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNG---QPEVCDLSLIQRLNIAI 794
++ + + + + + LV+EY+ L+++L V L Q L
Sbjct: 62 IVTLHDIIHT---EKSLT--LVFEYLDK-DLKQYLDDCGNIINMHNVKLF-LFQLL---- 110
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+ Y H ++H DLKP N+L++ ++DFGLAR + P +T +
Sbjct: 111 ---RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA-KSIP----TKTYDN 159
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCM 913
+ T+ Y PP + +GS T D++ +G + EM T RP +
Sbjct: 160 EVV---TLWYRPP------------DILLGSTDYSTQIDMWGVGCIFYEMAT-GRP---L 200
Query: 914 FQG 916
F G
Sbjct: 201 FPG 203
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+GS+G V K + G VA+K K K + E ++L+ RH NL+ ++ V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
C K + LV+E++ + ++ + L P D ++Q + + I + H
Sbjct: 93 CKK---KKRWY--LVFEFVDH-TILDDLELF---PNGLDYQVVQ--KYLFQIINGIGFCH 141
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT-SMETQSSSIGIKGTVG 863
H I+H D+KP N+L+ V + DFG AR A P + E T
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVA--------TRW 189
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
Y P L + ++YG +V DV+++G ++ EMF P +F G
Sbjct: 190 YRAPE-----LLVGDVKYGK----AV--DVWAIGCLVTEMFM-GEP---LFPG 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 62/258 (24%), Positives = 97/258 (37%), Gaps = 73/258 (28%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKII-TV 744
+G+G + V++ I N V VKIL ++K K E ++L N R N+I + V
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDL-SLIQRLNIAIDMAS----- 798
+ ALV+E++ N D L Q L D+
Sbjct: 101 KDPVSRT----PALVFEHVNN----------------TDFKQLYQTLTDY-DIRFYMYEI 139
Query: 799 --AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLFARPFDTSMETQSSS 855
A++Y H I+H D+KP NV++DH+ + D+GLA F
Sbjct: 140 LKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN-------- 188
Query: 856 IGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
V P +++ Y S+ D++SLG ML M R+ P
Sbjct: 189 -------VRVASRYFKGP---ELLVD--YQMYD----YSL--DMWSLGCMLASMIFRKEP 230
Query: 910 TNCMFQGGLTLHEFCKMA 927
F G + ++A
Sbjct: 231 ---FFHGHDNYDQLVRIA 245
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-19
Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 39/218 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIIT 743
+G G+FG V G G VAVKILN + + E + L+ RH ++IK+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
V I F +V EY+ G L +++ ++ E L Q++ S ++Y
Sbjct: 84 V---ISTPSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVDYC 132
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL-ARFLFARPFDTSMETQSSSIGIKGTV 862
H H +VH DLKP NVLLD M A ++DFGL TS G+
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----------GSP 179
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y P I+ L Y G E D++S GV+L
Sbjct: 180 NYAAPEVISGRL------YA-GPEV----DIWSSGVIL 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 48/259 (18%)
Query: 652 SKQESSISVPMEQYFPMVSYSELSEATN---EFSSSNMIGQGSFGSVYKGILGENGTFVA 708
S + + P + + E S F +G+GS+GSVYK I E G VA
Sbjct: 1 SLETVQLRNPPRR--QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVA 58
Query: 709 VKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA----LVYEYMQ 764
+K + + L+ + E +++ +++K + G+ FK +V EY
Sbjct: 59 IKQVPVESD--LQEIIKEISIMQQCDSPHVVK---------YYGSYFKNTDLWIVMEYCG 107
Query: 765 NGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824
GS+ + + N +++ I + +EYLH +H D+K N+LL+
Sbjct: 108 AGSVSDIIRLRNKTLTEDEIATILQ-----STLKGLEYLHFM---RKIHRDIKAGNILLN 159
Query: 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMG 884
+ A ++DFG A +M +++ I GT ++ P I E G
Sbjct: 160 TEGHAKLADFG-----VAGQLTDTMAKRNTVI---GTPFWMAPEVIQ--------EIGYN 203
Query: 885 SEASVTGDVYSLGVMLLEM 903
A D++SLG+ +EM
Sbjct: 204 CVA----DIWSLGITAIEM 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 43/219 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVL-RNTRHRNLIKIITVC 745
IG GS+ + I AVKI++ K E E+L R +H N+I + V
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPT-EEIEILLRYGQHPNIITLKDV- 84
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
+ + +V E M+ G L + + + E + S + + +EYLH
Sbjct: 85 ----YDDGKYVYVVTELMKGGELLDKILRQKFFSER-EASAVLF-----TITKTVEYLHA 134
Query: 806 HCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+VH DLKPSN+L + + DFG A+ L R + + T T
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMT------PCYT 183
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
+V P + + Y A+ D++SLGV+L
Sbjct: 184 ANFVAPEVLERQ------GYD----AAC--DIWSLGVLL 210
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 59/234 (25%), Positives = 104/234 (44%), Gaps = 35/234 (14%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+ F IG+GSFG V + A+K +N +++ +++ E ++++ H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
L+ + S F+ + +V + + G L L Q+ E + +L I +
Sbjct: 75 PFLVNLW--YS---FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETV---KLFIC-E 123
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+ A++YL + I+H D+KP N+LLD H++DF +A L P +T + T +
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMA-- 175
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + + Y +V D +SLGV E+ RRP
Sbjct: 176 ----GTKPYMAP-EM--FSSRKGAGYSF----AV--DWWSLGVTAYELLRGRRP 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 40/219 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+G+F V + + G A KI+N + + E + R +H N++++
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ F LV++ + G L E + E D S + + +I Y H
Sbjct: 74 -----IQEESFHYLVFDLVTGGELFEDIVAREFYSE-ADASHCIQ-----QILESIAYCH 122
Query: 805 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+ IVH +LKP N+LL ++DFGLA + + G GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---------VNDSEAWHGFAGT 170
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
GY+ P + K Y D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDP------YSK--PV----DIWACGVIL 197
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 50/228 (21%), Positives = 81/228 (35%), Gaps = 25/228 (10%)
Query: 362 IPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSL-GNLTL 419
IP + + NL+L FN L LQ + LS +Q I +L+
Sbjct: 22 IPDNLPFSTKNLDL---SFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 420 MTDLFLSSNHLQGNIPPSL-GNCKNLVSLNLSDNKL--IGAVPQQILTITTLSRFLDLGN 476
++ L L+ N +Q ++ +L L + L + P L L++ +
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK---ELNVAH 133
Query: 477 NHLNGSLPLEVG---NLKNLVALYISGNQFSGEIPV-TLTGCTGLEIF----HMQGNSFR 528
N + S L NL NL L +S N+ I L + + + N
Sbjct: 134 NLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 529 GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
I +KEL L N L + L+ L+ + L N +D
Sbjct: 191 -FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 40/216 (18%), Positives = 80/216 (37%), Gaps = 16/216 (7%)
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
S L + N S ++ L+ + L + +L +L + N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 255 FSGSIP-ESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313
S+ +FS S+++ + + G LK L L++ N + S
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-----FKL 141
Query: 314 VTILTNCSKLKVLAFEENRLGGVLPHSI----ANLSTTMTDIYMGVNQISGTIPSGIGNL 369
+N + L+ L N++ + + + + + +N ++ I G
Sbjct: 142 PEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 370 VNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSN 404
+ L L ++ NQL ++P I +L +LQ I L +N
Sbjct: 200 IRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 42/234 (17%), Positives = 77/234 (32%), Gaps = 39/234 (16%)
Query: 77 TELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEIGF--LFRLETLMLANNS 133
LDL + L Y + L+ ++L+ I + L L TL+L N
Sbjct: 31 KNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA-YQSLSHLSTLILTGN- 86
Query: 134 FSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGN 193
+ S + L+ + +L + IG+
Sbjct: 87 -------PIQS-----------------LALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 194 L-SIIYLHVGENQF-SGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFA-- 249
L ++ L+V N S +P N+++LE++ L N ++ L + +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS 181
Query: 250 --IGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGIN 301
+ N + I ++ + L N IF RL +L + L N
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 48/234 (20%), Positives = 87/234 (37%), Gaps = 61/234 (26%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVA---ECEVLR----NTRH 735
++G+G FG+V+ G + VA+K++ ++ L V E +L H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
+I+++ + + LV E ++ D + ++ +
Sbjct: 98 PGVIRLLDW---FETQEGFM--LVLERPLPAQ------------DLFDY-ITEKGPLGEG 139
Query: 796 MA--------SAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLFARPFD 846
+ +AI++ H +VH D+K N+L+D A + DFG L P+
Sbjct: 140 PSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT 196
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
GT Y PP I++ Y A V+SLG++L
Sbjct: 197 DFD----------GTRVYSPPEWISRHQ------Y-HALPA----TVWSLGILL 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 49/226 (21%), Positives = 83/226 (36%), Gaps = 46/226 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKI-----LNLMQKGALKSFVAECEVLRNTRHRNLIKI 741
IG+G F V + I E G AVKI + + E + +H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSL----EEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+ SS +V+E+M L + E S R +
Sbjct: 92 LETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-VASHYMR-----QIL 140
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
A+ Y H + I+H D+KP VLL ++ + FG+A L E+
Sbjct: 141 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--------ESGLV 189
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
+ G GT ++ P +++ G DV+ GV+L
Sbjct: 190 AGGRVGTPHFMAP----EVVK----REPYGKPV----DVWGCGVIL 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+F ++G+GSF +V A+KIL ++++ + E +V+ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
+K+ + F+ + Y +NG L +++ + E C R A +
Sbjct: 90 PFFVKLY--FT---FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-E 138
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQS 853
+ SA+EYLH I+H DLKP N+LL+ DM H+ +DFG A+ L +
Sbjct: 139 IVSALEYLHGK---GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANS-- 191
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP---- 909
GT YV P E A + D+++LG ++ ++ P
Sbjct: 192 ----FVGTAQYVSP------------ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235
Query: 910 -TNCMFQ 915
+FQ
Sbjct: 236 NEYLIFQ 242
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+GS+G V+K + G VA+K + K + E +L+ +H NL+ ++ V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
K LV+EY + ++ L + L++ +I A+ + H
Sbjct: 71 FRR---KRRLH--LVFEYCDH-TVLHELDRY---QRGVPEHLVK--SITWQTLQAVNFCH 119
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
H +H D+KP N+L+ V + DFG AR L P D
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDY 158
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 57/255 (22%), Positives = 104/255 (40%), Gaps = 64/255 (25%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN 737
++ + +IG GSFG VY+ L ++G VA+K + ++ + E +++R H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 738 LIKIITV-CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID- 795
++++ SS + K + LV +Y+ E +++ V + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYR------VARHYSRAKQTLPVIY 157
Query: 796 -------MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLFARPFDT 847
+ ++ Y+H I H D+KP N+LLD D V + DFG A+ L +
Sbjct: 158 VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 848 SMETQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901
S Y+ P I +Y + + DV+S G +L
Sbjct: 215 S---------------YICSRYYRAPELI-----FGATDY------TSSIDVWSAGCVLA 248
Query: 902 EMFTRRRPTNCMFQG 916
E+ +P +F G
Sbjct: 249 ELLL-GQP---IFPG 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 42/265 (15%)
Query: 309 NDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGN 368
+ + ++ ++ + + L ++ I + I ++ GI
Sbjct: 12 TPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIK-SV-QGIQY 66
Query: 369 LVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN 428
L N+ L + N+LT +I + L+NL + L N ++ ++ SSL +L + L L N
Sbjct: 67 LPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHN 122
Query: 429 HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVG 488
+ +I L + L SL L +N +I IT LS
Sbjct: 123 GIS-DING-LVHLPQLESLYLGNN--------KITDITVLS------------------- 153
Query: 489 NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSC 548
L L L + NQ S +I L G T L+ ++ N + +L LK++ L+L
Sbjct: 154 RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209
Query: 549 NNLSGQIPEFLENLSFLEYLNLSYN 573
+ NL + +
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDG 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 39/211 (18%)
Query: 364 SGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDL 423
++ +T + +L ++ I +++ ++ ++ + L +T L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 424 FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
FL+ N L +I P L N KNL L L +N ++ +++L
Sbjct: 74 FLNGNKLT-DIKP-LANLKNLGWLFLDEN--------KVKDLSSLK-------------- 109
Query: 484 PLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKE 543
+LK L +L + N S +I L LE ++ N LS L +
Sbjct: 110 -----DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDT 160
Query: 544 LDLSCNNLSGQIPEFLENLSFLEYLNLSYNH 574
L L N +S I L L+ L+ L LS NH
Sbjct: 161 LSLEDNQIS-DI-VPLAGLTKLQNLYLSKNH 189
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 56/281 (19%), Positives = 101/281 (35%), Gaps = 40/281 (14%)
Query: 214 LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIID 273
+ L T + + L ++ ++ S+ + N+ +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 74
Query: 274 LPINYFTGKVSIIFG--RLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN 331
L N K++ I LKNL L L N + ++ L + KLK L+ E N
Sbjct: 75 LNGN----KLTDIKPLANLKNLGWLFLDENKVKD--------LSSLKDLKKLKSLSLEHN 122
Query: 332 RLGGVLPHSIANLS--TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPRE 389
+ I L + +Y+G N+I T + + L L+ L +E NQ++ +I
Sbjct: 123 GI-----SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-P 173
Query: 390 IGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449
+ L LQ + LS N + ++ +L L + L L S N ++
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231
Query: 450 SDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNL 490
+D L+ T +S D ++ LP +
Sbjct: 232 TDGSLV--------TPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 47/235 (20%), Positives = 81/235 (34%), Gaps = 25/235 (10%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+ ++ + +I S+ + L + + L N +I K + L L L L N
Sbjct: 48 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK 103
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDI-GYSWL-KLEHISLARNHLTGMLPASIGN 193
+ ++L L S N + DI G L +LE + L N +T + +
Sbjct: 104 -DL-SSLKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKITDITV--LSR 154
Query: 194 L-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGD 252
L + L + +NQ S + P L ++ L+N+ L N + L L NL V +
Sbjct: 155 LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALA---GLKNLDVLELFS 209
Query: 253 NYFSGSIPESFSNASNIEIIDLPINYFTGKVSI----IFGRLKNLWSLDLGINNL 303
SN + I + + W L N +
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVA-ECEVLRNTRHRNLIKIIT 743
+G+GSFG V + VA+K ++ L++K + V E L+ RH ++IK+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
V I +V EY G L +++ + E Q++ AIEY
Sbjct: 77 V---ITTPTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI------ICAIEYC 124
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H H IVH DLKP N+LLD ++ ++DFGL+ + ++T G+
Sbjct: 125 HRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTSC------GSPN 172
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y P I Y G E DV+S G++L M R P
Sbjct: 173 YAAPEVING------KLYA-GPEV----DVWSCGIVLYVMLVGRLP 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 30/225 (13%)
Query: 651 RSKQESSISVPMEQYFPMVSYSELSEATN------EFSSSNMIGQGSFGSVYKGILGENG 704
+SK+ S+++V + + ++ S + ++G G FG V+K G
Sbjct: 55 KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114
Query: 705 TFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQ 764
+A KI+ + E V+ H NLI++ F+ + LV EY+
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-----FESKNDIVLVMEYVD 169
Query: 765 NGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824
G L + + + +L+ + + + I ++H I+H DLKP N+L
Sbjct: 170 GGELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCV 221
Query: 825 HDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPP 867
+ + DFGLAR +P ++ GT ++ P
Sbjct: 222 NRDAKQIKIIDFGLARRY--KP-REKLKV------NFGTPEFLAP 257
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV---LRNTRHRNLIKII 742
++G G G V + G A+K+L S A EV + + +++ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP--EVCDLSLIQRLNIAIDMASAI 800
V ++ ++ E M+ G L + + Q E + + I R D+ +AI
Sbjct: 89 DVYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTE-REAAEIMR-----DIGTAI 141
Query: 801 EYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
++LH H I H D+KP N+L + D V ++DFG A+ T
Sbjct: 142 QFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---------- 188
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
T YV P + +Y S D++SLGV++
Sbjct: 189 PCYTPYYVAPEVLGPE------KYD----KSC--DMWSLGVIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 50/243 (20%), Positives = 85/243 (34%), Gaps = 65/243 (26%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVA---ECEVLRNTRHR--NL 738
+G G FGSVY GI + VA+K + + G L + E +L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 739 IKIITVCSSIDFKGADFKALVYEY-----------MQNGSLEEWLHQSNGQPEVCDLSLI 787
I+++ + + L+ E + G+L+E
Sbjct: 111 IRLLDW---FERPDSFV--LILERPEPVQDLFDFITERGALQE--------ELAR----- 152
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLFARPFD 846
+ + A+ + H+ ++H D+K N+L+D + + DFG L +
Sbjct: 153 ---SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
GT Y PP I Y G A V+SLG++L +M
Sbjct: 207 DFD----------GTRVYSPPEWIRYHR------Y-HGRSA----AVWSLGILLYDMVCG 245
Query: 907 RRP 909
P
Sbjct: 246 DIP 248
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 50/231 (21%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVC 745
IG+GSFG V+KGI VA+KI++L + + ++ E VL + K
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK----- 84
Query: 746 SSIDFKGADFKA----LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI---DMAS 798
+ G+ K ++ EY+ GS + L + E IA ++
Sbjct: 85 ----YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQ---------IATILREILK 130
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
++YLH +H D+K +NVLL ++DFG+A L + +++ +
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-----TQIKRNTFV-- 180
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT ++ P I + S+A D++SLG+ +E+ P
Sbjct: 181 -GTPFWMAPEVIK--------QSAYDSKA----DIWSLGITAIELARGEPP 218
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 50/239 (20%), Positives = 93/239 (38%), Gaps = 15/239 (6%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAI 399
++L ++ + ++ I G +L + I N + I ++ L L I
Sbjct: 26 SDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84
Query: 400 GLS-SNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKLIGA 457
+ +N L P + NL + L +S+ ++ ++P + V L++ DN I
Sbjct: 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 458 VPQQILT-ITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV-TLTGCT 515
+ + ++ S L L N + + N L L +S N E+P G +
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 516 GLEIFHMQGNSFRGSIPL-SLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573
G I + S+P L +LK ++ NL ++P E L L +L+Y
Sbjct: 203 GPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLK-KLPTL-EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 47/245 (19%), Positives = 78/245 (31%), Gaps = 12/245 (4%)
Query: 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSS-LGNLTL 419
IPS + N L +L +L+ I +S N + I + NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 420 MTDLFLS-SNHLQGNIPPS-LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNN 477
+ ++ + +N+L I P N NL L +S+ I +P + LD+ +N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTG-IKHLPDVHKIHSLQKVLLDIQDN 138
Query: 478 HLNGSLPLEV--GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535
++ G V L+++ N G E+ N+
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTG 595
LD+S + LENL L + ++PT LT
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTY 255
Query: 596 NGKLC 600
C
Sbjct: 256 PSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 43/283 (15%), Positives = 85/283 (30%), Gaps = 42/283 (14%)
Query: 174 EHISLARNHLTGMLPASI-GNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG 232
+ +T +P+ + N + + + LE I + N
Sbjct: 12 RVFLCQESKVT-EIPSDLPRNAIELRFV--LTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKN 292
+ D+ LP L I A+N+ I F L N
Sbjct: 69 VIEADVFSNLPKLHEIRI-------------EKANNLLYI--NPEAFQN--------LPN 105
Query: 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN-RLGGVLPHSIANLSTTMTDI 351
L L + + D+ + + + +L ++N + + +S LS +
Sbjct: 106 LQYLLISNTGIKH--LPDVHKI----HSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159
Query: 352 YMGVNQISGTIPSGIGNLVNL-NLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGN 409
++ N I I + N L L + N L +P ++ + +S +
Sbjct: 160 WLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 217
Query: 410 IPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDN 452
L NL + + P+L L+ +L+
Sbjct: 218 PSYGLENLKKLRARSTYNL----KKLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 25/159 (15%), Positives = 50/159 (31%), Gaps = 16/159 (10%)
Query: 77 TELDLRHQNIGGSLSPYV-GNLSFLRYINLATNNFHGEIPKEI--GFLFRLETLMLANNS 133
L + + I L + +++ N I + G F L L N
Sbjct: 107 QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 134 FSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPA---- 189
+I + + + L NN + E+P D+ + + ++R + LP+
Sbjct: 166 IQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE 223
Query: 190 SIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVN 228
++ L P+L + +L L
Sbjct: 224 NLKKLRARST----YNLKKL--PTLEKLVALMEASLTYP 256
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 40/219 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+G+F V + + G A KI+N + + E + R +H N++++
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ F LV++ + G L E + E D S + + +I Y H
Sbjct: 97 -----IQEESFHYLVFDLVTGGELFEDIVAREFYSE-ADASHCIQ-----QILESIAYCH 145
Query: 805 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+ IVH +LKP N+LL ++DFGLA + + G GT
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---------VNDSEAWHGFAGT 193
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
GY+ P + K Y D+++ GV+L
Sbjct: 194 PGYLSPEVLKKDP------Y--SKPV----DIWACGVIL 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 56/278 (20%)
Query: 650 RRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAV 709
E+ P + + + +G+G++G VYK I VA+
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSID---RYRRITKLGEGTYGEVYKAIDTVTNETVAI 64
Query: 710 KILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGS 767
K + L + G + + E +L+ +HRN+I++ +V L++EY +N
Sbjct: 65 KRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH---NHRLH--LIFEYAEN-D 118
Query: 768 LEEWLHQSNG--QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825
L++++ ++ + L Q + + + + H +H DLKP N+LL
Sbjct: 119 LKKYMDKNPDVSMRVIKSF-LYQLI-------NGVNFCHSRR---CLHRDLKPQNLLLSV 167
Query: 826 DMVAH-----VSDFGLARFLFARPFDT-SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCL 879
+ + DFGLAR F P + E T+ Y PP
Sbjct: 168 SDASETPVLKIGDFGLARA-FGIPIRQFTHEII--------TLWYRPP------------ 206
Query: 880 EYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCMFQG 916
E +GS T D++S+ + EM + P +F G
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLM-KTP---LFPG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 47/252 (18%), Positives = 94/252 (37%), Gaps = 36/252 (14%)
Query: 651 RSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK 710
S ++ + +QY+P + + + +G G+FG V++ G A K
Sbjct: 129 SSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK 188
Query: 711 ILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEE 770
+ + ++ E + + RH L+ + F+ + ++YE+M G L E
Sbjct: 189 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFE 243
Query: 771 WLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830
+ + + + R + + ++H + VH DLKP N++
Sbjct: 244 KVADEHNKMSEDEAVEYMR-----QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 295
Query: 831 V--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888
+ DFGL L P S++ GT + P ++ G +
Sbjct: 296 LKLIDFGLTAHL--DP-KQSVKV------TTGTAEFAAP----EVAE--GKPVGYYT--- 337
Query: 889 VTGDVYSLGVML 900
D++S+GV+
Sbjct: 338 ---DMWSVGVLS 346
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 49/239 (20%), Positives = 96/239 (40%), Gaps = 38/239 (15%)
Query: 687 IGQGSFGSVYKGILGENGT--FVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+G++G VYK + A+K + G S E +LR +H N+I + V
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 745 CSSIDFKGADFKALVYEYMQN--GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
S L+++Y ++ + ++ S + L ++ + I Y
Sbjct: 87 FLS---HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLARFLFARPFDTSMETQSSSIGI 858
LH + ++H DLKP+N+L+ + ++D G AR F++ ++ + +
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL-----FNSPLKPLADLDPV 195
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCMFQG 916
T Y P E +G+ D++++G + E+ T P +F
Sbjct: 196 VVTFWYRAP------------ELLLGARHYTKAIDIWAIGCIFAELLT-SEP---IFHC 238
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 38/183 (20%), Positives = 70/183 (38%), Gaps = 24/183 (13%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+FG V++ + G K +N + E ++ H LI +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
F+ L+ E++ G L + + + + ++ R ++++H H
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR-----QACEGLKHMHEH 168
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
IVH D+KP N++ + + V DFGLA L P D ++ T +
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NP-DEIVKV------TTATAEF 216
Query: 865 VPP 867
P
Sbjct: 217 AAP 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 56/245 (22%), Positives = 98/245 (40%), Gaps = 53/245 (21%)
Query: 685 NMIGQGSFGSVYKGI-LGENGTFVAVKILNLMQKG------------ALKSFVAECEVLR 731
IG+G++G V+K L G FVA+K + + L+ L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-------LE 69
Query: 732 NTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN 791
H N++++ VC+ LV+E++ L +L + I+ +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG--VPTETIKDM- 125
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
+ +++LH H +VH DLKP N+L+ ++DFGLAR ++ +
Sbjct: 126 -MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVV 180
Query: 852 QSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911
T+ Y P E + S + D++S+G + EMF R+P
Sbjct: 181 V--------TLWYRAP------------EVLLQSSYATPVDLWSVGCIFAEMFR-RKP-- 217
Query: 912 CMFQG 916
+F+G
Sbjct: 218 -LFRG 221
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 55/270 (20%)
Query: 653 KQESSISVPMEQYFPMVS-YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKI 711
Q+ ++ ++ P+V E+ ++F +IG+G+F V + + G A+KI
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI 93
Query: 712 LN---LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSL 768
+N ++++G + F E +VL N R + ++ + F+ ++ LV EY G L
Sbjct: 94 MNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH--FA---FQDENYLYLVMEYYVGGDL 148
Query: 769 EEWLHQSNGQPEVCDLSLIQRLNIAID----------MASAIEYLHHHCQPPIVHGDLKP 818
L+L+ + I + AI+ +H VH D+KP
Sbjct: 149 ---------------LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKP 190
Query: 819 SNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKM-LN 875
N+LLD H+ +DFG +S GT Y+ P + +
Sbjct: 191 DNILLDRC--GHIRLADFGS-----CLKLRADGTVRSLVAV--GTPDYLSPEILQAVGGG 241
Query: 876 LPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
YG D ++LGV EMF
Sbjct: 242 PGTGSYGP----EC--DWWALGVFAYEMFY 265
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 62/241 (25%), Positives = 108/241 (44%), Gaps = 42/241 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHR 736
++ +G+G++G VYK G VA+K + L + G + + E +L+ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N++ +I V S + LV+E+M+ L++ L + S I+ +
Sbjct: 80 NIVSLIDVIHS---ERCLT--LVFEFMEK-DLKKVLDE---NKTGLQDSQIKIY--LYQL 128
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
+ + H H I+H DLKP N+L++ D ++DFGLAR F P + + + +
Sbjct: 129 LRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA-FGIP----VRSYTHEV 180
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCMFQ 915
T+ Y P + MGS+ T D++S+G + EM T +P +F
Sbjct: 181 V---TLWYRAP------------DVLMGSKKYSTSVDIWSIGCIFAEMIT-GKP---LFP 221
Query: 916 G 916
G
Sbjct: 222 G 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 46/209 (22%)
Query: 662 MEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK----------- 710
M + + + F M GQG+FG+V G G VA+K
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65
Query: 711 ILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD--FKALVYEYMQNGSL 768
L +MQ L H N++++ + ++ + + +V EY+
Sbjct: 66 ELQIMQD------------LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV----- 108
Query: 769 EEWLHQSNGQPEVCDLSLIQRLNIAID--------MASAIEYLHHHCQPPIVHGDLKPSN 820
+ LH+ C +++ + +I LH + H D+KP N
Sbjct: 109 PDTLHR------CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHN 161
Query: 821 VLLD-HDMVAHVSDFGLARFLFARPFDTS 848
VL++ D + DFG A+ L + +
Sbjct: 162 VLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 47/219 (21%), Positives = 83/219 (37%), Gaps = 39/219 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
+G+G+F V + + G A I+N + + E + R +H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
S L+++ + G L E + E D S + + A+ + H
Sbjct: 79 ISE-----EGHHYLIFDLVTGGELFEDIVAREYYSE-ADASHCIQ-----QILEAVLHCH 127
Query: 805 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+VH +LKP N+LL ++DFGLA + + GT
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFG------FAGT 176
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
GY+ P + K YG D+++ GV+L
Sbjct: 177 PGYLSPEVLRKD------PYGK--PV----DLWACGVIL 203
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 59/271 (21%), Positives = 98/271 (36%), Gaps = 58/271 (21%)
Query: 649 RRRSKQESSISVPMEQYFPMVSYSELSEATNE------FSSSNMIGQGSFGSVYKGILGE 702
Q + +P + +++E + FS IG GSFG+VY
Sbjct: 18 ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77
Query: 703 NGTFVAVKILNLMQKGA---LKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA-- 757
N VA+K ++ K + + + E L+ RH N I+ ++G +
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------YRGCYLREHT 128
Query: 758 --LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI---DMASAIEYLHHHCQPPIV 812
LV EY + + EV IA + YLH H ++
Sbjct: 129 AWLVMEYCLGSASDLLEVHKKPLQEVE---------IAAVTHGALQGLAYLHSH---NMI 176
Query: 813 HGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAK 872
H D+K N+LL + + DFG A + ++ + GT ++ P I
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSFV----------GTPYWMAPEVILA 224
Query: 873 MLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903
M E + DV+SLG+ +E+
Sbjct: 225 M-----DEGQYDGKV----DVWSLGITCIEL 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 40/217 (18%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA-ECEVLRNTRHRNLIKIITVC 745
+G+G FG V++ + + K + + KG + V E +L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
F+ + +++E++ + E ++ S + ++ + A+++LH
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QVCEALQFLHS 120
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H I H D++P N++ + + +FG AR L +P + +
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KP-GDNFRL------LFTAPE 168
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y P ++ + D++SLG ++
Sbjct: 169 YYAP----EVHQ--HDVVSTAT------DMWSLGTLV 193
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 6e-17
Identities = 62/236 (26%), Positives = 94/236 (39%), Gaps = 37/236 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+ F ++G+G FG V+ + G A K LN L ++ + + E ++L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
R + V + F+ LV M G + ++ + A
Sbjct: 245 RFI-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-IFYTA-Q 297
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQS 853
+ S +E+LH I++ DLKP NVLLD D +V SD GLA Q+
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLAV--------ELKAGQT 344
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ G GT G++ P + EY SV D ++LGV L EM R P
Sbjct: 345 KTKGYAGTPGFMAPELLLGE------EYDF----SV--DYFALGVTLYEMIAARGP 388
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-17
Identities = 46/188 (24%), Positives = 81/188 (43%), Gaps = 42/188 (22%)
Query: 673 ELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA-----EC 727
++ + + +G+G F +VYK VA+K + L + K + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 728 EVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDL-SL 786
++L+ H N+I ++ K LV+++M+ DL +
Sbjct: 64 KLLQELSHPNIIGLLDAFGH---KSNIS--LVFDFME-----------------TDLEVI 101
Query: 787 IQRLNIAIDMA----------SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
I+ ++ + + +EYLH H I+H DLKP+N+LLD + V ++DFGL
Sbjct: 102 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 837 ARFLFARP 844
A+ F P
Sbjct: 159 AKS-FGSP 165
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 44/213 (20%), Positives = 85/213 (39%), Gaps = 18/213 (8%)
Query: 356 NQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLG 415
I+ P L N + +T + +L +Q ++ +Q ++ + +
Sbjct: 7 TPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQ 60
Query: 416 NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLG 475
T + +L LS N + ++ P L + L L+++ N+L ++ L L
Sbjct: 61 FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL----FLD 114
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535
NN L + L +LKNL L I N+ I + L + LE+ + GN + L+
Sbjct: 115 NNELRDTDSLI--HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLT- 169
Query: 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568
LK + +DL+ + ++ L +
Sbjct: 170 -RLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 32/152 (21%), Positives = 57/152 (37%), Gaps = 14/152 (9%)
Query: 422 DLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG 481
+ + + P N V NL + V Q+ L + + + + N+++
Sbjct: 1 ESIQRPTPIN-QVFP-DPGLANAVKQNLGKQSVTDLVSQKEL--SGV-QNFNGDNSNIQS 55
Query: 482 SLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSI 541
++ NL L++S NQ S ++ L T LE + N + + L
Sbjct: 56 LAGMQ--FFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACL--- 108
Query: 542 KELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573
L L N L + L +L LE L++ N
Sbjct: 109 SRLFLDNNELRD--TDSLIHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 36/260 (13%), Positives = 77/260 (29%), Gaps = 49/260 (18%)
Query: 195 SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254
+ + ++G+ + V +S ++N D + + NL+ + N
Sbjct: 20 NAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGMQ---FFTNLKELHLSHNQ 74
Query: 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314
S + + + +E + + N ++ L L L N L
Sbjct: 75 IS-DL-SPLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNELRD--------T 121
Query: 315 TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNL 374
L + L++L+ N+L I +G L L +
Sbjct: 122 DSLIHLKNLEILSIRNNKL---------------KSI------------VMLGFLSKLEV 154
Query: 375 LGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434
L + N++T N + +L+ + I L+ L + +
Sbjct: 155 LDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--IS 210
Query: 435 PPSLGNCKNLVSLNLSDNKL 454
P + N + V +
Sbjct: 211 PYYISNGGSYVDGCVLWELP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 42/230 (18%), Positives = 81/230 (35%), Gaps = 43/230 (18%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFS 135
+ +L Q++ L LS ++ N +N + + F L+ L L++N
Sbjct: 21 AVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHN--- 73
Query: 136 GKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS 195
+I ++LS +L KLE +S+ RN L + I +
Sbjct: 74 -QI-SDLSPLKDLT----------------------KLEELSVNRNRLKNLNG--IPSAC 107
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
+ L + N+ T SL ++ +LE + + N + L L L+V + N
Sbjct: 108 LSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIVMLG---FLSKLEVLDLHGNEI 162
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGS 305
+ + + + IDL + L+ + + G
Sbjct: 163 T-NT-GGLTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGR 207
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 65/260 (25%), Positives = 111/260 (42%), Gaps = 37/260 (14%)
Query: 653 KQESSISVPMEQYFPMVSYSELSEAT-NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKI 711
++E +I +E P S + +F +IG+G+FG V L A+KI
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 712 LN---LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSL 768
LN ++++ F E +VL N + + + + F+ + LV +Y G L
Sbjct: 107 LNKWEMLKRAETACFREERDVLVNGDSKWITTLH--YA---FQDDNNLYLVMDYYVGGDL 161
Query: 769 EEWLHQSNGQ-PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827
L + + PE +++ R +A +M AI+ +H VH D+KP N+L+D +
Sbjct: 162 LTLLSKFEDRLPE--EMA---RFYLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMN- 211
Query: 828 VAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS 885
H+ +DFG + + S ++ GT Y+ P I + + YG
Sbjct: 212 -GHIRLADFGSC----LKLMEDGTVQSSVAV---GTPDYISP-EILQAMEGGKGRYGP-- 260
Query: 886 EASVTGDVYSLGVMLLEMFT 905
D +SLGV + EM
Sbjct: 261 --EC--DWWSLGVCMYEMLY 276
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 45/224 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA------ECEVLRNTRHRNLIK 740
+G G F V K G A K + Q A + V+ E +LR H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ V ++ L+ E + G L ++L Q E + + + + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIK-----QILDGV 128
Query: 801 EYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
YLH I H DLKP N++L + DFGLA + +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKN----- 177
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
I GT +V P +++N G+ + D++S+GV+
Sbjct: 178 -IFGTPEFVAP----EIVN--YEPLGLEA------DMWSIGVIT 208
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 55/298 (18%), Positives = 105/298 (35%), Gaps = 48/298 (16%)
Query: 647 ARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTF 706
+ ++ Q+ + M + + + ++IG GS+G V +
Sbjct: 21 SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80
Query: 707 VAVK-ILNLMQ-----KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA--L 758
VA+K IL + + K L+ E +L H +++K++ + D + F +
Sbjct: 81 VAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVE--KFDELYV 134
Query: 759 VYEYMQNGSLEEWLHQ--SNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816
V E + + L+ + + ++ ++Y+H I+H DL
Sbjct: 135 VLEIA-----DSDFKKLFRTPVY----LTELHIKTLLYNLLVGVKYVHSA---GILHRDL 182
Query: 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLN- 875
KP+N L++ D V DFGLAR + S S V + N+ + L
Sbjct: 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
Query: 876 -------------LPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
L Y ++ DV+S+G + E+ + L
Sbjct: 243 HVVTRWYRAPELILLQENYT----EAI--DVWSIGCIFAELLNMIKENVAYHADRGPL 294
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 48/238 (20%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKII 742
IG+G++G VYK G A+K + L ++ G + + E +L+ +H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNG---QPEVCDLSLIQRLNIAIDMASA 799
V + K LV+E++ L++ L G L+Q L +
Sbjct: 67 DVIHT---KKRLV--LVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-LLQLL-------NG 112
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
I Y H ++H DLKP N+L++ + ++DFGLAR F P + + I
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA-FGIP----VRKYTHEIV-- 162
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG-DVYSLGVMLLEMFTRRRPTNCMFQG 916
T+ Y P + MGS+ T D++S+G + EM P +F G
Sbjct: 163 -TLWYRAP------------DVLMGSKKYSTTIDIWSVGCIFAEMVN-GTP---LFPG 203
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 47/240 (19%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVL---RN 732
N+FS +IG+G FG VY + G A+K L+ + K + E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
+ VC S F D + + + M G L L Q E +
Sbjct: 249 GDCPFI-----VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-------ADMRF 296
Query: 793 -AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSM 849
A ++ +E++H+ +V+ DLKP+N+LLD HV SD GLA
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLACDF--------S 343
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ + + GT GY+ P L+ G+ ++S D +SLG ML ++ P
Sbjct: 344 KKKPHASV--GTHGYMAP---------EVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 50/250 (20%), Positives = 98/250 (39%), Gaps = 57/250 (22%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLR--------NTR 734
+G G F +V+ N T VA+KI+ + + A E ++L+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTKED 81
Query: 735 HRNLIKIITVCSSIDFKGADFK--ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
I+ + + KG + +V+E + +L + + + L +++ I
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG--IPLIYVKQ--I 136
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH------VSDFGLARFLFARPFD 846
+ + ++Y+H C I+H D+KP NVL++ ++D G A +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW------- 187
Query: 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906
E ++SI T Y P + L P +G G+ D++S ++ E+ T
Sbjct: 188 -YDEHYTNSI---QTREYRSPEVL---LGAP---WGCGA------DIWSTACLIFELITG 231
Query: 907 RRPTNCMFQG 916
+F+
Sbjct: 232 D----FLFEP 237
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 49/269 (18%), Positives = 99/269 (36%), Gaps = 55/269 (20%)
Query: 650 RRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAV 709
R++K + + + + ++ +IG+G+FG V A+
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMK--AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 710 KILN---LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNG 766
K+L+ ++++ F E +++ ++++ + F+ + +V EYM G
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYA---FQDDRYLYMVMEYMPGG 154
Query: 767 SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA--------SAIEYLHHHCQPPIVHGDLKP 818
L ++L+ ++ A A++ +H +H D+KP
Sbjct: 155 DL---------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKP 196
Query: 819 SNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNL 876
N+LLD H+ +DFG + + + + GT Y+ P +
Sbjct: 197 DNMLLDKS--GHLKLADFGTCMKM-----NKEGMVRCDTAV--GTPDYISPEVLKSQGGD 247
Query: 877 PCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
YG D +S+GV L EM
Sbjct: 248 G--YYGR----EC--DWWSVGVFLYEMLV 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 53/224 (23%), Positives = 84/224 (37%), Gaps = 45/224 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA------ECEVLRNTRHRNLIK 740
+G G F V K G A K + Q A + V E +LR H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ V ++ L+ E + G L ++L Q E + + + + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIK-----QILDGV 128
Query: 801 EYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
YLH I H DLKP N++L + DFGLA + E
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---------EDGVEFK 176
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
I GT +V P +++N G+ + D++S+GV+
Sbjct: 177 NIFGTPEFVAP----EIVN--YEPLGLEA------DMWSIGVIT 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV---LRNTRHRNLIKIIT 743
+G G G V + A+K+L A EV R ++ ++++I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP--EVCDLSLIQRLNIAIDMASAIE 801
V + + G +V E + G L + Q E + S I + + AI+
Sbjct: 123 VYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMK-----SIGEAIQ 175
Query: 802 YLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
YLH I H D+KP N+L + + ++DFG A+ + S+ T
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTT------P 223
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
T YV P + +Y S D++SLGV++
Sbjct: 224 CYTPYYVAPEVLGPE------KYD----KSC--DMWSLGVIM 253
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA------ECEVLRNTRHRNLIK 740
+G G F V K G A K + + + + V+ E +LR RH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ + F+ L+ E + G L ++L + E + + + + +
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLK-----QILDGV 121
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLARFLFARPFDTSMETQSSSI 856
YLH I H DLKP N++L V + + DFG+A + +
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKN----- 170
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
I GT +V P +++N G+ + D++S+GV+
Sbjct: 171 -IFGTPEFVAP----EIVN--YEPLGLEA------DMWSIGVIT 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 6e-16
Identities = 57/240 (23%), Positives = 89/240 (37%), Gaps = 48/240 (20%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
N F ++G+G FG V + G A K L + ++ + E ++L
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN----GQPEVCDLSLIQRLN 791
R + V + ++ D LV M G L+ ++ +
Sbjct: 244 RFV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFY 291
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSM 849
A ++ +E LH IV+ DLKP N+LLD H+ SD GLA +
Sbjct: 292 AA-EICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAV---------HV 336
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ G GTVGY+ P + Y S D ++LG +L EM + P
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNE------RYTF----SP--DWWALGCLLYEMIAGQSP 384
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 40/217 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G+G+ VY+ A+K+L + K E VL H N+IK+ +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-- 116
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
F+ +LV E + G L + + + E D + + + A+ YLH +
Sbjct: 117 ---FETPTEISLVLELVTGGELFDRIVEKGYYSER-DAADAVK-----QILEAVAYLHEN 167
Query: 807 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
IVH DLKP N+L D ++DFGL++ + M+T + GT G
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKT------VCGTPG 215
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
Y P + G E D++S+G++
Sbjct: 216 YCAPEILRGC--------AYGPEV----DMWSVGIIT 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 57/258 (22%), Positives = 102/258 (39%), Gaps = 67/258 (25%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH 735
+ +++ +IG GSFG V++ L E+ VA+K + ++ + E +++R +H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 736 RNLIKIITV-CSSIDFKGADFKALVYEYMQNGSLEEWLHQ------SNGQP---EVCDLS 785
N++ + S+ D K F LV EY+ E +++ Q + L
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 786 LIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLARFLFARP 844
+ Q + ++ Y+H I H D+KP N+LLD V + DFG A+ L A
Sbjct: 147 MYQ-------LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 845 FDTSMETQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898
+ S Y+ P I Y + D++S G
Sbjct: 197 PNVS---------------YICSRYYRAPELI-----FGATNY------TTNIDIWSTGC 230
Query: 899 MLLEMFTRRRPTNCMFQG 916
++ E+ + +F G
Sbjct: 231 VMAELMQGQ----PLFPG 244
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 8/163 (4%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
+L T +++ N + + + L L ++ +LT + G L L + L
Sbjct: 27 PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL 84
Query: 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL-GNCKNLVSLNLSDNKLIGAVPQ 460
S N LQ ++P L +T L +S N L ++P L L L N+L +P
Sbjct: 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL-KTLPP 141
Query: 461 QILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQ 502
+LT T L L NN+L LP + L+NL L + N
Sbjct: 142 GLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENS 183
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 395 NLQAIGLSSNFLQ---GNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD 451
+ + L ++P T L LS N L +L L LNL
Sbjct: 11 SHLEVNCDKRNLTALPPDLPKDT------TILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 452 NKLIGAVPQQILTITTLS--RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV 509
+L ++ TL LDL +N L SLPL L L L +S N+ + +P+
Sbjct: 65 AEL-----TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117
Query: 510 -TLTGCTGLEIFHMQGNSFRGSIPLSL-RSLKSIKELDLSCNNLSGQIPEFL-ENLSFLE 566
L G L+ +++GN + ++P L +++L L+ NNL+ ++P L L L+
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 567 YLNLSYNHFDGEVPTKGVFSNK--TRVQLTGN 596
L L N +P KG F + L GN
Sbjct: 176 TLLLQENSLYT-IP-KGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 39/188 (20%), Positives = 62/188 (32%), Gaps = 15/188 (7%)
Query: 267 SNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVL 326
+ I+ L N L L+L L + L L
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--------TLPVLGTL 82
Query: 327 AFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGN 385
N+L LP L +T + + N+++ ++P G L L L ++ N+L
Sbjct: 83 DLSHNQL-QSLPLLGQTL-PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138
Query: 386 IPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444
+P + L+ + L++N L L L + L L N L IP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 445 VSLNLSDN 452
L N
Sbjct: 198 PFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 30/139 (21%), Positives = 52/139 (37%), Gaps = 8/139 (5%)
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495
+ + +N L A+P + TT+ L L N L + L
Sbjct: 5 EVSKVA-SHLEVNCDKRNL-TALPPDLPKDTTI---LHLSENLLYTFSLATLMPYTRLTQ 59
Query: 496 LYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555
L + + + ++ V L + N + S+PL ++L ++ LD+S N L+
Sbjct: 60 LNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 556 PEFLENLSFLEYLNLSYNH 574
L L L+ L L N
Sbjct: 117 LGALRGLGELQELYLKGNE 135
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 40/157 (25%), Positives = 60/157 (38%), Gaps = 14/157 (8%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
T+L+L + + G L L ++L+ N +P L L L ++ N +
Sbjct: 58 TQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT- 113
Query: 137 KIPTNL-SSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI---- 191
+P L N L +P + KLE +SLA N+LT LPA +
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGL 171
Query: 192 GNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVN 228
NL + L EN T+P + L L N
Sbjct: 172 ENLDTLLLQ--ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 45/224 (20%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA------ECEVLRNTRHRNLIK 740
+G G F V K G A K + + + + V+ E +L+ +H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ V ++ L+ E + G L ++L + E + + + + + +
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLK-----QILNGV 127
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLARFLFARPFDTSMETQSSSI 856
YLH I H DLKP N++L V + DFGLA + F +
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKN----- 176
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
I GT +V P +++N +G EA D++S+GV+
Sbjct: 177 -IFGTPEFVAP----EIVN----YEPLGLEA----DMWSIGVIT 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 64/253 (25%), Positives = 102/253 (40%), Gaps = 59/253 (23%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL-KSFVAECEVLRNTRHRNLIKIITVC 745
+G+G++G V G VA+K + K + E ++L++ +H N+I I +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 746 SSIDFKGADFKA--LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID-------- 795
F+ +F ++ E MQ DL + + D
Sbjct: 79 RPDSFE--NFNEVYIIQELMQ-----------------TDLHRVISTQMLSDDHIQYFIY 119
Query: 796 -MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
A++ LH ++H DLKPSN+L++ + V DFGLAR + D S T
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 855 SIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
S V +V P + ML +Y ++ DV+S G +L E+F RR
Sbjct: 177 SG----MVEFVATRWYRAP-EV--MLT--SAKYS----RAM--DVWSCGCILAELFL-RR 220
Query: 909 PTNCMFQGGLTLH 921
P +F G H
Sbjct: 221 P---IFPGRDYRH 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 59/356 (16%), Positives = 110/356 (30%), Gaps = 108/356 (30%)
Query: 685 NMIGQGSFGSVYKGIL-----GENGTFVAVKILN-LMQKGALKSFVAECEVLRN-TRHRN 737
+G+G+FG V + VAVK+L ++ ++E ++L + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLH-----------------QSNGQPE 780
++ ++ C+ K ++ E+ + G+L +L Q
Sbjct: 88 VVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 781 VCDLSLIQRLNIAIDMASAIEYLHHHCQPP------------------------------ 810
+ L +RL+ S+ +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 811 ----------IVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
+H DL N+LL V + DFGLAR + ++
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-----------YKDPDYVRK 252
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGGLT 919
+P K + + + + S DV+S GV+L E+F+ P + G
Sbjct: 253 GDARLP----LKWMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASP----YPGVKI 301
Query: 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
EFC+ +G R + + + + C P +R
Sbjct: 302 DEEFCRR-----------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKS------FVAECEVLRNTRHRNL 738
IG G FG +Y A ++ + + G L S VA+ + ++ R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 739 IKIITV-----CSSIDFKGADFKALVYEYMQNG-SLEEWLHQSNGQPEVCDLSLIQRLNI 792
+ + + +FKG ++ +V E + G L++ + NG L +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGT-----FKKSTVLQL 156
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAR 838
I M +EY+H + VHGD+K +N+LL + D V +++D+GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 56/259 (21%), Positives = 88/259 (33%), Gaps = 60/259 (23%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNT 733
+ + IG G+ G V VA+K + Q K E +++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 734 RHRNLIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQ---SNGQPEVCDLSLIQ 788
H+N+I ++ V + +F+ +V E M + L Q E L Q
Sbjct: 82 NHKNIIGLLNVFTP-QKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQ 135
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
L I++LH I+H DLKPSN+++ D + DFGLAR T
Sbjct: 136 MLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT- 184
Query: 849 METQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
YV P E +G D++S+G ++ E
Sbjct: 185 --------------PYVVTRYYRAP------------EVILGMGYKENVDIWSVGCIMGE 218
Query: 903 MFTRRRPTNCMFQGGLTLH 921
M +F G +
Sbjct: 219 MIK-GGV---LFPGTDHID 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 36/317 (11%), Positives = 78/317 (24%), Gaps = 96/317 (30%)
Query: 687 IGQGSFGSVYKG---ILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR------HRN 737
G ++ L VA+ ++ Q + E L T
Sbjct: 39 HGGVPPLQFWQALDTALDRQ---VALTFVDP-QGVLPDDVLQE--TLSRTLRLSRIDKPG 92
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+ +++ V +V E+++ GSL+E S S + + +A
Sbjct: 93 VARVLDVVH-----TRAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLA 139
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+A + H + PS V + D ++
Sbjct: 140 AAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP----------------------- 173
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917
+A+ D+ +G L + R P
Sbjct: 174 ------------------------ATMPDANPQDDIRGIGASLYALLVNRWP----LPEA 205
Query: 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER-- 975
+ A + + ++P+ + + V V R
Sbjct: 206 -GVRSGLAPAERDTAGQPIEPA--------DIDRDIPFQISAVAARSVQ---GDGGIRSA 253
Query: 976 MEMRDVLAKLCAARQTL 992
+ +++ + A
Sbjct: 254 STLLNLMQQATAVADRT 270
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 46/222 (20%), Positives = 81/222 (36%), Gaps = 43/222 (19%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHR-NLIKIIT 743
+G+G F V + I G A K L + + E VL + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ--PEVCDLSLIQRLNIAIDMASAIE 801
V ++ L+ EY G + + E D+ + + + +
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLCLPELAEMVSEN-DVIRLIK-----QILEGVY 145
Query: 802 YLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
YLH + IVH DLKP N+LL + DFG++R + + I
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GH-ACELRE------I 193
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
GT Y+ P ++LN + D++++G++
Sbjct: 194 MGTPEYLAP----EILN--YDPITTAT------DMWNIGIIA 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 54/265 (20%), Positives = 91/265 (34%), Gaps = 58/265 (21%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNTRHRNLIKIITV 744
IG+GS+G VY VA+K + + + K + E +L + +I++ +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 745 CSSIDFKGADFKA--LVYEYMQNGSLEEWLHQ--SNGQPEVCDLSLIQRLNIAIDMASAI 800
D F +V E + L + L+ I ++
Sbjct: 94 IIPDDLL--KFDELYIVLEIA-----DSDLKKLFKTPIF----LTEEHIKTILYNLLLGE 142
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
++H + I+H DLKP+N LL+ D V DFGL AR ++ +T + +
Sbjct: 143 NFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL-----ARTINSEKDTNIVNDLEEN 194
Query: 861 TVGYVPPGNIAKMLN--------------LPCLEYGMGSEASVTGDVYSLGVMLLEMFT- 905
N+ K L L Y S+ D++S G + E+
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT----KSI--DIWSTGCIFAELLNM 248
Query: 906 ---------RRRPTNCMFQGGLTLH 921
R P +F G
Sbjct: 249 LQSHINDPTNRFP---LFPGSSCFP 270
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 45/264 (17%), Positives = 98/264 (37%), Gaps = 45/264 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLR-----NTRHRNLIK 740
+G G F +V+ + FVA+K++ + ++ + E +L+ + N
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 741 IITVCSSIDFKGADFK--ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
++ + G + +V+E + + L +W+ +SN Q L +++ I +
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG--LPLPCVKK--IIQQVLQ 157
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLL--DHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
++YLH C+ I+H D+KP N+LL + + ++ P + ++
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYG------------------------MGSEASVTGD 892
+ A+ L + + G +GS + D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 893 VYSLGVMLLEMFTRRRPTNCMFQG 916
++S M E+ T +F+
Sbjct: 276 IWSTACMAFELATGDY----LFEP 295
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 64/348 (18%), Positives = 107/348 (30%), Gaps = 58/348 (16%)
Query: 267 SNIEIIDLPINYFTGK-VSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKV 325
+I+ +D+ + + + L+ + L L D+ L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAE 60
Query: 326 LAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLT-- 383
L N LG V GV+ + + + + L+L LT
Sbjct: 61 LNLRSNELGDV-----------------GVHCVLQGLQTPSCKIQKLSLQN---CCLTGA 100
Query: 384 --GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTL-----MTDLFLSSNHLQ----G 432
G + + L LQ + LS N L L L + L L L
Sbjct: 101 GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQI---LTITTLS-RFLDLGNNHLN----GSLP 484
+ L + L +S+N + A + + L + L L + + L
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220
Query: 485 LEVGNLKNLVALYISGNQFSGE-----IPVTLTGCTGLEIFHMQGNSFR----GSIPLSL 535
V + +L L + N+ P L + L + G + L
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280
Query: 536 RSLKSIKELDLSCNNLSGQ-----IPEFLENLSFLEYLNLSYNHFDGE 578
R+ +S+KEL L+ N L + LE LE L + F
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 86/520 (16%), Positives = 162/520 (31%), Gaps = 123/520 (23%)
Query: 100 LRYINLATNNFHGEIPKEIGFLFR-LETLMLANNSFSGK----IPTNLSSCSNLLSFVAY 154
++ +++ E+ L + + + L + + I + L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 155 RNNL----VGEIPEDIGYSWLKLEHISLARNHLTG-----MLPASIGNLSIIYLHVGENQ 205
N L V + + + K++ +SL LTG + ++ LH+ +N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 206 FSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSN 265
+ L LLD L+ + S + E ++
Sbjct: 125 LGDA------GLQLLCEGLLDPQ--------------CRLEKLQLEYCSLSAASCEPLAS 164
Query: 266 A----SNIEIIDLPINYFTGK-VSIIFGRLK----NLWSLDLGINNLGSGGANDLDFVTI 316
+ + + + N V ++ LK L +L L + S DL I
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL--CGI 222
Query: 317 LTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLG 376
+ + + L+ LA N+LG V G+ ++ + L L +
Sbjct: 223 VASKASLRELALGSNKLGDV-----------------GMAELCPGLLHPSSRLRTLWI-- 263
Query: 377 IEFNQLT----GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNL-----TLMTDLFLSS 427
+T G++ R + +L+ + L+ N L L + L++ S
Sbjct: 264 -WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 428 NHLQG----NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
+ L + L+ L +S+N+L D G L L
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLE-----------------DAGVRELCQGL 365
Query: 484 PLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKE 543
L L+++ S C+ L +L + S++E
Sbjct: 366 GQ---PGSVLRVLWLADCDVSDS------SCSSLA--------------ATLLANHSLRE 402
Query: 544 LDLSCNNLSGQ----IPEFLE-NLSFLEYLNLSYNHFDGE 578
LDLS N L + E + LE L L ++ E
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 70/447 (15%), Positives = 133/447 (29%), Gaps = 96/447 (21%)
Query: 71 HRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLA 130
+ + EL+LR +G V L T + ++ L L
Sbjct: 53 RVNPALAELNLRSNELGDVGVHCVLQG-------LQTPSCK------------IQKLSLQ 93
Query: 131 NNSFSGK----IPTNLSSCSNLLSFVAYRNNL----VGEIPEDIGYSWLKLEHISLARNH 182
N +G + + L + L N L + + E + +LE + L
Sbjct: 94 NCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCS 153
Query: 183 LTGMLPASIG-----NLSIIYLHVGENQFSGTVPPSL-----YNMSSLENILLDVNGFTG 232
L+ + L V N + L + LE + L+ G T
Sbjct: 154 LSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS 213
Query: 233 NLPLDIGVTL---PNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGR 289
+ D+ + +L+ A+G N +
Sbjct: 214 DNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPG-------------------LLHP 254
Query: 290 LKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLG--GV--LPHSIANLS 345
L +L + + + G DL +L LK L+ N LG G L ++
Sbjct: 255 SSRLRTLWIWECGITAKGCGDL--CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 346 TTMTDIYMGVNQISGT----IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
+ +++ + S + L L I N+L + L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE-----------DAGVREL 361
Query: 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ----GNIPPSLGNCKNLVSLNLSDNKL--- 454
Q +++ L+L+ + ++ +L +L L+LS+N L
Sbjct: 362 CQGLGQPG--------SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413
Query: 455 -IGAVPQQILTITTLSRFLDLGNNHLN 480
I + + + L L L + + +
Sbjct: 414 GILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 63/256 (24%), Positives = 103/256 (40%), Gaps = 50/256 (19%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGAL-KSFVAECEVLRNTR 734
+ +++ + IG+G++G V N VA+K ++ + + + E ++L R
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 735 HRNLIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQ-SNGQPEVCDLSLIQRLN 791
H N+I I + + + K +V + M E L++ Q LS
Sbjct: 84 HENIIGINDIIRAPTIE--QMKDVYIVQDLM-----ETDLYKLLKTQH----LSNDHICY 132
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
+ ++Y+H ++H DLKPSN+LL+ + DFGLAR T T
Sbjct: 133 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 852 QSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
YV P I MLN Y S+ D++S+G +L EM +
Sbjct: 190 -----------EYVATRWYRAP-EI--MLN--SKGYT----KSI--DIWSVGCILAEMLS 227
Query: 906 RRRPTNCMFQGGLTLH 921
RP +F G L
Sbjct: 228 -NRP---IFPGKHYLD 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 59/288 (20%), Positives = 100/288 (34%), Gaps = 63/288 (21%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNT 733
+ + IG G+ G V VA+K + Q K E +++
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 734 RHRNLIK---IITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQ 788
H+N+I + T +++ +F+ LV E M + L Q L +
Sbjct: 119 NHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLCQVIQME----LDHER 165
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
+ M I++LH I+H DLKPSN+++ D + DFGLAR T
Sbjct: 166 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT- 221
Query: 849 METQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
YV P E +G D++S+G ++ E
Sbjct: 222 --------------PYVVTRYYRAP------------EVILGMGYKENVDIWSVGCIMGE 255
Query: 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRR 950
M + +F G + ++ K+ + + T P + R
Sbjct: 256 MVR-HKI---LFPGRDYIDQWNKVI---EQLGTPCPEFMKKLQPTVRN 296
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 62/259 (23%), Positives = 102/259 (39%), Gaps = 61/259 (23%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNT 733
E + S +G G++GSV I +G VA+K + Q K E +L++
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 734 RHRNLIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQ---SNGQPEVCDLSLIQ 788
+H N+I ++ V + +F LV +M + L + E + Q
Sbjct: 81 QHENVIGLLDVFTP-ASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQ 134
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
L ++Y+H +VH DLKP N+ ++ D + DFGL AR D
Sbjct: 135 MLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL-----ARHADAE 179
Query: 849 METQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
M GYV P +L+ + Y + T D++S+G ++ E
Sbjct: 180 M------------TGYVVTRWYRAP---EVILS--WMHY------NQTVDIWSVGCIMAE 216
Query: 903 MFTRRRPTNCMFQGGLTLH 921
M T + +F+G L
Sbjct: 217 MLT-GKT---LFKGKDYLD 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-14
Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 36/234 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRH 735
NEF ++G+G+FG V G + A+KIL ++ K + + E VL+N+RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
L + S F+ D V EY G L L + E D + R A +
Sbjct: 208 PFLTALK--YS---FQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRA---RFYGA-E 256
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+ SA++YLH +V+ DLK N++LD D ++DFGL + ++ ++
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATM 306
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + +YG +V D + LGV++ EM R P
Sbjct: 307 KTFCGTPEYLAPEVLEDN------DYGR----AV--DWWGLGVVMYEMMCGRLP 348
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 29/172 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV---LRNTRHRNLIKIIT 743
+G G G V + A+K+L A EV R ++ ++++I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 744 VCSSIDFKGADFKALVYEYMQNGSL----EEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
V + + G +V E + G L ++ Q+ + E + I + A
Sbjct: 79 VYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--------IMKSIGEA 129
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLARFLFARPFDTS 848
I+YLH I H D+KP N+L + + ++DFG A+ +D S
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKS 178
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 51/322 (15%), Positives = 99/322 (30%), Gaps = 74/322 (22%)
Query: 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIY 352
+ L ++ + + + +L +K + N +G
Sbjct: 6 IEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTE---------------- 47
Query: 353 MGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPS 412
+S I + +L + G++++ L +
Sbjct: 48 -AARWLS----ENIASKKDLEIAEFSDIF--------TGRVKDEIPEALRL------LLQ 88
Query: 413 SLGNLTLMTDLFLSSNHLQGN----IPPSLGNCKNLVSLNLSDNKL-------------I 455
+L + + LS N + L L L L +N L
Sbjct: 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQE 148
Query: 456 GAVPQQILTITTLSRFLDLGNNHLNG----SLPLEVGNLKNLVALYISGNQFSGE----- 506
AV ++ L + G N L + + L + + N E
Sbjct: 149 LAVNKKAKNAPPLRS-IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207
Query: 507 IPVTLTGCTGLEIFHMQGNSF--RGSIPLS--LRSLKSIKELDLSCNNLSGQ----IPEF 558
+ L C L++ +Q N+F GS L+ L+S +++EL L+ LS + + +
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267
Query: 559 LENLSF--LEYLNLSYNHFDGE 578
L L+ L L YN + +
Sbjct: 268 FSKLENIGLQTLRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 39/256 (15%), Positives = 78/256 (30%), Gaps = 51/256 (19%)
Query: 369 LVNLNL--LGIEFNQLTG----NIPREIGQLRNLQAIGLSSNFLQGN----IPSSLGNLT 418
+ ++ ++ + +T ++ + + +++ I LS N + + ++ +
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 419 LMTDLFLSSNHLQ----------GNIPPSLGNCKNLVSLNLSDNKL--IGAVP--QQILT 464
+ S + +L C L ++ LSDN P +
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 465 ITTLSRFLDLGNNHL-------------NGSLPLEVGNLKNLVALYISGNQFSGE----I 507
T L L L NN L ++ + N L ++ N+
Sbjct: 121 HTPL-EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 508 PVTLTGCTGLEIFHMQGNSFR-----GSIPLSLRSLKSIKELDLSCNNLSGQ----IPEF 558
T L M N R + L + +K LDL N + +
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 559 LENLSFLEYLNLSYNH 574
L++ L L L+
Sbjct: 240 LKSWPNLRELGLNDCL 255
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 56/350 (16%), Positives = 107/350 (30%), Gaps = 70/350 (20%)
Query: 191 IGNLSIIYLHVGENQFSG----TVPPSLYNMSSLENILLDVNGFTGNLPLDIGV------ 240
+ SI + + + +V L S++ I+L N
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-----TEAARWLSEN 55
Query: 241 --TLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDL 298
+ +L++ D + E + + L ++ L
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLL--------------LQALLKCPKLHTVRL 101
Query: 299 GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQI 358
N G L + L+ + L+ L N LG P + A ++ + ++ +
Sbjct: 102 SDNAFGPTAQEPL--IDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAK 156
Query: 359 SGTIPSGIGNLVNLNLLGIEFNQLTGN----IPREIGQLRNLQAIGLSSNFL-----QGN 409
+ L + N+L + R L + + N + +
Sbjct: 157 NAP---------PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207
Query: 410 IPSSLGNLTLMTDLFLSSNHL--QG--NIPPSLGNCKNLVSLNLSDNKL--IGAVP---- 459
+ L + L L N G + +L + NL L L+D L GA
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267
Query: 460 QQILTITTLSRFLDLGNNHLN--GSLPLE---VGNLKNLVALYISGNQFS 504
L L + L L N + L+ + +L+ L ++GN+FS
Sbjct: 268 FSKLENIGL-QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.2 bits (184), Expect = 5e-14
Identities = 43/244 (17%), Positives = 83/244 (34%), Gaps = 30/244 (12%)
Query: 267 SNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVL 326
S E + L + L+ +L + + L +C +L+ L
Sbjct: 327 SQKECVLLKDRPEC--WCRDSATDEQLFRCELSVEKS-------TVLQSELESCKELQEL 377
Query: 327 AFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEF--NQLTG 384
E + + L + + + S + + + ++ ++
Sbjct: 378 EPENKWCLLTIILLMRALDPLLYEK-----ETLQYF-STLKAVDPMRAAYLDDLRSKFLL 431
Query: 385 NIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444
+ +++ + L+ L + L L L+T L LS N L+ +PP+L + L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488
Query: 445 VSLNLSDNKLIGAVPQQILTITTLS--RFLDLGNNHLNGSLP--LEVGNLKNLVALYISG 500
L SDN L + + + L + L L NN L + + LV L + G
Sbjct: 489 EVLQASDNAL-----ENVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQG 542
Query: 501 NQFS 504
N
Sbjct: 543 NSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 9e-11
Identities = 33/240 (13%), Positives = 69/240 (28%), Gaps = 44/240 (18%)
Query: 363 PSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTD 422
L + + T + E+ + LQ + + + I + L +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 423 LFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTIT----TLSRFLDLGNNH 478
+ + K + + + + + ++ R L L +
Sbjct: 401 EKETLQYFS--------TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 479 LNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSL 538
L L + L + L +S N+ ++P +L +L
Sbjct: 453 LT-VLC-HLEQLLLVTHLDLSHNRLR-------------------------ALPPALAAL 485
Query: 539 KSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG--EVPTKGVFSNKTRVQLTGN 596
+ ++ L S N L + + NL L+ L L N + + L GN
Sbjct: 486 RCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 4e-08
Identities = 25/184 (13%), Positives = 64/184 (34%), Gaps = 9/184 (4%)
Query: 2 LNSISITCLATFIFSFSLLLHSQSFSAHTNETDRLALLAIKSQLHDPLGVTNSWNNSINL 61
+ +++L ++ E + L + + S L
Sbjct: 371 CKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFL 430
Query: 62 CQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFL 121
+ + + + R L L H+++ ++ ++ L + +++L+ N +P + L
Sbjct: 431 LENSVLKMEYADVR--VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAAL 485
Query: 122 FRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLK-LEHISLAR 180
LE L ++N+ + +++ L + NN + + L ++L
Sbjct: 486 RCLEVLQASDNALE-NVD-GVANLPRLQELLL-CNNRLQQSAAIQPLVSCPRLVLLNLQG 542
Query: 181 NHLT 184
N L
Sbjct: 543 NSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 5e-07
Identities = 27/185 (14%), Positives = 56/185 (30%), Gaps = 18/185 (9%)
Query: 395 NLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL 454
+L A L+ Q + L + + + L LS K
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKS 361
Query: 455 IGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGC 514
+ ++ + L L+ N ++ L + L L + E +
Sbjct: 362 T-VLQSELESCKELQE-LEPENKWCLLTIILLMRALDPL--------LYEKETLQYFSTL 411
Query: 515 TGLEIFHMQGNSFRGSI-----PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLN 569
++ S + ++ L L+ +L+ + LE L + +L+
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLD 469
Query: 570 LSYNH 574
LS+N
Sbjct: 470 LSHNR 474
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 24/159 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG G+FG + G +VA+K+ + + E + L +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFY-----KQLGSGDGIPQ 69
Query: 747 SIDF-KGADFKALVYEYMQNG-SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
F + A+V E + G SLE+ + SL L IAI + S +EY+H
Sbjct: 70 VYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122
Query: 805 HHCQPPIVHGDLKPSNVLLDHDM-----VAHVSDFGLAR 838
+++ D+KP N L+ V H+ DF LA+
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 33/174 (18%), Positives = 62/174 (35%), Gaps = 36/174 (20%)
Query: 687 IGQGSFGSVYKGI--------LGENGTFVAVKI----------LNLMQKGALKSFVAECE 728
+ + G +Y+ G ++K+ N Q+ A V + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 729 VLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNG-SLEEWLHQSNGQPEVCDLSLI 787
L +T + + ++ LV + G SL+ L S LS
Sbjct: 110 KLYSTPLLAIPTCM----GFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHV----LSER 159
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAR 838
L +A + A+E+LH + VHG++ N+ + D V ++ +G A
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 37/171 (21%), Positives = 69/171 (40%), Gaps = 30/171 (17%)
Query: 687 IGQGSFGSVYKGIL-----GENGTFVAVKI-----------LNLMQKGALKSFVAECEVL 730
IGQG FG +Y + + VK+ L Q+ A + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 731 RNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNG-SLEEWLHQSNGQPEVCDLSLIQR 789
R ++ + K D G ++ ++ + G L++ + + S
Sbjct: 103 RKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKR-----FSRKTV 154
Query: 790 LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLAR 838
L +++ + +EY+H H VHGD+K SN+LL+ + ++ D+GLA
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 36/189 (19%), Positives = 69/189 (36%), Gaps = 11/189 (5%)
Query: 393 LRNLQAIGLSSNFLQGNIPS-SLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLS 450
+ Q + L L+ IPS + NL ++ +++S + + S N + + +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 451 DNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLP--LEVGNLKNLVALYISGNQFSGEIP 508
+ + + + L L +FL + N L P +V + L I+ N + IP
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 509 V-TLTGCTG-LEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE--FLENLSF 564
V G + N F S+ + + + L+ N I + F S
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 565 LEYLNLSYN 573
L++S
Sbjct: 207 PSLLDVSQT 215
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 41/219 (18%), Positives = 78/219 (35%), Gaps = 23/219 (10%)
Query: 292 NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN-RLGGVLPHSIANLSTTMTD 350
+ +L L +L + ++ +N + + + L + HS NL + +T
Sbjct: 32 STQTLKLIETHLRTIPSHAF------SNLPNISRIYVSIDVTLQQLESHSFYNL-SKVTH 84
Query: 351 IYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIP--REIGQLRNLQAIGLSSNFLQ 407
I + + I L L LGI L P ++ + ++ N
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143
Query: 408 GNIP----SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQIL 463
+IP L N TL L L +N ++ N L ++ L+ NK + + +
Sbjct: 144 TSIPVNAFQGLCNETL--TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200
Query: 464 T-ITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGN 501
+ + LD+ + +LP L++L L
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALP--SKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 35/199 (17%), Positives = 56/199 (28%), Gaps = 39/199 (19%)
Query: 410 IPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDNKLIGAVPQQILTITTL 468
IPS + L L HL+ IP + N N+ + +S + + +
Sbjct: 26 IPSLPPSTQT---LKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFY---- 77
Query: 469 SRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV-TLTGCTGLEIFHMQGNSF 527
NL + + I + I L L+ +
Sbjct: 78 --------------------NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117
Query: 528 RGSIP--LSLRSLKSIKELDLSCNNLSGQIPE--FLENLSFLEYLNLSYNHFDGEVPTKG 583
+ P + S L+++ N IP F + L L N F V
Sbjct: 118 K-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQ-GY 174
Query: 584 VF--SNKTRVQLTGNGKLC 600
F + V L N L
Sbjct: 175 AFNGTKLDAVYLNKNKYLT 193
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 40/220 (18%), Positives = 75/220 (34%), Gaps = 25/220 (11%)
Query: 242 LPNLQVFAIGDNYFSGSIPE-SFSNASNIEIIDLPINYFTGKVSII----FGRLKNLWSL 296
P+ Q + + + +IP +FSN NI I + I+ + + F L + +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID---VTLQQLESHSFYNLSKVTHI 85
Query: 297 DLGINNLGSGGANDLDFV--TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMG 354
++ +L ++ L LK L L + + + +
Sbjct: 86 EIRNTR-------NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEIT 138
Query: 355 VNQISGTIPSGI-GNLVN-LNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPS 412
N +IP L N L + N T ++ L A+ L+ N I
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
Query: 413 SL--GNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNL 449
G + + L +S + +P L + K L++ N
Sbjct: 198 DAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 29/232 (12%), Positives = 63/232 (27%), Gaps = 37/232 (15%)
Query: 195 SIIYLHVGENQFSGTVPP-SLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDN 253
S L + E T+P + N+ ++ I + ++ L L + I +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 254 YFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313
I L L L + L
Sbjct: 91 RNLTYIDPD-----------------------ALKELPLLKFLGIFNTGLKM-----FPD 122
Query: 314 VTILTNCSKLKVLAFEEN-RLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNL 372
+T + + +L +N + + ++ L + + N + ++ N L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 373 NLLGIEFNQLTGNIPREI--GQLRNLQAIGLSSN---FLQGNIPSSLGNLTL 419
+ + + N+ I ++ G + +S L L L
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 20/142 (14%), Positives = 48/142 (33%), Gaps = 31/142 (21%)
Query: 435 PPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNL 493
C ++ + +P ++ ++ L L HL ++P NL N+
Sbjct: 4 SSPPCECHQEEDFRVTCKDI-QRIP----SLPPSTQTLKLIETHLR-TIPSHAFSNLPNI 57
Query: 494 VALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSG 553
+Y+S + + + ++ +SF L + +++
Sbjct: 58 SRIYVSID---------------VTLQQLESHSFYN--------LSKVTHIEIRNTRNLT 94
Query: 554 QIP-EFLENLSFLEYLNLSYNH 574
I + L+ L L++L +
Sbjct: 95 YIDPDALKELPLLKFLGIFNTG 116
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 63/260 (24%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNTR-HRNLIKIIT 743
+G+G++G V+K I G VAVK I + Q + E +L H N++ ++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID-------- 795
V + + + D LV++YM+ DL + R NI
Sbjct: 77 VLRADNDR--DV-YLVFDYME-----------------TDLHAVIRANILEPVHKQYVVY 116
Query: 796 -MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+ I+YLH ++H D+KPSN+LL+ + V+DFGL+R T+ S
Sbjct: 117 QLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 855 SIGIKGTV-------GYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901
+ + YV P I +L +Y + D++SLG +L
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAP-EI--LLG--STKYT----KGI--DMWSLGCILG 222
Query: 902 EMFTRRRPTNCMFQGGLTLH 921
E+ +P +F G T++
Sbjct: 223 EILC-GKP---IFPGSSTMN 238
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 48/198 (24%), Positives = 69/198 (34%), Gaps = 37/198 (18%)
Query: 385 NIPREIGQLRNLQAIGLSSNFLQGNIPS--SLGNLTLMTDLFLSSNHLQGNIPP-SLGNC 441
++P L LS N L + + + LT + L LS NHL I +
Sbjct: 36 SLPSYTALLD------LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 442 KNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISG 500
NL L+LS N L + + + + L L NNH+ + ++ L LY+S
Sbjct: 88 PNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 501 NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLE 560
NQ S PV + L + LDLS N L L+
Sbjct: 146 NQIS-RFPV---------------ELIKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQ 184
Query: 561 NLSFL--EYLNLSYNHFD 576
L L L N +
Sbjct: 185 KLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 37/176 (21%), Positives = 65/176 (36%), Gaps = 24/176 (13%)
Query: 243 PNLQVFAIGDNYFSGSIPE-SFSNASNIEIIDLPINYFTGKVSII----FGRLKNLWSLD 297
+ + N S E + + +N+ + L N ++ I F + NL LD
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN----HLNFISSEAFVPVPNLRYLD 94
Query: 298 LGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQ 357
L N+L + + L+VL N + V ++ ++ + +Y+ NQ
Sbjct: 95 LSSNHLHTLDEFLFS------DLQALEVLLLYNNHIVVVDRNAFEDM-AQLQKLYLSQNQ 147
Query: 358 ISGTIPSGI----GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGN 409
IS P + L L LL + N+L ++ +L GL L N
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY---LHNN 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 9/186 (4%)
Query: 395 NLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL-GNCKNLVSLNLSDNK 453
+ + + L SN L + LT + L+L+ N LQ +P + KNL +L ++DNK
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 454 LIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTL- 511
L A+P + L L N L SLP V +L L L + N+ +P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 512 TGCTGLEIFHMQGNSFRGSIPLSL-RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNL 570
T L+ + N + +P L +K L L N L ++L L+ L L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 571 SYNHFD 576
N +D
Sbjct: 213 QENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAI 399
+N+ + + N++S ++PS L L LL + N+L +P I +L+NL+ +
Sbjct: 33 SNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90
Query: 400 GLSSNFLQGNIPSSL-GNLTLMTDLFLSSNHLQGNIPP----SLGNCKNLVSLNLSDNKL 454
++ N LQ +P + L + +L L N L+ ++PP SL L L+L N+L
Sbjct: 91 WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT---KLTYLSLGYNEL 145
Query: 455 IGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTG 513
++P+ + T + L L NN L +P L L L + NQ
Sbjct: 146 -QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
Query: 514 CTGLEIFHMQGN 525
L++ +Q N
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 12/170 (7%)
Query: 156 NNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASI----GNLSIIYLHVGENQFSGTVP 211
+N + +P + KL + L N L LPA I NL L V +N+ +P
Sbjct: 46 SNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLE--TLWVTDNKLQ-ALP 101
Query: 212 PSLY-NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE-SFSNASNI 269
++ + +L + LD N +LP + +L L ++G N S+P+ F +++
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159
Query: 270 EIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTN 319
+ + L N F +L L +L L N L D + L
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 52/240 (21%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
++F +G GSFG V E+G A+KIL+ +++ ++ + E +L+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN---- 791
L+K+ S FK +V EY+ G + + H L I R +
Sbjct: 101 PFLVKLE--FS---FKDNSNLYMVMEYVAGGEM--FSH----------LRRIGRFSEPHA 143
Query: 792 --IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
A + EYLH +++ DLKP N+L+D V+DFG A+ + R
Sbjct: 144 RFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------ 194
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T + + GT + P I Y +V D ++LGV++ EM P
Sbjct: 195 -TWT----LCGTPEALAPEIILSK------GYNK----AV--DWWALGVLIYEMAAGYPP 237
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 48/288 (16%), Positives = 99/288 (34%), Gaps = 98/288 (34%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN 737
+ ++S +G GSFG V + E+G A+K + + + E ++++ H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 738 LIKIITVCSSIDFKGADFKA---------------------------------LVYEYMQ 764
+IK++ + + ++ EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 765 NGSLEEWLHQ------SNGQP---EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815
+ LH+ +G+ + + + Q + A+ ++H I H D
Sbjct: 121 ----PDTLHKVLKSFIRSGRSIPMNLISIYIYQ-------LFRAVGFIHSL---GICHRD 166
Query: 816 LKPSNVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYV------PPG 868
+KP N+L++ D + DFG A+ L + Y+ P
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA---------------YICSRFYRAPE 211
Query: 869 NIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
+ L EY + + D++S+G + E+ + +F G
Sbjct: 212 LM-----LGATEY------TPSIDLWSIGCVFGELILGK----PLFSG 244
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG GSFG +Y G G VA+K+ + K E ++ + + + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIY-----KMMQGGVGIPT 69
Query: 747 SIDF-KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
D+ +V E + SLE+ + + + SL L +A M S IEY+H
Sbjct: 70 IRWCGAEGDYNVMVME-LLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS 123
Query: 806 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAR 838
+H D+KP N L+ + ++ DFGLA+
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 22/158 (13%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+GSFG +++G N VA+K E + L + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY-----KLLAGCTGIPN 70
Query: 747 SIDF-KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
F + LV + + SLE+ L + S+ A M + ++ +H
Sbjct: 71 VYYFGQEGLHNVLVID-LLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE 124
Query: 806 HCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAR 838
+V+ D+KP N L+ + + +V DFG+ +
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 47/260 (18%), Positives = 96/260 (36%), Gaps = 71/260 (27%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITV-- 744
+G G G V+ + + VA+K + L ++K + E +++R H N++K+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 745 -----CSSIDFKGADFKA--LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID-- 795
+ + + +V EYM+ DL+ + ++
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYME-----------------TDLANVLEQGPLLEEH 121
Query: 796 -------MASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFARPFDT 847
+ ++Y+H ++H DLKP+N+ ++ D+V + DFGLAR +
Sbjct: 122 ARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 848 SMETQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901
+ + P + +L+ Y D+++ G +
Sbjct: 179 GHLS-----------EGLVTKWYRSP-RL--LLS--PNNYTKAI------DMWAAGCIFA 216
Query: 902 EMFTRRRPTNCMFQGGLTLH 921
EM T + +F G L
Sbjct: 217 EMLT-GKT---LFAGAHELE 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 50/257 (19%), Positives = 82/257 (31%), Gaps = 67/257 (26%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV-----------LRNTRH 735
I GS+G+V G+ G VA+K + + L + H
Sbjct: 30 ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 736 RNLIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQ---SNGQPEVCDLSLIQRL 790
N++ + + + LV E M L Q +S
Sbjct: 89 PNILGLRDIFVHFEEP--AMHKLYLVTELM-----RTDLAQVIHDQRIV----ISPQHIQ 137
Query: 791 NIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSME 850
+ + LH + +VH DL P N+LL + + DF LAR A T
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT--- 191
Query: 851 TQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
YV P + ++ + V D++S G ++ EMF
Sbjct: 192 ------------HYVTHRWYRAP-EL--VMQ--FKGFT----KLV--DMWSAGCVMAEMF 228
Query: 905 TRRRPTNCMFQGGLTLH 921
R+ +F+G +
Sbjct: 229 N-RKA---LFRGSTFYN 241
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 63/256 (24%), Positives = 103/256 (40%), Gaps = 54/256 (21%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVK-ILNLMQKGAL-KSFVAECEVLRNT 733
E + +G G++G+V + G G VA+K + Q K E +L++
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 734 RHRNLIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLN 791
RH N+I ++ V + D DF LV +M L + + + + Q L
Sbjct: 82 RHENVIGLLDVFTP-DETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 792 IAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMET 851
+ Y+H I+H DLKP N+ ++ D + DFGL AR D+ M
Sbjct: 140 -------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL-----ARQADSEM-- 182
Query: 852 QSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
GYV P + +LN + Y + T D++S+G ++ EM T
Sbjct: 183 ----------TGYVVTRWYRAP-EV--ILN--WMRY------TQTVDIWSVGCIMAEMIT 221
Query: 906 RRRPTNCMFQGGLTLH 921
+ +F+G L
Sbjct: 222 -GKT---LFKGSDHLD 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHR---NLI 739
+IG+GSFG V K + VA+K++ + A + E +L + R + N +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTM 159
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+I + + F+ + +E + +L E + ++ Q L L+++ A +
Sbjct: 160 NVIHMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQG--FSLPLVRK--FAHSILQC 212
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLARFLFARPFDTSMETQSSSIG 857
++ LH + I+H DLKP N+LL + V DFG + + R QS
Sbjct: 213 LDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTYIQSRF-- 264
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
Y P I L YGM D++SLG +L E+ T
Sbjct: 265 ------YRAPEVI---LGAR---YGMPI------DMWSLGCILAELLT 294
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 62/245 (25%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+F +G GSFG V+ NG + A+K+L +++ ++ E +L H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI--- 792
+I++ + F+ A ++ +Y++ G L SL+++
Sbjct: 66 PFIIRMW--GT---FQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPN 105
Query: 793 ------AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARP 844
A ++ A+EYLH I++ DLKP N+LLD + H+ +DFG A+++
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAKYVPDV- 159
Query: 845 FDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904
T + + GT Y+ P ++ Y S+ D +S G+++ EM
Sbjct: 160 ------TYT----LCGTPDYIAPEVVSTK------PYNK----SI--DWWSFGILIYEML 197
Query: 905 TRRRP 909
P
Sbjct: 198 AGYTP 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 62/261 (23%), Positives = 102/261 (39%), Gaps = 64/261 (24%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM------QKGALKSFVAECEV 729
E + + + +G G++GSV + G VAVK L+ K + E +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRL 81
Query: 730 LRNTRHRNLIKIITVCSSIDFKGADFKA--LVYEYMQNGSLEEWLHQ-SNGQPEVCDLSL 786
L++ +H N+I ++ V + +F LV M L+ Q L+
Sbjct: 82 LKHMKHENVIGLLDVFTP-ARSLEEFNDVYLVTHLM-----GADLNNIVKCQK----LTD 131
Query: 787 IQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFD 846
+ + ++Y+H I+H DLKPSN+ ++ D + DFGL AR
Sbjct: 132 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTA 183
Query: 847 TSMETQSSSIGIKGTVGYV------PPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
M GYV P I MLN + Y + T D++S+G ++
Sbjct: 184 DEM------------TGYVATRWYRAP-EI--MLN--WMHY------NQTVDIWSVGCIM 220
Query: 901 LEMFTRRRPTNCMFQGGLTLH 921
E+ T R +F G +
Sbjct: 221 AELLT-GRT---LFPGTDHID 237
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHRNLIKII 742
++G+G+FG V G + A+KIL ++ K + V E VL+NTRH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 70
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
+ F+ D V EY G L L + E + + R A ++ SA+EY
Sbjct: 71 -KYA---FQTHDRLCFVMEYANGGELFFHLSRERVFTE--ERA---RFYGA-EIVSALEY 120
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKG 860
LH +V+ D+K N++LD D H+ +DFGL + + ++ G
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK--------EGISDGATMKTFCG 167
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T Y+ P + +YG +V D + LGV++ EM R P
Sbjct: 168 TPEYLAPEVLEDN------DYGR----AV--DWWGLGVVMYEMMCGRLP 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 8e-12
Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 45/228 (19%)
Query: 686 MIGQGSFGSVY---KGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHRNLI 739
++GQGSFG V+ K + A+K+L L + +++ E ++L H ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
K+ + F+ L+ ++++ G L L + E + + +A ++A A
Sbjct: 90 KLH--YA---FQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDV---KFYLA-ELALA 138
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIG 857
+++LH I++ DLKP N+LLD + H+ +DFGL++ S++ + +
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK--------ESIDHEKKAYS 185
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
GTV Y+ P + + + S D +S GV++ EM T
Sbjct: 186 FCGTVEYMAPEVVNRR------GHTQ----SA--DWWSFGVLMFEMLT 221
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 3e-11
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG GSFG +Y G + VA+K+ N+ K + E ++ R L + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIY-----RILQGGTGIPN 67
Query: 747 SIDF-KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
F D+ LV + + SLE+ L + LSL L +A M + +E++H
Sbjct: 68 VRWFGVEGDYNVLVMD-LLGPSLED-LFNFCSRK----LSLKTVLMLADQMINRVEFVHS 121
Query: 806 HCQPPIVHGDLKPSNVLLDHDMVAH---VSDFGLAR 838
+H D+KP N L+ A+ + DFGLA+
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 686 MIGQGSFGSVY---KGILGENGTFVAVKIL---NLMQKG-ALKSFVAECEVLRNTRHRNL 738
++G+G +G V+ K G A+K+L +++ AE +L +H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+ +I + F+ L+ EY+ G L L + E D + +A +++
Sbjct: 84 VDLI--YA---FQTGGKLYLILEYLSGGELFMQLEREGIFME--DTA---CFYLA-EISM 132
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSI 856
A+ +LH I++ DLKP N++L+H HV +DFGL + S+ + +
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK--------ESIHDGTVTH 179
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
GT+ Y+ P + + + +V D +SLG ++ +M T
Sbjct: 180 TFCGTIEYMAPEILMRS------GHNR----AV--DWWSLGALMYDMLT 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 3e-11
Identities = 35/204 (17%), Positives = 61/204 (29%), Gaps = 53/204 (25%)
Query: 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL--------NLMQKGALKSFVAECE 728
T + IG+G FG V++ I + T VA+KI+ N + + + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 729 VLR---------NTRHRNLIKIITVC-------------------------SSIDFKGAD 754
+ + R I + +V DF D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHG 814
+V E+ G E + SL +I + +++ + H
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL-------SSLATAKSILHQLTASLAVAEASLR--FEHR 186
Query: 815 DLKPSNVLLDHDMVAHVSDFGLAR 838
DL NVLL + + +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 43/229 (18%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHR---NL 738
++IG+GSFG V K +VA+KI+ A E +L
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMK 115
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
I+ + F+ LV+E + +L + L +N + L+L ++ A M +
Sbjct: 116 YYIVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFRG--VSLNLTRK--FAQQMCT 168
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLARFLFARPFDTSMETQSSSI 856
A+ +L + I+H DLKP N+LL + + + DFG + Q
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----------LGQRIYQ 217
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
I+ + Y P + L +P Y + D++SLG +L+EM T
Sbjct: 218 YIQ-SRFYRSPEVL---LGMP---YDLAI------DMWSLGCILVEMHT 253
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 71/241 (29%), Positives = 106/241 (43%), Gaps = 47/241 (19%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVL-RNTRHRNLIKI 741
+IG+GSFG V F AVK+L +++K K ++E VL +N +H L+ +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
S F+ AD V +Y+ G L L + E + R A ++ASA+
Sbjct: 105 --HFS---FQTADKLYFVLDYINGGELFYHLQRERCFLE--PRA---RFYAA-EIASALG 153
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIK 859
YLH IV+ DLKP N+LLD H+ +DFGL + ++E S++
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK--------ENIEHNSTTSTFC 200
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP-----TNCMF 914
GT Y+ P + K Y +V D + LG +L EM P T M+
Sbjct: 201 GTPEYLAPEVLHKQ------PYDR----TV--DWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
Query: 915 Q 915
Sbjct: 249 D 249
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 1e-10
Identities = 62/274 (22%), Positives = 106/274 (38%), Gaps = 45/274 (16%)
Query: 646 YARRRRSKQESSISVPMEQYFPMVSYSELSEATNEFSSSN-----MIGQGSFGSVYKGIL 700
+ R+K P E+ +S + + + ++ ++G+GSFG V
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSER 362
Query: 701 GENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757
AVKIL ++Q ++ + E VL + + C F+ D
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC----FQTMDRLY 418
Query: 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817
V EY+ G L + Q E + A ++A + +L I++ DLK
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKE--PHA---VFYAA-EIAIGLFFLQSK---GIIYRDLK 469
Query: 818 PSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLN 875
NV+LD + H+ +DFG+ + ++ ++ GT Y+ P IA
Sbjct: 470 LDNVMLDSE--GHIKIADFGMCK--------ENIWDGVTTKTFCGTPDYIAPEIIAYQ-- 517
Query: 876 LPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
YG SV D ++ GV+L EM + P
Sbjct: 518 ----PYGK----SV--DWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 41/229 (17%)
Query: 686 MIGQGSFGSVY---KGILGENGTFVAVKIL---NLMQKG-ALKSFVAECEVLRNTRHRNL 738
++G G++G V+ K + G A+K+L ++QK + E +VL + R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+ +T+ + F+ L+ +Y+ G L L Q E ++ + ++
Sbjct: 121 L--VTLHYA--FQTETKLHLILDYINGGELFTHLSQRERFTE--HEV---QIYVG-EIVL 170
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSI 856
A+E+LH I++ D+K N+LLD + HV +DFGL++ A +
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER---AYD--- 219
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905
GT+ Y+ P +I + + G +V D +SLGV++ E+ T
Sbjct: 220 -FCGTIEYMAP-DI-----VRGGDSGHD--KAV--DWWSLGVLMYELLT 257
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 42/230 (18%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVL-RNTRHRNLIKI 741
M+G+GSFG V+ + F A+K L ++ ++ + E VL H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
C+ F+ + V EY+ G L + + A ++ ++
Sbjct: 84 --FCT---FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAA-EIILGLQ 132
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIK 859
+LH IV+ DLK N+LLD D H+ +DFG+ + +M + +
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK--------ENMLGDAKTNTFC 179
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + +Y SV D +S GV+L EM + P
Sbjct: 180 GTPDYIAPEILLGQ------KYNH----SV--DWWSFGVLLYEMLIGQSP 217
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 34/146 (23%), Positives = 59/146 (40%), Gaps = 19/146 (13%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVLR--NTRHRNLIK 740
+G G+FG V +N + AVK++ + A E ++L+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNNN 97
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
I+ + L++E + SL E + ++N + I+ I++ A+
Sbjct: 98 IVKYHGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNG--FHIEDIKL--YCIEILKAL 150
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHD 826
YL + H DLKP N+LLD
Sbjct: 151 NYLRKMS---LTHTDLKPENILLDDP 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 15/169 (8%)
Query: 287 FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLST 346
L N+ L LG N L A LTN L L N+L LP+ + + T
Sbjct: 59 IQYLPNVRYLALGGNKLHDISALK-----ELTN---LTYLILTGNQLQS-LPNGVFDKLT 109
Query: 347 TMTDIYMGVNQISGTIPSGIGN-LVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF 405
+ ++ + NQ+ ++P G+ + L NL L + NQL +L NL + LS N
Sbjct: 110 NLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ 168
Query: 406 LQGNIPSSL-GNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDN 452
LQ ++P + LT + DL L N L+ ++P +L + L DN
Sbjct: 169 LQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 295 SLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMG 354
+L ++ + + + + + + V I L + + +G
Sbjct: 23 KANLKKKSVTDAVTQN--------ELNSIDQIIANNSDIKSVQG--IQYL-PNVRYLALG 71
Query: 355 VNQISGTIPSGIG---NLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNI 410
N++ I L NL L + NQL ++P + +L NL+ + L N LQ
Sbjct: 72 GNKLHD-----ISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLP 125
Query: 411 PSSLGNLTLMTDLFLSSNHLQGNIPP----SLGNCKNLVSLNLSDNKLIGAVPQQIL-TI 465
LT +T L L+ N LQ ++P L N L L+LS N+L ++P+ + +
Sbjct: 126 DGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTN---LTELDLSYNQL-QSLPEGVFDKL 180
Query: 466 TTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQ 502
T L L L N L S+P V L +L +++ N
Sbjct: 181 TQLKD-LRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNP 216
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 51/177 (28%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 258 SIPESFSNASNI----EIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313
S+P S I E +DL F L L L+L N L + A D
Sbjct: 28 SVP------SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81
Query: 314 VTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNL 372
+T +L L N+L LP + + T + +Y+G NQ+ ++PSG+ L L
Sbjct: 82 LT------ELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKL 133
Query: 373 NLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN 428
L + NQL +IP +L NLQ + LS+N LQ + L + + L N
Sbjct: 134 KELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 15/169 (8%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIG 400
+ + + + ++ + L L L +++NQL + + L L +G
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89
Query: 401 LSSNFLQGNIPSSL-GNLTLMTDLFLSSNHLQGNIPP----SLGNCKNLVSLNLSDNKLI 455
L++N L ++P + +LT + L+L N L+ +P L L L L+ N+L
Sbjct: 90 LANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLT---KLKELRLNTNQL- 143
Query: 456 GAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQF 503
++P T + L L N L S+P L L + + GNQF
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 50/195 (25%), Positives = 73/195 (37%), Gaps = 37/195 (18%)
Query: 385 NIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNC-KN 443
IP + +L L S L ++ LT +T L L N LQ + + +
Sbjct: 32 GIPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 444 LVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQ 502
L +L L++N+L ++P + T L LG N L SLP V L L L ++ NQ
Sbjct: 85 LGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 503 FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL-RSLKSIKELDLSCNNLSGQIPEFLEN 561
SIP L +++ L LS N L +
Sbjct: 143 LQ-------------------------SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDR 177
Query: 562 LSFLEYLNLSYNHFD 576
L L+ + L N FD
Sbjct: 178 LGKLQTITLFGNQFD 192
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 42/230 (18%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVL-RNTRHRNLIKI 741
+IG+GS+ V L + A+K++ + + E V + + H L+ +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
F+ V EY+ G L + + PE + + R A +++ A+
Sbjct: 76 --HSC---FQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--EHA---RFYSA-EISLALN 124
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIK 859
YLH I++ DLK NVLLD + H+ +D+G+ + RP DT T +
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDT---TST----FC 171
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + +YG SV D ++LGV++ EM R P
Sbjct: 172 GTPNYIAPEILRGE------DYGF----SV--DWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 57/230 (24%), Positives = 93/230 (40%), Gaps = 42/230 (18%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVL-RNTRHRNLIKI 741
++G+GSFG V AVKIL ++Q ++ + E VL + L ++
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
F+ D V EY+ G L + Q E + A ++A +
Sbjct: 87 H--SC---FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE--PHA---VFYAA-EIAIGLF 135
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIK 859
+L I++ DLK NV+LD + H+ +DFG+ + ++ ++
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK--------ENIWDGVTTKTFC 182
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P IA YG SV D ++ GV+L EM + P
Sbjct: 183 GTPDYIAPEIIAYQ------PYGK----SV--DWWAFGVLLYEMLAGQAP 220
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 34/148 (22%), Positives = 67/148 (45%), Gaps = 21/148 (14%)
Query: 686 MIGQGSFGSVYKGI-LGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHR---NL 738
+G+G+FG V + + + VA+KI+ ++ A E VL+ + + N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKDKENK 81
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+ + +F G + +E + + E+L ++N QP L ++ +A +
Sbjct: 82 FLCVLMSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQP--YPLPHVRH--MAYQLCH 134
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHD 826
A+ +LH + + H DLKP N+L +
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNS 159
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 47/268 (17%)
Query: 653 KQESSISVPMEQYFPMVSYSELSEATNEFSSSN-----MIGQGSFGSVYKGILGENGTFV 707
+ ++ +E+ ++ E +A++ + +IG+GS+ V L +
Sbjct: 21 YFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIY 80
Query: 708 AVKIL---NLMQKGALKSFVAECEVL-RNTRHRNLIKIITVCSSIDFKGADFKALVYEYM 763
A++++ + + E V + + H L+ + F+ V EY+
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL--HSC---FQTESRLFFVIEYV 135
Query: 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823
G L + + PE + + R A +++ A+ YLH I++ DLK NVLL
Sbjct: 136 NGGDLMFHMQRQRKLPE--EHA---RFYSA-EISLALNYLHER---GIIYRDLKLDNVLL 186
Query: 824 DHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEY 881
D + H+ +D+G+ + RP DT T + GT Y+ P + +Y
Sbjct: 187 DSE--GHIKLTDYGMCK-EGLRPGDT---TST----FCGTPNYIAPEILRGE------DY 230
Query: 882 GMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G SV D ++LGV++ EM R P
Sbjct: 231 GF----SV--DWWALGVLMFEMMAGRSP 252
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 2e-09
Identities = 95/669 (14%), Positives = 180/669 (26%), Gaps = 214/669 (31%)
Query: 71 HRHQ---RVTELDLRHQNI-GGSLSPYVGNLS------FLRYINLATNNFHGEI---PKE 117
H H E ++++I +V N + I L+ I
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI-LSKEEID-HIIMSKDA 60
Query: 118 IGFLFRLETLMLANNS-----FSG------------KIPTNLSSCS-NLLSFVAYRNNLV 159
+ RL +L+ F I T S ++ R+ L
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 160 GEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLH--VGENQFSGTVPPSLYNM 217
+ Y+ +L+ R L + PA + + +G SG
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPA-----KNVLIDGVLG----SGK-------- 163
Query: 218 SSLENILLDVNGFTGNLP-----LDIG------VTLPNLQVFAIGDNYFSGSIPESFSNA 266
+ + + + L++ L LQ P S +
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ------KLLYQIDPNWTSRS 217
Query: 267 SNIEIIDLPINYFTGKVSIIFGR---------LKNLWSLDLGINNLGSGGANDLDFVTIL 317
+ I L I+ ++ + L N+ + N +
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA---------WNAFNL---- 264
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANL--STTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375
+C K+L + + + + T T I + + ++ T L L L
Sbjct: 265 -SC---KILLTTRFK-------QVTDFLSAATTTHISLDHHSMTLTPDEVKSLL--LKYL 311
Query: 376 GIEFNQLTGNIPREIGQLRNLQAIGL-----------SSNFLQGN-------IPSSLGNL 417
L PRE+ N + + + N+ N I SSL L
Sbjct: 312 DCRPQDL----PREVLTT-NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL 366
Query: 418 T------LMTDLFLSSNHLQGNIPPSLGNCKNLVSL--NLSDNKLIGAVPQQIL------ 463
+ L + +IP L L + ++ + ++
Sbjct: 367 EPAEYRKMFDRLSVFPPSA--HIPTIL-----LSLIWFDVIKS-----DVMVVVNKLHKY 414
Query: 464 ----------TITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE--IPVTL 511
TI+ S +L+L L L +++V Y F + IP L
Sbjct: 415 SLVEKQPKESTISIPSIYLEL-KVKLENEYALH----RSIVDHYNIPKTFDSDDLIPPYL 469
Query: 512 TGCTGLEIF-----HMQG-------NSFRGSIPLSLRSLKS-IKELDLSCNNLSGQIPEF 558
+ H++ FR + L R L+ I+ + N +
Sbjct: 470 DQ----YFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 559 LENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSK--RS 616
+ + Y+ + ++ V F LP S
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDF----------------------LPKIEENLICS 562
Query: 617 RKSTVLRLG 625
+ + +LR+
Sbjct: 563 KYTDLLRIA 571
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 4e-07
Identities = 42/329 (12%), Positives = 97/329 (29%), Gaps = 71/329 (21%)
Query: 531 IPLSLRSLKSIKELD-----------------LSCNNLSGQIPEFLE-----NLSFLEYL 568
+ +S+ S +E+D + + +F+E N FL
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL-MS 96
Query: 569 NLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRSRKSTVLRL---- 624
+ + T+ + R+ N + ++ + +L L
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLY-NDNQVF----AKYNVSRLQPYLKLRQALLELRPAK 151
Query: 625 ----------GKVGIPMIVSCLILSTC----------FIIVYARRRRSKQESSISVPMEQ 664
GK + + L C F I + + ++ +++
Sbjct: 152 NVLIDGVLGSGK-------TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK 204
Query: 665 YFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKIL-NLMQKGALKSF 723
+ + S + + SS+ + S + + +L + +L N+ A +F
Sbjct: 205 LLYQIDPNWTSRS--DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF 262
Query: 724 VAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ--PEV 781
C++L TR + + ++ ++ + L ++L EV
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322
Query: 782 CD-----LSLIQRLNIAIDMASAIEYLHH 805
LS+I D + + H
Sbjct: 323 LTTNPRRLSIIAES--IRDGLATWDNWKH 349
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 38/160 (23%), Positives = 59/160 (36%), Gaps = 44/160 (27%)
Query: 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS-----RFLDLG 475
+L ++ + +L K L LS N I I++LS R L LG
Sbjct: 28 VELHGMIPPIE-KMDATLSTLKACKHLALSTNN--------IEKISSLSGMENLRILSLG 78
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535
N + L+ L L+IS NQ I + G +
Sbjct: 79 RNLIKKIENLD-AVADTLEELWISYNQ----------------IASLSG----------I 111
Query: 536 RSLKSIKELDLSCNNLS--GQIPEFLENLSFLEYLNLSYN 573
L +++ L +S N ++ G+I + L L LE L L+ N
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 32/177 (18%), Positives = 66/177 (37%), Gaps = 32/177 (18%)
Query: 375 LGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434
L + + + L+ + + LS+N ++ I SSL + + L L N ++ I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 435 PPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF-----LDLGNNHLNGSLPLEV-G 488
L L +S N QI +++ + + L + NN + ++
Sbjct: 86 ENLDAVADTLEELWISYN--------QIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLA 137
Query: 489 NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELD 545
L L L ++GN + + +R + ++ L ++K+LD
Sbjct: 138 ALDKLEDLLLAGNP-----------LYNDYKENNATSEYRIEV---VKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 18/82 (21%), Positives = 33/82 (40%), Gaps = 4/82 (4%)
Query: 493 LVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552
V L+ ++ TL+ + + N+ I SL +++++ L L N +
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK 83
Query: 553 GQIPEFLENLSFLEYLNLSYNH 574
+I LE L +SYN
Sbjct: 84 -KIENLDAVADTLEELWISYNQ 104
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 26/120 (21%), Positives = 50/120 (41%), Gaps = 9/120 (7%)
Query: 337 LPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNL 396
+ +++ L + + N I I S + + NL +L + N + I L
Sbjct: 40 MDATLSTL-KACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 397 QAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ--GNIPPSLGNCKNLVSLNLSDNKL 454
+ + +S N + ++ S + L + L++S+N + G I L L L L+ N L
Sbjct: 96 EELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 26/144 (18%), Positives = 51/144 (35%), Gaps = 16/144 (11%)
Query: 190 SIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFT--GNLPLDIGVTLPNLQV 247
+ LH + +L + + +++ L N +L + NL++
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLS-----GMENLRI 74
Query: 248 FAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGG 307
++G N I + A +E + + N +S I +L NL L + N +
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGI-EKLVNLRVLYMSNNKI---- 127
Query: 308 ANDLDFVTILTNCSKLKVLAFEEN 331
+ + L KL+ L N
Sbjct: 128 -TNWGEIDKLAALDKLEDLLLAGN 150
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 52/305 (17%), Positives = 101/305 (33%), Gaps = 38/305 (12%)
Query: 284 SIIFGRLKNLWSLDL-GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIA 342
+ R +L +L L + + G ++I+T+C K+K L EE+ +
Sbjct: 131 RLAKARADDLETLKLDKCSGFTTDG-----LLSIVTHCRKIKTLLMEESSFSEKDGKWLH 185
Query: 343 NLSTTMT-----DIYM-GVNQIS----GTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ 392
L+ T + YM +IS TI +LV++ + E +L G +
Sbjct: 186 ELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVG-FFKAAAN 244
Query: 393 LRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDN 452
L L+ + +L + L LS +P + L+L
Sbjct: 245 LEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYA 303
Query: 453 KLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISG--NQFSGEIPVT 510
L ++ L+ N + L + K L L I ++ E
Sbjct: 304 LLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEG 363
Query: 511 LTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ----IPEFLENLSFLE 566
L GL + + ++ + + ++++ + I +L+NL
Sbjct: 364 LVSQRGLIAL--------------AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFR 409
Query: 567 YLNLS 571
+ L
Sbjct: 410 LVLLD 414
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 47/387 (12%), Positives = 112/387 (28%), Gaps = 55/387 (14%)
Query: 216 NMSSLENI-LLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFS----NASNIE 270
LE + L +GFT + L I ++ + ++ FS + + +++E
Sbjct: 136 RADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195
Query: 271 IIDLPINYFTG----KVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVL 326
+++ + F + I ++L S+ +G + F N +
Sbjct: 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVG----DFEILELVGFFKAAANLEEFCGG 251
Query: 327 AFEENRLGGVLPHSIANLST-TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN 385
+ E+ ++ + + + L+LL T +
Sbjct: 252 SLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLY--ALLETED 309
Query: 386 IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLG------ 439
I + NL+ + + + + L + + + G
Sbjct: 310 HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRG 369
Query: 440 ------NCKNLVSLNLSDNKL----IGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGN 489
C+ L + + + + + ++ + + R + L LPL+ G
Sbjct: 370 LIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF-RLVLLDREERITDLPLDNG- 427
Query: 490 LKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR---GSIPLSLRSLKSIKELDL 546
+ L GC L F + + +++ + L
Sbjct: 428 -----------------VRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLL 470
Query: 547 SCNNLSGQ-IPEFLENLSFLEYLNLSY 572
S + + EF L+ L +
Sbjct: 471 GYVGESDEGLMEFSRGCPNLQKLEMRG 497
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 42/230 (18%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKIL---NLMQKGALKSFVAECEVL-RNTRHRNLIKI 741
++G+GSFG V + E G AVK+L ++Q ++ + E +L H L ++
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
C F+ D V E++ G L + +S E + R A ++ SA+
Sbjct: 90 F--CC---FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE--ARA---RFYAA-EIISALM 138
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIK 859
+LH I++ DLK NVLLDH+ H +DFG+ + + ++
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK--------EGICNGVTTATFC 185
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + +M YG +V D +++GV+L EM P
Sbjct: 186 GTPDYIAPEILQEM------LYGP----AV--DWWAMGVLLYEMLCGHAP 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 33/148 (22%), Positives = 65/148 (43%), Gaps = 21/148 (14%)
Query: 686 MIGQGSFGSVYKGI-LGENGTFVAVKIL---NLMQKGALKSFVAECEVLRNTRHR---NL 738
+G+G+FG V + I G VAVKI+ + + A E +VL + +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNST 76
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+ + + + G +V+E + S +++ ++ P L I++ +A +
Sbjct: 77 FRCVQMLEWFEHHG--HICIVFELL-GLSTYDFIKENGFLP--FRLDHIRK--MAYQICK 129
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHD 826
++ +LH + + H DLKP N+L
Sbjct: 130 SVNFLHSNK---LTHTDLKPENILFVQS 154
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 55/321 (17%), Positives = 103/321 (32%), Gaps = 57/321 (17%)
Query: 291 KNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLG----GVLPHSIANLST 346
+ SLDL +NNL S +L + + L N LG L +A +
Sbjct: 22 HGVTSLDLSLNNLYSISTVEL-IQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 347 TMTDIYMGVNQISGTIPSGIGNLV-----NLNLLGIEFNQLTGNIPREIGQL-----RNL 396
+T + + N +S + + + +L + +N + E Q ++
Sbjct: 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140
Query: 397 QAIGLSSNFLQGNIPSSLG------NLTLMTDLFLSSNHLQGNIPPSLG-----NCKNLV 445
++ L N L L + L L N+L L ++
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANV-NSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 446 SLNLSDNKL----IGAVPQQILTITTLSRFLDLGNNHLNGS----LPLEVGNLKNLVALY 497
SL+LS N L + +I L+L N L+G L L +LK+L +Y
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 498 ISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSG---- 553
+ + ++ + +++ I +D + +
Sbjct: 260 LDYDIVKNM-----------------SKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302
Query: 554 QIPEFLENLSF-LEYLNLSYN 573
I + LS + +L
Sbjct: 303 PISNLIRELSGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 43/321 (13%), Positives = 100/321 (31%), Gaps = 76/321 (23%)
Query: 264 SNASNIEIIDLPINYFTGK-VSIIFGRLKN----LWSLDLGINNLGSGGANDLDFVTILT 318
+ +N+ ++L N+ + K + L + LDLG N+ S +++
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 319 NCSKLKVLAFEENRLGGV----LPHSIANLSTTMTDIYMGVNQISGTIPSGIGNL----- 369
S + L N LG L +A + + + + N ++ L
Sbjct: 137 PAS-ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLA 192
Query: 370 -VNLNL--LGIEFNQLTGNIPREIGQL-----RNLQAIGLSSNFLQG----NIPSSLGNL 417
+ ++ L + N L E+ + ++ ++ L N L G N+ +L
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 418 TLMTDLFLSSNHLQG-------NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSR 470
+ ++L + ++ + + N + ++ ++ + ++
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH--------------- 297
Query: 471 FLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGS 530
+ ++ + G +L + Q N +
Sbjct: 298 --PSHSIPISNLIRELSGKADVP----------------SLLNQCLIFAQKHQTNIEDLN 339
Query: 531 IPLSLRSLKSIKELDLSCNNL 551
IP LR E +C L
Sbjct: 340 IPDELR------ESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 37/167 (22%), Positives = 62/167 (37%), Gaps = 34/167 (20%)
Query: 438 LGNCKNLVSLNLSDNK--------LIGAVPQQILTITTLSRFLDLGNNHLNG------SL 483
+ SL+LS N LI A ++T+ L+L N L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTS----LNLSGNSLGFKNSDELVQ 73
Query: 484 PLEVGNLKNLVALYISGNQFSGE----IPVTLTGC-TGLEIFHMQGNSF--RGSIPLS-- 534
L N+ +L +SGN S + + TL + + + N F + S
Sbjct: 74 ILAAIP-ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA 132
Query: 535 LRSL-KSIKELDLSCNNLSGQ----IPEFLENL-SFLEYLNLSYNHF 575
+L SI L+L N+L + + + L + + + LNL N+
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 31/147 (21%), Positives = 61/147 (41%), Gaps = 13/147 (8%)
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLK 491
N+P + + L N I +P + R +DL NN ++ L + L+
Sbjct: 29 NLPE------TITEIRLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 492 NLVALYISGNQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPL-SLRSLKSIKELDLSCN 549
+L +L + GN+ + E+P G L++ + N + + + + L ++ L L N
Sbjct: 81 SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 550 NLSGQIPEFLENLSFLEYLNLSYNHFD 576
L L ++ ++L+ N F
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 28/131 (21%), Positives = 59/131 (45%), Gaps = 5/131 (3%)
Query: 324 KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQL 382
+ E+N + + P + + + I + NQIS + L +LN L + N++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPY-KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 383 TGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNC 441
T +P+ + L +LQ + L++N + + +L + L L N LQ +
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 442 KNLVSLNLSDN 452
+ + +++L+ N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 11/145 (7%)
Query: 385 NIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKN 443
N+P I ++R L N ++ P + + + LS+N + + P + ++
Sbjct: 29 NLPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 444 LVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQ 502
L SL L NK+ +P+ + + L L N +N L ++ +L NL L + N+
Sbjct: 82 LNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 503 FSGEIPVTLTGCTGLEIFHMQGNSF 527
T + ++ H+ N F
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 25/135 (18%), Positives = 50/135 (37%), Gaps = 11/135 (8%)
Query: 296 LDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGV 355
+ L N + KL+ + N++ L ++ + +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYK------KLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 356 NQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQ-LRNLQAIGLSSNFLQGNIPSS 413
N+I+ +P + L +L LL + N++ + + Q L NL + L N LQ +
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 414 LGNLTLMTDLFLSSN 428
L + + L+ N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 27/138 (19%), Positives = 47/138 (34%), Gaps = 31/138 (22%)
Query: 457 AVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLKNLVALYISGNQFSGEIPVTLTGCT 515
+P + T + L N + +P K L + +S NQ S E+
Sbjct: 25 EIPTNLPETITE---IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAP------ 73
Query: 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
++F+G L+S+ L L N ++ E L L+ L L+ N
Sbjct: 74 ---------DAFQG--------LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI 116
Query: 576 DGEVPTKGVFSNKTRVQL 593
+ F + + L
Sbjct: 117 -NCLR-VDAFQDLHNLNL 132
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 32/147 (21%), Positives = 58/147 (39%), Gaps = 10/147 (6%)
Query: 361 TIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLT 418
IP I L L N+ T I +L L+ I S+N + + +
Sbjct: 25 KIPEHIPQYTAELRL---NNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 419 LMTDLFLSSNHLQGNIPPSL-GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNN 477
+ ++ L+SN L+ N+ + ++L +L L N++ V + R L L +N
Sbjct: 82 GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDN 139
Query: 478 HLNGSLPLEV-GNLKNLVALYISGNQF 503
+ ++ L +L L + N F
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 29/149 (19%), Positives = 53/149 (35%), Gaps = 16/149 (10%)
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVG---N 489
+IP L L++N+ I R ++ NN + +E G
Sbjct: 29 HIPQ------YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD---IEEGAFEG 79
Query: 490 LKNLVALYISGNQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPL-SLRSLKSIKELDLS 547
+ + ++ N+ + G L+ ++ N + S L S++ L L
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 548 CNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
N ++ P + L L LNL N F+
Sbjct: 138 DNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 31/130 (23%), Positives = 59/130 (45%), Gaps = 4/130 (3%)
Query: 324 KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQL 382
++L +N++ L + + + ++Y+G NQ+ +P G+ +L L +L + NQL
Sbjct: 43 QILYLHDNQITK-LEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100
Query: 383 TGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCK 442
T +L +L+ + + N L +P + LT +T L L N L+ +
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 443 NLVSLNLSDN 452
+L L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 31/114 (27%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIG 400
A + T +Y+ NQI+ P +L+NL L + NQL +P + L L +
Sbjct: 36 AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94
Query: 401 LSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL 454
L +N L + L + +LF+ N L +P + +L L L N+L
Sbjct: 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 34/163 (20%)
Query: 267 SNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVL 326
+N +I+ L N T +F L NL L LG N LG+
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--------------------- 78
Query: 327 AFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGN 385
LP + + T +T + +G NQ++ +PS + LV+L L + N+LT
Sbjct: 79 ----------LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-E 126
Query: 386 IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN 428
+PR I +L +L + L N L+ + L+ +T +L N
Sbjct: 127 LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 5/114 (4%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIG 400
++ T++ + N++ G+ G L +L L ++ NQLTG P ++Q +
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 401 LSSNFLQGNIPSSL-GNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDN 452
L N ++ I + + L + L L N + + P S + +L SLNL+ N
Sbjct: 85 LGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 26/99 (26%), Positives = 42/99 (42%), Gaps = 13/99 (13%)
Query: 362 IPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPSSLGNLTL 419
IP I + L L N+L + G+L +L + L N L G P++ +
Sbjct: 23 IPRDIPLHTTELLL---NDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 420 MTDLFLSSNHLQGNIPP----SLGNCKNLVSLNLSDNKL 454
+ +L L N ++ I L L +LNL DN++
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLH---QLKTLNLYDNQI 114
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (128), Expect = 1e-07
Identities = 25/167 (14%), Positives = 63/167 (37%), Gaps = 16/167 (9%)
Query: 427 SNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS-RFLDLGNNHLNGSLPL 485
S Q ++ P L L +L + + + + +L L ++ + L
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS 216
Query: 486 EVGNLKNLVALYISGNQFSGEIPVTL-------TGCTGLEIFHMQGNSFRGSIPLSLRS- 537
++ NL+ LV LY+ + + + + L+ + + +
Sbjct: 217 DLPNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 538 --LKSIKELDLSCNNLSG----QIPEFLENLSFLEYLNLSYNHFDGE 578
L ++ +D+S L+ + + ++ + L+++N+ YN+ E
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 25/113 (22%), Positives = 49/113 (43%), Gaps = 4/113 (3%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIG 400
+ ++ T + + N++ ++P G+ L L L + NQ+ +L L +
Sbjct: 24 TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY 82
Query: 401 LSSNFLQGNIPSSL-GNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDN 452
L N LQ ++P+ + LT + +L L +N L+ +L + L N
Sbjct: 83 LHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 23/112 (20%), Positives = 48/112 (42%), Gaps = 3/112 (2%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
+ +T++Y+ NQ + +P + N +L L+ + N+++ + + L + L
Sbjct: 27 KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85
Query: 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP-SLGNCKNLVSLNLSDN 452
S N L+ P + L + L L N + +P + + L L + N
Sbjct: 86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 23/95 (24%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 337 LPHSIANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLR 394
+P ++N +T I + N+IS T+ + N+ L L + +N+L IP L+
Sbjct: 46 VPKELSNY-KHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLK 102
Query: 395 NLQAIGLSSNFLQGNIP-SSLGNLTLMTDLFLSSN 428
+L+ + L N + +P + +L+ ++ L + +N
Sbjct: 103 SLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 8/127 (6%)
Query: 452 NKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTL 511
NK + +P+ I T L L N +P E+ N K+L + +S N+ S +
Sbjct: 19 NKGLKVLPKGIPRDVTE---LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF 74
Query: 512 TGCTGLEIFHMQGNSFRGSIPLSL-RSLKSIKELDLSCNNLSGQIPEFL-ENLSFLEYLN 569
+ T L + N R IP LKS++ L L N++S +PE +LS L +L
Sbjct: 75 SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLA 132
Query: 570 LSYNHFD 576
+ N
Sbjct: 133 IGANPLY 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 39/132 (29%), Positives = 68/132 (51%), Gaps = 7/132 (5%)
Query: 324 KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGN-LVNLNLLGIEFNQL 382
L E N L LP+ + + T++T +Y+G N++ ++P+G+ N L +L L + NQL
Sbjct: 31 TYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL 88
Query: 383 TGNIPREIGQLRNLQAIGLSSNFLQGNIPSSL-GNLTLMTDLFLSSNHLQGNIPP-SLGN 440
+L L+ + L++N LQ ++P + LT + DL L N L+ ++P
Sbjct: 89 QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146
Query: 441 CKNLVSLNLSDN 452
+L + L DN
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 8/117 (6%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
+ T + + N + L +L L + N+L +L +L + L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83
Query: 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP----SLGNCKNLVSLNLSDNKL 454
S+N LQ LT + +L L++N LQ ++P L L L L N+L
Sbjct: 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLT---QLKDLRLYQNQL 136
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 22/89 (24%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 489 NLKNLVALYISGNQFS-GEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLS 547
++ L + ++ + G++ LE SI +L L +K+L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 548 CNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
N +SG + E L +LNLS N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 20/116 (17%), Positives = 44/116 (37%), Gaps = 7/116 (6%)
Query: 216 NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLP 275
S ++ ++LD + + L+ + + + SI + + ++ ++L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 276 INYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN 331
N +G + ++ + NL L+L N + DL + L LK L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 29/134 (21%), Positives = 49/134 (36%), Gaps = 28/134 (20%)
Query: 368 NLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427
++ L L N+ + + L+ + + L +I ++L L + L LS
Sbjct: 18 DVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV 487
N + G + C NL LNLS NK+ + + TI L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLK------------------ 110
Query: 488 GNLKNLVALYISGN 501
L+NL +L +
Sbjct: 111 -KLENLKSLDLFNC 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 16/105 (15%), Positives = 30/105 (28%), Gaps = 5/105 (4%)
Query: 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531
+ L + + N L + G + I + N R +
Sbjct: 2 VKLTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
L+ +K L ++ N + + L L L L+ N
Sbjct: 58 D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 21/118 (17%), Positives = 40/118 (33%), Gaps = 11/118 (9%)
Query: 364 SGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQ--GNIPSSLGNLTLMT 421
+ N V L + ++ I L AI S N ++ P L +
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLK 67
Query: 422 DLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS--RFLDLGNN 477
L +++N + +L L L++N L + + +L +L + N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 22/122 (18%), Positives = 35/122 (28%), Gaps = 13/122 (10%)
Query: 212 PSLYNMSSLENILLDVNGFT--GNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNI 269
N + L NL G TL DN + + F +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENL----GATLDQFDAIDFSDNEIR-KL-DGFPLLRRL 66
Query: 270 EIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFE 329
+ + + N + L +L L L N+L +L + L + L L
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASLKSLTYLCIL 121
Query: 330 EN 331
N
Sbjct: 122 RN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 30/111 (27%), Positives = 44/111 (39%), Gaps = 11/111 (9%)
Query: 75 RVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGF--LFRLETLMLANN 132
R ELDLR I + L I+ + N EI K GF L RL+TL++ NN
Sbjct: 20 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNN 74
Query: 133 SFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGY--SWLKLEHISLARN 181
+ +L + N+L D+ S L ++ + RN
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 73/528 (13%), Positives = 151/528 (28%), Gaps = 101/528 (19%)
Query: 71 HRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFR----LET 126
R +V ++L+ NL + + G + I + LE
Sbjct: 63 RRFPKVRSVELKG-------------KPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEE 109
Query: 127 LMLANNSFSGKIPTNLS-SCSNLLSFVAYRNNLVGEIP-EDIGYSWLKLEHISLARNHLT 184
+ L + ++ S N V I + L+ + L + +
Sbjct: 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVD 169
Query: 185 GMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENIL--------LDVNGFTGNLPL 236
+ + + Y + S S + S+LE ++ L +N L
Sbjct: 170 DVSGHWLSHFPDTYTSLVSLNISCL--ASEVSFSALERLVTRCPNLKSLKLNRAVPLEKL 227
Query: 237 -DIGVTLPNLQVFAIG------DNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGR 289
+ P L+ G + + S + + + + ++
Sbjct: 228 ATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287
Query: 290 LKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMT 349
L +L+L + D V +L C KL+ L + +
Sbjct: 288 CSRLTTLNLSYATV-----QSYDLVKLLCQCPKLQRL----------------WVLDYIE 326
Query: 350 DIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGN 409
D G+ ++ T +L L + E + N+ + + + L ++ + L+
Sbjct: 327 DA--GLEVLASTCK----DLRELRVFPSEPFVMEPNVA--LTE-QGLVSVSMGCPKLE-- 375
Query: 410 IPSSLGNLTLMTD---LFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTIT 466
S L MT+ + ++ N N+ L I
Sbjct: 376 --SVLYFCRQMTNAALITIARN------------RPNMTRFRLC--------------II 407
Query: 467 TLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNS 526
L L+ V + K+L L +SG T +E+ +
Sbjct: 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAG 467
Query: 527 FRG-SIPLSLRSLKSIKELDLS-CNNLSGQIPEFLENLSFLEYLNLSY 572
+ L S+++L++ C + L + L +S
Sbjct: 468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 70/472 (14%), Positives = 129/472 (27%), Gaps = 87/472 (18%)
Query: 141 NLSSCSNLLSF---VAYRNNLVGEIPEDIGYSWLKLEHISLARNHLT----GMLPASIGN 193
L + F V E + S+ LE I L R +T ++ S N
Sbjct: 72 ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131
Query: 194 LSIIYLHVGENQFSGTVPPSL-YNMSSLENILL---DVNGFTGNLPLDIGVTLPNLQVFA 249
++ L FS ++ +L+ + L DV+ +G+ T +L
Sbjct: 132 FKVLVLS-SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN 190
Query: 250 IGDNYFS---GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSG 306
I ++ + N++ + L K++ + R L L G
Sbjct: 191 ISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVR 250
Query: 307 GANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI 366
L+ C +L+ L+ + + LP + S
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS--------------------- 289
Query: 367 GNLVNLNLLGIEFNQLTGN-IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFL 425
L LNL + + + + + Q LQ + + D L
Sbjct: 290 -RLTTLNL---SYATVQSYDLVKLLCQCPKLQRLWVLDYI---------------EDAGL 330
Query: 426 SSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS---------RFLDLGN 476
CK+L L + ++ P LT L +
Sbjct: 331 EV---------LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFC 381
Query: 477 NHL-NGSLPLEVGNLKNLVALYISGNQFSGEIPVT-----------LTGCTGLEIFHMQG 524
+ N +L N N+ + + +T + C L + G
Sbjct: 382 RQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG 441
Query: 525 NSFRGSIPLSLRSLKSIKELDLSCNNLSGQ-IPEFLENLSFLEYLNLSYNHF 575
K ++ L ++ S + L L L + F
Sbjct: 442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 17/97 (17%), Positives = 34/97 (35%), Gaps = 3/97 (3%)
Query: 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV-GNLK 491
+ L +NL L + + + + + + L R L + + L + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 492 NLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528
L L +S N T+ G + L+ + GN
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPRE-IGQLRNLQAIGLSSNFLQGNIPSSLGNLTL 419
+ NL L IE Q ++ + L L+ + + + L+ P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 420 MTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKL 454
++ L LS N L+ ++ +L L LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 5/96 (5%)
Query: 338 PHSIANLSTTMTDIYMGVNQISGTIPSG-IGNLVNLNLLGIEFNQLTGNIPREIGQ-LRN 395
H + +T++Y+ Q + + L L L I + L + +
Sbjct: 24 LHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 396 LQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ 431
L + LS N L+ ++ L+L L LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 33/115 (28%), Positives = 48/115 (41%), Gaps = 14/115 (12%)
Query: 368 NLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427
+ L L + N G I + NL+ + L + L ++ S+L L + L LS
Sbjct: 25 AVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF-----LDLGNN 477
N + G + NL LNLS NKL + I T+ L + LDL N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 3/93 (3%)
Query: 485 LEVGNLKNLVALYISGNQFS-GEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKE 543
L + L + + + G+I LE + S+ +L L +K+
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKK 75
Query: 544 LDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576
L+LS N + G + E L L +LNLS N
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 20/116 (17%), Positives = 43/116 (37%), Gaps = 7/116 (6%)
Query: 216 NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLP 275
+++ ++LD + NL+ ++ + S+ + ++ ++L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 276 INYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN 331
N G + ++ +L NL L+L N L D+ + L LK L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 36/221 (16%), Positives = 69/221 (31%), Gaps = 32/221 (14%)
Query: 363 PSGIGNLVNLNLLGIEFNQ-LTGNIPREIGQLRNLQAIGLSSNFL-QGNIPSSLGNLTLM 420
P G L++ ++ + E +Q + LS++ + + L + +
Sbjct: 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLN 480
+L L L I +L NLV LNLS
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS-----------------------E 157
Query: 481 GSLPLEVGNLKNLVALYISGNQF---SGEIPVTLTGCTGLEIFHMQGNSFR---GSIPLS 534
+L + + L L +S + ++ G +
Sbjct: 158 FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 217
Query: 535 LRSLKSIKELDLS-CNNLSGQIPEFLENLSFLEYLNLSYNH 574
+R ++ LDLS L + L++L++L+LS +
Sbjct: 218 VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 15/75 (20%), Positives = 24/75 (32%), Gaps = 3/75 (4%)
Query: 768 LEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH---CQPPIVHGDLKPSNVLLD 824
L E + N D + D ++L + HGDL SN+ +
Sbjct: 139 LAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK 198
Query: 825 HDMVAHVSDFGLARF 839
V+ D G +
Sbjct: 199 DGKVSGFIDLGRSGR 213
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 39/314 (12%), Positives = 81/314 (25%), Gaps = 63/314 (20%)
Query: 290 LKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMT 349
L +L L+L + + V + + L + +L ++ +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAV-LGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129
Query: 350 DIYMGVNQISGT----IPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSN 404
+ + +N + + + + + L + N LT + GL+ N
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVL-------MEGLAGN 182
Query: 405 FLQGNIPSSLGNLTLMTDLFLSSNHLQGN----IPPSLGNCKNLVSLNLSDNKLIGAVPQ 460
+S+ T L L L + L + L LN++ N
Sbjct: 183 -------TSV------THLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL 229
Query: 461 QILTI----TTLSRFLDLGNNHLN-------GSLPLEVGNLKNLVALYISGNQFSGE--- 506
+ +L L L N L+ L +V G S
Sbjct: 230 ALARAAREHPSL-ELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSV 288
Query: 507 -IPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS----GQIPEFLEN 561
+ + +Q + + DL + + + + L
Sbjct: 289 ILSEVQRNLNSWDRARVQRH-------------LELLLRDLEDSRGATLNPWRKAQLLRV 335
Query: 562 LSFLEYLNLSYNHF 575
+ L
Sbjct: 336 EGEVRALLEQLGSS 349
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 7/32 (21%), Positives = 11/32 (34%)
Query: 808 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
+ HGD N++ D + D G
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAI 399
+ TT +Y+ NQI+ + G+ L L L ++ NQLT +P + +L L +
Sbjct: 26 TGIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQL 83
Query: 400 GLSSNFLQGNIPS-SLGNLTLMTDLFLSSN 428
L+ N L+ +IP + NL +T ++L +N
Sbjct: 84 SLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGI-GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIG 400
A + T +++ NQI+ + G+ +LVNL L N+LT +L L +
Sbjct: 29 AGIPTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLD 87
Query: 401 LSSNFLQGNIPS-SLGNLTLMTDLFLSSN 428
L+ N L+ +IP + NL +T ++L +N
Sbjct: 88 LNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 13/83 (15%), Positives = 26/83 (31%), Gaps = 11/83 (13%)
Query: 768 LEEWLHQSNGQPEVCDLS------LIQRLNIAIDMASAIEYLHHHCQPP-----IVHGDL 816
+ + +Q L+ Q + E L QP + H D+
Sbjct: 154 VRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDI 213
Query: 817 KPSNVLLDHDMVAHVSDFGLARF 839
NVL+ ++ ++ D+
Sbjct: 214 HAGNVLVGNEESIYIIDWDEPML 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 997 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.23 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.18 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.89 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.76 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.74 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.39 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.25 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.21 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.05 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.9 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.75 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.67 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.49 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.42 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.91 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.64 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.63 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.55 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.4 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.32 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.92 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.94 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.23 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-83 Score=799.30 Aligned_cols=580 Identities=28% Similarity=0.449 Sum_probs=460.0
Q ss_pred CCCCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCeeeeeeecCCCCcEEEEeccCCCCCCc---cc------------
Q 001908 27 SAHTNETDRLALLAIKSQLHDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGS---LS------------ 91 (997)
Q Consensus 27 ~~~~~~~~~~aLl~~k~~~~~~~~~~~sW~~~~~~c~w~gv~C~~~~~~v~~L~L~~~~l~g~---~~------------ 91 (997)
++.+.++|++|||+||+++.||. .+++|+.++|||+|+||+|+ ++||+.|||+++++.|. +|
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 34457899999999999999998 89999988899999999998 68999999999999887 55
Q ss_pred -----------ccccCccccccccccccccCCCCCc--cCCCCCCCeEEEccCCCccccCCccc-cCCCcccchhccccc
Q 001908 92 -----------PYVGNLSFLRYINLATNNFHGEIPK--EIGFLFRLETLMLANNSFSGKIPTNL-SSCSNLLSFVAYRNN 157 (997)
Q Consensus 92 -----------~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~l~l~~n~ 157 (997)
+.++++++|++|||++|+++|.+|. .++++++|++|||++|.++|.+|..+ +++++|++|++++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 4677888899999999999988888 88889999999999998888888766 667777777777666
Q ss_pred cccccccc---cc---------------------ccccccceeecccccccCcCcCccCcch-hhhhhccCccccccCCC
Q 001908 158 LVGEIPED---IG---------------------YSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPP 212 (997)
Q Consensus 158 ~~g~ip~~---~~---------------------~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~ 212 (997)
+.+..|.. +. ..+++|++|+|++|.+++.+|. +++++ +++|++++|++++.+|.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~ 241 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccH
Confidence 66555433 10 2456777788888888877776 76663 55677777777777777
Q ss_pred cccCCCccceeeccCCCCCCC----------------------CCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCc
Q 001908 213 SLYNMSSLENILLDVNGFTGN----------------------LPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIE 270 (997)
Q Consensus 213 ~l~~l~~L~~L~L~~N~l~g~----------------------lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 270 (997)
.+.++++|++|+|++|+++|. +|..++..+++|++|+|++|++++.+|..|+++++|+
T Consensus 242 ~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 321 (768)
T 3rgz_A 242 AISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321 (768)
T ss_dssp HTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCC
T ss_pred HHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCcc
Confidence 777777777777777666654 4444443345666666666666666666666666666
Q ss_pred EEeccCccCCCccccc-ccccCccCeeEccCccCCCCCCCCcc-------------------hhhhhcc--CCCCcEEEe
Q 001908 271 IIDLPINYFTGKVSII-FGRLKNLWSLDLGINNLGSGGANDLD-------------------FVTILTN--CSKLKVLAF 328 (997)
Q Consensus 271 ~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~-------------------~~~~l~~--l~~L~~L~L 328 (997)
+|+|++|+++|.+|.. |+.+++|++|+|++|++++..+..+. .+..+.. +++|++|++
T Consensus 322 ~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L 401 (768)
T 3rgz_A 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401 (768)
T ss_dssp EEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEEC
T ss_pred EEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEEC
Confidence 6666666666555443 56666666666666665422111110 0111122 456677777
Q ss_pred ecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccc
Q 001908 329 EENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQG 408 (997)
Q Consensus 329 ~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 408 (997)
++|++++.+|..+.++ ++|+.|++++|++++.+|..|+++++|++|++++|++++.+|..|..+++|++|+|++|++++
T Consensus 402 ~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 480 (768)
T 3rgz_A 402 QNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480 (768)
T ss_dssp CSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccC
Confidence 7777777777777766 678888888888888888888888888888888888888888888888888888888888888
Q ss_pred cchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCcccc-
Q 001908 409 NIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV- 487 (997)
Q Consensus 409 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~- 487 (997)
.+|..+.++++|+.|+|++|++++.+|.+|+++++|++|+|++|+++|.+|..+..++++ +.|++++|+++|.+|..+
T Consensus 481 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~ 559 (768)
T 3rgz_A 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMF 559 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTC-CEEECCSSEEESBCCGGGG
T ss_pred cCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCC-CEEECCCCccCCcCChHHh
Confidence 888888888999999999999988888888889999999999999988889888888888 889999998888777544
Q ss_pred ---------------------------------------------------------------------ccccccceecc
Q 001908 488 ---------------------------------------------------------------------GNLKNLVALYI 498 (997)
Q Consensus 488 ---------------------------------------------------------------------~~l~~L~~L~L 498 (997)
+.+++|+.|||
T Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdL 639 (768)
T 3rgz_A 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639 (768)
T ss_dssp TTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEEC
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEEC
Confidence 33567899999
Q ss_pred ccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCccc
Q 001908 499 SGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 499 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|||++|+|+|.
T Consensus 640 s~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ 719 (768)
T 3rgz_A 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719 (768)
T ss_dssp CSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEE
T ss_pred cCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCCCcceeecCCCCcCCCCCCCCCCCCCCcCC
Q 001908 579 VPTKGVFSNKTRVQLTGNGKLCGGSNELHLPSCPSKRS 616 (997)
Q Consensus 579 ~p~~~~~~~~~~~~~~~N~~~C~~~~~~~~~~c~~~~~ 616 (997)
||..++|.++...+|.|||++||.+ .++|+....
T Consensus 720 iP~~~~~~~~~~~~~~gN~~Lcg~~----l~~C~~~~~ 753 (768)
T 3rgz_A 720 IPEMGQFETFPPAKFLNNPGLCGYP----LPRCDPSNA 753 (768)
T ss_dssp CCSSSSGGGSCGGGGCSCTEEESTT----SCCCCSCC-
T ss_pred CCCchhhccCCHHHhcCCchhcCCC----CcCCCCCcc
Confidence 9999999999999999999999853 247865543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-64 Score=623.17 Aligned_cols=491 Identities=33% Similarity=0.547 Sum_probs=433.7
Q ss_pred CCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchh
Q 001908 73 HQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFV 152 (997)
Q Consensus 73 ~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ 152 (997)
-.+++.|+|++|.+.+.+|. +++++|++|+|++|++++.+|. ++++++|++|+|++|.++|.+|..++++++|++|+
T Consensus 177 l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ 253 (768)
T 3rgz_A 177 CGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253 (768)
T ss_dssp CTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEE
T ss_pred CCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEE
Confidence 35789999999998887664 8889999999999999988887 89999999999999999999999999999999999
Q ss_pred cccccccccccccccccccccceeecccccccCcCcCccCcc--hhhhhhccCccccccCCCcccCCCccceeeccCCCC
Q 001908 153 AYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL--SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGF 230 (997)
Q Consensus 153 l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l--~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l 230 (997)
+++|++.|.+|.. .+++|++|+|++|.++|.+|..++.. ++++|++++|++++.+|..++++++|++|+|++|++
T Consensus 254 Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 330 (768)
T 3rgz_A 254 ISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330 (768)
T ss_dssp CCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEE
T ss_pred CCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcc
Confidence 9999999888875 57889999999999999999888764 466799999999999999999999999999999999
Q ss_pred CCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCC-CCcEEeccCccCCCcccccccc--cCccCeeEccCccCCCCC
Q 001908 231 TGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNAS-NIEIIDLPINYFTGKVSIIFGR--LKNLWSLDLGINNLGSGG 307 (997)
Q Consensus 231 ~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~Ls~N~l~~~~ 307 (997)
+|.+|...+..+++|++|++++|+++|.+|..+.+++ +|++|+|++|++++.++..+.. +++|++|+|++|++++.
T Consensus 331 ~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~- 409 (768)
T 3rgz_A 331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK- 409 (768)
T ss_dssp EEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEE-
T ss_pred cCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccc-
Confidence 9889988666899999999999999999999998887 8999999999998888887776 88899999999988753
Q ss_pred CCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCC
Q 001908 308 ANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIP 387 (997)
Q Consensus 308 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 387 (997)
.+..+.++++|++|++++|++++.+|..+..+ ++|+.|++++|++++.+|..+..+++|++|++++|++++.+|
T Consensus 410 -----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 483 (768)
T 3rgz_A 410 -----IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483 (768)
T ss_dssp -----CCGGGGGCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred -----cCHHHhcCCCCCEEECcCCcccCcccHHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCC
Confidence 34567888999999999999998999888887 679999999999999999999999999999999999998899
Q ss_pred CCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccc---
Q 001908 388 REIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILT--- 464 (997)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--- 464 (997)
..+.++++|++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|..++++++|++|++++|+++|.+|..++.
T Consensus 484 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~ 563 (768)
T 3rgz_A 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTT
T ss_pred HHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccc
Confidence 99999999999999999999889999999999999999999999889999999999999999999998888876543
Q ss_pred -------------------------------------------------------------------ccccccccccCCC
Q 001908 465 -------------------------------------------------------------------ITTLSRFLDLGNN 477 (997)
Q Consensus 465 -------------------------------------------------------------------l~~ll~~L~Ls~N 477 (997)
+..+ ++|||++|
T Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L-~~LdLs~N 642 (768)
T 3rgz_A 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM-MFLDMSYN 642 (768)
T ss_dssp CBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC-CEEECCSS
T ss_pred hhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc-cEEECcCC
Confidence 3445 78999999
Q ss_pred cccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCch
Q 001908 478 HLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE 557 (997)
Q Consensus 478 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 557 (997)
+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..++.++.|++|||++|+++|.+|.
T Consensus 643 ~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~ 722 (768)
T 3rgz_A 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722 (768)
T ss_dssp CCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCS
T ss_pred cccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999997
Q ss_pred hccCCCCCCEEeCCCCc-Cccc
Q 001908 558 FLENLSFLEYLNLSYNH-FDGE 578 (997)
Q Consensus 558 ~~~~l~~L~~L~ls~N~-l~~~ 578 (997)
. ..+..+....+.+|+ |+|.
T Consensus 723 ~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 723 M-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp S-SSGGGSCGGGGCSCTEEEST
T ss_pred c-hhhccCCHHHhcCCchhcCC
Confidence 5 334555666777886 5653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-62 Score=597.75 Aligned_cols=524 Identities=20% Similarity=0.232 Sum_probs=423.4
Q ss_pred CHHHHHHHHHHHHhcCCCCC--------CCCCCCCCCCCCee---eeeeecCCCCcEEEEeccCCCCCCcccccccCccc
Q 001908 31 NETDRLALLAIKSQLHDPLG--------VTNSWNNSINLCQW---AGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSF 99 (997)
Q Consensus 31 ~~~~~~aLl~~k~~~~~~~~--------~~~sW~~~~~~c~w---~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~ 99 (997)
...|+.||.+||+++.++.. ...+|+.+++||.| .||+|+.. +||+.|+|+++++.|.+|+++++|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence 45799999999999765532 23489988999999 99999865 89999999999999999999999999
Q ss_pred cccccccccccC------C------CCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhccccccccccccccc
Q 001908 100 LRYINLATNNFH------G------EIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIG 167 (997)
Q Consensus 100 L~~L~Ls~N~l~------g------~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~ 167 (997)
|++|||++|++. | .+|.+. +.+|+ +++++|.+.|.+|. .+.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~------------------------~~~ 159 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRE------------------------DFS 159 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGG------------------------GSC
T ss_pred ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchh------------------------hHH
Confidence 999999999873 3 333333 34444 55555555554444 443
Q ss_pred ccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCC--------------
Q 001908 168 YSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGN-------------- 233 (997)
Q Consensus 168 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~-------------- 233 (997)
..+.++..+++....+... ..-.+...++....|+++| ||++++++++|++|+|++|+++|.
T Consensus 160 ~~~~~l~~~~l~~~~~~~~---~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~ 235 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKKS---SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235 (636)
T ss_dssp HHHHHHHHHCTTSCCCCCC---CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred HHHHHHhhcCccccccccc---cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchh
Confidence 3334444555554443311 1112223345556899999 999999999999999999999986
Q ss_pred ---CCcccc-ccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCcc-CCC-ccccccccc------CccCeeEccCc
Q 001908 234 ---LPLDIG-VTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY-FTG-KVSIIFGRL------KNLWSLDLGIN 301 (997)
Q Consensus 234 ---lp~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N 301 (997)
+|..++ .++++|++|+|++|++.|.+|.+|+++++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|
T Consensus 236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred cccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence 998875 379999999999999999999999999999999999998 999 889888887 99999999999
Q ss_pred cCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCC-CCEEeccCC
Q 001908 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVN-LNLLGIEFN 380 (997)
Q Consensus 302 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~L~~N 380 (997)
+++.++. ...+.++++|++|++++|+++|.+| .+..+ ++|+.|++++|+++ .+|..+.++++ |++|++++|
T Consensus 316 ~l~~ip~-----~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l-~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 316 NLKTFPV-----ETSLQKMKKLGMLECLYNQLEGKLP-AFGSE-IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp CCSSCCC-----HHHHTTCTTCCEEECCSCCCEEECC-CCEEE-EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred cCCccCc-----hhhhccCCCCCEEeCcCCcCccchh-hhCCC-CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 9985432 1168899999999999999999999 88877 78999999999999 88999999999 999999999
Q ss_pred CCCCCCCCCccccc--ccceeccccccccccchhhhc-------CCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCC
Q 001908 381 QLTGNIPREIGQLR--NLQAIGLSSNFLQGNIPSSLG-------NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD 451 (997)
Q Consensus 381 ~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 451 (997)
+++ .+|..+..++ +|++|+|++|++++.+|..+. .+++|+.|+|++|++++..+..+..+++|++|+|++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 999 7888887765 899999999999999999998 888999999999999954444566789999999999
Q ss_pred CcccCCccccccccc--------ccccccccCCCcccCCCccccc--cccccceeccccccccccccccccCCcCccEEE
Q 001908 452 NKLIGAVPQQILTIT--------TLSRFLDLGNNHLNGSLPLEVG--NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFH 521 (997)
Q Consensus 452 N~l~~~~p~~~~~l~--------~ll~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 521 (997)
|+++ .+|...+... ++ +.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+
T Consensus 467 N~l~-~i~~~~~~~~~~~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ 542 (636)
T 4eco_A 467 NMLT-EIPKNSLKDENENFKNTYLL-TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542 (636)
T ss_dssp SCCS-BCCSSSSEETTEECTTGGGC-CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEE
T ss_pred CCCC-CcCHHHhccccccccccCCc-cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEE
Confidence 9998 7887666543 66 88999999999 7888886 89999999999999996 899999999999999
Q ss_pred c------cCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCC---cCCCCccee
Q 001908 522 M------QGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKG---VFSNKTRVQ 592 (997)
Q Consensus 522 L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~~~~~~~~ 592 (997)
| ++|++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+... .......+.
T Consensus 543 Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~ 619 (636)
T 4eco_A 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLF 619 (636)
T ss_dssp CCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEECTTTHHHHHTTCCEEE
T ss_pred CCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccccHHhcchhhhcccceee
Confidence 9 56778889999999999999999999999 57888766 789999999998875433221 122333444
Q ss_pred ecCCCCcCCC
Q 001908 593 LTGNGKLCGG 602 (997)
Q Consensus 593 ~~~N~~~C~~ 602 (997)
+..+...|+|
T Consensus 620 ~~~~~~i~~C 629 (636)
T 4eco_A 620 YDKTQDIRGC 629 (636)
T ss_dssp CCTTSEEESC
T ss_pred cCCccccCCC
Confidence 4455555554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=580.71 Aligned_cols=538 Identities=20% Similarity=0.212 Sum_probs=429.0
Q ss_pred CeeeeeeecC---------CCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCC
Q 001908 62 CQWAGVTCGH---------RHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANN 132 (997)
Q Consensus 62 c~w~gv~C~~---------~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 132 (997)
|.++-|.|.. -..+++.|||++|++.+..+..++++++|++|||++|++++..|..++++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4455566653 1357999999999998877778999999999999999999888999999999999999999
Q ss_pred CccccCCc-cccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcch-hhhhhccCccccccC
Q 001908 133 SFSGKIPT-NLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTV 210 (997)
Q Consensus 133 ~l~g~iP~-~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~i 210 (997)
.++ .+|. .++++++|++|++++|++.+ +|...+..+++|++|+|++|.+++..|..+++++ +++|++++|++++..
T Consensus 84 ~l~-~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 84 ELS-QLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCCCC-CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred ccC-ccChhhhccCCCCCEEECCCCccCc-cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 998 5555 69999999999999999874 4444445688999999999999998888888874 667899999998776
Q ss_pred CCccc--CCCccceeeccCCCCCCCCCccccc--------------------------cCCCccEEEecCCcCcCCCCCC
Q 001908 211 PPSLY--NMSSLENILLDVNGFTGNLPLDIGV--------------------------TLPNLQVFAIGDNYFSGSIPES 262 (997)
Q Consensus 211 p~~l~--~l~~L~~L~L~~N~l~g~lp~~~~~--------------------------~l~~L~~L~L~~N~l~~~~p~~ 262 (997)
|..+. ++++|++|+|++|++++..|..+.. ..++|+.|++++|.+++..|..
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~ 241 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence 66554 5588888899888888655543321 1145666666666666666666
Q ss_pred CCCCCC--CcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcc-----------------------hh---
Q 001908 263 FSNASN--IEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD-----------------------FV--- 314 (997)
Q Consensus 263 ~~~l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----------------------~~--- 314 (997)
|.+++. |++|||++|++++..+..|+.+++|++|+|++|++..+.+..+. ++
T Consensus 242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~ 321 (680)
T 1ziw_A 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321 (680)
T ss_dssp TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence 666644 66666666666666666666666666666666666554322111 01
Q ss_pred -hhhccCCCCcEEEeecCccCCCCcccccccccccccccccCccccc--ccCCCCCCC--CCCCEEeccCCCCCCCCCCC
Q 001908 315 -TILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISG--TIPSGIGNL--VNLNLLGIEFNQLTGNIPRE 389 (997)
Q Consensus 315 -~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~--~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~ 389 (997)
..+..+++|++|++++|++++..|..|..+ ++|+.|++++|.+++ ..+..|..+ ++|+.|++++|++++..|..
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 145567777777777777777777667666 567777777776442 222334333 47888888888898888999
Q ss_pred cccccccceeccccccccccch-hhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCccc--CCccccccccc
Q 001908 390 IGQLRNLQAIGLSSNFLQGNIP-SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLI--GAVPQQILTIT 466 (997)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~ 466 (997)
|..+++|++|+|++|++++.+| ..|.++++|+.|++++|++.+..+..|..+++|+.|++++|.+. +.+|..+..++
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~ 480 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence 9999999999999999987666 68999999999999999999888999999999999999999986 67899999999
Q ss_pred ccccccccCCCcccCCCccccccccccceecccccccccccc--------ccccCCcCccEEEccCccccccCChhcccc
Q 001908 467 TLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP--------VTLTGCTGLEIFHMQGNSFRGSIPLSLRSL 538 (997)
Q Consensus 467 ~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 538 (997)
++ +.|++++|++++..|..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.++
T Consensus 481 ~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 481 NL-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CC-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 99 999999999998888889999999999999999986432 247899999999999999995555679999
Q ss_pred CcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-C-cCCCCcceeecCCCCcCCCC
Q 001908 539 KSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-G-VFSNKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 539 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~-~~~~~~~~~~~~N~~~C~~~ 603 (997)
++|+.|||++|+|++..+..|..+++|+.|+|++|++++.+|.. . .++++..+++.+|||.|+|.
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999999999877788899999999999999999987753 2 57889999999999999874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=578.39 Aligned_cols=519 Identities=19% Similarity=0.201 Sum_probs=358.8
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCCCCCCCCC-----CC--Cee------------eeeeecCCCCcEEEEeccCCCCCCc
Q 001908 29 HTNETDRLALLAIKSQLHDPLGVTNSWNNSI-----NL--CQW------------AGVTCGHRHQRVTELDLRHQNIGGS 89 (997)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~~~sW~~~~-----~~--c~w------------~gv~C~~~~~~v~~L~L~~~~l~g~ 89 (997)
.+..+|++||++||+++.|| +|+.+. +| |.| .||+|+. ++||+.|+|+++++.|.
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCc
Confidence 34578999999999999877 887544 55 999 9999986 68999999999999999
Q ss_pred ccccccCccccccccc-cccccCCCCCccCCCC----CC-----CeEEE-------ccCCCccc-----------cCCcc
Q 001908 90 LSPYVGNLSFLRYINL-ATNNFHGEIPKEIGFL----FR-----LETLM-------LANNSFSG-----------KIPTN 141 (997)
Q Consensus 90 ~~~~l~~l~~L~~L~L-s~N~l~g~~p~~~~~l----~~-----L~~L~-------Ls~N~l~g-----------~iP~~ 141 (997)
+|+++++|++|++||| ++|.++|..|...... +. ++..+ .....+++ ..+..
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 9999999866432211 00 00000 00011111 11222
Q ss_pred ccCCCcccchhcc--cccccccccccccccccccceeecccccccC-cCcCccCcchhhhhhccCccccccCCCccc--C
Q 001908 142 LSSCSNLLSFVAY--RNNLVGEIPEDIGYSWLKLEHISLARNHLTG-MLPASIGNLSIIYLHVGENQFSGTVPPSLY--N 216 (997)
Q Consensus 142 l~~l~~L~~l~l~--~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~--~ 216 (997)
..+...++.+.+. .|++.| ||..++ .+++|++|+|++|+|+| .+|..+.. .+.|.++|.+|+.++ +
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l~-~L~~L~~L~Ls~N~Lsg~~i~~~~~~-------~s~n~~~g~iP~~l~f~~ 489 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWED-------ANSDYAKQYENEELSWSN 489 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSC-------TTSHHHHHHTTSCCCGGG
T ss_pred cccccchhhceeccccCcccc-hhHHHh-cCCCCCEEECcCCcCCCCcccccccc-------cccccccccCChhhhhcc
Confidence 2333344444444 488887 888765 58889999999999987 34433322 233677788888887 8
Q ss_pred CCccceeeccCCCCCCCCCccccccCCCccEEEecCCc-CcC-CCCCCCCCCC-------CCcEEeccCccCCCcccc--
Q 001908 217 MSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY-FSG-SIPESFSNAS-------NIEIIDLPINYFTGKVSI-- 285 (997)
Q Consensus 217 l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~~~-- 285 (997)
+++|++|+|++|++.|.+|..++ ++++|++|+|++|+ ++| .+|..+++++ +|++|+|++|+++ .+|.
T Consensus 490 L~~L~~L~Ls~N~l~~~iP~~l~-~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 567 (876)
T 4ecn_A 490 LKDLTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA 567 (876)
T ss_dssp CTTCCEEEEESCTTCCSCCGGGG-GCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred CCCCCEEECcCCCCCccChHHHh-CCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence 88888888888888888886665 78888888888887 887 7887665554 8888888888888 5666
Q ss_pred cccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCC
Q 001908 286 IFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSG 365 (997)
Q Consensus 286 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~ 365 (997)
.|+++++|++|+|++|+++.++ .+..+++|++|+|++|+++ .+|..+..+..+|+.|++++|.|+ .+|..
T Consensus 568 ~l~~L~~L~~L~Ls~N~l~~lp--------~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~ 637 (876)
T 4ecn_A 568 SLQKMVKLGLLDCVHNKVRHLE--------AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637 (876)
T ss_dssp HHTTCTTCCEEECTTSCCCBCC--------CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSC
T ss_pred hhhcCCCCCEEECCCCCcccch--------hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchh
Confidence 7888888888888888877433 3567778888888888887 677777776333777777777777 66777
Q ss_pred CCCCCC--CCEEeccCCCCCCCCCCCc---c--cccccceeccccccccccchhh-hcCCCCCCeEEeecCcCCCCCCCC
Q 001908 366 IGNLVN--LNLLGIEFNQLTGNIPREI---G--QLRNLQAIGLSSNFLQGNIPSS-LGNLTLMTDLFLSSNHLQGNIPPS 437 (997)
Q Consensus 366 ~~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 437 (997)
+..++. |+.|+|++|++++.+|... . .+++|++|+|++|+++. +|.. +..+++|+.|+|++|+|+ .+|..
T Consensus 638 ~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~ 715 (876)
T 4ecn_A 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT-SIPEN 715 (876)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-CCHHHHHTTCCCSEEECCSCCCS-CCCTT
T ss_pred hhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-cCHHHHccCCCCCEEECCCCcCC-ccChH
Confidence 766654 7888888888877665322 2 33477778888887773 4444 447777778888877777 45544
Q ss_pred CCCC--------CCCcEEecCCCcccCCcccccc--cccccccccccCCCcccCCCccccccccccceeccccccccccc
Q 001908 438 LGNC--------KNLVSLNLSDNKLIGAVPQQIL--TITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 438 ~~~l--------~~L~~L~L~~N~l~~~~p~~~~--~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
+... ++|++|+|++|+++ .+|..+. .+++| +.|+|++|++++ +|..+.++++|+.|+|++|+
T Consensus 716 ~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L-~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~----- 787 (876)
T 4ecn_A 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL-SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR----- 787 (876)
T ss_dssp SSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTC-CEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-----
T ss_pred HhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCc-CEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-----
Confidence 3322 26666666666666 5555554 55555 556666666654 45555555666666655544
Q ss_pred cccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCC
Q 001908 508 PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFS 586 (997)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~ 586 (997)
++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+.. ....
T Consensus 788 -------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~ 851 (876)
T 4ecn_A 788 -------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYI 851 (876)
T ss_dssp -------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHH
T ss_pred -------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccc
Confidence 3345777778888888888888888888888 57777765 57888888888876544322 0111
Q ss_pred CCcceeecCCCCcC
Q 001908 587 NKTRVQLTGNGKLC 600 (997)
Q Consensus 587 ~~~~~~~~~N~~~C 600 (997)
......+.+|++.|
T Consensus 852 ~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 852 EAGMYVLLYDKTQD 865 (876)
T ss_dssp HTTCCEEECCTTSE
T ss_pred cchheeecCCCccc
Confidence 23445666666544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=553.07 Aligned_cols=513 Identities=21% Similarity=0.229 Sum_probs=372.3
Q ss_pred CcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhc
Q 001908 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVA 153 (997)
Q Consensus 74 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l 153 (997)
..++.|||++|.+++..|..++++++|++|+|++|++++..|.+|+++++|++|+|++|.+++..|..++++++|++|++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 46777777777777766777777777777777777777777777777777777887777777777777777777777777
Q ss_pred ccccccccccccccccccccceeecccccccCc-CcCccCcchhhhhhccCccccccCCCcccCCCccc--eeeccCCCC
Q 001908 154 YRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM-LPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLE--NILLDVNGF 230 (997)
Q Consensus 154 ~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~--~L~L~~N~l 230 (997)
++|++.+.-|..+ ..+++|++|+|++|++++. +|..++.-++.+|++++|++++..|..++++++|+ .|++++|++
T Consensus 113 ~~n~i~~l~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 113 IQTGISSIDFIPL-HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp TTSCCSCGGGSCC-TTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred cccCcccCCcchh-ccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 7777775334443 3567777777777777763 34444422455677777777766666677777777 677777777
Q ss_pred CCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCC-----CcccccccccC--ccCeeEccCccC
Q 001908 231 TGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFT-----GKVSIIFGRLK--NLWSLDLGINNL 303 (997)
Q Consensus 231 ~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~--~L~~L~Ls~N~l 303 (997)
++..|.. + ...+|+.|++++|. .++..+..+.++....+..+.+. ...+..|.++. +|++|++++|++
T Consensus 192 ~~~~~~~-~-~~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l 266 (606)
T 3t6q_A 192 AGIEPGA-F-DSAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF 266 (606)
T ss_dssp CEECTTT-T-TTCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCC
T ss_pred CccChhH-h-hhccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCcc
Confidence 7544433 3 23567777777665 23333333433333333222222 22233444444 677888888888
Q ss_pred CCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCC
Q 001908 304 GSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLT 383 (997)
Q Consensus 304 ~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 383 (997)
+.+++. .+..+++|++|++++|+++ .+|..+..+ ++|+.|++++|.+++..|..+.++++|++|++++|.+.
T Consensus 267 ~~~~~~------~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~ 338 (606)
T 3t6q_A 267 FNISSN------TFHCFSGLQELDLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338 (606)
T ss_dssp SSCCTT------TTTTCTTCSEEECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSC
T ss_pred CccCHH------HhccccCCCEEeccCCccC-CCChhhccc-ccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcc
Confidence 766543 3567778888888888887 667777666 67888888888888777778888888888888888887
Q ss_pred CCCCCC-cccccccceeccccccccccc--hhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc
Q 001908 384 GNIPRE-IGQLRNLQAIGLSSNFLQGNI--PSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ 460 (997)
Q Consensus 384 ~~~p~~-~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 460 (997)
+.+|.. +.++++|++|++++|++++.. |..+..+++|+.|++++|++++..|..|..+++|++|++++|++.+..|.
T Consensus 339 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 418 (606)
T 3t6q_A 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418 (606)
T ss_dssp CBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTC
T ss_pred cccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccc
Confidence 666544 778888888888888888665 67788888888888888888877788888888888888888888776655
Q ss_pred c-cccccccccccccCCCcccCCCccccccccccceecccccccccc---ccccccCCcCccEEEccCccccccCChhcc
Q 001908 461 Q-ILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE---IPVTLTGCTGLEIFHMQGNSFRGSIPLSLR 536 (997)
Q Consensus 461 ~-~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 536 (997)
. +..++++ +.|++++|.+++..|..+..+++|++|++++|++++. .+..+..+++|+.|++++|++++.+|..|.
T Consensus 419 ~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 497 (606)
T 3t6q_A 419 SPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497 (606)
T ss_dssp CTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTT
T ss_pred hhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhc
Confidence 4 6677777 8888888888877788888888888888888888762 235678888888888888888877788888
Q ss_pred ccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCcCCC
Q 001908 537 SLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 537 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~C~~ 602 (997)
.+++|+.|+|++|++++.+|..+..++.| +|+|++|++++.+|.. ..++.++.+++.+|||.|.|
T Consensus 498 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp TCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred cccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 88888888888888888888888888888 8888888888777654 45667788888888888865
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=570.24 Aligned_cols=518 Identities=20% Similarity=0.234 Sum_probs=448.8
Q ss_pred CeeeeeeecCCCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCC-CccCCCCCCCeEEEccCCCccccCCc
Q 001908 62 CQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEI-PKEIGFLFRLETLMLANNSFSGKIPT 140 (997)
Q Consensus 62 c~w~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~iP~ 140 (997)
|.|..|-+ ...+++.|||++|.+++..|..+.++++|++|||++|.+.+.+ |.+|+++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56888877 4578999999999999988999999999999999999888788 78899999999999999999988899
Q ss_pred cccCCCcccchhccccccccccccc-ccccccccceeecccccccCcCc-CccCcch-hhhhhccCccccccCCCcccCC
Q 001908 141 NLSSCSNLLSFVAYRNNLVGEIPED-IGYSWLKLEHISLARNHLTGMLP-ASIGNLS-IIYLHVGENQFSGTVPPSLYNM 217 (997)
Q Consensus 141 ~l~~l~~L~~l~l~~n~~~g~ip~~-~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l 217 (997)
.++++++|++|++++|++.+.+|.. .+..+++|++|+|++|.+++..| ..|++++ +.+|++++|++++..|..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999987765 34578999999999999998765 5788884 6689999999999999999988
Q ss_pred --CccceeeccCCCCCCCCCccccccCC------CccEEEecCCcCcCCCCCCCCCC---CCCcEEecc---------Cc
Q 001908 218 --SSLENILLDVNGFTGNLPLDIGVTLP------NLQVFAIGDNYFSGSIPESFSNA---SNIEIIDLP---------IN 277 (997)
Q Consensus 218 --~~L~~L~L~~N~l~g~lp~~~~~~l~------~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls---------~N 277 (997)
++|+.|+|+.|.+++.+|..++ .++ .|+.|++++|.+++.+|..+... ++++.|+++ .|
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred cCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 8999999999999998887754 333 39999999999999998877654 678888877 34
Q ss_pred cCCCccccccccc--CccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccC
Q 001908 278 YFTGKVSIIFGRL--KNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGV 355 (997)
Q Consensus 278 ~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~ 355 (997)
.+.+.....|.++ ++|+.|+|++|.+..+.+ ..+..+++|++|+|++|++++..|..|..+ ++|+.|++++
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~ 323 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS------RVFETLKDLKVLNLAYNKINKIADEAFYGL-DNLQVLNLSY 323 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS------CCSSSCCCCCEEEEESCCCCEECTTTTTTC-SSCCEEEEES
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccCh------hhhhcCCCCCEEECCCCcCCCCChHHhcCC-CCCCEEECCC
Confidence 5555556667665 789999999999987543 356789999999999999999889888887 6899999999
Q ss_pred cccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCC
Q 001908 356 NQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435 (997)
Q Consensus 356 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 435 (997)
|.+++..|..|.++++|++|++++|++++..+..|.++++|++|+|++|.+++ ++ .+++|+.|++++|+++ .+|
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~-~l~ 397 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLV-TLP 397 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCC-CCC
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCcc-ccc
Confidence 99998889999999999999999999998888899999999999999999984 33 3889999999999999 566
Q ss_pred CCCCCCCCCcEEecCCCcccCCc-ccccccccccccccccCCCcccCCCcc-ccccccccceecccccccc-----cccc
Q 001908 436 PSLGNCKNLVSLNLSDNKLIGAV-PQQILTITTLSRFLDLGNNHLNGSLPL-EVGNLKNLVALYISGNQFS-----GEIP 508 (997)
Q Consensus 436 ~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~ll~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p 508 (997)
.. ..+++.|++++|++++.- +..+..++++ +.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|
T Consensus 398 ~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~ 473 (844)
T 3j0a_A 398 KI---NLTANLIHLSENRLENLDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473 (844)
T ss_dssp CC---CTTCCEEECCSCCCCSSTTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCS
T ss_pred cc---ccccceeecccCccccCchhhhhhcCCcc-ceeeCCCCcccccccccccccCCccccccCCCCccccccccccch
Confidence 54 467999999999998532 2334578888 9999999999965543 4567899999999999997 4455
Q ss_pred ccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCC
Q 001908 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNK 588 (997)
Q Consensus 509 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~ 588 (997)
..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|.. +.++
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L 549 (844)
T 3j0a_A 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSL 549 (844)
T ss_dssp SCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSC
T ss_pred hhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCc
Confidence 6789999999999999999999999999999999999999999987777776 89999999999999998865 7789
Q ss_pred cceeecCCCCcCCCC
Q 001908 589 TRVQLTGNGKLCGGS 603 (997)
Q Consensus 589 ~~~~~~~N~~~C~~~ 603 (997)
..+++.||||.|+|.
T Consensus 550 ~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 550 SVLDITHNKFICECE 564 (844)
T ss_dssp CEEEEEEECCCCSSS
T ss_pred CEEEecCCCcccccc
Confidence 999999999999774
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=549.24 Aligned_cols=507 Identities=18% Similarity=0.201 Sum_probs=432.2
Q ss_pred EeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccc
Q 001908 79 LDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNL 158 (997)
Q Consensus 79 L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~ 158 (997)
+|.++.+++ .+|..+.. .+++|||++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|++
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 444555554 56766654 789999999999988899999999999999999999988899999999999999999999
Q ss_pred cccccccccccccccceeecccccccCcCcCccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCcc
Q 001908 159 VGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLD 237 (997)
Q Consensus 159 ~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~ 237 (997)
.+..|..+. .+++|++|+|++|++++..|..++++. +.+|++++|++++.-++.+..+++|++|+|++|++++ ++..
T Consensus 94 ~~~~~~~~~-~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~ 171 (606)
T 3t6q_A 94 IFMAETALS-GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKE 171 (606)
T ss_dssp SEECTTTTS-SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE-ECHH
T ss_pred cccChhhhc-ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc-cChh
Confidence 977777665 689999999999999987788888884 6679999999987444445558999999999999984 4444
Q ss_pred ccccCCCcc--EEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhh
Q 001908 238 IGVTLPNLQ--VFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVT 315 (997)
Q Consensus 238 ~~~~l~~L~--~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 315 (997)
.+..+++|+ .|++++|.+++..|..|.. .+|+.|++++|. ..+..+..+.++....+..+.+.......+. ..
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~-~~ 246 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS-PA 246 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCC-GG
T ss_pred hhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccC-hh
Confidence 445788888 8899999999877777655 589999999887 4566677777777666665555443322221 12
Q ss_pred hhccCC--CCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccc
Q 001908 316 ILTNCS--KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQL 393 (997)
Q Consensus 316 ~l~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 393 (997)
.+..+. +|+.|++++|.+++..+..|..+ ++|+.|++++|+++ .+|..+.++++|++|++++|++++..|..+.++
T Consensus 247 ~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 324 (606)
T 3t6q_A 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCF-SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324 (606)
T ss_dssp GGGGGGGSEEEEEECTTCCCSSCCTTTTTTC-TTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGC
T ss_pred HhchhhcCceeEEEeecCccCccCHHHhccc-cCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhcc
Confidence 333333 79999999999998888888887 78999999999999 789999999999999999999999889999999
Q ss_pred cccceeccccccccccchh-hhcCCCCCCeEEeecCcCCCCC--CCCCCCCCCCcEEecCCCcccCCccccccccccccc
Q 001908 394 RNLQAIGLSSNFLQGNIPS-SLGNLTLMTDLFLSSNHLQGNI--PPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSR 470 (997)
Q Consensus 394 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~ 470 (997)
++|++|++++|.+.+.+|. .+..+++|+.|++++|++++.. |..+.++++|++|++++|++.+..|..+..++++ +
T Consensus 325 ~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~ 403 (606)
T 3t6q_A 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL-E 403 (606)
T ss_dssp TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTC-S
T ss_pred CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccC-C
Confidence 9999999999999977765 4999999999999999999766 8889999999999999999998889999999998 9
Q ss_pred ccccCCCcccCCCccc-cccccccceeccccccccccccccccCCcCccEEEccCcccccc---CChhccccCcCCeeeC
Q 001908 471 FLDLGNNHLNGSLPLE-VGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGS---IPLSLRSLKSIKELDL 546 (997)
Q Consensus 471 ~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L 546 (997)
.|++++|++++..|.. +..+++|+.|++++|.+++..|..+.++++|++|++++|++++. .+..+..+++|+.|+|
T Consensus 404 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~L 483 (606)
T 3t6q_A 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483 (606)
T ss_dssp EEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEEC
T ss_pred eEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEEC
Confidence 9999999999877654 89999999999999999999999999999999999999999873 3467999999999999
Q ss_pred ccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCc
Q 001908 547 SCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKL 599 (997)
Q Consensus 547 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~ 599 (997)
++|++++.+|..|..+++|++|+|++|++++.+|.. ..+..+ .+++.+|...
T Consensus 484 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~ 536 (606)
T 3t6q_A 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536 (606)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCC
T ss_pred CCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccc
Confidence 999999999999999999999999999999988754 556677 8888999654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=547.01 Aligned_cols=524 Identities=18% Similarity=0.197 Sum_probs=379.7
Q ss_pred CCCeee----eeeecCC---------CCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeE
Q 001908 60 NLCQWA----GVTCGHR---------HQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLET 126 (997)
Q Consensus 60 ~~c~w~----gv~C~~~---------~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 126 (997)
+.|.|. .|.|... ..+++.|+|++|.+.+..+..++++++|++|||++|++++..|.+|+++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 456663 4667531 356888888888887777778888888888888888888777778888888888
Q ss_pred EEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccccccC-cCcCccCcch-hhhhhccCc
Q 001908 127 LMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTG-MLPASIGNLS-IIYLHVGEN 204 (997)
Q Consensus 127 L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~-~~~L~l~~N 204 (997)
|+|++|.+++..|..|+++++|++|++++|++.+..|..+ ..+++|++|+|++|.+++ .+|..+++++ +.+|++++|
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI-GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCC-TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCcccccccccc-CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 8888888887778888888888888888888775444544 457788888888888875 5688787774 556888888
Q ss_pred cccccCCCcccCCCccc----eeeccCCCCCCCCCccccccCCCccEEEecCCcCc-CCCCCCCCCCCCCcEEeccCccC
Q 001908 205 QFSGTVPPSLYNMSSLE----NILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFS-GSIPESFSNASNIEIIDLPINYF 279 (997)
Q Consensus 205 ~l~g~ip~~l~~l~~L~----~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l 279 (997)
++++..|..++.+++|+ +|++++|.++ .+|...+... +|+.|++++|.++ +.+|..+.++++|+.+++..+.+
T Consensus 164 ~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~ 241 (606)
T 3vq2_A 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241 (606)
T ss_dssp CCCEECTTTTHHHHHCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECC
T ss_pred cceecChhhhhhhhccccccceeeccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccc
Confidence 88877777777777665 6888888887 5666665433 7888888888776 45666777777777777755444
Q ss_pred CCc------ccccccccCc--cCeeEc-cCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCccccccccccccc
Q 001908 280 TGK------VSIIFGRLKN--LWSLDL-GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTD 350 (997)
Q Consensus 280 ~~~------~~~~~~~l~~--L~~L~L-s~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~ 350 (997)
.+. .+..+.++.. ++.+++ ..|.+... .+ .+..+++|+.|++++|.+.. +| .+..+ ++|+.
T Consensus 242 ~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~------~~-~~~~l~~L~~L~l~~~~~~~-l~-~l~~~-~~L~~ 311 (606)
T 3vq2_A 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD------IV-KFHCLANVSAMSLAGVSIKY-LE-DVPKH-FKWQS 311 (606)
T ss_dssp TTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGG------GG-SCGGGTTCSEEEEESCCCCC-CC-CCCTT-CCCSE
T ss_pred ccCCcccccChHHhhhhhhccHhheecccccccccc------cc-ccccCCCCCEEEecCccchh-hh-hcccc-ccCCE
Confidence 321 1222222222 333444 34444331 22 26677778888888888763 44 55555 56788
Q ss_pred ccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccccccccc--chhhhcCCCCCCeEEeecC
Q 001908 351 IYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGN--IPSSLGNLTLMTDLFLSSN 428 (997)
Q Consensus 351 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N 428 (997)
|++++|.+ +.+| .+ .+++|+.|++++|+..+.+ .+..+++|++|+|++|++++. +|..+..+++|+.|+|++|
T Consensus 312 L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n 386 (606)
T 3vq2_A 312 LSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386 (606)
T ss_dssp EEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSC
T ss_pred EEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCC
Confidence 88888888 5677 44 7788888888888655433 566778888888888888765 3777788888888888888
Q ss_pred cCCCCCCCCCCCCCCCcEEecCCCcccCCcc-cccccccccccccccCCCcccCCCccccccccccceeccccccccc-c
Q 001908 429 HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVP-QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG-E 506 (997)
Q Consensus 429 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~ 506 (997)
.+++ +|..|..+++|++|++++|++.+..| ..+..++++ +.|++++|++++..|..+.++++|++|++++|++++ .
T Consensus 387 ~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 464 (606)
T 3vq2_A 387 GAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464 (606)
T ss_dssp SEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred cccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcc
Confidence 8774 56777888888888888888877666 567777777 788888888887778888888888888888888876 3
Q ss_pred ccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCC
Q 001908 507 IPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFS 586 (997)
Q Consensus 507 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~ 586 (997)
+|..|..+++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+..+++|++|+|++|+++..++....++
T Consensus 465 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~ 544 (606)
T 3vq2_A 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544 (606)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSC
T ss_pred hHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhc
Confidence 67778888888888888888887777788888888888888888887778888888888888888888875444334454
Q ss_pred -CCcceeecCCCCcCCCC
Q 001908 587 -NKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 587 -~~~~~~~~~N~~~C~~~ 603 (997)
+++.+++.+|||.|+|.
T Consensus 545 ~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 545 KSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTCCEEECCSCCCCCSST
T ss_pred ccCcEEEccCCCcccCCc
Confidence 47778888888888764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=541.00 Aligned_cols=499 Identities=19% Similarity=0.220 Sum_probs=386.2
Q ss_pred cEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcc
Q 001908 75 RVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAY 154 (997)
Q Consensus 75 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~ 154 (997)
+++.|+|++|.+++..+.+++++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|+++
T Consensus 74 ~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 153 (680)
T 1ziw_A 74 MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECC
T ss_pred CcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEcc
Confidence 45666666666654333356666666666666666665555566666666666666666666666666666666666666
Q ss_pred ccccccccccccc-ccccccceeecccccccCcCcCccCcc----------------------------hhhhhhccCcc
Q 001908 155 RNNLVGEIPEDIG-YSWLKLEHISLARNHLTGMLPASIGNL----------------------------SIIYLHVGENQ 205 (997)
Q Consensus 155 ~n~~~g~ip~~~~-~~l~~L~~L~L~~N~l~g~~p~~~~~l----------------------------~~~~L~l~~N~ 205 (997)
+|++.+..|..+. ..+++|++|++++|.+++..|..++.+ ++.+|++++|+
T Consensus 154 ~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~ 233 (680)
T 1ziw_A 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233 (680)
T ss_dssp SSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSC
T ss_pred CCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCc
Confidence 6666655444432 134566677777776666666554432 13345666777
Q ss_pred ccccCCCcccCCCc--cceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCc-
Q 001908 206 FSGTVPPSLYNMSS--LENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGK- 282 (997)
Q Consensus 206 l~g~ip~~l~~l~~--L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~- 282 (997)
+++..|..+.+++. |++|+|++|++++..|.. +..+++|++|++++|++++..|..|.++++|++|+|++|...+.
T Consensus 234 l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~ 312 (680)
T 1ziw_A 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS-FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312 (680)
T ss_dssp CCEECTTTTGGGGGSCCCEEECTTSCCCEECTTT-TTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC--
T ss_pred ccccChhHhhccCcCCCCEEECCCCCcCccCccc-ccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccc
Confidence 77666777776654 777777777777444433 34677777777777777777777777777777777777655432
Q ss_pred ----cc----ccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCC--cccccccc-cccccc
Q 001908 283 ----VS----IIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVL--PHSIANLS-TTMTDI 351 (997)
Q Consensus 283 ----~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~-~~L~~L 351 (997)
+| ..|+.+++|++|++++|+++.+.+ ..+.++++|++|++++|.+.... +..+..+. ..|+.|
T Consensus 313 ~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L 386 (680)
T 1ziw_A 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS------NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386 (680)
T ss_dssp ----CCEECTTTTTTCTTCCEEECCSCCBCCCCT------TTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEE
T ss_pred ccccccccChhhcccCCCCCEEECCCCccCCCCh------hHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceE
Confidence 22 267788888999999998887654 35678999999999999865332 22333322 479999
Q ss_pred cccCcccccccCCCCCCCCCCCEEeccCCCCCCCCC-CCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcC
Q 001908 352 YMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIP-REIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHL 430 (997)
Q Consensus 352 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 430 (997)
++++|++++..|.+|.++++|++|+|++|++++.+| ..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+
T Consensus 387 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l 466 (680)
T 1ziw_A 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466 (680)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCC
T ss_pred ECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccc
Confidence 999999999999999999999999999999998766 6899999999999999999999999999999999999999999
Q ss_pred C--CCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCc--------cccccccccceecccc
Q 001908 431 Q--GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLP--------LEVGNLKNLVALYISG 500 (997)
Q Consensus 431 ~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~ 500 (997)
+ +.+|..|.++++|++|+|++|++++..|..+..++++ ++|+|++|++++..+ ..|.++++|+.|+|++
T Consensus 467 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 545 (680)
T 1ziw_A 467 KNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545 (680)
T ss_dssp BCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCS
T ss_pred cccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCC
Confidence 7 5789999999999999999999997777788899998 999999999986422 2478999999999999
Q ss_pred ccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhcc-CCCCCCEEeCCCCcCcccC
Q 001908 501 NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLE-NLSFLEYLNLSYNHFDGEV 579 (997)
Q Consensus 501 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~ 579 (997)
|+++...+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..|..+. .+++|+.|++++|++.+.+
T Consensus 546 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred CCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 999954455799999999999999999977777889999999999999999998888887 7899999999999999988
Q ss_pred CC
Q 001908 580 PT 581 (997)
Q Consensus 580 p~ 581 (997)
+.
T Consensus 626 ~~ 627 (680)
T 1ziw_A 626 ES 627 (680)
T ss_dssp CC
T ss_pred cc
Confidence 75
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=536.48 Aligned_cols=505 Identities=18% Similarity=0.155 Sum_probs=439.0
Q ss_pred EEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccc
Q 001908 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRN 156 (997)
Q Consensus 77 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n 156 (997)
+.++.++++++ .+|..+. ++|++|||++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 46899999985 5777665 89999999999999888889999999999999999999877889999999999999999
Q ss_pred cccccccccccccccccceeecccccccCcCcCccCcch-hhhhhccCccccc-cCCCcccCCCccceeeccCCCCCCCC
Q 001908 157 NLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSG-TVPPSLYNMSSLENILLDVNGFTGNL 234 (997)
Q Consensus 157 ~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g-~ip~~l~~l~~L~~L~L~~N~l~g~l 234 (997)
++.+..|..+. .+++|++|+|++|.+++..|..++++. +++|++++|++++ .+|..++++++|++|+|++|++++..
T Consensus 91 ~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 91 PIQSFSPGSFS-GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCCCCCTTSST-TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred cccccChhhcC-CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 99977777765 689999999999999988888899985 6789999999986 68999999999999999999999655
Q ss_pred CccccccCCCc----cEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCC-CcccccccccCccCeeEccCccCCCCCCC
Q 001908 235 PLDIGVTLPNL----QVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFT-GKVSIIFGRLKNLWSLDLGINNLGSGGAN 309 (997)
Q Consensus 235 p~~~~~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 309 (997)
|..+. .+++| +.|++++|.+++..+..+... +|++|+|++|.++ +..+..++.+++|+.+++..+.+.....-
T Consensus 170 ~~~~~-~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l 247 (606)
T 3vq2_A 170 VNDLQ-FLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247 (606)
T ss_dssp TTTTH-HHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCC
T ss_pred hhhhh-hhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcc
Confidence 55443 55554 489999999997766666665 8999999999998 56788899999999999987766542211
Q ss_pred ---CcchhhhhccCCCCcEEEe-ecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCC
Q 001908 310 ---DLDFVTILTNCSKLKVLAF-EENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN 385 (997)
Q Consensus 310 ---~~~~~~~l~~l~~L~~L~L-~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 385 (997)
....+..+..+ +++.+++ ..|.+.+.+|. +..+ ++|+.|++++|.++ .+| .+..+++|+.|++++|++ +.
T Consensus 248 ~~~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l-~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~ 321 (606)
T 3vq2_A 248 EIFEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCL-ANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQ 321 (606)
T ss_dssp SCCCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGG-TTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SS
T ss_pred cccChHHhhhhhhc-cHhheeccccccccccccc-cccC-CCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cc
Confidence 11122333333 5677888 78899988888 6666 78999999999997 566 899999999999999999 67
Q ss_pred CCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCC--CCCCCCCCCCCcEEecCCCcccCCcccccc
Q 001908 386 IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGN--IPPSLGNCKNLVSLNLSDNKLIGAVPQQIL 463 (997)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 463 (997)
+| .+ .+++|++|++++|+..+.+ .+..+++|++|++++|++++. +|..+..+++|++|++++|.++ .+|..+.
T Consensus 322 lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~ 396 (606)
T 3vq2_A 322 FP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFM 396 (606)
T ss_dssp CC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCT
T ss_pred cc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhcc
Confidence 88 55 9999999999999766544 688999999999999999876 4888999999999999999998 5788899
Q ss_pred cccccccccccCCCcccCCCc-cccccccccceeccccccccccccccccCCcCccEEEccCccccc-cCChhccccCcC
Q 001908 464 TITTLSRFLDLGNNHLNGSLP-LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG-SIPLSLRSLKSI 541 (997)
Q Consensus 464 ~l~~ll~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L 541 (997)
.++++ +.|++++|++++..| ..+..+++|++|++++|++++..|..+.++++|+.|++++|++++ .+|..++.+++|
T Consensus 397 ~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 475 (606)
T 3vq2_A 397 GLEEL-QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475 (606)
T ss_dssp TCTTC-CEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred CCCCC-CeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCC
Confidence 99998 999999999998888 689999999999999999999999999999999999999999998 479999999999
Q ss_pred CeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCc
Q 001908 542 KELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKL 599 (997)
Q Consensus 542 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~ 599 (997)
+.|+|++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++++.+++.+|..-
T Consensus 476 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 99999999999999999999999999999999999987754 66788999999999754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=532.68 Aligned_cols=488 Identities=20% Similarity=0.194 Sum_probs=427.8
Q ss_pred CCcEEEEeccCCCCCCcc-cccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCcc--ccCCCccc
Q 001908 73 HQRVTELDLRHQNIGGSL-SPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTN--LSSCSNLL 149 (997)
Q Consensus 73 ~~~v~~L~L~~~~l~g~~-~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~--l~~l~~L~ 149 (997)
-.+++.|||++|...+.+ |.++++|++|++|+|++|++++..|..|+++++|++|+|++|.+++.+|.. ++++++|+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 357999999999888888 668999999999999999999999999999999999999999999988876 99999999
Q ss_pred chhcccccccccccccccccccccceeecccccccCcCcCccCcc---hhhhhhccCccccccCCCcccCCCc------c
Q 001908 150 SFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL---SIIYLHVGENQFSGTVPPSLYNMSS------L 220 (997)
Q Consensus 150 ~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l---~~~~L~l~~N~l~g~ip~~l~~l~~------L 220 (997)
+|++++|++.+..|...+..+++|++|+|++|.+++..|..++.+ ++.+|++++|.+.+.+|..++++.+ |
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L 206 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCB
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCce
Confidence 999999999987776555679999999999999999999999876 4667999999999999998888776 9
Q ss_pred ceeeccCCCCCCCCCccccccC--CCccEEEecC---------CcCcCCCCCCCCCC--CCCcEEeccCccCCCcccccc
Q 001908 221 ENILLDVNGFTGNLPLDIGVTL--PNLQVFAIGD---------NYFSGSIPESFSNA--SNIEIIDLPINYFTGKVSIIF 287 (997)
Q Consensus 221 ~~L~L~~N~l~g~lp~~~~~~l--~~L~~L~L~~---------N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~~ 287 (997)
+.|+|++|.+++.+|..+...+ +.++.|.+++ |.+.+..+..|..+ ++|+.|+|++|.+++..+..|
T Consensus 207 ~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~ 286 (844)
T 3j0a_A 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286 (844)
T ss_dssp SEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS
T ss_pred eEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhh
Confidence 9999999999999998876543 5688888773 44555556667765 789999999999999999999
Q ss_pred cccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCC
Q 001908 288 GRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIG 367 (997)
Q Consensus 288 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~ 367 (997)
+.+++|++|+|++|+++.+.+ ..+.++++|++|+|++|++++..|..+..+ ++|+.|++++|+|++..+..|.
T Consensus 287 ~~l~~L~~L~L~~n~i~~~~~------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~ 359 (844)
T 3j0a_A 287 ETLKDLKVLNLAYNKINKIAD------EAFYGLDNLQVLNLSYNLLGELYSSNFYGL-PKVAYIDLQKNHIAIIQDQTFK 359 (844)
T ss_dssp SSCCCCCEEEEESCCCCEECT------TTTTTCSSCCEEEEESCCCSCCCSCSCSSC-TTCCEEECCSCCCCCCCSSCSC
T ss_pred hcCCCCCEEECCCCcCCCCCh------HHhcCCCCCCEEECCCCCCCccCHHHhcCC-CCCCEEECCCCCCCccChhhhc
Confidence 999999999999999987644 356789999999999999999999999988 6899999999999988889999
Q ss_pred CCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCC-CCCCCCCCCcE
Q 001908 368 NLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP-PSLGNCKNLVS 446 (997)
Q Consensus 368 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~ 446 (997)
++++|++|+|++|.+++. + .+++|+.|++++|+++ .+|.. ..+++.|++++|++++... ..+.++++|++
T Consensus 360 ~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~ 430 (844)
T 3j0a_A 360 FLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQI 430 (844)
T ss_dssp SCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCE
T ss_pred CCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccce
Confidence 999999999999999853 2 3789999999999999 56654 5689999999999996422 23568999999
Q ss_pred EecCCCcccCCccc-ccccccccccccccCCCccc-----CCCccccccccccceeccccccccccccccccCCcCccEE
Q 001908 447 LNLSDNKLIGAVPQ-QILTITTLSRFLDLGNNHLN-----GSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIF 520 (997)
Q Consensus 447 L~L~~N~l~~~~p~-~~~~l~~ll~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 520 (997)
|+|++|++++..+. .+..++++ +.|+|++|.++ +..|..|.++++|+.|+|++|++++..|..|.++++|+.|
T Consensus 431 L~Ls~N~l~~~~~~~~~~~~~~L-~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 509 (844)
T 3j0a_A 431 LILNQNRFSSCSGDQTPSENPSL-EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509 (844)
T ss_dssp EEEESCCCCCCCSSSSSCSCTTC-CBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEE
T ss_pred eeCCCCcccccccccccccCCcc-ccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhhee
Confidence 99999999865544 34456677 99999999997 4556778999999999999999999999999999999999
Q ss_pred EccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC
Q 001908 521 HMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 521 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 582 (997)
+|++|+|++..|..+. ++|+.|||++|+|++.+|..| .+|+.|++++|++.+.++..
T Consensus 510 ~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 510 SLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELS 566 (844)
T ss_dssp EEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCC
T ss_pred ECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccH
Confidence 9999999987777776 899999999999999999776 47899999999999988753
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=501.04 Aligned_cols=486 Identities=17% Similarity=0.192 Sum_probs=293.8
Q ss_pred CCeeeeeeecCCC-----------CcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEc
Q 001908 61 LCQWAGVTCGHRH-----------QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLML 129 (997)
Q Consensus 61 ~c~w~gv~C~~~~-----------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 129 (997)
.|.|.|| |+-.. .+++.|||++|.+++..|.+++++++|++|+|++|++++..|..|+.+++|++|||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4999998 86421 25666666666666655666666666666666666666666666666666666666
Q ss_pred cCCCccccCCccccCCCcccchhcccccccc-cccccccccccccceeecccccccCcCc-CccCcch-hhhhhccCccc
Q 001908 130 ANNSFSGKIPTNLSSCSNLLSFVAYRNNLVG-EIPEDIGYSWLKLEHISLARNHLTGMLP-ASIGNLS-IIYLHVGENQF 206 (997)
Q Consensus 130 s~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g-~ip~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~-~~~L~l~~N~l 206 (997)
++|.+++..|..++++++|++|++++|++.+ .+|..+. .+++|++|++++|.+.+.+| ..++.++ +.+|++++|++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP-NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCT-TCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhh-ccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 6666665544556666666666666666654 3444332 45666666666666444444 3555553 44566666666
Q ss_pred cccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCC--C-CCCCCCCCCcEEeccCccCCCcc
Q 001908 207 SGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSI--P-ESFSNASNIEIIDLPINYFTGKV 283 (997)
Q Consensus 207 ~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~L~~L~Ls~N~l~~~~ 283 (997)
++.+|..+.++++|++|+++.|.+. .+|..++..+++|++|++++|++++.. | .....+++|+.|++++|++++..
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred cccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 6666666666666666666666654 455555555666666666666666532 1 12334556666666666665543
Q ss_pred cc----cccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccc
Q 001908 284 SI----IFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQIS 359 (997)
Q Consensus 284 ~~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~ 359 (997)
+. .+..+++|+.|++++|.+..++.-.......+..+.+|+.|++.++.+..... +.
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~--~~----------------- 300 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL--FY----------------- 300 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG--SC-----------------
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhh--cc-----------------
Confidence 32 23445566666666665544322111111233445555555555554432100 00
Q ss_pred cccCCCCCCCCCCCEEeccCCCCCCCCCCCc-ccccccceeccccccccccchh---hhcCCCCCCeEEeecCcCCCCCC
Q 001908 360 GTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-GQLRNLQAIGLSSNFLQGNIPS---SLGNLTLMTDLFLSSNHLQGNIP 435 (997)
Q Consensus 360 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p 435 (997)
.++..+....+|+.|++++|+++ .+|..+ .++++|++|+|++|++++.+|. .++.+++|+.|+|++|++++..+
T Consensus 301 -~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 378 (549)
T 2z81_A 301 -DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK 378 (549)
T ss_dssp -CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHH
T ss_pred -cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccccccc
Confidence 01111122345666666666665 444444 3566666666666666655543 25566666666666666664322
Q ss_pred --CCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccC
Q 001908 436 --PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTG 513 (997)
Q Consensus 436 --~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 513 (997)
..+..+++|++|++++|+++ .+|..+..++++ ++|++++|+++ .+|..+ .++|++|+|++|++++.+ ..
T Consensus 379 ~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~ 449 (549)
T 2z81_A 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LF 449 (549)
T ss_dssp HHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CC
T ss_pred chhhhhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----cc
Confidence 34566666666666666665 566666666665 66666666665 333333 257788888888887543 46
Q ss_pred CcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCC
Q 001908 514 CTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 514 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
+++|++|+|++|+|+ .+|. ...+++|+.|||++|+|++.+|..+..+++|+.|++++|+++|.+|.
T Consensus 450 l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 450 LPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 778888888888887 5665 46678888888888888887777788888888888888888887774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=490.03 Aligned_cols=509 Identities=18% Similarity=0.193 Sum_probs=398.1
Q ss_pred CcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhc
Q 001908 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVA 153 (997)
Q Consensus 74 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l 153 (997)
.+++.|||++|++++..+.++.++++|++|||++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46788888888887777777888888888888888888766777888888888888888888666677888888888888
Q ss_pred ccccccccccccccccccccceeecccccccC-cCcCccCcch-hhhhhccCccccccCCCcccCCCcc----ceeeccC
Q 001908 154 YRNNLVGEIPEDIGYSWLKLEHISLARNHLTG-MLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSL----ENILLDV 227 (997)
Q Consensus 154 ~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L----~~L~L~~ 227 (997)
++|++.+ +|...+..+++|++|+|++|.+++ .+|..+++++ +++|++++|++++..|..++++++| +.|++++
T Consensus 108 ~~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 108 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp TTSCCCC-STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccc-CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 8887764 343223467788888888888776 4677777774 5567777777777667777777777 6777777
Q ss_pred CCCCCCCCccccccCCCccEEEecCCcCcC-CCCCCCCCCCCCcEEeccCccCC------CcccccccccCc--cCeeEc
Q 001908 228 NGFTGNLPLDIGVTLPNLQVFAIGDNYFSG-SIPESFSNASNIEIIDLPINYFT------GKVSIIFGRLKN--LWSLDL 298 (997)
Q Consensus 228 N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~------~~~~~~~~~l~~--L~~L~L 298 (997)
|.+++ ++...+... +|+.|++++|.... .+|..+..+++++.+++..+.+. ......|.++.+ ++.+++
T Consensus 187 n~l~~-~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 264 (570)
T 2z63_A 187 NPMNF-IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264 (570)
T ss_dssp CCCCE-ECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred CCcee-cCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence 77774 333344333 67777777775432 34455666666666665543322 222334444443 456666
Q ss_pred cCc-cCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEec
Q 001908 299 GIN-NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377 (997)
Q Consensus 299 s~N-~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 377 (997)
++| .+... .+..+..+++|++|++++|.++ .+|..+..+ .|+.|++++|.++ .+|. ..+++|+.|++
T Consensus 265 ~~~~~~~~~------~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l 332 (570)
T 2z63_A 265 AYLDYYLDD------IIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTF 332 (570)
T ss_dssp EETTEEESC------STTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEE
T ss_pred hcchhhhhh------chhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeC
Confidence 666 44332 2345678899999999999998 578777776 7999999999998 5565 57889999999
Q ss_pred cCCCCCCCCCCCcccccccceeccccccccccc--hhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCccc
Q 001908 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNI--PSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 378 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 455 (997)
++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|++++..+. +..+++|++|++++|.+.
T Consensus 333 ~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~ 409 (570)
T 2z63_A 333 TSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLK 409 (570)
T ss_dssp ESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEE
T ss_pred cCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccc
Confidence 99999877765 78999999999999998654 78899999999999999999965444 999999999999999998
Q ss_pred CCcc-cccccccccccccccCCCcccCCCccccccccccceecccccccc-ccccccccCCcCccEEEccCccccccCCh
Q 001908 456 GAVP-QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFS-GEIPVTLTGCTGLEIFHMQGNSFRGSIPL 533 (997)
Q Consensus 456 ~~~p-~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 533 (997)
+..| ..+..++++ ++|++++|++++..|..|.++++|++|++++|+++ +.+|..+..+++|+.|++++|++++..|.
T Consensus 410 ~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 488 (570)
T 2z63_A 410 QMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488 (570)
T ss_dssp SCTTSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred cccchhhhhcCCCC-CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChh
Confidence 7766 467788888 99999999999999999999999999999999998 68999999999999999999999998899
Q ss_pred hccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcC-C--CCcceeecCCCCcCCC
Q 001908 534 SLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVF-S--NKTRVQLTGNGKLCGG 602 (997)
Q Consensus 534 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-~--~~~~~~~~~N~~~C~~ 602 (997)
.|..+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+|....+ . .-....+.+.+ .|.+
T Consensus 489 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~ 559 (570)
T 2z63_A 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSG 559 (570)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTT
T ss_pred hhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCC
Confidence 9999999999999999999988889999999999999999999999875432 1 11123455555 7754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=492.17 Aligned_cols=514 Identities=17% Similarity=0.234 Sum_probs=416.0
Q ss_pred CCHHHHHHHHHHHHhcCCCCCCCCCCCCCCC----CCeeee-eeecCC--CCcEEEEeccCCCCCCcccccccCcccccc
Q 001908 30 TNETDRLALLAIKSQLHDPLGVTNSWNNSIN----LCQWAG-VTCGHR--HQRVTELDLRHQNIGGSLSPYVGNLSFLRY 102 (997)
Q Consensus 30 ~~~~~~~aLl~~k~~~~~~~~~~~sW~~~~~----~c~w~g-v~C~~~--~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~ 102 (997)
....+...-.++++-...-.+ .+|....+ .|.|.. ..|..= ...|+- + . -.+++.
T Consensus 24 ~~~~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C-~-----------~----~~~V~~ 85 (636)
T 4eco_A 24 RTAEYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL-N-----------S----NGRVTG 85 (636)
T ss_dssp CCCHHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTCCTTEEE-C-----------T----TCCEEE
T ss_pred hhhhHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccCCCCeEE-c-----------C----CCCEEE
Confidence 346666666777754433222 37874432 247963 222210 123431 1 0 046789
Q ss_pred ccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeeccccc
Q 001908 103 INLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNH 182 (997)
Q Consensus 103 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~ 182 (997)
|+|++|++.|.+|++|++|++|++|||++|.+.. -+.-++... ....+|... +.+|+ +++++|.
T Consensus 86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~-~~~~~~~~~-----------~~~~~~~~~---~~~l~-l~l~~~~ 149 (636)
T 4eco_A 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV-NERLFGPKG-----------ISANMSDEQ---KQKMR-MHYQKTF 149 (636)
T ss_dssp EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGG-TCCSBSTTS-----------BCTTCCHHH---HHHHH-THHHHHH
T ss_pred EEecCcccCCcCChHHhcCccceEEECcCCcccc-CCccccccc-----------cccCchHHH---HHHHH-hhHHHhh
Confidence 9999999999999999999999999999998741 111111110 011445444 45666 9999999
Q ss_pred ccCcCcCccCcc--hhhhhhccCccccccCCCcccCCCccceeecc--CCCCCCCCCccccccCCCccEEEecCCcCcCC
Q 001908 183 LTGMLPASIGNL--SIIYLHVGENQFSGTVPPSLYNMSSLENILLD--VNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGS 258 (997)
Q Consensus 183 l~g~~p~~~~~l--~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~--~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~ 258 (997)
+.+.+|..++.+ .+..+++....+.. .....++.+++. .|+++| ||..++ ++++|++|+|++|+++|.
T Consensus 150 l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~-~l~~L~~L~Ls~n~l~~~ 221 (636)
T 4eco_A 150 VDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVM-RLTKLRQFYMGNSPFVAE 221 (636)
T ss_dssp TCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGG
T ss_pred hccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHh-cccCCCEEECcCCccccc
Confidence 999999988865 23455655544431 223345555554 689998 999876 899999999999999996
Q ss_pred -----------------CCCCCC--CCCCCcEEeccCccCCCcccccccccCccCeeEccCcc-CCCCCCCCcchhhhhc
Q 001908 259 -----------------IPESFS--NASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINN-LGSGGANDLDFVTILT 318 (997)
Q Consensus 259 -----------------~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~~~l~ 318 (997)
+|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ ..+|..+.
T Consensus 222 ~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~-----~~lp~~~~ 296 (636)
T 4eco_A 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG-----EQLKDDWQ 296 (636)
T ss_dssp GBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCH-----HHHHHHHH
T ss_pred cccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcc-----ccchHHHH
Confidence 999999 99999999999999999999999999999999999998 763 02455566
Q ss_pred cC------CCCcEEEeecCccCCCCcc--cccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCc
Q 001908 319 NC------SKLKVLAFEENRLGGVLPH--SIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI 390 (997)
Q Consensus 319 ~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 390 (997)
.+ ++|++|++++|+++ .+|. .+.++ ++|+.|++++|+++|.+| .|+++++|++|+|++|+++ .+|..+
T Consensus 297 ~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l-~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l 372 (636)
T 4eco_A 297 ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKM-KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANF 372 (636)
T ss_dssp HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTC-TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTS
T ss_pred hhhccccCCCCCEEECCCCcCC-ccCchhhhccC-CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhh
Confidence 65 99999999999999 8888 88887 789999999999999999 9999999999999999999 889999
Q ss_pred ccccc-cceeccccccccccchhhhcCCC--CCCeEEeecCcCCCCCCCCCC-------CCCCCcEEecCCCcccCCccc
Q 001908 391 GQLRN-LQAIGLSSNFLQGNIPSSLGNLT--LMTDLFLSSNHLQGNIPPSLG-------NCKNLVSLNLSDNKLIGAVPQ 460 (997)
Q Consensus 391 ~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~ 460 (997)
.++++ |++|+|++|+++ .+|..+..++ +|+.|+|++|++++.+|..|. .+++|++|+|++|+++ .+|.
T Consensus 373 ~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~ 450 (636)
T 4eco_A 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPK 450 (636)
T ss_dssp EEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCT
T ss_pred hhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCH
Confidence 99999 999999999999 7899888765 899999999999999999998 8889999999999999 6777
Q ss_pred cccc-ccccccccccCCCcccCCCcccc-ccc-------cccceecccccccccccccccc--CCcCccEEEccCccccc
Q 001908 461 QILT-ITTLSRFLDLGNNHLNGSLPLEV-GNL-------KNLVALYISGNQFSGEIPVTLT--GCTGLEIFHMQGNSFRG 529 (997)
Q Consensus 461 ~~~~-l~~ll~~L~Ls~N~l~~~~p~~~-~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~ 529 (997)
.++. ++++ +.|+|++|+++ .+|..+ ..+ ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++
T Consensus 451 ~~~~~l~~L-~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ 527 (636)
T 4eco_A 451 ELFSTGSPL-SSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK 527 (636)
T ss_dssp HHHHTTCCC-SEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred HHHccCCCC-CEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC
Confidence 6654 7888 99999999999 566543 333 39999999999999 7888887 99999999999999997
Q ss_pred cCChhccccCcCCeeeC------ccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCC
Q 001908 530 SIPLSLRSLKSIKELDL------SCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 530 ~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~ 602 (997)
+|..+..+++|+.|+| ++|++.+.+|..+..+++|++|+|++|++ +.+|.. .++++..+++.+|++.|-.
T Consensus 528 -ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISID 603 (636)
T ss_dssp -CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred -cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcccc
Confidence 8999999999999999 56889999999999999999999999999 677765 3488999999999999854
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=482.68 Aligned_cols=504 Identities=19% Similarity=0.159 Sum_probs=424.9
Q ss_pred eccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhccccccc
Q 001908 80 DLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLV 159 (997)
Q Consensus 80 ~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~ 159 (997)
+-++.+++ .+|..+. +++++|||++|++++..|..|+++++|++|||++|++++..|..++++++|++|++++|++.
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~ 89 (570)
T 2z63_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (570)
T ss_dssp ECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC
Confidence 33444553 4666543 57999999999999888889999999999999999999777788999999999999999988
Q ss_pred ccccccccccccccceeecccccccCcCcCccCcch-hhhhhccCccccc-cCCCcccCCCccceeeccCCCCCCCCCcc
Q 001908 160 GEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSG-TVPPSLYNMSSLENILLDVNGFTGNLPLD 237 (997)
Q Consensus 160 g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g-~ip~~l~~l~~L~~L~L~~N~l~g~lp~~ 237 (997)
+..|.. +..+++|++|++++|++++..+..+++++ +++|++++|++++ .+|..++++++|++|++++|++++..|.
T Consensus 90 ~~~~~~-~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~- 167 (570)
T 2z63_A 90 SLALGA-FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT- 167 (570)
T ss_dssp EECTTT-TTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG-
T ss_pred ccCHhh-hcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH-
Confidence 544444 45689999999999999977666788884 6689999999987 5799999999999999999999854444
Q ss_pred ccccCCCc----cEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCC-cccccccccCccCeeEccCccCCC------C
Q 001908 238 IGVTLPNL----QVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTG-KVSIIFGRLKNLWSLDLGINNLGS------G 306 (997)
Q Consensus 238 ~~~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~------~ 306 (997)
.+..+++| +.|++++|.+++..|..|..+ +|+.|+|++|.... ..+..+..+++++.+.+..+.+.. +
T Consensus 168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~ 246 (570)
T 2z63_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246 (570)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEEC
T ss_pred HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhc
Confidence 34467777 889999999998888888776 79999999986553 346677788888877776544332 2
Q ss_pred CCCCcchhhhhccCCCCcEEEeecC-ccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCC
Q 001908 307 GANDLDFVTILTNCSKLKVLAFEEN-RLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN 385 (997)
Q Consensus 307 ~~~~~~~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 385 (997)
....+ ..+..+ .++.+++++| .+.+..|..+..+ ++|+.|++++|.++ .+|..+..+ +|+.|++++|+++ .
T Consensus 247 ~~~~~---~~l~~l-~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~ 318 (570)
T 2z63_A 247 DKSAL---EGLCNL-TIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-Q 318 (570)
T ss_dssp CTTTT---GGGGGS-EEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-S
T ss_pred chhhh---cccccc-chhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-c
Confidence 22111 122222 3678888888 8888889888887 78999999999998 688899999 9999999999999 5
Q ss_pred CCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCC--CCCCCCCCCCcEEecCCCcccCCcccccc
Q 001908 386 IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI--PPSLGNCKNLVSLNLSDNKLIGAVPQQIL 463 (997)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 463 (997)
+|. ..+++|++|++++|.+.+..+. ..+++|+.|++++|++++.. |..+.++++|++|++++|.+.+ +|..+.
T Consensus 319 l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~ 393 (570)
T 2z63_A 319 FPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393 (570)
T ss_dssp CCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEE
T ss_pred cCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-cccccc
Confidence 665 5789999999999999977665 78999999999999998654 6788899999999999999985 455588
Q ss_pred cccccccccccCCCcccCCCc-cccccccccceeccccccccccccccccCCcCccEEEccCcccc-ccCChhccccCcC
Q 001908 464 TITTLSRFLDLGNNHLNGSLP-LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR-GSIPLSLRSLKSI 541 (997)
Q Consensus 464 ~l~~ll~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L 541 (997)
.++++ +.|++++|++++..| ..+.++++|++|++++|++++..|..|.++++|+.|++++|+++ +.+|..+..+++|
T Consensus 394 ~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L 472 (570)
T 2z63_A 394 GLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472 (570)
T ss_dssp TCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred ccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCC
Confidence 89998 999999999998776 57899999999999999999999999999999999999999998 6799999999999
Q ss_pred CeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCcCCCC
Q 001908 542 KELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 542 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~C~~~ 603 (997)
+.|+|++|++++..|..+..+++|++|++++|++++.+|.. ..+++++.+++.+||+.|.++
T Consensus 473 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99999999999999999999999999999999999988764 677889999999999999763
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=481.13 Aligned_cols=490 Identities=17% Similarity=0.181 Sum_probs=387.3
Q ss_pred eecCCCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCc
Q 001908 68 TCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSN 147 (997)
Q Consensus 68 ~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~ 147 (997)
.|.. ..+ .|.++++++ .+|+.+. ++|++|||++|++++..|.+|+++++|++|+|++|++++..|..++++++
T Consensus 3 ~C~~--~~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDA--SGV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECT--TSE--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCC--Cce--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 5753 234 789999986 6777665 78999999999999888899999999999999999999877788888887
Q ss_pred ccchhcccccccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccC
Q 001908 148 LLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDV 227 (997)
Q Consensus 148 L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~ 227 (997)
|++|++++|++.+..|..++ .+++|++|+|++|.+++. .+|..++++++|++|+|++
T Consensus 76 L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~----------------------~~~~~~~~l~~L~~L~L~~ 132 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWFG-PLSSLKYLNLMGNPYQTL----------------------GVTSLFPNLTNLQTLRIGN 132 (549)
T ss_dssp CCEEECTTSCCCSCCHHHHT-TCTTCCEEECTTCCCSSS----------------------CSSCSCTTCTTCCEEEEEE
T ss_pred CCEEECCCCccCccCHHHhc-cCCCCcEEECCCCccccc----------------------chhhhhhccCCccEEECCC
Confidence 77666666665543333332 455555555555555431 3566778888888888888
Q ss_pred CCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCC
Q 001908 228 NGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGG 307 (997)
Q Consensus 228 N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 307 (997)
|++.+.+|...+..+++|++|++++|++++.+|..++.+++|++|+++.|.+.......+..+++|++|++++|+++...
T Consensus 133 n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 212 (549)
T 2z81_A 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212 (549)
T ss_dssp SSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCC
T ss_pred CccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccccc
Confidence 88666787666668888888888888888888888888999999999988887665555677888999999999888753
Q ss_pred CCCcchhhhhccCCCCcEEEeecCccCCCCccccccc---ccccccccccCccccccc------CCCCCCCCCCCEEecc
Q 001908 308 ANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANL---STTMTDIYMGVNQISGTI------PSGIGNLVNLNLLGIE 378 (997)
Q Consensus 308 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~~L~~L~l~~N~l~~~~------p~~~~~l~~L~~L~L~ 378 (997)
.... .....+++|+.|++++|.+++..+..+... ...++.+++++|.+.+.. ...+..+.+|+.|++.
T Consensus 213 ~~~~---~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~ 289 (549)
T 2z81_A 213 FSPL---PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289 (549)
T ss_dssp CCCC---SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEE
T ss_pred cccc---chhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccccccc
Confidence 2211 123457788899999998887655444321 256788888888887532 2346778899999999
Q ss_pred CCCCCCC-----CCCCcccccccceeccccccccccchhhh-cCCCCCCeEEeecCcCCCCCC---CCCCCCCCCcEEec
Q 001908 379 FNQLTGN-----IPREIGQLRNLQAIGLSSNFLQGNIPSSL-GNLTLMTDLFLSSNHLQGNIP---PSLGNCKNLVSLNL 449 (997)
Q Consensus 379 ~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L 449 (997)
++.+... ++..+..+.+|++|++++|+++ .+|..+ .++++|++|+|++|++++.+| ..++.+++|++|+|
T Consensus 290 ~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~L 368 (549)
T 2z81_A 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368 (549)
T ss_dssp SCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEEC
T ss_pred ccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEc
Confidence 9987642 1222344578999999999998 677666 689999999999999998664 45889999999999
Q ss_pred CCCcccCCcc--cccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccc
Q 001908 450 SDNKLIGAVP--QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSF 527 (997)
Q Consensus 450 ~~N~l~~~~p--~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 527 (997)
++|++++..+ ..+..++++ ++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+. ++|+.|+|++|++
T Consensus 369 s~N~l~~~~~~~~~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l 443 (549)
T 2z81_A 369 SQNHLRSMQKTGEILLTLKNL-TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNL 443 (549)
T ss_dssp TTSCCCCHHHHHHHGGGCTTC-CEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCC
T ss_pred cCCcccccccchhhhhcCCCC-CEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCCh
Confidence 9999985432 457888888 99999999999 78989999999999999999998 5555443 6899999999999
Q ss_pred cccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCcCCC
Q 001908 528 RGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 528 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~C~~ 602 (997)
++.+ ..+++|++|||++|+|+ .+|. ...+++|++|+|++|++++.+|.. ..+.+++.+++.+|||.|.+
T Consensus 444 ~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 444 DSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp SCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred hhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 9753 57899999999999998 6776 568999999999999999988863 67889999999999999975
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=499.13 Aligned_cols=462 Identities=17% Similarity=0.204 Sum_probs=300.8
Q ss_pred cccccccccccccCCCCCccCCCCCCCeEEEc-cCCCccccCCccccCC----Ccccchhcccc---ccccccccccccc
Q 001908 98 SFLRYINLATNNFHGEIPKEIGFLFRLETLML-ANNSFSGKIPTNLSSC----SNLLSFVAYRN---NLVGEIPEDIGYS 169 (997)
Q Consensus 98 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L-s~N~l~g~iP~~l~~l----~~L~~l~l~~n---~~~g~ip~~~~~~ 169 (997)
.+++.|+|++|++.|.+|++|++|++|++||| ++|.++|..|-..... +.++...+... .+....|.. .
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~---~ 399 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL---N 399 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGG---G
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcch---h
Confidence 57899999999999999999999999999999 9999999866442222 11100000000 000000000 0
Q ss_pred ccccceeecccccccCcCcCc-cCcchhhhh--hccCccccccCCCcccCCCccceeeccCCCCCCC-------------
Q 001908 170 WLKLEHISLARNHLTGMLPAS-IGNLSIIYL--HVGENQFSGTVPPSLYNMSSLENILLDVNGFTGN------------- 233 (997)
Q Consensus 170 l~~L~~L~L~~N~l~g~~p~~-~~~l~~~~L--~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~------------- 233 (997)
+..+....+..+. ...+.. ...+.+..+ ....|+++| ||+.|+++++|++|+|++|+|+|.
T Consensus 400 ~s~l~~~~l~~~~--~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~ 476 (876)
T 4ecn_A 400 LSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476 (876)
T ss_dssp SCHHHHHHHHTCT--TSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHH
T ss_pred hhHHHHHHhhhCc--cccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccccc
Confidence 0000000000010 011111 111223333 344599998 899999999999999999999972
Q ss_pred ----CCccc-cccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCcc-CCC-cccccccccCccCeeEccCccCCCC
Q 001908 234 ----LPLDI-GVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY-FTG-KVSIIFGRLKNLWSLDLGINNLGSG 306 (997)
Q Consensus 234 ----lp~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~ 306 (997)
+|..+ |.++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..|+.++
T Consensus 477 ~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~--------------- 541 (876)
T 4ecn_A 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA--------------- 541 (876)
T ss_dssp HHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHH---------------
T ss_pred ccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhh---------------
Confidence 55554 3355566666666666666666666666666666666665 555 4555444443
Q ss_pred CCCCcchhhhhccCCCCcEEEeecCccCCCCcc--cccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCC
Q 001908 307 GANDLDFVTILTNCSKLKVLAFEENRLGGVLPH--SIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTG 384 (997)
Q Consensus 307 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 384 (997)
..+..+++|++|+|++|+++ .+|. .+.++ ++|+.|++++|+++ .+| .|+++++|+.|+|++|+++
T Consensus 542 --------~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L-~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~- 608 (876)
T 4ecn_A 542 --------DDEDTGPKIQIFYMGYNNLE-EFPASASLQKM-VKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE- 608 (876)
T ss_dssp --------HCTTTTTTCCEEECCSSCCC-BCCCHHHHTTC-TTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-
T ss_pred --------hcccccCCccEEEeeCCcCC-ccCChhhhhcC-CCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-
Confidence 01122335555555555555 4555 55554 45555666666665 555 6666677777777777776
Q ss_pred CCCCCcccccc-cceeccccccccccchhhhcCCCC--CCeEEeecCcCCCCCCCCC---C--CCCCCcEEecCCCcccC
Q 001908 385 NIPREIGQLRN-LQAIGLSSNFLQGNIPSSLGNLTL--MTDLFLSSNHLQGNIPPSL---G--NCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 385 ~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~ 456 (997)
.+|..+.++++ |++|+|++|+|+ .+|..+..++. |+.|+|++|++++.+|... . .+++|+.|+|++|+++
T Consensus 609 ~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~- 686 (876)
T 4ecn_A 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ- 686 (876)
T ss_dssp CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-
T ss_pred cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-
Confidence 66666777766 777777777776 56666665543 7777777777766555322 2 2346777777777776
Q ss_pred Ccccccc-cccccccccccCCCcccCCCccccc--------cccccceecccccccccccccccc--CCcCccEEEccCc
Q 001908 457 AVPQQIL-TITTLSRFLDLGNNHLNGSLPLEVG--------NLKNLVALYISGNQFSGEIPVTLT--GCTGLEIFHMQGN 525 (997)
Q Consensus 457 ~~p~~~~-~l~~ll~~L~Ls~N~l~~~~p~~~~--------~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N 525 (997)
.+|..++ .++++ +.|+|++|+++ .+|..+. ++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|
T Consensus 687 ~lp~~~~~~l~~L-~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N 763 (876)
T 4ecn_A 687 KFPTELFATGSPI-STIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYN 763 (876)
T ss_dssp SCCHHHHHTTCCC-SEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSS
T ss_pred ccCHHHHccCCCC-CEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCC
Confidence 5665554 45565 67777777777 4454433 2348888888888888 7788776 8888888888888
Q ss_pred cccccCChhccccCcCCeeeCcc------ccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCc
Q 001908 526 SFRGSIPLSLRSLKSIKELDLSC------NNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKL 599 (997)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~ 599 (997)
+|++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|+|++|++ +.+|.. ..+++..+++.+|++.
T Consensus 764 ~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 764 CFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNI 840 (876)
T ss_dssp CCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTC
T ss_pred CCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCC
Confidence 8886 788888888888888866 889999999999999999999999999 788875 3478999999999986
Q ss_pred CC
Q 001908 600 CG 601 (997)
Q Consensus 600 C~ 601 (997)
.-
T Consensus 841 ~i 842 (876)
T 4ecn_A 841 SI 842 (876)
T ss_dssp EE
T ss_pred cc
Confidence 53
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=442.07 Aligned_cols=265 Identities=26% Similarity=0.427 Sum_probs=211.4
Q ss_pred hcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|.+.++||+|+||+||+|++. .++..||||+++.......+.|.+|+++|++++|||||+++++|.+ +
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence 57888999999999999999975 3578899999987777777899999999999999999999999753 4
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCC-------CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNG-------QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 826 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~ 826 (997)
+..++|||||++|+|.+++++... ......++|.++++|+.||++||+|||++ +|+||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 579999999999999999987531 11223589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT- 905 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt- 905 (997)
+++||+|||+|+...... .........||+.|||||++. +..|+.++|||||||++|||+|
T Consensus 165 ~~~Ki~DFGla~~~~~~~------~~~~~~~~~gt~~ymAPE~~~------------~~~~~~k~DVwS~Gvvl~Ellt~ 226 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTD------YYRVGGHTMLPIRWMPPESIM------------YRKFTTESDVWSLGVVLWEIFTY 226 (299)
T ss_dssp GCEEECCCSCHHHHTGGG------CEEETTTEEECGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CcEEECCcccceecCCCC------ceeecCceecChhhcCHHHHc------------CCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999998763211 112223456899999997765 4679999999999999999999
Q ss_pred CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 906 RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 906 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
|+.||.... ..+......... ..+.+..+++++.+++.+||+.||++||||+||.+.|
T Consensus 227 G~~Pf~~~~-----~~~~~~~i~~~~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 227 GKQPWYQLS-----NNEVIECITQGR-----------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp TCCTTTTSC-----HHHHHHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCC-----HHHHHHHHHcCC-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 899997432 122211111000 0111234567889999999999999999999999999
Q ss_pred HHHHHH
Q 001908 986 CAARQT 991 (997)
Q Consensus 986 ~~~~~~ 991 (997)
+++.++
T Consensus 285 ~~~~~~ 290 (299)
T 4asz_A 285 QNLAKA 290 (299)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 988764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=436.37 Aligned_cols=266 Identities=29% Similarity=0.431 Sum_probs=205.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+++++.++||+|+||+||+|+++. .||||+++.. .....+.|.+|++++++++|||||+++++|.. +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 3578889999999999999998752 5999999743 34556789999999999999999999998742 35
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++|||||++|+|.++++.... .+++.++++|+.||++||+|||++ +|+||||||+|||+++++++||+|||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred EEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence 7999999999999999986542 489999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+...... ........+||+.|||||++... ..+.|+.++|||||||++|||+||+.||.....
T Consensus 178 la~~~~~~~------~~~~~~~~~GT~~ymAPE~l~~~---------~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 178 LATVKSRWS------GSQQVEQPTGSVLWMAPEVIRMQ---------DNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp SCBC------------------CCCCTTSCCHHHHHCC---------SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CceecccCC------cceeecccccCCCccCHHHhhcc---------CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 998652211 11223446899999999887531 135689999999999999999999999974321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
......... . ....|... ..+.+++.++.+++.+||+.||++||||.||++.|+.+..++
T Consensus 243 ----~~~~~~~~~-~---~~~~p~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 243 ----RDQIIFMVG-R---GYASPDLS---------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ----HHHHHHHHH-T---TCCCCCST---------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ----HHHHHHHHh-c---CCCCCCcc---------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111111110 0 01111111 112245678899999999999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=443.66 Aligned_cols=265 Identities=26% Similarity=0.421 Sum_probs=207.0
Q ss_pred hcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|.+.++||+|+||+||+|+++ .+++.||||+++.......+.|.+|+++|++++|||||+++++|.. .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 46778899999999999999975 3578999999987777777899999999999999999999999753 4
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCC---------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQP---------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
+..++|||||++|+|.+++++..... ...+++|.++++|+.||++||+|||++ +|+||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 57999999999999999998754211 123589999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
+++++||+|||+|+...... .........||+.|||||++. +..|+.++|||||||++|||+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~------~~~~~~~~~gt~~ymAPE~~~------------~~~~~~~sDvwS~Gvvl~Ell 254 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTD------YYRVGGRTMLPIRWMPPESIL------------YRKFTTESDVWSFGVVLWEIF 254 (329)
T ss_dssp TTTEEEECCCC----------------------CCCCGGGCCHHHHT------------TCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCcEEEcccccceeccCCC------cceecCcccccccccChhhhc------------CCCCCccccccchHHHHHHHH
Confidence 99999999999998753221 112223457999999996654 578999999999999999999
Q ss_pred h-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 T-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
| |+.||.... ..+...... ... +.+.+..+++++.+++.+||+.||++||||+||++
T Consensus 255 t~G~~Pf~~~~-----~~~~~~~i~-----~g~------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 255 TYGKQPWYQLS-----NTEAIDCIT-----QGR------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp TTSCCTTCSSC-----HHHHHHHHH-----HTC------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCCCC-----HHHHHHHHH-----cCC------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9 899997432 112111110 000 11122345678899999999999999999999999
Q ss_pred HHHHHHHH
Q 001908 984 KLCAARQT 991 (997)
Q Consensus 984 ~L~~~~~~ 991 (997)
.|+++.+.
T Consensus 313 ~L~~l~~~ 320 (329)
T 4aoj_A 313 RLQALAQA 320 (329)
T ss_dssp HHHHHHHS
T ss_pred HHHHHhhC
Confidence 99998875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=475.21 Aligned_cols=463 Identities=18% Similarity=0.190 Sum_probs=342.5
Q ss_pred EEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccc
Q 001908 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRN 156 (997)
Q Consensus 77 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n 156 (997)
+.||+++|+++ .+|..+. ++|++|||++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999997 5887776 89999999999999877788999999999999999999877888998888888888877
Q ss_pred cccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCc
Q 001908 157 NLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPL 236 (997)
Q Consensus 157 ~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~ 236 (997)
++. .+|.. .+++|++|+|++|++++. .+|..++++++|++|+|++|++++
T Consensus 80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~----------------------~~p~~~~~l~~L~~L~L~~n~l~~---- 129 (520)
T 2z7x_B 80 KLV-KISCH---PTVNLKHLDLSFNAFDAL----------------------PICKEFGNMSQLKFLGLSTTHLEK---- 129 (520)
T ss_dssp CCC-EEECC---CCCCCSEEECCSSCCSSC----------------------CCCGGGGGCTTCCEEEEEESSCCG----
T ss_pred cee-ecCcc---ccCCccEEeccCCccccc----------------------cchhhhccCCcceEEEecCcccch----
Confidence 776 57765 466777777777776641 345666666777777777777664
Q ss_pred cccccCCCc--cEEEecCCcC--cCCCCCCCCCCC-CCcEEeccCccCCCccc-ccccccCccCeeEccCccCCCCCCCC
Q 001908 237 DIGVTLPNL--QVFAIGDNYF--SGSIPESFSNAS-NIEIIDLPINYFTGKVS-IIFGRLKNLWSLDLGINNLGSGGAND 310 (997)
Q Consensus 237 ~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~ 310 (997)
..+..+++| +.|++++|.+ ++..|..+..+. +...+++++|++.+.++ ..+..+++|+.|++++|.-.......
T Consensus 130 ~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 209 (520)
T 2z7x_B 130 SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF 209 (520)
T ss_dssp GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHH
T ss_pred hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccccccee
Confidence 123356666 7777777777 667777776665 34456777777766543 35667777777777777511000000
Q ss_pred cchhhhhccCCCCcEEEeecCccCCCCccccccc--ccccccccccCcccccccCCCC-----CCCCCCCEEeccCCCCC
Q 001908 311 LDFVTILTNCSKLKVLAFEENRLGGVLPHSIANL--STTMTDIYMGVNQISGTIPSGI-----GNLVNLNLLGIEFNQLT 383 (997)
Q Consensus 311 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~ 383 (997)
....+.+..+++|+.|++++|.+++..+..+... .++|+.|++++|+++|.+|..+ +++++|+.+++++|.+
T Consensus 210 ~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~- 288 (520)
T 2z7x_B 210 LSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF- 288 (520)
T ss_dssp HHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-
T ss_pred ecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-
Confidence 0123356777888888888887765433322210 1367777777787777777777 7888888888888888
Q ss_pred CCCC-CCcccc---cccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC--C
Q 001908 384 GNIP-REIGQL---RNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG--A 457 (997)
Q Consensus 384 ~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~ 457 (997)
.+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++ .
T Consensus 289 -~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 365 (520)
T 2z7x_B 289 -GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK 365 (520)
T ss_dssp -CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHH
T ss_pred -ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCcccc
Confidence 455 455554 56888888888887432 12678888888888888888888888888888888888888876 5
Q ss_pred cccccccccccccccccCCCcccCCCccc-cccccccceeccccccccccccccccCCcCccEEEccCccccccCChhcc
Q 001908 458 VPQQILTITTLSRFLDLGNNHLNGSLPLE-VGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLR 536 (997)
Q Consensus 458 ~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 536 (997)
+|..+..++++ ++|++++|++++.+|.. +..+++|+.|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+.
T Consensus 366 ~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~ 441 (520)
T 2z7x_B 366 IAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV 441 (520)
T ss_dssp HHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred chHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence 66777888887 88888888888756654 77888888888888888877777665 68888888888888 7787777
Q ss_pred ccCcCCeeeCccccccccCchh-ccCCCCCCEEeCCCCcCcccCCC
Q 001908 537 SLKSIKELDLSCNNLSGQIPEF-LENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 537 ~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
.+++|+.|+|++|+|++ +|.. +..+++|++|++++|++++.++.
T Consensus 442 ~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 442 KLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp GCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCCc
Confidence 88888888888888884 5554 88888888888888888877653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=436.67 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=206.8
Q ss_pred hcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.++++.++||+|+||+||+|++. .+++.||||+++... ....+.|.+|++++++++|||||+++|+|..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----- 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----- 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----
Confidence 35677889999999999999974 356899999997433 3345789999999999999999999999754
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQP----------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
++..++|||||++|+|.+++....... ....++|.++++|+.|||+||+|||++ +|+||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 457899999999999999997653211 123589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
+++++++||+|||+|+...... .........||+.|||||++. ++.|+.++|||||||++||
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~------~~~~~~~~~gt~~ymAPE~l~------------~~~~s~ksDVwSfGvvl~E 239 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAAD------YYKLLGNSLLPIRWMAPEAIM------------YGKFSIDSDIWSYGVVLWE 239 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGG------CBCSSSSSCBCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHH
T ss_pred ECCCCCEEECCcccceeccCCC------ceeEecccccCCcccCHHHHh------------CCCCCccchhhhHHHHHHH
Confidence 9999999999999998763221 112233457999999997665 4679999999999999999
Q ss_pred HHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 903 MFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 903 llt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
|+| |+.||.... ..+....... +...+.+.+|+.++.++|.+||+.||++||||+||
T Consensus 240 l~t~g~~Pf~~~~-----~~~~~~~i~~-----------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 240 VFSYGLQPYCGYS-----NQDVVEMIRN-----------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp HHTTTCCTTTTCC-----HHHHHHHHHT-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhCCCCCCCCCC-----HHHHHHHHHc-----------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999 899987432 1222111110 11112234567789999999999999999999999
Q ss_pred HHHHHH
Q 001908 982 LAKLCA 987 (997)
Q Consensus 982 l~~L~~ 987 (997)
++.|++
T Consensus 298 ~~~L~a 303 (308)
T 4gt4_A 298 HSRLRA 303 (308)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=422.43 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=198.9
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.++||+|+||+||+|+++.++..||+|++... .....+.+.+|++++++++|||||++++++... ...+...|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEE
Confidence 36677899999999999999999999999999633 344567899999999999999999999987542 233567899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCcEEEcccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLA 837 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFg~a 837 (997)
|||||++|+|.+++++.. .+++..++.++.||+.||+|||++. ++|+||||||+|||++. +|.+||+|||+|
T Consensus 107 vmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999998764 4889999999999999999999981 13999999999999984 899999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+.... ......+||+.|||||++. +.|+.++|||||||++|||+||+.||....
T Consensus 180 ~~~~~----------~~~~~~~GTp~YmAPE~~~-------------~~y~~~~DiwSlGvilyelltg~~Pf~~~~--- 233 (290)
T 3fpq_A 180 TLKRA----------SFAKAVIGTPEFMAPEMYE-------------EKYDESVDVYAFGMCMLEMATSEYPYSECQ--- 233 (290)
T ss_dssp GGCCT----------TSBEESCSSCCCCCGGGGG-------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS---
T ss_pred EeCCC----------CccCCcccCccccCHHHcC-------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---
Confidence 75311 1233468999999998663 358999999999999999999999996321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.......... ....|.. .+..+++++.+++.+||..||++|||++|+++
T Consensus 234 -~~~~~~~~i~-----~~~~~~~-----------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 234 -NAAQIYRRVT-----SGVKPAS-----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -SHHHHHHHHT-----TTCCCGG-----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cHHHHHHHHH-----cCCCCCC-----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222211111 1111110 01112346789999999999999999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=465.79 Aligned_cols=453 Identities=16% Similarity=0.160 Sum_probs=371.1
Q ss_pred ccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeeccc
Q 001908 101 RYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLAR 180 (997)
Q Consensus 101 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~ 180 (997)
++||+++|+++ .+|..+. ++|++|+|++|.+++..|..++++++|++|++++|++.+..|..+. .+++|++|+|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L-- 76 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK-FNQELEYLDL-- 76 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGT-TCTTCCEEEC--
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhh-cccCCCEEec--
Confidence 57899999999 7888777 8999999999999876667787777776555555555543333332 3444555554
Q ss_pred ccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCC-CCCccccccCCCccEEEecCCcCcCCC
Q 001908 181 NHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG-NLPLDIGVTLPNLQVFAIGDNYFSGSI 259 (997)
Q Consensus 181 N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g-~lp~~~~~~l~~L~~L~L~~N~l~~~~ 259 (997)
++|+++ .+|.. .+++|++|+|++|++++ .+|..++ .+++|++|++++|++++
T Consensus 77 ---------------------s~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~-~l~~L~~L~L~~n~l~~-- 129 (520)
T 2z7x_B 77 ---------------------SHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFG-NMSQLKFLGLSTTHLEK-- 129 (520)
T ss_dssp ---------------------CSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGG-GCTTCCEEEEEESSCCG--
T ss_pred ---------------------CCCcee-ecCcc--ccCCccEEeccCCccccccchhhhc-cCCcceEEEecCcccch--
Confidence 445444 46666 78999999999999996 5777765 89999999999999986
Q ss_pred CCCCCCCCCC--cEEeccCccC--CCcccccccccC-ccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCc--
Q 001908 260 PESFSNASNI--EIIDLPINYF--TGKVSIIFGRLK-NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENR-- 332 (997)
Q Consensus 260 p~~~~~l~~L--~~L~Ls~N~l--~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~-- 332 (997)
..+..+++| ++|+|++|++ ++..|..|..+. +...+++++|++..... ...+.++++|+.|++++|.
T Consensus 130 -~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~-----~~~~~~l~~L~~L~l~~n~~~ 203 (520)
T 2z7x_B 130 -SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL-----DVSVKTVANLELSNIKCVLED 203 (520)
T ss_dssp -GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCC-----CCCCTTCSEEEECCEEECCST
T ss_pred -hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhh-----hhhhhcccceeeccccccccc
Confidence 467778888 9999999999 888888888776 45567888888765322 2346789999999999998
Q ss_pred -----cCCCCcccccccccccccccccCcccccccCCCCC---CCCCCCEEeccCCCCCCCCCCCc-----cccccccee
Q 001908 333 -----LGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIG---NLVNLNLLGIEFNQLTGNIPREI-----GQLRNLQAI 399 (997)
Q Consensus 333 -----l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L 399 (997)
+.+.+| .+..+ +.|+.|++++|.+++..+..+. ..++|++|++++|+++|.+|..+ +++++|+.+
T Consensus 204 ~~~~~~~~~~~-~l~~l-~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l 281 (520)
T 2z7x_B 204 NKCSYFLSILA-KLQTN-PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281 (520)
T ss_dssp TTTHHHHHHHH-GGGGC-TTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEE
T ss_pred cccceeecchh-hhccc-cchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEec
Confidence 776666 66666 6899999999998865433221 24689999999999999999998 999999999
Q ss_pred ccccccccccch-hhhcCC---CCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccC
Q 001908 400 GLSSNFLQGNIP-SSLGNL---TLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLG 475 (997)
Q Consensus 400 ~Ls~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls 475 (997)
++++|.+ .+| ..+..+ ++|+.|++++|.+.... .+..+++|++|++++|++++.+|..+..++++ +.|+|+
T Consensus 282 ~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~ 356 (520)
T 2z7x_B 282 QVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTEL-ETLILQ 356 (520)
T ss_dssp EEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSC-CEEECC
T ss_pred cccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCC-CEEEcc
Confidence 9999999 455 566555 78999999999987432 23688999999999999999899999999999 999999
Q ss_pred CCcccC--CCccccccccccceecccccccccccccc-ccCCcCccEEEccCccccccCChhccccCcCCeeeCcccccc
Q 001908 476 NNHLNG--SLPLEVGNLKNLVALYISGNQFSGEIPVT-LTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552 (997)
Q Consensus 476 ~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (997)
+|++++ .+|..++.+++|++|++++|++++.+|.. +..+++|+.|++++|++++.+|..+. ++|+.|||++|+|+
T Consensus 357 ~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp SSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred CCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 999997 56788999999999999999999867764 88999999999999999988887775 79999999999999
Q ss_pred ccCchhccCCCCCCEEeCCCCcCcccCCC-CCcCCCCcceeecCCCCcCCC
Q 001908 553 GQIPEFLENLSFLEYLNLSYNHFDGEVPT-KGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 553 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~N~~~C~~ 602 (997)
.+|..+..+++|++|+|++|++++.++. ...++.+..+++.+||+.|.|
T Consensus 435 -~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp -CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred -ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence 7888888999999999999999965444 456788999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=424.58 Aligned_cols=282 Identities=23% Similarity=0.277 Sum_probs=206.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|...++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++++|...+ ......|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 5688889999999999999998 6899999999754322 122334566667889999999999986532 22346899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC-----QPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
|||||++|+|.++++... ++|..+.+++.|+++||+|||+++ .++|+||||||+|||++.++++||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~~-------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EecCCCCCcHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999999998754 889999999999999999999762 45899999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+....... .........+||+.|||||++..... .....++.++|||||||++|||+||.+||...
T Consensus 152 FGla~~~~~~~~----~~~~~~~~~~GT~~ymAPE~l~~~~~------~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 152 LGLAVRHDSATD----TIDIAPNHRVGTKRYMAPEVLDDSIN------MKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTCEEEETTTT----EESCC-----CCGGGCCHHHHTTCSC------TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCCCccccCCCC----ceeeecccccccccccCHHHhccccc------ccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 999987632211 11122334679999999988863210 11235788999999999999999998877533
Q ss_pred cCCC----------ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGG----------LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~----------~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ....+....... ...+|.+... ....+++..+.+++.+||+.||++||||.||++
T Consensus 222 ~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~rp~~p~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 222 EDYQLPYYDLVPSDPSVEEMRKVVCE----QKLRPNIPNR-------WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTT----SCCCCCCCGG-------GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccccchhcccccchHHHHHHHHhc----ccCCCCCCcc-------ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 2211 112222111111 1112222111 112356778899999999999999999999999
Q ss_pred HHHHHHHHh
Q 001908 984 KLCAARQTL 992 (997)
Q Consensus 984 ~L~~~~~~~ 992 (997)
.|+++.++-
T Consensus 291 ~L~~l~~~~ 299 (303)
T 3hmm_A 291 TLSQLSQQE 299 (303)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHHHc
Confidence 999988754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=429.86 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=204.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+.|+..++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++. +++..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 46889999999999999999999999999999997655555677899999999999999999999954 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|||||++|+|.+++.... +++.++..++.||+.||+|||++ +|+||||||+|||++.+|++||+|||+|+
T Consensus 149 vmEy~~gg~L~~~l~~~~-------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EECCCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 999999999999998643 88999999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.+... .......+||+.|||||++. +..|+.++||||+||++|||++|++||...
T Consensus 219 ~~~~~--------~~~~~~~~GTp~YmAPEvl~------------~~~y~~~~DiWSlGvilyeml~G~~PF~~~----- 273 (346)
T 4fih_A 219 QVSKE--------VPRRKSLVGTPYWMAPELIS------------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----- 273 (346)
T ss_dssp ECCSS--------SCCBCCCCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----
T ss_pred ecCCC--------CCcccccccCcCcCCHHHHC------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----
Confidence 75221 12234568999999997664 567999999999999999999999999742
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+..... .....+... ....+.+++.+++.+||..||++|||+.|+++
T Consensus 274 ~~~~~~~~i-----~~~~~~~~~----------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 274 PPLKAMKMI-----RDNLPPRLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHH-----HHSSCCCCS----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHH-----HcCCCCCCC----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 111111110 01123456789999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=430.20 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=199.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.++||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++|||||++++++ .+++..
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence 5799999999999999999999999999999999643 344567899999999999999999999995 446689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+|||||+||+|.+++...... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|++||+|||+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGV----LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EEEEeCCCCCcHHHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999865422 478889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.... ........+||+.|||||++. +..|+.++||||+||++|||+||+.||...
T Consensus 172 a~~~~~--------~~~~~~~~~GT~~YmAPE~l~------------~~~y~~~~DiwSlGvilyemltG~~PF~~~--- 228 (350)
T 4b9d_A 172 ARVLNS--------TVELARACIGTPYYLSPEICE------------NKPYNNKSDIWALGCVLYELCTLKHAFEAG--- 228 (350)
T ss_dssp ESCCCH--------HHHHHHHHHSCCTTCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---
T ss_pred ceeecC--------CcccccccCCCccccCHHHHC------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---
Confidence 986511 112234568999999997664 567999999999999999999999999742
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+.......... +.. +..++.++.+++.+||..||++|||++|+++
T Consensus 229 --~~~~~~~~i~~~~~-----~~~------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 229 --SMKNLVLKIISGSF-----PPV------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --SHHHHHHHHHHTCC-----CCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CHHHHHHHHHcCCC-----CCC------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222222111110 000 1122456789999999999999999999975
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=467.38 Aligned_cols=541 Identities=18% Similarity=0.156 Sum_probs=364.7
Q ss_pred CCCCCCCCCCCCC----CCCeee----eeeecCC---------CCcEEEEeccCCCCCCcccccccCccccccccccccc
Q 001908 47 DPLGVTNSWNNSI----NLCQWA----GVTCGHR---------HQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNN 109 (997)
Q Consensus 47 ~~~~~~~sW~~~~----~~c~w~----gv~C~~~---------~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~ 109 (997)
|+...+++|+.+. +.|.|. -|.|... +..++.|||++|.|++..+.+|.++++|++|||++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 4444566665432 245543 3567532 1346666666666665445566666666666666666
Q ss_pred cCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccccccC-cCc
Q 001908 110 FHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTG-MLP 188 (997)
Q Consensus 110 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g-~~p 188 (997)
+++..|.+|++|++|++|+|++|+|++..|..|+++++|++|++++|++. .+|...+..+++|++|+|++|.+++ .+|
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCc
Confidence 66555556666666666666666666333344566666666666666665 3444433456666666666666654 345
Q ss_pred CccCcch-hhhhhccCccccccCCCcccCCCccc----eeeccCCCCCCCCCccccccCCCccEEEecCCcCcCC-CCCC
Q 001908 189 ASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLE----NILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGS-IPES 262 (997)
Q Consensus 189 ~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~----~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~-~p~~ 262 (997)
..++.++ +.+|++++|++++..|..+..+.+++ .++++.|.++ .++...+ ....++.+++++|..+.. .+..
T Consensus 167 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~ 244 (635)
T 4g8a_A 167 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF-KEIRLHKLTLRNNFDSLNVMKTC 244 (635)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESCCSSHHHHHHH
T ss_pred hhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc-ccCcccc-cchhhhhhhhhcccccccccchh
Confidence 5555553 44566666666655555555444433 3455556555 3443333 233445555555544322 2233
Q ss_pred CCCCCCCcEEeccCcc------CCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCC
Q 001908 263 FSNASNIEIIDLPINY------FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGV 336 (997)
Q Consensus 263 ~~~l~~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 336 (997)
+..+..++..++..+. +.......+..+..+..+++..+....... .....+..+.+++.+++.+|.+...
T Consensus 245 ~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~---~~~~~~~~~~~l~~l~~~~~~~~~~ 321 (635)
T 4g8a_A 245 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD---GIIDLFNCLTNVSSFSLVSVTIERV 321 (635)
T ss_dssp HHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEE---ECTTTTGGGTTCSEEEEESCEEEEC
T ss_pred hcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhccccc---chhhhhhhhcccccccccccccccc
Confidence 4455555555543332 222233344455555555555443322111 1123355677888888888888754
Q ss_pred CcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccc--cchhhh
Q 001908 337 LPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQG--NIPSSL 414 (997)
Q Consensus 337 ~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~ 414 (997)
.+.. .. ..++.|++.+|.+.+..+. .+..|+.+++..|.+... ..+..+++|+.|++++|.+.. ..+..+
T Consensus 322 ~~~~--~~-~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 393 (635)
T 4g8a_A 322 KDFS--YN-FGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSD 393 (635)
T ss_dssp GGGG--SC-CCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred cccc--cc-hhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccch
Confidence 4322 22 4688899999988755443 457788999999988743 345678999999999999863 456778
Q ss_pred cCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc-ccccccccccccccCCCcccCCCcccccccccc
Q 001908 415 GNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ-QILTITTLSRFLDLGNNHLNGSLPLEVGNLKNL 493 (997)
Q Consensus 415 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L 493 (997)
..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|+.....+. .+..+.++ +.++++.|.+++..|..+..+++|
T Consensus 394 ~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l-~~l~ls~n~l~~~~~~~~~~~~~L 471 (635)
T 4g8a_A 394 FGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSL 471 (635)
T ss_dssp HSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTC
T ss_pred hhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccc-ccccccccccccccccccccchhh
Confidence 88999999999999988 4667788999999999999988766654 45667777 899999999999999999999999
Q ss_pred ceeccccccc-cccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCC
Q 001908 494 VALYISGNQF-SGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSY 572 (997)
Q Consensus 494 ~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 572 (997)
+.|+|++|++ .+.+|..|..+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++..|..|..+++|++|||++
T Consensus 472 ~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~ 551 (635)
T 4g8a_A 472 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 551 (635)
T ss_dssp CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTT
T ss_pred hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCC
Confidence 9999999985 456788999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCcccCCCC-CcC-CCCcceeecCCCCcCCCC
Q 001908 573 NHFDGEVPTK-GVF-SNKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 573 N~l~~~~p~~-~~~-~~~~~~~~~~N~~~C~~~ 603 (997)
|+|++.+|.. ..+ .+++.+++.+|||.|+|.
T Consensus 552 N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 552 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp SCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999998865 334 578999999999999873
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=424.58 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=206.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+.|+..++||+|+||+||+|+++.+|+.||||+++.... ..+|++++++++|||||++++++. +++..|+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 568888999999999999999999999999999974322 246999999999999999999954 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEcccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLA 837 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFg~a 837 (997)
|||||+||+|.+++++.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+| ++||+|||+|
T Consensus 128 vmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp EECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred EEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 999999999999998765 488999999999999999999999 999999999999999998 6999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+........ .........+||+.|||||++. +..|+.++||||+||++|||+||+.||.......
T Consensus 199 ~~~~~~~~~---~~~~~~~~~~GT~~YmAPE~~~------------~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 199 LCLQPDGLG---KSLLTGDYIPGTETHMAPEVVM------------GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp EEC---------------CCCCCCGGGCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred eEccCCCcc---cceecCCccccCccccCHHHHC------------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 876332111 1111223467999999997664 5779999999999999999999999997543322
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.+........ ... ..+..+++.+.+++.+||..||++|||+.|+++.|....++.
T Consensus 264 -~~~~i~~~~~----------~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 264 -LCLKIASEPP----------PIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -CHHHHHHSCC----------GGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -HHHHHHcCCC----------Cch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 2222111100 000 011233567789999999999999999999999999887765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=431.67 Aligned_cols=277 Identities=21% Similarity=0.313 Sum_probs=216.7
Q ss_pred ChHHHHHHhhcCccCCcccccCcceEEEEEECCC-----CcEEEEEEeccc-chhhHHHHHHHHHHHhhcCC-CCcceEE
Q 001908 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGEN-----GTFVAVKILNLM-QKGALKSFVAECEVLRNTRH-RNLIKII 742 (997)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~ 742 (997)
+.++++...++|++.++||+|+||+||+|++... ++.||||+++.. .....+.+.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 4455566678999999999999999999998643 368999999743 33456789999999999965 8999999
Q ss_pred eeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcE
Q 001908 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIV 812 (997)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~iv 812 (997)
++|.. ..+..++|||||++|+|.++++..... .....+++.+++.++.|||+||+|||++ +|+
T Consensus 135 g~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~ii 207 (353)
T 4ase_A 135 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 207 (353)
T ss_dssp EEECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Cee
Confidence 99743 345689999999999999999864321 0123488999999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccch
Q 001908 813 HGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGD 892 (997)
Q Consensus 813 HrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~D 892 (997)
||||||+|||+++++++||+|||+|+.+.... ........+||+.|||||++. +..|+.++|
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~------~~~~~~~~~gt~~ymAPE~l~------------~~~y~~ksD 269 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIF------------DRVYTIQSD 269 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCT------TSEEETTEEECGGGCCHHHHH------------HCCCCHHHH
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCC------CceeeccccccccccCHHHHh------------cCCCCCccc
Confidence 99999999999999999999999998663221 112233467999999997765 467999999
Q ss_pred hHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 893 VYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 893 vwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
||||||++|||+| |+.||....... .+...+. +... .+.+..+++++.++|.+||+.|
T Consensus 270 VwS~Gv~l~El~t~G~~Pf~~~~~~~-~~~~~i~--------~g~~------------~~~p~~~~~~~~~li~~c~~~d 328 (353)
T 4ase_A 270 VWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLK--------EGTR------------MRAPDYTTPEMYQTMLDCWHGE 328 (353)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHH--------HTCC------------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred EeehHHHHHHHHhCCCCCCCCCCHHH-HHHHHHH--------cCCC------------CCCCccCCHHHHHHHHHHcCcC
Confidence 9999999999998 899997542211 1111111 1111 1112234667889999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHh
Q 001908 972 PIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 972 P~~Rps~~evl~~L~~~~~~~ 992 (997)
|++|||+.|+++.|+++.++-
T Consensus 329 P~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 329 PSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp GGGSCCHHHHHHHHHHHHHHT
T ss_pred hhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999988753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=417.17 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=204.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++|||||+++++ +.+++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence 5799999999999999999999999999999999642 33456789999999999999999999999 556779
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 999999999999999998765 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.+.... ........+||+.|||||++. +..|+.++||||+||++|||+||+.||...
T Consensus 178 la~~~~~~~------~~~~~~~~~GTp~YmAPEvl~------------~~~y~~~~DiWSlGvilyeml~G~~PF~~~-- 237 (311)
T 4aw0_A 178 TAKVLSPES------KQARANSFVGTAQYVSPELLT------------EKSACKSSDLWALGCIIYQLVAGLPPFRAG-- 237 (311)
T ss_dssp TCEECCTTT------TCCCBCCCCSCGGGCCHHHHH------------HSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred CceecCCCC------CcccccCcccCcccCCHHHHc------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--
Confidence 998763211 112234568999999998775 467899999999999999999999999742
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
+..+......... ..+ +....+++.+++.+|+..||++|||++|++
T Consensus 238 ---~~~~~~~~i~~~~------~~~------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 238 ---NEGLIFAKIIKLE------YDF------------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---SHHHHHHHHHHTC------CCC------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CHHHHHHHHHcCC------CCC------------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2222222111110 000 011234567999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=431.11 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=204.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+.|+..++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++. ..+..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEEE
Confidence 56999999999999999999999999999999998665555677899999999999999999999954 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
|||||+||+|.++++... +++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+
T Consensus 226 VmEy~~gG~L~~~i~~~~-------l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEECCTTEEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 999999999999997653 88999999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.+.. ........+||+.|||||++. +..|+.++||||+||++|||++|+.||...
T Consensus 296 ~~~~--------~~~~~~~~~GTp~YmAPEvl~------------~~~y~~~~DiWSlGvilyeml~G~~PF~~~----- 350 (423)
T 4fie_A 296 QVSK--------EVPRRKSLVGTPYWMAPELIS------------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----- 350 (423)
T ss_dssp ECCS--------SCCCBCCCEECTTTCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----
T ss_pred ECCC--------CCccccccccCcCcCCHHHHC------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----
Confidence 7522 112234568999999997664 567999999999999999999999999732
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+..... .....+... ....+.+++.+++.+||..||++|||+.|+++
T Consensus 351 ~~~~~~~~i-----~~~~~~~~~----------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 351 PPLKAMKMI-----RDNLPPRLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHH-----HHSCCCCCS----------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHH-----HcCCCCCCc----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 111111110 01122456789999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=406.25 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=188.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++|||||+++++ +.+++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECCE
Confidence 5899999999999999999999999999999999643 23345678999999999999999999999 455678
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+ +|+|.+++.+.. .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence 99999999 689999998765 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
+|+.... .......+||+.|||||++. +..| +.++||||+||++|||+||+.||...
T Consensus 158 la~~~~~---------~~~~~~~~GT~~Y~APE~~~------------~~~y~~~~~DiwSlGvily~lltg~~PF~~~- 215 (275)
T 3hyh_A 158 LSNIMTD---------GNFLKTSCGSPNYAAPEVIS------------GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE- 215 (275)
T ss_dssp CC------------------------CTTSCHHHHS------------SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred CCeecCC---------CCccCCeeECcccCChhhhc------------CCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-
Confidence 9986522 11223468999999997764 3444 57999999999999999999999742
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+......... ..+ +....+++.+++.+||+.||++|||++|+++
T Consensus 216 ----~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 216 ----SIPVLFKNISNGV------YTL------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----SHHHHHHHHHHTC------CCC------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CHHHHHHHHHcCC------CCC------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222222111100 000 0112346779999999999999999999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=453.74 Aligned_cols=460 Identities=17% Similarity=0.194 Sum_probs=328.3
Q ss_pred EEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccc
Q 001908 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRN 156 (997)
Q Consensus 77 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n 156 (997)
+.+|++++++++ +|..+. ++|++|||++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 789999999986 887665 89999999999999887889999999999999999999878889999999988888888
Q ss_pred cccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCc
Q 001908 157 NLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPL 236 (997)
Q Consensus 157 ~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~ 236 (997)
++. .+|.. .+++|++|+|++|++++. .+|..|+++++|++|+|++|++++. +
T Consensus 111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l----------------------~~p~~~~~l~~L~~L~L~~n~l~~~-~- 162 (562)
T 3a79_B 111 RLQ-NISCC---PMASLRHLDLSFNDFDVL----------------------PVCKEFGNLTKLTFLGLSAAKFRQL-D- 162 (562)
T ss_dssp CCC-EECSC---CCTTCSEEECCSSCCSBC----------------------CCCGGGGGCTTCCEEEEECSBCCTT-T-
T ss_pred cCC-ccCcc---ccccCCEEECCCCCcccc----------------------CchHhhcccCcccEEecCCCccccC-c-
Confidence 877 67766 467777777777777641 2456677777788888888777642 1
Q ss_pred cccccCCCc--cEEEecCCcC--cCCCCCCCCCCC--CCcEEeccCccCCCcccc-cccccCccCeeEccCccCCCCCCC
Q 001908 237 DIGVTLPNL--QVFAIGDNYF--SGSIPESFSNAS--NIEIIDLPINYFTGKVSI-IFGRLKNLWSLDLGINNLGSGGAN 309 (997)
Q Consensus 237 ~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~ 309 (997)
+..+++| ++|++++|.+ ++..|.+|..+. .+ .+++++|.+.+.++. .+..+++|+.|++++|+.... .
T Consensus 163 --~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~--~ 237 (562)
T 3a79_B 163 --LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ--R 237 (562)
T ss_dssp --TGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH--H
T ss_pred --hhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccc--h
Confidence 2244555 8888888888 777787777765 33 567888888775543 567788888888888852100 0
Q ss_pred CcchhhhhccCCCCcEEEeecCccCCCCcccccc--cccccccccccCcccccccCCCC-----CCCCCCCEEeccCCCC
Q 001908 310 DLDFVTILTNCSKLKVLAFEENRLGGVLPHSIAN--LSTTMTDIYMGVNQISGTIPSGI-----GNLVNLNLLGIEFNQL 382 (997)
Q Consensus 310 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l 382 (997)
.......+..+++|+.|+++++.+.+.....+.. ...+|++|++++|.++|.+|..+ .+++.|+.++++.|.+
T Consensus 238 l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~ 317 (562)
T 3a79_B 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF 317 (562)
T ss_dssp HHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC
T ss_pred HHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee
Confidence 0113445778888888888888776432211110 01267777777777777777766 6666777777777766
Q ss_pred CCCCC-CCcccc---cccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC--
Q 001908 383 TGNIP-REIGQL---RNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG-- 456 (997)
Q Consensus 383 ~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-- 456 (997)
.+| ..+..+ .+|++|++++|.+.... ....+++|++|+|++|++++.+|..|.++++|++|+|++|++++
T Consensus 318 --~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 393 (562)
T 3a79_B 318 --LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF 393 (562)
T ss_dssp --SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT
T ss_pred --ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc
Confidence 344 222222 45778888887775321 12567778888888888877777777778888888888887775
Q ss_pred CcccccccccccccccccCCCcccCCCcc-ccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhc
Q 001908 457 AVPQQILTITTLSRFLDLGNNHLNGSLPL-EVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535 (997)
Q Consensus 457 ~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 535 (997)
.+|..+..++++ +.|++++|++++.+|. .+..+++|++|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+
T Consensus 394 ~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~ 469 (562)
T 3a79_B 394 KVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDV 469 (562)
T ss_dssp HHHHTTTTCTTC-CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTT
T ss_pred cchhhhcCCCCC-CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhh
Confidence 334566677777 7777777777764444 467777777777777777776666554 67777777777777 566666
Q ss_pred cccCcCCeeeCccccccccCchh-ccCCCCCCEEeCCCCcCcccCCC
Q 001908 536 RSLKSIKELDLSCNNLSGQIPEF-LENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 536 ~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
..+++|+.|+|++|+|++ +|.. +..+++|+.|++++|+++|.+|.
T Consensus 470 ~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 470 THLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred cCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 677777777777777773 4444 77777777777777777776654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=404.06 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=190.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-------
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF------- 750 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 750 (997)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .+...+.+.+|++++++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999999999999999999743 34455788999999999999999999999754321
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
....+.|+|||||++|+|.+++...... ...++..++.++.||+.||+|||++ +|+||||||+|||++.++++|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 1234579999999999999999876532 2356777899999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCc----cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 831 VSDFGLARFLFARPFDTS----METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
|+|||+|+.......... ..........+||+.|||||++. +..|+.++||||+||++|||++
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~------------~~~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH------------GNSYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHT------------TCCCCTHHHHHHHHHHHHHHHS-
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHc------------CCCCCCHHHHHHHHHHHHHHcc-
Confidence 999999987643221111 01112234467999999997664 5679999999999999999996
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
||.... ....... ...... ..+...+..+...+++.+||+.||++|||+.|+++
T Consensus 226 --Pf~~~~----~~~~~~~-----~~~~~~------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 --PFSTQM----ERVRTLT-----DVRNLK------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --CCSSHH----HHHHHHH-----HHHTTC------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcc----HHHHHHH-----HHhcCC------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 765211 0000000 000000 01122233445678999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=409.46 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=189.7
Q ss_pred hcCccCCcccccCcceEEEEEEC---CCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|++.+.||+|+||+||+|+.. .+++.||||+++... ......+.+|++++++++|||||++++++ .++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 57999999999999999999874 467899999996432 22334678899999999999999999995 446
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..|+|||||+||+|.+++.+.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 68999999999999999998765 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.... ........+||+.|||||++. +..|+.++||||+||++|||+||+.||...
T Consensus 170 FGla~~~~~--------~~~~~~~~~GT~~YmAPE~~~------------~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 170 FGLSKESID--------HEKKAYSFCGTVEYMAPEVVN------------RRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp SEEEEC-------------CCCCSCCCCGGGCCHHHHH------------TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceeccC--------CCccccccccCcccCCHHHhc------------cCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 999986422 112233468999999997765 467899999999999999999999999742
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
+..+......... +.. +..+++++.+++.+||..||++|||+
T Consensus 230 -----~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 230 -----DRKETMTMILKAK------LGM------------PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -----SHHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -----CHHHHHHHHHcCC------CCC------------CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 2222222111100 000 11224567899999999999999985
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=427.08 Aligned_cols=423 Identities=23% Similarity=0.272 Sum_probs=269.6
Q ss_pred ccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhccccccccccccccccc
Q 001908 90 LSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYS 169 (997)
Q Consensus 90 ~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~ 169 (997)
|.|.-...++|++|++++|++ |.+|+++++|++|++|+|++|.++|.+|..++++.+|+.+++..|..
T Consensus 3 ~~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~----------- 70 (454)
T 1jl5_A 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD----------- 70 (454)
T ss_dssp --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------
T ss_pred ccccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------
Confidence 344444568888999999988 78898899999999999999999888999999888888777766532
Q ss_pred ccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEE
Q 001908 170 WLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFA 249 (997)
Q Consensus 170 l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~ 249 (997)
.++++|++++|.+++ +|... -++++|++++|++++ +|..+ ++|++|++++|++++ +|.. .++|++|+
T Consensus 71 -~~l~~L~l~~~~l~~-lp~~~--~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~-l~~~----~~~L~~L~ 137 (454)
T 1jl5_A 71 -RQAHELELNNLGLSS-LPELP--PHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA-LSDL----PPLLEYLG 137 (454)
T ss_dssp -HTCSEEECTTSCCSC-CCSCC--TTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC-CCSC----CTTCCEEE
T ss_pred -cCCCEEEecCCcccc-CCCCc--CCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCc-ccCC----CCCCCEEE
Confidence 467889999998886 34422 245678888888887 77643 788999999999983 5532 26899999
Q ss_pred ecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEee
Q 001908 250 IGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFE 329 (997)
Q Consensus 250 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~ 329 (997)
+++|++++ +| +|+++++|++|++++|++++. |.. ..+|++|++++|+++.++ .+.++++|++|+++
T Consensus 138 L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 138 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYAD 203 (454)
T ss_dssp CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECC
T ss_pred CcCCCCCC-Cc-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCcCc--------cccCCCCCCEEECC
Confidence 99999986 77 599999999999999999874 333 358999999999988743 25788999999999
Q ss_pred cCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccccccccc
Q 001908 330 ENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGN 409 (997)
Q Consensus 330 ~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 409 (997)
+|++++ +|... .+|+.|++++|+++ .+| .++++++|++|++++|++++ +|.. +++|++|++++|++++
T Consensus 204 ~N~l~~-l~~~~----~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~- 271 (454)
T 1jl5_A 204 NNSLKK-LPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD- 271 (454)
T ss_dssp SSCCSS-CCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-
T ss_pred CCcCCc-CCCCc----CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-
Confidence 999986 44322 47888999999988 667 48899999999999999985 4543 4788999999999985
Q ss_pred chhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccc-cccccccccCCCcccCCCccccc
Q 001908 410 IPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTI-TTLSRFLDLGNNHLNGSLPLEVG 488 (997)
Q Consensus 410 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~ll~~L~Ls~N~l~~~~p~~~~ 488 (997)
+|.. +++|+.|++++|++++ +|.. .++|++|++++|++++ ++ .+ .++ +.|++++|++++ +|..
T Consensus 272 l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L-~~L~Ls~N~l~~-lp~~-- 335 (454)
T 1jl5_A 272 LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLPPSL-EELNVSNNKLIE-LPAL-- 335 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCCTTC-CEEECCSSCCSC-CCCC--
T ss_pred cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCcCcC-CEEECCCCcccc-cccc--
Confidence 5553 3788999999999886 2321 2678999999998874 33 23 245 888999999885 5654
Q ss_pred cccccceeccccccccccccccccCCcCccEEEccCccccc--cCChhccccCcCCeeeCccccccccCchhccCCCCCC
Q 001908 489 NLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG--SIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLE 566 (997)
Q Consensus 489 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 566 (997)
+++|+.|++++|+++ .+|. .+++|+.|++++|++++ .+|.++.. |+.|++.|.+|.. +++|+
T Consensus 336 -~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~ 399 (454)
T 1jl5_A 336 -PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLK 399 (454)
T ss_dssp -CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC----------------
T ss_pred -CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCC
Confidence 478889999999988 5666 46888999999999987 66766554 3456777777764 47889
Q ss_pred EEeCCCCcCcc--cCCCCCcCCCCcceeecCCCCcC
Q 001908 567 YLNLSYNHFDG--EVPTKGVFSNKTRVQLTGNGKLC 600 (997)
Q Consensus 567 ~L~ls~N~l~~--~~p~~~~~~~~~~~~~~~N~~~C 600 (997)
+|++++|++++ .+|. ++..+.+.+|...|
T Consensus 400 ~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~ 430 (454)
T 1jl5_A 400 QLHVETNPLREFPDIPE-----SVEDLRMNSERVVD 430 (454)
T ss_dssp ------------------------------------
T ss_pred EEECCCCcCCccccchh-----hHhheeCcCcccCC
Confidence 99999999987 5663 34455666665544
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=431.22 Aligned_cols=451 Identities=19% Similarity=0.179 Sum_probs=354.6
Q ss_pred cccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecc
Q 001908 100 LRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLA 179 (997)
Q Consensus 100 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~ 179 (997)
.+++|+++|+++ .+|..+. ++|++|+|++|.+++..|..++++++|+ +|+|+
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~-------------------------~L~Ls 84 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELR-------------------------VLRLS 84 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCC-------------------------EEECC
T ss_pred CcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCcc-------------------------EEECC
Confidence 489999999999 5888765 8999999999999966667787777766 45555
Q ss_pred cccccCcCcCccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCC-CCCccccccCCCccEEEecCCcCcC
Q 001908 180 RNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG-NLPLDIGVTLPNLQVFAIGDNYFSG 257 (997)
Q Consensus 180 ~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g-~lp~~~~~~l~~L~~L~L~~N~l~~ 257 (997)
+|++++..|..|+.++ +++|+|++|+++ .+|.. .+++|++|+|++|++++ .+|..+ .++++|++|++++|++++
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~-~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 85 HNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEF-GNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGG-GGCTTCCEEEEECSBCCT
T ss_pred CCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhh-cccCcccEEecCCCcccc
Confidence 5555554455555542 344555555555 56766 78999999999999985 344554 489999999999999986
Q ss_pred CCCCCCCCCCCC--cEEeccCccC--CCcccccccccC--ccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecC
Q 001908 258 SIPESFSNASNI--EIIDLPINYF--TGKVSIIFGRLK--NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEEN 331 (997)
Q Consensus 258 ~~p~~~~~l~~L--~~L~Ls~N~l--~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N 331 (997)
. .+..+++| ++|+|++|++ ++..|..|..+. .| .++++.|.+..... ...+..+++|+.|++++|
T Consensus 161 ~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~-----~~~~~~l~~L~~L~l~~n 231 (562)
T 3a79_B 161 L---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQV-----NMSVNALGHLQLSNIKLN 231 (562)
T ss_dssp T---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCC-----EEEESSEEEEEEEEEECC
T ss_pred C---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhh-----hhcccccceEEEeccccc
Confidence 3 45556666 9999999999 888998888765 33 66888888875322 234567889999999999
Q ss_pred cc-----CCCCcccccccccccccccccCccccccc----CCCCCCCCCCCEEeccCCCCCCCCCCCc-----ccccccc
Q 001908 332 RL-----GGVLPHSIANLSTTMTDIYMGVNQISGTI----PSGIGNLVNLNLLGIEFNQLTGNIPREI-----GQLRNLQ 397 (997)
Q Consensus 332 ~l-----~~~~p~~~~~l~~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~ 397 (997)
+. .+. +..+..+ +.++.+++.++.+++.. +..+ ..++|++|++++|+++|.+|..+ .+++.|+
T Consensus 232 ~~~~~~l~~~-~~~l~~l-~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~ 308 (562)
T 3a79_B 232 DENCQRLMTF-LSELTRG-PTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308 (562)
T ss_dssp STTHHHHHHH-HHHHHSC-SSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEE
T ss_pred ccccchHHHH-HHHHhcc-CcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchhee
Confidence 52 211 1233333 45677777776665321 2222 23589999999999999999988 8888888
Q ss_pred eeccccccccccch-hhhcCC---CCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccc
Q 001908 398 AIGLSSNFLQGNIP-SSLGNL---TLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLD 473 (997)
Q Consensus 398 ~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~ 473 (997)
.++++.|.+ .+| .++..+ .+|+.|++++|.+.... ....+++|++|++++|++++.+|..+..++++ +.|+
T Consensus 309 ~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~ 383 (562)
T 3a79_B 309 IEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL-QTLI 383 (562)
T ss_dssp EEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSC-CEEE
T ss_pred hhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCC-CEEE
Confidence 888888888 344 444333 67999999999987432 23688999999999999999999999999999 9999
Q ss_pred cCCCcccCC--Cccccccccccceeccccccccccccc-cccCCcCccEEEccCccccccCChhccccCcCCeeeCcccc
Q 001908 474 LGNNHLNGS--LPLEVGNLKNLVALYISGNQFSGEIPV-TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNN 550 (997)
Q Consensus 474 Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 550 (997)
|++|++++. +|..|+++++|+.|++++|++++.+|. .+..+++|+.|++++|++++.+|..+. ++|+.|+|++|+
T Consensus 384 L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~ 461 (562)
T 3a79_B 384 LQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNR 461 (562)
T ss_dssp CCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSC
T ss_pred CCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCc
Confidence 999999973 357799999999999999999985665 588999999999999999988887665 799999999999
Q ss_pred ccccCchhccCCCCCCEEeCCCCcCcccCCC-CCcCCCCcceeecCCCCcCCC
Q 001908 551 LSGQIPEFLENLSFLEYLNLSYNHFDGEVPT-KGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 551 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~N~~~C~~ 602 (997)
|+ .+|..+..+++|++|+|++|++++.++. ...++.++.+++.+|||.|.|
T Consensus 462 l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 462 IM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred Cc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 99 7888777999999999999999965554 467788999999999999975
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=400.13 Aligned_cols=296 Identities=32% Similarity=0.570 Sum_probs=214.6
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCe--eeeeeecCCC--CcEEEEeccCCCCCC--cccccccCcccccc
Q 001908 29 HTNETDRLALLAIKSQLHDPLGVTNSWNNSINLCQ--WAGVTCGHRH--QRVTELDLRHQNIGG--SLSPYVGNLSFLRY 102 (997)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~~~sW~~~~~~c~--w~gv~C~~~~--~~v~~L~L~~~~l~g--~~~~~l~~l~~L~~ 102 (997)
.|.++|++||++||+++.||. .+++|+.+++||. |.||+|+..+ ++|+.|+|++|++.| .+|+.++++++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 488999999999999998887 7899988889998 9999998655 899999999999999 89999999999999
Q ss_pred ccccc-cccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccc
Q 001908 103 INLAT-NNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARN 181 (997)
Q Consensus 103 L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N 181 (997)
|+|++ |++.+.+|..|+++++|++|+|++|.++|.+|..++++++|+ +|+|++|
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~-------------------------~L~Ls~N 135 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV-------------------------TLDFSYN 135 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC-------------------------EEECCSS
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC-------------------------EEeCCCC
Confidence 99995 999999999999999999999999999999998887776665 5666666
Q ss_pred cccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCC-CccEEEecCCcCcCCCC
Q 001908 182 HLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLP-NLQVFAIGDNYFSGSIP 260 (997)
Q Consensus 182 ~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~-~L~~L~L~~N~l~~~~p 260 (997)
.+++.+| ..+.++++|++|+|++|+++|.+|..++ .++ +|++|++++|++++.+|
T Consensus 136 ~l~~~~p-----------------------~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~~L~~L~L~~N~l~~~~~ 191 (313)
T 1ogq_A 136 ALSGTLP-----------------------PSISSLPNLVGITFDGNRISGAIPDSYG-SFSKLFTSMTISRNRLTGKIP 191 (313)
T ss_dssp EEESCCC-----------------------GGGGGCTTCCEEECCSSCCEEECCGGGG-CCCTTCCEEECCSSEEEEECC
T ss_pred ccCCcCC-----------------------hHHhcCCCCCeEECcCCcccCcCCHHHh-hhhhcCcEEECcCCeeeccCC
Confidence 6654443 3344445555555555555555555544 333 55666666666666666
Q ss_pred CCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCccc
Q 001908 261 ESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHS 340 (997)
Q Consensus 261 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 340 (997)
..|..++ |++|+|++|++++.++..|+.+++|++|+|++|+++.. ++.+..+++|++|
T Consensus 192 ~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~l~~L~~L-------------- 249 (313)
T 1ogq_A 192 PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-------LGKVGLSKNLNGL-------------- 249 (313)
T ss_dssp GGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB-------GGGCCCCTTCCEE--------------
T ss_pred hHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee-------cCcccccCCCCEE--------------
Confidence 6666665 66666666666666666565555555555555555421 1112333444444
Q ss_pred ccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccccc-ccc
Q 001908 341 IANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF-LQG 408 (997)
Q Consensus 341 ~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 408 (997)
++++|+|++.+|..|.++++|++|+|++|+++|.+|.. +.+++|+.|++++|. +.|
T Consensus 250 -----------~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 250 -----------DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp -----------ECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred -----------ECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 44444444555666666777888888888888777765 777888888888887 554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=402.85 Aligned_cols=279 Identities=22% Similarity=0.277 Sum_probs=203.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeecc-CcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSI-DFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++|++++|||||++++++... .+.+.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999999999999999999643 234456788999999999999999999987543 2445678
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+|||||+ |+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence 999999995 68999998754 589999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.+..... .........+||+.|||||++.. ...++.++||||+||++|||++|++||.....
T Consensus 204 la~~~~~~~~----~~~~~~~~~~GT~~Y~APEv~~~-----------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 204 MARGLCTSPA----EHQYFMTEYVATRWYRAPELMLS-----------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp TCBCC-----------CCCCCSSCCCCTTCCHHHHTT-----------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred eeeecccCcc----ccccccccceeChHhcCHHHhcC-----------CCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 9986632211 11223345789999999977642 23468999999999999999999999974311
Q ss_pred CCccHHHHHHhh--cchhhhhhcCc-cc---ccccccchhh---hhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMA--LPEKVMETVDP-SL---LLAWSDGRRR---AKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~--~~~~~~~~~d~-~~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..+....... .+......... .. .......... .......++..+++.+||..||++|||+.|+++
T Consensus 269 ~-~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 269 V-HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp H-HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred H-HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1 0011111100 00000000000 00 0000000000 000112346779999999999999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=432.15 Aligned_cols=490 Identities=19% Similarity=0.193 Sum_probs=415.2
Q ss_pred CcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhc
Q 001908 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVA 153 (997)
Q Consensus 74 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l 153 (997)
.+++.|||++|++++..|.+|.+|++|++|+|++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|++
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 57999999999998877778999999999999999999766678999999999999999999665667999999999999
Q ss_pred ccccccc-cccccccccccccceeecccccccCcCcCccCcchh-----hhhhccCccccccCCCcccCCCccceeeccC
Q 001908 154 YRNNLVG-EIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSI-----IYLHVGENQFSGTVPPSLYNMSSLENILLDV 227 (997)
Q Consensus 154 ~~n~~~g-~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~-----~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~ 227 (997)
++|++.+ .+|..+ ..+++|++|+|++|++++..|..+..+.. ..++++.|.++. ++........++.+++++
T Consensus 156 s~N~l~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~-i~~~~~~~~~~~~l~l~~ 233 (635)
T 4g8a_A 156 AHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 233 (635)
T ss_dssp CSSCCCCCCCCGGG-GGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE-ECTTTTTTCEEEEEEEES
T ss_pred ccCccccCCCchhh-ccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccc-cCcccccchhhhhhhhhc
Confidence 9999976 455554 46899999999999999999998887642 246789999985 555566667789999999
Q ss_pred CCCCCCCCccccccCCCccEEEecCCc------CcCCCCCCCCCCCCCcEEeccCccCCCc---ccccccccCccCeeEc
Q 001908 228 NGFTGNLPLDIGVTLPNLQVFAIGDNY------FSGSIPESFSNASNIEIIDLPINYFTGK---VSIIFGRLKNLWSLDL 298 (997)
Q Consensus 228 N~l~g~lp~~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~L 298 (997)
|.....++...+..++.++...+..+. +....+..+..+..+..+++..+..... ....+..+.+++.+++
T Consensus 234 n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~ 313 (635)
T 4g8a_A 234 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSL 313 (635)
T ss_dssp CCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEE
T ss_pred ccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccc
Confidence 988766776767788888888775443 4445556777888888888887766543 3445778889999999
Q ss_pred cCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEecc
Q 001908 299 GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIE 378 (997)
Q Consensus 299 s~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 378 (997)
..|.+..+ ..+.....|+.|++++|.+.+..+..+ ..++.+++..|.+... ..+..+++|+.|+++
T Consensus 314 ~~~~~~~~--------~~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls 379 (635)
T 4g8a_A 314 VSVTIERV--------KDFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLS 379 (635)
T ss_dssp ESCEEEEC--------GGGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECC
T ss_pred cccccccc--------cccccchhhhhhhcccccccCcCcccc----hhhhhcccccccCCCC--cccccccccccchhh
Confidence 99987653 235667899999999999987665543 4577888888887643 345689999999999
Q ss_pred CCCCCC--CCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCC-CCCCCCCCCcEEecCCCccc
Q 001908 379 FNQLTG--NIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP-PSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 379 ~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 455 (997)
+|.+.. ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.+++++|+.....+ ..|.++++++.++++.|.+.
T Consensus 380 ~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~ 458 (635)
T 4g8a_A 380 RNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 458 (635)
T ss_dssp SSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCE
T ss_pred ccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccc
Confidence 999963 45666778899999999999998 467788999999999999988775554 56889999999999999999
Q ss_pred CCcccccccccccccccccCCCcc-cCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChh
Q 001908 456 GAVPQQILTITTLSRFLDLGNNHL-NGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLS 534 (997)
Q Consensus 456 ~~~p~~~~~l~~ll~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 534 (997)
+..|..+..++.+ +.|+|++|++ .+..|..|..+++|++|||++|+|++..|..|.++++|++|+|++|+|++..|..
T Consensus 459 ~~~~~~~~~~~~L-~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~ 537 (635)
T 4g8a_A 459 VAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 537 (635)
T ss_dssp ECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGG
T ss_pred cccccccccchhh-hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhH
Confidence 8888888888888 9999999985 4467889999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCeeeCccccccccCchhccCC-CCCCEEeCCCCcCcccCCC
Q 001908 535 LRSLKSIKELDLSCNNLSGQIPEFLENL-SFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 535 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~ 581 (997)
|..+++|++|||++|+|++.+|..+..+ ++|++|+|++|+|++.+..
T Consensus 538 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 538 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp GTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred HhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 9999999999999999999999999998 6899999999999998763
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=409.23 Aligned_cols=412 Identities=25% Similarity=0.265 Sum_probs=273.5
Q ss_pred CcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCC-------------eEEEccCCCccccCCc
Q 001908 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRL-------------ETLMLANNSFSGKIPT 140 (997)
Q Consensus 74 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L-------------~~L~Ls~N~l~g~iP~ 140 (997)
.+++.|++++|++ |.+|+++++|++|++|+|++|++.|.+|.+++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 5799999999999 9999999999999999999999999999999999876 999999999994 666
Q ss_pred cccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCcc
Q 001908 141 NLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSL 220 (997)
Q Consensus 141 ~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L 220 (997)
. .++|++|++++|++.+ +|.. ..+|++|++++|++++ +|... -++.+|++++|++++ +| .++++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~~--~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDLP--PLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSCC--TTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCCC--CCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 3 3688999999999997 8864 3689999999999986 33322 246689999999996 88 69999999
Q ss_pred ceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccC
Q 001908 221 ENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300 (997)
Q Consensus 221 ~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 300 (997)
++|++++|++++ +|... ++|++|++++|++++ +| .|+++++|++|++++|++++.+. . .++|++|++++
T Consensus 156 ~~L~l~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-~---~~~L~~L~l~~ 224 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-L---PLSLESIVAGN 224 (454)
T ss_dssp CEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-C---CTTCCEEECCS
T ss_pred CEEECCCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-C---cCcccEEECcC
Confidence 999999999994 77543 589999999999997 66 69999999999999999997433 2 25899999999
Q ss_pred ccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCC
Q 001908 301 NNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFN 380 (997)
Q Consensus 301 N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 380 (997)
|+++.++ .+..+++|++|++++|++++ +|.. ..+|+.|++++|++++ +|.. .++|++|++++|
T Consensus 225 n~l~~lp--------~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N 287 (454)
T 1jl5_A 225 NILEELP--------ELQNLPFLTTIYADNNLLKT-LPDL----PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSEN 287 (454)
T ss_dssp SCCSSCC--------CCTTCTTCCEEECCSSCCSS-CCSC----CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred CcCCccc--------ccCCCCCCCEEECCCCcCCc-cccc----ccccCEEECCCCcccc-cCcc---cCcCCEEECcCC
Confidence 9998653 25689999999999999986 4442 2678999999999986 5554 378999999999
Q ss_pred CCCCCCCCCcccccccceeccccccccccchhhhcCC-CCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcc
Q 001908 381 QLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNL-TLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVP 459 (997)
Q Consensus 381 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 459 (997)
++++. |.. .++|++|++++|++++ ++ .+ ++|+.|++++|++++ +|.. +++|++|++++|+++ .+|
T Consensus 288 ~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp 353 (454)
T 1jl5_A 288 IFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVP 353 (454)
T ss_dssp CCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCC
T ss_pred ccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-ccc
Confidence 99862 221 2689999999999985 33 23 589999999999996 6654 478999999999998 577
Q ss_pred cccccccccccccccCCCcccC--CCccccccccccceeccccccccccccccccCCcCccEEEccCccccc--cCChhc
Q 001908 460 QQILTITTLSRFLDLGNNHLNG--SLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG--SIPLSL 535 (997)
Q Consensus 460 ~~~~~l~~ll~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~ 535 (997)
. .++++ +.|++++|++++ .+|..+.. |+.|.+.|.+|.. +++|+.|++++|++++ .+|.
T Consensus 354 ~---~l~~L-~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~-- 416 (454)
T 1jl5_A 354 E---LPQNL-KQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE-- 416 (454)
T ss_dssp C---CCTTC-CEEECCSSCCSSCCCCCTTCCE--------EECCC-----------------------------------
T ss_pred c---hhhhc-cEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchh--
Confidence 6 35666 889999999998 67766543 3457777788764 4789999999999997 6664
Q ss_pred cccCcCCeeeCccccccccCchhccCCC
Q 001908 536 RSLKSIKELDLSCNNLSGQIPEFLENLS 563 (997)
Q Consensus 536 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 563 (997)
.|+.|.+.+|.+.+.+|.+.....
T Consensus 417 ----sl~~L~~~~~~~~~~~~~~~~~~~ 440 (454)
T 1jl5_A 417 ----SVEDLRMNSERVVDPYEFAHETTD 440 (454)
T ss_dssp ----------------------------
T ss_pred ----hHhheeCcCcccCCccccCHHHhh
Confidence 456678899999887776655443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=393.73 Aligned_cols=209 Identities=24% Similarity=0.359 Sum_probs=168.8
Q ss_pred HHHhhcCccCCcccccCcceEEEEEEC---CCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
+...+.|++.++||+|+||+||+|+.+ .+++.||+|++.... ....+.+|+++++.+ +||||+++++++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~----- 89 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF----- 89 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE-----
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE-----
Confidence 345678999999999999999999874 457899999986443 235678999999998 699999999984
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-CcE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVA 829 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~ 829 (997)
...++.|+||||+++|+|.+++.. +++.+++.++.|++.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~~---------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~ 157 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILNS---------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKY 157 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred EECCEEEEEEeCCCcccHHHHHcC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeE
Confidence 456799999999999999999842 78889999999999999999999 99999999999999877 899
Q ss_pred EEcccccchhcccCCCCCc--------------------cccccccccccccccccCCcchhcccccCccccCCCCCCCc
Q 001908 830 HVSDFGLARFLFARPFDTS--------------------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASV 889 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~ 889 (997)
||+|||+|+.......... ..........+||+.|||||++.. ...|+.
T Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~y~~ 226 (361)
T 4f9c_A 158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-----------CPNQTT 226 (361)
T ss_dssp EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-----------CSCCCT
T ss_pred EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-----------CCCCCC
Confidence 9999999986533211100 001112234579999999987642 234889
Q ss_pred cchhHHHHHHHHHHHhCCCCCCcC
Q 001908 890 TGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 890 ~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
++||||+||++|||+||+.||...
T Consensus 227 ~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 227 AIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccchhhhHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=405.40 Aligned_cols=377 Identities=19% Similarity=0.195 Sum_probs=269.6
Q ss_pred eeecccccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCc
Q 001908 175 HISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY 254 (997)
Q Consensus 175 ~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~ 254 (997)
.++.+++.++ .+|. +. -++++|+|++|++++..|..|.++++|++|+|++|.+.+.+|...+..+++|++|+|++|+
T Consensus 14 ~~~c~~~~l~-~lp~-l~-~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~ 90 (455)
T 3v47_A 14 NAICINRGLH-QVPE-LP-AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90 (455)
T ss_dssp EEECCSSCCS-SCCC-CC-TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCT
T ss_pred ccCcCCCCcc-cCCC-CC-CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCc
Confidence 4555555554 3443 21 1344566666666666677777777888888888877777776666677778888888887
Q ss_pred CcCCCCCCCCCCCCCcEEeccCccCCCccccc--ccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCc
Q 001908 255 FSGSIPESFSNASNIEIIDLPINYFTGKVSII--FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENR 332 (997)
Q Consensus 255 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 332 (997)
+++..|..|+++++|++|+|++|++++..+.. |+.+++|++|+|++|+++.+.+. ..+.++++|++|++++|+
T Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA-----SFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC-----GGGGGCTTCCEEECTTCC
T ss_pred cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc-----cccCCCCcccEEeCCCCc
Confidence 77777777777888888888888777644433 77777777777777777654332 124566677777777766
Q ss_pred cCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCC--------cccccccceeccccc
Q 001908 333 LGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPRE--------IGQLRNLQAIGLSSN 404 (997)
Q Consensus 333 l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--------~~~l~~L~~L~Ls~N 404 (997)
+++..|..+..+. ..+|+.|++++|.+.+..+.. +..+++|++|+|++|
T Consensus 166 l~~~~~~~l~~l~-----------------------~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 222 (455)
T 3v47_A 166 VKSICEEDLLNFQ-----------------------GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGN 222 (455)
T ss_dssp BSCCCTTTSGGGT-----------------------TCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTS
T ss_pred ccccChhhhhccc-----------------------cccccccccccCcccccchhhccccccccccccceeeeEecCCC
Confidence 6666555554431 034555555555555433332 224556666677777
Q ss_pred cccccchhhhcCC---CCCCeEEeecCcCCCC----------CCCCCCC--CCCCcEEecCCCcccCCcccccccccccc
Q 001908 405 FLQGNIPSSLGNL---TLMTDLFLSSNHLQGN----------IPPSLGN--CKNLVSLNLSDNKLIGAVPQQILTITTLS 469 (997)
Q Consensus 405 ~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~----------~p~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~ll 469 (997)
++++..|..+..+ ++|+.|++++|.+.+. .+..+.. .++|++|++++|++.+..|..+..++++
T Consensus 223 ~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L- 301 (455)
T 3v47_A 223 GFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL- 301 (455)
T ss_dssp CCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTC-
T ss_pred cccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCC-
Confidence 6666666655443 6666677766654432 2223332 2578888888888888888888888888
Q ss_pred cccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 302 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 381 (455)
T 3v47_A 302 EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN 381 (455)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCC
Confidence 88888888888888888889999999999999998888888999999999999999999888889999999999999999
Q ss_pred cccccCchhccCCCCCCEEeCCCCcCcccCCCCC
Q 001908 550 NLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKG 583 (997)
Q Consensus 550 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 583 (997)
+|++..+..+..+++|++|++++|+++|.+|...
T Consensus 382 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 382 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred ccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 9997777778899999999999999999888653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=410.10 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=196.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHH---HHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFV---AECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
++|++.+.||+|+||+||+|+.+.+|+.||||+++... ......+. .++++++.++|||||+++++ +.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EEC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EEE
Confidence 68999999999999999999999999999999996321 12223333 34566677899999999998 556
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..|+|||||+||+|.+++.+.. .+++..++.++.||+.||+|||++ +||||||||+|||++.+|++||+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEec
Confidence 779999999999999999998765 488999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+.... ......+||+.|||||++.. +..|+.++||||+||++|||++|++||..
T Consensus 335 DFGlA~~~~~----------~~~~t~~GTp~YmAPEvl~~-----------~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 335 DLGLACDFSK----------KKPHASVGTHGYMAPEVLQK-----------GVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CCTTCEECSS----------CCCCSCCSCGGGCCHHHHST-----------TCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred ccceeeecCC----------CCCCCccCCcCccCHHHHhC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999986522 12234689999999977642 35689999999999999999999999975
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
.... ...+........ .... +....+++.+++.+|+..||++|++ ++||++
T Consensus 394 ~~~~--~~~~i~~~i~~~------~~~~------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 394 HKTK--DKHEIDRMTLTM------AVEL------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp GGCC--CHHHHHHHHHHC------CCCC------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CChH--HHHHHHHhhcCC------CCCC------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 3222 122221111100 0000 0112345679999999999999998 577643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=401.47 Aligned_cols=395 Identities=17% Similarity=0.202 Sum_probs=244.4
Q ss_pred CCCeeee--eeecCCCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCcccc
Q 001908 60 NLCQWAG--VTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGK 137 (997)
Q Consensus 60 ~~c~w~g--v~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 137 (997)
..|.|.+ |.|+. +++ ..+|. + .++|++|||++|++++..|..|+++++|++|+|++|.+.+.
T Consensus 6 ~~c~~~~~~~~c~~------------~~l-~~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~ 69 (455)
T 3v47_A 6 SECSVIGYNAICIN------------RGL-HQVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69 (455)
T ss_dssp -CCEEETTEEECCS------------SCC-SSCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE
T ss_pred ceeEEEccccCcCC------------CCc-ccCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce
Confidence 4577776 66753 333 24555 2 27899999999999988889999999999999999999877
Q ss_pred CC-ccccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcch-hhhhhccCccccccCCCc--
Q 001908 138 IP-TNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPPS-- 213 (997)
Q Consensus 138 iP-~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~-- 213 (997)
+| ..++++++|+ +|+|++|++++..|..|+.++ +++|++++|++++.+|..
T Consensus 70 i~~~~~~~l~~L~-------------------------~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 124 (455)
T 3v47_A 70 IRNNTFRGLSSLI-------------------------ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124 (455)
T ss_dssp ECTTTTTTCTTCC-------------------------EEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSST
T ss_pred ECcccccccccCC-------------------------EEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCccc
Confidence 75 4566666665 555555555444344433332 223334444443333322
Q ss_pred ccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCC--CCCcEEeccCccCCCcccccccccC
Q 001908 214 LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNA--SNIEIIDLPINYFTGKVSIIFGRLK 291 (997)
Q Consensus 214 l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~ 291 (997)
+.++++|++|+|++|++++..|..++..+++|++|++++|++++..|..+..+ .+|+.|++++|.+++..+..++.
T Consensus 125 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~-- 202 (455)
T 3v47_A 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW-- 202 (455)
T ss_dssp TTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH--
T ss_pred ccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc--
Confidence 55566666666666666654455544455666666666666655555555544 45555555555555444332210
Q ss_pred ccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccc--cccccccccCcccccccCCCCCCC
Q 001908 292 NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLS--TTMTDIYMGVNQISGTIPSGIGNL 369 (997)
Q Consensus 292 ~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~~L~~L~l~~N~l~~~~p~~~~~l 369 (997)
.....+..+++|++|++++|++++..|..+.... .+++.|++++|.+.+..
T Consensus 203 --------------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~------- 255 (455)
T 3v47_A 203 --------------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS------- 255 (455)
T ss_dssp --------------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC-------
T ss_pred --------------------cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc-------
Confidence 0001122344555555555555555554443321 33445555544433211
Q ss_pred CCCCEEeccCCCCCCCCCCCcccc--cccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEE
Q 001908 370 VNLNLLGIEFNQLTGNIPREIGQL--RNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSL 447 (997)
Q Consensus 370 ~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 447 (997)
+..+.+.+..+..+..+ ++|++|+|++|++++.+|..+..+++|+.|+|++|++++..|..|.++++|++|
T Consensus 256 -------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 328 (455)
T 3v47_A 256 -------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328 (455)
T ss_dssp -------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred -------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEE
Confidence 11222222333333332 467777777777776667777777777777777777776667777777777777
Q ss_pred ecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccc
Q 001908 448 NLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSF 527 (997)
Q Consensus 448 ~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 527 (997)
+|++|++++..|..+..++++ +.|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|++++|++
T Consensus 329 ~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 407 (455)
T 3v47_A 329 NLSQNFLGSIDSRMFENLDKL-EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407 (455)
T ss_dssp ECCSSCCCEECGGGGTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ECCCCccCCcChhHhcCcccC-CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc
Confidence 777777766666666777776 7777777777777788888888899999999998876666778889999999999999
Q ss_pred cccCC
Q 001908 528 RGSIP 532 (997)
Q Consensus 528 ~~~~p 532 (997)
++..|
T Consensus 408 ~~~~~ 412 (455)
T 3v47_A 408 DCSCP 412 (455)
T ss_dssp CCCTT
T ss_pred ccCCC
Confidence 88776
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=401.64 Aligned_cols=252 Identities=19% Similarity=0.274 Sum_probs=204.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|+.++|||||+++++ +.+....|+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEEE
Confidence 689999999999999999999999999999999986666666788999999999999999999999 455679999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC--CcEEEccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHVSDFGL 836 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFg~ 836 (997)
|||||+||+|.+++....+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 232 v~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999999976432 488999999999999999999999 99999999999999854 8999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.+.. .......+||+.|||||++. +..|+.++||||+||++|||++|+.||....
T Consensus 304 a~~~~~---------~~~~~~~~GT~~y~APEv~~------------~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-- 360 (573)
T 3uto_A 304 TAHLDP---------KQSVKVTTGTAEFAAPEVAE------------GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-- 360 (573)
T ss_dssp CEECCT---------TSEEEEECSSGGGCCHHHHT------------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--
T ss_pred eeEccC---------CCceeeeEECccccCHHHhC------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--
Confidence 987622 12234468999999997664 5678999999999999999999999997431
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.......... ...++. ......+..+++.+||..||++|||+.|+++
T Consensus 361 ---~~~~~~~i~~~~~-~~~~~~-------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 361 ---DDETLRNVKSCDW-NMDDSA-------------FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ---HHHHHHHHHTTCC-CCCSGG-------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHHHhCCC-CCCccc-------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222111110000 000000 0112345678999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=369.02 Aligned_cols=283 Identities=26% Similarity=0.406 Sum_probs=210.6
Q ss_pred hhcCccCCcccccCcceEEEEE----ECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGI----LGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.++||+|+||+||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++... +.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 4689999999999999999998 4568899999999877667778899999999999999999999987532 23
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 458999999999999999987542 388999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+...... ..........+|..|+|||.+. +..++.++|||||||++|||+||..|+...
T Consensus 158 fg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 158 FGLTKVLPQDK-----EFFKVKEPGESPIFWYAPESLT------------ESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp CCSCC------------------CTTCGGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred CcccccccCCc-----ceeeeccCCCCccceeCcHHhc------------CCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 99998753221 1111223345778899997765 456899999999999999999999998632
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
. .++...........................+.+..++.++.+++.+||+.||++|||++|+++.|+++.+++.
T Consensus 221 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 221 P------AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp H------HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred h------HHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 1 1111111000000000000000001111112233456788999999999999999999999999999988764
Q ss_pred c
Q 001908 994 G 994 (997)
Q Consensus 994 ~ 994 (997)
+
T Consensus 295 g 295 (295)
T 3ugc_A 295 G 295 (295)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=379.10 Aligned_cols=363 Identities=18% Similarity=0.211 Sum_probs=227.0
Q ss_pred CCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhccccccccccccc
Q 001908 86 IGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPED 165 (997)
Q Consensus 86 l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~ 165 (997)
..+..+..++++++|++|||++|++++ +| .++.+++|++|+|++|.+++ +| ++++++|+
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~---------------- 88 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLT---------------- 88 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCS----------------
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCC----------------
Confidence 344455567777777777777777775 35 57777777777777777774 33 55554444
Q ss_pred ccccccccceeecccccccCcCcCccCcc-hhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCC
Q 001908 166 IGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPN 244 (997)
Q Consensus 166 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~ 244 (997)
+|+|++|++++. | ++++ ++++|++++|++++ +| ++++++|++|++++|++++ +| ...+++
T Consensus 89 ---------~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~ 149 (457)
T 3bz5_A 89 ---------YLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID---VSHNTQ 149 (457)
T ss_dssp ---------EEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC---CTTCTT
T ss_pred ---------EEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec---cccCCc
Confidence 444444444431 1 2222 12223333333332 22 5555666666666666664 33 224566
Q ss_pred ccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCc
Q 001908 245 LQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLK 324 (997)
Q Consensus 245 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~ 324 (997)
|++|++++|+..+.+ .++.+++|++|++++|++++.. ++.+++|+.|++++|+++.++ +..+++|+
T Consensus 150 L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~~---------l~~l~~L~ 215 (457)
T 3bz5_A 150 LTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKLD---------LNQNIQLT 215 (457)
T ss_dssp CCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCCC---------CTTCTTCS
T ss_pred CCEEECCCCCccccc--ccccCCcCCEEECCCCccceec---cccCCCCCEEECcCCcCCeec---------cccCCCCC
Confidence 666666666444444 3555566666666666665532 455555555555555554421 23344444
Q ss_pred EEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccc
Q 001908 325 VLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSN 404 (997)
Q Consensus 325 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 404 (997)
+| ++++|++++ +| ++.+++|++|++++|++++.. ++.+++|+.|++++|
T Consensus 216 ~L-------------------------~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 216 FL-------------------------DCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT 264 (457)
T ss_dssp EE-------------------------ECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC
T ss_pred EE-------------------------ECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC
Confidence 44 444444443 33 556677777777777777643 344566667766654
Q ss_pred cccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCc
Q 001908 405 FLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLP 484 (997)
Q Consensus 405 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p 484 (997)
+|+.|++++|.+.+.+| ++.+++|+.|++++|.+.+.+|.. ...+ +.|++++|
T Consensus 265 --------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L-~~L~l~~~------- 317 (457)
T 3bz5_A 265 --------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGI-TELDLSQN------- 317 (457)
T ss_dssp --------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCC-SCCCCTTC-------
T ss_pred --------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcc-eEechhhc-------
Confidence 34567777777776666 467788888888888877777743 2333 55555554
Q ss_pred cccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCC
Q 001908 485 LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSF 564 (997)
Q Consensus 485 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 564 (997)
++|++|++++|++++. + ++++++|+.|++++|+|++ ++.|..|++++|+++|. ..+..
T Consensus 318 ------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~ 375 (457)
T 3bz5_A 318 ------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTIT 375 (457)
T ss_dssp ------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEE
T ss_pred ------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeee
Confidence 6889999999999873 3 8889999999999999985 35677788999999876 34566
Q ss_pred CCEEeCCCCcCcccCCCC
Q 001908 565 LEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 565 L~~L~ls~N~l~~~~p~~ 582 (997)
|+.+++++|+++|.+|..
T Consensus 376 l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 376 MPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CCCBCCBTTBEEEECCTT
T ss_pred cCccccccCcEEEEcChh
Confidence 888899999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=367.79 Aligned_cols=287 Identities=23% Similarity=0.286 Sum_probs=210.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||+||+|++. ++.||||+++.... ......+|+.++++++||||+++++++.... ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 468999999999999999999984 79999999975433 3345567899999999999999999976532 1244589
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhC-------CCCCcEecCCCCCCeeeCCCCcEE
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH-------CQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~-------~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
+||||+++|+|.++++... +++..++.++.|++.||+|||+. +.++|+||||||+||+++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKANV-------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 9999999999999998753 88999999999999999999986 234799999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+....... ........||+.|+|||++.... .....++.++|||||||++|||+||+.||
T Consensus 172 L~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~DiwslG~il~el~tg~~pf 238 (322)
T 3soc_A 172 IADFGLALKFEAGKS------AGDTHGQVGTRRYMAPEVLEGAI-------NFQRDAFLRIDMYAMGLVLWELASRCTAA 238 (322)
T ss_dssp ECCCTTCEEECTTSC------CCCCTTCCCCGGGCCHHHHTTCC-------CCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred EccCCcccccccccC------ccccccCccCccccCHhhccccc-------ccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence 999999987632211 11223357999999998876311 11235677899999999999999999999
Q ss_pred CcCcCCCc-cHHHHHHhh-cchhhhhhc-CcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 911 NCMFQGGL-TLHEFCKMA-LPEKVMETV-DPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 911 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
........ ......... ......... ......... .......++.++.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp SSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhccchhhhhccCCchhhhhhhhhcccCCCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 75433221 111110000 000111111 000000000 011123456779999999999999999999999999999
Q ss_pred HHHH
Q 001908 988 ARQT 991 (997)
Q Consensus 988 ~~~~ 991 (997)
+.+.
T Consensus 316 l~~~ 319 (322)
T 3soc_A 316 MQRL 319 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=363.21 Aligned_cols=269 Identities=25% Similarity=0.398 Sum_probs=214.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|.+.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.. .+..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 3678999999999999999999999999999999977667777899999999999999999999999653 45899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence 99999999999999987532 488999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCcc------ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 838 RFLFARPFDTSM------ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 838 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+........... ..........||+.|+|||++. +..++.++|||||||++|||++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~~l~el~~g~~~~~ 223 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN------------GRSYDEKVDVFSFGIVLCEIIGRVNADP 223 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHTCCSST
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhc------------CCCCCcHHHHHHHHHHHHHHhcCCCCCc
Confidence 876332211100 0111122467999999997654 5678999999999999999999999987
Q ss_pred cCcCCCc----cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 912 CMFQGGL----TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 912 ~~~~~~~----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
....... ......... .+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 224 DYLPRTMDFGLNVRGFLDRY------------------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279 (310)
T ss_dssp TTSCBCTTSSBCHHHHHHHT------------------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhhhHHHHhhhhhcccccc------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 4322111 111110000 011234567899999999999999999999999999
Q ss_pred HHHHhhcc
Q 001908 988 ARQTLVGR 995 (997)
Q Consensus 988 ~~~~~~~~ 995 (997)
+.....+.
T Consensus 280 l~~~~~~~ 287 (310)
T 3s95_A 280 LRMHLAGH 287 (310)
T ss_dssp HHHHHHHC
T ss_pred HHHhccCc
Confidence 98876543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=365.97 Aligned_cols=284 Identities=33% Similarity=0.494 Sum_probs=223.7
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++..++++|+..+.||+|+||+||+|+++ +++.||||++........+.+.+|++++++++||||+++++++ .
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 105 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----D 105 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----C
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----c
Confidence 344557789999999999999999999976 7899999999866666678899999999999999999999995 4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
..+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEE
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEE
Confidence 45688999999999999999976542 123589999999999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+++...... .........||+.|+|||++. +..++.++|||||||++|||+||+.||.
T Consensus 181 ~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 181 TDFGISKKGTELD------QTHLSTVVKGTLGYIDPEYFI------------KGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp CCCTTCEECSSSS------CCCCBCCCEEETTTCCHHHHH------------HCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred eeccccccccccc------ccccccccCCCccccCHHHhc------------CCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 9999997642211 111223456899999997764 3568899999999999999999999997
Q ss_pred cCcCC-CccHHHHHHhh-cchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 912 CMFQG-GLTLHEFCKMA-LPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 912 ~~~~~-~~~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
..... .....++.... ........+++... .....+++.++.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLA--------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT--------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHhhhccccccHHHhcChhhc--------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 54332 22333332211 11122222333221 1223466788999999999999999999999999999987
Q ss_pred HHh
Q 001908 990 QTL 992 (997)
Q Consensus 990 ~~~ 992 (997)
...
T Consensus 315 ~~~ 317 (321)
T 2qkw_B 315 RLQ 317 (321)
T ss_dssp HSS
T ss_pred hcc
Confidence 543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=373.50 Aligned_cols=354 Identities=17% Similarity=0.160 Sum_probs=289.4
Q ss_pred CcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhc
Q 001908 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVA 153 (997)
Q Consensus 74 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l 153 (997)
.+++.|||++|++++. | .++.+++|++|+|++|++++ +| ++.+++|++|+|++|.+++ +| ++++++|++|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 4799999999999874 4 79999999999999999997 45 9999999999999999996 55 899999999999
Q ss_pred ccccccccccccccccccccceeecccccccCcCcCccCcc-hhhhhhccCccccccCCCcccCCCccceeeccCCCCCC
Q 001908 154 YRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG 232 (997)
Q Consensus 154 ~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g 232 (997)
++|++.+ +| ...+++|++|++++|++++. | ++.+ ++.+|++++|+..+.+ .+..+++|++|++++|++++
T Consensus 114 ~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 114 DTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp CSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred CCCcCCe-ec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence 9999986 55 34688999999999999974 3 6666 3567888888777776 47888889999999999885
Q ss_pred CCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcc
Q 001908 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD 312 (997)
Q Consensus 233 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 312 (997)
+| +..+++|+.|++++|++++. .++.+++|++|+|++|++++. | ++.+++|++|++++|+++.++.
T Consensus 185 -l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~~---- 250 (457)
T 3bz5_A 185 -LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELDV---- 250 (457)
T ss_dssp -CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCCC----
T ss_pred -ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcCH----
Confidence 66 34788899999999988875 488888899999999998884 3 7888889999999998887542
Q ss_pred hhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCccc
Q 001908 313 FVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ 392 (997)
Q Consensus 313 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 392 (997)
..+++|+.|++++|+ |+.|++++|.+.+.+| ++++++|+.|++++|.+.+.+|. .
T Consensus 251 -----~~l~~L~~L~l~~n~---------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~ 305 (457)
T 3bz5_A 251 -----STLSKLTTLHCIQTD---------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---Q 305 (457)
T ss_dssp -----TTCTTCCEEECTTCC---------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---T
T ss_pred -----HHCCCCCEEeccCCC---------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---C
Confidence 467788888887764 4567888888888887 57788999999999988887774 3
Q ss_pred ccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccccccccc
Q 001908 393 LRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFL 472 (997)
Q Consensus 393 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L 472 (997)
..+|+.|++++| ++|+.|+|++|+|++. + ++++++|+.|++++|++++ + +.+ ..|
T Consensus 306 ~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l-------~~L-~~L 360 (457)
T 3bz5_A 306 AAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-F-------SSV-GKI 360 (457)
T ss_dssp TCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-C-------TTG-GGS
T ss_pred CCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-c-------ccc-ccc
Confidence 466777776665 6889999999999974 3 8899999999999999985 2 344 678
Q ss_pred ccCCCcccCCCccccccccccceeccccccccccccccccC
Q 001908 473 DLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTG 513 (997)
Q Consensus 473 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 513 (997)
++++|+++|. +.+..|+.+++++|+++|.+|..+..
T Consensus 361 ~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 361 PALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp SGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred cccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 8888988875 35677888899999999988876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=359.03 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=203.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 3689999999999999999999998999999999976655556788999999999999999999999643 55899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++.... +++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 94 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999998753 78899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... ........||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 164 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~--- 220 (297)
T 3fxz_A 164 AQITPE--------QSKRSTMVGTPYWMAPEVVT------------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--- 220 (297)
T ss_dssp EECCST--------TCCBCCCCSCGGGCCHHHHH------------CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---
T ss_pred eecCCc--------ccccCCccCCcCccChhhhc------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 765221 11233457999999997664 4678999999999999999999999996421
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... .... ....+.. ..+..++..+.+++.+||..||++|||+.|+++
T Consensus 221 -~~~~~-~~~~-----~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 221 -PLRAL-YLIA-----TNGTPEL----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -HHHHH-HHHH-----HHCSCCC----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHH-HHHH-----hCCCCCC----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11111 1100 0000000 011123456789999999999999999999975
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=384.83 Aligned_cols=348 Identities=21% Similarity=0.214 Sum_probs=292.4
Q ss_pred ceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccC
Q 001908 221 ENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300 (997)
Q Consensus 221 ~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 300 (997)
+.++.++++++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 45666777776 6776654 5678888888888877788888888888888888888888788888888888888877
Q ss_pred ccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCC
Q 001908 301 NNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFN 380 (997)
Q Consensus 301 N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 380 (997)
|+++.++.. .+.++++|++|+|++|++ ++..|..|.++++|+.|+|++|
T Consensus 90 n~l~~~~~~------~~~~l~~L~~L~Ls~n~i-------------------------~~~~~~~~~~l~~L~~L~l~~n 138 (477)
T 2id5_A 90 NRLKLIPLG------VFTGLSNLTKLDISENKI-------------------------VILLDYMFQDLYNLKSLEVGDN 138 (477)
T ss_dssp SCCCSCCTT------SSTTCTTCCEEECTTSCC-------------------------CEECTTTTTTCTTCCEEEECCT
T ss_pred CcCCccCcc------cccCCCCCCEEECCCCcc-------------------------ccCChhHccccccCCEEECCCC
Confidence 777765432 234555555555555544 4456667888899999999999
Q ss_pred CCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc
Q 001908 381 QLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ 460 (997)
Q Consensus 381 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 460 (997)
++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++.+..+..|..+++|++|++++|.+.+.+|.
T Consensus 139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~ 218 (477)
T 2id5_A 139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218 (477)
T ss_dssp TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence 99988888999999999999999999987778899999999999999999988888999999999999999998888888
Q ss_pred ccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCc
Q 001908 461 QILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKS 540 (997)
Q Consensus 461 ~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 540 (997)
......++ +.|+|++|++++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++
T Consensus 219 ~~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 297 (477)
T 2id5_A 219 NCLYGLNL-TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297 (477)
T ss_dssp TTTTTCCC-SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTT
T ss_pred ccccCccc-cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCccc
Confidence 88877777 89999999999666678999999999999999999888889999999999999999999999999999999
Q ss_pred CCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCCCC
Q 001908 541 IKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGSN 604 (997)
Q Consensus 541 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~~~ 604 (997)
|+.|+|++|+|++..+..|..+++|++|+|++|+|++.++..+.+.......+.++...|.++.
T Consensus 298 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp CCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred CCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 9999999999998888889999999999999999998877555445555677888999997543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=365.41 Aligned_cols=287 Identities=35% Similarity=0.579 Sum_probs=225.7
Q ss_pred CCccChHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEee
Q 001908 666 FPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITV 744 (997)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 744 (997)
...++..++....++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 455788899999999999999999999999999865 68999999997433 2223468899999999999999999999
Q ss_pred eeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
+. .....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+++.++|+||||||+||+++
T Consensus 96 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 96 CM-----TPTERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168 (326)
T ss_dssp EC-----CSSCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred Ee-----cCCceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence 64 455789999999999999999876522 23589999999999999999999998777899999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.++.+||+|||+|+..... .........||+.|+|||.+. +..++.++|||||||++|||+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~ 229 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYK-------DTHVTTAVRGTIGHIAPEYLS------------TGKSSEKTDVFGYGVMLLELI 229 (326)
T ss_dssp TTCCEEECCCSSCEECCSS-------SSCEECCCCSCGGGCCHHHHH------------HSEECHHHHHHHHHHHHHHHH
T ss_pred CCCCEEeccCccccccCcc-------cccccccccCCcCccCHHHhc------------cCCCCccccchhHHHHHHHHH
Confidence 9999999999999865221 112233456999999997764 356789999999999999999
Q ss_pred hCCCCCCcC---cCCCccHHHHHHhhcch-hhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 905 TRRRPTNCM---FQGGLTLHEFCKMALPE-KVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 905 tg~~P~~~~---~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
+|+.||... ........++....... ......+..... ....+++..+.+++.+||+.||++|||++|
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 301 (326)
T 3uim_A 230 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG--------NYKDEEVEQLIQVALLCTQSSPMERPKMSE 301 (326)
T ss_dssp HCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT--------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred hCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc--------ccCHHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence 999999632 12233344444333222 222222322221 223456788999999999999999999999
Q ss_pred HHHHHHH
Q 001908 981 VLAKLCA 987 (997)
Q Consensus 981 vl~~L~~ 987 (997)
+++.|++
T Consensus 302 ll~~L~~ 308 (326)
T 3uim_A 302 VVRMLEG 308 (326)
T ss_dssp HHHHHHT
T ss_pred HHHHhcC
Confidence 9999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=355.72 Aligned_cols=274 Identities=22% Similarity=0.358 Sum_probs=207.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhh--cCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN--TRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||+||+|++ +++.||||++.... ...+.+|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 46899999999999999999998 68999999986432 3556677777766 7999999999987543 234567
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCcEecCCCCCCeeeCCCC
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH--------HHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
.++||||+++|+|.++++.. .+++..+++++.|++.||+||| +. +|+||||||+||+++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 89999999999999999654 3889999999999999999999 77 999999999999999999
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC-
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR- 906 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg- 906 (997)
.+||+|||+|+....... ..........||+.|+|||++..... .....++.++|||||||++|||+||
T Consensus 151 ~~kl~Dfg~a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~DvwslG~il~el~tg~ 220 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTN----QLDVGNNPRVGTKRYMAPEVLDETIQ------VDCFDSYKRVDIWAFGLVLWEVARRM 220 (301)
T ss_dssp CEEECCCTTCEEEETTTT----EEECCCCCCCCCGGGCCHHHHTTCCC------TTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred CEEEeeCCCeeecccccc----cccccccccccccceeChhhhcCcCC------CCcccCCchhhHHHHHHHHHHHHhhh
Confidence 999999999976532211 11111233579999999988763110 0001456799999999999999999
Q ss_pred ---------CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 907 ---------RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 907 ---------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
+.||..................... ..+.... ......++.++.+++.+||+.||++|||
T Consensus 221 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ----QRPNIPN-------RWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCG-------GGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred cCccccccccccccccCCCCcchhhhhHHHhccC----CCCCCCh-------hhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 8888765444444433322211111 1111110 1122346778999999999999999999
Q ss_pred HHHHHHHHHHH
Q 001908 978 MRDVLAKLCAA 988 (997)
Q Consensus 978 ~~evl~~L~~~ 988 (997)
+.|+++.|+++
T Consensus 290 ~~~i~~~L~~i 300 (301)
T 3q4u_A 290 ALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHhcc
Confidence 99999999876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=358.17 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=201.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
..+|++.+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+++++.++||||+++++++ ...+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCE
Confidence 45799999999999999999999989999999999643 344567789999999999999999999995 44568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred EEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999999998764 478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
+|+.... .......+||+.|+|||++. +..+ +.++||||+||++|||++|+.||...
T Consensus 160 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~- 217 (328)
T 3fe3_A 160 FSNEFTV---------GGKLDAFCGAPPYAAPELFQ------------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ- 217 (328)
T ss_dssp CCGGGSS---------SCGGGTTSSSGGGCCHHHHH------------TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred CceecCC---------CCccccccCCcceeCccccc------------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-
Confidence 9976521 12234567999999998765 3444 57999999999999999999999743
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+.......... .. +.....++.+++.+||..||++|||+.|+++
T Consensus 218 ----~~~~~~~~i~~~~~------~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 218 ----NLKELRERVLRGKY------RI------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----SHHHHHHHHHHCCC------CC------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CHHHHHHHHHhCCC------CC------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22222221111100 00 0112345779999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=364.99 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=206.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCc---EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGT---FVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||+||+|++..+++ .||||+++.. .....+.+.+|++++++++||||+++++++. ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 3578889999999999999999975444 5999999753 4445678999999999999999999999954 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.++++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence 678999999999999999976532 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+++....... .........+|+.|+|||++. +..++.++|||||||++|||++ |+.||..
T Consensus 195 fg~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 195 FGLSRVLEDDPD-----AAYTTTGGKIPIRWTAPEAIA------------FRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp CSSCEECC---------CCEECC---CCGGGSCHHHHH------------HCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCcccccccCcc-----ceeeccCCCCcccccCHhHhc------------CCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 999987632211 111223345688899997765 3568899999999999999999 9999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.. ..+...... ..... +.+..++..+.+++..||..||++|||+.|+++.|+++....
T Consensus 258 ~~-----~~~~~~~~~-----~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 258 MT-----NRDVISSVE-----EGYRL------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp SC-----HHHHHHHHH-----TTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CC-----HHHHHHHHH-----cCCCC------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 31 111111110 00000 111234567889999999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=367.53 Aligned_cols=266 Identities=23% Similarity=0.369 Sum_probs=209.0
Q ss_pred hhcCccCCcccccCcceEEEEEEC-------CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-------ENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
.++|++.+.||+|+||.||+|++. .++..||||+++.. .....+.+.+|+++++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 468999999999999999999874 34568999999744 344567899999999999 8999999999954
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
..+..++||||+++|+|.+++...... .....+++..++.++.||+.||+|||++ +|+||||||
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 455799999999999999999876421 1123478999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+||+++.++.+||+|||+|+....... ........+|+.|+|||++. +..++.++|||||||
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~DvwslG~ 293 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALF------------DRVYTHQSDVWSFGV 293 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCT------TCTTTTTTSCGGGCCHHHHH------------TCCCCHHHHHHHHHH
T ss_pred hhEEECCCCCEEEccccCCcccCcccc------eecccCCCcccceECHhHhc------------CCCCCcHHHHHHHHH
Confidence 999999999999999999986532211 11223345788999997664 467899999999999
Q ss_pred HHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 899 MLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 899 vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++|||+| |+.||...... .+...... ...+ ..+..++.++.+++.+||..||++||+
T Consensus 294 il~ellt~g~~p~~~~~~~--~~~~~~~~--------~~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rpt 351 (370)
T 2psq_A 294 LMWEIFTLGGSPYPGIPVE--ELFKLLKE--------GHRM------------DKPANCTNELYMMMRDCWHAVPSQRPT 351 (370)
T ss_dssp HHHHHHTTSCCSSTTCCGG--GHHHHHHT--------TCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHcCCCCCCCCCCHH--HHHHHHhc--------CCCC------------CCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 9999999 99998743211 11111110 0000 111234567889999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 001908 978 MRDVLAKLCAARQT 991 (997)
Q Consensus 978 ~~evl~~L~~~~~~ 991 (997)
+.|+++.|+++...
T Consensus 352 ~~ell~~L~~il~~ 365 (370)
T 2psq_A 352 FKQLVEDLDRILTL 365 (370)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=354.89 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=199.3
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
...++|++.+.||+|+||+||+|++ +++.||||++... .....+.+.+|++++++++||||+++++++ ...
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 3456899999999999999999988 6889999998643 344557889999999999999999999995 345
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCeeeCCCCcEEE
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~~kl 831 (997)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEE
T ss_pred CceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEE
Confidence 578999999999999999987541 11378899999999999999999999 7 999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+..... ........||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 181 ~Dfg~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 181 CDFGLSRLKAST--------FLSSKSAAGTPEWMAPEVLR------------DEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp CCCC-------------------------CCTTSCHHHHT------------TCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred CCCCCCcccccc--------ccccccCCCCccccChhhhc------------CCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999754211 11223457999999997664 4668899999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
... ..+...... ....... .+..++.++.+++.+||..||++|||+.|+++.|+++.+.
T Consensus 241 ~~~-----~~~~~~~~~----~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 241 NLN-----PAQVVAAVG----FKCKRLE------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TSC-----HHHHHHHHH----HSCCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCC-----HHHHHHHHH----hcCCCCC------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 431 111111100 0000000 1112345688999999999999999999999999988764
Q ss_pred h
Q 001908 992 L 992 (997)
Q Consensus 992 ~ 992 (997)
.
T Consensus 300 ~ 300 (309)
T 3p86_A 300 A 300 (309)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.56 Aligned_cols=284 Identities=32% Similarity=0.462 Sum_probs=222.0
Q ss_pred cCCccChHHHHHHhhcCccC------CcccccCcceEEEEEECCCCcEEEEEEeccc----chhhHHHHHHHHHHHhhcC
Q 001908 665 YFPMVSYSELSEATNEFSSS------NMIGQGSFGSVYKGILGENGTFVAVKILNLM----QKGALKSFVAECEVLRNTR 734 (997)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~ 734 (997)
..+.+++.++..++++|... +.||+|+||+||+|+. +++.||||++... .....+.+.+|++++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34667889999999998877 8999999999999987 6889999998642 2344678899999999999
Q ss_pred CCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEec
Q 001908 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHG 814 (997)
Q Consensus 735 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHr 814 (997)
||||+++++++. ..+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||
T Consensus 89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~ 157 (307)
T 2nru_A 89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHR 157 (307)
T ss_dssp CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecC
Confidence 999999999954 45578999999999999999985432 12488999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhH
Q 001908 815 DLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894 (997)
Q Consensus 815 Dlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dvw 894 (997)
||||+||+++.++.+||+|||.++...... .........||+.|+|||.+. +.++.++|||
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~-------------~~~~~~~Dv~ 218 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFA------QTVMTSRIVGTTAYMAPEALR-------------GEITPKSDIY 218 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCS------SCEECSSCCSCGGGCCHHHHT-------------TEECTHHHHH
T ss_pred CCCHHHEEEcCCCcEEEeeccccccccccc------ccccccccCCCcCcCChHHhc-------------CCCCccchhH
Confidence 999999999999999999999997652211 111223357899999998764 3478899999
Q ss_pred HHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhh--cchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCC
Q 001908 895 SLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMA--LPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972 (997)
Q Consensus 895 SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 972 (997)
||||++|||++|+.||........ ...+.... ........+++.+. .....++..+.+++.+||+.||
T Consensus 219 slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p 288 (307)
T 2nru_A 219 SFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKMN---------DADSTSVEAMYSVASQCLHEKK 288 (307)
T ss_dssp HHHHHHHHHHHCCCSBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSCS---------CCCHHHHHHHHHHHHHHTCSST
T ss_pred HHHHHHHHHHHCCCCcccCcchHH-HHHHHHHhhhhhhhhhhhcccccc---------ccchHHHHHHHHHHHHHcCCCc
Confidence 999999999999999986543321 22221111 11122233333221 1233567789999999999999
Q ss_pred CCCCCHHHHHHHHHHHHH
Q 001908 973 IERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 973 ~~Rps~~evl~~L~~~~~ 990 (997)
++|||+.++++.|+++..
T Consensus 289 ~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 289 NKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTSCCHHHHHHHHHHHC-
T ss_pred ccCcCHHHHHHHHHHHhc
Confidence 999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=355.53 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=209.1
Q ss_pred CccChHHHHHHhhc----------CccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCC
Q 001908 667 PMVSYSELSEATNE----------FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHR 736 (997)
Q Consensus 667 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ 736 (997)
+.++.++++.+++. |+..++||+|+||.||+|+.+.+|+.||||+++.......+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777777754 67778999999999999999989999999999866666667889999999999999
Q ss_pred CcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCC
Q 001908 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDL 816 (997)
Q Consensus 737 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 816 (997)
||+++++++.. .+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||
T Consensus 103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl 167 (321)
T 2c30_A 103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI 167 (321)
T ss_dssp TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence 99999999654 45899999999999999998754 388999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHH
Q 001908 817 KPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896 (997)
Q Consensus 817 k~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSl 896 (997)
||+||+++.++.+||+|||+++..... ........||+.|+|||++. +..++.++|||||
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Dv~sl 227 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKD--------VPKRKSLVGTPYWMAPEVIS------------RSLYATEVDIWSL 227 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSS--------SCCBCCCCSCGGGCCHHHHT------------TCCBCTHHHHHHH
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccC--------ccccccccCCccccCHhhhc------------CCCCCchhhHHHH
Confidence 999999999999999999999765221 11223457999999997654 4678899999999
Q ss_pred HHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 897 GVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 897 Gvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
||++|||++|+.||.... ..+.... ......+.... ....+..+.+++.+||..||++||
T Consensus 228 G~il~el~~g~~pf~~~~-----~~~~~~~-----~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rp 287 (321)
T 2c30_A 228 GIMVIEMVDGEPPYFSDS-----PVQAMKR-----LRDSPPPKLKN----------SHKVSPVLRDFLERMLVRDPQERA 287 (321)
T ss_dssp HHHHHHHHHSSCTTTTSC-----HHHHHHH-----HHHSSCCCCTT----------GGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHhCCCCCCCCC-----HHHHHHH-----HhcCCCCCcCc----------cccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999987421 1111111 11111111110 112245678999999999999999
Q ss_pred CHHHHHH
Q 001908 977 EMRDVLA 983 (997)
Q Consensus 977 s~~evl~ 983 (997)
|+.|+++
T Consensus 288 s~~ell~ 294 (321)
T 2c30_A 288 TAQELLD 294 (321)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999976
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.06 Aligned_cols=288 Identities=21% Similarity=0.300 Sum_probs=214.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEE
Confidence 57999999999999999999999899999999997433 3345778899999999999999999998653 2345789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee----CCCCcEEEcc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSD 833 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~D 833 (997)
+||||+++|+|.+++...... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred EEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 999999999999999875421 2388999999999999999999999 99999999999999 8888999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+..... .......||+.|+|||++..... ....+..++.++|||||||++|||+||+.||...
T Consensus 160 fg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 160 FGAARELEDD---------EQFVSLYGTEEYLHPDMYERAVL----RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CTTCEECCTT---------CCBCCCCSCGGGCCHHHHHHHTS----CCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CCCceecCCC---------CceeecccCCCccCHHHhhhccc----cccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999865221 12233569999999998763211 1112467889999999999999999999999754
Q ss_pred cCCCccHHHHHHh--hcchhhhhhcCccc--cccccc--chhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKM--ALPEKVMETVDPSL--LLAWSD--GRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 914 ~~~~~~~~~~~~~--~~~~~~~~~~d~~~--~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
............. ..+......+.... ...+.. .............+.+++.+||..||++|||++|+++...+
T Consensus 227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp TCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 3322222221111 11111000000000 000000 00112235667788999999999999999999999998875
Q ss_pred H
Q 001908 988 A 988 (997)
Q Consensus 988 ~ 988 (997)
.
T Consensus 307 ~ 307 (319)
T 4euu_A 307 I 307 (319)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=374.15 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=208.1
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
..++|.+.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++||||++++++|. ..+.
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCC
Confidence 346889999999999999999999989999999998743 2334567889999999999999999999964 3457
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred cEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence 899999999999999998653 1378999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 914 (997)
+|+...... .........+++.|+|||++. ++.++.++|||||||++|||+| |..||....
T Consensus 259 ~s~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 259 MSREEADGV------YAASGGLRQVPVKWTAPEALN------------YGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp GCEECTTSE------EECCSSCCEEEGGGSCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CceecCCCc------eeecCCCCCCCcCcCCHhHhc------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 997542111 011112234577899998765 3568899999999999999999 999987432
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.. ...+.+... .+.+.+..++.++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 321 ~~--~~~~~~~~~--------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 321 NQ--QTREFVEKG--------------------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HH--HHHHHHHTT--------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH--HHHHHHHcC--------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 10 111111000 00111223466788999999999999999999999999998764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=366.46 Aligned_cols=169 Identities=28% Similarity=0.415 Sum_probs=83.3
Q ss_pred CCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEec
Q 001908 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449 (997)
Q Consensus 370 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 449 (997)
++|+.|++++|++++. ..+..+++|++|++++|++++..| +..+++|+.|++++|++++..+ +..+++|++|++
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence 3444444444444322 233444444444444444443322 4444444444444444443222 444444555555
Q ss_pred CCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccc
Q 001908 450 SDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG 529 (997)
Q Consensus 450 ~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (997)
++|++.+..| +..++++ +.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++
T Consensus 295 ~~n~l~~~~~--~~~l~~L-~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 367 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNL-TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISD 367 (466)
T ss_dssp CSSCCSCCGG--GGGCTTC-SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred CCCcccCchh--hcCCCCC-CEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCc
Confidence 5554443222 3444444 455555555554433 44555666666666666543 245556666666666666665
Q ss_pred cCChhccccCcCCeeeCccccccc
Q 001908 530 SIPLSLRSLKSIKELDLSCNNLSG 553 (997)
Q Consensus 530 ~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (997)
.+| +..+++|+.|++++|++++
T Consensus 368 ~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 368 LTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CGG--GTTCTTCCEEECCCEEEEC
T ss_pred cch--hhcCCCCCEEeccCCcccC
Confidence 554 5556666666666666654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=365.60 Aligned_cols=327 Identities=29% Similarity=0.387 Sum_probs=252.5
Q ss_pred ccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCcc
Q 001908 214 LYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNL 293 (997)
Q Consensus 214 l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 293 (997)
+..+++|++|+|++|.++ .+|. +..+++|++|++++|.+++..| ++++++|++|+|++|++++..+ |+.+++|
T Consensus 64 ~~~l~~L~~L~Ls~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 136 (466)
T 1o6v_A 64 VEYLNNLTQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNL 136 (466)
T ss_dssp GGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred hhhhcCCCEEECCCCccC-Cchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCC
Confidence 555666677777777666 3343 3466677777777777765544 6777777777777777766544 6677777
Q ss_pred CeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCC
Q 001908 294 WSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLN 373 (997)
Q Consensus 294 ~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 373 (997)
++|++++|+++.++ .+..+++|++|+++ |.+.+..+ +.++ ++|+.|++++|.+++. ..+..+++|+
T Consensus 137 ~~L~l~~n~l~~~~--------~~~~l~~L~~L~l~-~~~~~~~~--~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~ 202 (466)
T 1o6v_A 137 NRLELSSNTISDIS--------ALSGLTSLQQLSFG-NQVTDLKP--LANL-TTLERLDISSNKVSDI--SVLAKLTNLE 202 (466)
T ss_dssp SEEEEEEEEECCCG--------GGTTCTTCSEEEEE-ESCCCCGG--GTTC-TTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred CEEECCCCccCCCh--------hhccCCcccEeecC-CcccCchh--hccC-CCCCEEECcCCcCCCC--hhhccCCCCC
Confidence 77777777766531 35667777777775 44443332 4444 5677777777777643 2478889999
Q ss_pred EEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCc
Q 001908 374 LLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNK 453 (997)
Q Consensus 374 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 453 (997)
+|++++|++++..| ++.+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|++|++++|+
T Consensus 203 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~ 276 (466)
T 1o6v_A 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276 (466)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred EEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCc
Confidence 99999999997766 77899999999999999853 468889999999999999997655 8889999999999999
Q ss_pred ccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCCh
Q 001908 454 LIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPL 533 (997)
Q Consensus 454 l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 533 (997)
+++..| +..++++ +.|++++|++++..| +..+++|+.|++++|++++..| +..+++|+.|++++|++++. .
T Consensus 277 l~~~~~--~~~l~~L-~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 347 (466)
T 1o6v_A 277 ISNISP--LAGLTAL-TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--S 347 (466)
T ss_dssp CCCCGG--GTTCTTC-SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred cCcccc--ccCCCcc-CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--h
Confidence 985544 7778888 899999999997554 7889999999999999997766 78899999999999999865 4
Q ss_pred hccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCccc
Q 001908 534 SLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 534 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
.+..+++|+.|++++|++++.+| +..+++|+.|++++|++++.
T Consensus 348 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp GGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred hhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 78899999999999999998877 88999999999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=365.56 Aligned_cols=278 Identities=20% Similarity=0.312 Sum_probs=215.5
Q ss_pred cChHHHHHHhhcCccCCcccccCcceEEEEE-----ECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceE
Q 001908 669 VSYSELSEATNEFSSSNMIGQGSFGSVYKGI-----LGENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKI 741 (997)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 741 (997)
....+++...++|++.+.||+|+||.||+|+ ...+++.||||+++.. .....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4556666778899999999999999999998 4456789999999753 334457889999999999 79999999
Q ss_pred EeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCC------------------------------------------
Q 001908 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQP------------------------------------------ 779 (997)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------ 779 (997)
+++|.. .....++||||+++|+|.++++......
T Consensus 92 ~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999743 2345899999999999999998764210
Q ss_pred ------------------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcc
Q 001908 780 ------------------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLF 841 (997)
Q Consensus 780 ------------------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~ 841 (997)
....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 011278899999999999999999999 99999999999999999999999999998652
Q ss_pred cCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccH
Q 001908 842 ARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTL 920 (997)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 920 (997)
... .........||+.|+|||++. +..++.++|||||||++|||+| |+.||....... .+
T Consensus 245 ~~~------~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~ 305 (359)
T 3vhe_A 245 KDP------DYVRKGDARLPLKWMAPETIF------------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 305 (359)
T ss_dssp SCT------TCEEC--CEECGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HH
T ss_pred ccc------cchhccccCCCceeEChhhhc------------CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HH
Confidence 211 112233456899999997765 4668899999999999999998 999987432221 11
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
...... ...... +..+++++.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus 306 ~~~~~~--------~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 306 CRRLKE--------GTRMRA------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHH--------TCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHc--------CCCCCC------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 111110 000000 1112456789999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=358.95 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=201.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||.||+|+.+.+++.||+|++... .....+.+.+|+++++.++||||+++++++ ...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 36799999999999999999999999999999999633 233457889999999999999999999985 4556
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 8999999999999999998754 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... .......+||+.|+|||++.. ..+..++.++||||+||++|||++|+.||....
T Consensus 160 G~a~~~~~---------~~~~~~~~gt~~Y~aPE~~~~---------~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 160 NIAAMLPR---------ETQITTMAGTKPYMAPEMFSS---------RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TTCEECCT---------TCCBCCCCSCGGGCCGGGTCC---------CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred ceeeeccC---------CCceeccCCCccccCCeeecc---------CCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 99986522 122344679999999987642 123568899999999999999999999997432
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-HHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-MRDVL 982 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl 982 (997)
.. ...+....... ..... +..+...+.+++.+||..||++||+ ++++.
T Consensus 222 ~~--~~~~~~~~~~~------~~~~~------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 222 ST--SSKEIVHTFET------TVVTY------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp TS--CHHHHHHHHHH------CCCCC------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred Cc--cHHHHHHHHhh------cccCC------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 22 22222111100 00000 1122456789999999999999998 66654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=366.44 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=195.9
Q ss_pred hcCccCCcccccCcceEEEEEEC---CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||+||+|+++ .++..||||+++.. .....+.+.+|++++++++||||+++++++. ..+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~ 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KSK 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCC
Confidence 57999999999999999999886 46778999999743 3445678999999999999999999999964 345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.++++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence 78999999999999999986532 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|+++....... .........+|+.|+|||.+. +..++.++|||||||++|||++ |+.||...
T Consensus 192 g~a~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 192 GLGRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIA------------YRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ---------------------------CTTSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccccccccCCc-----cceeccCCCcCCCccChhhhc------------cCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987632111 111112234577899997664 4678999999999999999998 99998643
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
. ..+..... +.... .+.+..++.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 255 ~-----~~~~~~~i---------~~~~~--------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 255 S-----NQDVIKAV---------DEGYR--------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp C-----HHHHHHHH---------HTTEE--------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C-----HHHHHHHH---------HcCCC--------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1 11111111 00000 001123456788999999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=356.96 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=201.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||+||+|+.+.+++.||+|+++.. .......+.+|+++++.++||||+++++++ ...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 36899999999999999999999999999999999643 234457789999999999999999999985 4556
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 8999999999999999998754 478899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ........+||+.|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 150 G~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~Pf~~~- 208 (337)
T 1o6l_A 150 GLCKEGIS--------DGATMKTFCGTPEYLAPEVLE------------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ- 208 (337)
T ss_dssp TTCBCSCC--------TTCCBCCCEECGGGCCGGGGS------------SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred cchhhccc--------CCCcccccccChhhCChhhhc------------CCCCCchhhcccchhHHHHHhcCCCCCCCC-
Confidence 99975321 112233467999999996653 567899999999999999999999999742
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
...+......... ... +.....++.+++.+||..||++|| +++|+++
T Consensus 209 ----~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 209 ----DHERLFELILMEE------IRF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----SHHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CHHHHHHHHHcCC------CCC------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1222211111000 000 011245678999999999999999 8888865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=348.11 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=205.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++. .....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence 367899999999999999999997 678899999975432 2367899999999999999999999954 455799
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999976542 478999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+.... ..........+|+.|+|||.+. +..++.++||||+||++|||++ |+.||....
T Consensus 154 ~~~~~-------~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-- 212 (269)
T 4hcu_A 154 RFVLD-------DQYTSSTGTKFPVKWASPEVFS------------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-- 212 (269)
T ss_dssp GGBCC-------HHHHSTTSTTCCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred ccccc-------cccccccCcccccccCCHHHhc------------CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--
Confidence 86522 1112223445788899997765 4568899999999999999999 999987431
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..+...... ....+.. +..++.++.+++.+||+.||++||+++|+++.|+++.++
T Consensus 213 ---~~~~~~~~~-----~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 213 ---NSEVVEDIS-----TGFRLYK------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---HHHHHHHHH-----TTCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHHh-----cCccCCC------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 112111110 0000000 011245678999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.20 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=203.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||.||+|++..+++.||+|++.. ......+.+.+|++++++++||||+++++++ ...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 3579999999999999999999999999999999853 2334457889999999999999999999995 4456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence 8999999999999999998764 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+...... ........||+.|+|||.+. +..++.++||||+||++|||+||+.||....
T Consensus 156 g~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 156 GIAKALSETS-------LTQTNHVLGTVQYFSPEQAK------------GEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp SSSTTC--------------------CCSSCCHHHHH------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CCcccccccc-------ccccCccccCccccCHhHhc------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998652211 11223456999999997664 4667889999999999999999999997431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-EMRDVLAKLCAARQ 990 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~ 990 (997)
..+.......... +... ......++..+.+++.+||+.||++|| +++++.+.|.++..
T Consensus 217 -----~~~~~~~~~~~~~-----~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 217 -----AVSIAIKHIQDSV-----PNVT--------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -----HHHHHHHHHSSCC-----CCHH--------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -----hHHHHHHHhhccC-----CCcc--------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111111110000 0000 001112356788999999999999999 99999999887543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=365.48 Aligned_cols=266 Identities=24% Similarity=0.389 Sum_probs=207.0
Q ss_pred hcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
++|++.+.||+|+||+||+|++ ..+++.||||+++.. .......+.+|+.++++++||||+++++++. .
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 145 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----Q 145 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence 5789999999999999999995 346778999999643 3445567899999999999999999999954 4
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCC-CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC---c
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQP-EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---V 828 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~ 828 (997)
....++||||+++|+|.+++....... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence 557899999999999999998765322 223589999999999999999999999 999999999999999555 5
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RR 907 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~ 907 (997)
+||+|||+|+....... ........||+.|+|||++. +..++.++|||||||++|||++ |.
T Consensus 223 ~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGY------YRKGGCAMLPVKWMPPEAFM------------EGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp EEECCCHHHHHHHHHSS------CTTCCGGGSCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EEECCCccccccccccc------cccCCCcCCcccEECHHHhc------------CCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999986532111 11223356799999997764 4668999999999999999998 99
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.||.... ..+........ ..+ ..+..++..+.+++.+||+.||++||++.|+++.|+.
T Consensus 285 ~pf~~~~-----~~~~~~~i~~~-----~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 285 MPYPSKS-----NQEVLEFVTSG-----GRM------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CSSTTCC-----HHHHHHHHHTT-----CCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC-----HHHHHHHHHcC-----CCC------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 9987431 12211111100 000 0111234568899999999999999999999999999
Q ss_pred HHHHh
Q 001908 988 ARQTL 992 (997)
Q Consensus 988 ~~~~~ 992 (997)
+.+..
T Consensus 343 ~~~~~ 347 (367)
T 3l9p_A 343 CTQDP 347 (367)
T ss_dssp HHHCH
T ss_pred HhhCh
Confidence 87643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=354.98 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=201.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchh------hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG------ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.+.|++.+.||+|+||+||+|+.+.+|+.||+|+++..... ..+.+.+|++++++++||||+++++++ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 46799999999999999999999999999999999743221 346789999999999999999999995 4
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC----
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---- 827 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---- 827 (997)
.....++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 4668999999999999999997654 488999999999999999999999 999999999999998877
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||+|+..... .......||+.|+|||++. +..++.++||||+||++|+|++|.
T Consensus 157 ~vkl~DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslGvil~~ll~g~ 215 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDG---------VEFKNIFGTPEFVAPEIVN------------YEPLGLEADMWSIGVITYILLSGA 215 (361)
T ss_dssp CEEECCCSSCEECCTT---------CCCCCCCSCGGGCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred CEEEEecCCceEcCCC---------CccccCCCCccEECchHHc------------CCCCCccccHHHHHHHHHHHHhCC
Confidence 7999999999865221 1223457999999997664 467899999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.||.... ..+.......... ..++ .........+.+++.+||..||++|||+.|+++
T Consensus 216 ~Pf~~~~-----~~~~~~~i~~~~~--~~~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 216 SPFLGDT-----KQETLANITAVSY--DFDE------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CSSCCSS-----HHHHHHHHHTTCC--CCCH------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCC-----HHHHHHHHHhcCC--CCCc------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9997431 1111111100000 0000 111123456789999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=359.80 Aligned_cols=294 Identities=23% Similarity=0.343 Sum_probs=207.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHH--HhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV--LRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||+||+|+. +++.||||++..... ..+..|.++ +..++|+||+++++++......+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999987 789999999964432 334444444 45689999999998766554556667
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCcEecCCCCCCeeeCCCCcE
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC------QPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~------~~~ivHrDlk~~NIll~~~~~~ 829 (997)
.++||||+++|+|.+++.... .++..+++++.||+.||+|||+.+ .++|+||||||+||+++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 899999999999999998764 578899999999999999999873 3389999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+|+.....................||+.|+|||++..... ......++.++|||||||++|||++|..|
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN-----LRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC-----GGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc-----cccccccccccchHHHHHHHHHHHhcCCc
Confidence 9999999987643222111122223334579999999988753110 00013467789999999999999999777
Q ss_pred CCcCcCCCc---cHHHHHHhhcc-hhhhh-----hcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 910 TNCMFQGGL---TLHEFCKMALP-EKVME-----TVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 910 ~~~~~~~~~---~~~~~~~~~~~-~~~~~-----~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
|........ ........... ..... ...+.+...+. ....+++++.+++.+||+.||++|||++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK------ENSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC------CCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc------cccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 653322111 00000000000 00000 00111111111 11235668999999999999999999999
Q ss_pred HHHHHHHHHHHhhc
Q 001908 981 VLAKLCAARQTLVG 994 (997)
Q Consensus 981 vl~~L~~~~~~~~~ 994 (997)
+++.|+++...+.+
T Consensus 309 ~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 309 AEERMAELMMIWER 322 (336)
T ss_dssp HHHHHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999877654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.85 Aligned_cols=271 Identities=23% Similarity=0.334 Sum_probs=199.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.++||+|+||+||+|++. +++.||+|++.... ......+.+|++++++++||||+++++++ .....
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence 468999999999999999999996 68999999996432 33356788999999999999999999995 45568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||++ |+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEcCCC-CCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 999999997 588888876542 388999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+..... ........||+.|+|||++.. ...++.++||||+||++|||++|+.||.....
T Consensus 165 ~a~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 165 LARAFGIP--------VRSYTHEVVTLWYRAPDVLMG-----------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp TCEETTSC--------CC---CCCCCCTTCCHHHHTT-----------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred CceecCCC--------cccccCCcccCCcCCHHHhcC-----------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 99865221 112233568999999987642 24578999999999999999999999985433
Q ss_pred CCccHHHHHHhh---cchhhhhhcCc-----ccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMA---LPEKVMETVDP-----SLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~---~~~~~~~~~d~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. .+....... .+..+....+. .....+...........+..++.+++.+||..||++|||++|+++
T Consensus 226 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 226 DD-QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TT-HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HH-HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 32 222222111 01111110000 000000000111111223456789999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=352.36 Aligned_cols=277 Identities=21% Similarity=0.321 Sum_probs=189.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||+||+|+++.+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 468999999999999999999999899999999997433 33446788999999999999999999995 446689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++ |+|.+++...........+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999997 69999998654222223588999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... ........||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 155 ~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 215 (317)
T 2pmi_A 155 ARAFGIP--------VNTFSSEVVTLWYRAPDVLMG-----------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE 215 (317)
T ss_dssp CEETTSC--------CCCCCCCCSCCTTCCHHHHTT-----------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ceecCCC--------cccCCCCcccccccCchHhhC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9765221 111233568999999987642 245789999999999999999999999743211
Q ss_pred CccHHHHHHhh-c-chhhhhhc------Ccccccccccch----hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMA-L-PEKVMETV------DPSLLLAWSDGR----RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~-~-~~~~~~~~------d~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+....... . +...+..+ .+.......... ..........++.+++.+||..||++|||+.|+++
T Consensus 216 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 216 -EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp -HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 1111111110 0 00000000 000000000000 00001123457889999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.96 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=199.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+++++.++||||+++++++. ..+..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 368999999999999999999999999999999986432 233467889999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999997654 488999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-CCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
++...... .........||+.|+|||++.. .. ++.++||||+||++|||++|+.||.....
T Consensus 152 a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 152 ATVFRYNN------RERLLNKMCGTLPYVAPELLKR------------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp CEECEETT------EECCBCSCCSCGGGSCHHHHHC------------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cceeccCC------cccccCCCccCcCccCcHHhcc------------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 97652211 1122234679999999987752 33 37789999999999999999999975433
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.......+..... ...+ .......+.+++.+||..||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~------~~~~--------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 214 SCQEYSDWKEKKT------YLNP--------------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TSHHHHHHHTTCT------TSTT--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhcccc------cCCc--------------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 3222222211100 0000 0112445678999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=370.03 Aligned_cols=254 Identities=28% Similarity=0.385 Sum_probs=205.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|++ .++.||||+++... ..+.+.+|++++++++||||+++++++.. .....+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence 46788999999999999999998 47899999997543 45789999999999999999999999743 334789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 264 iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 99999999999999987642 1368899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+.... ......+++.|+|||++. +..++.++|||||||++|||+| |+.||......
T Consensus 337 ~~~~~-----------~~~~~~~~~~y~aPE~~~------------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 337 KEASS-----------TQDTGKLPVKWTAPEALR------------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp EECC-----------------CCCTTTSCHHHHH------------SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred ccccc-----------cccCCCCCcceeCHHHhc------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 75311 111235688999997664 4678999999999999999999 99999754322
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.+...+... .+.+.+..++.++.++|.+||+.||++|||+.++++.|+++...
T Consensus 394 --~~~~~i~~~--------------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 394 --DVVPRVEKG--------------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --THHHHHHTT--------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHHHHcC--------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111111100 00111224567889999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=356.93 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=198.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcE----EEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTF----VAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|++.+.||+|+||+||+|++..+++. ||+|+++.. .....+.+.+|++++++++||||++++++|..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 88 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 88 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence 5799999999999999999998777765 577877532 33455789999999999999999999999753
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++|+||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D 160 (327)
T 3poz_A 89 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp SSEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEcc
Confidence 247899999999999999987542 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+|+...... .........+|+.|+|||.+. +..++.++|||||||++|||+| |+.||..
T Consensus 161 fg~a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 161 FGLAKLLGAEE------KEYHAEGGKVPIKWMALESIL------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp TTHHHHHTTTC------C-------CCCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcceeEccCCc------ccccccCCCccccccChHHhc------------cCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 99998763221 111223345788999997664 4678999999999999999999 9999974
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.... .+........ . .+.+..++.++.+++.+||+.||++||++.|+++.|+++..+
T Consensus 223 ~~~~--~~~~~~~~~~--------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 223 IPAS--EISSILEKGE--------R------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCGG--GHHHHHHTTC--------C------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCHH--HHHHHHHcCC--------C------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 3221 1222111110 0 001112345688999999999999999999999999988754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=363.56 Aligned_cols=267 Identities=23% Similarity=0.268 Sum_probs=205.1
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeecc
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSI 748 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 748 (997)
.++....++|++.++||+|+||+||+|+.+.+++.||+|+++... ......+.+|+++++.++||||++++++|
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--- 143 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF--- 143 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE---
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---
Confidence 344455689999999999999999999999999999999996422 22234578999999999999999999985
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
.+.+..|+||||+++|+|.+++.+... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 144 --~~~~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 144 --QDDNNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp --ECSSEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred --eeCCEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCC
Confidence 446689999999999999999987431 488999999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+..... ........+||+.|+|||++.... ..+..++.++|||||||++|||++|+.
T Consensus 214 vkL~DFGla~~~~~~-------~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~~~~~~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 214 IRLADFGSCLKLMED-------GTVQSSVAVGTPDYISPEILQAME-------GGKGRYGPECDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp EEECCCTTCEECCTT-------SCEECCSCCSCGGGCCHHHHHHHH-------TSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred EEEcchhhhhhcccC-------CCcccccccCCcCeeChHHHhhcc-------cCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence 999999999765221 111223467999999998876311 113568899999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE--RMEMRDVLA 983 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~ 983 (997)
||... ...+.......... ...-|... .....++.+++.+|+..+|++ ||+++|+++
T Consensus 280 Pf~~~-----~~~~~~~~i~~~~~-~~~~p~~~------------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 280 PFYAE-----SLVETYGKIMNHKE-RFQFPTQV------------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp TTCCS-----SHHHHHHHHHTHHH-HCCCCSSC------------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCCCC-----ChhHHHHhhhhccc-cccCCccc------------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 99742 12222111111100 00001100 012346778999999998888 999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=349.16 Aligned_cols=252 Identities=17% Similarity=0.256 Sum_probs=201.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|+++.+++.||+|++.... .....+.+|+++++.++||||+++++++. +.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 468999999999999999999999999999999997443 34467889999999999999999999964 455899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC--CCcEEEcccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFG 835 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFg 835 (997)
+||||+++|+|.+++.... ..+++..++.++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 78 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 9999999999999997653 1488999999999999999999999 9999999999999997 7899999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++.... ........||+.|+|||++. +..++.++||||+||++|||++|..||....
T Consensus 150 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~- 207 (321)
T 1tki_A 150 QARQLKP---------GDNFRLLFTAPEYYAPEVHQ------------HDVVSTATDMWSLGTLVYVLLSGINPFLAET- 207 (321)
T ss_dssp TCEECCT---------TCEEEEEESCGGGSCHHHHT------------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-
T ss_pred CCeECCC---------CCccccccCChhhcCcHHhc------------CCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-
Confidence 9986521 12233467899999997664 4567899999999999999999999997431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+......... .+. ........+.++.+++.+||..||++|||+.|+++
T Consensus 208 ----~~~~~~~i~~~~----~~~----------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 208 ----NQQIIENIMNAE----YTF----------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHHHHHHHHTC----CCC----------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHHHHcCC----CCC----------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111110000 000 00011123456789999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=359.90 Aligned_cols=272 Identities=25% Similarity=0.391 Sum_probs=209.4
Q ss_pred HHhhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
...++|++.+.||+|+||.||+|++. .+++.||||+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 120 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA--- 120 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc---
Confidence 34578999999999999999999996 34589999999754 3445678899999999999999999999964
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCC------------------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQP------------------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPI 811 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~i 811 (997)
..+..++||||+++|+|.+++....... ....+++.+++.++.||+.||+|||++ +|
T Consensus 121 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred --cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3557899999999999999998753210 013589999999999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 812 vHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+||||||+||+++.++.+||+|||+++...... .........+|+.|+|||.+. +..++.++
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~ 257 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD------YYKADGNDAIPIRWMPPESIF------------YNRYTTES 257 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG------CBC----CCBCGGGCCHHHHH------------HCCCCHHH
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCc------cccccCCCcccceecChhhhc------------cCCcCccc
Confidence 999999999999999999999999998763211 111223456789999997765 35688999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCC
Q 001908 892 DVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970 (997)
Q Consensus 892 DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 970 (997)
|||||||++|||+| |..||.... ..+.......... +. .+..++.++.+++.+||..
T Consensus 258 Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~~~-----~~------------~~~~~~~~l~~li~~~l~~ 315 (343)
T 1luf_A 258 DVWAYGVVLWEIFSYGLQPYYGMA-----HEEVIYYVRDGNI-----LA------------CPENCPLELYNLMRLCWSK 315 (343)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHTTCC-----CC------------CCTTCCHHHHHHHHHHTCS
T ss_pred ccHHHHHHHHHHHhcCCCcCCCCC-----hHHHHHHHhCCCc-----CC------------CCCCCCHHHHHHHHHHccc
Confidence 99999999999999 999987431 2222111110000 00 0112356788999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhhcc
Q 001908 971 SPIERMEMRDVLAKLCAARQTLVGR 995 (997)
Q Consensus 971 dP~~Rps~~evl~~L~~~~~~~~~~ 995 (997)
||++||++.|+++.|+++.+...+.
T Consensus 316 ~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 316 LPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp SGGGSCCHHHHHHHHHHTTC-----
T ss_pred CcccCCCHHHHHHHHHHHHhhhhhh
Confidence 9999999999999999988766543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=348.51 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=201.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch------hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK------GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.+.|++.+.||+|+||.||+|+.+.+++.||+|+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 4679999999999999999999999999999999964322 13577899999999999999999999954
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC----
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---- 827 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---- 827 (997)
.....++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 4568999999999999999997654 488999999999999999999999 999999999999999888
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||+|+..... .......||+.|+|||++. +..++.++||||+||++|||++|+
T Consensus 156 ~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~~ll~g~ 214 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFG---------NEFKNIFGTPEFVAPEIVN------------YEPLGLEADMWSIGVITYILLSGA 214 (326)
T ss_dssp CEEECCCTTCEECCTT---------SCCCCCCSCTTTCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred CEEEEECCCCeECCCC---------CccccccCCcCcCCceeec------------CCCCCcHHHHHHHHHHHHHHHHCc
Confidence 8999999999865211 1123357999999997654 467899999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.||.... ..+...... . ..... .......++..+.+++.+||..||++|||+.|+++
T Consensus 215 ~pf~~~~-----~~~~~~~~~-----~-~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 215 SPFLGDT-----KQETLANVS-----A-VNYEF--------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CSSCCSS-----HHHHHHHHH-----H-TCCCC--------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCC-----HHHHHHHHH-----h-cCCCc--------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9986431 111111100 0 00000 00111223456789999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=349.76 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=208.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||+||+|+...+++.||||++..... .+.+.+|+++++++ +||||+++++++.. .+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCcc
Confidence 3579999999999999999999988999999999864332 24578999999999 99999999998543 5589
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc-----EEE
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV-----AHV 831 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl 831 (997)
++||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred EEEEEeC-CCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence 9999999 9999999987531 489999999999999999999999 9999999999999999987 999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+.......... ..........||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 152 ~DFg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 152 IDFALAKEYIDPETKKH-IPYREHKSLTGTARYMSINTHL------------GKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp CCCTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEcccceeeecCCCCcc-ccccccCCcCCCccccChHHHc------------CCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 99999987633221110 1111234567999999996654 5678999999999999999999999998
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..... ...+........... .... .....++ ++.+++..||+.||.+||++.++.+.|+++.+.
T Consensus 219 ~~~~~--~~~~~~~~i~~~~~~--~~~~-----------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 219 GLKAD--TLKERYQKIGDTKRA--TPIE-----------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp TCCCS--SHHHHHHHHHHHHHH--SCHH-----------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccc--cHHHHHHHHHhhhcc--CCHH-----------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 54222 222211111000000 0000 0001124 788999999999999999999999999988776
Q ss_pred h
Q 001908 992 L 992 (997)
Q Consensus 992 ~ 992 (997)
.
T Consensus 283 ~ 283 (330)
T 2izr_A 283 K 283 (330)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=360.22 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=195.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.++||+|+||+||+|+.+.+++.||+|+++.. .....+.+.+|..+++++ +||||+++++++ ...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence 46899999999999999999999999999999999743 233345678899999887 899999999984 456
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 68999999999999999998754 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.... ........+||+.|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 197 FGla~~~~~--------~~~~~~~~~gt~~Y~aPE~l~------------~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 197 YGMCKEGLR--------PGDTTSTFCGTPNYIAPEILR------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CTTCBCCCC--------TTCCBCCCCBCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cceeeeccc--------CCCccccccCCcccCCchhhc------------CCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999975311 112234568999999997664 567899999999999999999999999743
Q ss_pred cCCC----ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 914 FQGG----LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 914 ~~~~----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
.... ............. ...+ +.....++.+++.+||+.||++||++
T Consensus 257 ~~~~~~~~~~~~~~~~~i~~~------~~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 257 GSSDNPDQNTEDYLFQVILEK------QIRI------------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TC------CCHHHHHHHHHHC------CCCC------------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccccccchhhHHHHHHHHhcc------ccCC------------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 2111 1111111111000 0000 11124567799999999999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=355.89 Aligned_cols=272 Identities=23% Similarity=0.385 Sum_probs=194.5
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCc---EEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGT---FVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
..++|++.+.||+|+||+||+|++..++. .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 44689999999999999999999876664 8999999743 344567899999999999999999999997543211
Q ss_pred -CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 752 -GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 752 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.....++||||+++|+|.+++...........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 1122489999999999999997654322233588999999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRP 909 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P 909 (997)
|+|||+|+....... ........+|+.|+|||.+. +..++.++|||||||++|||++ |+.|
T Consensus 178 l~Dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~ell~~g~~p 239 (323)
T 3qup_A 178 VADFGLSRKIYSGDY------YRQGCASKLPVKWLALESLA------------DNLYTVHSDVWAFGVTMWEIMTRGQTP 239 (323)
T ss_dssp ECCCCC-----------------------CCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred Eeecccccccccccc------ccccccccCcccccCchhhc------------CCCCCCccchhhHHHHHHHHHhCCCCC
Confidence 999999986532211 11223345688999997765 4568899999999999999999 8999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
|...... ......... ... ..+..++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 240 ~~~~~~~--~~~~~~~~~--------~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 240 YAGIENA--EIYNYLIGG--------NRL------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp TTTCCGG--GHHHHHHTT--------CCC------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccChH--HHHHHHhcC--------CCC------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8743221 111111000 000 001123457889999999999999999999999999987
Q ss_pred HH
Q 001908 990 QT 991 (997)
Q Consensus 990 ~~ 991 (997)
..
T Consensus 298 ~~ 299 (323)
T 3qup_A 298 GH 299 (323)
T ss_dssp HC
T ss_pred HH
Confidence 53
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=357.64 Aligned_cols=282 Identities=17% Similarity=0.220 Sum_probs=208.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECCC-----CcEEEEEEecccchhh-----------HHHHHHHHHHHhhcCCCCcce
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGEN-----GTFVAVKILNLMQKGA-----------LKSFVAECEVLRNTRHRNLIK 740 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 740 (997)
..++|++.+.||+|+||+||+|+++.+ ++.||||++....... ...+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999999754 5789999986443211 123345556677788999999
Q ss_pred EEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCC
Q 001908 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSN 820 (997)
Q Consensus 741 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~N 820 (997)
+++++... ..+....++||||+ +++|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 99997653 22345689999999 9999999987531 489999999999999999999999 99999999999
Q ss_pred eeeC--CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 821 VLLD--HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 821 Ill~--~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
|+++ .++.+||+|||+|+.......... ..........||+.|+|||++. +..++.++|||||||
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKA-YAADPKRCHDGTIEFTSIDAHN------------GVAPSRRGDLEILGY 249 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCC-SSCCSSCCCCCCTTTCCHHHHT------------TCCCCHHHHHHHHHH
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccc-cccCcccccCCCCCccCHHHhC------------CCCCCchhhHHHHHH
Confidence 9999 889999999999987633221111 1111223456999999996654 567899999999999
Q ss_pred HHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 899 MLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 899 vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
++|||+||+.||....... ...............+..++.+. ...++.++.+++..||..||++||++
T Consensus 250 ~l~el~~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~cl~~~p~~RP~~ 317 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLKDP-KYVRDSKIRYRENIASLMDKCFP-----------AANAPGEIAKYMETVKLLDYTEKPLY 317 (364)
T ss_dssp HHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHCHHHHHHHHSC-----------TTCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred HHHHHHhCCCCccccccCH-HHHHHHHHHhhhhHHHHHHHhcc-----------cccCHHHHHHHHHHHhcCCCCCCCCH
Confidence 9999999999998533221 11221121222222222221110 01235678899999999999999999
Q ss_pred HHHHHHHHHHHHHhh
Q 001908 979 RDVLAKLCAARQTLV 993 (997)
Q Consensus 979 ~evl~~L~~~~~~~~ 993 (997)
.++++.|+++.++..
T Consensus 318 ~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 318 ENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHcC
Confidence 999999999887653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.22 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=203.5
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.||+|+||+||+|+++ ++..||+|+++.... ..+.+.+|++++++++||||+++++++ ......
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 3568999999999999999999997 778899999975432 236789999999999999999999995 345679
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999987431 488999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
++.... ..........+|+.|+|||.+. +..++.++||||+||++|||+| |+.||....
T Consensus 167 ~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~- 226 (283)
T 3gen_A 167 SRYVLD-------DEYTSSVGSKFPVRWSPPEVLM------------YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT- 226 (283)
T ss_dssp GGGBCC-------HHHHSTTSTTSCGGGCCHHHHH------------HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-
T ss_pred cccccc-------cccccccCCccCcccCCHHHhc------------cCCCCchhhHHHHHHHHHHHHhCCCCCccccC-
Confidence 986522 1112223345688899997765 3568899999999999999998 999987432
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..+..... ........ +..++..+.+++.+||+.||++|||++|+++.|.++.++
T Consensus 227 ----~~~~~~~~-----~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 227 ----NSETAEHI-----AQGLRLYR------------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----HHHHHHHH-----HTTCCCCC------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----hhHHHHHH-----hcccCCCC------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11111111 11111000 011235678999999999999999999999999998865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=354.19 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=201.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
..++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+.+|++++++++||||+++++++. ..+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 457899999999999999999999999999999999643 3345577899999999999999999999954 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC---cEEE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHV 831 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl 831 (997)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 8999999999999999998654 478999999999999999999999 999999999999998654 5999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+..... .......||+.|+|||++. +..++.++||||+||++|||++|+.||.
T Consensus 173 ~DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 173 ADFGLAIEVNDS---------EAWHGFAGTPGYLSPEVLK------------KDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CCCTTCBCCTTC---------CSCCCSCSCTTTCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecCcceEecCC---------cccccCCCCccccCHHHHc------------cCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999999765221 1223457999999997664 4678999999999999999999999987
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
... ..+......... .....+. ...++.++.+++.+||..||++||++.|+++.
T Consensus 232 ~~~-----~~~~~~~i~~~~-~~~~~~~-------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 232 DED-----QHRLYAQIKAGA-YDYPSPE-------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CSS-----HHHHHHHHHHTC-CCCCTTG-------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCC-----HHHHHHHHHhCC-CCCCccc-------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 431 122111110000 0000000 01224567899999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.99 Aligned_cols=283 Identities=26% Similarity=0.409 Sum_probs=212.2
Q ss_pred hhcCccCCcccccCcceEEEEEE----CCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGIL----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 35789999999999999999994 56889999999987666677889999999999999999999998643 224
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence 468999999999999999987642 378999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++...... ..........++..|+|||.+. +..++.++|||||||++|||+||..||...
T Consensus 189 fg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 189 FGLTKVLPQDK-----EYYKVKEPGESPIFWYAPESLT------------ESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp CTTCEECCSSC-----SEEECSSCCSCCGGGCCHHHHH------------HCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred Ccchhhccccc-----cccccccCCCCceeEECchhhc------------CCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99998753211 1111122345778899998765 356788999999999999999999997632
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
. .++................+..........+.+..++.++.+++.+||..||++|||+.|+++.|+++.+.+.
T Consensus 252 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 252 P------AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp H------HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred H------HHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 1111110000000000000000000000111122346778999999999999999999999999999998775
Q ss_pred c
Q 001908 994 G 994 (997)
Q Consensus 994 ~ 994 (997)
|
T Consensus 326 g 326 (326)
T 2w1i_A 326 G 326 (326)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=361.26 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=201.6
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
...++|++.+.||+|+||+||+|..+.+++.||+|++.... ....+.+.+|++++++++||||+++++++ ...
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence 34678999999999999999999999999999999997432 34456789999999999999999999995 456
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC---CCCcEE
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAH 830 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~k 830 (997)
+..++||||+++|+|.+++.... .+++..+..++.||+.|++|||++ +|+||||||+||+++ .++.+|
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred CEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence 68999999999999999998764 488999999999999999999999 999999999999998 568899
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+..... ........||+.|+|||++. +..++.++||||+||++|+|++|..||
T Consensus 154 L~DFG~a~~~~~~--------~~~~~~~~gt~~Y~APE~l~------------~~~~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 154 LADFGLAIEVEGE--------QQAWFGFAGTPGYLSPEVLR------------KDPYGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp ECCCSSCBCCCTT--------CCBCCCSCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EccCceeEEecCC--------CceeecccCCcccCCHHHhc------------CCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 9999999765221 11223467999999997664 467899999999999999999999999
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ..+......... .....+. ...+++++.+++.+||..||++|||+.|+++
T Consensus 214 ~~~~-----~~~~~~~i~~~~-~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 214 WDED-----QHRLYQQIKAGA-YDFPSPE-------------WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCSS-----HHHHHHHHHHTC-CCCCTTT-------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcc-----HHHHHHHHHhCC-CCCCccc-------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 6421 222111110000 0000000 0122456789999999999999999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.37 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=197.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|.+.+.||+|+||+||+|++..+++.||||++.... ......+.+|+++++.++||||+++++++. .+..
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPTD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 57999999999999999999999999999999986322 223457889999999999999999999954 4568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+ +|+|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence 99999999 789999987754 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
+|..... .......+||+.|+|||++. +..+ ++++||||+||++|||++|+.||....
T Consensus 154 ~s~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 154 LSNIMTD---------GNFLKTSCGSPNYAAPEVIN------------GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp CTBTTTT---------SBTTCCCTTSTTTSCGGGSC------------CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred cceeccC---------CcccccccCCcCcCCHHHHc------------CCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 9976522 12223457999999997654 3444 689999999999999999999997432
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
... .... +.... ...+...++.+.+++.+||..||++|||++|+++
T Consensus 213 ~~~----------~~~~----i~~~~---------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 213 IPN----------LFKK----VNSCV---------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp STT----------CBCC----CCSSC---------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHH----------HHHH----HHcCC---------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 0000 00000 0001123456789999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.44 Aligned_cols=274 Identities=25% Similarity=0.388 Sum_probs=205.4
Q ss_pred hhcCccCCcccccCcceEEEEE----ECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGI----LGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.+.|++.+.||+|+||.||+|+ ...+++.||||+++.. .....+.+.+|++++++++||||+++++++... +
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3568999999999999999999 4568899999999743 333457889999999999999999999997532 2
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
....++||||+++|+|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEEC
Confidence 3568999999999999999966542 388999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+++...... ..........||..|+|||.+. +..++.++||||+||++|||+||..|+..
T Consensus 169 Dfg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 169 DFGLTKAIETDK-----EYYTVKDDRDSPVFWYAPECLM------------QSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CCTTCEECCTTC-----CEEECCCCTTCCGGGCCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccCCC-----cceeccCCCCCCccccCCeeec------------CCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 999998753211 1112233456888999997765 35678899999999999999999998652
Q ss_pred CcCCCccHHHHHHhhcc---hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALP---EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~---~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
. .........+ .......... ...+...+.+..++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 232 ~------~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 232 P------MALFLKMIGPTHGQMTVTRLVNT----LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H------HHHHHHHHCSCCGGGHHHHHHHH----HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h------hhHHhhccCCcccccCHHHHHHH----HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2 1111111000 0000000000 0000111112234567889999999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=345.30 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=193.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch--------------------------hhHHHHHHHHHHHh
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--------------------------GALKSFVAECEVLR 731 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~ 731 (997)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3679999999999999999999999999999999864321 12356889999999
Q ss_pred hcCCCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 001908 732 NTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPI 811 (997)
Q Consensus 732 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~i 811 (997)
+++||||+++++++.. ...+..++||||+++++|.+++... .+++..++.++.|++.||+|||++ +|
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999753 2256899999999999998765432 489999999999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 812 vHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+||||||+||+++.++.+||+|||+|+..... ........||+.|+|||++.... ...++.++
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~~~~ 221 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--------DALLSNTVGTPAFMAPESLSETR---------KIFSGKAL 221 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSS--------SCEECCCCSCGGGCCGGGCCTTC---------CCEESHHH
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccc--------cccccCCcCCccccChhhhccCC---------CCCCCchh
Confidence 99999999999999999999999999865221 11223457999999997764210 01147789
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
|||||||++|||++|+.||... .............. .. +. ...++.++.+++.+||..|
T Consensus 222 Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~-~~--~~-------------~~~~~~~l~~li~~~l~~d 280 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFMDE-----RIMCLHSKIKSQAL-EF--PD-------------QPDIAEDLKDLITRMLDKN 280 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-CC--CS-------------SSCCCHHHHHHHHHHTCSC
T ss_pred hhHhHHHHHHHHHHCCCCCCCc-----cHHHHHHHHhcccC-CC--CC-------------ccccCHHHHHHHHHHhhcC
Confidence 9999999999999999998742 12211111100000 00 00 0112456789999999999
Q ss_pred CCCCCCHHHHHH
Q 001908 972 PIERMEMRDVLA 983 (997)
Q Consensus 972 P~~Rps~~evl~ 983 (997)
|++|||+.|+++
T Consensus 281 p~~R~s~~e~l~ 292 (298)
T 2zv2_A 281 PESRIVVPEIKL 292 (298)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=345.82 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=204.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|+++ ++..||+|+++.... ..+.+.+|++++++++||||+++++++ ......+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 468999999999999999999887 677899999975432 336789999999999999999999995 3456799
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++.... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 80 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp EEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence 9999999999999998753 1388999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+...... ........+|+.|+|||.+. +..++.++||||+|+++|||+| |+.||....
T Consensus 152 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-- 210 (268)
T 3sxs_A 152 RYVLDDQ-------YVSSVGTKFPVKWSAPEVFH------------YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-- 210 (268)
T ss_dssp EECCTTC-------EEECCSCCCCGGGCCHHHHH------------HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred eecchhh-------hhcccCCCcCcccCCHHHHh------------ccCCchhhhhHHHHHHHHHHHcCCCCCccccC--
Confidence 8653211 11223345678899997765 3567889999999999999999 999987431
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..+......... ....+ ..++..+.+++..||+.||++|||+.|+++.|+++.+.
T Consensus 211 ---~~~~~~~~~~~~--~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 211 ---NSEVVLKVSQGH--RLYRP---------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---HHHHHHHHHTTC--CCCCC---------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---hHHHHHHHHcCC--CCCCC---------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111111110000 00001 11234678999999999999999999999999887653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.94 Aligned_cols=264 Identities=25% Similarity=0.432 Sum_probs=212.1
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
+...++|++.+.||+|+||+||+|+++.++..||+|++.... ...+.+.+|++++++++||||+++++++ ...+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 82 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP 82 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 345678999999999999999999999889999999997543 3457889999999999999999999995 3456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++..... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CEEEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccC
Confidence 79999999999999999987542 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|.++..... .........+|+.|+|||.+. +..++.++||||+|+++|+|++ |..||...
T Consensus 156 g~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 156 GLSRLMTGD-------TYTAHAGAKFPIKWTAPESLA------------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp CGGGTSCSS-------SSEEETTEEECGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceeccCC-------ccccccCCccccCcCChhhhc------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999865321 112233456788999997764 4568899999999999999999 99998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
... ...+..... .... .+..++..+.+++.+||..||++|||+.|+++.|+++.++.
T Consensus 217 ~~~--~~~~~~~~~--------~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 217 DLS--QVYELLEKD--------YRME------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CGG--GHHHHHHTT--------CCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHH--HHHHHHhcc--------CCCC------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 211 111111110 0000 01123467889999999999999999999999999877653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.65 Aligned_cols=287 Identities=24% Similarity=0.379 Sum_probs=207.4
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc--CCCCcceEEeeeeccCcC
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT--RHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~ 751 (997)
.....++|++.+.||+|+||+||+|++ +++.||||++.... ...+.+|.+++... +||||+++++++.... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~ 105 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT-G 105 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-G
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-C
Confidence 344567999999999999999999998 48999999986432 24455666666554 8999999999976431 2
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCcEecCCCCCCeeeCCC
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC-----QPPIVHGDLKPSNVLLDHD 826 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivHrDlk~~NIll~~~ 826 (997)
.....++||||+++|+|.++++... +++..++.++.|++.||+|||+++ .++|+||||||+||+++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 2257899999999999999997653 889999999999999999999762 3489999999999999999
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
+.+||+|||+|+........ .........||+.|+|||++..... .....++.++|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNE----VDIPPNTRVGTKRYMPPEVLDESLN------RNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp SCEEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCC------TTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEEEeCCCceeecccccc----ccCCCCCCccCcceeChhhcccccC------CccccCccccchHHHHHHHHHHHhc
Confidence 99999999999765322111 1111224579999999987753110 0001112349999999999999999
Q ss_pred ----------CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 907 ----------RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 907 ----------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
+.||..................... ..+.... .....+++.++.+++.+||+.||++||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK----LRPSFPN-------RWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCG-------GGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred cCcccccccccccHhhhcCCCCchhhhHHHHhhhc----cCccccc-------cchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 6666544333333333222111111 1111110 112236788899999999999999999
Q ss_pred CHHHHHHHHHHHHHHhhc
Q 001908 977 EMRDVLAKLCAARQTLVG 994 (997)
Q Consensus 977 s~~evl~~L~~~~~~~~~ 994 (997)
|+.|+++.|+++.++...
T Consensus 318 s~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 318 TALRVKKTLAKMSESQDI 335 (337)
T ss_dssp CHHHHHHHHHHHHHTTTC
T ss_pred CHHHHHHHHHHHHhhccc
Confidence 999999999999887643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=354.61 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=196.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (997)
..++|++.+.||+|+||+||+|+.+.+++.||||+++.. .....+.+.+|+++++.+ +||||+++++++ ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 346899999999999999999999999999999999743 234456788999999988 799999999984 45
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence 668999999999999999998764 488999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+.... ........+||+.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 167 DFG~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 167 DFGMCKEGIC--------NGVTTATFCGTPDYIAPEILQ------------EMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp CCTTCBCSCC-----------------CCGGGCCHHHHH------------HHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccceeeccc--------CCccccccCCCcCeEChhhcC------------CCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 9999975311 122334568999999998775 34578899999999999999999999974
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM------RDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~ 983 (997)
. ...+......... ... +......+.+++.+|+..||++||++ .|+++
T Consensus 227 ~-----~~~~~~~~i~~~~------~~~------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 227 E-----NEDDLFEAILNDE------VVY------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp S-----SHHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C-----CHHHHHHHHHcCC------CCC------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 3 1222211111100 000 01123457789999999999999998 66654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.29 Aligned_cols=267 Identities=24% Similarity=0.371 Sum_probs=209.4
Q ss_pred HhhcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
..++|.+.+.||+|+||.||+|++ +.+++.||||+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS---- 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----
Confidence 357899999999999999999987 345689999999743 3445678899999999999999999999953
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCC------------------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQP------------------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIV 812 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~iv 812 (997)
..+..++||||+++|+|.+++....... ....+++..+++++.|++.||+|||++ +|+
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv 172 (314)
T 2ivs_A 97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172 (314)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence 4557999999999999999998764311 112378999999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccch
Q 001908 813 HGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGD 892 (997)
Q Consensus 813 HrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~D 892 (997)
||||||+||+++.++.+||+|||+++...... .........+|+.|+|||.+. +..++.++|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~D 234 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEED------SYVKRSQGRIPVKWMAIESLF------------DHIYTTQSD 234 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTS------CEECSSCCCSCGGGCCHHHHH------------HCEECHHHH
T ss_pred ccccchheEEEcCCCCEEEccccccccccccc------cceeccCCCCcccccChhhhc------------CCCcCchhh
Confidence 99999999999999999999999998653211 111223345788999997765 356889999
Q ss_pred hHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 893 VYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 893 vwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
|||+||++|||++ |+.||...... .+.+..... ..+. .+..++.++.+++.+||+.|
T Consensus 235 i~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~--------~~~~------------~~~~~~~~~~~li~~~l~~d 292 (314)
T 2ivs_A 235 VWSFGVLLWEIVTLGGNPYPGIPPE--RLFNLLKTG--------HRME------------RPDNCSEEMYRLMLQCWKQE 292 (314)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTT--------CCCC------------CCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHhhcC--------CcCC------------CCccCCHHHHHHHHHHccCC
Confidence 9999999999999 99998743221 111111110 0000 01123557889999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHH
Q 001908 972 PIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 972 P~~Rps~~evl~~L~~~~~~ 991 (997)
|++||++.|+++.|+++.++
T Consensus 293 p~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 293 PDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGSCCHHHHHHHHHHHHHT
T ss_pred hhhCcCHHHHHHHHHHHHhh
Confidence 99999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.24 Aligned_cols=276 Identities=24% Similarity=0.403 Sum_probs=202.9
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECC---CCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeecc
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGE---NGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSI 748 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 748 (997)
.....++|.+.+.||+|+||+||+|+... +++.||+|+++.. .....+.+.+|++++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 33455789999999999999999998764 4568999999743 344557889999999999999999999998654
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
+.......++||||+++|+|.+++...........+++..++.++.|++.||.|||++ +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 4333345799999999999999996543222334589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RR 907 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~ 907 (997)
+||+|||+++....... ........+++.|+|||.+. +..++.++|||||||++|||++ |.
T Consensus 186 ~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~~~g~ 247 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDY------YRQGRIAKMPVKWIAIESLA------------DRVYTSKSDVWAFGVTMWEIATRGM 247 (313)
T ss_dssp EEECSCSCC----------------------CCGGGSCHHHHH------------SSCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EEEeecCcceecccccc------cCcccccCCCccccCchhhc------------CCCccchhhhHHHHHHHHHHHhcCC
Confidence 99999999986532111 11223345788999997664 4678899999999999999999 88
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.||...... ........ ...+. .+..++.++.+++.+||..||++|||+.++++.|++
T Consensus 248 ~p~~~~~~~--~~~~~~~~--------~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 248 TPYPGVQNH--EMYDYLLH--------GHRLK------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp CSSTTCCGG--GHHHHHHT--------TCCCC------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCCHH--HHHHHHHc--------CCCCC------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 898643211 11111110 00000 011234578899999999999999999999999999
Q ss_pred HHHHh
Q 001908 988 ARQTL 992 (997)
Q Consensus 988 ~~~~~ 992 (997)
+.+.+
T Consensus 306 l~~~l 310 (313)
T 3brb_A 306 LLESL 310 (313)
T ss_dssp HHHHC
T ss_pred HHHhc
Confidence 98765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.36 Aligned_cols=266 Identities=24% Similarity=0.447 Sum_probs=197.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCC---cEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENG---TFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
..|++.+.||+|+||+||+|++..++ ..||+|+++.. .....+.+.+|++++++++||||++++++|. ...+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCC
Confidence 35677889999999999999875332 46899998643 3455678999999999999999999999873 3345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++..... .+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence 78999999999999999986542 378889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|+|+........ .........+|+.|+|||.+. +..++.++|||||||++|||+| |.+||...
T Consensus 237 G~a~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 237 GLARDMYDKEFD----SVHNKTGAKLPVKWMALESLQ------------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp -------------------------CCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccccccccc----cccccCCCCCcccccChHHhc------------CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 999866332111 111223356788999997765 4678899999999999999999 67777643
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
... .......... .+ ..+..++..+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus 301 ~~~--~~~~~~~~~~--------~~------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 301 NTF--DITVYLLQGR--------RL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CSS--CHHHHHHTTC--------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHH--HHHHHHHcCC--------CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 221 1221111100 00 0112235678899999999999999999999999999987665
Q ss_pred c
Q 001908 994 G 994 (997)
Q Consensus 994 ~ 994 (997)
+
T Consensus 359 ~ 359 (373)
T 3c1x_A 359 G 359 (373)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.29 Aligned_cols=271 Identities=24% Similarity=0.369 Sum_probs=210.4
Q ss_pred hcCccCCcccccCcceEEEEEE----CCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGIL----GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. .+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCCc
Confidence 6899999999999999999994 56889999999987766677889999999999999999999998753 2456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred eEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence 78999999999999999987431 388999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++...... ..........||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 172 g~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 172 GLAKLLPLDK-----DYYVVREPGQSPIFWYAPESLS------------DNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GGCEECCTTC-----SEEECSSCCCSCGGGSCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ccceecccCC-----ccceeeccCCccccccCHHHhc------------cCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 9998653211 1112223356888999997765 3567889999999999999999999986321
Q ss_pred CCCccHHHHHHhhc-c------hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMAL-P------EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 915 ~~~~~~~~~~~~~~-~------~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
. +...... . ......+. .+...+.+..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus 235 ~------~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 300 (327)
T 3lxl_A 235 A------EFLRMMGCERDVPALSRLLELLE--------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300 (327)
T ss_dssp H------HHHHHCC----CCHHHHHHHHHH--------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c------hhhhhcccccccccHHHHHHHhh--------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 1111000 0 00000000 001111122345678899999999999999999999999998
Q ss_pred HHHH
Q 001908 988 ARQT 991 (997)
Q Consensus 988 ~~~~ 991 (997)
+...
T Consensus 301 ~~~~ 304 (327)
T 3lxl_A 301 LWSG 304 (327)
T ss_dssp C---
T ss_pred HHhh
Confidence 7653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=341.09 Aligned_cols=261 Identities=22% Similarity=0.226 Sum_probs=206.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.||+|+||+||+|+++.++..||+|++........+.+.+|++++++++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeE
Confidence 4568999999999999999999999999999999997655556678999999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee---CCCCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~D 833 (997)
++||||+++++|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||++ +.++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999998754 478999999999999999999999 99999999999999 8889999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+...... .......||+.|+|||++. +.++.++||||+||++|||++|+.||...
T Consensus 153 fg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~-------------~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 153 FGLAARFKPG---------KMMRTKVGTPYYVSPQVLE-------------GLYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp CTTCEECCTT---------SCBCCCCSCTTTCCHHHHT-------------TCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceeccCc---------cchhccCCCCCccChHHhc-------------ccCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 9999765221 1223456899999998764 34788999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA--KLCAARQT 991 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~~~~~ 991 (997)
.. .+...... ... ... .......+++++.+++.+||+.||++|||+.|+++ .+++....
T Consensus 211 ~~-----~~~~~~~~-----~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 211 TD-----SEVMLKIR-----EGT-FTF--------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp SH-----HHHHHHHH-----HCC-CCC--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred CH-----HHHHHHHH-----hCC-CCC--------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 21 11111100 000 000 00001123567889999999999999999999986 34444443
Q ss_pred h
Q 001908 992 L 992 (997)
Q Consensus 992 ~ 992 (997)
-
T Consensus 272 ~ 272 (277)
T 3f3z_A 272 S 272 (277)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=351.29 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=196.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||.||+|+.+.+++.||+|+++.. .....+.+.+|+++++++ +||||+++++++ ...+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeCC
Confidence 5799999999999999999999999999999999743 334456788999999988 899999999985 4466
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++++||+||
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence 8999999999999999998754 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ........+||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 155 G~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 155 GMCKEGLR--------PGDTTSTFCGTPNYIAPEILR------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp GGCBCSCC--------TTCCBCCCCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred cccccccC--------CCCcccccCCCccccCccccC------------CCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 99975321 112234468999999997664 4678999999999999999999999997432
Q ss_pred CCC----ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 915 QGG----LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 915 ~~~----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
... ............. ...+ +.....++.+++.+||..||++||++
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~------~~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVILEK------QIRI------------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C-------CHHHHHHHHHHC------CCCC------------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cccccccccHHHHHHHHHcC------CCCC------------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 0111111100000 0000 11224567899999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=349.23 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=200.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc------
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF------ 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 750 (997)
.++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46899999999999999999999999999999999743 33456789999999999999999999998754321
Q ss_pred ----------------------------------------------CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCC
Q 001908 751 ----------------------------------------------KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDL 784 (997)
Q Consensus 751 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 784 (997)
......++||||+++|+|.+++...... ...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~ 161 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDR 161 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGS
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cch
Confidence 1123489999999999999999876532 235
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCcc----ccccccccccc
Q 001908 785 SLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM----ETQSSSIGIKG 860 (997)
Q Consensus 785 ~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~----~~~~~~~~~~g 860 (997)
++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+........... ..........|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 6778899999999999999999 9999999999999999999999999999876332111100 00122344579
Q ss_pred cccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCccc
Q 001908 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSL 940 (997)
Q Consensus 861 t~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 940 (997)
|+.|+|||.+. +..++.++||||+||++|||++|..|+... .+... ......
T Consensus 239 t~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~-----~~~~~~---- 290 (332)
T 3qd2_B 239 TKLYMSPEQIH------------GNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIIT-----DVRNLK---- 290 (332)
T ss_dssp CGGGSCHHHHH------------CCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHH-----HHHTTC----
T ss_pred CcCccChHHhc------------CCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHH-----HhhccC----
Confidence 99999997664 467899999999999999999987774310 01000 000000
Q ss_pred ccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 941 LLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.........+++.+++.+||+.||++|||+.|+++
T Consensus 291 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 291 --------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp --------CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred --------CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 01122344566789999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.27 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=197.1
Q ss_pred HhhcCccCCcccccCcceEEEEEECCC---CcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGEN---GTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
..++|++.+.||+|+||.||+|++..+ +..||+|+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence 346899999999999999999998643 457999998743 3445678899999999999999999999853
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred cCccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEEC
Confidence 3467999999999999999986541 478999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTN 911 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 911 (997)
|||+|+...... ........+|+.|+|||++. +..++.++|||||||++|||++ |..||.
T Consensus 159 Dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 159 DFGLSRYMEDST-------YYKASKGKLPIKWMAPESIN------------FRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp C--------------------------CCGGGCCHHHHH------------HCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccccCccc-------ccccccCCCcccccChhhcc------------cCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 999998653211 11122345678999997765 3568899999999999999997 999987
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..... ......... ..+ +.+..++.++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 220 ~~~~~--~~~~~i~~~--------~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 220 GVKNN--DVIGRIENG--------ERL------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCGG--GHHHHHHTT--------CCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHH--HHHHHHHcC--------CCC------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 43221 111111100 000 01113356788999999999999999999999999998875
Q ss_pred h
Q 001908 992 L 992 (997)
Q Consensus 992 ~ 992 (997)
.
T Consensus 278 ~ 278 (281)
T 1mp8_A 278 E 278 (281)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.74 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=200.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchh-------hHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG-------ALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
.++|++.+.||+|+||+||+|++..+++.||+|++...... ..+.+.+|++++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 36799999999999999999999999999999998633221 12678999999999999999999998633
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCeeeCCCCc
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~ 828 (997)
. .++||||+++|+|.+++..... .+++..++.++.|++.|++|||++ + |+||||||+||+++.++.
T Consensus 95 --~--~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 95 --P--PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp --T--TEEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred --C--CeEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence 2 2699999999999999876542 489999999999999999999999 7 999999999999988876
Q ss_pred -----EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHH
Q 001908 829 -----AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEM 903 (997)
Q Consensus 829 -----~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~el 903 (997)
+||+|||+|+... .......||+.|+|||++.. ....++.++||||+||++|||
T Consensus 163 ~~~~~~kl~Dfg~~~~~~-----------~~~~~~~g~~~y~aPE~~~~----------~~~~~~~~~Di~slG~~l~~l 221 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSV-----------HSVSGLLGNFQWMAPETIGA----------EEESYTEKADTYSFAMILYTI 221 (287)
T ss_dssp TCSCCEEECCCTTCBCCS-----------SCEECCCCCCTTSCGGGSSC----------SSCEECHHHHHHHHHHHHHHH
T ss_pred CCceeEEeCCCCcccccc-----------ccccccCCCccccCchhhcc----------CCCCcCchhhHHHHHHHHHHH
Confidence 9999999997431 12234578999999976631 234578899999999999999
Q ss_pred HhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 904 FTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 904 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
++|+.||................ ....+.. +..+++++.+++.+||+.||++|||+.|+++
T Consensus 222 ~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 222 LTGEGPFDEYSYGKIKFINMIRE-------EGLRPTI------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHSSCTTTTCCCCHHHHHHHHHH-------SCCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCccccccHHHHHHHHhc-------cCCCCCC------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999997543221111111100 0011111 1123567889999999999999999999999
Q ss_pred HHHH
Q 001908 984 KLCA 987 (997)
Q Consensus 984 ~L~~ 987 (997)
.|++
T Consensus 283 ~L~~ 286 (287)
T 4f0f_A 283 ELSE 286 (287)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.88 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=200.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+.|.+.+.||+|+||+||+|.+..++..||+|++... .....+.+.+|++++++++||||+++++++... ..+....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 4578888999999999999999999999999998643 344567889999999999999999999987543 2345678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCeeeC-CCCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP--IVHGDLKPSNVLLD-HDMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NIll~-~~~~~kl~D 833 (997)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ + |+||||||+||+++ .++.+||+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence 99999999999999998754 478899999999999999999998 7 99999999999998 889999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||++..... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||...
T Consensus 176 fg~~~~~~~----------~~~~~~~~t~~y~aPE~~~-------------~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 176 LGLATLKRA----------SFAKAVIGTPEFMAPEMYE-------------EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TTGGGGCCT----------TSBEESCSSCCCCCGGGGG-------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCcccccc----------cccccccCCcCcCCHHHHh-------------ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 999975421 1223456899999998663 35888999999999999999999998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ............ ..+.. .....++++.+++.+||..||++|||+.|+++
T Consensus 233 ~----~~~~~~~~~~~~-----~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 233 Q----NAAQIYRRVTSG-----VKPAS-----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp S----SHHHHHHHHTTT-----CCCGG-----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----cHHHHHHHHhcc-----CCccc-----------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2 122221111110 01100 01112346789999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=374.19 Aligned_cols=258 Identities=25% Similarity=0.443 Sum_probs=207.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||+||+|+++.++..||||+++.... ..+.+.+|++++++++||||++++++|. ..+..+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEE
Confidence 4578899999999999999999998899999999975432 3578999999999999999999999964 345789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 293 lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 99999999999999987542 2478999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+...... ........+|..|+|||++. +..++.++|||||||++|||+| |..||......
T Consensus 366 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 366 RLMTGDT-------YTAHAGAKFPIKWTAPESLA------------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp ECCTTCC-------EECCTTCCCCGGGCCHHHHH------------HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eeccCCc-------eeecCCCcCCcceeCHhHHh------------cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 8652211 11222345678999997765 3568899999999999999999 99998743211
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
.+.+.+... .. ...+..++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 427 --~~~~~~~~~--------~~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 427 --QVYELLEKD--------YR------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --GHHHHHHTT--------CC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --HHHHHHHcC--------CC------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111111100 00 1112234667889999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=345.94 Aligned_cols=267 Identities=23% Similarity=0.436 Sum_probs=204.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCC---cEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENG---TFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.+|++.+.||+|+||+||+|++..++ ..||+|+++.. .....+.+.+|++++++++||||++++++|. ..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence 56888999999999999999975333 36899998743 3445678899999999999999999999863 3456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred ceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence 78999999999999999976432 478899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|.|+....... ..........||+.|+|||.+. +..++.++||||+||++|||++ |.+||...
T Consensus 173 g~a~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 173 GLARDMYDKEY----YSVHNKTGAKLPVKWMALESLQ------------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GGGCCCSCGGG----CBC-----CCBCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred cccccccccch----hccccccCCCCCccccChHHhc------------CCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 99986532111 1122233456788999997764 4568899999999999999999 55555533
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
... ......... ..+. .+..++.++.+++.+||+.||++|||++|+++.|+++...+.
T Consensus 237 ~~~--~~~~~~~~~--------~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 237 NTF--DITVYLLQG--------RRLL------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CTT--THHHHHHTT--------CCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CHH--HHHHHHhcC--------CCCC------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 211 111111110 0000 011224568899999999999999999999999999998776
Q ss_pred cc
Q 001908 994 GR 995 (997)
Q Consensus 994 ~~ 995 (997)
++
T Consensus 295 ~~ 296 (298)
T 3f66_A 295 GE 296 (298)
T ss_dssp CS
T ss_pred cC
Confidence 54
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=363.93 Aligned_cols=208 Identities=23% Similarity=0.349 Sum_probs=160.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||+||+|+++.+++.||||++... .....+.+.+|++++++++||||+++++++...++.....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999999999999999998642 3345578899999999999999999999986655556678
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+ +|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence 99999998 679999998654 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCc-------------------cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHH
Q 001908 836 LARFLFARPFDTS-------------------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896 (997)
Q Consensus 836 ~a~~~~~~~~~~~-------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSl 896 (997)
+|+.......... ..........+||+.|+|||++. .+..++.++|||||
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----------~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL-----------LQENYTEAIDVWSI 270 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT-----------TCCCCCTHHHHHHH
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh-----------CCCCCCcHhHHHHH
Confidence 9987632211100 00012234567899999997653 24568999999999
Q ss_pred HHHHHHHHhC
Q 001908 897 GVMLLEMFTR 906 (997)
Q Consensus 897 Gvvl~elltg 906 (997)
||++|||++|
T Consensus 271 G~il~elltg 280 (458)
T 3rp9_A 271 GCIFAELLNM 280 (458)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHHh
Confidence 9999999993
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.46 Aligned_cols=265 Identities=28% Similarity=0.439 Sum_probs=195.0
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
..++|++.++||+|+||+||+|++.. .||+|+++.. .....+.+.+|++++++++||||+++++++. ..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------AP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CC
Confidence 34689999999999999999998742 5999999743 3445678899999999999999999999742 34
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred ccEEEEEecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence 5899999999999999997654 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++...... .........||+.|+|||++.. ..+..++.++||||+||++|||++|+.||....
T Consensus 165 g~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 165 GLATEKSRWS------GSHQFEQLSGSILWMAPEVIRM---------QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp C------------------------CCCTTCCHHHHC-------------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eecccccccc------ccccccccCCCccccCchhhcc---------cCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 9997642211 1112234568999999987742 124568889999999999999999999997432
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
... .+.+..... ...+.... ....++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 230 ~~~-~~~~~~~~~-------~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 230 NRD-QIIEMVGRG-------SLSPDLSK---------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CHH-HHHHHHHHT-------SCCCCTTS---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hHH-HHHHHhccc-------ccCcchhh---------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111 111111110 00111000 011235678899999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=351.75 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=199.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-----KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.+.|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|+++++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 467999999999999999999999999999999986321 113577899999999999999999999954 3
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc---E
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---A 829 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~ 829 (997)
.+..++||||+++|+|.+++.+.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence 56899999999999999888754311 12478999999999999999999999 9999999999999987654 9
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+++..... ........||+.|+|||++. +..++.++||||+||++|||++|+.|
T Consensus 173 kl~Dfg~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 173 KLGGFGVAIQLGES--------GLVAGGRVGTPHFMAPEVVK------------REPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp EECCCTTCEECCTT--------SCBCCCCCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEecCcceeEecCC--------CeeecCCcCCcCccCHHHHc------------CCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 99999999865221 11223457999999997664 46688999999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
|.... .+.......... ..++ ......+.++.+++.+||..||++|||+.|+++
T Consensus 233 f~~~~------~~~~~~i~~~~~--~~~~------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 233 FYGTK------ERLFEGIIKGKY--KMNP------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SCSSH------HHHHHHHHHTCC--CCCH------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCcH------HHHHHHHHcCCC--CCCc------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 97421 111111000000 0000 011123456789999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=343.45 Aligned_cols=272 Identities=22% Similarity=0.313 Sum_probs=198.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.++||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++||||+++++++. ..+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 4789999999999999999999999999999999743 3334577889999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++ ++.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999965 67666665431 488999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... ........||+.|+|||++.. ...++.++||||+||++|||++|..||......
T Consensus 148 ~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~ 208 (292)
T 3o0g_A 148 ARAFGIP--------VRCYSAEVVTLWYRPPDVLFG-----------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp CEECCSC--------CSCCCSCCSCGGGCCHHHHTT-----------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred ceecCCc--------cccccCCccccCCcChHHHcC-----------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH
Confidence 9765211 112234578999999977642 233789999999999999999988886432221
Q ss_pred CccHHHHHHhhc-c--hhhhhh---cCccccccc-ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMAL-P--EKVMET---VDPSLLLAW-SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~-~--~~~~~~---~d~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+........ + ..+... .+..-.... ..............++.+++.+|++.||++|||++|+++
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 111111111110 0 000000 000000000 000000111123456789999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=343.45 Aligned_cols=269 Identities=22% Similarity=0.348 Sum_probs=195.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||+||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 4788999999999999999999 478999999996432 223467889999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++ +|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999999965 99999986532 378899999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... ........||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 147 ~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (288)
T 1ob3_A 147 ARAFGIP--------VRKYTHEIVTLWYRAPDVLMG-----------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (288)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTT-----------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccCcc--------ccccccccccccccCchheeC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9875221 112233568999999987642 245789999999999999999999999743211
Q ss_pred CccHHHHHHhhc-c--hhhhh-----hcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMAL-P--EKVME-----TVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~-~--~~~~~-----~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. .+........ + ..+.. ..++.... +............+.++.+++.+||+.||++|||++|+++
T Consensus 208 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 208 D-QLMRIFRILGTPNSKNWPNVTELPKYDPNFTV-YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp H-HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC-CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H-HHHHHHHHHCCCChhhchhhhccccccccccc-ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1 1111111100 0 00000 00111000 0000000111123456789999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=348.59 Aligned_cols=272 Identities=22% Similarity=0.345 Sum_probs=211.8
Q ss_pred HhhcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLMQ-KGALKSFVAECEVLRNT-RHRNLIKIITVCSSID 749 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 749 (997)
..++|++.+.||+|+||.||+|++ ..+++.||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--- 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence 346899999999999999999985 4567899999997443 34557889999999999 8999999999954
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCC------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQ------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 817 (997)
..+..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+|||||
T Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 455789999999999999999876421 1122489999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHH
Q 001908 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897 (997)
Q Consensus 818 ~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlG 897 (997)
|+||+++.++.+||+|||+++...... .........||+.|+|||.+. +..++.++||||||
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG 234 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDS------NYVVKGNARLPVKWMAPESIF------------NCVYTFESDVWSYG 234 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCT------TSEECSSSEECGGGCCHHHHH------------HCCCCHHHHHHHHH
T ss_pred cceEEEcCCCCEEEccccccccccccc------cceeccCCCCcceeeChHHhc------------CCCCChHHHHHHHH
Confidence 999999999999999999998653221 111223345788999997664 35688999999999
Q ss_pred HHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 898 VMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 898 vvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
|++|||+| |+.||....... ......... ..+.. +..++.++.+++.+||..||++||
T Consensus 235 ~il~ellt~g~~p~~~~~~~~-~~~~~~~~~--------~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 235 IFLWELFSLGSSPYPGMPVDS-KFYKMIKEG--------FRMLS------------PEHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHHHTTTCCSSTTCCSSH-HHHHHHHHT--------CCCCC------------CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHhCCCCCCCcccchh-HHHHHhccC--------CCCCC------------cccCCHHHHHHHHHHcCCCchhCc
Confidence 99999999 999987543221 111111110 11000 112345688999999999999999
Q ss_pred CHHHHHHHHHHHHHHhhcc
Q 001908 977 EMRDVLAKLCAARQTLVGR 995 (997)
Q Consensus 977 s~~evl~~L~~~~~~~~~~ 995 (997)
|+.|+++.|+++.++....
T Consensus 294 s~~ell~~L~~~~~~~~~~ 312 (313)
T 1t46_A 294 TFKQIVQLIEKQISESTNH 312 (313)
T ss_dssp CHHHHHHHHHHHHHHTCC-
T ss_pred CHHHHHHHHHHHHHHhhcC
Confidence 9999999999998876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=338.83 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=189.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ----KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||+||+|++ .++.||||+++... ....+.+.+|+++++.++||||+++++++. ..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEP 79 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC-
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence 5789999999999999999998 58899999986432 223567899999999999999999999954 455
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC--------C
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH--------D 826 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~--------~ 826 (997)
..++||||+++++|.+++... .+++..++.++.|++.|++|||++...+|+||||||+||+++. +
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred ceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 789999999999999999654 3889999999999999999999992222999999999999986 7
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
+.+||+|||.++..... ......||+.|+|||.+. +..++.++||||+|+++|||++|
T Consensus 153 ~~~kl~Dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 153 KILKITDFGLAREWHRT----------TKMSAAGAYAWMAPEVIR------------ASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp CCEEECCCCC-----------------------CCGGGSCHHHHH------------HCCCSHHHHHHHHHHHHHHHHHC
T ss_pred cceEEccCCcccccccc----------cccCCCCccceeCHHHhc------------cCCCCchhhHHHHHHHHHHHHhC
Confidence 88999999999765221 122356899999997764 45688999999999999999999
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
+.||..... .......... ..... .+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 211 ~~p~~~~~~-----~~~~~~~~~~----~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 211 EVPFRGIDG-----LAVAYGVAMN----KLALP------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CCTTTTSCH-----HHHHHHHHTS----CCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCH-----HHHHHhhhcC----CCCCC------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 999974311 1111110000 00000 11123457889999999999999999999999997
Q ss_pred HH
Q 001908 987 AA 988 (997)
Q Consensus 987 ~~ 988 (997)
++
T Consensus 270 ~l 271 (271)
T 3dtc_A 270 TI 271 (271)
T ss_dssp C-
T ss_pred cC
Confidence 53
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=358.94 Aligned_cols=263 Identities=18% Similarity=0.253 Sum_probs=203.8
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeecc
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSI 748 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 748 (997)
.++....++|++.++||+|+||+||+|+.+.+++.||+|+++... ....+.+.+|+++++.++||||+++++++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--- 138 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--- 138 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 344455689999999999999999999999999999999996421 22334578999999999999999999985
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
.+.+..|+||||+++|+|.++++... +++..++.++.||+.||+|||++ +|+||||||+||+++.+|.
T Consensus 139 --~~~~~~~lV~E~~~gg~L~~~l~~~~-------~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 139 --QDDRYLYMVMEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp --ECSSEEEEEECCCTTEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred --EECCEEEEEEeCCCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 45668999999999999999998653 78899999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+..... ........+||+.|+|||++.... ....++.++|||||||++|||++|+.
T Consensus 207 ikL~DFG~a~~~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~--------~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 207 LKLADFGTCMKMNKE-------GMVRCDTAVGTPDYISPEVLKSQG--------GDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp EEECCCTTCEECCTT-------SEEECCSCCSCGGGCCHHHHHTTT--------TTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred EEEeccceeEeeccC-------CcccccCCcCCccccCHHHhhccC--------CCcCCCCcceEecchHHHHHHHhCCC
Confidence 999999999865221 111223467999999998876311 11237889999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE--RMEMRDVLA 983 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~ 983 (997)
||... ...+.......... ....|.. .....++.+++.+|+..+|++ ||++.|+++
T Consensus 272 Pf~~~-----~~~~~~~~i~~~~~-~~~~p~~-------------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 272 PFYAD-----SLVGTYSKIMNHKN-SLTFPDD-------------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp TTCCS-----SHHHHHHHHHTHHH-HCCCCTT-------------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCCCC-----ChhhHHHHHHhccc-cccCCCc-------------ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 99742 12222111111100 0000100 012346779999999999998 999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=353.52 Aligned_cols=253 Identities=18% Similarity=0.245 Sum_probs=201.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|..+.+++.||+|++..........+.+|++++++++||||+++++++ ......+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 36799999999999999999999999999999999766555567889999999999999999999995 4456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC--CCcEEEcccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFG 835 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFg 835 (997)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 125 lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 9999999999999997653 1478999999999999999999999 9999999999999974 5789999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... ........||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 197 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~- 254 (387)
T 1kob_A 197 LATKLNP---------DEIVKVTTATAEFAAPEIVD------------REPVGFYTDMWAIGVLGYVLLSGLSPFAGED- 254 (387)
T ss_dssp TCEECCT---------TSCEEEECSSGGGCCHHHHT------------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-
T ss_pred cceecCC---------CcceeeeccCCCccCchhcc------------CCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-
Confidence 9986522 11223357999999997664 4668899999999999999999999997431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.......... ..++.. ....+.++.+++.+||..||++|||+.|+++
T Consensus 255 ----~~~~~~~i~~~~~--~~~~~~------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 255 ----DLETLQNVKRCDW--EFDEDA------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ----HHHHHHHHHHCCC--CCCSST------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHHhCCC--CCCccc------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1111111100000 000000 0122456789999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=350.41 Aligned_cols=274 Identities=26% Similarity=0.378 Sum_probs=208.4
Q ss_pred cCccCCcccccCcceEEEEEEC----CCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILG----ENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.|++.++||+|+||+||++.++ .+++.||||+++... ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~ 108 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAA 108 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTT
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCc
Confidence 3489999999999999888653 478899999997543 3456788999999999999999999999754 2356
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++.... +++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred eEEEEEecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence 7899999999999999998754 88999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++...... ..........+|..|+|||++. +..++.++||||+||++|||+||+.||....
T Consensus 179 g~a~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 179 GLAKAVPEGH-----EYYRVREDGDSPVFWYAPECLK------------EYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp GGCEECCTTC-----SEEEC---CCCCGGGCCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cccccccccc-----cccccccCCCCCceeeChHHhc------------CCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 9998763211 1112233456888999997765 3567889999999999999999999986421
Q ss_pred CCCccHHHHHHhhcc----hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALP----EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~----~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
.. .......... ....+.++. ....+.+..++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 242 ~~---~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 242 TK---FLELIGIAQGQMTVLRLTELLER--------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HH---HHHHHCSCCHHHHHHHHHHHHHT--------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hh---hhhhhcccccchhHHHHHHHHhc--------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 0000000000 000111100 00111122345678999999999999999999999999999988
Q ss_pred Hhhc
Q 001908 991 TLVG 994 (997)
Q Consensus 991 ~~~~ 994 (997)
++.+
T Consensus 311 ~~~~ 314 (318)
T 3lxp_A 311 KYQG 314 (318)
T ss_dssp HHHC
T ss_pred hhcc
Confidence 7654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=354.94 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=199.5
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
....++|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+..|.++++.+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~----- 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF----- 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----
Confidence 345578999999999999999999999999999999997432 33456778899999887 899999999984
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.+.+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+|
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence 45668999999999999999998754 488999999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+.... ........+||+.|+|||++. +..++.++||||+||++|||++|+.||
T Consensus 159 L~DFG~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~Pf 218 (345)
T 1xjd_A 159 IADFGMCKENML--------GDAKTNTFCGTPDYIAPEILL------------GQKYNHSVDWWSFGVLLYEMLIGQSPF 218 (345)
T ss_dssp ECCCTTCBCCCC--------TTCCBCCCCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeEChhhhhccc--------CCCcccCCCCCcccCChhhhc------------CCCCCChhhhHHHHHHHHHHhcCCCCC
Confidence 999999975421 111234568999999997664 467899999999999999999999999
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR-DVL 982 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 982 (997)
.... ..+........ .+... .....++.+++.+||..||++||++. |++
T Consensus 219 ~~~~-----~~~~~~~i~~~------~~~~p------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 219 HGQD-----EEELFHSIRMD------NPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCSS-----HHHHHHHHHHC------CCCCC------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCC-----HHHHHHHHHhC------CCCCC------------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 7431 22221111000 01110 11234677999999999999999987 554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.69 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=199.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||+||+|+.+.+++.||+|+++... ....+.+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 367999999999999999999999999999999996432 23456788999999999999999999985 4566
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 8999999999999999998754 478899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... .....+||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 151 g~a~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 151 GFAKYVPD-----------VTYTLCGTPDYIAPEVVS------------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp SSCEECSS-----------CBCCCCSCTTTCCHHHHT------------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CcceecCC-----------ccccccCCccccCHhHhc------------CCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 99976421 123457999999997664 4678899999999999999999999997421
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
..+......... ... +.....++.+++.+|+..||++|| ++.|+++
T Consensus 208 -----~~~~~~~i~~~~------~~~------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 208 -----TMKTYEKILNAE------LRF------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----HHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----HHHHHHHHHhCC------CCC------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111111111000 000 011234677999999999999999 8888864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.09 Aligned_cols=272 Identities=17% Similarity=0.164 Sum_probs=210.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+++++++ +|+|++++++++. .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCcee
Confidence 457999999999999999999998899999999986432 234578899999999 7999999999854 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc-----EEE
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV-----AHV 831 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl 831 (997)
++||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999999 9999999987542 388999999999999999999999 9999999999999988776 999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+.......... ..........||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 153 ~Dfg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHL------------GREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp CCCTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EECcccccccccccccc-ccccCccCCCCCcccCCchhhc------------CCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 99999987643221111 1112234567999999997654 5678999999999999999999999998
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
...... ..+.......... ....+ .....++.++.+++..||+.||++||+++++++.|+++.++
T Consensus 220 ~~~~~~--~~~~~~~~~~~~~-~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 220 GLKAAT--NKQKYERIGEKKQ-STPLR------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp SCCSCC--HHHHHHHHHHHHH-HSCHH------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhccc--cHHHHHHHHhhcc-CccHH------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 543221 1111111100000 00000 00112356788999999999999999999999999999876
Q ss_pred hh
Q 001908 992 LV 993 (997)
Q Consensus 992 ~~ 993 (997)
..
T Consensus 285 ~~ 286 (298)
T 1csn_A 285 LN 286 (298)
T ss_dssp TT
T ss_pred cC
Confidence 53
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.52 Aligned_cols=254 Identities=22% Similarity=0.254 Sum_probs=190.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|+.+.+++.||||++..... ..+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence 4689999999999999999999999999999999974332 2366889999999999999999999954 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc--EEEcccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--AHVSDFG 835 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFg 835 (997)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 93 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 9999999999999998754 488999999999999999999999 9999999999999987775 9999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCc-cchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASV-TGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~-~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
+|+.... ........||+.|+|||++. +..++. ++||||+||++|||++|+.||....
T Consensus 164 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 164 YSKSSVL---------HSQPKSTVGTPAYIAPEVLL------------RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp CC------------------------CTTSCHHHHH------------CSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ccccccc---------cCCCCCCcCCCCcCChhhhc------------CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 9974311 11223457999999997765 344544 4899999999999999999997543
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
... .............. .. +.......++.+++.+||..||++|||+.|+++.
T Consensus 223 ~~~-~~~~~~~~~~~~~~------~~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 223 EPR-DYRKTIQRILSVKY------SI----------PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CC-CHHHHHHHHHTTCC------CC----------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHH-HHHHHHHHHhcCCC------CC----------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 222 22222211111000 00 0000123567799999999999999999999763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.53 Aligned_cols=276 Identities=25% Similarity=0.346 Sum_probs=200.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-----hhhHHHHHHHHHHHhhcC---CCCcceEEeeeecc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-----KGALKSFVAECEVLRNTR---HRNLIKIITVCSSI 748 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 748 (997)
..++|++.++||+|+||+||+|++..+++.||||+++... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999998899999999986322 112346677888777764 99999999998764
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
........++||||++ |+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 4333446899999996 6999999876522 388999999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+.... ........||+.|+|||++. +..++.++||||+||++|||++|+.
T Consensus 159 ~kl~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~~l~~g~~ 217 (308)
T 3g33_A 159 VKLADFGLARIYSY---------QMALTPVVVTLWYRAPEVLL------------QSTYATPVDMWSVGCIFAEMFRRKP 217 (308)
T ss_dssp EEECSCSCTTTSTT---------CCCSGGGGCCCSSCCHHHHH------------TSCCCSTHHHHHHHHHHHHTTTSSC
T ss_pred EEEeeCccccccCC---------CcccCCccccccccCchHHc------------CCCCCchHHHHHHHHHHHHHHhCCC
Confidence 99999999976521 12224467899999997664 4668999999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhh-cc--hhhhhhcCcccccccccch---hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMA-LP--EKVMETVDPSLLLAWSDGR---RRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~-~~--~~~~~~~d~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
||...... ..+....... .+ ..+..... .....+.... ......+...++.+++.+||+.||++|||+.|++
T Consensus 218 pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 218 LFCGNSEA-DQLGKIFDLIGLPPEDDWPRDVS-LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp SCCCSSHH-HHHHHHHHHHCCCCTTTSCSSCS-SCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCHH-HHHHHHHHHhCCCChhhccchhh-ccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 99743211 1111111110 00 00000000 0000000000 0111123446788999999999999999999997
Q ss_pred H
Q 001908 983 A 983 (997)
Q Consensus 983 ~ 983 (997)
+
T Consensus 296 ~ 296 (308)
T 3g33_A 296 Q 296 (308)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.56 Aligned_cols=246 Identities=22% Similarity=0.227 Sum_probs=191.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.++||+|+||+||+|++..+++.||||++... ..........|+..+.++ +|+||++++++|. ..+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence 46899999999999999999999989999999998642 233344556666666655 8999999999964 356
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred EEEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence 899999999 7799999887642 489999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ........||+.|+|||++. +.++.++|||||||++|||++|..|+...
T Consensus 202 G~a~~~~~---------~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~DiwslG~il~el~~g~~~~~~~- 258 (311)
T 3p1a_A 202 GLLVELGT---------AGAGEVQEGDPRYMAPELLQ-------------GSYGTAADVFSLGLTILEVACNMELPHGG- 258 (311)
T ss_dssp TTCEECC---------------CCCCCGGGCCGGGGG-------------TCCSTHHHHHHHHHHHHHHHHTCCCCSSH-
T ss_pred eeeeeccc---------CCCCcccCCCccccCHhHhc-------------CCCCchhhHHHHHHHHHHHHhCCCCCCCc-
Confidence 99876522 11223356999999997653 35889999999999999999997765421
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.......... ..+ .....++.++.+++.+||+.||++|||+.|+++
T Consensus 259 ---~~~~~~~~~~--------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 ---EGWQQLRQGY--------LPP------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHHHTTTC--------CCH------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cHHHHHhccC--------CCc------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111110000 000 112233567889999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=370.53 Aligned_cols=258 Identities=24% Similarity=0.427 Sum_probs=205.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence 3468899999999999999999997 57889999997543 34578999999999999999999999863 3468
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999986431 1378889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
|+..... .........+|..|+|||++. +..++.++|||||||++|||+| |+.||....
T Consensus 331 a~~~~~~-------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~- 390 (454)
T 1qcf_A 331 ARVIEDN-------EYTAREGAKFPIKWTAPEAIN------------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS- 390 (454)
T ss_dssp GGGBCCH-------HHHTTCSSSSCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred ceEcCCC-------ceeccCCCcccccccCHHHhc------------cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-
Confidence 9865211 111122345678999997765 3568999999999999999999 999987431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
..+..... .... +.+.+..++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 391 ----~~~~~~~i-----~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 391 ----NPEVIRAL-----ERGY------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ----HHHHHHHH-----HHTC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ----HHHHHHHH-----HcCC------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11211111 0000 011122356778999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=351.23 Aligned_cols=267 Identities=24% Similarity=0.367 Sum_probs=209.3
Q ss_pred hhcCccCCcccccCcceEEEEEECC-------CCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGE-------NGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
.++|.+.++||+|+||+||+|++.. .+..||||+++.. .....+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence 4689999999999999999999742 3457999999743 344557889999999999 8999999999954
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
..+..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 455789999999999999999876421 1123489999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+||+++.++.+||+|||+|+....... ........+|+.|+|||++. +..++.++|||||||
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~DiwslG~ 281 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALF------------DRIYTHQSDVWSFGV 281 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCT------TCCCTTCCCGGGGSCHHHHH------------SCCCCHHHHHHHHHH
T ss_pred ceEEEcCCCcEEEcccCcccccccccc------cccccCCCCCcceeCHHHhc------------CCCCCchhHHHHHHH
Confidence 999999999999999999986532111 11223346788999997664 567899999999999
Q ss_pred HHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 899 MLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 899 vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++|||++ |..||... ...+....... ...+.. +..++.++.+++.+||+.||++|||
T Consensus 282 il~ellt~g~~p~~~~-----~~~~~~~~~~~-----~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps 339 (382)
T 3tt0_A 282 LLWEIFTLGGSPYPGV-----PVEELFKLLKE-----GHRMDK------------PSNCTNELYMMMRDCWHAVPSQRPT 339 (382)
T ss_dssp HHHHHHTTSCCSSTTC-----CHHHHHHHHHT-----TCCCCC------------CSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHhCCCCCCCCC-----CHHHHHHHHHc-----CCCCCC------------CccCCHHHHHHHHHHcCCChhhCcC
Confidence 9999999 99998633 22222111110 001100 1123457889999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 001908 978 MRDVLAKLCAARQTL 992 (997)
Q Consensus 978 ~~evl~~L~~~~~~~ 992 (997)
++|+++.|+++....
T Consensus 340 ~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 340 FKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.79 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=197.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||+||+|++ .++.||||++... ...+.+.+|++++++++||||+++++++. +..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence 5788999999999999999998 4789999998643 34578899999999999999999999853 24799
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc-EEEcccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV-AHVSDFGLA 837 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-~kl~DFg~a 837 (997)
||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++
T Consensus 77 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp EEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 9999999999999987542 224788899999999999999999932228999999999999998886 799999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 154 ~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~- 209 (307)
T 2eva_A 154 CDIQT-----------HMTNNKGSAAWMAPEVFE------------GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP- 209 (307)
T ss_dssp ----------------------CCTTSSCHHHHT------------CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-
T ss_pred ccccc-----------ccccCCCCCceEChhhhC------------CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-
Confidence 75421 112346899999997654 467899999999999999999999999743221
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
......... ....+.. ...++..+.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus 210 --~~~~~~~~~-----~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 210 --AFRIMWAVH-----NGTRPPL------------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --HHHHHHHHH-----TTCCCCC------------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --HHHHHHHHh-----cCCCCCc------------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111100 0001111 1123456789999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.96 Aligned_cols=254 Identities=25% Similarity=0.326 Sum_probs=195.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|.+.++||+|+||+||+|+.+.++..||+|++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeE
Confidence 467999999999999999999999999999999987443 334578899999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee---CCCCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~D 833 (997)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 9999999999999998654210 12488999999999999999999999 99999999999999 5568899999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.... ........||+.|+|||++. +.++.++||||+||++|||++|+.||...
T Consensus 171 fg~a~~~~~---------~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 171 FGLAELFKS---------DEHSTNAAGTALYMAPEVFK-------------RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp CCCCCC-------------------CTTGGGCCHHHHT-------------TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecceecCC---------cccCcCcccccCcCChHHhc-------------cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 999976422 11223456899999998763 35788999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..+...... ...+..... ....++++.+++.+||..||++|||+.|+++
T Consensus 229 ~-----~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 229 S-----LEEVQQKAT------YKEPNYAVE---------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp S-----HHHHHHHHH------HCCCCCCC-----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred C-----HHHHHhhhc------cCCcccccc---------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 222111110 000110000 0012356779999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.31 Aligned_cols=292 Identities=21% Similarity=0.295 Sum_probs=216.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|.+.++||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 357999999999999999999999899999999997433 3345778899999999999999999998753 234578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee----CCCCcEEEc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVS 832 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~ 832 (997)
++||||+++|+|.+++...... ..+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence 9999999999999999875421 2388999999999999999999999 99999999999999 888899999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+.... ........||+.|+|||++..... .......++.++|||||||++|||++|+.||..
T Consensus 159 DFG~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 159 DFGAARELED---------DEQFVSLYGTEEYLHPDMYERAVL----RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CGGGCEECCC---------GGGSSCSSSCCTTCCHHHHHHHCC------CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred cCCCceEccC---------CCccccccCCccccCHHHhhcccc----ccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999986521 112234579999999998753210 000013567899999999999999999999975
Q ss_pred CcCCCccHHHHHHhh--cchhhhhhcCcccc--ccccc--chhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMA--LPEKVMETVDPSLL--LAWSD--GRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~--~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
............... .+......+..... ..|.. .............+.+++..||+.||++||+++|+++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp TTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 443332222221111 11110000000000 00100 0011223566778899999999999999999999999998
Q ss_pred HHHHH
Q 001908 987 AARQT 991 (997)
Q Consensus 987 ~~~~~ 991 (997)
++...
T Consensus 306 ~il~~ 310 (396)
T 4eut_A 306 DILHR 310 (396)
T ss_dssp HHHTC
T ss_pred HHhhc
Confidence 87654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.87 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=185.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..+.|++.+.||+|+||+||+|+++.+++.||||+++... ..+.+.+|++++++++||||+++++++. ..+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence 3467999999999999999999999899999999997543 3356789999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~D 833 (997)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence 99999999999999998654 478999999999999999999999 9999999999999975 89999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++.... ........||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 195 fg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 195 FGLSKIVEH---------QVLMKTVCGTPGYCAPEILR------------GCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp CC-------------------------CGGGSCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred CccccccCc---------ccccccccCCCCccCHHHhc------------CCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999986522 11223457899999997654 567899999999999999999999998643
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
... ........... .....+ ...+.+.++.+++.+||..||++|||+.|+++
T Consensus 254 ~~~----~~~~~~i~~~~-~~~~~~-------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 254 RGD----QFMFRRILNCE-YYFISP-------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TCH----HHHHHHHHTTC-CCCCTT-------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc----HHHHHHHHhCC-CccCCc-------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 211 11111110000 000000 00123456789999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.39 Aligned_cols=282 Identities=16% Similarity=0.196 Sum_probs=204.5
Q ss_pred hhcCccCCccccc--CcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQG--SFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.++||+| +||+||+|+++.+++.||||+++.. .....+.+.+|++++++++||||+++++++. ..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----AD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----EC
Confidence 4689999999999 9999999999999999999999743 2445678889999999999999999999964 35
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++...... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred CEEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 5899999999999999999875322 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+........... ..........||+.|+|||++... ...++.++||||+||++|||++|+.||...
T Consensus 172 fg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 172 LRSNLSMISHGQRQR-VVHDFPKYSVKVLPWLSPEVLQQN----------LQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp GGGCEECEETTEECS-CBCCCCTTCTTTGGGSCHHHHSTT----------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccceeecccccccc-ccccccccccccccccCHHHHhcc----------CCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 999876533211110 111222335789999999876421 146889999999999999999999999754
Q ss_pred cCCCccHHHHHHhhcch----------hhhh-----h----cCccccc-----ccccchhhhhHHHHHHHHHHHHhhcCC
Q 001908 914 FQGGLTLHEFCKMALPE----------KVME-----T----VDPSLLL-----AWSDGRRRAKVEECLVTVIRIGVACSM 969 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~----------~~~~-----~----~d~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~ 969 (997)
.......... ....+. .... . ....... ........+....+.+++.+++.+||+
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 241 PATQMLLEKL-NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CSTTHHHHC---------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CHHHHHHHHh-cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 3322111110 000000 0000 0 0000000 000000111223445678999999999
Q ss_pred CCCCCCCCHHHHHH
Q 001908 970 ESPIERMEMRDVLA 983 (997)
Q Consensus 970 ~dP~~Rps~~evl~ 983 (997)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpta~ell~ 333 (389)
T 3gni_B 320 RNPDARPSASTLLN 333 (389)
T ss_dssp SCTTTSCCHHHHTT
T ss_pred cCcccCCCHHHHhc
Confidence 99999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=352.18 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=199.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|++++++++||||+++++++ .+.+.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 115 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCCE
Confidence 6899999999999999999999999999999999643 223456788999999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence 999999999999999998754 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 187 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~Pf~~~-- 241 (350)
T 1rdq_E 187 FAKRVKG-----------RTWTLCGTPEALAPEIIL------------SKGYNKAVDWWALGVLIYEMAAGYPPFFAD-- 241 (350)
T ss_dssp TCEECSS-----------CBCCCEECGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred cceeccC-----------CcccccCCccccCHHHhc------------CCCCCCcCCEecccHhHhHHhhCCCCCCCC--
Confidence 9986521 123457999999997664 467899999999999999999999999742
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
...+......... ... +..+..++.+++.+||..||++||+ ++|+++
T Consensus 242 ---~~~~~~~~i~~~~------~~~------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 242 ---QPIQIYEKIVSGK------VRF------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---SHHHHHHHHHHCC------CCC------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CHHHHHHHHHcCC------CCC------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1122111111000 000 0122456789999999999999998 777764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=374.35 Aligned_cols=174 Identities=21% Similarity=0.249 Sum_probs=127.3
Q ss_pred CCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecc
Q 001908 419 LMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYI 498 (997)
Q Consensus 419 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 498 (997)
+|+.|++++|.++.. |..+ .++|+.|+|++|.+++ +..+..+++| +.|+|++|.+++..|..|+.+++|+.|+|
T Consensus 212 ~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 285 (597)
T 3oja_B 212 AVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYI 285 (597)
T ss_dssp TCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEEC
T ss_pred hhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCCC-CEEECCCCccCCCCHHHhcCccCCCEEEC
Confidence 445555555554422 2211 1456666666666654 2455566666 66777777777677778888888889999
Q ss_pred ccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCccc
Q 001908 499 SGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 499 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|+|++|+|+|.
T Consensus 286 s~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 286 SNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp TTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 9998884 6777788899999999999998 6888889999999999999999864 3 67788999999999999987
Q ss_pred CCCCCcCCCCcceeecCCCCcCCCCC
Q 001908 579 VPTKGVFSNKTRVQLTGNGKLCGGSN 604 (997)
Q Consensus 579 ~p~~~~~~~~~~~~~~~N~~~C~~~~ 604 (997)
.+. ..+..+....+.+|+..|+...
T Consensus 361 ~~~-~~~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 361 SLR-ALFRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp HHH-HHTTTCCTTTBCCCCCCCCTTC
T ss_pred hHH-HHHHHHhhhccccccccCCcch
Confidence 543 3456666677889999998644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.71 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=197.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+.|+..+.||+|+||+||+|+...+++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 5688999999999999999999889999999999643 23345678999999999999999999999643 458
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||++ |++.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEecCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 999999996 68888886543 1488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++.... .....||+.|+|||++... .+..++.++|||||||++|||++|+.||....
T Consensus 200 ~a~~~~~------------~~~~~gt~~y~aPE~~~~~---------~~~~~~~~~DiwslG~il~ell~g~~p~~~~~- 257 (348)
T 1u5q_A 200 SASIMAP------------ANSFVGTPYWMAPEVILAM---------DEGQYDGKVDVWSLGITCIELAERKPPLFNMN- 257 (348)
T ss_dssp TCBSSSS------------BCCCCSCGGGCCHHHHHTT---------SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-
T ss_pred CceecCC------------CCcccCCcceeCHhhhccc---------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 9975411 1235799999999877421 24568899999999999999999999986431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... ... .....+... ...++..+.+++.+||+.||++|||+.|+++
T Consensus 258 ---~~~~~-~~~-----~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 258 ---AMSAL-YHI-----AQNESPALQ-----------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ---HHHHH-HHH-----HHSCCCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---hHHHH-HHH-----HhcCCCCCC-----------CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11111 110 011111110 0112456789999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=345.91 Aligned_cols=266 Identities=21% Similarity=0.340 Sum_probs=196.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||+||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 46899999999999999999999889999999999743 2334567899999999999999999999875432 1223
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 4699999999999999998754 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++...... ..........||+.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 161 g~a~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 161 GIARAIADSG-----NSVTQTAAVIGTAQYLSPEQAR------------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp SCC-----------------------CCTTCCHHHHH------------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCcccccccc-----cccccccccCcCcccCCHHHhc------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998653211 1112223456899999997664 4678999999999999999999999997431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH-HHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL-AKLCAAR 989 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl-~~L~~~~ 989 (997)
..+......... ...+. .....++.++.+++.+||+.||++||++.+++ +.+.++.
T Consensus 224 -----~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 224 -----PVSVAYQHVRED---PIPPS-----------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----HHHHHHHHHHCC---CCCHH-----------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----hHHHHHHHhcCC---CCCcc-----------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 111111110000 00000 00112355788999999999999999665554 4555443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=344.73 Aligned_cols=286 Identities=23% Similarity=0.320 Sum_probs=215.4
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhh--cCCCCcceEEeeeecc
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN--TRHRNLIKIITVCSSI 748 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 748 (997)
...-....++|++.+.||+|+||.||+|++ +++.||||++... ..+.+.+|+++++. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 333455668999999999999999999998 5899999998643 23567889999887 7899999999997542
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCcEecCCCCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH--------HHCQPPIVHGDLKPSN 820 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivHrDlk~~N 820 (997)
. ......++||||+++|+|.+++.+.. +++..++.++.|++.||+||| +. +|+||||||+|
T Consensus 109 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N 177 (342)
T 1b6c_B 109 N-GTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN 177 (342)
T ss_dssp C-SSCCCEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred C-CccceeEEEEeecCCCcHHHHHhccC-------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence 1 11237899999999999999998653 789999999999999999999 67 99999999999
Q ss_pred eeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHH
Q 001908 821 VLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900 (997)
Q Consensus 821 Ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl 900 (997)
|+++.++++||+|||+++....... ..........||+.|+|||++..... .....++.++|||||||++
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATD----TIDIAPNHRVGTKRYMAPEVLDDSIN------MKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTT----EEEECCCSCCCCGGGCCHHHHTSCCC------TTCHHHHHHHHHHHHHHHH
T ss_pred EEECCCCCEEEEECCCceecccccc----ccccccccCCcCcccCCHhhhccccc------ccccccCCcccHHHHHHHH
Confidence 9999999999999999976532211 00112234579999999988753210 0001344789999999999
Q ss_pred HHHHhC----------CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCC
Q 001908 901 LEMFTR----------RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970 (997)
Q Consensus 901 ~elltg----------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 970 (997)
|||+|| ..||............+........ .++..... ....+++..+.+++.+||+.
T Consensus 248 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-------~~~~~~~~~l~~li~~cl~~ 316 (342)
T 1b6c_B 248 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNR-------WQSCEALRVMAKIMRECWYA 316 (342)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGG-------GGTSHHHHHHHHHHHHHCCS
T ss_pred HHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH----hCCCCccc-------ccchhHHHHHHHHHHHHhcc
Confidence 999999 7788755444434444333221111 11111111 11235677899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhh
Q 001908 971 SPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 971 dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
||++|||+.|+++.|+++.++..
T Consensus 317 dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 317 NGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTTC
T ss_pred ChhhCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=352.15 Aligned_cols=272 Identities=20% Similarity=0.317 Sum_probs=206.3
Q ss_pred HHhhcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
...++|++.+.||+|+||+||+|++ ..+++.||||+++.. .....+.+.+|+++++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-- 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 3457899999999999999999997 345678999999743 333457889999999999 8999999999954
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCC-----------------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQP-----------------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPI 811 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~i 811 (997)
..+..++||||+++|+|.+++....... ....+++..++.++.|++.||+|||++ +|
T Consensus 120 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 193 (344)
T 1rjb_A 120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193 (344)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ---eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 3557999999999999999998764210 012378999999999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 812 vHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+||||||+||+++.++.+||+|||+++...... .........||+.|+|||.+. +..++.++
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~ 255 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS------NYVVRGNARLPVKWMAPESLF------------EGIYTIKS 255 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCT------TSEEETTEEECGGGCCHHHHH------------HCCCCHHH
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCc------cceeccCccCccCccCHHHhc------------cCCCChhH
Confidence 999999999999999999999999998653221 111233456788999997764 35688999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCC
Q 001908 892 DVYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970 (997)
Q Consensus 892 DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 970 (997)
|||||||++|||+| |..||....... .+....... ..+. .+..++.++.+++.+||..
T Consensus 256 Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~--------~~~~------------~~~~~~~~l~~li~~~l~~ 314 (344)
T 1rjb_A 256 DVWSYGILLWEIFSLGVNPYPGIPVDA-NFYKLIQNG--------FKMD------------QPFYATEEIYIIMQSCWAF 314 (344)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHTT--------CCCC------------CCTTCCHHHHHHHHHHTCS
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCcHH-HHHHHHhcC--------CCCC------------CCCCCCHHHHHHHHHHcCC
Confidence 99999999999998 999997542211 111111110 0000 0112345788999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhhc
Q 001908 971 SPIERMEMRDVLAKLCAARQTLVG 994 (997)
Q Consensus 971 dP~~Rps~~evl~~L~~~~~~~~~ 994 (997)
||++|||+.|+++.|+.+..+...
T Consensus 315 dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 315 DSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp SGGGSCCHHHHHHHHHHHC-----
T ss_pred CchhCcCHHHHHHHHHHHHHHHHH
Confidence 999999999999999998765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.33 Aligned_cols=271 Identities=21% Similarity=0.292 Sum_probs=197.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++. ..+..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 57899999999999999999999899999999986432 334567889999999999999999999964 35589
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 99999999999999887654 478999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... ........||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 149 ARLLTGP--------SDYYDDEVATRWYRSPELLVG-----------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp CEECC--------------------GGGCCHHHHHT-----------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred chhccCc--------ccccCCCcCCccccChHHHhc-----------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9765221 112234578999999987642 256789999999999999999999999743211
Q ss_pred CccHHHHHHh---hcchhhhhhcCcccccc--ccc----chhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKM---ALPEKVMETVDPSLLLA--WSD----GRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~---~~~~~~~~~~d~~~~~~--~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ........ ..+.............. ..+ ..........+.++.+++.+||+.||++|||++|+++
T Consensus 210 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 210 D-QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp H-HHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred H-HHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1 11111110 00000000000000000 000 0000011234556889999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=349.26 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=198.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCC----cEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENG----TFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|+..+.||+|+||+||+|+++.++ ..||||+++.. .......+.+|++++++++||||+++++++. ..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence 46777899999999999999886443 46999999743 3345567899999999999999999999953 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence 689999999999999999987532 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||.++....... .........+|+.|+|||++. +..++.++|||||||++|||++ |+.||..
T Consensus 191 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 191 FGLSRVLEDDPE-----ATYTTSGGKIPIRWTAPEAIS------------YRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp CCC----------------------CCCGGGSCHHHHH------------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCcchhhccccc-----cccccCCCCccccccCchhcc------------cCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 999987632211 111122345688999997664 4678899999999999999999 9999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.. ..+...... ..... +.+..++.++.+++.+||+.||++||++.|+++.|+++..+.
T Consensus 254 ~~-----~~~~~~~~~-----~~~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 254 LS-----NHEVMKAIN-----DGFRL------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CC-----HHHHHHHHH-----TTCCC------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CC-----HHHHHHHHH-----CCCcC------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 31 111111110 00000 011123557889999999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=338.78 Aligned_cols=258 Identities=27% Similarity=0.406 Sum_probs=205.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++. ..+..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence 367899999999999999999997 678999999975433 2367899999999999999999999954 355789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999987542 378999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+.... ..........+|..|+|||++. +..++.++||||+|+++|||++ |+.||....
T Consensus 152 ~~~~~-------~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-- 210 (267)
T 3t9t_A 152 RFVLD-------DQYTSSTGTKFPVKWASPEVFS------------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-- 210 (267)
T ss_dssp GGBCC-------HHHHSTTSTTCCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred ccccc-------ccccccccccccccccChhhhc------------CCCccchhchhhhHHHHHHHhccCCCCCCCCC--
Confidence 86521 1111223345788999997765 3568899999999999999999 899987421
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..+...... ....+.. +..++..+.+++.+||..||++||+++|+++.|+++.++
T Consensus 211 ---~~~~~~~i~-----~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 211 ---NSEVVEDIS-----TGFRLYK------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ---HHHHHHHHH-----TTCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHHh-----cCCcCCC------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111110 0000000 011245678999999999999999999999999998763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=351.93 Aligned_cols=212 Identities=24% Similarity=0.370 Sum_probs=165.9
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 752 (997)
...++|++.+.||+|+||+||+|.++.+++.||||++.. ......+.+.+|+.+++++. ||||+++++++.. .+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence 345789999999999999999999999999999999853 23445567889999999997 9999999999753 23
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
....|+||||++ |+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRANI-------LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CCEEEEEecccC-cCHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 457899999996 69999998743 88899999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCc-------------cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHH
Q 001908 833 DFGLARFLFARPFDTS-------------METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM 899 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvv 899 (997)
|||+|+.......... ..........+||+.|+|||++.. ...++.++||||+||+
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwSlG~i 220 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-----------STKYTKGIDMWSLGCI 220 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-----------CCCCCTHHHHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-----------CCCCCChhhHHHHHHH
Confidence 9999986532111000 011122344689999999977642 2568999999999999
Q ss_pred HHHHHhCCCCCCc
Q 001908 900 LLEMFTRRRPTNC 912 (997)
Q Consensus 900 l~elltg~~P~~~ 912 (997)
+|||++|++||..
T Consensus 221 l~ell~g~~pf~~ 233 (388)
T 3oz6_A 221 LGEILCGKPIFPG 233 (388)
T ss_dssp HHHHHHSSCSCCC
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=351.45 Aligned_cols=275 Identities=21% Similarity=0.324 Sum_probs=212.0
Q ss_pred HHHHHhhcCccCCcccccCcceEEEEEECCCCc-----EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeee
Q 001908 673 ELSEATNEFSSSNMIGQGSFGSVYKGILGENGT-----FVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVC 745 (997)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 745 (997)
+.+...++|++.+.||+|+||.||+|++..+++ .||+|+++.. .....+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999999876554 7999999744 334567889999999999 899999999995
Q ss_pred eccCcCCCceEEEEEeeccCCCHHHHhhcCCCC--------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 001908 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ--------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817 (997)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 817 (997)
. ..+..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+|||||
T Consensus 120 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 191 (333)
T 2i1m_A 120 T-----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA 191 (333)
T ss_dssp C-----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred e-----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcc
Confidence 4 455799999999999999999864210 0012478999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHH
Q 001908 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897 (997)
Q Consensus 818 ~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlG 897 (997)
|+||+++.++.+||+|||+|+...... .........||+.|+|||++. +..++.++||||||
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG 253 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDS------NYIVKGNARLPVKWMAPESIF------------DCVYTVQSDVWSYG 253 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCT------TSEECSSCEECGGGSCHHHHH------------HCCCCHHHHHHHHH
T ss_pred cceEEECCCCeEEECcccccccccccc------ceeecCCCCCCccccCHHHhc------------cCCCChHHHHHHHH
Confidence 999999999999999999998653221 111223345788999997664 35688999999999
Q ss_pred HHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 898 VMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 898 vvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
|++|||+| |..||....... ......... ..+. .+..++..+.+++.+||+.||++||
T Consensus 254 ~il~el~t~g~~p~~~~~~~~-~~~~~~~~~--------~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rp 312 (333)
T 2i1m_A 254 ILLWEIFSLGLNPYPGILVNS-KFYKLVKDG--------YQMA------------QPAFAPKNIYSIMQACWALEPTHRP 312 (333)
T ss_dssp HHHHHHTTTSCCSSTTCCSSH-HHHHHHHHT--------CCCC------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHcCCCCCCcccchhH-HHHHHHhcC--------CCCC------------CCCCCCHHHHHHHHHHhccChhhCc
Confidence 99999999 999987432221 111111111 0000 0111245678999999999999999
Q ss_pred CHHHHHHHHHHHHHHhhc
Q 001908 977 EMRDVLAKLCAARQTLVG 994 (997)
Q Consensus 977 s~~evl~~L~~~~~~~~~ 994 (997)
|+.|+++.|+++.++..+
T Consensus 313 s~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 313 TFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp CHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhhhc
Confidence 999999999998876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=357.03 Aligned_cols=213 Identities=23% Similarity=0.311 Sum_probs=171.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++||||+++++++...++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999999999999999999642 3345578899999999999999999999976544444467
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||++ |+|.+++.... .+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 999999995 69999998754 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCcc--------------ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHH
Q 001908 836 LARFLFARPFDTSM--------------ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901 (997)
Q Consensus 836 ~a~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ 901 (997)
+|+........... .........+||+.|+|||++. ....++.++||||+||++|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----------~~~~~~~~~DiwSlG~il~ 243 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-----------LQENYTKSIDIWSTGCIFA 243 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHT-----------TCSCCCTHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh-----------cCCCCCcccccchHHHHHH
Confidence 99876332111000 0011235578999999997653 2456899999999999999
Q ss_pred HHHhCCCCCC
Q 001908 902 EMFTRRRPTN 911 (997)
Q Consensus 902 elltg~~P~~ 911 (997)
||++|..||.
T Consensus 244 ell~g~~p~~ 253 (432)
T 3n9x_A 244 ELLNMLQSHI 253 (432)
T ss_dssp HHHTTCTTTC
T ss_pred HHHhcccccc
Confidence 9998666554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=336.33 Aligned_cols=272 Identities=21% Similarity=0.263 Sum_probs=206.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.+|+++++.++|++++..+.++. ...+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence 45789999999999999999999988999999998754322 245788999999999988888777763 345678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee---CCCCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~D 833 (997)
++||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 9999999 9999999986432 388999999999999999999999 99999999999999 7899999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.......... ..........||+.|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 152 fg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 152 FGLAKKYRDARTHQH-IPYRENKNLTGTARYASINTHL------------GIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CTTCEECBCTTTCCB-CCCCCSCCCCSCGGGCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred CccceeccCcccCcc-CCCCcccccCCCccccchHHhc------------CCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 999987633221110 1112233567999999997654 567899999999999999999999999854
Q ss_pred cCCC--ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 914 FQGG--LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 914 ~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.... ..+............ + .....++.++.+++..||+.||++|||++++++.|+++.++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~-----~------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 219 KAATKRQKYERISEKKMSTPI-----E------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CCSSSSSHHHHHHHHHHHSCH-----H------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhhhhcccccchh-----h------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 3221 111111111100000 0 00012346788999999999999999999999999999886
Q ss_pred hh
Q 001908 992 LV 993 (997)
Q Consensus 992 ~~ 993 (997)
..
T Consensus 282 ~~ 283 (296)
T 4hgt_A 282 QG 283 (296)
T ss_dssp HT
T ss_pred hC
Confidence 53
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.59 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=202.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||+||+|++ .++.||||+++.. .....+.+.+|++++++++||||+++++++... ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 35799999999999999999999 4889999999743 344557899999999999999999999997532 2367
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCeeeCCCCcEEEcc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~~kl~D 833 (997)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+|++|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred eEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 8999999999999999987542 2489999999999999999999998 7 99999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||++... ......||+.|+|||.+.... ...++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~---------~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 157 ADVKFSF-------------QSPGRMYAPAWVAPEALQKKP---------EDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp GGSCCTT-------------SCTTCBSCGGGSCHHHHHSCG---------GGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ccceeee-------------cccCccCCccccChhhhccCC---------CCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9887542 112346899999998875311 123345899999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
. ..+..... ......+.. +..++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 215 ~-----~~~~~~~~----~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 215 S-----NMEIGMKV----ALEGLRPTI------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp C-----HHHHHHHH----HHSCCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred C-----hHHHHHHH----HhcCCCCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 11111111 001111111 11234568899999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=350.58 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=192.7
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEee
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
..+.||+|+||.||+|+...+++.||+|+++.......+.+.+|++++++++||||+++++++. ..+..++||||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~ 167 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEY 167 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEEC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeC
Confidence 3578999999999999999899999999998766566678999999999999999999999954 45689999999
Q ss_pred ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee--CCCCcEEEcccccchhc
Q 001908 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL--DHDMVAHVSDFGLARFL 840 (997)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll--~~~~~~kl~DFg~a~~~ 840 (997)
+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 168 ~~~~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 168 VDGGELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp CTTCEEHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999997643 2478999999999999999999999 99999999999999 67789999999999865
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccH
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 920 (997)
... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.... .
T Consensus 240 ~~~---------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~ 293 (373)
T 2x4f_A 240 KPR---------EKLKVNFGTPEFLAPEVVN------------YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-----D 293 (373)
T ss_dssp CTT---------CBCCCCCSSCTTCCHHHHT------------TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-----H
T ss_pred CCc---------cccccccCCCcEeChhhcc------------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----H
Confidence 221 1122346999999997654 4678899999999999999999999997431 1
Q ss_pred HHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 921 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+.......... ...++ .....+.++.+++.+||..||++|||+.|+++
T Consensus 294 ~~~~~~i~~~~~-~~~~~-------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 294 AETLNNILACRW-DLEDE-------------EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHHHTCC-CSCSG-------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccC-CCChh-------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111110000 00000 01123456789999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=347.20 Aligned_cols=250 Identities=23% Similarity=0.297 Sum_probs=199.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (997)
..++|++.+.||+|+||+||+|+.+.+++.||||+++.. .....+.+.+|.++++.+ +||+|+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 346899999999999999999999988999999999743 233456788999999988 799999999984 45
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence 668999999999999999998754 488999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+.... ........+||+.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 164 DFG~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 164 DFGMCKENIW--------DGVTTKTFCGTPDYIAPEIIA------------YQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCTTCBCCCC--------TTCCBCCCCSCGGGCCHHHHT------------TCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eCCccccccc--------CCcccccccCCccccChhhhc------------CCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 9999975321 112234467999999997664 46789999999999999999999999974
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
. ...+......... ... +.....++.+++.+||..||++||+ ++|+++
T Consensus 224 ~-----~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 224 E-----DEDELFQSIMEHN------VAY------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp S-----SHHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C-----CHHHHHHHHHhCC------CCC------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2 1222211111100 000 0112456789999999999999995 466543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=347.53 Aligned_cols=277 Identities=20% Similarity=0.318 Sum_probs=213.5
Q ss_pred ChHHHHHHhhcCccCCcccccCcceEEEEEE-----CCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEE
Q 001908 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKII 742 (997)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~ 742 (997)
.........++|++.+.||+|+||+||+|++ ..+++.||||+++.. .....+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678999999999999999999985 356789999999743 334456889999999999 799999999
Q ss_pred eeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCC----------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcE
Q 001908 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE----------VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIV 812 (997)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~iv 812 (997)
+++.. .....++||||+++|+|.+++........ ...+++..++.++.|++.||+|||++ +|+
T Consensus 98 ~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 98 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp EEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 99643 23468999999999999999987652100 11278899999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccch
Q 001908 813 HGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGD 892 (997)
Q Consensus 813 HrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~D 892 (997)
||||||+||+++.++.+||+|||+++...... .........||+.|+|||++. +..++.++|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~D 232 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIF------------DRVYTIQSD 232 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCT------TSEEETTEEECGGGCCHHHHH------------HCCCCHHHH
T ss_pred cccCccceEEECCCCCEEECCCccccccccCc------cceeccCCCcceeecCchhhc------------cccccchhH
Confidence 99999999999999999999999998653211 112223456789999997764 466889999
Q ss_pred hHHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 893 VYSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 893 vwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
||||||++|||+| |+.||....... .+....... ..... +..+++++.+++.+||+.|
T Consensus 233 i~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~--------~~~~~------------~~~~~~~l~~li~~~l~~d 291 (316)
T 2xir_A 233 VWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEG--------TRMRA------------PDYTTPEMYQTMLDCWHGE 291 (316)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSH-HHHHHHHHT--------CCCCC------------CTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHHhCCCCCCcccchhH-HHHHHhccC--------ccCCC------------CCCCCHHHHHHHHHHcCCC
Confidence 9999999999998 999987432221 111111100 00000 0112456789999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHh
Q 001908 972 PIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 972 P~~Rps~~evl~~L~~~~~~~ 992 (997)
|++|||+.|+++.|+++.++.
T Consensus 292 p~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 292 PSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp GGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHhhh
Confidence 999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=339.92 Aligned_cols=266 Identities=23% Similarity=0.411 Sum_probs=204.4
Q ss_pred cCccCCcccccCcceEEEEEECCCCc---EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGT---FVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~---~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.|...++||+|+||+||+|++..+++ .||+|++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence 45667899999999999999754444 7999999743 33456788999999999999999999999643 2334
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+.+|+|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred cEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence 5899999999999999987432 478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+....... ..........+|+.|+|||.+. +..++.++|||||||++|||++|..|+.....
T Consensus 170 ~~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 170 LARDILDREY----YSVQQHRHARLPVKWTALESLQ------------TYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp SSCTTTTGGG----GCSCCSSCTTCGGGGSCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CcccccCCcc----cccccCcCCCCCccccChhhhc------------cCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 9976532111 1112233456889999997654 56789999999999999999996655432211
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhc
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLVG 994 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 994 (997)
...+........ .. +.+..++..+.+++.+||+.||++|||++++++.|+++..++.+
T Consensus 234 -~~~~~~~~~~~~--------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 234 -PFDLTHFLAQGR--------RL------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -GGGHHHHHHTTC--------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -HHHHHHHhhcCC--------CC------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 111222111110 00 00112345688999999999999999999999999999887654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=357.18 Aligned_cols=269 Identities=22% Similarity=0.258 Sum_probs=196.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 754 (997)
.++|++.++||+|+||+||+|++..+++.||||++... .....+.+.+|+++++.++||||+++++++.... .....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999999643 3445678899999999999999999999975432 13346
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+++ ++.+.+.. .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence 78999999965 57777653 278889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ........||+.|+|||++. +..|+.++||||+||++|||++|+.||....
T Consensus 209 G~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 209 GLARTAGT---------SFMMTPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CCC--------------CCCC----CCCTTCCHHHHT------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeeecCC---------CcccCCCcccccccCHHHHc------------CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986522 12234467999999997664 5678999999999999999999999997432
Q ss_pred CCCccHHHHHHh--hcc---hhhhhhcCcccc---------------ccccc---chhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 915 QGGLTLHEFCKM--ALP---EKVMETVDPSLL---------------LAWSD---GRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 915 ~~~~~~~~~~~~--~~~---~~~~~~~d~~~~---------------~~~~~---~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
....+... ... ........+... ..+.. ............++.+++.+||..|
T Consensus 268 ----~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 343 (464)
T 3ttj_A 268 ----YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343 (464)
T ss_dssp ----HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred ----HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCC
Confidence 11111111 000 000000000000 00000 0001112233567889999999999
Q ss_pred CCCCCCHHHHHH
Q 001908 972 PIERMEMRDVLA 983 (997)
Q Consensus 972 P~~Rps~~evl~ 983 (997)
|++|||++|+++
T Consensus 344 P~~R~ta~e~L~ 355 (464)
T 3ttj_A 344 PAKRISVDDALQ 355 (464)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=354.60 Aligned_cols=268 Identities=24% Similarity=0.257 Sum_probs=204.0
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeecc
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSI 748 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 748 (997)
.+.....++|++.+.||+|+||+||+|+.+.+++.||||+++.. .....+.+.+|++++..++||||+++++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--- 130 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF--- 130 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE---
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE---
Confidence 34445568999999999999999999999999999999999642 223345678999999999999999999984
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
.+.+..|+||||+++|+|.+++.+... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+++
T Consensus 131 --~~~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 131 --QDENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred --eeCCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence 456689999999999999999987531 388999999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+...... .......+||+.|+|||++..... ...+..++.++|||||||++|||++|+.
T Consensus 201 vkL~DFGla~~~~~~~-------~~~~~~~~Gt~~Y~APE~l~~~~~-----~~~~~~~~~~~DiwSlGvilyelltG~~ 268 (412)
T 2vd5_A 201 IRLADFGSCLKLRADG-------TVRSLVAVGTPDYLSPEILQAVGG-----GPGTGSYGPECDWWALGVFAYEMFYGQT 268 (412)
T ss_dssp EEECCCTTCEECCTTS-------CEECSSCCSCGGGCCHHHHHHHHT-----CTTCSEECTHHHHHHHHHHHHHHHHSSC
T ss_pred EEEeechhheeccCCC-------ccccceeccccCcCCHHHHhhccc-----CcCCCCCChHHhhhHHhHHHHHHHhCCC
Confidence 9999999998652211 112234579999999998863210 0113468899999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCC---CCHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER---MEMRDVLA 983 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~ 983 (997)
||.... ..+.......... ....|.. ....+.++.+++.+||. +|++| |+++|+++
T Consensus 269 Pf~~~~-----~~~~~~~i~~~~~-~~~~p~~------------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 269 PFYADS-----TAETYGKIVHYKE-HLSLPLV------------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp TTCCSS-----HHHHHHHHHTHHH-HCCCC----------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCCCC-----HHHHHHHHHhccc-CcCCCcc------------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 997431 1121111111000 0000100 11234567899999999 99998 58888864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.93 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=200.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcE----EEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTF----VAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|++.+.||+|+||+||+|++..+++. ||+|++.... ......+.+|+.++++++||||+++++++. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 5788999999999999999999877765 7777775322 233456778999999999999999999863 3
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 158 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD 158 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred CccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence 468999999999999999987531 377889999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+|+...... .........||..|+|||.+. +..++.++|||||||++|||+| |+.||..
T Consensus 159 fg~a~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 159 FGVADLLPPDD------KQLLYSEAKTPIKWMALESIH------------FGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp CSGGGGSCCCT------TCCC-----CCTTTSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCcccccCccc------ccccccCCCCcccccChHHhc------------cCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 99998763321 111223456788999997765 4668999999999999999999 9999975
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
.... .+.+...... ... .+..++.++.+++.+||..||++||+++|+++.|+++...
T Consensus 221 ~~~~--~~~~~~~~~~--------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 221 LRLA--EVPDLLEKGE--------RLA------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp SCTT--HHHHHHHTTC--------BCC------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cCHH--HHHHHHHcCC--------CCC------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3211 1222111110 000 0011233567899999999999999999999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.44 Aligned_cols=254 Identities=21% Similarity=0.370 Sum_probs=200.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCC-------cEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENG-------TFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
.++|++.+.||+|+||+||+|+++.++ ..||+|++........+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 367899999999999999999998666 479999998666666788999999999999999999999954
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc--
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV-- 828 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-- 828 (997)
..+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence 35578999999999999999987541 378899999999999999999999 9999999999999998887
Q ss_pred ------EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 829 ------AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 829 ------~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
+||+|||.+.... ......||+.|+|||++.. ...++.++|||||||++||
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~------------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~e 210 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVL------------PKDILQERIPWVPPECIEN-----------PKNLNLATDKWSFGTTLWE 210 (289)
T ss_dssp GTBCCEEEECCCCSCTTTS------------CHHHHHHTTTTSCHHHHHC-----------GGGCCHHHHHHHHHHHHHH
T ss_pred ccccceeeeccCccccccc------------CccccCCcCcccCHHHhCC-----------CCCCCchhHHHHHHHHHHH
Confidence 9999999986541 1123458899999987752 1457889999999999999
Q ss_pred HHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 903 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
|++|..|+..... .......... .+.... ..+.++.+++.+||+.||++|||+.|++
T Consensus 211 l~~g~~~~~~~~~----~~~~~~~~~~-------~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll 267 (289)
T 4fvq_A 211 ICSGGDKPLSALD----SQRKLQFYED-------RHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAII 267 (289)
T ss_dssp HHTTTCCTTTTSC----HHHHHHHHHT-------TCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHcCCCCCccccc----hHHHHHHhhc-------cCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9996555432211 1111110000 000000 0123467899999999999999999999
Q ss_pred HHHHHHHH
Q 001908 983 AKLCAARQ 990 (997)
Q Consensus 983 ~~L~~~~~ 990 (997)
+.|+++..
T Consensus 268 ~~l~~l~~ 275 (289)
T 4fvq_A 268 RDLNSLFT 275 (289)
T ss_dssp HHHHTCC-
T ss_pred HHHHHhcC
Confidence 99987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=335.08 Aligned_cols=271 Identities=21% Similarity=0.262 Sum_probs=209.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.+|+++++.++|++++..+.++. ...+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence 4689999999999999999999988999999999864332 246889999999999988777777653 3356789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee---CCCCcEEEccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDF 834 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DF 834 (997)
+||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 999999 9999999985432 488999999999999999999999 99999999999999 48899999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++.......... ..........||+.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 153 g~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 153 GLAKKYRDARTHQH-IPYRENKNLTGTARYASINTHL------------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTCEECBCTTTCCB-CCCCCSCCCCSCTTTCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCcccccccccccc-cccccccccccccccCChhhhc------------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 99987643221110 1111234567999999996654 5678999999999999999999999998543
Q ss_pred CCC--ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 915 QGG--LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 915 ~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
... ..+............ +. ....++.++.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~-----~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 220 AATKRQKYERISEKKMSTPI-----EV------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSCH-----HH------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred chhhhhhhhhhcccccCCch-----HH------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 221 111111111100000 00 01123567889999999999999999999999999998775
Q ss_pred h
Q 001908 993 V 993 (997)
Q Consensus 993 ~ 993 (997)
.
T Consensus 283 ~ 283 (296)
T 3uzp_A 283 G 283 (296)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=347.44 Aligned_cols=274 Identities=20% Similarity=0.213 Sum_probs=194.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccC---cCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSID---FKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~---~~~~ 753 (997)
..+|++.++||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999999899999999997666666778899999999996 999999999974321 1345
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cEecCCCCCCeeeCCCCcEEE
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~--ivHrDlk~~NIll~~~~~~kl 831 (997)
...++||||++ |+|.+++...... ..+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 66899999995 7999998763211 1489999999999999999999998 7 999999999999999999999
Q ss_pred cccccchhcccCCCCCcc----ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 832 SDFGLARFLFARPFDTSM----ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
+|||+++........... ..........||+.|+|||++.. ..+..++.++|||||||++|||++|+
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL---------YSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------C---------CTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhc---------cccCCCChHHhHHHHHHHHHHHHhCC
Confidence 999999876332111000 00111224568999999987631 13466889999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
.||...... ........ ... ...++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 251 ~p~~~~~~~-----~~~~~~~~-----~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 251 HPFEDGAKL-----RIVNGKYS-----IPP---------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp CCC-----------------CC-----CCT---------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhHH-----HhhcCccc-----CCc---------------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 998642111 11000000 000 00112346789999999999999999999999999
Q ss_pred HHHHh
Q 001908 988 ARQTL 992 (997)
Q Consensus 988 ~~~~~ 992 (997)
+..+.
T Consensus 306 ~~~~~ 310 (337)
T 3ll6_A 306 IAAAR 310 (337)
T ss_dssp HHHHT
T ss_pred HHhcc
Confidence 87653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=356.56 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=193.1
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCCcceEEeeeec
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNTRHRNLIKIITVCSS 747 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 747 (997)
...++|.+.+.||+|+||+||+|.++.+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999999999999999986432 112235789999999999999999999853
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
.+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 211 -----~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 211 -----AEDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp -----SSEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred -----cCceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 235799999999999999887654 488999999999999999999999 999999999999997544
Q ss_pred ---cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 828 ---VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 828 ---~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.+||+|||+|+.... ........||+.|+|||++... ....++.++|||||||++|||+
T Consensus 277 ~~~~~kl~DFG~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGE---------TSLMRTLCGTPTYLAPEVLVSV---------GTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------------CTTCCTTTTC-------------CTTHHHHHHHHHHHHHHHHH
T ss_pred CcceEEEeecccceecCC---------CccccccCCCCCccCceeeecC---------CCCCCCchhhhHhHHHHHHHHH
Confidence 599999999986521 1122346799999999876321 1356788999999999999999
Q ss_pred hCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 TRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+|+.||....... .+.+......... . .......+.++.+++.+||..||++|||+.|+++
T Consensus 339 tg~~pf~~~~~~~-~~~~~i~~~~~~~-----~------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 339 SGYPPFSEHRTQV-SLKDQITSGKYNF-----I------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HSSCSSCCCSSSC-CHHHHHHTTCCCC-----C------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCCCCcchH-HHHHHHhcCCCCC-----C------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 9999997543222 2222111110000 0 0111123456789999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=343.25 Aligned_cols=263 Identities=25% Similarity=0.328 Sum_probs=204.4
Q ss_pred hhcCccCC-cccccCcceEEEEEE--CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 678 TNEFSSSN-MIGQGSFGSVYKGIL--GENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 678 ~~~~~~~~-~lg~G~~g~V~~~~~--~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
.++|++.+ .||+|+||+||+|.+ ..+++.||||+++... ....+.+.+|++++++++||||+++++++.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------ 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence 35788877 999999999999954 5567899999997432 334578899999999999999999999862
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence 346899999999999999998754 478999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTN 911 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 911 (997)
|||+++...... ..........+|+.|+|||.+. +..++.++|||||||++|||++ |+.||.
T Consensus 160 Dfg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 160 DFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECIN------------YYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp CCTTCEECCTTC-----SEEEC----CCCGGGCCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cCCcceeeccCC-----CcccccccCCCCceeeChHHhc------------cCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 999998653211 1111222345678999998765 3557889999999999999999 999987
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
... ..+...... ....+. .+..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 223 ~~~-----~~~~~~~~~-----~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 223 GMK-----GSEVTAMLE-----KGERMG------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp TCC-----HHHHHHHHH-----TTCCCC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCC-----HHHHHHHHH-----cCCCCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 432 111111110 000010 0112356788999999999999999999999999998876
Q ss_pred hhc
Q 001908 992 LVG 994 (997)
Q Consensus 992 ~~~ 994 (997)
..+
T Consensus 281 ~~~ 283 (291)
T 1xbb_A 281 VVN 283 (291)
T ss_dssp HHH
T ss_pred Hhh
Confidence 544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.59 Aligned_cols=260 Identities=19% Similarity=0.351 Sum_probs=202.9
Q ss_pred HhhcCccCCcccccCcceEEEEEECC---CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGE---NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
..++|.+.+.||+|+||+||+|++.. ++..||+|+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 34689999999999999999998753 3346999999754 34456788999999999999999999998532
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
+..++||||+++++|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEEC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeC
Confidence 346899999999999999987542 378999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTN 911 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 911 (997)
|||.++...... ........+|+.|+|||++. +..++.++|||||||++|||+| |+.||.
T Consensus 156 Dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 156 DFGLSRYIEDED-------YYKASVTRLPIKWMSPESIN------------FRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp CCCGGGCC----------------CCCCCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccCCCccccccc-------ccccccCCCCcceeCchhhc------------cCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 999998653211 11223345788999997764 4568899999999999999998 999987
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..... .......... ... .+..+++.+.+++.+||..||++||++.|+++.|+++.+.
T Consensus 217 ~~~~~--~~~~~~~~~~--------~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 217 WLENK--DVIGVLEKGD--------RLP------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TSCGG--GHHHHHHHTC--------CCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCChH--HHHHHHhcCC--------CCC------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 43221 1111111100 000 0112345688999999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=349.21 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=199.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcE----EEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTF----VAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|++.+.||+|+||+||+|++..+++. ||+|.+.. ......+.+.+|++++++++||||+++++++..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------ 88 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 88 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES------
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec------
Confidence 5799999999999999999999877765 46676643 233456788999999999999999999999753
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++|+||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~D 160 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred CCceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEcc
Confidence 247899999999999999987542 388999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+|+...... .........+|+.|+|||.+. +..++.++|||||||++|||++ |+.||..
T Consensus 161 fG~a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 161 FGLAKLLGAEE------KEYHAEGGKVPIKWMALESIL------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp TTC----------------------CCCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcceeEccCcc------ccccccCCCccccccCHHHHc------------CCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99998753211 111222345788999997665 4678999999999999999999 9999975
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.... .+........ .. +.+..++.++.+++.+||..||++||++.|+++.|+++....
T Consensus 223 ~~~~--~~~~~~~~~~--------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 223 IPAS--EISSILEKGE--------RL------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCGG--GHHHHHHTTC--------CC------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCHH--HHHHHHHcCC--------CC------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 3221 1222111110 00 011123456889999999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.68 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=206.0
Q ss_pred hcCccCC-cccccCcceEEEEEEC--CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSN-MIGQGSFGSVYKGILG--ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|.+.+ .||+|+||.||+|+++ .++..||||+++.. .....+.+.+|++++++++||||+++++++. .+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence 4566665 9999999999999864 46788999999753 3445678899999999999999999999863 23
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence 5899999999999999997543 1488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|+++...... ..........+|+.|+|||++. +..++.++|||||||++|||+| |+.||...
T Consensus 155 g~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 155 GLSKALGADD-----SYYTARSAGKWPLKWYAPECIN------------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp TTCEECTTCS-----CEECCCCSSCCCGGGCCHHHHH------------HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cceeeeccCc-----ceeeccccccccccccCHHHhc------------cCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9998663211 1111223345789999998764 3567889999999999999999 99998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
.. ..+....... ..+. .+..++.++.+++.+||..||++||++.|+++.|+++..+..
T Consensus 218 ~~--~~~~~~i~~~--------~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 218 KG--PEVMAFIEQG--------KRME------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CT--HHHHHHHHTT--------CCCC------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CH--HHHHHHHhcC--------CcCC------------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 21 1111111100 0000 111335678899999999999999999999999999987664
Q ss_pred c
Q 001908 994 G 994 (997)
Q Consensus 994 ~ 994 (997)
+
T Consensus 276 ~ 276 (287)
T 1u59_A 276 S 276 (287)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.68 Aligned_cols=272 Identities=22% Similarity=0.342 Sum_probs=192.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
..++|++.++||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCC
Confidence 4468999999999999999999999999999999997433 223456789999999999999999999954 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee-----CCCCcE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVA 829 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll-----~~~~~~ 829 (997)
..++||||++ |+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEE
T ss_pred EEEEEEecCC-CCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceE
Confidence 8999999997 59999998765 478999999999999999999999 99999999999999 455669
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+|+..... ........||+.|+|||++.. ...++.++||||+||++|||++|+.|
T Consensus 177 kl~Dfg~a~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~p 237 (329)
T 3gbz_A 177 KIGDFGLARAFGIP--------IRQFTHEIITLWYRPPEILLG-----------SRHYSTSVDIWSIACIWAEMLMKTPL 237 (329)
T ss_dssp EECCTTHHHHHC-------------------CCTTCCHHHHTT-----------CCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EECcCCCccccCCc--------ccccCCCcCCccccCHHHhcC-----------CCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999876221 112234568999999977642 23478999999999999999999999
Q ss_pred CCcCcCCCccHHHHHHh-hcch-hhh-hhc-Cccccccc----ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 910 TNCMFQGGLTLHEFCKM-ALPE-KVM-ETV-DPSLLLAW----SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~-~~~~-~~~-~~~-d~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
|....... .+...... ..+. ... ... .+.....+ ..............++.+++.+||+.||++|||+.|+
T Consensus 238 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 316 (329)
T 3gbz_A 238 FPGDSEID-QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316 (329)
T ss_dssp SCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCCCHHH-HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 97432111 11111111 0110 000 000 00000000 0000011111234678899999999999999999999
Q ss_pred HH
Q 001908 982 LA 983 (997)
Q Consensus 982 l~ 983 (997)
++
T Consensus 317 l~ 318 (329)
T 3gbz_A 317 LE 318 (329)
T ss_dssp HT
T ss_pred hC
Confidence 75
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.88 Aligned_cols=268 Identities=23% Similarity=0.376 Sum_probs=207.4
Q ss_pred HhhcCccCCcccccCcceEEEEEEC-------CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeec
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILG-------ENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSS 747 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 747 (997)
..++|++.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+++++++ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence 3578999999999999999999975 35678999999743 344567889999999999 8999999999954
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQP----------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLK 817 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 817 (997)
..+..++||||+++|+|.+++....... ....+++..++.++.||+.||+|||++ +|+|||||
T Consensus 112 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 184 (334)
T 2pvf_A 112 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA 184 (334)
T ss_dssp ----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred ----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence 4557899999999999999998764211 112478999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHH
Q 001908 818 PSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLG 897 (997)
Q Consensus 818 ~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlG 897 (997)
|+||+++.++.+||+|||+++...... .........+|+.|+|||++. +..++.++||||||
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG 246 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNID------YYKKTTNGRLPVKWMAPEALF------------DRVYTHQSDVWSFG 246 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTS------SEECCSCCCCCGGGCCHHHHH------------HCEECHHHHHHHHH
T ss_pred cceEEEcCCCCEEEccccccccccccc------cccccCCCCcccceeChHHhc------------CCCcChHHHHHHHH
Confidence 999999999999999999998653211 111222345788999997764 35678999999999
Q ss_pred HHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 898 VMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 898 vvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
|++|||++ |+.||... ...+..... .....+. .+..++.++.+++.+||..||++||
T Consensus 247 ~il~ellt~g~~p~~~~-----~~~~~~~~~-----~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rp 304 (334)
T 2pvf_A 247 VLMWEIFTLGGSPYPGI-----PVEELFKLL-----KEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRP 304 (334)
T ss_dssp HHHHHHHTTSCCSSTTC-----CHHHHHHHH-----HHTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHhCCCCCcCcC-----CHHHHHHHH-----hcCCCCC------------CCccCCHHHHHHHHHHccCChhhCc
Confidence 99999999 99998643 122221111 0000000 0112345788999999999999999
Q ss_pred CHHHHHHHHHHHHHHh
Q 001908 977 EMRDVLAKLCAARQTL 992 (997)
Q Consensus 977 s~~evl~~L~~~~~~~ 992 (997)
|+.|+++.|+++....
T Consensus 305 s~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 305 TFKQLVEDLDRILTLT 320 (334)
T ss_dssp CHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHhcc
Confidence 9999999999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=339.21 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=198.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||.||+|....+++.||||+++. ........+.+|++++++++||||+++++++.. .+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 3579999999999999999999988999999999974 234456788999999999999999999999654 45
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence 899999999999999999753211 12478999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++..... ........|++.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 181 g~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 181 GLGRFFSSK--------TTAAHSLVGTPYYMSPERIH------------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp --------------------------CCSSCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cceeeecCC--------CccccccCCCeeEeChHHhC------------CCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999765221 11123356899999997654 4678899999999999999999999987432
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
. ...+...... ....+... ...++.++.+++.+||..||++|||+.++++.|+++....
T Consensus 241 ~---~~~~~~~~~~-----~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 241 M---NLYSLCKKIE-----QCDYPPLP-----------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp C---CHHHHHHHHH-----TTCSCCCC-----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred h---hHHHHHHHhh-----cccCCCCc-----------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1 1222111110 00000000 0123456889999999999999999999999999998754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.66 Aligned_cols=349 Identities=16% Similarity=0.198 Sum_probs=218.7
Q ss_pred CCCCCCCCCCCe-eeeeeecCCCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCc-cCCCCCCCeEEEc
Q 001908 52 TNSWNNSINLCQ-WAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPK-EIGFLFRLETLML 129 (997)
Q Consensus 52 ~~sW~~~~~~c~-w~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~L 129 (997)
+++|....+||. |.+..|.....++ ............-..+++|++|++++|.++ .+|. .++.+++|++|+|
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L 76 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNL 76 (390)
T ss_dssp ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEEC
T ss_pred cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEEC
Confidence 678998888885 5555553222121 222222222223345688888888888887 4554 4677888888888
Q ss_pred cCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcchhhhhhccCcccccc
Q 001908 130 ANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGT 209 (997)
Q Consensus 130 s~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ 209 (997)
++|.+++..|..++.+++| ++|+|++|.+++ .
T Consensus 77 ~~n~i~~~~~~~~~~l~~L-------------------------~~L~L~~n~l~~-----------------------~ 108 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTI-------------------------QKLYMGFNAIRY-----------------------L 108 (390)
T ss_dssp TTSCCCEECTTTTTTCTTC-------------------------CEEECCSSCCCC-----------------------C
T ss_pred CCCcccccChhhccCCCCc-------------------------CEEECCCCCCCc-----------------------C
Confidence 8888875545566555544 455665555543 3
Q ss_pred CCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccc
Q 001908 210 VPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGR 289 (997)
Q Consensus 210 ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 289 (997)
.|..+.++++|++|+|++|+++ .+|..++..+++|++|++++|.+++..|..|..+++|++|+|++|++++.. ++.
T Consensus 109 ~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~ 184 (390)
T 3o6n_A 109 PPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSL 184 (390)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGG
T ss_pred CHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---ccc
Confidence 3455667778888888888887 677777667888888888888888777777888888888888888887652 455
Q ss_pred cCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCC
Q 001908 290 LKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNL 369 (997)
Q Consensus 290 l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l 369 (997)
+++|+.|++++|.++.+ ....+|++|++++|.+. .. |.. ..
T Consensus 185 l~~L~~L~l~~n~l~~~-----------~~~~~L~~L~l~~n~l~-------------------------~~-~~~--~~ 225 (390)
T 3o6n_A 185 IPSLFHANVSYNLLSTL-----------AIPIAVEELDASHNSIN-------------------------VV-RGP--VN 225 (390)
T ss_dssp CTTCSEEECCSSCCSEE-----------ECCSSCSEEECCSSCCC-------------------------EE-ECC--CC
T ss_pred ccccceeeccccccccc-----------CCCCcceEEECCCCeee-------------------------ec-ccc--cc
Confidence 66667777776666532 12234555555554443 22 211 12
Q ss_pred CCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEec
Q 001908 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449 (997)
Q Consensus 370 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 449 (997)
++|+.|++++|++++. ..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus 226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L 302 (390)
T 3o6n_A 226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302 (390)
T ss_dssp SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence 5677777777777753 456677777777777777776667777777777777777777764 4555566666666666
Q ss_pred CCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccc
Q 001908 450 SDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG 529 (997)
Q Consensus 450 ~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (997)
++|++. .+ |..+..+++|+.|++++|++++ +| +..+++|+.|++++|+++.
T Consensus 303 ~~n~l~-~~-------------------------~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 303 SHNHLL-HV-------------------------ERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CSSCCC-CC-------------------------GGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEH
T ss_pred CCCcce-ec-------------------------CccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccc
Confidence 666654 33 3344455566666666666653 22 5566677777777777764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.42 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=180.6
Q ss_pred hcCcc---CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSS---SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~---~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++ .+.||+|+||+||+|+++.+++.||||++... ....+.+|+++++.+. ||||+++++++ .+..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~ 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQL 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCC
Confidence 34544 37899999999999999999999999998643 3356788999999997 99999999995 4456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC---cEEE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHV 831 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl 831 (997)
..++||||+++|+|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++ .+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEE
T ss_pred EEEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEE
Confidence 8999999999999999998764 488999999999999999999999 999999999999998766 8999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+.... .........||+.|+|||++. +..++.++||||+||++|||++|+.||.
T Consensus 151 ~Dfg~a~~~~~--------~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 151 IDFGFARLKPP--------DNQPLKTPCFTLHYAAPELLN------------QNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp CCCTTCEECCC------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eccccceecCC--------CCCcccccCCCcCccCHHHhc------------CCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 99999975422 112223456899999996653 5678999999999999999999999997
Q ss_pred cCcCC--CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 912 CMFQG--GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 912 ~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
..... .....+........ .. . ...........++.+++.+||..||++|||++|++
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~--------~~----~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 211 SHDRSLTCTSAVEIMKKIKKG--------DF----S--FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp -------CCCHHHHHHHHTTT--------CC----C--CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CCccccccccHHHHHHHHHcC--------CC----C--CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 54321 11112221111100 00 0 00011223456788999999999999999999886
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=350.59 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=191.0
Q ss_pred hcCccC-CcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhh-cCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSS-NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRN-TRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|.+. +.||+|+||+||+|+++.+++.||||+++.. ..+.+|++++.+ .+||||+++++++... +.+....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence 456665 6899999999999999999999999998632 456788888754 5899999999987532 2345679
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~D 833 (997)
|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 999999999999999987542 2489999999999999999999999 9999999999999998 78999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.... .......+||+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 208 FG~a~~~~~---------~~~~~~~~gt~~y~aPE~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 208 FGFAKETTS---------HNSLTTPCYTPYYVAPEVL------------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp CTTCEECC--------------------CTTCCGGGS------------CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccccccCC---------CCccccCCCCCCccCHhhc------------CCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 999986421 1122346789999999655 3577899999999999999999999999754
Q ss_pred cCCCc--cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 914 FQGGL--TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 914 ~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..... .......... .....+ ....+..++.+++.+||..||++|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~i~~~~----~~~~~~-------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 267 HGLAISPGMKTRIRMGQ----YEFPNP-------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTCSSCCSHHHHHHHTC----CCCCTT-------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccccHHHHHHHHcCc----ccCCCc-------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 32211 1111111000 000000 001234567899999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=349.24 Aligned_cols=278 Identities=21% Similarity=0.263 Sum_probs=206.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|++++++++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999999999999999999743 33445788999999999999999999999876554555679
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++ |+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~-------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEcccC-cCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 99999996 59999998653 88999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+...... ..........||+.|+|||++.. +..++.++||||+||++|||++|+.||......
T Consensus 175 a~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 175 ARVADPDH-----DHTGFLTEYVATRWYRAPEIMLN-----------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp CEECCGGG-----CBCCTTCCCCSCGGGCCHHHHHT-----------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred eEecCCCC-----CccccccccccccCCCCCHHhcC-----------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 98653211 11112234579999999987642 345789999999999999999999999754221
Q ss_pred CccHHHHHHhhc--chhhhhh-cCccc---ccccccch---hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMAL--PEKVMET-VDPSL---LLAWSDGR---RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~--~~~~~~~-~d~~~---~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. .+........ ....... .+... ........ ..........++.+++.+||..||++|||+.|+++
T Consensus 239 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 239 D-QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp G-HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H-HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 1111111110 0000000 00000 00000000 00011123456889999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=333.43 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=200.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||.||+|.++.+++.||+|++... .....+.+.+|++++++++||||+++++++. ..+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 46899999999999999999999999999999999643 3345577889999999999999999999954 4568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc---EEEc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHVS 832 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~ 832 (997)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++. +||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 899999999999999988764 488999999999999999999999 9999999999999987665 9999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.+..... ........||+.|+|||++. +..++.++||||+|+++|+|++|+.||..
T Consensus 151 Dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 151 DFGLAIEVND---------SEAWHGFAGTPGYLSPEVLK------------KDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CCTTCEECCS---------SCBCCCSCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eceeeEEccc---------CccccCCCCCcCCcCchhhc------------CCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 9999976522 11223357899999997654 46688999999999999999999999864
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+........ ......+. ...+++++.+++.+||+.||++|||+.|+++
T Consensus 210 ~~-----~~~~~~~~~~~-~~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 210 ED-----QHRLYAQIKAG-AYDYPSPE-------------WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp SS-----HHHHHHHHHHT-CCCCCTTT-------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc-----hhHHHHHHHhc-cccCCchh-------------hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 21 11111111000 00000000 0122456789999999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=339.64 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=199.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.+.|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++. ..+..+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeEE
Confidence 467999999999999999999999899999999998666666788999999999999999999999964 345899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999876431 388999999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
..... .........||+.|+|||.+.. +...+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~--------~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--- 226 (302)
T 2j7t_A 165 AKNLK--------TLQKRDSFIGTPYWMAPEVVMC-------ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--- 226 (302)
T ss_dssp HHHHH--------HHHC-----CCGGGCCHHHHHH-------HHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC---
T ss_pred ccccc--------cccccccccCChhhcCCeeecc-------ccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC---
Confidence 65311 1112233568999999988753 22235678899999999999999999999987432
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+..... .....+.. ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~~~-----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 227 --PMRVLLKI-----AKSDPPTL----------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --HHHHHHHH-----HHSCCCCC----------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --HHHHHHHH-----hccCCccc----------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111110 00000100 001123456789999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.39 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=201.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch------hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK------GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 4679999999999999999999999999999999974322 13577899999999999999999999954
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC----
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---- 827 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---- 827 (997)
.....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 4568999999999999999998653 478899999999999999999999 999999999999999888
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||+++..... .......||+.|+|||++. +..++.++|||||||++|||++|+
T Consensus 157 ~~kl~Dfg~~~~~~~~---------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~ 215 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDG---------VEFKNIFGTPEFVAPEIVN------------YEPLGLEADMWSIGVITYILLSGA 215 (321)
T ss_dssp CEEECCCTTCEECCTT---------CCCCCCCSCGGGCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred CEEEccCccceecCcc---------ccccccCCCCCccCccccc------------CCCCCCccccHHHHHHHHHHHHCC
Confidence 8999999999765221 1123456899999997654 467889999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.||.... ..+......... ...++ ......+..+.+++.+||..||++|||+.|+++
T Consensus 216 ~pf~~~~-----~~~~~~~i~~~~--~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 216 SPFLGDT-----KQETLANITSVS--YDFDE------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CSSCCSS-----HHHHHHHHHTTC--CCCCH------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCCCC-----HHHHHHHHHhcc--cccCh------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9986431 111111110000 00000 111123456789999999999999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=348.95 Aligned_cols=251 Identities=27% Similarity=0.334 Sum_probs=190.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHH-HhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEV-LRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||+||+|+.+.+++.||||+++... ......+.+|..+ ++.++||||+++++++ ...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence 367999999999999999999999999999999996432 2334566777776 5778999999999984 456
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+||+++.+|++||+|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 68999999999999999998754 478889999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+..... .......+||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 183 FG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 183 FGLCKENIEH--------NSTTSTFCGTPEYLAPEVLH------------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp CCBCGGGBCC--------CCCCCSBSCCCCCCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CccccccccC--------CCccccccCCccccCHHHhC------------CCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999864221 12234468999999997664 467899999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 985 (997)
...+......... .... ......+.+++.+||..||++||++.+.++.+
T Consensus 243 -----~~~~~~~~i~~~~------~~~~------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 243 -----NTAEMYDNILNKP------LQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -----BHHHHHHHHHHSC------CCCC------------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -----CHHHHHHHHHhcc------cCCC------------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1222211111100 0000 01234677999999999999999986544433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=337.68 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=198.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
+.++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence 3468999999999999999999999999999999986332 223567889999999999999999999954 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence 68999999999999999998754 478999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||++..... .......||+.|+|||.+. +..++.++||||+|+++|||++|+.||...
T Consensus 153 fg~~~~~~~----------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 153 FGWSVHAPS----------SRRTDLCGTLDYLPPEMIE------------GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp CCEESCC------------------CCCCTTCCHHHHT------------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccccCCc----------ccccccCCCCCccCHhHhc------------cCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 999865321 1223457899999997654 466788999999999999999999998732
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
...+...... . ..... +...+..+.+++.+||+.||++|||+.|+++.
T Consensus 211 -----~~~~~~~~~~-----~-~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 211 -----TYQETYKRIS-----R-VEFTF------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----SHHHHHHHHH-----H-TCCCC------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----cHHHHHHHHH-----h-CCCCC------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111110 0 00000 01124567799999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=365.87 Aligned_cols=259 Identities=28% Similarity=0.423 Sum_probs=200.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.++||+|+||+||+|+++ .+..||||+++.... ..+.+.+|++++++++||||+++++++.. +..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 253 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 253 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence 3467889999999999999999997 457799999975432 34678999999999999999999998642 468
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.+++....+ ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EEEehhhcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence 999999999999999985421 1478999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
|+...... ........+|..|+|||++. +..++.++|||||||++|||+| |+.||....
T Consensus 327 a~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~- 386 (452)
T 1fmk_A 327 ARLIEDNE-------YTARQGAKFPIKWTAPEAAL------------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV- 386 (452)
T ss_dssp TC---------------------CCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred ceecCCCc-------eecccCCcccccccCHhHHh------------cCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-
Confidence 98653211 11122345788999997665 4578999999999999999999 999987431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..+...... .. .+.+.+..++..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 387 ----~~~~~~~i~-----~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 387 ----NREVLDQVE-----RG------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----HHHHHHHHH-----TT------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----HHHHHHHHH-----cC------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 111111110 00 00111224566788999999999999999999999999887543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=373.22 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred cccccCcceEEEEEEC--CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEEee
Q 001908 686 MIGQGSFGSVYKGILG--ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
+||+|+||+||+|.++ .++..||||+++.. .....+.+.+|++++++++||||++++++|.. +..++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999875 35667999999754 33456789999999999999999999999742 358999999
Q ss_pred ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhccc
Q 001908 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842 (997)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~ 842 (997)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 417 ~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 417 AGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp CTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999997653 2488999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCccHH
Q 001908 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLTLH 921 (997)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 921 (997)
... .........+|+.|+|||++. +..++.++|||||||++|||+| |+.||..... ..+.
T Consensus 489 ~~~-----~~~~~~~~~~~~~y~APE~~~------------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~ 549 (613)
T 2ozo_A 489 DDS-----YYTARSAGKWPLKWYAPECIN------------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVM 549 (613)
T ss_dssp ------------------CCTTSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHH
T ss_pred CCc-----eeeeccCCCCccceeCHhhhc------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHH
Confidence 111 111122334678999997764 4678999999999999999998 9999974321 1111
Q ss_pred HHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhc
Q 001908 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLVG 994 (997)
Q Consensus 922 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 994 (997)
+.+... .+...+..++.++.++|.+||..||++||++.++++.|+++..+...
T Consensus 550 ~~i~~~--------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 550 AFIEQG--------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HHHHTT--------------------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHcC--------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 111100 00111224567889999999999999999999999999998876643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=360.31 Aligned_cols=345 Identities=21% Similarity=0.200 Sum_probs=259.0
Q ss_pred hccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccC
Q 001908 200 HVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYF 279 (997)
Q Consensus 200 ~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 279 (997)
+.++++++ .+|..+. ++++.|+|++|++++ ++...+..+++|++|+|++|.+++..|..|.++++|++|+|++|++
T Consensus 17 ~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 17 LCHRKRFV-AVPEGIP--TETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp ECCSCCCS-SCCSCCC--TTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EeCCCCcC-cCCCCCC--CCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 33344443 4555553 467788888888874 4444445788888888888888888888888888888888888888
Q ss_pred CCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccc
Q 001908 280 TGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQIS 359 (997)
Q Consensus 280 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~ 359 (997)
++.++..|.++++|++|+|++|++..+.+ ..+.++++|++|++++|.+++
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~------~~~~~l~~L~~L~l~~n~l~~------------------------ 142 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLD------YMFQDLYNLKSLEVGDNDLVY------------------------ 142 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECT------TTTTTCTTCCEEEECCTTCCE------------------------
T ss_pred CccCcccccCCCCCCEEECCCCccccCCh------hHccccccCCEEECCCCccce------------------------
Confidence 88888888888888999998888876533 245667777777777776653
Q ss_pred cccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCC
Q 001908 360 GTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLG 439 (997)
Q Consensus 360 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 439 (997)
..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|..+.
T Consensus 143 -~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~ 221 (477)
T 2id5_A 143 -ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221 (477)
T ss_dssp -ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTT
T ss_pred -eChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccc
Confidence 3455666677778888888877766666677778888888888888777677777888888888888777777777666
Q ss_pred CCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccE
Q 001908 440 NCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEI 519 (997)
Q Consensus 440 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 519 (997)
...+|++|+|++|++++..+..+..+++| +.|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|+.
T Consensus 222 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 300 (477)
T 2id5_A 222 YGLNLTSLSITHCNLTAVPYLAVRHLVYL-RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300 (477)
T ss_dssp TTCCCSEEEEESSCCCSCCHHHHTTCTTC-CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCE
T ss_pred cCccccEEECcCCcccccCHHHhcCcccc-CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCE
Confidence 66678888888888774433566677777 78888888888777778888899999999999999888889999999999
Q ss_pred EEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCC
Q 001908 520 FHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 520 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
|+|++|+|++..+..|..+++|+.|+|++|.+.+..+.. .-...+..+++.+|...+..|.
T Consensus 301 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~-~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 301 LNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLL-WVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp EECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGH-HHHTTTTSSCCTTCCCBEEESG
T ss_pred EECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchH-hHHhhhhccccCccCceeCCch
Confidence 999999999777778888999999999999987643321 1123344456667766665554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=344.34 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=199.0
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCCcceEEeeeec
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNTRHRNLIKIITVCSS 747 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 747 (997)
...++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++||||+++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-- 98 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-- 98 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence 34578999999999999999999999999999999997432 11334667899999999999999999995
Q ss_pred cCcCCCceEEEEEeeccCC-CHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC
Q 001908 748 IDFKGADFKALVYEYMQNG-SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 826 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~ 826 (997)
...+..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 99 ---~~~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 99 ---ENQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED 166 (335)
T ss_dssp ---ECSSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred ---eeCCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence 4466899999999777 9999998764 488999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHHHh
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~ellt 905 (997)
+.+||+|||+++..... .......||+.|+|||++. +..+ +.++|||||||++|||++
T Consensus 167 ~~~kL~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~ 225 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERG---------KLFYTFCGTIEYCAPEVLM------------GNPYRGPELEMWSLGVTLYTLVF 225 (335)
T ss_dssp SCEEECCCTTCEECCTT---------CCBCEECSCGGGCCHHHHT------------TCCBCSHHHHHHHHHHHHHHHHH
T ss_pred CcEEEeecccceECCCC---------CceeccCCCccccChhhhc------------CCCCCCCcccchhHHHHHHHHHh
Confidence 99999999999865221 1223457999999997764 3444 789999999999999999
Q ss_pred CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 906 RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 906 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
|+.||...... ......+ +..++.++.+++.+||..||++|||+.|+++.
T Consensus 226 g~~pf~~~~~~---------------~~~~~~~--------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 226 EENPFCELEET---------------VEAAIHP--------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSCSCSSGGGG---------------TTTCCCC--------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCCchhhHHHH---------------HhhccCC--------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999742110 0000000 00124567899999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.42 Aligned_cols=265 Identities=23% Similarity=0.354 Sum_probs=205.9
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhc-CCCCcceE
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNT-RHRNLIKI 741 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l 741 (997)
+.......++|++.+.||+|+||.||+|+++.+|+.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999998899999999986432 12245778999999999 79999999
Q ss_pred EeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCe
Q 001908 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNV 821 (997)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NI 821 (997)
++++. .....++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||
T Consensus 166 ~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI 231 (365)
T 2y7j_A 166 IDSYE-----SSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI 231 (365)
T ss_dssp EEEEE-----BSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred EEEEe-----eCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 99854 3568999999999999999998654 488999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHH
Q 001908 822 LLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901 (997)
Q Consensus 822 ll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ 901 (997)
+++.++.+||+|||++...... .......||+.|+|||++..... .....++.++|||||||++|
T Consensus 232 l~~~~~~ikl~DfG~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 232 LLDDNMQIRLSDFGFSCHLEPG---------EKLRELCGTPGYLAPEILKCSMD------ETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp EECTTCCEEECCCTTCEECCTT---------CCBCCCCSCGGGCCHHHHHHTTC------TTSCCBCTTHHHHHHHHHHH
T ss_pred EECCCCCEEEEecCcccccCCC---------cccccCCCCCCccChhhcccccc------ccCcCCCchhhHHhHHHHHH
Confidence 9999999999999999765221 12234679999999998764211 11345888999999999999
Q ss_pred HHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 902 EMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 902 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
||++|+.||.... ........... .... ..+....++..+.+++.+||..||++|||+.|+
T Consensus 297 ell~g~~pf~~~~-----~~~~~~~i~~~----~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 357 (365)
T 2y7j_A 297 TLLAGSPPFWHRR-----QILMLRMIMEG----QYQF----------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357 (365)
T ss_dssp HHHHSSCSSCCSS-----HHHHHHHHHHT----CCCC----------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHCCCCCCCCC-----HHHHHHHHHhC----CCCC----------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9999999986421 11111110000 0000 001111234568899999999999999999999
Q ss_pred HH
Q 001908 982 LA 983 (997)
Q Consensus 982 l~ 983 (997)
++
T Consensus 358 l~ 359 (365)
T 2y7j_A 358 LQ 359 (365)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=359.53 Aligned_cols=253 Identities=24% Similarity=0.289 Sum_probs=199.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
..++|++.++||+|+||+||+|+++.+++.||||++... .......+.+|++++++++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCC
Confidence 456899999999999999999999999999999998632 2334578899999999999999999999954 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC---CCCcEEE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHV 831 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl 831 (997)
..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 8999999999999999998754 488999999999999999999999 999999999999995 5568999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+.... ........||+.|+|||++. +.++.++||||+||++|+|++|+.||.
T Consensus 166 ~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 166 IDFGLSTCFQQ---------NTKMKDRIGTAYYIAPEVLR-------------GTYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp CSCSCTTTBCC---------C----CCTTGGGGCCGGGGG-------------SCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EECCcCeECCC---------CCccCCCcCCCCCCCHHHhC-------------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999976522 11223457999999998764 348899999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
... ..+.......... .... +.......++.+++.+||..||++|||+.|+++.
T Consensus 224 ~~~-----~~~~~~~i~~~~~-~~~~-------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 224 GKN-----EYDILKRVETGKY-AFDL-------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSS-----HHHHHHHHHHTCC-CSCS-------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCC-----HHHHHHHHHhCCC-CCCC-------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 431 1111111100000 0000 0111234567899999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=349.95 Aligned_cols=271 Identities=23% Similarity=0.382 Sum_probs=209.3
Q ss_pred HHHHHhhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeee
Q 001908 673 ELSEATNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCS 746 (997)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 746 (997)
++....++|++.+.||+|+||.||+|+++ .+++.||||++... .......+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 44456688999999999999999999876 35788999999743 3344567899999999999999999999953
Q ss_pred ccCcCCCceEEEEEeeccCCCHHHHhhcCCC----CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNG----QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
..+..++||||+++|+|.+++..... ......+++..+++++.|++.||+|||++ +|+||||||+||+
T Consensus 99 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 99 -----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred -----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 45578999999999999999986321 01112468899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 823 LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
++.++.+||+|||+++...... .........+|+.|+|||++. +..++.++||||+||++||
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~e 232 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMSPESLK------------DGVFTTYSDVWSFGVVLWE 232 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGG------CEEGGGSSEECGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHH
T ss_pred EcCCCeEEECcCcccccccccc------ccccccCCCCCCCccChhhhc------------cCCCCchhhHHHHHHHHHH
Confidence 9999999999999997652211 111223345788999997765 4568899999999999999
Q ss_pred HHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 903 MFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 903 llt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
|++ |+.||.... ..+.......... +. .+..++..+.+++.+||..||++|||+.|+
T Consensus 233 l~~~g~~p~~~~~-----~~~~~~~~~~~~~-----~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~ 290 (322)
T 1p4o_A 233 IATLAEQPYQGLS-----NEQVLRFVMEGGL-----LD------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290 (322)
T ss_dssp HHHTSCCTTTTSC-----HHHHHHHHHTTCC-----CC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhcCCCccccCC-----HHHHHHHHHcCCc-----CC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 999 889986431 1221111110000 00 011235568899999999999999999999
Q ss_pred HHHHHHHHHH
Q 001908 982 LAKLCAARQT 991 (997)
Q Consensus 982 l~~L~~~~~~ 991 (997)
++.|+++...
T Consensus 291 l~~L~~~~~~ 300 (322)
T 1p4o_A 291 ISSIKEEMEP 300 (322)
T ss_dssp HHHHGGGSCT
T ss_pred HHHHHHhhcc
Confidence 9999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.83 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=201.8
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
..++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+++++.++||||+++++++. ..+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCE
Confidence 346899999999999999999999989999999999643 2344578899999999999999999999964 3558
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence 899999999999999987643 478999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-CCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
.+....... .........||+.|+|||.+. +.. ++.++|||||||++|||++|+.||....
T Consensus 151 ~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 151 LATVFRYNN------RERLLNKMCGTLPYVAPELLK------------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp TCEECEETT------EECCBCCCCSCGGGCCGGGGT------------CSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred CccccCCCc------chhcccCCccccCccChHHHh------------cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 997652211 111223457899999997664 333 3678999999999999999999998543
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........+..... ... .....+..+.+++.+||..||++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~------~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 213 DSCQEYSDWKEKKT------YLN--------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTSHHHHHHHTTCT------TST--------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHhhhccc------ccC--------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 33222222211000 000 00122456779999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=355.62 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=199.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|.+.+.||+|+||.||+|++..+|+.||||+++... ......+.+|+++++.++||||+++++++. ..+.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~~ 90 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPSD 90 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 57899999999999999999999999999999996432 233567899999999999999999999954 4568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999998654 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-CCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
+|+.... .......+||+.|+|||++. +.. .+.++||||+||++|||++|+.||....
T Consensus 162 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 162 LSNMMSD---------GEFLRTSCGSPNYAAPEVIS------------GRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp SCEECCT---------TCCBCCCCSCSTTCCHHHHT------------TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhccc---------cccccccCCCcCeEChhhcc------------CCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 9986522 11223457999999997765 333 3689999999999999999999997431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.......... .. +.....++.+++.+||..||++|||+.|+++
T Consensus 221 -----~~~~~~~i~~~~~---~~---------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 221 -----VPTLFKKICDGIF---YT---------------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----SHHHHHHHHTTCC---CC---------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHHHhcCCc---CC---------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111111100000 00 0112346789999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=345.27 Aligned_cols=270 Identities=21% Similarity=0.257 Sum_probs=201.5
Q ss_pred HHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCCcceEEeeeec
Q 001908 673 ELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-----QKGALKSFVAECEVLRNTRHRNLIKIITVCSS 747 (997)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 747 (997)
++....++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 98 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE- 98 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence 4566778999999999999999999999999999999998633 2345678899999999999999999999954
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCC----------------------------------CcCCCCHHHHHHHH
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQP----------------------------------EVCDLSLIQRLNIA 793 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------~~~~~~~~~~~~i~ 793 (997)
..+..++||||+++|+|.+++....... ....+++..++.++
T Consensus 99 ----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 99 ----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp ----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred ----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 4568999999999999999996321100 00113567788999
Q ss_pred HHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC--cEEEcccccchhcccCCCCCccccccccccccccccccCCcchh
Q 001908 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIA 871 (997)
Q Consensus 794 ~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~--~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 871 (997)
.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+|+....... ..........||+.|+|||++.
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN----GEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC----C--------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCc----cccccccccCCCccccCchhhc
Confidence 9999999999999 999999999999998777 899999999986532111 1111233457999999998764
Q ss_pred cccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhh
Q 001908 872 KMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRA 951 (997)
Q Consensus 872 ~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 951 (997)
. ....++.++|||||||++|||++|+.||.... ..+.......... ....+
T Consensus 248 ~----------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~-~~~~~------------- 298 (345)
T 3hko_A 248 T----------TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN-----DADTISQVLNKKL-CFENP------------- 298 (345)
T ss_dssp C----------SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC-CTTSG-------------
T ss_pred c----------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHhccc-ccCCc-------------
Confidence 2 12568889999999999999999999997432 1111111110000 00000
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 952 KVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 952 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........+.+++.+||..||++||++.|+++
T Consensus 299 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 01123456789999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=340.75 Aligned_cols=279 Identities=18% Similarity=0.211 Sum_probs=209.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||.||+|+...+++.||||++........+.+.+|+++++.++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 46899999999999999999999889999999999766666678899999999999999999999997532 12345789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999874211 12488999999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCc-cccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 838 RFLFARPFDTS-METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
........... ...........||+.|+|||.+... ....++.++|||||||++|||++|+.||......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ---------SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC---------SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccC---------CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 75421100000 0000111234579999999876421 1123688999999999999999999998643222
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
........... .. .+....++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 253 ~~~~~~~~~~~--------~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 253 GDSVALAVQNQ--------LS------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp TSCHHHHHHCC----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred cchhhHHhhcc--------CC------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 22222111100 00 000012245688999999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=347.65 Aligned_cols=276 Identities=18% Similarity=0.231 Sum_probs=201.5
Q ss_pred hhcCccCCcccccCcceEEEEEECC---CCcEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCCcceEEe
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGE---NGTFVAVKILNLMQKG-----------ALKSFVAECEVLRNTRHRNLIKIIT 743 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 743 (997)
.++|++.+.||+|+||+||+|++.. ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3679999999999999999999986 7889999998743221 1234667888999999999999999
Q ss_pred eeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
++... +.+....++||||+ +++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 97653 24467899999999 999999998754 488999999999999999999999 99999999999999
Q ss_pred CCCC--cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHH
Q 001908 824 DHDM--VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLL 901 (997)
Q Consensus 824 ~~~~--~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ 901 (997)
+.++ .+||+|||+|+......... ...........||+.|+|||++. +..++.++|||||||++|
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~ 251 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHK-QYQENPRKGHNGTIEFTSLDAHK------------GVALSRRSDVEILGYCML 251 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCC-CCCCCGGGCSCSCTTTCCHHHHH------------TCCCCHHHHHHHHHHHHH
T ss_pred ccCCCCcEEEEeCCCceecccccccc-cchhccccccCCCccccCHHHhc------------CCCCCchhhHHHHHHHHH
Confidence 9887 99999999998763221110 01112224467999999997664 457899999999999999
Q ss_pred HHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 902 EMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 902 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
||++|+.||............... .......+....... ...++.++.+++..||..||++||++.++
T Consensus 252 ell~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l 319 (345)
T 2v62_A 252 RWLCGKLPWEQNLKDPVAVQTAKT-----NLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQAL 319 (345)
T ss_dssp HHHHSSCTTGGGTTCHHHHHHHHH-----HHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHhCCCCccccccccHHHHHHHH-----hhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence 999999999643222111111111 111111111000000 00235578899999999999999999999
Q ss_pred HHHHHHHH
Q 001908 982 LAKLCAAR 989 (997)
Q Consensus 982 l~~L~~~~ 989 (997)
++.|++..
T Consensus 320 ~~~L~~~~ 327 (345)
T 2v62_A 320 KKILNPHG 327 (345)
T ss_dssp HHHHCTTC
T ss_pred HHHHhccC
Confidence 99998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.74 Aligned_cols=209 Identities=26% Similarity=0.353 Sum_probs=177.0
Q ss_pred CccChHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-----CCCcceE
Q 001908 667 PMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-----HRNLIKI 741 (997)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 741 (997)
..+++.+.....++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+..|+++++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3345555556678999999999999999999999989999999999743 334466788999999986 9999999
Q ss_pred EeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCe
Q 001908 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNV 821 (997)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NI 821 (997)
++++.. .+..++||||+ +++|.+++...... .+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 102 ~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 168 (360)
T 3llt_A 102 HGKFMY-----YDHMCLIFEPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENI 168 (360)
T ss_dssp EEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cceeeE-----CCeeEEEEcCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccE
Confidence 999653 45899999999 99999999876522 488999999999999999999999 999999999999
Q ss_pred eeCC-------------------------CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhccccc
Q 001908 822 LLDH-------------------------DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNL 876 (997)
Q Consensus 822 ll~~-------------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 876 (997)
+++. ++.+||+|||+|+.... ......||+.|+|||++.
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----------~~~~~~gt~~y~aPE~~~----- 232 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----------YHGSIINTRQYRAPEVIL----- 232 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----------CCCSCCSCGGGCCHHHHT-----
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----------CCcCccCcccccCcHHHc-----
Confidence 9975 88999999999975311 122457899999997654
Q ss_pred CccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 877 PCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 877 ~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
+..++.++||||+||++|||++|+.||..
T Consensus 233 -------~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 233 -------NLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp -------TCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -------CCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 56789999999999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.86 Aligned_cols=254 Identities=28% Similarity=0.382 Sum_probs=196.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|++ +++.||||+++... ..+.+.+|++++++++||||+++++++. ...+..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence 46899999999999999999998 58899999997433 4467899999999999999999999863 2345789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++..... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence 99999999999999986531 1267889999999999999999999 9999999999999999999999999998
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+.... ......+++.|+|||.+. +..++.++||||||+++|||+| |+.||......
T Consensus 165 ~~~~~-----------~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 221 (278)
T 1byg_A 165 KEASS-----------TQDTGKLPVKWTAPEALR------------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221 (278)
T ss_dssp ----------------------CCTTTSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred ccccc-----------cccCCCccccccCHHHhC------------CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 75421 112235788999997765 3568899999999999999998 99998743211
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
....... ....+. .+..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 222 --~~~~~~~--------~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 222 --DVVPRVE--------KGYKMD------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --GHHHHHT--------TTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHh--------cCCCCC------------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1111100 000000 1112356788999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=339.23 Aligned_cols=278 Identities=21% Similarity=0.267 Sum_probs=197.8
Q ss_pred hcCccC-CcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSS-NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+.|++. +.||+|+||+||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++. ..+..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCEE
Confidence 467774 7899999999999999989999999999766555567889999999985 7999999999954 35689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc---EEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~D 833 (997)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred EEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999999999998754 478999999999999999999999 9999999999999998876 99999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+++......... ...........||+.|+|||++..... ....++.++||||+||++|||++|+.||...
T Consensus 158 fg~~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 158 FDLGSGIKLNGDCS-PISTPELLTPCGSAEYMAPEVVEAFSE-------EASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp TTCCC--------------------CCSGGGCCHHHHHHTSH-------HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccCccccccCCccc-cccccccccccCCcCccChHHhhcccc-------cccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 99997653211100 001112234569999999998753110 0134788999999999999999999999854
Q ss_pred cCCCccHHHHHH-hhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCK-MALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~-~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
............ ........+.+..... .+. .......+.++.+++.+||..||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 230 CGSDCGWDRGEACPACQNMLFESIQEGKY-EFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCSCSCC----CCHHHHHHHHHHHHHCCC-CCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccccccccchhHHHHHHHHHhccCc-ccC----chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 332211000000 0000000000000000 000 0011123457889999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.83 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=202.2
Q ss_pred hhcCccCCcccccCcceEEEEE-----ECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGI-----LGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++|++.+.||+|+||.||+|+ ...+++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence 4689999999999999999999 4457789999999643 3445678899999999999999999999954
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCC-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CC
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPE-VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DM 827 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~ 827 (997)
.....++||||+++|+|.+++........ ...+++..++.++.|++.||.|||++ +|+||||||+||+++. +.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 45578999999999999999997653221 23488999999999999999999999 9999999999999994 44
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-C
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-R 906 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g 906 (997)
.+||+|||+++....... ........||+.|+|||.+. +..++.++|||||||++|||+| |
T Consensus 181 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~ellt~g 242 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASY------YRKGGCAMLPVKWMPPEAFM------------EGIFTSKTDTWSFGVLLWEIFSLG 242 (327)
T ss_dssp CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eEEECccccccccccccc------cccCCCcCCCcceeCHhHhc------------CCCCCchhhHHHHHHHHHHHHcCC
Confidence 699999999986532211 11223356789999997764 3568899999999999999998 9
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
+.||.... ..+........ ..+. .+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus 243 ~~p~~~~~-----~~~~~~~~~~~-----~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 243 YMPYPSKS-----NQEVLEFVTSG-----GRMD------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp CCSSTTCC-----HHHHHHHHHTT-----CCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcC-----HHHHHHHHhcC-----CCCC------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 99986431 11111111000 0000 01123457889999999999999999999999999
Q ss_pred HHHHH
Q 001908 987 AARQT 991 (997)
Q Consensus 987 ~~~~~ 991 (997)
.+.++
T Consensus 301 ~~~~~ 305 (327)
T 2yfx_A 301 YCTQD 305 (327)
T ss_dssp HHHHC
T ss_pred HHhcC
Confidence 88764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.49 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=189.0
Q ss_pred hhcCccCCcccccCcceEEEEEEC---CCCcEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLMQ----KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|++++++++||||+++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence 468999999999999999999984 588999999997432 23345678899999999999999999985
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
...+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence 34568999999999999999998754 478889999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+++..... ........||+.|+|||++. +..++.++|||||||++|||++|+.||
T Consensus 162 l~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 162 LTDFGLCKESIHD--------GTVTHTFCGTIEYMAPEILM------------RSGHNRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp ECCCSCC------------------CTTSSCCTTSCHHHHT------------TSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEeCCcccccccC--------CccccccCCCcCccCHhhCc------------CCCCCCcccchhHHHHHHHHHHCCCCC
Confidence 9999999754211 11223457999999997654 466889999999999999999999999
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
.... ..+......... ... +.....++.+++.+||..||++|| ++.|+++
T Consensus 222 ~~~~-----~~~~~~~i~~~~------~~~------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 222 TGEN-----RKKTIDKILKCK------LNL------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCSS-----HHHHHHHHHHTC------CCC------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCC-----HHHHHHHHHhCC------CCC------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 7431 111111111000 000 011245678999999999999999 6777754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=373.12 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=198.3
Q ss_pred CcccccCcceEEEEEE--CCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGIL--GENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~--~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
++||+|+||+||+|.+ +.+++.||||+++... ....+.+.+|++++++++||||++++++|.. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4799999999999965 4567899999997432 3346789999999999999999999998742 3578999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 9999999999998654 488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCcc
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLT 919 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 919 (997)
..... .........+|+.|+|||++. +..++.++|||||||++|||++ |+.||....
T Consensus 520 ~~~~~-----~~~~~~~~~~t~~y~APE~~~------------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~----- 577 (635)
T 4fl3_A 520 RADEN-----YYKAQTHGKWPVKWYAPECIN------------YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----- 577 (635)
T ss_dssp TC------------------CGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----
T ss_pred ccCcc-----ccccccCCCCceeeeChhhhc------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 32211 111223345788999997764 4678999999999999999998 999997432
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
..+....... ... ...+..++.++.+++..||+.||++||++.++++.|+++..++
T Consensus 578 ~~~~~~~i~~-----~~~------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 578 GSEVTAMLEK-----GER------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHHT-----TCC------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHc-----CCC------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1111111100 000 0111234667889999999999999999999999999988765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=359.40 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=202.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||.||+|+.+.+|+.||||++... .......+.+|++++++++||||+++++++ .+.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence 46799999999999999999999999999999999643 223456788999999999999999999984 4566
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 89999999999999999987542 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... .......+||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 331 Gla~~~~~---------~~~~~~~~GT~~Y~APEvl~------------~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 331 GLAVHVPE---------GQTIKGRVGTVGYMAPEVVK------------NERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTCEECCT---------TCCEECCCSCGGGCCHHHHT------------TCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccceeccc---------CccccccCCCccccCHHHHc------------CCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 99986522 11223457999999997664 4668999999999999999999999998543
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
... ...+...... . ...... .....++.+++.+||..||++|| +++|+++
T Consensus 390 ~~~-~~~~i~~~i~-----~-~~~~~p------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 390 KKI-KREEVERLVK-----E-VPEEYS------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SCC-CHHHHHHHHH-----H-CCCCCC------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cch-hHHHHHHHhh-----c-ccccCC------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 221 1122111110 0 000100 11235678999999999999999 7788864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.73 Aligned_cols=271 Identities=19% Similarity=0.282 Sum_probs=193.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchh-hHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKG-ALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.++||+|+||+||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++. ..+..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 4789999999999999999999989999999999643322 2224567999999999999999999954 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||++ |+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEecccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 9999996 599999987542 478899999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... ........||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 148 ~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~- 207 (324)
T 3mtl_A 148 RAKSIP--------TKTYDNEVVTLWYRPPDILLG-----------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE- 207 (324)
T ss_dssp ECC--------------------CGGGCCHHHHTT-----------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccCC--------ccccccccCcccccChhhhcC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 754211 112233568999999987642 245789999999999999999999999743211
Q ss_pred ccHHHHHHhh---cchhhhhhcCcc-cc----cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA---LPEKVMETVDPS-LL----LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~---~~~~~~~~~d~~-~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.......... ....+....... .. .................++.+++.+||+.||++|||+.|+++
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 208 EQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1111111110 000010000000 00 000000011111233456789999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.70 Aligned_cols=261 Identities=24% Similarity=0.403 Sum_probs=205.5
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++++++||||+++++++. .+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 82 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPI 82 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCc
Confidence 3468999999999999999999986 677899999975432 3467899999999999999999999853 2358
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 99999999999999997642 12488999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
++...... ........++..|+|||.+. +..++.++|||||||++|||++ |+.||....
T Consensus 156 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~- 215 (279)
T 1qpc_A 156 ARLIEDNE-------YTAREGAKFPIKWTAPEAIN------------YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT- 215 (279)
T ss_dssp CEECSSSC-------EECCTTCCCCTTTSCHHHHH------------HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred cccccCcc-------cccccCCCCccCccChhhhc------------cCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-
Confidence 98653211 11222345688999997765 3567889999999999999999 899986431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
..+..... .....+. .+..++.++.+++.+||..||++|||+.++++.|+++..+..
T Consensus 216 ----~~~~~~~~-----~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 216 ----NPEVIQNL-----ERGYRMV------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ----HHHHHHHH-----HTTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----HHHHHHHH-----hcccCCC------------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11111111 0000000 011234578899999999999999999999999999887654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=334.93 Aligned_cols=259 Identities=21% Similarity=0.364 Sum_probs=204.6
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-----
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF----- 750 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 750 (997)
...++|++.+.||+|+||.||+|++..+++.||+|+++... +.+.+|++++++++||||+++++++...++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34578999999999999999999999899999999997543 346689999999999999999998754221
Q ss_pred ------CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 751 ------KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 751 ------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
......++||||+++|+|.+++..... ..+++..++.++.|++.|+.|||++ +|+||||||+||+++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 124568999999999999999986531 2488999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.++.+||+|||.++..... .......||+.|+|||.+. +..++.++|||||||++|||+
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKND---------GKRTRSKGTLRYMSPEQIS------------SQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp ETTEEEECCCTTCEESSCC---------SCCCCCCSCCTTSCHHHHH------------CSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCEEECcchhheecccc---------ccccccCCcccccChhhhc------------cCCCcchhhhHHHHHHHHHHH
Confidence 9999999999999765321 1123346899999997664 456889999999999999999
Q ss_pred hCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 905 TRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 905 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
+|..|+... ....... . +.... ..++..+.+++.+||..||++|||+.|+++.
T Consensus 216 ~~~~~~~~~-------~~~~~~~-----~---~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 268 (284)
T 2a19_B 216 HVCDTAFET-------SKFFTDL-----R---DGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268 (284)
T ss_dssp SCCSSHHHH-------HHHHHHH-----H---TTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCcchhH-------HHHHHHh-----h---ccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999886421 1111000 0 00000 0123457789999999999999999999999
Q ss_pred HHHHHHHhh
Q 001908 985 LCAARQTLV 993 (997)
Q Consensus 985 L~~~~~~~~ 993 (997)
|..+.+...
T Consensus 269 l~~~~~~~~ 277 (284)
T 2a19_B 269 LTVWKKSPE 277 (284)
T ss_dssp HHHHTC---
T ss_pred HHHHhhCCC
Confidence 998876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.27 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=203.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||.||+|+...+++.||+|++... .....+.+.+|++++++++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 46899999999999999999999999999999999743 34456788999999999999999999998643 23567
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----cEecCCCCCCeeeCCCCcEE
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPP-----IVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~-----ivHrDlk~~NIll~~~~~~k 830 (997)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred EEEEEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence 9999999999999999986431 112488999999999999999999998 7 99999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||.++..... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||
T Consensus 157 l~dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 157 LGDFGLARILNHD--------TSFAKTFVGTPYYMSPEQMN------------RMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp ECCCCHHHHC-----------CHHHHHHHSCCTTCCHHHHH------------CC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EecCchheeeccc--------cccccccCCCccccChHHhc------------cCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999875221 11123356899999997764 456889999999999999999999998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLC 986 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 986 (997)
.... ..+..... .....+.. +..++.++.+++.+||+.||++||++.|+++.+.
T Consensus 217 ~~~~-----~~~~~~~i-----~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 217 TAFS-----QKELAGKI-----REGKFRRI------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCSS-----HHHHHHHH-----HHTCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccC-----HHHHHHHH-----hhcccccC------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 7431 11111111 00000011 1123457889999999999999999999997653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=345.56 Aligned_cols=253 Identities=25% Similarity=0.300 Sum_probs=196.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCce
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 755 (997)
..++|++.+.||+|+||.||+|+++.+++.||||+++.... ...+|++++.++ +||||+++++++ .+.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence 45789999999999999999999999999999999975432 235688888888 799999999995 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC----CcEEE
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHV 831 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl 831 (997)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||++.++ +.+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence 999999999999999998754 488999999999999999999999 99999999999998543 35999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+..... .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.
T Consensus 162 ~Dfg~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~------------~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 162 CDFGFAKQLRAE--------NGLLMTPCYTANFVAPEVLER------------QGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp CCCTTCEECBCT--------TCCBCCSSCCSSCCCHHHHHH------------HHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EECCCcccCcCC--------CCceeccCCCccccCHHHhcC------------CCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 999999865221 112234578999999987753 457889999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ....+.......... .... . .......++.+++.+||..||++||++.|+++
T Consensus 222 ~~~~--~~~~~~~~~i~~~~~-~~~~-~------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 222 NGPD--DTPEEILARIGSGKF-SLSG-G------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SSTT--SCHHHHHHHHHHCCC-CCCS-T------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCc--CCHHHHHHHHccCCc-ccCc-c------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4321 122222221111000 0000 0 00112456789999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=337.28 Aligned_cols=262 Identities=20% Similarity=0.238 Sum_probs=197.4
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 3478999999999999999999999899999999997432 3335788999999999999999999999643 5
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred CeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence 58999999999999999998754 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||++....... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||...
T Consensus 178 fg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 178 FGIASATTDEK-------LTQLGNTVGTLYYMAPERFS------------ESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp CCC-----------------------CCGGGCCGGGTC------------C----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred CccCccccccc-------cccccccCCCcCccCHHHHc------------CCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 99997652211 11223456899999996553 567888999999999999999999998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-EMRDVLAKLCAARQT 991 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~~ 991 (997)
. .... ....... ...+. .....++.++.+++.+||..||++|| +++++++.|++....
T Consensus 239 ~-----~~~~-~~~~~~~---~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 239 Q-----LSVM-GAHINQA---IPRPS-----------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp H-----HHHH-HHHHHSC---CCCGG-----------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred h-----HHHH-HHHhccC---CCCcc-----------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 1 1111 1100000 00000 00112345678999999999999999 999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.89 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=200.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|+||+||+|++..+++.||||+++... .+.+.+|++++++++ ||||+++++++... .....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceE
Confidence 67999999999999999999999899999999987433 367889999999997 99999999997532 255789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFg~ 836 (997)
+||||+++++|.+++.. ++...++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 110 lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp EEEECCCCCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeccCchhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 99999999999999853 67889999999999999999999 999999999999999777 899999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... .......||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 178 a~~~~~~---------~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 237 (330)
T 3nsz_A 178 AEFYHPG---------QEYNVRVASRYFKGPELLVD-----------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237 (330)
T ss_dssp CEECCTT---------CCCCSCCSCGGGCCHHHHTT-----------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred ceEcCCC---------CccccccccccccChhhhcC-----------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence 9765221 12233578999999976642 256889999999999999999999999643222
Q ss_pred CccHHHHHHhhcchhhhhhc-------Ccc--------cccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETV-------DPS--------LLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~-------d~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
...+.............+.+ ++. ....+..............++.+++.+||+.||++|||++|+
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 11122211111111111110 000 000010000011112245678899999999999999999999
Q ss_pred HH
Q 001908 982 LA 983 (997)
Q Consensus 982 l~ 983 (997)
++
T Consensus 318 l~ 319 (330)
T 3nsz_A 318 ME 319 (330)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=362.84 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=191.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||.||+|+.+.+++.||||+++.. .......+.+|+++++.++||||+++++++.. .+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 46799999999999999999999999999999999742 33345677889999999999999999999643 45
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 8999999999999999998754 48899999999999999999998 7 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.... ........+||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 293 FG~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 293 FGLCKEGIK--------DGATMKTFCGTPEYLAPEVLE------------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp CCCCCTTCC-------------CCSSSCGGGCCHHHHH------------TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCceeccC--------CCcccccccCCccccCHhhcC------------CCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 999975321 112233467999999997664 567899999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
...+......... ... +...++++.+++.+||..||++|| +++|+++
T Consensus 353 -----~~~~~~~~i~~~~------~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 353 -----DHEKLFELILMEE------IRF------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----SHHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CHHHHHHHHHhCC------CCC------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1222211111000 000 011245678999999999999999 9999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=347.07 Aligned_cols=275 Identities=21% Similarity=0.303 Sum_probs=194.4
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch-----hhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-----GALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
....++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 81 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF---- 81 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence 3445789999999999999999999998999999999964321 1234678999999999999999999995
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
...+..++||||+++ +|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 82 -~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 82 -GHKSNISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp -CCTTCCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred -eeCCceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence 445689999999975 89999876542 367788999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+|+..... ........||+.|+|||++.. ...++.++|||||||++|||++|.+|
T Consensus 152 kl~Dfg~a~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~~ 212 (346)
T 1ua2_A 152 KLADFGLAKSFGSP--------NRAYTHQVVTRWYRAPELLFG-----------ARMYGVGVDMWAVGCILAELLLRVPF 212 (346)
T ss_dssp EECCCGGGSTTTSC--------CCCCCCSCCCCTTCCHHHHTT-----------CSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEecccceeccCC--------cccCCcccccccccCchHhhC-----------CCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999865221 112234578999999987642 23478899999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhh-cc--hhhhhhcC-cccc--cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMA-LP--EKVMETVD-PSLL--LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~-~~--~~~~~~~d-~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
|...... ..+....... .+ ..+..... +... ..............+..++.+++.+||..||++|||+.|+++
T Consensus 213 ~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 213 LPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCHH-HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 8643211 1111111110 00 00000000 0000 000000000011233467889999999999999999999976
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=358.56 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=195.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+.|++.++||+|+||+||+|+++.++..||+|++.... ......+.+|+++++.++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 467999999999999999999999999999999997432 334577899999999999999999999954 4568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC---CcEEEc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVS 832 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~ 832 (997)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.. +.+||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 999999999999999988754 488999999999999999999999 99999999999999764 559999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+.... ........||+.|+|||++. +.++.++||||+||++|+|++|+.||..
T Consensus 182 DfG~a~~~~~---------~~~~~~~~gt~~y~aPE~l~-------------~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 182 DFGLSAVFEN---------QKKMKERLGTAYYIAPEVLR-------------KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp CCTTCEECBT---------TBCBCCCCSCTTTCCHHHHT-------------TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ECCCCeECCC---------CccccccCCCcCeeCHHHHc-------------ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999976522 11223457999999998763 3588999999999999999999999974
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+......... .....+. ....+..+.+++.+||..||++|||+.|+++
T Consensus 240 ~~-----~~~~~~~i~~~~-~~~~~~~-------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 240 QT-----DQEILRKVEKGK-YTFDSPE-------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SS-----HHHHHHHHHHTC-CCCCSGG-------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC-----HHHHHHHHHhCC-CCCCchh-------------cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 32 122211110000 0000011 0122456789999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.78 Aligned_cols=281 Identities=22% Similarity=0.327 Sum_probs=201.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc---CC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF---KG 752 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 752 (997)
.++|++.++||+|+||+||+|+++.+++.||||++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999999899999999986332 2334677899999999999999999999865321 11
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..++||||+++ ++.+.+..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 4578999999964 88888876532 488999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+........ .........||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 167 Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 167 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLG-----------ERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp CCTTCEECCCCSSS----SCCCCCSSCSCGGGCCHHHHTT-----------CCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cchhcccccccccc----cccccCCcccccCccCchhhcC-----------CCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999875322111 1122334578999999987642 24578999999999999999999999874
Q ss_pred CcCCCccHHHHHHhh--cchhhhhhcC-ccccccc--ccchhhhh-----HHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 913 MFQGGLTLHEFCKMA--LPEKVMETVD-PSLLLAW--SDGRRRAK-----VEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~--~~~~~~~~~d-~~~~~~~--~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
..... ......... .+.......+ ....... ........ .....+.+.+++.+||..||++|||++|++
T Consensus 232 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 232 NTEQH-QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp SSHHH-HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CChHH-HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 32110 111111110 0111100000 0000000 00000000 111235688999999999999999999997
Q ss_pred H
Q 001908 983 A 983 (997)
Q Consensus 983 ~ 983 (997)
+
T Consensus 311 ~ 311 (351)
T 3mi9_A 311 N 311 (351)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=333.43 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=182.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence 467999999999999999999998899999999996432 223467899999999999999999999954 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++.... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence 8999999999999999998653 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.+...... ........||+.|+|||.+. +..++.++||||+||++|||++|+.||....
T Consensus 157 g~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 157 GLATQLKMP--------HEKHYTLCGTPNYISPEIAT------------RSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp TTCEECC------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cceeeccCC--------CCcceeccCCCCcCCcchhc------------CCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 999765211 11223356899999996654 4567889999999999999999999997432
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
... ..... .... +. .+...+.++.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~-----~~~~~--------~~~~----~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 217 VKN-----TLNKV--------VLAD----YE------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC----------C--------CSSC----CC------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHH-----HHHHH--------hhcc----cC------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 211 00000 0000 00 00112456789999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=360.03 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=201.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
..++|++.+.||+|+||+||+|+.+.+++.||||++... .....+.+.+|++++++++||||+++++++ ...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 346899999999999999999999999999999998632 233467889999999999999999999995 445
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee---CCCCcEE
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAH 830 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~k 830 (997)
...++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 169 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIR 169 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEE
Confidence 68999999999999999998754 488999999999999999999999 99999999999999 5678999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+.... ........||+.|+|||++. +.++.++||||+||++|+|++|++||
T Consensus 170 l~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 170 IIDFGLSTHFEA---------SKKMKDKIGTAYYIAPEVLH-------------GTYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp ECCTTHHHHBCC---------CCSHHHHTTGGGTCCHHHHH-------------TCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEeeeeeEEccc---------ccccccCCCCccccCceeec-------------CCCCCcceeHHHHHHHHHHHHCCCCC
Confidence 999999987622 11233457999999998764 35888999999999999999999999
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ..+.......... .... +.....++.+.+++.+||..||++|||+.|+++
T Consensus 228 ~~~~-----~~~~~~~i~~~~~-~~~~-------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 228 NGAN-----EYDILKKVEKGKY-TFEL-------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCSS-----HHHHHHHHHHCCC-CCCS-------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-----HHHHHHHHHcCCC-CCCC-------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 7431 1111111100000 0000 011123456789999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=336.15 Aligned_cols=249 Identities=16% Similarity=0.243 Sum_probs=195.7
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 753 (997)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|+..+.++ +||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence 457899999999999999999999989999999999743 334457788999999999 99999999999643 5
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-------
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------- 826 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~------- 826 (997)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred CeEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence 5899999999999999999874210 12478999999999999999999999 99999999999999844
Q ss_pred ------------CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhH
Q 001908 827 ------------MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894 (997)
Q Consensus 827 ------------~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dvw 894 (997)
..+||+|||.+..... .....||+.|+|||++.. ...++.++|||
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------------~~~~~gt~~y~aPE~~~~-----------~~~~~~~~Di~ 215 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISS------------PQVEEGDSRFLANEVLQE-----------NYTHLPKADIF 215 (289)
T ss_dssp -----------CCCEEECCCTTCEETTC------------SCCCCCCGGGCCHHHHTT-----------CCTTHHHHHHH
T ss_pred cccccccccCCceEEEEcccccccccCC------------ccccCCCccccChhHhcC-----------CCCCCchhhHH
Confidence 4899999999976521 112358999999987652 23566899999
Q ss_pred HHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCC
Q 001908 895 SLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974 (997)
Q Consensus 895 SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 974 (997)
||||++|||++|.+|+... ........ ...+.. +..++.++.+++.+||+.||++
T Consensus 216 slG~il~~l~~~~~~~~~~----~~~~~~~~---------~~~~~~------------~~~~~~~~~~li~~~l~~dp~~ 270 (289)
T 1x8b_A 216 ALALTVVCAAGAEPLPRNG----DQWHEIRQ---------GRLPRI------------PQVLSQEFTELLKVMIHPDPER 270 (289)
T ss_dssp HHHHHHHHHTTCCCCCSSS----HHHHHHHT---------TCCCCC------------SSCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHhcCCCCCcch----hHHHHHHc---------CCCCCC------------CcccCHHHHHHHHHHhCCCccc
Confidence 9999999999998876421 11111110 000111 0112456789999999999999
Q ss_pred CCCHHHHHH
Q 001908 975 RMEMRDVLA 983 (997)
Q Consensus 975 Rps~~evl~ 983 (997)
|||+.|+++
T Consensus 271 Rps~~~ll~ 279 (289)
T 1x8b_A 271 RPSAMALVK 279 (289)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhh
Confidence 999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=339.33 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=197.8
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCCcceEEeeeec
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNTRHRNLIKIITVCSS 747 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 747 (997)
...++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34578999999999999999999999999999999986422 1223457899999999999999999998642
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 827 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 827 (997)
. ..++||||+++++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 87 -----~-~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 87 -----E-DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp -----S-SEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS
T ss_pred -----C-ceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC
Confidence 2 3799999999999999997654 488999999999999999999999 999999999999998766
Q ss_pred c---EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 828 V---AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 828 ~---~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
. +||+|||+++.... ........||+.|+|||++.. .....++.++|||||||++|||+
T Consensus 152 ~~~~~kl~Dfg~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGE---------TSLMRTLCGTPTYLAPEVLVS---------VGTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp SSCCEEECCCTTCEECCC---------CHHHHHHHSCCTTCCHHHHHH---------TTTTTCTTHHHHHHHHHHHHHHH
T ss_pred CCCeEEEccCccceeccc---------ccccccccCCcCccCchhhcc---------CCCCCCCchhhHHHHHHHHHHHH
Confidence 4 99999999976521 112234568999999987642 12356889999999999999999
Q ss_pred hCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 TRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+|+.||....... .+.......... ..+ .....++..+.+++.+||..||++||++.|+++
T Consensus 214 ~g~~pf~~~~~~~-~~~~~~~~~~~~-----~~~------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 214 SGYPPFSEHRTQV-SLKDQITSGKYN-----FIP------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HSSCSSCSTTCSS-CHHHHHHHTCCC-----CCH------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCCCcccchHH-HHHHHHHhCccc-----cCc------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999997543222 122211111000 000 011123457789999999999999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.00 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=203.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEE--EEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFV--AVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--AvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||.||+|+++.++..+ |+|+++.. .....+.+.+|+++++++ +||||+++++++. ..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence 57999999999999999999998888765 99988642 333456789999999999 8999999999964 355
Q ss_pred eEEEEEeeccCCCHHHHhhcCCC----------CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNG----------QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
..++||||+++|+|.+++..... ......+++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 89999999999999999987531 01122588999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.++.+||+|||+++... .........+++.|+|||++. +..++.++|||||||++|||+
T Consensus 177 ~~~~~kL~Dfg~~~~~~---------~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~ell 235 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLN------------YSVYTTNSDVWSYGVLLWEIV 235 (327)
T ss_dssp GGGCEEECCTTCEESSC---------EECCC----CCTTTCCHHHHH------------HCEECHHHHHHHHHHHHHHHH
T ss_pred CCCeEEEcccCcCcccc---------ccccccCCCCCccccChhhhc------------cccCCchhcchHHHHHHHHHH
Confidence 99999999999997431 111223345788999998764 356788999999999999999
Q ss_pred h-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 T-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
| |+.||... ...+...... ...... .+..++.++.+++.+||..||++|||+.|+++
T Consensus 236 t~g~~pf~~~-----~~~~~~~~~~-----~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 236 SLGGTPYCGM-----TCAELYEKLP-----QGYRLE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp TTSCCTTTTC-----CHHHHHHHGG-----GTCCCC------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCC-----cHHHHHHHhh-----cCCCCC------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8 99998743 1222211111 000000 01123456889999999999999999999999
Q ss_pred HHHHHHHHh
Q 001908 984 KLCAARQTL 992 (997)
Q Consensus 984 ~L~~~~~~~ 992 (997)
.|.++.++.
T Consensus 294 ~L~~~~~~~ 302 (327)
T 1fvr_A 294 SLNRMLEER 302 (327)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHHhh
Confidence 999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=336.31 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=186.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.++...++.++||||+++++++. ..+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence 468999999999999999999999899999999997432 223334455555678889999999999964 4557
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||++ |+|.+++...... ...+++..++.++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred EEEEEehhc-cchHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence 999999996 5888887652111 124899999999999999999999853 89999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.|+..... .......||+.|+|||.+.. ...+..++.++||||+||++|||++|+.||.....
T Consensus 156 ~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (290)
T 3fme_A 156 ISGYLVDD---------VAKDIDAGCKPYMAPERINP--------ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218 (290)
T ss_dssp -----------------------CCCCCCSCHHHHSC--------CTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred Cccccccc---------ccccccCCCccccChhhcCh--------hhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence 99765221 12223468999999988642 12346688999999999999999999999974321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
......... ....+... ...++.++.+++.+||+.||++|||+.|+++
T Consensus 219 ---~~~~~~~~~------~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 219 ---PFQQLKQVV------EEPSPQLP-----------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---HHHHHHHHH------HSCCCCCC-----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---hHHHHHHHh------ccCCCCcc-----------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111110 00011100 0122456789999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=328.64 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=201.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch------hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK------GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++|++.+.||+|+||.||+|+...+++.||+|+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE----- 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----
Confidence 4679999999999999999999998999999999864321 13578899999999999999999999954
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC----
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---- 827 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---- 827 (997)
.....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred CCCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence 4568999999999999999998654 488999999999999999999999 999999999999999887
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||.++..... .......||+.|+|||.+. +..++.++||||||+++|||++|+
T Consensus 150 ~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~ 208 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAG---------NEFKNIFGTPEFVAPEIVN------------YEPLGLEADMWSIGVITYILLSGA 208 (283)
T ss_dssp CEEECCCTTCEECC-----------------CCCGGGCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ceEEEecccceeccCC---------CcccccCCCcCccCcceec------------CCCCCcchhhhhHHHHHHHHHHCC
Confidence 8999999999765221 1123356899999997654 467889999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HH
Q 001908 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA--KL 985 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L 985 (997)
.||.... ..+....... ..... ........+..+.+++.+||..||++|||+.|+++ .+
T Consensus 209 ~p~~~~~-----~~~~~~~~~~------~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 209 SPFLGET-----KQETLTNISA------VNYDF--------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp CTTCCSS-----HHHHHHHHHT------TCCCC--------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred CCCCCcc-----hHHHHHHhHh------cccCC--------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 9987431 1111111000 00000 00111223456789999999999999999999987 45
Q ss_pred HHHHH
Q 001908 986 CAARQ 990 (997)
Q Consensus 986 ~~~~~ 990 (997)
++++.
T Consensus 270 ~~~~~ 274 (283)
T 3bhy_A 270 KAIRR 274 (283)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.38 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=198.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|.+.+.||+|+||+||+|+...+++.||+|+++.......+.+.+|++++++++||||+++++++. ..+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEE
Confidence 3468999999999999999999999899999999998655445567889999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee---CCCCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~D 833 (997)
++||||+++++|.+++.... .+++..++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred EEEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEcc
Confidence 99999999999999997654 478899999999999999999999 99999999999999 7889999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.++.... .......||+.|+|||++ .+..++.++||||+||++|||++|+.||...
T Consensus 153 fg~~~~~~~----------~~~~~~~~~~~y~aPE~~------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 153 FGLSKMEQN----------GIMSTACGTPGYVAPEVL------------AQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CSTTCCCCC----------BTTHHHHSCCCBCCTTTB------------SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCcceecCC----------CccccccCCCCccChHHh------------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999864311 122335689999999655 3567899999999999999999999998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..+........ ...... +.....+..+.+++.+||..||++|||+.|+++
T Consensus 211 ~-----~~~~~~~i~~~-~~~~~~-------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 211 T-----ESKLFEKIKEG-YYEFES-------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp C-----HHHHHHHHHHC-CCCCCT-------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred C-----HHHHHHHHHcC-CCCCCc-------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11111111000 000000 001123456789999999999999999999976
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=343.93 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=193.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCC--CCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRH--RNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~ 753 (997)
.+.|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++| +||+++++++. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 467999999999999999999986 7899999998643 34455788999999999976 99999999954 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++|||+ .+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred CEEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence 689999995 5889999998764 478999999999999999999999 999999999999996 68899999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+...... .........||+.|+|||++........ +......++.++|||||||++|||++|+.||...
T Consensus 151 FG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 151 FGIANQMQPDT------TSVVKDSQVGTVNYMPPEAIKDMSSSRE-NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp CSSSCCC------------------CCCCSSCCHHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccCccc------ccccCCCCcCCcCcCCHHHHhhcccccc-ccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 99998652211 1112234579999999998864211000 0112356889999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
... ..... ..+++.....+.. ....++.+++..||..||++|||+.|+++.
T Consensus 224 ~~~---~~~~~---------~~~~~~~~~~~~~--------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 224 INQ---ISKLH---------AIIDPNHEIEFPD--------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CSH---HHHHH---------HHHCTTSCCCCCC--------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhH---HHHHH---------HHhcCCcccCCcc--------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 211 11111 1111111111110 113467799999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=357.00 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=198.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|...+.||+|+||+||+|+.+.+|+.||+|++.... ....+.+.+|++++++++||||+++++++ .....
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~~ 259 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKTD 259 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCCE
Confidence 67889999999999999999999999999999996432 23456788999999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecc
Confidence 99999999999999999865421 22488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+...... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||.....
T Consensus 335 la~~~~~~~--------~~~~~~~GT~~Y~APE~l~------------~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 335 LAVELKAGQ--------TKTKGYAGTPGFMAPELLL------------GEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp TCEECCTTC--------CCBCCCCSCTTTSCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred eeeeccCCC--------cccccccCCccccChhhhc------------CCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 998652211 1123357999999997664 56789999999999999999999999975422
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
. ....+......... ... +...+..+.+++.+||..||++||++
T Consensus 395 ~-~~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 395 K-VENKELKQRVLEQA------VTY------------PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp C-CCHHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred c-hhHHHHHHHHhhcc------cCC------------CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1 12222221111000 000 01224567899999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.26 Aligned_cols=283 Identities=23% Similarity=0.305 Sum_probs=204.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|++++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46899999999999999999999989999999999743 33445678899999999999999999999766555556789
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||++ |+|.+++.... +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQM-------LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 99999996 69999998743 88999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCcc--ccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 837 ARFLFARPFDTSM--ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 837 a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+........... ..........||+.|+|||++.. +..++.++|||||||++|||++|+.||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-----------SAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHS-----------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccCccccccchhhccccccccCCeeecc-----------CCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876332111110 01112234578999999987642 3568899999999999999999999997432
Q ss_pred CCCccHHHHHHhh-cc--hhhhhhc-Ccccc------cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA-LP--EKVMETV-DPSLL------LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~-~~--~~~~~~~-d~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
... .+....... .+ ....... .+... ..+...........++.++.+++.+||..||++|||+.|+++
T Consensus 228 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 228 YRH-QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHH-HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cHH-HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110 001110000 00 0000000 00000 000000001111234567889999999999999999999976
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=345.16 Aligned_cols=335 Identities=20% Similarity=0.228 Sum_probs=265.4
Q ss_pred CCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCe
Q 001908 216 NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWS 295 (997)
Q Consensus 216 ~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 295 (997)
.+++++.|++++|.++ .+|..++..+++|++|++++|.+++..|..|..+++|++|+|++|++++.++..|+++++|++
T Consensus 43 ~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 4678888899888887 788888778889999999999988877788889999999999999998888888888888888
Q ss_pred eEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEE
Q 001908 296 LDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375 (997)
Q Consensus 296 L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 375 (997)
|+|++|+++.++.. .+.++++|++|++++|+++ +..|..|.++++|++|
T Consensus 122 L~L~~n~l~~l~~~------~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 122 LVLERNDLSSLPRG------IFHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNL 170 (390)
T ss_dssp EECCSSCCCCCCTT------TTTTCTTCCEEECCSSCCC-------------------------BCCTTTTSSCTTCCEE
T ss_pred EECCCCccCcCCHH------HhcCCCCCcEEECCCCccC-------------------------ccChhhccCCCCCCEE
Confidence 88888888765442 2345666666666665554 3455567777888888
Q ss_pred eccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCccc
Q 001908 376 GIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 376 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 455 (997)
++++|++++. .+..+++|+.|++++|.+++ +...++|+.|++++|+++.. |..+ .++|+.|++++|+++
T Consensus 171 ~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~ 239 (390)
T 3o6n_A 171 QLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLT 239 (390)
T ss_dssp ECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCC
T ss_pred ECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCc
Confidence 8888888754 35667888888888888874 23446788888888888854 4332 478899999999887
Q ss_pred CCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhc
Q 001908 456 GAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535 (997)
Q Consensus 456 ~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 535 (997)
+. ..+..++++ +.|++++|.+++..|..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+
T Consensus 240 ~~--~~l~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~ 314 (390)
T 3o6n_A 240 DT--AWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314 (390)
T ss_dssp CC--GGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGH
T ss_pred cc--HHHcCCCCc-cEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccc
Confidence 53 567778887 88999999998888889999999999999999998 46777788999999999999998 677788
Q ss_pred cccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCC
Q 001908 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 536 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~ 602 (997)
..+++|+.|+|++|++++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|.+
T Consensus 315 ~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 315 PQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp HHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCT
T ss_pred cccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecc
Confidence 8999999999999999854 3 77889999999999999875432 34555666677888888864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=356.80 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=198.3
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch-------------hhHHHHHHHHHHHhhcCCCCcceEEe
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-------------GALKSFVAECEVLRNTRHRNLIKIIT 743 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 743 (997)
..++|++.++||+|+||+||+|+.+.+++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999864321 23467899999999999999999999
Q ss_pred eeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee
Q 001908 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL 823 (997)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll 823 (997)
++. .....++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 114 VFE-----DKKYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179 (504)
T ss_dssp EEE-----CSSEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred EEE-----cCCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence 954 4668999999999999999998754 488999999999999999999999 99999999999999
Q ss_pred CCCC---cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHH
Q 001908 824 DHDM---VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900 (997)
Q Consensus 824 ~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl 900 (997)
+.++ .+||+|||+|+..... .......||+.|+|||++. +.++.++||||+||++
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~-------------~~~~~~~DiwslG~il 237 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKD---------YKLRDRLGTAYYIAPEVLK-------------KKYNEKCDVWSCGVIM 237 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTT---------SCBCCCCSCTTTCCHHHHT-------------TCBCTHHHHHHHHHHH
T ss_pred ecCCCCccEEEEECCCCEEcCCC---------CccccccCCcCCCCHHHhc-------------cCCCchHHHHHHHHHH
Confidence 9876 6999999999865221 1223457999999998764 3588999999999999
Q ss_pred HHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 901 LEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 901 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
|+|++|+.||.... ..+......... ... ..+.....+.++.+++.+||..||++|||+.|
T Consensus 238 ~~ll~g~~pf~~~~-----~~~~~~~i~~~~----~~~----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 298 (504)
T 3q5i_A 238 YILLCGYPPFGGQN-----DQDIIKKVEKGK----YYF----------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298 (504)
T ss_dssp HHHHHSSCSSCCSS-----HHHHHHHHHHCC----CCC----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCCCCCC-----HHHHHHHHHcCC----CCC----------CccccCCCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 99999999997431 122211110000 000 00111123456789999999999999999999
Q ss_pred HHH
Q 001908 981 VLA 983 (997)
Q Consensus 981 vl~ 983 (997)
+++
T Consensus 299 ~l~ 301 (504)
T 3q5i_A 299 ALN 301 (504)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.10 Aligned_cols=199 Identities=26% Similarity=0.417 Sum_probs=172.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|+||+||+|++..+++.||+|+++.. .....+.+.+|++++++++||||+++++++.. .+..+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 107 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 107 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEEE
Confidence 5799999999999999999999999999999999754 34456788999999999999999999999643 55899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++.... .+++..+..++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||++
T Consensus 108 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999999998764 4788999999999999999999842 7999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
+.... .......||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 180 ~~~~~----------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 180 GQLID----------SMANSFVGTRSYMSPERLQ------------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp HHHHH----------HC----CCCCTTCCHHHHT------------TCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ccccc----------ccccCCCCCCCeECHHHHc------------CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 76522 1223357899999997654 56789999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=345.49 Aligned_cols=274 Identities=16% Similarity=0.136 Sum_probs=204.5
Q ss_pred hhcCccCCcccccCcceEEEEEECC--------CCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcce---------
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGE--------NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK--------- 740 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 740 (997)
.++|++.+.||+|+||+||+|++.. .++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999986 3789999998643 35788999999999999988
Q ss_pred ------EEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEec
Q 001908 741 ------IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHG 814 (997)
Q Consensus 741 ------l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHr 814 (997)
+++++. ......++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +|+||
T Consensus 116 ~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~ 183 (352)
T 2jii_A 116 LLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHG 183 (352)
T ss_dssp TCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred ccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence 444432 2356899999999 999999998752 12489999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCC--cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccch
Q 001908 815 DLKPSNVLLDHDM--VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGD 892 (997)
Q Consensus 815 Dlk~~NIll~~~~--~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~D 892 (997)
||||+||+++.++ .+||+|||+|+.......... ..........||+.|+|||++. +..++.++|
T Consensus 184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~D 250 (352)
T 2jii_A 184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA-YVEGSRSPHEGDLEFISMDLHK------------GCGPSRRSD 250 (352)
T ss_dssp CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC-CCTTSSCTTCSCTTTCCHHHHT------------TCCCCHHHH
T ss_pred CCCHHHEEEcCCCCceEEEecCcceeeccCCCcccc-ccccccccccCCccccCHHHHc------------cCCCCchhh
Confidence 9999999999998 999999999987633211110 1111223457999999997654 467899999
Q ss_pred hHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCC
Q 001908 893 VYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972 (997)
Q Consensus 893 vwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 972 (997)
||||||++|||++|+.||.........+....... ........++... ....+.++.+++.+||..||
T Consensus 251 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 251 LQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGH-----------WIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp HHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSC-----------EECCCHHHHHHHHHHHTCCT
T ss_pred HHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhccc-----------cCCCcHHHHHHHHHHHhCCh
Confidence 99999999999999999985432221121111100 0000000000000 00124568899999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHhh
Q 001908 973 IERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 973 ~~Rps~~evl~~L~~~~~~~~ 993 (997)
++||+++++++.|+++.++..
T Consensus 319 ~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 319 EEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCCCCHHHHHHHHHHHHHHTT
T ss_pred hhCCCHHHHHHHHHHHHHhcC
Confidence 999999999999999987653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=341.39 Aligned_cols=270 Identities=19% Similarity=0.239 Sum_probs=209.4
Q ss_pred CCCHHHHHHHHHHHHhc-CCCCCCCCCC----CCCCCCCeeeeeeecC--------CCCcEEEEeccCCCCCCccccccc
Q 001908 29 HTNETDRLALLAIKSQL-HDPLGVTNSW----NNSINLCQWAGVTCGH--------RHQRVTELDLRHQNIGGSLSPYVG 95 (997)
Q Consensus 29 ~~~~~~~~aLl~~k~~~-~~~~~~~~sW----~~~~~~c~w~gv~C~~--------~~~~v~~L~L~~~~l~g~~~~~l~ 95 (997)
.+..+|++||++||+++ .||.+.+++| ....++|.|.||+|+. ...+|+.|+|++|++. .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 34578999999999997 6888888999 4567899999999952 4578999999999997 8999999
Q ss_pred CccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccc-------
Q 001908 96 NLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGY------- 168 (997)
Q Consensus 96 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~------- 168 (997)
++++|++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|++++|++.+.+|..++.
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 9999999999999999 99999999999999999999999 99999999999999999999999999988753
Q ss_pred -cccccceeecccccccCcCcCccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCcc
Q 001908 169 -SWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQ 246 (997)
Q Consensus 169 -~l~~L~~L~L~~N~l~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~ 246 (997)
.+++|++|+|++|+++ .+|..++.++ +.+|++++|++++ +|+.++++++|++|+|++|.+.+.+|..++ .+++|+
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~ 256 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLK 256 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT-CCCCCC
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc-CCCCCC
Confidence 4677888888888777 6666666653 4456666666663 555566666666666666666666665544 566666
Q ss_pred EEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCC
Q 001908 247 VFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLG 304 (997)
Q Consensus 247 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 304 (997)
+|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..|+.+++|+.+++..|.+.
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 6666666666666666666666666666666666666666666666666666655544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=337.42 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=200.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
+.|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence 56899999999999999999999899999999997432 3456788999999999999999999999643 45899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++++|.+++... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 97 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp EEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence 999999999999999754 388999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
...... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 167 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--- 223 (303)
T 3a7i_A 167 GQLTDT--------QIKRNTFVGTPFWMAPEVIK------------QSAYDSKADIWSLGITAIELARGEPPHSELH--- 223 (303)
T ss_dssp EECBTT--------BCCBCCCCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---
T ss_pred eecCcc--------ccccCccCCCcCccCHHHHh------------cCCCCchhhhHHHHHHHHHHccCCCCCCCcC---
Confidence 765221 11223457899999997664 4668889999999999999999999987431
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..+..... .....+... ..++..+.+++.+||+.||++|||+.|+++.
T Consensus 224 --~~~~~~~~-----~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 224 --PMKVLFLI-----PKNNPPTLE------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --HHHHHHHH-----HHSCCCCCC------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --HHHHHHHh-----hcCCCCCCc------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111100 000111111 1124567899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.69 Aligned_cols=271 Identities=23% Similarity=0.317 Sum_probs=197.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++. ..+..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 99 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKRW 99 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCEE
Confidence 57999999999999999999999899999999986432 334566789999999999999999999964 35589
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.++..... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCC
Confidence 99999999999988876544 488999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
++..... ........||+.|+|||.+.. ...++.++||||+||++|||++|+.||......
T Consensus 171 ~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 171 ARTLAAP--------GEVYDDEVATRWYRAPELLVG-----------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp C--------------------CCCCCTTCCHHHHTT-----------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ceeecCC--------ccccCCCcCCccccCcccccC-----------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9765221 112234568999999987642 236788999999999999999999998743211
Q ss_pred CccHHHHHHhh--cchhhhhhc--Ccccc----ccc-ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMA--LPEKVMETV--DPSLL----LAW-SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~--~~~~~~~~~--d~~~~----~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ......... ......... ++... ... ...........++..+.+++.+||..||++|||+.|+++
T Consensus 232 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 232 D-QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp H-HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred H-HHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 111111100 000000000 00000 000 000001111234567899999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=339.51 Aligned_cols=272 Identities=22% Similarity=0.279 Sum_probs=195.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 754 (997)
.++|+..+.||+|+||.||+|++..+|+.||||++.. ......+.+.+|++++++++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3578999999999999999999999999999999853 23344577899999999999999999999975432 11224
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+ +++|.+++.... +++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~-------l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 579999999 889999998743 78899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ......||+.|+|||++.. ...++.++||||+||++|||++|+.||....
T Consensus 173 g~a~~~~~-----------~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 173 GLARQADS-----------EMTGYVVTRWYRAPEVILN-----------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp TTCEECCS-----------SCCSSCSCGGGCCTHHHHT-----------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccccccc-----------ccCcCcCCCCcCCHHHHhC-----------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986421 1234578999999987652 2568899999999999999999999997432
Q ss_pred CCCccHHHHHHhh--cchhhhhhcCccccc-------ccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA--LPEKVMETVDPSLLL-------AWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~--~~~~~~~~~d~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+....... .+......+...... ...............+.+.+++.+|+..||++|||+.|+++
T Consensus 231 ~~-~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 231 HL-DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HH-HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH-HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11 0111111100 011111111000000 00000000011123456789999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=330.85 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=202.9
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---------hhhHHHHHHHHHHHhhcC-CCCcceEEeeee
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---------KGALKSFVAECEVLRNTR-HRNLIKIITVCS 746 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 746 (997)
..++|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|+++++++. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 3468999999999999999999999999999999996432 223467789999999995 99999999995
Q ss_pred ccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC
Q 001908 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 826 (997)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~ 826 (997)
......++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD 160 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence 34568999999999999999998754 488999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
+.+||+|||.+...... .......||+.|+|||++..... .....++.++||||||+++|||++|
T Consensus 161 ~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPG---------EKLREVCGTPSYLAPEIIECSMN------DNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp CCEEECCCTTCEECCTT---------CCBCCCCSCGGGCCHHHHHHHHC------TTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CcEEEecccchhhcCCC---------cccccccCCccccCHHHhccccc------cccccCCcccccHhHHHHHHHHHHC
Confidence 99999999999765221 12234568999999998753211 1235678899999999999999999
Q ss_pred CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 907 RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+.||.... ..+.......... ....+ ....++..+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~p~~~~~-----~~~~~~~~~~~~~-~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 226 SPPFWHRK-----QMLMLRMIMSGNY-QFGSP-------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SCSSCCSS-----HHHHHHHHHHTCC-CCCTT-------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCcCcc-----HHHHHHHHhcCCc-ccCcc-------------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 99986431 1111111100000 00000 01123457889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.17 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=199.7
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccC
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSID 749 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 749 (997)
..++....++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+++++++ +||||+++++++....
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 33444566789999999999999999999998999999999974432 346788999999999 7999999999976532
Q ss_pred cC-CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 750 FK-GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 750 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
.. ..+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 11 14678999999999999999987531 2488899999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||++...... ........||+.|+|||++... ...+..++.++|||||||++|||++|+.
T Consensus 168 ~kl~Dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~~~~Di~slG~il~~l~~g~~ 232 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRT--------VGRRNTFIGTPYWMAPEVIACD-------ENPDATYDFKSDLWSLGITAIEMAEGAP 232 (326)
T ss_dssp EEECCCTTTC---------------------CCGGGCCHHHHC---------------CCTTHHHHHHHHHHHHHHHSSC
T ss_pred EEEeeCcCceecCcC--------ccccccccCCccccChhhhccc-------cccCcCCCccchHHHHHHHHHHHHhCCC
Confidence 999999998765211 1122345689999999887531 1124568899999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
||.... ........ .....+... ...++..+.+++.+||..||++||++.|+++
T Consensus 233 p~~~~~-----~~~~~~~~-----~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 233 PLCDMH-----PMRALFLI-----PRNPAPRLK-----------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp TTTTSC-----HHHHHHHH-----HHSCCCCCS-----------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCc-----HHHHHHHh-----hcCccccCC-----------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 986431 11111100 011111110 0112456789999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=335.05 Aligned_cols=250 Identities=19% Similarity=0.289 Sum_probs=201.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|.+.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++. ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 46799999999999999999999999999999998643 3345678899999999999999999999954 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 8999999999999999988754 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++..... ........||+.|+|||.+. +..++.++||||+|+++|||++|+.||....
T Consensus 160 g~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 160 GLATKVEYD--------GERKKVLCGTPNYIAPEVLS------------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TTCEECCST--------TCCBCCCCSCCSSCCHHHHT------------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCceecccC--------ccccccccCCCCcCCcchhc------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999765211 11223356899999997654 4567889999999999999999999987431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
..+........ .... +......+.+++.+||+.||++|||+.|+++.
T Consensus 220 -----~~~~~~~~~~~------~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 220 -----LKETYLRIKKN------EYSI------------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----HHHHHHHHHTT------CCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----HHHHHHHHhhc------cCCC------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111111000 0000 01123467789999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=368.41 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=204.2
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.++||+|+||+||+|+++ .+..||||+++.... ..+.+.+|++++++++|+||+++++++.. +..
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 336 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 336 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence 3467889999999999999999997 457799999975432 34678999999999999999999998642 468
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++|+|.++++...+ ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred eEeeehhcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 999999999999999986421 1378999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQ 915 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 915 (997)
++.... ..........++..|+|||++. +..++.++|||||||++|||+| |+.||....
T Consensus 410 a~~~~~-------~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~- 469 (535)
T 2h8h_A 410 ARLIED-------NEYTARQGAKFPIKWTAPEAAL------------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV- 469 (535)
T ss_dssp TTTCCC-------HHHHTTCSTTSCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-
T ss_pred ceecCC-------CceecccCCcCcccccCHHHhc------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 986521 1111122345678999997664 4568999999999999999999 999987431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
..+...... ... +.+.+..++..+.++|.+||+.||++|||+.++++.|+++..
T Consensus 470 ----~~~~~~~i~-----~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 470 ----NREVLDQVE-----RGY------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----HHHHHHHHH-----TTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----HHHHHHHHH-----cCC------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 112111110 000 011122346678899999999999999999999999987654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=338.64 Aligned_cols=254 Identities=29% Similarity=0.477 Sum_probs=232.8
Q ss_pred ccccccccCccccc--ccCCCCCCCCCCCEEeccC-CCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeE
Q 001908 347 TMTDIYMGVNQISG--TIPSGIGNLVNLNLLGIEF-NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDL 423 (997)
Q Consensus 347 ~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 423 (997)
.++.|++++|.+++ .+|..|+++++|++|+|++ |++++.+|..|+++++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45566666666666 6777888889999999994 99999999999999999999999999998999999999999999
Q ss_pred EeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccc-ccccccccCCCcccCCCccccccccccceecccccc
Q 001908 424 FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTIT-TLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQ 502 (997)
Q Consensus 424 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 502 (997)
+|++|++++.+|..|..+++|++|+|++|++++.+|..+..+. .+ +.|++++|++++.+|..+..++ |+.|++++|+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L-~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF-TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTC-CEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcC-cEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 9999999999999999999999999999999999999999988 55 9999999999999999999987 9999999999
Q ss_pred ccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC
Q 001908 503 FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 503 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 582 (997)
+++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9999999999999999999999999977775 889999999999999999999999999999999999999999999999
Q ss_pred CcCCCCcceeecCCCCcCCCC
Q 001908 583 GVFSNKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 583 ~~~~~~~~~~~~~N~~~C~~~ 603 (997)
+.+++++.+++.+||++||.+
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTT
T ss_pred ccccccChHHhcCCCCccCCC
Confidence 889999999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.13 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=199.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 368999999999999999999999899999999986432 223467899999999999999999999954 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++|+|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 8999999999999999998754 478999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|++..... .......|++.|+|||.+. +..++.++||||||+++|||++|+.||....
T Consensus 159 g~~~~~~~----------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 159 GWSVHAPS----------LRRRTMCGTLDYLPPEMIE------------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp TTCEECSS----------SCBCCCCSCGGGCCHHHHT------------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCcc----------cccccccCCCCcCCHHHhc------------cCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 99865421 1123357899999997654 4668899999999999999999999987431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+....... .+... +...+..+.+++.+||+.||++||++.|+++
T Consensus 217 -----~~~~~~~~~~------~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 217 -----HTETHRRIVN------VDLKF------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -----HHHHHHHHHT------TCCCC------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HhHHHHHHhc------cccCC------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111111100 01110 0112356789999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.86 Aligned_cols=266 Identities=19% Similarity=0.229 Sum_probs=203.5
Q ss_pred CCccChHHHHHHhhcCccC-CcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCCcceE
Q 001908 666 FPMVSYSELSEATNEFSSS-NMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNT-RHRNLIKI 741 (997)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l 741 (997)
.+...+...+...+.|.+. +.||+|+||+||+|+...+++.||+|+++... ......+.+|+.+++++ +||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3444555566777888887 89999999999999999999999999997432 23457889999999999 57999999
Q ss_pred EeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCe
Q 001908 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNV 821 (997)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NI 821 (997)
++++ ...+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 95 ~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NI 162 (327)
T 3lm5_A 95 HEVY-----ENTSEIILILEYAAGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNI 162 (327)
T ss_dssp EEEE-----ECSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred EEEE-----EeCCeEEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHE
Confidence 9995 445689999999999999999865432 2488999999999999999999999 999999999999
Q ss_pred eeCC---CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 822 LLDH---DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 822 ll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+++. ++.+||+|||+++..... .......||+.|+|||++. +..++.++||||+||
T Consensus 163 l~~~~~~~~~~kL~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~ 221 (327)
T 3lm5_A 163 LLSSIYPLGDIKIVDFGMSRKIGHA---------CELREIMGTPEYLAPEILN------------YDPITTATDMWNIGI 221 (327)
T ss_dssp EESCBTTBCCEEECCGGGCEEC------------------CCCGGGCCHHHHT------------TCCCCTHHHHHHHHH
T ss_pred EEecCCCCCcEEEeeCccccccCCc---------cccccccCCcCccCCeeec------------CCCCCchhhHHHHHH
Confidence 9998 789999999999865221 1123357999999997654 567889999999999
Q ss_pred HHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 899 MLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 899 vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
++|||++|+.||.... ..+...... .. .... .......++..+.+++.+||..||++|||+
T Consensus 222 il~~ll~g~~pf~~~~-----~~~~~~~i~-----~~-~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 282 (327)
T 3lm5_A 222 IAYMLLTHTSPFVGED-----NQETYLNIS-----QV-NVDY--------SEETFSSVSQLATDFIQSLLVKNPEKRPTA 282 (327)
T ss_dssp HHHHHHHSSCSSCCSS-----HHHHHHHHH-----HT-CCCC--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHHhCCCCCCCCC-----chHHHHHHH-----hc-cccc--------CchhhcccCHHHHHHHHHHcCCChhhCcCH
Confidence 9999999999997431 111111100 00 0000 000011234567899999999999999999
Q ss_pred HHHHH
Q 001908 979 RDVLA 983 (997)
Q Consensus 979 ~evl~ 983 (997)
.|+++
T Consensus 283 ~~ll~ 287 (327)
T 3lm5_A 283 EICLS 287 (327)
T ss_dssp HHHTT
T ss_pred HHHhC
Confidence 99975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=346.24 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=193.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcC--CCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTR--HRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~ 754 (997)
+.|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++ ||||+++++++. ..+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 46999999999999999999987 4899999998643 3445678899999999996 599999999854 345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||| +.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+||
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred EEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence 7999999 55889999998764 478889999999999999999999 999999999999995 689999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+...... .........||+.|+|||++........ .......++.++|||||||++|||++|+.||....
T Consensus 199 G~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 199 GIANQMQPDT------TSVVKDSQVGAVNYMPPEAIKDMSSSRE-NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp SSSCCC---------------CCSCCCGGGCCHHHHHCC-------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CccccccCCC------ccccCCCCCcCCCccChHHhhhcccccc-ccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 9998652211 1112234579999999998864211000 00112468899999999999999999999997432
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
.. .... ....++.....+.. ....++.+++.+||..||++|||+.|+++.
T Consensus 272 ~~---~~~~---------~~~~~~~~~~~~~~--------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 272 NQ---ISKL---------HAIIDPNHEIEFPD--------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CH---HHHH---------HHHHCTTSCCCCCC--------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH---HHHH---------HHHhCccccCCCCc--------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 1111 11111111111110 113467899999999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=348.10 Aligned_cols=272 Identities=22% Similarity=0.267 Sum_probs=205.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++|++.+..+.++. ...+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 46899999999999999999999889999999998643322 35788999999998755444444432 2356789
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee---CCCCcEEEccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDF 834 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DF 834 (997)
+||||+ +++|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 80 lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence 999999 9999999986432 489999999999999999999999 99999999999999 68899999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.......... ..........||+.|+|||.+. +..++.++|||||||++|||++|+.||....
T Consensus 151 Gla~~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~------------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 151 GLAKKYRDTSTHQH-IPYRENKNLTGTARYASVNTHL------------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp TTCEECBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CcceeccCCccccc-cccccccccCCCccccCHHHhc------------CCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 99987643221110 1112233567999999996554 5678999999999999999999999998543
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
... ..+.............+ ......++.++.+++..||..+|++||++.++++.|+++....
T Consensus 218 ~~~--~~~~~~~i~~~~~~~~~-------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 218 AGT--KKQKYEKISEKKVATSI-------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp CSS--HHHHHHHHHHHHHHSCH-------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred chh--HHHHHHHHhhccccccH-------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 221 11111111111110000 0111234567899999999999999999999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=332.12 Aligned_cols=278 Identities=18% Similarity=0.266 Sum_probs=197.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC--------
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-------- 749 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 749 (997)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357899999999999999999999899999999998766667788999999999999999999999874321
Q ss_pred -cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC-CCC
Q 001908 750 -FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDM 827 (997)
Q Consensus 750 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~ 827 (997)
.......++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 234567899999997 6999999753 378899999999999999999999 999999999999997 567
Q ss_pred cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCC
Q 001908 828 VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907 (997)
Q Consensus 828 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~ 907 (997)
.+||+|||.++...... ..........+|..|+|||.+.. ...++.++|||||||++|||++|+
T Consensus 159 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHY-----SHKGHLSEGLVTKWYRSPRLLLS-----------PNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp EEEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHC-----------TTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eEEEccCccccccCCCc-----ccccccccccccccccCcHHhcC-----------cccCCchhhhHhHHHHHHHHHhCC
Confidence 99999999998652211 11112234567999999986642 256889999999999999999999
Q ss_pred CCCCcCcCCCccHHHHHHhhc--ch----hhhhhcCcccccccc--cchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 001908 908 RPTNCMFQGGLTLHEFCKMAL--PE----KVMETVDPSLLLAWS--DGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979 (997)
Q Consensus 908 ~P~~~~~~~~~~~~~~~~~~~--~~----~~~~~~d~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 979 (997)
.||...... ........... .. ............... ..........++.++.+++.+||+.||++|||++
T Consensus 223 ~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (320)
T 2i6l_A 223 TLFAGAHEL-EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301 (320)
T ss_dssp CSSCCSSHH-HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CCCCCCCHH-HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH
Confidence 999743211 01111111100 00 000000000000000 0000011123456788999999999999999999
Q ss_pred HHHH
Q 001908 980 DVLA 983 (997)
Q Consensus 980 evl~ 983 (997)
|+++
T Consensus 302 ell~ 305 (320)
T 2i6l_A 302 EALS 305 (320)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=330.85 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=196.8
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
+|.....||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEE
Confidence 44555699999999999999998999999999986666666789999999999999999999999643 4589999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCcEEEcccccch
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLAR 838 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFg~a~ 838 (997)
|||+++++|.+++..... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||.++
T Consensus 98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 999999999999987532 12467889999999999999999999 9999999999999987 8999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... ........||+.|+|||++... ...++.++|||||||++|||++|+.||......
T Consensus 172 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 231 (295)
T 2clq_A 172 RLAGI--------NPCTETFTGTLQYMAPEIIDKG----------PRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-- 231 (295)
T ss_dssp ESCC-------------CCCCCCGGGCCHHHHHHG----------GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--
T ss_pred ccCCC--------CCcccccCCCccccChhhhcCC----------CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--
Confidence 65221 1112345689999999887531 123788999999999999999999998743211
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
....... ......+.. +..++.++.+++.+||+.||++||++.|+++
T Consensus 232 -~~~~~~~-----~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 232 -QAAMFKV-----GMFKVHPEI------------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -HHHHHHH-----HHHCCCCCC------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -hHHHHhh-----ccccccccc------------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111000 000111111 1123456789999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=336.61 Aligned_cols=272 Identities=19% Similarity=0.279 Sum_probs=182.7
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKD 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecC
Confidence 34578999999999999999999998899999999986432 334567889999999999999999999964 345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCC--CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNG--QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
..++||||+++++|.+++..... ......+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 79999999999999999975210 11122488999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.+........ ...........||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 164 dfg~~~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 164 DFGVSAFLATGGD---ITRNKVRKTFVGTPCWMAPEVMEQ-----------VRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp CCHHHHHCC------------------CCCTTCCHHHHHH-----------HHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eccchheeccCCC---ccchhhhcccCCCccccCHHHhcc-----------ccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999987632111 011112234578999999987753 13478899999999999999999999975
Q ss_pred CcCCCccHHHHHHhhcchhhh-hhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVM-ETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... .........+.... ...++.. ...++.++.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 230 YPPMK--VLMLTLQNDPPSLETGVQDKEM------------LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCGGG--HHHHHHTSSCCCTTC-----CC------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cchhh--HHHHHhccCCCccccccccchh------------hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 42211 11100000000000 0001111 0122456789999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.99 Aligned_cols=249 Identities=19% Similarity=0.289 Sum_probs=201.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|.+.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++++++|+||+++++++. ..+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 36799999999999999999999999999999998643 3345678899999999999999999999954 456
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 8999999999999999988754 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++..... ........||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 186 g~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 186 GLATKVEYD--------GERKKVLCGTPNYIAPEVLS------------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TTCEECCST--------TCCBCCCCSCCSSCCHHHHH------------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCceecccC--------cccccccCCCccccCHHHhc------------cCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 999865221 11223457899999997764 4567889999999999999999999987421
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+........ .... +..+...+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~~~~~~~~~------~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 246 -----LKETYLRIKKN------EYSI------------PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----HHHHHHHHHHT------CCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----HHHHHHHHhcC------CCCC------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111000 0000 0112346778999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=337.79 Aligned_cols=269 Identities=20% Similarity=0.227 Sum_probs=193.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 754 (997)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+++++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 35799999999999999999999989999999999642 3445577889999999999999999999975432 22334
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||++ |+|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCC-CCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 7899999996 588888863 278889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ........||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 172 g~a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 172 GLARTAGT---------SFMMTPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp CC-------------------------CTTCCHHHHT------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccccccc---------ccccCCceecCCccCHHHhc------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99976521 11223457899999997664 4668899999999999999999999997432
Q ss_pred CCCccHHHHHHhh--cc---hhhhhhcCccc----------cc-----ccc---cchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 915 QGGLTLHEFCKMA--LP---EKVMETVDPSL----------LL-----AWS---DGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 915 ~~~~~~~~~~~~~--~~---~~~~~~~d~~~----------~~-----~~~---~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
....+.... .. ........+.. .. .+. .............++.+++.+||..|
T Consensus 231 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 306 (371)
T 2xrw_A 231 ----HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306 (371)
T ss_dssp ----HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred ----HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCC
Confidence 111111110 00 00000000000 00 000 00001122344677899999999999
Q ss_pred CCCCCCHHHHHH
Q 001908 972 PIERMEMRDVLA 983 (997)
Q Consensus 972 P~~Rps~~evl~ 983 (997)
|++|||++|+++
T Consensus 307 P~~R~t~~e~l~ 318 (371)
T 2xrw_A 307 ASKRISVDEALQ 318 (371)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHhC
Confidence 999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.86 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=191.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++. ..+.
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 85 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPTD 85 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCCe
Confidence 57999999999999999999999899999999996432 234567899999999999999999999954 4568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++++|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecc
Confidence 999999999999999998754 478899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCC-CCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
.+...... .......||+.|+|||.+. +.. .+.++||||+|+++|||++|+.||...
T Consensus 157 ~~~~~~~~---------~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~- 214 (276)
T 2h6d_A 157 LSNMMSDG---------EFLRTSCGSPNYAAPEVIS------------GRLYAGPEVDIWSCGVILYALLCGTLPFDDE- 214 (276)
T ss_dssp GGGCCCC----------------------CCTGGGT------------TSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred cccccCCC---------cceecccCCccccCHHHHc------------CCCCCCccchHHHHHHHHHHHHhCCCCCCCC-
Confidence 99765221 1123356899999997664 233 367999999999999999999998642
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
...+...... ... ... +..++..+.+++.+||+.||++|||+.|+++.
T Consensus 215 ----~~~~~~~~~~-----~~~-~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 215 ----HVPTLFKKIR-----GGV-FYI------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----SHHHHHHHHH-----HCC-CCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cHHHHHHHhh-----cCc-ccC------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111110 000 000 01123567899999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=339.35 Aligned_cols=282 Identities=21% Similarity=0.226 Sum_probs=201.8
Q ss_pred ChHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-----------hhhHHHHHHHHHHHhhcCCCCc
Q 001908 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-----------KGALKSFVAECEVLRNTRHRNL 738 (997)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ni 738 (997)
...++....++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34567788899999999999999999999987 59999999985321 1223788999999999999999
Q ss_pred ceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 739 v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
+++++++...+.......++||||++ |+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 162 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP 162 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence 99999986544344567899999996 69999888653 2488999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+||+++.++.+||+|||+|+.... ........||+.|+|||++.. ...++.++||||+||
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~---------~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~ 222 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTA---------DANKTHYVTHRWYRAPELVMQ-----------FKGFTKLVDMWSAGC 222 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------------CGGGCCHHHHTT-----------CTTCCTHHHHHHHHH
T ss_pred HHEEEcCCCCEEEEecCccccccc---------ccccceecccceecCcHHhcC-----------CCCCCcHhHHHhHHH
Confidence 999999999999999999975421 122234578999999976642 256889999999999
Q ss_pred HHHHHHhCCCCCCcCcCCCccHHHHHHhhc-c----------hhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhc
Q 001908 899 MLLEMFTRRRPTNCMFQGGLTLHEFCKMAL-P----------EKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVAC 967 (997)
Q Consensus 899 vl~elltg~~P~~~~~~~~~~~~~~~~~~~-~----------~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 967 (997)
++|||++|+.||...... ........... + ............ ...............+.+.+++.+|
T Consensus 223 il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~ 300 (362)
T 3pg1_A 223 VMAEMFNRKALFRGSTFY-NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS-NVPARAWTAVVPTADPVALDLIAKM 300 (362)
T ss_dssp HHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCC-CCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcc-cCChhhHHhhCCCCCHHHHHHHHHH
Confidence 999999999999743211 01111111100 0 000011111100 0001111111223356788999999
Q ss_pred CCCCCCCCCCHHHHHH
Q 001908 968 SMESPIERMEMRDVLA 983 (997)
Q Consensus 968 l~~dP~~Rps~~evl~ 983 (997)
|+.||++|||+.|+++
T Consensus 301 L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 301 LEFNPQRRISTEQALR 316 (362)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred hcCChhhCCCHHHHHc
Confidence 9999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=355.45 Aligned_cols=270 Identities=15% Similarity=0.165 Sum_probs=191.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc---cchhhHHHHHHHHH---HHhhcCCCCcceEEe-------e
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECE---VLRNTRHRNLIKIIT-------V 744 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~E~~---~l~~l~h~niv~l~~-------~ 744 (997)
.++|++.+.||+|+||+||+|++..+++.||||++.. ......+.+.+|++ ++++++||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4678899999999999999999988999999999973 33445678899995 455568999999984 3
Q ss_pred eeccC-------cCCCc-----eEEEEEeeccCCCHHHHhhcCCCCCC-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 001908 745 CSSID-------FKGAD-----FKALVYEYMQNGSLEEWLHQSNGQPE-VCDLSLIQRLNIAIDMASAIEYLHHHCQPPI 811 (997)
Q Consensus 745 ~~~~~-------~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~i 811 (997)
+.... +.+.+ ..++||||+ +|+|.+++.......+ ...+++..++.++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 32210 00111 378999999 6899999987532111 11244678889999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 812 vHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++........ .......++.++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----------~~~~~~~g-~~y~aPE~~~~~~~~~~-~~~~~~~~~~~~ 294 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----------ARVVSSVS-RGFEPPELEARRATISY-HRDRRTLMTFSF 294 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----------CEEECCCC-TTCCCHHHHHHHTSTHH-HHCCEEECCHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----------CcccCCCC-cCccChhhhcccccccc-cccccccCChhh
Confidence 999999999999999999999999997531 12234567 99999988764200000 000012688999
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
|||||||++|||++|+.||....... ........ . ..++.++.+++.+||..|
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~~----------~~~~~~~~--------~---------~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAALG----------GSEWIFRS--------C---------KNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC------C----------CSGGGGSS--------C---------CCCCHHHHHHHHHHTCSS
T ss_pred hHHHHHHHHHHHHHCCCCCccccccc----------chhhhhhh--------c---------cCCCHHHHHHHHHHcCCC
Confidence 99999999999999999986432110 00000000 0 122456789999999999
Q ss_pred CCCCCCHHHHHH--HHHHHHHH
Q 001908 972 PIERMEMRDVLA--KLCAARQT 991 (997)
Q Consensus 972 P~~Rps~~evl~--~L~~~~~~ 991 (997)
|++|||+.|+++ .+.++.+.
T Consensus 348 p~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHHHHH
T ss_pred chhCCCHHHHhhChHHHHHHHH
Confidence 999999999986 45555443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=344.82 Aligned_cols=278 Identities=19% Similarity=0.241 Sum_probs=196.5
Q ss_pred HHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc----
Q 001908 675 SEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF---- 750 (997)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 750 (997)
+...++|++.+.||+|+||+||+|++..+++.||||++..... ...+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999999999999999999864322 22469999999999999999999754321
Q ss_pred -----------------------------CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHH
Q 001908 751 -----------------------------KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801 (997)
Q Consensus 751 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~ 801 (997)
....+.++||||++ |+|.+.+...... ...+++..++.++.||++||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHH
Confidence 23456889999997 5888777642110 124889999999999999999
Q ss_pred HHhhCCCCCcEecCCCCCCeeeC-CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccc
Q 001908 802 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLE 880 (997)
Q Consensus 802 yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e 880 (997)
|||++ +|+||||||+||+++ .++.+||+|||+|+..... .......||+.|+|||++..
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~-------- 215 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---------EPSVAYICSRFYRAPELMLG-------- 215 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---------SCCCCCCCCSSCCCHHHHTT--------
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---------CCCcCcccCCCccCHHHhcC--------
Confidence 99999 999999999999997 6899999999999865221 12234578999999976642
Q ss_pred cCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhh-cc-hhhhhhcCcccccc----c-ccchhhhhH
Q 001908 881 YGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMA-LP-EKVMETVDPSLLLA----W-SDGRRRAKV 953 (997)
Q Consensus 881 ~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~-~~~~~~~d~~~~~~----~-~~~~~~~~~ 953 (997)
...++.++||||+||++|||++|+.||...... ..+....... .+ .......++..... . ........+
T Consensus 216 ---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 216 ---ATEYTPSIDLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp ---CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred ---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 234889999999999999999999999743211 1111111111 00 01111111111000 0 000011112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 954 EECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 954 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..++.++.+++.+||..||++|||+.|+++
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 234567889999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=339.62 Aligned_cols=260 Identities=15% Similarity=0.105 Sum_probs=199.7
Q ss_pred HHhhcCccCCcccccCcceEEEEE-----ECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC---CCCcceEEeeeec
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGI-----LGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR---HRNLIKIITVCSS 747 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 747 (997)
...++|.+.+.||+|+||+||+|. ...+++.||||+++... ...+.+|++++++++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~- 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL- 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee-
Confidence 345789999999999999999994 56688999999997543 346677888887776 999999999964
Q ss_pred cCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC--
Q 001908 748 IDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-- 825 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-- 825 (997)
..+..++||||+++|+|.+++....... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 138 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 138 ----FQNGSVLVGELYSYGTLLNAINLYKNTP-EKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp ----CSSCEEEEECCCCSCBHHHHHHHHHTST-TCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred ----cCCCcEEEEeccCCCcHHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence 3457899999999999999998643211 12489999999999999999999999 9999999999999998
Q ss_pred ---------CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHH
Q 001908 826 ---------DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896 (997)
Q Consensus 826 ---------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSl 896 (997)
++.+||+|||+|+..... ..........||+.|+|||++. +..++.++|||||
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~Diwsl 271 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLF------PKGTIFTAKCETSGFQCVEMLS------------NKPWNYQIDYFGV 271 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGS------CTTEEECCSSCTTSCCCHHHHT------------TCCBSTHHHHHHH
T ss_pred cCccccccccCCEEEeeCchhhhhhcc------CCCceeeeecCCCCCCChHHhc------------CCCCCccccHHHH
Confidence 899999999999754211 1122334567999999996654 5678999999999
Q ss_pred HHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCC-
Q 001908 897 GVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER- 975 (997)
Q Consensus 897 Gvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R- 975 (997)
||++|||+||+.||.....+.. ..+...... + ....+.+++..|++.+|.+|
T Consensus 272 G~il~elltg~~pf~~~~~~~~----------------~~~~~~~~~-------~----~~~~~~~~~~~~l~~~p~~r~ 324 (365)
T 3e7e_A 272 AATVYCMLFGTYMKVKNEGGEC----------------KPEGLFRRL-------P----HLDMWNEFFHVMLNIPDCHHL 324 (365)
T ss_dssp HHHHHHHHHSSCCCEEEETTEE----------------EECSCCTTC-------S----SHHHHHHHHHHHHCCCCTTCC
T ss_pred HHHHHHHHhCCCccccCCCCce----------------eechhcccc-------C----cHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999864322110 000000000 1 13345678889999999998
Q ss_pred CCHHHHHHHHHHHHHHh
Q 001908 976 MEMRDVLAKLCAARQTL 992 (997)
Q Consensus 976 ps~~evl~~L~~~~~~~ 992 (997)
|+++++.+.|++..+..
T Consensus 325 ~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 325 PSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHh
Confidence 57888888888876653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=364.37 Aligned_cols=245 Identities=23% Similarity=0.301 Sum_probs=198.6
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCC
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (997)
..++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+.+..|.+++..+ +|++|++++++ +.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence 346899999999999999999999999999999999742 234456788899999987 79999999998 566
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 778999999999999999998764 488999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+..... .......+||+.|+|||++. +..|+.++|||||||++|||++|+.||..
T Consensus 485 DFGla~~~~~~--------~~~~~~~~GT~~Y~APE~l~------------~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 485 DFGMCKENIWD--------GVTTKTFCGTPDYIAPEIIA------------YQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp CCTTCEECCCT--------TCCBCCCCSCSSSCCHHHHT------------CCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecceeeccccC--------CcccccccCCCcccCHhhhc------------CCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 99999853211 12234568999999997654 56789999999999999999999999974
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
. ...+......... ..+ +.....++.+++.+||..||++||++
T Consensus 545 ~-----~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 545 E-----DEDELFQSIMEHN------VAY------------PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp S-----SHHHHHHHHHSSC------CCC------------CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred C-----CHHHHHHHHHhCC------CCC------------CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 3 1222222111110 000 01224567899999999999999997
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.30 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=194.0
Q ss_pred hhcCccCCcccccCcceEEEEEECC-CCc--EEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGE-NGT--FVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~--~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
.++|++.+.||+|+||+||+|++.. +++ .||||+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 3679999999999999999998642 333 6899998643 33456788999999999999999999998643
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
+..++||||+++++|.+++.... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred --CCceeeEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence 23789999999999999998753 1378999999999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPT 910 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 910 (997)
+|||+++...... ..........+|..|+|||.+. +..++.++|||||||++|||++ |+.||
T Consensus 163 ~Dfg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~~g~~p~ 225 (291)
T 1u46_A 163 GDFGLMRALPQND-----DHYVMQEHRKVPFAWCAPESLK------------TRTFSHASDTWMFGVTLWEMFTYGQEPW 225 (291)
T ss_dssp CCCTTCEECCC-C-----CEEEC-----CCGGGCCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccccccccccc-----cchhhhccCCCCceeeCchhhc------------CCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999998653211 1111223356788999998765 3557889999999999999999 99998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
.... ..+......... ... +.+..++.++.+++.+||..||++|||+.++++.|+++.+
T Consensus 226 ~~~~-----~~~~~~~~~~~~----~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 226 IGLN-----GSQILHKIDKEG----ERL------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TTCC-----HHHHHHHHHTSC----CCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ccCC-----HHHHHHHHHccC----CCC------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 7431 122111110000 000 0111235678899999999999999999999999998765
Q ss_pred H
Q 001908 991 T 991 (997)
Q Consensus 991 ~ 991 (997)
.
T Consensus 285 ~ 285 (291)
T 1u46_A 285 T 285 (291)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.48 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=198.5
Q ss_pred hhcCccCCcccccCcceEEEEEEC---CCCcEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG---ENGTFVAVKILNLMQ----KGALKSFVAECEVLRNT-RHRNLIKIITVCSSID 749 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 749 (997)
.++|++.+.||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 367999999999999999999984 588999999986422 23345677899999999 6999999999854
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
.....++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred --eCceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence 3558999999999999999998754 478999999999999999999999 99999999999999999999
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+|+.... ..........||+.|+|||++... ...++.++|||||||++|||++|+.|
T Consensus 199 kl~DfG~a~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 199 VLTDFGLSKEFVA-------DETERAYDFCGTIEYMAPDIVRGG----------DSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp EESCSSEEEECCG-------GGGGGGCGGGSCCTTCCHHHHTTC----------C---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEeeCCCCeeccc-------CCCCcccCcccCcCccChhhhcCC----------CCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999976521 111223346799999999876521 13468899999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLAK 984 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 984 (997)
|....... ...+....... ..+.. +.++...+.+++.+||..||++|| +++|+++.
T Consensus 262 f~~~~~~~-~~~~~~~~~~~------~~~~~------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 262 FTVDGEKN-SQAEISRRILK------SEPPY------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp TSCTTSCC-CHHHHHHHHHH------CCCCC------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CccCCccc-hHHHHHHHHhc------cCCCC------------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 97443221 22222111110 00110 112245677999999999999999 99998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.61 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=194.9
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 4568999999999999999999999899999999997533 34678899999999999999999999643 4578
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++||||+++++|.+++.... ..+++..++.++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 99999999999999997433 1488999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+...... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||.....
T Consensus 172 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 230 (314)
T 3com_A 172 AGQLTDT--------MAKRNTVIGTPFWMAPEVIQ------------EIGYNCVADIWSLGITAIEMAEGKPPYADIHP- 230 (314)
T ss_dssp CEECBTT--------BSCBCCCCSCGGGCCHHHHS------------SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred chhhhhh--------ccccCccCCCCCccChhhcC------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 9765221 11223456899999997654 45688999999999999999999999874311
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ... .....+.. ..+..++..+.+++.+||..||++|||+.|+++
T Consensus 231 ---~~~~-~~~-----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 231 ---MRAI-FMI-----PTNPPPTF----------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---HHHH-HHH-----HHSCCCCC----------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HHHH-HHH-----hcCCCccc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111 100 00001110 001123456789999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=340.61 Aligned_cols=272 Identities=21% Similarity=0.256 Sum_probs=184.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 754 (997)
.++|++.+.||+|+||.||+|.+..+|+.||||++.. ......+.+.+|++++++++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3689999999999999999999999999999999864 23345578889999999999999999999975421 12235
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++|+||+ +++|.+++... .+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 689999999 78999988763 388999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ......||+.|+|||++.. ...++.++||||+||++|||++|+.||....
T Consensus 177 G~a~~~~~-----------~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 177 GLARHTAD-----------EMTGYVATRWYRAPEIMLN-----------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp -------------------------CCCTTCCHHHHTT-----------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccc-----------cCCCcCcCcCccChHHHcC-----------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99976421 1234578999999987642 2568899999999999999999999997432
Q ss_pred CCCccHHHHHHhh-cc-hhhhhhcCcccc----ccc---ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA-LP-EKVMETVDPSLL----LAW---SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~-~~-~~~~~~~d~~~~----~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+....... .+ ......+..... ... .............+.+.+++.+||..||++|||+.|+++
T Consensus 235 ~~-~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 235 HI-DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HH-HHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11 0111111110 00 011110100000 000 000000001123456789999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.87 Aligned_cols=262 Identities=10% Similarity=0.007 Sum_probs=180.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhc--CCCCcceEEe-------ee
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNT--RHRNLIKIIT-------VC 745 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~~-------~~ 745 (997)
..+|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+++++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346889999999999999999999899999999997533 33456778886655555 6999888553 22
Q ss_pred eccCc------------CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHH------HHHHHHHHHHHHHHhhCC
Q 001908 746 SSIDF------------KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQR------LNIAIDMASAIEYLHHHC 807 (997)
Q Consensus 746 ~~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~------~~i~~~i~~~L~yLH~~~ 807 (997)
..... ......++||||++ |+|.+++..... .+.+..+ ..++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 11100 00145899999998 899999987531 1233445 67889999999999999
Q ss_pred CCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC
Q 001908 808 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA 887 (997)
Q Consensus 808 ~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~ 887 (997)
+|+||||||+|||++.++.+||+|||+|+... .......+|+.|+|||++.. ....+
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----------~~~~~~~~t~~y~aPE~~~~----------~~~~~ 270 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----------TRGPASSVPVTYAPREFLNA----------STATF 270 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETT-----------CEEEGGGSCGGGCCHHHHTC----------SEEEC
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecC-----------CCccCccCCcCCcChhhccC----------CCCCc
Confidence 99999999999999999999999999998541 11113457799999977642 01468
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhc
Q 001908 888 SVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVAC 967 (997)
Q Consensus 888 ~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 967 (997)
+.++|||||||++|||+||+.||......... .+ ............ ...+....++..+.+++.+|
T Consensus 271 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIKG--SW----KRPSLRVPGTDS--------LAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT--CC----CBCCTTSCCCCS--------CCCTTSSCCCHHHHHHHHHH
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCcCccccc--ch----hhhhhhhccccc--------cchhhccCCCHHHHHHHHHH
Confidence 89999999999999999999999854221100 00 000000000000 00011113356788999999
Q ss_pred CCCCCCCCCCHHHHHH
Q 001908 968 SMESPIERMEMRDVLA 983 (997)
Q Consensus 968 l~~dP~~Rps~~evl~ 983 (997)
|+.||++|||+.|+++
T Consensus 337 L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 337 LNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCSSTTTCCCHHHHTT
T ss_pred cCCChhhCCCHHHHhc
Confidence 9999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=346.21 Aligned_cols=199 Identities=25% Similarity=0.331 Sum_probs=168.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc------CCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT------RHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 751 (997)
..+|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 35799999999999999999999989999999999753 23346677888888877 57799999998543
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc--E
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--A 829 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~ 829 (997)
....++||||++ ++|.+++...... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 468999999995 6999999876522 488999999999999999999999 9999999999999999987 9
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+|+.... ......||+.|+|||++. +..++.++|||||||++|||+||++|
T Consensus 242 kL~DFG~a~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlG~il~elltG~~p 298 (429)
T 3kvw_A 242 KVIDFGSSCYEHQ-----------RVYTYIQSRFYRAPEVIL------------GARYGMPIDMWSLGCILAELLTGYPL 298 (429)
T ss_dssp EECCCTTCEETTC-----------CCCSSCSCGGGCCHHHHH------------TBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEeecccceecCC-----------cccccCCCCCccChHHHh------------CCCCCchHHHHhHHHHHHHHHhCCCC
Confidence 9999999975411 122357899999997664 45689999999999999999999999
Q ss_pred CCcC
Q 001908 910 TNCM 913 (997)
Q Consensus 910 ~~~~ 913 (997)
|...
T Consensus 299 f~~~ 302 (429)
T 3kvw_A 299 LPGE 302 (429)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 9743
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=343.95 Aligned_cols=210 Identities=21% Similarity=0.321 Sum_probs=155.8
Q ss_pred hcCcc-CCcccccCcceEEEEEEC--CCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSS-SNMIGQGSFGSVYKGILG--ENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+.|.+ .++||+|+||+||+|+++ .+++.||||++.... ....+.+|++++++++||||+++++++.. .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence 45665 558999999999999976 468899999997432 23567899999999999999999999753 34568
Q ss_pred EEEEEeeccCCCHHHHhhcCCC---CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee----CCCCc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNG---QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMV 828 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~ 828 (997)
.++||||++ |+|.+++..... ......+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 999999995 588888764321 11122488999999999999999999999 99999999999999 77899
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+...... ..........||+.|+|||++.. ...++.++||||+||++|||++|+.
T Consensus 171 ~kl~Dfg~a~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~ell~g~~ 234 (405)
T 3rgf_A 171 VKIADMGFARLFNSPL-----KPLADLDPVVVTFWYRAPELLLG-----------ARHYTKAIDIWAIGCIFAELLTSEP 234 (405)
T ss_dssp EEECCTTCCC---------------------CCCTTCCHHHHTT-----------CCSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEEECCCceecCCCC-----cccccCCCceecCcccCchhhcC-----------CCcccchhhhHHHHHHHHHHHhCCC
Confidence 9999999998652211 11122334679999999977642 2458899999999999999999999
Q ss_pred CCCcC
Q 001908 909 PTNCM 913 (997)
Q Consensus 909 P~~~~ 913 (997)
||...
T Consensus 235 pf~~~ 239 (405)
T 3rgf_A 235 IFHCR 239 (405)
T ss_dssp TTCCC
T ss_pred CCCCc
Confidence 99754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.85 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=199.5
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
...++|++.+.||+|+||+||+|+...+++.||+|++... .....+.+.+|++++++++||||+++++++. ..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CC
Confidence 3457899999999999999999999989999999998643 2334578899999999999999999999954 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC---CcEE
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAH 830 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~k 830 (997)
...++||||+++++|.+++.... .+++..++.++.|++.|++|||++ +|+||||||+||+++.+ +.+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence 68999999999999999987654 478999999999999999999999 99999999999999764 4799
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+++..... .......||+.|+|||.+. +.++.++||||||+++|+|++|+.||
T Consensus 165 L~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~-------------~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (287)
T 2wei_A 165 IIDFGLSTCFQQN---------TKMKDRIGTAYYIAPEVLR-------------GTYDEKCDVWSAGVILYILLSGTPPF 222 (287)
T ss_dssp ECSTTGGGTBCCC---------SSCSCHHHHHTTCCHHHHT-------------TCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccCcceeecCC---------CccccccCcccccChHHhc-------------CCCCCchhhHhHHHHHHHHHhCCCCC
Confidence 9999999865221 1122345899999998764 34788999999999999999999998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ..+......... .... .+....++.++.+++.+||..||++|||+.|+++
T Consensus 223 ~~~~-----~~~~~~~~~~~~----~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 223 YGKN-----EYDILKRVETGK----YAFD----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSS-----HHHHHHHHHHCC----CCCC----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-----HHHHHHHHHcCC----CCCC----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 7431 111111110000 0000 0001123456789999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=342.07 Aligned_cols=273 Identities=22% Similarity=0.283 Sum_probs=191.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~ 757 (997)
.+|++.+.||+|+||+||+|++..+++ ||+|++..... ...+|+++++.++||||+++++++..... .+....+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 478999999999999999999985554 88887753322 12369999999999999999999755332 3344588
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC-CCCcEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFg~ 836 (997)
+||||++++ +.+.+...... ...+++..++.++.||++||+|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKL--KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccCcc-HHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 999999764 44443321100 11488999999999999999999999 999999999999999 899999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... .......||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 189 a~~~~~~---------~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 248 (394)
T 4e7w_A 189 AKILIAG---------EPNVSYICSRYYRAPELIFG-----------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI 248 (394)
T ss_dssp CEECCTT---------CCCCSSCSCGGGCCHHHHTT-----------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccccCC---------CCCcccccCcCccCHHHHcC-----------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9865221 12234578999999976642 235889999999999999999999999743211
Q ss_pred CccHHHHHHhh-cc-hhhhhhcCcccccc-cccchh----hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMA-LP-EKVMETVDPSLLLA-WSDGRR----RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~-~~-~~~~~~~d~~~~~~-~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.+..... .+ .......++..... +..... .......++++.+++.+||..||++|||+.|+++
T Consensus 249 -~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 249 -DQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1111111111 00 11111111111100 000000 0011124567889999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=339.50 Aligned_cols=274 Identities=19% Similarity=0.254 Sum_probs=201.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC--------CCCcceEEeeeeccC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR--------HRNLIKIITVCSSID 749 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~ 749 (997)
.++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36799999999999999999999989999999999743 334567889999999985 788999999865321
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC--
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-- 827 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-- 827 (997)
......++||||+ ++++.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred -CCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 2456899999999 6677777765432 24889999999999999999999964 799999999999999876
Q ss_pred -----------------------------------------------cEEEcccccchhcccCCCCCccccccccccccc
Q 001908 828 -----------------------------------------------VAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860 (997)
Q Consensus 828 -----------------------------------------------~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~g 860 (997)
.+||+|||.|+.... ......|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----------~~~~~~g 255 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----------HFTEDIQ 255 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----------CSCSCCS
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----------cCccCCC
Confidence 899999999976521 1223478
Q ss_pred cccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc--HHHH---HHhh--cchhhh
Q 001908 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT--LHEF---CKMA--LPEKVM 933 (997)
Q Consensus 861 t~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~--~~~~---~~~~--~~~~~~ 933 (997)
|+.|+|||++. +..++.++|||||||++|||+||+.||......... .... .... .+....
T Consensus 256 t~~y~aPE~~~------------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 323 (397)
T 1wak_A 256 TRQYRSLEVLI------------GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323 (397)
T ss_dssp CGGGCCHHHHH------------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred CCcccCChhhc------------CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence 99999997664 466899999999999999999999999854332211 1111 1100 011110
Q ss_pred h-------hcCccc-ccccccc----------hhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 934 E-------TVDPSL-LLAWSDG----------RRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 934 ~-------~~d~~~-~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ...... ....... .....+.+....+.+++.+||+.||++|||+.|+++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 000000 0000000 000113456678999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=328.14 Aligned_cols=266 Identities=21% Similarity=0.296 Sum_probs=193.4
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-------
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID------- 749 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 749 (997)
..++|++.+.||+|+||.||+|+...+++.||||++... ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356899999999999999999999989999999999643 344578899999999999999999999875421
Q ss_pred -cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 750 -FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 750 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
.......++||||+++|+|.+++.... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 123567899999999999999998653 1367889999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCC------ccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHH
Q 001908 829 AHVSDFGLARFLFARPFDT------SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~------~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~e 902 (997)
+||+|||.++......... ............||+.|+|||++.. .+.++.++||||+||++||
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~~ 223 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-----------TGHYNEKIDMYSLGIIFFE 223 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTS-----------CSCCCTHHHHHHHHHHHHH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-----------CCCCcchhhHHHHHHHHHH
Confidence 9999999997653211000 0001122334578999999987642 2357899999999999999
Q ss_pred HHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 903 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
|++ ||.... ...+..... .. ........ ....++..+.+++.+||+.||++|||+.|++
T Consensus 224 l~~---p~~~~~----~~~~~~~~~-----~~-~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 282 (303)
T 1zy4_A 224 MIY---PFSTGM----ERVNILKKL-----RS-VSIEFPPD--------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282 (303)
T ss_dssp HHS---CCSSHH----HHHHHHHHH-----HS-TTCCCCTT--------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHh---ccCCch----hHHHHHHhc-----cc-cccccCcc--------ccccchHHHHHHHHHHHhcCcccCcCHHHHh
Confidence 998 544211 111111110 00 00000000 0112345678999999999999999999997
Q ss_pred H
Q 001908 983 A 983 (997)
Q Consensus 983 ~ 983 (997)
+
T Consensus 283 ~ 283 (303)
T 1zy4_A 283 N 283 (303)
T ss_dssp H
T ss_pred C
Confidence 6
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=323.36 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=198.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ----KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 468999999999999999999999899999999997432 2345788999999999999999999998642 335
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
...++||||++++ +.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CeEEEEehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence 6789999999776 8888776542 2488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||.+....... .........||+.|+|||++... ...++.++||||+||++|||++|+.||...
T Consensus 153 fg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 153 LGVAEALHPFA------ADDTCRTSQGSPAFQPPEIANGL----------DTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp CTTCEECCTTC------SSCEECCCCSCGGGCCHHHHTCC----------SCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCccc------cccccccCCCCCCCcChhhccCc----------ccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 99998653211 11122345689999999876521 123477999999999999999999998742
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
...+........ .... +..++..+.+++.+||..||++|||+.|+++.
T Consensus 217 -----~~~~~~~~i~~~------~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 217 -----NIYKLFENIGKG------SYAI------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----SHHHHHHHHHHC------CCCC------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----hHHHHHHHHhcC------CCCC------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122221111000 0000 11234567899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=334.56 Aligned_cols=284 Identities=20% Similarity=0.235 Sum_probs=191.6
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF- 750 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 750 (997)
.......++|++.+.||+|+||+||+|+++.+++.||||++.... .......+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999999899999999986432 223456778888899999999999999865322
Q ss_pred -CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCcEecCCCCCCeeeCC-C
Q 001908 751 -KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH--HHCQPPIVHGDLKPSNVLLDH-D 826 (997)
Q Consensus 751 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH--~~~~~~ivHrDlk~~NIll~~-~ 826 (997)
......++||||+++ ++.+.+..... ....+++..+..++.|++.|+.||| +. +|+||||||+||+++. +
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 223347899999975 66555443111 1124788899999999999999999 77 9999999999999997 8
Q ss_pred CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC
Q 001908 827 MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR 906 (997)
Q Consensus 827 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg 906 (997)
+.+||+|||+|+..... .......||+.|+|||++.. ...++.++|||||||++|||++|
T Consensus 169 ~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~ell~g 228 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPS---------EPNVAYICSRYYRAPELIFG-----------NQHYTTAVDIWSVGCIFAEMMLG 228 (360)
T ss_dssp TEEEECCCTTCBCCCTT---------SCCCSTTSCGGGCCHHHHTT-----------CSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CcEEEeeCCCceecCCC---------CCcccccCCcceeCHHHHcC-----------CCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999865221 12234568999999976642 23478999999999999999999
Q ss_pred CCCCCcCcCCCccHHHHHHhh--cchhhhhhcCccccc-ccccchhhh-------hHHHHHHHHHHHHhhcCCCCCCCCC
Q 001908 907 RRPTNCMFQGGLTLHEFCKMA--LPEKVMETVDPSLLL-AWSDGRRRA-------KVEECLVTVIRIGVACSMESPIERM 976 (997)
Q Consensus 907 ~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~-~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rp 976 (997)
+.||...... ..+....... .+.......++.... ........+ ....+..++.+++.+||+.||++||
T Consensus 229 ~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 307 (360)
T 3e3p_A 229 EPIFRGDNSA-GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307 (360)
T ss_dssp SCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC
T ss_pred CCCcCCCChH-HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC
Confidence 9999743211 1112221111 111111111111100 000000000 0112356788999999999999999
Q ss_pred CHHHHHH
Q 001908 977 EMRDVLA 983 (997)
Q Consensus 977 s~~evl~ 983 (997)
|+.|+++
T Consensus 308 t~~e~l~ 314 (360)
T 3e3p_A 308 KPYEALC 314 (360)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=345.35 Aligned_cols=274 Identities=22% Similarity=0.297 Sum_probs=194.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~ 757 (997)
.+|+..+.||+|+||+||+|++..+++.||||++..... ...+|++++++++||||+++++++.... ..+..+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468899999999999999999998999999999864322 2346999999999999999999875432 12334577
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-CcEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFg~ 836 (997)
+||||+++ ++.+.+..... ....+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 99999965 77766653211 012488999999999999999999999 99999999999999965 6789999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... .......||+.|+|||++.. ...++.++|||||||++|||++|+.||......
T Consensus 204 a~~~~~~---------~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~ 263 (420)
T 1j1b_A 204 AKQLVRG---------EPNVSYICSRYYRAPELIFG-----------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263 (420)
T ss_dssp CEECCTT---------CCCCSCCSCTTSCCHHHHTT-----------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhcccC---------CCceeeeeCCCcCCHHHHcC-----------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9865221 12234578999999976642 236889999999999999999999999743211
Q ss_pred CccHHHHHHhhc-c-hhhhhhcCccccc-ccccch----hhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMAL-P-EKVMETVDPSLLL-AWSDGR----RRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~-~-~~~~~~~d~~~~~-~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.+...... + .......++.... .+.... ........+.++.+++.+||..||++|||+.|+++
T Consensus 264 -~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 264 -DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp -HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11122211110 0 0111111111100 000000 00001123467889999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=363.16 Aligned_cols=262 Identities=21% Similarity=0.321 Sum_probs=204.1
Q ss_pred HHhhcCccCCcccccCcceEEEEEECC---CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGE---NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 751 (997)
...++|++.+.||+|+||+||+|++.. .+..||+|+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 345789999999999999999999864 3467999998743 3444578899999999999999999999863
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEE
Confidence 235899999999999999998653 1478999999999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPT 910 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 910 (997)
+|||+|+...... ........+|+.|+|||++. +..++.++|||||||++|||++ |..||
T Consensus 533 ~DFG~a~~~~~~~-------~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 533 GDFGLSRYMEDST-------YYKASKGKLPIKWMAPESIN------------FRRFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp CCCCCCCSCCC-----------------CCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EecCCCeecCCCc-------ceeccCCCCCcceeCHHHhc------------CCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 9999998652211 11122345788999997764 4568899999999999999997 99998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
.... ..+..... .....+ +.+..++..+.+++.+||..||++|||+.|+++.|+++.+
T Consensus 594 ~~~~-----~~~~~~~i-----~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 594 QGVK-----NNDVIGRI-----ENGERL------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp TTCC-----HHHHHHHH-----HHTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-----HHHHHHHH-----HcCCCC------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 7431 11111111 000000 0112345678899999999999999999999999999876
Q ss_pred Hh
Q 001908 991 TL 992 (997)
Q Consensus 991 ~~ 992 (997)
+.
T Consensus 652 ~~ 653 (656)
T 2j0j_A 652 EE 653 (656)
T ss_dssp HH
T ss_pred Hh
Confidence 53
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.01 Aligned_cols=277 Identities=25% Similarity=0.366 Sum_probs=200.8
Q ss_pred HhhcCccCCcccccCcceEEEEEEC-CCCcEEEEEEecccc--hhhHHHHHHHHHHHhhc---CCCCcceEEeeeeccCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILG-ENGTFVAVKILNLMQ--KGALKSFVAECEVLRNT---RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~ 750 (997)
+.++|++.+.||+|+||.||+|++. .+++.||+|+++... ......+.+|+++++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 678999999986432 22234566788877766 89999999999764333
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
......++||||++ |+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 35668999999997 6999999876422 378999999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||.++.... ........||+.|+|||++. +..++.++|||||||++|||++|+.||
T Consensus 161 l~Dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf 219 (326)
T 1blx_A 161 LADFGLARIYSF---------QMALTSVVVTLWYRAPEVLL------------QSSYATPVDLWSVGCIFAEMFRRKPLF 219 (326)
T ss_dssp ECSCCSCCCCCG---------GGGGCCCCCCCTTCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EecCcccccccC---------CCCccccccccceeCHHHHh------------cCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 999999975421 11233457899999997654 466889999999999999999999999
Q ss_pred CcCcCCCccHHHHHHhh-cc--hhhhhhcC-cccccc-cccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMA-LP--EKVMETVD-PSLLLA-WSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~-~~--~~~~~~~d-~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...... ..+....... .+ ..+..... +..... ............++..+.+++.+||..||++|||+.|+++
T Consensus 220 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 220 RGSSDV-DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCSSHH-HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHH-HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 743211 1111111110 00 00000000 000000 0000000111234567789999999999999999999984
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=352.37 Aligned_cols=312 Identities=20% Similarity=0.164 Sum_probs=253.6
Q ss_pred CCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCee
Q 001908 217 MSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSL 296 (997)
Q Consensus 217 l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 296 (997)
+++++.|++++|.++ .+|..++..+++|++|+|++|.+++..|..|+++++|++|+|++|.+++.+|..|+++++|++|
T Consensus 50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 456677777777776 6777777778888888888888887777788888888888888888888777777766666666
Q ss_pred EccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEe
Q 001908 297 DLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLG 376 (997)
Q Consensus 297 ~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 376 (997)
+|++|.|+.+ .+..|+++++|++|+
T Consensus 129 ~L~~n~l~~l-------------------------------------------------------~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 129 VLERNDLSSL-------------------------------------------------------PRGIFHNTPKLTTLS 153 (597)
T ss_dssp ECCSSCCCCC-------------------------------------------------------CTTTTTTCTTCCEEE
T ss_pred EeeCCCCCCC-------------------------------------------------------CHHHhccCCCCCEEE
Confidence 6666655432 223356667777777
Q ss_pred ccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC
Q 001908 377 IEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 377 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 456 (997)
|++|.+++..|..|+++++|++|+|++|.+++.. ++.+++|+.|++++|.+++. ...++|+.|++++|.+.
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~- 224 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSIN- 224 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCC-
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccc-
Confidence 7777777777777888888888888888887542 55678889999999988752 34568999999999997
Q ss_pred CcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhcc
Q 001908 457 AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLR 536 (997)
Q Consensus 457 ~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 536 (997)
.+|..+. .++ +.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|.++++|+.|+|++|++++ +|..+.
T Consensus 225 ~~~~~~~--~~L-~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~ 298 (597)
T 3oja_B 225 VVRGPVN--VEL-TILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ 298 (597)
T ss_dssp EEECSCC--SCC-CEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSS
T ss_pred ccccccC--CCC-CEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccc
Confidence 4444332 455 899999999996 4779999999999999999999999999999999999999999995 677888
Q ss_pred ccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCC
Q 001908 537 SLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 537 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~ 602 (997)
.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++.. ...++++..+++.+|||.|.+
T Consensus 299 ~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp CCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred cCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChh
Confidence 8999999999999999 68888999999999999999999764 345789999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.70 Aligned_cols=266 Identities=21% Similarity=0.342 Sum_probs=197.6
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhh-----------------HHHHHHHHHHHhhcCCCCcce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGA-----------------LKSFVAECEVLRNTRHRNLIK 740 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 740 (997)
.++|++.+.||+|+||.||+|++ +++.||||++....... .+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 35899999999999999999999 89999999996332111 178899999999999999999
Q ss_pred EEeeeeccCcCCCceEEEEEeeccCCCHHHH------hhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEe
Q 001908 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEW------LHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVH 813 (997)
Q Consensus 741 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH 813 (997)
+++++. ..+..++||||+++|+|.++ +.... ...+++..++.++.|++.|++|||+ . +|+|
T Consensus 108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 999964 35689999999999999998 54421 2358999999999999999999999 8 9999
Q ss_pred cCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCC-CCCc-cc
Q 001908 814 GDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS-EASV-TG 891 (997)
Q Consensus 814 rDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~-~~~~-~~ 891 (997)
|||||+||+++.++.+||+|||.+...... ......||+.|+|||++. +. .++. ++
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~------------~~~~~~~~~~ 233 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFS------------NESSYNGAKV 233 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGS------------SCCCEEHHHH
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhc------------CCCCCCcchh
Confidence 999999999999999999999999765221 233457899999997664 23 4555 99
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcC-cccccccccchhhhhHHHHHHHHHHHHhhcCCC
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVD-PSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 970 (997)
|||||||++|||++|+.||...... .+..............+ ..................++.++.+++.+||..
T Consensus 234 Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 309 (348)
T 2pml_X 234 DIWSLGICLYVMFYNVVPFSLKISL----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309 (348)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSCS----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCS
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccC
Confidence 9999999999999999999754221 11111111110000000 000000000000111123456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 001908 971 SPIERMEMRDVLA 983 (997)
Q Consensus 971 dP~~Rps~~evl~ 983 (997)
||++|||+.|+++
T Consensus 310 dP~~Rps~~e~l~ 322 (348)
T 2pml_X 310 NPAERITSEDALK 322 (348)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=330.73 Aligned_cols=271 Identities=22% Similarity=0.243 Sum_probs=196.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 754 (997)
.++|.+.+.||+|+||+||+|++..+++.||||++... .....+.+.+|+++++.++||||+++++++...+. ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46789999999999999999999999999999999743 33445788999999999999999999999754321 1112
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||++ ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence 3499999996 689888743 378999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+.... ......||+.|+|||++.. ...++.++||||+||++|||++|+.||....
T Consensus 189 g~a~~~~~-----------~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 189 GLARHADA-----------EMTGYVVTRWYRAPEVILS-----------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp TCC-------------------CTTCCCTTSCHHHHSC-----------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Cccccccc-----------CcCCcccCccccCHHHhcC-----------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99975421 1234578999999976642 2568899999999999999999999997432
Q ss_pred CCCccHHHHHHhh--cchhhhhhcCccccc----cc---ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA--LPEKVMETVDPSLLL----AW---SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~--~~~~~~~~~d~~~~~----~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+....... .+............. .. ...........+..++.+++.+||..||++|||+.|+++
T Consensus 247 ~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 247 YL-DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HH-HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hH-HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 11 0111111100 011111111100000 00 000000111223567889999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=334.42 Aligned_cols=277 Identities=21% Similarity=0.273 Sum_probs=200.6
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
.+.....++|++.+.||+|+||+||+|+++. .||+|+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--- 99 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM--- 99 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE---
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe---
Confidence 3334445789999999999999999999853 3999998643 2233456778999999999999999999964
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcE
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 829 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 829 (997)
..+..++||||+++++|.+++.... ..+++..++.++.|++.|++|||++ +|+||||||+||+++ ++.+
T Consensus 100 --~~~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 100 --SPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp --CSSCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CC
T ss_pred --cCCceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCE
Confidence 3457999999999999999998653 2478889999999999999999999 999999999999998 7899
Q ss_pred EEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 830 HVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 830 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
||+|||+++....... ...........||+.|+|||++...... .......++.++|||||||++|||++|+.|
T Consensus 169 ~l~Dfg~~~~~~~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 169 VITDFGLFSISGVLQA---GRREDKLRIQNGWLCHLAPEIIRQLSPD---TEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp EECCCSCCC-------------CCSCBCCSGGGGTSCHHHHSCBSCC-----CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEeecCCccccccccc---cccccccccCCCcccccChHHhhhcccc---ccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999876422111 1112223345689999999988642110 111234578999999999999999999999
Q ss_pred CCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
|.... ..+..... .....+.... ..++.++.+++.+||..||++|||+.++++.|+++.
T Consensus 243 ~~~~~-----~~~~~~~~-----~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 243 FKTQP-----AEAIIWQM-----GTGMKPNLSQ-----------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp SSSCC-----HHHHHHHH-----HTTCCCCCCC-----------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCCCC-----HHHHHHHh-----ccCCCCCCCc-----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 87431 12211111 1111111110 012345779999999999999999999999999877
Q ss_pred HHh
Q 001908 990 QTL 992 (997)
Q Consensus 990 ~~~ 992 (997)
...
T Consensus 302 ~~~ 304 (319)
T 2y4i_B 302 KRN 304 (319)
T ss_dssp ---
T ss_pred Hhh
Confidence 543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=333.48 Aligned_cols=202 Identities=26% Similarity=0.330 Sum_probs=167.1
Q ss_pred HhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CC-----CcceEEeeeeccCc
Q 001908 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HR-----NLIKIITVCSSIDF 750 (997)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 750 (997)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+++++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~---- 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM---- 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE----
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec----
Confidence 457899999999999999999999999999999999743 233466788999988885 55 4899998854
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC--CCCc
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMV 828 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~ 828 (997)
..+..++||||++ |+|.+++..... ..+++..++.++.|++.||.|||+. ..+|+||||||+||+++ .++.
T Consensus 127 -~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 127 -FRNHLCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp -ETTEEEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred -cCCceEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence 3468999999995 599999987642 2488999999999999999999952 12899999999999995 4788
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+.... ......||+.|+|||++. +..++.++|||||||++|||+||+.
T Consensus 200 ~kL~DFG~a~~~~~-----------~~~~~~~t~~y~aPE~~~------------~~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ-----------RIYQYIQSRFYRSPEVLL------------GMPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp EEECCCTTCEETTC-----------CCCSSCSCGGGCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEEEeccCceeccc-----------ccccccCCccccChHHHc------------CCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999976521 122357899999997654 5678999999999999999999999
Q ss_pred CCCcC
Q 001908 909 PTNCM 913 (997)
Q Consensus 909 P~~~~ 913 (997)
||...
T Consensus 257 pf~~~ 261 (382)
T 2vx3_A 257 LFSGA 261 (382)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 99743
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.08 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=189.0
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch------hhHHHHHHHHHHHhhc----CCCCcce
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK------GALKSFVAECEVLRNT----RHRNLIK 740 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~ 740 (997)
..+.....++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+++++++ +|+||++
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 34455667899999999999999999999998999999999964322 1223456799999998 8999999
Q ss_pred EEeeeeccCcCCCceEEEEEee-ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCC
Q 001908 741 IITVCSSIDFKGADFKALVYEY-MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPS 819 (997)
Q Consensus 741 l~~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~ 819 (997)
+++++ ...+..++|||| +++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 103 ~~~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 168 (312)
T 2iwi_A 103 LLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDE 168 (312)
T ss_dssp EEEEC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGG
T ss_pred EEEEE-----ecCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChh
Confidence 99984 445678999999 78999999998754 488999999999999999999999 9999999999
Q ss_pred CeeeC-CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 820 NVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 820 NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
||+++ .++.+||+|||+++..... ......||..|+|||.+.. ....+.++||||+||
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~slG~ 227 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDE----------PYTDFDGTRVYSPPEWISR-----------HQYHALPATVWSLGI 227 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSS----------CBCCCCSCTTTSCHHHHHH-----------SCBCHHHHHHHHHHH
T ss_pred hEEEeCCCCeEEEEEcchhhhcccC----------cccccCCcccccCceeeec-----------CCCCCccchHHHHHH
Confidence 99999 8999999999999865221 1233568999999987753 122345899999999
Q ss_pred HHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCH
Q 001908 899 MLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978 (997)
Q Consensus 899 vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 978 (997)
++|||++|+.||... .+..... ... +..+..++.+++.+||+.||++|||+
T Consensus 228 il~~l~~g~~pf~~~-------~~~~~~~----------~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~ 278 (312)
T 2iwi_A 228 LLYDMVCGDIPFERD-------QEILEAE----------LHF------------PAHVSPDCCALIRRCLAPKPSSRPSL 278 (312)
T ss_dssp HHHHHHHSSCSCCSH-------HHHHHTC----------CCC------------CTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHHCCCCCCCh-------HHHhhhc----------cCC------------cccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999998632 1111000 000 01124567899999999999999999
Q ss_pred HHHHH
Q 001908 979 RDVLA 983 (997)
Q Consensus 979 ~evl~ 983 (997)
.|+++
T Consensus 279 ~e~l~ 283 (312)
T 2iwi_A 279 EEILL 283 (312)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=327.72 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=174.4
Q ss_pred HhhcCccCC-cccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHH-HHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 677 ATNEFSSSN-MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECE-VLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 677 ~~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
..++|.+.+ .||+|+||+||+|+++.+++.||||++.... ...+|+. .++.++||||+++++++... ..+..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCc
Confidence 346788855 6999999999999999999999999986432 1223333 35667999999999997542 12345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEE
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHV 831 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl 831 (997)
..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred eEEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEE
Confidence 68999999999999999987642 2489999999999999999999999 9999999999999986 456999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+++.... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 173 ~Dfg~~~~~~~----------~~~~~~~~t~~y~aPE~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 173 TDFGFAKETTQ----------NALQTPCYTPYYVAPEVLG------------PEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp CCCTTCEEC--------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eccccceeccc----------cccccCCCCcCccChhhhC------------CCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999975421 1223456899999996653 4668889999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........ ... ............. +....++.++.+++.+||..||++|||+.|+++
T Consensus 231 ~~~~~~~~-~~~-~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 231 SNTGQAIS-PGM-KRRIRLGQYGFPN-------------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----------------------CCCT-------------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cccchhhh-hhH-HHhhhccccccCc-------------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 44221100 000 0000000000000 001123456789999999999999999999987
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=320.70 Aligned_cols=318 Identities=21% Similarity=0.290 Sum_probs=225.9
Q ss_pred ccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCC
Q 001908 201 VGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFT 280 (997)
Q Consensus 201 l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 280 (997)
+..+.+.+. ..+..+++|++|++++|.++ .+|. +..+++|++|++++|++++..+ +..+++|++|+|++|+++
T Consensus 29 ~~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~ 101 (347)
T 4fmz_A 29 LQKASVTDV--VTQEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT 101 (347)
T ss_dssp HTCSCTTSE--ECHHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ccccccCCc--ccchhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc
Confidence 344444432 23456778888888888887 5654 3467788888888887775433 777778888888888777
Q ss_pred CcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCccccc
Q 001908 281 GKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISG 360 (997)
Q Consensus 281 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~ 360 (997)
+. ..|..+++|++|++++|+++.++ .+..+++|++|++++|.....+
T Consensus 102 ~~--~~~~~l~~L~~L~l~~n~i~~~~--------~~~~l~~L~~L~l~~n~~~~~~----------------------- 148 (347)
T 4fmz_A 102 DI--SALQNLTNLRELYLNEDNISDIS--------PLANLTKMYSLNLGANHNLSDL----------------------- 148 (347)
T ss_dssp CC--GGGTTCTTCSEEECTTSCCCCCG--------GGTTCTTCCEEECTTCTTCCCC-----------------------
T ss_pred Cc--hHHcCCCcCCEEECcCCcccCch--------hhccCCceeEEECCCCCCcccc-----------------------
Confidence 64 24777777777777777776532 1556666777776666443222
Q ss_pred ccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCC
Q 001908 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGN 440 (997)
Q Consensus 361 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 440 (997)
..+..+++|++|++++|.+++..+ +..+++|++|++++|.+++. +. +..+++|+.|++++|.+++..+ +..
T Consensus 149 ---~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~ 219 (347)
T 4fmz_A 149 ---SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VAN 219 (347)
T ss_dssp ---GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGG
T ss_pred ---cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhc
Confidence 225666777777777777775443 66777777777777777743 33 6777777777777777775433 677
Q ss_pred CCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEE
Q 001908 441 CKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIF 520 (997)
Q Consensus 441 l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 520 (997)
+++|++|++++|++++. |. +..++++ +.|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|
T Consensus 220 ~~~L~~L~l~~n~l~~~-~~-~~~l~~L-~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L 292 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITDL-SP-LANLSQL-TWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL 292 (347)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTC-CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CCcCCEEEccCCccCCC-cc-hhcCCCC-CEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEE
Confidence 77777777777777643 33 6666666 7777777777743 3577888888999999988853 357888899999
Q ss_pred EccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCc
Q 001908 521 HMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 521 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 576 (997)
++++|++++..|..+..+++|+.|+|++|++++..| +..+++|++|++++|+++
T Consensus 293 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999988888888889999999999999887666 788889999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=327.72 Aligned_cols=268 Identities=20% Similarity=0.307 Sum_probs=198.6
Q ss_pred hhcCccCCcccccCcceEEEEEE-CCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC------cceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGIL-GENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN------LIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 750 (997)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 35899999999999999999998 567899999999743 334567889999999887654 899999854
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-----
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH----- 825 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~----- 825 (997)
..+..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 455899999999 8899999987642 2478999999999999999999999 9999999999999987
Q ss_pred --------------CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 826 --------------DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 826 --------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
++.+||+|||.|+.... ......||+.|+|||++. +..++.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~ 215 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE-----------HHSTLVSTRHYRAPEVIL------------ALGWSQPC 215 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTS-----------CCCSSCSCGGGCCHHHHT------------TSCCCTHH
T ss_pred ccCCccccccccccCCCceEeeCcccccCcc-----------ccccccCCccccChHHhh------------CCCCCcch
Confidence 67899999999975311 122357899999997654 46789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHh--hcchhhhhhcCcccc-----cccccch---------------h
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKM--ALPEKVMETVDPSLL-----LAWSDGR---------------R 949 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~~~-----~~~~~~~---------------~ 949 (997)
|||||||++|||++|+.||....... ........ ..+............ ..+.... .
T Consensus 216 Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (339)
T 1z57_A 216 DVWSIGCILIEYYLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294 (339)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred hhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhh
Confidence 99999999999999999997432111 11111110 111111111100000 0000000 0
Q ss_pred hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 950 RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 950 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
......++.++.+++.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0112245678899999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.74 Aligned_cols=244 Identities=20% Similarity=0.281 Sum_probs=195.1
Q ss_pred HHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch------hhHHHHHHHHHHHhhcC--CCCcceEEeeeec
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK------GALKSFVAECEVLRNTR--HRNLIKIITVCSS 747 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 747 (997)
...++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++ |+||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 345689999999999999999999998999999999964321 12245678999999996 599999999954
Q ss_pred cCcCCCceEEEEEeeccC-CCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC-C
Q 001908 748 IDFKGADFKALVYEYMQN-GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-H 825 (997)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-~ 825 (997)
..+..++|||++.+ ++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 45689999999976 89999998754 478899999999999999999999 999999999999999 7
Q ss_pred CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh
Q 001908 826 DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 826 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt 905 (997)
++.+||+|||+++..... ......||+.|+|||++.. ...++.++|||||||++|||++
T Consensus 186 ~~~~kL~Dfg~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~el~~ 244 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT----------VYTDFDGTRVYSPPEWIRY-----------HRYHGRSAAVWSLGILLYDMVC 244 (320)
T ss_dssp TTEEEECCCTTCEECCSS----------CBCCCCSCGGGSCHHHHHH-----------SCBCHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEeeCccccccccc----------cccCCCCCccCCChHHhcc-----------CCCCCccchHHhHHHHHHHHHH
Confidence 899999999999865221 1223568999999987753 1234678999999999999999
Q ss_pred CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 906 RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 906 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
|+.||... .+..... ... . ..++.++.+++.+||..||++|||+.|+++
T Consensus 245 g~~pf~~~-------~~~~~~~----------~~~----~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 245 GDIPFEHD-------EEIIRGQ----------VFF----R--------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp SSCSCCSH-------HHHHHCC----------CCC----S--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCh-------hhhhccc----------ccc----c--------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99998632 1110000 000 0 012456789999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.11 Aligned_cols=268 Identities=25% Similarity=0.373 Sum_probs=195.1
Q ss_pred HHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcC--CCCcceEEeeeecc
Q 001908 673 ELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTR--HRNLIKIITVCSSI 748 (997)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 748 (997)
.+....++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|++++++++ |+||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-- 98 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-- 98 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee--
Confidence 33445678999999999999999999986 6889999999643 3445678899999999996 599999999954
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
..+..++||| +.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ ++.
T Consensus 99 ---~~~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~ 164 (313)
T 3cek_A 99 ---TDQYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGM 164 (313)
T ss_dssp ---CSSEEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTE
T ss_pred ---cCCEEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCe
Confidence 3558999999 55889999998754 478899999999999999999999 999999999999996 489
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+++...... .........||+.|+|||.+........ +......++.++|||||||++|||++|+.
T Consensus 165 ~kL~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (313)
T 3cek_A 165 LKLIDFGIANQMQPDT------TSVVKDSQVGTVNYMPPEAIKDMSSSRE-NGKSKSKISPKSDVWSLGCILYYMTYGKT 237 (313)
T ss_dssp EEECCCSSSCC--------------------CCGGGCCHHHHTTCC-----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEeeccccccccCcc------ccccccCCCCCCCcCCHHHHhhcccccc-cccccccCCchHHHHHHHHHHHHHHhCCC
Confidence 9999999997652211 1112234568999999998764211000 01112468889999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
||...... ..... ...++.....+. ..++.++.+++.+||..||++||++.|+++.
T Consensus 238 pf~~~~~~---~~~~~---------~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 238 PFQQIINQ---ISKLH---------AIIDPNHEIEFP--------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTTTCCSH---HHHHH---------HHHCTTSCCCCC--------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhHHHH---HHHHH---------HHHhcccccCCc--------ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 99743211 11111 111111111110 0113467899999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.81 Aligned_cols=257 Identities=20% Similarity=0.259 Sum_probs=177.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch--hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|+..+.||+|+||.||+|+++.+++.||||++..... ...+.+.++..+++.++||||+++++++. ..+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence 3678899999999999999999998999999999974322 22334445555678889999999999964 3558
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
.++||||+ ++.+..+..... ..+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+||+||
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecc-CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999 556666555432 147899999999999999999998 5 8999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++..... .......||+.|+|||.+... ...+..++.++|||||||++|||++|+.||....
T Consensus 170 g~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 170 GISGRLVDD---------KAKDRSAGCAAYMAPERIDPP-------DPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp TTC-----------------------CCTTCCHHHHC---------------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCchhccCC---------ccccccCCCccccChhhcccc-------cccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 999765221 122335689999999887531 1124568899999999999999999999997422
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..+....... ...+.... ...++.++.+++.+||..||++||++.|+++
T Consensus 234 ~----~~~~~~~~~~-----~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 234 T----DFEVLTKVLQ-----EEPPLLPG----------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp S----HHHHHHHHHH-----SCCCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c----cHHHHHHHhc-----cCCCCCCc----------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 1111111110 00111100 0012456789999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=331.62 Aligned_cols=274 Identities=18% Similarity=0.262 Sum_probs=198.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCCcceEEeeee
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-----------HRNLIKIITVCS 746 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 746 (997)
.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999999989999999999743 234467788999998876 899999999875
Q ss_pred ccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC--
Q 001908 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-- 824 (997)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-- 824 (997)
... ......++||||+ +++|.+++...... .+++..++.++.||+.||+|||+++ +|+||||||+||+++
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 421 2234789999999 88999999875422 3889999999999999999999953 899999999999994
Q ss_pred ----CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHH
Q 001908 825 ----HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900 (997)
Q Consensus 825 ----~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl 900 (997)
..+.+||+|||+|+.... ......||+.|+|||++. +..++.++|||||||++
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~t~~y~aPE~~~------------~~~~~~~~Di~slG~il 225 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE-----------HYTNSIQTREYRSPEVLL------------GAPWGCGADIWSTACLI 225 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB-----------CCCSCCSCGGGCCHHHHH------------TCCCCTHHHHHHHHHHH
T ss_pred CCCcCcceEEEcccccccccCC-----------CCCCCCCCccccCcHHHh------------CCCCCchHhHHHHHHHH
Confidence 445899999999976521 122346899999997664 46689999999999999
Q ss_pred HHHHhCCCCCCcCcCCCc--c---HHHHHHhh--cchhhhh-------hcCc-cccccccc----------chhhhhHHH
Q 001908 901 LEMFTRRRPTNCMFQGGL--T---LHEFCKMA--LPEKVME-------TVDP-SLLLAWSD----------GRRRAKVEE 955 (997)
Q Consensus 901 ~elltg~~P~~~~~~~~~--~---~~~~~~~~--~~~~~~~-------~~d~-~~~~~~~~----------~~~~~~~~~ 955 (997)
|||+||+.||........ . +.+..... .+..... ..+. ........ ......+..
T Consensus 226 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (373)
T 1q8y_A 226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305 (373)
T ss_dssp HHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHH
T ss_pred HHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcc
Confidence 999999999985432110 1 11111100 0111000 0000 00000000 000112345
Q ss_pred HHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 956 CLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 956 ~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+..++.+++.+||..||++|||+.|+++
T Consensus 306 ~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 306 EAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 6788999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=326.45 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=176.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHH-HHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECE-VLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|+..+.||+|+||.||+|..+.+++.||||+++.. .......+.+|+. +++.++||||+++++++. ..+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence 36788999999999999999999989999999999743 2333455666666 677789999999999964 3568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++ +|.+++...... ....+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999975 888887641100 0124889999999999999999999853 79999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+++..... .......||+.|+|||++... ..+..++.++|||||||++|||++|+.||.....
T Consensus 172 ~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (327)
T 3aln_A 172 ISGQLVDS---------IAKTRDAGCRPYMAPERIDPS--------ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234 (327)
T ss_dssp SSCC-----------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--
T ss_pred Cceecccc---------cccccCCCCccccCceeeccc--------cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 99765221 112234689999999877421 1245688999999999999999999999974311
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. .+....... ...+.+... ....++.++.+++.+||..||++|||+.|+++
T Consensus 235 ~----~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 235 V----FDQLTQVVK-----GDPPQLSNS--------EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---------CCCCC-----SCCCCCCCC--------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred H----HHHHHHHhc-----CCCCCCCCc--------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1 010000000 000111000 00123457889999999999999999999976
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.59 Aligned_cols=304 Identities=25% Similarity=0.398 Sum_probs=232.7
Q ss_pred cc-hhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcE
Q 001908 193 NL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEI 271 (997)
Q Consensus 193 ~l-~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 271 (997)
.+ ++++|++++|.+.. +| .+..+++|++|+|++|+++ .+|. +..+++|++|++++|.+++ +| .|.++++|++
T Consensus 42 ~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~ 114 (347)
T 4fmz_A 42 ELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE 114 (347)
T ss_dssp HHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred hcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence 44 35679999999984 55 4899999999999999998 5666 5689999999999999996 34 6999999999
Q ss_pred EeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccc
Q 001908 272 IDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDI 351 (997)
Q Consensus 272 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L 351 (997)
|+|++|++++..+ +..+++|++|++++|..... +..+..+++|++|++++|.+.+..+
T Consensus 115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-------~~~~~~l~~L~~L~l~~~~~~~~~~------------- 172 (347)
T 4fmz_A 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-------LSPLSNMTGLNYLTVTESKVKDVTP------------- 172 (347)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-------CGGGTTCTTCCEEECCSSCCCCCGG-------------
T ss_pred EECcCCcccCchh--hccCCceeEEECCCCCCccc-------ccchhhCCCCcEEEecCCCcCCchh-------------
Confidence 9999999998765 89999999999999965432 2347889999999999998874332
Q ss_pred cccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCC
Q 001908 352 YMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ 431 (997)
Q Consensus 352 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 431 (997)
+..+++|+.|++++|++++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|+++
T Consensus 173 --------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~ 234 (347)
T 4fmz_A 173 --------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234 (347)
T ss_dssp --------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred --------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC
Confidence 3445566666666666664333 6666667777777776664433 666677777777777776
Q ss_pred CCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccc
Q 001908 432 GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTL 511 (997)
Q Consensus 432 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 511 (997)
+..+ +..+++|++|++++|.+++ + ..+..++++ +.|++++|++++. ..+..+++|+.|++++|++++..|..+
T Consensus 235 ~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L-~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 235 DLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKL-KMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC-CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred CCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCc-CEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 4333 6667777777777777663 2 345566666 7777777777743 357788899999999999998888889
Q ss_pred cCCcCccEEEccCccccccCChhccccCcCCeeeCcccccc
Q 001908 512 TGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552 (997)
Q Consensus 512 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (997)
.++++|+.|++++|++++..| +..+++|+.||+++|.|+
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999997666 888999999999999886
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=324.32 Aligned_cols=271 Identities=22% Similarity=0.242 Sum_probs=195.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 754 (997)
.++|.+.+.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35789999999999999999999999999999999643 33445778999999999999999999999754221 1112
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++||||++ ++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 4699999996 588877643 378899999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+++.... ......||+.|+|||++.. ...++.++||||+||++|||++|+.||....
T Consensus 171 g~~~~~~~-----------~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 171 GLARHADA-----------EMTGYVVTRWYRAPEVILS-----------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TCTTC-------------------CCSBCCSCHHHHSC-----------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred ccccCCCC-----------CccccccCcCcCCHHHHhC-----------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99975411 1223578999999976642 2567889999999999999999999997432
Q ss_pred CCCccHHHHHHhh--cchhhhhhcCcccc----cccccc---hhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA--LPEKVMETVDPSLL----LAWSDG---RRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~--~~~~~~~~~d~~~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+....... .+......+..... ...... ........+..++.+++.+|+..||++|||+.|+++
T Consensus 229 ~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 229 YL-DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HH-HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HH-HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11 0111111100 00111111110000 000000 000011133567889999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=320.97 Aligned_cols=268 Identities=21% Similarity=0.315 Sum_probs=195.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCC-cEEEEEEecccchhhHHHHHHHHHHHhhcCCCC------cceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENG-TFVAVKILNLMQKGALKSFVAECEVLRNTRHRN------LIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 750 (997)
.++|++.+.||+|+||+||+|++..++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 468999999999999999999997666 78999999743 334567888999999987665 888888743
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeee-------
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLL------- 823 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll------- 823 (997)
..+..++||||+ ++++.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 93 -~~~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 93 -FHGHMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred -eCCeEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence 455899999999 6788888876542 2488999999999999999999999 99999999999999
Q ss_pred ------------CCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 824 ------------DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 824 ------------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+.++.+||+|||+|+.... ......||+.|+|||++. +..++.++
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~ 220 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----------HHTTIVATRHYRPPEVIL------------ELGWAQPC 220 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTS-----------CCCSSCSCGGGCCHHHHT------------TCCCCTHH
T ss_pred cccccccccccccCCCcEEEeecCccccccc-----------cccCCcCCCcccCCeeee------------cCCCCCcc
Confidence 5688999999999975311 123357899999997664 46789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHh--hcchhhhhhcCcccc-----cccccch---------------h
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKM--ALPEKVMETVDPSLL-----LAWSDGR---------------R 949 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~~~-----~~~~~~~---------------~ 949 (997)
|||||||++|||++|+.||....... .+...... ..+............ ..+.... .
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (355)
T 2eu9_A 221 DVWSIGCILFEYYRGFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299 (355)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred chHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccc
Confidence 99999999999999999997432111 11111111 111111111100000 0000000 0
Q ss_pred hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 950 RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 950 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.........++.+++.+||..||++|||+.|+++
T Consensus 300 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0011233567889999999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.28 Aligned_cols=234 Identities=14% Similarity=0.090 Sum_probs=183.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++. ..+.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECCc
Confidence 57999999999999999999999889999999997432 344578899999999999999999999954 3468
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++++|.++++.. ....++.+++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence 99999999999999999542 24457889999999999999999 99999999999999999999998543
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
|++| ++.++|||||||++|||+||+.||.....
T Consensus 175 ----------------------------~~~~-------------------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ----------------------------TMPD-------------------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ----------------------------CCTT-------------------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ----------------------------ccCC-------------------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3334 67899999999999999999999985422
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
...... . ......... ........++.++.+++.+||+.||++| |+.|+++.|+++....
T Consensus 208 ~~~~~~-----~-~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 208 RSGLAP-----A-ERDTAGQPI----------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCCSEE-----C-CBCTTSCBC----------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred chhhHH-----H-HHHhccCCC----------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 110000 0 000000000 0001112345678899999999999999 9999999999977543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=346.40 Aligned_cols=281 Identities=22% Similarity=0.274 Sum_probs=201.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~ 755 (997)
.++|++.++||+|+||+||+|.+..+++.||||+++.. .....+.+.+|++++++++||||+++++++.... +...+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 46899999999999999999999989999999998743 4445678899999999999999999999865422 223667
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc---EEEc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHVS 832 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~ 832 (997)
.++||||+++|+|.+++...... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++. +||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 89999999999999999875421 2477788999999999999999999 9999999999999997764 9999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||.++..... .......||+.|+|||.+ .+..++.++||||+||++|||++|+.||..
T Consensus 167 DFG~a~~~~~~---------~~~~~~~gt~~Y~APE~l------------~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 167 DLGYAKELDQG---------ELCTEFVGTLQYLAPELL------------EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp SCCCCCBTTSC---------CCCCCCCSCCTTCSSCSS------------CCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccc---------cccccccCCcccCChHHh------------ccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99999865221 122345789999999654 457789999999999999999999999974
Q ss_pred CcCCCccHHHHHHhhcchhhh-hhcCcccccc--cccc--hhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH-----HH
Q 001908 913 MFQGGLTLHEFCKMALPEKVM-ETVDPSLLLA--WSDG--RRRAKVEECLVTVIRIGVACSMESPIERMEMRD-----VL 982 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~-~~~d~~~~~~--~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-----vl 982 (997)
.. ....|.......... .......... +... .........+..+.+++..||..||++|||+.| ..
T Consensus 226 ~~----~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F 301 (676)
T 3qa8_A 226 NW----QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301 (676)
T ss_dssp SC----HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred cc----chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence 21 111111100000000 0000000000 0000 000112234677889999999999999999988 44
Q ss_pred HHHHHHH
Q 001908 983 AKLCAAR 989 (997)
Q Consensus 983 ~~L~~~~ 989 (997)
+.+.++.
T Consensus 302 ~~l~~iL 308 (676)
T 3qa8_A 302 QALDSIL 308 (676)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5555544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.87 Aligned_cols=289 Identities=20% Similarity=0.212 Sum_probs=180.5
Q ss_pred CccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeE
Q 001908 218 SSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLD 297 (997)
Q Consensus 218 ~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 297 (997)
.+++.+++++|.++ .+|..++ ++|++|++++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred ccCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 36888888888887 7887664 6788888888888877778888888888888888888888787788777777777
Q ss_pred ccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEec
Q 001908 298 LGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377 (997)
Q Consensus 298 Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 377 (997)
|++|+++.++... . ++| ++|++++|++++..+..|.++++|+.|++
T Consensus 109 L~~n~l~~l~~~~-------~--~~L-------------------------~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 154 (332)
T 2ft3_A 109 ISKNHLVEIPPNL-------P--SSL-------------------------VELRIHDNRIRKVPKGVFSGLRNMNCIEM 154 (332)
T ss_dssp CCSSCCCSCCSSC-------C--TTC-------------------------CEEECCSSCCCCCCSGGGSSCSSCCEEEC
T ss_pred CCCCcCCccCccc-------c--ccC-------------------------CEEECCCCccCccCHhHhCCCccCCEEEC
Confidence 7777776543320 0 233 33344444444333445666677777777
Q ss_pred cCCCCC--CCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCccc
Q 001908 378 EFNQLT--GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 378 ~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 455 (997)
++|.++ +..|..|..+ +|++|++++|++++ +|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 155 ~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (332)
T 2ft3_A 155 GGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230 (332)
T ss_dssp CSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC
T ss_pred CCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 777775 3556666666 67777777777663 444433 45666666666666555555555555555555555554
Q ss_pred CCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhc
Q 001908 456 GAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535 (997)
Q Consensus 456 ~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 535 (997)
+ ..|..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 231 ~-------------------------~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 231 M-------------------------IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp C-------------------------CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred c-------------------------CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence 4 33344445555555555555555 455555555555555555555554444444
Q ss_pred cc------cCcCCeeeCcccccc--ccCchhccCCCCCCEEeCCCCc
Q 001908 536 RS------LKSIKELDLSCNNLS--GQIPEFLENLSFLEYLNLSYNH 574 (997)
Q Consensus 536 ~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ls~N~ 574 (997)
.. ...|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 285 ~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 33 245666666666665 4556666666677777766663
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=331.13 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=183.2
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.|...+.||+|+||+||.+... +|+.||||++.... .+.+.+|+++++++ +||||+++++++ ...+..++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence 4556788999999999876543 79999999986432 35678899999886 899999999984 44568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC-----------
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVC-DLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----------- 826 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~----------- 826 (997)
||||++ |+|.+++.......... ..++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999995 69999998765322111 113335678999999999999999 99999999999999754
Q ss_pred --CcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 827 --MVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 827 --~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
+.+||+|||+|+....... ..........||+.|+|||++.... .......++.++|||||||++|||+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~~~DiwSlG~il~ell 233 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQS----SFRTNLNNPSGTSGWRAPELLEESN-----NLQTKRRLTRSIDIFSMGCVFYYIL 233 (434)
T ss_dssp CSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCC-----TTSCCCCCCTHHHHHHHHHHHHHHH
T ss_pred CceEEEEcccccceecCCCCc----cceeeecCCCCCCCccCHHHhcccc-----ccccccCcchhhhhHhHHHHHHHHH
Confidence 4899999999987632111 0011123457999999998875321 1112366899999999999999999
Q ss_pred h-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 T-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
| |+.||...... ........ .+.... .......++.++.+++.+||+.||++|||+.|+++
T Consensus 234 t~g~~Pf~~~~~~---~~~i~~~~--------~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 234 SKGKHPFGDKYSR---ESNIIRGI--------FSLDEM-------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTSCCTTCSTTTH---HHHHHHTC--------CCCCCC-------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCchhh---HHHHhcCC--------CCcccc-------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 9 99998643211 11111100 000000 00111245667889999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=309.25 Aligned_cols=235 Identities=20% Similarity=0.321 Sum_probs=180.6
Q ss_pred hcCccC-CcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHH-hhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSS-NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVL-RNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ..+.+|++++ +..+||||+++++++... +.+....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence 456666 7799999999999999989999999998642 4567888888 556899999999987542 2335678
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~D 833 (997)
++||||+++|+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 9999999999999999876422 488999999999999999999999 9999999999999998 78999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|... .+..++.++||||+||++|||++|+.||...
T Consensus 164 fg~a~~~------------------------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 164 FGFAKET------------------------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp CTTCEEC------------------------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccccccc------------------------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9988643 0134678999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... . . ......+.. ... ....+....++.++.+++.+||..||++|||+.|+++
T Consensus 202 ~~~~-----~-~----~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 202 HGLA-----I-S----PGMKTRIRM---GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ----------------CCSCCSSCT---TCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchh-----h-h----HHHHHHHhh---ccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2110 0 0 000000000 000 0001111234567889999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=346.61 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=194.7
Q ss_pred hcCccCCcccccCcceEEEEEECC-CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGE-NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||+||+|++.. +++.||||++... .......+.+|++++++++||||+++++++...+..+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999975 7899999998643 34455678999999999999999999999876443223337
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||+
T Consensus 160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 999999999999987754 388999999999999999999999 99999999999999885 999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
++.... .....||+.|+|||++.. .++.++|||||||++|||++|.+||......
T Consensus 228 a~~~~~------------~~~~~gt~~y~aPE~~~~-------------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~ 282 (681)
T 2pzi_A 228 VSRINS------------FGYLYGTPGFQAPEIVRT-------------GPTVATDIYTVGRTLAALTLDLPTRNGRYVD 282 (681)
T ss_dssp CEETTC------------CSCCCCCTTTSCTTHHHH-------------CSCHHHHHHHHHHHHHHHHSCCCEETTEECS
T ss_pred chhccc------------CCccCCCccccCHHHHcC-------------CCCCceehhhhHHHHHHHHhCCCCCcccccc
Confidence 976521 134579999999987752 2478999999999999999999887632111
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-EMRDVLAKLCAARQT 991 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~~ 991 (997)
.. + . ..........+.+++.+||..||++|| +++++.+.+.++..+
T Consensus 283 ~~----------~-------~------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 283 GL----------P-------E------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp SC----------C-------T------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred cc----------c-------c------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 00 0 0 001112345678999999999999999 567777777766543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.65 Aligned_cols=292 Identities=17% Similarity=0.197 Sum_probs=168.7
Q ss_pred CccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeE
Q 001908 218 SSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLD 297 (997)
Q Consensus 218 ~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 297 (997)
.+++.++++++.++ .+|..+. ++|++|++++|++++..+..|+++++|++|+|++|++++..|..|+.+++|++|+
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 36778888888877 6776654 5678888888888877777788888888888888888877777777777777777
Q ss_pred ccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEec
Q 001908 298 LGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377 (997)
Q Consensus 298 Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 377 (997)
|++|+++.++... .++ |+.|++++|++++..+..|.++++|++|++
T Consensus 107 Ls~n~l~~l~~~~---------~~~-------------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 152 (330)
T 1xku_A 107 LSKNQLKELPEKM---------PKT-------------------------LQELRVHENEITKVRKSVFNGLNQMIVVEL 152 (330)
T ss_dssp CCSSCCSBCCSSC---------CTT-------------------------CCEEECCSSCCCBBCHHHHTTCTTCCEEEC
T ss_pred CCCCcCCccChhh---------ccc-------------------------ccEEECCCCcccccCHhHhcCCccccEEEC
Confidence 7666665432210 022 222333333333233333444455555555
Q ss_pred cCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCC
Q 001908 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA 457 (997)
Q Consensus 378 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 457 (997)
++|+++. .+..+..+.++++|+.|++++|+++. +|..+. ++|++|++++|++++.
T Consensus 153 ~~n~l~~----------------------~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~ 207 (330)
T 1xku_A 153 GTNPLKS----------------------SGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKV 207 (330)
T ss_dssp CSSCCCG----------------------GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEE
T ss_pred CCCcCCc----------------------cCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCcc
Confidence 5555532 11334444444455555555555442 333322 4455555555555544
Q ss_pred cccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccc
Q 001908 458 VPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRS 537 (997)
Q Consensus 458 ~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 537 (997)
.|..+..++++ +.|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|..
T Consensus 208 ~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~ 285 (330)
T 1xku_A 208 DAASLKGLNNL-AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 285 (330)
T ss_dssp CTGGGTTCTTC-CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred CHHHhcCCCCC-CEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCC
Confidence 44444444444 55555555555444455566666666666666666 56666666666666666666666555555533
Q ss_pred ------cCcCCeeeCccccccc--cCchhccCCCCCCEEeCCCCc
Q 001908 538 ------LKSIKELDLSCNNLSG--QIPEFLENLSFLEYLNLSYNH 574 (997)
Q Consensus 538 ------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~ 574 (997)
.+.|+.|++++|.+.. ..|..|..+..++.++|++|+
T Consensus 286 ~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 2566777777777652 455667777777777777764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=325.39 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=180.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
..+|...+.||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||+++++++. +....
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEE
Confidence 35688899999999999664333 3789999999864322 2356799999999 7999999999854 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-----CCcEEE
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-----DMVAHV 831 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl 831 (997)
++||||++ |+|.+++...... .....++.++.||+.||+|||++ +|+||||||+||+++. ...+||
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EEEEECCC-CCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999995 6999999876522 33335678999999999999999 9999999999999953 236889
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPT 910 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 910 (997)
+|||+|+...... ..........||+.|+|||++... .+..++.++||||+||++|||+| |..||
T Consensus 165 ~DFG~a~~~~~~~-----~~~~~~~~~~gt~~y~APE~l~~~---------~~~~~t~~~DiwSlG~il~ellt~g~~pf 230 (432)
T 3p23_A 165 SDFGLCKKLAVGR-----HSFSRRSGVPGTEGWIAPEMLSED---------CKENPTYTVDIFSAGCVFYYVISEGSHPF 230 (432)
T ss_dssp CCTTEEECC-----------------CCSCTTSCCGGGTSCC------------CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred ecccceeeccCCC-----cceeeccccCCCcCccChhhhhcc---------cccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 9999998663211 111223346799999999877521 13557789999999999999999 89998
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... ..... ...........+ .......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~---~~~~~---~~~~~~~~~~~~--------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 231 GKSLQ---RQANI---LLGACSLDCLHP--------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp BSTTT---HHHHH---HTTCCCCTTSCT--------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhH---HHHHH---HhccCCccccCc--------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 53211 01110 000000000000 1123445678999999999999999999983
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-32 Score=303.85 Aligned_cols=276 Identities=19% Similarity=0.191 Sum_probs=189.4
Q ss_pred CccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeE
Q 001908 218 SSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLD 297 (997)
Q Consensus 218 ~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 297 (997)
++|++|+|++|.++ .+|...+..+++|++|++++|++++..|..|+++++|++|+|++|+++..++..+ ++|++|+
T Consensus 54 ~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~---~~L~~L~ 129 (332)
T 2ft3_A 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELR 129 (332)
T ss_dssp TTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCC---TTCCEEE
T ss_pred CCCeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcccc---ccCCEEE
Confidence 45666666666666 3433334466677777777777776667777777777777777777775444333 6777777
Q ss_pred ccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEec
Q 001908 298 LGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377 (997)
Q Consensus 298 Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 377 (997)
+++|+++.++. ..+.++++|++|++++|.++. .+..|..|..+ +|++|++
T Consensus 130 l~~n~i~~~~~------~~~~~l~~L~~L~l~~n~l~~-----------------------~~~~~~~~~~l-~L~~L~l 179 (332)
T 2ft3_A 130 IHDNRIRKVPK------GVFSGLRNMNCIEMGGNPLEN-----------------------SGFEPGAFDGL-KLNYLRI 179 (332)
T ss_dssp CCSSCCCCCCS------GGGSSCSSCCEEECCSCCCBG-----------------------GGSCTTSSCSC-CCSCCBC
T ss_pred CCCCccCccCH------hHhCCCccCCEEECCCCcccc-----------------------CCCCcccccCC-ccCEEEC
Confidence 77777765443 235566677777776666541 12456667777 8999999
Q ss_pred cCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCC
Q 001908 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA 457 (997)
Q Consensus 378 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 457 (997)
++|++++ +|..+. ++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+++ .
T Consensus 180 ~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ 255 (332)
T 2ft3_A 180 SEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-R 255 (332)
T ss_dssp CSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-B
T ss_pred cCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-e
Confidence 9999996 666554 79999999999999888899999999999999999999888889999999999999999987 6
Q ss_pred cccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcccc--ccCChhc
Q 001908 458 VPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR--GSIPLSL 535 (997)
Q Consensus 458 ~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~ 535 (997)
+|..+..++++ +.|++++|++++..+..|..... -.....|+.|++++|.+. +..|..|
T Consensus 256 lp~~l~~l~~L-~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~ 316 (332)
T 2ft3_A 256 VPAGLPDLKLL-QVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATF 316 (332)
T ss_dssp CCTTGGGCTTC-CEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGG
T ss_pred cChhhhcCccC-CEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccc
Confidence 66666666655 56666666666444444432200 000244556666666555 4455666
Q ss_pred cccCcCCeeeCcccc
Q 001908 536 RSLKSIKELDLSCNN 550 (997)
Q Consensus 536 ~~l~~L~~L~Ls~N~ 550 (997)
..+++|+.|+|++|+
T Consensus 317 ~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 317 RCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTBCCSTTEEC----
T ss_pred cccchhhhhhccccc
Confidence 666666666666663
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=321.30 Aligned_cols=261 Identities=16% Similarity=0.141 Sum_probs=182.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHHHHHHHhhcCC-CCcceEE---------ee
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVAECEVLRNTRH-RNLIKII---------TV 744 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~---------~~ 744 (997)
.+.|...+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.+++.++| +|..... ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346778899999999999999999999999999997332 2235788999999999977 3221111 11
Q ss_pred eec------------cCcCCCceEEEEEeeccCCCHHHHhhcCCC-CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 001908 745 CSS------------IDFKGADFKALVYEYMQNGSLEEWLHQSNG-QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPI 811 (997)
Q Consensus 745 ~~~------------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~i 811 (997)
+.. .........+++|+++ +++|.+++..... ......+++..++.++.|+++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 000 0000022456777766 7899999852210 00112467889999999999999999999 99
Q ss_pred EecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccc
Q 001908 812 VHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891 (997)
Q Consensus 812 vHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~ 891 (997)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++....... ....+..++.++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~--~~~~~~~~~~~~ 298 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------SAVSPIG-RGFAPPETTAERMLPF--GQHHPTLMTFAF 298 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----------EECCCCC-TTTCCHHHHHHHTSTT--GGGCCEEECHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----------ccccCCC-CceeCchhhhcccccc--ccccCcCCCchh
Confidence 9999999999999999999999999875411 1234567 9999999885211000 000345678899
Q ss_pred hhHHHHHHHHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCC
Q 001908 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMES 971 (997)
Q Consensus 892 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 971 (997)
|||||||++|||+||+.||....... ..+..+. .. ..++.++.+++.+||+.|
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~-----------------~~~~~~~-~~---------~~~~~~~~~li~~~l~~d 351 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALG-----------------GSEWIFR-SC---------KNIPQPVRALLEGFLRYP 351 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGS-----------------CSGGGGS-SC---------CCCCHHHHHHHHHHTCSS
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhh-----------------hHHHHHh-hc---------ccCCHHHHHHHHHHccCC
Confidence 99999999999999999997432110 0000000 00 012456889999999999
Q ss_pred CCCCCCHHHHHH
Q 001908 972 PIERMEMRDVLA 983 (997)
Q Consensus 972 P~~Rps~~evl~ 983 (997)
|++||++.|+++
T Consensus 352 P~~Rpt~~~~l~ 363 (413)
T 3dzo_A 352 KEDRLLPLQAME 363 (413)
T ss_dssp GGGSCCHHHHTT
T ss_pred hhhCcCHHHHHh
Confidence 999999888754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-36 Score=349.76 Aligned_cols=377 Identities=16% Similarity=0.126 Sum_probs=264.6
Q ss_pred CccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcC----CCCCCCCCCCCCcEEeccCccCCCcccccc-cccC-
Q 001908 218 SSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSG----SIPESFSNASNIEIIDLPINYFTGKVSIIF-GRLK- 291 (997)
Q Consensus 218 ~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~- 291 (997)
++|++|+|++|+++..-...++..+++|++|+|++|.+++ .++..+..+++|++|||++|++++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 4567777777777633333345567777777777777764 345667777778888888777766444333 3455
Q ss_pred ---ccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCccccccc----ccccccccccCcccccc---
Q 001908 292 ---NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANL----STTMTDIYMGVNQISGT--- 361 (997)
Q Consensus 292 ---~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l----~~~L~~L~l~~N~l~~~--- 361 (997)
+|++|+|++|+++..+.. .++..+..+++|++|++++|.+++..+..+... ..+|+.|++++|++++.
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~--~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCG--VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHH--HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred CCCceeEEEccCCCCCHHHHH--HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence 578888888777642211 245567777788888888887765544444331 23578888888887753
Q ss_pred -cCCCCCCCCCCCEEeccCCCCCCCCCCCccc-----ccccceecccccccccc----chhhhcCCCCCCeEEeecCcCC
Q 001908 362 -IPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ-----LRNLQAIGLSSNFLQGN----IPSSLGNLTLMTDLFLSSNHLQ 431 (997)
Q Consensus 362 -~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 431 (997)
++..+..+++|++|++++|.++...+..+.. .++|++|+|++|.+++. ++..+..+++|+.|+|++|+++
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 3555666788888888888887554444432 45888888888888864 5777788888888888888876
Q ss_pred CCC-----CCCCCCCCCCcEEecCCCcccCC----cccccccccccccccccCCCcccCCCccccccc-----cccceec
Q 001908 432 GNI-----PPSLGNCKNLVSLNLSDNKLIGA----VPQQILTITTLSRFLDLGNNHLNGSLPLEVGNL-----KNLVALY 497 (997)
Q Consensus 432 ~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~ 497 (997)
+.. +..+..+++|++|++++|.+++. ++..+..++++ +.|++++|.+++..+..+... ++|+.|+
T Consensus 241 ~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 319 (461)
T 1z7x_W 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL-KELSLAGNELGDEGARLLCETLLEPGCQLESLW 319 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTC-CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred hHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCc-ceEECCCCCCchHHHHHHHHHhccCCccceeeE
Confidence 432 33344678888888888888753 56667677777 888888888875544444432 6889999
Q ss_pred ccccccccc----ccccccCCcCccEEEccCccccccCChhccc-----cCcCCeeeCccccccc----cCchhccCCCC
Q 001908 498 ISGNQFSGE----IPVTLTGCTGLEIFHMQGNSFRGSIPLSLRS-----LKSIKELDLSCNNLSG----QIPEFLENLSF 564 (997)
Q Consensus 498 Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~ 564 (997)
+++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|+.|+|++|++++ .+|..+..+++
T Consensus 320 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~ 399 (461)
T 1z7x_W 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399 (461)
T ss_dssp CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred cCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCC
Confidence 999998865 5667778889999999999888766665554 6789999999999886 77888888899
Q ss_pred CCEEeCCCCcCccc--------CCCCCcCCCCcceeecCCCCc
Q 001908 565 LEYLNLSYNHFDGE--------VPTKGVFSNKTRVQLTGNGKL 599 (997)
Q Consensus 565 L~~L~ls~N~l~~~--------~p~~~~~~~~~~~~~~~N~~~ 599 (997)
|++|+|++|++++. +|. ...+++.+.+.++.+-
T Consensus 400 L~~L~l~~N~i~~~~~~~l~~~l~~--~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 400 LRELDLSNNCLGDAGILQLVESVRQ--PGCLLEQLVLYDIYWS 440 (461)
T ss_dssp CCEEECCSSSCCHHHHHHHHHHHTS--TTCCCCEEECTTCCCC
T ss_pred ccEEECCCCCCCHHHHHHHHHHhcc--CCcchhheeecccccC
Confidence 99999999988754 332 1345666666666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-35 Score=348.63 Aligned_cols=347 Identities=17% Similarity=0.163 Sum_probs=243.2
Q ss_pred CCCcccCCCccceeeccCCCCCCCCCccccccCC----CccEEEecCCcCcC----CCCCCCCCCCCCcEEeccCccCCC
Q 001908 210 VPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLP----NLQVFAIGDNYFSG----SIPESFSNASNIEIIDLPINYFTG 281 (997)
Q Consensus 210 ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~ 281 (997)
+|..+..+++|++|+|++|.+++..+..++..++ +|++|+|++|+++. .+|..+..+++|++|+|++|++++
T Consensus 48 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 127 (461)
T 1z7x_W 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 127 (461)
T ss_dssp HHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred HHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCch
Confidence 4556667778888888888877544545555555 68888898888884 568888899999999999999876
Q ss_pred ccccccc-----ccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCc
Q 001908 282 KVSIIFG-----RLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVN 356 (997)
Q Consensus 282 ~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N 356 (997)
..+..+. ..++|++|+|++|+++..... .++..+..+++|++|++++|.+++..+..+.....
T Consensus 128 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~---------- 195 (461)
T 1z7x_W 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK---------- 195 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHH----------
T ss_pred HHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHh----------
Confidence 5544433 255788888888887653221 23456677788888888888876443333322100
Q ss_pred ccccccCCCCCCCCCCCEEeccCCCCCCC----CCCCcccccccceeccccccccccc-----hhhhcCCCCCCeEEeec
Q 001908 357 QISGTIPSGIGNLVNLNLLGIEFNQLTGN----IPREIGQLRNLQAIGLSSNFLQGNI-----PSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 357 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls~ 427 (997)
...++|++|++++|++++. ++..+..+++|++|+|++|++++.. +..+..+++|++|+|++
T Consensus 196 ----------~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 196 ----------DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp ----------HSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ----------cCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcC
Confidence 1234677777777777653 4556666777777777777776532 22333577888888888
Q ss_pred CcCCCC----CCCCCCCCCCCcEEecCCCcccCCcccccccc-----cccccccccCCCcccCC----Cccccccccccc
Q 001908 428 NHLQGN----IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTI-----TTLSRFLDLGNNHLNGS----LPLEVGNLKNLV 494 (997)
Q Consensus 428 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~ll~~L~Ls~N~l~~~----~p~~~~~l~~L~ 494 (997)
|++++. ++..+..+++|++|+|++|.+.+..+..+... +++ +.|++++|.+++. ++..+..+++|+
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~~~~L~ 344 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNRFLL 344 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCSSCC
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccc-eeeEcCCCCCchHHHHHHHHHHhhCCCcc
Confidence 877743 45666667788888888887765444444332 355 7888888888765 466677788999
Q ss_pred eeccccccccccccccccC-----CcCccEEEccCccccc----cCChhccccCcCCeeeCccccccccCchhcc-----
Q 001908 495 ALYISGNQFSGEIPVTLTG-----CTGLEIFHMQGNSFRG----SIPLSLRSLKSIKELDLSCNNLSGQIPEFLE----- 560 (997)
Q Consensus 495 ~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----- 560 (997)
+|++++|++++..+..+.. .++|+.|+|++|++++ .+|..+..+++|++|||++|++++.-...+.
T Consensus 345 ~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~ 424 (461)
T 1z7x_W 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 424 (461)
T ss_dssp EEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTS
T ss_pred EEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhcc
Confidence 9999999998766655543 6799999999999986 7888888999999999999999864222222
Q ss_pred CCCCCCEEeCCCCcCcccC
Q 001908 561 NLSFLEYLNLSYNHFDGEV 579 (997)
Q Consensus 561 ~l~~L~~L~ls~N~l~~~~ 579 (997)
....|+.|++.+|.+....
T Consensus 425 ~~~~L~~L~~~~~~~~~~~ 443 (461)
T 1z7x_W 425 PGCLLEQLVLYDIYWSEEM 443 (461)
T ss_dssp TTCCCCEEECTTCCCCHHH
T ss_pred CCcchhheeecccccCHHH
Confidence 2446888888888776543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=295.12 Aligned_cols=267 Identities=22% Similarity=0.248 Sum_probs=210.5
Q ss_pred CCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceec
Q 001908 321 SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIG 400 (997)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 400 (997)
++|++|+|++|++++..+..+.++ ++|++|++++|++++..|..|+++++|++|++++|+++ .+|..+. ++|++|+
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~ 127 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELR 127 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEE
T ss_pred CCCeEEECCCCcCCEeChhhhccC-CCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEE
Confidence 355666666666665555555555 56777777777777777888888999999999999998 4565554 7899999
Q ss_pred cccccccccchhhhcCCCCCCeEEeecCcCCC--CCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCc
Q 001908 401 LSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG--NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNH 478 (997)
Q Consensus 401 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~ 478 (997)
+++|++++..+..|.++++|+.|++++|+++. ..+..|.++++|++|++++|+++ .+|..+. +++ +.|++++|+
T Consensus 128 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L-~~L~l~~n~ 203 (330)
T 1xku_A 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSL-TELHLDGNK 203 (330)
T ss_dssp CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTC-SEEECTTSC
T ss_pred CCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccC-CEEECCCCc
Confidence 99999998888889999999999999999963 67888999999999999999987 5676554 556 889999999
Q ss_pred ccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchh
Q 001908 479 LNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEF 558 (997)
Q Consensus 479 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 558 (997)
+++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|++..+..
T Consensus 204 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~ 282 (330)
T 1xku_A 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282 (330)
T ss_dssp CCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhh
Confidence 98888888999999999999999998877778888999999999999998 78888888999999999999998777777
Q ss_pred ccCC------CCCCEEeCCCCcCcc--cCCC-CCcCCCCcceeecCC
Q 001908 559 LENL------SFLEYLNLSYNHFDG--EVPT-KGVFSNKTRVQLTGN 596 (997)
Q Consensus 559 ~~~l------~~L~~L~ls~N~l~~--~~p~-~~~~~~~~~~~~~~N 596 (997)
|... +.|+.|++++|++.. ..|. ...+..++.+++.+|
T Consensus 283 f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp SSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred cCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 7543 678888888888863 2221 233456677777766
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=307.75 Aligned_cols=247 Identities=19% Similarity=0.209 Sum_probs=184.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhcC---------CCCcce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNTR---------HRNLIK 740 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 740 (997)
.++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|+++++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 68999999997432 223477889999998885 777777
Q ss_pred EEeeeecc-------------------------CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHH
Q 001908 741 IITVCSSI-------------------------DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795 (997)
Q Consensus 741 l~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ 795 (997)
+.+++... ++...+..++||||+++|++.+.+.+. .+++..++.++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~q 169 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHH
Confidence 77764211 012367899999999999777766542 3789999999999
Q ss_pred HHHHHHHHh-hCCCCCcEecCCCCCCeeeCCCC--------------------cEEEcccccchhcccCCCCCccccccc
Q 001908 796 MASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDM--------------------VAHVSDFGLARFLFARPFDTSMETQSS 854 (997)
Q Consensus 796 i~~~L~yLH-~~~~~~ivHrDlk~~NIll~~~~--------------------~~kl~DFg~a~~~~~~~~~~~~~~~~~ 854 (997)
|+.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------ 234 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------ 234 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------
Confidence 999999999 88 999999999999999887 999999999986521
Q ss_pred cccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHH-HHHHHhCCCCCCcCcCCCccHHHHHHhhcchhhh
Q 001908 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM-LLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVM 933 (997)
Q Consensus 855 ~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvv-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 933 (997)
....||+.|+|||++. +.. +.++||||+|++ .+++++|..||... .|... ..+...
T Consensus 235 -~~~~gt~~y~aPE~~~------------g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~-~~~~~~ 291 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFT------------GDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHY-LTDKML 291 (336)
T ss_dssp -TEEECCCCTTCSGGGC------------CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHH-HHHHHH
T ss_pred -CcEEEeecccChhhhc------------CCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhH-HHHhhh
Confidence 1347999999997764 233 789999998777 78899999997421 01000 001111
Q ss_pred hhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 001908 934 ETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982 (997)
Q Consensus 934 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 982 (997)
.... +.............+++.+++.+||+.| |++|++
T Consensus 292 ~~~~------~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 292 KQMT------FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HTCC------CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhc------cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 0000 0111112334567788999999999976 888887
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-33 Score=340.51 Aligned_cols=477 Identities=16% Similarity=0.134 Sum_probs=261.6
Q ss_pred CHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCeeeeeeecCCCCcEEEEeccCCCCCCcccccccCcccccccccccccc
Q 001908 31 NETDRLALLAIKSQLHDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNF 110 (997)
Q Consensus 31 ~~~~~~aLl~~k~~~~~~~~~~~sW~~~~~~c~w~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l 110 (997)
.++| .|..+-+.+.++.. ...+ +.-|++|.++.+... + .+.+. +.....++..+..+++|++|+|+++..
T Consensus 16 LPde--il~~I~~~L~~~~d-~~~~--s~vck~W~~~~~~~~--~--~l~~~-~~~~~~~~~~~~~~~~L~~L~L~~~~~ 85 (592)
T 3ogk_B 16 TVDD--VIEQVMTYITDPKD-RDSA--SLVCRRWFKIDSETR--E--HVTMA-LCYTATPDRLSRRFPNLRSLKLKGKPR 85 (592)
T ss_dssp CGGG--THHHHHTTCCCHHH-HHHH--TTSCHHHHHHHHHHC--C--EEEES-CGGGSCHHHHHHHCTTCSEEEEECSCG
T ss_pred CCHH--HHHHHHHhcCCHHH-HHHH--HHHhHHHHHhhhccc--c--EEEEe-eccccChHHHHHhCCCCeEEEecCCcc
Confidence 3444 45566655522211 1111 223558999965432 2 22232 223334455677889999999988532
Q ss_pred ---CCCCCccCC------------CCCCCeEEEccCCCccccCCccccCC--Ccccchhcccccccc-cccccccccccc
Q 001908 111 ---HGEIPKEIG------------FLFRLETLMLANNSFSGKIPTNLSSC--SNLLSFVAYRNNLVG-EIPEDIGYSWLK 172 (997)
Q Consensus 111 ---~g~~p~~~~------------~l~~L~~L~Ls~N~l~g~iP~~l~~l--~~L~~l~l~~n~~~g-~ip~~~~~~l~~ 172 (997)
.|.+|..++ .+++|++|+|++|.+++..+..++.+ .+|++|++.+|.... .--..+...+++
T Consensus 86 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~ 165 (592)
T 3ogk_B 86 AAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRK 165 (592)
T ss_dssp GGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTT
T ss_pred hhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCC
Confidence 256676655 68899999999999988777777764 448888888776211 111112235678
Q ss_pred cceeecccccccCc----CcCccCcc-hhhhhhccCcccc----ccCCCcccCCCccceeeccCCCCCCCCCccccccCC
Q 001908 173 LEHISLARNHLTGM----LPASIGNL-SIIYLHVGENQFS----GTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLP 243 (997)
Q Consensus 173 L~~L~L~~N~l~g~----~p~~~~~l-~~~~L~l~~N~l~----g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~ 243 (997)
|++|+|++|.+++. ++..+..+ ++.+|++++|.++ +.++..+.++++|++|+|++|.+.+ +|.. +..++
T Consensus 166 L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~-~~~~~ 243 (592)
T 3ogk_B 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGF-FKAAA 243 (592)
T ss_dssp CSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHH-HHHCT
T ss_pred CCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHH-Hhhhh
Confidence 88888888887654 22222222 2445666666665 3344445556666666666666653 4433 33566
Q ss_pred CccEEEecCCcCc---CCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccC
Q 001908 244 NLQVFAIGDNYFS---GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNC 320 (997)
Q Consensus 244 ~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l 320 (997)
+|+.|+++++... +..+..+..+++|+.|+++++. .+.++..+..+++|++|+|++|.++.. .+...+..+
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~-----~~~~~~~~~ 317 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETE-----DHCTLIQKC 317 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHH-----HHHHHHTTC
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHH-----HHHHHHHhC
Confidence 6666666543222 2334455566666666666542 234455555666666666666654321 122234555
Q ss_pred CCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEecc-----------CCCCCCCC-CC
Q 001908 321 SKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIE-----------FNQLTGNI-PR 388 (997)
Q Consensus 321 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~~-p~ 388 (997)
++|++|+++ |.+.. +.++..+..+++|++|+++ .|.+++.. +.
T Consensus 318 ~~L~~L~L~-~~~~~------------------------~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~ 372 (592)
T 3ogk_B 318 PNLEVLETR-NVIGD------------------------RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372 (592)
T ss_dssp TTCCEEEEE-GGGHH------------------------HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHH
T ss_pred cCCCEEecc-CccCH------------------------HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHH
Confidence 666666555 22221 0111122334556666666 24444321 11
Q ss_pred CcccccccceeccccccccccchhhhcC-CCCCCeEEee----cCcCCCC-----CCCCCCCCCCCcEEecCCCcccCCc
Q 001908 389 EIGQLRNLQAIGLSSNFLQGNIPSSLGN-LTLMTDLFLS----SNHLQGN-----IPPSLGNCKNLVSLNLSDNKLIGAV 458 (997)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~ 458 (997)
.+..+++|++|+++.|++++..+..+.. +++|+.|+|+ .|++++. ++..+.++++|++|++++|.
T Consensus 373 l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~----- 447 (592)
T 3ogk_B 373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ----- 447 (592)
T ss_dssp HHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCG-----
T ss_pred HHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCC-----
Confidence 2334566666666666666655555554 6666666665 4555532 11223445555555554322
Q ss_pred ccccccccccccccccCCCcccCCCccccc-cccccceeccccccccc-cccccccCCcCccEEEccCcccccc-CChhc
Q 001908 459 PQQILTITTLSRFLDLGNNHLNGSLPLEVG-NLKNLVALYISGNQFSG-EIPVTLTGCTGLEIFHMQGNSFRGS-IPLSL 535 (997)
Q Consensus 459 p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~ 535 (997)
|.+++..+..+. .+++|+.|++++|++++ .++..+.++++|+.|+|++|++++. ++..+
T Consensus 448 ------------------~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 509 (592)
T 3ogk_B 448 ------------------GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAV 509 (592)
T ss_dssp ------------------GGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHH
T ss_pred ------------------CCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHH
Confidence 112222222222 25667777777777765 3344556677777777777777644 33344
Q ss_pred cccCcCCeeeCccccccccCchhc-cCCCCCCEEeCCCC
Q 001908 536 RSLKSIKELDLSCNNLSGQIPEFL-ENLSFLEYLNLSYN 573 (997)
Q Consensus 536 ~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N 573 (997)
..+++|+.|+|++|+++..--..+ ..++.+....+..+
T Consensus 510 ~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 510 TKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 567777777777777765433333 34565555555443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=305.79 Aligned_cols=86 Identities=15% Similarity=0.266 Sum_probs=57.0
Q ss_pred CCCCCCCCCCCCCCCCeeeeeeec------CCCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCC
Q 001908 47 DPLGVTNSWNNSINLCQWAGVTCG------HRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGF 120 (997)
Q Consensus 47 ~~~~~~~sW~~~~~~c~w~gv~C~------~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 120 (997)
|.....++|....+||.|+|..|. -....++.|++++|+++ .+|..+. ++|++|+|++|+++ .+|. .
T Consensus 7 ~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~ 79 (622)
T 3g06_A 7 EYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---L 79 (622)
T ss_dssp ---CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---C
T ss_pred HHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---c
Confidence 334556788878899999775431 11234777888887776 6666665 67777777777777 5665 4
Q ss_pred CCCCeEEEccCCCccccCCc
Q 001908 121 LFRLETLMLANNSFSGKIPT 140 (997)
Q Consensus 121 l~~L~~L~Ls~N~l~g~iP~ 140 (997)
+++|++|+|++|.++ .||.
T Consensus 80 l~~L~~L~Ls~N~l~-~lp~ 98 (622)
T 3g06_A 80 PPELRTLEVSGNQLT-SLPV 98 (622)
T ss_dssp CTTCCEEEECSCCCS-CCCC
T ss_pred CCCCCEEEcCCCcCC-cCCC
Confidence 677777777777776 4554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=285.99 Aligned_cols=272 Identities=19% Similarity=0.248 Sum_probs=217.5
Q ss_pred EEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCC--CCCCcccccccceeccc
Q 001908 325 VLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN--IPREIGQLRNLQAIGLS 402 (997)
Q Consensus 325 ~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls 402 (997)
.++.+++.++ .+|..+. ++++.|++++|+++...+..|.++++|++|+|++|+++.. .|..+.++++|++|+|+
T Consensus 11 ~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp EEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred EEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 4455555554 3343322 4566777777777755455678888999999999988733 36677778899999999
Q ss_pred cccccccchhhhcCCCCCCeEEeecCcCCCCCC-CCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccC
Q 001908 403 SNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP-PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG 481 (997)
Q Consensus 403 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~ 481 (997)
+|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..|..+..++++ +.|++++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~ 164 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQE 164 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTC-CEEECTTCEEGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCC-CEEECCCCcccc
Confidence 99988 577778889999999999999986555 578889999999999999988888888888888 889999999886
Q ss_pred -CCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhcc
Q 001908 482 -SLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLE 560 (997)
Q Consensus 482 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 560 (997)
.+|..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|||++|++++..|..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 5788899999999999999999988888999999999999999999987788899999999999999999999999999
Q ss_pred CCC-CCCEEeCCCCcCcccCCCC---CcCCCCcceeecCCCCcCCC
Q 001908 561 NLS-FLEYLNLSYNHFDGEVPTK---GVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 561 ~l~-~L~~L~ls~N~l~~~~p~~---~~~~~~~~~~~~~N~~~C~~ 602 (997)
.++ +|++|+|++|++++..+.. ..+.....+....+...|..
T Consensus 245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~ 290 (306)
T 2z66_A 245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 290 (306)
T ss_dssp CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEE
T ss_pred hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCC
Confidence 884 8999999999999876532 12233344455566677754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=282.31 Aligned_cols=280 Identities=19% Similarity=0.183 Sum_probs=132.9
Q ss_pred ceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcc--cccccccCccCeeEc
Q 001908 221 ENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKV--SIIFGRLKNLWSLDL 298 (997)
Q Consensus 221 ~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L 298 (997)
+.++++++.++ .+|..++ ++|++|+|++|+++...+..|.++++|++|+|++|+++... +..+..+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~-------- 77 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT-------- 77 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSC--------
T ss_pred CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccc--------
Confidence 45667777766 5665443 45666666666666433334556666666666666555321 2333333
Q ss_pred cCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccC-CCCCCCCCCCEEec
Q 001908 299 GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIP-SGIGNLVNLNLLGI 377 (997)
Q Consensus 299 s~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L 377 (997)
++|++|++++|.+. .+|..+..+ ++|+.|++++|++++..+ ..+.++++|++|++
T Consensus 78 ----------------------~~L~~L~Ls~n~i~-~l~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 133 (306)
T 2z66_A 78 ----------------------TSLKYLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 133 (306)
T ss_dssp ----------------------SCCCEEECCSCSEE-EEEEEEETC-TTCCEEECTTSEEESSTTTTTTTTCTTCCEEEC
T ss_pred ----------------------cccCEEECCCCccc-cChhhcCCC-CCCCEEECCCCcccccccchhhhhccCCCEEEC
Confidence 44444444444433 122222222 223333333333332222 34444555555555
Q ss_pred cCCCCCCCCCCCcccccccceeccccccccc-cchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC
Q 001908 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQG-NIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 378 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 456 (997)
++|++++..|..|.++++|++|+|++|.+++ .+|..+..+++|+.|+|++|++++..|..|..+++|++|+|++|+++
T Consensus 134 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~- 212 (306)
T 2z66_A 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF- 212 (306)
T ss_dssp TTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS-
T ss_pred CCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC-
Confidence 5555555445555555555555555555543 34444444444555555554444444444444444444444444443
Q ss_pred CcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCc-CccEEEccCccccccCC--h
Q 001908 457 AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCT-GLEIFHMQGNSFRGSIP--L 533 (997)
Q Consensus 457 ~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~ 533 (997)
+..+..+..+++|+.|+|++|++++..|..+..++ +|+.|+|++|++++..+ .
T Consensus 213 ------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~ 268 (306)
T 2z66_A 213 ------------------------SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 268 (306)
T ss_dssp ------------------------BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHH
T ss_pred ------------------------ccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHH
Confidence 22333344455555555555555555555555552 55555555555554321 1
Q ss_pred hccccCcCCeeeCccccccccCchhccC
Q 001908 534 SLRSLKSIKELDLSCNNLSGQIPEFLEN 561 (997)
Q Consensus 534 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 561 (997)
....+...+.+.+..+.+....|..+.+
T Consensus 269 ~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 269 FLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp HHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred HHHHHHhhhhhhccccccccCCchhhCC
Confidence 1122333444445555555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=289.90 Aligned_cols=233 Identities=17% Similarity=0.182 Sum_probs=139.6
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccch-hhhcCCCCCCeEEe
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIP-SSLGNLTLMTDLFL 425 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L 425 (997)
+|+.|++++|++++..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..+.++++|++|++
T Consensus 77 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l 156 (353)
T 2z80_A 77 NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEE
T ss_pred CCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEEC
Confidence 34444444444444444555555666666666666664444445566666666666666653222 25556666666666
Q ss_pred ecC-cCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccc
Q 001908 426 SSN-HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFS 504 (997)
Q Consensus 426 s~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 504 (997)
++| .+++..+..|.++++|++|++++|++++..|..+..++++ +.|++++|+++...+..+..+++|+.|++++|+++
T Consensus 157 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L-~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV-SHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp EESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE-EEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred CCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccC-CeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence 666 3554445556666666666666666665555566666655 56666666665322223344666777777777776
Q ss_pred cccccccc---CCcCccEEEccCccccc----cCChhccccCcCCeeeCccccccccCchh-ccCCCCCCEEeCCCCcCc
Q 001908 505 GEIPVTLT---GCTGLEIFHMQGNSFRG----SIPLSLRSLKSIKELDLSCNNLSGQIPEF-LENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 505 ~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~ 576 (997)
+..+..+. ....++.++|++|.+++ .+|..+..+++|+.|||++|+|+ .+|.. |..+++|++|+|++|+++
T Consensus 236 ~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~ 314 (353)
T 2z80_A 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314 (353)
T ss_dssp TCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCcc
Confidence 54444332 34566677777777665 36677777888888888888887 44444 577888888888888888
Q ss_pred ccCCC
Q 001908 577 GEVPT 581 (997)
Q Consensus 577 ~~~p~ 581 (997)
+.+|.
T Consensus 315 ~~~~~ 319 (353)
T 2z80_A 315 CSCPR 319 (353)
T ss_dssp CCHHH
T ss_pred CcCCC
Confidence 77763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-31 Score=315.16 Aligned_cols=241 Identities=17% Similarity=0.177 Sum_probs=174.3
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEee
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS 426 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 426 (997)
+|+.|+|++|.|++..|..|+++++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|+.|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 45555556666665566677777788888888888876655 7778888888888888875332 2778888888
Q ss_pred cCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccc-cccccceeccccccccc
Q 001908 427 SNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVG-NLKNLVALYISGNQFSG 505 (997)
Q Consensus 427 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 505 (997)
+|+|++..+.. +++|+.|+|++|.+++..|..+..+++| +.|+|++|.+++..|..+. .+++|+.|+|++|.+++
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 88888665543 4678888888888887777777777777 7888888888877777775 67888888888888885
Q ss_pred cccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCc-ccCCCC-C
Q 001908 506 EIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD-GEVPTK-G 583 (997)
Q Consensus 506 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~-~ 583 (997)
..+ +..+++|+.|+|++|+|++ +|..+..+++|+.|||++|+|++ +|..+..+++|+.|++++|+++ +.+|.. .
T Consensus 184 ~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 VKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred ccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 522 3357888888888888885 44458888888888888888885 6777888888888888888887 333321 2
Q ss_pred cCCCCcceeec-------CCCCcCCC
Q 001908 584 VFSNKTRVQLT-------GNGKLCGG 602 (997)
Q Consensus 584 ~~~~~~~~~~~-------~N~~~C~~ 602 (997)
.++.+..+.+. +|++.|.+
T Consensus 260 ~l~~L~~l~~~~~~~~~~~~~~~c~~ 285 (487)
T 3oja_A 260 KNQRVQTVAKQTVKKLTGQNEEECTV 285 (487)
T ss_dssp TCHHHHHHHHHHHHHHTSSSSCCCSS
T ss_pred hCCCCcEEeccccccccCCCcccccC
Confidence 33344444444 66666654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=286.37 Aligned_cols=279 Identities=17% Similarity=0.188 Sum_probs=235.0
Q ss_pred cCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccce
Q 001908 319 NCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQA 398 (997)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 398 (997)
.|+.....++++|.++ .+|..+. ++++.|++++|+|++..+..|.++++|++|++++|++++..|..|.++++|++
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 3444555677777777 4555443 46888889999998777779999999999999999999988999999999999
Q ss_pred eccccccccccchhhhcCCCCCCeEEeecCcCCCCCC-CCCCCCCCCcEEecCCCc-ccCCcccccccccccccccccCC
Q 001908 399 IGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP-PSLGNCKNLVSLNLSDNK-LIGAVPQQILTITTLSRFLDLGN 476 (997)
Q Consensus 399 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~ll~~L~Ls~ 476 (997)
|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++|. +.+..|..+..++++ +.|++++
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L-~~L~l~~ 183 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL-EELEIDA 183 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEE-EEEEEEE
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCC-CEEECCC
Confidence 9999999997766779999999999999999996444 489999999999999994 665556788889998 9999999
Q ss_pred CcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhcc---ccCcCCeeeCccccccc
Q 001908 477 NHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLR---SLKSIKELDLSCNNLSG 553 (997)
Q Consensus 477 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~ 553 (997)
|++++..|..+..+++|++|++++|+++...+..+..+++|+.|++++|++++..+..+. ....++.++|++|.+++
T Consensus 184 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~ 263 (353)
T 2z80_A 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263 (353)
T ss_dssp TTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH
T ss_pred CCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC
Confidence 999999999999999999999999999744444456689999999999999977665543 35678888888888876
Q ss_pred ----cCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCcCCC
Q 001908 554 ----QIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 554 ----~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~C~~ 602 (997)
.+|..+..+++|++|+|++|+++..++.. ..+++++.+++.+||+.|.+
T Consensus 264 ~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 264 ESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 57889999999999999999999544443 57889999999999999975
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=278.53 Aligned_cols=211 Identities=21% Similarity=0.310 Sum_probs=175.1
Q ss_pred ccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCC
Q 001908 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGN 440 (997)
Q Consensus 361 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 440 (997)
.+|..++++++|++|+|++|+++ .+|..|+++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..
T Consensus 95 ~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~ 172 (328)
T 4fcg_A 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172 (328)
T ss_dssp SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE
T ss_pred hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh
Confidence 44555666677777777777777 67777777777777777777777 66777777777888888877777777776654
Q ss_pred ---------CCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccc
Q 001908 441 ---------CKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTL 511 (997)
Q Consensus 441 ---------l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 511 (997)
+++|++|+|++|+++ .+|..+..+++| +.|+|++|++++ +|..++.+++|++|+|++|++.+.+|..|
T Consensus 173 ~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L-~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~ 249 (328)
T 4fcg_A 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIF 249 (328)
T ss_dssp EC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC-CEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCT
T ss_pred ccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC-CEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHh
Confidence 888888888888887 778888888887 888888888884 56678889999999999999999999999
Q ss_pred cCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCc
Q 001908 512 TGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 512 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 576 (997)
.++++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+.++++|+.+++..|.+.
T Consensus 250 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 250 GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99999999999999999899999999999999999999999999999999999999999887765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-29 Score=287.66 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=197.0
Q ss_pred CCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecc
Q 001908 322 KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401 (997)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 401 (997)
..+.++.+++.++ .+|..+. +.++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 4667888888888 5666554 56788888888888888888888888888888888888777788888888888888
Q ss_pred ccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc-ccccccccccccccCCCccc
Q 001908 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ-QILTITTLSRFLDLGNNHLN 480 (997)
Q Consensus 402 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~ll~~L~Ls~N~l~ 480 (997)
++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+..+.++. .+..+++| ++|+|++|+++
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~ 198 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL-RYLNLAMCNLR 198 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSC-CEEECTTSCCS
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccccc-CeecCCCCcCc
Confidence 88888876666788888888888888888877777888888888888888554445544 56667776 77888888877
Q ss_pred CCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhcc
Q 001908 481 GSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLE 560 (997)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 560 (997)
.+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|||++|+|++..+..|.
T Consensus 199 -~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 276 (440)
T 3zyj_A 199 -EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276 (440)
T ss_dssp -SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred -ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence 445 367777788888888888777777777788888888888888777777777778888888888888776667777
Q ss_pred CCCCCCEEeCCCCcCcccCC
Q 001908 561 NLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 561 ~l~~L~~L~ls~N~l~~~~p 580 (997)
.+++|+.|+|++|+|.+...
T Consensus 277 ~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 277 PLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp SCTTCCEEECCSSCEECSST
T ss_pred cccCCCEEEcCCCCccCCCC
Confidence 77777777777777776554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=288.68 Aligned_cols=245 Identities=20% Similarity=0.226 Sum_probs=194.8
Q ss_pred CCcEEEeecCccCCCCcccccccccccccccccCccc-ccccCCCCC-------CCCCCCEEeccCCCCCCCCCCCc--c
Q 001908 322 KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQI-SGTIPSGIG-------NLVNLNLLGIEFNQLTGNIPREI--G 391 (997)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~--~ 391 (997)
+|++|++++|.+ .+|..+.. .++.|++++|++ .+.+|..+. ++++|++|+|++|++++.+|..+ .
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~---~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 118 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTD---IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHH---HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred CceeEeeccccc--ccHHHHHH---HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence 333444444444 34444332 266677777777 345555554 68899999999999998888876 8
Q ss_pred cccccceeccccccccccchhhhcCC-----CCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCC--ccccc--
Q 001908 392 QLRNLQAIGLSSNFLQGNIPSSLGNL-----TLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA--VPQQI-- 462 (997)
Q Consensus 392 ~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~-- 462 (997)
.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. +|..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 899999999999999976 8878777 8999999999999988889999999999999999998765 34444
Q ss_pred ccccccccccccCCCcccCC--Cc-cccccccccceecccccccccccc-ccccCCcCccEEEccCccccccCChhcccc
Q 001908 463 LTITTLSRFLDLGNNHLNGS--LP-LEVGNLKNLVALYISGNQFSGEIP-VTLTGCTGLEIFHMQGNSFRGSIPLSLRSL 538 (997)
Q Consensus 463 ~~l~~ll~~L~Ls~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 538 (997)
..++++ +.|+|++|++++. ++ ..+.++++|++|+|++|++++.+| ..+..+++|++|+|++|+|+ .+|..+.
T Consensus 198 ~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-- 273 (312)
T 1wwl_A 198 LKFPTL-QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-- 273 (312)
T ss_dssp TSCTTC-CEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--
T ss_pred ccCCCC-CEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--
Confidence 677887 8999999999832 22 344678899999999999998775 46677899999999999998 7887776
Q ss_pred CcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCccc
Q 001908 539 KSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 539 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
++|+.|||++|+|++. |. +..+++|++|+|++|++++.
T Consensus 274 ~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 274 AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 8999999999999976 66 88999999999999999863
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=287.99 Aligned_cols=253 Identities=20% Similarity=0.300 Sum_probs=218.3
Q ss_pred CCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecc
Q 001908 322 KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401 (997)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 401 (997)
....++.+++.++ .+|..+. +.++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 4578899999988 5666543 57899999999999998999999999999999999999888899999999999999
Q ss_pred ccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc-ccccccccccccccCCCccc
Q 001908 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ-QILTITTLSRFLDLGNNHLN 480 (997)
Q Consensus 402 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~ll~~L~Ls~N~l~ 480 (997)
++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|++++|+..+.+|. .+..+++| ++|+|++|+++
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~ 209 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL-KYLNLGMCNIK 209 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTC-CEEECTTSCCS
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCC-CEEECCCCccc
Confidence 99999987777899999999999999999977777899999999999999554445654 56777787 88999999998
Q ss_pred CCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhcc
Q 001908 481 GSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLE 560 (997)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 560 (997)
+ +| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|||++|+|++..+..|.
T Consensus 210 ~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 287 (452)
T 3zyi_A 210 D-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287 (452)
T ss_dssp S-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSST
T ss_pred c-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhc
Confidence 5 44 478888999999999999888888899999999999999999888888888899999999999999877777888
Q ss_pred CCCCCCEEeCCCCcCcccCCC
Q 001908 561 NLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 561 ~l~~L~~L~ls~N~l~~~~p~ 581 (997)
.+++|+.|+|++|++.+....
T Consensus 288 ~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 288 PLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TCTTCCEEECCSSCEECSTTT
T ss_pred cccCCCEEEccCCCcCCCCCc
Confidence 888999999999988877653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=287.43 Aligned_cols=247 Identities=19% Similarity=0.175 Sum_probs=158.5
Q ss_pred cCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCC
Q 001908 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNL 372 (997)
Q Consensus 293 L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L 372 (997)
...++.+++.++.++.. -.++|++|+|++|++++..|..|.++ ++|+.|+|++|+|++..|..|.++++|
T Consensus 56 ~~~v~c~~~~l~~iP~~---------~~~~l~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L 125 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQG---------IPSNTRYLNLMENNIQMIQADTFRHL-HHLEVLQLGRNSIRQIEVGAFNGLASL 125 (452)
T ss_dssp SCEEECCSSCCSSCCSC---------CCTTCSEEECCSSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred CcEEEECCCCcCccCCC---------CCCCccEEECcCCcCceECHHHcCCC-CCCCEEECCCCccCCcChhhccCcccC
Confidence 45566666666655432 11466666666666666666666665 566666666666666666666666666
Q ss_pred CEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec-CcCCCCCCCCCCCCCCCcEEecCC
Q 001908 373 NLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS-NHLQGNIPPSLGNCKNLVSLNLSD 451 (997)
Q Consensus 373 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~ 451 (997)
++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++ |.+....+..|.++++|++|+|++
T Consensus 126 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~ 205 (452)
T 3zyi_A 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205 (452)
T ss_dssp CEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCC
Confidence 7777766666665555666666666677766666655555666666666666666 344433334566666666677766
Q ss_pred CcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccC
Q 001908 452 NKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531 (997)
Q Consensus 452 N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 531 (997)
|++++ +| .+..+++| +.|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..
T Consensus 206 n~l~~-~~-~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 282 (452)
T 3zyi_A 206 CNIKD-MP-NLTPLVGL-EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282 (452)
T ss_dssp SCCSS-CC-CCTTCTTC-CEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred Ccccc-cc-cccccccc-cEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccC
Confidence 66653 33 35555665 66666666666666666666666666677666666666666666666666777666666555
Q ss_pred ChhccccCcCCeeeCcccccc
Q 001908 532 PLSLRSLKSIKELDLSCNNLS 552 (997)
Q Consensus 532 p~~~~~l~~L~~L~Ls~N~l~ 552 (997)
+..|..+++|+.|+|++|.+.
T Consensus 283 ~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 283 HDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTSSTTCTTCCEEECCSSCEE
T ss_pred hHHhccccCCCEEEccCCCcC
Confidence 556666666666666666664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=286.25 Aligned_cols=248 Identities=23% Similarity=0.237 Sum_probs=144.9
Q ss_pred ccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecC
Q 001908 349 TDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN 428 (997)
Q Consensus 349 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 428 (997)
..++..++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34455555555 4444443 45666666666666555566666666666666666666555556666666666666666
Q ss_pred cCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCC-cccCCCccccccccccceeccccccccccc
Q 001908 429 HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNN-HLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 429 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
+|++..+..|..+++|++|+|++|++.+..+..+..+++| +.|+|++| .+....+..|.++++|++|+|++|+++ .+
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L-~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSL-RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTC-CEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCccc-CEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence 6665445556666666666666666654444455555555 56666653 333233335566666666666666665 34
Q ss_pred cccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCC
Q 001908 508 PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFS 586 (997)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~ 586 (997)
| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|++++.++.. ..+.
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 4 3555666666666666666555666666666666666666666655666666666666666666666544432 3445
Q ss_pred CCcceeecCCCCcCCC
Q 001908 587 NKTRVQLTGNGKLCGG 602 (997)
Q Consensus 587 ~~~~~~~~~N~~~C~~ 602 (997)
+++.+++.+|||.|+|
T Consensus 280 ~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 280 HLERIHLHHNPWNCNC 295 (440)
T ss_dssp TCCEEECCSSCEECSS
T ss_pred CCCEEEcCCCCccCCC
Confidence 5566666666666654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=281.14 Aligned_cols=253 Identities=18% Similarity=0.199 Sum_probs=166.0
Q ss_pred cccccceeecccccccCcCcCccCcchhhhhhccCccc-cccCCCccc-------CCCccceeeccCCCCCCCCCcccc-
Q 001908 169 SWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQF-SGTVPPSLY-------NMSSLENILLDVNGFTGNLPLDIG- 239 (997)
Q Consensus 169 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~~N~l-~g~ip~~l~-------~l~~L~~L~L~~N~l~g~lp~~~~- 239 (997)
...+|++|++++|.+ .+|..+... +.+|++++|++ .+.+|..+. ++++|++|+|++|+++|.+|..++
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 117 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHH
Confidence 344556666666666 555544433 45566666666 345666555 677888888888888877887764
Q ss_pred ccCCCccEEEecCCcCcCCCCCCCCCC-----CCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchh
Q 001908 240 VTLPNLQVFAIGDNYFSGSIPESFSNA-----SNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFV 314 (997)
Q Consensus 240 ~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 314 (997)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..+..|+.+++|++|+|++|++.+. ..++
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~ 192 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE----RGLI 192 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHH----HHHH
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcc----hHHH
Confidence 5778888888888888876 7777766 7888888888888887777888888888888888876431 0122
Q ss_pred hhh--ccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCC-CCcc
Q 001908 315 TIL--TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIP-REIG 391 (997)
Q Consensus 315 ~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~ 391 (997)
..+ ..+++|++|+|++|++++. +. .....+.++++|++|+|++|++++.+| ..+.
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~-~~---------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETP-SG---------------------VCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCH-HH---------------------HHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred HHHHhccCCCCCEEECCCCcCcch-HH---------------------HHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 333 6677777777777777631 10 001122345566666666666666554 3455
Q ss_pred cccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC
Q 001908 392 QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 392 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 456 (997)
.+++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 251 ~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5666777777777776 5666555 6677777777777754 44 6677777777777777653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=272.54 Aligned_cols=232 Identities=23% Similarity=0.268 Sum_probs=151.0
Q ss_pred CCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCc-CCCCCCCCCCCCCCCcEEe
Q 001908 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNH-LQGNIPPSLGNCKNLVSLN 448 (997)
Q Consensus 370 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 448 (997)
++|++|++++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+ ++...|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 345555555555554444455555555555555555554445555555555555555554 4444455555555555555
Q ss_pred cCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcccc
Q 001908 449 LSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528 (997)
Q Consensus 449 L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (997)
+++|++++..|..+..++++ ++|++++|++++..+..|+.+++|+.|+|++|++++..+..|.++++|+.|++++|+++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCEECHhHhhCCcCC-CEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 55555554445555555555 55666666666555556777778888888888887666666888888888888888888
Q ss_pred ccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCC
Q 001908 529 GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 529 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~ 602 (997)
+..|..|..+++|+.|+|++|++++..+..+..+++|++|+|++|++++..+..+.+..+.......|...|..
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~ 264 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCC
Confidence 77788888888888888888888876667788888888888888888877665433334445555666666753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-31 Score=325.06 Aligned_cols=425 Identities=12% Similarity=0.075 Sum_probs=261.3
Q ss_pred cCCCCCccCCCCCCCeEEEccCCCc---cccCCccccCCCcccchhcccccccccccccccccccccceeecccccccCc
Q 001908 110 FHGEIPKEIGFLFRLETLMLANNSF---SGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM 186 (997)
Q Consensus 110 l~g~~p~~~~~l~~L~~L~Ls~N~l---~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~ 186 (997)
+...++..+..+++|++|+|+++.. .|.+|..++.... .....+...+++|++|+|++|.+++.
T Consensus 61 ~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~-------------~~l~~l~~~~~~L~~L~L~~~~i~~~ 127 (592)
T 3ogk_B 61 YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVT-------------PWVTEISNNLRQLKSVHFRRMIVSDL 127 (592)
T ss_dssp GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCH-------------HHHHHHHHHCTTCCEEEEESCBCCHH
T ss_pred cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccch-------------HHHHHHHhhCCCCCeEEeeccEecHH
Confidence 3334444556788999999988542 2566665542110 00011122345666666666666554
Q ss_pred CcCccCcc--h-hhhhhccCcc-cc-ccCCCcccCCCccceeeccCCCCCCCCCc---cccccCCCccEEEecCCcCc--
Q 001908 187 LPASIGNL--S-IIYLHVGENQ-FS-GTVPPSLYNMSSLENILLDVNGFTGNLPL---DIGVTLPNLQVFAIGDNYFS-- 256 (997)
Q Consensus 187 ~p~~~~~l--~-~~~L~l~~N~-l~-g~ip~~l~~l~~L~~L~L~~N~l~g~lp~---~~~~~l~~L~~L~L~~N~l~-- 256 (997)
.+..++.. + +++|++++|. ++ ..++....++++|++|+|++|.+++.-+. .+...+++|+.|++++|.++
T Consensus 128 ~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~ 207 (592)
T 3ogk_B 128 DLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKI 207 (592)
T ss_dssp HHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSC
T ss_pred HHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCcc
Confidence 44444432 2 3344454443 11 01222234566677777777766543111 12235666666666666665
Q ss_pred --CCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccC
Q 001908 257 --GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLG 334 (997)
Q Consensus 257 --~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 334 (997)
+.++..+.++++|++|+|++|.+.+ ++..+..+++|++|+++......... .....+..+++|+.|+++++.
T Consensus 208 ~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~---~~~~~l~~~~~L~~L~l~~~~-- 281 (592)
T 3ogk_B 208 SPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMP---EKYMNLVFPRKLCRLGLSYMG-- 281 (592)
T ss_dssp CHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCT---TSSSCCCCCTTCCEEEETTCC--
T ss_pred CHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchH---HHHHHhhccccccccCccccc--
Confidence 2334444566666666666666665 34556666666666665422211000 112234445555555554432
Q ss_pred CCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCC-CCcccccccceeccccccccccchhh
Q 001908 335 GVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIP-REIGQLRNLQAIGLSSNFLQGNIPSS 413 (997)
Q Consensus 335 ~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~ 413 (997)
.+.+|..+..+++|++|+|++|.+++... ..+.++++|++|+|+++...+.++..
T Consensus 282 ------------------------~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~ 337 (592)
T 3ogk_B 282 ------------------------PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVL 337 (592)
T ss_dssp ------------------------TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHH
T ss_pred ------------------------hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHH
Confidence 12445556667778888888877664433 33567788888888844333344555
Q ss_pred hcCCCCCCeEEee-----------cCcCCCC-CCCCCCCCCCCcEEecCCCcccCCccccccc-ccccccccccC----C
Q 001908 414 LGNLTLMTDLFLS-----------SNHLQGN-IPPSLGNCKNLVSLNLSDNKLIGAVPQQILT-ITTLSRFLDLG----N 476 (997)
Q Consensus 414 ~~~l~~L~~L~Ls-----------~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~ll~~L~Ls----~ 476 (997)
+..+++|++|+|+ .|.+++. ++..+..+++|++|+++.|++++..+..+.. ++++ +.|+++ .
T Consensus 338 ~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L-~~L~l~~~~~~ 416 (592)
T 3ogk_B 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNL-CDFRLVLLDRE 416 (592)
T ss_dssp HHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSC-CEEEEEECSCC
T ss_pred HHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCC-cEEEEeecCCC
Confidence 5677888888888 3555532 1222345778888888888887766666665 6666 778885 6
Q ss_pred CcccCC-----Cccccccccccceeccccc--cccccccccccC-CcCccEEEccCccccc-cCChhccccCcCCeeeCc
Q 001908 477 NHLNGS-----LPLEVGNLKNLVALYISGN--QFSGEIPVTLTG-CTGLEIFHMQGNSFRG-SIPLSLRSLKSIKELDLS 547 (997)
Q Consensus 477 N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls 547 (997)
|++++. ++..+.++++|+.|+++++ .+++..+..+.. +++|+.|++++|++++ .++..+..+++|+.|+|+
T Consensus 417 n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~ 496 (592)
T 3ogk_B 417 ERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMR 496 (592)
T ss_dssp SCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEE
T ss_pred ccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeecc
Confidence 777753 3444777999999999853 477766666654 8999999999999986 345666889999999999
Q ss_pred ccccccc-CchhccCCCCCCEEeCCCCcCccc
Q 001908 548 CNNLSGQ-IPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 548 ~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
+|.+++. ++..+..+++|++|+|++|+++..
T Consensus 497 ~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 497 GCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp SCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 9998765 445557899999999999999865
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-28 Score=287.17 Aligned_cols=268 Identities=25% Similarity=0.282 Sum_probs=148.6
Q ss_pred ccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEc
Q 001908 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDL 298 (997)
Q Consensus 219 ~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 298 (997)
+++.|++++|.++ .+|..++ ++|++|+|++|+|+ .+|. .+++|++|+|++|+|++.++ .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEEC
Confidence 3566677777666 6666554 56666666666666 3444 45666666666666664333 4455556666
Q ss_pred cCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEecc
Q 001908 299 GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIE 378 (997)
Q Consensus 299 s~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 378 (997)
++|+|+.++. .+++|+.|++++|++++ +|.. +++|++|+|+
T Consensus 109 s~N~l~~l~~----------~l~~L~~L~L~~N~l~~--------------------------lp~~---l~~L~~L~Ls 149 (622)
T 3g06_A 109 FSNPLTHLPA----------LPSGLCKLWIFGNQLTS--------------------------LPVL---PPGLQELSVS 149 (622)
T ss_dssp CSCCCCCCCC----------CCTTCCEEECCSSCCSC--------------------------CCCC---CTTCCEEECC
T ss_pred cCCcCCCCCC----------CCCCcCEEECCCCCCCc--------------------------CCCC---CCCCCEEECc
Confidence 5555554322 23444455554444442 2221 2556666666
Q ss_pred CCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCc
Q 001908 379 FNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAV 458 (997)
Q Consensus 379 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 458 (997)
+|++++ +|. .+++|+.|++++|+|++ +| ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.++ .+
T Consensus 150 ~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l 216 (622)
T 3g06_A 150 DNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SL 216 (622)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SC
T ss_pred CCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-cc
Confidence 666653 232 23456666666666663 44 345666666666666663 3432 255666666666665 34
Q ss_pred ccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhcccc
Q 001908 459 PQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSL 538 (997)
Q Consensus 459 p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 538 (997)
|.. ++++ +.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++
T Consensus 217 ~~~---~~~L-~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l 283 (622)
T 3g06_A 217 PAL---PSGL-KELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHL 283 (622)
T ss_dssp CCC---CTTC-CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred CCC---CCCC-CEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence 432 1333 555555555553 33 23455666666666665 3444 4455666666666666 555566666
Q ss_pred CcCCeeeCccccccccCchhccCCC
Q 001908 539 KSIKELDLSCNNLSGQIPEFLENLS 563 (997)
Q Consensus 539 ~~L~~L~Ls~N~l~~~~p~~~~~l~ 563 (997)
++|+.|+|++|++++.+|..+..++
T Consensus 284 ~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 284 SSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cccCEEEecCCCCCCcCHHHHHhcc
Confidence 6666666666666666665555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=266.67 Aligned_cols=234 Identities=20% Similarity=0.187 Sum_probs=151.4
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccccc-ccccchhhhcCCCCCCeEEe
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF-LQGNIPSSLGNLTLMTDLFL 425 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L 425 (997)
+++.|++++|.+++..+..|.++++|++|++++|++++..|..|.++++|++|+|++|. ++...|..|..+++|++|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 34445555555554445556666666666666666666556666666666666666665 55444666666666666666
Q ss_pred ecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccc
Q 001908 426 SSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG 505 (997)
Q Consensus 426 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 505 (997)
++|++++..|..|.++++|++|++++|++++..+..+..++++ +.|+|++|++++..+..|..+++|+.|++++|++++
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL-THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCc-cEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 6666666556666666666666666666664444455566666 666666666665555567777777777777777777
Q ss_pred cccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC
Q 001908 506 EIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 506 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 582 (997)
..|..|.++++|+.|++++|++++..+..+..+++|+.|+|++|.+....+.. .-+..++.+..+.|.+.+..|..
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence 77777777777777888777777666666777777888888888776544321 11123445556777777777753
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-29 Score=281.75 Aligned_cols=266 Identities=17% Similarity=0.143 Sum_probs=165.8
Q ss_pred eeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCc
Q 001908 222 NILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGIN 301 (997)
Q Consensus 222 ~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 301 (997)
.++++.+.+. ..+..++..+++|++|+|++|++++..|..|.++++|++|+|++|++++.++ |..+++|++|+|++|
T Consensus 14 i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred Eeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 3344444443 3334444455566666666666666656666666777777777776665544 666666666666666
Q ss_pred cCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCC
Q 001908 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQ 381 (997)
Q Consensus 302 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 381 (997)
+++.+ ...++|++|++++|++++. .+.. +++|++|++++|+
T Consensus 91 ~l~~l-----------~~~~~L~~L~l~~n~l~~~-------------------------~~~~---~~~L~~L~l~~N~ 131 (317)
T 3o53_A 91 YVQEL-----------LVGPSIETLHAANNNISRV-------------------------SCSR---GQGKKNIYLANNK 131 (317)
T ss_dssp EEEEE-----------EECTTCCEEECCSSCCSEE-------------------------EECC---CSSCEEEECCSSC
T ss_pred ccccc-----------cCCCCcCEEECCCCccCCc-------------------------Cccc---cCCCCEEECCCCC
Confidence 65432 1235555555555555532 2222 3456666666666
Q ss_pred CCCCCCCCcccccccceeccccccccccchhhhc-CCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc
Q 001908 382 LTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLG-NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ 460 (997)
Q Consensus 382 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 460 (997)
+++..|..|+.+++|++|+|++|++++..|..+. .+++|++|+|++|++++. |. ...+++|++|+|++|+++ .+|.
T Consensus 132 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~ 208 (317)
T 3o53_A 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA-FMGP 208 (317)
T ss_dssp CCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC-EECG
T ss_pred CCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC-cchh
Confidence 6666666666667777777777777665555553 567777777777777643 22 223667777777777776 3444
Q ss_pred ccccccccccccccCCCcccCCCccccccccccceecccccccc-ccccccccCCcCccEEEcc-CccccccCChh
Q 001908 461 QILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFS-GEIPVTLTGCTGLEIFHMQ-GNSFRGSIPLS 534 (997)
Q Consensus 461 ~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~ 534 (997)
.+..++++ +.|+|++|+++ .+|..+..+++|+.|++++|+++ +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus 209 ~~~~l~~L-~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 209 EFQSAAGV-TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp GGGGGTTC-SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred hhcccCcc-cEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 56666666 77777777777 45666777777777777777777 6677777777777777777 34566555543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=278.85 Aligned_cols=271 Identities=20% Similarity=0.174 Sum_probs=217.3
Q ss_pred CccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCC
Q 001908 244 NLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKL 323 (997)
Q Consensus 244 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L 323 (997)
.++..+++++.+...++..+..+++|++|||++|++++..+..|+.+++|++|+|++|+++... .+..+++|
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--------~~~~l~~L 82 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL--------DLESLSTL 82 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE--------EETTCTTC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch--------hhhhcCCC
Confidence 3556677777776555566667777888888888888777777777777777777777775421 14556666
Q ss_pred cEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccc
Q 001908 324 KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSS 403 (997)
Q Consensus 324 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 403 (997)
++|++++|+++ +.. ..++|++|++++|++++..+.. +++|++|+|++
T Consensus 83 ~~L~Ls~n~l~-------------------------~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~ 129 (317)
T 3o53_A 83 RTLDLNNNYVQ-------------------------ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLAN 129 (317)
T ss_dssp CEEECCSSEEE-------------------------EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCS
T ss_pred CEEECcCCccc-------------------------ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCC
Confidence 66666666554 222 2278999999999999776654 57899999999
Q ss_pred ccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCC-CCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCC
Q 001908 404 NFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLG-NCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGS 482 (997)
Q Consensus 404 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~ 482 (997)
|++++..|..+..+++|+.|+|++|++++..+..+. .+++|++|+|++|++++. |... .++++ +.|+|++|++++
T Consensus 130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~-~l~~L-~~L~Ls~N~l~~- 205 (317)
T 3o53_A 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQV-VFAKL-KTLDLSSNKLAF- 205 (317)
T ss_dssp SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCC-CCTTC-CEEECCSSCCCE-
T ss_pred CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cccc-ccccC-CEEECCCCcCCc-
Confidence 999988888999999999999999999987777764 789999999999999844 4333 47777 999999999995
Q ss_pred CccccccccccceeccccccccccccccccCCcCccEEEccCcccc-ccCChhccccCcCCeeeCc-cccccccCchhcc
Q 001908 483 LPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR-GSIPLSLRSLKSIKELDLS-CNNLSGQIPEFLE 560 (997)
Q Consensus 483 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~ 560 (997)
+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++ +.+|..+..+++|+.|+++ .+.++|..|....
T Consensus 206 l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~~ 284 (317)
T 3o53_A 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284 (317)
T ss_dssp ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCCS
T ss_pred chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhccC
Confidence 5556999999999999999999 68889999999999999999999 8889999999999999999 5567777665443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-31 Score=317.25 Aligned_cols=463 Identities=13% Similarity=0.107 Sum_probs=250.5
Q ss_pred CCeeeeeeecCCCCcEEEEeccCCCCCCccc-ccccCccccccccccccccCC---CCCcc------------CCCCCCC
Q 001908 61 LCQWAGVTCGHRHQRVTELDLRHQNIGGSLS-PYVGNLSFLRYINLATNNFHG---EIPKE------------IGFLFRL 124 (997)
Q Consensus 61 ~c~w~gv~C~~~~~~v~~L~L~~~~l~g~~~-~~l~~l~~L~~L~Ls~N~l~g---~~p~~------------~~~l~~L 124 (997)
|++|.++... ....++++... +..| ..+..+++|++|+|+++.... ..|.. ...+++|
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHhhhh----hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 5589988322 23455665432 2333 346678899999999876432 22222 2357899
Q ss_pred eEEEccCCCccccCCcccc-CCCcccchhccccc-ccccccccccccccccceeecccccccCcCcCccCcchhhhhhcc
Q 001908 125 ETLMLANNSFSGKIPTNLS-SCSNLLSFVAYRNN-LVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLSIIYLHVG 202 (997)
Q Consensus 125 ~~L~Ls~N~l~g~iP~~l~-~l~~L~~l~l~~n~-~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~~~L~l~ 202 (997)
++|+|++|.+++..+..+. ++++|++|++.+|. +...-...+...+++|++|+|++|.+++..+..+.
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~---------- 177 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLS---------- 177 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGG----------
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHH----------
Confidence 9999999999988777776 68899999988884 33322233444578888888888888765443322
Q ss_pred CccccccCCCcccCCCccceeeccCCCCCCCCCcc----ccccCCCccEEEecCC-cCcCCCCCCCCCCCCCcEEeccCc
Q 001908 203 ENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLD----IGVTLPNLQVFAIGDN-YFSGSIPESFSNASNIEIIDLPIN 277 (997)
Q Consensus 203 ~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~----~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N 277 (997)
.....+++|++|+|++|. +.++.. +...+++|++|++++| .+++ +|..+..+++|+.|+++.+
T Consensus 178 ---------~~~~~~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 178 ---------HFPDTYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp ---------GSCTTCCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBC
T ss_pred ---------HHhhcCCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccc
Confidence 222355667777777765 233322 2223567777777766 3333 5666666667777764333
Q ss_pred -------cCCCcccccccccCccCee-EccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccc
Q 001908 278 -------YFTGKVSIIFGRLKNLWSL-DLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMT 349 (997)
Q Consensus 278 -------~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~ 349 (997)
.+.+.. ..+.++++|+.| .+..... ..++..+..+++|++|++++|.+++.....+....++|+
T Consensus 246 ~~~~~~~~~~~l~-~~l~~~~~L~~Ls~~~~~~~-------~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~ 317 (594)
T 2p1m_B 246 TAEVRPDVYSGLS-VALSGCKELRCLSGFWDAVP-------AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQ 317 (594)
T ss_dssp CCCCCHHHHHHHH-HHHHTCTTCCEEECCBTCCG-------GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCC
T ss_pred cCccchhhHHHHH-HHHhcCCCcccccCCcccch-------hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcC
Confidence 333322 245556666665 2222111 112233334556666666665544222111111113333
Q ss_pred cccccCcccccc-cCCCCCCCCCCCEEecc---------CCCCCCCCCCCcc-cccccceeccccccccccchhhhc-CC
Q 001908 350 DIYMGVNQISGT-IPSGIGNLVNLNLLGIE---------FNQLTGNIPREIG-QLRNLQAIGLSSNFLQGNIPSSLG-NL 417 (997)
Q Consensus 350 ~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l 417 (997)
.|++++| ++.. ++.....+++|+.|+++ .|.+++.....+. ++++|++|+++.|.+++..+..+. .+
T Consensus 318 ~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~ 396 (594)
T 2p1m_B 318 RLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNR 396 (594)
T ss_dssp EEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHC
T ss_pred EEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhC
Confidence 3333333 2111 11111224445555442 2233221111111 244444444444444443333332 24
Q ss_pred CCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC-----CcccccccccccccccccCCCcccCCCcccccc-cc
Q 001908 418 TLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG-----AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGN-LK 491 (997)
Q Consensus 418 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~-l~ 491 (997)
++|+.|+|+.|...+ -|.+++ .++..+..++++ +.|+|++ .+++..+..+.. ++
T Consensus 397 ~~L~~L~L~~~~~~~------------------~~~l~~~~~~~~~~~l~~~~~~L-~~L~L~~-~l~~~~~~~l~~~~~ 456 (594)
T 2p1m_B 397 PNMTRFRLCIIEPKA------------------PDYLTLEPLDIGFGAIVEHCKDL-RRLSLSG-LLTDKVFEYIGTYAK 456 (594)
T ss_dssp TTCCEEEEEESSTTC------------------CCTTTCCCTHHHHHHHHHHCTTC-CEEECCS-SCCHHHHHHHHHHCT
T ss_pred CCcceeEeecccCCC------------------cccccCCchhhHHHHHHhhCCCc-cEEeecC-cccHHHHHHHHHhch
Confidence 444444444110000 023321 111123344455 5666655 444444444444 67
Q ss_pred ccceeccccccccccccccc-cCCcCccEEEccCccccccCCh-hccccCcCCeeeCccccccccCchhc-cCCCCCCEE
Q 001908 492 NLVALYISGNQFSGEIPVTL-TGCTGLEIFHMQGNSFRGSIPL-SLRSLKSIKELDLSCNNLSGQIPEFL-ENLSFLEYL 568 (997)
Q Consensus 492 ~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 568 (997)
+|+.|+|++|.+++..+..+ .++++|+.|+|++|.+++.... ....+++|+.|++++|+++......+ ..++.|+..
T Consensus 457 ~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~ 536 (594)
T 2p1m_B 457 KMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVE 536 (594)
T ss_dssp TCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEE
T ss_pred hccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEE
Confidence 88888888888876666555 6688899999999988655444 34458899999999998864444444 567788777
Q ss_pred eCCCCcCcccCC
Q 001908 569 NLSYNHFDGEVP 580 (997)
Q Consensus 569 ~ls~N~l~~~~p 580 (997)
.+..+.-....|
T Consensus 537 ~~~~~~~~~~~~ 548 (594)
T 2p1m_B 537 VIDERGAPDSRP 548 (594)
T ss_dssp EECSSSCGGGSC
T ss_pred EecCCCcccccc
Confidence 777665544333
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-28 Score=286.71 Aligned_cols=186 Identities=16% Similarity=0.043 Sum_probs=130.3
Q ss_pred cccccCcceEEEEEECCCCcEEEEEEeccc----------chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 686 MIGQGSFGSVYKGILGENGTFVAVKILNLM----------QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
..+.|+.|.+..++..-.|+.||+|++... .+...+++.+|+++|+++ .|+||++++++ ++++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence 456677776666666557889999999632 123346799999999999 79999999999 56677
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..||||||++|++|.+++.+.. +++.. +|+.||+.||+|+|++ |||||||||+|||++.+|++||+||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence 9999999999999999998765 34443 5889999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
|+|+..... .......+||+.|||||++. +.+..++|+||+|++++++.++..|
T Consensus 384 GlAr~~~~~--------~~~~~t~vGTp~YmAPE~l~-------------g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 384 GSIVTTPQD--------CSWPTNLVQSFFVFVNELFA-------------ENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TTEESCC-----------CCSHHHHHHHHHHHHHHC------------------------------CCCCTTHHH
T ss_pred ccCeeCCCC--------CccccCceechhhccHHHhC-------------CCCCCcccccccccchhhhccccch
Confidence 999865221 12234468999999998764 3456789999999998888766544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=274.69 Aligned_cols=227 Identities=21% Similarity=0.184 Sum_probs=199.8
Q ss_pred CCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCC
Q 001908 363 PSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCK 442 (997)
Q Consensus 363 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 442 (997)
......+++|+.|+|++|++++..|..|+++++|++|+|++|.+++.+| +..+++|++|+|++|.|++..+ .+
T Consensus 27 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~ 99 (487)
T 3oja_A 27 ASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GP 99 (487)
T ss_dssp HTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CT
T ss_pred HHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CC
Confidence 3334456699999999999999889999999999999999999998766 9999999999999999996433 38
Q ss_pred CCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccccccccc-CCcCccEEE
Q 001908 443 NLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLT-GCTGLEIFH 521 (997)
Q Consensus 443 ~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 521 (997)
+|++|++++|.+++..+.. ++++ +.|+|++|.+++..|..|+++++|+.|+|++|.+++.+|..+. .+++|+.|+
T Consensus 100 ~L~~L~L~~N~l~~~~~~~---l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 100 SIETLHAANNNISRVSCSR---GQGK-KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TCCEEECCSSCCCCEEECC---CSSC-EEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECcCCcCCCCCccc---cCCC-CEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 9999999999999766543 4566 8999999999999999999999999999999999998998887 799999999
Q ss_pred ccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCC
Q 001908 522 MQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCG 601 (997)
Q Consensus 522 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~ 601 (997)
|++|.|++..+ +..+++|+.|+|++|+|++. |..+..+++|+.|+|++|.+++.++....++++..+++.+|++.|+
T Consensus 176 Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred cCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 99999997633 34699999999999999975 4459999999999999999998666667778999999999999997
Q ss_pred CC
Q 001908 602 GS 603 (997)
Q Consensus 602 ~~ 603 (997)
+.
T Consensus 253 ~~ 254 (487)
T 3oja_A 253 TL 254 (487)
T ss_dssp HH
T ss_pred ch
Confidence 53
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=247.11 Aligned_cols=215 Identities=19% Similarity=0.283 Sum_probs=135.6
Q ss_pred CCCCeeeeeeecCCCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCCeEEEccCCCccccC
Q 001908 59 INLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKI 138 (997)
Q Consensus 59 ~~~c~w~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 138 (997)
.++|.|.|+.|.- ...++.+++++++++ .+|..+. +.|++|+|++|++++..|..|+.+++|++|+|++|.++ .+
T Consensus 2 ~~~C~~~~~~C~c-~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i 76 (270)
T 2o6q_A 2 EALCKKDGGVCSC-NNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TL 76 (270)
T ss_dssp CCCBGGGTCSBEE-ETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CC
T ss_pred CccCCCCCCCCEe-CCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-ee
Confidence 4799999999863 345678999999997 4776665 68999999999999766678999999999999999998 45
Q ss_pred Ccc-ccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcc-hhhhhhccCccccccCCCcccC
Q 001908 139 PTN-LSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYN 216 (997)
Q Consensus 139 P~~-l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~~~L~l~~N~l~g~ip~~l~~ 216 (997)
|.. +.++++|+ +|+|++|++++..+..++.+ ++.+|++++|++++..|..|.+
T Consensus 77 ~~~~~~~l~~L~-------------------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 131 (270)
T 2o6q_A 77 PAGIFKELKNLE-------------------------TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS 131 (270)
T ss_dssp CTTTTSSCTTCC-------------------------EEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTT
T ss_pred ChhhhcCCCCCC-------------------------EEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCc
Confidence 543 35555555 55555555543333333322 1223333333333333444555
Q ss_pred CCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCee
Q 001908 217 MSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSL 296 (997)
Q Consensus 217 l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 296 (997)
+++|++|+|++|+++ .+|...+..+++|++|+|++|++++..+..|..+++|++|+|++|++++.++..|..+++|+.|
T Consensus 132 l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 210 (270)
T 2o6q_A 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210 (270)
T ss_dssp CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CcCCCEEECCCCcCC-ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEE
Confidence 566666666666665 4554444455666666666666665555556666666666666666665555555555555555
Q ss_pred EccCccCC
Q 001908 297 DLGINNLG 304 (997)
Q Consensus 297 ~Ls~N~l~ 304 (997)
+|++|.+.
T Consensus 211 ~l~~N~~~ 218 (270)
T 2o6q_A 211 QLQENPWD 218 (270)
T ss_dssp ECCSSCBC
T ss_pred EecCCCee
Confidence 55555554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=247.67 Aligned_cols=210 Identities=22% Similarity=0.221 Sum_probs=135.1
Q ss_pred CCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecC
Q 001908 371 NLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLS 450 (997)
Q Consensus 371 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 450 (997)
+|++|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555554444455555555555555555554444455555555555555555554444555555555555555
Q ss_pred CCcccCCcccccccccccccccccCCCcccCC-CccccccccccceeccccccccccccccccCCcCcc----EEEccCc
Q 001908 451 DNKLIGAVPQQILTITTLSRFLDLGNNHLNGS-LPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLE----IFHMQGN 525 (997)
Q Consensus 451 ~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N 525 (997)
+|++.+..+..+..++++ +.|++++|++++. +|..|.++++|+.|++++|++++..+..+..+.+|+ .|++++|
T Consensus 109 ~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTL-KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TSCCCCSTTCCCTTCTTC-CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCccccCchhcccCCCC-CEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 555554444345555555 5555555555542 466777777788888888887766666776666666 7888888
Q ss_pred cccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC
Q 001908 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 582 (997)
++++..+..+. ..+|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|..
T Consensus 188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred cccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 88865554444 447899999999998776777888999999999999999888754
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=240.90 Aligned_cols=209 Identities=17% Similarity=0.199 Sum_probs=181.6
Q ss_pred cccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEe
Q 001908 346 TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFL 425 (997)
Q Consensus 346 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 425 (997)
++++.|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46777888888888777778889999999999999999888888999999999999999999887888999999999999
Q ss_pred ecCcCCCCCCCCCCCCCCCcEEecCCCcccCC-cccccccccccccccccCCCcccCCCccccccccccc----eecccc
Q 001908 426 SSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGA-VPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLV----ALYISG 500 (997)
Q Consensus 426 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~ 500 (997)
++|++++..+..+.++++|++|++++|++++. +|..+..++++ +.|+|++|++++..+..+..+++|+ .|++++
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~ 186 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL-EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTC-CEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCC-CEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence 99999987777899999999999999999863 68889999888 8999999999988888888888887 899999
Q ss_pred ccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCc
Q 001908 501 NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIP 556 (997)
Q Consensus 501 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 556 (997)
|++++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus 187 n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 187 NPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp SCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 999965555554 4589999999999997777778999999999999999997544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=234.80 Aligned_cols=205 Identities=24% Similarity=0.249 Sum_probs=126.4
Q ss_pred CCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCC
Q 001908 372 LNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD 451 (997)
Q Consensus 372 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 451 (997)
.+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 445555555555 2443332 3455555555555544444555555566666666655544444455555666666666
Q ss_pred CcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccC
Q 001908 452 NKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531 (997)
Q Consensus 452 N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 531 (997)
|++++..+..+..+++| ++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 95 n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNL-AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SCCCCCCTTTTTTCSSC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CcCCcCCHhHcccccCC-CEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 55553333334444444 55555555555555556667777777777777777555555777777777777777777666
Q ss_pred ChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCC
Q 001908 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 532 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 6667777777777777777776656667777777777777777766554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=240.96 Aligned_cols=204 Identities=25% Similarity=0.259 Sum_probs=135.3
Q ss_pred CCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCc
Q 001908 366 IGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLV 445 (997)
Q Consensus 366 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 445 (997)
+.++++++.+++++|+++ .+|..+. +++++|+|++|++++..|..|.++++|+.|+|++|+|++..+ . ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCC
Confidence 567888999999999998 4565553 678899999999988888889999999999999999885433 2 6788888
Q ss_pred EEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCc
Q 001908 446 SLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGN 525 (997)
Q Consensus 446 ~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 525 (997)
+|+|++|+++ .+|..+..++++ ++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchhhccCCCC-CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 8888888876 566655555555 56666666666555555556666666666666665444445555555555555555
Q ss_pred cccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcc
Q 001908 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 577 (997)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.+
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 555444444555555555555555555 445444444555555555555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=236.50 Aligned_cols=206 Identities=26% Similarity=0.234 Sum_probs=157.8
Q ss_pred cccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccc
Q 001908 390 IGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS 469 (997)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll 469 (997)
+.++++|+++++++|.++ .+|..+. ++++.|+|++|++++..|..|.++++|++|+|++|.+++ +|.. ..++++
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L- 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVL- 79 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTC-
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcC-
Confidence 566777888888888887 5665554 678888888888887777778888888888888888874 3333 566666
Q ss_pred cccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+.|+|++|+++ .+|..+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 78888888887 67777788888888888888888666677888888888888888888766777778888888888888
Q ss_pred cccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCC
Q 001908 550 NLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 550 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~ 602 (997)
+|++..+..|..+++|++|+|++|+++..++.......++.+.+.+|||.|.|
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 88866666677788888888888888855444455566778888888888865
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-28 Score=295.94 Aligned_cols=214 Identities=13% Similarity=0.077 Sum_probs=155.0
Q ss_pred ccCCCCCCCCCCCEEeccCCCCCCCCCC-Ccccccccceecccccccccc-chhhhcCCCCCCeEEeec---------Cc
Q 001908 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPR-EIGQLRNLQAIGLSSNFLQGN-IPSSLGNLTLMTDLFLSS---------NH 429 (997)
Q Consensus 361 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~---------N~ 429 (997)
.++..+..+++|+.|+|++|.+++.... .+..+++|++|++++| ++.. ++.....+++|+.|+|++ |.
T Consensus 280 ~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~ 358 (594)
T 2p1m_B 280 YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVA 358 (594)
T ss_dssp GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSC
T ss_pred hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCC
Confidence 3444445678899999998887643322 2557888999999988 4422 333344588899999844 44
Q ss_pred CCCCCCCCCC-CCCCCcEEecCCCcccCCcccccc-cccccccccccC--C----CcccCC-----Ccccccccccccee
Q 001908 430 LQGNIPPSLG-NCKNLVSLNLSDNKLIGAVPQQIL-TITTLSRFLDLG--N----NHLNGS-----LPLEVGNLKNLVAL 496 (997)
Q Consensus 430 l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~ll~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L 496 (997)
+++.....+. ++++|++|+++.|.+++..+..+. .++++ +.|+++ + |.+++. ++..+..+++|+.|
T Consensus 359 l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L-~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L 437 (594)
T 2p1m_B 359 LTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM-TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRL 437 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTC-CEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEE
T ss_pred CCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCc-ceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEE
Confidence 4432222222 378899998888888766666555 46677 888988 4 566632 12236778999999
Q ss_pred ccccccccccccccccC-CcCccEEEccCccccccCChhc-cccCcCCeeeCccccccccCch-hccCCCCCCEEeCCCC
Q 001908 497 YISGNQFSGEIPVTLTG-CTGLEIFHMQGNSFRGSIPLSL-RSLKSIKELDLSCNNLSGQIPE-FLENLSFLEYLNLSYN 573 (997)
Q Consensus 497 ~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N 573 (997)
+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. ....+++|++|++++|
T Consensus 438 ~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 438 SLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516 (594)
T ss_dssp ECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred eecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence 9988 777776667766 8999999999999987666666 6799999999999999765544 4456899999999999
Q ss_pred cCcc
Q 001908 574 HFDG 577 (997)
Q Consensus 574 ~l~~ 577 (997)
+++.
T Consensus 517 ~~~~ 520 (594)
T 2p1m_B 517 SVSF 520 (594)
T ss_dssp CCBH
T ss_pred CCCH
Confidence 9853
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=234.56 Aligned_cols=91 Identities=31% Similarity=0.260 Sum_probs=39.6
Q ss_pred CCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCC
Q 001908 365 GIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444 (997)
Q Consensus 365 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 444 (997)
.|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..|.++++|
T Consensus 104 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 183 (272)
T 3rfs_A 104 VFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQL 183 (272)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccC
Confidence 33444444444444444444433344444444444444444443333334444444444444444444333334444444
Q ss_pred cEEecCCCccc
Q 001908 445 VSLNLSDNKLI 455 (997)
Q Consensus 445 ~~L~L~~N~l~ 455 (997)
++|++++|+++
T Consensus 184 ~~L~L~~N~l~ 194 (272)
T 3rfs_A 184 KDLRLYQNQLK 194 (272)
T ss_dssp CEEECCSSCCS
T ss_pred CEEECCCCcCC
Confidence 44444444444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-25 Score=236.78 Aligned_cols=222 Identities=22% Similarity=0.223 Sum_probs=189.6
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEee
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS 426 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 426 (997)
.+..+.+..+.+... ..+..+++|+.|++++|.++. + ..+..+++|++|+|++|++++ + ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECC
Confidence 355566666666543 335678889999999999874 3 358889999999999999986 3 478899999999999
Q ss_pred cCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccc
Q 001908 427 SNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE 506 (997)
Q Consensus 427 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 506 (997)
+|++++..+..|.++++|++|+|++|++++..|..+..++++ ++|++++|++++..+..|+.+++|+.|++++|++++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNL-TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCC-CEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 999998888888999999999999999987777778888888 8999999999987777889999999999999999987
Q ss_pred ccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCC
Q 001908 507 IPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 507 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 582 (997)
.+..|..+++|+.|++++|++++..|..+..+++|+.|+|++|.+.+. ++.|+.|+++.|.++|.+|..
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 777889999999999999999988888899999999999999998865 457889999999999999865
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=234.78 Aligned_cols=202 Identities=20% Similarity=0.190 Sum_probs=165.1
Q ss_pred CCCCCEEeccCCCCCCCCCCCc--ccccccceeccccccccccch----hhhcCCCCCCeEEeecCcCCCCCCCCCCCCC
Q 001908 369 LVNLNLLGIEFNQLTGNIPREI--GQLRNLQAIGLSSNFLQGNIP----SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCK 442 (997)
Q Consensus 369 l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 442 (997)
+++|++|++++|++++..|..+ ..+++|++|+|++|++++..| ..+..+++|++|+|++|++++..|..|.+++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3568889999999988888887 888999999999999987544 4556789999999999999988889999999
Q ss_pred CCcEEecCCCcccCC--cc--cccccccccccccccCCCcccCCCcc----ccccccccceeccccccccccccccccCC
Q 001908 443 NLVSLNLSDNKLIGA--VP--QQILTITTLSRFLDLGNNHLNGSLPL----EVGNLKNLVALYISGNQFSGEIPVTLTGC 514 (997)
Q Consensus 443 ~L~~L~L~~N~l~~~--~p--~~~~~l~~ll~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 514 (997)
+|++|+|++|++.+. ++ ..+..++++ ++|+|++|+++ .+|. .++.+++|++|||++|++++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L-~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAI-QNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCC-CSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCC-CEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 999999999998653 22 223567777 88999999987 3333 25678899999999999998878877776
Q ss_pred ---cCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcc
Q 001908 515 ---TGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 515 ---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 577 (997)
++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999998 6777764 7999999999999864 43 6788899999999999874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-26 Score=255.05 Aligned_cols=233 Identities=18% Similarity=0.202 Sum_probs=131.6
Q ss_pred hhccCccccccCCCcccCCCccceeeccCCCCCCCCCc----cccccCC-CccEEEecCCcCcCCCCCCCCCC-----CC
Q 001908 199 LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPL----DIGVTLP-NLQVFAIGDNYFSGSIPESFSNA-----SN 268 (997)
Q Consensus 199 L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 268 (997)
+.++.|+++|.+|..+...++|++|+|++|.+++ ++. ..+..++ +|++|+|++|++++..+..|..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYS-ISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGG-SCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCCh-HHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 4577788887777777776777777777777763 333 3333555 67777777777766666555554 66
Q ss_pred CcEEeccCccCCCccccccccc-----CccCeeEccCccCCCCCCCCcchhhhhcc-CCCCcEEEeecCccCCCCccccc
Q 001908 269 IEIIDLPINYFTGKVSIIFGRL-----KNLWSLDLGINNLGSGGANDLDFVTILTN-CSKLKVLAFEENRLGGVLPHSIA 342 (997)
Q Consensus 269 L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~-l~~L~~L~L~~N~l~~~~p~~~~ 342 (997)
|++|+|++|++++..+..+... ++|++|+|++|+++..+.. .+...+.. .++|++|+|++|++++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~--~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l- 158 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSS--EFKQAFSNLPASITSLNLRGNDLGIKSSDEL- 158 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHH--HHHHHHTTSCTTCCEEECTTSCGGGSCHHHH-
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHH--HHHHHHHhCCCceeEEEccCCcCCHHHHHHH-
Confidence 6666666666666555543332 5555555555555443221 11122223 2355555555555443222211
Q ss_pred ccccccccccccCcccccccCCCCCCCC-CCCEEeccCCCCCCCCCCCcccc-----cccceecccccccccc----chh
Q 001908 343 NLSTTMTDIYMGVNQISGTIPSGIGNLV-NLNLLGIEFNQLTGNIPREIGQL-----RNLQAIGLSSNFLQGN----IPS 412 (997)
Q Consensus 343 ~l~~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~ 412 (997)
+..+..++ +|++|+|++|++++..+..+... ++|++|+|++|.|++. ++.
T Consensus 159 --------------------~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 159 --------------------IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp --------------------HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred --------------------HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 12222333 67777777777765555444332 4677777777776642 444
Q ss_pred hhcC-CCCCCeEEeecCcCCCCCC----CCCCCCCCCcEEecCCCccc
Q 001908 413 SLGN-LTLMTDLFLSSNHLQGNIP----PSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 413 ~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~ 455 (997)
.+.. .++|+.|+|++|++++..+ ..+..+++|++|+|++|.+.
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~ 266 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCcc
Confidence 4544 3467777777777665433 23455566666666666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-25 Score=256.93 Aligned_cols=193 Identities=17% Similarity=0.204 Sum_probs=122.5
Q ss_pred CCCCCCCEEeccCCCCCC----CCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCC-
Q 001908 367 GNLVNLNLLGIEFNQLTG----NIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNC- 441 (997)
Q Consensus 367 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l- 441 (997)
..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++..+..+... +..+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--------------------l~~l~ 150 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--------------------LQELA 150 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--------------------HHHHH
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--------------------HHHHh
Confidence 445555555555555554 244445555555555555555543322222221 1111
Q ss_pred --------CCCcEEecCCCccc-CCcc---cccccccccccccccCCCccc--C---CCccccccccccceecccccccc
Q 001908 442 --------KNLVSLNLSDNKLI-GAVP---QQILTITTLSRFLDLGNNHLN--G---SLPLEVGNLKNLVALYISGNQFS 504 (997)
Q Consensus 442 --------~~L~~L~L~~N~l~-~~~p---~~~~~l~~ll~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~ 504 (997)
++|++|+|++|+++ +.+| ..+..++++ +.|+|++|+++ | ..|..+..+++|+.|+|++|.++
T Consensus 151 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~ 229 (386)
T 2ca6_A 151 VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229 (386)
T ss_dssp HHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred hhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCc-CEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCC
Confidence 45555555555554 2233 233344444 55555555554 1 23446777888888888888886
Q ss_pred ----ccccccccCCcCccEEEccCcccccc----CChhccc--cCcCCeeeCccccccc----cCchhc-cCCCCCCEEe
Q 001908 505 ----GEIPVTLTGCTGLEIFHMQGNSFRGS----IPLSLRS--LKSIKELDLSCNNLSG----QIPEFL-ENLSFLEYLN 569 (997)
Q Consensus 505 ----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~--l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~ 569 (997)
+.+|..+..+++|+.|+|++|++++. +|..+.. +++|+.|+|++|++++ .+|..+ .++++|++|+
T Consensus 230 ~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~ 309 (386)
T 2ca6_A 230 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 309 (386)
T ss_dssp HHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred cHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEE
Confidence 56788888888899999999988865 5666633 8889999999999987 477777 6689999999
Q ss_pred CCCCcCcccCC
Q 001908 570 LSYNHFDGEVP 580 (997)
Q Consensus 570 ls~N~l~~~~p 580 (997)
|++|++++..+
T Consensus 310 l~~N~l~~~~~ 320 (386)
T 2ca6_A 310 LNGNRFSEEDD 320 (386)
T ss_dssp CTTSBSCTTSH
T ss_pred ccCCcCCcchh
Confidence 99999986654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=222.74 Aligned_cols=196 Identities=18% Similarity=0.157 Sum_probs=103.4
Q ss_pred CCCEEeccCCCCCCCCCCCcccccccceecccccc-ccccchhhhcCCCCCCeEEeec-CcCCCCCCCCCCCCCCCcEEe
Q 001908 371 NLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF-LQGNIPSSLGNLTLMTDLFLSS-NHLQGNIPPSLGNCKNLVSLN 448 (997)
Q Consensus 371 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 448 (997)
+|++|++++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444455555555555555554 4433334455555555555555 555544444555555555555
Q ss_pred cCCCcccCCccccccccccccc---ccccCCC-cccCCCccccccccccc-eeccccccccccccccccCCcCccEEEcc
Q 001908 449 LSDNKLIGAVPQQILTITTLSR---FLDLGNN-HLNGSLPLEVGNLKNLV-ALYISGNQFSGEIPVTLTGCTGLEIFHMQ 523 (997)
Q Consensus 449 L~~N~l~~~~p~~~~~l~~ll~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 523 (997)
+++|++++ +|. +..+.++ + .|++++| ++++..+..|.++++|+ .|++++|+++ .+|......++|+.|+|+
T Consensus 112 l~~n~l~~-lp~-~~~l~~L-~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYST-DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBC-CSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred CCCCCCcc-ccc-ccccccc-ccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 55555542 333 3333333 2 4444444 44444444556666666 6666666666 344332222566666666
Q ss_pred Ccc-ccccCChhcccc-CcCCeeeCccccccccCchhccCCCCCCEEeCCCC
Q 001908 524 GNS-FRGSIPLSLRSL-KSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573 (997)
Q Consensus 524 ~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 573 (997)
+|+ +++..+..|..+ ++|+.|||++|+|++ +|.. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 663 665555566666 666666666666663 3332 4556666666554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-25 Score=249.10 Aligned_cols=271 Identities=15% Similarity=0.172 Sum_probs=191.6
Q ss_pred CCCCeeeeeeecCCCCcEEEEeccCCCCCCcccccccCc--cccccccccccccCCCCCccCCCCCCCeEEEccCCCccc
Q 001908 59 INLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNL--SFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136 (997)
Q Consensus 59 ~~~c~w~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 136 (997)
.-|.+|.++.|+. ..++.+|++++.+. +..++.+ +++++|++++|.+.+..|. +..+++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 3466899999864 35789999999886 5667777 8999999999999977665 6689999999999999987
Q ss_pred c-CCccccCCCcccchhcccccccccccccccccccccceeecccc-cccCcCcCccCcchhhhhhccCccccccCCCcc
Q 001908 137 K-IPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARN-HLTGMLPASIGNLSIIYLHVGENQFSGTVPPSL 214 (997)
Q Consensus 137 ~-iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l 214 (997)
. +|..+.++++|++|++++|++.+.+|..+.. +++|++|+|++| .+++. .+|..+
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~~~L~~L~L~~~~~l~~~----------------------~l~~~~ 164 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEF----------------------ALQTLL 164 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT-CTTCSEEECTTCBSCCHH----------------------HHHHHH
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc-CCCCCEEECCCCCCCCHH----------------------HHHHHH
Confidence 6 8888888888888888888777777766653 677777777777 45431 134445
Q ss_pred cCCCccceeeccCC-CCCCC-CCccccccCC-CccEEEecCC--cCc-CCCCCCCCCCCCCcEEeccCcc-CCCcccccc
Q 001908 215 YNMSSLENILLDVN-GFTGN-LPLDIGVTLP-NLQVFAIGDN--YFS-GSIPESFSNASNIEIIDLPINY-FTGKVSIIF 287 (997)
Q Consensus 215 ~~l~~L~~L~L~~N-~l~g~-lp~~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~ 287 (997)
.++++|++|+|++| .+++. +|..+ ..++ +|++|++++| .++ +.+|..+.++++|++|+|++|. +++..+..+
T Consensus 165 ~~~~~L~~L~l~~~~~l~~~~~~~~~-~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l 243 (336)
T 2ast_B 165 SSCSRLDELNLSWCFDFTEKHVQVAV-AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF 243 (336)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHH-HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred hcCCCCCEEcCCCCCCcChHHHHHHH-HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence 56677777777777 77643 34333 3677 7777777777 454 4566667777888888888887 676667777
Q ss_pred cccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCC
Q 001908 288 GRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIG 367 (997)
Q Consensus 288 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~ 367 (997)
..+++|++|++++|. .+.. .....+.++++|++|++++| ++ ...+..+...+..|++++|++++..|..++
T Consensus 244 ~~l~~L~~L~l~~~~--~~~~---~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 244 FQLNYLQHLSLSRCY--DIIP---ETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp GGCTTCCEEECTTCT--TCCG---GGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred hCCCCCCEeeCCCCC--CCCH---HHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 788888888888875 1111 11235667888888888877 32 223333333455666666666666665554
Q ss_pred C
Q 001908 368 N 368 (997)
Q Consensus 368 ~ 368 (997)
+
T Consensus 315 ~ 315 (336)
T 2ast_B 315 N 315 (336)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-25 Score=249.25 Aligned_cols=252 Identities=17% Similarity=0.171 Sum_probs=168.0
Q ss_pred EeecCccCCCCcccccccccccccccccCcccccccC----CCCCCCC-CCCEEeccCCCCCCCCCCCcccc-----ccc
Q 001908 327 AFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIP----SGIGNLV-NLNLLGIEFNQLTGNIPREIGQL-----RNL 396 (997)
Q Consensus 327 ~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L 396 (997)
++++|.++|.+|..+... .+|+.|++++|.|++..+ ..|.+++ +|++|+|++|++++..+..|..+ ++|
T Consensus 4 ~ls~n~~~~~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIP-HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp ECCCCTTCCHHHHHHTSC-TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred ccccccchHHHHHHHhCC-CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 344444444444333222 335555555555544444 4555666 78888888888877767666665 778
Q ss_pred ceeccccccccccchhhhc----CC-CCCCeEEeecCcCCCCCCCCC----CC-CCCCcEEecCCCcccCCccc----cc
Q 001908 397 QAIGLSSNFLQGNIPSSLG----NL-TLMTDLFLSSNHLQGNIPPSL----GN-CKNLVSLNLSDNKLIGAVPQ----QI 462 (997)
Q Consensus 397 ~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~~~----~~-l~~L~~L~L~~N~l~~~~p~----~~ 462 (997)
++|+|++|++++..+..+. .+ ++|+.|+|++|++++..+..+ .. .++|++|+|++|++++..+. .+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 8888888888776666443 33 788888888888876555433 33 35788888888888754333 33
Q ss_pred cccc-ccccccccCCCcccCCCccccccc-----cccceecccccccccc----ccccccC-CcCccEEEccCccccccC
Q 001908 463 LTIT-TLSRFLDLGNNHLNGSLPLEVGNL-----KNLVALYISGNQFSGE----IPVTLTG-CTGLEIFHMQGNSFRGSI 531 (997)
Q Consensus 463 ~~l~-~ll~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~ 531 (997)
...+ ++ +.|+|++|++++..+..+... ++|+.|||++|++++. ++..+.. .++|+.|+|++|++++..
T Consensus 163 ~~~~~~L-~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 163 AAIPANV-NSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HTSCTTC-CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred hcCCccc-cEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 4444 55 788888888887766555433 5888999999988753 4555655 358999999999888655
Q ss_pred C----hhccccCcCCeeeCccccccccC-------chhccCCCCCCEEeCCCCcCcccCC
Q 001908 532 P----LSLRSLKSIKELDLSCNNLSGQI-------PEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 532 p----~~~~~l~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
+ ..+..+++|+.|+|++|++.+.. +..+..+++|+.||+++|++....+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 4 33466788999999999855433 3356778888999999999876533
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-25 Score=255.27 Aligned_cols=257 Identities=18% Similarity=0.223 Sum_probs=158.9
Q ss_pred CCCCCCCCCCCCcEEeccCccCCCcccc----cccccCccCeeEccCccCCCCCCC----CcchhhhhccCCCCcEEEee
Q 001908 258 SIPESFSNASNIEIIDLPINYFTGKVSI----IFGRLKNLWSLDLGINNLGSGGAN----DLDFVTILTNCSKLKVLAFE 329 (997)
Q Consensus 258 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~~~~l~~l~~L~~L~L~ 329 (997)
.++..+..+++|++|+|++|++++..+. .|..+++|++|+|++|.+..+... ...+...+..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 3444455555566666666655544322 244455555555555443322110 00111223455666666666
Q ss_pred cCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCccc----c---------ccc
Q 001908 330 ENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ----L---------RNL 396 (997)
Q Consensus 330 ~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----l---------~~L 396 (997)
+|++++.-. ..+|..+.++++|++|+|++|++++..+..+.. + ++|
T Consensus 103 ~n~l~~~~~---------------------~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L 161 (386)
T 2ca6_A 103 DNAFGPTAQ---------------------EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL 161 (386)
T ss_dssp SCCCCTTTH---------------------HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred CCcCCHHHH---------------------HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCC
Confidence 555542100 046778889999999999999997554444443 3 778
Q ss_pred ceecccccccc-ccch---hhhcCCCCCCeEEeecCcCC--C---CCCCCCCCCCCCcEEecCCCcccCCcccccccccc
Q 001908 397 QAIGLSSNFLQ-GNIP---SSLGNLTLMTDLFLSSNHLQ--G---NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITT 467 (997)
Q Consensus 397 ~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 467 (997)
++|+|++|+++ +.+| ..+..+++|+.|+|++|+++ | ..|..+..+++|++|+|++|.++...
T Consensus 162 ~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g--------- 232 (386)
T 2ca6_A 162 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG--------- 232 (386)
T ss_dssp CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH---------
T ss_pred cEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH---------
Confidence 88888888886 3444 45667777888888887776 2 34446666777777777777664100
Q ss_pred cccccccCCCcccCCCccccccccccceecccccccccc----cccccc--CCcCccEEEccCccccc----cCChhc-c
Q 001908 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE----IPVTLT--GCTGLEIFHMQGNSFRG----SIPLSL-R 536 (997)
Q Consensus 468 ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~ 536 (997)
.+.+|..+..+++|+.|+|++|++++. +|..+. .+++|+.|+|++|++++ .+|..+ .
T Consensus 233 ------------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~ 300 (386)
T 2ca6_A 233 ------------SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 300 (386)
T ss_dssp ------------HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHh
Confidence 023455566667777777777777755 455663 37888888888888886 477766 5
Q ss_pred ccCcCCeeeCccccccccCc
Q 001908 537 SLKSIKELDLSCNNLSGQIP 556 (997)
Q Consensus 537 ~l~~L~~L~Ls~N~l~~~~p 556 (997)
++++|+.|+|++|++++..|
T Consensus 301 ~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 301 KMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HCTTCCEEECTTSBSCTTSH
T ss_pred cCCCceEEEccCCcCCcchh
Confidence 67888888888888887664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-24 Score=254.14 Aligned_cols=207 Identities=25% Similarity=0.306 Sum_probs=143.9
Q ss_pred CCCCCCCCCCCC-----eeeee-eecCCCCcEEEEeccCCCCCCcccccccCccccccccccccccCCCCCccCCCCCCC
Q 001908 51 VTNSWNNSINLC-----QWAGV-TCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRL 124 (997)
Q Consensus 51 ~~~sW~~~~~~c-----~w~gv-~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 124 (997)
.+.+|..+.++| .|.|+ .|.. .+++.|+|++|++++ +|+.++ ++|++|+|++|+++ .+| +.+++|
T Consensus 32 ~l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 356676666778 79999 7863 479999999999987 888774 89999999999999 788 568999
Q ss_pred eEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccccccCcCcCccCcc-hhhhhhccC
Q 001908 125 ETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHVGE 203 (997)
Q Consensus 125 ~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~~~L~l~~ 203 (997)
++|+|++|.|++ ||. +++ +|++|++++|++.+ +|. .+++|++|+|++|.|++ +|. .+ ++.+|+|++
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN 169 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence 999999999996 888 766 88888888888876 776 35678888888888775 554 22 344566666
Q ss_pred ccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCc-------cEEEecCCcCcCCCCCCCCCCCCCcEEeccC
Q 001908 204 NQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNL-------QVFAIGDNYFSGSIPESFSNASNIEIIDLPI 276 (997)
Q Consensus 204 N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 276 (997)
|++++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|++|+|++
T Consensus 170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~---~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~ 239 (571)
T 3cvr_A 170 NQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV---RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED 239 (571)
T ss_dssp SCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC-----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCS
T ss_pred CCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH---hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeC
Confidence 66664 555 44 56666666666665 5555 321 34 55555555555 3555555555555555555
Q ss_pred ccCCCcccccccc
Q 001908 277 NYFTGKVSIIFGR 289 (997)
Q Consensus 277 N~l~~~~~~~~~~ 289 (997)
|.|++.+|..|..
T Consensus 240 N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 240 NPLSSRIRESLSQ 252 (571)
T ss_dssp SSCCHHHHHHHHH
T ss_pred CcCCCcCHHHHHH
Confidence 5555555544443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=216.36 Aligned_cols=182 Identities=23% Similarity=0.231 Sum_probs=118.8
Q ss_pred CCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecC
Q 001908 371 NLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLS 450 (997)
Q Consensus 371 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 450 (997)
+.+.+++++|.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3455666666665 3444333 355555555555555555555555555555555555555555555555555555555
Q ss_pred CCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcccccc
Q 001908 451 DNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGS 530 (997)
Q Consensus 451 ~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 530 (997)
+|++ ++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|++|+|++.
T Consensus 92 ~n~l-------------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 92 NNQL-------------------------ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp TSCC-------------------------CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcc-------------------------cccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 5554 444445566677777777777777765556677777777888888877766
Q ss_pred CChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCC
Q 001908 531 IPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 531 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
.+..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++...
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 66677778888888888888887777777788888888888888877643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-24 Score=251.32 Aligned_cols=196 Identities=16% Similarity=0.149 Sum_probs=141.2
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--------KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF 750 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 750 (997)
..+...+.||+|+||+||+|+. .++.+|+|+..... ....+.+.+|++++++++||||+++..++..
T Consensus 336 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--- 410 (540)
T 3en9_A 336 KRKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--- 410 (540)
T ss_dssp ------------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE---
T ss_pred ccCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe---
Confidence 3345567999999999999965 67889999864221 1124568999999999999999954444332
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.+..++||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. ++|
T Consensus 411 --~~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~k 469 (540)
T 3en9_A 411 --LDNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLY 469 (540)
T ss_dssp --TTTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEE
T ss_pred --CCccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEE
Confidence 3356999999999999999975 347899999999999999 9999999999999998 999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+........ ............||+.|||||++.... ..|+..+|+|+..+-..+-+.++.+|
T Consensus 470 L~DFGla~~~~~~~~~-~~~~~~~~~~~~GT~~y~APEv~~~~~----------~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 470 IIDFGLGKISNLDEDK-AVDLIVFKKAVLSTHHEKFDEIWERFL----------EGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCTTCEECCCHHHH-HHHHHHHHHHHHHHCGGGHHHHHHHHH----------HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEECccCEECCCcccc-ccchhhhhhhhcCCCCcCCHHHHHHHH----------HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999999875211000 000000123567999999999887421 34777889999999999888887776
Q ss_pred C
Q 001908 911 N 911 (997)
Q Consensus 911 ~ 911 (997)
.
T Consensus 539 ~ 539 (540)
T 3en9_A 539 V 539 (540)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=231.33 Aligned_cols=199 Identities=16% Similarity=0.172 Sum_probs=146.1
Q ss_pred cccccccCcccccccCCCC--CCCCCCCEEeccCCCCCCCCC----CCcccccccceeccccccccccchhhhcCCCCCC
Q 001908 348 MTDIYMGVNQISGTIPSGI--GNLVNLNLLGIEFNQLTGNIP----REIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMT 421 (997)
Q Consensus 348 L~~L~l~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 421 (997)
|++|++++|.+++..|..+ .++++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..|..+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 4455555555555555555 667777777777777776554 2345677788888888888777777777888888
Q ss_pred eEEeecCcCCCC--C--CCCCCCCCCCcEEecCCCcccCCcccc----cccccccccccccCCCcccCCCccccccc---
Q 001908 422 DLFLSSNHLQGN--I--PPSLGNCKNLVSLNLSDNKLIGAVPQQ----ILTITTLSRFLDLGNNHLNGSLPLEVGNL--- 490 (997)
Q Consensus 422 ~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l--- 490 (997)
+|+|++|++.+. + +..+..+++|++|+|++|+++ .+|.. +..++++ ++|+|++|++++..|..+..+
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQP-HSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCC-SSEECTTSCCCCCCCSCCSSCCCC
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCC-CEEECCCCCCCccchhhHHhccCc
Confidence 888888877642 1 233467788888888888886 33332 3456777 888888888887778777766
Q ss_pred cccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccc
Q 001908 491 KNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSG 553 (997)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (997)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 68999999999998 7787775 7999999999999964 43 6788999999999999873
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-23 Score=217.31 Aligned_cols=196 Identities=18% Similarity=0.204 Sum_probs=161.9
Q ss_pred cccccccccCcccccccCCCCCCCCCCCEEeccCCC-CCCCCCCCcccccccceecccc-ccccccchhhhcCCCCCCeE
Q 001908 346 TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQ-LTGNIPREIGQLRNLQAIGLSS-NFLQGNIPSSLGNLTLMTDL 423 (997)
Q Consensus 346 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 423 (997)
..++.|++++|+|++..+..|.++++|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 467778888888887777788889999999999997 8877777888999999999998 89987667788899999999
Q ss_pred EeecCcCCCCCCCCCCCCCCCc---EEecCCC-cccCCccccccccccccc-ccccCCCcccCCCcc-ccccccccceec
Q 001908 424 FLSSNHLQGNIPPSLGNCKNLV---SLNLSDN-KLIGAVPQQILTITTLSR-FLDLGNNHLNGSLPL-EVGNLKNLVALY 497 (997)
Q Consensus 424 ~Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~ll~-~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 497 (997)
++++|++++ +|. |..+++|+ +|++++| ++++..+..+..++++ + .|++++|+++ .+|. .|.. ++|+.|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L-~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~ 185 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE-TLTLKLYNNGFT-SVQGYAFNG-TKLDAVY 185 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSS-EEEEECCSCCCC-EECTTTTTT-CEEEEEE
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcc-eeEEEcCCCCCc-ccCHhhcCC-CCCCEEE
Confidence 999999986 666 88888888 9999999 8875555667788888 8 8999999998 4444 4444 8999999
Q ss_pred ccccc-ccccccccccCC-cCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 498 ISGNQ-FSGEIPVTLTGC-TGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 498 Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+++|+ +++..+..|.++ ++|+.|++++|++++ +|.. .+++|+.|+++++
T Consensus 186 L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred cCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 99995 987667789999 999999999999984 4544 6778999999876
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=224.29 Aligned_cols=212 Identities=26% Similarity=0.350 Sum_probs=172.1
Q ss_pred cccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 348 MTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 348 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
+..+.++.+.++..+ .+..+++|+.|++++|+++. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++
T Consensus 21 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (308)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccC
Confidence 344556666665433 24567889999999999885 44 68888999999999999985444 88999999999999
Q ss_pred CcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccc
Q 001908 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 428 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
|++++ ++ .+..+++|++|++++|++++ +|. +..++++ +.|++++|++++..+ +..+++|+.|++++|++++.
T Consensus 95 n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L-~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~- 166 (308)
T 1h6u_A 95 NPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNL-QVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL- 166 (308)
T ss_dssp CCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTC-CEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred CcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCC-CEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-
Confidence 99985 33 68889999999999999875 443 7788888 889999999986544 88899999999999999854
Q ss_pred cccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCccc
Q 001908 508 PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
+. +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|++++|++++.
T Consensus 167 ~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 167 TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 43 8899999999999999986544 8899999999999999986553 88999999999999999863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-22 Score=211.35 Aligned_cols=181 Identities=19% Similarity=0.194 Sum_probs=139.4
Q ss_pred cccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEe
Q 001908 346 TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFL 425 (997)
Q Consensus 346 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 425 (997)
...+.++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 35678999999998 6777665 68999999999999999999999999999999999999988889999999999999
Q ss_pred ecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccc
Q 001908 426 SSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG 505 (997)
Q Consensus 426 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 505 (997)
++|++++..+..|..+++|++|+|++|++++..+.. |..+++|++|+|++|++++
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------------------~~~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGV-------------------------FDRLTKLKELRLNTNQLQS 145 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEECCSSCCCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhH-------------------------hccCCcccEEECcCCcCCc
Confidence 999999888888999999999999999887433333 3444555555555555554
Q ss_pred cccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcccccccc
Q 001908 506 EIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554 (997)
Q Consensus 506 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (997)
..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus 146 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 4444555556666666666666655555566666666666666666544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=224.68 Aligned_cols=241 Identities=18% Similarity=0.198 Sum_probs=149.0
Q ss_pred cEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCC-CCcccccccce-ecc
Q 001908 324 KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIP-REIGQLRNLQA-IGL 401 (997)
Q Consensus 324 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L 401 (997)
++++.++|+++ .+|..+ ++++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.++++|++ +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 34555666665 345433 2456777777777775555678888888888888888876555 46788887764 566
Q ss_pred ccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCC-CcccCCcccccccccccccccccCCCccc
Q 001908 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD-NKLIGAVPQQILTITTLSRFLDLGNNHLN 480 (997)
Q Consensus 402 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~ 480 (997)
+.|+|++..|..|.++++|++|++++|+|++..+..+....++..|++.+ |++....+..+..+...++.|+|++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 77888877778888888888888888888877666777777788888855 45543323344444443366666666666
Q ss_pred CCCccccccccccceecccc-ccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhc
Q 001908 481 GSLPLEVGNLKNLVALYISG-NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFL 559 (997)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 559 (997)
. +|.......+|+.|++++ |.++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++ +++. .+| .+
T Consensus 168 ~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l 242 (350)
T 4ay9_X 168 E-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TL 242 (350)
T ss_dssp E-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CT
T ss_pred C-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cc
Confidence 3 333333445666666653 4454222335566666666666666666433333443333333322 2233 344 25
Q ss_pred cCCCCCCEEeCCCC
Q 001908 560 ENLSFLEYLNLSYN 573 (997)
Q Consensus 560 ~~l~~L~~L~ls~N 573 (997)
.++++|+.++++++
T Consensus 243 ~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 243 EKLVALMEASLTYP 256 (350)
T ss_dssp TTCCSCCEEECSCH
T ss_pred hhCcChhhCcCCCC
Confidence 55666666666544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7.7e-24 Score=236.80 Aligned_cols=251 Identities=18% Similarity=0.188 Sum_probs=169.4
Q ss_pred CcEEEeecCccCCCCccccccc-ccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCC-CCCCcccccccceec
Q 001908 323 LKVLAFEENRLGGVLPHSIANL-STTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN-IPREIGQLRNLQAIG 400 (997)
Q Consensus 323 L~~L~L~~N~l~~~~p~~~~~l-~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 400 (997)
++.+++++|.+. |..+..+ .+.++.|++++|.+++..+. +..+++|++|++++|++++. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 555555555554 2222222 13455566666666655444 44677788888888877755 666777778888888
Q ss_pred cccccccccchhhhcCCCCCCeEEeecC-cCCCC-CCCCCCCCCCCcEEecCCC-cccCC-ccccccccc-ccccccccC
Q 001908 401 LSSNFLQGNIPSSLGNLTLMTDLFLSSN-HLQGN-IPPSLGNCKNLVSLNLSDN-KLIGA-VPQQILTIT-TLSRFLDLG 475 (997)
Q Consensus 401 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~ll~~L~Ls 475 (997)
|++|.+++..|..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ ++ +.|+++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L-~~L~l~ 203 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI-TQLNLS 203 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC-CEEECC
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC-CEEEeC
Confidence 8888877777777777888888888887 56642 5555677778888888888 77643 566666777 66 778888
Q ss_pred CC--ccc-CCCccccccccccceecccccc-ccccccccccCCcCccEEEccCcc-ccccCChhccccCcCCeeeCcccc
Q 001908 476 NN--HLN-GSLPLEVGNLKNLVALYISGNQ-FSGEIPVTLTGCTGLEIFHMQGNS-FRGSIPLSLRSLKSIKELDLSCNN 550 (997)
Q Consensus 476 ~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~ 550 (997)
+| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 87 444 3556667778888888888888 676777788888888888888885 32222225777888888888888
Q ss_pred ccccCchhccCC-CCCCEEeCCCCcCcccCCCC
Q 001908 551 LSGQIPEFLENL-SFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 551 l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~ 582 (997)
++. ..+..+ ..|+.|++++|++++..|..
T Consensus 283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 VPD---GTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence 432 233333 23666678888888877754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-22 Score=222.04 Aligned_cols=238 Identities=15% Similarity=0.093 Sum_probs=127.4
Q ss_pred hhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCC-CCCCCCCCCcE-EeccC
Q 001908 199 LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIP-ESFSNASNIEI-IDLPI 276 (997)
Q Consensus 199 L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls~ 276 (997)
++.++|+++ .||..+. +++++|+|++|+|+ .||...|.++++|++|+|++|++.+.+| .+|.++++++. ++++.
T Consensus 14 v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEESTTCC-SCCTTCC--TTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEecCCCCC-ccCcCcC--CCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 344444444 4555442 45666667666666 5666666666667777777776655554 34666666553 55556
Q ss_pred ccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeec-CccCCCCcccccccccccccccccC
Q 001908 277 NYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEE-NRLGGVLPHSIANLSTTMTDIYMGV 355 (997)
Q Consensus 277 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~~L~~L~l~~ 355 (997)
|+++.+.+..|..+++|++|++++|+++.++.. .+....++..|++.+ |++....+..|..+...++.|++++
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~------~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~ 163 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV------HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCC------TTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred CcccccCchhhhhccccccccccccccccCCch------hhcccchhhhhhhccccccccccccchhhcchhhhhhcccc
Confidence 667666666666666777777766666654432 122344555666644 3444433444444444455556666
Q ss_pred cccccccCCCCCCCCCCCEEeccC-CCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCC
Q 001908 356 NQISGTIPSGIGNLVNLNLLGIEF-NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI 434 (997)
Q Consensus 356 N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 434 (997)
|+|+. +|.......+|+.|++++ |.++.+.++.|.++++|++|+|++|+|+...+.. +.+|+.|.+.++.--..+
T Consensus 164 N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~---~~~L~~L~~l~~~~l~~l 239 (350)
T 4ay9_X 164 NGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG---LENLKKLRARSTYNLKKL 239 (350)
T ss_dssp SCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS---CTTCCEEECTTCTTCCCC
T ss_pred ccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh---hccchHhhhccCCCcCcC
Confidence 66653 333333344566666553 4444333344566666666666666665322222 334444443333222244
Q ss_pred CCCCCCCCCCcEEecCC
Q 001908 435 PPSLGNCKNLVSLNLSD 451 (997)
Q Consensus 435 p~~~~~l~~L~~L~L~~ 451 (997)
| .+.++++|+.+++++
T Consensus 240 P-~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 240 P-TLEKLVALMEASLTY 255 (350)
T ss_dssp C-CTTTCCSCCEEECSC
T ss_pred C-CchhCcChhhCcCCC
Confidence 4 255556666666544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=214.93 Aligned_cols=174 Identities=26% Similarity=0.423 Sum_probs=137.8
Q ss_pred CCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCC
Q 001908 365 GIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444 (997)
Q Consensus 365 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 444 (997)
.+..+++|++|+|++|++++..+ +.++++|++|+|++|++++ +| .+..+++|+.|+|++|++++ ++. +..+++|
T Consensus 58 ~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L 131 (308)
T 1h6u_A 58 GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNL 131 (308)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTC
T ss_pred hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCC
Confidence 45667788888888888876544 7788888888888888875 33 57888888888888888875 333 7888888
Q ss_pred cEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccC
Q 001908 445 VSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQG 524 (997)
Q Consensus 445 ~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 524 (997)
++|++++|++++..+ +..++++ +.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++
T Consensus 132 ~~L~l~~n~l~~~~~--l~~l~~L-~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~ 204 (308)
T 1h6u_A 132 QVLYLDLNQITNISP--LAGLTNL-QYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKN 204 (308)
T ss_dssp CEEECCSSCCCCCGG--GGGCTTC-CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTT
T ss_pred CEEECCCCccCcCcc--ccCCCCc-cEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccC
Confidence 888888888874433 6777777 888888888885433 8888999999999999985443 88899999999999
Q ss_pred ccccccCChhccccCcCCeeeCccccccc
Q 001908 525 NSFRGSIPLSLRSLKSIKELDLSCNNLSG 553 (997)
Q Consensus 525 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (997)
|++++..| +..+++|+.|+|++|++++
T Consensus 205 N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 205 NQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp SCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CccCcccc--ccCCCCCCEEEccCCeeec
Confidence 99986553 8899999999999999985
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=230.57 Aligned_cols=188 Identities=24% Similarity=0.335 Sum_probs=96.7
Q ss_pred CCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecc
Q 001908 322 KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401 (997)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 401 (997)
+|+.|+|++|++++ +|..+. ++|+.|++++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 67777777777765 444332 34555555555554 333 223444445555544443 333 332 4444444
Q ss_pred ccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccC
Q 001908 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG 481 (997)
Q Consensus 402 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~ 481 (997)
++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++| +.|+|++|+|++
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L-------------------------~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSL-------------------------EVLSVRNNQLTF 174 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTC-------------------------CEEECCSSCCSC
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCc-------------------------CEEECCCCCCCC
Confidence 4444443 333 33444444444444443 332 23344 444444444443
Q ss_pred CCccccccccccceeccccccccccccccccCCcCc-------cEEEccCccccccCChhccccCcCCeeeCcccccccc
Q 001908 482 SLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGL-------EIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554 (997)
Q Consensus 482 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (997)
+|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.
T Consensus 175 -lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~ 245 (571)
T 3cvr_A 175 -LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSR 245 (571)
T ss_dssp -CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHH
T ss_pred -cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCc
Confidence 333 33 55555666666555 4444 433 44 66677777666 4666666677777777777777766
Q ss_pred CchhccCCC
Q 001908 555 IPEFLENLS 563 (997)
Q Consensus 555 ~p~~~~~l~ 563 (997)
+|..+..++
T Consensus 246 ~p~~l~~l~ 254 (571)
T 3cvr_A 246 IRESLSQQT 254 (571)
T ss_dssp HHHHHHHHH
T ss_pred CHHHHHHhh
Confidence 666665543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-23 Score=249.45 Aligned_cols=222 Identities=18% Similarity=0.119 Sum_probs=135.5
Q ss_pred eeeeeeecCCCCcEEEEeccCCCCC-------------------------Cccccc---ccCccccccccccccccCCCC
Q 001908 63 QWAGVTCGHRHQRVTELDLRHQNIG-------------------------GSLSPY---VGNLSFLRYINLATNNFHGEI 114 (997)
Q Consensus 63 ~w~gv~C~~~~~~v~~L~L~~~~l~-------------------------g~~~~~---l~~l~~L~~L~Ls~N~l~g~~ 114 (997)
+|+++.|+....+|-.+++..-.+. |..+.. +..+++|+.|+|++|+++ .+
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L 364 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence 5888888777778888887654331 111111 256778888888888887 78
Q ss_pred CccCCCCCCCeEEEccCCC-------------ccccCCccccCCCcccchh-cccccccccccccccccccccceeeccc
Q 001908 115 PKEIGFLFRLETLMLANNS-------------FSGKIPTNLSSCSNLLSFV-AYRNNLVGEIPEDIGYSWLKLEHISLAR 180 (997)
Q Consensus 115 p~~~~~l~~L~~L~Ls~N~-------------l~g~iP~~l~~l~~L~~l~-l~~n~~~g~ip~~~~~~l~~L~~L~L~~ 180 (997)
|+++++|++|++|++++|. +.|.+|..++++++|+.|+ +..|.+ .+|..+.+++
T Consensus 365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~------------~~L~~l~l~~ 432 (567)
T 1dce_A 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL------------DDLRSKFLLE 432 (567)
T ss_dssp HHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH------------HHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc------------chhhhhhhhc
Confidence 8888888888888887765 4455555566666666555 333322 2344555555
Q ss_pred ccccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCC
Q 001908 181 NHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIP 260 (997)
Q Consensus 181 N~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p 260 (997)
|.+++..+. .+.+|+|++|++++ +|. ++++++|+.|+|++|+|+ .+|..++ .+++|+.|+|++|+|++ +|
T Consensus 433 n~i~~l~~~-----~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L~~L~Ls~N~l~~-lp 502 (567)
T 1dce_A 433 NSVLKMEYA-----DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA-ALRCLEVLQASDNALEN-VD 502 (567)
T ss_dssp HHHHHHHHT-----TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCC-CG
T ss_pred ccccccCcc-----CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh-cCCCCCEEECCCCCCCC-Cc
Confidence 555532221 23446666666664 554 666666666666666666 5665444 56666666666666664 44
Q ss_pred CCCCCCCCCcEEeccCccCCCcc-cccccccCccCeeEccCccCCCCCC
Q 001908 261 ESFSNASNIEIIDLPINYFTGKV-SIIFGRLKNLWSLDLGINNLGSGGA 308 (997)
Q Consensus 261 ~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~ 308 (997)
.|+++++|++|+|++|+|++.. |..|+.+++|++|+|++|++++.++
T Consensus 503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred -ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 5666666666666666666655 5666666666666666666655433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.1e-21 Score=196.46 Aligned_cols=161 Identities=23% Similarity=0.198 Sum_probs=74.6
Q ss_pred CCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecC
Q 001908 371 NLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLS 450 (997)
Q Consensus 371 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 450 (997)
+|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44555555555554444444445555555555555544333344445555555555555544434444444444444444
Q ss_pred CCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcccccc
Q 001908 451 DNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGS 530 (997)
Q Consensus 451 ~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 530 (997)
+|++++ ..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|.+.+
T Consensus 109 ~N~l~~-------------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~- 162 (208)
T 2o6s_A 109 TNQLQS-------------------------LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC- 162 (208)
T ss_dssp SSCCCC-------------------------CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-
T ss_pred CCcCcc-------------------------cCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-
Confidence 444442 222223344444444444444443333334444444444444444432
Q ss_pred CChhccccCcCCeeeCccccccccCchhccCCC
Q 001908 531 IPLSLRSLKSIKELDLSCNNLSGQIPEFLENLS 563 (997)
Q Consensus 531 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 563 (997)
.+++|+.|+++.|+++|.+|..++.++
T Consensus 163 ------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 163 ------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp ------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 223445555555555555555544443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=194.32 Aligned_cols=163 Identities=21% Similarity=0.184 Sum_probs=111.6
Q ss_pred cccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEe
Q 001908 346 TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFL 425 (997)
Q Consensus 346 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 425 (997)
++++.|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 34566666666666555666777778888888888887666666777788888888888887666666777888888888
Q ss_pred ecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccc
Q 001908 426 SSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG 505 (997)
Q Consensus 426 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 505 (997)
++|+|++..+..|.++++|++|+|++|++++..+..+..++++ +.|++++|.+.+. +++|+.|+++.|+++|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL-QYIWLHDNPWDCT-------CPGIRYLSEWINKHSG 179 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC-CEEECCSCCBCCC-------TTTTHHHHHHHHHCTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCc-cEEEecCCCeecC-------CCCHHHHHHHHHhCCc
Confidence 8888876666667777788888887777775444445555555 6666666655532 3456666666666666
Q ss_pred cccccccCCcC
Q 001908 506 EIPVTLTGCTG 516 (997)
Q Consensus 506 ~~p~~~~~l~~ 516 (997)
.+|.+++.++.
T Consensus 180 ~ip~~~~~l~~ 190 (208)
T 2o6s_A 180 VVRNSAGSVAP 190 (208)
T ss_dssp TBBCTTSSBCT
T ss_pred eeeccCccccC
Confidence 66666555443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5e-21 Score=207.23 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=112.0
Q ss_pred HHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch------------------hhHHHHHHHHHHHhhcC
Q 001908 673 ELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK------------------GALKSFVAECEVLRNTR 734 (997)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 734 (997)
.+......|.+.+.||+|+||.||+|++ .+|+.||||+++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3344445677779999999999999999 6899999999963221 13467899999999998
Q ss_pred CCCcceEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEec
Q 001908 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHG 814 (997)
Q Consensus 735 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHr 814 (997)
| +++.+++. .+..++||||+++|+|.+ +... ....++.|++.|+.|||+. +|+||
T Consensus 163 ~---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~~------------~~~~i~~qi~~~l~~lH~~---giiHr 217 (282)
T 1zar_A 163 G---LAVPKVYA------WEGNAVLMELIDAKELYR-VRVE------------NPDEVLDMILEEVAKFYHR---GIVHG 217 (282)
T ss_dssp T---SSSCCEEE------EETTEEEEECCCCEEGGG-CCCS------------CHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred C---CCcCeEEe------ccceEEEEEecCCCcHHH-cchh------------hHHHHHHHHHHHHHHHHHC---CCEeC
Confidence 4 55555432 135699999999999988 4221 2346999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEcccccchh
Q 001908 815 DLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 815 Dlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
||||+||+++ ++.+||+|||+|+.
T Consensus 218 Dlkp~NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 218 DLSQYNVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp CCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred CCCHHHEEEE-CCcEEEEECCCCeE
Confidence 9999999999 99999999999863
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.3e-22 Score=241.54 Aligned_cols=232 Identities=17% Similarity=0.152 Sum_probs=127.2
Q ss_pred CHHHHHHHHHHHHhcCC-CCCCCCCCC-CCCCCCeeeeeeecCCCCcEEEEeccCCCCCCcccccccCccccccc-----
Q 001908 31 NETDRLALLAIKSQLHD-PLGVTNSWN-NSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYI----- 103 (997)
Q Consensus 31 ~~~~~~aLl~~k~~~~~-~~~~~~sW~-~~~~~c~w~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L----- 103 (997)
...++++|+++..++.. ....-.+|. .++..+.|.+++++. .+++.|+|.+|++.+ ++..+.....|+.+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccCc
Confidence 45688999999988532 223344674 445678999999864 689999999999876 34433333223332
Q ss_pred cccccccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccccc
Q 001908 104 NLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHL 183 (997)
Q Consensus 104 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N~l 183 (997)
+++.|.+. ..|..+..+++|++|+|++|.+. .||..++++++|++|++++|++. .||..++ .+++|++|+|++|.|
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIK-NLSNLRVLDLSHNRL 282 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGG-GGTTCCEEECTTSCC
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhh-CCCCCCEEeCcCCcC
Confidence 23334444 55788999999999999999998 89999999999999999999988 8898774 688999999999999
Q ss_pred cCcCcCccCcch-hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCC
Q 001908 184 TGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPES 262 (997)
Q Consensus 184 ~g~~p~~~~~l~-~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~ 262 (997)
+ .+|..|+++. +.+|+|++|+++ .+|..|+++++|+.|+|++|.|+|.+|..++.....+..++|++|.++|.+|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 8 7788888874 567888888886 778888888888888888888887777666532223344678888888887764
Q ss_pred CCCCCCCcEEeccCc
Q 001908 263 FSNASNIEIIDLPIN 277 (997)
Q Consensus 263 ~~~l~~L~~L~Ls~N 277 (997)
|+.|++++|
T Consensus 361 ------l~~l~l~~n 369 (727)
T 4b8c_D 361 ------RRFIEINTD 369 (727)
T ss_dssp ---------------
T ss_pred ------cceeEeecc
Confidence 455666666
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-20 Score=195.55 Aligned_cols=158 Identities=19% Similarity=0.232 Sum_probs=121.0
Q ss_pred CeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc-ccccccccccccccCCCcccCCCccccccccccceeccc
Q 001908 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ-QILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYIS 499 (997)
Q Consensus 421 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 499 (997)
+.+++++|.++ .+|..+. ..+++|+|++|++++..|. .+..++++ +.|+|++|+|++..+..|.++++|++|+|+
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L-~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQL-RKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCC-CEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 35566666665 3444432 3345666666666644332 34556665 666777777776666678888889999999
Q ss_pred cccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccC
Q 001908 500 GNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEV 579 (997)
Q Consensus 500 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 579 (997)
+|++++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++.+
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99998877778889999999999999999888889999999999999999999888899999999999999999999877
Q ss_pred CCC
Q 001908 580 PTK 582 (997)
Q Consensus 580 p~~ 582 (997)
+..
T Consensus 170 ~l~ 172 (220)
T 2v70_A 170 YLA 172 (220)
T ss_dssp GGH
T ss_pred chH
Confidence 643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=7.3e-20 Score=199.57 Aligned_cols=189 Identities=24% Similarity=0.331 Sum_probs=111.6
Q ss_pred cccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 348 MTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 348 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
+..+.++.+.+++.. .+..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|+.|+|++
T Consensus 26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 344455555555332 234567777777777777743 3 36777777777777777775433 77777777777777
Q ss_pred CcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccc
Q 001908 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 428 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
|++++ +| .+..+++|++|++++|++++ + ..+ ..+++|+.|++++|++++.
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l-------------------------~~l~~L~~L~l~~n~l~~~- 149 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGL-------------------------VHLPQLESLYLGNNKITDI- 149 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGG-------------------------GGCTTCCEEECCSSCCCCC-
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhh-------------------------cCCCCCCEEEccCCcCCcc-
Confidence 77764 33 36677777777777777653 2 223 3444555555555555432
Q ss_pred cccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcc
Q 001908 508 PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 577 (997)
..+..+++|+.|++++|++++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++.
T Consensus 150 -~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 150 -TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred -hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 345555555555555555554333 5555555555555555553 22 25555666666666665554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.6e-20 Score=192.29 Aligned_cols=137 Identities=20% Similarity=0.267 Sum_probs=92.1
Q ss_pred CCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEc
Q 001908 443 NLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHM 522 (997)
Q Consensus 443 ~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 522 (997)
+|++|+|++|++++..+..+..++++ +.|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L-~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKL-RRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTC-CEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCC-CEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 44444444444443333334444444 44444444444455666777777777777777777555555677788888888
Q ss_pred cCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCC
Q 001908 523 QGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 523 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|.+...
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 8888887777778888888888888888887777778888888888888888876554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-19 Score=215.04 Aligned_cols=188 Identities=22% Similarity=0.276 Sum_probs=97.3
Q ss_pred hhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccC
Q 001908 197 IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPI 276 (997)
Q Consensus 197 ~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 276 (997)
..+.++.+.+...++ +..+++|+.|+|++|.+. .+|. +..+++|+.|+|++|+|++..| +..+++|+.|+|++
T Consensus 24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 345666666654333 456677777777777776 4442 2356666666666666665444 56666666666666
Q ss_pred ccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCc
Q 001908 277 NYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVN 356 (997)
Q Consensus 277 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N 356 (997)
|+|++.. .|..+++|+.|+|++|+|+.+ +.+..+++|+.|+|++|++++
T Consensus 97 N~l~~l~--~l~~l~~L~~L~Ls~N~l~~l--------~~l~~l~~L~~L~Ls~N~l~~--------------------- 145 (605)
T 1m9s_A 97 NKIKDLS--SLKDLKKLKSLSLEHNGISDI--------NGLVHLPQLESLYLGNNKITD--------------------- 145 (605)
T ss_dssp SCCCCCT--TSTTCTTCCEEECTTSCCCCC--------GGGGGCTTCSEEECCSSCCCC---------------------
T ss_pred CCCCCCh--hhccCCCCCEEEecCCCCCCC--------ccccCCCccCEEECCCCccCC---------------------
Confidence 6665432 345555555555555554432 123344444444444443332
Q ss_pred ccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCC
Q 001908 357 QISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG 432 (997)
Q Consensus 357 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 432 (997)
. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++.+
T Consensus 146 ----l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 146 ----I--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp ----C--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEEC
T ss_pred ----c--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcC
Confidence 1 123344555555555555554433 44555555555555555532 2 34555555555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=197.50 Aligned_cols=172 Identities=28% Similarity=0.343 Sum_probs=125.8
Q ss_pred ccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccccccc
Q 001908 391 GQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSR 470 (997)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~ 470 (997)
..+++|++|++++|.++. ++ .+..+++|+.|+|++|++++..+ +.++++|++|++++|
T Consensus 43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n------------------ 100 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN------------------ 100 (291)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS------------------
T ss_pred hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC------------------
Confidence 345555555555555552 22 24455555555555555553322 445555555555554
Q ss_pred ccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcccc
Q 001908 471 FLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNN 550 (997)
Q Consensus 471 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 550 (997)
++++ +| .+..+++|+.|++++|++++ + ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|+
T Consensus 101 -------~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~ 167 (291)
T 1h6t_A 101 -------KVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQ 167 (291)
T ss_dssp -------CCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred -------cCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCc
Confidence 4442 22 37778899999999999985 3 4788999999999999999965 689999999999999999
Q ss_pred ccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcC
Q 001908 551 LSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLC 600 (997)
Q Consensus 551 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C 600 (997)
+++..| +..+++|++|++++|.+++. |....++++..+++.+|+..+
T Consensus 168 l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 168 ISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred cccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 997655 99999999999999999974 556678899999999998755
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.3e-20 Score=206.32 Aligned_cols=178 Identities=24% Similarity=0.203 Sum_probs=104.4
Q ss_pred CEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhc-CCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCC
Q 001908 373 NLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLG-NLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD 451 (997)
Q Consensus 373 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 451 (997)
+.+++++|+++ .+|..+. +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 56777877777 3555443 3467777777777766666666 777777777777777766666677777777777777
Q ss_pred CcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccC
Q 001908 452 NKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531 (997)
Q Consensus 452 N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 531 (997)
|++++..+ ..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus 98 N~l~~~~~-------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 98 NHLHTLDE-------------------------FLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp SCCCEECT-------------------------TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred CcCCcCCH-------------------------HHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 76653333 33444455555555555555444555555555555555555555322
Q ss_pred Chhc---cccCcCCeeeCccccccccCchhccCCCC--CCEEeCCCCcCccc
Q 001908 532 PLSL---RSLKSIKELDLSCNNLSGQIPEFLENLSF--LEYLNLSYNHFDGE 578 (997)
Q Consensus 532 p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~ls~N~l~~~ 578 (997)
+..| ..+++|+.|||++|+|++..+..+..++. |+.|+|++|+|.+.
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 2223 34555666666666665444445555554 25555555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=214.49 Aligned_cols=191 Identities=24% Similarity=0.328 Sum_probs=140.7
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEee
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS 426 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 426 (997)
.+..+.++.+.+....+ +..+++|+.|++++|.++.. | .+..+++|+.|+|++|+|++..| +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 35556667777665443 46778888899999988743 3 58888899999999999986554 8888999999999
Q ss_pred cCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccc
Q 001908 427 SNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE 506 (997)
Q Consensus 427 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 506 (997)
+|+|++ +| .+..+++|+.|+|++|++.+ + ..+..+++| +.|+|++|++++. ..++.+++|+.|+|++|+|++.
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L-~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQL-ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTC-SEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCcc-CEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 999885 33 68888889999999888874 3 346666666 7777777777754 4567777777777777777755
Q ss_pred ccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcccccccc
Q 001908 507 IPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ 554 (997)
Q Consensus 507 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (997)
.| +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred hh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 55 77777777777777777743 3 567777777777777777654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=184.71 Aligned_cols=154 Identities=19% Similarity=0.220 Sum_probs=138.6
Q ss_pred cEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccC
Q 001908 445 VSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQG 524 (997)
Q Consensus 445 ~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 524 (997)
+.+++++|.++ .+|..+. ..+ +.|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l-~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETI-TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTC-CEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC--cCC-CEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 57788888877 6776554 445 8999999999988888999999999999999999988899999999999999999
Q ss_pred ccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCC-CCcCCCCcceeecCCCCcCCC
Q 001908 525 NSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT-KGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 525 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~N~~~C~~ 602 (997)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+. ...+.++..+++.+|||.|.|
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 999976677789999999999999999999999999999999999999999988775 356788999999999999975
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.5e-19 Score=183.57 Aligned_cols=156 Identities=22% Similarity=0.215 Sum_probs=111.0
Q ss_pred cceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccC
Q 001908 396 LQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLG 475 (997)
Q Consensus 396 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls 475 (997)
-+.++.+++.++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l--------------------- 76 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL--------------------- 76 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC---------------------
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC---------------------
Confidence 445666666665 4554333 5566666666666655555555555555555555555
Q ss_pred CCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccC
Q 001908 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI 555 (997)
Q Consensus 476 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 555 (997)
++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..
T Consensus 77 ----~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~ 151 (229)
T 3e6j_A 77 ----GALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP 151 (229)
T ss_dssp ----CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCC
T ss_pred ----CCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccC
Confidence 3333445667777888888888888666666788888888888888888 77888888888888888888888776
Q ss_pred chhccCCCCCCEEeCCCCcCcccCC
Q 001908 556 PEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 556 p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
+..|..+++|+.|+|++|++++.++
T Consensus 152 ~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 152 HGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHHhCCCCCCEEEeeCCCccCCcc
Confidence 7778888888888888888887765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-21 Score=232.64 Aligned_cols=192 Identities=20% Similarity=0.218 Sum_probs=135.0
Q ss_pred CCCCCCCEEeccCCCCCCCCCCCcccccccceecccccc-------------ccccchhhhcCCCCCCeEE-eecCcCCC
Q 001908 367 GNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF-------------LQGNIPSSLGNLTLMTDLF-LSSNHLQG 432 (997)
Q Consensus 367 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~ 432 (997)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 55677778888888876 677778888888888877665 4566677777777777777 5666442
Q ss_pred CCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccccccccc
Q 001908 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLT 512 (997)
Q Consensus 433 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 512 (997)
+|+.+.+++|.+.+ +|. ..+ +.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+
T Consensus 424 ----------~L~~l~l~~n~i~~-l~~-----~~L-~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLK-MEY-----ADV-RVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHH-HHH-----TTC-SEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------hhhhhhhhcccccc-cCc-----cCc-eEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 34555555555542 221 123 667777777774 555 777777777777777777 6777777
Q ss_pred CCcCccEEEccCccccccCChhccccCcCCeeeCccccccccC-chhccCCCCCCEEeCCCCcCcccCCCC
Q 001908 513 GCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQI-PEFLENLSFLEYLNLSYNHFDGEVPTK 582 (997)
Q Consensus 513 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~ 582 (997)
++++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..+..+++|+.|+|++|++++.+|..
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 77777777777777775 56 6777777777777777777665 777777777777777777777776644
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.2e-19 Score=200.04 Aligned_cols=179 Identities=20% Similarity=0.169 Sum_probs=130.6
Q ss_pred ccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcc-cccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 349 TDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIG-QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 349 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57889999998 5777665 4689999999999998888888 999999999999999988888999999999999999
Q ss_pred CcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccc
Q 001908 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 428 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
|+|++..+..|.++++|++|+|++|++++..|..+..+++| +.|+|++|+|++..+..|..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~------------------ 158 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL-QKLYLSQNQISRFPVELIKD------------------ 158 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCSSCCCSCCGGGTC-------------------
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccC-CEEECCCCcCCeeCHHHhcC------------------
Confidence 99998888889999999999999999875545445444444 44444444444322222200
Q ss_pred cccccCCcCccEEEccCccccccCChhccccCc--CCeeeCcccccc
Q 001908 508 PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKS--IKELDLSCNNLS 552 (997)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~ 552 (997)
+..+++|+.|+|++|+|++..+..+..++. |+.|+|++|.+.
T Consensus 159 ---~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 159 ---GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp ------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ---cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 034555666666666665444445555554 366666666665
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-19 Score=222.06 Aligned_cols=200 Identities=20% Similarity=0.237 Sum_probs=101.6
Q ss_pred ccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCC
Q 001908 353 MGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG 432 (997)
Q Consensus 353 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 432 (997)
+..|.+. ..|..|..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 55667777777888888888877 56666667777888888888777 67777777777777777777777
Q ss_pred CCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccc-cceeccccccccccccccc
Q 001908 433 NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKN-LVALYISGNQFSGEIPVTL 511 (997)
Q Consensus 433 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~ 511 (997)
.+|..|+++++|++|+|++|.|+ .+|..+..+++| +.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNL-QFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTC-CCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCc-cEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 66777777777777777777775 666666666666 66777777776666666554322 233666777776666643
Q ss_pred cCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCC
Q 001908 512 TGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 512 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
|..|++++|... -. ..+.|.+..+..+..+..+....+++|-+.+...
T Consensus 361 -----l~~l~l~~n~~~---~~-------------~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~ 408 (727)
T 4b8c_D 361 -----RRFIEINTDGEP---QR-------------EYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYA 408 (727)
T ss_dssp --------------------------------------------------------------CCCGGGC
T ss_pred -----cceeEeeccccc---cc-------------ccCCccccccchhhcccccceeeeeccccccccC
Confidence 344455555100 00 1113333444455566666677777777765443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-18 Score=178.98 Aligned_cols=110 Identities=20% Similarity=0.186 Sum_probs=63.8
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEee
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS 426 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 426 (997)
+|+.|++++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|+
T Consensus 58 ~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 137 (220)
T 2v70_A 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLY 137 (220)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECT
T ss_pred CCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECC
Confidence 44444444444444444555555666666666666665555555666666666666666665555556666666666666
Q ss_pred cCcCCCCCCCCCCCCCCCcEEecCCCcccC
Q 001908 427 SNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 427 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 456 (997)
+|+|++..|..|..+++|++|+|++|.+.+
T Consensus 138 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 138 DNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp TSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 666665555566666666666666665553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.8e-18 Score=177.60 Aligned_cols=135 Identities=25% Similarity=0.226 Sum_probs=78.2
Q ss_pred CCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEec
Q 001908 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449 (997)
Q Consensus 370 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 449 (997)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 55666666666666555556666666666666666665444445556666666666666666555555555666666666
Q ss_pred CCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccc
Q 001908 450 SDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG 529 (997)
Q Consensus 450 ~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (997)
++|+++ .+ |..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+
T Consensus 120 s~N~l~-~l-------------------------p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 120 CCNKLT-EL-------------------------PRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSSCCC-SC-------------------------CTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccc-cc-------------------------CcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 665554 33 4444455555556666666554444455556666666666666654
Q ss_pred c
Q 001908 530 S 530 (997)
Q Consensus 530 ~ 530 (997)
.
T Consensus 174 ~ 174 (229)
T 3e6j_A 174 E 174 (229)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-18 Score=177.95 Aligned_cols=133 Identities=26% Similarity=0.323 Sum_probs=77.8
Q ss_pred cccccCCCcccCCCcc-ccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcc
Q 001908 470 RFLDLGNNHLNGSLPL-EVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSC 548 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 548 (997)
+.|++++|++++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 32 ~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 111 (192)
T 1w8a_A 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111 (192)
T ss_dssp SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCS
T ss_pred CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence 4444444444433332 355666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCC
Q 001908 549 NNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 549 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~ 602 (997)
|+|++.+|..+..+++|++|+|++|+|+|.++..+....+....+.++...|+.
T Consensus 112 N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 112 NQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred CcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence 666666666666666666667777766666553322112222334445555553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-18 Score=185.82 Aligned_cols=170 Identities=21% Similarity=0.290 Sum_probs=101.5
Q ss_pred CCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEe
Q 001908 369 LVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLN 448 (997)
Q Consensus 369 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 448 (997)
+.++..+++++|.+++.. .+..+++|++|++++|.++ .+| .+..+++|+.|+|++|+|++..+ +.++++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 444555555555555322 3455555555555555555 233 45555555555555555553322 55555555555
Q ss_pred cCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcccc
Q 001908 449 LSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528 (997)
Q Consensus 449 L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (997)
|++|+++ + +|.. .. ++|+.|+|++|++++ ++ .+..+++|+.|+|++|+++
T Consensus 92 L~~N~l~-------------------------~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 92 VNRNRLK-------------------------N-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp CCSSCCS-------------------------C-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCC
T ss_pred CCCCccC-------------------------C-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCC
Confidence 5555544 2 2211 11 567777777777764 33 4777777777777777777
Q ss_pred ccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCccc
Q 001908 529 GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 529 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
+. | .+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++.
T Consensus 142 ~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 142 SI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 43 3 577777777777777777755 5677777788888888877765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=174.94 Aligned_cols=82 Identities=18% Similarity=0.239 Sum_probs=34.3
Q ss_pred ccccceeccccccccccccccccCCcCccEEEccCcc-ccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEE
Q 001908 490 LKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNS-FRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568 (997)
Q Consensus 490 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 568 (997)
+++|++|++++|++++..|..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|
T Consensus 111 l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L 186 (197)
T 4ezg_A 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQL 186 (197)
T ss_dssp CTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEE
T ss_pred CCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEE
Confidence 3334444444444443333444444444444444443 22 233 34444444444444444443 22 34444445555
Q ss_pred eCCCCcC
Q 001908 569 NLSYNHF 575 (997)
Q Consensus 569 ~ls~N~l 575 (997)
++++|++
T Consensus 187 ~l~~N~i 193 (197)
T 4ezg_A 187 YAFSQTI 193 (197)
T ss_dssp EECBC--
T ss_pred EeeCccc
Confidence 5555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=185.22 Aligned_cols=167 Identities=20% Similarity=0.302 Sum_probs=114.5
Q ss_pred cccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEe
Q 001908 346 TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFL 425 (997)
Q Consensus 346 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 425 (997)
..+..+++++|.+++.. .+..+++|++|++++|+++. +| .+..+++|++|+|++|+|++..| +.++++|+.|+|
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 45777888888887543 67889999999999999984 55 78899999999999999996544 999999999999
Q ss_pred ecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccc
Q 001908 426 SSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG 505 (997)
Q Consensus 426 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 505 (997)
++|++++ +|.... ++|++|+|++|++++ +| .+..++++ +.|+|++|++++. | .+..+++|+.|+|++|++++
T Consensus 93 ~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L-~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 93 NRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNL-EILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTC-CEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccc-cEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 9999996 444332 888888888888863 22 34444444 5555555555532 2 34445555555555555543
Q ss_pred cccccccCCcCccEEEccCcccc
Q 001908 506 EIPVTLTGCTGLEIFHMQGNSFR 528 (997)
Q Consensus 506 ~~p~~~~~l~~L~~L~Ls~N~l~ 528 (997)
. ..+..+++|+.|++++|+++
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEE
T ss_pred h--HHhccCCCCCEEeCCCCccc
Confidence 3 33444444444444444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=5.9e-18 Score=173.17 Aligned_cols=156 Identities=15% Similarity=0.238 Sum_probs=134.8
Q ss_pred CcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccccc
Q 001908 389 EIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTL 468 (997)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l 468 (997)
..+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..++++
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467889999999999998 566 6899999999999999776 34578899999999999999998888899999998
Q ss_pred ccccccCCCcccCCCccccccccccceecccccc-ccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCc
Q 001908 469 SRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQ-FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLS 547 (997)
Q Consensus 469 l~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (997)
++|++++|++++..|..++.+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|+++
T Consensus 115 -~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~ 189 (197)
T 4ezg_A 115 -TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAF 189 (197)
T ss_dssp -CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEEC
T ss_pred -CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEee
Confidence 999999999998888999999999999999998 55 666 78999999999999999985 44 78899999999999
Q ss_pred cccccc
Q 001908 548 CNNLSG 553 (997)
Q Consensus 548 ~N~l~~ 553 (997)
+|++.+
T Consensus 190 ~N~i~~ 195 (197)
T 4ezg_A 190 SQTIGG 195 (197)
T ss_dssp BC----
T ss_pred CcccCC
Confidence 999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=9.3e-18 Score=170.82 Aligned_cols=175 Identities=19% Similarity=0.230 Sum_probs=111.1
Q ss_pred CeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccc-ccccccccccccccCCCcccCCCccccccccccceeccc
Q 001908 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ-QILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYIS 499 (997)
Q Consensus 421 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 499 (997)
+.+++++|+++ .+|..+.. +|++|++++|++++..+. .+..++++ ++|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHL-VKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTC-CEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCC-CEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 45555555554 34444332 566666666666543333 25555555 666666666666667777777777777888
Q ss_pred cccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchh-ccCCCCCCEEeCCCCcCccc
Q 001908 500 GNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEF-LENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 500 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~ 578 (997)
+|+|++..|..|.++++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++..+.. +. ..++...+..+...+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCC
Confidence 88777777777777788888888888888777777888888888888888887665421 11 1122234455555555
Q ss_pred CCCCCcCCCCcceeecCCCCcCCCC
Q 001908 579 VPTKGVFSNKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 579 ~p~~~~~~~~~~~~~~~N~~~C~~~ 603 (997)
.|.. +.......+..+...|.+.
T Consensus 165 ~P~~--l~~~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 165 APSK--VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp SSTT--TTTSBGGGSCTTTCCCCCC
T ss_pred CChH--HcCCChhhCcHhhcCcCCC
Confidence 5543 5555666677777778644
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.6e-18 Score=180.51 Aligned_cols=138 Identities=20% Similarity=0.168 Sum_probs=107.6
Q ss_pred cCccCCcccccCcceEEEEEECCCCcE--EEEEEecccch------------------------hhHHHHHHHHHHHhhc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTF--VAVKILNLMQK------------------------GALKSFVAECEVLRNT 733 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~--vAvK~~~~~~~------------------------~~~~~~~~E~~~l~~l 733 (997)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++.... .....+.+|+++++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999668888 99999753211 1123678999999999
Q ss_pred CCCCc--ceEEeeeeccCcCCCceEEEEEeeccC-C----CHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh-h
Q 001908 734 RHRNL--IKIITVCSSIDFKGADFKALVYEYMQN-G----SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH-H 805 (997)
Q Consensus 734 ~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH-~ 805 (997)
+|+++ +..+++ ...++||||+.+ | +|.++.... ++..+..++.|++.|+.||| +
T Consensus 128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~~---------~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGREL---------KELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGGG---------GGSCHHHHHHHHHHHHHHHHHT
T ss_pred HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhcc---------ChHHHHHHHHHHHHHHHHHHHH
Confidence 88764 344432 246899999942 4 787765431 12356788999999999999 8
Q ss_pred CCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 806 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 806 ~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
. +|+||||||+|||++. .++|+|||+|...
T Consensus 190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp S---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred C---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 8 9999999999999988 9999999999653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=185.66 Aligned_cols=269 Identities=12% Similarity=0.067 Sum_probs=150.5
Q ss_pred ccccceeeccccccc--CcCcCccCcch---hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCC
Q 001908 170 WLKLEHISLARNHLT--GMLPASIGNLS---IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPN 244 (997)
Q Consensus 170 l~~L~~L~L~~N~l~--g~~p~~~~~l~---~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~ 244 (997)
+++|++|||++|++. ...+..+.... .....+..+.|.+.+|..+.+|++|+.|+|.. +++ .|+...|.++++
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~ 125 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDN 125 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTT
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcc
Confidence 456788888888887 22222222200 01112333334444444444488888888887 776 677777777888
Q ss_pred ccEEEecCCcCcCCCCCCCCCCCCCcEEeccCc----cCCCcccccccccCccC-eeEccCccCCCCCCCCcchhhhhcc
Q 001908 245 LQVFAIGDNYFSGSIPESFSNASNIEIIDLPIN----YFTGKVSIIFGRLKNLW-SLDLGINNLGSGGANDLDFVTILTN 319 (997)
Q Consensus 245 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N----~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~~~~l~~ 319 (997)
|+.+++++|.++...+.+|.++.++..+.+..+ .........|.++.+|+ .+++.... .++. .....-..
T Consensus 126 L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~--~l~~---~~~~~~~~ 200 (329)
T 3sb4_A 126 LKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG--KLED---EIMKAGLQ 200 (329)
T ss_dssp CCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC--CHHH---HHHHTTCC
T ss_pred cceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC--cHHH---HHhhcccC
Confidence 888888888777666777777777777766653 22333344555555555 34333211 0000 00000112
Q ss_pred CCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccc-e
Q 001908 320 CSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQ-A 398 (997)
Q Consensus 320 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~ 398 (997)
..+++.+.+.++-.. .....+....++|+.+++++|+++.+.+.+|.++++|+.++|.+| ++.+.+.+|.++++|+ .
T Consensus 201 ~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~ 278 (329)
T 3sb4_A 201 PRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGT 278 (329)
T ss_dssp GGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred ccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEE
Confidence 344555555544211 111111111245666666666666555566666666666666666 5555556666666666 6
Q ss_pred eccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEe
Q 001908 399 IGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLN 448 (997)
Q Consensus 399 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 448 (997)
+++.+ .++...+.+|.++++|+.|++++|+++...+.+|.++++|+.++
T Consensus 279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 66666 55545556666666666666666666655555666666666665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=4e-17 Score=181.41 Aligned_cols=194 Identities=10% Similarity=0.069 Sum_probs=95.5
Q ss_pred CCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecC----cCCCCCCCCCCCCCCC
Q 001908 369 LVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN----HLQGNIPPSLGNCKNL 444 (997)
Q Consensus 369 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N----~l~~~~p~~~~~l~~L 444 (997)
+++|+.|+|.+ +++.+.+.+|.++++|+.|++++|.++...+..|.++.++..+.+..+ .........|.++.+|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 66666666666 666555556666666666666666666555555665555544444432 1222333445555555
Q ss_pred c-EEecCCCcccCCcccccc----------------------------cccccccccccCCCcccCCCccccccccccce
Q 001908 445 V-SLNLSDNKLIGAVPQQIL----------------------------TITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495 (997)
Q Consensus 445 ~-~L~L~~N~l~~~~p~~~~----------------------------~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~ 495 (997)
+ .+.+.... .++..+. .+.++ +.++|++|+++...+..|.++++|+.
T Consensus 179 ~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L-~~l~L~~n~i~~I~~~aF~~~~~L~~ 254 (329)
T 3sb4_A 179 ETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNL-VSLDISKTNATTIPDFTFAQKKYLLK 254 (329)
T ss_dssp EEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTC-CEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred ceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCC-eEEECCCCCcceecHhhhhCCCCCCE
Confidence 5 34333221 1222111 12333 44555555555444444555555555
Q ss_pred eccccccccccccccccCCcCcc-EEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEe
Q 001908 496 LYISGNQFSGEIPVTLTGCTGLE-IFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLN 569 (997)
Q Consensus 496 L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 569 (997)
|+|++| ++...+.+|.+|.+|+ .+++.+ +++...+.+|.++++|+.|++++|+++...+.+|.++++|+.++
T Consensus 255 l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 255 IKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 555554 4433344455555555 555554 44433344555555555555555555544444555555555443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.3e-17 Score=165.16 Aligned_cols=130 Identities=25% Similarity=0.283 Sum_probs=93.2
Q ss_pred EEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCc
Q 001908 446 SLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGN 525 (997)
Q Consensus 446 ~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 525 (997)
.+++++|.++ .+|..+. .++ +.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l-~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDV-TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTC-CEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCCCC--CCC-CEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4444444444 3443322 223 55566666665 55667777778888888888888777777888888888888888
Q ss_pred cccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCC
Q 001908 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.+...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 8887777788888888888888888886666678888888888888888877554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.3e-16 Score=157.74 Aligned_cols=130 Identities=22% Similarity=0.325 Sum_probs=118.2
Q ss_pred cccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+.+++++|.++ .+|..+. ++|++|+|++|+++ .+|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 56899999999 6776653 68999999999998 88899999999999999999999888889999999999999999
Q ss_pred cccccCchhccCCCCCCEEeCCCCcCcccCCC-CCcCCCCcceeecCCCCcCCCC
Q 001908 550 NLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT-KGVFSNKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 550 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~N~~~C~~~ 603 (997)
+|++..|..|..+++|++|+|++|++++..+. ...++++..+++.+|||.|+|.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99998889999999999999999999977664 3567889999999999999763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.5e-16 Score=154.65 Aligned_cols=133 Identities=22% Similarity=0.247 Sum_probs=84.7
Q ss_pred CCCCeEEeecCcCC-CCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCcccccccccccee
Q 001908 418 TLMTDLFLSSNHLQ-GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVAL 496 (997)
Q Consensus 418 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L 496 (997)
++|+.|+|++|+++ +.+|..+..+++|++|++++|.++ +. ..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L 76 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-------------------------SV--SNLPKLPKLKKL 76 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-------------------------CC--SSCCCCSSCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-------------------------Ch--hhhccCCCCCEE
Confidence 55666666666665 455555555555555555555554 22 345556667777
Q ss_pred ccccccccccccccccCCcCccEEEccCccccccC-ChhccccCcCCeeeCccccccccCc---hhccCCCCCCEEeCCC
Q 001908 497 YISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI-PLSLRSLKSIKELDLSCNNLSGQIP---EFLENLSFLEYLNLSY 572 (997)
Q Consensus 497 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls~ 572 (997)
++++|++++.+|..+..+++|+.|+|++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|++|++++
T Consensus 77 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp EEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 77777776556666666777777777777776432 2566777777777777777775444 4677777777777777
Q ss_pred CcCcc
Q 001908 573 NHFDG 577 (997)
Q Consensus 573 N~l~~ 577 (997)
|.+..
T Consensus 157 n~~~~ 161 (168)
T 2ell_A 157 REDQE 161 (168)
T ss_dssp TTSCB
T ss_pred CChhh
Confidence 77663
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5.2e-16 Score=154.22 Aligned_cols=132 Identities=24% Similarity=0.183 Sum_probs=76.1
Q ss_pred CCCCEEeccCCCCC-CCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEe
Q 001908 370 VNLNLLGIEFNQLT-GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLN 448 (997)
Q Consensus 370 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 448 (997)
++|+.|++++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|+.|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 56666677777777777777777654 5666677777777777777665666665666666666
Q ss_pred cCCCcccCCc-ccccccccccccccccCCCcccCCCc---cccccccccceecccccccc
Q 001908 449 LSDNKLIGAV-PQQILTITTLSRFLDLGNNHLNGSLP---LEVGNLKNLVALYISGNQFS 504 (997)
Q Consensus 449 L~~N~l~~~~-p~~~~~l~~ll~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 504 (997)
|++|++++.. +..+..++++ +.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L-~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECL-KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCC-CEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCC-CEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666665321 1333333333 344444444442222 23444444444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=153.20 Aligned_cols=112 Identities=24% Similarity=0.253 Sum_probs=86.9
Q ss_pred cccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+.|++++|++++..+..|..+++|++|++++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus 31 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 110 (177)
T 2o6r_A 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110 (177)
T ss_dssp SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC
Confidence 55556666665555556677788888888888888666666788888888888888888777777888888888888888
Q ss_pred cccccCchhccCCCCCCEEeCCCCcCcccCCC
Q 001908 550 NLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 550 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
++++..+..+..+++|++|+|++|++++.+|.
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 111 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 88876666678888888888888888887763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.5e-16 Score=150.65 Aligned_cols=128 Identities=22% Similarity=0.304 Sum_probs=79.0
Q ss_pred CCCCCeEEeecCcCC-CCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccce
Q 001908 417 LTLMTDLFLSSNHLQ-GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495 (997)
Q Consensus 417 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~ 495 (997)
.++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. . .++.+++|++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~-------------------------~~~~l~~L~~ 68 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--A-------------------------NLPKLNKLKK 68 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--T-------------------------TCCCCTTCCE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--h-------------------------hhhcCCCCCE
Confidence 356777777777776 66777777777777777777776533 3 3444555555
Q ss_pred eccccccccccccccccCCcCccEEEccCcccccc-CChhccccCcCCeeeCccccccccCc---hhccCCCCCCEEeCC
Q 001908 496 LYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGS-IPLSLRSLKSIKELDLSCNNLSGQIP---EFLENLSFLEYLNLS 571 (997)
Q Consensus 496 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls 571 (997)
|++++|++++.+|..+..+++|+.|++++|++++. .|..+..+++|+.|++++|++++..+ ..+..+++|++||++
T Consensus 69 L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 66666666554555555556666666666666542 23556666666666666666665444 356666666666665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7.8e-16 Score=149.60 Aligned_cols=129 Identities=18% Similarity=0.162 Sum_probs=95.3
Q ss_pred cccccceecccccccc-ccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccccccc
Q 001908 392 QLRNLQAIGLSSNFLQ-GNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSR 470 (997)
Q Consensus 392 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~ 470 (997)
..++|++|++++|.++ +.+|..+..+++|+.|++++|++++. ..+.++++|++|++++|++++.+|..+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~------- 85 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAE------- 85 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHH-------
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhh-------
Confidence 3478999999999999 78999999999999999999999975 7889999999999999988755554444
Q ss_pred ccccCCCcccCCCccccccccccceecccccccccc-ccccccCCcCccEEEccCccccccCC---hhccccCcCCeeeC
Q 001908 471 FLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE-IPVTLTGCTGLEIFHMQGNSFRGSIP---LSLRSLKSIKELDL 546 (997)
Q Consensus 471 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L 546 (997)
.+++|++|++++|++++. .|..+..+++|+.|++++|++++..+ ..+..+++|+.||+
T Consensus 86 ------------------~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 86 ------------------KCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp ------------------HCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred ------------------hCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 344555555555555532 23556666666666666666665444 45666777777776
Q ss_pred c
Q 001908 547 S 547 (997)
Q Consensus 547 s 547 (997)
+
T Consensus 148 ~ 148 (149)
T 2je0_A 148 Y 148 (149)
T ss_dssp B
T ss_pred C
Confidence 5
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=8.7e-15 Score=146.70 Aligned_cols=132 Identities=20% Similarity=0.224 Sum_probs=97.3
Q ss_pred cEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccc
Q 001908 324 KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSS 403 (997)
Q Consensus 324 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 403 (997)
+.+++++|+++. +|..+. ++++.|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++
T Consensus 10 ~~l~~~~~~l~~-~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCSS-CCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCcc-CCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 445555555552 333222 4566667777777766666778888888888888888877777778888888888888
Q ss_pred ccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcc
Q 001908 404 NFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVP 459 (997)
Q Consensus 404 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 459 (997)
|+|++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+.+..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88887766777888888888888888887666667788888888888888876544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.9e-14 Score=161.88 Aligned_cols=223 Identities=13% Similarity=0.107 Sum_probs=127.8
Q ss_pred cccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCc
Q 001908 213 SLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKN 292 (997)
Q Consensus 213 ~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 292 (997)
.|.++ +|+.+.|..| ++ .|+...|.+ .+|+.+.+.+ .++..-+.+|.++++|+.++|++|+++.+....|. ..+
T Consensus 131 aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~ 204 (401)
T 4fdw_A 131 AFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG 204 (401)
T ss_dssp TTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred hcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence 34443 5777776655 44 566666655 3577777764 55555556677777777777777777766666666 467
Q ss_pred cCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCC
Q 001908 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNL 372 (997)
Q Consensus 293 L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L 372 (997)
|+.+.|.. +++.++.. .|.++++|+.+++..| ++.....+|.+ ..|+.+.+ .|.++.+...+|.++++|
T Consensus 205 L~~l~lp~-~l~~I~~~------aF~~~~~L~~l~l~~~-l~~I~~~aF~~--~~L~~i~l-p~~i~~I~~~aF~~c~~L 273 (401)
T 4fdw_A 205 IEEVLLPV-TLKEIGSQ------AFLKTSQLKTIEIPEN-VSTIGQEAFRE--SGITTVKL-PNGVTNIASRAFYYCPEL 273 (401)
T ss_dssp CSEEECCT-TCCEECTT------TTTTCTTCCCEECCTT-CCEECTTTTTT--CCCSEEEE-ETTCCEECTTTTTTCTTC
T ss_pred cCEEEeCC-chheehhh------HhhCCCCCCEEecCCC-ccCcccccccc--CCccEEEe-CCCccEEChhHhhCCCCC
Confidence 77777763 35555443 3456667777776654 34333334443 34555555 334444445566666666
Q ss_pred CEEeccCCCCC-----CCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEE
Q 001908 373 NLLGIEFNQLT-----GNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSL 447 (997)
Q Consensus 373 ~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 447 (997)
+.+++.+|.+. .+.+..|.++++|+.++|. |.++.....+|.++++|+.++|.+| ++...+.+|.++ +|+.+
T Consensus 274 ~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l 350 (401)
T 4fdw_A 274 AEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEV 350 (401)
T ss_dssp CEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEE
T ss_pred CEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEE
Confidence 66666655543 2334555566666666665 3354444455555566666666333 444444555555 56666
Q ss_pred ecCCCccc
Q 001908 448 NLSDNKLI 455 (997)
Q Consensus 448 ~L~~N~l~ 455 (997)
++++|.+.
T Consensus 351 ~l~~n~~~ 358 (401)
T 4fdw_A 351 KVEGTTPP 358 (401)
T ss_dssp EECCSSCC
T ss_pred EEcCCCCc
Confidence 66555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=8.4e-17 Score=164.69 Aligned_cols=131 Identities=27% Similarity=0.323 Sum_probs=64.7
Q ss_pred ccccceeccccccccccchh------hhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccc
Q 001908 393 LRNLQAIGLSSNFLQGNIPS------SLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTIT 466 (997)
Q Consensus 393 l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 466 (997)
...++.++++.|.++|.+|. .+..+++|+.|+|++|++++ +| .+.++++|++|++++|+++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34455555555555554443 66666666666666666664 44 5566666666666666655 3444333333
Q ss_pred ccccccccCCCcccCCCccccccccccceecccccccccccc-ccccCCcCccEEEccCccccc
Q 001908 467 TLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP-VTLTGCTGLEIFHMQGNSFRG 529 (997)
Q Consensus 467 ~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 529 (997)
++ +.|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++
T Consensus 94 ~L-~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 94 TL-EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HC-SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred cC-CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 33 444444444442 22 34444444444444444442111 234444444444444444443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3.5e-15 Score=165.08 Aligned_cols=136 Identities=15% Similarity=0.188 Sum_probs=99.9
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccch--------------hhH--------HHHHHHHHHHhhcCCCC
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK--------------GAL--------KSFVAECEVLRNTRHRN 737 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~h~n 737 (997)
-|++.++||+|++|.||+|... +|+.||||+++.... ... ....+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3889999999999999999986 799999998752110 001 11245666777775444
Q ss_pred cc--eEEeeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecC
Q 001908 738 LI--KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGD 815 (997)
Q Consensus 738 iv--~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 815 (997)
+. ..+++ ...++||||++|++|.++... .....++.|++.+|.|||+. ||||||
T Consensus 175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gIVHrD 230 (397)
T 4gyi_A 175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GLIHGD 230 (397)
T ss_dssp CSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCCeeeec---------cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence 32 22222 124799999999888654321 12346789999999999998 999999
Q ss_pred CCCCCeeeCCCC----------cEEEcccccchhc
Q 001908 816 LKPSNVLLDHDM----------VAHVSDFGLARFL 840 (997)
Q Consensus 816 lk~~NIll~~~~----------~~kl~DFg~a~~~ 840 (997)
|||.|||+++++ .+.|+||+.+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999877 4899999987643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.55 E-value=4.7e-14 Score=160.09 Aligned_cols=265 Identities=12% Similarity=0.140 Sum_probs=148.8
Q ss_pred CccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeE
Q 001908 218 SSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLD 297 (997)
Q Consensus 218 ~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 297 (997)
..++.+.+.+ .++ .|+...|.+ .+|+.+.+.+| ++..-..+|.++ +|+.+++.. .++.+.+.+|.++++|+.++
T Consensus 113 ~~l~~i~ip~-~i~-~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPN-SVK-SIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCT-TCC-EECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred CCccEEEECC-ccC-EehHhhccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 3444444432 233 445554544 24555555544 443444445553 455555553 44444455555555555555
Q ss_pred ccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEec
Q 001908 298 LGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377 (997)
Q Consensus 298 Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 377 (997)
|+.|+++.++.. .|. . ..|+.+.+.. .++.+...+|.++++|+.+++
T Consensus 187 l~~n~l~~I~~~------------------------------aF~-~-~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 187 LSKTKITKLPAS------------------------------TFV-Y-AGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CTTSCCSEECTT------------------------------TTT-T-CCCSEEECCT-TCCEECTTTTTTCTTCCCEEC
T ss_pred cCCCcceEechh------------------------------hEe-e-cccCEEEeCC-chheehhhHhhCCCCCCEEec
Confidence 555555444332 222 1 2344444432 244455567777777777777
Q ss_pred cCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCC-----CCCCCCCCCCCCCcEEecCCC
Q 001908 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ-----GNIPPSLGNCKNLVSLNLSDN 452 (997)
Q Consensus 378 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N 452 (997)
..| ++.+-..+|.+ .+|+.+.| .|.++...+.+|.++++|+.+++.+|.+. ...+.+|.++++|+.++|.+
T Consensus 234 ~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~- 309 (401)
T 4fdw_A 234 PEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE- 309 (401)
T ss_dssp CTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-
T ss_pred CCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-
Confidence 754 55455566666 66777777 34455455667777777777777776664 34455666666666666653
Q ss_pred cccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCC
Q 001908 453 KLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP 532 (997)
Q Consensus 453 ~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 532 (997)
.++ .....+|.++++|+.++|..| ++..-+.+|.++ +|+.+++++|.+....+
T Consensus 310 ~i~-------------------------~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~ 362 (401)
T 4fdw_A 310 SIR-------------------------ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFE 362 (401)
T ss_dssp TCC-------------------------EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCC
T ss_pred ceE-------------------------EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccc
Confidence 233 233445666666666666444 554445567777 77777777776665555
Q ss_pred hhccccC-cCCeeeCcccccc
Q 001908 533 LSLRSLK-SIKELDLSCNNLS 552 (997)
Q Consensus 533 ~~~~~l~-~L~~L~Ls~N~l~ 552 (997)
..|.+++ .++.|++..|.+.
T Consensus 363 ~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 363 KVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SSCCCSCTTCCEEEECGGGHH
T ss_pred ccccCCCCCccEEEeCHHHHH
Confidence 6666663 5667777666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.8e-17 Score=165.87 Aligned_cols=155 Identities=24% Similarity=0.284 Sum_probs=120.3
Q ss_pred hcCCCCCCeEEeecCcCCCCCCC------CCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCcccc
Q 001908 414 LGNLTLMTDLFLSSNHLQGNIPP------SLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEV 487 (997)
Q Consensus 414 ~~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~ 487 (997)
+.....++.++++.|.++|.+|. .|..+++|++|+|++|++++ +| .+..++++ ++|++++|+++ .+|..+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L-~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENL-RILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTC-CEEEEEEEEEC-SCSSHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCC-CEEECCCCCcc-cccchh
Confidence 56667888889999999888877 78888888888888888875 66 77777777 88888888887 667777
Q ss_pred ccccccceeccccccccccccccccCCcCccEEEccCccccccCC-hhccccCcCCeeeCccccccccCchh--------
Q 001908 488 GNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP-LSLRSLKSIKELDLSCNNLSGQIPEF-------- 558 (997)
Q Consensus 488 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~-------- 558 (997)
..+++|+.|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+++.+|..
T Consensus 90 ~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~ 167 (198)
T 1ds9_A 90 AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167 (198)
T ss_dssp HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHH
T ss_pred hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHH
Confidence 777888888888888874 45 57778888888888888874332 46778888888888888887766543
Q ss_pred --ccCCCCCCEEeCCCCcCc
Q 001908 559 --LENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 559 --~~~l~~L~~L~ls~N~l~ 576 (997)
+..+++|+.|| +|+++
T Consensus 168 ~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 168 EVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHCSSCSEEC--CGGGT
T ss_pred HHHHhCCCcEEEC--CcccC
Confidence 67778888776 66665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=8.9e-15 Score=146.46 Aligned_cols=132 Identities=18% Similarity=0.177 Sum_probs=80.2
Q ss_pred hcCCCCCCeEEeecCcCCCCCCCCCCCC-CCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccc
Q 001908 414 LGNLTLMTDLFLSSNHLQGNIPPSLGNC-KNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKN 492 (997)
Q Consensus 414 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~ 492 (997)
+.++++|+.|++++|+++. +|. +..+ ++|++|++++|.++ +. ..|..+++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~-------------------------~~--~~l~~l~~ 65 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIR-------------------------KL--DGFPLLRR 65 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCC-------------------------EE--CCCCCCSS
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCC-------------------------cc--cccccCCC
Confidence 4555666666666666663 333 2232 25555555555554 22 34555666
Q ss_pred cceeccccccccccccccccCCcCccEEEccCccccccCCh--hccccCcCCeeeCccccccccCchh----ccCCCCCC
Q 001908 493 LVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPL--SLRSLKSIKELDLSCNNLSGQIPEF----LENLSFLE 566 (997)
Q Consensus 493 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~ 566 (997)
|++|+|++|++++..|..|..+++|+.|+|++|+++ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+
T Consensus 66 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~ 143 (176)
T 1a9n_A 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR 143 (176)
T ss_dssp CCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred CCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccc
Confidence 667777777766444444566677777777777775 4454 6667777777777777776 34443 66777777
Q ss_pred EEeCCCCcCc
Q 001908 567 YLNLSYNHFD 576 (997)
Q Consensus 567 ~L~ls~N~l~ 576 (997)
.||+++|...
T Consensus 144 ~Ld~~~n~~~ 153 (176)
T 1a9n_A 144 VLDFQKVKLK 153 (176)
T ss_dssp EETTEECCHH
T ss_pred eeCCCcCCHH
Confidence 7777777664
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.5e-14 Score=144.88 Aligned_cols=135 Identities=14% Similarity=0.157 Sum_probs=96.0
Q ss_pred CCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccc
Q 001908 388 REIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITT 467 (997)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 467 (997)
..+.++.+|++|+|++|+++. +|......++|+.|+|++|+|++. ..|..+++|++|+|++|++++ +|.
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~------- 81 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGE------- 81 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECS-------
T ss_pred HhcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCc-------
Confidence 356778999999999999994 565333344999999999999964 678889999999999988873 332
Q ss_pred cccccccCCCcccCCCccccccccccceeccccccccccccc--cccCCcCccEEEccCccccccCCh----hccccCcC
Q 001908 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV--TLTGCTGLEIFHMQGNSFRGSIPL----SLRSLKSI 541 (997)
Q Consensus 468 ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L 541 (997)
..|..+++|++|++++|+++ .+|. .+..+++|+.|++++|.++ .+|. .+..+++|
T Consensus 82 -----------------~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L 142 (176)
T 1a9n_A 82 -----------------GLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV 142 (176)
T ss_dssp -----------------CHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC
T ss_pred -----------------chhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcc
Confidence 22344555666666666664 4444 5666666777777777766 3444 37777777
Q ss_pred CeeeCcccccc
Q 001908 542 KELDLSCNNLS 552 (997)
Q Consensus 542 ~~L~Ls~N~l~ 552 (997)
+.||+++|.+.
T Consensus 143 ~~Ld~~~n~~~ 153 (176)
T 1a9n_A 143 RVLDFQKVKLK 153 (176)
T ss_dssp SEETTEECCHH
T ss_pred ceeCCCcCCHH
Confidence 77777777765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=4.2e-14 Score=140.52 Aligned_cols=109 Identities=21% Similarity=0.234 Sum_probs=90.4
Q ss_pred cccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 56777777777 4665553 78888899999998877888888999999999999998777777888999999999999
Q ss_pred cccccCchhccCCCCCCEEeCCCCcCcccCCC
Q 001908 550 NLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 550 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
+|++..+..|..+++|++|+|++|+|++.++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 99877777788999999999999999887763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.9e-13 Score=153.13 Aligned_cols=312 Identities=12% Similarity=0.060 Sum_probs=156.5
Q ss_pred CcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccC
Q 001908 212 PSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLK 291 (997)
Q Consensus 212 ~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 291 (997)
..|.++++|+.+.|.. .++ .|+...|.++++|+.+++.++ ++..-..+|.++.+|+.+.+..+ +......+|.+..
T Consensus 65 ~AF~~c~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTCTTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHhhCCCCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 3466677777777753 354 566666666666666666544 44333455666666666655533 3334444555443
Q ss_pred ccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCC
Q 001908 292 NLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVN 371 (997)
Q Consensus 292 ~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~ 371 (997)
.+...... .+..++. ..|.++++|+.+.+.++. .......|.++.+
T Consensus 141 ~~~~~~~~--~~~~i~~------~aF~~c~~L~~i~l~~~~--------------------------~~I~~~~F~~c~~ 186 (394)
T 4fs7_A 141 FKEITIPE--GVTVIGD------EAFATCESLEYVSLPDSM--------------------------ETLHNGLFSGCGK 186 (394)
T ss_dssp CSEEECCT--TCCEECT------TTTTTCTTCCEEECCTTC--------------------------CEECTTTTTTCTT
T ss_pred ccccccCc--cccccch------hhhcccCCCcEEecCCcc--------------------------ceeccccccCCCC
Confidence 32222211 1111111 234556666666554332 1123344555555
Q ss_pred CCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCC
Q 001908 372 LNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD 451 (997)
Q Consensus 372 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 451 (997)
|+.+.+..| ++.+....|.++..|+.+.+.++... +........+|+.+.+..+ ++......|.++.+|+.+.+..
T Consensus 187 L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~ 262 (394)
T 4fs7_A 187 LKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQN 262 (394)
T ss_dssp CCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECC
T ss_pred ceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCC
Confidence 555555544 33334445555555555555544332 2233333455555555433 2223344555555666665555
Q ss_pred CcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccC
Q 001908 452 NKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSI 531 (997)
Q Consensus 452 N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 531 (997)
+... .....+.....+ +.+....+.+ ....|..+.+|+.+.+..+ ++..-..+|.+|.+|+.++|.++ ++..-
T Consensus 263 ~~~~-i~~~~F~~~~~l-~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~ 335 (394)
T 4fs7_A 263 NKLR-IGGSLFYNCSGL-KKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIG 335 (394)
T ss_dssp TTCE-ECSCTTTTCTTC-CEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred Ccce-eecccccccccc-ceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEh
Confidence 5332 222333333333 4344433322 1234555566666666544 44334455666666666666533 44344
Q ss_pred ChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCC
Q 001908 532 PLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573 (997)
Q Consensus 532 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 573 (997)
..+|.++.+|+.+++..| ++..-..+|.++++|+.+++..|
T Consensus 336 ~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 336 KRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred HHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 556666666666666555 55444556666666666666543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=8.8e-14 Score=138.65 Aligned_cols=108 Identities=21% Similarity=0.268 Sum_probs=86.7
Q ss_pred cccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45777777776 5666554 77888888888888777888888888888888888888766666788888888888888
Q ss_pred cccccCchhccCCCCCCEEeCCCCcCcccCC
Q 001908 550 NLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 550 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 580 (997)
+|++..+..|..+++|++|+|++|+|++.++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 8887666668888888888888888887655
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-12 Score=148.96 Aligned_cols=314 Identities=14% Similarity=0.070 Sum_probs=212.5
Q ss_pred CCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcc
Q 001908 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLD 312 (997)
Q Consensus 233 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 312 (997)
.|+...|.++.+|+.+.+.++ ++..-..+|.++++|+.++|.++ ++.+....|.++.+|+.+.+..+ +..++.
T Consensus 61 sIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~---- 133 (394)
T 4fs7_A 61 SIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV---- 133 (394)
T ss_dssp EECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT----
T ss_pred EhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc----
Confidence 355555556667777777533 55444556777777777777544 55555556666666666555432 222222
Q ss_pred hhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCccc
Q 001908 313 FVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQ 392 (997)
Q Consensus 313 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 392 (997)
.+|.+. ..+.... .+.+......+|.++++|+.+.+..+- .......|.+
T Consensus 134 --------------------------~aF~~~-~~~~~~~--~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~ 183 (394)
T 4fs7_A 134 --------------------------EAFKGC-DFKEITI--PEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSG 183 (394)
T ss_dssp --------------------------TTTTTC-CCSEEEC--CTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTT
T ss_pred --------------------------eeeecc-ccccccc--CccccccchhhhcccCCCcEEecCCcc-ceeccccccC
Confidence 222221 1111111 112222445689999999999998664 4466778999
Q ss_pred ccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccccccccc
Q 001908 393 LRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFL 472 (997)
Q Consensus 393 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L 472 (997)
+.+|+.+++..| ++......|.+...|+.+.+..+... +...+....+|+.+.+..+. +..-...+.....+ +.+
T Consensus 184 c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l-~~~ 258 (394)
T 4fs7_A 184 CGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDL-ESI 258 (394)
T ss_dssp CTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSC-CEE
T ss_pred CCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccc-eeE
Confidence 999999999887 55466778999999999998887654 44555667889999987653 32333455566666 778
Q ss_pred ccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcccccc
Q 001908 473 DLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552 (997)
Q Consensus 473 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (997)
.+..+..+ .....|.....++.+....+.+ ....|.++.+|+.+.+.++ ++..-..+|.++.+|+.++|.++ ++
T Consensus 259 ~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~ 332 (394)
T 4fs7_A 259 SIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE 332 (394)
T ss_dssp EECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred EcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc
Confidence 88877655 6677888999999988877654 3457889999999999866 66556778999999999999755 77
Q ss_pred ccCchhccCCCCCCEEeCCCCcCcccCCCC--CcCCCCcceeecCC
Q 001908 553 GQIPEFLENLSFLEYLNLSYNHFDGEVPTK--GVFSNKTRVQLTGN 596 (997)
Q Consensus 553 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--~~~~~~~~~~~~~N 596 (997)
..-..+|.++++|+.+++..| ++ .|+.. ....+++.+.+..+
T Consensus 333 ~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 333 EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp EECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG
T ss_pred EEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC
Confidence 566789999999999999877 55 33332 22345667766544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=5.7e-13 Score=132.26 Aligned_cols=106 Identities=25% Similarity=0.278 Sum_probs=82.1
Q ss_pred ccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecC
Q 001908 349 TDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN 428 (997)
Q Consensus 349 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 428 (997)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 34455555554 3454443 67888888888888888888888888888888888888777777888888888888888
Q ss_pred cCCCCCCCCCCCCCCCcEEecCCCcccCC
Q 001908 429 HLQGNIPPSLGNCKNLVSLNLSDNKLIGA 457 (997)
Q Consensus 429 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 457 (997)
+|++..+..|.++++|++|+|++|.+...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 88877777788888888898888888743
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.7e-13 Score=132.24 Aligned_cols=103 Identities=27% Similarity=0.291 Sum_probs=79.2
Q ss_pred cccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCc
Q 001908 350 DIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNH 429 (997)
Q Consensus 350 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 429 (997)
.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 3444455543 4455443 678888888888888778888888888888888888887666667888888888888888
Q ss_pred CCCCCCCCCCCCCCCcEEecCCCccc
Q 001908 430 LQGNIPPSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 430 l~~~~p~~~~~l~~L~~L~L~~N~l~ 455 (997)
|++..+..|..+++|++|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 88766666888888888888888887
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.4e-12 Score=145.79 Aligned_cols=131 Identities=21% Similarity=0.207 Sum_probs=100.9
Q ss_pred ccccCCC-cccCCCccccccccccceecccc-ccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcc
Q 001908 471 FLDLGNN-HLNGSLPLEVGNLKNLVALYISG-NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSC 548 (997)
Q Consensus 471 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 548 (997)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++.+|..|.+|++|+.|||++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677777 787 4777 88888999999996 999877778899999999999999999988888899999999999999
Q ss_pred ccccccCchhccCCCCCCEEeCCCCcCcccCCCCC--cCCCCcceeecCCCCcCCCCC
Q 001908 549 NNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKG--VFSNKTRVQLTGNGKLCGGSN 604 (997)
Q Consensus 549 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~~~~~~~~~~N~~~C~~~~ 604 (997)
|+|++..+..|..++ |+.|+|++|+|.+.....+ .+.......+..+...|..++
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 999977667777666 9999999999987654221 011112233455667786544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.5e-14 Score=157.37 Aligned_cols=86 Identities=17% Similarity=0.307 Sum_probs=41.0
Q ss_pred cccceecccccccccc----ccccccCCcCccEEEccCcccccc----CChhccccCcCCeeeCcccccccc----Cchh
Q 001908 491 KNLVALYISGNQFSGE----IPVTLTGCTGLEIFHMQGNSFRGS----IPLSLRSLKSIKELDLSCNNLSGQ----IPEF 558 (997)
Q Consensus 491 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 558 (997)
++|+.|+|++|.|+.. ++..+..+++|++|+|++|+|+.. ++..+...++|+.|||++|+|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 3455555555555421 222334445555555555555432 233444455555555555555432 2233
Q ss_pred ccCCCCCCEEeCCCCcCc
Q 001908 559 LENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 559 ~~~l~~L~~L~ls~N~l~ 576 (997)
+...++|++|||++|+++
T Consensus 235 L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 235 AREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHCSSCCEEECTTSSCC
T ss_pred HHhCCCCCEEeccCCCCC
Confidence 334455555566555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-11 Score=137.97 Aligned_cols=108 Identities=19% Similarity=0.213 Sum_probs=96.5
Q ss_pred ceeccccc-cccccccccccCCcCccEEEccC-ccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCC
Q 001908 494 VALYISGN-QFSGEIPVTLTGCTGLEIFHMQG-NSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571 (997)
Q Consensus 494 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 571 (997)
..++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|..+++|+.|+|++|+|++.+|..|.++++|++|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 898 6888 99999999999996 99998888999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCCCcCCCCcceeecCCCCcCCCC
Q 001908 572 YNHFDGEVPTKGVFSNKTRVQLTGNGKLCGGS 603 (997)
Q Consensus 572 ~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~~ 603 (997)
+|+|++.++.......+..+.+.+|++.|.|.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 99999877765333348999999999999763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.9e-13 Score=152.05 Aligned_cols=168 Identities=18% Similarity=0.164 Sum_probs=114.6
Q ss_pred ccccceeccccccccccchhhhcCC-----CCCCeEEeecCcCCCCCCCCC-CCCCCCcEEecCCCcccCCccccccc--
Q 001908 393 LRNLQAIGLSSNFLQGNIPSSLGNL-----TLMTDLFLSSNHLQGNIPPSL-GNCKNLVSLNLSDNKLIGAVPQQILT-- 464 (997)
Q Consensus 393 l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~-- 464 (997)
+++|++|+|++|.|+......+... ++|+.|+|++|.|+......+ ..+++|++|+|++|.++......+..
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4578888888888876544444332 688888888888864322222 23567888888888886444444332
Q ss_pred ---ccccccccccCCCcccCC----Cccccccccccceecccccccccc----ccccccCCcCccEEEccCcccccc---
Q 001908 465 ---ITTLSRFLDLGNNHLNGS----LPLEVGNLKNLVALYISGNQFSGE----IPVTLTGCTGLEIFHMQGNSFRGS--- 530 (997)
Q Consensus 465 ---l~~ll~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~--- 530 (997)
..++ +.|+|++|.|+.. ++..+...++|++|+|++|.|++. ++..+...++|+.|+|++|.|+..
T Consensus 151 ~~~~~~L-~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~ 229 (372)
T 3un9_A 151 LHDQCQI-TTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL 229 (372)
T ss_dssp HSTTCCC-CEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH
T ss_pred HhcCCcc-ceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH
Confidence 3445 8888888888642 344456678888888888888743 355667777888888888888753
Q ss_pred -CChhccccCcCCeeeCccccccccCchhccC
Q 001908 531 -IPLSLRSLKSIKELDLSCNNLSGQIPEFLEN 561 (997)
Q Consensus 531 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 561 (997)
++..+...++|++|||++|.|+..-...+..
T Consensus 230 ~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 230 ALARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 3344556688888888888887655555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.6e-10 Score=129.66 Aligned_cols=201 Identities=11% Similarity=0.107 Sum_probs=103.5
Q ss_pred CCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhh--------------hcCCCCCCeEEeecC
Q 001908 363 PSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSS--------------LGNLTLMTDLFLSSN 428 (997)
Q Consensus 363 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--------------~~~l~~L~~L~Ls~N 428 (997)
..+|.+ .+|+.+.+..+-. ......|.++.+|+......+.... +... +.....+..+.+. +
T Consensus 176 ~~aF~~-~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~ 251 (394)
T 4gt6_A 176 ERAFTG-TALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-N 251 (394)
T ss_dssp TTTTTT-CCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-T
T ss_pred cccccc-cceeEEEECCccc-ccccchhhhccccceeccccccccc-ccceeecccccccccccccccccccceEEcC-C
Confidence 344443 4577776654433 2445566677777666655444331 1111 1112223333332 2
Q ss_pred cCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccccc
Q 001908 429 HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP 508 (997)
Q Consensus 429 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 508 (997)
.++..-..+|.++.+|+.+.+.++... .-...|.++..| +.+.+. +.++......|.++.+|+.++|..+ ++..-.
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L-~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~ 327 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPAL-QDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILD 327 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTC-CEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECT
T ss_pred cceEcccceeeecccccEEecccccce-ecCccccccccc-ccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehH
Confidence 233234456777777777777655432 333444555555 556664 3344344556667777777777654 443445
Q ss_pred ccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcC
Q 001908 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575 (997)
Q Consensus 509 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 575 (997)
.+|.+|.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 328 ~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 328 DAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred hHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 56777777777777544 553445667777777777777665431 3455566666666655544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.6e-10 Score=127.59 Aligned_cols=310 Identities=12% Similarity=0.155 Sum_probs=184.6
Q ss_pred ccceeeccCCCCCCCCCccccccCCCccEEEecCCc---CcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCe
Q 001908 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNY---FSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWS 295 (997)
Q Consensus 219 ~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 295 (997)
.|+.+.+-.+ ++ .|+...|.++++|+.+.+++|. ++..-..+|.++.+|+.+.+..+ ++.+....|..+.+|+.
T Consensus 65 ~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~ 141 (394)
T 4gt6_A 65 VLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDT 141 (394)
T ss_dssp CCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCE
T ss_pred cCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccc
Confidence 3555555432 43 5555566666666666666553 44333455666666766666543 44455566666777777
Q ss_pred eEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEE
Q 001908 296 LDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375 (997)
Q Consensus 296 L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 375 (997)
+.+..+ +..++.. .+..+.+|+.+.+..+ ++..-..+|.. ..|+.+.+..+- ......+|.++.+|+..
T Consensus 142 i~lp~~-~~~I~~~------~F~~c~~L~~i~~~~~-~~~I~~~aF~~--~~l~~i~ip~~~-~~i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 142 VTIPEG-VTSVADG------MFSYCYSLHTVTLPDS-VTAIEERAFTG--TALTQIHIPAKV-TRIGTNAFSECFALSTI 210 (394)
T ss_dssp EECCTT-CCEECTT------TTTTCTTCCEEECCTT-CCEECTTTTTT--CCCSEEEECTTC-CEECTTTTTTCTTCCEE
T ss_pred ccccce-eeeeccc------ceecccccccccccce-eeEeccccccc--cceeEEEECCcc-cccccchhhhcccccee
Confidence 766532 3333222 3456667777766544 33233333332 345555555433 22556677778888877
Q ss_pred eccCCCCCCCCCCCcc--------------cccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCC
Q 001908 376 GIEFNQLTGNIPREIG--------------QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNC 441 (997)
Q Consensus 376 ~L~~N~l~~~~p~~~~--------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 441 (997)
....+.... +...+. ....+..+.+. +.++..-..+|.++++|+.+.+.++..+ ....+|.++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c 287 (394)
T 4gt6_A 211 TSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNC 287 (394)
T ss_dssp EECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTC
T ss_pred ccccccccc-ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccc
Confidence 766655542 221111 11223333332 2334344567888889999988776554 666788889
Q ss_pred CCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEE
Q 001908 442 KNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFH 521 (997)
Q Consensus 442 ~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 521 (997)
++|+.+.+.. .++..-...|.++.+| +.+++..+ ++.....+|.++.+|+.+.+..+ ++..-..+|.+|++|+.++
T Consensus 288 ~~L~~i~l~~-~i~~I~~~aF~~c~~L-~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 288 PALQDIEFSS-RITELPESVFAGCISL-KSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIE 363 (394)
T ss_dssp TTCCEEECCT-TCCEECTTTTTTCTTC-CEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEE
T ss_pred cccccccCCC-cccccCceeecCCCCc-CEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEE
Confidence 9999999864 4552333456667777 88888765 55456778999999999999765 6645567899999999999
Q ss_pred ccCccccccCChhccccCcCCeeeCcccccc
Q 001908 522 MQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552 (997)
Q Consensus 522 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (997)
+.+|.... ..+.....|+.+.+..|.+.
T Consensus 364 ~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 364 YSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp ESSCHHHH---HTCBCCCCC-----------
T ss_pred ECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 99987642 46777888999988877653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.2e-10 Score=124.49 Aligned_cols=147 Identities=17% Similarity=0.142 Sum_probs=112.0
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCC
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 752 (997)
+......|++....+.|+.+.||++.. .++.+++|+...........+.+|+++++.+. +..+.++++++. .
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~ 81 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----H 81 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----E
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----c
Confidence 334456788888899999999999976 46889999986432222346888999999884 677888888854 3
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC------------------------- 807 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~------------------------- 807 (997)
.+..++||||++|.++.+.+... .....++.++++++..||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCTT-----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred CCceEEEEEecCCeehhhccCCc-----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 45789999999999998763211 123467889999999999810
Q ss_pred -------------------------------CCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 808 -------------------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 808 -------------------------------~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
.+.++|+|+++.||+++.+..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1359999999999999876667899999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-09 Score=116.22 Aligned_cols=136 Identities=18% Similarity=0.112 Sum_probs=96.0
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC--cceEEeeeeccCcCCCceEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN--LIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~ 757 (997)
.+.+....+.|..+.||++... +|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++.. ..+..+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~ 91 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDW 91 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEE
T ss_pred CCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCE
Confidence 3444333345666999999764 6778999997643 2245678999999886544 456777632 345689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC------------------------------ 807 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~------------------------------ 807 (997)
+||||++|.++. ... .+ ...++.++++.+..||+..
T Consensus 92 ~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp EEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred EEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 999999998884 211 11 2256777888888888642
Q ss_pred -------------------------CCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 808 -------------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 808 -------------------------~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
.+.++|+|++|.||+++.++.++|+|||.|.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887777899999874
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.89 E-value=1e-09 Score=122.03 Aligned_cols=159 Identities=18% Similarity=0.183 Sum_probs=77.4
Q ss_pred chhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccc--cccccccccccCC--CcccCC---
Q 001908 410 IPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQIL--TITTLSRFLDLGN--NHLNGS--- 482 (997)
Q Consensus 410 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~ll~~L~Ls~--N~l~~~--- 482 (997)
++..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.+.......+. .+++| +.|+|+. |...+.
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L-~~L~L~~~~~~~~~~~~~ 239 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNL-EKLVLYVGVEDYGFDGDM 239 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTC-CEEEEECBCGGGTCCSCG
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCC-cEEEEeccccccccchhH
Confidence 4556667778888888777311 2333 32 67778888777766433222222 34454 5555532 111111
Q ss_pred --Ccccc--ccccccceecccccccccccccccc---CCcCccEEEccCcccccc----CChhccccCcCCeeeCccccc
Q 001908 483 --LPLEV--GNLKNLVALYISGNQFSGEIPVTLT---GCTGLEIFHMQGNSFRGS----IPLSLRSLKSIKELDLSCNNL 551 (997)
Q Consensus 483 --~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 551 (997)
+...+ ..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.+++. ++..+..+++|+.|+|++|.|
T Consensus 240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 00111 1345666666666665543332222 345566666666665542 222334455566666666655
Q ss_pred cccCchhccC-CCCCCEEeCCCCc
Q 001908 552 SGQIPEFLEN-LSFLEYLNLSYNH 574 (997)
Q Consensus 552 ~~~~p~~~~~-l~~L~~L~ls~N~ 574 (997)
+...-..+.. + ...+++++|+
T Consensus 320 ~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 320 SDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp CHHHHHHHHHHC--CSEEECCSBC
T ss_pred CHHHHHHHHHHc--CCEEEecCCc
Confidence 5332222322 1 2345555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.85 E-value=7.6e-08 Score=108.62 Aligned_cols=84 Identities=14% Similarity=0.136 Sum_probs=37.9
Q ss_pred ccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCC
Q 001908 486 EVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFL 565 (997)
Q Consensus 486 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 565 (997)
.|.++.+|+.+.+..+ ++......|.+|.+|+.+.+.++.++...+.+|.++.+|+.++|..+ ++..-..+|.++++|
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 3444444444444332 32222334455555555555554444333444555555555555432 332333445555555
Q ss_pred CEEeCC
Q 001908 566 EYLNLS 571 (997)
Q Consensus 566 ~~L~ls 571 (997)
+.+.+.
T Consensus 336 ~~i~ip 341 (379)
T 4h09_A 336 STISYP 341 (379)
T ss_dssp CCCCCC
T ss_pred CEEEEC
Confidence 555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.3e-07 Score=106.66 Aligned_cols=302 Identities=11% Similarity=0.054 Sum_probs=198.7
Q ss_pred ccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhcc
Q 001908 240 VTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTN 319 (997)
Q Consensus 240 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~ 319 (997)
..-.+|+.+.+.. .++..-..+|.++++|+.++|..+ ++.+...+|.+. +|+.+.+.. +++.++... +..
T Consensus 43 ~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~a------F~~ 112 (379)
T 4h09_A 43 KDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYV------FQG 112 (379)
T ss_dssp GGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTT------TTT
T ss_pred ccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccce------ecc
Confidence 3456788888864 466555678999999999999754 777778888887 688888764 466555442 233
Q ss_pred CCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCC------------CC
Q 001908 320 CSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGN------------IP 387 (997)
Q Consensus 320 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~------------~p 387 (997)
.+|+.+.+..+- .......|.+. .++.+.+.. .++......|.+..+++...+..+..... ..
T Consensus 113 -~~L~~i~lp~~~-~~i~~~~F~~~--~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (379)
T 4h09_A 113 -TDLDDFEFPGAT-TEIGNYIFYNS--SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTIL 187 (379)
T ss_dssp -CCCSEEECCTTC-CEECTTTTTTC--CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEE
T ss_pred -CCcccccCCCcc-ccccccccccc--eeeeeeccc-eeeccccchhcccccccccccccccceeecccceeccccccee
Confidence 479999887653 32333333332 344444332 34445566788888888887776544311 11
Q ss_pred CCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccc
Q 001908 388 REIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITT 467 (997)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 467 (997)
..+.....+..+.+..+.-. .....+....+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-...+.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~ 264 (379)
T 4h09_A 188 ESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTA 264 (379)
T ss_dssp EECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTT
T ss_pred ccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeeh
Confidence 22333344444444433222 44556777788888888665 44456677888888999988776 44233445555666
Q ss_pred cccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCc
Q 001908 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLS 547 (997)
Q Consensus 468 ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (997)
+ +.+.+..+ ++......|.++++|+.+++.++.++..-..+|.+|.+|+.+.|..+ ++..-..+|.++.+|+.+.+.
T Consensus 265 l-~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 265 L-KTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp C-CEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred h-cccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 6 77777654 44355567888889999999888887556678889999999999755 664556788888999988886
Q ss_pred cccccccCchhccCCC
Q 001908 548 CNNLSGQIPEFLENLS 563 (997)
Q Consensus 548 ~N~l~~~~p~~~~~l~ 563 (997)
.+ ++..-..+|.+.+
T Consensus 342 ~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 342 KS-ITLIESGAFEGSS 356 (379)
T ss_dssp TT-CCEECTTTTTTSS
T ss_pred Cc-cCEEchhHhhCCC
Confidence 55 5544455666543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.74 E-value=2.3e-09 Score=119.27 Aligned_cols=160 Identities=14% Similarity=0.263 Sum_probs=108.7
Q ss_pred hcCCCCCCeEEeecCcCC---------CCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCc
Q 001908 414 LGNLTLMTDLFLSSNHLQ---------GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLP 484 (997)
Q Consensus 414 ~~~l~~L~~L~Ls~N~l~---------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p 484 (997)
...+++|+.|.+..+... +.++..+..+++|+.|+|++|.-. .++. + .+++| +.|+|..|.++....
T Consensus 135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L-~~L~L~~~~l~~~~l 210 (362)
T 2ra8_A 135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNL-KSLEIISGGLPDSVV 210 (362)
T ss_dssp HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTC-SEEEEECSBCCHHHH
T ss_pred hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCC-cEEEEecCCCChHHH
Confidence 444556666666544321 123345567899999999988411 3343 3 36777 899999988764433
Q ss_pred cccc--cccccceecccc--cccccc-----ccccc--cCCcCccEEEccCccccccCChhcc---ccCcCCeeeCcccc
Q 001908 485 LEVG--NLKNLVALYISG--NQFSGE-----IPVTL--TGCTGLEIFHMQGNSFRGSIPLSLR---SLKSIKELDLSCNN 550 (997)
Q Consensus 485 ~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~ 550 (997)
..+. .+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+.+..+..+. .+++|++|||+.|.
T Consensus 211 ~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290 (362)
T ss_dssp HHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred HHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence 3444 689999999863 332221 11223 2478999999999999865554444 58899999999999
Q ss_pred cccc----CchhccCCCCCCEEeCCCCcCcc
Q 001908 551 LSGQ----IPEFLENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 551 l~~~----~p~~~~~l~~L~~L~ls~N~l~~ 577 (997)
|++. ++..+..+++|+.|+|++|.++.
T Consensus 291 L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 291 LTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 9864 34445677999999999998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.8e-08 Score=112.82 Aligned_cols=145 Identities=17% Similarity=0.207 Sum_probs=105.0
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEec--ccc-hhhHHHHHHHHHHHhhcC--CCCcceEEeeeeccCcCCCceEE
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQ-KGALKSFVAECEVLRNTR--HRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
..+.++.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..++++++++.... ..+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence 3567899999999999874 4678899875 322 112356788999999986 456888888865421 224578
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC------------------------------ 807 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~------------------------------ 807 (997)
+||||++|..+.+.. ...++..++..++.+++++|..||+..
T Consensus 118 ~vme~v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEECCCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 999999987764311 113567788889999999999999731
Q ss_pred -------------------------CCCcEecCCCCCCeeeCCCCc--EEEcccccchh
Q 001908 808 -------------------------QPPIVHGDLKPSNVLLDHDMV--AHVSDFGLARF 839 (997)
Q Consensus 808 -------------------------~~~ivHrDlk~~NIll~~~~~--~kl~DFg~a~~ 839 (997)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.68 E-value=1.3e-08 Score=111.09 Aligned_cols=139 Identities=17% Similarity=0.229 Sum_probs=97.3
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCC--cceEEeeeeccCcCCCceEEEEE
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRN--LIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++.+... .......|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence 4568999999999863 45889986532 33467889999998883 332 4445444211 11112357899
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH---------------------------------- 806 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~---------------------------------- 806 (997)
|+++|.++.+.... .++..++..++.++++.+..||+.
T Consensus 96 ~~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp ECCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 99999888654322 255667777888888888888851
Q ss_pred ---------------------CCCCcEecCCCCCCeeeCC--CCcEEEcccccchh
Q 001908 807 ---------------------CQPPIVHGDLKPSNVLLDH--DMVAHVSDFGLARF 839 (997)
Q Consensus 807 ---------------------~~~~ivHrDlk~~NIll~~--~~~~kl~DFg~a~~ 839 (997)
..+.++|+|++|.||+++. +..+.++||+.+..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 1236899999999999998 56789999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.45 E-value=4.8e-08 Score=102.90 Aligned_cols=65 Identities=22% Similarity=0.230 Sum_probs=28.1
Q ss_pred CcCccEEEccCccccc--cCChhccccCcCCeeeCccccccccCchhccCCC--CCCEEeCCCCcCcccCC
Q 001908 514 CTGLEIFHMQGNSFRG--SIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLS--FLEYLNLSYNHFDGEVP 580 (997)
Q Consensus 514 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p 580 (997)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++++.+|
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 3444444444444443 2233444444444444444444432 1222222 44555555555544433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.39 E-value=7.1e-08 Score=101.58 Aligned_cols=96 Identities=23% Similarity=0.375 Sum_probs=75.5
Q ss_pred cccCCCccc---CCCccccccccccceeccccccccc--cccccccCCcCccEEEccCccccccCChhccccC--cCCee
Q 001908 472 LDLGNNHLN---GSLPLEVGNLKNLVALYISGNQFSG--EIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLK--SIKEL 544 (997)
Q Consensus 472 L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L 544 (997)
++++.|+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|+.|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 778888543 2222233568899999999999997 5567788999999999999999965 3455555 99999
Q ss_pred eCccccccccCch-------hccCCCCCCEEe
Q 001908 545 DLSCNNLSGQIPE-------FLENLSFLEYLN 569 (997)
Q Consensus 545 ~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 569 (997)
+|++|.+++.+|. .+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 9999999987763 477889998886
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.25 E-value=1.2e-07 Score=94.93 Aligned_cols=119 Identities=18% Similarity=0.198 Sum_probs=69.1
Q ss_pred CCCCCCCCcEEecCCC-cccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccc----ccccc
Q 001908 437 SLGNCKNLVSLNLSDN-KLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE----IPVTL 511 (997)
Q Consensus 437 ~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~ 511 (997)
.+...++|++|+|++| .+...-... +...+...++|++|+|++|++... +...+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~---------------------l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L 89 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKA---------------------CAEALKTNTYVKKFSIVGTRSNDPVAFALAEML 89 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHH---------------------HHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHH---------------------HHHHHHhCCCcCEEECcCCCCChHHHHHHHHHH
Confidence 3455667777777777 664221111 112233345566666666666532 23344
Q ss_pred cCCcCccEEEccCcccccc----CChhccccCcCCeeeC--cccccccc----CchhccCCCCCCEEeCCCCcCc
Q 001908 512 TGCTGLEIFHMQGNSFRGS----IPLSLRSLKSIKELDL--SCNNLSGQ----IPEFLENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 512 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 576 (997)
...+.|++|+|++|.|+.. +...+...+.|++|+| ++|.|... +...+...+.|++|+|++|.+.
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4456677777777777643 3445566667777777 66777643 2344555577777777777764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.21 E-value=2.1e-07 Score=93.28 Aligned_cols=123 Identities=12% Similarity=0.122 Sum_probs=81.9
Q ss_pred cchhhhcCCCCCCeEEeecC-cCCCC----CCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCC
Q 001908 409 NIPSSLGNLTLMTDLFLSSN-HLQGN----IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483 (997)
Q Consensus 409 ~~p~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~ 483 (997)
.+...+...++|++|+|++| .|... +...+...++|++|+|++|.+...-...+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l--------------------- 85 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFAL--------------------- 85 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHH---------------------
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHH---------------------
Confidence 45567788999999999999 88732 34456677889999999998863221111
Q ss_pred ccccccccccceecccccccccc----ccccccCCcCccEEEc--cCcccccc----CChhccccCcCCeeeCcccccc
Q 001908 484 PLEVGNLKNLVALYISGNQFSGE----IPVTLTGCTGLEIFHM--QGNSFRGS----IPLSLRSLKSIKELDLSCNNLS 552 (997)
Q Consensus 484 p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 552 (997)
...+...++|++|+|++|.|+.. +...+...+.|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 86 ~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 86 AEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 12223335566777777776643 3455666677777777 67777643 2344555578888888888775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=7.9e-06 Score=87.19 Aligned_cols=135 Identities=18% Similarity=0.109 Sum_probs=96.8
Q ss_pred cccccCcc-eEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEEEEEeec
Q 001908 686 MIGQGSFG-SVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKALVYEYM 763 (997)
Q Consensus 686 ~lg~G~~g-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 763 (997)
.+..|..+ .||+......+..++||+-... ....+.+|...|+.+. +-.+.++++++.. .+..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEee
Confidence 44556655 6999888777788999986532 3456788999998884 4447778877543 35789999999
Q ss_pred cCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 001908 764 QNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC------------------------------------ 807 (997)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~------------------------------------ 807 (997)
+|.++.+...... .....++.+++..+..||..-
T Consensus 103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 9988877654321 123345666666677776421
Q ss_pred -------------------CCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 808 -------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 808 -------------------~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1148999999999999988777899999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-05 Score=86.10 Aligned_cols=137 Identities=18% Similarity=0.180 Sum_probs=91.6
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCC---CcceEEeeeeccCcCCCceEEEEE
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHR---NLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
.+.++.|....||+. ++.+++|+.. .......+.+|+++++.+.+. .+.+.+.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 456788888899987 4568889853 233456788999999999642 3566666643 1234578999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH---------------------------------- 806 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~---------------------------------- 806 (997)
||++|.++.+.... .++..+...++.++++.+..||+.
T Consensus 93 e~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 93 RKVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp ECCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 99999888763211 123334444444444444444432
Q ss_pred -----------------------CCCCcEecCCCCCCeeeCC---CCc-EEEcccccchh
Q 001908 807 -----------------------CQPPIVHGDLKPSNVLLDH---DMV-AHVSDFGLARF 839 (997)
Q Consensus 807 -----------------------~~~~ivHrDlk~~NIll~~---~~~-~kl~DFg~a~~ 839 (997)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 58999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=3.4e-05 Score=85.87 Aligned_cols=84 Identities=7% Similarity=-0.027 Sum_probs=54.7
Q ss_pred CCcc-cccCcceEEEEEEC--C----CCcEEEEEEecccc---hhhHHHHHHHHHHHhhcC-C--CCcceEEeeeeccCc
Q 001908 684 SNMI-GQGSFGSVYKGILG--E----NGTFVAVKILNLMQ---KGALKSFVAECEVLRNTR-H--RNLIKIITVCSSIDF 750 (997)
Q Consensus 684 ~~~l-g~G~~g~V~~~~~~--~----~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~ 750 (997)
.+.| +.|....+|+.... . +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~- 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD- 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence 3567 88888999988753 0 16678999875432 101245678888888874 3 35777887754321
Q ss_pred CCCceEEEEEeeccCCCHH
Q 001908 751 KGADFKALVYEYMQNGSLE 769 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~ 769 (997)
..+..++||||++|.++.
T Consensus 104 -~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 -VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp -TTSSCEEEEECCCCBCCC
T ss_pred -ccCCceEEEEecCCCChh
Confidence 113568999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=4.5e-05 Score=86.30 Aligned_cols=76 Identities=14% Similarity=0.110 Sum_probs=49.1
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccch-------hhHHHHHHHHHHHhhcCC--C-CcceEEeeeeccCcCCC
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-------GALKSFVAECEVLRNTRH--R-NLIKIITVCSSIDFKGA 753 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~ 753 (997)
.+.+|.|..+.||+++...+++.|+||....... ...+.+..|.++++.+.. + .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 4678999999999997755678899998653211 123456789999888742 3 344566542 2
Q ss_pred ceEEEEEeeccCC
Q 001908 754 DFKALVYEYMQNG 766 (997)
Q Consensus 754 ~~~~lv~e~~~~g 766 (997)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2458999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.49 E-value=4e-05 Score=74.67 Aligned_cols=84 Identities=18% Similarity=0.103 Sum_probs=59.3
Q ss_pred cccceeccccccccccccccccCCcCccEEEccCcc-ccccCChhcccc----CcCCeeeCccc-cccccCchhccCCCC
Q 001908 491 KNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNS-FRGSIPLSLRSL----KSIKELDLSCN-NLSGQIPEFLENLSF 564 (997)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N-~l~~~~p~~~~~l~~ 564 (997)
.+|+.||+|++.++..--..+.++++|+.|+|++|. ++..--..++.+ ++|+.|+|+++ +|+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467888888888776555667788888888888884 664433445553 36888888887 476544456777888
Q ss_pred CCEEeCCCCc
Q 001908 565 LEYLNLSYNH 574 (997)
Q Consensus 565 L~~L~ls~N~ 574 (997)
|++|+|++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00083 Score=73.96 Aligned_cols=148 Identities=18% Similarity=0.146 Sum_probs=80.0
Q ss_pred CcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCC--CCcceEEeeeeccC-cCCCceEEEEEe
Q 001908 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH--RNLIKIITVCSSID-FKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~~~~~~~lv~e 761 (997)
+.|+.|..+.||+.... +..+++|+.... . ..+..|+++++.+.. -.+.+++....... ....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566778999999874 345999998752 1 233445666655531 13344443110000 012456789999
Q ss_pred eccCCCHH--------------HHhhcCC-CC--CCc-----CCCCHHHH------------------------------
Q 001908 762 YMQNGSLE--------------EWLHQSN-GQ--PEV-----CDLSLIQR------------------------------ 789 (997)
Q Consensus 762 ~~~~gsL~--------------~~l~~~~-~~--~~~-----~~~~~~~~------------------------------ 789 (997)
|++|.++. ..++... .. +.. ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99886532 1122211 00 100 01123211
Q ss_pred -HHHHHHHHHHHHHHhh----------CCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 790 -LNIAIDMASAIEYLHH----------HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 790 -~~i~~~i~~~L~yLH~----------~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
..+..++..++++|++ ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224445667763 013489999999999999888899999999774
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.18 E-value=6.8e-05 Score=73.05 Aligned_cols=84 Identities=17% Similarity=0.114 Sum_probs=52.9
Q ss_pred CCCCEEeccCCCCCCCCCCCcccccccceecccccc-ccccchhhhcCC----CCCCeEEeecCc-CCCCCCCCCCCCCC
Q 001908 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF-LQGNIPSSLGNL----TLMTDLFLSSNH-LQGNIPPSLGNCKN 443 (997)
Q Consensus 370 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 443 (997)
.+|+.||++++.|+..--..+.++++|++|+|+++. |+..--..+..+ ++|++|+|+++. |+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 457777777777665444556667777777777764 654444445554 357777777764 65433344566777
Q ss_pred CcEEecCCCc
Q 001908 444 LVSLNLSDNK 453 (997)
Q Consensus 444 L~~L~L~~N~ 453 (997)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0018 Score=69.40 Aligned_cols=79 Identities=19% Similarity=0.104 Sum_probs=57.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCC---CCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH---RNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~~~~ 755 (997)
.+....+.+|.|..+.||+.+.. +|+.|+||+...........+.+|++.|+.+.. -.+.+++++. .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~ 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------D 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------T
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------C
Confidence 34556778999999999999986 788999998764433333467889999988842 2355666542 2
Q ss_pred EEEEEeeccCCC
Q 001908 756 KALVYEYMQNGS 767 (997)
Q Consensus 756 ~~lv~e~~~~gs 767 (997)
.++||||++++.
T Consensus 85 ~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 RTLAMEWVDERP 96 (288)
T ss_dssp TEEEEECCCCCC
T ss_pred ceEEEEeecccC
Confidence 378999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00079 Score=62.45 Aligned_cols=58 Identities=24% Similarity=0.339 Sum_probs=37.4
Q ss_pred cEEEccCcccc-ccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcc
Q 001908 518 EIFHMQGNSFR-GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 518 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 577 (997)
..++.+++.++ ..+|..+. ++|+.|||++|+|+...+..|..+++|+.|+|++|+|..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 36777777776 34554433 357777788887776666667777777766666555543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0013 Score=74.72 Aligned_cols=30 Identities=27% Similarity=0.560 Sum_probs=26.8
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 809 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 809 ~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
+.++|+|+++.||+++.++ ++++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3899999999999998776 99999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0041 Score=67.09 Aligned_cols=142 Identities=20% Similarity=0.169 Sum_probs=91.1
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC---CCCcceEEeeeeccCcCCCceEEEE
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR---HRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
..+.|+.|....+|+... ++..++||+.... ....+.+|.+.|+.+. ...++++++++.. .+..++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lv 109 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLL 109 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEE
Confidence 346789999999999876 5678899987533 2466788999998884 3568888877532 3578999
Q ss_pred EeeccCCCHH-----------HHhhcCCCCCC----------------cCCCCHHHHH---HHHH---------------
Q 001908 760 YEYMQNGSLE-----------EWLHQSNGQPE----------------VCDLSLIQRL---NIAI--------------- 794 (997)
Q Consensus 760 ~e~~~~gsL~-----------~~l~~~~~~~~----------------~~~~~~~~~~---~i~~--------------- 794 (997)
|||+++..+. -.++.....+. .-.-+|.... ++..
T Consensus 110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~ 189 (312)
T 3jr1_A 110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI 189 (312)
T ss_dssp EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 9999987541 13343321000 0012454321 1111
Q ss_pred -HHHHH-HHHHhh-CCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 795 -DMASA-IEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 795 -~i~~~-L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
+++.. ...|.. ...|.++|+|+.+.|++++.++ +.|.||+
T Consensus 190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223432 2356899999999999999887 8899974
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0013 Score=60.88 Aligned_cols=58 Identities=17% Similarity=0.165 Sum_probs=32.6
Q ss_pred eeeCcccccc-ccCchhccCCCCCCEEeCCCCcCcccCCCC-CcCCCCcceeecCCCCcCCC
Q 001908 543 ELDLSCNNLS-GQIPEFLENLSFLEYLNLSYNHFDGEVPTK-GVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 543 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~N~~~C~~ 602 (997)
.+|.+++.|+ ..+|..+. ++|++|+|++|+|+...+.. ..+..++.+.+.+|||.|++
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence 5666666664 24454332 34666666666666544432 33455666666666666655
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.011 Score=64.23 Aligned_cols=167 Identities=14% Similarity=0.108 Sum_probs=89.0
Q ss_pred ccChHHHHHHhhcCcc-----CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC--cce
Q 001908 668 MVSYSELSEATNEFSS-----SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN--LIK 740 (997)
Q Consensus 668 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 740 (997)
..+..++......|.. .+.|+.|....+|+.... ++ .+++|+..... ....+..|+++++.+.... +.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 3455566666666654 235667888899999874 33 68899886521 1234556888877774222 333
Q ss_pred EEeeeeccC-cCCCceEEEEEeeccCCCHH--------------HHhhcCC-CCCCc--CCC---CHHHHHH--------
Q 001908 741 IITVCSSID-FKGADFKALVYEYMQNGSLE--------------EWLHQSN-GQPEV--CDL---SLIQRLN-------- 791 (997)
Q Consensus 741 l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~-~~~~~--~~~---~~~~~~~-------- 791 (997)
++....... ....+..+++++|++|..+. -.++... ..... ... .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 332210000 00124578999999876431 1122211 10000 001 1222100
Q ss_pred ----HHHHHHHHHHHHhhC----CCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 792 ----IAIDMASAIEYLHHH----CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 792 ----i~~~i~~~L~yLH~~----~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
+...+...++++++. ..++++|+|+.+.||+++.++.+.++||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 12379999999999999887667899999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0037 Score=67.35 Aligned_cols=141 Identities=14% Similarity=0.099 Sum_probs=76.2
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCc-ceEEeeeeccCcCCCceEEEEEe
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL-IKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e 761 (997)
-.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++++ .+..++++|
T Consensus 22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~e 87 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVTR 87 (301)
T ss_dssp SCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEEE
T ss_pred ceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEEe
Confidence 3678899999999998 45889987643221 1223568888877742222 4566542 223478999
Q ss_pred ec-cCCCHHH------------------HhhcCCCCCCcCCCCHHH-HHHHHH--------------HHHHHH----HHH
Q 001908 762 YM-QNGSLEE------------------WLHQSNGQPEVCDLSLIQ-RLNIAI--------------DMASAI----EYL 803 (997)
Q Consensus 762 ~~-~~gsL~~------------------~l~~~~~~~~~~~~~~~~-~~~i~~--------------~i~~~L----~yL 803 (997)
|+ ++.++.. .+|....... ...+... ...+.. .+.+.+ +.+
T Consensus 88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFP-FRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCS-SBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCC-CCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 99 6544421 1122111000 0011111 111110 011111 112
Q ss_pred hh-CCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 804 HH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 804 H~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
.. ...+.++|+|+.+.||+ ..++.+.++||..|..
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 11 12236899999999999 5677889999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.00025 Score=70.41 Aligned_cols=42 Identities=21% Similarity=0.369 Sum_probs=18.8
Q ss_pred CccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccC
Q 001908 291 KNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLG 334 (997)
Q Consensus 291 ~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 334 (997)
+.|+.|+|++|.|...++. .+.+.+..-+.|++|+|++|+|.
T Consensus 70 ~~L~~L~L~~n~igd~ga~--alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEAR--GLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SCCCEEECTTSCCBHHHHT--THHHHHHHCSSCCEEECCSSBCC
T ss_pred CCcCEEEccCCCCChHHHH--HHHHHHhcCCccCeEecCCCcCC
Confidence 3444444444444432222 22334444455555555555554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.00022 Score=70.85 Aligned_cols=62 Identities=13% Similarity=0.187 Sum_probs=33.5
Q ss_pred ccccceecccccccccc----chhhhcCCCCCCeEEeecCcC---CC----CCCCCCCCCCCCcEEecCCCcc
Q 001908 393 LRNLQAIGLSSNFLQGN----IPSSLGNLTLMTDLFLSSNHL---QG----NIPPSLGNCKNLVSLNLSDNKL 454 (997)
Q Consensus 393 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l---~~----~~p~~~~~l~~L~~L~L~~N~l 454 (997)
-+.|++|+|++|+|... +-+.+..-+.|+.|+|++|.. .. .+...+..-+.|+.|+++.|.+
T Consensus 97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 34556666666665532 233444555677777765432 21 1223344556777777777654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.40 E-value=0.026 Score=61.46 Aligned_cols=166 Identities=14% Similarity=0.100 Sum_probs=88.2
Q ss_pred ccChHHHHHHhhcCcc-----CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC--cce
Q 001908 668 MVSYSELSEATNEFSS-----SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN--LIK 740 (997)
Q Consensus 668 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 740 (997)
..+...+....+.|.. ...++ |....||+.... +|+.+++|+..... .....+..|.++++.+.... +++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 3444555555555533 23466 788899988764 56679999986321 12345667888888774222 344
Q ss_pred EEeeeeccC-cCCCceEEEEEeeccCCCHH-----H---------HhhcCC---CCCCcCCCCHHHH----HH-------
Q 001908 741 IITVCSSID-FKGADFKALVYEYMQNGSLE-----E---------WLHQSN---GQPEVCDLSLIQR----LN------- 791 (997)
Q Consensus 741 l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~---------~l~~~~---~~~~~~~~~~~~~----~~------- 791 (997)
++.. .... ....+..++||||++|.++. . .++... ........++... ..
T Consensus 87 ~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 87 PVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred eeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 4432 1100 01134668899999875421 1 122110 0000111222111 00
Q ss_pred --------HHHHHHHHHHHHhhC----CCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 792 --------IAIDMASAIEYLHHH----CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 792 --------i~~~i~~~L~yLH~~----~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
+...+...++.+.+. ..+.++|+|+++.||+++ + .+.++||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011111223333221 233689999999999998 4 899999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0083 Score=66.57 Aligned_cols=144 Identities=13% Similarity=0.144 Sum_probs=83.1
Q ss_pred CCcccccCcceEEEEEECC-------CCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCce
Q 001908 684 SNMIGQGSFGSVYKGILGE-------NGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+.+..|....+|++.... +++.|++|+..... .....+.+|.++++.+. +.-..++++++ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVF-----PE--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC---
Confidence 3567778889999998742 35789999864321 22355678999998874 33345666653 11
Q ss_pred EEEEEeeccCCCHHH-----------------HhhcCCCCCCcCCCC--HHHHHHHHHHHHH------------------
Q 001908 756 KALVYEYMQNGSLEE-----------------WLHQSNGQPEVCDLS--LIQRLNIAIDMAS------------------ 798 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~-----------------~l~~~~~~~~~~~~~--~~~~~~i~~~i~~------------------ 798 (997)
.+||||++|.++.. .++.... +-..... +.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~-~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM-PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC-SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC-CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 28999998765421 1222111 0011122 3444445444322
Q ss_pred -HHHHHh----hC-CCCCcEecCCCCCCeeeCCC----CcEEEcccccch
Q 001908 799 -AIEYLH----HH-CQPPIVHGDLKPSNVLLDHD----MVAHVSDFGLAR 838 (997)
Q Consensus 799 -~L~yLH----~~-~~~~ivHrDlk~~NIll~~~----~~~kl~DFg~a~ 838 (997)
.+++|. .. ....++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 21 12379999999999999876 789999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.008 Score=68.59 Aligned_cols=75 Identities=13% Similarity=0.054 Sum_probs=47.6
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCc-ceEEeeeeccCcCCCceEEEEEee
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL-IKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
.+.|+.|-...+|++.....++.+++|+........ ....+|..+++.+...++ .++++++ . . .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence 457888888999999885435789999875322211 122578899988864444 5666653 1 1 259999
Q ss_pred ccCCCH
Q 001908 763 MQNGSL 768 (997)
Q Consensus 763 ~~~gsL 768 (997)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.024 Score=61.85 Aligned_cols=144 Identities=13% Similarity=0.069 Sum_probs=73.2
Q ss_pred CcccccCcce-EEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCC--CCcceEEeeeeccCcCCCceEEEEEe
Q 001908 685 NMIGQGSFGS-VYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH--RNLIKIITVCSSIDFKGADFKALVYE 761 (997)
Q Consensus 685 ~~lg~G~~g~-V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e 761 (997)
+.++.|+... +|+.... +++.+++|....... ..+..|+++++.+.. -.+.+++.+.. .. .+++||
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~-----~~--g~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH-----AR--GLLLIE 92 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET-----TT--TEEEEC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC-----CC--CEEEEe
Confidence 4566665554 6677542 366777886543221 223456777776632 23556666521 12 268999
Q ss_pred eccCCCHHHHhhcCCC--------------------CCCcCCCCHHHHH-------H-------------HHHHHHHHHH
Q 001908 762 YMQNGSLEEWLHQSNG--------------------QPEVCDLSLIQRL-------N-------------IAIDMASAIE 801 (997)
Q Consensus 762 ~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~~-------~-------------i~~~i~~~L~ 801 (997)
++.+.++.+++..... ......++..... . ....+...++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 9977777655432110 0000112211100 0 0011222233
Q ss_pred HHhh---CCCCCcEecCCCCCCeeeCCC----CcEEEcccccchh
Q 001908 802 YLHH---HCQPPIVHGDLKPSNVLLDHD----MVAHVSDFGLARF 839 (997)
Q Consensus 802 yLH~---~~~~~ivHrDlk~~NIll~~~----~~~kl~DFg~a~~ 839 (997)
.+.+ ...+.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3311 123479999999999999875 7899999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.78 E-value=0.038 Score=62.57 Aligned_cols=73 Identities=18% Similarity=0.185 Sum_probs=48.6
Q ss_pred CCcccccCcceEEEEEECC-------CCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC-cceEEeeeeccCcCCCce
Q 001908 684 SNMIGQGSFGSVYKGILGE-------NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN-LIKIITVCSSIDFKGADF 755 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~ 755 (997)
.+.|+.|....||++.... .++.+++|+..... ....+.+|..+++.+...+ ..++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIF-----SG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence 4567888889999998752 25789999984311 1144557999988885333 35666652 11
Q ss_pred EEEEEeeccCCC
Q 001908 756 KALVYEYMQNGS 767 (997)
Q Consensus 756 ~~lv~e~~~~gs 767 (997)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 38999998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.014 Score=64.75 Aligned_cols=74 Identities=16% Similarity=0.163 Sum_probs=44.3
Q ss_pred CCcccccCcceEEEEEECC--------CCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC-cceEEeeeeccCcCCCc
Q 001908 684 SNMIGQGSFGSVYKGILGE--------NGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN-LIKIITVCSSIDFKGAD 754 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~ 754 (997)
.+.++.|....+|+..... .++.+++|+....... ......|.++++.+...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~--- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF-----N--- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec-----C---
Confidence 3567788889999998753 1268899987543221 122457888888875333 44666542 1
Q ss_pred eEEEEEeeccCCC
Q 001908 755 FKALVYEYMQNGS 767 (997)
Q Consensus 755 ~~~lv~e~~~~gs 767 (997)
.++||||++|.+
T Consensus 109 -~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 -GGRIEEWLYGDP 120 (369)
T ss_dssp -TEEEEECCCSEE
T ss_pred -CcEEEEEecCCc
Confidence 268999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.06 E-value=0.033 Score=61.02 Aligned_cols=31 Identities=19% Similarity=0.341 Sum_probs=27.7
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 809 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 809 ~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888999999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.92 E-value=0.076 Score=52.86 Aligned_cols=102 Identities=18% Similarity=0.118 Sum_probs=65.8
Q ss_pred CHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCC
Q 001908 767 SLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFD 846 (997)
Q Consensus 767 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~ 846 (997)
+|.+.+...+ .++++.++|.++.|.+++|.-+-.+.. . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence 7999999876 269999999999999999877622111 1 1223446889999999998774 2110
Q ss_pred CccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCC
Q 001908 847 TSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909 (997)
Q Consensus 847 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P 909 (997)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ------------~~~~~~~~pe~~~-------------~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------------AGEPPPVAGKLGY-------------SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------------CCSS-------------SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------------ccccCCCChhhcc-------------ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123456775431 3456788899999999999874444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.20 E-value=0.12 Score=58.11 Aligned_cols=145 Identities=15% Similarity=0.132 Sum_probs=84.4
Q ss_pred CCcccccCcceEEEEEECCC-------CcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCce
Q 001908 684 SNMIGQGSFGSVYKGILGEN-------GTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+.+..|-...+|+...... ++.|++|+....... ..+..+|.++++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~---------~ 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF---------P 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---------T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc---------C
Confidence 45677788899999987521 578999987543221 123357888888874 33345555532 1
Q ss_pred EEEEEeeccCCCHHH-----------------HhhcCC----CCC---CcCCCCHHHHHHHHHHH---------------
Q 001908 756 KALVYEYMQNGSLEE-----------------WLHQSN----GQP---EVCDLSLIQRLNIAIDM--------------- 796 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~-----------------~l~~~~----~~~---~~~~~~~~~~~~i~~~i--------------- 796 (997)
.+.|+||++|.++.. .+|... +.+ ...+.-+.++.++..++
T Consensus 145 ~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 145 EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 268999998865311 111110 001 11111233333333222
Q ss_pred ----HHHHHHHhhC---------------------CCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 797 ----ASAIEYLHHH---------------------CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 797 ----~~~L~yLH~~---------------------~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
...+++|.+. ....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233333211 1236899999999999 8889999999998853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.94 E-value=0.71 Score=51.52 Aligned_cols=30 Identities=23% Similarity=0.425 Sum_probs=25.4
Q ss_pred CcEecCCCCCCeee------CCCCcEEEcccccchh
Q 001908 810 PIVHGDLKPSNVLL------DHDMVAHVSDFGLARF 839 (997)
Q Consensus 810 ~ivHrDlk~~NIll------~~~~~~kl~DFg~a~~ 839 (997)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998853
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.23 E-value=0.22 Score=56.76 Aligned_cols=60 Identities=13% Similarity=0.084 Sum_probs=17.4
Q ss_pred cCCcccccCcceEEEEEECCCCcEEEE------EEecc--cchhhHHHHHHHHHHHhhcCCCCcceEEeee
Q 001908 683 SSNMIGQGSFGSVYKGILGENGTFVAV------KILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITVC 745 (997)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vAv------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 745 (997)
..+++| ||+||+|.+.....+||| |..+. ...+....+.+|..+++..+|+|+++..++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 456776 999999999755568898 66543 2233445788899999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 997 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 8e-58
Identities = 73/316 (23%), Positives = 128/316 (40%), Gaps = 51/316 (16%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHR 736
+ + IG GSFG+VYKG + VAVK+LN+ L++F E VLR TRH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
N++ + ++ A+V ++ + SL LH + +I+ ++IA
Sbjct: 65 NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQT 113
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A ++YLH I+H DLK +N+ L D+ + DFGLA +
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK------SRWSGSHQFE 164
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
+ G++ ++ P + + S DVY+ G++L E+ T + P
Sbjct: 165 QLSGSILWMAP---------EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP------- 208
Query: 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM 976
+ + ++++ V L C + R+ C + ER
Sbjct: 209 ------YSNINNRDQIIFMVGRGYL----SPDLSKVRSNCPKAMKRLMAECLKKKRDERP 258
Query: 977 EMRDVLAKLCAARQTL 992
+LA + ++L
Sbjct: 259 LFPQILASIELLARSL 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 2e-55
Identities = 76/329 (23%), Positives = 143/329 (43%), Gaps = 62/329 (18%)
Query: 670 SYSELSEATNEFSSS---------NMIGQGSFGSVYKGIL---GENGTFVAVKILNL-MQ 716
++ + +EA EF+ +IG G FG V G L G+ FVA+K L
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 717 KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSN 776
+ + F++E ++ H N+I + V + + ++ E+M+NGSL+ +L Q++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 777 GQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836
GQ ++IQ + + +A+ ++YL VH DL N+L++ ++V VSDFGL
Sbjct: 123 GQF-----TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSL 896
+RFL DTS T +S++G K + + P E + + DV+S
Sbjct: 175 SRFL---EDDTSDPTYTSALGGKIPIRWTAP------------EAIQYRKFTSASDVWSY 219
Query: 897 GVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEEC 956
G+++ E+ + + M + V+ ++ R +C
Sbjct: 220 GIVMWEVMSYGERP------------YWDMT-NQDVINAIE--------QDYRLPPPMDC 258
Query: 957 LVTVIRIGVACSMESPIERMEMRDVLAKL 985
+ ++ + C + R + ++ L
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-51
Identities = 63/312 (20%), Positives = 122/312 (39%), Gaps = 43/312 (13%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV--LRNTRHRNLIKIITV 744
IG+G FG V++G G VAVKI + ++ +S+ E E+ RH N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
+ + LV +Y ++GSL ++L++ +++ + +A+ AS + +LH
Sbjct: 66 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 117
Query: 805 HHC-----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+P I H DLK N+L+ + ++D GLA + +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH----DSATDTIDIAPNHRV 173
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN------CM 913
GT Y+ P + +N+ E + D+Y++G++ E+ R
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRA------DIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973
+ + + + + P++ W E L + +I C +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS-------CEALRVMAKIMRECWYANGA 280
Query: 974 ERMEMRDVLAKL 985
R+ + L
Sbjct: 281 ARLTALRIKKTL 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 7e-51
Identities = 63/313 (20%), Positives = 122/313 (38%), Gaps = 39/313 (12%)
Query: 677 ATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRH 735
++F + +G G+ G V+K +G +A K+++L ++ + E +VL
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
++ S ++ E+M GSL++ L ++ PE ++I
Sbjct: 64 PYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAGRIPEQ------ILGKVSIA 112
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+ + YL I+H D+KPSN+L++ + DFG++ L +++ ++S
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSMANS 162
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP---TNC 912
GT Y+ P E G+ SV D++S+G+ L+EM R P +
Sbjct: 163 --FVGTRSYMSP------------ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972
+ + A L ++ R L+ I + S
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268
Query: 973 IERMEMRDVLAKL 985
+ +E +D + K
Sbjct: 269 VFSLEFQDFVNKC 281
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 67/307 (21%), Positives = 127/307 (41%), Gaps = 55/307 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
+G G FG V+ G T VAVK L + +F+AE +++ +H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+++ V + + ++ EYM+NGSL ++L +G L++ + L++A +A
Sbjct: 71 VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAE 120
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+ ++ +H DL+ +N+L+ + ++DFGLAR + ++ G
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGA 170
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918
K + + P + YG + S DV+S G++L E+ T R
Sbjct: 171 KFPIKWTAP---------EAINYGTFTIKS---DVWSFGILLTEIVTHGRIP-------- 210
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978
+ M PE ++ G R + + C + ++ C E P +R
Sbjct: 211 ----YPGMTNPE---------VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257
Query: 979 RDVLAKL 985
+ + L
Sbjct: 258 DYLRSVL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-50
Identities = 69/315 (21%), Positives = 124/315 (39%), Gaps = 53/315 (16%)
Query: 684 SNMIGQGSFGSVYKGILGEN---GTFVAVKILN-LMQKGALKSFVAECEVLRNTRHRNLI 739
+ +IG+G FG VY G L +N AVK LN + G + F+ E ++++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
++ +C + +V YM++G L ++ P V D + + +A
Sbjct: 92 SLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-----LIGFGLQVAKG 142
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+ VH DL N +LD V+DFGLAR + +D ++ + G K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAK 195
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919
V ++ E + + DV+S GV+L E+ TR P +
Sbjct: 196 LPVKWMAL------------ESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVN 239
Query: 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR 979
+ + + GRR + E C + + + C R
Sbjct: 240 TFD-----------------ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282
Query: 980 DVLAKLCAARQTLVG 994
++++++ A T +G
Sbjct: 283 ELVSRISAIFSTFIG 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-49
Identities = 61/317 (19%), Positives = 119/317 (37%), Gaps = 56/317 (17%)
Query: 673 ELSEATNEFSSSNM-IGQGSFGSVYKGIL--GENGTFVAVKILNL-MQKGALKSFVAECE 728
+L + +++ +G G+FGSV +G+ + VA+K+L +K + + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 729 VLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQ 788
++ + ++++I VC + LV E G L ++L + + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREE-----IPVSN 110
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
+ ++ ++YL VH DL NVLL + A +SDFGL++ L
Sbjct: 111 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL-----GAD 162
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
++ K + + P E + S DV+S GV + E + +
Sbjct: 163 DSYYTARSAGKWPLKWYAP------------ECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
Query: 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACS 968
+ KM PE ++ G+R EC + + C
Sbjct: 211 K------------PYKKMKGPE---------VMAFIEQGKRMECPPECPPELYALMSDCW 249
Query: 969 MESPIERMEMRDVLAKL 985
+ +R + V ++
Sbjct: 250 IYKWEDRPDFLTVEQRM 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-48
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 54/299 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+GSF +VYKG+ E VA L + K + F E E+L+ +H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
S KG LV E M +G+L+ +L + + + + + +++LH
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLH 129
Query: 805 HHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
PPI+H DLK N+ + + D GLA S + + GT
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----------RASFAKAVIGTPE 178
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEF 923
++ P E + + DVY+ G+ +LEM T P +
Sbjct: 179 FMAP------------EM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSE-----CQ 216
Query: 924 CKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982
+ +V V P+ + + +E C+ ++ ER ++D+L
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR-----------QNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-48
Identities = 65/307 (21%), Positives = 109/307 (35%), Gaps = 51/307 (16%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRN 737
++ IG GS+G K +G + K L+ M + + V+E +LR +H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+++ + +V EY + G L + + + + L L + +
Sbjct: 65 IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQY--LDEEFVLRVMTQLT 119
Query: 798 SAIEYLHHH--CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
A++ H ++H DLKP+NV LD + DFGLAR L S +
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--------NHDTSFA 171
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915
GT Y+ P E + D++SLG +L E+ P F
Sbjct: 172 KAFVGTPYYMSP------------EQMNRMSYNEKSDIWSLGCLLYELCALMPP----FT 215
Query: 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975
F + L K+ E + +SD L +I R
Sbjct: 216 A------FSQKELAGKIREGKFRRIPYRYSDE---------LNEIIT---RMLNLKDYHR 257
Query: 976 MEMRDVL 982
+ ++L
Sbjct: 258 PSVEEIL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-48
Identities = 69/312 (22%), Positives = 132/312 (42%), Gaps = 56/312 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL----GENGTFVAVKILNL-MQKGALKSFVAECEVLRNT 733
+ + +IG G FG VYKG+L G+ VA+K L + F+ E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
H N+I++ V S ++ EYM+NG+L+++L + +G+ S++Q + +
Sbjct: 67 SHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGML 116
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+A+ + + VH DL N+L++ ++V VSDFGL+R L + E
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEATY 168
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913
++ G K + + P E + + DV+S G+++ E+ T
Sbjct: 169 TTSGGKIPIRWTAP------------EAISYRKFTSASDVWSFGIVMWEVMTYGER---- 212
Query: 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973
+VM+ ++ DG R +C + ++ + C +
Sbjct: 213 ---------PYWELSNHEVMKAIN--------DGFRLPTPMDCPSAIYQLMMQCWQQERA 255
Query: 974 ERMEMRDVLAKL 985
R + D+++ L
Sbjct: 256 RRPKFADIVSIL 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 8e-48
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 55/307 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
+GQG FG V+ G T VA+K L + ++F+ E +V++ RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+++ V S + +V EYM GSL ++L G+ Q +++A +AS
Sbjct: 75 VQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIAS 124
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+ Y+ VH DL+ +N+L+ ++V V+DFGLAR + ++ G
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGA 174
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918
K + + P E + ++ DV+S G++L E+ T+ R G+
Sbjct: 175 KFPIKWTAP------------EAALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGM 218
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978
E +L G R EC ++ + C + P ER
Sbjct: 219 VNRE-----------------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 261
Query: 979 RDVLAKL 985
+ A L
Sbjct: 262 EYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 9e-48
Identities = 70/316 (22%), Positives = 135/316 (42%), Gaps = 53/316 (16%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEV 729
+Y + + + + +G G +G VY+G+ + VAVK L ++ F+ E V
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66
Query: 730 LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQR 789
++ +H NL++++ VC+ ++ E+M G+L ++L + N Q +S +
Sbjct: 67 MKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQE----VSAVVL 117
Query: 790 LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
L +A ++SA+EYL +H DL N L+ + + V+DFGL+R + +
Sbjct: 118 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 167
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+T ++ G K + + P E ++ S+ DV++ GV+L E+ T
Sbjct: 168 DTYTAHAGAKFPIKWTAP------------ESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215
Query: 910 TNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSM 969
G+ L + ++ + ME + E C V + AC
Sbjct: 216 ----PYPGIDLSQVYELLEKDYRME-----------------RPEGCPEKVYELMRACWQ 254
Query: 970 ESPIERMEMRDVLAKL 985
+P +R ++
Sbjct: 255 WNPSDRPSFAEIHQAF 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 9e-48
Identities = 73/307 (23%), Positives = 112/307 (36%), Gaps = 59/307 (19%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
E IG+G FG V G G VAVK + ++F+AE V+ RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 62
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
++++ V + +V EYM GSL ++L L L ++D+
Sbjct: 63 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 114
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
A+EYL + VH DL NVL+ D VA VSDFGL + S+
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----------SSTQDTG 160
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918
K V + P E + S DV+S G++L E+++ R +
Sbjct: 161 KLPVKWTAP------------EALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRI 204
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978
L + ++ G + + C V + C R
Sbjct: 205 PLKD-----------------VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 247
Query: 979 RDVLAKL 985
+ +L
Sbjct: 248 LQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (420), Expect = 3e-46
Identities = 74/340 (21%), Positives = 124/340 (36%), Gaps = 71/340 (20%)
Query: 670 SYSELSEATNEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNL-MQKGALKSF 723
L N IG+G+FG V++ E T VAVK+L F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 724 VAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ----- 778
E ++ + N++K++ VC+ L++EYM G L E+L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 779 -------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825
P LS ++L IA +A+ + YL VH DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 826 DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGS 885
+MV ++DFGL+R ++ S + + + ++PP E +
Sbjct: 176 NMVVKIADFGLSRNIY------SADYYKADGNDAIPIRWMPP------------ESIFYN 217
Query: 886 EASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWS 945
+ DV++ GV+L E+F+ + MA E ++
Sbjct: 218 RYTTESDVWAYGVVLWEIFSYGLQP------------YYGMAHEE---------VIYYVR 256
Query: 946 DGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
DG A E C + + + C + P +R + L
Sbjct: 257 DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
+E + IG G FG V+ G N VA+K + + + F+ E EV+ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+++ VC LV+E+M++G L ++L + + L + +D+
Sbjct: 63 VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCE 112
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+ + + ++H DL N L+ + V VSDFG+ RF+ + +SS G
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-------LDDQYTSSTGT 162
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918
K V + P E S S DV+S GV++ E+F+ +
Sbjct: 163 KFPVKWASP------------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKI--------- 201
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978
+ +V+E + S G R K V +I C E P +R
Sbjct: 202 ----PYENRSNSEVVEDI--------STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAF 249
Query: 979 RDVLAKL 985
+L +L
Sbjct: 250 SRLLRQL 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 63/305 (20%), Positives = 105/305 (34%), Gaps = 57/305 (18%)
Query: 685 NMIGQGSFGSVYKGIL--GENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIK 740
+G G+FG+V KG + VAVKIL +AE V++ + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+I +C + + LV E + G L ++L Q+ + + + ++ +
Sbjct: 73 MIGICEA------ESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGM 120
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
+YL VH DL NVLL A +SDFGL++ L + K
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL-----RADENYYKAQTHGKW 172
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
V + P E + S DV+S GV++ E F+ + G+
Sbjct: 173 PVKWYAP------------ECINYYKFSSKSDVWSFGVLMWEAFSYGQK----PYRGMKG 216
Query: 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980
E + G R C + + C R
Sbjct: 217 SE-----------------VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259
Query: 981 VLAKL 985
V +L
Sbjct: 260 VELRL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-46
Identities = 58/297 (19%), Positives = 112/297 (37%), Gaps = 48/297 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+FG VYK E A K+++ + L+ ++ E ++L + H N++K++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
+ ++ E+ G+++ + + L+ Q + A+ YLH +
Sbjct: 80 Y-----ENNLWILIEFCAGGAVDAVMLELERP-----LTESQIQVVCKQTLDALNYLHDN 129
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVP 866
I+H DLK N+L D ++DFG++ T GT ++
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--------TRTIQRRDSFIGTPYWMA 178
Query: 867 PGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKM 926
P + E DV+SLG+ L+EM P HE M
Sbjct: 179 PEVVM-------CETSKDRPYDYKADVWSLGITLIEMAEIEPP----------HHELNPM 221
Query: 927 ALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983
+ K+ ++ P+L + ++ ++ C ++ R +L
Sbjct: 222 RVLLKIAKSEPPTL-------AQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-45
Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 55/307 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNL 738
+ + +G G FG V G VA+K++ + F+ E +V+ N H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+++ VC+ ++ EYM NG L +L + + Q L + D+
Sbjct: 62 VQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCE 111
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
A+EYL +H DL N L++ V VSDFGL+R++ + +SS+G
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGS 161
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918
K V + PP E M S+ S D+++ GV++ E+++ + ++
Sbjct: 162 KFPVRWSPP------------EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YER-- 204
Query: 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEM 978
+ + G R + V I +C E ER
Sbjct: 205 ----------------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 248
Query: 979 RDVLAKL 985
+ +L+ +
Sbjct: 249 KILLSNI 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 1e-45
Identities = 59/305 (19%), Positives = 101/305 (33%), Gaps = 59/305 (19%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKSFVAECEVLRNTRHRN 737
FS IG GSFG+VY N VA+K ++ + + E L+ RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
I+ LV EY + + L ++ +
Sbjct: 77 TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKP------LQEVEIAAVTHGAL 125
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+ YLH H ++H D+K N+LL + + DFG A + + +
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANS 170
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917
GT ++ P + + DV+SLG+ +E+ R+ P
Sbjct: 171 FVGTPYWMAP---------EVILAMDEGQYDGKVDVWSLGITCIELAERKPP-------- 213
Query: 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977
L M+ + + P+L + E + +C + P +R
Sbjct: 214 --LFNMNAMSALYHIAQNESPAL--------QSGHWSEYFRNFVD---SCLQKIPQDRPT 260
Query: 978 MRDVL 982
+L
Sbjct: 261 SEVLL 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 76/334 (22%), Positives = 124/334 (37%), Gaps = 71/334 (21%)
Query: 666 FPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL---MQKGALKS 722
+P++ + N+ ++IG+G+FG V K + ++G + I + K +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 723 FVAECEVLRN-TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPE- 780
F E EVL H N+I ++ C + + L EY +G+L ++L +S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 781 ---------VCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831
LS Q L+ A D+A + + Q +H DL N+L+ + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTG 891
+DFGL+R E + V ++ L Y + + S
Sbjct: 169 ADFGLSR---------GQEVYVKKTMGRLPVRWMAI---------ESLNYSVYTTNS--- 207
Query: 892 DVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRA 951
DV+S GV+L E+ + +C M E L G R
Sbjct: 208 DVWSYGVLLWEIVSLGGTP------------YCGMTCAE---------LYEKLPQGYRLE 246
Query: 952 KVEECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
K C V + C E P ER +L L
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 41/284 (14%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+F +G+G FG+VY ++ +A+K+L L + G E E+ + RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
N++++ A L+ EY G++ L + + + +
Sbjct: 66 PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITE 114
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
+A+A+ Y H ++H D+KP N+LL ++DFG + S
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRR 161
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM-F 914
+ GT+ Y+PP E G D++SLGV+ E + P +
Sbjct: 162 TTLCGTLDYLPP------------EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209
Query: 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWS-DGRRRAKVEECL 957
Q + P+ V E + + +R + E L
Sbjct: 210 QETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 7e-44
Identities = 56/287 (19%), Positives = 102/287 (35%), Gaps = 41/287 (14%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEVLRNTRHRN 737
++ +G+G++G V + VAVKI+++ ++ E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
++K + + + L EY G L + + G PE +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD------AQRFFHQLM 113
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
+ + YLH I H D+KP N+LLD +SDFGLA + +
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 164
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSE-ASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
+ GT+ YV P E E + DV+S G++L M P +
Sbjct: 165 MCGTLPYVAP------------ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212
Query: 917 GLTLHEFCKMALPEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
++ + + +D + +L + R + +
Sbjct: 213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE-NPSARITIPDIK 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 9e-44
Identities = 71/309 (22%), Positives = 110/309 (35%), Gaps = 57/309 (18%)
Query: 687 IGQGSFGSVYKGIL---GENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIK 740
+G GSFG V +G VAVK L L Q A+ F+ E + + HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ V + K +V E GSL + L + G L A+ +A +
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGM 124
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKG 860
YL +H DL N+LL + + DFGL R L + + K
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL-----PQNDDHYVMQEHRKV 176
Query: 861 TVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTL 920
+ P ++ S D + GV L EMFT + + G
Sbjct: 177 PFAWCAPESL------------KTRTFSHASDTWMFGVTLWEMFTYGQE---PWIG---- 217
Query: 921 HEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980
+++ +D +G R + E+C + + V C P +R
Sbjct: 218 ------LNGSQILHKID-------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264
Query: 981 VLAKLCAAR 989
+ L A+
Sbjct: 265 LRDFLLEAQ 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 61/283 (21%), Positives = 107/283 (37%), Gaps = 50/283 (17%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IGQG+ G+VY + G VA++ +NL Q+ + + E V+R ++ N++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
D +V EY+ GSL + + ++ Q + + A+E+LH
Sbjct: 86 YLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH 133
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
+ ++H D+K N+LL D ++DFG + QS + GT +
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI--------TPEQSKRSTMVGTPYW 182
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLHEFC 924
+ P E D++SLG+M +EM P + L
Sbjct: 183 MAP------------EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALY 226
Query: 925 KMAL----PEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
+A + E + L D +R +E L
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDM-DVEKRGSAKELL 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-43
Identities = 57/331 (17%), Positives = 111/331 (33%), Gaps = 70/331 (21%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNL-MQKGALKSFVAECEVLRN 732
++G G+FG V VAVK+L ++ ++E +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 733 -TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ------------- 778
H N++ ++ C+ + L++EY G L +L +
Sbjct: 97 LGSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 779 ----PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834
++ L+ L A +A +E+L VH DL NVL+ H V + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208
Query: 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVY 894
GLAR + S + V ++ P E ++ DV+
Sbjct: 209 GLARDI------MSDSNYVVRGNARLPVKWMAP------------ESLFEGIYTIKSDVW 250
Query: 895 SLGVMLLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVE 954
S G++L E+F+ + + + + + +G + +
Sbjct: 251 SYGILLWEIFSLGVNP------------YPGIPVDANFYKLIQ--------NGFKMDQPF 290
Query: 955 ECLVTVIRIGVACSMESPIERMEMRDVLAKL 985
+ I +C +R ++ + L
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 58/311 (18%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTF----VAVKILNL-MQKGALKSFVAECEVLRNTR 734
EF ++G G+FG+VYKG+ G VA+K L A K + E V+ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
+ ++ +++ +C + + L+ + M G L +++ + LN +
Sbjct: 70 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNI-----GSQYLLNWCV 118
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+A + YL +VH DL NVL+ ++DFGLA+ L + E +
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GAEEKEYH 169
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914
+ G K + ++ E + + DV+S GV + E+ T
Sbjct: 170 AEGGKVPIKWMAL------------ESILHRIYTHQSDVWSYGVTVWELMTFGSK----P 213
Query: 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIE 974
G+ E + G R + C + V I V C M
Sbjct: 214 YDGIPASEISSI-----------------LEKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 975 RMEMRDVLAKL 985
R + R+++ +
Sbjct: 257 RPKFRELIIEF 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-43
Identities = 60/326 (18%), Positives = 110/326 (33%), Gaps = 65/326 (19%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNL-MQKGALKSFVAECEVLRN 732
N S +G G+FG V + + VAVK+L ++ ++E +VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 733 -TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD-------- 783
H N++ ++ C+ ++ EY G L +L +
Sbjct: 83 LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 784 ----LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
L L L+ + +A + +L +H DL N+LL H + + DFGLAR
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM 899
+ + + V ++ P E + DV+S G+
Sbjct: 195 I------KNDSNYVVKGNARLPVKWMAP------------ESIFNCVYTFESDVWSYGIF 236
Query: 900 LLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVT 959
L E+F+ + M + K + + +G R E
Sbjct: 237 LWELFSLGSSP------------YPGMPVDSKFYKMIK--------EGFRMLSPEHAPAE 276
Query: 960 VIRIGVACSMESPIERMEMRDVLAKL 985
+ I C P++R + ++ +
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 157 bits (397), Expect = 1e-42
Identities = 55/316 (17%), Positives = 108/316 (34%), Gaps = 52/316 (16%)
Query: 655 ESSISVPMEQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL 714
++ + +QY+P + + + +G G+FG V++ G A K +
Sbjct: 2 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61
Query: 715 MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQ 774
+ ++ E + + RH L+ + + ++YE+M G L E +
Sbjct: 62 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVMIYEFMSGGELFEKVAD 116
Query: 775 SNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--S 832
+ + +S + + + + ++H + VH DLKP N++ +
Sbjct: 117 EHNK-----MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI 168
Query: 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGD 892
DFGL L + + S GT + P E G D
Sbjct: 169 DFGLTAHL---------DPKQSVKVTTGTAEFAAP------------EVAEGKPVGYYTD 207
Query: 893 VYSLGVMLLEMFTRRRPTNCMFQGG-----LTLHEFCKMALPEKVMETVDPSL------L 941
++S+GV+ + + P F G L + C + + + L
Sbjct: 208 MWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 942 LAWSDGRRRAKVEECL 957
L D R + + L
Sbjct: 264 LLA-DPNTRMTIHQAL 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 63/317 (19%), Positives = 117/317 (36%), Gaps = 57/317 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNL-MQKGALKSFVAECEVLRN 732
+ + S +GQGSFG VY+G+ E T VA+K +N F+ E V++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNG----QPEVCDLSLIQ 788
++++++ V S ++ E M G L+ +L P + SL +
Sbjct: 80 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 789 RLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTS 848
+ +A ++A + YL+ + VH DL N ++ D + DFG+ R +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YE 185
Query: 849 METQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908
+ V ++ P E + DV+S GV+L E+ T
Sbjct: 186 TDYYRKGGKGLLPVRWMSP------------ESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
Query: 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACS 968
+QG + +L +G K + C + + C
Sbjct: 234 QP---YQG------------------LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCW 272
Query: 969 MESPIERMEMRDVLAKL 985
+P R ++++ +
Sbjct: 273 QYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-41
Identities = 49/233 (21%), Positives = 87/233 (37%), Gaps = 35/233 (15%)
Query: 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHR 736
+F ++G+GSF +V A+KIL ++++ + E +V+ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 737 NLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDM 796
+K+ + Y +NG L +++ + E C
Sbjct: 69 FFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKIGSFDETC---------TRFYT 114
Query: 797 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A + L + I+H DLKP N+LL+ DM ++DFG A+ L +
Sbjct: 115 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS----- 169
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT YV P E A + D+++LG ++ ++ P
Sbjct: 170 -FVGTAQYVSP------------ELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 152 bits (384), Expect = 7e-41
Identities = 52/280 (18%), Positives = 94/280 (33%), Gaps = 44/280 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G G+FG V++ + G K +N + E ++ H LI +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
L+ E++ G L + + + + +S + +N ++++H H
Sbjct: 97 D-----KYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEH 146
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
IVH D+KP N++ + + V DFGLA L T +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL---------NPDEIVKVTTATAEF 194
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP-TNCMFQGGLTLHEF 923
P E D++++GV+ + + P L +
Sbjct: 195 AAP------------EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
Query: 924 CKMALPEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
C E +V P LL + R+R V + L
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQK-EPRKRLTVHDAL 281
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (370), Expect = 8e-40
Identities = 58/300 (19%), Positives = 104/300 (34%), Gaps = 45/300 (15%)
Query: 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTR 734
++ + ++G G V+ VAVK+L F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H ++ + + + +V EY+ +L + +H ++ + + +
Sbjct: 66 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIA 118
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
D A+ + H + I+H D+KP+N+++ V DFG AR S + +
Sbjct: 119 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG-----IARAIADSGNSVTQ 170
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914
+ + GT Y+ P E G DVYSLG +L E+ T P F
Sbjct: 171 TAAVIGTAQYLSP------------EQARGDSVDARSDVYSLGCVLYEVLTGEPP----F 214
Query: 915 QGGLTLHEFCKMA-----LPEKVMETVDPSL------LLAWSDGRRRAKVEECLVTVIRI 963
G + + P E + L LA + R E ++R+
Sbjct: 215 TGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-40
Identities = 56/304 (18%), Positives = 102/304 (33%), Gaps = 58/304 (19%)
Query: 686 MIGQGSFGSVYKGIL---GENGTFVAVKILNLMQK-GALKSFVAECEVLRNTRHRNLIKI 741
IG+G FG V++GI VA+K + F+ E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 742 ITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
I V + + ++ E G L +L L L + A +++A
Sbjct: 74 IGVITE------NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTA-- 120
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
L + VH D+ NVL+ + + DFGL+R++ T + K
Sbjct: 121 -LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------EDSTYYKASKGKLP 172
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921
+ ++ P E + DV+ GV + E+ +
Sbjct: 173 IKWMAP------------ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------ 214
Query: 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981
+ ++ +G R C T+ + C P R ++
Sbjct: 215 ---------------NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259
Query: 982 LAKL 985
A+L
Sbjct: 260 KAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 65/326 (19%), Positives = 115/326 (35%), Gaps = 66/326 (20%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL-------GENGTFVAVKILNL-MQKGALKSFVAECEVL 730
+ +G+G+FG V T VAVK+L + L ++E E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 731 RN-TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD------ 783
+ +H+N+I ++ C+ ++ EY G+L E+L
Sbjct: 73 KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 784 ----LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839
LS ++ A +A + + +H DL NVL+ D V ++DFGLAR
Sbjct: 128 PEEQLSSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVM 899
+ ++ + + V ++ P E + DV+S GV+
Sbjct: 185 I------HHIDYYKKTTNGRLPVKWMAP------------EALFDRIYTHQSDVWSFGVL 226
Query: 900 LLEMFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVT 959
L E+FT G+ + E L +G R K C
Sbjct: 227 LWEIFTLGGS----PYPGVPVEE-----------------LFKLLKEGHRMDKPSNCTNE 265
Query: 960 VIRIGVACSMESPIERMEMRDVLAKL 985
+ + C P +R + ++ L
Sbjct: 266 LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 56/323 (17%), Positives = 109/323 (33%), Gaps = 60/323 (18%)
Query: 679 NEFSSSNMIGQGSFGSVYKGIL-----GENGTFVAVKILNL-MQKGALKSFVAECEVLRN 732
+ +G+G+FG V + VAVK+L ++ ++E ++L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCD--------- 783
H + K ++ E+ + G+L +L +
Sbjct: 73 IGHHL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 784 -LSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
L+L + + +A +E+L +H DL N+LL V + DFGLAR ++
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY- 185
Query: 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
+ + ++ P I ++ DV+S GV+L E
Sbjct: 186 -----KDPDYVRKGDARLPLKWMAPETI------------FDRVYTIQSDVWSFGVLLWE 228
Query: 903 MFTRRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIR 962
+F+ + G EFC+ +G R + + +
Sbjct: 229 IFSLGAS---PYPGVKIDEEFCRR-----------------LKEGTRMRAPDYTTPEMYQ 268
Query: 963 IGVACSMESPIERMEMRDVLAKL 985
+ C P +R +++ L
Sbjct: 269 TMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (358), Expect = 3e-37
Identities = 55/268 (20%), Positives = 100/268 (37%), Gaps = 41/268 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL------MQKGALKSFVAECEVLRN 732
N+FS +IG+G FG VY + G A+K L+ + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 733 TRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNI 792
++ + + D + + + M G L L Q E
Sbjct: 64 GDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFY 112
Query: 793 AIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQ 852
A ++ +E++H+ +V+ DLKP+N+LLD +SD GLA ++
Sbjct: 113 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----------SK 159
Query: 853 SSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912
GT GY+ P L+ G+ ++S D +SLG ML ++ P
Sbjct: 160 KKPHASVGTHGYMAP---------EVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSPFRQ 208
Query: 913 MFQGGLTLHEFCKMALPEKVMETVDPSL 940
+ + + ++ ++ P L
Sbjct: 209 HKTKDKHEIDRMTLTMAVELPDSFSPEL 236
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (350), Expect = 3e-37
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 55/294 (18%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL---------MQKGALKSFVAECEVLRNTR- 734
++G+G V + I AVKI+++ + ++ + E ++LR
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H N+I++ + F LV++ M+ G L ++L + LS + I
Sbjct: 69 HPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMR 117
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+ I LH IVH DLKP N+LLD DM ++DFG + L +
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL---------DPGEK 165
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914
+ GT Y+ P I +N YG D++S GV++ + P F
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEV------DMWSTGVIMYTLLAGSPP----F 215
Query: 915 QGG-----LTLHEFCKMALPEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
L + + ++ L ++R EE L
Sbjct: 216 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV-QPQKRYTAEEAL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 47/284 (16%), Positives = 103/284 (36%), Gaps = 53/284 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
+G+G FG V++ + + K + + + E +L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
S + +++E++ + E ++ S + L+ + ++ + A+++LH H
Sbjct: 72 S-----MEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSH 121
Query: 807 CQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
I H D++P N++ + + +FG AR L + Y
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---------FTAPEY 169
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG-----LT 919
P ++ + S A+ D++SLG ++ + + P F +
Sbjct: 170 YAP---------EVHQHDVVSTAT---DMWSLGTLVYVLLSGINP----FLAETNQQIIE 213
Query: 920 LHEFCKMALPEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
+ E+ + + LL + + R E L
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVK-ERKSRMTASEAL 256
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-36
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 32/231 (13%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK 740
++ + +IG GSFG VY+ L ++G VA+K + + + E +++R H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 741 IITVC-SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+ SS + K + LV +Y+ H S + L +I + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---LPVIYVKLYMYQLFRS 134
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+ Y+H I H D+KP N+LLD D V + DFG A+ L + S
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS------ 185
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
Y P I +Y DV+S G +L E+ +
Sbjct: 186 ---RYYRAPELI-----FGATDYTSSI------DVWSAGCVLAELLLGQPI 222
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (342), Expect = 1e-35
Identities = 52/299 (17%), Positives = 95/299 (31%), Gaps = 49/299 (16%)
Query: 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL-MQKGALKSFVAECEV 729
+ + + + + +++G G+F V VA+K + +G S E V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 730 LRNTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQR 789
L +H N++ + + S L+ + + G L + + + E
Sbjct: 61 LHKIKHPNIVALDDIYES-----GGHLYLIMQLVSGGELFDRIVEKGFYTE------RDA 109
Query: 790 LNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSM 849
+ + A++YLH LD D +SDFGL++
Sbjct: 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--------- 160
Query: 850 ETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ S GT GYV P +A+ Y D +S+GV+ + P
Sbjct: 161 DPGSVLSTACGTPGYVAPEVLAQK------PYSKAV------DCWSIGVIAYILLCGYPP 208
Query: 910 TNCMFQGG-----LTLHEFCKMALPEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
F + + + S L+ D +R E+ L
Sbjct: 209 ----FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK-DPEKRFTCEQAL 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-35
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 28/235 (11%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTR 734
+ +++ + IG+G++G V N VA+K ++ + + + + E ++L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H N+I I + + + LV M L + L + LS
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH-------LSNDHICYFLY 116
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
+ ++Y+H ++H DLKPSN+LL+ + DFGLAR D +
Sbjct: 117 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV-----ADPDHDHTGF 168
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T Y P + G S+ D++S+G +L EM + R
Sbjct: 169 LTEYVATRWYRAP---------EIMLNSKGYTKSI--DIWSVGCILAEMLSNRPI 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 67/320 (20%), Positives = 123/320 (38%), Gaps = 39/320 (12%)
Query: 674 LSEATNEFSSSNMIGQGSFGSVYKGI-LGENGTFVAVKILNL--MQKGALKSFVAECEVL 730
L A ++ IG+G++G V+K L G FVA+K + + ++G S + E VL
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 731 R---NTRHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLI 787
R H N++++ VC+ LV+E++ +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-----VPTE 116
Query: 788 QRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDT 847
++ + +++LH H +VH DLKP N+L+ ++DFGLAR + T
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173
Query: 848 SMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRR 907
S+ T+ Y P + + S + D++S+G + EMF R+
Sbjct: 174 SV---------VVTLWYRAPEVL------------LQSSYATPVDLWSVGCIFAEMFRRK 212
Query: 908 RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGV-- 965
+ LP + D +L + +E+ + + +G
Sbjct: 213 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 272
Query: 966 --ACSMESPIERMEMRDVLA 983
C +P +R+ L+
Sbjct: 273 LLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (341), Expect = 1e-35
Identities = 49/234 (20%), Positives = 89/234 (38%), Gaps = 40/234 (17%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
+F +G GSFG V+ NG + A+K+L +++ ++ E +L H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
+I++ A ++ +Y++ G L L +S P
Sbjct: 64 PFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPNPV---------AKFY 109
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
A L + I++ DLKP N+LLD + ++DFG A+++ +
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----------PDVT 158
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ GT Y+ P E + + D +S G+++ EM P
Sbjct: 159 YTLCGTPDYIAP------------EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 38/235 (16%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNT-R 734
+F M+G+GSFG V+ + F A+K L ++ ++ + E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
H L + + + V EY+ G L + + L + A
Sbjct: 62 HPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAA 110
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSS 854
++ +++LH IV+ DLK N+LLD D ++DFG+ + M +
Sbjct: 111 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN--------MLGDAK 159
Query: 855 SIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
+ GT Y+ P E +G + + + D +S GV+L EM + P
Sbjct: 160 TNTFCGTPDYIAP------------EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 3e-35
Identities = 68/304 (22%), Positives = 129/304 (42%), Gaps = 38/304 (12%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IGQG+FG V+K + G VA+K + + ++G + + E ++L+ +H N++ +I +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 745 CSSIDFKGADFKA---LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIE 801
C + K LV+++ ++ + S I+R+ M +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL----SEIKRV-----MQMLLN 128
Query: 802 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
L++ + I+H D+K +NVL+ D V ++DFGLAR + T
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN----RVVT 184
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921
+ Y PP L L +YG D++ G ++ EM+TR QG H
Sbjct: 185 LWYRPP-----ELLLGERDYGPPI------DLWGAGCIMAEMWTRSPI----MQGNTEQH 229
Query: 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981
+ + ++ ++ P + + K+E LV + V +++ + D+
Sbjct: 230 QLALI---SQLCGSITPEVWPNVDNYELYEKLE--LVKGQKRKVKDRLKAYVRDPYALDL 284
Query: 982 LAKL 985
+ KL
Sbjct: 285 IDKL 288
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-35
Identities = 56/287 (19%), Positives = 102/287 (35%), Gaps = 50/287 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVL-RNTRHRNLIKIITV 744
++G G G V + A+K+L K E E+ R ++ ++++I+ V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
++ + G +V E + G L + Q + + I + AI+YLH
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH 128
Query: 805 HHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
I H D+KP N+L + + ++DFG A+ + +S T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---------TTSHNSLTTPCYT 176
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP-----TNCMFQG 916
YV P E + + D++SLGV++ + P + G
Sbjct: 177 PYYVAP------------EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 917 GLTLHEFCKMALPEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
T + P V + LL + +R + E +
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT-EPTQRMTITEFM 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 8e-35
Identities = 54/232 (23%), Positives = 83/232 (35%), Gaps = 31/232 (13%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVC 745
IG GSFG +Y G G VA+K+ + K E ++ + + I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 746 SSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH 805
D+ +V E + + + S SL L +A M S IEY+H
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIHS 121
Query: 806 HCQPPIVHGDLKPSNVL---LDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
+H D+KP N L + ++ DFGLA+ + + + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK-YRDARTHQHIPYRENKNLTGTA 177
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914
Y +G E S D+ SLG +L+ P +
Sbjct: 178 RYASI------------NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 38/230 (16%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL-----MQKGALKSFVAECEVLRNTRHRNLI 739
+ +G+G F +VYK VA+K + L + G ++ + E ++L+ H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
++ +LV+++M+ S +
Sbjct: 64 GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+EYLH H I+H DLKP+N+LLD + V ++DFGLA+ +
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF--------GSPNRAYTHQV 161
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
T Y P L V D++++G +L E+ R
Sbjct: 162 VTRWYRAP---------ELLFGARMYGVGV--DMWAVGCILAELLLRVPF 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-33
Identities = 55/234 (23%), Positives = 89/234 (38%), Gaps = 37/234 (15%)
Query: 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN---LMQKGALKSFVAECEVLRNTRH 735
N+F ++G+G+FG V G + A+KIL ++ K + V E VL+NTRH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 736 RNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAID 795
L + + D V EY G L L + E
Sbjct: 65 PFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRERVFTEER---------ARFY 110
Query: 796 MASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSS 855
A + L + +V+ D+K N++LD D ++DFGL + + ++
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--------ISDGATM 162
Query: 856 IGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT Y+ P + ++ D + LGV++ EM R P
Sbjct: 163 KTFCGTPEYLAPEVL------------EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (317), Expect = 1e-32
Identities = 54/313 (17%), Positives = 99/313 (31%), Gaps = 51/313 (16%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCS 746
IG+GSFG +++G N VA+K ++ E + I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHH 806
LV + + G E L G+ S+ A M + ++ +H
Sbjct: 71 QEG----LHNVLVIDLL--GPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEK 120
Query: 807 CQPPIVHGDLKPSNVLLD-----HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGT 861
+V+ D+KP N L+ + + +V DFG+ +F + P + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF-YRDPVTKQHIPYREKKNLSGT 176
Query: 862 VGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLTLH 921
Y+ +G E S D+ +LG + + +QG L
Sbjct: 177 ARYMSI------------NTHLGREQSRRDDLEALGHVFMYFLRGS----LPWQG---LK 217
Query: 922 EFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER---MEM 978
E++ E + L G E + + +
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAG-----FPEEFYKYMH---YARNLAFDATPDYDYL 269
Query: 979 RDVLAKLCAARQT 991
+ + +K+ T
Sbjct: 270 QGLFSKVLERLNT 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 52/288 (18%), Positives = 97/288 (33%), Gaps = 53/288 (18%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLM------QKGALKSFVAECEVLRNTRHRNLIK 740
+G G F V K G A K + + + + E +L+ +H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 741 IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAI 800
+ V + L+ E + G L ++L + E ++++ +
Sbjct: 78 LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123
Query: 801 EYLHHHCQPPIVHGDLKPSNVLLDHDMVA----HVSDFGLARFLFARPFDTSMETQSSSI 856
+++ I H DLKP N++L V + DFGLA + + +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---------DFGNEFK 174
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM-FQ 915
I GT +V P E + D++S+GV+ + + P Q
Sbjct: 175 NIFGTPEFVAP------------EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
Query: 916 GGLTLHEFCKMALPEKVMETVDPSL------LLAWSDGRRRAKVEECL 957
L ++ LL D ++R +++ L
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK-DPKKRMTIQDSL 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 61/311 (19%), Positives = 115/311 (36%), Gaps = 40/311 (12%)
Query: 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNL 738
F IG+G++G VYK G VA+K + L +G + + E +L+ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 739 IKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
+K++ V + + LV+E++ + L++++ S + +
Sbjct: 64 VKLLDVIHT-----ENKLYLVFEFL-HQDLKKFMDASALTGIPLP----LIKSYLFQLLQ 113
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGI 858
+ + H H ++H DLKP N+L++ + ++DFGLAR + ++ + +
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF-------GVPVRTYTHEV 163
Query: 859 KGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP------TNC 912
P S D++SLG + EM TRR +
Sbjct: 164 VTLWYRAPE------------ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972
+F+ TL ++ P W+ V + P
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 973 IERMEMRDVLA 983
+R+ + LA
Sbjct: 272 NKRISAKAALA 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (310), Expect = 4e-31
Identities = 59/270 (21%), Positives = 103/270 (38%), Gaps = 44/270 (16%)
Query: 647 ARRRRSKQES---SISVPMEQYFPMVSYSELSEAT-NEFSSSNMIGQGSFGSVYKGILGE 702
A ++ S+QES ++ E + + A ++F +G GSFG V E
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 703 NGTFVAVKILN---LMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759
+G A+KIL+ +++ ++ + E +L+ L+K+ V
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----V 119
Query: 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPS 819
EY+ G + L + E A + EYLH +++ DLKP
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEP------HARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 820 NVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCL 879
N+L+D V+DFG A+ + R + + GT + P
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----------LCGTPEALAP------------ 207
Query: 880 EYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
E + + D ++LGV++ EM P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 50/225 (22%), Positives = 91/225 (40%), Gaps = 35/225 (15%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG+G++G+V+K E VA+K + L +G S + E +L+ +H+N++++ V
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 745 CSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLH 804
S LV+E+ + + + S + +L ++ L
Sbjct: 70 LHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---------LKGLG 115
Query: 805 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGY 864
++H DLKP N+L++ + +++FGLAR S E T+ Y
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--------TLWY 167
Query: 865 VPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
PP S + D++S G + E+ RP
Sbjct: 168 RPP-----------DVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 118 bits (296), Expect = 5e-30
Identities = 52/310 (16%), Positives = 105/310 (33%), Gaps = 48/310 (15%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL--MQKGALKSFVAECEVLRNTRHRNLIKII 742
IG+G++G VYK G A+K + L +G + + E +L+ +H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEY 802
V + LV+E++ + G V + +
Sbjct: 67 DVIHT-----KKRLVLVFEHLDQDLKKLLDVCEGGLESVT---------AKSFLLQLLNG 112
Query: 803 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTV 862
+ + ++H DLKP N+L++ + ++DFGLAR T+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--------GIPVRKYTHEIVTL 164
Query: 863 GYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP---------TNCM 913
Y P L ++ D++S+G + EM +
Sbjct: 165 WYRAP---------DVLMGSKKYSTTI--DIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213
Query: 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPI 973
F+ T + + E + ++ ++E + ++ P
Sbjct: 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPN 270
Query: 974 ERMEMRDVLA 983
+R+ + L
Sbjct: 271 QRITAKQALE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 6e-30
Identities = 52/282 (18%), Positives = 93/282 (32%), Gaps = 49/282 (17%)
Query: 686 MIGQGSFGSVYKGILGENGTFVAVKILNL------MQKGALKSFVAECEVLR--NTRHRN 737
++G G FGSVY GI + VA+K + + E +L+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 738 LIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMA 797
+I+++ D L+ E + G L + +
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVL 120
Query: 798 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFLFARPFDTSMETQSSSI 856
A+ + H+ ++H D+K N+L+D + + DFG L +
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--------- 168
Query: 857 GIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916
GT Y PP I G A V+SLG++L +M P F+
Sbjct: 169 -FDGTRVYSPPEWIRY-------HRYHGRSA----AVWSLGILLYDMVCGDIP----FEH 212
Query: 917 GLTLHEFCKMALPEKVMETVDPSLLLAWS-DGRRRAKVEECL 957
+ ++ ++V + + R EE
Sbjct: 213 DEEIIR-GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (294), Expect = 2e-29
Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 40/249 (16%)
Query: 663 EQYFPMVSYSELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKS 722
+Y+ S+ +++ +G+G + V++ I N V VKIL ++K K
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KK 75
Query: 723 FVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEV 781
E ++L N R N+I + + + ALV+E++ N ++
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSR---TPALVFEHVNNTDFKQLYQT------- 125
Query: 782 CDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLARFL 840
L+ ++ A++Y H I+H D+KP NV++DH+ + D+GLA F
Sbjct: 126 --LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF- 179
Query: 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900
+ + P L + Y D++SLG ML
Sbjct: 180 --------YHPGQEYNVRVASRYFKGP-----ELLVDYQMYDYSL------DMWSLGCML 220
Query: 901 LEMFTRRRP 909
M R+ P
Sbjct: 221 ASMIFRKEP 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-29
Identities = 55/247 (22%), Positives = 94/247 (38%), Gaps = 40/247 (16%)
Query: 670 SYSELSEATNEFSSS----NMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSF 723
E+++ E + +G G++G+V + G G VA+K L + K
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 724 VAECEVLRNTRHRNLIKIITVCSSID-FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVC 782
E +L++ RH N+I ++ V + + LV +M G+ L +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK----- 117
Query: 783 DLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFA 842
L + + M + Y+H H DLKP N+ ++ D + DFGLAR
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-- 171
Query: 843 RPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLE 902
S G T Y P I L + ++ D++S+G ++ E
Sbjct: 172 ---------DSEMTGYVVTRWYRAPEVI--------LNWMRYTQTV---DIWSVGCIMAE 211
Query: 903 MFTRRRP 909
M T +
Sbjct: 212 MITGKTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 37/230 (16%)
Query: 687 IGQGSFGSVYKG---ILGENGTFVAVKILN----LMQKGALKSFVAECEVLRNTRHRNLI 739
+G G++G V+ + G A+K+L + + + E +VL + R +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 740 KIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASA 799
+ F+ L+ +Y+ G L L Q E + I +
Sbjct: 92 VTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE---------VQIYVGEI 138
Query: 800 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIK 859
+ L H + I++ D+K N+LLD + ++DFGL++ A + + +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------- 191
Query: 860 GTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
GT+ Y+ P + + G D +SLGV++ E+ T P
Sbjct: 192 GTIEYMAPDIVRGG------DSGHDKAV----DWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 48/236 (20%), Positives = 85/236 (36%), Gaps = 34/236 (14%)
Query: 676 EATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNT 733
E + + + +G G++GSV + G VAVK L+ K E +L++
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 734 RHRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIA 793
+H N+I ++ V + + ++ L + L+ +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLI 127
Query: 794 IDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQS 853
+ ++Y+H H DLKPSN+ ++ D + DFGLA T
Sbjct: 128 YQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA-----------RHTDD 173
Query: 854 SSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP 909
G T Y P + T D++S+G ++ E+ T R
Sbjct: 174 EMTGYVATRWYRAPE-----------IMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-27
Identities = 57/303 (18%), Positives = 108/303 (35%), Gaps = 37/303 (12%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILN--LMQKGALKSFVAECEVLRNTRHRNLIKIITV 744
IG G+ G V VA+K L+ + K E +++ H+N+I ++ V
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 745 CSSID-FKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYL 803
+ + LV E M + + + + + + M I++L
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135
Query: 804 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVG 863
H +H DLKPSN+++ D + DFGLAR T T
Sbjct: 136 HSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---------VVTRY 183
Query: 864 YVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM-FQGGLTLHE 922
Y P E +G D++S+G ++ EM + +
Sbjct: 184 YRAP------------EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 923 FCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVL 982
+ M+ + P++ + + A + + + A S + ++ + RD+L
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 983 AKL 985
+K+
Sbjct: 292 SKM 294
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 3e-26
Identities = 57/315 (18%), Positives = 107/315 (33%), Gaps = 40/315 (12%)
Query: 687 IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIK------ 740
+G G F +V+ N T VA+KI+ K ++ E ++L+ + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 741 --IITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMAS 798
I+ + + KG + +V + G L + + LI I+ +
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI---PLIYVKQISKQLLL 136
Query: 799 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLARFLFARPFDTSMETQSSSIG 857
++Y+H C I+H D+KP NVL++ D ++ +A A +D
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN------ 188
Query: 858 IKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRP-------T 910
T Y P E +G+ D++S ++ E+ T +
Sbjct: 189 SIQTREYRSP------------EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236
Query: 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSME 970
+ LP ++ + S G R + + +
Sbjct: 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296
Query: 971 SPIERMEMRDVLAKL 985
S E E+ D L+ +
Sbjct: 297 SKDEAKEISDFLSPM 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 104 bits (258), Expect = 9e-25
Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 33/307 (10%)
Query: 31 NETDRLALLAIKSQLHDPLGVTNSWNNSINLCQ--WAGVTC--GHRHQRVTELDLRHQNI 86
N D+ ALL IK L +P +SW + + C W GV C + RV LDL N+
Sbjct: 4 NPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 87 GG--SLSPYVGNLSFLRYINLATN-NFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLS 143
+ + NL +L ++ + N G IP I L +L L + + + SG IP LS
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 144 SCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL--SIIYLHV 201
L++ N L G +P I S L I+ N ++G +P S G+ + +
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 202 GENQFSGTVPPSLYNMSSLEN---------------------ILLDVNGFTGNLPLDIGV 240
N+ +G +PP+ N++ + + + L
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 241 TLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300
NL + +N G++P+ + + +++ N G++ G L+
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
Query: 301 NNLGSGG 307
N G
Sbjct: 301 NKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.4 bits (225), Expect = 2e-20
Identities = 68/266 (25%), Positives = 107/266 (40%), Gaps = 9/266 (3%)
Query: 349 TDIYMGVNQISG--TIPSGIGNLVNLNLLGIEFN-QLTGNIPREIGQLRNLQAIGLSSNF 405
++ + + IPS + NL LN L I L G IP I +L L + ++
Sbjct: 53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
Query: 406 LQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTI 465
+ G IP L + + L S N L G +PPS+ + NLV + N++ GA+P +
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 466 TTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGN 525
+ L + + N L G +P NL + + +I + +
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
Query: 526 SFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVF 585
+ L + DL N + G +P+ L L FL LN+S+N+ GE+P G
Sbjct: 233 LAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 586 SNKTRVQLTGNGKLCGGSNELHLPSC 611
N LCG LP+C
Sbjct: 291 QRFDVSAYANNKCLCGS----PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.2 bits (170), Expect = 2e-13
Identities = 54/267 (20%), Positives = 98/267 (36%), Gaps = 22/267 (8%)
Query: 165 DIGYSWLKLEHISLARNHLTGM--LPASIGNLSIIYLHV--GENQFSGTVPPSLYNMSSL 220
D ++ ++ L+ +L +P+S+ NL + G N G +PP++ ++ L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 221 ENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFT 280
+ + +G +P D + L N SG++P S S+ N+ I N +
Sbjct: 104 HYLYITHTNVSGAIP-DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 281 GKVSIIFGRLKNLWSLDLGINN----------------LGSGGANDLDFVTILTNCSKLK 324
G + +G L++ N N L+ + S
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 325 VLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTG 384
+ LS + + + N+I GT+P G+ L L+ L + FN L G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 385 NIPREIGQLRNLQAIGLSSNFLQGNIP 411
IP + G L+ ++N P
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.6 bits (114), Expect = 2e-06
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 1/109 (0%)
Query: 55 WNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEI 114
+ + + + T+ +N VG L ++L N +G +
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 115 PKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIP 163
P+ + L L +L ++ N+ G+IP + N + P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 33/141 (23%), Positives = 56/141 (39%), Gaps = 2/141 (1%)
Query: 412 SSLGNLTLMTDLFLSSNHLQGN--IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS 469
+ + +L LS +L IP SL N L L + + + T
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG 529
+L + + +++G++P + +K LV L S N SG +P +++ L GN G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 530 SIPLSLRSLKSIKELDLSCNN 550
+IP S S + N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 3e-04
Identities = 19/61 (31%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 128 MLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGML 187
L NN G +P L+ L S NNL GEIP+ G + + + + A N
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGS 307
Query: 188 P 188
P
Sbjct: 308 P 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 100 bits (248), Expect = 6e-23
Identities = 75/383 (19%), Positives = 132/383 (34%), Gaps = 30/383 (7%)
Query: 197 IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFS 256
+ +G+ + TV + ++ + + D G +D L NL +N +
Sbjct: 25 MKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFSNNQLT 79
Query: 257 GSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTI 316
P N + + I + N + +L N + +
Sbjct: 80 DITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 137
Query: 317 LTNCSKLKVLAFEENRLGGVLPHSIAN------LSTTMTDIYMGVNQISGTIPSGIGNLV 370
+ + + ++ L+ T + ++ + S + L
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197
Query: 371 NLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHL 430
NL L NQ++ P I NL + L+ N L+ +L +LT +TDL L++N +
Sbjct: 198 NLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 431 QGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNL 490
P L L L L N++ P LT T + ++ + NL
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS-----PISNL 306
Query: 491 KNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNN 550
KNL L + N S P ++ T L+ N SL +L +I L N
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 551 LSGQIPEFLENLSFLEYLNLSYN 573
+S P L NL+ + L L+
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 5e-20
Identities = 75/379 (19%), Positives = 134/379 (35%), Gaps = 39/379 (10%)
Query: 74 QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNS 133
+VT L I S+ V L+ L IN + N P + L +L +++ NN
Sbjct: 44 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 134 FSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGN 193
+ P + L+ + + + + L+L +++
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS----------- 148
Query: 194 LSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDN 253
++ L + G L +++L + + + L NL+ +N
Sbjct: 149 -ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNN 207
Query: 254 YFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDF 313
S P +N++ + L N + L NL LDL N + +
Sbjct: 208 QISDITPLGIL--TNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISN-------- 255
Query: 314 VTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLN 373
+ L+ +KL L N++ + P + T + + IS NL NL
Sbjct: 256 LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS-----NLKNLT 310
Query: 374 LLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGN 433
L + FN ++ P + L LQ + ++N + SSL NLT + L N +
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 434 IPPSLGNCKNLVSLNLSDN 452
P L N + L L+D
Sbjct: 367 TP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.4 bits (184), Expect = 6e-15
Identities = 63/385 (16%), Positives = 128/385 (33%), Gaps = 52/385 (13%)
Query: 242 LPNLQVFAIGDNYFSGSIPES-FSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGI 300
L +G + ++ ++ + ++ L I G L NL ++
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 301 NNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISG 360
N L D+ + LT + + + + + + T + ++ +
Sbjct: 76 NQL-----TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSS---------NFLQGNIP 411
L + + I ++ + + L++ + + +
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190
Query: 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRF 471
S L LT + L ++N + P NL L+L+ N+L + ++T L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNL-TD 245
Query: 472 LDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV--------------------TL 511
LDL NN ++ PL L L L + NQ S P+ +
Sbjct: 246 LDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303
Query: 512 TGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571
+ L + N+ P+S SL ++ L + N +S L NL+ + +L+
Sbjct: 304 SNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 572 YNHFDGEVPTKGVFSNKTRVQLTGN 596
+N P + T++ L
Sbjct: 360 HNQISDLTPLAN-LTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.8 bits (159), Expect = 8e-12
Identities = 36/193 (18%), Positives = 69/193 (35%), Gaps = 17/193 (8%)
Query: 62 CQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFL 121
Q + +T + EL L + + +L+ L ++LA N P + L
Sbjct: 207 NQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 262
Query: 122 FRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARN 181
+L L L N S P + L + N + L +++L N
Sbjct: 263 TKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 182 HLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGV 240
+++ + P + +L + L N+ S SL N++++ + N + PL
Sbjct: 318 NISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL---A 370
Query: 241 TLPNLQVFAIGDN 253
L + + D
Sbjct: 371 NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 3e-10
Identities = 40/223 (17%), Positives = 72/223 (32%), Gaps = 17/223 (7%)
Query: 52 TNSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFH 111
T I+ + + ++ + + L + I L+ L ++L N
Sbjct: 175 TTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLK 232
Query: 112 GEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWL 171
+ L L L LANN S P LS + L N + P + L
Sbjct: 233 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP----LAGL 284
Query: 172 KLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFT 231
+ + ++ YL + N S P + +++ L+ + N +
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS 342
Query: 232 GNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDL 274
L L N+ + G N S P +N + I + L
Sbjct: 343 DVSSLA---NLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 3e-08
Identities = 56/283 (19%), Positives = 99/283 (34%), Gaps = 25/283 (8%)
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377
T ++ + + + + + TT+ +G+ I G + L NL +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437
NQLT P + L L I +++N + P + LF + +
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 438 LGNCKNLVSLNL------------SDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPL 485
+ +S N G + + L+ L + S
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 486 EVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELD 545
+ L NL +L + NQ S P+ + T L+ + GN + +L SL ++ +LD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 546 LSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNK 588
L+ N +S P L L+ L L L N P G+ +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT 288
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 3e-06
Identities = 21/104 (20%), Positives = 39/104 (37%), Gaps = 6/104 (5%)
Query: 45 LHDPLGVTNSWNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYIN 104
+ G+T N +N Q ++ + +T L L NI V +L+ L+ +
Sbjct: 278 ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLF 335
Query: 105 LATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNL 148
A N + L + L +N S P L++ + +
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 375
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 2e-20
Identities = 25/166 (15%), Positives = 48/166 (28%), Gaps = 29/166 (17%)
Query: 685 NMIGQGSFGSVYKGILGENGTFVAVKILNL----------MQKGALKSFVAECEVLRNTR 734
++G+G +V+ E VK + + F
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 735 HRNLIKIITVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAI 794
R L K+ + + A++ E + L + +
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVE-------------NPDEVLD 110
Query: 795 DMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840
+ + +H IVHGDL NVL+ + + DF + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.9 bits (211), Expect = 9e-19
Identities = 55/260 (21%), Positives = 92/260 (35%), Gaps = 17/260 (6%)
Query: 323 LKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQL 382
+L + N++ + NL + + + N+IS P LV L L + NQL
Sbjct: 33 TALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 383 TGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ--GNIPPSLGN 440
+ L+ L+ N + S L M + L +N L+ G +
Sbjct: 92 KELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148
Query: 441 CKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISG 500
K L + ++D + +PQ + L L N + + L NL L +S
Sbjct: 149 MKKLSYIRIADTNI-TTIPQGLPP---SLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 501 NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSG------Q 554
N S +L L H+ N +P L K I+ + L NN+S
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 555 IPEFLENLSFLEYLNLSYNH 574
P + + ++L N
Sbjct: 264 PPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 2e-18
Identities = 44/236 (18%), Positives = 93/236 (39%), Gaps = 10/236 (4%)
Query: 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401
+L + + N+I+ NL NL+ L + N+++ P L L+ + L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD--NKLIGAVP 459
S N L+ +P + + +L + N + ++ + L K G
Sbjct: 87 SKNQLK-ELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 460 QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEI 519
+ L ++ + + ++ + G +L L++ GN+ + +L G L
Sbjct: 144 GAFQGMKKL-SYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 520 FHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
+ NS SL + ++EL L+ N L ++P L + +++ + L N+
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 51/295 (17%), Positives = 93/295 (31%), Gaps = 33/295 (11%)
Query: 258 SIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTIL 317
+P+ + ++DL N T F LKNL +L L N +
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA----- 76
Query: 318 TNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGI 377
KL+ L +N+L LP + + + ++ ++ +G+ ++ + L
Sbjct: 77 -PLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPS 437
+ +G ++ L I ++ + IP L +T+L L N + S
Sbjct: 135 P-LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 190
Query: 438 LGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALY 497
L NL L LS N + + L N + P + + K + +Y
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV--PGGLADHKYIQVVY 248
Query: 498 ISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLS 552
+ N S P S + L N +
Sbjct: 249 LHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 49/281 (17%), Positives = 85/281 (30%), Gaps = 15/281 (5%)
Query: 62 CQWAGVTCGHRH---------QRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHG 112
C V C LDL++ I NL L + L N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 113 EIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLK 172
P L +LE L L+ N + L + + + + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMI 127
Query: 173 LEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTG 232
+ + +G+ + + + + T+P L SL + LD N T
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITK 185
Query: 233 NLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKN 292
+ L NL + N S S +N ++ + N KV K
Sbjct: 186 VDAASL-KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH-LNNNKLVKVPGGLADHKY 243
Query: 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRL 333
+ + L NN+ + G+ND T + ++ N +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 4e-14
Identities = 55/321 (17%), Positives = 120/321 (37%), Gaps = 51/321 (15%)
Query: 143 SSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNL-SIIYLHV 201
C L V + + ++P+D+ + L N +T + NL ++ L +
Sbjct: 6 FRCQCHLRVVQCSDLGLEKVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLIL 62
Query: 202 GENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE 261
N+ S P + + LE + L N LP + TL L+V +N +
Sbjct: 63 INNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVH---ENEITKVRKS 118
Query: 262 SFSNASNIEIIDL--PINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTN 319
F+ + + +++L +G + F +K L + + N+ +
Sbjct: 119 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-------------- 164
Query: 320 CSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEF 379
+P L ++T++++ N+I+ + + L NL LG+ F
Sbjct: 165 -----------------IPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 380 NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQG------N 433
N ++ + +L+ + L++N L +P L + + ++L +N++
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 434 IPPSLGNCKNLVSLNLSDNKL 454
P + ++L N +
Sbjct: 264 PPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 2e-07
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 8/162 (4%)
Query: 432 GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLK 491
G + P C +L + SD L VP+ + T LDL NN + + NLK
Sbjct: 1 GPVCPFRCQC-HLRVVQCSDLGLE-KVPKDLPPDTA---LLDLQNNKITEIKDGDFKNLK 55
Query: 492 NLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551
NL L + N+ S P LE ++ N + +P + K+++EL + N +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEI 112
Query: 552 SGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQL 593
+ L+ + + L N G F ++
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (195), Expect = 7e-17
Identities = 46/255 (18%), Positives = 77/255 (30%), Gaps = 5/255 (1%)
Query: 323 LKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQL 382
+ + NR+ V S + G + L + QL
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 383 TGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCK 442
P L L + L LQ P L + L+L N LQ + +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 443 NLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQ 502
NL L L N++ + + +L R L N + P +L L+ LY+ N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 503 FSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENL 562
S L L+ + N + +++ S + + +P+ L
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 563 SFLEYLNLSYNHFDG 577
L+ N G
Sbjct: 272 DL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 51/272 (18%), Positives = 90/272 (33%), Gaps = 14/272 (5%)
Query: 234 LPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNL 293
+P+ I Q + N S SF N+ I+ L N + F L L
Sbjct: 26 VPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 294 WSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYM 353
LDL N +L L + L + + +Y+
Sbjct: 83 EQLDLSDNAQLRSVDPA-----TFHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQYLYL 136
Query: 354 GVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSS 413
N + +L NL L + N+++ R L +L + L N + P +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 414 LGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLD 473
+L + L+L +N+L +L + L L L+DN + + + +
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC--DCRARPLWAWLQKFR 254
Query: 474 LGNNHLNGSLPLEVGNLKNLVALYISGNQFSG 505
++ + SLP L ++ N G
Sbjct: 255 GSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 48/282 (17%), Positives = 88/282 (31%), Gaps = 13/282 (4%)
Query: 175 HISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNL 234
S + L +P I + + + N+ S S +L + L N
Sbjct: 15 TTSCPQQGLQA-VPVGIPA-ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 235 PLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLW 294
Q+ + P +F + + L +F L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 295 SLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMG 354
L L N L + + + L L NR+ V + L ++ + +
Sbjct: 133 YLYLQDNALQALPDD------TFRDLGNLTHLFLHGNRISSVPERAFRGL-HSLDRLLLH 185
Query: 355 VNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSL 414
N+++ P +L L L + N L+ + LR LQ + L+ N + +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-AR 244
Query: 415 GNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456
+ SS+ + ++P L L+ N L G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (154), Expect = 1e-11
Identities = 52/247 (21%), Positives = 82/247 (33%), Gaps = 28/247 (11%)
Query: 386 IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI----------- 434
+P I Q I L N + +S +T L+L SN L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 435 --------------PPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLN 480
P + L +L+L L P + L L +N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL-YLQDNALQ 142
Query: 481 GSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKS 540
+L NL L++ GN+ S G L+ + N P + R L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 541 IKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLC 600
+ L L NNLS E L L L+YL L+ N + + + +++ + + + + C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 601 GGSNELH 607
L
Sbjct: 263 SLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (147), Expect = 1e-10
Identities = 41/286 (14%), Positives = 82/286 (28%), Gaps = 37/286 (12%)
Query: 100 LRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLV 159
+ I L N L L L +N + + + L N +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 160 GEIPEDIGYSWLKLEHISLARNHLTG-MLPASIGNLSIIYLHVGENQFSGTVPPSLYNMS 218
+ + +L + L R L G ++ YL++ +N + ++
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY 278
+L ++ L N + +P L +L + N + P +F + + + L N
Sbjct: 154 NLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 279 FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLP 338
+ + L+ L L L N C
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPW---------------VCD----------------- 240
Query: 339 HSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTG 384
L + +++ ++P L +L + N L G
Sbjct: 241 CRARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (118), Expect = 5e-07
Identities = 34/202 (16%), Positives = 54/202 (26%), Gaps = 11/202 (5%)
Query: 7 ITCLATFIFSFSLLLHSQSFSAHTNETDRLALLAIKSQLHDPLGVTNSWNNSINLCQWAG 66
+ + F LH+ + L + L N+ +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR-- 150
Query: 67 VTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLET 126
+T L L I L L + L N P L RL T
Sbjct: 151 -----DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 127 LMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGM 186
L L N+ S L+ L N V + ++WL+ + + +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ--KFRGSSSEVPCS 263
Query: 187 LPASIGNLSIIYLHVGENQFSG 208
LP + + L N G
Sbjct: 264 LPQRLAGRDLKRLA--ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 27/201 (13%), Positives = 47/201 (23%), Gaps = 26/201 (12%)
Query: 55 WNNSINLCQWAGVTCGHRHQRVTELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEI 114
+ + H R+ L L + L+ L+Y+ L N
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 115 PKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGY------ 168
L L L L N S +L + ++N + P
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 169 -----------------SWLKLEHISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVP 211
L+++ L N A + ++ ++P
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265
Query: 212 PSLYNMSSLENILLDVNGFTG 232
L L N G
Sbjct: 266 QRLAGRDLKR---LAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 44/212 (20%), Positives = 67/212 (31%), Gaps = 7/212 (3%)
Query: 389 EIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLN 448
E+ ++ + + L +P L T T L LS N L +L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDT--TILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 449 LSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP 508
L +L L + L +S N+ +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL----DVSFNRLTSLPL 117
Query: 509 VTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568
L G L+ +++GN + P L +++L L+ NNL+ L L L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 569 NLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLC 600
L N L GN LC
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 40/216 (18%), Positives = 68/216 (31%), Gaps = 15/216 (6%)
Query: 216 NMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLP 275
++S + D T LP D+ + + + +N + + + ++L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNL- 62
Query: 276 INYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGG 335
+ + G L L +LDL N L S + L
Sbjct: 63 -DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL--------T 113
Query: 336 VLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRN 395
LP + ++Y+ N++ P + L L + N LT + L N
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 396 LQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQ 431
L + L N L IP L+ FL N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 33/192 (17%), Positives = 60/192 (31%), Gaps = 9/192 (4%)
Query: 361 TIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSS-NFLQGNIPSSLGNLTL 419
+P + + +L + N L + L + L + + +L L
Sbjct: 24 ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 420 MTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHL 479
+ +H Q P LG +++ + ++P L + L L N L
Sbjct: 82 LD-----LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 480 NGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLK 539
P + L L ++ N + L G L+ +Q NS +IP
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 540 SIKELDLSCNNL 551
+ L N
Sbjct: 196 LLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.004
Identities = 30/176 (17%), Positives = 58/176 (32%), Gaps = 22/176 (12%)
Query: 76 VTELDLRHQNIGGSLSPYVGNLSFLRYINLA--------------------TNNFHGEIP 115
T L L + + + L +NL ++ +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92
Query: 116 KEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEH 175
+G T++ + + +P L + + N + +P + KLE
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 176 ISLARNHLTGMLPASIGNL-SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGF 230
+SLA N+LT + + L ++ L + EN T+P + L L N +
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 33/273 (12%), Positives = 84/273 (30%), Gaps = 7/273 (2%)
Query: 175 HISLARNHLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNL 234
+ L +L + + + +I + + + ++++ L + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 235 PLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPI--NYFTGKVSIIFGRLKN 292
I LQ ++ S I + + SN+ ++L + + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 293 LWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIY 352
L L+L + + + ++L + + +N L + +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 353 MGVNQISGTIPSGIGNLVNLNLLGIEF-NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIP 411
+ L L L + + E+G++ L+ + + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 412 SSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNL 444
L L ++ +H P++GN KN
Sbjct: 243 LLKEALP---HLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 33/230 (14%), Positives = 70/230 (30%), Gaps = 37/230 (16%)
Query: 387 PREIGQL--RNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGN-IPPSLGNCKN 443
P G+L + + A +F+ + + + LS++ ++ + + L C
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEVSTLHGILSQCSK 72
Query: 444 LVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHL-NGSLPLEVGNLKNLVALYIS--- 499
L +L+L +L + + + L R G + +L + + L L +S
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 500 -----------GNQFSGEIPVTLTGCTGLEIFHMQGNSFR-----------------GSI 531
+ + L+G R
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 532 PLSLRSLKSIKELDLS-CNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVP 580
L ++ L LS C ++ + L + L+ L + DG +
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 40/302 (13%), Positives = 79/302 (26%), Gaps = 28/302 (9%)
Query: 77 TELDLRHQNIGGSLSPYVGNLSFLRYINLATNNFHGEIPKEIGFLFRLETLMLANNSFSG 136
LDL +N+ ++ + + + +F + E FR++ + L+N+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCP-RSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 137 K-IPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARNHLTGMLPASIGNLS 195
+ LS CS L + L I + L ++L+
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLA-KNSNLVRLNLSGCS------------- 106
Query: 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYF 255
Q + L ++ + +
Sbjct: 107 --GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 164
Query: 256 SGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVT 315
S + + + F +L L L L + +
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP-----ETLL 219
Query: 316 ILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLL 375
L LK L G V ++ L + + + + + IGN N +
Sbjct: 220 ELGEIPTLKTL----QVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIW 275
Query: 376 GI 377
GI
Sbjct: 276 GI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 15/100 (15%), Positives = 38/100 (38%), Gaps = 2/100 (2%)
Query: 397 QAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456
Q + L+ L ++ L + + + + + + + ++LS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGV-IAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 457 AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVAL 496
+ IL+ + + L L L+ + + NLV L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 8e-09
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 6/110 (5%)
Query: 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG 529
R L L + L ++ + L + L +S N+ P L LE+ N+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE- 56
Query: 530 SIPLSLRSLKSIKELDLSCNNL-SGQIPEFLENLSFLEYLNLSYNHFDGE 578
+ +L ++EL L N L + L + L LNL N E
Sbjct: 57 -NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 32/107 (29%), Positives = 43/107 (40%), Gaps = 7/107 (6%)
Query: 401 LSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ 460
L+ L + L L L+T L LS N L+ PP+L + L L SDN L
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVDGV 61
Query: 461 QILTITTLSRFLDLGNNHLNG-SLPLEVGNLKNLVALYISGNQFSGE 506
L + L L NN L + + + LV L + GN E
Sbjct: 62 ANLPRL---QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 9e-07
Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 356 NQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLG 415
+ T+ + L+ + L + N+L P + LR L+ L ++ +
Sbjct: 8 KDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENVDGVA 62
Query: 416 NLTLMTDLFLSSNHLQG-NIPPSLGNCKNLVSLNLSDNKLIG 456
NL + +L L +N LQ L +C LV LNL N L
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 26/149 (17%), Positives = 42/149 (28%), Gaps = 32/149 (21%)
Query: 423 LFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGS 482
L L+ L + L + L+LS N+L P + L L +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56
Query: 483 LPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIK 542
V NL L L + N+ + L S +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQ-----------------------SAAIQPLVSCPRLV 93
Query: 543 ELDLSCNNLSGQ---IPEFLENLSFLEYL 568
L+L N+L + E L + +
Sbjct: 94 LLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 39/222 (17%), Positives = 68/222 (30%), Gaps = 21/222 (9%)
Query: 351 IYMGVNQISGTIP-SGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGN 409
I G + ++ T+ + + + L+ G + G + L NL + L N +
Sbjct: 24 IAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKDNQITDL 78
Query: 410 IPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLS 469
P +L + I ++ + L +
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD-------VTPLAGLSNL 131
Query: 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRG 529
+ L L N + PL Y+S L + L N
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQ----YLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 530 SIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571
PL+ SL ++ E+ L N +S P L N S L + L+
Sbjct: 188 ISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 34/202 (16%), Positives = 65/202 (32%), Gaps = 19/202 (9%)
Query: 392 QLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSD 451
L N I + + + + +L +T L + I + NL+ L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 452 NKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISG----------- 500
N++ P + LT T +++ L+ +L + I+
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 501 --NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEF 558
+I + ++ + + S L +L + L N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 559 LENLSFLEYLNLSYNHFDGEVP 580
L +L L ++L N P
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 31/207 (14%), Positives = 61/207 (29%), Gaps = 29/207 (14%)
Query: 386 IPREIGQ------LRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLG 439
+P I Q L + + + L + + +++ ++ +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 440 NCKNLVSLNLSDNKLIGAVPQQILTITTLSRF---------------LDLGNNHLNGSLP 484
N+ L L+ NKL P L + + +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 485 LEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKEL 544
G + + L+ T L+ ++ N +PL+ L ++ L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNL 183
Query: 545 DLSCNNLSGQIPEFLENLSFLEYLNLS 571
LS N++S L L L+ L L
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (111), Expect = 1e-06
Identities = 24/157 (15%), Positives = 55/157 (35%), Gaps = 9/157 (5%)
Query: 425 LSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGN-NHLNGSL 483
L ++ + + + L L + + + + L + + +L
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQNIDVVLNRRSSMAATL 57
Query: 484 PLEVGNLKNLVALYISGNQFSG--EIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSI 541
+ N+ L++L +S N+ ++ + L+I ++ GN + L +
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 542 KELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGE 578
+EL L N+LS + +S + DG
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 9/90 (10%)
Query: 379 FNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSL 438
N + I +L+ + +S+N L +P+ L L S NHL +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELP 323
Query: 439 GNCKNLVSLNLSDNKLIGAVPQQILTITTL 468
NL L++ N L P ++ L
Sbjct: 324 Q---NLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 476 NNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSL 535
N + + +L L +S N+ E+P LE N +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPELP 323
Query: 536 RSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLN 569
++LK +L + N L + P+ E++ L +N
Sbjct: 324 QNLK---QLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 16/76 (21%), Positives = 33/76 (43%), Gaps = 10/76 (13%)
Query: 346 TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF 405
++ ++ + N++ +P+ L L FN L +P L+ L + N
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLIA---SFNHLA-EVPELPQNLKQLH---VEYNP 335
Query: 406 LQG--NIPSSLGNLTL 419
L+ +IP S+ +L +
Sbjct: 336 LREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 6e-05
Identities = 24/96 (25%), Positives = 33/96 (34%), Gaps = 10/96 (10%)
Query: 424 FLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSL 483
N I +L LN+S+NKLI +P + L NHL +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER----LIASFNHLA-EV 319
Query: 484 PLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEI 519
P NLK L++ N E P L +
Sbjct: 320 PELPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 15/98 (15%), Positives = 35/98 (35%), Gaps = 16/98 (16%)
Query: 277 NYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGV 336
N + ++ + +L L++ N L + + +L+ L N L
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL----------IELPALPPRLERLIASFNHLAE- 318
Query: 337 LPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNL 374
+P NL +++ N + P ++ +L +
Sbjct: 319 VPELPQNLKQ----LHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 14/94 (14%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 492 NLVALYISGNQFSGE-IPVTLTGCTGLEIFHMQGNSFRG----SIPLSLRSLKSIKELDL 546
++ +L I + S L ++ + I +LR ++ EL+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 547 SCNNLSGQIPEFL-----ENLSFLEYLNLSYNHF 575
N L + ++ L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 513 GCTGLEIFHMQGNSFRG----SIPLSLRSLKSIKELDLSCNNLSGQIPEFL-----ENLS 563
+ L + + S+ +L + S++ELDLS N L L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 564 FLEYLNLSYNHFDGEVP 580
LE L L ++ E+
Sbjct: 427 LLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 5/67 (7%)
Query: 517 LEIFHMQGNSFRGS-IPLSLRSLKSIKELDLSCNNLSGQ----IPEFLENLSFLEYLNLS 571
++ +Q + L L+ + + L L+ I L L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 572 YNHFDGE 578
N
Sbjct: 64 SNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 10/73 (13%), Positives = 26/73 (35%), Gaps = 4/73 (5%)
Query: 443 NLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG----SLPLEVGNLKNLVALYI 498
++ SL++ +L A ++L + + + L + L + + L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 499 SGNQFSGEIPVTL 511
N+ +
Sbjct: 63 RSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 14/83 (16%), Positives = 28/83 (33%), Gaps = 9/83 (10%)
Query: 489 NLKNLVALYISGNQFSGE----IPVTLTGCTGLEIFHMQGNSFRGSIPLSL-----RSLK 539
L L+++ S + TL L + N + L L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 540 SIKELDLSCNNLSGQIPEFLENL 562
+++L L S ++ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 3/78 (3%)
Query: 268 NIEIIDLPINYFTGK-VSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVL 326
+I+ +D+ + + + L+ + L L D+ + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 327 AFEENRLGGVLPHSIANL 344
N LG V H +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 15/84 (17%), Positives = 35/84 (41%), Gaps = 8/84 (9%)
Query: 416 NLTLMTDLFLSSNHLQGN----IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTI----TT 467
+++ L+L+ + + + +L +L L+LS+N L A Q++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 468 LSRFLDLGNNHLNGSLPLEVGNLK 491
L L L + + + + + L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 395 NLQAIGLSSNFLQGN-IPSSLGNLTLMTDLFLSSNHLQG----NIPPSLGNCKNLVSLNL 449
++Q++ + L L L + L L +I +L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 450 SDNKL----IGAVPQQILTITTLSRFLDLGNNH 478
N+L + V Q + T + + L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 16/92 (17%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 62 CQWAGVTCGHRHQRVTELDLRHQNIGG----SLSPYVGNLSFLRYINLATNNFHGEIPKE 117
+ G + L L ++ SL+ + LR ++L+ N +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 118 IGFLFR-----LETLMLANNSFSGKIPTNLSS 144
+ R LE L+L + +S ++ L +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 10/63 (15%), Positives = 20/63 (31%), Gaps = 4/63 (6%)
Query: 520 FHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQ----IPEFLENLSFLEYLNLSYNHF 575
++ R + ++ L L+ ++S + L L L+LS N
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 576 DGE 578
Sbjct: 410 GDA 412
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 5/86 (5%)
Query: 263 FSNASNIEIIDLPINYFTGK----VSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILT 318
S + ++ L + ++ +L LDL N LG G L ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423
Query: 319 NCSKLKVLAFEENRLGGVLPHSIANL 344
L+ L + + + L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 13/80 (16%), Positives = 28/80 (35%), Gaps = 9/80 (11%)
Query: 395 NLQAIGLSSNFLQGN----IPSSLGNLTLMTDLFLSSNHLQGNIPPSLG-----NCKNLV 445
L+ + L+ + + + ++L + +L LS+N L L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 446 SLNLSDNKLIGAVPQQILTI 465
L L D + ++ +
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 22/151 (14%), Positives = 48/151 (31%), Gaps = 10/151 (6%)
Query: 401 LSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQ 460
L++ ++ N +L L + I +++ SDN++
Sbjct: 3 LTAELIE-QAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 461 QILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSG----EIPVTLTGCTG 516
+L + L + NN + L +L L ++ N + +L T
Sbjct: 60 PLLRRL---KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116
Query: 517 LEIFHMQGNSFRGSIPLSLRSLKSIKELDLS 547
L I + + + + ++ LD
Sbjct: 117 LCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.001
Identities = 8/43 (18%), Positives = 14/43 (32%), Gaps = 1/43 (2%)
Query: 533 LSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHF 575
+ +ELDL + I L + ++ S N
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 10/58 (17%), Positives = 15/58 (25%)
Query: 514 CTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571
E+ N+ LD+S + LENL L +
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 25/220 (11%), Positives = 51/220 (23%), Gaps = 6/220 (2%)
Query: 234 LPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNL 293
+P D+ N +FS ++E I++ N +
Sbjct: 23 IPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 294 WSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYM 353
N F + L ++ HS+ + + D
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 354 GVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSS 413
+ V L L ++ + + L ++
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 414 LGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNK 453
L +S + L N K L + + + K
Sbjct: 200 ASGPV---ILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 30/189 (15%), Positives = 59/189 (31%), Gaps = 19/189 (10%)
Query: 393 LRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDN 452
L L + + + +L +T L ++ +I + NL +N S+N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72
Query: 453 KLIGAVP-------------QQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYIS 499
+L P + T L + + + +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 500 GNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFL 559
S I + + +S + + L +L +++ LD+S N +S L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 560 ENLSFLEYL 568
L+ LE L
Sbjct: 191 AKLTNLESL 199
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 12/52 (23%), Positives = 18/52 (34%), Gaps = 5/52 (9%)
Query: 532 PLSLRSLKSIKELDLSCNNLSGQIPEFL-----ENLSFLEYLNLSYNHFDGE 578
S ++ L L N + L E + L +L L+ N F E
Sbjct: 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 12/50 (24%), Positives = 20/50 (40%), Gaps = 4/50 (8%)
Query: 530 SIPLSLRSLKSIKELDLSCNNLSGQ----IPEFLENLSFLEYLNLSYNHF 575
S+ L S+KE+ LS N + + + E + + LE S
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 20/116 (17%), Positives = 34/116 (29%), Gaps = 2/116 (1%)
Query: 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVA 495
P L + + + + L+ HL ++ L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 496 LYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551
L I + P L ++ N+ S+ S++EL LS N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 0.001
Identities = 34/175 (19%), Positives = 62/175 (35%), Gaps = 8/175 (4%)
Query: 107 TNNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDI 166
T EIP++I L+L +N L L + + N + I +
Sbjct: 16 TGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 167 GYSWLKLEHISLARNHLTGMLPASIGNLS-IIYLHVGENQFSGTVPPSLYNMSSLENILL 225
++ + L N + + L + L++ +NQ S +P S +++SL ++ L
Sbjct: 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 226 DVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFT 280
N F N L + P +++I DLP + F
Sbjct: 134 ASNPFNCNCHLAWFAEWLRKKSLNG--GAARCGAPSKV---RDVQIKDLPHSEFK 183
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 997 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.39 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.22 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.22 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.92 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.32 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=416.47 Aligned_cols=267 Identities=28% Similarity=0.431 Sum_probs=206.2
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.. +.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 467999999999999999999874 35999999633 34566889999999999999999999998642 35
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++..... .+++..+.+++.||++||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred EEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence 7999999999999999986542 489999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+...... .........||+.|||||++... ....|+.++|||||||++|||+||+.||.....
T Consensus 150 la~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~---------~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 150 LATVKSRWS------GSHQFEQLSGSILWMAPEVIRMQ---------DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp CSCC------------------CCCCGGGCCHHHHTTC---------SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ceeeccccC------CcccccccccCcccCCHHHHhcc---------cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 997652211 11223346799999999887531 134689999999999999999999999974321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
.. .+...... ....|... ....++++++.+++.+||+.||++||||+|+++.|+.+.+++.
T Consensus 215 ~~-~~~~~~~~-------~~~~p~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 215 RD-QIIFMVGR-------GYLSPDLS---------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HH-HHHHHHHH-------TSCCCCGG---------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HH-HHHHHHhc-------CCCCCcch---------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 11111111 01111111 1112346678899999999999999999999999999887653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=412.62 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=199.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++||||+++++++. +++..|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCceeE
Confidence 57999999999999999999999999999999997432 233467899999999999999999999954 456899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 80 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp EEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhh
Confidence 9999999999999997654 488999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCC-CccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEA-SVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
+...... ........+||+.|||||++. +..+ +.++||||+||++|||+||+.||......
T Consensus 151 ~~~~~~~------~~~~~~~~~GT~~Y~APE~~~------------~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 151 TVFRYNN------RERLLNKMCGTLPYVAPELLK------------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp EECEETT------EECCBCCCCSCGGGSCTHHHH------------CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred eeeccCC------ccccccceeeCcCccCHhHhc------------CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 8753211 112234568999999998775 3444 67899999999999999999999754332
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
........... .. ..+ .....+++.+++.+||+.||++|||++|+++
T Consensus 213 ~~~~~~~~~~~---~~---~~~--------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 213 CQEYSDWKEKK---TY---LNP--------------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SHHHHHHHTTC---TT---STT--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhcCC---CC---CCc--------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22111111100 00 000 0112345678999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=417.36 Aligned_cols=263 Identities=27% Similarity=0.450 Sum_probs=195.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc---EEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT---FVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.+.||+|+||+||+|+++.+++ .||||++.. ......+.|.+|++++++++|||||+++++|. .++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence 345667899999999999999976654 689998864 34455678999999999999999999999964 345
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..++|||||++|+|.+++..... .+++.++.+++.||++||+|||++ +|+||||||+|||++.++++||+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence 79999999999999999887542 489999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|+|+........ ..........||+.|||||.+. ++.++.++|||||||++|||+| |+.||...
T Consensus 173 Gla~~~~~~~~~---~~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 173 GLSRFLEDDTSD---PTYTSALGGKIPIRWTAPEAIQ------------YRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp --------------------------CGGGSCHHHHH------------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccceEccCCCCc---ceeeecccccCCccccCHHHHh------------cCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 999876332111 1112223356899999997654 5679999999999999999998 89998743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
. ..+...... ... +.+.+.+++.++.+++.+||+.||++||||+|+++.|+++.+.
T Consensus 238 ~-----~~~~~~~i~-----~~~------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 238 T-----NQDVINAIE-----QDY------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp C-----HHHHHHHHH-----TTC------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C-----HHHHHHHHH-----cCC------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2 111111110 000 0111223566788999999999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=408.35 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=203.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++||||+++++++. .++..|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence 47999999999999999999999999999999998665556678999999999999999999999954 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.+++.+.. +++.+++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+
T Consensus 95 vmEy~~gg~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEECCTTCBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 999999999999887653 88999999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... .......+||+.|+|||++. +..++.++||||+||++|||+||+.||....
T Consensus 165 ~~~~~--------~~~~~~~~gt~~Y~aPE~~~------------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---- 220 (293)
T d1yhwa1 165 QITPE--------QSKRSTMVGTPYWMAPEVVT------------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---- 220 (293)
T ss_dssp ECCST--------TCCBCCCCSCGGGCCHHHHS------------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----
T ss_pred eeccc--------cccccccccCCCccChhhhc------------CCCCCchhceehHhHHHHHHhhCCCCCCCCC----
Confidence 75221 12234467999999997664 5678999999999999999999999996321
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+......... .+.. ..+..+..++.+++.+||..||++|||++|+++
T Consensus 221 -~~~~~~~~~~~~-----~~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 221 -PLRALYLIATNG-----TPEL----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -HHHHHHHHHHHC-----SCCC----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -HHHHHHHHHhCC-----CCCC----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111000 0000 011123456789999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=403.43 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=198.6
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
|++.++||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++|||||++++++... ..+....++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEE
Confidence 46677899999999999999999999999998643 344567889999999999999999999997543 234567899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC-CCCcEEEcccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLA 837 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFg~a 837 (997)
||||+++|+|.+++.+.. .+++..++.++.||++||+|||++. ++|+||||||+|||++ .++.+||+|||+|
T Consensus 90 vmE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999998754 4889999999999999999999981 1399999999999996 5799999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+.... .......||+.|||||++. +.++.++||||+||++|||++|+.||....
T Consensus 163 ~~~~~----------~~~~~~~GT~~Y~aPE~~~-------------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~--- 216 (270)
T d1t4ha_ 163 TLKRA----------SFAKAVIGTPEFMAPEMYE-------------EKYDESVDVYAFGMCMLEMATSEYPYSECQ--- 216 (270)
T ss_dssp GGCCT----------TSBEESCSSCCCCCGGGGG-------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS---
T ss_pred eeccC----------CccCCcccCccccCHHHhC-------------CCCCCcCchhhHHHHHHHHHHCCCCCCCcc---
Confidence 75311 1223467999999998764 358999999999999999999999996321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+...... ....+.. ....+.+++.+++.+||+.||++|||+.|+++
T Consensus 217 -~~~~~~~~i~-----~~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 217 -NAAQIYRRVT-----SGVKPAS-----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -SHHHHHHHHT-----TTCCCGG-----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cHHHHHHHHH-----cCCCCcc-----------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2222211111 1111100 01112345789999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=406.96 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=196.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.++||+|+||+||+|+++ +++.||||+++... ...+++.+|++++++++|||||+++++|.. ++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence 47888999999999999999997 67889999997543 334679999999999999999999999653 457899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.+++..... .+++..+++++.||++||+|||++ +|+||||||+||++++++++||+|||+|+
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 9999999999999886542 478999999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhC-CCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTR-RRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~~~~ 917 (997)
...... ........||+.|+|||++. +..++.++|||||||++|||+|+ ++||...
T Consensus 150 ~~~~~~-------~~~~~~~~gt~~y~aPE~l~------------~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---- 206 (263)
T d1sm2a_ 150 FVLDDQ-------YTSSTGTKFPVKWASPEVFS------------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---- 206 (263)
T ss_dssp ----------------------CTTSCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----
T ss_pred eccCCC-------ceeecceecCcccCChHHhc------------CCCCCchhhhcchHHHHHHHHHCCCCCCCCC----
Confidence 653211 11223457899999997664 56799999999999999999995 4444321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
...+..... .....+ ..+..++.++.+++.+||+.||++||||+|+++.|+++.++
T Consensus 207 -~~~~~~~~i-----~~~~~~------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 207 -SNSEVVEDI-----STGFRL------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -CHHHHHHHH-----HHTCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CHHHHHHHH-----HhcCCC------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 122221111 010110 01123356788999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=411.63 Aligned_cols=257 Identities=22% Similarity=0.329 Sum_probs=206.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
+.|++.++||+|+||+||+|+++.+++.||||+++.......+.+.+|++++++++|||||++++++. +++..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 36889999999999999999999999999999998666666788999999999999999999999954 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|+|.+++.+... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+
T Consensus 87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999876431 488999999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
.... .........||+.|+|||++.. +...+..|+.++||||+||++|||+||+.||.......
T Consensus 159 ~~~~--------~~~~~~~~~Gt~~y~APE~l~~-------~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~- 222 (288)
T d2jfla1 159 KNTR--------TIQRRDSFIGTPYWMAPEVVMC-------ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR- 222 (288)
T ss_dssp ECHH--------HHHHHTCCCSCCTTCCHHHHTT-------CSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-
T ss_pred ccCC--------CcccccccccccccCCHHHHhh-------cccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-
Confidence 5411 1122334679999999998853 22235678999999999999999999999997432111
Q ss_pred cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+..... ...+.. ..+..++.++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~i~~---------~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 223 VLLKIAK---------SEPPTL----------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHH---------SCCCCC----------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHc---------CCCCCC----------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111100 000110 011223456789999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=415.38 Aligned_cols=264 Identities=25% Similarity=0.432 Sum_probs=210.5
Q ss_pred HHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 674 LSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++...++|++.++||+|+||+||+|+++.+++.||||+++... ...+.+.+|++++++++|||||+++++|. ++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~ 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----RE 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eC
Confidence 3344578999999999999999999999899999999997543 34567999999999999999999999964 45
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++++||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred CeeEEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcc
Confidence 688999999999999999987542 2489999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+..... .........||+.|+|||++. +..|+.++|||||||++|||++|..||...
T Consensus 159 FG~a~~~~~~-------~~~~~~~~~g~~~y~aPE~~~------------~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 159 FGLSRLMTGD-------TYTAHAGAKFPIKWTAPESLA------------YNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CCCTTTCCSS-------SSEEETTEEECGGGCCHHHHH------------HCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceeecCCC-------CceeeccccccccccChHHHc------------CCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 9999865221 112223456899999997765 467899999999999999999977776432
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
....+...... ....+ +.+..++.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 220 ----~~~~~~~~~i~-----~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 220 ----IDLSQVYELLE-----KDYRM------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----CCHHHHHHHHH-----TTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----chHHHHHHHHh-----cCCCC------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12222211110 00111 1112345678899999999999999999999999987643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=404.58 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=202.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 5799999999999999999999999999999998632 233457789999999999999999999995 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 999999999999999998754 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... .......||+.|||||++. +..++.++|||||||++|||+||+.||...
T Consensus 152 ~a~~~~~----------~~~~~~~Gt~~Y~APE~~~------------~~~~~~~~DiwSlGvilyell~G~~Pf~~~-- 207 (263)
T d2j4za1 152 WSVHAPS----------SRRTTLCGTLDYLPPEMIE------------GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-- 207 (263)
T ss_dssp SCSCCCC----------CCCEETTEEGGGCCHHHHT------------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--
T ss_pred eeeecCC----------CcccccCCCCcccCHHHHc------------CCCCCchhhhhhHhHHHHHHhcCCCCCCCC--
Confidence 9976421 1223467999999997664 567899999999999999999999999742
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+........ ++.. +..+++++.+++.+||+.||++|||++|+++
T Consensus 208 ---~~~~~~~~i~~~------~~~~------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 ---TYQETYKRISRV------EFTF------------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---SHHHHHHHHHTT------CCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CHHHHHHHHHcC------CCCC------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122221111110 0000 1123456789999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=408.47 Aligned_cols=264 Identities=23% Similarity=0.364 Sum_probs=207.9
Q ss_pred hcCccCC-cccccCcceEEEEEECC--CCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSN-MIGQGSFGSVYKGILGE--NGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~-~lg~G~~g~V~~~~~~~--~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|.+.+ +||+|+||+||+|.++. ++..||||+++.. .....+.|.+|++++++++|||||+++++|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 4566666 49999999999998753 4558999999743 34456789999999999999999999998742 3
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+++|+|.+++..... .+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence 58999999999999999875432 489999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcC
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCM 913 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 913 (997)
|+|+...... ..........||+.|+|||++. ++.++.++|||||||++|||+| |+.||...
T Consensus 154 Gla~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 154 GLSKALGADD-----SYYTARSAGKWPLKWYAPECIN------------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TTCEECTTCS-----CEECCCCSSCCCGGGCCHHHHH------------HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhhhcccccc-----cccccccccccCccccChHHHh------------CCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 9998763321 1122233456899999997765 4678999999999999999998 89999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhh
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLV 993 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 993 (997)
.. ..+...+.. +.+.+.+..+++++.+++.+||+.||++||||.+|.+.|+....++.
T Consensus 217 ~~--~~~~~~i~~--------------------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 217 KG--PEVMAFIEQ--------------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp CT--HHHHHHHHT--------------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CH--HHHHHHHHc--------------------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 21 111111110 00111123456778899999999999999999999999998877665
Q ss_pred cc
Q 001908 994 GR 995 (997)
Q Consensus 994 ~~ 995 (997)
.+
T Consensus 275 ~~ 276 (285)
T d1u59a_ 275 SK 276 (285)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=403.24 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=192.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .+...+.+.+|++++++++|||||++++++.+ ......
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence 6799999999999999999999999999999999643 34456788999999999999999999998753 234568
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
|+|||||++|+|.+++.+... ....+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 999999999999999875321 1124899999999999999999999872 114999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+..... ........||+.|||||++. +..|+.++|||||||++|||+||+.||....
T Consensus 159 G~a~~~~~~--------~~~~~~~~gt~~Y~APE~l~------------~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 159 GLARILNHD--------TSFAKAFVGTPYYMSPEQMN------------RMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HHHHHC-------------------CCCSCCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cceeecccC--------CCccccCCCCcccCCHHHHc------------CCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 999876221 11223467999999997664 5678999999999999999999999997431
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+...... ....+.. +..+++++.+++.+||+.||++|||++|+++
T Consensus 219 -----~~~~~~~i~-----~~~~~~~------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 219 -----QKELAGKIR-----EGKFRRI------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----HHHHHHHHH-----HTCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHHH-----cCCCCCC------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 222211111 1000111 1123456789999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-46 Score=407.20 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=200.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
+.|+..++||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++|||||++++++. +++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCE
Confidence 4589999999999999999999999999999998643 2344567899999999999999999999964 3568
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+|||||++|++..++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 999999999999987776544 489999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+... ......||+.|||||++... ..+.|+.++|||||||++|||++|+.||....
T Consensus 161 ~a~~~~------------~~~~~~GT~~Y~APE~~~~~---------~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~- 218 (309)
T d1u5ra_ 161 SASIMA------------PANSFVGTPYWMAPEVILAM---------DEGQYDGKVDVWSLGITCIELAERKPPLFNMN- 218 (309)
T ss_dssp TCBSSS------------SBCCCCSCGGGCCHHHHTTT---------TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-
T ss_pred cccccC------------CCCccccCccccCHHHHhcc---------CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-
Confidence 997541 12235799999999887532 13568999999999999999999999986321
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+...... ....+... ...+++++.+++.+||+.||++|||++|+++
T Consensus 219 ----~~~~~~~i~-----~~~~~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 219 ----AMSALYHIA-----QNESPALQ-----------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----HHHHHHHHH-----HSCCCCCS-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHHHHHHH-----hCCCCCCC-----------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111110 11111110 0112456789999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=403.55 Aligned_cols=254 Identities=26% Similarity=0.339 Sum_probs=199.4
Q ss_pred CcccccCcceEEEEEEC--CCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEEE
Q 001908 685 NMIGQGSFGSVYKGILG--ENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALVY 760 (997)
Q Consensus 685 ~~lg~G~~g~V~~~~~~--~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 760 (997)
++||+|+||+||+|.++ .+++.||||+++.. ++...+.+.+|++++++++|||||+++++|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 57999999999999875 34578999999632 33446789999999999999999999999742 2478999
Q ss_pred eeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchhc
Q 001908 761 EYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~ 840 (997)
||+++|+|.+++++.. .+++..+++++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 9999999999998765 489999999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCCcc
Q 001908 841 FARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGGLT 919 (997)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 919 (997)
.... ..........||+.|||||++. +..++.++|||||||++|||+| |+.||....
T Consensus 158 ~~~~-----~~~~~~~~~~gt~~y~APE~l~------------~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----- 215 (277)
T d1xbba_ 158 RADE-----NYYKAQTHGKWPVKWYAPECIN------------YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----- 215 (277)
T ss_dssp CTTC-----SEEEC----CCCGGGCCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----
T ss_pred cccc-----cccccccccCCCceecCchhhc------------CCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----
Confidence 3211 1222334457899999998765 4668999999999999999998 899987431
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
..+....... .. +.+.+..++.++.+++.+||+.||++|||++||.+.|+....+.
T Consensus 216 ~~~~~~~i~~-----~~------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 216 GSEVTAMLEK-----GE------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHHHHHHHT-----TC------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHc-----CC------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 1121111100 00 01112234667889999999999999999999999998876554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=402.89 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=204.1
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++|||||+++++|.. +..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence 468899999999999999999987 67899999997543 334679999999999999999999998642 3579
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++..... ..+++..+++|+.||++||.|||++ +|+||||||+||++++++.+||+|||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence 99999999999998876532 2489999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... .........||+.|+|||++. ++.++.++|||||||++|||+||..|+....
T Consensus 157 ~~~~~~-------~~~~~~~~~gt~~y~APE~~~------------~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--- 214 (272)
T d1qpca_ 157 RLIEDN-------EYTAREGAKFPIKWTAPEAIN------------YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--- 214 (272)
T ss_dssp EECSSS-------CEECCTTCCCCTTTSCHHHHH------------HCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---
T ss_pred EEccCC-------ccccccccCCcccccChHHHh------------CCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---
Confidence 876321 112233457899999997765 3568999999999999999999666544221
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
...+..... ....++ ..+..+++++.+++.+||+.||++||||+|+++.|++...
T Consensus 215 -~~~~~~~~i-----~~~~~~------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 215 -TNPEVIQNL-----ERGYRM------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CHHHHHHHH-----HTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CHHHHHHHH-----HhcCCC------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 112211111 011111 1112345678899999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=396.78 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=204.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.++||+|+||+||+|+++ +++.||||+++.... ..+++.+|++++++++||||++++++|. .++..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEE
Confidence 58999999999999999999996 788999999975433 3468999999999999999999999964 3557999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||+++|++.+++..... .+++..+++++.|+++||+|||++ +|+||||||+||++++++.+||+|||+|+
T Consensus 77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence 9999999999999776542 478999999999999999999999 99999999999999999999999999998
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCCC
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQGG 917 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 917 (997)
...... ........||+.|+|||.+. +..++.++|||||||++|||+| |+.||....
T Consensus 149 ~~~~~~-------~~~~~~~~~t~~y~aPE~~~------------~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--- 206 (258)
T d1k2pa_ 149 YVLDDE-------YTSSVGSKFPVRWSPPEVLM------------YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--- 206 (258)
T ss_dssp BCSSSS-------CCCCCCSCCCGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---
T ss_pred eccCCC-------ceeecccCCCCCcCCcHHhc------------CCCCCcceeecccchhhHhHHhcCCCCCCCCC---
Confidence 653211 11223457899999997765 4678999999999999999998 899987432
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCA 987 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 987 (997)
..+...... ....+ ..+..+++++.+++.+||+.||++|||++|+++.|.+
T Consensus 207 --~~~~~~~i~-----~~~~~------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 207 --NSETAEHIA-----QGLRL------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --HHHHHHHHH-----TTCCC------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --HHHHHHHHH-----hCCCC------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 222221111 11000 1112335678899999999999999999999998854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=401.87 Aligned_cols=262 Identities=26% Similarity=0.461 Sum_probs=199.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCC----cEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENG----TFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
++|+..+.||+|+||+||+|.++.++ ..||||+++.. .+.....|.+|++++++++|||||+++++|.. .
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----C
Confidence 46888999999999999999987544 47999999643 34455678999999999999999999999643 4
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|++.+++..... .+++.++++++.||+.|++|||++ +|+||||||+|||++.++++||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence 578999999999999998876542 489999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+...... ..........||+.|||||++. ++.++.++|||||||++|||+||..|+...
T Consensus 154 FGla~~~~~~~-----~~~~~~~~~~gt~~Y~APE~l~------------~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 154 FGLSRVLEDDP-----EATYTTSGGKIPIRWTAPEAIS------------YRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp CCC----------------------CCCGGGSCHHHHH------------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cchhhcccCCC-----ccceEeccCCCCccccCHHHHc------------cCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 99998763221 1112233456899999997664 567899999999999999999976665422
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
. ...+..... .+... .+.+.+++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 217 ~----~~~~~~~~i-----~~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 217 L----SNHEVMKAI-----NDGFR------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp C----CHHHHHHHH-----HTTCC------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C----CHHHHHHHH-----hccCC------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 112211111 01111 111223456788999999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=407.83 Aligned_cols=201 Identities=25% Similarity=0.406 Sum_probs=175.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.++||+|+||+||+|+++.+|+.||+|+++.. .+...+.+.+|++++++++|||||+++++|. ++++.
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 57899999999999999999999999999999999743 3444578899999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+||||+++|+|.+++.+.. .+++..++.++.|++.||.|||+++ +|+||||||+|||++.+|++||+|||+
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCC
Confidence 99999999999999998764 4889999999999999999999732 899999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
|+.... ......+||+.|||||++. +..|+.++||||+||++|||++|+.||...
T Consensus 152 a~~~~~----------~~~~~~~GT~~Y~APEvl~------------~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 152 SGQLID----------SMANSFVGTRSYMSPERLQ------------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CHHHHH----------HTC---CCSSCCCCHHHHH------------CSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ccccCC----------CccccccCCccccCchHHc------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 987622 1223468999999997765 567999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=397.09 Aligned_cols=250 Identities=21% Similarity=0.335 Sum_probs=200.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+++.+++.||||+++.. .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 5799999999999999999999999999999999632 234457889999999999999999999994 45678
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 999999999999999998765 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.+.... ........+||+.|+|||++. +..|+.++||||+||++|||+||+.||...
T Consensus 154 ~a~~~~~~~------~~~~~~~~~GT~~Y~APE~~~------------~~~~~~~~DiwSlGvilyell~g~~Pf~~~-- 213 (288)
T d1uu3a_ 154 TAKVLSPES------KQARANSFVGTAQYVSPELLT------------EKSACKSSDLWALGCIIYQLVAGLPPFRAG-- 213 (288)
T ss_dssp TCEECC----------------CCCCGGGCCHHHHH------------TCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred cceecccCC------cccccccccCCccccCceeec------------cCCCCcccceehhhHHHHHHhhCCCCCCCc--
Confidence 998752211 112223457999999997765 467899999999999999999999999743
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+..+......... ..+ +....+++.+++.+||..||++|||++|+++
T Consensus 214 ---~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 214 ---NEYLIFQKIIKLE------YDF------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---SHHHHHHHHHTTC------CCC------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CHHHHHHHHHcCC------CCC------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1222211111100 000 0112346779999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=401.24 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=187.3
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ-KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
.+.|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|++++++++||||+++++++ .+++..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 466999999999999999999999999999999996432 23346678999999999999999999994 456789
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC---CCCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~D 833 (997)
|+|||||++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+||++. .++.+||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 99999999999999998754 489999999999999999999999 999999999999995 578999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+.... .......+||+.|||||++. +..|+.++||||+||++|||++|+.||...
T Consensus 154 FG~a~~~~~---------~~~~~~~~GT~~y~APE~~~------------~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 154 FGLSKMEDP---------GSVLSTACGTPGYVAPEVLA------------QKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp C---------------------------CTTSCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceeEEccC---------CCeeeeeeeCccccCcHHHc------------CCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 999986521 12223467999999997664 567899999999999999999999999742
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ..+.......... .. + .+.....++++.+++.+||..||++|||++|+++
T Consensus 213 ~-----~~~~~~~i~~~~~-~~-~------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 213 N-----DAKLFEQILKAEY-EF-D------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp S-----HHHHHHHHHTTCC-CC-C------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-----HHHHHHHHhccCC-CC-C------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 1221111111000 00 0 0011123456789999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=406.78 Aligned_cols=263 Identities=21% Similarity=0.335 Sum_probs=203.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCc-----EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGT-----FVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
.++|++.++||+|+||+||+|+++..++ .||+|++... .......+.+|+++++++ +|||||+++++|.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~---- 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---- 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence 3678999999999999999999865443 6999998643 344457889999999998 8999999999954
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCC-----------------CcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEe
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQP-----------------EVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVH 813 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivH 813 (997)
..+..++|||||++|+|.++++...... ....+++..++.++.||++||+|||++ +|+|
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 4568999999999999999998764211 112478999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchh
Q 001908 814 GDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDV 893 (997)
Q Consensus 814 rDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dv 893 (997)
|||||+||+++.++++||+|||+|+...... .........||+.|||||++. ++.++.++||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~l~------------~~~~~~~~Di 249 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS------NYVVRGNARLPVKWMAPESLF------------EGIYTIKSDV 249 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT------TSEEETTEEECGGGCCHHHHH------------HCCCCHHHHH
T ss_pred ccCchhccccccCCeEEEeeccccccccCCC------ceeeeccccCCCccCChHHHc------------CCCCCcceec
Confidence 9999999999999999999999998653221 112233456899999997765 4678999999
Q ss_pred HHHHHHHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCC
Q 001908 894 YSLGVMLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972 (997)
Q Consensus 894 wSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 972 (997)
|||||++|||+| |+.||...... ..+.+.+... .. .+.+..++.++.+++.+||+.||
T Consensus 250 wS~Gvil~emlt~g~~Pf~~~~~~-~~~~~~~~~~--------~~------------~~~p~~~~~~l~~li~~cl~~dP 308 (325)
T d1rjba_ 250 WSYGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNG--------FK------------MDQPFYATEEIYIIMQSCWAFDS 308 (325)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTT--------CC------------CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cchhHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcC--------CC------------CCCCCcCCHHHHHHHHHHcCCCh
Confidence 999999999998 89999743222 1122211110 01 11122345678899999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 001908 973 IERMEMRDVLAKLCA 987 (997)
Q Consensus 973 ~~Rps~~evl~~L~~ 987 (997)
++|||++||++.|..
T Consensus 309 ~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 309 RKRPSFPNLTSFLGC 323 (325)
T ss_dssp GGSCCHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHhC
Confidence 999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-44 Score=400.54 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=203.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++. +++..|+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 57999999999999999999999999999999998666666778999999999999999999999954 4568999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC--CCcEEEccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFGL 836 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFg~ 836 (997)
|||||++|+|.+++.+..+ .+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 101 vmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999999999975432 489999999999999999999999 9999999999999964 68999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.... ........||+.|||||++. +..++.++||||+||++|||+||+.||...
T Consensus 173 a~~~~~---------~~~~~~~~gT~~Y~aPEv~~------------~~~~~~~~DiwSlGvilyell~G~~Pf~~~--- 228 (350)
T d1koaa2 173 TAHLDP---------KQSVKVTTGTAEFAAPEVAE------------GKPVGYYTDMWSVGVLSYILLSGLSPFGGE--- 228 (350)
T ss_dssp CEECCT---------TSCEEEECSCTTTCCHHHHH------------TCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred heeccc---------ccccceecCcccccCHHHHc------------CCCCChhHhhhhhhHHHHHHHhCCCCCCCC---
Confidence 986522 12234468999999997765 567899999999999999999999999743
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+.......... . .++.. ......++.+++.+||..||++|||++|+++
T Consensus 229 --~~~~~~~~i~~~~~-~-~~~~~------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 229 --NDDETLRNVKSCDW-N-MDDSA------------FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --SHHHHHHHHHHTCC-C-SCCGG------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CHHHHHHHHHhCCC-C-CCccc------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12222111110000 0 00000 0112346779999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=400.05 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=202.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCc----EEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGT----FVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.+|++.++||+|+||+||+|++..+|+ +||+|+++. ......+.+.+|++++++++|||||+++++|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999987776 688888864 334456789999999999999999999999754
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++++||+.+|+|.+++..... .+++..+++++.||++||+|||++ +|+||||||+||+++.++++||+|
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred CCeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence 247889999999999999887542 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+|+....... ........||+.|+|||++. ++.++.++|||||||++|||+| |.+||..
T Consensus 155 FGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~------------~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 155 FGLAKLLGAEEK------EYHAEGGKVPIKWMALESIL------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp CSHHHHTTTTCC--------------CCTTTSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccceecccccc------cccccccccCccccChHHHh------------cCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 999987632211 11223346899999997665 4678999999999999999999 7888874
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.... .+...+... . +.+.+..+++++.+++.+||+.||++|||++|+++.|..+.++.
T Consensus 217 ~~~~--~~~~~i~~~--------~------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 217 IPAS--EISSILEKG--------E------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp SCGG--GHHHHHHHT--------C------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred CCHH--HHHHHHHcC--------C------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 3211 122211111 0 01112234567889999999999999999999999999876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-45 Score=400.11 Aligned_cols=269 Identities=26% Similarity=0.401 Sum_probs=208.2
Q ss_pred HHHHHhhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeee
Q 001908 673 ELSEATNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCS 746 (997)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 746 (997)
+++...++|++.++||+|+||+||+|+++ .+++.||||+++.. .....+.+.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 33444578999999999999999999975 35678999999743 3344678999999999999999999999964
Q ss_pred ccCcCCCceEEEEEeeccCCCHHHHhhcCCCC------------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 001908 747 SIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ------------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQ 808 (997)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~ 808 (997)
.....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++
T Consensus 87 -----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-- 159 (301)
T d1lufa_ 87 -----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159 (301)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred -----cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--
Confidence 345799999999999999999865421 1122478999999999999999999999
Q ss_pred CCcEecCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCC
Q 001908 809 PPIVHGDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEAS 888 (997)
Q Consensus 809 ~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~ 888 (997)
+|+||||||+|||++.++++||+|||+|+...... .........||+.|+|||.+. +..++
T Consensus 160 -~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~------~~~~~~~~~~~~~y~aPE~~~------------~~~~t 220 (301)
T d1lufa_ 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD------YYKADGNDAIPIRWMPPESIF------------YNRYT 220 (301)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG------CBC----CCBCGGGCCHHHHH------------HCCCC
T ss_pred -CeEeeEEcccceEECCCCcEEEccchhheeccCCc------cccccCCCCcCcCcCCHHHHc------------cCCCC
Confidence 99999999999999999999999999998663211 112233467899999997765 46789
Q ss_pred ccchhHHHHHHHHHHHhCC-CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhc
Q 001908 889 VTGDVYSLGVMLLEMFTRR-RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVAC 967 (997)
Q Consensus 889 ~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 967 (997)
.++|||||||++|||++|. +||... ...+......... .+ +.+..++.++.+|+..|
T Consensus 221 ~ksDVwS~Gvvl~ell~~~~~p~~~~-----~~~e~~~~v~~~~-----~~------------~~p~~~~~~~~~li~~c 278 (301)
T d1lufa_ 221 TESDVWAYGVVLWEIFSYGLQPYYGM-----AHEEVIYYVRDGN-----IL------------ACPENCPLELYNLMRLC 278 (301)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTC-----CC------------CCCTTCCHHHHHHHHHH
T ss_pred hhhhhccchhhHHHHHccCCCCCCCC-----CHHHHHHHHHcCC-----CC------------CCCccchHHHHHHHHHH
Confidence 9999999999999999986 566532 2222221111110 01 11223456788999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHH
Q 001908 968 SMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 968 l~~dP~~Rps~~evl~~L~~~~ 989 (997)
|+.||++||||.||++.|+++.
T Consensus 279 l~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 279 WSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999998864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-44 Score=385.00 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=205.3
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---------hhhHHHHHHHHHHHhhcC-CCCcceEEeeeecc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---------KGALKSFVAECEVLRNTR-HRNLIKIITVCSSI 748 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 748 (997)
++|++.+.||+|+||+||+|+++.+++.||||+++... +...+.+.+|++++++++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 68999999999999999999999999999999986432 123356889999999997 99999999994
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCc
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 828 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 828 (997)
.+++..|+||||+++|+|.++++... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred --ccCcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 55679999999999999999998755 489999999999999999999999 9999999999999999999
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+.... ........||+.|+|||.+... +......++.++||||+||++|||+||+.
T Consensus 149 ~kl~DFG~a~~~~~---------~~~~~~~~gt~~y~~PE~~~~~------~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 149 IKLTDFGFSCQLDP---------GEKLREVCGTPSYLAPEIIECS------MNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp EEECCCTTCEECCT---------TCCBCCCCSCGGGCCHHHHHHH------HCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eEEccchheeEccC---------CCceeeeeccCCCCCHHHhhcc------ccccCCCCCchheEcccchhhhhhccCCC
Confidence 99999999987522 1122346799999999998753 23334568999999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
||.+.. ..+.......... .... +....+++++.+++.+||..||++|||++|+++
T Consensus 214 Pf~~~~-----~~~~~~~i~~~~~-~~~~-------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 214 PFWHRK-----QMLMLRMIMSGNY-QFGS-------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp SSCCSS-----HHHHHHHHHHTCC-CCCT-------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCC-----HHHHHHHHHhCCC-CCCC-------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 997432 1111111111000 0000 011123456789999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=388.51 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=201.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ------KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
+.|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|++++++++|||||++++++ .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 57999999999999999999999999999999986321 12357889999999999999999999995 45
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC----c
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----V 828 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~ 828 (997)
++..|+|||||++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred CCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence 678999999999999999998764 488999999999999999999999 999999999999999877 5
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+|++|||+|+.... ........||+.|+|||++. +..++.++||||+||++|||+||+.
T Consensus 156 vkl~DfG~a~~~~~---------~~~~~~~~~t~~y~APE~~~------------~~~~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 156 IKIIDFGLAHKIDF---------GNEFKNIFGTPEFVAPEIVN------------YEPLGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp EEECCCTTCEECTT---------SCBCSCCCCCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eEecchhhhhhcCC---------CccccccCCCCcccCHHHHc------------CCCCCCcccchhhhHHHHHHHcCCC
Confidence 99999999986521 12233457899999997664 4678999999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
||.... ..+........ ... ........++.++.+++.+||+.||++|||++|+++
T Consensus 215 Pf~~~~-----~~~~~~~i~~~------~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 215 PFLGDT-----KQETLANVSAV------NYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SSCCSS-----HHHHHHHHHTT------CCC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCC-----HHHHHHHHHhc------CCC--------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 997431 11111111000 000 001112233456789999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-44 Score=397.52 Aligned_cols=252 Identities=18% Similarity=0.255 Sum_probs=203.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++ .+++..|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 5799999999999999999999999999999999866555567889999999999999999999994 45678999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC--CCCcEEEccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGL 836 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFg~ 836 (997)
|||||++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 104 vmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence 999999999999887654 2489999999999999999999999 999999999999998 678999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.... ........||+.|+|||++. +..++.++||||+||++|||+||+.||....
T Consensus 176 a~~~~~---------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-- 232 (352)
T d1koba_ 176 ATKLNP---------DEIVKVTTATAEFAAPEIVD------------REPVGFYTDMWAIGVLGYVLLSGLSPFAGED-- 232 (352)
T ss_dssp CEECCT---------TSCEEEECSSGGGCCHHHHT------------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--
T ss_pred ceecCC---------CCceeeccCcccccCHHHHc------------CCCCCCccchHHHHHHHHHHHhCCCCCCCCC--
Confidence 987522 22334467999999997664 5678999999999999999999999997431
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.......... . ..+.. ....++++.+++.+||..||++|||++|+++
T Consensus 233 ---~~~~~~~i~~~~~-~-~~~~~------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 233 ---DLETLQNVKRCDW-E-FDEDA------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---HHHHHHHHHHCCC-C-CCSST------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHHhCCC-C-CCccc------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111100000 0 00000 0122456789999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=388.97 Aligned_cols=281 Identities=23% Similarity=0.315 Sum_probs=206.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHH--HHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVA--ECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|...++||+|+||+||+|++ +|+.||||+++.... +.+.+ |+..+.+++||||++++++|...+ .....
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceE
Confidence 35788889999999999999998 689999999864332 33344 445556789999999999987542 23346
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCcEecCCCCCCeeeCCCCcEE
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC-----QPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.++||||+++|+|.+++++.. ++|..+++++.|++.||+|+|+.. .++|+||||||+|||++.++++|
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~-------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred EEEEEecccCCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 899999999999999998754 889999999999999999999731 23999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+....... ..........||+.|+|||.+..... .....++.++|||||||++|||+||..||
T Consensus 149 l~DFGl~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 149 IADLGLAVRHDSATD----TIDIAPNHRVGTKRYMAPEVLDDSIN------MKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp ECCCTTCEEEETTTT----EECC----CCSCGGGCCHHHHTTCSC------TTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred EEecCccccccCCCc----ceeccccceecccCcCChhhcccccc------ccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 999999987643221 11122334679999999998764211 11224678999999999999999999887
Q ss_pred CcCcCCCc----------cHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 001908 911 NCMFQGGL----------TLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRD 980 (997)
Q Consensus 911 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 980 (997)
........ ...+...... ....+|.+.. .....+++..+.+++.+||..||++|||+.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~p~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVC----EQKLRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHT----TSCCCCCCCG-------GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred CcccccccchhhcccccchHHHHHHHHh----ccccCCCCCc-------ccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 54322211 1111111110 0111222111 1223346677899999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 001908 981 VLAKLCAARQTL 992 (997)
Q Consensus 981 vl~~L~~~~~~~ 992 (997)
|++.|+++.++-
T Consensus 288 i~~~L~~i~~~~ 299 (303)
T d1vjya_ 288 IKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHhc
Confidence 999999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=390.25 Aligned_cols=260 Identities=21% Similarity=0.323 Sum_probs=198.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCC---CcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGEN---GTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 753 (997)
.++|++.+.||+|+||+||+|++..+ +..||||+++.. .....+.+.+|++++++++||||+++++++. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 35789999999999999999998644 356899998643 3445678999999999999999999999863 2
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||+++|++.+++..... .+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 468999999999999999876542 488999999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNC 912 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 912 (997)
||+|+...... ........||+.|+|||++. +..++.++|||||||++|||+| |.+||..
T Consensus 152 fG~a~~~~~~~-------~~~~~~~~gt~~y~apE~l~------------~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 152 FGLSRYMEDST-------YYKASKGKLPIKWMAPESIN------------FRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp --------------------------CCGGGCCHHHHH------------HCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chhheeccCCc-------ceeccceecCcccchhhHhc------------cCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 99998652211 12223456899999997765 4678999999999999999998 8889874
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHh
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTL 992 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 992 (997)
.... .+.+.+... ..+ +.+..++.++.+++.+||+.||++|||+.||++.|+++.++-
T Consensus 213 ~~~~--~~~~~i~~~--------~~~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 213 VKNN--DVIGRIENG--------ERL------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CCGG--GHHHHHHTT--------CCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHH--HHHHHHHcC--------CCC------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 4221 111111110 000 112234567889999999999999999999999999987753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=388.37 Aligned_cols=253 Identities=28% Similarity=0.375 Sum_probs=196.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.++||+|+||.||+|++ .|++||||+++.. ...+.+.+|++++++++||||++++++|.+ ..+..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEE
Confidence 35788899999999999999999 5789999999643 344678999999999999999999998743 345689
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|.+++.+... ..+++..+++++.||+.||.|||+. +|+||||||+||+++.++++|++|||++
T Consensus 78 lv~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence 99999999999999976531 1378999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCCcCcCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTNCMFQG 916 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 916 (997)
+.... ......+|..|+|||.+. ++.++.++|||||||++|||+| |++||....
T Consensus 151 ~~~~~-----------~~~~~~~~~~y~aPE~l~------------~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-- 205 (262)
T d1byga_ 151 KEASS-----------TQDTGKLPVKWTAPEALR------------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-- 205 (262)
T ss_dssp ----------------------CCTTTSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--
T ss_pred eecCC-----------CCccccccccCCChHHHh------------CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--
Confidence 86421 122346789999997664 4678999999999999999998 677776431
Q ss_pred CccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 001908 917 GLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQ 990 (997)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 990 (997)
...+...+.. ...+. .+..+++++.+++.+||..||++||||+|+++.|+.++.
T Consensus 206 ~~~~~~~i~~--------~~~~~------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 206 LKDVVPRVEK--------GYKMD------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp GGGHHHHHTT--------TCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHc--------CCCCC------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1122222111 11111 122335678899999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-43 Score=383.12 Aligned_cols=266 Identities=20% Similarity=0.333 Sum_probs=203.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
.++|++.+.||+|+||+||+|++..+++.||||+++.. +....+.+.+|++++++++||||+++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 46799999999999999999999999999999999643 3344568899999999999999999999876432 2334
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.++++||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred eEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 6899999999999999998765 488999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.++...... ..........||+.|+|||++. +..++.++||||+||++|||+||+.||...
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~~Gt~~Y~aPE~~~------------~~~~~~~~DiwSlGvilyelltG~~Pf~~~- 217 (277)
T d1o6ya_ 156 GIARAIADSG-----NSVTQTAAVIGTAQYLSPEQAR------------GDSVDARSDVYSLGCVLYEVLTGEPPFTGD- 217 (277)
T ss_dssp TTCEECC---------------------TTCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-
T ss_pred hhhhhhcccc-----ccccccccccCcccccCHHHHc------------CCCCCcceecccchHHHHHHHhCCCCCCCc-
Confidence 9987552211 1222344567999999997664 567899999999999999999999999742
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-EMRDVLAKLCAAR 989 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~ 989 (997)
...+......... ...+.. .....++++.+++.+||+.||++|| |++++++.|.+++
T Consensus 218 ----~~~~~~~~~~~~~---~~~~~~-----------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 218 ----SPVSVAYQHVRED---PIPPSA-----------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----SHHHHHHHHHHCC---CCCGGG-----------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHhcC---CCCCch-----------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1122211111100 000000 0112345678999999999999999 8999999988774
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=390.59 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=198.0
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|+++ +++.||||+++.... ..+.|.+|++++++++|||||+++++|.+ +..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence 368999999999999999999997 456799999974433 34679999999999999999999998632 3578
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 837 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a 837 (997)
+||||+++|+|..++..... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEEecCCCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence 99999999999999886432 1489999999999999999999999 9999999999999999999999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+...... ........||+.|+|||.+. ++.++.++|||||||++|||+||..|+....
T Consensus 161 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~------------~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--- 218 (285)
T d1fmka3 161 RLIEDNE-------YTARQGAKFPIKWTAPEAAL------------YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--- 218 (285)
T ss_dssp C---------------------CCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---
T ss_pred hhccCCC-------ceeeccccccccccChHHHh------------CCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---
Confidence 8652211 12233457899999997665 4678999999999999999999766654321
Q ss_pred ccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 001908 918 LTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAAR 989 (997)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 989 (997)
...+....... ...+ +.+.+++.++.+++.+||+.||++|||+++|++.|++..
T Consensus 219 -~~~~~~~~i~~-----~~~~------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 219 -VNREVLDQVER-----GYRM------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -CHHHHHHHHHT-----TCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -CHHHHHHHHHh-----cCCC------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 22222211110 0011 111234567889999999999999999999998887643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=395.23 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=202.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+.+.+++.||||+++.. .....+.+.+|++++++++||||++++++ +.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----eccccc
Confidence 5799999999999999999999999999999999642 23456788999999999999999999999 455679
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred cccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecc
Confidence 999999999999999999865 478889999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... ........+||+.|+|||++ .+..|+.++||||+||++|||++|++||....
T Consensus 151 ~a~~~~~--------~~~~~~~~~GT~~Y~aPE~~------------~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~- 209 (337)
T d1o6la_ 151 LCKEGIS--------DGATMKTFCGTPEYLAPEVL------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD- 209 (337)
T ss_dssp TCBCSCC--------TTCCBCCCEECGGGCCGGGG------------SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred ccccccc--------CCcccccceeCHHHhhhhhc------------cCCCCChhhcccchhhHHHHHHHCCCCCCCcC-
Confidence 9986522 11223456899999999655 46789999999999999999999999997432
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
..+......... ... +....+++.+++.+||..||++||+ ++|+++
T Consensus 210 ----~~~~~~~i~~~~------~~~------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 210 ----HERLFELILMEE------IRF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----HHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----HHHHHHHHhcCC------CCC------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222221111100 000 1112345679999999999999995 777765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=391.15 Aligned_cols=262 Identities=24% Similarity=0.458 Sum_probs=204.5
Q ss_pred CCcccccCcceEEEEEECCCC---cEEEEEEecc-cchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEEE
Q 001908 684 SNMIGQGSFGSVYKGILGENG---TFVAVKILNL-MQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKALV 759 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~---~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 759 (997)
.++||+|+||+||+|++..++ ..||||+++. ......++|.+|++++++++||||++++++|.. .+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 568999999999999986543 3689999974 455566889999999999999999999999753 34578999
Q ss_pred EeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccchh
Q 001908 760 YEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLARF 839 (997)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~~ 839 (997)
||||++|+|.+++..... ..++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence 999999999999986542 367888999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCcc
Q 001908 840 LFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGLT 919 (997)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 919 (997)
...... ..........||+.|+|||.+. +..++.++|||||||++|||+||+.||........
T Consensus 180 ~~~~~~----~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~- 242 (311)
T d1r0pa_ 180 MYDKEF----DSVHNKTGAKLPVKWMALESLQ------------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD- 242 (311)
T ss_dssp TTTTTC----CCTTCTTCSSCCGGGSCHHHHH------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------
T ss_pred cccccc----ccceecccccccccccChHHHh------------cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-
Confidence 643221 1122233457899999997665 46789999999999999999998888764322111
Q ss_pred HHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHhhc
Q 001908 920 LHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQTLVG 994 (997)
Q Consensus 920 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 994 (997)
+...+. ....+ ..+..++.++.+++.+||+.||++||+|.||++.|+++..+..+
T Consensus 243 ~~~~i~--------~g~~~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 243 ITVYLL--------QGRRL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CHHHHH--------TTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHH--------cCCCC------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 111111 00011 11123456788999999999999999999999999999877544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=389.16 Aligned_cols=275 Identities=21% Similarity=0.311 Sum_probs=202.4
Q ss_pred hHHHHHHhhcCccCCcccccCcceEEEEEECC-----CCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEe
Q 001908 671 YSELSEATNEFSSSNMIGQGSFGSVYKGILGE-----NGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIIT 743 (997)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 743 (997)
.++++...++|++.++||+|+||+||+|++.. +++.||||+++.. .....+.+.+|.+++.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 33444445789999999999999999999753 4468999999743 344556788888888877 6899999999
Q ss_pred eeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEe
Q 001908 744 VCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVH 813 (997)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivH 813 (997)
++. ......++|||||++|+|.++++..... .....+++.+++.++.||++||+|||++ +|+|
T Consensus 85 ~~~----~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivH 157 (299)
T d1ywna1 85 ACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 157 (299)
T ss_dssp EEC----STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred eec----cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcC
Confidence 863 3345789999999999999999865421 0112478999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchh
Q 001908 814 GDLKPSNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDV 893 (997)
Q Consensus 814 rDlk~~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~Dv 893 (997)
|||||+|||+++++++||+|||+|+....... ........||+.|+|||++. +..++.++||
T Consensus 158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~------------~~~~~~~sDi 219 (299)
T d1ywna1 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIF------------DRVYTIQSDV 219 (299)
T ss_dssp SCCCGGGEEECGGGCEEECC------CCSCTT------SCCTTSCCCGGGGCCHHHHH------------HCCCCHHHHH
T ss_pred CcCCccceeECCCCcEEEccCcchhhcccccc------ccccCceeeCccccchhHhh------------cCCCCcccce
Confidence 99999999999999999999999986532211 12233457999999997765 4678999999
Q ss_pred HHHHHHHHHHHhCC-CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCC
Q 001908 894 YSLGVMLLEMFTRR-RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESP 972 (997)
Q Consensus 894 wSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 972 (997)
|||||++|||+||. +||...... ..+...+.. ...+. .+..+++++.+++.+||+.||
T Consensus 220 wS~Gvil~ellt~~~~p~~~~~~~-~~~~~~~~~--------~~~~~------------~~~~~~~~l~~li~~cl~~dP 278 (299)
T d1ywna1 220 WSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKE--------GTRMR------------APDYTTPEMYQTMLDCWHGEP 278 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCS-HHHHHHHHH--------TCCCC------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred eehHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhc--------CCCCC------------CCccCCHHHHHHHHHHcCCCh
Confidence 99999999999965 566533211 111111111 11111 111235578899999999999
Q ss_pred CCCCCHHHHHHHHHHHHHH
Q 001908 973 IERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 973 ~~Rps~~evl~~L~~~~~~ 991 (997)
++|||++|+++.|+++.++
T Consensus 279 ~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 279 SQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp GGSCCHHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHHhC
Confidence 9999999999999998864
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.8e-44 Score=394.97 Aligned_cols=297 Identities=32% Similarity=0.541 Sum_probs=200.8
Q ss_pred CCCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCC--eeeeeeecCC--CCcEEEEeccCCCCCC--cccccccCcccccc
Q 001908 29 HTNETDRLALLAIKSQLHDPLGVTNSWNNSINLC--QWAGVTCGHR--HQRVTELDLRHQNIGG--SLSPYVGNLSFLRY 102 (997)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~~~sW~~~~~~c--~w~gv~C~~~--~~~v~~L~L~~~~l~g--~~~~~l~~l~~L~~ 102 (997)
-|.++||+||++||+++.||. .+++|..++||| .|+||+|+.. .+||++|||+++++.| .+|+++++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 388999999999999998885 689999889999 5999999864 3589999999999988 57899999999999
Q ss_pred ccccc-cccCCCCCccCCCCCCCeEEEccCCCccccCCccccCCCcccchhcccccccccccccccccccccceeecccc
Q 001908 103 INLAT-NNFHGEIPKEIGFLFRLETLMLANNSFSGKIPTNLSSCSNLLSFVAYRNNLVGEIPEDIGYSWLKLEHISLARN 181 (997)
Q Consensus 103 L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~l~~n~~~g~ip~~~~~~l~~L~~L~L~~N 181 (997)
|||++ |+++|.+|++|++|++|++|||++|++.|..|..+.++.+|+ ++++++|
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~-------------------------~l~l~~N 135 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV-------------------------TLDFSYN 135 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC-------------------------EEECCSS
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhc-------------------------ccccccc
Confidence 99997 899999999999999999999999999987777666655554 5666666
Q ss_pred cccCcCcCccCcchhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCC
Q 001908 182 HLTGMLPASIGNLSIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPE 261 (997)
Q Consensus 182 ~l~g~~p~~~~~l~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~ 261 (997)
.+.+.+|.+++ ++++|+.+++++|.++|.+|..++.....++.+++++|+++|..|.
T Consensus 136 ~~~~~~p~~l~-----------------------~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~ 192 (313)
T d1ogqa_ 136 ALSGTLPPSIS-----------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192 (313)
T ss_dssp EEESCCCGGGG-----------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCG
T ss_pred cccccCchhhc-----------------------cCcccceeeccccccccccccccccccccccccccccccccccccc
Confidence 66554444444 3444444444444444444444432222234455555555555555
Q ss_pred CCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccc
Q 001908 262 SFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSI 341 (997)
Q Consensus 262 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 341 (997)
.+.++..+ ++++++|.+.+.+|..+..+++|+.|++++|.+... ++.+..+++
T Consensus 193 ~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~-------~~~~~~~~~------------------- 245 (313)
T d1ogqa_ 193 TFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-------LGKVGLSKN------------------- 245 (313)
T ss_dssp GGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB-------GGGCCCCTT-------------------
T ss_pred cccccccc-cccccccccccccccccccccccccccccccccccc-------ccccccccc-------------------
Confidence 55544333 455555555555555444444444444444444321 112223333
Q ss_pred cccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccccc-ccc
Q 001908 342 ANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNF-LQG 408 (997)
Q Consensus 342 ~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 408 (997)
++.|++++|+|+|.+|.+|+++++|++|+|++|+|+|.+| .++++++|+.+++++|+ +.|
T Consensus 246 ------L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 246 ------LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp ------CCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSSEEES
T ss_pred ------cccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCccccC
Confidence 4444444555555666666677778888888888877777 35677788888888886 454
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=396.14 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=195.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc---hhhHHHHHH---HHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ---KGALKSFVA---ECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ......+.+ |+++++.++|||||++++++ ..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence 57999999999999999999999999999999986321 122233344 46667777899999999994 45
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
.+..|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred CCEEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence 668999999999999999998765 478889999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNC 912 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 912 (997)
|||+|+.... .......||+.|+|||++.. +..|+.++||||+||++|||+||+.||..
T Consensus 150 DFGla~~~~~----------~~~~~~~GT~~y~APE~~~~-----------~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 150 DLGLACDFSK----------KKPHASVGTHGYMAPEVLQK-----------GVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCTTCEECSS----------SCCCSCCSCGGGCCHHHHST-----------TCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeceeeecCC----------CcccccccccccchhHHhhc-----------CCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 9999986522 12234579999999987642 35689999999999999999999999975
Q ss_pred CcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 913 MFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
.... ...+......... +.. +..+++++.+++.+||..||++||| ++|+++
T Consensus 209 ~~~~--~~~~~~~~~~~~~------~~~------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 209 HKTK--DKHEIDRMTLTMA------VEL------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCSS--CHHHHHHHSSSCC------CCC------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCHH--HHHHHHHhcccCC------CCC------------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 4222 2222222111100 000 0112456789999999999999999 577764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-43 Score=385.53 Aligned_cols=245 Identities=23% Similarity=0.314 Sum_probs=200.7
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 5799999999999999999999999999999999632 234467889999999999999999999994 45679
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+++|++.+++.... .+++..++.++.||+.|++|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeeEeeecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 999999999999999998765 467888899999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... .....+||+.|||||++. +..|+.++||||+||++|||+||+.||...
T Consensus 150 ~a~~~~~-----------~~~~~~Gt~~Y~APE~l~------------~~~y~~~~DiwSlGvilyemltG~~Pf~~~-- 204 (316)
T d1fota_ 150 FAKYVPD-----------VTYTLCGTPDYIAPEVVS------------TKPYNKSIDWWSFGILIYEMLAGYTPFYDS-- 204 (316)
T ss_dssp SCEECSS-----------CBCCCCSCTTTCCHHHHT------------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--
T ss_pred cceEecc-----------ccccccCcccccCHHHHc------------CCCCCchhhccccchhHHHHHhCCCCCCCc--
Confidence 9986521 123468999999997664 567899999999999999999999999742
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
...+......... ... +...++++.+++.+||..||++|| |++|+++
T Consensus 205 ---~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 205 ---NTMKTYEKILNAE------LRF------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---SHHHHHHHHHHCC------CCC------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CHHHHHHHHHcCC------CCC------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1222211111100 000 011234677999999999999996 8888865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=381.02 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=194.0
Q ss_pred hcCccCCcccccCcceEEEEEECC-CC--cEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGE-NG--TFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKG 752 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (997)
++|++.+.||+|+||+||+|++.. ++ ..||||+++.. .....+.|.+|++++++++||||++++++|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 579999999999999999998742 22 37899998642 34456789999999999999999999999743
Q ss_pred CceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEc
Q 001908 753 ADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 832 (997)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 832 (997)
+..++||||+++|++.+++....+ .+++..+++++.||+.||.|||++ +|+||||||+||+++.++++||+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred -cchheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence 256899999999999998886542 489999999999999999999999 99999999999999999999999
Q ss_pred ccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 001908 833 DFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT-RRRPTN 911 (997)
Q Consensus 833 DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 911 (997)
|||+|+...... ..........||..|+|||.+. +..++.++|||||||++|||+| |+.||.
T Consensus 154 DfGl~~~~~~~~-----~~~~~~~~~~~~~~~~aPE~~~------------~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 154 DFGLMRALPQND-----DHYVMQEHRKVPFAWCAPESLK------------TRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCTTCEECCC-C-----CEEEC-----CCGGGCCHHHHH------------HCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cchhhhhcccCC-----CcceecCccccCcccCCHHHHh------------CCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 999998763221 1222333456888999997775 4568899999999999999998 899987
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAA 988 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 988 (997)
.. ...+......... .. .+.+..++.++.+++.+||+.||++||||+||.+.|++.
T Consensus 217 ~~-----~~~~~~~~i~~~~----~~------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 217 GL-----NGSQILHKIDKEG----ER------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TC-----CHHHHHHHHHTSC----CC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-----CHHHHHHHHHhCC----CC------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 33 2222211111100 00 011123356788999999999999999999999988764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=389.51 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=203.1
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcE--EEEEEecc-cchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTF--VAVKILNL-MQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vAvK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|++.++||+|+||+||+|+++.++.. ||||+++. ......+.+.+|+++++++ +|||||+++++|.. .+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 6788999999999999999999877764 67787753 3344556899999999998 79999999999754 45
Q ss_pred eEEEEEeeccCCCHHHHhhcCCC----------CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeC
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNG----------QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLD 824 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~ 824 (997)
..++||||+++|+|.++++.... ......+++..+++++.||+.||.|+|++ +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 89999999999999999986521 11223589999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHH
Q 001908 825 HDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMF 904 (997)
Q Consensus 825 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ell 904 (997)
.++.+||+|||+|+.... ........||..|+|||.+. ++.++.++|||||||++|||+
T Consensus 162 ~~~~~kl~DfG~a~~~~~---------~~~~~~~~gt~~y~aPE~l~------------~~~~~~~sDvwSfGvil~ell 220 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEV---------YVKKTMGRLPVRWMAIESLN------------YSVYTTNSDVWSYGVLLWEIV 220 (309)
T ss_dssp GGGCEEECCTTCEESSCE---------ECCC----CCTTTCCHHHHH------------HCEECHHHHHHHHHHHHHHHH
T ss_pred CCCceEEccccccccccc---------cccccceecCCcccchHHhc------------cCCCCccceeehhHHHHHHHH
Confidence 999999999999975421 11223456899999997775 467899999999999999999
Q ss_pred hCCC-CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 905 TRRR-PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 905 tg~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
+|.. ||... ...+....... ..++. .+..++.++.+++.+||+.||++||||.||++
T Consensus 221 ~~~~~p~~~~-----~~~~~~~~i~~-----~~~~~------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 278 (309)
T d1fvra_ 221 SLGGTPYCGM-----TCAELYEKLPQ-----GYRLE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278 (309)
T ss_dssp TTSCCTTTTC-----CHHHHHHHGGG-----TCCCC------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCC-----CHHHHHHHHHh-----cCCCC------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9765 55432 22222221111 01111 11234567889999999999999999999999
Q ss_pred HHHHHHHHh
Q 001908 984 KLCAARQTL 992 (997)
Q Consensus 984 ~L~~~~~~~ 992 (997)
.|+++.++.
T Consensus 279 ~L~~i~~~~ 287 (309)
T d1fvra_ 279 SLNRMLEER 287 (309)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhcC
Confidence 999988654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=385.09 Aligned_cols=256 Identities=19% Similarity=0.269 Sum_probs=197.2
Q ss_pred hcCccCC-cccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSN-MIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|.+.+ .||+|+||+||+|+++.+++.||||+++.. ..+.+|++++.++ +|||||++++++... +......
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCEE
Confidence 5788765 599999999999999989999999998643 4567899987655 899999999986542 2345679
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEEcc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 833 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~D 833 (997)
|+|||||+||+|.+++.+... ..+++.+++.++.||+.||+|||++ +|+||||||+||++++ ++.+||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 999999999999999987542 2489999999999999999999999 9999999999999986 56799999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+..... .......||+.|||||++. +..|+.++||||+||++|||+||+.||...
T Consensus 158 FG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~------------~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 158 FGFAKETTSH---------NSLTTPCYTPYYVAPEVLG------------PEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp CTTCEECCCC---------CCCCCCSCCCSSCCCCCCC------------GGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred cceeeeccCC---------CccccccCCcccCCcHHHc------------CCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 9999865221 2233467999999996654 567899999999999999999999999743
Q ss_pred cCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.... ....... .... ..+ ....+....+.+++.+++.+||..||++|||+.|+++
T Consensus 217 ~~~~-~~~~~~~-~i~~-----------~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 217 HGLA-ISPGMKT-RIRM-----------GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TCC----------CCCS-----------CSS--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHH-HHHHHHH-HHhc-----------CCC--CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2211 0111100 0000 000 0001122345567889999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-43 Score=382.40 Aligned_cols=252 Identities=17% Similarity=0.267 Sum_probs=200.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
.++|++.+.||+|+||+||+|+++.+++.||||+++.... ....+.+|+++|++++||||+++++++ .+.+..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 4679999999999999999999999999999999975543 335688999999999999999999994 4566899
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCC--CcEEEcccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHVSDFG 835 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFg 835 (997)
+|||||++|+|.+++.+... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.+ +++||+|||
T Consensus 78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence 99999999999999986541 488999999999999999999999 99999999999999854 489999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... ........||+.|+|||.+. +..++.++||||+||++|||++|+.||....
T Consensus 150 ~~~~~~~---------~~~~~~~~~t~~y~ape~~~------------~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~- 207 (321)
T d1tkia_ 150 QARQLKP---------GDNFRLLFTAPEYYAPEVHQ------------HDVVSTATDMWSLGTLVYVLLSGINPFLAET- 207 (321)
T ss_dssp TCEECCT---------TCEEEEEESCGGGSCHHHHT------------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-
T ss_pred hhhcccc---------CCcccccccccccccchhcc------------CCCCCchhhcccHHHHHHHHHhCCCCCCCCC-
Confidence 9986521 12234467899999996554 5678999999999999999999999997431
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..+.......... ..+ ......+..++.+++.+|+..||++|||++|+++
T Consensus 208 ----~~~~~~~i~~~~~--~~~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 208 ----NQQIIENIMNAEY--TFD------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHHHHHHHHTCC--CCC------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHHHHhCCC--CCC------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111100000 000 0011123456789999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=384.77 Aligned_cols=266 Identities=21% Similarity=0.265 Sum_probs=191.4
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEecccch-----hhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK-----GALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
.++||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++ ..+++.|+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCceee
Confidence 4689999999999999999999999999864322 1235688999999999999999999994 45668999
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
||||++++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.|+
T Consensus 78 vmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp EEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred hhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence 999998887776665433 367778999999999999999999 99999999999999999999999999997
Q ss_pred hcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCCc
Q 001908 839 FLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGGL 918 (997)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 918 (997)
..... .......+||+.|+|||++.. +..|+.++||||+||++|||+||.+||......+
T Consensus 149 ~~~~~--------~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~- 208 (299)
T d1ua2a_ 149 SFGSP--------NRAYTHQVVTRWYRAPELLFG-----------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD- 208 (299)
T ss_dssp TTTSC--------CCCCCCSCCCCTTCCHHHHTT-----------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred ccCCC--------cccccceecChhhccHHHHcc-----------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-
Confidence 65221 122234579999999987642 3457899999999999999999999987432110
Q ss_pred cHHHHHHhhc-c--hhhhhhcCccc---ccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 919 TLHEFCKMAL-P--EKVMETVDPSL---LLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 919 ~~~~~~~~~~-~--~~~~~~~d~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+........ + ........... .................+++.+++.+||..||++|||++|+++
T Consensus 209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 1111111100 0 00000000000 0000000000011122456889999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-43 Score=390.65 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=200.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++||||+++++++ .....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 5799999999999999999999999999999998632 234457789999999999999999999984 45668
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.++||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+|++||+|||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 999999999999999998765 488999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+.... ......||+.|||||++. +..++.++||||+||++|||+||+.||...
T Consensus 187 ~a~~~~~-----------~~~~~~Gt~~Y~APE~~~------------~~~~~~~~DiwSlGvilyemltG~~Pf~~~-- 241 (350)
T d1rdqe_ 187 FAKRVKG-----------RTWTLCGTPEALAPEIIL------------SKGYNKAVDWWALGVLIYEMAAGYPPFFAD-- 241 (350)
T ss_dssp TCEECSS-----------CBCCCEECGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred eeeeccc-----------ccccccCccccCCHHHHc------------CCCCCccccccchhHHHHHHHhCCCCCCCc--
Confidence 9986521 123467999999997664 567899999999999999999999999742
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERM-----EMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 983 (997)
...+......... +.. +..+++++.+++.+||..||++|+ |++|+++
T Consensus 242 ---~~~~~~~~i~~~~------~~~------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 ---QPIQIYEKIVSGK------VRF------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---SHHHHHHHHHHCC------CCC------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CHHHHHHHHhcCC------CCC------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1222211111000 000 012245678999999999999994 8999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=382.82 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=202.8
Q ss_pred hhcCccCCcccccCcceEEEEEECCCC-------cEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCCcceEEeeeecc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENG-------TFVAVKILNLMQ-KGALKSFVAECEVLRNT-RHRNLIKIITVCSSI 748 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 748 (997)
.++|.+.+.||+|+||.||+|+...++ ..||||+++... ......+.+|...+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence 468899999999999999999875443 479999997543 34457889999999888 8999999999964
Q ss_pred CcCCCceEEEEEeeccCCCHHHHhhcCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLEEWLHQSNGQ----------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
.++..++||||+++|+|.+++...... .....+++.++++++.||+.||+|||+. +|+||||||
T Consensus 90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 356899999999999999999876421 1223589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+|||++.++.+||+|||.++....... ........||+.|+|||.+. ++.|+.++|||||||
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~l~------------~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALF------------DRIYTHQSDVWSFGV 225 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCT------TCCCTTSCCGGGGSCHHHHH------------HCCCCHHHHHHHHHH
T ss_pred cceeecCCCCeEeccchhhcccccccc------ccccccCCCChhhhhhhHhc------------CCCCCchhhhHHhHH
Confidence 999999999999999999987633221 12234467899999997665 467999999999999
Q ss_pred HHHHHHh-CCCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 899 MLLEMFT-RRRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 899 vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++|||++ |++||.... ..+..... .....+. .+..++.++.+++.+||+.||++|||
T Consensus 226 vl~ell~~g~~p~~~~~-----~~~~~~~i-----~~~~~~~------------~p~~~~~~l~~li~~cl~~dP~~Rps 283 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVP-----VEELFKLL-----KEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPT 283 (299)
T ss_dssp HHHHHHTTSCCSSTTCC-----HHHHHHHH-----HTTCCCC------------CCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHhccCCCCCCCCCC-----HHHHHHHH-----HcCCCCC------------CCccchHHHHHHHHHHccCCHhHCcC
Confidence 9999998 688876332 22221111 1111111 11123457889999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 001908 978 MRDVLAKLCAARQ 990 (997)
Q Consensus 978 ~~evl~~L~~~~~ 990 (997)
+.||++.|+++..
T Consensus 284 ~~eil~~L~~i~a 296 (299)
T d1fgka_ 284 FKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998853
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=379.96 Aligned_cols=267 Identities=22% Similarity=0.352 Sum_probs=208.4
Q ss_pred hhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCCcceEEeeeeccCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNT-RHRNLIKIITVCSSIDF 750 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 750 (997)
.++|++.++||+|+||+||+|+++ .+++.||||+++.. .......+.+|+.+++++ +|||||+++++|.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~---- 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---- 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe----
Confidence 468899999999999999999873 46678999999743 344556889999999999 6999999999964
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCC------------CCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCC
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQ------------PEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKP 818 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~ 818 (997)
..+..++|||||++|+|.++++..... .....+++..+.+++.||++|++|||++ +|+||||||
T Consensus 98 -~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred -eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 345789999999999999999875421 1223588999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHH
Q 001908 819 SNVLLDHDMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGV 898 (997)
Q Consensus 819 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGv 898 (997)
+||+++.++.+|++|||.++...... .........||+.|+|||.+. ++.++.++|||||||
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDS------NYVVKGNARLPVKWMAPESIF------------NCVYTFESDVWSYGI 235 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT------TSEECSSSEECGGGCCHHHHH------------HCCCCHHHHHHHHHH
T ss_pred ccccccccCcccccccchheeccCCC------cceEeeecccChHHcCHHHhc------------CCCCCCcccccchHH
Confidence 99999999999999999998763221 122334467899999997664 467899999999999
Q ss_pred HHHHHHhC-CCCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC
Q 001908 899 MLLEMFTR-RRPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME 977 (997)
Q Consensus 899 vl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 977 (997)
++|||+|+ .+||... .....+.+.+.... .+. .+..++..+.+|+.+||+.||++|||
T Consensus 236 ~l~ellt~g~p~~~~~-~~~~~~~~~i~~~~--------~~~------------~~~~~~~~l~~Li~~cl~~dP~~RPs 294 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGM-PVDSKFYKMIKEGF--------RML------------SPEHAPAEMYDIMKTCWDADPLKRPT 294 (311)
T ss_dssp HHHHHHTTTCCSSTTC-CSSHHHHHHHHHTC--------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHhCCCCCCCCC-CHHHHHHHHHhcCC--------CCC------------CcccccHHHHHHHHHHcCCChhHCcC
Confidence 99999995 5554432 22212222221111 111 11123457889999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 001908 978 MRDVLAKLCAARQT 991 (997)
Q Consensus 978 ~~evl~~L~~~~~~ 991 (997)
|.|+++.|+++..+
T Consensus 295 ~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 295 FKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcc
Confidence 99999999987654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=379.84 Aligned_cols=273 Identities=23% Similarity=0.332 Sum_probs=197.9
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ--KGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.++||+|+||+||+|+++.+++.||||+++... +...+.+.+|++++++++||||+++++++. +++..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 47999999999999999999999999999999996432 233578899999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
|+||||+.+ ++.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||.
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred eEEEeecCC-chhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 999999965 55555544321 2489999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+.... .........||+.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 149 a~~~~~--------~~~~~~~~~gt~~y~apE~~~~-----------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~ 209 (298)
T d1gz8a_ 149 ARAFGV--------PVRTYTHEVVTLWYRAPEILLG-----------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209 (298)
T ss_dssp HHHHCC--------CSBCTTCCBCCCTTCCHHHHTT-----------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ceeccC--------Ccccceeecccceeeehhhhcc-----------ccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence 987622 1223344579999999987653 234578999999999999999999999743211
Q ss_pred CccHHHHHHh-hcch-hhhhhc--Cccccccc---ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 917 GLTLHEFCKM-ALPE-KVMETV--DPSLLLAW---SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 917 ~~~~~~~~~~-~~~~-~~~~~~--d~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
. .+...... ..+. ...... .+...... ..............++.+++.+|+..||++|||++|+++.
T Consensus 210 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 210 D-QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp H-HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 11111111 0010 000000 00000000 0000011111233567899999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=381.58 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=198.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc---chhhHHHHHHHHHHHh-hcCCCCcceEEeeeeccCcCCCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM---QKGALKSFVAECEVLR-NTRHRNLIKIITVCSSIDFKGAD 754 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~ 754 (997)
++|.+.++||+|+||+||+|+++.+++.||||+++.. .....+.+.+|+.++. .++||||+++++++ .+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 5799999999999999999999999999999999632 2334566777777765 68999999999994 4566
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
..|+||||+++|+|.++++... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEEeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 8999999999999999998765 478889999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|+|+..... ........||+.|+|||++. +..++.++||||+||++|||+||+.||...
T Consensus 148 G~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlGvilyemltG~~PF~~~- 206 (320)
T d1xjda_ 148 GMCKENMLG--------DAKTNTFCGTPDYIAPEILL------------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ- 206 (320)
T ss_dssp TTCBCCCCT--------TCCBCCCCSCGGGCCHHHHT------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred chhhhcccc--------cccccccCCCCCcCCHHHHc------------CCCCCchhhhhhhhHHHHHHHhCCCCCCCC-
Confidence 999865221 12233457999999996654 577999999999999999999999999743
Q ss_pred CCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 001908 915 QGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMR-DVL 982 (997)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 982 (997)
+..+........ .+.. +..++.++.+++.+||..||++||++. |++
T Consensus 207 ----~~~~~~~~i~~~------~~~~------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 207 ----DEEELFHSIRMD------NPFY------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ----SHHHHHHHHHHC------CCCC------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CHHHHHHHHHcC------CCCC------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 222222111100 1111 012245678999999999999999985 664
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=385.90 Aligned_cols=269 Identities=22% Similarity=0.376 Sum_probs=208.9
Q ss_pred HHhhcCccCCcccccCcceEEEEEEC-----CCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC
Q 001908 676 EATNEFSSSNMIGQGSFGSVYKGILG-----ENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID 749 (997)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 749 (997)
...++|+..++||+|+||+||+|.++ .+++.||||+++.. .......+.+|++++++++||||++++++|.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--- 93 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 93 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC---
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe---
Confidence 33578899999999999999999885 23578999999743 3445567899999999999999999999964
Q ss_pred cCCCceEEEEEeeccCCCHHHHhhcCCC----CCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC
Q 001908 750 FKGADFKALVYEYMQNGSLEEWLHQSNG----QPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH 825 (997)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~ 825 (997)
.++..++||||+++|+|.+++..... ......+++..+.+++.|+++||.|||++ +|+||||||+|||+++
T Consensus 94 --~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 94 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 168 (308)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred --cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence 34578999999999999999875421 11223478999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHh
Q 001908 826 DMVAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFT 905 (997)
Q Consensus 826 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~ellt 905 (997)
++++||+|||+|+..... ..........||+.|+|||.+. +..++.++|||||||++|||+|
T Consensus 169 ~~~~Kl~DFGla~~~~~~------~~~~~~~~~~~t~~y~aPe~l~------------~~~~~~~~Dv~S~G~il~El~t 230 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYET------DYYRKGGKGLLPVRWMSPESLK------------DGVFTTYSDVWSFGVVLWEIAT 230 (308)
T ss_dssp TCCEEECCTTCCCGGGGG------GCEEGGGSSEECGGGCCHHHHH------------HCCCCHHHHHHHHHHHHHHHHH
T ss_pred CceEEEeecccceeccCC------cceeeccceecccccCCHHHHc------------cCCCCcccccccHHHHHHHHHh
Confidence 999999999999876321 1122233456899999997665 4678999999999999999999
Q ss_pred CC-CCCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 001908 906 RR-RPTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAK 984 (997)
Q Consensus 906 g~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 984 (997)
|. +||... ...+......... ..+.+..++..+.+++.+||+.||++|||+.||++.
T Consensus 231 ~~~~p~~~~-----~~~~~~~~i~~~~-----------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 231 LAEQPYQGL-----SNEQVLRFVMEGG-----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp TSCCTTTTS-----CHHHHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCC-----CHHHHHHHHHhCC-----------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 85 666432 2222222111111 011112345678999999999999999999999999
Q ss_pred HHHHHHHh
Q 001908 985 LCAARQTL 992 (997)
Q Consensus 985 L~~~~~~~ 992 (997)
|++..+..
T Consensus 289 L~~~~~~~ 296 (308)
T d1p4oa_ 289 IKEEMEPG 296 (308)
T ss_dssp HGGGSCTT
T ss_pred HHHhcCCC
Confidence 98765543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=371.90 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=192.4
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccch------hhHHHHHHHHHHHhhcC--CCCcceEEeeeeccCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQK------GALKSFVAECEVLRNTR--HRNLIKIITVCSSIDF 750 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 750 (997)
++|++.+.||+|+||+||+|++..+++.||||+++.... .....+.+|++++++++ ||||+++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 579999999999999999999999999999999863211 11234678999999996 89999999994
Q ss_pred CCCceEEEEEeeccC-CCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-CCc
Q 001908 751 KGADFKALVYEYMQN-GSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMV 828 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~ 828 (997)
.+++..++||||+.+ +++.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++. ++.
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred eeCCeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence 456689999999976 68888887654 488999999999999999999999 9999999999999985 479
Q ss_pred EEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCC
Q 001908 829 AHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRR 908 (997)
Q Consensus 829 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~ 908 (997)
+||+|||+|+.... .......||+.|+|||++.. ...++.++||||+||++|||+||+.
T Consensus 150 vkl~DFG~a~~~~~----------~~~~~~~GT~~y~aPE~~~~-----------~~~~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 150 LKLIDFGSGALLKD----------TVYTDFDGTRVYSPPEWIRY-----------HRYHGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp EEECCCTTCEECCS----------SCBCCCCSCGGGSCHHHHHH-----------SCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred EEECccccceeccc----------ccccccccCCCcCCHHHHcC-----------CCCCCcccccccceeeehhHhhCCC
Confidence 99999999976421 12234679999999987753 1234678999999999999999999
Q ss_pred CCCcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 909 PTNCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 909 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
||... .+...... ...+ ..+.++.+++.+||..||++|||++|+++
T Consensus 209 Pf~~~-------~~i~~~~~------~~~~----------------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 209 PFEHD-------EEIIRGQV------FFRQ----------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SCCSH-------HHHHHCCC------CCSS----------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCc-------hHHhhccc------CCCC----------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99732 11111000 0000 12346789999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=375.35 Aligned_cols=276 Identities=23% Similarity=0.323 Sum_probs=198.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCC-CcEEEEEEecccc--hhhHHHHHHHHHHHhhc---CCCCcceEEeeeeccCcC
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGEN-GTFVAVKILNLMQ--KGALKSFVAECEVLRNT---RHRNLIKIITVCSSIDFK 751 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~ 751 (997)
.++|++.++||+|+||+||+|++..+ ++.||||+++... +.....+.+|+++++.+ +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999655 6779999986432 22234566788887766 799999999998665455
Q ss_pred CCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEE
Q 001908 752 GADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 831 (997)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 831 (997)
.....+++|||++++++........ ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 6678999999998876655544332 2478899999999999999999999 9999999999999999999999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||.++... .........||+.|+|||++. +..|+.++||||+||++|||+||++||.
T Consensus 158 ~dfg~~~~~~---------~~~~~~~~~gT~~Y~APE~~~------------~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 158 ADFGLARIYS---------FQMALTSVVVTLWYRAPEVLL------------QSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CSCCSCCCCC---------GGGGGCCCCCCCTTCCHHHHT------------TCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cchhhhhhhc---------ccccCCCcccChhhcCcchhc------------CCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 9999987541 223344568999999997654 5779999999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhc-ch--hhhhhcC-cccc-cccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMAL-PE--KVMETVD-PSLL-LAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~-~~--~~~~~~d-~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
..... ..+........ +. .+..... +... ................+.+.+++.+||..||++|||++|+++
T Consensus 217 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 217 GSSDV-DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSSHH-HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHH-HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 43211 11111111110 00 0000000 0000 000000001111223456778999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-42 Score=371.34 Aligned_cols=270 Identities=20% Similarity=0.286 Sum_probs=196.6
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.++||+|+||+||+|+++ +|+.||||+++.. .+...+.+.+|+.++++++||||+++++++ ..++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 57899999999999999999997 7899999999643 233457899999999999999999999995 456689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
+++|||+.++.+..+..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 99999998776666665443 489999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|...... ........|++.|+|||.+.. ...++.++||||+||++|||++|+.||......
T Consensus 147 a~~~~~~--------~~~~~~~~~~~~y~~pE~~~~-----------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 147 ARAFGIP--------VRKYTHEIVTLWYRAPDVLMG-----------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTT-----------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ceecccC--------ccccceecccchhhhHHHHhC-----------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 9876321 122234568999999987642 345789999999999999999999999743211
Q ss_pred CccHHHHHHhhcc---hhhhhhcC-cccccc---cccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALP---EKVMETVD-PSLLLA---WSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~---~~~~~~~d-~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. .+......... ........ +..... ..............+.+.+++.+|+..||++|||++|+++
T Consensus 208 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 208 D-QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp H-HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H-HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11111111100 00000000 000000 0000001111223456789999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=376.63 Aligned_cols=277 Identities=20% Similarity=0.230 Sum_probs=199.4
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM-QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
+.+|++.++||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++|++++||||+++++++....+......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35699999999999999999999999999999999743 34456788999999999999999999999876544444455
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
+++ +|+.+|+|.+++.... +++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~l~-~~~~~g~L~~~l~~~~-------l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEE-EECCCEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEE-EeecCCchhhhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 555 5566899999997653 88999999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+...... ..........||+.|+|||++.. +..++.++||||+||++|||++|+.||......
T Consensus 156 a~~~~~~~-----~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~ 219 (345)
T d1pmea_ 156 ARVADPDH-----DHTGFLTEYVATRWYRAPEIMLN-----------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219 (345)
T ss_dssp CEECCGGG-----CBCCTTCCCCSCGGGCCGGGTTT-----------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred eeeccCCC-----ccceeeccccccceechHHHhhc-----------CCCCCchhhhhccCceehHHhhCCCCCCCCCHH
Confidence 98652211 11222345679999999987643 345788999999999999999999999753221
Q ss_pred CccHHHHHHh--hcch-hh-hhhcCccccc---ccccchhhh---hHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKM--ALPE-KV-METVDPSLLL---AWSDGRRRA---KVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~--~~~~-~~-~~~~d~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. ....... ..+. .. .......... ........+ .......++.+++.+|+..||++|||+.|+++
T Consensus 220 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 220 D--QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp H--HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H--HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1111000 0000 00 0000000000 000000000 00112245789999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-41 Score=369.05 Aligned_cols=280 Identities=22% Similarity=0.319 Sum_probs=196.8
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC---cCCC
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID---FKGA 753 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~ 753 (997)
++|++.++||+|+||+||+|+++.+|+.||||++... .+...+.+.+|+++|++++||||+++++++.... ....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999999999999999998633 3334577889999999999999999999975532 1234
Q ss_pred ceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcc
Q 001908 754 DFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 833 (997)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 833 (997)
+..++||||++++.+..+..... .++...++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence 57899999998776665554433 478889999999999999999999 999999999999999999999999
Q ss_pred cccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcC
Q 001908 834 FGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCM 913 (997)
Q Consensus 834 Fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 913 (997)
||+|+........ .........||+.|+|||++.. ...++.++||||+||++|||++|+.||...
T Consensus 161 fg~~~~~~~~~~~----~~~~~~~~~gT~~Y~aPE~~~~-----------~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 161 FGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLG-----------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp CTTCEECCC---------CCCCCSCCSCGGGCCHHHHTT-----------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceeeeccccccc----ccccccceecCHHHhhHHHHcC-----------CCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 9999765322211 1122234579999999987642 245889999999999999999999999743
Q ss_pred cCCCccHHHHHHhh--cchhhhhhcCc-cccccc--ccchh-----hhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 914 FQGGLTLHEFCKMA--LPEKVMETVDP-SLLLAW--SDGRR-----RAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 914 ~~~~~~~~~~~~~~--~~~~~~~~~d~-~~~~~~--~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
... .......... .+.......+. ...... ..... ........+.+.+++.+||..||++|||++|+++
T Consensus 226 ~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 226 TEQ-HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp SHH-HHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHH-HHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 211 0011111110 11111111110 000000 00000 0111122346678999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=373.19 Aligned_cols=273 Identities=22% Similarity=0.295 Sum_probs=193.0
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCceEEE
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGADFKAL 758 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l 758 (997)
+|+..++||+|+||+||+|+++.+|+.||||+++.... ...+|++++++++||||+++++++.... ..+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 68889999999999999999999999999999975432 2347999999999999999999975532 234556899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEcccccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLA 837 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFg~a 837 (997)
||||++++.+........ ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|
T Consensus 97 v~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEeccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 999997654333332111 112489999999999999999999999 999999999999999775 8999999999
Q ss_pred hhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCCC
Q 001908 838 RFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQGG 917 (997)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 917 (997)
+..... .......||+.|+|||.+. ....++.++||||+||++|||++|++||.......
T Consensus 171 ~~~~~~---------~~~~~~~gt~~y~aPE~~~-----------~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~ 230 (350)
T d1q5ka_ 171 KQLVRG---------EPNVSYICSRYYRAPELIF-----------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230 (350)
T ss_dssp EECCTT---------SCCCSCCSCTTSCCHHHHT-----------TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH
T ss_pred hhccCC---------cccccccccccccChHHhh-----------cccCCCcceeecccceEEEehhhCCCCCCCCCHHH
Confidence 865221 1223457999999997553 23568999999999999999999999997432111
Q ss_pred ccHHHHHHhh--cchhhhhhcCccccc-cccc----chhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 918 LTLHEFCKMA--LPEKVMETVDPSLLL-AWSD----GRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 918 ~~~~~~~~~~--~~~~~~~~~d~~~~~-~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.+....... ..........+.... .+.. ...........+++.+++.+||..||++|||++|+++
T Consensus 231 -~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 231 -QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp -HHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111110 000111011110000 0000 0000001123456789999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=367.83 Aligned_cols=272 Identities=22% Similarity=0.277 Sum_probs=195.9
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccC-cCCCc
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSID-FKGAD 754 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 754 (997)
.++|++.++||+|+||+||+|+++.+|+.||||+++.. .+...+.+.+|+++|++++|||||+++++|...+ .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999999999999999999742 3445678899999999999999999999976533 22344
Q ss_pred eEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccc
Q 001908 755 FKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 834 (997)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 834 (997)
+.|+||||+ +.+|..+.+... +++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 689999999 668888876543 89999999999999999999999 9999999999999999999999999
Q ss_pred ccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCc
Q 001908 835 GLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMF 914 (997)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 914 (997)
|.|+.... ......||+.|+|||++.. ...++.++||||+||++|||++|++||....
T Consensus 166 g~a~~~~~-----------~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 166 GLARQADS-----------EMTGYVVTRWYRAPEVILN-----------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp TTCEECCS-----------SCCSSCSCGGGCCTHHHHT-----------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceeccCC-----------ccccccccccccCHHHHcC-----------CCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 99986421 2234679999999987652 2456889999999999999999999997432
Q ss_pred CCCccHHHHHHhh--cchhhhhhcCccccc-------ccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 915 QGGLTLHEFCKMA--LPEKVMETVDPSLLL-------AWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 915 ~~~~~~~~~~~~~--~~~~~~~~~d~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
.. ..+....... .+............. ...............+.+.+++.+|+..||++|||++|+++
T Consensus 224 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 224 HL-DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HH-HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hH-HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11 1111111110 111111111100000 00000000011122345679999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-40 Score=366.68 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=197.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCceEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADFKA 757 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~ 757 (997)
++|++.++||+|+||+||+|+++.+++.||||+++... .+.+.+|+++|++++ ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 57999999999999999999999999999999987433 367889999999995 9999999998653 3356799
Q ss_pred EEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCC-cEEEccccc
Q 001908 758 LVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 836 (997)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFg~ 836 (997)
+||||+++++|.++.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||+
T Consensus 109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 9999999999976542 378899999999999999999999 999999999999998655 699999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+..... .......||+.|+|||.+.. ...++.++||||+||++|||++|+.||......
T Consensus 177 a~~~~~~---------~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 177 AEFYHPG---------QEYNVRVASRYFKGPELLVD-----------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp CEECCTT---------CCCCSCCSCGGGCCHHHHTT-----------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred ceeccCC---------CcccccccCccccCcccccC-----------CCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 9865221 22334578999999987642 245789999999999999999999998754321
Q ss_pred CccHHHHHHhhc---chhhhhhc----Cccc--------ccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 001908 917 GLTLHEFCKMAL---PEKVMETV----DPSL--------LLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDV 981 (997)
Q Consensus 917 ~~~~~~~~~~~~---~~~~~~~~----d~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 981 (997)
............ ........ ++.. ...+.............+++.+++.+|+..||++|||++|+
T Consensus 237 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~ 316 (328)
T d3bqca1 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316 (328)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 111111111000 00000000 0000 00000000111112234567899999999999999999999
Q ss_pred HH
Q 001908 982 LA 983 (997)
Q Consensus 982 l~ 983 (997)
++
T Consensus 317 L~ 318 (328)
T d3bqca1 317 ME 318 (328)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-40 Score=359.60 Aligned_cols=270 Identities=23% Similarity=0.267 Sum_probs=200.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceEEE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFKAL 758 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 758 (997)
++|++.++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|++++..+..|. ...+..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 469999999999999999999998999999999864332 245788999999998887666665553 34568899
Q ss_pred EEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC---CCcEEEcccc
Q 001908 759 VYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFG 835 (997)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFg 835 (997)
||||+ ++++.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||
T Consensus 81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 99999 6677777665432 488999999999999999999999 9999999999999864 4579999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
+|+......... ...........||+.|||||++. +..++.++|||||||++|||+||+.||.....
T Consensus 152 ~a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 152 LAKKYRDARTHQ-HIPYRENKNLTGTARYASINTHL------------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp SCEECBCTTTCC-BCCCCBCCSCCCCSSSCCHHHHT------------TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cceecccccccc-ceeccccCCcCCCccccCHHHHh------------CCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 998764322211 11122334567999999996654 56789999999999999999999999975432
Q ss_pred CCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 916 GGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
..... .. .... ........+ .....+++++.+++..||+.+|++||+++++.+.|+.+...
T Consensus 219 ~~~~~-~~-~~~~-~~~~~~~~~------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 219 ATKRQ-KY-ERIS-EKKMSTPIE------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -------H-HHHH-HHHHHSCHH------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHH-HH-HHhh-cccCCCChh------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 21111 00 0000 000000000 01113456788999999999999999999999999887553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=360.25 Aligned_cols=272 Identities=20% Similarity=0.268 Sum_probs=200.5
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCceE
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 756 (997)
++|++.++||+|+||+||+|++..+++.||||+++.. .+...+.+.+|+.++++++||||+++++++. .....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 4799999999999999999999999999999999633 3345678899999999999999999999954 45689
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEccccc
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 836 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~ 836 (997)
++|+|++.++++..++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 99999999999988887654 478889999999999999999999 999999999999999999999999999
Q ss_pred chhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcCC
Q 001908 837 ARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQG 916 (997)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 916 (997)
|+...... .......+++.|+|||++.. ...++.++||||+||++|||++|+.||......
T Consensus 148 a~~~~~~~--------~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFG-----------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTT-----------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred hhcccCCC--------ccceeeccccchhhhhHhcc-----------CCCCCchhhccccchHHHHHhhCCCCCCCCCCH
Confidence 98753211 12233457788999976542 234688999999999999999999997532211
Q ss_pred CccHHHHHHhhcc--hhhh----hhcCccccccc-ccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 917 GLTLHEFCKMALP--EKVM----ETVDPSLLLAW-SDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 917 ~~~~~~~~~~~~~--~~~~----~~~d~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...+......... .... ...+....... .............+.+.+++.+|++.||++|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111110 0000 00000000000 000001111223346778999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-39 Score=350.96 Aligned_cols=271 Identities=17% Similarity=0.193 Sum_probs=206.5
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCC-CCcceEEeeeeccCcCCCceE
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRH-RNLIKIITVCSSIDFKGADFK 756 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~ 756 (997)
.++|++.++||+|+||+||+|++..+++.||||+++.... ...+.+|++.++.++| +|++.+++++. .....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCcc
Confidence 3579999999999999999999999999999999864332 2456788999999865 89999998843 45688
Q ss_pred EEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCC-----CCcEEE
Q 001908 757 ALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDH-----DMVAHV 831 (997)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl 831 (997)
++||||+ +++|.+++..... .++..++.+++.|++.||+|||++ +|+||||||+||+++. ++.+||
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence 9999999 7899999887542 488999999999999999999999 9999999999999975 578999
Q ss_pred cccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 001908 832 SDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTN 911 (997)
Q Consensus 832 ~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~ 911 (997)
+|||+|+......... ...........||+.|||||++. +..++.++|||||||++|||+||+.||.
T Consensus 148 ~DFG~a~~~~~~~~~~-~~~~~~~~~~~GT~~y~aPE~~~------------~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQ-HIPYREKKNLSGTARYMSINTHL------------GREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CCCTTCEESBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHT------------TCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccceeEEcccCcccc-ceeecccCceEEchhhcCHHHhc------------CCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 9999998764322111 11122334568999999996654 5779999999999999999999999997
Q ss_pred cCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001908 912 CMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLAKLCAARQT 991 (997)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 991 (997)
....... ...+ ......+ ....+ ......+++++.+++..|+..+|++||+++.+.+.|+++.++
T Consensus 215 ~~~~~~~-~~~~-~~i~~~~--~~~~~-----------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 215 GLKAATN-KQKY-ERIGEKK--QSTPL-----------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp SCCSCCH-HHHH-HHHHHHH--HHSCH-----------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CccchhH-HHHH-HHHHhcc--CCCCh-----------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 5433221 1111 1100000 00000 001112456788999999999999999999999999888765
Q ss_pred h
Q 001908 992 L 992 (997)
Q Consensus 992 ~ 992 (997)
.
T Consensus 280 ~ 280 (293)
T d1csna_ 280 L 280 (293)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-40 Score=362.09 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=197.4
Q ss_pred hcCccCCcccccCcceEEEEEE---CCCCcEEEEEEeccc----chhhHHHHHHHHHHHhhcCC-CCcceEEeeeeccCc
Q 001908 679 NEFSSSNMIGQGSFGSVYKGIL---GENGTFVAVKILNLM----QKGALKSFVAECEVLRNTRH-RNLIKIITVCSSIDF 750 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~---~~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 750 (997)
++|++.++||+|+||+||+|+. +.+|+.||||+++.. .....+.+.+|++++++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----- 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence 5799999999999999999987 446899999998632 22334667899999999976 8999999984
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEE
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 830 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 830 (997)
.+....+++|||+.+|+|.+++.... .+....++.++.|++.|++|+|++ +|+||||||+||+++.++.+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence 44568999999999999999998775 367788999999999999999999 999999999999999999999
Q ss_pred EcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 001908 831 VSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPT 910 (997)
Q Consensus 831 l~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 910 (997)
|+|||+|+.... ..........|++.|+|||.+... ...++.++||||+||++|||+||+.||
T Consensus 170 L~DFG~a~~~~~-------~~~~~~~~~~g~~~~~~pe~~~~~----------~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 170 LTDFGLSKEFVA-------DETERAYDFCGTIEYMAPDIVRGG----------DSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp ESCSSEEEECCG-------GGGGGGCGGGSCCTTCCHHHHTTC----------C---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred Eeeccchhhhcc-------cccccccccccccccchhHHhhcC----------CcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 999999986522 112223446799999999876421 234678999999999999999999999
Q ss_pred CcCcCCCccHHHHHHhhcchhhhhhcCcccccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 001908 911 NCMFQGGLTLHEFCKMALPEKVMETVDPSLLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIERME-----MRDVLA 983 (997)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 983 (997)
....... ............ .+. .+..+..++.+++.+||..||++||| ++|+++
T Consensus 233 ~~~~~~~-~~~~i~~~~~~~------~~~------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 233 TVDGEKN-SQAEISRRILKS------EPP------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCC-CHHHHHHHHHHC------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCHHH-HHHHHHHhcccC------CCC------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 7653332 222221111000 000 01123457789999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=359.39 Aligned_cols=271 Identities=21% Similarity=0.208 Sum_probs=192.0
Q ss_pred hcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCc-CCCce
Q 001908 679 NEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDF-KGADF 755 (997)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~ 755 (997)
++|++.++||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++||||+++++++..... +...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999999999999999999733 34455678999999999999999999999754432 34578
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.|+||||+.++ +.+.+.. .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEeccchH-HHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence 99999999664 5455532 378899999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.++... .........||+.|+|||++. +..+++++||||+||++|||++|++||.....
T Consensus 165 ~~~~~~---------~~~~~~~~~~t~~y~aPE~l~------------~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 165 LARTAG---------TSFMMTPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp C------------------------CCTTCCHHHHT------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhccc---------cccccccccccccccChhhhc------------CCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 987652 122334567899999997654 56789999999999999999999999974321
Q ss_pred CCccHHHHHHhhcc--hhhhhhcCcc------------------cccccccchhhhhHHHHHHHHHHHHhhcCCCCCCCC
Q 001908 916 GGLTLHEFCKMALP--EKVMETVDPS------------------LLLAWSDGRRRAKVEECLVTVIRIGVACSMESPIER 975 (997)
Q Consensus 916 ~~~~~~~~~~~~~~--~~~~~~~d~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 975 (997)
. ............ .......... ...................++.+++.+|+..||++|
T Consensus 224 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 302 (355)
T d2b1pa1 224 I-DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_dssp H-HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred H-HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHC
Confidence 1 001111110000 0000000000 000000011122234456678899999999999999
Q ss_pred CCHHHHHH
Q 001908 976 MEMRDVLA 983 (997)
Q Consensus 976 ps~~evl~ 983 (997)
||++|+++
T Consensus 303 ~ta~elL~ 310 (355)
T d2b1pa1 303 ISVDDALQ 310 (355)
T ss_dssp CCHHHHHT
T ss_pred cCHHHHhc
Confidence 99999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=361.59 Aligned_cols=273 Identities=19% Similarity=0.224 Sum_probs=196.7
Q ss_pred hhcCccCCcccccCcceEEEEEECCCCcEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCCcceEEeeeeccCcCCCce
Q 001908 678 TNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLM--QKGALKSFVAECEVLRNTRHRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 755 (997)
.++|++.++||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++||||+++++++..........
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999999999999999999743 3344567899999999999999999999875443223344
Q ss_pred EEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCeeeCCCCcEEEcccc
Q 001908 756 KALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 835 (997)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFg 835 (997)
.+++++|+.+|+|.+++..+. +++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~-------l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhccccc-------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 566677888999999997543 89999999999999999999999 99999999999999999999999999
Q ss_pred cchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHHHHHHhCCCCCCcCcC
Q 001908 836 LARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVMLLEMFTRRRPTNCMFQ 915 (997)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 915 (997)
.|... ........||+.|+|||+... ...++.++||||+||++|+|++|+.||.....
T Consensus 167 ~a~~~-----------~~~~~~~~g~~~y~apE~~~~-----------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 167 LARHT-----------DDEMTGYVATRWYRAPEIMLN-----------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp ---CC-----------TGGGSSSCHHHHTSCHHHHTT-----------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhccc-----------CcccccccccccccCchhhcC-----------CccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 99754 122344678999999976542 24468899999999999999999999974311
Q ss_pred CCccHHHHHHhh--cchhhhhhcCccccc-------ccccchhhhhHHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 916 GGLTLHEFCKMA--LPEKVMETVDPSLLL-------AWSDGRRRAKVEECLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 916 ~~~~~~~~~~~~--~~~~~~~~~d~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
. .......... ............... ................++.+++.+|+..||++|||++|+++
T Consensus 225 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 225 I-DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp H-HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H-HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 1 0011111110 000111100000000 00000000001123456789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-34 Score=322.74 Aligned_cols=270 Identities=18% Similarity=0.216 Sum_probs=186.9
Q ss_pred cCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCCcceEEeeeecc
Q 001908 680 EFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-----------HRNLIKIITVCSSI 748 (997)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 748 (997)
+|++.++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~- 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH- 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE-
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee-
Confidence 5999999999999999999999999999999997543 23456788999888775 5789999988643
Q ss_pred CcCCCceEEEEEeeccCCCHH-HHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcEecCCCCCCeeeCCC
Q 001908 749 DFKGADFKALVYEYMQNGSLE-EWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH-HCQPPIVHGDLKPSNVLLDHD 826 (997)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NIll~~~ 826 (997)
......+++++++..+... ....... ...+++..+..++.||+.|++|||+ . +|+||||||+|||++.+
T Consensus 92 --~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 92 --KGPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp --EETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred --ccccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeecc
Confidence 2345667777776554333 3332222 2247888999999999999999998 5 89999999999999876
Q ss_pred C------cEEEcccccchhcccCCCCCccccccccccccccccccCCcchhcccccCccccCCCCCCCccchhHHHHHHH
Q 001908 827 M------VAHVSDFGLARFLFARPFDTSMETQSSSIGIKGTVGYVPPGNIAKMLNLPCLEYGMGSEASVTGDVYSLGVML 900 (997)
Q Consensus 827 ~------~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~e~~~~~~~~~~~DvwSlGvvl 900 (997)
+ .+|++|||.|..... ......||+.|+|||++. +..++.++||||+||++
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~-----------~~~~~~gt~~y~aPE~~~------------~~~~~~~~DiwSlG~il 219 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE-----------HYTNSIQTREYRSPEVLL------------GAPWGCGADIWSTACLI 219 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB-----------CCCSCCSCGGGCCHHHHH------------TCCCCTHHHHHHHHHHH
T ss_pred CcccccceeeEeeccccccccc-----------ccccccccccccChhhcc------------ccCCCccccccchHHHH
Confidence 5 499999999875421 223457999999997654 46789999999999999
Q ss_pred HHHHhCCCCCCcCcCCCc--cH---HHHHHhh--cchhhh-------hhcCcc-cccccccch----------hhhhHHH
Q 001908 901 LEMFTRRRPTNCMFQGGL--TL---HEFCKMA--LPEKVM-------ETVDPS-LLLAWSDGR----------RRAKVEE 955 (997)
Q Consensus 901 ~elltg~~P~~~~~~~~~--~~---~~~~~~~--~~~~~~-------~~~d~~-~~~~~~~~~----------~~~~~~~ 955 (997)
+||++|+.||........ .. ....... .+.... ...+.. ......... .......
T Consensus 220 ~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (362)
T d1q8ya_ 220 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299 (362)
T ss_dssp HHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHH
T ss_pred HHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcc
Confidence 999999999975432211 11 1111110 011110 011100 000000000 0111235
Q ss_pred HHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 001908 956 CLVTVIRIGVACSMESPIERMEMRDVLA 983 (997)
Q Consensus 956 ~~~~l~~li~~cl~~dP~~Rps~~evl~ 983 (997)
...++.+++.+|+..||++|||++|+++
T Consensus 300 ~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 300 EAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 5678899999999999999999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.1e-34 Score=316.60 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=236.9
Q ss_pred cccccccCccccc--ccCCCCCCCCCCCEEeccC-CCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEE
Q 001908 348 MTDIYMGVNQISG--TIPSGIGNLVNLNLLGIEF-NQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLF 424 (997)
Q Consensus 348 L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 424 (997)
++.|+|++|.++| .+|..++++++|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..|..+..+.+|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4445555555554 4788899999999999986 899999999999999999999999999999999999999999999
Q ss_pred eecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccc
Q 001908 425 LSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFS 504 (997)
Q Consensus 425 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 504 (997)
+++|++.+.+|..|.+++.|+++++++|.+.|.+|..+..+..+++.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 999999999999999999999999999999999999999999888899999999999999999887655 6999999999
Q ss_pred ccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCc
Q 001908 505 GEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGV 584 (997)
Q Consensus 505 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 584 (997)
|.+|..+..+++|+.+++++|.+++.+| .++.+++|+.|||++|+|+|.+|..|+++++|++|||++|+|+|.+|..+.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 9999999999999999999999997665 688999999999999999999999999999999999999999999999888
Q ss_pred CCCCcceeecCCCCcCCCCCCCCCCCCC
Q 001908 585 FSNKTRVQLTGNGKLCGGSNELHLPSCP 612 (997)
Q Consensus 585 ~~~~~~~~~~~N~~~C~~~~~~~~~~c~ 612 (997)
+++++.+++.||+.+||.+ +|+|+
T Consensus 290 L~~L~~l~l~~N~~l~g~p----lp~c~ 313 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSP----LPACT 313 (313)
T ss_dssp GGGSCGGGTCSSSEEESTT----SSCCC
T ss_pred CCCCCHHHhCCCccccCCC----CCCCC
Confidence 9999999999999999953 36774
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5.4e-29 Score=281.37 Aligned_cols=339 Identities=26% Similarity=0.343 Sum_probs=212.8
Q ss_pred hhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCcc
Q 001908 199 LHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINY 278 (997)
Q Consensus 199 L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 278 (997)
..++.+.+++.++ ...+.+|++|++++|.++ .++ .+ ..+++|++|+|++|+|++..| ++++++|++|++++|+
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l~-gl-~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GV-EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CCT-TG-GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Ccc-cc-ccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccc
Confidence 3455556665443 245567777777777776 443 23 357777777777777775432 7777778888888887
Q ss_pred CCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccc-------------
Q 001908 279 FTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLS------------- 345 (997)
Q Consensus 279 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~------------- 345 (997)
+++..+ ++.+++|+.|++++|.++.... ......+..+....|.+....+.......
T Consensus 100 i~~i~~--l~~l~~L~~L~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (384)
T d2omza2 100 IADITP--LANLTNLTGLTLFNNQITDIDP--------LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK 169 (384)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCCGG--------GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG
T ss_pred cccccc--cccccccccccccccccccccc--------ccccccccccccccccccccccccccccccccccccccchhh
Confidence 776543 6777778888877777765422 23445666666666665533322211110
Q ss_pred -----cccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCC
Q 001908 346 -----TTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLM 420 (997)
Q Consensus 346 -----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 420 (997)
..........|.. .....+..+++++.+++++|.+++..| +...++|++|++++|+++. + +.+..+++|
T Consensus 170 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L 243 (384)
T d2omza2 170 PLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNL 243 (384)
T ss_dssp GGTTCTTCCEEECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTC
T ss_pred hhcccccccccccccccc--ccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhccccc
Confidence 1111112222222 233445666777777777777776544 3456677777777777763 3 356677777
Q ss_pred CeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccc
Q 001908 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISG 500 (997)
Q Consensus 421 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 500 (997)
+.|++++|++++..+ +..+++|++|++++|++++..+ +..+..+ +.++++.|++++. ..+..+++++.|++++
T Consensus 244 ~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l-~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL-TNLELNENQLEDI--SPISNLKNLTYLTLYF 316 (384)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTC-SEEECCSSCCSCC--GGGGGCTTCSEEECCS
T ss_pred chhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccc-ccccccccccccc--cccchhcccCeEECCC
Confidence 777777777775432 6667777777777777764322 4455555 6677777777642 3466677777777777
Q ss_pred ccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCC
Q 001908 501 NQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYN 573 (997)
Q Consensus 501 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 573 (997)
|++++.. .+..+++|++|++++|+|++ +| .++++++|++|+|++|+|++.+| +.++++|+.|+|++|
T Consensus 317 n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 317 NNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7777543 26677777777777777763 33 57777777777777777776544 677777777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3.7e-28 Score=274.45 Aligned_cols=186 Identities=28% Similarity=0.406 Sum_probs=142.4
Q ss_pred ccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEee
Q 001908 347 TMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS 426 (997)
Q Consensus 347 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 426 (997)
.++.+++++|.+++..| +...++|+.|++++|+++.. +.+..+++|+.|++++|++++..+ +..+++|+.|+++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 271 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeecc
Confidence 34455555555554433 34456788888888888742 357778888888888888886443 7778888888888
Q ss_pred cCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccc
Q 001908 427 SNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGE 506 (997)
Q Consensus 427 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 506 (997)
+|++++.. .+.+++.++.+++++|++++ +..+..+..+ +.|++++|++++.. .+..+++|++|++++|++++
T Consensus 272 ~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l-~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~- 343 (384)
T d2omza2 272 ANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNL-TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD- 343 (384)
T ss_dssp SSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTC-SEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-
T ss_pred CcccCCCC--cccccccccccccccccccc--ccccchhccc-CeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-
Confidence 88888543 36778888888888888874 2346667777 88899999988653 37889999999999999984
Q ss_pred ccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 507 IPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 507 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
++ .+.++++|++|++++|+|++.+| +.++++|+.|+|++|
T Consensus 344 l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 344 VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 44 68999999999999999997665 889999999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=4e-26 Score=249.02 Aligned_cols=289 Identities=22% Similarity=0.239 Sum_probs=170.1
Q ss_pred ccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEc
Q 001908 219 SLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDL 298 (997)
Q Consensus 219 ~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 298 (997)
.++.+|-++++++ .+|..++ +++++|+|++|+|+...+.+|.++++|++|++++|.++...|..|..+++|++|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 4556666666676 6776654 46777777777777555567777888888888888887777777777788888888
Q ss_pred cCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCccc--ccccCCCCCCCCCCCEEe
Q 001908 299 GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQI--SGTIPSGIGNLVNLNLLG 376 (997)
Q Consensus 299 s~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l--~~~~p~~~~~l~~L~~L~ 376 (997)
++|+++.++.. ....++.|++++|.+.+..+..+... .....+....|.. ....+..|..+++|+.++
T Consensus 87 ~~n~l~~l~~~---------~~~~l~~L~~~~n~l~~l~~~~~~~~-~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~ 156 (305)
T d1xkua_ 87 SKNQLKELPEK---------MPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156 (305)
T ss_dssp CSSCCSBCCSS---------CCTTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred cCCccCcCccc---------hhhhhhhhhccccchhhhhhhhhhcc-ccccccccccccccccCCCccccccccccCccc
Confidence 87777765432 23466777777777765444333322 3344445544432 233345566666666677
Q ss_pred ccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC
Q 001908 377 IEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 377 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 456 (997)
+++|+++. +|..+ +++|++|++++|.+++..+..|.+++.++.|++++|++++..+..|.++++|++|+|++|+|+
T Consensus 157 l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~- 232 (305)
T d1xkua_ 157 IADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232 (305)
T ss_dssp CCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred cccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-
Confidence 76666663 33332 456666666666666666666666666666666666666655666666666666666666655
Q ss_pred CcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcccc--ccCChh
Q 001908 457 AVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR--GSIPLS 534 (997)
Q Consensus 457 ~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~ 534 (997)
.+|.++..+++| ++|+|++|+|+......|.. +..+..+.+|+.|+|++|.++ ...|.+
T Consensus 233 ~lp~~l~~l~~L-~~L~Ls~N~i~~i~~~~f~~------------------~~~~~~~~~L~~L~L~~N~~~~~~~~~~~ 293 (305)
T d1xkua_ 233 KVPGGLADHKYI-QVVYLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQYWEIQPST 293 (305)
T ss_dssp SCCTTTTTCSSC-CEEECCSSCCCCCCTTSSSC------------------SSCCTTSCCCSEEECCSSSSCGGGSCGGG
T ss_pred ccccccccccCC-CEEECCCCccCccChhhccC------------------cchhcccCCCCEEECCCCcCccCcCCHhH
Confidence 344444444444 44444444444221111110 112234456666666666654 234555
Q ss_pred ccccCcCCee
Q 001908 535 LRSLKSIKEL 544 (997)
Q Consensus 535 ~~~l~~L~~L 544 (997)
|..+.....+
T Consensus 294 f~~~~~~~~~ 303 (305)
T d1xkua_ 294 FRCVYVRAAV 303 (305)
T ss_dssp GTTCCCGGGE
T ss_pred hcccccCccc
Confidence 5554444433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=3.1e-25 Score=241.82 Aligned_cols=267 Identities=24% Similarity=0.272 Sum_probs=163.6
Q ss_pred CccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCC
Q 001908 244 NLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKL 323 (997)
Q Consensus 244 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L 323 (997)
.++.++=++++++ .+|..+. +++++|||++|+|+..++..|.++++|++|++++|.+..+.
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~---------------- 71 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS---------------- 71 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBC----------------
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccc----------------
Confidence 3456777777777 6676653 56888888888887777667777777777766666665432
Q ss_pred cEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecccc
Q 001908 324 KVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSS 403 (997)
Q Consensus 324 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 403 (997)
|..|.++++|++|++++|+++. +|..+ ...++.|++++
T Consensus 72 ---------------------------------------~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~ 109 (305)
T d1xkua_ 72 ---------------------------------------PGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHE 109 (305)
T ss_dssp ---------------------------------------TTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCS
T ss_pred ---------------------------------------hhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccc
Confidence 2333444444444444444442 22221 12344455555
Q ss_pred ccccccchhhhcCCCCCCeEEeecCcCC--CCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccC
Q 001908 404 NFLQGNIPSSLGNLTLMTDLFLSSNHLQ--GNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG 481 (997)
Q Consensus 404 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~ 481 (997)
|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|.+. .+|..+ .+++ +.|++++|.+++
T Consensus 110 n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L-~~L~l~~n~~~~ 185 (305)
T d1xkua_ 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSL-TELHLDGNKITK 185 (305)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTC-SEEECTTSCCCE
T ss_pred cchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCcc-CEEECCCCcCCC
Confidence 5555444444445555555555555332 223344555555555555555554 344332 2334 556666666666
Q ss_pred CCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchh---
Q 001908 482 SLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEF--- 558 (997)
Q Consensus 482 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--- 558 (997)
..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+......
T Consensus 186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~ 264 (305)
T d1xkua_ 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264 (305)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred CChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccC
Confidence 66666777777777777777777766777777777777778777777 56777777788888888888777443333
Q ss_pred ---ccCCCCCCEEeCCCCcCc
Q 001908 559 ---LENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 559 ---~~~l~~L~~L~ls~N~l~ 576 (997)
+..+.+|+.|+|++|+++
T Consensus 265 ~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 265 PGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp SSCCTTSCCCSEEECCSSSSC
T ss_pred cchhcccCCCCEEECCCCcCc
Confidence 345677888888888885
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.7e-26 Score=246.35 Aligned_cols=232 Identities=23% Similarity=0.266 Sum_probs=172.1
Q ss_pred CCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEee-cCcCCCCCCCCCCCCCCCcEEe
Q 001908 370 VNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLS-SNHLQGNIPPSLGNCKNLVSLN 448 (997)
Q Consensus 370 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~ 448 (997)
+++++|+|++|+|+...+.+|.++++|++|++++|++.+..+..+.+++.+..++.. .|.++...|..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 356667777777765555667777777777777777776666666666777776553 5556655566777777777777
Q ss_pred cCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCcccc
Q 001908 449 LSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFR 528 (997)
Q Consensus 449 L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (997)
+++|.+....+..+....++ +.+++++|++++..+..|..+++|+.|++++|++++..+..|.++++|+++++++|+++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L-~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCcccccccccccchhccc-chhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccc
Confidence 77777765555555555665 67777777777666677888888899999999998777888889999999999999998
Q ss_pred ccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecCCCCcCCC
Q 001908 529 GSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTGNGKLCGG 602 (997)
Q Consensus 529 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~N~~~C~~ 602 (997)
+..|..|..+++|++||+++|++++..|..|..+++|++|+|++|++.+..+..+....++......+...|..
T Consensus 191 ~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~ 264 (284)
T d1ozna_ 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred ccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCC
Confidence 88888999999999999999999988888898999999999999999887764333333444555556666643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.6e-25 Score=241.45 Aligned_cols=223 Identities=22% Similarity=0.244 Sum_probs=135.2
Q ss_pred eeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCcccccccccCccCeeEcc-Cc
Q 001908 223 ILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGKVSIIFGRLKNLWSLDLG-IN 301 (997)
Q Consensus 223 L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls-~N 301 (997)
++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++||+++|++....+..+..+..++.++.. .|
T Consensus 16 v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 344555555 5555543 345666666666665555567777777777777777776666666666666666543 44
Q ss_pred cCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCC
Q 001908 302 NLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQ 381 (997)
Q Consensus 302 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 381 (997)
.++.++. ..+.++++|++|++++|.+....+..+... ..|+.+++++|+|+++.+..|..+++|+.|++++|+
T Consensus 92 ~~~~l~~------~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 92 QLRSVDP------ATFHGLGRLHTLHLDRCGLQELGPGLFRGL-AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp TCCCCCT------TTTTTCTTCCEEECTTSCCCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccccccc------hhhcccccCCEEecCCcccccccccccchh-cccchhhhccccccccChhHhccccchhhcccccCc
Confidence 4544432 234556666666666666654443333332 445555555555555555556666666666666666
Q ss_pred CCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccC
Q 001908 382 LTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIG 456 (997)
Q Consensus 382 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 456 (997)
+++..+..|.++++|+++++++|++++..|..|.++++|++|++++|++.+..+..|.++++|++|+|++|.+..
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 666666666666666666666666666666666666666666666666666555666666666666666666653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.1e-24 Score=228.63 Aligned_cols=201 Identities=25% Similarity=0.267 Sum_probs=134.5
Q ss_pred CCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEE
Q 001908 368 NLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSL 447 (997)
Q Consensus 368 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 447 (997)
+...+...+.++++|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccc
Confidence 4556777899999998 4676664 578899999999987667788899999999999999884 44 35678888888
Q ss_pred ecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccc
Q 001908 448 NLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSF 527 (997)
Q Consensus 448 ~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 527 (997)
+|++|+++ .++..+..++++ +.|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++|+.|++++|++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L-~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccc-cccccccccccc-ccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 88888886 445555556655 6666666666655555556666666666666666644455555556666666666666
Q ss_pred cccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCc
Q 001908 528 RGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFD 576 (997)
Q Consensus 528 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 576 (997)
++..+..|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|+|.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 6555555555666666666666665 45555555555555555544444
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1e-23 Score=224.54 Aligned_cols=193 Identities=21% Similarity=0.201 Sum_probs=89.2
Q ss_pred ccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcC
Q 001908 351 IYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHL 430 (997)
Q Consensus 351 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 430 (997)
++.+++.|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|++
T Consensus 15 v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCC
T ss_pred EEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccccc
Confidence 344444444 2343332 24445555555554444444444455555555555444 222 134444455555555554
Q ss_pred CCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceecccccccccccccc
Q 001908 431 QGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVT 510 (997)
Q Consensus 431 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 510 (997)
+ ..+..+.++++|+.|++++|.+.+..+..+..+.++ +.|++++|.++...+..+..+++|+.|++++|++++..+..
T Consensus 90 ~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l-~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~ 167 (266)
T d1p9ag_ 90 Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL-QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (266)
T ss_dssp S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred c-ccccccccccccccccccccccceeecccccccccc-ccccccccccceeccccccccccchhcccccccccccCccc
Confidence 4 234444444455555555554443333333344444 44455555544444444444444555555555554444444
Q ss_pred ccCCcCccEEEccCccccccCChhccccCcCCeeeCccccc
Q 001908 511 LTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNL 551 (997)
Q Consensus 511 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 551 (997)
|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 168 ~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp TTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred cccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 444455555555555544 4444444444455555555444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=1.5e-19 Score=200.33 Aligned_cols=186 Identities=28% Similarity=0.394 Sum_probs=96.5
Q ss_pred CCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCC
Q 001908 364 SGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKN 443 (997)
Q Consensus 364 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 443 (997)
..+..++.++.|++++|.+... +.. ....+.+..+++.+. .+| .+..++.|+.+++++|... .++.. ..+
T Consensus 156 ~~l~~l~~l~~L~l~~n~~~~~-~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~~~ 225 (353)
T d1jl5a_ 156 PELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL---PPS 225 (353)
T ss_dssp CCCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC---CTT
T ss_pred ccccccccceeccccccccccc-ccc---ccccccccccccccc-ccc-ccccccccccccccccccc-ccccc---ccc
Confidence 3455566666666666666532 211 122344445544444 233 2455666677777666655 23332 345
Q ss_pred CcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEcc
Q 001908 444 LVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQ 523 (997)
Q Consensus 444 L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 523 (997)
+..+.+.+|.+. ..+.... .+ ...++..|.+.+. +.. .......++..|.+.+ ++ ..+++|++|+|+
T Consensus 226 l~~~~~~~~~~~-~~~~~~~---~l-~~~~~~~~~~~~l-~~l---~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls 292 (353)
T d1jl5a_ 226 LEALNVRDNYLT-DLPELPQ---SL-TFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC---DLPPSLEELNVS 292 (353)
T ss_dssp CCEEECCSSCCS-CCCCCCT---TC-CEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC---CCCTTCCEEECC
T ss_pred cccccccccccc-ccccccc---cc-ccccccccccccc-ccc---cchhcccccccCcccc-cc---ccCCCCCEEECC
Confidence 666666666654 2222211 11 3334444433311 000 1223445555555542 22 234667777777
Q ss_pred CccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccCCC
Q 001908 524 GNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEVPT 581 (997)
Q Consensus 524 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 581 (997)
+|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.
T Consensus 293 ~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 293 NNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp SSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 77777 45533 456777777777776 45543 356777777777776 3443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=2e-19 Score=199.23 Aligned_cols=313 Identities=21% Similarity=0.281 Sum_probs=223.5
Q ss_pred hhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEecc
Q 001908 196 IIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLP 275 (997)
Q Consensus 196 ~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 275 (997)
+.+|+|++|.++ .+|+.+ ++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.- .++|++||++
T Consensus 40 l~~LdLs~~~L~-~lp~~~---~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp CSEEECTTSCCS-CCCSCC---TTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCEEEeCCCCCC-CCCCCC---CCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 347899999998 588753 57889999999998 88864 458999999999988 44432 2469999999
Q ss_pred CccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccC
Q 001908 276 INYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGV 355 (997)
Q Consensus 276 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~ 355 (997)
+|+++..+ .++.+++|+.|++++|.+...+. ....+..+.+..+.... +..+..+ +.++.+++++
T Consensus 107 ~n~l~~lp--~~~~l~~L~~L~l~~~~~~~~~~----------~~~~l~~l~~~~~~~~~--~~~l~~l-~~l~~L~l~~ 171 (353)
T d1jl5a_ 107 NNQLEKLP--ELQNSSFLKIIDVDNNSLKKLPD----------LPPSLEFIAAGNNQLEE--LPELQNL-PFLTAIYADN 171 (353)
T ss_dssp SSCCSSCC--CCTTCTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCSS--CCCCTTC-TTCCEEECCS
T ss_pred cccccccc--chhhhccceeecccccccccccc----------ccccccchhhccccccc--ccccccc-ccceeccccc
Confidence 99998654 36789999999999998876443 34567778877766653 3334444 5678889998
Q ss_pred cccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCC
Q 001908 356 NQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIP 435 (997)
Q Consensus 356 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 435 (997)
|.+... +.. ....+.+....+.+. .+| .+..++.|+.+++++|... .+|. ...++..+.+.+|++.. .+
T Consensus 172 n~~~~~-~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~-~~ 240 (353)
T d1jl5a_ 172 NSLKKL-PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTD-LP 240 (353)
T ss_dssp SCCSSC-CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSC-CC
T ss_pred cccccc-ccc---ccccccccccccccc-ccc-ccccccccccccccccccc-cccc---ccccccccccccccccc-cc
Confidence 887632 222 234566777777665 333 4677899999999999887 3443 34678889999999873 33
Q ss_pred CCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCc
Q 001908 436 PSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCT 515 (997)
Q Consensus 436 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 515 (997)
.. ...+...++..|.+.+ +..+.......++..|.+.+. ...+++|++|+|++|+|+ .+|.. ++
T Consensus 241 ~~---~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~ 304 (353)
T d1jl5a_ 241 EL---PQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PP 304 (353)
T ss_dssp CC---CTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CT
T ss_pred cc---cccccccccccccccc-----cccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cC
Confidence 33 3567778887777652 122222224566777766632 234678999999999998 67754 57
Q ss_pred CccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCC
Q 001908 516 GLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLS 571 (997)
Q Consensus 516 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 571 (997)
+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|... ..|+.|.+.
T Consensus 305 ~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 305 RLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp TCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred CCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence 8999999999998 67743 568999999999998 667543 356666653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=8.9e-22 Score=197.96 Aligned_cols=133 Identities=19% Similarity=0.186 Sum_probs=104.5
Q ss_pred CccCCcccccCcceEEEEEECCCCcEEEEEEecccc------------------hhhHHHHHHHHHHHhhcCCCCcceEE
Q 001908 681 FSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQ------------------KGALKSFVAECEVLRNTRHRNLIKII 742 (997)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~ 742 (997)
+.+.++||+|+||+||+|+.. +|+.||||+++... ........+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 346789999999999999986 78999999875211 11123456788899999999999888
Q ss_pred eeeeccCcCCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcEecCCCCCCee
Q 001908 743 TVCSSIDFKGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHCQPPIVHGDLKPSNVL 822 (997)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk~~NIl 822 (997)
++. ..+++|||+++..+.+ ++.....+++.|++.|++|||++ +|+||||||+|||
T Consensus 81 ~~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL 135 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 135 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred Eec---------CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence 652 2379999998755432 22234567899999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccchhc
Q 001908 823 LDHDMVAHVSDFGLARFL 840 (997)
Q Consensus 823 l~~~~~~kl~DFg~a~~~ 840 (997)
++++ .++++|||.|+..
T Consensus 136 v~~~-~~~liDFG~a~~~ 152 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEV 152 (191)
T ss_dssp EETT-EEEECCCTTCEET
T ss_pred eeCC-CEEEEECCCcccC
Confidence 9865 4899999999754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=4.6e-19 Score=183.39 Aligned_cols=206 Identities=26% Similarity=0.337 Sum_probs=164.5
Q ss_pred cccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 348 MTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 348 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
+..++++.+.+++.. .+..+.+|+.|++.+|+|+. ++ .+.++++|++|++++|++++..| +..+++|+.+++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 455677777777544 45678899999999999985 43 58899999999999999986544 88999999999999
Q ss_pred CcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccc
Q 001908 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 428 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
|.++. ++ .+..+++|+.+++++|...+..+ +.....+ +.+.++++.+.... .+...++|+.|++++|++++..
T Consensus 95 n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~-~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~ 167 (227)
T d1h6ua2 95 NPLKN-VS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNL-QVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT 167 (227)
T ss_dssp CCCSC-CG-GGTTCTTCCEEECTTSCCCCCGG--GTTCTTC-CEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG
T ss_pred ccccc-cc-cccccccccccccccccccccch--hccccch-hhhhchhhhhchhh--hhccccccccccccccccccch
Confidence 99883 43 57889999999999998764432 4444555 77888888887443 3677889999999999997433
Q ss_pred cccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCC
Q 001908 508 PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSY 572 (997)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 572 (997)
.+.++++|+.|+|++|++++ +| .++.+++|++|+|++|+|++. | .+.++++|+.|++++
T Consensus 168 --~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 168 --PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp --GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred --hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence 38899999999999999985 44 388999999999999999854 3 388999999999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.2e-18 Score=182.18 Aligned_cols=219 Identities=14% Similarity=0.029 Sum_probs=115.0
Q ss_pred ceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccCccCCCc-ccccccccCccCeeEcc
Q 001908 221 ENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPINYFTGK-VSIIFGRLKNLWSLDLG 299 (997)
Q Consensus 221 ~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls 299 (997)
+.++.+++.++ .+|..++ +++++|+|++|+|+...+.+|.++++|++|+|++|.+... .+..|.+++++++|++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 34555555555 5555443 3456666666666544444566666666666666665543 23455666666666554
Q ss_pred C-ccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCC-CCCEEec
Q 001908 300 I-NNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLV-NLNLLGI 377 (997)
Q Consensus 300 ~-N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L 377 (997)
. |++..... ..+.++++|++|++++|.+....+..+......+..+..+++.+....+..|.+++ .++.|++
T Consensus 87 ~~n~l~~~~~------~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l 160 (242)
T d1xwdc1 87 KANNLLYINP------EAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 160 (242)
T ss_dssp CCTTCCEECT------TSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred cccccccccc------ccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeec
Confidence 3 44443322 23455666666666666665333222222223344444455555544455555543 5666666
Q ss_pred cCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEec
Q 001908 378 EFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNL 449 (997)
Q Consensus 378 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 449 (997)
++|+++...+..|.....++.+++++|+|+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++
T Consensus 161 ~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 161 NKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 666666444433333222333355666666433445666666666666666666444445555555555444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=5.1e-19 Score=185.06 Aligned_cols=210 Identities=14% Similarity=0.076 Sum_probs=135.7
Q ss_pred cCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCC-CCCCCCCCCCcEEecc-CccCCCccccc
Q 001908 209 TVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSI-PESFSNASNIEIIDLP-INYFTGKVSII 286 (997)
Q Consensus 209 ~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls-~N~l~~~~~~~ 286 (997)
.+|..+. +++++|+|++|+++ .+|...|.++++|++|++++|.+...+ +.+|.+++++++|++. .|.+....+..
T Consensus 22 ~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~ 98 (242)
T d1xwdc1 22 EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEA 98 (242)
T ss_dssp SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTS
T ss_pred CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccc
Confidence 4554443 35667777777766 566666666777777777777666544 3456677777777654 35666666667
Q ss_pred ccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCC
Q 001908 287 FGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGI 366 (997)
Q Consensus 287 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~ 366 (997)
|.++++|++|++++|++...+.. ..+..+..++.+..+++.+....+..+..+...++.+++++|+++...+..|
T Consensus 99 ~~~l~~L~~l~l~~~~l~~~~~~-----~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~ 173 (242)
T d1xwdc1 99 FQNLPNLQYLLISNTGIKHLPDV-----HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF 173 (242)
T ss_dssp EECCTTCCEEEEESCCCCSCCCC-----TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT
T ss_pred ccccccccccccchhhhcccccc-----cccccccccccccccccccccccccccccccccceeeecccccccccccccc
Confidence 77777777777777776654321 2344556666666677777666666666665667777888888875444444
Q ss_pred CCCCCCC-EEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 367 GNLVNLN-LLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 367 ~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
. ..+++ .+++++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus 174 ~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 174 N-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp T-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred c-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 3 44443 445677778765556678888888888888888854455566666666665543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1e-18 Score=180.79 Aligned_cols=204 Identities=23% Similarity=0.329 Sum_probs=109.7
Q ss_pred hhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEecCCcCcCCCCCCCCCCCCCcEEeccC
Q 001908 197 IYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIGDNYFSGSIPESFSNASNIEIIDLPI 276 (997)
Q Consensus 197 ~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 276 (997)
..++++.+++++.+ .+..+++|+.|++++|.++ .++ .+ ..+++|++|++++|++++..| +..+++|+++++++
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l-~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GV-QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TG-GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hH-hcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 34567777776543 4455666777777777666 443 22 356666666666666654433 55666666666666
Q ss_pred ccCCCcccccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCc
Q 001908 277 NYFTGKVSIIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVN 356 (997)
Q Consensus 277 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N 356 (997)
|.++... .|.++++|++|+++.+..... ..+...+.++.+.++.+.+..
T Consensus 95 n~~~~i~--~l~~l~~L~~l~l~~~~~~~~--------~~~~~~~~~~~l~~~~~~~~~--------------------- 143 (227)
T d1h6ua2 95 NPLKNVS--AIAGLQSIKTLDLTSTQITDV--------TPLAGLSNLQVLYLDLNQITN--------------------- 143 (227)
T ss_dssp CCCSCCG--GGTTCTTCCEEECTTSCCCCC--------GGGTTCTTCCEEECCSSCCCC---------------------
T ss_pred ccccccc--ccccccccccccccccccccc--------chhccccchhhhhchhhhhch---------------------
Confidence 6555322 344555555555555544332 112333444444444444332
Q ss_pred ccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCC
Q 001908 357 QISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPP 436 (997)
Q Consensus 357 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 436 (997)
.. .+.+.++|+.|++++|.+++.. .++++++|++|+|++|++++ ++ .+.++++|++|+|++|+|++. +
T Consensus 144 ----~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i-~- 211 (227)
T d1h6ua2 144 ----IS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDV-S- 211 (227)
T ss_dssp ----CG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBC-G-
T ss_pred ----hh--hhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCC-c-
Confidence 11 2344555666666666655322 25556666666666666653 22 255666666666666666632 2
Q ss_pred CCCCCCCCcEEecC
Q 001908 437 SLGNCKNLVSLNLS 450 (997)
Q Consensus 437 ~~~~l~~L~~L~L~ 450 (997)
.+.++++|++|+++
T Consensus 212 ~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 212 PLANTSNLFIVTLT 225 (227)
T ss_dssp GGTTCTTCCEEEEE
T ss_pred ccccCCCCCEEEee
Confidence 25566666666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=3.3e-21 Score=221.87 Aligned_cols=183 Identities=21% Similarity=0.158 Sum_probs=79.1
Q ss_pred ccccceeccccccccc-----cchhhhcCCCCCCeEEeecCcCCCCC----CCCCCCCCCCcEEecCCCcccCCcccccc
Q 001908 393 LRNLQAIGLSSNFLQG-----NIPSSLGNLTLMTDLFLSSNHLQGNI----PPSLGNCKNLVSLNLSDNKLIGAVPQQIL 463 (997)
Q Consensus 393 l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 463 (997)
.+.++.+++++|++.. ..+........++.|++++|.+.... ...+...+.++.+++++|.+.......+.
T Consensus 225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~ 304 (460)
T d1z7xw1 225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 304 (460)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 3445555555554431 12223333445555555555554211 11223345555555555555322111111
Q ss_pred ----c-ccccccccccCCCcccCCCcccc----ccccccceecccccccccc----cccccc-CCcCccEEEccCccccc
Q 001908 464 ----T-ITTLSRFLDLGNNHLNGSLPLEV----GNLKNLVALYISGNQFSGE----IPVTLT-GCTGLEIFHMQGNSFRG 529 (997)
Q Consensus 464 ----~-l~~ll~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~ 529 (997)
. ...+ +.+++++|.++......+ ...++|++|+|++|++++. ++..+. ..+.|++|+|++|+|+.
T Consensus 305 ~~l~~~~~~L-~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 305 ETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp HHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred cccccccccc-ccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 1 1122 455555555543322222 2233555555555555432 222222 23445555555555542
Q ss_pred c----CChhccccCcCCeeeCccccccccCchhc----c-CCCCCCEEeCCCCcCc
Q 001908 530 S----IPLSLRSLKSIKELDLSCNNLSGQIPEFL----E-NLSFLEYLNLSYNHFD 576 (997)
Q Consensus 530 ~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~ls~N~l~ 576 (997)
. ++..+...++|++|||++|+|+......+ . +-..|+.|++++|.+.
T Consensus 384 ~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 384 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 1 23334444555555555555543222222 1 2224555555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.8e-21 Score=224.19 Aligned_cols=354 Identities=15% Similarity=0.143 Sum_probs=216.8
Q ss_pred CcccCCCccceeeccCCCCCC----CCCccccccCCCccEEEecCCcCcCC----CCCCCCCCCCCcEEeccCccCCCcc
Q 001908 212 PSLYNMSSLENILLDVNGFTG----NLPLDIGVTLPNLQVFAIGDNYFSGS----IPESFSNASNIEIIDLPINYFTGKV 283 (997)
Q Consensus 212 ~~l~~l~~L~~L~L~~N~l~g----~lp~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 283 (997)
..+..+++|++|||++|+|+. .+...+.....+|+.|+|++|++++. ++..+..+++|++|+|++|.++...
T Consensus 49 ~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~ 128 (460)
T d1z7xw1 49 SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAG 128 (460)
T ss_dssp HHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHH
T ss_pred HHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhh
Confidence 345556677777777776641 11111222234677888888877643 4566777888888888888876543
Q ss_pred ccccc-----ccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCC----ccccccccccccccccc
Q 001908 284 SIIFG-----RLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVL----PHSIANLSTTMTDIYMG 354 (997)
Q Consensus 284 ~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~~L~~L~l~ 354 (997)
...+. ..............+.... .......+.....++.++++++...... ...+.........+.+.
T Consensus 129 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~ 206 (460)
T d1z7xw1 129 LQLLCEGLLDPQCRLEKLQLEYCSLSAAS--CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE 206 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGG--HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECT
T ss_pred hhhhhhcccccccccccccccccccchhh--hcccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22221 1122233333333322110 0112334566778888888877654211 11111111234445555
Q ss_pred Ccccccc----cCCCCCCCCCCCEEeccCCCCCC-----CCCCCcccccccceecccccccccc----chhhhcCCCCCC
Q 001908 355 VNQISGT----IPSGIGNLVNLNLLGIEFNQLTG-----NIPREIGQLRNLQAIGLSSNFLQGN----IPSSLGNLTLMT 421 (997)
Q Consensus 355 ~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~ 421 (997)
.+.+... ....+...+.++.+++++|++.. ..+..+.....|+.|++++|.+... ....+...+.++
T Consensus 207 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~ 286 (460)
T d1z7xw1 207 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK 286 (460)
T ss_dssp TSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCC
T ss_pred cccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccc
Confidence 5554321 11223456788999999998742 1223344567899999999988743 334556788999
Q ss_pred eEEeecCcCCCCCCCC-----CCCCCCCcEEecCCCcccCCcccccc----cccccccccccCCCcccCC----Cccccc
Q 001908 422 DLFLSSNHLQGNIPPS-----LGNCKNLVSLNLSDNKLIGAVPQQIL----TITTLSRFLDLGNNHLNGS----LPLEVG 488 (997)
Q Consensus 422 ~L~Ls~N~l~~~~p~~-----~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~ll~~L~Ls~N~l~~~----~p~~~~ 488 (997)
.+++++|.++...... ......|+.+++++|.++......+. ...++ +.|+|++|+++.. ++..+.
T Consensus 287 ~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L-~~L~Ls~N~i~~~g~~~l~~~l~ 365 (460)
T d1z7xw1 287 ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL-LELQISNNRLEDAGVRELCQGLG 365 (460)
T ss_dssp EEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC-CEEECCSSBCHHHHHHHHHHHHT
T ss_pred ccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccch-hhhheeeecccCcccchhhhhhh
Confidence 9999999886321111 12346799999999998755433333 33456 8999999998743 233333
Q ss_pred -cccccceecccccccccc----ccccccCCcCccEEEccCccccccCChhcc-----ccCcCCeeeCccccccccCchh
Q 001908 489 -NLKNLVALYISGNQFSGE----IPVTLTGCTGLEIFHMQGNSFRGSIPLSLR-----SLKSIKELDLSCNNLSGQIPEF 558 (997)
Q Consensus 489 -~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~ 558 (997)
..+.|++|+|++|.|+.. ++..+..+++|++|+|++|+|+......+. +...|+.|++++|.+....+..
T Consensus 366 ~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~ 445 (460)
T d1z7xw1 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445 (460)
T ss_dssp STTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred cccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHH
Confidence 456799999999999853 455677889999999999999864444432 3347999999999998655554
Q ss_pred c----cCCCCCCEE
Q 001908 559 L----ENLSFLEYL 568 (997)
Q Consensus 559 ~----~~l~~L~~L 568 (997)
+ ...++|+.|
T Consensus 446 l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 446 LQALEKDKPSLRVI 459 (460)
T ss_dssp HHHHHHHCTTSEEE
T ss_pred HHHHHHhCCCCEEe
Confidence 4 344566554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=9.9e-19 Score=175.52 Aligned_cols=134 Identities=21% Similarity=0.272 Sum_probs=60.0
Q ss_pred CCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCcc
Q 001908 439 GNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLE 518 (997)
Q Consensus 439 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 518 (997)
.++++|++|+|++|++.+..+..+..++.+ ++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+
T Consensus 51 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L-~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~ 129 (192)
T d1w8aa_ 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHI-QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCTTTTTTCTTC-CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred CCCceEeeeecccccccccccccccccccc-ceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccc
Confidence 334444444444444333333333333333 3333333333333444455555555555555555555555555555555
Q ss_pred EEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcc
Q 001908 519 IFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 519 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 577 (997)
+|+|++|.+....+..+ -...++.+.+..|.++...|..+ ..++.++|+.|.|++
T Consensus 130 ~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 130 SLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp EEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred cccccccccccccchHH-HhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence 55555555553222111 11234444555555554444332 233444555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2.3e-18 Score=172.80 Aligned_cols=177 Identities=20% Similarity=0.218 Sum_probs=143.1
Q ss_pred CeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCc-ccccccccccccccccCCCcccCCCccccccccccceeccc
Q 001908 421 TDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAV-PQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYIS 499 (997)
Q Consensus 421 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 499 (997)
+.++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|..+++| +.|+|++|++++..+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L-~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHL-VKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTC-CEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceE-eeeeccccccccccccccccccccceeeec
Confidence 57888888888 5776653 68899999999998655 4456778888 899999999998889999999999999999
Q ss_pred cccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCCCcCcccC
Q 001908 500 GNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSYNHFDGEV 579 (997)
Q Consensus 500 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 579 (997)
+|+|++..|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+....+... -...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCC
Confidence 999998888889999999999999999998888889999999999999999976443221 1234666778888888877
Q ss_pred CCCCcCCCCcceeecCCCCcCCCCC
Q 001908 580 PTKGVFSNKTRVQLTGNGKLCGGSN 604 (997)
Q Consensus 580 p~~~~~~~~~~~~~~~N~~~C~~~~ 604 (997)
|.. +.+....++..|...|.+..
T Consensus 166 p~~--l~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 166 PSK--VRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp STT--TTTSBGGGSCTTTCCCCCC-
T ss_pred Chh--hcCCEeeecCHhhCcCCCCC
Confidence 754 66777788888888886543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=6.2e-18 Score=172.19 Aligned_cols=182 Identities=24% Similarity=0.313 Sum_probs=111.9
Q ss_pred cccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCc
Q 001908 350 DIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNH 429 (997)
Q Consensus 350 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 429 (997)
...++.+.+++.++. ..+.+|+.|++++|.++... .+..+++|++|+|++|+|++. + .++++++|+.|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccc
Confidence 345566666554442 34567777777777776432 366677777777777777753 3 25677777777777777
Q ss_pred CCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccc
Q 001908 430 LQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPV 509 (997)
Q Consensus 430 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 509 (997)
|++ +| .+.++++|+.|++++|.+. .+ ..+..+++|+.+++++|.+++ +.
T Consensus 102 i~~-l~-~l~~l~~L~~L~l~~~~~~-~~--------------------------~~l~~l~~l~~l~~~~n~l~~--~~ 150 (210)
T d1h6ta2 102 VKD-LS-SLKDLKKLKSLSLEHNGIS-DI--------------------------NGLVHLPQLESLYLGNNKITD--IT 150 (210)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCC-CC--------------------------GGGGGCTTCCEEECCSSCCCC--CG
T ss_pred ccc-cc-ccccccccccccccccccc-cc--------------------------ccccccccccccccccccccc--cc
Confidence 763 33 3666777777777776654 11 124445556666666666652 22
Q ss_pred cccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEEeCCC
Q 001908 510 TLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYLNLSY 572 (997)
Q Consensus 510 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 572 (997)
.+..+++|+.+++++|++++. + .++++++|+.|+|++|+|+. +| .+.++++|++|+|++
T Consensus 151 ~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 151 VLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 455566666666666666642 2 26666777777777777663 33 466677777777653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=8e-18 Score=171.38 Aligned_cols=181 Identities=22% Similarity=0.301 Sum_probs=124.0
Q ss_pred eccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCc
Q 001908 399 IGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNH 478 (997)
Q Consensus 399 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~ 478 (997)
..++.+.+++.++. ..+.+|+.|++++|.++. ++ .+..+++|++|+|++|++++ ++ .+..++++ ++|++++|+
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L-~~L~l~~n~ 101 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNL-GWLFLDENK 101 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTC-CEEECCSSC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccc-ccccccccc
Confidence 34444444433332 123445555555555553 22 24455555555555555553 22 23445555 556666666
Q ss_pred ccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchh
Q 001908 479 LNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEF 558 (997)
Q Consensus 479 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 558 (997)
+++ +| .+..+++|+.|++++|.+. .+ ..+..++.|+.+++++|.+++ +..+..+++|+.+++++|++++. + .
T Consensus 102 i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~ 173 (210)
T d1h6ta2 102 VKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-P 173 (210)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-G
T ss_pred ccc-cc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-c
Confidence 653 34 4778899999999999987 33 468899999999999999984 34678899999999999999864 3 3
Q ss_pred ccCCCCCCEEeCCCCcCcccCCCCCcCCCCcceeecC
Q 001908 559 LENLSFLEYLNLSYNHFDGEVPTKGVFSNKTRVQLTG 595 (997)
Q Consensus 559 ~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~ 595 (997)
+.++++|++|+|++|+++. +|....+++++.+++.+
T Consensus 174 l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 8999999999999999985 55556677888887754
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.9e-17 Score=165.72 Aligned_cols=180 Identities=29% Similarity=0.427 Sum_probs=113.9
Q ss_pred cccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 348 MTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 348 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
.....++.+.+++.++ ...+.+++.|++++|.++.. +.+..+++|++|+|++|++++..| ++++++|+.|++++
T Consensus 20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~ 93 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 93 (199)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccc
Confidence 3445667777765443 24567777888888877742 246667777777777777775332 67777777777777
Q ss_pred CcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccc
Q 001908 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEI 507 (997)
Q Consensus 428 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (997)
|.+.. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++. .+
T Consensus 94 n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~---------------------------~~~~~l~~L~~L~l~~n~l~-~~ 143 (199)
T d2omxa2 94 NQIAD-IT-PLANLTNLTGLTLFNNQITDI---------------------------DPLKNLTNLNRLELSSNTIS-DI 143 (199)
T ss_dssp SCCCC-CG-GGTTCTTCSEEECCSSCCCCC---------------------------GGGTTCTTCSEEECCSSCCC-CC
T ss_pred ccccc-cc-ccccccccccccccccccccc---------------------------cccchhhhhHHhhhhhhhhc-cc
Confidence 77763 33 366667777777766665421 12344566666777777665 23
Q ss_pred cccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCchhccCCCCCCEE
Q 001908 508 PVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPEFLENLSFLEYL 568 (997)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 568 (997)
+ .+..+++|+.|++++|++++. + .++++++|+.|++++|+++. +| .++.+++|++|
T Consensus 144 ~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 144 S-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp G-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred c-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 3 466667777777777777643 2 36677777777777777764 33 46667776654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.4e-17 Score=165.12 Aligned_cols=167 Identities=28% Similarity=0.360 Sum_probs=118.7
Q ss_pred CCcEEEeecCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCcccccccceecc
Q 001908 322 KLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREIGQLRNLQAIGL 401 (997)
Q Consensus 322 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 401 (997)
+...+.++.+.+++.++. ..+ ..++.|++++|.|+. + +.+..+++|++|++++|++++..| ++++++|++|++
T Consensus 19 ~~i~~~l~~~~~~~~~~~--~~l-~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l 91 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVSQ--TDL-DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHTTCSSTTSEECH--HHH-TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHhCCCCCCCccCH--HHh-cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence 334456777888765543 233 578999999999984 3 458899999999999999997544 899999999999
Q ss_pred ccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccC
Q 001908 402 SSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNG 481 (997)
Q Consensus 402 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~ 481 (997)
++|.+.. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++. .+| .+..++++ +.|++++|++++
T Consensus 92 ~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L-~~L~l~~n~l~~ 164 (199)
T d2omxa2 92 NNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSL-QQLNFSSNQVTD 164 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTC-SEEECCSSCCCC
T ss_pred ccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccc-cccccccccccC
Confidence 9999984 44 489999999999999999853 34788999999999999875 232 34444444 445555554442
Q ss_pred CCccccccccccceecccccccc
Q 001908 482 SLPLEVGNLKNLVALYISGNQFS 504 (997)
Q Consensus 482 ~~p~~~~~l~~L~~L~Ls~N~l~ 504 (997)
. + .++++++|++|++++|+++
T Consensus 165 l-~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 165 L-K-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp C-G-GGTTCTTCCEEECCSSCCC
T ss_pred C-c-cccCCCCCCEEECCCCCCC
Confidence 2 1 1344444444444444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.3e-16 Score=166.30 Aligned_cols=254 Identities=14% Similarity=0.140 Sum_probs=138.2
Q ss_pred eeecccccccCcCcCccCcc---hhhhhhccCccccccCCCcccCCCccceeeccCCCCCCCCCccccccCCCccEEEec
Q 001908 175 HISLARNHLTGMLPASIGNL---SIIYLHVGENQFSGTVPPSLYNMSSLENILLDVNGFTGNLPLDIGVTLPNLQVFAIG 251 (997)
Q Consensus 175 ~L~L~~N~l~g~~p~~~~~l---~~~~L~l~~N~l~g~ip~~l~~l~~L~~L~L~~N~l~g~lp~~~~~~l~~L~~L~L~ 251 (997)
.|||+++.+.. +.++.+ ....+.++.......+ .......+|++|||+++.+++.....++..+++|++|+|+
T Consensus 4 ~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 4 TLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp EEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred EEECCCCCCCc---hHHHHHHhccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 67777776652 222222 1122334444443222 2334456778888887777654444556677777777777
Q ss_pred CCcCcCCCCCCCCCCCCCcEEeccCc-cCCCc-ccccccccCccCeeEccCc-cCCCCCCCCcchhhhhc-cCCCCcEEE
Q 001908 252 DNYFSGSIPESFSNASNIEIIDLPIN-YFTGK-VSIIFGRLKNLWSLDLGIN-NLGSGGANDLDFVTILT-NCSKLKVLA 327 (997)
Q Consensus 252 ~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~l~-~l~~L~~L~ 327 (997)
+|.+++..+..++.+++|++|+|+++ .++.. ....+..+++|++|+++++ +++.. .....+. .+++|+.|+
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~-----~~~~~~~~~~~~L~~L~ 154 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-----HVQVAVAHVSETITQLN 154 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-----HHHHHHHHSCTTCCEEE
T ss_pred ccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccc-----cchhhhcccccccchhh
Confidence 77777766777777777777777773 55532 2223455677777777663 33210 1111222 235666666
Q ss_pred eecCccCCCCcccccccccccccccccCcccccc-cCCCCCCCCCCCEEeccCC-CCCCCCCCCcccccccceecccc-c
Q 001908 328 FEENRLGGVLPHSIANLSTTMTDIYMGVNQISGT-IPSGIGNLVNLNLLGIEFN-QLTGNIPREIGQLRNLQAIGLSS-N 404 (997)
Q Consensus 328 L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N 404 (997)
++++.. .++.. +...+.++++|++|++++| .+++.....+.++++|++|+|++ +
T Consensus 155 l~~~~~-----------------------~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~ 211 (284)
T d2astb2 155 LSGYRK-----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211 (284)
T ss_dssp CCSCGG-----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred hccccc-----------------------ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCC
Confidence 654321 11111 1111234566777777664 45655666666777777777777 3
Q ss_pred cccccchhhhcCCCCCCeEEeecCcCCC-CCCCCCCCCCCCcEEecCCCcccCCccccccc
Q 001908 405 FLQGNIPSSLGNLTLMTDLFLSSNHLQG-NIPPSLGNCKNLVSLNLSDNKLIGAVPQQILT 464 (997)
Q Consensus 405 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 464 (997)
.+++.....++++++|+.|+++++ ++. .++.....+++| .+..++++...++.++.
T Consensus 212 ~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 212 DIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTIARPTIGN 268 (284)
T ss_dssp TCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCTTCSSCSS
T ss_pred CCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCCCCCccCc
Confidence 566555566677777777777665 221 111111223333 34566666555544443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.48 E-value=1.5e-15 Score=167.32 Aligned_cols=256 Identities=14% Similarity=0.154 Sum_probs=145.1
Q ss_pred ccccccCccCeeEccCccCCCCCCCCcchhhhhccCCCCcEEEeecCccCCCCcccccccccccccccccCcccccccCC
Q 001908 285 IIFGRLKNLWSLDLGINNLGSGGANDLDFVTILTNCSKLKVLAFEENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPS 364 (997)
Q Consensus 285 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~ 364 (997)
..+....+|+.|+|++|.|...+.. .+...+...++|+.|+++++............ . ..+..
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~--~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~----~-----------~~l~~ 87 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAAR--WLSENIASKKDLEIAEFSDIFTGRVKDEIPEA----L-----------RLLLQ 87 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHH--HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHH----H-----------HHHHH
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHH--HHHHHHHhCCCCCEEECCCCcccccccccchH----H-----------HHHHH
Confidence 3456677788888888877542211 12345666777777777776554211110000 0 01223
Q ss_pred CCCCCCCCCEEeccCCCCCCCC----CCCcccccccceeccccccccccchhh-------------hcCCCCCCeEEeec
Q 001908 365 GIGNLVNLNLLGIEFNQLTGNI----PREIGQLRNLQAIGLSSNFLQGNIPSS-------------LGNLTLMTDLFLSS 427 (997)
Q Consensus 365 ~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~Ls~ 427 (997)
.+...++|+.|+|++|.++... ...+...++|++|++++|.+...-... ....+.|+.+++++
T Consensus 88 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~ 167 (344)
T d2ca6a1 88 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 167 (344)
T ss_dssp HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred HHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccc
Confidence 3445677888888888776532 223345567777777777764221111 12345566666666
Q ss_pred CcCCCC----CCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccc
Q 001908 428 NHLQGN----IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQF 503 (997)
Q Consensus 428 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 503 (997)
|+++.. +...+...+.|++|+|++|++... .+. ..+...+...++|+.|+|++|.+
T Consensus 168 n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~---g~~-----------------~~l~~~l~~~~~L~~L~Ls~N~i 227 (344)
T d2ca6a1 168 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE---GIE-----------------HLLLEGLAYCQELKVLDLQDNTF 227 (344)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH---HHH-----------------HHHHTTGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccchhhhhhhhccccccccccccc---ccc-----------------cchhhhhcchhhhcccccccccc
Confidence 655421 111223344555555555554311 000 01223345667788888888887
Q ss_pred ccc----ccccccCCcCccEEEccCccccccCChhc----cc--cCcCCeeeCcccccccc----Cchhcc-CCCCCCEE
Q 001908 504 SGE----IPVTLTGCTGLEIFHMQGNSFRGSIPLSL----RS--LKSIKELDLSCNNLSGQ----IPEFLE-NLSFLEYL 568 (997)
Q Consensus 504 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L 568 (997)
+.. +...+..+++|++|+|++|.|++.....+ .. .+.|++||+++|+|+.. +...+. +.+.|+.|
T Consensus 228 ~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L 307 (344)
T d2ca6a1 228 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307 (344)
T ss_dssp HHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEE
T ss_pred cccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEE
Confidence 533 34556778888888888888875433333 22 35788899999888642 233342 56788899
Q ss_pred eCCCCcCcc
Q 001908 569 NLSYNHFDG 577 (997)
Q Consensus 569 ~ls~N~l~~ 577 (997)
+|++|++..
T Consensus 308 ~l~~N~~~~ 316 (344)
T d2ca6a1 308 ELNGNRFSE 316 (344)
T ss_dssp ECTTSBSCT
T ss_pred ECCCCcCCC
Confidence 999998864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=4.4e-14 Score=129.55 Aligned_cols=104 Identities=26% Similarity=0.332 Sum_probs=74.3
Q ss_pred cccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
++|+|++|+++ .++ .+..+++|++||+++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 35677777776 444 3677777788888888777 566677777788888888888773 44 4777788888888888
Q ss_pred cccccCc-hhccCCCCCCEEeCCCCcCccc
Q 001908 550 NLSGQIP-EFLENLSFLEYLNLSYNHFDGE 578 (997)
Q Consensus 550 ~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~ 578 (997)
+|+.... ..+..+++|++|++++|+++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 8774432 4677777888888888887753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=4.9e-15 Score=157.92 Aligned_cols=182 Identities=19% Similarity=0.175 Sum_probs=105.4
Q ss_pred CCCCCCEEeccCCCCCCC-CCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecC-cCCCC-CCCCCCCCCCC
Q 001908 368 NLVNLNLLGIEFNQLTGN-IPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSN-HLQGN-IPPSLGNCKNL 444 (997)
Q Consensus 368 ~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L 444 (997)
...+|++|+++++.++.. ++..+.++++|++|+|+++.+++..+..++.+++|++|+|+++ .++.. +...+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 445778888887777643 2344667778888888888877777777777888888888774 45421 11223456778
Q ss_pred cEEecCCCc-ccCC-cccccccccccccccccCCC--cccCC-Cccccccccccceeccccc-cccccccccccCCcCcc
Q 001908 445 VSLNLSDNK-LIGA-VPQQILTITTLSRFLDLGNN--HLNGS-LPLEVGNLKNLVALYISGN-QFSGEIPVTLTGCTGLE 518 (997)
Q Consensus 445 ~~L~L~~N~-l~~~-~p~~~~~l~~ll~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~ 518 (997)
++|+++++. ++.. ++..+......++.|+++++ .++.. +...+.++++|++|++++| .+++.....+.++++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 888887753 3211 11222222222255666543 22211 1222334566666666654 35555555666666666
Q ss_pred EEEccCc-cccccCChhccccCcCCeeeCccc
Q 001908 519 IFHMQGN-SFRGSIPLSLRSLKSIKELDLSCN 549 (997)
Q Consensus 519 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 549 (997)
+|+|+++ .+++.....++++++|+.|+++++
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 6666663 455555555666666666666655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=9.7e-14 Score=127.20 Aligned_cols=117 Identities=22% Similarity=0.290 Sum_probs=67.1
Q ss_pred EEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceeccccccccccccccccCCcCccEEEccCc
Q 001908 446 SLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVTLTGCTGLEIFHMQGN 525 (997)
Q Consensus 446 ~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 525 (997)
+|+|++|+++ .++ .+..+..+ ++|++++|+|+ .+|..|+.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L-~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLV-THLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTC-CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCC-CEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 4444555444 232 24444444 45555555554 34555666666777777777776 334 3667777777777777
Q ss_pred cccccC-ChhccccCcCCeeeCcccccccc---CchhccCCCCCCEE
Q 001908 526 SFRGSI-PLSLRSLKSIKELDLSCNNLSGQ---IPEFLENLSFLEYL 568 (997)
Q Consensus 526 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L 568 (997)
+|+... ...+..+++|+.|++++|+++.. .......+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 776432 24567777777777777777632 12234445666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.7e-14 Score=136.82 Aligned_cols=128 Identities=17% Similarity=0.112 Sum_probs=73.1
Q ss_pred hcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCcccccccccc
Q 001908 414 LGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNL 493 (997)
Q Consensus 414 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L 493 (997)
+.+..+|+.|+|++|+|+ .++..+..+++|+.|+|++|+++ .++ .|..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~--------------------------~~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD--------------------------GFPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC--------------------------CCCCCSSC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC--------------------------CcccCcch
Confidence 556666777777777776 34555566666777777777665 221 23445556
Q ss_pred ceeccccccccccccccccCCcCccEEEccCccccccCC-hhccccCcCCeeeCccccccccC---chhccCCCCCCEEe
Q 001908 494 VALYISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP-LSLRSLKSIKELDLSCNNLSGQI---PEFLENLSFLEYLN 569 (997)
Q Consensus 494 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 569 (997)
++|++++|+++...+..+..+++|+.|++++|+++.... ..+..+++|+.|++++|.++... +..+..+++|++||
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666666654333344556666666666666653211 34556666666666666665321 12455666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.3e-14 Score=137.21 Aligned_cols=127 Identities=13% Similarity=0.197 Sum_probs=88.2
Q ss_pred CcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCccccccccccc
Q 001908 389 EIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTL 468 (997)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l 468 (997)
.|.+..+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+. ++ .|..+++|++|++++|+++ .+|..+
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~-~l~~~~------ 82 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRIC-RIGEGL------ 82 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCC-EECSCH------
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhccccccc-CCCccc------
Confidence 4667888999999999999 567777889999999999999994 44 5888999999999999987 333222
Q ss_pred ccccccCCCcccCCCccccccccccceecccccccccccc--ccccCCcCccEEEccCccccccCC----hhccccCcCC
Q 001908 469 SRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIP--VTLTGCTGLEIFHMQGNSFRGSIP----LSLRSLKSIK 542 (997)
Q Consensus 469 l~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~ 542 (997)
+..+++|+.|++++|+++. ++ ..+..+++|+.|++++|.++. .| ..+..+++|+
T Consensus 83 ------------------~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~ 142 (162)
T d1a9na_ 83 ------------------DQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVR 142 (162)
T ss_dssp ------------------HHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCS
T ss_pred ------------------cccccccccceeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcC
Confidence 2334445555555555542 22 245556666666666666652 33 2466677777
Q ss_pred eee
Q 001908 543 ELD 545 (997)
Q Consensus 543 ~L~ 545 (997)
.||
T Consensus 143 ~LD 145 (162)
T d1a9na_ 143 VLD 145 (162)
T ss_dssp EET
T ss_pred eeC
Confidence 776
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=1.8e-15 Score=166.62 Aligned_cols=253 Identities=18% Similarity=0.197 Sum_probs=166.5
Q ss_pred CCCCCCCCCCCCcEEeccCccCCCcc----cccccccCccCeeEccCccCCCCCCCC----cchhhhhccCCCCcEEEee
Q 001908 258 SIPESFSNASNIEIIDLPINYFTGKV----SIIFGRLKNLWSLDLGINNLGSGGAND----LDFVTILTNCSKLKVLAFE 329 (997)
Q Consensus 258 ~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~~~l~~l~~L~~L~L~ 329 (997)
.+..++.+.++|+.|+|++|.|+... ...+...++|+.|+++++......... ..+...+..+++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 45566788899999999999987543 344667899999999988765433211 1234556778899999999
Q ss_pred cCccCCCCcccccccccccccccccCcccccccCCCCCCCCCCCEEeccCCCCCCCCCCCc-------------cccccc
Q 001908 330 ENRLGGVLPHSIANLSTTMTDIYMGVNQISGTIPSGIGNLVNLNLLGIEFNQLTGNIPREI-------------GQLRNL 396 (997)
Q Consensus 330 ~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-------------~~l~~L 396 (997)
+|.++..-...+ ...+...++|+.|++++|.++......+ ...+.|
T Consensus 102 ~n~i~~~~~~~l---------------------~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L 160 (344)
T d2ca6a1 102 DNAFGPTAQEPL---------------------IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL 160 (344)
T ss_dssp SCCCCTTTHHHH---------------------HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred ccccccccccch---------------------hhhhcccccchheecccccccccccccccccccccccccccccCccc
Confidence 998874322222 1223346789999999998852211111 235679
Q ss_pred ceecccccccccc----chhhhcCCCCCCeEEeecCcCCCC-----CCCCCCCCCCCcEEecCCCcccCCcccccccccc
Q 001908 397 QAIGLSSNFLQGN----IPSSLGNLTLMTDLFLSSNHLQGN-----IPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITT 467 (997)
Q Consensus 397 ~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 467 (997)
+.+++++|+++.. +...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++......
T Consensus 161 ~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~------ 234 (344)
T d2ca6a1 161 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA------ 234 (344)
T ss_dssp CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH------
T ss_pred ceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc------
Confidence 9999999998743 444567789999999999998732 3455777889999999999875221111
Q ss_pred cccccccCCCcccCCCccccccccccceecccccccccccccc----ccC--CcCccEEEccCcccccc----CChhcc-
Q 001908 468 LSRFLDLGNNHLNGSLPLEVGNLKNLVALYISGNQFSGEIPVT----LTG--CTGLEIFHMQGNSFRGS----IPLSLR- 536 (997)
Q Consensus 468 ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~--l~~L~~L~Ls~N~l~~~----~p~~~~- 536 (997)
+...+...++|++|+|++|.|++.-... +.. ...|+.|++++|+|+.. +...+.
T Consensus 235 ---------------L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~ 299 (344)
T d2ca6a1 235 ---------------LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299 (344)
T ss_dssp ---------------HHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHH
T ss_pred ---------------ccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHc
Confidence 1122334456666666666665432222 222 35677777777777532 223332
Q ss_pred ccCcCCeeeCcccccc
Q 001908 537 SLKSIKELDLSCNNLS 552 (997)
Q Consensus 537 ~l~~L~~L~Ls~N~l~ 552 (997)
++++|+.|+|++|++.
T Consensus 300 ~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 300 KMPDLLFLELNGNRFS 315 (344)
T ss_dssp HCTTCCEEECTTSBSC
T ss_pred cCCCCCEEECCCCcCC
Confidence 4567888888888875
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=3e-14 Score=142.55 Aligned_cols=115 Identities=27% Similarity=0.328 Sum_probs=66.8
Q ss_pred cchhhhcCCCCCCeEEeecCcCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccc
Q 001908 409 NIPSSLGNLTLMTDLFLSSNHLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVG 488 (997)
Q Consensus 409 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~ 488 (997)
.+|..+..+++|++|+|++|+|+. ++ .|.++++|++|+|++|+++ .+|.....++.+ +.|++++|+++. ++ .+.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L-~~L~l~~N~i~~-l~-~~~ 112 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL-EELWISYNQIAS-LS-GIE 112 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHC-CEEECSEEECCC-HH-HHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccc-cccccccccccc-cc-ccc
Confidence 345566667777777777777763 33 3666777777777777765 444333333344 556666666552 22 355
Q ss_pred cccccceecccccccccccc-ccccCCcCccEEEccCccccc
Q 001908 489 NLKNLVALYISGNQFSGEIP-VTLTGCTGLEIFHMQGNSFRG 529 (997)
Q Consensus 489 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 529 (997)
.+++|+.|++++|+++.... ..+..+++|+.|+|++|++..
T Consensus 113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 56666666666666652211 345566666666666666553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=2.1e-12 Score=123.41 Aligned_cols=106 Identities=20% Similarity=0.132 Sum_probs=70.4
Q ss_pred cccccCCCcccCCCccccccccccceeccccc-cccccccccccCCcCccEEEccCccccccCChhccccCcCCeeeCcc
Q 001908 470 RFLDLGNNHLNGSLPLEVGNLKNLVALYISGN-QFSGEIPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSC 548 (997)
Q Consensus 470 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 548 (997)
+.++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|++|||++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 45666777766 45666777777777777655 36655556677777777777777777766666777777777777777
Q ss_pred ccccccCchhccCCCCCCEEeCCCCcCcc
Q 001908 549 NNLSGQIPEFLENLSFLEYLNLSYNHFDG 577 (997)
Q Consensus 549 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 577 (997)
|+|+...+..|.. ..|+.|+|++|+|.+
T Consensus 90 N~l~~l~~~~~~~-~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 90 NALESLSWKTVQG-LSLQELVLSGNPLHC 117 (156)
T ss_dssp SCCSCCCSTTTCS-CCCCEEECCSSCCCC
T ss_pred CCCcccChhhhcc-ccccccccCCCcccC
Confidence 7777444444443 357777777777654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=3e-14 Score=142.50 Aligned_cols=127 Identities=22% Similarity=0.281 Sum_probs=72.1
Q ss_pred CCeEEeecC--cCCCCCCCCCCCCCCCcEEecCCCcccCCcccccccccccccccccCCCcccCCCccccccccccceec
Q 001908 420 MTDLFLSSN--HLQGNIPPSLGNCKNLVSLNLSDNKLIGAVPQQILTITTLSRFLDLGNNHLNGSLPLEVGNLKNLVALY 497 (997)
Q Consensus 420 L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 497 (997)
++.++++++ .++ .+|..+..+++|++|+|++|+++ .++ .+..+++| +.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L-~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENL-RILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTC-CEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccc-cChhhcccccc-cccccccccccccccc
Confidence 444555443 232 34455666777777777777766 343 35556665 66666666665 4444444455666666
Q ss_pred cccccccccccccccCCcCccEEEccCccccccCC-hhccccCcCCeeeCccccccc
Q 001908 498 ISGNQFSGEIPVTLTGCTGLEIFHMQGNSFRGSIP-LSLRSLKSIKELDLSCNNLSG 553 (997)
Q Consensus 498 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 553 (997)
+++|+++. ++ .+..+++|+.|++++|+|+.... ..+..+++|+.|+|++|.+..
T Consensus 100 l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 100 ISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CSEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccc-cc-cccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 66666652 22 35556666666666666653221 345566666666666666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=9.2e-12 Score=118.85 Aligned_cols=105 Identities=21% Similarity=0.122 Sum_probs=70.0
Q ss_pred ccccccCcccccccCCCCCCCCCCCEEeccCC-CCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeec
Q 001908 349 TDIYMGVNQISGTIPSGIGNLVNLNLLGIEFN-QLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSS 427 (997)
Q Consensus 349 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 427 (997)
+.++.+++.+. ..|..+..+++|+.|++++| .|+.+.+.+|.++++|+.|+|++|+|+...|..|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 44566666665 45666777777777777655 36665566677777777777777777766666777777777777777
Q ss_pred CcCCCCCCCCCCCCCCCcEEecCCCccc
Q 001908 428 NHLQGNIPPSLGNCKNLVSLNLSDNKLI 455 (997)
Q Consensus 428 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 455 (997)
|+|+...+..|.. .+|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCCcccChhhhcc-ccccccccCCCccc
Confidence 7777444444433 35777777777663
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.1e-08 Score=97.61 Aligned_cols=90 Identities=21% Similarity=0.278 Sum_probs=57.6
Q ss_pred ccccccccccceecccccccccc--ccccccCCcCccEEEccCccccccCChhccccCcCCeeeCccccccccCch----
Q 001908 484 PLEVGNLKNLVALYISGNQFSGE--IPVTLTGCTGLEIFHMQGNSFRGSIPLSLRSLKSIKELDLSCNNLSGQIPE---- 557 (997)
Q Consensus 484 p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---- 557 (997)
+..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+..+.....|+.|+|++|.++.....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 33344566777777777777643 234456677777777777777744443444555678888888888755442
Q ss_pred ---hccCCCCCCEEeCCCCcC
Q 001908 558 ---FLENLSFLEYLNLSYNHF 575 (997)
Q Consensus 558 ---~~~~l~~L~~L~ls~N~l 575 (997)
.+..+++|+.|| ++.+
T Consensus 138 ~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 138 ISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHTTSTTCCEET--TEEC
T ss_pred HHHHHHHCCCCCEEC--cCCC
Confidence 256778888775 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=2.7e-08 Score=94.96 Aligned_cols=104 Identities=20% Similarity=0.103 Sum_probs=61.5
Q ss_pred CCEEeccCCCCCCCCCCCcccccccceeccccccccccchhhhcCCCCCCeEEeecCcCCCCC--CCCCCCCCCCcEEec
Q 001908 372 LNLLGIEFNQLTGNIPREIGQLRNLQAIGLSSNFLQGNIPSSLGNLTLMTDLFLSSNHLQGNI--PPSLGNCKNLVSLNL 449 (997)
Q Consensus 372 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L 449 (997)
.+.|+++++... ..+..+..+..++..+|... .++..+.++++|++|+|++|+|+... +..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 445566554432 23445555666777666655 56666677888999999999888532 234556777888888
Q ss_pred CCCcccCCcccccccccccccccccCCCcccC
Q 001908 450 SDNKLIGAVPQQILTITTLSRFLDLGNNHLNG 481 (997)
Q Consensus 450 ~~N~l~~~~p~~~~~l~~ll~~L~Ls~N~l~~ 481 (997)
++|+++..-+-.+.....+ +.|++++|.++.
T Consensus 99 s~N~i~~l~~l~~l~~~~L-~~L~L~~Npl~~ 129 (162)
T d1koha1 99 SGNELKSERELDKIKGLKL-EELWLDGNSLSD 129 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCC-SSCCCTTSTTSS
T ss_pred ccCccccchhhhhhhcccc-ceeecCCCCcCc
Confidence 8887763222122223333 445555555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=1.1e-06 Score=90.90 Aligned_cols=149 Identities=17% Similarity=0.155 Sum_probs=101.6
Q ss_pred HHHHHHhhcCccCCcccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCc
Q 001908 672 SELSEATNEFSSSNMIGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDF 750 (997)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 750 (997)
.++....+.|+..+..+.++.+.||+... +++.++||+...........+.+|.+.++.+. +-.+.+++++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~---- 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER---- 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe----
Confidence 35556666777666655455578998865 56678899886554444456678888888774 434667776633
Q ss_pred CCCceEEEEEeeccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------
Q 001908 751 KGADFKALVYEYMQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHHHC----------------------- 807 (997)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~~~----------------------- 807 (997)
.++..++||++++|.++.+...... ....++.++++.+..||+..
T Consensus 81 -~~~~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 81 -HDGWSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp -ETTEEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred -cCCceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 3457899999999988866543211 12234555666666666421
Q ss_pred ---------------------------------CCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 808 ---------------------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 808 ---------------------------------~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1148999999999999987777899999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.41 E-value=0.00017 Score=73.32 Aligned_cols=130 Identities=17% Similarity=0.098 Sum_probs=80.8
Q ss_pred cccccCc-ceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcC--CCCcceEEeeeeccCcCCCceEEEEEee
Q 001908 686 MIGQGSF-GSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTR--HRNLIKIITVCSSIDFKGADFKALVYEY 762 (997)
Q Consensus 686 ~lg~G~~-g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~ 762 (997)
.+..|.. +.||+.... ++..+++|....... ..+..|++.++.+. .-.+.++++++. +++..++||||
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEe
Confidence 3445554 578998875 666788998754432 34567888887764 233566676633 34578999999
Q ss_pred ccCCCHHHHhhcCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 001908 763 MQNGSLEEWLHQSNGQPEVCDLSLIQRLNIAIDMASAIEYLHH------------------------------------- 805 (997)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~L~yLH~------------------------------------- 805 (997)
++|.++.+.- ... ...+.++.+.+.-||+
T Consensus 88 i~G~~~~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 88 VPGQDLLSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp CSSEETTTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred eecccccccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 9876542200 000 1112223333333332
Q ss_pred --------------CC----CCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 806 --------------HC----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 806 --------------~~----~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
.. .+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 1248999999999999987778899999774
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.31 E-value=1.8e-05 Score=75.07 Aligned_cols=18 Identities=33% Similarity=0.464 Sum_probs=7.9
Q ss_pred hccCCCCcEEEeecCccC
Q 001908 317 LTNCSKLKVLAFEENRLG 334 (997)
Q Consensus 317 l~~l~~L~~L~L~~N~l~ 334 (997)
+...+.|++|+|++|.++
T Consensus 68 L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 68 IETSPSLRVLNVESNFLT 85 (167)
T ss_dssp HHHCSSCCEEECCSSBCC
T ss_pred hhhcccccceeeehhhcc
Confidence 333444444444444443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.22 E-value=0.00023 Score=77.31 Aligned_cols=77 Identities=14% Similarity=0.120 Sum_probs=49.2
Q ss_pred CCcccccCcceEEEEEECCCCcEEEEEEeccc----c---hhhHHHHHHHHHHHhhcC-C--CCcceEEeeeeccCcCCC
Q 001908 684 SNMIGQGSFGSVYKGILGENGTFVAVKILNLM----Q---KGALKSFVAECEVLRNTR-H--RNLIKIITVCSSIDFKGA 753 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vAvK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~ 753 (997)
.+.||.|....||++....+++.|+||.-... . +....+...|++.++.+. + ..+++++.+. +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 35689999999999998777888999975421 1 112334567888887763 2 3466676652 2
Q ss_pred ceEEEEEeeccCCC
Q 001908 754 DFKALVYEYMQNGS 767 (997)
Q Consensus 754 ~~~~lv~e~~~~gs 767 (997)
+..++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 34578999997643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.22 E-value=6.7e-05 Score=70.98 Aligned_cols=16 Identities=19% Similarity=0.227 Sum_probs=8.1
Q ss_pred hccCCCCCCEEeCCCC
Q 001908 558 FLENLSFLEYLNLSYN 573 (997)
Q Consensus 558 ~~~~l~~L~~L~ls~N 573 (997)
.+..-+.|+.|+++.+
T Consensus 126 ~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 126 AIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHCSSCCEEECCCC
T ss_pred HHHhCCCccEeeCcCC
Confidence 3344455555555544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.37 E-value=0.00017 Score=68.12 Aligned_cols=19 Identities=16% Similarity=0.170 Sum_probs=9.4
Q ss_pred hhccCCCCcEEEeecCccC
Q 001908 316 ILTNCSKLKVLAFEENRLG 334 (997)
Q Consensus 316 ~l~~l~~L~~L~L~~N~l~ 334 (997)
.+...++|++|+|++|.++
T Consensus 41 al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HHTTCCSCCEEECTTSCCC
T ss_pred HHhcCCccCeeeccCCccc
Confidence 3344455555555555444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.92 E-value=0.012 Score=61.43 Aligned_cols=73 Identities=10% Similarity=0.022 Sum_probs=45.2
Q ss_pred cceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC--cceEEeeeeccCcCCCceEEEEEeeccCC
Q 001908 692 FGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN--LIKIITVCSSIDFKGADFKALVYEYMQNG 766 (997)
Q Consensus 692 ~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g 766 (997)
--.||+++.. +|+.|++|+.+.... ..+.+..|.+.+..+.... ++..+.......+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3589999885 788899999864321 2356777888888774322 22222221111123355688899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.91 E-value=0.00048 Score=64.78 Aligned_cols=116 Identities=14% Similarity=0.182 Sum_probs=59.5
Q ss_pred CCCccceeeccC-CCCCCCCCcccc---ccCCCccEEEecCCcCcCC----CCCCCCCCCCCcEEeccCccCCCcc----
Q 001908 216 NMSSLENILLDV-NGFTGNLPLDIG---VTLPNLQVFAIGDNYFSGS----IPESFSNASNIEIIDLPINYFTGKV---- 283 (997)
Q Consensus 216 ~l~~L~~L~L~~-N~l~g~lp~~~~---~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~---- 283 (997)
+.++|++|+|++ +.++...=..++ ...++|++|+|++|.++.. +-..+...++++.+++++|.++...
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 456677777765 344311000011 1355666666666666432 2233455566777777777665432
Q ss_pred cccccccCccCeeEc--cCccCCCCCCCCcchhhhhccCCCCcEEEeecCcc
Q 001908 284 SIIFGRLKNLWSLDL--GINNLGSGGANDLDFVTILTNCSKLKVLAFEENRL 333 (997)
Q Consensus 284 ~~~~~~l~~L~~L~L--s~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 333 (997)
...+...++|+.++| ++|.+...+. ..+.+.+...++|+.|+++.+..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~--~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVE--MEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHH--HHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHH--HHHHHHHHhCCCcCEEeCcCCCC
Confidence 234455566665444 3455543211 12344555667777777665543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.67 E-value=0.012 Score=63.27 Aligned_cols=73 Identities=16% Similarity=0.131 Sum_probs=49.2
Q ss_pred CCcccccCcceEEEEEECC-------CCcEEEEEEecccchhhHHHHHHHHHHHhhcC-CCCcceEEeeeeccCcCCCce
Q 001908 684 SNMIGQGSFGSVYKGILGE-------NGTFVAVKILNLMQKGALKSFVAECEVLRNTR-HRNLIKIITVCSSIDFKGADF 755 (997)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 755 (997)
.+.|+.|-.-.+|++.... ..+.|.+++... .. ......+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 4578888889999998752 345677777652 22 2345568899988884 444457777642
Q ss_pred EEEEEeeccCCC
Q 001908 756 KALVYEYMQNGS 767 (997)
Q Consensus 756 ~~lv~e~~~~gs 767 (997)
-.+|+||++|.+
T Consensus 116 ~g~I~efi~g~~ 127 (395)
T d1nw1a_ 116 GGRLEEYIPSRP 127 (395)
T ss_dssp TEEEECCCCEEE
T ss_pred CceEEEEecccc
Confidence 267899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.32 E-value=0.056 Score=55.76 Aligned_cols=165 Identities=12% Similarity=0.039 Sum_probs=81.7
Q ss_pred ChHHHHHHhhcCccCCc-----ccccCcceEEEEEECCCCcEEEEEEecccchhhHHHHHHHHHHHhhcCCCC--cceEE
Q 001908 670 SYSELSEATNEFSSSNM-----IGQGSFGSVYKGILGENGTFVAVKILNLMQKGALKSFVAECEVLRNTRHRN--LIKII 742 (997)
Q Consensus 670 ~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 742 (997)
+.+++.....+|...+. |..|---+.|+.+.. + ..+++|++.... ..+.+..|++++..+...+ +...+
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~-g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-S-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-C-CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 45677777788876543 345556789998874 3 458999986432 1234455677777764222 22221
Q ss_pred eeeecc-CcCCCceEEEEEeeccCCCHH--------------HHhhcCC---CCCCcCCCCH------------------
Q 001908 743 TVCSSI-DFKGADFKALVYEYMQNGSLE--------------EWLHQSN---GQPEVCDLSL------------------ 786 (997)
Q Consensus 743 ~~~~~~-~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~---~~~~~~~~~~------------------ 786 (997)
...... -.......+.++.+..+.... ..++... ..........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110000 001123455666666553211 1111000 0000000000
Q ss_pred HHHHHHHHHHHHHHHHHhh-CCCCCcEecCCCCCCeeeCCCCcEEEcccccch
Q 001908 787 IQRLNIAIDMASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAR 838 (997)
Q Consensus 787 ~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFg~a~ 838 (997)
......+..+...+.-.+. ....+++|+|+.+.||+++.+...-|.||+.|.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222222 123389999999999999998888899999885
|